FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Berry, CC
   Curtis, ASG
   Oreffo, ROC
   Agheli, H
   Sutherland, DS
AF Berry, C. C.
   Curtis, A. S. G.
   Oreffo, R. O. C.
   Agheli, H.
   Sutherland, D. S.
TI Human fibroblast and human bone marrow cell response to lithographically
   nanopatterned adhesive domains on protein rejecting substrates
SO IEEE TRANSACTIONS ON NANOBIOSCIENCE
LA English
DT Article
DE colloidal lithography; fibroblast; HBMSC; nanotopography; PLL-PEG;
   protein nanopatterns
ID MESENCHYMAL STEM-CELLS; MULTIPLE GROOVED SUBSTRATA; COLLOIDAL
   LITHOGRAPHY; TOPOGRAPHICAL CONTROL; BIOLOGICAL APPLICATIONS; BIOMATERIAL
   SURFACES; GLYCOL) COPOLYMERS; IN-VITRO; NANOTOPOGRAPHY; BEHAVIOR
AB The separate influence of topographical and chemical cues on cell attachment and spreading are well documented; however, that of duel-cue substrates is less so. In this study graft copolymers that sterically stabilize biological surfaces were employed alongside nanotopographical features fabricated by colloidal lithography. This resulted in the production of a range of substrates whereby the effect of chemistry and or topography on both on human fibroblast and bone marrow cell adhesion and spreading could be observed. The current studies indicate an enhancement of cell response as a consequence of modifications in material topography, whereas the current selected chemical cues inhibited cell function. Critically, in combination, topography modulated the effects of chemical environment.
C1 Univ Glasgow, Inst Biomed & Life Sci, Ctr Cell Engn, Glasgow G12 8QQ, Lanark, Scotland.
   Univ Southampton, Bone & Joint Res Grp, Southampton SO16 6YD, Hants, England.
   Dept Appl Phys, S-41296 Gothenburg, Sweden.
RP Berry, CC (reprint author), Univ Glasgow, Inst Biomed & Life Sci, Ctr Cell Engn, Glasgow G12 8QQ, Lanark, Scotland.
EM Catherine.berry@bio.gla.ac.uk
RI Oreffo, Richard/A-4615-2011; Sutherland, Duncan/E-4385-2010
OI Oreffo, Richard/0000-0001-5995-6726; Sutherland,
   Duncan/0000-0002-5045-9915
FU Biotechnology and Biological Sciences Research Council [BB/D013682/1]
CR Agheli H, 2006, MAT SCI ENG C-BIO S, V26, P911, DOI 10.1016/j.msec.2005.09.105
   Agheli H, 2006, NANO LETT, V6, P1165, DOI 10.1021/nl060403i
   AGHELI H, UNPUB MAT SCI ENG
   Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014
   Baksh D, 2004, J CELL MOL MED, V8, P301, DOI 10.1111/j.1582-4934.2004.tb00320.x
   Baksh D, 2003, EXP HEMATOL, V31, P723, DOI 10.1016/S0301-472X(03)00106-1
   BANARP P, 2003, COLLOID SURF A, V214, P233
   Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180
   Britland S, 1996, EXP CELL RES, V228, P313, DOI 10.1006/excr.1996.0331
   Brunette D M, 1988, Int J Oral Maxillofac Implants, V3, P231
   Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1089, DOI 10.1002/jbm.820290909
   CLARK P, 1990, DEVELOPMENT, V108, P635
   CLARK P, 1991, J CELL SCI, V99, P73
   CLARK P, 1987, DEVELOPMENT, V99, P439
   Csucs G, 2003, BIOMATERIALS, V24, P1713, DOI 10.1016/S0142-9612(02)00568-9
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Curtis A, 2001, TRENDS BIOTECHNOL, V19, P97, DOI 10.1016/S0167-7799(00)01536-5
   Cyster LA, 2003, J BIOMED MATER RES A, V67A, P138, DOI 10.1002/jbm.a.10087
   Dalby MJ, 2002, TISSUE ENG, V8, P1099, DOI 10.1089/107632702320934191
   Dalby MJ, 2004, INT J BIOCHEM CELL B, V36, P2005, DOI 10.1016/j.biocel.2004.03.001
   Dalby MJ, 2004, EUR J CELL BIOL, V83, P159, DOI 10.1078/0171-9335-00369
   Dalby MJ, 2004, BIOMATERIALS, V25, P5415, DOI 10.1016/j.biomaterials.2003.12.049
   Dalby MJ, 2003, EXP CELL RES, V284, P274, DOI 10.1016/S0014-4827(02)00053-8
   denBraber ET, 1996, BIOMATERIALS, V17, P2037, DOI 10.1016/0142-9612(96)00032-4
   Denis FA, 2002, LANGMUIR, V18, P819, DOI 10.1021/la011011o
   Denis FA, 2002, NANO LETT, V2, P1419, DOI 10.1021/nl025750g
   FRANKS W, IN PRESS BIOSENS BIO
   GUSTAFSON T, 1961, EXP CELL RES, V24, P64, DOI 10.1016/0014-4827(61)90248-8
   Hanarp P, 2003, J PHYS CHEM B, V107, P5768, DOI 10.1021/jp027562k
   Hanarp P, 1999, NANOSTRUCT MATER, V12, P429, DOI 10.1016/S0965-9773(99)00151-8
   Harris LG, 2004, BIOMATERIALS, V25, P4135, DOI 10.1016/j.biomaterials.2003.11.033
   Ito Y, 1999, BIOMATERIALS, V20, P2333, DOI 10.1016/S0142-9612(99)00162-3
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   Kato M, 2004, BIOCHEMISTRY-US, V43, P2699, DOI 10.1021/bi0352670
   Matsuzaka K, 2000, CLIN ORAL IMPLAN RES, V11, P325, DOI 10.1034/j.1600-0501.2000.011004325.x
   Michel R, 2002, LANGMUIR, V18, P8580, DOI 10.1021/la0258244
   Mrksich M, 1996, ANNU REV BIOPH BIOM, V25, P55, DOI 10.1146/annurev.bb.25.060196.000415
   Oreffo ROC, 2005, STEM CELL REV, V1, P169, DOI 10.1385/SCR:1:2:169
   OREFFO RO, 1998, CLIN SCI, V95, P549
   Rajnicek AM, 1997, J CELL SCI, V110, P2905
   Rice JM, 2003, BIOMATERIALS, V24, P4799, DOI 10.1016/S0142-9612(03)00381-8
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   Sutherland DS, 2001, MACROMOL BIOSCI, V1, P270, DOI 10.1002/1616-5195(20010801)1:6<270::AID-MABI270>3.3.CO;2-V
   TEXTOR M, 2003, BIO IMPLANT INTERFAC, P241
   VandeVondele S, 2003, BIOTECHNOL BIOENG, V82, P784, DOI 10.1002/bit.10625
   VONRECUM AF, 1995, J BIOMAT SCI-POLYM E, V7, P181, DOI 10.1163/156856295X00698
   Wagner VE, 2004, BIOMATERIALS, V25, P2247, DOI 10.1016/j.biomaterials.2003.09.020
   Wang DJ, 2004, J BIOL CHEM, V279, P43725, DOI 10.1074/jbc.M407368200
   Wilkinson CDW, 2002, MAT SCI ENG C-BIO S, V19, P263, DOI 10.1016/S0928-4931(01)00396-4
   Winblade ND, 2002, J BIOMED MATER RES, V59, P618, DOI 10.1002/jbm.1273
   WOJCIAKSTOTHARD B, 1995, CELL BIOL INT, V19, P485, DOI 10.1006/cbir.1995.1092
   Wood W, 2002, INT J BIOCHEM CELL B, V34, P726, DOI 10.1016/S1357-2725(01)00172-8
NR 55
TC 16
Z9 16
U1 0
U2 9
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 1536-1241
J9 IEEE T NANOBIOSCI
JI IEEE Trans. Nanobiosci.
PD SEP
PY 2007
VL 6
IS 3
BP 201
EP 209
DI 10.1109/TNB.2007.903457
PG 9
WC Biochemical Research Methods; Nanoscience & Nanotechnology
SC Biochemistry & Molecular Biology; Science & Technology - Other Topics
GA 210KZ
UT WOS:000249456400001
PM 17926777
DA 2018-10-20
ER

PT J
AU Holman, WL
AF Holman, W. L.
TI Microbiology of infection in mechanical circulatory support
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Review
DE infection; ventricular assist device; total artificial heart; mechanical
   circulatory; support; Biofilm
ID ASSIST DEVICE INFECTIONS; PSEUDOMONAS-AERUGINOSA; BACTERIAL PERSISTENCE;
   BIOFILMS; PREVENTION; EXPERIENCE; TRANSPLANTATION; STAPHYLOCOCCI;
   STRATEGIES; TOLERANCE
AB The results of MCSS therapy for patients with severe heart failure are improving, and there are increasing numbers of implants as device therapy enters the era of permanent use (i.e., destination therapy). Device-related infection of implanted pumps and sepsis remain important risk factors for death, and once infections are established on biomaterial surfaces they usually persist despite prolonged antimicrobial therapy. This paper covers the topic of infection in mechanical circulatory support. Methods to prevent and manage infection are described. Recent information from the field of microbiology that is relevant to understanding device-related infection is reviewed, including the mechanisms for microbial adhesion to prosthetic surfaces, quorum sensing, and biofilm formation. Characteristics that are important to antimicrobial resistance of microbes dwelling in biofilms are described (e.g. responses to microenvironmental conditions that result in resistance to antibiotics). This information may lead to new therapies that further diminish rates of device infection, and allow complete eradication of infections when they occur
C1 Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA.
RP Holman, WL (reprint author), Room 719 ZRB,703 19th St S, Birmingham, AL 35294 USA.
EM wholman@uab.edu
CR Archer GL, 2001, SCIENCE, V291, P1915, DOI 10.1126/science.1059671
   Arciola CR, 2005, INT J ARTIF ORGANS, V28, P1119
   Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390
   Bjarnsholt T, 2005, MICROBIOL-SGM, V151, P373, DOI 10.1099/mic.0.27463-0
   Borriello G, 2004, ANTIMICROB AGENTS CH, V48, P2659, DOI 10.1128/AAC.48.7.2659-2664.2004
   Chinn R, 2005, ASAIO J, V51, P461, DOI 10.1097/01.mat.0000170620.65279.aa
   Copeland JG, 2004, NEW ENGL J MED, V351, P859, DOI 10.1056/NEJMoa040186
   Costantini Todd W, 2005, Surg Infect (Larchmt), V6, P409
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Costerton JW, 2005, INT J ARTIF ORGANS, V28, P1062
   DEE K, 2002, BIOMATERIALS TISSUE, P1
   Fleck TM, 2002, ANN THORAC SURG, V74, P1596, DOI 10.1016/S0003-4975(02)03948-6
   Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010
   Gordon SM, 2001, ANN THORAC SURG, V72, P725, DOI 10.1016/S0003-4975(01)02888-0
   Gotz F, 2004, CURR OPIN MICROBIOL, V7, P477, DOI 10.1016/j.mib.2004.08.014
   Holman WL, 1996, ANN THORAC SURG, V61, P366, DOI 10.1016/0003-4975(95)01021-1
   Holman WL, 2005, ASAIO J, V51, P452, DOI 10.1097/01.mat.0000169120.48527.87
   Holman WL, 2004, J HEART LUNG TRANSPL, V23, P1359, DOI 10.1016/j.healun.2003.09.025
   Holman WL, 2003, ANN THORAC SURG, V75, pS48, DOI 10.1016/S0003-4975(03)00479-X
   Horwitz LD, 2003, CARDIOVASC DRUG REV, V21, P77
   Hutchinson OZ, 2001, PLAST RECONSTR SURG, V107, P364, DOI 10.1097/00006534-200102000-00011
   Icenogle T, 2003, J HEART LUNG TRANSPL, V22, P818, DOI 10.1016/S1053-2498(02)00644-7
   Jones MB, 2005, J INFECT DIS, V191, P1881, DOI 10.1086/429696
   JOYCE LD, 1989, CIRCULATION, V80, P192
   Kussell E, 2005, GENETICS, V169, P1807, DOI 10.1534/genetics.2=104.035352
   Long James W, 2005, Congest Heart Fail, V11, P133, DOI 10.1111/j.1527-5299.2005.04540.x
   Lowy FD, 2004, AM HEART J, V147, P575, DOI 10.1016/j.ahj.2003.08.016
   McKellar SH, 1999, ANN THORAC SURG, V67, P554, DOI 10.1016/S0003-4975(98)01243-0
   Milano CA, 1999, ANN THORAC SURG, V67, P377, DOI 10.1016/S0003-4975(99)00022-3
   Norris P, 2005, ANTIMICROB AGENTS CH, V49, P4272, DOI 10.1128/AAC.49.10.4272-4279.2005
   Rani SA, 2005, ANTIMICROB AGENTS CH, V49, P728, DOI 10.1128/AAC.49.2.728-732.2005
   RANI SA, RAPID DIFFUSION FLOR
   Rivas JM, 2004, CURR OPIN DRUG DISC, V7, P223
   SHEN AC, 1972, AM J PATHOL, V67, P441
   Tjan TDT, 2000, ANN THORAC SURG, V70, P538, DOI 10.1016/S0003-4975(00)01348-5
   *US DEP HHS, 1985, ART HEART ASS DEV DI
   Wilhelm MJ, 2005, J THORAC CARDIOV SUR, V130, P1122, DOI 10.1016/j.jtcvs.2004.10.029
NR 37
TC 5
Z9 5
U1 0
U2 3
PU WICHTIG PUBLISHING
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
EI 1724-6040
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD SEP
PY 2007
VL 30
IS 9
BP 764
EP 770
PG 7
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 228LK
UT WOS:000250731200003
PM 17918120
DA 2018-10-20
ER

PT J
AU Baldassarri, L
   Montanaro, L
   Creti, R
   Arciola, CR
AF Baldassarri, L.
   Montanaro, L.
   Creti, R.
   Arciola, C. R.
TI Underestimated collateral effects of antibiotic therapy in
   prosthesis-associated bacterial infections
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Review
DE antibiotic therapy; virulence; biomaterial-associated infections
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; IMPLANT ORTHOPEDIC INFECTIONS;
   PNEUMONIAE BIOFILM RESISTANCE; FIBRONECTIN-BINDING PROTEINS;
   SUBINHIBITORY CONCENTRATIONS; PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI;
   PHENOTYPIC VARIATION; NUTRIENT LIMITATION; SLIME PRODUCTION
AB Antibiotic treatment of infections associated with the use of indwelling medical devices in ageing and/or severely ill patients represents a significant healthcare problem due to the difficulty of treating such infections and to the various collateral effects that may be observed following the often aggressive therapy. We summarize some effects of antibiotics on the expression of virulence factors of the microorganisms which cause such infections. These effects, particularly those resulting in a stimulation of bacterial virulence, might be usefully included among the other well-known collateral effects of antibiotic therapy.
C1 Natl Inst Hlth, Dept Infect Parasit & Immunomed Dis, Rome, Italy.
   Rizzoli Orthoped Inst, Res Unit Implant Infect, Bologna, Italy.
   Univ Bologna, Dept Expt Pathol, Bologna, Italy.
RP Baldassarri, L (reprint author), Ist Super Sanita, Dipartimento Malattie Infett Parassiatarie Immuno, Viale Regina Elena 299, I-00161 Rome, Italy.
EM baldassa@iss.it
RI Baldassarri, Lucilla/B-1042-2013; Creti, Roberta/C-8813-2016
OI Creti, Roberta/0000-0003-4290-9039
CR Al-Fattani MA, 2004, ANTIMICROB AGENTS CH, V48, P3291, DOI 10.1128/AAC.48.9.3291-3297.2004
   Anderl JN, 2003, ANTIMICROB AGENTS CH, V47, P1251, DOI 10.1128/AAC.47.4.1251-1256.2003
   Anderl JN, 2000, ANTIMICROB AGENTS CH, V44, P1818, DOI 10.1128/AAC.44.7.1818-1824.2000
   Arciola CR, 2005, INT J ARTIF ORGANS, V28, P1091
   Azizoglu RO, 2007, J FOOD PROTECT, V70, P194, DOI 10.4315/0362-028X-70.1.194
   Baldassarri L, 2005, INT J ARTIF ORGANS, V28, P1101
   Baldassarri L, 2001, MED MICROBIOL IMMUN, V190, P113, DOI 10.1007/s00430-001-0096-8
   Baldassarri L, 2006, J CLIN MICROBIOL, V44, P2721, DOI 10.1128/JCM.00512-06
   Barbosa TM, 2000, J BACTERIOL, V182, P3467, DOI 10.1128/JB.182.12.3467-3474.2000
   BIGGER JW, 1944, IRISH J MED SCI, V227, P533
   Bisognano C, 1997, ANTIMICROB AGENTS CH, V41, P906, DOI 10.1128/AAC.41.5.906
   Bisognano C, 2000, ANTIMICROB AGENTS CH, V44, P1428, DOI 10.1128/AAC.44.6.1428-1437.2000
   Borriello G, 2004, ANTIMICROB AGENTS CH, V48, P2659, DOI 10.1128/AAC.48.7.2659-2664.2004
   BRAGA PC, 1994, CHEMOTHERAPY, V40, P304, DOI 10.1159/000239211
   BRAGA PC, 1993, EXPER CHEMOTHER, V39, P4324
   BUTCHER WG, 1994, CHEMOTHERAPY, V40, P114, DOI 10.1159/000239182
   Campoccia D, 2005, INT J ARTIF ORGANS, V28, P1186
   Cerca N, 2005, RES MICROBIOL, V156, P650, DOI 10.1016/j.resmic.2005.02.004
   Chisari G, 2002, J CHEMOTHERAPY, V14, P574, DOI 10.1179/joc.2002.14.6.574
   CHRISTENSEN GD, 1983, INFECT IMMUN, V40, P407
   CHRISTENSEN GD, 1987, INFECT IMMUN, V55, P2870
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Costerton JW, 2005, INT J ARTIF ORGANS, V28, P1062
   Craig WA, 1998, CLIN INFECT DIS, V26, P1, DOI 10.1086/516284
   DESNOTTES JF, 1990, J ANTIMICROB CHEMOTH, V26, P17, DOI 10.1093/jac/26.suppl_B.17
   Di Rosa Roberta, 1999, Microbial Ecology in Health and Disease, V11, P84
   Donelli G, 2004, J CLIN MICROBIOL, V42, P3419, DOI 10.1128/JCM.42.8.3419.3427.2004
   Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a
   DUNNE WM, 1990, ANTIMICROB AGENTS CH, V34, P390, DOI 10.1128/AAC.34.3.390
   EAGLE H, 1949, J BACTERIOL, V58, P475
   El-Azizi Mohamed, 2005, Ann Clin Microbiol Antimicrob, V4, P2, DOI 10.1186/1476-0711-4-2
   Fabretti F, 2005, INT J ARTIF ORGANS, V28, P1079
   Ferrara A, 2001, INT J ANTIMICROB AG, V17, P401, DOI 10.1016/S0924-8579(00)00346-0
   GRIMWOOD K, 1989, J ANTIMICROB CHEMOTH, V24, P937, DOI 10.1093/jac/24.6.937
   GRISTINA AG, 1993, INT J ARTIF ORGANS, V16, P755
   HACHLER H, 1991, J BACTERIOL, V173, P5532
   Henriques M, 2005, INT J ARTIF ORGANS, V28, P1181
   KERNODLE DS, 1995, J INFECT DIS, V172, P410, DOI 10.1093/infdis/172.2.410
   Konig C, 2001, EUR J CLIN MICROBIOL, V20, P20
   Mah TF, 2003, NATURE, V426, P306, DOI 10.1038/nature02122
   MARTINEZ JL, 1994, EUR J CLIN MICROBIOL, V13, P1015, DOI 10.1007/BF02111820
   MCDONALD PJ, 1977, J INFECT DIS, V135, P217, DOI 10.1093/infdis/135.2.217
   OBST U, 2005, INT J ARTIF ORGANS, V29, P387
   Odenholt I, 2001, INT J ANTIMICROB AG, V17, P1, DOI 10.1016/S0924-8579(00)00243-0
   ODENHOLTTORNQVIST I, 1992, ANTIMICROB AGENTS CH, V36, P1852, DOI 10.1128/AAC.36.9.1852
   Pagano PJ, 2004, INT J ANTIMICROB AG, V23, P226, DOI 10.1016/j.ijantimicag.2003.07.012
   PARKER RF, 1948, J BACTERIOL, V56, P75
   PROCTOR RA, 1983, J ANTIMICROB CHEMOTH, V12, P85, DOI 10.1093/jac/12.suppl_C.85
   PROCTOR RA, 1983, ANTIMICROB AGENTS CH, V24, P823, DOI 10.1128/AAC.24.5.823
   Rachid S, 2000, ANTIMICROB AGENTS CH, V44, P3357, DOI 10.1128/AAC.44.12.3357-3363.2000
   Roberts ME, 2004, ANTIMICROB AGENTS CH, V48, P48, DOI 10.1128/AAC.48.1.48-52.2004
   SCHIFFERLI DM, 1988, ANTIMICROB AGENTS CH, V32, P1603, DOI 10.1128/AAC.32.11.1603
   SHIBL AM, 1987, REV INFECT DIS, V9, P704
   Sofer D, 1999, CHEMOTHERAPY, V45, P335, DOI 10.1159/000007224
   SONSTEIN SA, 1993, DIAGN MICR INFEC DIS, V16, P277, DOI 10.1016/0732-8893(93)90078-L
   WEBER DJ, 2006, INT J INFECT DIS S2, V10, P17
   Whiteley M, 2001, NATURE, V413, P860, DOI 10.1038/35101627
   Zheng ZL, 2002, ANTIMICROB AGENTS CH, V46, P900, DOI 10.1128/AAC.46.3.900-903.2002
NR 58
TC 4
Z9 4
U1 0
U2 2
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD SEP
PY 2007
VL 30
IS 9
BP 786
EP 791
PG 6
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 228LK
UT WOS:000250731200006
PM 17918123
DA 2018-10-20
ER

PT J
AU Arciola, CR
   Baldassarri, L
   Von Eiff, C
   Campoccia, D
   Ravaioli, S
   Pirini, V
   Becker, K
   Montanaro, L
AF Arciola, C. R.
   Baldassarri, L.
   Von Eiff, C.
   Campoccia, D.
   Ravaioli, S.
   Pirini, V.
   Becker, K.
   Montanaro, L.
TI Prevalence of genes encoding for staphylococcal leukocidal toxins among
   clinical isolates of Staphylococcus aureus from implant orthopedic
   infections
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE staphylococcus aureus; leukocidal toxins; implant infections
ID PANTON-VALENTINE LEUKOCIDIN; STRAINS; LEUCOTOXINS; PNEUMONIA; VIRULENCE;
   ALLELES
AB Staphylococcus aureus has emerged as a major cause of implant infections. It is known that it is able to produce several toxins that contribute to its armory of virulent weapons, but there are still no data on their prevalence among isolates recovered from biomaterial-centered infections. In this study, 200 Staphylococcus aureus isolates from infections related to different types of orthopedic implants (hip and knee arthroprostheses, internal and external fixation devices) were tested by polymerase chain reaction for the prevalence of genes encoding for leukotoxins. Although almost all isolates were positive for the gamma-hemolysin gene (99%), none was positive for lukM. The leukotoxin genes lukE/lukD were found in 67% of isolates. The presence of lukE/lukD was significantly associated with that of Accessory Gene Regulatory locus agr II. The lukE/lukD-positive isolates were significantly more prevalent in the staphylococcal isolates from knee arthroprostheses than in the isolates from the other implant types. The genes encoding Panton-Valentine leukocidin components were detected in only one isolate that, curiously enough, was taken solely from a knee arthroprosthesis infection.
C1 Inst Orthoped Rizzoli, Res Unit Implant Infect, I-40136 Bologna, Italy.
   Univ Bologna, Dept Expt Pathol, Bologna, Italy.
   Ist Super Sanita, Dipartimento Malattie Infett Parassitarie & Immun, I-00161 Rome, Italy.
   Univ Munster, Inst Med Microbiol, D-4400 Munster, Germany.
RP Arciola, CR (reprint author), Inst Orthoped Rizzoli, Res Unit Implant Infect, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM carlarenata.arciola@ior.it
RI Campoccia, Davide/K-5348-2018; Becker, Karsten/O-2302-2018; Baldassarri,
   Lucilla/B-1042-2013
OI Campoccia, Davide/0000-0002-3336-0219; Becker,
   Karsten/0000-0002-6391-1341; 
CR Arciola CR, 2005, INT J ARTIF ORGANS, V28, P1091
   Arciola CR, 2001, J CLIN MICROBIOL, V39, P2151, DOI 10.1128/JCM.39.6.2151-2156.2001
   Campoccia D, 2006, INT J ARTIF ORGANS, V29, P421
   Chini V, 2006, J CLIN MICROBIOL, V44, P1881, DOI 10.1128/JCM.44.5.1881-1883.2006
   Costerton JW, 2005, INT J ARTIF ORGANS, V28, P1062
   COUPPIE P, 1994, ARCH DERMATOL, V130, P1208, DOI 10.1001/archderm.130.9.1208
   Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7
   Gravet A, 1998, FEBS LETT, V436, P202, DOI 10.1016/S0014-5793(98)01130-2
   Jarraud S, 2000, J BACTERIOL, V182, P6517, DOI 10.1128/JB.182.22.6517-6522.2000
   Jarraud S, 2002, INFECT IMMUN, V70, P631, DOI 10.1128/IAI.70.2.631-641.2002
   KONIG B, 1995, J INFECT DIS, V171, P607, DOI 10.1093/infdis/171.3.607
   Lina G, 2003, APPL ENVIRON MICROB, V69, P18, DOI 10.1128/AEM.69.1.18-23.2003
   Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461
   Montanaro L, 2006, INT J ARTIF ORGANS, V29, P462
   Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x
   Peacock SJ, 2002, INFECT IMMUN, V70, P4987, DOI 10.1128/IAI.70.9.4987-4996.2002
   PREVOST G, 1995, J MED MICROBIOL, V42, P237, DOI 10.1099/00222615-42-4-237
   Prevost G, 2001, CURR TOP MICROBIOL, V257, P53
   PREVOST G, 1995, INFECT IMMUN, V63, P4121
   Siqueira JA, 1997, J MED MICROBIOL, V46, P486, DOI 10.1099/00222615-46-6-486
   Vadyvaloo V, 2005, INT J ARTIF ORGANS, V28, P1069
   von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102
   VONEIFF C, 2004, DIAGN MICROBIOL INFE, V49, P147
   Vuong C, 2000, J INFECT DIS, V182, P1688, DOI 10.1086/317606
NR 24
TC 12
Z9 12
U1 0
U2 2
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD SEP
PY 2007
VL 30
IS 9
BP 792
EP 797
PG 6
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 228LK
UT WOS:000250731200007
PM 17918124
DA 2018-10-20
ER

PT J
AU Qiu, Y
   Zhang, N
   An, YH
   Wen, X
AF Qiu, Y.
   Zhang, N.
   An, Y. H.
   Wen, X.
TI Biomaterial strategies to reduce implant-associated infections
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Review
DE implant-associated infections; biomaterials; surface modification
ID CENTRAL VENOUS CATHETERS; STAPHYLOCOCCUS-EPIDERMIDIS ADHESION;
   RNAIII-INHIBITING PEPTIDE; POLYMETHYLMETHACRYLATE BONE CEMENTS;
   ANTIBIOTIC-RELEASING POLYMERS; POLY(ETHYLENE OXIDE) BRUSHES;
   SILVER-SULFADIAZINE; BACTERIAL ADHESION; IN-VITRO; SILICONE-RUBBER
AB Although the prophylaxis in controlling sterility within the operating room environment has been greatly improved, implant-associated infection is still one of the most serious complications in implant surgeries due to the existence of immune depression in the peri-implant area. The antibacterial ability of materials themselves logically becomes an important factor in preventing implant-associated infections. With the understanding of the pathogenesis of implant-associated infections, many approaches have been developed through providing an anti-adhesive surface, delivering antibacterial agents to disrupt cell-cell communication and preventing bacteria aggregation or biofilm formation, or killing bacteria directly (lysing the cell membrane). In this article, we review the current strategies in improving the antibacterial ability of materials to prevent implant infection and further present promising tactics in materials design and applications.
C1 Clemson Univ, Clemson MUSC Bioengn Program, Charleston, SC 29425 USA.
   Med Univ S Carolina, Dept Cell Biol & Anat, Charleston, SC 29425 USA.
   Med Univ S Carolina, Dept Orthoped Surg, Charleston, SC 29425 USA.
RP Wen, X (reprint author), Clemson Univ, Clemson MUSC Bioengn Program, 173 Ashley Ave,CRI 610, Charleston, SC 29425 USA.
EM xjwen@clemson.edu
CR AbuElAsrar AM, 1997, INT OPHTHALMOL, V21, P71, DOI 10.1023/A:1005835013581
   An YH, 1996, J ORTHOPAED RES, V14, P846, DOI 10.1002/jor.1100140526
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   An YH, 2000, HDB BACTERIAL ADHESI, P609
   Andersson J, 2006, J BIOMED MATER RES A, V76A, P25, DOI 10.1002/jbm.a.30377
   ANWAR H, 1992, ANTIMICROB AGENTS CH, V36, P1347, DOI 10.1128/AAC.36.7.1347
   Atiyeh BS, 2007, BURNS, V33, P139, DOI 10.1016/j.burns.2006.06.010
   Balaban N, 2004, ANTIMICROB AGENTS CH, V48, P2544, DOI 10.1128/AAC.487.2544-2550.2004
   Balaban N, 2003, J INFECT DIS, V187, P625, DOI 10.1086/345879
   Balogh L, 2001, NANO LETT, V1, P18, DOI 10.1021/nl005502p
   Barton AJ, 1996, J BIOMED MATER RES, V30, P403, DOI 10.1002/(SICI)1097-4636(199603)30:3<403::AID-JBM15>3.0.CO;2-K
   Bassetti S, 2001, ANTIMICROB AGENTS CH, V45, P1535, DOI 10.1128/AAC.45.5.1535-1538.2001
   BERTRAND JC, 1994, RES MICROBIOL, V145, P53, DOI 10.1016/0923-2508(94)90070-1
   Borkow G, 2005, CURR MED CHEM, V12, P2163, DOI 10.2174/0929867054637617
   Borkow G, 2004, FASEB J, V18, P1728, DOI 10.1096/fj.04-2029fje
   Boulmedais F, 2004, BIOMATERIALS, V25, P2003, DOI 10.1016/j.biomaterials.2003.08.039
   Brokke P, 1991, J Biomater Appl, V5, P204, DOI 10.1177/088532829100500305
   Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044
   Chen H, 2005, J BIOMAT SCI-POLYM E, V16, P531, DOI 10.1163/1568562053700183
   CHISELLI R, 2006, SHOCK, V26, P296
   Cho Se-Hyun, 1997, Bulletin Hospital for Joint Diseases, V56, P140
   Choi YS, 2001, J MATER SCI-MATER M, V12, P67, DOI 10.1023/A:1026765321117
   Cirioni O, 2006, PEPTIDES, V27, P1210, DOI 10.1016/j.peptides.2005.10.007
   Cirioni O, 2006, PEPTIDES, V27, P2104, DOI 10.1016/j.peptides.2006.03.007
   Cordero J, 1996, J ORTHOPAED RES, V14, P663, DOI 10.1002/jor.1100140423
   Crabtree JH, 2003, PERITON DIALYSIS INT, V23, P368
   Del Curto B, 2005, INT J ARTIF ORGANS, V28, P718
   Dell'Acqua G, 2004, J INFECT DIS, V190, P318, DOI 10.1086/386546
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Dong BY, 2005, J APPL POLYM SCI, V97, P485, DOI 10.1002/app.21766
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002
   FLETCHER M, 1982, APPL ENVIRON MICROB, V44, P184
   FOX CL, 1967, MODERN TREATMENT, P1259
   Fu JH, 2005, BIOMATERIALS, V26, P6684, DOI 10.1016/j.biomaterials.2005.04.034
   Fuller Frederick W., 1994, Journal of Burn Care and Rehabilitation, V15, P213, DOI 10.1097/00004630-199405000-00003
   GAMELLI RL, 1993, SURG GYNECOL OBSTET, V177, P115
   Gan BS, 2002, J INFECT DIS, V185, P1369, DOI 10.1086/340126
   Garvin K, 2005, CLIN ORTHOP RELAT R, P105, DOI 10.1097/01.blo.0000175720.99118.fe
   George N, 1997, BURNS, V23, P493, DOI 10.1016/S0305-4179(97)00047-8
   GERHART TN, 1993, J ORTHOPAED RES, V11, P250, DOI 10.1002/jor.1100110212
   Gov Y, 2001, PEPTIDES, V22, P1609, DOI 10.1016/S0196-9781(01)00496-X
   Grainger DW, 2004, EXPERT OPIN BIOL TH, V4, P1029, DOI 10.1517/14712598.4.7.1029
   GRECO RS, 1982, ANN SURG, V195, P168, DOI 10.1097/00000658-198202000-00008
   Groll J, 2005, J BIOMED MATER RES A, V74A, P607, DOI 10.1002/jbm.a.30335
   Haldar J, 2006, P NATL ACAD SCI USA, V103, P17667, DOI 10.1073/pnas.0608803103
   Harris LG, 2004, BIOMATERIALS, V25, P4135, DOI 10.1016/j.biomaterials.2003.11.033
   Haugan T, 2007, CONTRACEPTION, V75, P171, DOI 10.1016/j.contraception.2006.09.005
   Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b
   HOFFMAN J, 1983, CARBOHYD RES, V117, P328, DOI 10.1016/0008-6215(83)88103-8
   HOFFMANN S, 1984, SCAND J PLAST RECONS, V18, P119, DOI 10.3109/02844318409057413
   JAGPAL R, 1979, AM SURGEON, V45, P774
   Jou CH, 2007, POLYM ADVAN TECHNOL, V18, P235, DOI 10.1002/pat.866
   Kalfon P, 2007, CRIT CARE MED, V35, P1032, DOI 10.1097/01.CCM.0000259378.53166.1B
   KAMAL GD, 1991, JAMA-J AM MED ASSOC, V265, P2364, DOI 10.1001/jama.265.18.2364
   KAMATH KR, 1994, J APPL BIOMATER, V5, P163, DOI 10.1002/jab.770050210
   Kaper HJ, 2003, J BIOMAT SCI-POLYM E, V14, P313, DOI 10.1163/156856203321478847
   Katanchalee MN, 2006, COLLOID SURFACE B, V49, P117, DOI 10.1016/j.colsurfb.2006.03.007
   Kawai K, 2001, J BIOMED MATER RES, V57, P346, DOI 10.1002/1097-4636(20011205)57:3<346::AID-JBM1177>3.0.CO;2-8
   Kim JH, 2003, J BIOMAT SCI-POLYM E, V14, P601, DOI 10.1163/15685620360674281
   Kingshott P, 2003, LANGMUIR, V19, P6912, DOI 10.1021/la034032m
   Kitamoto D, 2002, J BIOSCI BIOENG, V94, P187, DOI 10.1263/jbb.94.187
   Klasen HJ, 2000, BURNS, V26, P131, DOI 10.1016/S0305-4179(99)00116-3
   KOTTKEMARCHANT K, 1989, BIOMATERIALS, V10, P147, DOI 10.1016/0142-9612(89)90017-3
   Kurita K, 2006, MAR BIOTECHNOL, V8, P203, DOI 10.1007/s10126-005-0097-5
   Kwok CS, 1999, J CONTROL RELEASE, V62, P289, DOI 10.1016/S0168-3659(99)00106-6
   Kwok CS, 1999, J CONTROL RELEASE, V62, P301, DOI 10.1016/S0168-3659(99)00105-4
   LARM O, 1983, BIOMATER ARTIF CELL, V11, P161, DOI 10.3109/10731198309118804
   Lee ARC, 2003, ARCH PHARM RES, V26, P855, DOI 10.1007/BF02980032
   Lee HJ, 2000, COLLOID SURFACE B, V18, P355, DOI 10.1016/S0927-7765(99)00161-7
   Lee JE, 2002, ARTIF ORGANS, V26, P521, DOI 10.1046/j.1525-1594.2002.06890.x
   Lee JE, 2002, ARTIF ORGANS, V26, P636, DOI 10.1046/j.1525-1594.2002.06847.x
   Lee YM, 2000, J MATER SCI-MATER M, V11, P817, DOI 10.1023/A:1008961730929
   Lin J, 2003, BIOTECHNOL BIOENG, V83, P168, DOI 10.1002/bit.10651
   Lin J, 2002, BIOTECHNOL PROGR, V18, P1082, DOI 10.1021/bp025597w
   Liu SJ, 2007, INT J PHARM, V330, P45, DOI 10.1016/j.ijpharm.2006.08.036
   Liu XF, 2001, J APPL POLYM SCI, V79, P1324
   MCDOWELL SG, 1995, LETT APPL MICROBIOL, V21, P1, DOI 10.1111/j.1472-765X.1995.tb00992.x
   McLaren AC, 2004, CLIN ORTHOP RELAT R, P101, DOI 10.1097/01.blo.0000143554.56897.26
   Mi FL, 2002, J BIOMED MATER RES, V59, P438, DOI 10.1002/jbm.1260
   Milovic NM, 2005, BIOTECHNOL BIOENG, V90, P715, DOI 10.1002/bit.20454
   Morra M, 1999, J BIOMAT SCI-POLYM E, V10, P1107, DOI 10.1163/156856299X00711
   Nagelschmidt M, 1997, J SURG RES, V67, P113, DOI 10.1006/jsre.1996.4973
   Neut D, 2003, BIOMATERIALS, V24, P1829, DOI 10.1016/S0142-9612(02)00614-2
   Neut D, 2003, ACTA ORTHOP SCAND, V74, P670, DOI 10.1080/00016470310018180
   Nnebe IM, 2004, J COLLOID INTERF SCI, V276, P306, DOI 10.1016/j.jcis.2004.03.065
   Ohko Y, 2001, J BIOMED MATER RES, V58, P97, DOI 10.1002/1097-4636(2001)58:1<97::AID-JBM140>3.0.CO;2-8
   Ostendorf T, 2005, SUPPORT CARE CANCER, V13, P993, DOI 10.1007/s00520-005-0812-9
   Park D, 2006, BIOTECHNOL PROGR, V22, P584, DOI 10.1021/bp0503383
   Park JH, 2002, BIOMATERIALS, V23, P3991, DOI 10.1016/S0142-9612(02)00144-8
   Park KD, 1998, BIOMATERIALS, V19, P851, DOI 10.1016/S0142-9612(97)00245-7
   PASCUAL A, 1986, EUR J CLIN MICROBIOL, V5, P518, DOI 10.1007/BF02017694
   Pavesio A, 1997, Med Device Technol, V8, P20
   Pavesio A, 1997, MED DEVICE TECHNOL, V8, P24
   Piozzi A, 2004, J CHEMOTHERAPY, V16, P446, DOI 10.1179/joc.2004.16.5.446
   Piozzi A, 2004, INT J PHARM, V280, P173, DOI 10.1016/j.ijpharm.2004.05.017
   Price JS, 1996, J BIOMED MATER RES, V30, P281, DOI 10.1002/(SICI)1097-4636(199603)30:3<281::AID-JBM2>3.0.CO;2-M
   Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m
   Ramstedt M, 2007, LANGMUIR, V23, P3314, DOI 10.1021/la062670+
   REID G, 1994, J IND MICROBIOL, V13, P90, DOI 10.1007/BF01584104
   REYNOLDS EC, 1983, INFECT IMMUN, V39, P1285
   Rodrigues L, 2006, J ANTIMICROB CHEMOTH, V57, P609, DOI 10.1093/jac/dkl024
   Rodrigues L, 2006, FEMS IMMUNOL MED MIC, V46, P107, DOI 10.1111/j.1574-695X.2005.00006.x
   Rodrigues L, 2004, APPL MICROBIOL BIOT, V66, P306, DOI 10.1007/s00253-004-1674-7
   Rodrigues LR, 2006, J APPL MICROBIOL, V100, P470, DOI 10.1111/j.1365-2672.2005.02826.x
   Rojas IA, 2000, J CONTROL RELEASE, V63, P175, DOI 10.1016/S0168-3659(99)00195-9
   Roosjen A, 2004, LANGMUIR, V20, P10949, DOI 10.1021/la0484691
   Rupp ME, 2004, AM J INFECT CONTROL, V32, P445, DOI 10.1016/j.ajic.2004.05.002
   SANDERSON PJ, 1991, J HOSP INFECT, V18, P367, DOI 10.1016/0195-6701(91)90043-8
   Sawada H, 1997, J FLUORINE CHEM, V84, P141, DOI 10.1016/S0022-1139(97)00050-X
   Schierholz JM, 1997, BIOMATERIALS, V18, P839, DOI 10.1016/S0142-9612(96)00199-8
   Schierholz JM, 1998, J HOSP INFECT, V40, P257, DOI 10.1016/S0195-6701(98)90301-2
   Schiffer CA, 2001, CURR OPIN ONCOL, V13, P1, DOI 10.1097/00001622-200101000-00001
   Schmitt SK, 1996, J CLIN MICROBIOL, V34, P508
   Schnieders J, 2006, BIOMATERIALS, V27, P4239, DOI 10.1016/j.biomaterials.2006.03.032
   Shah A, 2004, ANTIMICROB AGENTS CH, V48, P2704, DOI 10.1128/AAC.48.7.2704-2707.2004
   Shanmugasundaram N, 2006, J BIOMED MATER RES B, V77B, P378, DOI 10.1002/jbm.b.30405
   Shi ZL, 2006, BIOMATERIALS, V27, P2440, DOI 10.1016/j.biomaterials.2005.11.036
   Silver S, 2003, FEMS MICROBIOL REV, V27, P341, DOI 10.1016/S0168-6445(03)00047-0
   Sofia SJ, 1998, MACROMOLECULES, V31, P5059, DOI 10.1021/ma971016l
   Spinnato JA, 1997, AM J OBSTET GYNECOL, V176, P503, DOI 10.1016/S0002-9378(97)70537-4
   Stigter M, 2004, J CONTROL RELEASE, V99, P127, DOI 10.1016/j.jconrel.2004.06.011
   STRACHAN CJL, 1995, J HOSP INFECT, V30, P54, DOI 10.1016/0195-6701(95)90006-3
   Suzuki A, 2006, J ORTHOP RES, V24, P327, DOI 10.1002/jor.20049
   Tang HY, 2007, J BIOMED MATER RES A, V80A, P885, DOI 10.1002/jbm.a.30952
   Tashiro T, 2001, MACROMOL MATER ENG, V286, P63
   Tiller JC, 2002, BIOTECHNOL BIOENG, V79, P465, DOI 10.1002/bit.10299
   Tiller JC, 2001, P NATL ACAD SCI USA, V98, P5981, DOI 10.1073/pnas.111143098
   Tobin EJ, 2003, THER APHER DIAL, V7, P504, DOI 10.1046/j.1526-0968.2003.00097.x
   TOKURA S, 1994, J CONTROL RELEASE, V28, P235
   TSENG YC, 1993, BIOMATERIALS, V14, P392, DOI 10.1016/0142-9612(93)90060-F
   Turner MS, 2007, SYST APPL MICROBIOL, V30, P58, DOI 10.1016/j.syapm.2006.01.013
   Ueng SWN, 2007, J ORTHOP RES, V25, P62, DOI 10.1002/jor.20286
   Vacheethasanee K, 2000, J BIOMED MATER RES, V50, P302, DOI 10.1002/(SICI)1097-4636(20000605)50:3<302::AID-JBM3>3.0.CO;2-1
   van de Belt H, 2000, ACTA ORTHOP SCAND, V71, P625, DOI 10.1080/000164700317362280
   Velraeds MMC, 2000, WORLD J UROL, V18, P422, DOI 10.1007/PL00007084
   Velraeds MMC, 1997, UROLOGY, V49, P790, DOI 10.1016/S0090-4295(97)00065-4
   Vinh Donald C, 2005, J Long Term Eff Med Implants, V15, P467, DOI 10.1615/JLongTermEffMedImplants.v15.i5.20
   WAHLIG H, 1978, J BONE JOINT SURG BR, V60, P270
   Walker CB, 2004, PERIODONTOL 2000, V36, P146, DOI 10.1111/j.1600-0757.2004.03677.x
   Wei J, 2003, COLLOID SURFACE B, V32, P275, DOI 10.1016/S0927-7765(03)00180-2
   Wininger DA, 1996, ANTIMICROB AGENTS CH, V40, P2675, DOI 10.1128/AAC.40.12.2675
   Wu P, 2006, BIOMATERIALS, V27, P2450, DOI 10.1016/j.biomaterials.2005.11.031
   Yoo HJ, 2004, J APPL POLYM SCI, V91, P2348, DOI 10.1002/app.13377
   YU H, 1995, J CONTROL RELEASE, V34, P117, DOI 10.1016/0168-3659(94)00127-G
   Yu HJ, 2007, J APPL POLYM SCI, V103, P125, DOI 10.1002/app.24835
   Yu SH, 2005, J APPL POLYM SCI, V98, P538, DOI 10.1002/app.2159
   Zhang W, 2006, POLYMER, V47, P7441, DOI 10.1016/j.polymer.2006.08.057
NR 147
TC 23
Z9 25
U1 4
U2 40
PU WICHTIG PUBLISHING
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
EI 1724-6040
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD SEP
PY 2007
VL 30
IS 9
BP 828
EP 841
PG 14
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 228LK
UT WOS:000250731200012
PM 17918129
DA 2018-10-20
ER

PT J
AU Brooks, AE
   Brothers, TJ
   Creager, MS
   Lewis, RV
AF Brooks, A. E.
   Brothers, T. J.
   Creager, M. S.
   Lewis, R. V.
TI A novel methodology to explore the viscoelasticity of spider major
   ampullate silk
SO JOURNAL OF APPLIED BIOMATERIALS & BIOMECHANICS
LA English
DT Article
DE spider silk; Argiope aurantia; Nephila clavipes; mechanical properties;
   viscoelasticity; hysteresis
ID NEPHILA-CLAVIPES ARANEAE; MECHANICAL-PROPERTIES; DRAGLINE SILK; ORB-WEB;
   FIBROIN; ARANEIDAE; PROTEINS; SEQUENCE; DESIGN; FIBERS
AB Even before material science was a recognized discipline, the amazing mechanical properties of spider silk were documented and became the object of much study. In addition to the exceptional material properties of spider silk and the reported low immunogenicity, its concatenated amino acid motif arrangement facilitates a distinct possibility of manipulating the silk to create a designer biomaterial for medical applications. Crystalline protein regions imbedded in a mobile protein matrix give it a distinct set of viscoelastic abilities. Consequently, elasticity cannot be simply quantified by only measuring extensibility. To understand how the sequence of the major ampullate proteins affects elasticity, the hysteresis of single fibers from two different species, Argiope aurantia and Nephila clavipes, were examined using cyclic loading and unloading. The yield point that discriminates a transition from elastic extension to a plastic extension was analyzed by examining three different properties: Young's modulus, energy recovery and slack in the fiber after recovery. Young's modulus remained relatively constant regardless of the cycle. However, the energy recovered decreased as the slack and cycle number increased. Large standard deviations masked any quantitative differences between species and substantiated the necessity of developing synthetic silk to harness the amazing mechanical properties of spider silk.
C1 [Brooks, A. E.; Creager, M. S.; Lewis, R. V.] Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA.
   [Brothers, T. J.] Univ Wyoming, Dept Elect Engn, Laramie, WY 82071 USA.
RP Brooks, AE (reprint author), Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA.
EM abrooks@uwyo.edu
CR Brooks AE, 2005, BIOMACROMOLECULES, V6, P3095, DOI 10.1021/bm050421e
   Brooks Amanda E., 2005, V41, P1
   CONTENTO AL, 2001, THESIS U WYOMING, V65
   DENNY M, 1976, J EXP BIOL, V65, P483
   Elices M, 2004, J APPL POLYM SCI, V92, P3537, DOI 10.1002/app.20383
   Emile O, 2006, NATURE, V440, P621, DOI 10.1038/440621a
   Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561
   GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Guerette PA, 1996, SCIENCE, V272, P112, DOI 10.1126/science.272.5258.112
   Guess KB, 1998, THERMOCHIM ACTA, V315, P61, DOI 10.1016/S0040-6031(98)00277-9
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   HINMAN MB, 1992, J BIOL CHEM, V267, P19320
   LOMBARDI SJ, 1990, J ARACHNOL, V18, P297
   LUCAS FRED, 1964, DISCOVERY, V25, P20
   Madsen B, 1999, INT J BIOL MACROMOL, V24, P301, DOI 10.1016/S0141-8130(98)00094-4
   Parkhe AD, 1997, J MOL RECOGNIT, V10, P1, DOI 10.1002/(SICI)1099-1352(199701/02)10:1<1::AID-JMR338>3.0.CO;2-7
   Perez-Rigueiro J, 2005, J EXP BIOL, V208, P2633, DOI 10.1242/jeb.01701
   Porter D, 2005, EUR PHYS J E, V16, P199, DOI 10.1140/epje/e2005-00021-2
   SHAO Z, 1999, POLYMERS, P1799
   TERMONIA Y, 1994, MACROMOLECULES, V27, P7378, DOI 10.1021/ma00103a018
   TILLINGHAST EK, 1984, INSECT BIOCHEM, V14, P115, DOI 10.1016/0020-1790(84)90091-X
   TILLINGHAST EK, 1984, J ARACHNOL, V12, P69
   WORK RW, 1987, J ARACHNOL, V15, P65
   XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120
NR 25
TC 7
Z9 7
U1 0
U2 8
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 1722-6899
J9 J APPL BIOMATER BIOM
JI J. Appl. Biomater. Biomech.
PD SEP-DEC
PY 2007
VL 5
IS 3
BP 158
EP 165
PG 8
WC Biophysics; Engineering, Biomedical; Materials Science, Biomaterials
SC Biophysics; Engineering; Materials Science
GA 298ZX
UT WOS:000255726700004
PM 20799185
DA 2018-10-20
ER

PT J
AU Keen, I
   Raggatt, LJ
   Cool, SM
   Nurcombe, V
   Fredericks, P
   Trau, M
   Grondahl, L
AF Keen, Imelda
   Raggatt, Liza J.
   Cool, Simon M.
   Nurcombe, Victor
   Fredericks, Peter
   Trau, Matt
   Grondahl, Lisbeth
TI Investigations into poly(3-hydroxybutyrate-co-3-hydroxyvalerate) surface
   properties causing delayed osteoblast growth
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE roughness; surface crystallinity; wettability; osteoblast proliferation;
   PHBV
ID IN-VITRO; BIOMATERIAL SURFACES; CELL BEHAVIOR; PROLIFERATION; BONE;
   ROUGHNESS; WETTABILITY; SUBSTRATUM; ADHESION; MICRO
AB Osteoblast proliferation is sensitive to material surface properties. In this study, the proliferation of MC3T3 E1-S14 osteoblastic cells on poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) films with different surface characteristics was investigated with the aim of evaluating the cause of a lag in cell growth previously observed. The solvent-cast films were prepared using three different solvents/solvent mixtures which produced PHBV films with both a rough (at the air interface) and smooth (at the glass interface) surface. Investigation of the surface roughness by scanning electron and scanning probe microscopy revealed that the surfaces had features that were different in both average lateral size and average amplitude (R-a 20-200 nm). Water contact angles showed that all surfaces were hydrophobic in nature (theta(A) in the range 69-82 degrees). The lateral distribution of surface crystallinity of the films was evaluated by use of micro-attenuated total reflectance Fourier transform infrared (ATR-FT-IR) by determining the surface crystallinity index (CI) which was found to differ between samples. MC3T3-E1-S14 osteoblasts were cultured on the six surfaces and proliferation was determined. After 2 days, cell proliferation on all surfaces was significantly less than on the control substrate; however, after 4 days cell proliferation was optimal on three surfaces. It was concluded that the initial lag on all substrates was due to the hydrophobic nature of the substrates. The ability of the cells to recover on the materials was attributed to the degree of heterogeneity of the crystallinity and surface roughness: samples with a roughness of >= 80 nm were found to support cell proliferation. In addition, the lateral surface features influenced the proliferation of osteoblasts on the PHBV film surface.
C1 Univ Queensland, Sch Mol & Microbial Sci, Brisbane, Qld 4072, Australia.
   Queensland Univ Technol, Sch Phys & Chem Sci, Brisbane, Qld, Australia.
   Inst Mol & Cell Biol, Singapore 138673, Singapore.
   Natl Univ Singapore, Dept Orthopaed Surg, Singapore 117597, Singapore.
   Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.
   Univ Queensland, Nanotechnol & Biomat Ctr, Brisbane, Qld 4072, Australia.
RP Grondahl, L (reprint author), Univ Queensland, Sch Mol & Microbial Sci, Brisbane, Qld 4072, Australia.
EM l.grondahl@uq.edu.au
RI ASTAR, IMCB/E-2320-2012; Raggatt, Liza-Jane/A-5297-2011; Trau,
   Matt/E-3944-2015; Raggatt, Liza-Jane/S-4530-2016
OI Trau, Matt/0000-0001-5516-1280; Raggatt, Liza-Jane/0000-0002-7920-6225;
   Grondahl, Lisbeth/0000-0001-6012-9808
CR Altankov G, 1996, J BIOMAT SCI-POLYM E, V8, P299
   Anselme K, 2002, J BIOMED MATER RES, V60, P529, DOI 10.1002/jbm.10101
   Avella M, 2000, J MATER SCI, V35, P829, DOI 10.1023/A:1004773603516
   BLOEMBERGEN S, 1986, MACROMOLECULES, V19, P2865, DOI 10.1021/ma00165a034
   BOWER DL, 1988, VIB SPECTROSC, P264
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Chang EJ, 2005, EXP CELL RES, V303, P197, DOI 10.1016/j.yexcr.2004.09.024
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1101, DOI 10.1002/jbm.820290910
   Dalby MJ, 2000, J MATER SCI-MATER M, V11, P805, DOI 10.1023/A:1008957630020
   DOYLE C, 1991, BIOMATERIALS, V12, P841, DOI 10.1016/0142-9612(91)90072-I
   ERBIL HY, 2003, HDB SURFACE COLLOID, P5
   Faghihi S, 2005, MATER SCI FORUM, V495-497, P705, DOI 10.4028/www.scientific.net/MSF.495-497.705
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Galego N, 2000, POLYM TEST, V19, P485, DOI 10.1016/S0142-9418(99)00011-2
   GOGOLEWSKI S, 1993, J BIOMED MATER RES, V27, P1135, DOI 10.1002/jbm.820270904
   Grondahl L, 2005, BIOMACROMOLECULES, V6, P2197, DOI 10.1021/bm050127m
   Groth T, 1996, BIOMATERIALS, V17, P1227, DOI 10.1016/0142-9612(96)84943-X
   HAMMOND T, 1995, DEGRADABLE POLYM PRI, P88
   HANEIN D, 1994, SCIENCE, V263, P1413, DOI 10.1126/science.8128221
   Hatano K, 1999, BONE, V25, P439, DOI 10.1016/S8756-3282(99)00192-1
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   Keen I, 2001, APPL SPECTROSC, V55, P984, DOI 10.1366/0003702011953126
   KENNY B, 2002, THESIS U QUEENSLAND
   Kikuchi T, 2001, J IMMUNOL, V166, P3574, DOI 10.4049/jimmunol.166.5.3574
   KIREMITCI M, 1990, Clinical Materials, V6, P227, DOI 10.1016/0267-6605(90)90060-9
   Koegler WS, 2004, BIOMATERIALS, V25, P2819, DOI 10.1016/j.biomaterials.2003.09.064
   Kose GT, 2003, J MATER SCI-MATER M, V14, P121
   Kumarasuriyar A, 2005, TISSUE ENG, V11, P1281, DOI 10.1089/ten.2005.11.1281
   Kwok DY, 1999, ADV COLLOID INTERFAC, V81, P167, DOI 10.1016/S0001-8686(98)00087-6
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   Liao HH, 2003, BIOMATERIALS, V24, P649, DOI 10.1016/S0142-9612(02)00379-4
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   Lutton C, 2001, AUST J CHEM, V54, P621, DOI 10.1071/CH01118
   MARAYUMA N, 1998, THIN SOLID FILMS, V327, P854
   Matsuzaka K, 1999, BIOMATERIALS, V20, P1293, DOI 10.1016/S0142-9612(99)00029-0
   Meyer U, 2005, Eur Cell Mater, V9, P39
   Mirabella F. M. J., 1993, PRACTICAL SPECTROSCO, V15, P17
   Redey SA, 2000, J BIOMED MATER RES, V50, P353, DOI 10.1002/(SICI)1097-4636(20000605)50:3<353::AID-JBM9>3.0.CO;2-C
   Riehle MO, 2003, MAT SCI ENG C-BIO S, V23, P337, DOI 10.1016/S0928-4931(02)00282-5
   Runt J. P., 1986, ENCY POLYM SCI ENG, P482
   SINGHVI R, 1994, BIOTECHNOL BIOENG, V43, P764, DOI 10.1002/bit.260430811
   Smith R, 2002, J APPL POLYM SCI, V83, P997, DOI 10.1002/app.2280
   TAMADA Y, 1994, J BIOMED MATER RES, V28, P783, DOI 10.1002/jbm.820280705
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Wan YQ, 2005, BIOMATERIALS, V26, P4453, DOI 10.1016/j.biomaterials.2004.11.016
   Washburn NR, 2004, BIOMATERIALS, V25, P1215, DOI 10.1016/j.biomaterials.2003.08.043
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wu ACK, 2006, BIOMATERIALS, V27, P4715, DOI 10.1016/j.biomaterials.2006.05.010
   Zeng J, 2003, J APPL POLYM SCI, V89, P1085, DOI 10.1002/app.12260
NR 50
TC 15
Z9 15
U1 2
U2 7
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PD SEP
PY 2007
VL 18
IS 9
BP 1101
EP 1123
DI 10.1163/156856207781554046
PG 23
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 208JK
UT WOS:000249315400001
PM 17931502
DA 2018-10-20
ER

PT J
AU McNally, AK
   MacEwan, SR
   Anderson, JM
AF McNally, Amy K.
   MacEwan, Sarah R.
   Anderson, James M.
TI alpha subunit partners to beta 1 and beta 2 integrins during
   IL-4-induced foreign body giant cell formation
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE adhesion; macrophage; foreign body giant cell; integrins; matrix
   proteins
ID HUMAN MACROPHAGE ADHESION; ALPHA-3-BETA-1 INTEGRIN; BETA(2) INTEGRINS;
   MODIFIED SURFACES; IN-VITRO; EXPRESSION; NEUTROPHILS; ENGAGEMENT; FUSION
AB As beta 1 and beta 2 integrins were previously found to mediate adhesion during IL-4-induced foreign body giant cell (FBGC) formation, we pursued the identities of the a integrin partners of these adhesion receptors using our in vitro system of human monocyte-derived macrophage fusion. Immunoprecipitation with beta 1 and immunoblotting reveal the presence of alpha 5 and alpha V, as well as alpha 2 and alpha 3. alpha M and (alpha X immunoprecipitate with 2 but not with beta 1. Immunocytochernistry coupled with confocal microscopy indicates that alpha 5 and alpha X are poorly expressed on day 0. However, following the induction of fusion by IL-4 on day 3, they are each readily detectable in fusing macrophages/FBGC on day 7. In contrast, alpha M and alpha V are present throughout the culture period, with very strong aM expression on day 7. We also demonstrate expression and colocalization of alpha 3, alpha 5, or alpha V with beta 1 on fusing macrophages/FBGC at this time point as well as strong colocalization of alpha M and alpha X with beta 2 in FBGC and at fusion interfaces. Therefore, IL-4-induced FBGC are characterized by the expression of alpha MP2, alpha XP2, alpha 5 beta 1, alpha V beta 1, alpha 2 beta 1, and alpha 3 beta 1, which indicates potential interactions with fragments of complement C3, fibrin(ogen), fibronectin, Factor X, and vitronectin, and possibly with certain collagens, laminin, and thrombosponclin at sites of biomaterial implantation. (C) 2007 Wiley Periodicals, Inc.
C1 Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
RP McNally, AK (reprint author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
EM amy.mcnally@case.edu
OI MacEwan, Sarah/0000-0002-4365-6232
FU NIBIB NIH HHS [EB00275]
CR Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008
   ANDERSSON T, 1991, Drug Investigation, V3, P45
   Berton G, 1999, CELL SIGNAL, V11, P621, DOI 10.1016/S0898-6568(99)00003-0
   Dadsetan M, 2004, J BIOMED MATER RES A, V71A, P439, DOI 10.1002/jbm.a.30165
   Flick MJ, 2004, J CLIN INVEST, V113, P1596, DOI 10.1172/JCI200420741
   Gordon S., 1999, INFLAMMATION BASIC P, P35
   HARBERS GM, 2006, INTRO BIOMATERIALS, P15
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Iyer V, 2005, J CELL SCI, V118, P1185, DOI 10.1242/jcs.01708
   Jenney CR, 1999, J BIOMED MATER RES, V46, P11, DOI 10.1002/(SICI)1097-4636(199907)46:1<11::AID-JBM2>3.3.CO;2-P
   Jenney CR, 1999, J BIOMED MATER RES, V44, P206, DOI 10.1002/(SICI)1097-4636(199902)44:2<206::AID-JBM11>3.0.CO;2-D
   Jenney CR, 1998, J BIOMED MATER RES, V41, P171, DOI 10.1002/(SICI)1097-4636(199808)41:2<171::AID-JBM1>3.0.CO;2-F
   JONES JA, 2004, J BIOMAT SCI-POLYM E, V15, P576
   Lishko VK, 2003, EXP CELL RES, V283, P116, DOI 10.1016/S0014-4827(02)00024-1
   Mayadas TN, 2005, TRENDS IMMUNOL, V26, P388, DOI 10.1016/j.it.2005.05.002
   McNally AK, 2002, AM J PATHOL, V160, P621, DOI 10.1016/S0002-9440(10)64882-1
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   McNally AK, 1996, 5 WORLD BIOM C TOR C
   Morini M, 2000, INT J CANCER, V87, P336, DOI 10.1002/1097-0215(20000801)87:3<336::AID-IJC5>3.3.CO;2-V
   Oh JE, 2005, J BIOL CHEM, V280, P21629, DOI 10.1074/jbc.m412293200
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Tsuji T, 2004, J MEMBRANE BIOL, V200, P115, DOI 10.1007/s00232-004-0696-5
   Werr J, 2000, J LEUKOCYTE BIOL, V68, P553
   White DJ, 2004, INT J BIOCHEM CELL B, V36, P1405, DOI 10.1016/j.biocel.2003.08.016
NR 24
TC 29
Z9 29
U1 0
U2 4
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 1
PY 2007
VL 82A
IS 3
BP 568
EP 574
DI 10.1002/bjm.a.31161
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 199JW
UT WOS:000248693100006
PM 17311314
DA 2018-10-20
ER

PT J
AU Wu, ACK
   Toulson, S
   Pettit, A
   Grondahl, L
   Mackie, EJ
   Cassady, AI
AF Wu, A. C. K.
   Toulson, S.
   Pettit, A.
   Grondahl, L.
   Mackie, E. J.
   Cassady, A. I.
TI Analysis of in vivo responses to hydrogen peroxide purified PHBV
   biomaterial implanted in a murine tibial defect
SO JOURNAL OF BONE AND MINERAL RESEARCH
LA English
DT Meeting Abstract
CT 29th Annual Meeting of the
   American-Society-for-Bone-and-Mineral-Research
CY SEP 16-19, 2007
CL Honolulu, HI
SP Amer Soc Bone & Mineral Res
C1 [Wu, A. C. K.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia.
   [Toulson, S.; Mackie, E. J.] Univ Melbourne, Fac Vet Sci, Parkville, Vic 3052, Australia.
   [Pettit, A.; Cassady, A. I.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.
   [Grondahl, L.] Univ Queensland, Sch Mol & Microbiol Sci, Brisbane, Qld, Australia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC BONE & MINERAL RES
PI WASHINGTON
PA 2025 M ST, N W, STE 800, WASHINGTON, DC 20036-3309 USA
SN 0884-0431
J9 J BONE MINER RES
JI J. Bone Miner. Res.
PD SEP
PY 2007
VL 22
SU 1
MA T140
BP S265
EP S265
PG 1
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 225IA
UT WOS:000250509101361
DA 2018-10-20
ER

PT J
AU Colnot, C
   Romero, DM
   Huang, S
   Rahman, J
   Currey, JA
   Nanci, A
   Brunski, JB
   Helms, JA
AF Colnot, C.
   Romero, D. M.
   Huang, S.
   Rahman, J.
   Currey, J. A.
   Nanci, A.
   Brunski, J. B.
   Helms, J. A.
TI Molecular analysis of healing at a bone-implant interface
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Article
DE bone; healing; implants; osteoblast
ID TITANIUM IMPLANTS; ENDOSSEOUS IMPLANTS; SURFACE-PROPERTIES; DENTAL
   IMPLANTS; REPAIR; MODEL; ROUGHNESS; ADJACENT; MATRIX
AB While bone healing occurs around implants, the extent to which this differs from healing at sites without implants remains unknown. We tested the hypothesis that an implant surface may affect the early stages of healing. In a new mouse model, we made cellular and molecular evaluations of healing at bone-implant interfaces vs. empty cortical defects. We assessed healing around Ti-6Al-4V, poly( L- lactide- co- D, L,- lactide), and 303 stainless steel implants with surface characteristics comparable with those of commercial implants. Our qualitative cellular and molecular evaluations showed that osteoblast differentiation and new bone deposition began sooner around the implants, suggesting that the implant surface and microenvironment around implants favored osteogenesis. The general stages of healing in this mouse model resembled those in larger animal models, and supported the use of this new model as a test bed for studying cellular and molecular responses to biomaterial and biomechanical conditions.
C1 Rensselaer Polytech Inst, Jonsson Engn Ctr, Dept Biomed Engn, Troy, NY 12180 USA.
   Univ Calif San Francisco, Dept Orthopaed Surg, San Francisco, CA 94110 USA.
   Univ Montreal, Fac Dent, Montreal, PQ H3C 3J7, Canada.
   Stanford Univ, Dept Plast & Reconstruct Surg, Stanford, CA 94305 USA.
RP Brunski, JB (reprint author), Rensselaer Polytech Inst, Jonsson Engn Ctr, Dept Biomed Engn, Troy, NY 12180 USA.
EM brunsj@rpi.edu
RI Colnot, Celine/D-4997-2017
FU NIDCR NIH HHS [R01 DE024000, R03 DE16701]; NIA NIH HHS [R01 AG23218-01];
   NIBIB NIH HHS [R01 EB000504]
CR Albrektsson T, 2004, INT J PROSTHODONT, V17, P536
   ASK M, 1989, APPL SURF SCI, V35, P283, DOI 10.1016/0169-4332(89)90013-5
   Berglundh T, 2003, CLIN ORAL IMPLAN RES, V14, P251, DOI 10.1034/j.1600-0501.2003.00972.x
   Branemark P I, 1977, Scand J Plast Reconstr Surg Suppl, V16, P1
   Branemark PI, 1985, TISSUE INTEGRATED PR, p[11, 253]
   Brunski J B, 1999, Adv Dent Res, V13, P99
   Campbell TM, 2003, CALCIFIED TISSUE INT, V73, P49, DOI 10.1007/s00223-002-2120-4
   Chiba S, 2001, J VET MED SCI, V63, P603, DOI 10.1292/jvms.63.603
   Colnot C, 2005, CLIN ORTHOP RELAT R, P69, DOI 10.1097/01.blo.0000167251.26164.37
   Colnot C, 2003, DEVELOPMENT, V130, P4123, DOI 10.1242/dev.00559
   Davies J.E., 2000, BONE ENG, P1
   Ellingsen JE, 2004, INT J ORAL MAX IMPL, V19, P659
   Esposito M, 2000, Clin Implant Dent Relat Res, V2, P18, DOI 10.1111/j.1708-8208.2000.tb00103.x
   HOSHAW SJ, 1995, T ORTHOP RES SOC, P188
   Hoshaw SJ, 1994, INT J ORAL MAXILLOF, V9, P345
   Huja SS, 1999, BONE, V25, P217, DOI 10.1016/S8756-3282(99)00151-9
   Isidor F, 1997, CLIN ORAL IMPLAN RES, V8, P1, DOI 10.1111/j.1600-0501.1997.tb00001.x
   Lazzara RJ, 1999, INT J PERIODONT REST, V19, P117
   Massaro C, 2002, J MATER SCI-MATER M, V13, P535, DOI 10.1023/A:1015170625506
   Masuda T, 1997, INT J ORAL MAX IMPL, V12, P472
   MISchenk R, 1994, BONE FORMATION REPAI, P117
   Monsees TK, 2005, CELLS TISSUES ORGANS, V180, P81, DOI 10.1159/000086749
   NANCI A, 1994, CELL MATER, V4, P1
   Ogawa T, 2006, J DENT RES, V85, P566, DOI 10.1177/154405910608500617
   Pilliar RM, 2002, AGING, OSTEOPOROSIS, AND DENTAL IMPLANTS, P35
   PLENK H, 1996, ENDOSSEOUS IMPLANTS, P63
   PRITCHARD JJ, 1964, MODERN TRENDS ORTH 4, P69
   Schatzker J, 2002, AGING, OSTEOPOROSIS, AND DENTAL IMPLANTS, P45
   Shalabi MM, 2006, J DENT RES, V85, P496, DOI 10.1177/154405910608500603
   SOBALLE K, 1992, J ORTHOPAED RES, V10, P285, DOI 10.1002/jor.1100100216
   Sul YT, 2005, INT J ORAL MAX IMPL, V20, P349
   SUNDGREN JE, 1985, J BIOMED MATER RES, V19, P663, DOI 10.1002/jbm.820190606
   Uusitalo H, 2001, BONE, V28, P423, DOI 10.1016/S8756-3282(01)00406-9
   Wang ML, 2004, J ARTHROPLASTY, V19, P1028, DOI 10.1016/j.arth.2004.03.024
   Watzak G, 2005, CLIN ORAL IMPLAN RES, V16, P408, DOI 10.1111/j.1600-0501.2005.01155.x
   WIRELAND M, 2000, BONE ENG, P163
NR 36
TC 31
Z9 31
U1 0
U2 13
PU INT AMER ASSOC DENTAL RESEARCHI A D R/A A D R
PI ALEXANDRIA
PA 1619 DUKE ST, ALEXANDRIA, VA 22314-3406 USA
SN 0022-0345
J9 J DENT RES
JI J. Dent. Res.
PD SEP
PY 2007
VL 86
IS 9
BP 862
EP 867
DI 10.1177/154405910708600911
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 203ZS
UT WOS:000249013200011
PM 17720856
DA 2018-10-20
ER

PT J
AU Kimura, Y
   Tabata, Y
AF Kimura, Yu
   Tabata, Yasuhiko
TI Experimental tissue regeneration by DDS technology of bio-signaling
   molecules
SO JOURNAL OF DERMATOLOGICAL SCIENCE
LA English
DT Review
DE drug delivery system (DDS); release technology; growth factor; plasmid
   DNA; tissue regeneration
ID FIBROBLAST-GROWTH-FACTOR; SMALL INTERFERENCE RNA; IMPREGNATED GELATIN
   MICROSPHERES; INTERNAL THORACIC ARTERIES; INDUCED ORGAN REGENERATION;
   SKULL BONE REGENERATION; MURINE HAIR-FOLLICLES; CONTROLLED-RELEASE;
   PLASMID DNA; BIOARTIFICIAL PANCREAS
AB The medical therapy of tissue regeneration achieved by biomaterialbased tissue engineering has been currently expected as the third option following reconstructive surgery and organ transplantation. The basic idea of this regenerative therapy is to assist the self-heating potentials of body to induce the natural regeneration and repairing of defective or injured tissue. To this end, it is practically important to create a local environment which enables cells to promote their proliferation and differentiation, resulting in the induction of cell-based tissue regeneration. Tissue engineering is a biomedical technology or methodology to build up this regeneration environment by making use of biomaterials. Drug delivery system (DDS) is a biomaterial technology to enhance the in vivo biological functions of biosignaling molecules (growth factors and genes) for promoted tissue regeneration. This paper overviews the recent status of tissue regeneration therapy based on the DDS technology of bio-signaling molecules. (c) 2007 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.
C1 Kyoto Univ, Inst Frontier Med Sci, Field Tissue Engn, Dept Mat,Sakyo Ku, Kyoto 6068507, Japan.
RP Tabata, Y (reprint author), Kyoto Univ, Inst Frontier Med Sci, Field Tissue Engn, Dept Mat,Sakyo Ku, 53 Kawara Cho Shogoin, Kyoto 6068507, Japan.
EM yasuhiko@frontier.kyoto-u.ac.jp
RI Kimura, Yu/C-3442-2008; Sanguansri, Luz/B-6630-2011
OI Sanguansri, Luz/0000-0003-1908-7604
CR Aoyama T, 2003, TISSUE ENG, V9, P1289, DOI 10.1089/10763270360728206
   Bach AD, 2003, CLIN PLAST SURG, V30, P589, DOI 10.1016/S0094-1298(03)00077-4
   Balamurugan AN, 2003, PANCREAS, V26, P279, DOI 10.1097/00006676-200304000-00012
   Bannasch H, 2003, CLIN PLAST SURG, V30, P573, DOI 10.1016/S0094-1298(03)00075-0
   Chen RR, 2003, PHARMACEUT RES, V20, P1103, DOI 10.1023/A:1025034925152
   Ehrenreich M, 2006, TISSUE ENG, V12, P2407, DOI 10.1089/ten.2006.12.2407
   Hong L, 2000, J BIOMAT SCI-POLYM E, V11, P1357, DOI 10.1163/156856200744381
   Hong L, 2000, J NEUROSURG, V92, P315, DOI 10.3171/jns.2000.92.2.0315
   Hong L, 2000, TISSUE ENG, V6, P331, DOI 10.1089/107632700418056
   HONG L, 1998, J BIOMAT SCI-POLYM E, V9, P1014
   Hubbel JA, 2004, CURR OPIN BIOTECH, V15, P381, DOI 10.1016/j.copbio.2004.08.015
   Iimuro Y, 2003, GASTROENTEROLOGY, V124, P445, DOI 10.1053/gast.2003.50063
   Ikada Y., 1998, ADV DRUG DELIV REV, V31, P287
   Ikada Y, 2006, J R SOC INTERFACE, V3, P589, DOI 10.1098/rsif.2006.0124
   Itoh M, 2004, TISSUE ENG, V10, P818, DOI 10.1089/1076327041348400
   Iwakura A, 2003, J THORAC CARDIOV SUR, V126, P1113, DOI 10.1016/S0022-5223(03)00025-4
   Iwakura A, 2003, HEART VESSELS, V18, P93, DOI 10.1007/s10380-002-0686-5
   Iwakura A, 2000, CIRCULATION, V102, P307
   IWAKURA A, 2001, CIRCULATION, V104, P1325
   Kasahara H, 2003, J AM COLL CARDIOL, V41, P1056, DOI 10.1016/S0735-1097(02)03007-3
   Kawai K, 2005, BRIT J PLAST SURG, V58, P1115, DOI 10.1016/j.bjps.2005.04.010
   Kawai K, 2000, BIOMATERIALS, V21, P489, DOI 10.1016/S0142-9612(99)00207-0
   Kimura Y, 2003, BIOMATERIALS, V24, P2513, DOI 10.1016/S0142-9612(03)00049-8
   Kojima K, 2004, J THORAC CARDIOV SUR, V128, P147, DOI 10.1016/j.jtcvs.2004.02.038
   Kushibiki T, 2006, J CONTROL RELEASE, V110, P610, DOI 10.1016/j.jconrel.2005.11.007
   Kushibiki T, 2005, J CONTROL RELEASE, V105, P318, DOI 10.1016/j.jconrel.2005.02.030
   Kushibiki T, 2003, J CONTROL RELEASE, V90, P207, DOI 10.1016/S0168-3659(03)00197-4
   Kushibiki Toshihiro, 2004, Current Drug Delivery, V1, P153, DOI 10.2174/1567201043479948
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Levenberg S, 2004, CURR TOP DEV BIOL, V61, P113, DOI 10.1016/S0070-2153(04)61005-2
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Marui A, 2005, J VASC SURG, V41, P82, DOI 10.1016/j.jvs.2004.10.029
   Matsumoto G, 2006, CANCER SCI, V97, P313, DOI 10.1111/j.1349-7006.2006.00174.x
   Miyazaki M, 2006, PERITON DIALYSIS INT, V26, P633
   Mligiliche NL, 1999, E AFR MED J, V76, P400
   Nagaya N, 2003, CIRCULATION, V108, P889, DOI 10.1161/01.CIR.0000079161.56080.22
   Nakahara T, 2003, TISSUE ENG, V9, P153, DOI 10.1089/107632703762687636
   Nakajima Hiroyuki, 2004, J Artif Organs, V7, P58
   Nishida T, 2004, J BONE MINER RES, V19, P1308, DOI 10.1359/JBMR.040322
   Oe S, 2003, J CONTROL RELEASE, V88, P193, DOI 10.1016/S0168-3659(02)00463-7
   Ogawa K, 2001, CELL TRANSPLANT, V10, P723
   Ohlstein B, 2004, CURR OPIN CELL BIOL, V16, P693, DOI 10.1016/j.ceb.2004.09.003
   Okamoto T, 2004, J THORAC CARDIOV SUR, V127, P329, DOI 10.1016/j.jtcvs.2003.08.017
   Ozeki M, 2003, BIOMATERIALS, V24, P2387, DOI 10.1016/S0142-9612(03)00045-0
   Ozeki M, 2002, BIOMATERIALS, V23, P2367, DOI 10.1016/S0142-9612(01)00372-6
   Ozeki M, 2002, TISSUE ENG, V8, P359, DOI 10.1089/107632702760184637
   RIFKIN DB, 1989, J CELL BIOL, V109, P1, DOI 10.1083/jcb.109.1.1
   Rozga J, 2006, XENOTRANSPLANTATION, V13, P380, DOI 10.1111/j.1399-3089.2006.00323.x
   Saito A, 2003, J AM SOC NEPHROL, V14, P2025, DOI 10.1097/01.ASN.0000078804.98322.4A
   Sakakibara Y, 2003, EUR J CARDIO-THORAC, V24, P105, DOI 10.1016/S1010-7940(03)00159-3
   Sakakibara Y, 2002, J THORAC CARDIOV SUR, V124, P50, DOI 10.1067/mtc.2002.121293
   Sakurai T, 2004, PANCREAS, V28, pE70, DOI 10.1097/00006676-200404000-00028
   Silva EA, 2004, CURR TOP DEV BIOL, V64, P181, DOI 10.1016/S0070-2153(04)64008-7
   Tabata Y, 2000, J BIOMAT SCI-POLYM E, V11, P915, DOI 10.1163/156856200744101
   Tabata Y, 2000, J BIOMAT SCI-POLYM E, V11, P891, DOI 10.1163/156856200744084
   Tabata Y, 1999, J NEUROSURG, V91, P851, DOI 10.3171/jns.1999.91.5.0851
   TABATA Y, 2001, CONNECT TISSUE, V33, P315
   TSUJISASO Y, IN PRESS SCAND J PLA
   UEDA H, 2002, BIOMATERIALS, V23, P1010
   Vacanti CA, 2006, TISSUE ENG, V12, P1137, DOI 10.1089/ten.2006.12.1137
   Wang HL, 2005, J PERIODONTOL, V76, P1601
   Wang WJ, 2002, TRANSPLANTATION, V73, P122, DOI 10.1097/00007890-200201150-00023
   Yamada K, 1997, J NEUROSURG, V86, P871, DOI 10.3171/jns.1997.86.5.0871
   Yamamoto M, 2000, J CONTROL RELEASE, V64, P133, DOI 10.1016/S0168-3659(99)00129-7
   Yamamoto M, 2006, ADV DRUG DELIVER REV, V58, P535, DOI 10.1016/j.addr.2006.03.003
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108
   Yannas IV, 2005, ADV BIOCHEM ENG BIOT, V93, P1, DOI 10.1007/b99965
   Yannas IV, 2005, J R SOC INTERFACE, V2, P403, DOI 10.1098/rsif.2005.0062
   YOKOTA S, 2002, J JPN STOMATOL SOC, V51, P324
   Yoshida S, 2003, J INVEST DERMATOL, V120, P335, DOI 10.1046/j.1523-1747.2003.12039.x
   Zhao YN, 2005, AM J PATHOL, V167, P1519, DOI 10.1016/S0002-9440(10)61238-2
NR 71
TC 11
Z9 11
U1 0
U2 4
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0923-1811
J9 J DERMATOL SCI
JI J. Dermatol. Sci.
PD SEP
PY 2007
VL 47
IS 3
BP 189
EP 199
DI 10.1016/j.jdermsci.2007.04.002
PG 11
WC Dermatology
SC Dermatology
GA 203JJ
UT WOS:000248970600001
PM 17507205
DA 2018-10-20
ER

PT J
AU De Giglio, E
   Stefania, C
   Calvano, CD
   Luigia, S
   Pier, GZ
   Silvia, C
   Adriana, DB
   Colaianni, G
AF De Giglio, Elvira
   Stefania, Cometa
   Calvano, Cosima-Damiana
   Luigia, Sabbatini
   Pier, Giorgio Zambonin
   Silvia, Colucci
   Adriana, Di Benedetto
   Colaianni, Graziana
TI A new titanium biofunctionalized interface based on
   poly(pyrrole-3-acetic acid) coating: proliferation of osteoblast-like
   cells and future perspectives
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID IN-VIVO; CONDUCTING POLYMER; POLYPYRROLE FILMS; MAMMALIAN-CELLS;
   PYRROLE; ADHESION; ELECTROPOLYMERIZATION; DIFFERENTIATION; TI
AB In recent years, many procedures based on surface modification have been suggested to improve the biocompatibility and biofunctionality of orthopedic titanium-based implants. In this contest, the development of a new titanium-based biomaterial that could be covalently modified with biologically active molecules (i. e., RGD-peptides, growth factors, etc.) able to improve osteoblasts response was investigated. The strategy followed was based on a preliminary coating of the implant material by an adherent thin polymer film to which bioactive molecules could be grafted exploiting the polymer surface chemical reactivity. In this work, we focused our attention on pyrrole-3- acetic acid (Py-3-acetic), a pyrrole with carboxylic acid substituent, whose electrosynthesis and characterization on titanium substrates were already accomplished and whose potentialities in the design of new biocompatible surfaces are well evident. As first step, the biocompatibility of the electrochemically grown PPy-3-acetic films was investigated performing in vitro tests ( adhesion and proliferation) with mouse bone marrow cells. Successively, the availability and reactivity of surface carboxylic groups were tested through the grafting of an aminoacidic residue to PPy-3-acetic films.
C1 Univ Bari, Dipartimento Chim, I-70126 Bari, Italy.
   Univ Bari, Dipartimento Anat Umana & Istol, I-70124 Bari, Italy.
RP De Giglio, E (reprint author), Univ Bari, Dipartimento Chim, Via E Orabona 4, I-70126 Bari, Italy.
EM e.degiglio@chimica.uniba.it
OI Sabbatini, Luigia/0000-0002-5099-2242; Colucci,
   Silvia/0000-0001-9970-3539; Calvano, Cosima Damiana/0000-0001-8832-7072;
   Colaianni, Graziana/0000-0001-8501-5399; De Giglio,
   Elvira/0000-0001-9387-6201
CR Aoki T, 1996, BIOMATERIALS, V17, P1971, DOI 10.1016/0142-9612(96)00015-4
   AOKI T, 1995, SYNTHETIC MET, V71, P2229, DOI 10.1016/0379-6779(94)03235-X
   Bartlett PN, 2000, J ELECTROANAL CHEM, V487, P142, DOI 10.1016/S0022-0728(00)00183-2
   Browne M, 2000, BIOMATERIALS, V21, P385, DOI 10.1016/S0142-9612(99)00200-8
   Castano H, 2004, MACROMOL BIOSCI, V4, P785, DOI 10.1002/mabi.200300123
   Cui XY, 2003, BIOMATERIALS, V24, P777, DOI 10.1016/S0142-9612(02)00415-5
   De Giglio E, 1999, J BIOMAT SCI-POLYM E, V10, P845, DOI 10.1163/156856299X00919
   De Giglio E, 2005, SURF INTERFACE ANAL, V37, P580, DOI 10.1002/sia.2053
   De Giglio E, 2001, J BIOMAT SCI-POLYM E, V12, P63, DOI 10.1163/156856201744452
   De Giglio E, 2001, BIOMATERIALS, V22, P2609, DOI 10.1016/S0142-9612(00)00449-X
   De Giglio E, 2000, J BIOMAT SCI-POLYM E, V11, P1073, DOI 10.1163/156856200743580
   DEGIGLIO E, 1997, THESIS NATL LIB FLOR
   DELABOUGLISE D, 1991, NEW J CHEM, V15, P233
   GARNIER F, 1994, J AM CHEM SOC, V116, P8813, DOI 10.1021/ja00098a053
   Garnier F, 1999, SYNTHETIC MET, V100, P89, DOI 10.1016/S0379-6779(98)00169-6
   Godillot P, 1996, SYNTHETIC MET, V83, P117, DOI 10.1016/S0379-6779(97)80064-1
   Grano M, 2002, CALCIFIED TISSUE INT, V70, P176, DOI 10.1007/s00223-001-2034-6
   Idla K, 2000, ELECTROCHIM ACTA, V45, P2121, DOI 10.1016/S0013-4686(99)00433-8
   INAGAKI T, 1988, MOL CRYST LIQ CRYST, V160, P79, DOI 10.1080/15421408808083002
   Jiang XP, 2002, TISSUE ENG, V8, P635, DOI 10.1089/107632702760240553
   KUMAZAWA R, 2002, BIOMATERIALS, V23, P37
   Lakard S, 2004, BIOELECTROCHEMISTRY, V62, P19, DOI 10.1016/j.bioelechem.2003.03.009
   PICKUP PG, 1987, J ELECTROANAL CHEM, V225, P273, DOI 10.1016/0022-0728(87)80021-9
   Ryder KS, 1997, BIOSENS BIOELECTRON, V12, P721, DOI 10.1016/S0956-5663(97)00039-0
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   TESSIER D, 2000, J BIOMAT SCI-POLYM E, V11, P1083
   Wang XD, 2004, J BIOMED MATER RES A, V68A, P411, DOI 10.1002/jbm.a.20065
   WILLIAMS RL, 1994, J MATER SCI-MATER M, V5, P429, DOI 10.1007/BF00058978
   WONG JY, 1994, P NATL ACAD SCI USA, V91, P3201, DOI 10.1073/pnas.91.8.3201
   YONHIN BFY, 1994, J ELECTROANAL CHEM, V374, P167, DOI 10.1016/0022-0728(94)03364-1
NR 30
TC 22
Z9 22
U1 1
U2 11
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD SEP
PY 2007
VL 18
IS 9
BP 1781
EP 1789
DI 10.1007/s10856-007-3037-2
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 232JQ
UT WOS:000251015800014
PM 17483896
DA 2018-10-20
ER

PT J
AU Kyung-Ju, H
   Choi, KH
   Kim, MJ
   Park, CS
   Cha, J
AF Kyung-Ju, Hwang
   Choi, Kyoung-Hwa
   Kim, Myo-Jeong
   Park, Cheon-Seok
   Cha, Jaeho
TI Purification and characterization of a new fibrinolytic enzyme of
   Bacillus licheniformis KJ-31, isolated from Korean traditional Jeot-gal
SO JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY
LA English
DT Article
DE Jeot-gal; Bacillus lichenifoinis KJ-31; fibrinolytic; enzyme; zymography
ID VEGETABLE CHEESE NATTO; PLASMINOGEN-ACTIVATOR; SUBTILIS-NATTO; SOYBEAN
   FOOD; DOEN-JANG; IDENTIFICATION; NATTOKINASE; PROTEIN
AB Jeot-gal is a traditional Korean fermented seafood and has long been used for seasoning. We isolated 188 strains from shrimp, anchovy, and yellow corvina Jeot-gal, and screened sixteen strains that showed strong fibrinolytic activities on a fibrin plate. Among those strains, the strain that had the largest halo zone was chosen and identified as Bacillus licheniformis by using 16S rDNA sequencing and an API CHB kit. The fibrinolytic activity of Bacillus licheniformis was characterized and designated as bpKJ-31. The active component of bpKJ-31 was identified as a 37 kDa protein, designated bacillopeptidase F, by internal peptide mapping and N-terminal sequencing. The optimum activity of bpKJ-31 was shown at pH9 and 40 degrees C, with a chromogenic substrate for plasmin. It had high degrading activity for the Bp-chain and A alpha-chain of fibrin(ogen), and also acted on thrombin, but not skim milk and casein. The amidolytic activity of bpKJ-31 was inhibited by I mM phenylmethanesulfonyl fluoride, but I mM EDTA did not affect the enzyme activity, indicating that bpKJ-31 is an alkaline serine protease, like a plasmin. The bpKJ-31 showed approximately 14.3% higher fibrinolytic activity than the plasmin. These features of bpKJ-31 make it attractive as a health-promoting biomaterial.
C1 Pusan Natl Univ, Coll Nat Sci, Dept Microbiol, Pusan 609735, South Korea.
   Inje Univ, Food Res Inst, Gimhae 621749, South Korea.
   Inje Univ, Sch Food & Life Sci, Gimhae 621749, South Korea.
   Inje Univ, Biohlth Prod Res Ctr, Gimhae 621749, South Korea.
   Kyung Hee Univ, Dept Food Sci & Biotechnol, Yongin 446701, South Korea.
   Kyung Hee Univ, Inst Life Sci & Resources, Yongin 446701, South Korea.
RP Cha, J (reprint author), Pusan Natl Univ, Coll Nat Sci, Dept Microbiol, Pusan 609735, South Korea.
EM jhcha@pusan.ac.kr
CR ASTRUP T, 1952, ARCH BIOCHEM BIOPHYS, V40, P346, DOI 10.1016/0003-9861(52)90121-5
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   Choi NS, 2005, J MICROBIOL BIOTECHN, V15, P537
   Choi NS, 2005, J MICROBIOL BIOTECHN, V15, P72
   Choi NS, 2005, J MICROBIOL BIOTECHN, V15, P35
   Collen D, 2004, J THROMB HAEMOST, V2, P541, DOI 10.1111/j.1538-7933.2004.00645.x
   COLLEN D, 1994, BLOOD, V84, P680
   Duffy MJ, 2002, CLIN CHEM, V48, P1194
   FUJITA M, 1993, BIOCHEM BIOPH RES CO, V197, P1340, DOI 10.1006/bbrc.1993.2624
   Jeong YK, 2004, WORLD J MICROB BIOT, V20, P711, DOI 10.1007/s11274-003-4514-5
   Kim HK, 1997, J FERMENT BIOENG, V84, P307
   Kim SH, 2000, BIOSCI BIOTECH BIOCH, V64, P1722, DOI 10.1271/bbb.64.1722
   Kim W, 1996, APPL ENVIRON MICROB, V62, P2482
   Ko JH, 2004, COMP BIOCHEM PHYS C, V137, P65, DOI 10.1016/j.cca.2003.11.008
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lee JS, 2006, J MICROBIOL BIOTECHN, V16, P264
   Lee SK, 2001, J MICROBIOL BIOTECHN, V11, P845
   Lee SY, 2005, PROTEIN EXPRES PURIF, V43, P10, DOI 10.1016/j.pep.2005.05.004
   Matsubara K, 1999, PHYTOCHEMISTRY, V52, P993, DOI 10.1016/S0031-9422(99)00356-8
   MATSUBARA K, 2000, COMP BIOCHEM PHYS B, V125, P134
   MILHARA H, 1991, LUMBRICUS RUBELLUS J, V41, P461
   Omura K, 2004, BIOFACTORS, V22, P185, DOI 10.1002/biof.5520220138
   Omura O, 2005, J PHARMACOL SCI, V99, P247
   Paik HD, 2004, J MICROBIOL BIOTECHN, V14, P829
   Park SK, 2006, J MICROBIOL BIOTECHN, V16, P1053
   Peng Y, 2005, APPL MICROBIOL BIOT, V69, P126, DOI 10.1007/s00253-005-0159-7
   Peng Y, 2003, COMP BIOCHEM PHYS B, V134, P45, DOI 10.1016/S1096-4959(02)00183-5
   RODRIGUES RC, 1988, RECOMBINANT DNA TECH, P162
   ROITSCH CA, 1983, J BACTERIOL, V155, P145
   SUMI H, 1990, ACTA HAEMATOL-BASEL, V84, P139, DOI 10.1159/000205051
   SUMI H, 1987, EXPERIENTIA, V43, P1110, DOI 10.1007/BF01956052
   WANG C, 2006, DOUCHI J IND MICROBI, V33, P750
   Wang J, 1999, Chin J Biotechnol, V15, P83
   YOON K, 2003, KOR J MICROBIOL BIOT, V31, P284
NR 34
TC 18
Z9 20
U1 0
U2 3
PU KOREAN SOC MICROBIOLOGY & BIOTECHNOLOGY
PI SEOUL
PA KOREA SCI TECHNOL CENTER #507,  635-4 YEOGSAM-DONG, KANGNAM-GU, SEOUL
   135-703, SOUTH KOREA
SN 1017-7825
EI 1738-8872
J9 J MICROBIOL BIOTECHN
JI J. Microbiol. Biotechnol.
PD SEP
PY 2007
VL 17
IS 9
BP 1469
EP 1476
PG 8
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA 216JV
UT WOS:000249875200007
PM 18062224
DA 2018-10-20
ER

PT J
AU Mazzocca, AD
   McCarthy, MB
   Arciero, C
   Jhaveri, A
   Obopilwe, E
   Rincon, L
   Wyman, J
   Gronowicz, GA
   Arciero, RA
AF Mazzocca, Augustus D.
   McCarthy, Mary B.
   Arciero, Cristina
   Jhaveri, Ankur
   Obopilwe, Elifho
   Rincon, Lina
   Wyman, Jeffrey
   Gronowicz, Gloria A.
   Arciero, Robert A.
TI Tendon and bone responses to a collagen-coated suture material
SO JOURNAL OF SHOULDER AND ELBOW SURGERY
LA English
DT Article
ID CHONDROITIN SULFATE; TITANIUM IMPLANTS; IN-VITRO; CELLS; PEPTIDE;
   MATRIX; BIOMATERIAL; MODEL
AB Tendon to bone integration after rotator cuff repair is not a reproducible process. During repair, bioabsorbable and nonabsorbable suture material is universally used to facilitate the procedure. Improving the biological architecture of inert suture might aid in overall tendon to bone healing. The objective of our study is to enhance the bone to tendon union by absorbing type I Collagen onto high strength nonabsorbable polyesterlpolyethylene suture commonly used in rotator cuff surgery. Our purpose was to evaluate the tendon and bone cellular response to this novel coated suture compared to uncoated suture. Primary human osteoblasts (HOBs) and tenocytes; were plated onto polyesterlpolyethylene suture that was either uncoated or coated with type I bovine collagen. Cell adhesion to the sutures was assayed at 24 hours. Proliferation was determined at 48 hours by measuring [3H]Thymidine incorporation in cells attached to the sutures. At 24 and 48 hours, respectively, cells grown on the Collagencoated suture showed a significantly greater response measured by adhesion and proliferation than cells grown on uncoated suture. At five days of culture, alkaline phos-phatase activity and protein synthesis was significantly greater on the collagen-coated suture compared to uncoated. Collagen-coated polyester/polyethylene suture appears to stimulate adhesion, proliferation alkaline phosphatase, and protein synthesis more than uncoated sutures, and therefore may aid in the tendon to bone incorporation process critical to rotator cuff repair.
C1 Arthrex Inc, Naples, FL 34108 USA.
RP Mazzocca, AD (reprint author), Univ Connecticut, Dept Orthopaed Surg, MARB Bldg MC 4037, Farmington, CT 06031 USA.
EM mazzocco@uchc.edu
OI Gronowicz, Gloria/0000-0001-7158-3598
CR Bierbaum S, 2006, J BIOMED MATER RES A, V77A, P551, DOI 10.1002/jbm.a.30572
   Bradt JH, 1999, CHEM MATER, V11, P2694, DOI 10.1021/cm991002p
   Dee KC, 1999, BIOMATERIALS, V20, P221, DOI 10.1016/S0142-9612(98)00161-6
   Du C, 1999, J BIOMED MATER RES, V44, P407, DOI 10.1002/(SICI)1097-4636(19990315)44:4<407::AID-JBM6>3.0.CO;2-T
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Kanematsu A, 2004, BIOMATERIALS, V25, P4513, DOI 10.1016/j.biomaterials.2003.11.035
   LAI WF, 2006, INT J ORAL MAXILLOF, V34, P311
   Liu YW, 2006, INVEST OPHTH VIS SCI, V47, P1869, DOI 10.1167/iovs.05-1339
   Maffulli N, 2000, AM J SPORT MED, V28, P499, DOI 10.1177/03635465000280040901
   McCarthy JB, 1996, BIOPOLYMERS, V40, P371, DOI 10.1002/(SICI)1097-0282(1996)40:4<371::AID-BIP3>3.0.CO;2-T
   Minamide A, 2005, SPINE, V30, P1134, DOI 10.1097/01.brs.0000162394.75425.04
   Nakase Y, 2006, TISSUE ENG, V12, P403, DOI 10.1089/ten.2006.12.403
   Pluhar GE, 2006, J BONE JOINT SURG BR, V88B, P960, DOI 10.1302/0301-620X.88B7.17056
   Rammelt S, 2006, BIOMATERIALS, V27, P5561, DOI 10.1016/j.biomaterials.2006.06.034
   Rezania A, 1997, J BIOMED MATER RES, V37, P9, DOI 10.1002/(SICI)1097-4636(199710)37:1<9::AID-JBM2>3.0.CO;2-W
   Rocha LB, 2002, BIOMATERIALS, V23, P449, DOI 10.1016/S0142-9612(01)00126-0
   TAKAOKA K, 1991, J ORTHOPAED RES, V9, P902, DOI 10.1002/jor.1100090617
   WERKMEISTER J A, 1992, Clinical Materials, V9, P137
   Zhang H, 2004, J ORTHOPAED RES, V22, P30, DOI 10.1016/S0736-0266(03)00155-4
   Zreiqat H, 2003, J BIOMED MATER RES A, V64A, P105, DOI 10.1002/jbm.a.10376
NR 20
TC 17
Z9 17
U1 1
U2 12
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1058-2746
J9 J SHOULDER ELB SURG
JI J. Shoulder Elbow Surg.
PD SEP-OCT
PY 2007
VL 16
IS 5
SU S
BP 222S
EP 230S
DI 10.1016/j.jse.2007.02.113
PG 9
WC Orthopedics; Sport Sciences; Surgery
SC Orthopedics; Sport Sciences; Surgery
GA 222XW
UT WOS:000250332800015
PM 17448699
DA 2018-10-20
ER

PT J
AU Jawad, H
   Ali, NN
   Lyon, AR
   Chen, QZ
   Harding, SE
   Boccaccini, AR
AF Jawad, H.
   Ali, N. N.
   Lyon, A. R.
   Chen, Q. Z.
   Harding, S. E.
   Boccaccini, A. R.
TI Myocardial tissue engineering: a review
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Review
DE myocardial infarction; tissue engineering; biomaterials; scaffolds; cell
   therapy
ID EMBRYONIC STEM-CELLS; SKELETAL MYOBLAST TRANSPLANTATION;
   BONE-MARROW-CELLS; ASSEMBLING PEPTIDE NANOFIBERS; BIOENGINEERED CARDIAC
   GRAFTS; SHEET MANIPULATION TECHNIQUE; LEFT-VENTRICULAR FUNCTION;
   IN-VITRO; INFARCTED MYOCARDIUM; HEART-FAILURE
AB Myocardial tissue engineering, a concept that intends to overcome the obstacles to prolonging patients' life after myocardial infarction, is continuously improving. It comprises a biomaterial based 'vehicle', either a porous scaffold or dense patch, made of either natural or synthetic polymeric materials, to aid transportation of cells into the diseased region in the heart. Many different cell types have been suggested for cell therapy and myocardial tissue engineering. These include both autologous and embryonic stem cells, both having their advantages and disadvantages. Biomaterials suggested for this specific tissue-engineering application need to be biocompatible with the cardiac cells and have particular mechanical properties matching those of native myocardium, so that the delivered donor cells integrate and remain intact in vivo. Although much research is being carried out, many questions still remain unanswered requiring further research efforts. In this review, we discuss the various approaches reported in the field of myocardial tissue engineering, focusing on the achievements of combining biomaterials and cells by various techniques to repair the infarcted region, also providing an insight on clinical trials and possible cell sources in cell therapy. Alternative suggestions to myocardial tissue engineering, in situ engineering and left ventricular devices are also discussed. Copyright (c) 2007 John Wiley & Sons, Ltd.
C1 [Jawad, H.; Chen, Q. Z.; Boccaccini, A. R.] Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2BP, England.
   [Ali, N. N.; Lyon, A. R.; Harding, S. E.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW3 6LY, England.
RP Boccaccini, AR (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Mat, Prince Consort Rd, London SW7 2BP, England.
EM a.boccaccini@imperial.ac.uk
RI Boccaccini, Aldo/C-7905-2013
FU British Heart Foundation [FS/11/67/28954]
CR Akhyari P, 2002, CIRCULATION, V106, P1137
   Akins RE, 2002, CIRC RES, V90, P120, DOI 10.1161/res.90.2.120
   Al Attar N, 2002, J ROY COLL SURG EDIN, V47, P749
   Ali NN, 2004, BASIC RES CARDIOL, V99, P382, DOI 10.1007/s00395-004-0484-5
   Anversa P, 2002, J MOL CELL CARDIOL, V34, P91, DOI 10.1006/jmcc.2001.1506
   Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460
   Behfar A, 2002, FASEB J, V16, P1558, DOI 10.1096/fj.02-0072com
   Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303
   Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1
   Birks EJ, 2006, NEW ENGL J MED, V355, P1873, DOI 10.1056/NEJMoa053063
   Birla RK, 2005, TISSUE ENG, V11, P803, DOI 10.1089/ten.2005.11.803
   Boccaccini AR, 2003, COMPOS SCI TECHNOL, V63, P2417, DOI 10.1016/S0266-3538(03)00275-6
   Boheler KR, 2002, CIRC RES, V91, P189, DOI 10.1161/01.RES.0000027865.61704.32
   Bonassar LJ, 1998, J CELL BIOCHEM, P297, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<297::AID-JCB36>3.0.CO;2-6
   BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0
   Bursac N, 1999, AM J PHYSIOL-HEART C, V277, pH433, DOI 10.1152/ajpheart.1999.277.2.H433
   CARRIER R, 2001, BIOTECHNOL BIOENG, V78, P617
   Carrier RL, 1999, BIOTECHNOL BIOENG, V64, P580, DOI 10.1002/(SICI)1097-0290(19990905)64:5<580::AID-BIT8>3.0.CO;2-X
   Carrier RL, 2002, TISSUE ENG, V8, P175, DOI 10.1089/107632702753724950
   Caspi O, 2006, EUR HEART J SUPPL, V8, pE43, DOI 10.1093/eurheartj/sul031
   CHEKANOV V, 2003, PACE, V26, P469
   CHIU RCJ, 1995, ANN THORAC SURG, V60, P12
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Christman KL, 2005, BIOMATERIALS, V26, P1139, DOI 10.1016/j.biomaterials.2004.04.025
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Courtney T, 2006, BIOMATERIALS, V27, P3631, DOI 10.1016/j.biomaterials.2006.02.024
   Cui JH, 2005, CARDIOVASC REVASCULA, V6, P113, DOI 10.1016/j.carrev.2005.07.006
   Dai WD, 2005, J AM COLL CARDIOL, V46, P714, DOI 10.1016/j.jacc.2005.04.056
   Dar A, 2002, BIOTECHNOL BIOENG, V80, P305, DOI 10.1002/bit.10372
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   El Fray M, 2005, MATER LETT, V59, P2300, DOI 10.1016/j.matlet.2005.03.008
   El Fray M, 2003, NANOSTRUCTURED ELAST, P1
   Enomoto Y, 2005, ANN THORAC SURG, V79, P881, DOI 10.1016/j.athorascur.2004.05.072
   Eschenhagen T, 2006, CIRC RES, V98, P573, DOI 10.1161/01.RES.0000215627.13049.5d
   Etzion S, 2001, Am J Cardiovasc Drugs, V1, P233, DOI 10.2165/00129784-200101040-00002
   EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0
   Freed LE, 2006, TISSUE ENG, V12, P3285, DOI 10.1089/ten.2006.12.3285
   Fukuda K, 2001, ARTIF ORGANS, V25, P187, DOI 10.1046/j.1525-1594.2001.025003187.x
   Furuta A, 2006, CIRC RES, V98, P705, DOI 10.1161/01.RES.0000209515.59115.70
   Gaballa MA, 2006, J HEART LUNG TRANSPL, V25, P946, DOI 10.1016/j.healun.2006.04.008
   Grossman PM, 2002, CATHETER CARDIO INTE, V55, P392, DOI 10.1002/ccd.10136
   Guo XM, 2006, CIRCULATION, V113, P2229, DOI 10.1161/CIRCULATIONAHA.105.583039
   Habib N. A., 2005, STEM CELL REPAIR REG
   Haraguchi Y, 2006, BIOMATERIALS, V27, P4765, DOI 10.1016/j.biomaterials.2006.04.034
   HARDING SE, 2007, J PHARM THER, V113, P341
   Hassink RJ, 2003, J AM COLL CARDIOL, V41, P711, DOI 10.1016/S0735-1097(02)02933-9
   Heeschen C, 2004, CIRCULATION, V109, P1615, DOI 10.1161/01.CIR.0000124476.32871.E3
   Heng BC, 2005, MED HYPOTHESES, V64, P1085, DOI 10.1016/j.mehy.2004.11.036
   Hofmann M, 2005, CIRCULATION, V111, P2198, DOI 10.1161/01.CIR.0000163546.27639.AA
   Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878
   Huang NF, 2005, TISSUE ENG, V11, P1860, DOI 10.1089/ten.2005.11.1860
   Hutcheson KA, 2000, CELL TRANSPLANT, V9, P359, DOI 10.1177/096368970000900307
   Ishii O, 2005, J THORAC CARDIOV SUR, V130, P1358, DOI 10.1016/j.jtcvs.2005.05.048
   Iwakura A, 2003, HEART VESSELS, V18, P93, DOI 10.1007/s10380-002-0686-5
   Iyer RK, 2006, J MOL CELL CARDIOL, V40, P877, DOI 10.1016/j.yjmcc.2006.03.322
   Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150
   Kawada H, 2004, BLOOD, V104, P3581, DOI 10.1182/blood-2004-04-1488
   Ke Qingen, 2005, Shengli Xuebao, V57, P673
   Kehat I, 2004, NAT BIOTECHNOL, V22, P1282, DOI 10.1038/nbt1014
   Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI200112131
   Kellar RS, 2005, TISSUE ENG, V11, P1678, DOI 10.1089/ten.2005.11.1678
   Kellar RS, 2001, CIRCULATION, V104, P2063, DOI 10.1161/hc4201.097192
   Kelley ST, 1999, CIRCULATION, V99, P135, DOI 10.1161/01.CIR.99.1.135
   Klemenz A, 2003, J BIOMED MATER RES A, V65A, P237, DOI 10.1002/jbm.a.10473
   Klug MG, 1996, J CLIN INVEST, V98, P216, DOI 10.1172/JCI118769
   Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498
   Kochupura P.V., 2005, CIRCULATION, V112, P1144
   Kofidis T, 2002, J THORAC CARDIOV SUR, V124, P63, DOI 10.1067/mtc.2002.121971
   Kofidis T, 2005, J HEART LUNG TRANSPL, V24, P737, DOI 10.1016/j.healun.2004.03.023
   Kofidis T, 2003, EUR J CARDIO-THORAC, V24, P906, DOI 10.1016/S1010-7940(03)00577-3
   Kofidis T, 2003, TISSUE ENG, V9, P517, DOI 10.1089/107632703322066697
   Kofidis T, 2002, EUR J CARDIO-THORAC, V22, P238, DOI 10.1016/S1010-7940(02)00256-7
   Kofidis T., 2005, CIRCULATION, V112, pI173
   Krupnick AS, 2002, J HEART LUNG TRANSPL, V21, P233, DOI 10.1016/S1053-2498(01)00349-7
   Kumar D, 2005, CORONARY ARTERY DIS, V16, P111, DOI 10.1097/00019501-200503000-00006
   KUTSCHKA I, 2006, CIRCULATION, V114, P176
   LAAKE LWV, 2005, ANN MED, V37, P499
   Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117
   Laflamme MA, 2005, AM J PATHOL, V167, P663, DOI 10.1016/S0002-9440(10)62041-X
   Lanza R, 2000, PRINCIPLES TISSUE EN
   Lehrke S, 2006, CIRC RES, V99, P553, DOI 10.1161/01.RES.0000238375.88582.d8
   Leor J, 2000, CIRCULATION, V102, P56
   Leor J, 2004, ANN NY ACAD SCI, V1015, P312, DOI 10.1196/annals.1302.026
   Leor J, 2005, PHARMACOL THERAPEUT, V105, P151, DOI 10.1016/j.pharmthera.2004.10.003
   Leor J, 2005, J AM COLL CARDIOL, V45, p151A
   Leor J., 2006, CIRCULATION, V114, pI94
   Li RK, 2000, J THORAC CARDIOV SUR, V119, P368, DOI 10.1016/S0022-5223(00)70193-0
   Li RK, 1999, CIRCULATION, V100, P63
   Liu MY, 1999, IN VITRO CELL DEV-AN, V35, P87, DOI 10.1007/s11626-999-0006-8
   Lyon A, 2007, CURR OPIN PHARMACOL, V7, P164, DOI 10.1016/j.coph.2006.10.003
   Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298
   McDevitt T, 2002, J BIOMATER RES A, V66A, P586
   Menasche P, 2002, EUR HEART J SUPPL, V4, pD73, DOI 10.1016/S0195-668X(02)80031-8
   Menasche P, 2001, LANCET, V357, P279, DOI 10.1016/S0140-6736(00)03617-5
   MENRAD C, 2005, LANCET, V366, P1005
   Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51
   Min JY, 2002, J APPL PHYSIOL, V92, P288
   Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391
   Moainie SL, 2002, ANN THORAC SURG, V74, P444, DOI 10.1016/S0003-4975(02)03747-5
   Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68
   Mummery C, 2002, J ANAT, V200, P233, DOI 10.1046/j.1469-7580.2002.00031.x
   Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446
   Murry CE, 1996, J CLIN INVEST, V98, P2512, DOI 10.1172/JCI119070
   Naito H, 2006, CIRCULATION, V114, P172, DOI DOI 10.1161/CIRCULATIONAHA.105.001560
   NORAL F, 2003, BLOOD, V102, P4361
   Nygren JM, 2004, NAT MED, V10, P494, DOI 10.1038/nm1040
   Orlic D, 2002, CIRC RES, V91, P1092, DOI 10.1161/01.RES.0000046045.00846.B0
   Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587
   ORLIC D, 2001, J CELL MOL MED, V9, P25
   Papadaki M, 2001, AM J PHYSIOL-HEART C, V280, pH168
   Park H, 2005, IN VITRO CELL DEV-AN, V41, P188
   Pego AP, 2003, J BIOMED MATER RES A, V67A, P1044, DOI 10.1002/jbm.a.10121
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Piao H, 2007, BIOMATERIALS, V28, P641, DOI 10.1016/j.biomaterials.2006.09.009
   Polak JM, 2006, ANN NY ACAD SCI, V1068, P352, DOI 10.1196/annals.1346.001
   Quaini F, 2002, NEW ENGL J MED, V346, P5, DOI 10.1056/NEJMoa012081
   Radisic M, 2006, BIOTECHNOL BIOENG, V93, P332, DOI 10.1002/bit.20722
   Radisic M, 2003, BIOTECHNOL BIOENG, V82, P403, DOI 10.1002/bit.10594
   Radisic M, 2006, TISSUE ENG, V12, P2077, DOI 10.1089/ten.2006.12.2077
   Ratner B.D., 2004, BIOMATERIALS SCI
   Reinecke H, 2004, HUM GENE THER, V15, P627, DOI 10.1089/1043034041361253
   RemunanLopez C, 1997, J CONTROL RELEASE, V44, P215, DOI 10.1016/S0168-3659(96)01525-8
   Robinson KA, 2005, CIRCULATION, V112, pI135
   Rosenzweig A, 2006, NEW ENGL J MED, V355, P1274, DOI 10.1056/NEJMe068172
   Ryu JH, 2005, BIOMATERIALS, V26, P319, DOI 10.1016/j.biomaterials.2004.02.058
   Sabbah HN, 2003, ANN THORAC SURG, V75, pS13, DOI 10.1016/S0003-4975(03)00463-6
   Sachinidis A, 2003, CARDIOVASC RES, V58, P278, DOI 10.1016/S0008-6363(03)00248-7
   Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186
   Schroder JN, 2006, EUR J CARDIO-THORAC, V29, P848, DOI 10.1016/j.ejcts.2006.02.019
   Scorsin M, 1997, CIRCULATION, V96, P188
   Scorsin M, 2000, J THORAC CARDIOV SUR, V119, P1169, DOI 10.1067/mtc.2000.104865
   Sekine H, 2006, J HEART LUNG TRANSPL, V25, P324, DOI 10.1016/j.healun.2005.09.017
   Sekiya S, 2006, BIOCHEM BIOPH RES CO, V341, P573, DOI 10.1016/j.bbrc.2005.12.217
   Shapiro L, 1997, BIOMATERIALS, V18, P583, DOI 10.1016/S0142-9612(96)00181-0
   Shimizu T, 2002, CIRC RES, V90, pE40, DOI 10.1161/hh0302.105722
   Shimizu T, 2003, BIOMATERIALS, V24, P2309, DOI 10.1016/S0142-9612(03)00110-8
   Shimizu T, 2006, TISSUE ENG, V12, P499, DOI 10.1089/ten.2006.12.499
   Shimizu T, 2001, TISSUE ENG, V7, P141, DOI 10.1089/107632701300062732
   Shin M, 2004, BIOMATERIALS, V25, P3717, DOI 10.1016/j.biomaterials.2003.10.055
   Smits AM, 2005, J CELL MOL MED, V9, P25, DOI 10.1111/j.1582-4934.2005.tb00334.x
   Stankus JJ, 2004, J BIOMED MATER RES A, V70A, P603, DOI 10.1002/jbm.a.30122
   Stojkovic P, 2005, STEM CELLS, V23, P306, DOI 10.1634/stemcells.2004-0137
   Suuronen EJ, 2006, CIRCULATION, V114, pI138
   Takahashi M, 2006, AM J PHYSIOL-HEART C, V291, pH886, DOI 10.1152/ajpheart.00142.2006
   Taylor DA, 1998, NAT MED, V4, P929, DOI 10.1038/nm0898-929
   THOMPSON WD, 1992, J PATHOL, V168, P47, DOI 10.1002/path.1711680109
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Tomita S, 1999, CIRCULATION, V100, P247
   Van Laake LW, 2005, ANN MED, V37, P499, DOI 10.1080/07853890500327843
   Vunjak-Novakovic G, 2006, J CHEM TECHNOL BIOT, V81, P485, DOI 10.1002/jctb.1467
   Walsh RG, 2005, HEART FAIL REV, V10, P101, DOI 10.1007/s10741-005-4637-x
   Wang JS, 2000, J THORAC CARDIOV SUR, V120, P999, DOI 10.1067/mtc.2000.110250
   Wei H, 2005, J CELL MOL MED, V9, P804, DOI 10.1111/j.1582-4934.2005.tb00381.x
   Wobus AM, 1997, J MOL CELL CARDIOL, V29, P1525, DOI 10.1006/jmcc.1997.0433
   Wu KH, 2006, TRANSPL IMMUNOL, V16, P1, DOI 10.1016/j.trim.2006.03.004
   Xiang Z, 2006, TISSUE ENG, V12, P2467, DOI 10.1089/ten.2006.12.2467
   Xu CH, 2002, CIRC RES, V91, P501, DOI 10.1161/01.RES.0000035254.80718.91
   Zammaretti P, 2004, CURR OPIN BIOTECH, V15, P430, DOI 10.1016/j.copbio.2004.08.007
   Zhang PC, 2006, ARTIF ORGANS, V30, P86, DOI 10.1111/j.1525-1594.2006.00186.x
   Zhong SP, 2005, BIOMACROMOLECULES, V6, P2998, DOI 10.1021/bm050318p
   Zimmermann W.H., 2002, CIRCULATION, V106, P1151
   Zimmermann WH, 2004, BIOMATERIALS, V25, P1639, DOI 10.1016/S0142-9612(03)00521-0
   Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394
   Zimmermann WH, 2000, BIOTECHNOL BIOENG, V68, P106
   Zund G, 1997, EUR J CARDIO-THORAC, V11, P493, DOI 10.1016/S1010-7940(96)01005-6
NR 166
TC 131
Z9 135
U1 3
U2 52
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD SEP-OCT
PY 2007
VL 1
IS 5
BP 327
EP 342
DI 10.1002/term.46
PG 16
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 310HS
UT WOS:000256520100001
PM 18038427
DA 2018-10-20
ER

PT J
AU Luttikhuizen, DT
   Harmsen, MC
   van Luyn, MJA
AF Luttikhuizen, Daniel T.
   Harmsen, Martin C.
   van Luyn, Marja J. A.
TI Cytokine and chemokine dynamics differ between rats and mice after
   collagen implantation
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE foreign body reaction; cytokine; chemokine; macrophage; foreign body
   giant cell; PMN
ID FOREIGN-BODY REACTION; DERMAL SHEEP COLLAGEN; BIODEGRADABLE BIOMATERIAL;
   TISSUE REACTION; IFN-GAMMA; IN-VITRO; MACROPHAGES; LIPOPOLYSACCHARIDE;
   INFLAMMATION; SECRETION
AB Implanted scaffold materials induce an inflammatory reaction known as the 'foreign body reaction' (FBR). We hypothesized that the observed difference in FBR between rats and mice correlate with different expression dynamics of cytokines and chemokines, which are key orchestrators of the FBR. After implantation of hexamethylene diisocyanate cross-linked dermal sheep collagen, the overall gene expression pattern of IL-1, IL-6, IL-10, TNF alpha, CXCL1/KC, CXCL2/MIP2 and CCL2/MCP1 was roughly similar for the two species. During the onset of the FBR these genes were maximally expressed in rats and mice, after which the expression decreased to basal levels. The expression of CCL3/MIP1 alpha had a similar course, yet it increased after the progression phase of the FBR in both species. The expression of cytokines and chemokines in sham-operated animals was low throughout, showing that the implanted material by itself exerted the changes in gene expression of the invading cells. During the progression, genes encoding the PMN attractants CXCL1/KC and CXCL2/MIP2 were more highly expressed in mice than in rats, which would explain the prolonged presence of PMNs in mice during the FBR. Additionally, the strong induction of IFN gamma in rats coincided with a higher phagocytotic activity by macrophages. Throughout the FBR, the expression of TGF beta was constitutive and high in both species, but increased in mice during the progression phase. This could explain the extensive stroma formation during the murine FBR. Unexpectedly, the stronger expression of TNFa and CCL3/MIP1 alpha in mice, did not result in high macrophage attraction or phagocytosis of the implanted collagen disks. Copyright (c) 2007 John Wiley & Sons, Ltd.
C1 [Luttikhuizen, Daniel T.; Harmsen, Martin C.; van Luyn, Marja J. A.] Univ Groningen, Univ Med Ctr Groningen, Med Biol Sect, Dept Pathol & Lab Med, NL-9713 GZ Groningen, Netherlands.
RP van Luyn, MJA (reprint author), Univ Groningen, Univ Med Ctr Groningen, Med Biol Sect, Dept Pathol & Lab Med, Hanzepl 1, NL-9713 GZ Groningen, Netherlands.
EM m.j.a.van.luyn@med.umcg.nl
CR Armstrong DA, 2004, J LEUKOCYTE BIOL, V75, P641, DOI 10.1189/jlb.0803370
   Biswas R, 2003, J IMMUNOL, V170, P6202, DOI 10.4049/jimmunol.170.12.6202
   Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159
   CHVAPIL M, 1983, J SURG RES, V35, P402, DOI 10.1016/0022-4804(83)90029-X
   Gessani S, 1998, CYTOKINE GROWTH F R, V9, P117, DOI 10.1016/S1359-6101(98)00007-0
   Hancock WW, 2000, CURR OPIN IMMUNOL, V12, P511, DOI 10.1016/S0952-7915(00)00130-8
   Kalltorp M, 1999, BIOMATERIALS, V20, P2123, DOI 10.1016/S0142-9612(99)00115-5
   Khouw IMSL, 2001, J BIOMED MATER RES, V54, P234, DOI 10.1002/1097-4636(200102)54:2<234::AID-JBM10>3.0.CO;2-S
   Khouw IMSL, 2000, J BIOMED MATER RES, V52, P439, DOI 10.1002/1097-4636(20001205)52:3<439::AID-JBM1>3.0.CO;2-C
   Khouw IMSL, 1998, J BIOMED MATER RES, V41, P202, DOI 10.1002/(SICI)1097-4636(199808)41:2<202::AID-JBM4>3.0.CO;2-M
   Kidd KR, 2002, J BIOMED MATER RES, V59, P682, DOI 10.1002/jbm.10032
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   Marques AP, 2004, J BIOMED MATER RES A, V71A, P419, DOI 10.1002/jbm.a.30155
   Menten P, 2002, CYTOKINE GROWTH F R, V13, P455, DOI 10.1016/S1359-6101(02)00045-X
   Nakagawa H, 1996, BIOCHEM BIOPH RES CO, V220, P945, DOI 10.1006/bbrc.1996.0511
   Ono SJ, 2003, J ALLERGY CLIN IMMUN, V111, P1185, DOI 10.1067/mai.2003.1594
   Popi AF, 2004, IMMUNOLOGY, V113, P348, DOI 10.1111/j.1365-2567.2004.01969.x
   Ramos CDL, 2005, J LEUKOCYTE BIOL, V78, P167, DOI 10.1189/jlb.0404237
   Refai AK, 2004, J BIOMED MATER RES A, V70A, P194, DOI 10.1002/jbm.a.30075
   Robitaille R, 2005, BIOMATERIALS, V26, P4119, DOI 10.1016/j.biomaterials.2004.10.028
   Schmidt-Weber CB, 2004, CURR OPIN IMMUNOL, V16, P709, DOI 10.1016/j.coi.2004.09.008
   Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252
   VANWACHEM PB, 1994, J BIOMED MATER RES, V28, P353, DOI 10.1002/jbm.820280310
   Wagner VE, 2003, J BIOMED MATER RES A, V66A, P62, DOI 10.1002/jbm.a.10516
   WATANABE K, 1991, EXP MOL PATHOL, V55, P30, DOI 10.1016/0014-4800(91)90016-Q
NR 26
TC 16
Z9 16
U1 0
U2 1
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD SEP-OCT
PY 2007
VL 1
IS 5
BP 398
EP 405
DI 10.1002/term.50
PG 8
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 310HS
UT WOS:000256520100008
PM 18038434
DA 2018-10-20
ER

PT J
AU Bodin, A
   Concaro, S
   Brittberg, M
   Gatenholm, P
AF Bodin, Aase
   Concaro, Sebastian
   Brittberg, Mats
   Gatenholm, Paul
TI Bacterial cellulose as a potential meniscus implant
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE bacterial cellulose; biomaterial; meniscus; biomechanics
ID KNEE MENISCUS
AB Traumatic or degenerative meniscal lesions are a frequent problem. The meniscus cannot regenerate after resection. These lesions often progress and lead to osteoarthritis. Collagen meniscal implants have been used in clinical practice to regenerate meniscal tissue after partial meniscectomy. The mechanical properties of bacterial cellulose (BC) gel were compared with a collagen material and the pig meniscus. BC was grown statically in corn steep liquid medium, as described elsewhere. Pig meniscus was harvested from pigs. The collagen implant was packed in sterile conditions until use. The different materials were evaluated under tensile and compression load, using an Instron 5542 with a 500 N load cell. The feasibility for implantation was explored using a pig model. The Young's modulus of bacterial cellulose was measured to be 1 MPa, 100 times less for the collagen material, 0.01 MPa in tensile load. The Young's modulus of bacterial cellulose and meniscus are similar in magnitude under a compression load of 2 kPa and with five times better mechanical properties than the collagen material. At higher compression strain, however, the pig meniscus is clearly stronger. These differences are clearly due to a more ordered and arranged structure of the collagen fibrils in the meniscus. The combination of the facts that BC is inexpensive, can be produced in a meniscus shape, and promotes cell migration makes it an attractive material for consideration as a meniscus implant. Copyright (c) 2007 John Wiley & Sons, Ltd.
C1 [Bodin, Aase; Concaro, Sebastian; Gatenholm, Paul] Chalmers, Dept Chem & Biol Engn, SE-41296 Gothenburg, Sweden.
   [Concaro, Sebastian; Brittberg, Mats] Sahlgrens Univ Hosp, Dept Orthopaed & Regenerat Med, Gothenburg, Sweden.
RP Gatenholm, P (reprint author), Chalmers, Dept Chem & Biol Engn, SE-41296 Gothenburg, Sweden.
EM Paul.Gatenholm@chalmers.se
RI Sano, Michael/E-1715-2011
CR AufderHeide AC, 2004, ANN BIOMED ENG, V32, P1161
   Backdahl H, 2006, BIOMATERIALS, V27, P2141, DOI 10.1016/j.biomaterials.2005.10.026
   Matsuoka M, 1996, BIOSCI BIOTECH BIOCH, V60, P575, DOI 10.1271/bbb.60.575
   Sweigart MA, 2001, TISSUE ENG, V7, P111, DOI 10.1089/107632701300062697
   Tienen TG, 2004, AM J SPORT MED, V32, P1182, DOI 10.1177/0363546503262160
   Zaffagnini S, 2007, KNEE SURG SPORT TR A, V15, P175, DOI 10.1007/s00167-006-0144-4
NR 6
TC 88
Z9 96
U1 5
U2 36
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD SEP-OCT
PY 2007
VL 1
IS 5
BP 406
EP 408
DI 10.1002/term.51
PG 3
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 310HS
UT WOS:000256520100009
PM 18038435
DA 2018-10-20
ER

PT J
AU Catauro, M
   Raucci, MG
   Continenza, MA
AF Catauro, M.
   Raucci, M. G.
   Continenza, M. A.
TI Release kinetics of ampicillin, biocompatibility tests with a fibroblast
   strain of a Zirconia gel glass
SO LETTERS IN DRUG DESIGN & DISCOVERY
LA English
DT Article
DE sol-gel; drug delivery; in vitro biocompatibility
ID BIOMATERIAL; SURFACES; DELIVERY
AB Biocompatibility remains the central theme for biomaterials applications in medicine. It is generally accepted that this term does not indicate only absence of a cytotoxic effect but also positive effects in the sense of biofunctionality, i.e. promotion of biological processes considering the intended aim of the application of a biomaterial.
   Biocompatibility of zirconia gel glass was studied using in vitro testing methods, the incubation period was 7, 14, 21 days. The bioactivity of the synthesized material had been shown by the formation of a layer of hydroxyapatite on the surface of ZrO2-Y2O3(5wt%) samples soaked in a fluid simulating the composition of the human blood plasma (SBF), as observed by SEM and EDS microscopy.
   Studies of drug delivery kinetics were also carried out. The amount of sodium ampicillin released has been detected by UV-VIS spectroscopy. The released kinetics seems to occur in more than one stage. HPLC analysis had also been carried out to ensure the integrity of ampicillin after the synthetic treatment.
C1 Dept Aerosp & Mech Engn, I-81031 Aversa, CE, Italy.
   Univ Aquila, Dept Surg Sci, I-67100 Laquila, Italy.
RP Catauro, M (reprint author), Dept Aerosp & Mech Engn, Real Casa Annunziata Via Roma 29, I-81031 Aversa, CE, Italy.
EM michelina.catauro@unina2.it
CR Campbell C E, 1989, J Invest Surg, V2, P51, DOI 10.3109/08941938909016503
   DENBRABER ET, 1995, J BIOMED MATER RES, V29, P511, DOI 10.1002/jbm.820290411
   DENBRABER ET, 1996, J BIOMED MATER RES, V17, P1093
   Di Silvio L, 1999, J MATER SCI-MATER M, V10, P653
   HENCH LL, 1978, J NON-CRYST SOLIDS, V28, P83, DOI 10.1016/0022-3093(78)90077-7
   HENCH LL, 1974, J BIOMED MATER RES, V8, P49, DOI 10.1002/jbm.820080307
   HENCH LL, 1977, J BIOMED MATER RES, V11, P267, DOI 10.1002/jbm.820110211
   HENCH LL, 1973, J BIOMED MATER RES, V7, P25, DOI 10.1002/jbm.820070304
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   HOHN HP, 1995, IN VITRO CELL DEV-AN, V31, P37
   INGBER DE, 1993, J CELL SCI, V104, P613
   MEYLE J, 1991, J APPL BIOMATER, V2, P273, DOI 10.1002/jab.770020409
   MEYLE J, 1994, J MATER SCI-MATER M, V5, P463, DOI 10.1007/BF00058984
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   PIOTROWSKI G, 1975, J BIOMED MATER RES, V9, P47, DOI 10.1002/jbm.820090408
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   SINGHVI R, 1994, BIOTECHNOL BIOENG, V43, P764, DOI 10.1002/bit.260430811
   Soskolne WA, 1997, J PERIODONTOL, V68, P32, DOI 10.1902/jop.1997.68.1.32
   STEINBERG D, 1990, J PERIODONTOL, V61, P393, DOI 10.1902/jop.1990.61.7.393
   THOMAS M, 1996, ULTAVIOLET VISIBLE S
   WILLIAMS DF, 1987, PROGR BIOMEDICAL ENG
NR 21
TC 11
Z9 11
U1 0
U2 7
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1570-1808
EI 1875-628X
J9 LETT DRUG DES DISCOV
JI Lett. Drug Des. Discov.
PD SEP
PY 2007
VL 4
IS 6
BP 453
EP 459
PG 7
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA 207DT
UT WOS:000249232500012
DA 2018-10-20
ER

PT J
AU Bloisi, F
   Vicari, L
   Papa, R
   Califano, V
   Pedrazzani, R
   Bontempi, E
   Depero, LE
AF Bloisi, F.
   Vicari, L.
   Papa, R.
   Califano, V.
   Pedrazzani, R.
   Bontempi, E.
   Depero, L. E.
TI Biomaterial thin film deposition and characterization by means of MAPLE
   technique
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT Symposium on Current Trends in Nanoscience - From Materials to
   Applications held at the 2006 E-MRS Spring Meeting
CY MAY 29-JUN 02, 2006
CL Nice, FRANCE
SP E-MRS
DE MAPLE (Matrix assisted pulsed laser evaporation); Nd : YAG laser; PEG
   (polyethylene glycol); biomaterials; FTIR microscopy; X-ray reflectivity
ID PULSED-LASER EVAPORATION; MATRIX; ABLATION; POLYMERS; SURFACES; GROWTH
AB Polyethylene glycol (PEG) is a polymer with technologically important applications, especially as a biomaterial. Several biomedical applications (such as tissue engineering, spatial patterning of cells, anti-biofouling and biocompatible coatings) require the application of high quality PEG thin films. In order to have a good adhesion to substrate chemically modified polymer molecules have been used, but for some "in vivo" applications it is essential to deposit a film with the same chemical and structural properties of bulk PEG. Pulsed laser deposition (PLD) technique is generally able to produce high quality thin films but it is inadequate for polymer/organic molecules. MAPLE (Matrix Assisted Pulsed Laser Evaporation) is a recently developed PLD based thin film deposition technique, particularly well suited for organic/polymer thin film deposition. Up to now MAPLE depositions have been carried out mainly by means of modified PLD systems, using excimer lasers operating in UV, but the use of less energetic radiations can minimize the photochemical decomposition of the polymer molecules. We have used a deposition system explicitly designed for MAPLE technique connected to a Q-switched Ng:YAG pulsed laser which can be operated at different wavelength ranging from IR to UV in order to optimise the deposition parameters. The capability of MAPLE technique to deposit PEG has been confirmed and preliminary results show that visible (532 nm wavelength) radiation gives better results with respect to UV (355 nm) radiation. Despite usually UV wavelengths have been used and even if more systematic tests must be performed, it is important to underline that the choice of laser wavelength plays an important role in the application of MAPLE thin film deposition technique. (C) 2007 Published by Elsevier B.V.
C1 Univ Naples Federico 2, Dipartimento Sci Fisiche, CNR, INFM Coherentia, I-80125 Naples, Italy.
   Univ Brescia, Lab Chim Tecnol, I-25123 Brescia, Italy.
RP Bloisi, F (reprint author), Univ Naples Federico 2, Dipartimento Sci Fisiche, CNR, INFM Coherentia, P Le V Tecchio 80, I-80125 Naples, Italy.
EM bloisi@na.infn.it
RI Bloisi, Francesco/A-4296-2008; VICARI, Luciano Rosario Mari/L-6131-2015;
   Depero, Laura/A-3176-2009; Bontempi, Elza/F-3216-2010; Pedrazzani,
   Roberta/L-3176-2015
OI Bloisi, Francesco/0000-0002-9714-9244; VICARI, Luciano Rosario
   Mari/0000-0003-1835-6411; Depero, Laura/0000-0001-7818-3212; Bontempi,
   Elza/0000-0003-1656-7506; Pedrazzani, Roberta/0000-0003-2796-1517
CR BLANCHET GB, 1993, APPL PHYS LETT, V62, P1026, DOI 10.1063/1.108514
   Bontempi E, 2004, RECENT RES DEV CHEM, V5, P461
   Bubb DM, 2002, J APPL PHYS, V91, P2055, DOI 10.1063/1.1427138
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   CHRISEY DB, 1991, THIN SOLID FILMS, V206, P111, DOI 10.1016/0040-6090(91)90402-J
   Chrisey DB, 2003, CHEM REV, V103, P553, DOI 10.1021/cr010428w
   Dalsin JL, 2005, MATER TODAY, V8, P38, DOI 10.1016/S1369-7021(05)71079-8
   Dalsin JL, 2003, J AM CHEM SOC, V125, P4253, DOI 10.1021/ja0284963
   Itina TE, 2001, NUCL INSTRUM METH B, V180, P238, DOI 10.1016/S0168-583X(01)00423-2
   Lowndes DH, 1996, SCIENCE, V273, P898, DOI 10.1126/science.273.5277.898
   Mercado AL, 2005, APPL PHYS A-MATER, V81, P591, DOI 10.1007/s00339-004-2994-2
   Pique A, 2002, APPL SURF SCI, V186, P408, DOI 10.1016/S0169-4332(01)00704-8
   Pique A, 1999, THIN SOLID FILMS, V355, P536, DOI 10.1016/S0257-8972(99)00376-X
   Vansteenkiste SO, 2000, LANGMUIR, V16, P3330, DOI 10.1021/la981740c
   Wu PK, 2001, THIN SOLID FILMS, V398, P607, DOI 10.1016/S0040-6090(01)01347-5
NR 15
TC 22
Z9 22
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD SEP
PY 2007
VL 27
IS 5-8
SI SI
BP 1185
EP 1190
DI 10.1016/j.msec.2006.12.005
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 210SV
UT WOS:000249476800055
DA 2018-10-20
ER

PT J
AU Iucci, G
   Dettin, M
   Battocchio, C
   Gambaretto, R
   Di Bello, C
   Polzonetti, G
AF Iucci, G.
   Dettin, M.
   Battocchio, C.
   Gambaretto, R.
   Di Bello, C.
   Polzonetti, G.
TI Novel immobilizations of an adhesion peptide on the TiO2 surface: An XPS
   investigation
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT Symposium on Current Trends in Nanoscience - From Materials to
   Applications held at the 2006 E-MRS Spring Meeting
CY MAY 29-JUN 02, 2006
CL Nice, FRANCE
SP E-MRS
DE titanium; peptide; immobilization; XPS
ID CELL RESPONSE; TITANIUM; BIOMATERIALS; FILM
AB The covalent attachment of an adhesive peptide, reproducing the 351-359 sequence of human vitronectin, to oxidized titanium surfaces was investigated by XPS spectroscopy. The peptide enhances osteoblast adhesion to titanium, the most used biomaterial for implants and prostheses. Core level spectra of the TiO2 surface and of the biomimetic surface were investigated.
   Novel selective covalent immobilization of (351-359) HVP was carried out by treatment of the TiO2 surface with (3-aminopropyl) triethoxysilane, glutaric anhydride and a side chain protected peptide sequence presenting only a free terminal amino group, followed by side chain deprotection.
   An alternative strategy for covalent attachment consists in photoactivation of physisorbed (351-359) HVP directly on the TiO2 surface; samples were incubated with HVP solution and subsequently irradiated with UV light. A comparison with the results previously obtained for nonselective HVP immobilization will be discussed. (C) 2006 Elsevier B.V. All rights reserved.
C1 Univ Roma Tre, Dept Phys, Unita INSTM, I-00146 Rome, Italy.
   Univ Roma Tre, CISDiC, I-00146 Rome, Italy.
   Univ Padua, Dept Chem Proc Engn, I-35131 Padua, Italy.
RP Iucci, G (reprint author), Univ Roma Tre, Dept Phys, Unita INSTM, Via Vasca Navale 84, I-00146 Rome, Italy.
EM iucci@uniroma3.it
RI battocchio, chiara/M-4686-2015
CR Beamson G., 1992, HIGH RESOLUTION XPS
   Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.3.CO;2-G
   Dee KC, 1999, BIOMATERIALS, V20, P221, DOI 10.1016/S0142-9612(98)00161-6
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   Dettin M, 2002, J BIOMED MATER RES, V60, P466, DOI 10.1002/jbm.10066
   Dettin M, 2005, BIOMATERIALS, V26, P4507, DOI 10.1016/j.biomaterials.2004.11.023
   DETTIN M, UNPUB BIOMATERIALS
   Hiromoto S, 2004, BIOMATERIALS, V25, P979, DOI 10.1016/S0142-9612(03)00620-3
   LEBUGLE A, 1995, BBA-PROTEIN STRUCT M, V1248, P107, DOI 10.1016/0167-4838(95)00009-J
   Moulder J. F., 1996, HDB XRAY PHOTOELECTR
   POLZONETTI G, 1993, APPL SURF SCI, V72, P227, DOI 10.1016/0169-4332(93)90191-D
   Rezania A, 1999, LANGMUIR, V15, P6931, DOI 10.1021/la990024n
   SCHMIDT M, 1991, FRESEN J ANAL CHEM, V341, P412, DOI 10.1007/BF00321947
   SUGAWARA T, 1995, J BIOMED MATER RES, V29, P1047, DOI 10.1002/jbm.820290904
   Xiao SJ, 1998, LANGMUIR, V14, P5507, DOI 10.1021/la980257z
NR 15
TC 20
Z9 20
U1 2
U2 19
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD SEP
PY 2007
VL 27
IS 5-8
SI SI
BP 1201
EP 1206
DI 10.1016/j.msec.2006.09.038
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 210SV
UT WOS:000249476800058
DA 2018-10-20
ER

PT J
AU Hatakeyama, J
   Hatakeyama, Y
   Takahashi, I
   Suzuki, O
   Sasano, Y
AF Hatakeyama, J.
   Hatakeyama, Y.
   Takahashi, I.
   Suzuki, O.
   Sasano, Y.
TI Proliferation and adhesion of periodontal ligament cells on synthetic
   biominerals
SO ORAL DISEASES
LA English
DT Article
DE periodontal ligament; synthetic biominerals; cell adhesion; integrin;
   RGD peptide; cell proliferation
ID IMPLANTED OCTACALCIUM PHOSPHATE; BONE-FORMATION; RGD PEPTIDES; IN-VITRO;
   HYDROXYAPATITE; FIBROBLASTS; AMELOGENIN; REGENERATION; FIBRONECTIN;
   CONVERSION
AB OBJECTIVE: Hydroxiapatite (HA) has been suggested as a useful biomaterial to support the regeneration of tissues. In this study, we investigated the adhesion of periodontal ligament (PDL) cells on octacalcium phosphate (OCP) and its hydrolyzed apatitic product (HL), which are known precursors of HA.
   METHODS: Rat PDL cells were cultured on OCP or HL-coated dishes. Cell proliferation and adhesion and mRNA expression of collagen I, fibronectin integrin subunits were examined. Cell adhesion inhibition assays were carried out by GRGDSPK (Gly-Arg-Gly-Asp-Ser-Pro-Lys).
   RESULTS: In early culture period, the cell number of PDL cells was lower on OCP and HL than that on control without any coating. However, the cell number on OCP or HL caught up with control later period. mRNA expression level of collagen I and fibronectin on OCP and HL were similar among OCP HL and control, although they differed early in the culture period. Integrin subunits were expressed on both OCP and HL as well as on control. Cell adhesion was inhibited by RGD inhibitor peptide.
   CONCLUSION: Our findings indicated that rat PDL cells produce collagen I and fibronectin on OCP and HL, and then show increased cell numbers depending on adhesion to the matrices through integrins.
C1 Tohoku Univ, Grad Sch Dent, Div Craniofacial Dev & Regenerat, Aoba Ku, Sendai, Miyagi 9808575, Japan.
   Tohoku Univ, Grad Sch Dent, Div Pediat Dent, Sendai, Miyagi 980, Japan.
   Tohoku Univ, Grad Sch Dent, Div Orthodont & Dentofacial Orthoped, Sendai, Miyagi 980, Japan.
   Tohoku Univ, Grad Sch Dent, Div Carniofacial Funct Engn, Sendai, Miyagi 980, Japan.
RP Hatakeyama, J (reprint author), Tohoku Univ, Grad Sch Dent, Div Craniofacial Dev & Regenerat, Aoba Ku, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.
EM junko-h@mail.tains.tohoku.ac.jp
CR Azzaroli F, 2002, HEPATOLOGY, V36, P49, DOI 10.1053/jhep.2002.34511
   Bartold PM, 2000, PERIODONTOL 2000, V24, P253, DOI 10.1034/j.1600-0757.2000.2240113.x
   Bodier-Houlle P, 1998, ACTA CRYSTALLOGR D, V54, P1377, DOI 10.1107/S0907444998005769
   BROWN WE, 1962, NATURE, V196, P1050, DOI 10.1038/1961050a0
   Crane NJ, 2006, BONE, V39, P434, DOI 10.1016/j.bone.2006.02.059
   Gilbert M, 2003, J BIOMED MATER RES A, V67A, P69, DOI 10.1002/jbm.a.10053
   Gilbert M, 2000, J BIOL CHEM, V275, P16213, DOI 10.1074/jbc.M001773200
   Grzesik WJ, 1998, J DENT RES, V77, P1606, DOI 10.1177/00220345980770080801
   HAN SW, 2006, ONCOGENE, V113, P1693
   Hatakeyama J, 2006, J DENT RES, V85, P144, DOI 10.1177/154405910608500206
   Hatakeyama J, 2003, J BIOL CHEM, V278, P35743, DOI 10.1074/jbc.M306284200
   Hatakeyama J, 2003, ORAL MICROBIOL IMMUN, V18, P14, DOI 10.1034/j.1399-302X.2003.180103.x
   Hoang AM, 2002, J DENT RES, V81, P497, DOI 10.1177/154405910208100713
   Imaizumi H, 2006, CALCIFIED TISSUE INT, V78, P45, DOI 10.1007/s00223-005-0170-0
   Kamakura S, 2004, J BIOMED MATER RES A, V71A, P299, DOI 10.1002/jbm.a.30157
   Kamakura S, 1999, J DENT RES, V78, P1682, DOI 10.1177/00220345990780110401
   Kamakura S, 2002, J BIOMED MATER RES, V59, P29, DOI 10.1002/jbm.1213.abs
   Kamakura S, 1996, ARCH ORAL BIOL, V41, P1029, DOI 10.1016/S0003-9969(96)00080-5
   Kapila YL, 1998, J PERIODONTOL, V69, P1008, DOI 10.1902/jop.1998.69.9.1008
   Lekic P, 2001, J PERIODONTAL RES, V36, P71, DOI 10.1034/j.1600-0765.2001.360202.x
   Matsumura K, 2004, BIOMATERIALS, V25, P4817, DOI 10.1016/j.biomaterials.2003.11.055
   Milliano MT, 2003, J HEPATOL, V39, P32, DOI 10.1016/S0168-8278(03)00161-2
   Murakami Y, 2003, J PERIODONTOL, V74, P780, DOI 10.1902/jop.2003.74.6.780
   Okamoto K, 1998, J DENT RES, V77, P481, DOI 10.1177/00220345980770030701
   Sasano Y, 1999, ANAT RECORD, V256, P1, DOI 10.1002/(SICI)1097-0185(19990901)256:1<1::AID-AR1>3.0.CO;2-X
   Sawyer AA, 2005, BIOMATERIALS, V26, P1467, DOI 10.1016/j.biomaterials.2004.05.008
   Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0
   Shimono M, 2003, MICROSC RES TECHNIQ, V60, P491, DOI 10.1002/jemt.10290
   SUZUKI O, 1993, BONE MINER, V20, P151, DOI 10.1016/S0169-6009(08)80024-4
   Suzuki O, 2006, BIOMATERIALS, V27, P2671, DOI 10.1016/j.boimaterials.2005.12.004
   Suzuki O, 1995, J DENT RES, V74, P1764, DOI 10.1177/00220345950740110801
   SUZUKI O, 1991, TOHOKU J EXP MED, V164, P37, DOI 10.1620/tjem.164.37
   SUZUKI O, 1995, CELL MATER, V5, P45
   Tohda H, 1997, J ELECTRON MICROSC, V46, P97, DOI 10.1093/oxfordjournals.jmicro.a023496
   van der Pauw MTM, 2002, J PERIODONTAL RES, V37, P317, DOI 10.1034/j.1600-0765.2002.00349.x
   White DJ, 2004, INT J BIOCHEM CELL B, V36, P1405, DOI 10.1016/j.biocel.2003.08.016
NR 36
TC 3
Z9 4
U1 0
U2 8
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 1354-523X
J9 ORAL DIS
JI Oral Dis.
PD SEP
PY 2007
VL 13
IS 5
BP 500
EP 506
DI 10.1111/j.1601-0825.2006.01333.x
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 206PD
UT WOS:000249194500009
PM 17714354
DA 2018-10-20
ER

PT J
AU Ogawa, R
   Oki, K
   Hyakusoku, H
AF Ogawa, Rei
   Oki, Koichiro
   Hyakusoku, Hiko
TI Vascular tissue engineering and vascularized 3D tissue regeneration
SO REGENERATIVE MEDICINE
LA English
DT Review
DE artificial vessels; vascular bundle transfer; vascular graft; vascular
   regeneration; vascular tissue engineering; vascularized tissue
   regeneration
ID GRAFTS; FLAPS; PROSTHESES; POLYTETRAFLUOROETHYLENE; RECONSTRUCTION;
   MUSCLE; FIBRIN
AB Vascularized tissue regeneration has a great deal of potential in clinical medicine. Appropriate 3D tissue regeneration that yields tissue with the desired function and shape requires both growth signals and vascularization. In this paper, we discuss vascularized tissue regeneration using various vessel systems: artificial vessel, autologous vascular graft, autologous vascular bundle transfer and tissue engineered vessel. Vascularized 3D tissue regeneration will require a great deal of additional research before it can be applied to clinical situations. Several promising studies of vascularized tissue regeneration have been reported. However, additional studies into the maturation of neovascularization, the development of effective biomaterial, and the possibility of using stem cells will be needed before these techniques can be used in the clinical situation.
C1 Nippon Med Sch, Dept Plast & Reconstruct Surg, Tokyo 1138603, Japan.
RP Ogawa, R (reprint author), Nippon Med Sch, Dept Plast & Reconstruct Surg, 1-1-5 Sendagi, Tokyo 1138603, Japan.
EM r.ogawa@nms.ac.jp
CR BELDEN TA, 1982, T AM SOC ART INT ORG, V28, P173
   BELL E, 2000, PRINCIPLES TISSUE EN
   BERGGREN A, 1982, PLAST RECONSTR SURG, V69, P19, DOI 10.1097/00006534-198269010-00003
   BOS GW, 1989, ARCH PHYSIOL BIOCHEM, V106, P100
   Bowlin GL, 1997, CELL TRANSPLANT, V6, P623, DOI 10.1016/S0963-6897(97)00096-1
   HARDINYOUNG J, 2000, PRINCIPLES TISSUE EN, P281
   HARII K, 1975, PLAST RECONSTR SURG, V55, P588, DOI 10.1097/00006534-197505000-00008
   HERRING MB, 1987, J VASC SURG, V6, P114, DOI 10.1067/mva.1987.avs0060114
   Hirai T, 1996, ANN PLAS SURG, V37, P394, DOI 10.1097/00000637-199610000-00008
   HYAKUSOKU H, 1993, BRIT J PLAST SURG, V46, P45, DOI 10.1016/0007-1226(93)90064-I
   Jeschke MG, 1999, J VASC SURG, V29, P168, DOI 10.1016/S0741-5214(99)70358-7
   KOSHIMA I, 1991, ANN PLAS SURG, V26, P284, DOI 10.1097/00000637-199103000-00012
   L'Heureux N, 2006, NAT MED, V12, P361, DOI 10.1038/nm1364
   Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109
   Lokmic Z, 2007, FASEB J, V21, P511, DOI 10.1096/fj.06-6614com
   Meinhart JG, 2005, TISSUE ENG, V11, P887, DOI 10.1089/ten.2005.11.887
   Neumeister MW, 2006, PLAST RECONSTR SURG, V117, P116, DOI 10.1097/01.prs.0000195071.01699.ce
   NUNN DB, 1979, ANN SURG, V189, P741, DOI 10.1097/00000658-197906000-00010
   Ogawa Rei, 2006, Curr Stem Cell Res Ther, V1, P13, DOI 10.2174/157488806775269043
   Pan YC, 2006, ANN PLAS SURG, V56, P116, DOI 10.1097/01.sap.0000189705.09281.5a
   Safak T, 1998, ANN PLAS SURG, V41, P156, DOI 10.1097/00000637-199808000-00007
   Sasajima T, 2000, J VASC SURG, V32, P374, DOI 10.1067/mva.2000.105677
   Staudenmaier R, 2004, J RECONSTR MICROSURG, V20, P555, DOI 10.1055/s-2004-836127
   Sukop A, 2005, Acta Chir Plast, V47, P103
   Suma Hisayoshi, 2002, Semin Thorac Cardiovasc Surg, V14, P346, DOI 10.1053/stcs.2002.35299
   Tanaka Y, 2006, PLAST RECONSTR SURG, V117, P1860, DOI 10.1097/01.prs.0000218842.28359.f1
   VOORHEES AB, 1952, ANN SURG, V135, P332, DOI 10.1097/00000658-195203000-00006
   Weiland A J, 1984, Instr Course Lect, V33, P446
   WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816
   Zdrahala RJ, 1996, J BIOMATER APPL, V10, P309, DOI 10.1177/088532829601000402
NR 30
TC 17
Z9 20
U1 2
U2 9
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0751
EI 1746-076X
J9 REGEN MED
JI Regen. Med.
PD SEP
PY 2007
VL 2
IS 5
BP 831
EP 837
DI 10.2217/17460751.2.5.831
PG 7
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA 221ZI
UT WOS:000250265500014
PM 17907934
DA 2018-10-20
ER

PT J
AU Sovar, MM
   Tihan, GT
   Miculescu, F
   Mitran, V
AF Sovar, Maria Magdalena
   Tihan, Gratiela Teodora
   Miculescu, Florin
   Mitran, Valentina
TI Effect of saliva pH on electrochemical stability of Co-Cr-Mo bioalloy
   with a bio-chemically modified surface
SO REVISTA DE CHIMIE
LA English
DT Article
DE biocompatibility; Co-Cr-Mo alloy; collagen gel; electrochemical
   stability; cell viability
ID BEHAVIOR; ALLOYS
AB This paper is focused on the effect of saliva pH on electrochemical stability of Co-Cr-Mo bioalloy with a biochemical surface modification. The surface modification involves treatment with collagen gel oil Co-Cr-Mo alloy used for biomedical applications. It is an approach to controll cell biomaterial interactions using cell adhesion molecules as collagen one of the most abundant protein in the human body and a promoter of cell attachment. Such way to modulate tissue response is associated with electrochemical stability and this paper is a study of corrosion behaviour of collagen treated Co-Cr-Mo alloy in artificial saliva at pH 3 from acid, to neutral and alkaline. The results prove a good electrochemical stability in all cases, combined with positive results regarding its biocompatibility. Contact angle measurements and surface analysis were correlated in order to explain the biocompatibility as a tissue response.
C1 Univ Politehn Bucuresti, Fac Appl Chem & Mat Sci, Bucharest 011061, Romania.
   Univ Politehn Bucuresti, Mat Sci & Engn Fac, Bucharest 060042, Romania.
   Univ Bucharest, Fac Biol, Bucharest 050095, Romania.
RP Sovar, MM (reprint author), Univ Politehn Bucuresti, Fac Appl Chem & Mat Sci, Str Polizu 1-7, Bucharest 011061, Romania.
EM ela_magda@yahoo.com
RI Miculescu, Florin/A-4524-2011
OI Miculescu, Florin/0000-0001-6757-5616; Mitran,
   Valentina/0000-0002-5192-9595
CR Aionicesei E, 2006, REV CHIM-BUCHAREST, V57, P813
   BLAK J, 1988, CORROSION DEGRADATIO, P235
   BUJORIONESCU I, 2003, EUR CELL MAT S1, V5, P10
   Duffo GS, 2004, CORROSION-US, V60, P594, DOI 10.5006/1.3287764
   Geissler U, 2000, J BIOMED MATER RES, V51, P752, DOI 10.1002/1097-4636(20000915)51:4<752::AID-JBM25>3.0.CO;2-7
   Giacomelli FC, 2004, J BRAZIL CHEM SOC, V15, P541, DOI 10.1590/S0103-50532004000400016
   Ionita D, 2007, KEY ENG MATER, V330-332, P545, DOI 10.4028/www.scientific.net/KEM.330-332.545
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Puleo DA, 1996, BIOMATERIALS, V17, P217, DOI 10.1016/0142-9612(96)85766-8
NR 9
TC 2
Z9 2
U1 0
U2 2
PU CHIMINFORM DATA S A
PI BUCHAREST
PA CALEA PLEVNEI NR 139, SECTOR 6, BUCHAREST R-77131, ROMANIA
SN 0034-7752
J9 REV CHIM-BUCHAREST
JI Rev. Chim.
PD SEP
PY 2007
VL 58
IS 9
BP 886
EP 889
PG 4
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA 227DG
UT WOS:000250636800006
DA 2018-10-20
ER

PT J
AU Koide, T
AF Koide, Takaki
TI Designed triple-helical peptides as tools for collagen biochemistry and
   matrix engineering
SO PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
LA English
DT Article
DE biomaterial; collagen; extracellular matrix; peptide; supramolecule;
   triple helix
ID BASEMENT-MEMBRANE COLLAGEN; DEFINED MOLECULAR-WEIGHTS;
   AMINO-ACID-SEQUENCE; CHAPERONE HSP47; MODEL PEPTIDES; BINDING-SITES;
   INTEGRINS ALPHA(1)BETA(1); CONFORMATIONAL PROPERTIES; AMPHIPHILE
   NANOFIBERS; RECOGNITION SITE
AB Collagens, characterized by a unique triple-helical structure, are the predominant component of extracellular matrices (ECMs) existing in all multicellular animals. Collagens not only maintain structural integrity of tissues and organs, but also regulate a number of biological events, including cell attachment, migration and differentiation, tissue regeneration and animal development. The specific functions of collagens are generally triggered by specific interactions of collagen-binding molecules (membrane receptors, soluble factors and other ECM components) with certain structures displayed on the collagen triple helices. Thus, synthetic triple-helical peptides that mimic the structure of native collagens have been used to investigate the individual collagen-protein interactions, as well as collagen structure and stability. The first part of this article illustrates the design of various collagen-mimetic peptides and their recent applications in matrix biology. Collagen is also acknowledged as one of the most promising biornaterials in regenerative medicine and tissue engineering. However, the use of animal-derived collagens in human could put the recipients at risks of pathogen transmission or allergic reactions. Hence, the production of safe artificial collagen surrogates is currently of considerable interest. The latter part of this article reviews recent attempts to develop artificial collagens as novel biomaterials.
C1 Waseda Univ, Grad Sch Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan.
RP Koide, T (reprint author), Waseda Univ, Grad Sch Sci & Engn, Shinjuku Ku, 3-4-1 Ohkubo, Tokyo 1698555, Japan.
EM koi@waseda.jp
CR BACHINGER HP, 1991, INT J BIOL MACROMOL, V13, P152, DOI 10.1016/0141-8130(91)90040-2
   Beck K, 1998, J STRUCT BIOL, V122, P17, DOI 10.1006/jsbi.1998.3965
   Bretscher LE, 2001, J AM CHEM SOC, V123, P777, DOI 10.1021/ja005542v
   Cai WB, 2004, J AM CHEM SOC, V126, P15030, DOI 10.1021/ja0442062
   Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200
   EBLE JA, 1993, EMBO J, V12, P4795, DOI 10.1002/j.1460-2075.1993.tb06168.x
   Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4
   FIELDS CG, 1993, J BIOL CHEM, V268, P14153
   Fields GB, 1996, BIOPOLYMERS, V40, P345, DOI 10.1002/(SICI)1097-0282(1996)40:4<345::AID-BIP1>3.0.CO;2-W
   Fields GB, 1998, BIOPOLYMERS, V47, P143, DOI 10.1002/(SICI)1097-0282(1998)47:2<143::AID-BIP3>3.3.CO;2-P
   Frank S, 2003, J BIOL CHEM, V278, P7747, DOI 10.1074/jbc.C200698200
   Frank S, 2001, J MOL BIOL, V308, P1081, DOI 10.1006/jmbi.2001.4644
   Golbik R, 2000, J MOL BIOL, V297, P501, DOI 10.1006/jmbi.2000.3575
   GOLDBERG I, 1989, GENE, V80, P305, DOI 10.1016/0378-1119(89)90294-1
   Goodman M, 1998, BIOPOLYMERS, V47, P127, DOI 10.1002/(SICI)1097-0282(1998)47:2<127::AID-BIP2>3.0.CO;2-W
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   HEIDEMANN E, 1982, ADV POLYM SCI, V43, P143
   Hodges JA, 2005, J AM CHEM SOC, V127, P15923, DOI 10.1021/ja054674r
   Holmgren SK, 1998, NATURE, V392, P666, DOI 10.1038/33573
   Hosomichi J, 2005, BIOCHEM BIOPH RES CO, V335, P756, DOI 10.1016/j.bbrc.2005.07.140
   Kajino T, 2000, APPL ENVIRON MICROB, V66, P304, DOI 10.1128/AEM.66.1.304-309.2000
   KEMP DS, 1981, J ORG CHEM, V46, P5140, DOI 10.1021/jo00338a014
   Kinberger GA, 2006, INORG CHEM, V45, P961, DOI 10.1021/ic0520059
   Kishimoto T, 2005, BIOPOLYMERS, V79, P163, DOI 10.1002/bip.20348
   Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35
   Koide T, 2005, BIOORG MED CHEM LETT, V15, P5230, DOI 10.1016/j.bmcl.2005.08.041
   Koide T, 2006, J BIOL CHEM, V281, P3432, DOI 10.1074/jc.M509707200
   Koide T, 2006, J BIOL CHEM, V281, P11177, DOI 10.1074/jbc.M601369200
   Koide T, 2005, TOP CURR CHEM, V247, P85, DOI 10.1007/b103820
   Koide T, 2004, BIOORG MED CHEM LETT, V14, P125, DOI 10.1016/j.bmcl.2003.10.005
   Koide T, 2002, J BIOL CHEM, V277, P6178, DOI 10.1074/jbc.M106497200
   Koide T, 2002, J AM CHEM SOC, V124, P9388, DOI 10.1021/ja026182+
   Koide T, 2000, J BIOL CHEM, V275, P27957
   Kotch FW, 2006, P NATL ACAD SCI USA, V103, P3028, DOI 10.1073/pnas.0508783103
   Kozaki K, 1998, J BIOL CHEM, V273, P15125, DOI 10.1074/jbc.273.24.15125
   Kramer RZ, 1999, NAT STRUCT BIOL, V6, P454
   Kramer RZ, 2001, J MOL BIOL, V311, P131, DOI 10.1006/jmbi.2001.4849
   Lauer-Fields JL, 2000, J BIOL CHEM, V275, P13282, DOI 10.1074/jbc.275.18.13282
   Lauer-Fields JL, 2003, J BIOL CHEM, V278, P14321, DOI 10.1074/jbc.M212246200
   Lauer-Fields JL, 2001, BIOCHEMISTRY-US, V40, P5795, DOI 10.1021/bi0101190
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096
   Martin R, 2003, BIOPOLYMERS, V70, P435, DOI 10.1002/bip.10464
   Mechling DE, 2000, J BIOL CHEM, V275, P14532, DOI 10.1074/jbc.275.19.14532
   Minond D, 2004, BIOCHEMISTRY-US, V43, P11474, DOI 10.1021/bi048938i
   Mochizuki M, 2003, FASEB J, V17, P875, DOI 10.1096/fj.02-0564fje
   Muller JCD, 2000, BIOCHEMISTRY-US, V39, P5111, DOI 10.1021/bi992724x
   Myllyharju J, 2005, TOP CURR CHEM, V247, P115, DOI 10.1007/b103821
   Narins RS, 2005, CLIN PLAST SURG, V32, P151, DOI 10.1016/j.cps.2004.12.002
   O'Grady JE, 2003, ADV DRUG DELIVER REV, V55, P1699, DOI 10.1016/j.addr.2003.08.006
   Ogihara NL, 2001, P NATL ACAD SCI USA, V98, P1404, DOI 10.1073/pnas.98.4.1404
   Ottl J, 2000, CHEM BIOL, V7, P119, DOI 10.1016/S1074-5521(00)00077-6
   Ottl J, 1999, J AM CHEM SOC, V121, P653, DOI 10.1021/ja983456d
   Pandya MJ, 2000, BIOCHEMISTRY-US, V39, P8728, DOI 10.1021/bi000246g
   Paramonov SE, 2005, MACROMOLECULES, V38, P7555, DOI 10.1021/ma0514065
   Persikov AV, 2000, BIOCHEMISTRY-US, V39, P14960, DOI 10.1021/bi001560d
   Persikov AV, 2005, J BIOL CHEM, V280, P19343, DOI 10.1074/jbc.M501657200
   Persikov AV, 2005, BIOCHEMISTRY-US, V44, P1414, DOI 10.1021/bi048216r
   Persikov AV, 2002, J MOL BIOL, V316, P385, DOI 10.1006/jmbi.2001.5342
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   PIETU G, 1987, J LAB CLIN MED, V109, P637
   Potekhin SA, 2001, CHEM BIOL, V8, P1025, DOI 10.1016/S1074-5521(01)00073-4
   Rainey JK, 2004, BIOINFORMATICS, V20, P2458, DOI 10.1093/bioinformatics/bth247
   Ramshaw JAM, 1998, J STRUCT BIOL, V122, P86, DOI 10.1006/jsbi.1998.3977
   Raynal N, 2006, J BIOL CHEM, V281, P3821, DOI 10.1074/jbc.M509818200
   Renner C, 2001, ANGEW CHEM INT EDIT, V40, P923, DOI 10.1002/1521-3773(20010302)40:5<923::AID-ANIE923>3.0.CO;2-#
   Reyes CD, 2003, J BIOMED MATER RES A, V65A, P511, DOI 10.1002/jbm.a.10550
   Ricard-Blum S, 2005, TOP CURR CHEM, V247, P35, DOI 10.1007/b103819
   Rosso F, 2005, J CELL PHYSIOL, V203, P465, DOI 10.1002/jcp.20270
   Rump ET, 2002, CHEM-EUR J, V8, P4613, DOI 10.1002/1521-3765(20021018)8:20<4613::AID-CHEM4613>3.0.CO;2-R
   Ruszczak Z, 2003, ADV DRUG DELIVER REV, V55, P1595, DOI 10.1016/j.addr.2003.08.003
   Ryadnov MG, 2003, ANGEW CHEM INT EDIT, V42, P3021, DOI 10.1002/anie.200351418
   Ryadnov MG, 2003, NAT MATER, V2, P329, DOI 10.1038/nmat885
   Ryadnov MG, 2004, J AM CHEM SOC, V126, P7454, DOI 10.1021/ja048144r
   SACCA B, 2002, CHEMBIOCHEM, V9, P904
   Sakaguchi M, 1999, J ALLERGY CLIN IMMUN, V104, P695, DOI 10.1016/S0091-6749(99)70344-1
   SAKAKIBARA S, 1973, BIOCHIM BIOPHYS ACTA, V303, P198, DOI 10.1016/0005-2795(73)90164-5
   SAKAKIBARA S, 1968, B CHEM SOC JPN, V41, P1273, DOI 10.1246/bcsj.41.1273
   Shah NK, 1996, BIOCHEMISTRY-US, V35, P10262, DOI 10.1021/bi960046y
   Shrivastava A, 1997, MOL CELL, V1, P25, DOI 10.1016/S1097-2765(00)80004-0
   Siljander PRM, 2004, J BIOL CHEM, V279, P47763, DOI 10.1074/jbc.M404685200
   Somasundaram R, 2000, J BIOL CHEM, V275, P38170, DOI 10.1074/jbc.M006616200
   Suzuki N, 2005, CONNECT TISSUE RES, V46, P142, DOI 10.1080/03008200591008527
   Suzuki N, 2003, J BIOL CHEM, V278, P45697, DOI 10.1074/jbc.M304667200
   Tanaka Y, 1998, J PEPT RES, V51, P413
   Valluzzi R, 2000, BIOPOLYMERS, V53, P350, DOI 10.1002/(SICI)1097-0282(20000405)53:4<350::AID-BIP7>3.0.CO;2-O
   Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9
   Vogel WF, 2001, EUR J DERMATOL, V11, P506
   Wallace DG, 2003, ADV DRUG DELIVER REV, V55, P1631, DOI 10.1016/j.addr.2003.08.004
   Xu Y, 2000, J BIOL CHEM, V275, P38981, DOI 10.1074/jbc.M007668200
   Yarlagadda PKDV, 2005, BIO-MED MATER ENG, V15, P159
   Yasui N, 2003, J AM CHEM SOC, V125, P15728, DOI 10.1021/ja038148g
   Yasui N, 2003, BIOCHEMISTRY-US, V42, P3160, DOI 10.1021/bi0206558
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zong YN, 2005, EMBO J, V24, P4224, DOI 10.1038/sj.emboj.7600888
NR 96
TC 41
Z9 42
U1 0
U2 16
PU ROYAL SOCIETY
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 0962-8436
J9 PHILOS T R SOC B
JI Philos. Trans. R. Soc. B-Biol. Sci.
PD AUG 29
PY 2007
VL 362
IS 1484
BP 1281
EP 1291
DI 10.1098/rstb.2007.2115
PG 11
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 194VX
UT WOS:000248373000004
PM 17581806
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Kielty, CM
   Stephan, S
   Sherratt, MJ
   Williamson, M
   Shuttleworth, CA
AF Kielty, Cay M.
   Stephan, Simon
   Sherratt, Michael J.
   Williamson, Matthew
   Shuttleworth, C. Adrian
TI Applying elastic fibre biology in vascular tissue engineering
SO PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
LA English
DT Review
DE elastic fibres; blood vessels; tissue engineering; elastin; fibrillin;
   fibulin
ID SMOOTH-MUSCLE-CELLS; FIBRILLIN-RICH MICROFIBRILS; SCANNING PROBE
   MICROSCOPY; DIP-PEN NANOLITHOGRAPHY; ATOMIC-FORCE MICROSCOPY; BETA
   BINDING-PROTEINS; MITRAL-VALVE-PROLAPSE; FORMATION IN-VITRO; LATENT
   TGF-BETA; MARFAN-SYNDROME
AB For the treatment of vascular disease, the major cause of death in Western society, there is an urgent need for tissue-engineered, biocompatible, small calibre artery substitutes that restore biological function. Vascular tissue engineering of such grafts involves the development of compliant synthetic or biomaterial scaffolds that incorporate vascular cells and extracellular matrix. Elastic fibres are major structural elements of arterial walls that can enhance vascular graft design and patency. In blood vessels, they endow vessels with the critical property of elastic recoil. They also influence vascular cell behaviour through direct interactions and by regulating growth factor activation. This review addresses physiological elastic fibre assembly and contributions to vessel structure and function, and how elastic fibre biology is now being exploited in small diameter vascular graft design.
C1 Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England.
RP Kielty, CM (reprint author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.
EM cay.kielty@manchester.ac.uk
RI Sherratt, Michael/A-1175-2015
OI Sherratt, Michael/0000-0003-4759-6617
FU Medical Research Council [G0200246]
CR American Heart Association, 2004, HEART DIS STROK STAT
   Apenberg S, 2003, BIOCHEM BIOPH RES CO, V310, P355, DOI 10.1016/j.bbrc.2003.09.025
   Bachmann J, 2000, J HYDROL, V231, P66, DOI 10.1016/S0022-1694(00)00184-0
   Baguneid M, 2004, BIOTECHNOL APPL BIOC, V39, P151, DOI 10.1042/BA20030148
   Baldock C, 2001, J CELL BIOL, V152, P1045, DOI 10.1083/jcb.152.5.1045
   Ball SG, 2004, INT J BIOCHEM CELL B, V36, P714, DOI 10.1016/j.biocel.2003.10.015
   Bandiera A, 2005, BIOTECHNOL APPL BIOC, V42, P247, DOI 10.1042/BA20050114
   Bax DV, 2007, J CELL SCI, V120, P1383, DOI 10.1242/jcs.003954
   Bax DV, 2003, J BIOL CHEM, V278, P34605, DOI 10.1074/jbc.M303159200
   Bellingham CM, 2001, BBA-PROTEIN STRUCT M, V1550, P6, DOI 10.1016/S0167-4838(01)00262-X
   Bergkvist M, 2003, J BIOMED MATER RES A, V64A, P349, DOI 10.1002/jbm.a.10423
   Berglund JD, 2004, TISSUE ENG, V10, P1526, DOI 10.1089/1076327042500427
   BISACCIA F, 1994, INT J PEPT PROT RES, V44, P332
   Booms P, 2005, HUM GENET, V116, P51, DOI 10.1007/s00439-004-1194-7
   Borschel GH, 2005, TISSUE ENG, V11, P778, DOI 10.1089/ten.2005.11.778
   Bottomley LA, 1998, ANAL CHEM, V70, p425R
   Broekelmann TJ, 2005, J BIOL CHEM, V280, P40939, DOI 10.1074/jbc.M507309200
   Brooke BS, 2003, TRENDS CARDIOVAS MED, V13, P176, DOI 10.1016/S1050-1738(03)00065-3
   Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024
   Cagiannos C, 2005, J VASC SURG, V42, P980, DOI 10.1016/j.jvs.2005.06.018
   Cain SA, 2006, PROTEOMICS, V6, P111, DOI 10.1002/pmic.200401340
   Cain SA, 2005, J BIOL CHEM, V280, P30526, DOI 10.1074/jbc.M501390200
   Charbonneau Noe L, 2004, Birth Defects Res C Embryo Today, V72, P37, DOI 10.1002/bdrc.20000
   Chaudhry SS, 2007, J CELL BIOL, V176, P355, DOI 10.1083/jcb.200608167
   Chaudhry SS, 2001, HUM MOL GENET, V10, P835, DOI 10.1093/hmg/10.8.835
   Chen L, 2004, NEW ASTRON, V10, P39, DOI 10.1016/j.newast.2004.04.008
   Chu Mon-Li, 2004, Birth Defects Res C Embryo Today, V72, P25, DOI 10.1002/bdrc.20003
   Chue WL, 2004, J VASC SURG, V39, P859, DOI 10.1016/j.jvs.2003.03.003
   Civelek M, 2002, J APPL PHYSIOL, V93, P1907, DOI 10.1152/japplphysiol.00988.2001
   Clarke AW, 2005, BIOCHEMISTRY-US, V44, P10271, DOI 10.1021/bi050530d
   Corson GM, 2004, GENOMICS, V83, P461, DOI 10.1016/j.ygeno.2003.08.023
   Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Czirok A, 2006, J CELL PHYSIOL, V207, P97, DOI 10.1002/jcp.20573
   Daly CD, 2004, FRONT BIOSCI, V9, P1915, DOI 10.2741/1384
   Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729
   DAVIS EC, 1993, CELL TISSUE RES, V272, P211, DOI 10.1007/BF00302726
   DAVIS EC, 1993, LAB INVEST, V68, P89
   DEGENNES PG, 1985, REV MOD PHYS, V57, P827, DOI 10.1103/RevModPhys.57.827
   Denis FA, 2002, LANGMUIR, V18, P819, DOI 10.1021/la011011o
   Dietz HC, 2005, AM J MED GENET C, V139C, P4, DOI 10.1002/ajmg.c.30068
   Duca L, 2004, CRIT REV ONCOL HEMAT, V49, P235, DOI 10.1016/j.critrevonc.2003.09.007
   Faury G, 2001, PATHOL BIOL, V49, P310, DOI 10.1016/S0369-8114(01)00147-X
   Freeman LJ, 2005, BIOCHEM J, V388, P1, DOI 10.1042/BJ20050368
   Gao PJ, 2003, J MOL CELL CARDIOL, V35, P1105, DOI 10.1016/S0022-2828(03)00207-4
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Gheduzzi D, 2005, MATRIX BIOL, V24, P15, DOI 10.1016/j.matbio.2004.12.001
   Ghosh J, 2006, J VASC SURG, V43, P142, DOI 10.1016/j.jvs.2005.08.041
   Ghosh J, 2005, CARDIOVASC PATHOL, V14, P28, DOI 10.1016/j.carpath.2004.11.005
   Gobin AS, 2003, J BIOMED MATER RES A, V67A, P255, DOI 10.1002/jbm.a.10110
   Grinnell F, 2003, TRENDS CELL BIOL, V13, P264, DOI 10.1016/S0962-8924(03)00057-6
   Haider M, 2005, MOL PHARMACEUT, V2, P139, DOI 10.1021/mp049906s
   Hamilton DW, 2004, TISSUE ENG, V10, P361, DOI 10.1089/107632704323061726
   HAYNES CA, 1995, J COLLOID INTERF SCI, V169, P313, DOI 10.1006/jcis.1995.1039
   Hellstrom M, 1999, DEVELOPMENT, V126, P3047
   Herrero-Vanrell R, 2005, J CONTROL RELEASE, V102, P113, DOI 10.1016/j.jconrel.2004.10.001
   Hinek A, 2006, J BIOL CHEM, V281, P3698, DOI 10.1074/jbc.M508736200
   Huang R, 2006, CIRC RES, V98, P370, DOI 10.1161/01.RES.0000202051.28319.c8
   Hubbell JA, 2003, CURR OPIN BIOTECH, V14, P551, DOI 10.1016/j.copbio.2003.09.004
   Hungerford JE, 1999, J VASC RES, V36, P2, DOI 10.1159/000025622
   Hyytiainen M, 2004, CRIT REV CL LAB SCI, V41, P233, DOI 10.1080/10408360490460933
   Isogai Z, 2002, J BIOL CHEM, V277, P4565, DOI 10.1074/jbc.M110583200
   Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200
   Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685
   Jean JC, 2002, AM J PHYSIOL-LUNG C, V282, pL75
   JENSEN RP, 2001, INT J GEOMECH, V1, P1, DOI DOI 10.1061/(ASCE)1532-3641(2001)1:1(1)
   Junger A, 2005, MACROMOL BIOSCI, V5, P494, DOI 10.1002/mabi.200400213
   Kannan RY, 2005, J BIOMED MATER RES B, V74B, P570, DOI 10.1002/jbm.b.30247
   Keeley FW, 2002, PHILOS T R SOC B, V357, P185, DOI 10.1098/rstb.2001.1027
   Kielty Cay M., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S146239940600007X
   Kielty CM, 1996, FEBS LETT, V386, P169, DOI 10.1016/0014-5793(96)00423-1
   Kielty CM, 2005, ADV PROTEIN CHEM, V70, P405, DOI 10.1016/S0065-3233(04)70012-1
   KIELTY CM, 1992, J CELL SCI, V103, P445
   Kielty CM, 2002, J CELL SCI, V115, P2817
   KIELTY CM, 2005, SURFACES INTERFACES, P637
   Kielty CM, 2002, CONNECTIVE TISSUE IT, P159
   Kim BS, 1999, NAT BIOTECHNOL, V17, P979, DOI 10.1038/13671
   Kowal RC, 1999, CIRC RES, V84, P1166, DOI 10.1161/01.RES.84.10.1166
   Kozel BA, 2006, J CELL PHYSIOL, V207, P87, DOI 10.1002/jcp.20546
   Krammer A, 2002, MATRIX BIOL, V21, P139, DOI 10.1016/S0945-053X(01)00197-4
   Krijgsman B, 2002, TISSUE ENG, V8, P673, DOI 10.1089/107632702760240580
   L'Heureux N, 1998, FASEB J, V12, P47
   L'Heureux N, 2001, FASEB J, V15, P515, DOI 10.1096/fj.00-0283com
   Lee AA, 2002, J BIOMECH ENG-T ASME, V124, P37, DOI 10.1115/1.1427697
   Lee KB, 2003, J AM CHEM SOC, V125, P5588, DOI 10.1021/ja034236p
   Lee SSJ, 2004, STRUCTURE, V12, P717, DOI 10.1016/j.str.2004.02.023
   Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030
   LIU SQ, 2003, AM J PHYSIOL-HEART C, V285, pH1075
   Liu XQ, 2004, NAT GENET, V36, P178, DOI 10.1038/ng1297
   Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511
   LOMAS AC, BIOCH J
   Long JL, 2003, MATRIX BIOL, V22, P339, DOI 10.1016/S0945-053X(03)00052-0
   Maki JM, 2005, AM J PATHOL, V167, P927, DOI 10.1016/S0002-9440(10)61183-2
   Mann BK, 2002, J BIOMED MATER RES, V60, P86, DOI 10.1002/jbm.10042
   Marson A, 2005, J BIOL CHEM, V280, P5013, DOI 10.1074/jbc.M409029200
   Martin ND, 2005, J SURG RES, V129, P17, DOI 10.1016/j.jss.2005.06.037
   Massague J, 2000, GENE DEV, V14, P627
   McConnell CJ, 1997, J PHYSIOL-LONDON, V499, P513, DOI 10.1113/jphysiol.1997.sp021945
   McIntire LV, 1998, BIOL BULL, V194, P394, DOI 10.2307/1543123
   Mecham R. P., 1994, EXTRACELLULAR MATRIX, P281
   Megill WM, 2005, J EXP BIOL, V208, P3819, DOI 10.1242/jeb.01765
   Merrilees MJ, 2002, CIRC RES, V90, P481, DOI 10.1161/hh0402.105791
   Miao M, 2005, BIOCHEMISTRY-US, V44, P14367, DOI 10.1021/bi0510173
   Miao M, 2003, J BIOL CHEM, V278, P48553, DOI 10.1074/jbc.M308465200
   Michael KE, 2003, LANGMUIR, V19, P8033, DOI 10.1021/la034810a
   Mitchell SL, 2003, CARDIOVASC PATHOL, V12, P59, DOI 10.1016/S1054-8807(02)00183-7
   Mithieux SM, 2005, ADV PROTEIN CHEM, V70, P437, DOI 10.1016/S0065-3233(05)70013-9
   Mithieux SM, 2005, J STRUCT BIOL, V149, P282, DOI 10.1016/j.jsb.2004.11.005
   Mithieux SM, 2004, BIOMATERIALS, V25, P4921, DOI 10.1016/j.biomaterials.2004.01.055
   Mochizuki S, 2002, J BIOL CHEM, V277, P44854, DOI 10.1074/jbc.M205630200
   Morbidelli L, 2003, CLIN CANCER RES, V9, P5358
   Mould AP, 2004, CURR OPIN CELL BIOL, V16, P544, DOI 10.1016/j.ceb.2004.07.003
   Muller DJ, 1997, J STRUCT BIOL, V119, P172, DOI 10.1006/jsbi.1997.3875
   Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a
   Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116
   Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715
   Nguyen AD, 2004, CIRC RES, V95, P1067, DOI 10.1161/01.RES.0000149568.85071.FB
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   OWENS GK, 1995, PHYSIOL REV, V75, P487
   Pepe A, 2005, MATRIX BIOL, V24, P96, DOI 10.1016/j.matbio.2005.01.004
   PEREIRA L, 1993, HUM MOL GENET, V2, P961, DOI 10.1093/hmg/2.7.961
   Pfaff M, 1996, FEBS LETT, V384, P247, DOI 10.1016/0014-5793(96)00325-0
   Piner RD, 1999, SCIENCE, V283, P661, DOI 10.1126/science.283.5402.661
   Privitera S, 1998, J BIOL CHEM, V273, P6319, DOI 10.1074/jbc.273.11.6319
   QUAGLINO D, 2002, CONNECTIVE TISSUE IT, P121
   Quondamatteo F, 2002, MATRIX BIOL, V21, P637, DOI 10.1016/S0945-053X(02)00100-2
   Rashid ST, 2004, CELL PROLIFERAT, V37, P351, DOI 10.1111/j.1365-2184.2004.00318.x
   Reinboth B, 2002, J BIOL CHEM, V277, P3950, DOI 10.1074/jbc.M109540200
   Reinhardt DP, 1996, J MOL BIOL, V258, P104, DOI 10.1006/jmbi.1996.0237
   Ricard-Blum S, 2004, J BIOL CHEM, V279, P2927, DOI 10.1074/jbc.M309868200
   Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200
   Robinson PN, 2002, HUM MUTAT, V20, P153, DOI 10.1002/humu.10113
   Rock MJ, 2004, J BIOL CHEM, V279, P23748, DOI 10.1074/jbc.M400212200
   Rodgers UR, 2004, BIOCHIMIE, V86, P173, DOI 10.1016/j.biochi.2004.03.002
   Saharinen J, 2000, MOL BIOL CELL, V11, P2691, DOI 10.1091/mbc.11.8.2691
   Sakamoto H, 1996, J BIOL CHEM, V271, P4916
   Salacinski HJ, 2003, J BIOMED MATER RES A, V66A, P688, DOI 10.1002/jbm.a.10020
   Schaner PJ, 2004, J VASC SURG, V40, P146, DOI 10.1016/j.jvs.2004.03.033
   Sgarbi N, 2004, BIOMATERIALS, V25, P1349, DOI 10.1016/j.biomaterials.2003.08.017
   Sherratt MJ, 2004, BIOPHYS J, V86, P3211, DOI 10.1016/S0006-3495(04)74369-6
   Sherratt MJ, 2003, J MOL BIOL, V332, P183, DOI 10.1016/S0022-2836(03)00829-5
   Sherratt MJ, 2005, BIOMATERIALS, V26, P7192, DOI 10.1016/j.biomaterials.2005.05.010
   Shi Y, 1996, CIRCULATION, V94, P1655, DOI 10.1161/01.CIR.94.7.1655
   Simionescua DT, 2006, BIOMATERIALS, V27, P702, DOI 10.1016/j.biomaterials.2005.06.013
   Sinha S, 2001, INT J EXP PATHOL, V82, P295, DOI 10.1046/j.1365-2613.2001.00201.x
   Spencer JA, 2005, P NATL ACAD SCI USA, V102, P2946, DOI 10.1073/pnas.0500058102
   Stitzel J, 2006, BIOMATERIALS, V27, P1088, DOI 10.1016/j.biomaterials.2005.07.048
   Swartz DD, 2005, AM J PHYSIOL-HEART C, V288, pH1451, DOI 10.1152/ajpheart.00479.2004
   Tamburro AM, 2005, PATHOL BIOL, V53, P383, DOI 10.1016/j.patbio.2004.12.014
   Tamburro AM, 2005, J BIOL CHEM, V280, P2682, DOI 10.1074/jbc.M411617200
   Thomas AC, 2003, CARDIOVASC PATHOL, V12, P271, DOI 10.1016/S1054-8807(03)00086-3
   Thomas AG, 2005, TOP CAN WEED SCI, V1, P1
   Thurmond FA, 1997, CONNECT TISSUE RES, V36, P211, DOI 10.3109/03008209709160221
   Tiedemann K, 2005, J BIOL CHEM, V280, P11404, DOI 10.1074/jbc.M409882200
   Tiedemann K, 2001, J BIOL CHEM, V276, P36035, DOI 10.1074/jbc.M104985200
   Tiwari A, 2003, EUR J VASC ENDOVASC, V25, P325, DOI 10.1053/ejvs.2002.1854
   Trask BC, 2000, MOL BIOL CELL, V11, P1499, DOI 10.1091/mbc.11.5.1499
   Ueba H, 1997, ARTERIOSCL THROM VAS, V17, P1512, DOI 10.1161/01.ATV.17.8.1512
   Uemura Y, 1997, BIOCHEM MOL BIOL INT, V41, P57
   VANDULM P, 1983, J COLLOID INTERF SCI, V91, P248, DOI 10.1016/0021-9797(83)90329-6
   Vara DS, 2005, PATHOL BIOL, V53, P599, DOI 10.1016/j.patbio.2004.12.006
   Vorp DA, 2005, FRONT BIOSCI, V10, P768, DOI 10.2741/1571
   Walles T, 2003, BIOMATERIALS, V24, P1233, DOI 10.1016/S0142-9612(02)00490-8
   WANG DM, 1995, J BIOMECH ENG-T ASME, V117, P127, DOI 10.1115/1.2792260
   Weyman AE, 2004, J CLIN INVEST, V114, P1543, DOI 10.1172/JCI200423701
   Wiberg C, 2002, J BIOL CHEM, V277, P49120, DOI 10.1074/jbc.M206891200
   Williamson MR, 2006, BIOMATERIALS, V27, P3608, DOI 10.1016/j.biomaterials.2006.02.025
   WILLIAMSON MR, UNPUB FIBULIN 5 FIBR
   Wise SG, 2005, J STRUCT BIOL, V149, P273, DOI 10.1016/j.jsb.2004.11.006
   WojciakStothard B, 1996, EXP CELL RES, V223, P426, DOI 10.1006/excr.1996.0098
   Woodhouse KA, 2004, BIOMATERIALS, V25, P4543, DOI 10.1016/j.biomaterials.2003.11.013
   Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a
   Yang GC, 2002, J AM CHEM SOC, V124, P10648, DOI 10.1021/ja027302g
   Zanetti M, 2004, MOL CELL BIOL, V24, P638, DOI 10.1128/MCB.24.2.638-650.2004
   ZHANG H, 1994, J CELL BIOL, V124, P855, DOI 10.1083/jcb.124.5.855
   Zhang M, 2002, NANOTECHNOLOGY, V13, P212, DOI 10.1088/0957-4484/13/2/315
   Zhang Z, 2004, BIOMATERIALS, V25, P177, DOI 10.1016/S0142-9612(03)00478-2
   Zisch AH, 2004, CURR OPIN BIOTECH, V15, P424, DOI 10.1016/j.copbio.2004.08.005
NR 178
TC 38
Z9 38
U1 4
U2 17
PU ROYAL SOCIETY
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 0962-8436
J9 PHILOS T R SOC B
JI Philos. Trans. R. Soc. B-Biol. Sci.
PD AUG 29
PY 2007
VL 362
IS 1484
BP 1293
EP 1312
DI 10.1098/rstb.2007.2134
PG 20
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 194VX
UT WOS:000248373000005
PM 17588872
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Wang, XY
   Hu, X
   Daley, A
   Rabotyagova, O
   Cebe, P
   Kaplan, DL
AF Wang, Xianyan
   Hu, Xiao
   Daley, Andrea
   Rabotyagova, Olena
   Cebe, Peggy
   Kaplan, David L.
TI Nanolayer biomaterial coatings of silk fibroin for controlled release
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE controlled release; silk fibroin; nanolayers; biomaterials
ID X-RAY-SCATTERING; MULTILAYER FILMS; DRUG-DELIVERY; POLYELECTROLYTE
   MULTILAYERS; INFRARED-SPECTROSCOPY; MOLECULAR-WEIGHT; THERMAL-ANALYSIS;
   SCAFFOLDS; POLYMER; CRYSTALLIZATION
AB An all-aqueous, stepwise deposition process with silk fibroin protein for the assembly of nanoscale layered controlled release coatings was exploited. Model compounds, Rhodamine B, Even Blue and Azoalbumin, representing small molecule drugs and therapeutically relevant proteins were incorporated in the nanocoating process and their loading and release behavior was quantified. In addition, the structure and morphology of the coatings were characterized. Release studies in vitro showed that control of beta-sheet crystal content and the multilayer structure of the silk coatings correlated with the release properties of the incorporated compounds. In particular, higher crystallinity and a thicker silk capping layer suppressed the initial burst of release and prolonged the duration of release. These novel coatings and deposition approach provide a unique option to regulate structure and morphology, and thus release kinetics. The results also suggest these systems as a promising framework for surface engineering of biomaterials and medical devices to regulate the release of drugs, when considered with the all-aqueous process involved, the conformal nature of the coatings, the robust material properties of silk fibroin, and the degradability and biocompatibility of this family of protein. (C) 2007 Elsevier B.V. All rights reserved.
C1 Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   Tufts Univ, Dept Chem, Medford, MA 02155 USA.
   Tufts Univ, Dept Biol & Chem Engn, Medford, MA 02155 USA.
   Tufts Univ, Dept Phys & Astron, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
RI Hu, Xiao/F-2403-2012
OI Hu, Xiao/0000-0002-2579-2820; Cebe, Peggy/0000-0002-8721-644X
FU NIBIB NIH HHS [P41 EB002520-04, P41 EB002520, EB003210, R01 EB003210,
   EB002520]; NIDCR NIH HHS [R01 DE013405, R01 DE013405-04]
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   ASAKURA T, 1985, MACROMOLECULES, V18, P1841, DOI 10.1021/ma00152a009
   Bayraktar O, 2005, EUR J PHARM BIOPHARM, V60, P373, DOI 10.1016/j.ejpb.2005.02.002
   Bini E, 2004, J MOL BIOL, V335, P27, DOI 10.1016/j.jmb.2003.10.043
   Chung AJ, 2002, LANGMUIR, V18, P1176, DOI 10.1021/la010873m
   DECHER G, 1992, THIN SOLID FILMS, V210, P831, DOI 10.1016/0040-6090(92)90417-A
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Forzani ES, 2002, LANGMUIR, V18, P9867, DOI 10.1021/la0264419
   Fraser R. D. B., 1973, CONFORMATION FIBROUS, P94
   Fredin NJ, 2005, LANGMUIR, V21, P5803, DOI 10.1021/la050596+
   Hammond PT, 2004, ADV MATER, V16, P1271, DOI 10.1002/adma.200400760
   He JA, 1998, LANGMUIR, V14, P1674, DOI 10.1021/la971336y
   Hofmann S, 2006, J CONTROL RELEASE, V111, P219, DOI 10.1016/j.jconrel.205.12.009
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Katayama H, 2000, BIOL PHARM BULL, V23, P1229
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Koenig J., 1966, APPL INFRARED SPECTR, P245
   KORSMEYER RW, 1983, INT J PHARM, V15, P25, DOI 10.1016/0378-5173(83)90064-9
   Kumaraswamy G, 2004, MACROMOLECULES, V37, P9005, DOI 10.1021/ma035840n
   LVOV Y, 1995, J AM CHEM SOC, V117, P6117, DOI 10.1021/ja00127a026
   MAGOSHI J, 1979, J POLYM SCI POL PHYS, V17, P515, DOI 10.1002/pol.1979.180170315
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   Nam J, 2001, J APPL POLYM SCI, V81, P3008, DOI 10.1002/app.1751
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Recksiedler CL, 2006, LANGMUIR, V22, P2811, DOI 10.1021/la053031m
   Rinaki E, 2003, INT J PHARM, V255, P199, DOI 10.1016/S0378-5173(03)00079-6
   RITGER P L, 1987, Journal of Controlled Release, V5, P23, DOI 10.1016/0168-3659(87)90034-4
   Rujiravanit R, 2003, MACROMOL BIOSCI, V3, P604, DOI 10.1002/mabi.200300027
   Siepmann J, 2001, ADV DRUG DELIVER REV, V48, P139, DOI 10.1016/S0169-409X(01)00112-0
   Sukhishvili SA, 2002, MACROMOLECULES, V35, P301, DOI 10.1021/ma011346c
   Thierry B, 2003, BIOMACROMOLECULES, V4, P1564, DOI 10.1021/bm0341834
   Um IC, 2001, INT J BIOL MACROMOL, V29, P91, DOI 10.1016/S0141-8130(01)00159-3
   Wang XY, 2005, LANGMUIR, V21, P11335, DOI 10.1021/la051862m
   Wang ZG, 2000, MACROMOLECULES, V33, P978, DOI 10.1021/ma991468t
   WONG FC, 2006, APPL PHYS A, V82, P223
   Wood KC, 2005, LANGMUIR, V21, P1603, DOI 10.1021/la0476480
   Xu H, 2005, POLYMER, V46, P8734, DOI 10.1016/j.polymer.2005.01.105
   Zhu HG, 2005, J AM CHEM SOC, V127, P13448, DOI 10.1021/ja052188y
NR 42
TC 115
Z9 123
U1 3
U2 41
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
J9 J CONTROL RELEASE
JI J. Control. Release
PD AUG 28
PY 2007
VL 121
IS 3
BP 190
EP 199
DI 10.1016/j.jconrel.2007.06.006
PG 10
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 212KH
UT WOS:000249594700008
PM 17628161
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Becker, ML
   Aamer, KA
   Gallant, ND
   Morgan, AW
   Simon, CG
   Roskov, KE
   Yang, YY
AF Becker, Matthew L.
   Aamer, Khaled A.
   Gallant, Nathan D.
   Morgan, Abby W.
   Simon, Carl G., Jr.
   Roskov, Kristen E.
   Yang, Yanyin
TI Identifying "optimal" biomaterial properties using well-defined material
   gradients
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 [Becker, Matthew L.; Aamer, Khaled A.; Gallant, Nathan D.; Morgan, Abby W.; Simon, Carl G., Jr.; Roskov, Kristen E.; Yang, Yanyin] Natl Inst Stand & Technol, Div Polymers, Gaithersburg, MD 20899 USA.
EM matthew.becker@nist.gov; nathan.gallant@nist.gov;
   kristen.roskov@nist.gov
RI Whittington, Abby/D-9266-2014
OI Whittington, Abby/0000-0001-7401-7209
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 19
PY 2007
VL 234
MA 464-PMSE
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA V12IW
UT WOS:000207593905795
DA 2018-10-20
ER

PT J
AU Chung, C
   Brey, DM
   Ifkovits, JL
   Burdick, JA
AF Chung, Cindy
   Brey, Darren M.
   Ifkovits, Jamie L.
   Burdick, Jason A.
TI Controlling novel photocrosslinked biomaterial properties through
   macromer structure
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 [Chung, Cindy; Brey, Darren M.; Ifkovits, Jamie L.; Burdick, Jason A.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.
EM cchung3@seas.upenn.edu; brey@seas.upenn.edu; ifkovits@seas.upenn.edu;
   burdick2@seas.upenn.edu
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 19
PY 2007
VL 234
MA 187-PMSE
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA V12IW
UT WOS:000207593905379
DA 2018-10-20
ER

PT J
AU Hwang, DS
   Gim, Y
   Cha, HJ
AF Hwang, Dong Soo
   Gim, Youngsoo
   Cha, Hyung Joon
TI BIOT 454-Novel cell adhesion biomaterial based on mussel adhesive
   protein fused with RGD peptide
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 [Hwang, Dong Soo; Gim, Youngsoo; Cha, Hyung Joon] POSTECH Pohang Univ Sci & Technol, Dept Chem Engn, Pohang 790784, South Korea.
EM pang@postech.ac.kr; kugjung@postech.ac.kr; hjcha@postech.ac.kr
RI Hwang, Dong Soo/C-7291-2011
OI Hwang, Dong Soo/0000-0002-2487-2255
NR 0
TC 0
Z9 0
U1 1
U2 2
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 19
PY 2007
VL 234
MA 454-BIOT
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA V12IW
UT WOS:000207593903026
DA 2018-10-20
ER

PT J
AU Wang, XY
   Vepari, C
   Abraham, L
   Murphy, A
   Wang, XQ
   Kaplan, DL
AF Wang, Xianyan
   Vepari, Charu
   Abraham, Leah
   Murphy, Amanda
   Wang, Xiaoqin
   Kaplan, David L.
TI POLY 533-Protein biomaterial designs to direct cell and tissue outcomes
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 [Vepari, Charu; Abraham, Leah; Murphy, Amanda; Wang, Xiaoqin; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Biotechnol & Bioengn Ctr, Medford, MA 02155 USA.
EM xianyan.want@tufts.edu; Amanda.Murphy@tufts.edu; David.Kaplan@tufts.edu
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 19
PY 2007
VL 234
MA 533-POLY
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA V12IW
UT WOS:000207593908665
DA 2018-10-20
ER

PT J
AU Cass, AEG
AF Cass, A. E. G.
TI Building bioelectronic interfaces
SO ELECTRONICS LETTERS
LA English
DT Letter
ID PROTEIN; IMMOBILIZATION; NANOSCALE; SURFACES; FILMS; CONSTRUCTION;
   BIOMOLECULES; NANOFIBERS; BIOSENSOR; CHIPS
AB Combining the unique properties of electronic materials and devices and bionnaterials is currently an area of intense interest and opportunity. However, there are obvious incompatibilities between the 'hard' properties of electronic materials and the 'soft' properties of biomatcrials. Combined with this is the need to ensure retention of function as well as spatial control over the biomaterial deposition and effective coupling of the two elements. Advances in molecular engineering, nanotechnology, fabrication and the introduction of novel characterisation tools are opening exciting opportunities in this highly multidisciplinary field.
C1 Univ London Imperial Coll Sci Technol & Med, Inst Biomed Engn, London SW7 2AZ, England.
RP Cass, AEG (reprint author), Univ London Imperial Coll Sci Technol & Med, Inst Biomed Engn, London SW7 2AZ, England.
EM t.cass@imperial.ac.uk
CR Carrico I. S., 2007, J AM CHEM SOC, V129, P4874
   Choi HJ, 2005, ANAL BIOCHEM, V347, P60, DOI 10.1016/j.ab.2005.08.015
   Christman KL, 2006, LANGMUIR, V22, P7444, DOI 10.1021/la0608213
   Drakakis TS, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2359533
   Falsey JR, 2001, BIOCONJUGATE CHEM, V12, P346, DOI 10.1021/bc000141q
   Gilardi G, 2001, TRENDS BIOTECHNOL, V19, P468, DOI 10.1016/S0167-7799(01)01769-3
   Halliwell CM, 2002, ANAL CHIM ACTA, V453, P191, DOI 10.1016/S0003-2670(01)01408-8
   Hammond PT, 2004, ADV MATER, V16, P1271, DOI 10.1002/adma.200400760
   Hoff JD, 2004, NANO LETT, V4, P853, DOI 10.1021/nl049758x
   Hou CSJ, 2006, ANAL CHEM, V78, P2526, DOI 10.1021/ac0520689
   Hu Y, 2005, LANGMUIR, V21, P9103, DOI 10.1021/la046857h
   Huang X, 2007, J BIOCHEM BIOPH METH, V70, P435, DOI 10.1016/j.jbbm.2006.10.006
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Kanno S, 2000, J BIOTECHNOL, V76, P207, DOI 10.1016/S0168-1656(99)00186-8
   Kumar N, 2005, LANGMUIR, V21, P6652, DOI 10.1021/la050331v
   Lee CS, 2003, BIOSENS BIOELECTRON, V18, P437, DOI 10.1016/S0956-5663(02)00147-1
   Lee NY, 2006, BIOSENS BIOELECTRON, V21, P2188, DOI 10.1016/j.bios.2005.11.003
   Lemieux B, 1998, MOL BREEDING, V4, P277, DOI 10.1023/A:1009654300686
   Li D, 2004, ADV MATER, V16, P1151, DOI 10.1002/adma.200400719
   Michel M, 2006, LANGMUIR, V22, P2358, DOI 10.1021/la053006g
   Murugan R, 2006, TISSUE ENG, V12, P435, DOI 10.1089/ten.2006.12.435
   Pena DJ, 2003, LANGMUIR, V19, P9028, DOI 10.1021/la034787t
   Petrou PS, 2007, BIOSENS BIOELECTRON, V22, P1994, DOI 10.1016/j.bios.2006.08.036
   Ramsay G, 1998, NAT BIOTECHNOL, V16, P40, DOI 10.1038/nbt0198-40
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Schoning MJ, 2005, SENSORS-BASEL, V5, P126, DOI 10.3390/s5030126
   Schulze H, 2005, ANAL CHEM, V77, P5823, DOI 10.1021/ac050383p
   SZENTGYORGYI A, 1968, SCIENCE, V161, P988, DOI 10.1126/science.161.3845.988
   Toumazou C, 2007, ELECTRON LETT, V43, P65, DOI 10.1049/el:20073870
   Wada A, 2003, J AM CHEM SOC, V125, P16228, DOI 10.1021/ja036459l
   Wilchek M., 1998, IMMOBILIZED BIOMOLEC, P15
   Zheng LZ, 2006, CURR ANAL CHEM, V2, P279, DOI 10.2174/157341106777698260
NR 32
TC 4
Z9 4
U1 0
U2 3
PU INST ENGINEERING TECHNOLOGY-IET
PI HERTFORD
PA MICHAEL FARADAY HOUSE SIX HILLS WAY STEVENAGE, HERTFORD SG1 2AY, ENGLAND
SN 0013-5194
J9 ELECTRON LETT
JI Electron. Lett.
PD AUG 16
PY 2007
VL 43
IS 17
BP 903
EP 905
DI 10.1049/el:20072159
PG 3
WC Engineering, Electrical & Electronic
SC Engineering
GA 207WQ
UT WOS:000249282200001
DA 2018-10-20
ER

PT J
AU Karkhaneh, A
   Mirzadeh, H
   Ghaffariyeh, AR
AF Karkhaneh, A.
   Mirzadeh, H.
   Ghaffariyeh, A. R.
TI Simultaneous graft copolymerization of 2-hydroxyethyl methacrylate and
   acrylic acid onto polydimethylsiloxane surfaces using a two-step plasma
   treatment
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE two-step plasma treatment; surface modification; polydimetylsiloxane;
   hydroxyethyl methacrylate; acrylic acid; graft copolymerization
ID SILICONE-RUBBER MEMBRANE; ETHYLENE-PROPYLENE RUBBER; GLOW-DISCHARGE;
   BIOMEDICAL APPLICATIONS; ARTIFICIAL CORNEA; CELL ATTACHMENT; IN-VITRO;
   ACRYLAMIDE; POLYMERIZATION; BIOMATERIAL
AB Acrylic acid (AAc) and 2-hydroxyethyl methacrylate (HEMA) mixtures were simultaneously grafted onto the surfaces of polydimethylsiloxane (PDMS) films using a two-step oxygen plasma treatment (TSPT). The first step of this method includes: oxygen plasma pretreatment of the PDMS films, immersion in HEMA/AAc mixtures, removal from the mixtures, and drying. The second step was carried out by plasma copolymerization of preadsorbed reactive monomers on the surfaces of dried pretreated films. The effects of pretreatment and polymerization time length, monomer concentration, and ratio on peroxide formation and graft amount were studied. The films were characterized by attenuated total reflection Furrier transformer infrared (ATR-FTIR) spectroscopy, scanning electron microscopy (SEM), atomic force microscopy (AFM), zeta potential, surface tension, and water contact angle measurements. The ATR-FTIR spectrum of the modified film after alkaline treatment showed the two new characteristic bands of PHEMA and PAAc. Both increase the polar part of surface tension (7,) after grafting and the evaluation of surface charge at pH 1.8, 7, and 12 confirmed the presence of polar groups on the surface of grafted films with a mixture of HEMA/AAc. Morphological studies using both AFM and SEM evaluation illustrated various amounts of grafted copolymer on the surface of PDMS films. (c) 2007 Wiley Periodicals, Inc.
C1 Amir Kabir Univ Technol, Biomed Engn Dept, Tehran, Iran.
   Iran Polymer & Petrochem Inst, Dept Biomat, Tehran, Iran.
   Shiraz Univ, Fasa Med Sch, Ophthalmol Ward, Shiraz, Iran.
RP Mirzadeh, H (reprint author), Amir Kabir Univ Technol, Biomed Engn Dept, Tehran, Iran.
EM h.mirzadeh@ippi.ac.ir
OI Karkhaneh, Akbar/0000-0003-0514-4858
CR Abbasi F, 2002, POLYM INT, V51, P882, DOI 10.1002/pi.1069
   Abbasi F, 2001, POLYM INT, V50, P1279, DOI 10.1002/pi.783
   Aucoin L, 2002, J BIOMAT SCI-POLYM E, V13, P447, DOI 10.1163/156856202320253956
   BODAS DS, 2005, APPL SURF SCI, V254, P186
   Chang PCT, 1998, J BIOMED MATER RES, V39, P380
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Chun HJ, 1999, J APPL POLYM SCI, V72, P251, DOI 10.1002/(SICI)1097-4628(19990411)72:2<251::AID-APP10>3.0.CO;2-V
   Dadsetan M, 2001, J BIOMED MATER RES, V57, P183, DOI 10.1002/1097-4636(200111)57:2<183::AID-JBM1157>3.0.CO;2-M
   DE S, 2005, J BIOMAT SCI-POLYM E, V16, P937
   DEVANATHAN T, 1981, BIOMATER ARTIF CELL, V9, P225, DOI 10.3109/10731198109119002
   ELIMELECH M, 1994, DESALINATION, V95, P269, DOI 10.1016/0011-9164(94)00064-6
   Hsiue GH, 1998, J BIOMED MATER RES, V42, P134, DOI 10.1002/(SICI)1097-4636(199810)42:1<134::AID-JBM17>3.0.CO;2-L
   HSIUE GH, 1993, BIOMATERIALS, V14, P591
   HSIUE GH, 1994, BIOMATERIALS, V15, P591
   INAGAKI N, 1996, PLASMA SURFACE MODIF, pCH3
   ITO Y, 1992, MACROMOLECULES, V25, P7313, DOI 10.1021/ma00052a037
   Khorasani MT, 2004, COLLOID SURFACE B, V35, P67, DOI 10.1016/j.colsurfb.2004.01.011
   Khorasani MT, 2004, J BIOMAT SCI-POLYM E, V15, P59, DOI 10.1163/156856204322752237
   Khorasani MT, 1999, RADIAT PHYS CHEM, V55, P685, DOI 10.1016/S0969-806X(99)00212-1
   Klenkler BJ, 2005, BIOMATERIALS, V26, P7286, DOI 10.1016/j.biomaterials.2005.05.045
   LAWTON RA, 2004, COLLOID SURF A, V253, P213
   Lee SD, 1996, BIOMATERIALS, V17, P1599, DOI 10.1016/0142-9612(95)00316-9
   Lee SD, 1996, BIOMATERIALS, V17, P587, DOI 10.1016/0142-9612(96)88709-6
   LEE SD, 1994, J APPL POLYM SCI, V54, P1279, DOI 10.1002/app.1994.070540909
   Lee SD, 1996, J POLYM SCI POL CHEM, V34, P141, DOI 10.1002/(SICI)1099-0518(19960115)34:1<141::AID-POLA15>3.0.CO;2-L
   MILLS KL, 2006, MAT RES SOC S P 924E
   MIRZADEH H, 1995, BIOMATERIALS, V16, P641, DOI 10.1016/0142-9612(95)93862-8
   MIRZADEH H, 1993, RADIAT PHYS CHEM, V42, P53, DOI 10.1016/0969-806X(93)90201-5
   MORRISON RT, 1987, ORGANIC CHEM, pCH18
   OCCHIELLO E, 1991, J APPL POLYM SCI, V42, P551, DOI 10.1002/app.1991.070420228
   OKADA T, 1991, MAKROMOL CHEM, V192, P1705
   ORLANDER B, 2004, J APPL POLYM SCI, V91, P4098
   OWEN MJ, 1994, J ADHES SCI TECHNOL, V8, P1063, DOI 10.1163/156856194X00942
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   RATNER BD, 1978, J APPL POLYM SCI, V22, P643, DOI 10.1002/app.1978.070220306
   SCHURZ J, 1990, J MACROMOL SCI CHEM, VA27, P1673
   SIOSHANSI P, 1987, MATER SCI ENG, V90, P373, DOI 10.1016/0025-5416(87)90235-7
   Suh TS, 2002, J APPL POLYM SCI, V85, P2361, DOI 10.1002/app.10870
   SUZUKI M, 1986, MACROMOLECULES, V19, P1804, DOI 10.1021/ma00161a005
   TERLINGEN JGA, 1993, J COLLOID INTERF SCI, V155, P55, DOI 10.1006/jcis.1993.1009
   TERLINGEN JGA, 1993, J BIOMAT SCI-POLYM E, V4, P165, DOI 10.1163/156856293X00500
   UCHIDA E, 1990, J POLYM SCI A, V28, P2883
   WADDELL WH, 1992, RUBBER CHEM TECHNOL, V65, P687, DOI 10.5254/1.3538634
   Walker SL, 2002, LANGMUIR, V18, P2193, DOI 10.1021/la011284j
   Zhang J, 1997, J APPL POLYM SCI, V64, P1713, DOI 10.1002/(SICI)1097-4628(19970531)64:9<1713::AID-APP6>3.0.CO;2-I
NR 45
TC 32
Z9 33
U1 0
U2 27
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD AUG 15
PY 2007
VL 105
IS 4
BP 2208
EP 2217
DI 10.1002/app.26216
PG 10
WC Polymer Science
SC Polymer Science
GA 183MJ
UT WOS:000247576600061
DA 2018-10-20
ER

PT J
AU Parekh, BB
   Joshi, MJ
   Vaidya, ADB
AF Parekh, Bharat B.
   Joshi, M. J.
   Vaidya, A. D. B.
TI Modification of gel technique for nucro-crystals of biomaterials: In
   situ growth and dissolution studies
SO CURRENT SCIENCE
LA English
DT Article
DE biocrystals; gel growth; litholytic agent; micro-crystals; urolithiasis
ID CITRIC-ACID; CRYSTALLIZATION; NEPHROLITHIASIS; CATARACTS; CITRATE
AB In the process of biocrystallization and biomineralization, the growth of crystals occurs under tissue conditions prevalent in the body. Many biomaterial crystals are initiated at micrometre size and have different morphologies. Such micro-crystals play a pathogenetic role in different diseases. Hence, an in vitro method to induce micro-crystals of biomaterials is desirable as a model to study the morphogenesis as well as its reversal by intervention. A modified gel technique for the growth of micro-crystals of biomaterials is proposed. The growth of urinary type-calcium hydrogen phosphate dihydrate (CHPD) is carried out to verify the utility of the technique. Growth inhibition and dissolution of CHPD crystals by solutions of different concentrations of citric acid is studied in situ. This technique is economical, needs less amount of material and can be used in batches in aseptic conditions with in situ observations under optical microscope. For in vitro studies of growth inhibition and dissolution of biomaterial crystals by different solutions and herbal ayurvedic plant under aseptic conditions, the present model provides a screening tool for drug development of urinary litholytic agents.
C1 Nirma Univ Sci & Technol, Inst Diploma Studies, Ahmadabad 384481, Gujarat, India.
   Saurashtra Univ, Dept Phys, Crystal Growth Lab, Rajkot 360005, Gujarat, India.
   Bhavans SPARC, Bombay 400049, Maharashtra, India.
RP Joshi, MJ (reprint author), Nirma Univ Sci & Technol, Inst Diploma Studies, Ahmadabad 384481, Gujarat, India.
EM mshilp24@rediffmail.com
CR Brooks DG, 2002, INVEST OPHTH VIS SCI, V43, P1121
   Chayen NE, 1999, J CRYST GROWTH, V198, P649, DOI 10.1016/S0022-0248(98)01151-8
   Dalbeth N, 2005, RHEUMATOLOGY, V44, P1090, DOI 10.1093/rheumatology/keh640
   DOHERTY M, 1988, RHEUM DIS CLIN N AM, V14, P395
   Ettinger B, 1997, J UROLOGY, V158, P2069, DOI 10.1016/S0022-5347(01)68155-2
   Garcia E, 1999, J CRYST GROWTH, V198, P1360, DOI 10.1016/S0022-0248(98)01023-9
   GOGTE VM, AYURVEDIC PHARM THER
   GUPTA SJ, 2002, INDIAN RHEUMATOL ASS, V10, P5
   Henisch H.K., 1973, CRYSTAL GROWTH GELS, P41
   HENISCH HK, 1965, J PHYS CHEM SOLIDS, V26, P493
   HENNESSY A, 2003, 6 INT WORKSH CRYST G
   Holmback X, 1999, J CRYST GROWTH, V198, P780, DOI 10.1016/S0022-0248(98)01027-6
   HONGKORNG E, 2004, CURR RHEUM REP, V6, P221
   HWANG DQ, 1996, J LIPID RES, V37, P606
   JOSEPH KC, 2005, CURR SCI, V85, P1232
   JOSHI V, 2005, URINARY CALCULUS DIS
   Joshi VS, 2005, J CRYST GROWTH, V275, pE1403, DOI 10.1016/j.jcrysgro.2004.11.240
   Joshi VS, 2003, INDIAN J PURE AP PHY, V41, P183
   Joshi VS, 2003, CRYST RES TECHNOL, V38, P817, DOI 10.1002/crat.200310100
   KHORY RN, 1984, MAT MED INDIA THEIR
   LEFAUCHEUX F, 1995, INT C CRYST GROWTH 9
   Mattle D, 2005, UROL RES, V33, P73, DOI 10.1007/s00240-005-0464-8
   Menon M., 1998, CAMPBELLS UROLOGY, V3, P2661
   PADMAVATI S, 2005, PREVENTION HEART DIS
   Pande A, 2001, P NATL ACAD SCI USA, V98, P6116, DOI 10.1073/pnas.101124798
   Parekh BB, 2005, INDIAN J PURE AP PHY, V43, P675
   SCHNEIDER HJ, 1985, HDB UROLOGY, V1, P137
   SEEGMILLER JE, 1962, JAMA-J AM MED ASSOC, V469, P180
   Seltzer MA, 1996, J UROLOGY, V156, P907, DOI 10.1016/S0022-5347(01)65659-3
   SIKRIC M, 1998, PROG COLLOID POLYM S, V110, P300
   VANIVAN A, MICROCRYSTAL GROWTH
   WARD MD, 2003, 6 INT WORKSH CRYST G
   Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646
   WRENN SP, 2001, CHEM ENG, P1
NR 34
TC 8
Z9 8
U1 0
U2 5
PU CURRENT SCIENCE ASSOC
PI BANGALORE
PA C V RAMAN AVENUE, PO BOX 8005, BANGALORE 560 080, INDIA
SN 0011-3891
J9 CURR SCI INDIA
JI Curr. Sci.
PD AUG 10
PY 2007
VL 93
IS 3
BP 373
EP 378
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 205SQ
UT WOS:000249135300028
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Ishikawa, J
   Tsuji, H
   Sato, H
   Gotoh, Y
AF Ishikawa, Junzo
   Tsuji, Hiroshi
   Sato, Hiroko
   Gotoh, Yasuhito
TI Ion implantation of negative ions for cell growth manipulation and
   nervous system repair
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 14th International Conference on Surface Modification by Ion Beams
   (SMMIB 05)
CY SEP 04-09, 2005
CL Kusadasi, TURKEY
SP TUBITAK, Ege Univ, AKZ NOBEL KEMIPOL A S, ESBAS, HIPOKRAT A S, EYUP ALTAN, MEHMET ALTAN, MUSTAFA ALTAN, Off Naval Res Global, CemeCon Scandinavia, EBSO, Ford Otosan, Turk Otomobil Fabridasi, Egen Otomotiv Sanayi ve Ticaret A S, Kale Kahp Makina ve Kalp Sanayi A S, Canakkale Seramilk Kalevodur, Kale Grp, Ege Univ Sci & Technol Ctr, Mat Res Soc
DE negative-ion implantation; biomaterial; neuron; nerve regeneration
ID SILICONE CHAMBER; REGENERATION; SURFACE; GAP; POLYSTYRENE; MATRIX; RAT
AB We use a negative-ion implantation technique for surface modification for novel biological purpose. Negative-ion implantation has an advantage of '' charge-up free '' property of implanted material surfaces when negative ions are implanted into an insulator such as polymers for biomaterial use. We performed the modification of polymer surfaces so as to enhance the growth of neurons when cultured on the modified surfaces by negative ions such as carbon, silver, copper etc. Regions of growth enhancement can be formed on the surface, thus providing a tool for selective and enhanced neuron cell growth. This approach to neuronal growth stimulation could offer a technique for constructing an artificial neuron network for future biomaterial science. For another approach, we used it as a tool for bringing about the reconnection and growth of severed nerve bundles in living animals. Experiments include the modification of plastic tube by negative-ion implantation and the evaluation of the nerve regeneration in the modified nerve grafting plastic tube in living animals (rat). (c) 2007 Elsevier B.V. All rights reserved.
C1 Kyoto Univ, Dept Elect Sci & Engn, Nishikyo Ku, Kyoto 6158510, Japan.
RP Ishikawa, J (reprint author), Kyoto Univ, Dept Elect Sci & Engn, Nishikyo Ku, Kyoto 6158510, Japan.
EM ishikawa@kuee.kyoto-u.ac.jp
CR BHAACHARYA RS, 1998, SURF COAT TECH, V103, P151
   Ikeguchi R, 2003, DEV BRAIN RES, V140, P127, DOI 10.1016/S0165-3806(02)00587-4
   ISHIKAWA J, 1995, NUCL INSTRUM METH B, V96, P7, DOI 10.1016/0168-583X(94)00444-7
   Kakinoki R, 1995, Neurosci Res, V23, P35
   LUNDBORG G, 1982, EXP NEUROL, V76, P361, DOI 10.1016/0014-4886(82)90215-1
   MADISON RD, 1988, BRAIN RES, V447, P325, DOI 10.1016/0006-8993(88)91135-3
   MADISON RD, 1985, EXP NEUROL, V76, P767
   Sato H, 1999, J BIOMED MATER RES, V44, P22, DOI 10.1002/(SICI)1097-4636(199901)44:1<22::AID-JBM3>3.3.CO;2-1
   SUZUKI Y, 1991, NUCL INSTRUM METH B, V59, P698, DOI 10.1016/0168-583X(91)95306-X
   Tsuji H, 2005, NUCL INSTRUM METH B, V237, P459, DOI 10.1016/j.nimb.2005.05.020
   Tsuji H, 2003, NUCL INSTRUM METH B, V206, P507, DOI 10.1016/S0168-583X(03)00809-7
   Tsuji H, 2002, NUCL INSTRUM METH B, V191, P815, DOI 10.1016/S0168-583X(02)00659-6
   Tsuji H., 1983, Proceedings of the International Ion Engineering Congress. The 7th Symposium (1983 International) on Ion Sources and Ion Assisted Technology (ISIAT '83) and the 4th International Conference on Ion and Plasma Assisted Techniques (IPAT '83), P141
   Tsuji H, 1998, NUCL INSTRUM METH B, V141, P197, DOI 10.1016/S0168-583X(98)00090-1
   Tsuji H, 1997, NUCL INSTRUM METH B, V127, P278, DOI 10.1016/S0168-583X(97)00072-4
   Tsuji H, 1998, NUCL INSTRUM METH B, V141, P645, DOI 10.1016/S0168-583X(98)00168-2
   Tsuji H, 2000, NUCL INSTRUM METH B, V166, P815, DOI 10.1016/S0168-583X(99)01055-1
   TSUJI H, 1995, ION IMPLANTATION TEC, V94, P612
   TSUJI H, 2004, T MAT RES SOC JAPAN, V29, P575
   WILLIAMS LR, 1987, J COMP NEUROL, V264, P284, DOI 10.1002/cne.902640211
   YANNAS IV, 1989, T 6 EUR C BIOM PAR, P4
NR 21
TC 6
Z9 8
U1 0
U2 5
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD AUG 5
PY 2007
VL 201
IS 19-20
BP 8083
EP 8090
DI 10.1016/j.surfcoat.2006.01.073
PG 8
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 204HG
UT WOS:000249034000018
DA 2018-10-20
ER

PT J
AU Braceras, I
   Alava, JI
   Goikoetxea, L
   de Maeztu, MA
   Onate, JI
AF Braceras, I.
   Alava, J. I.
   Goikoetxea, L.
   de Maeztu, M. A.
   Onate, J. I.
TI Interaction of engineered surfaces with the living world: Ion
   implantation vs. osseointegration
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 14th International Conference on Surface Modification by Ion Beams
   (SMMIB 05)
CY SEP 04-09, 2005
CL Kusadasi, TURKEY
SP TUBITAK, EGE Univ, AKZ NOBEL KEMIPOL A S, ESBAS, HIPOKRAT A S, EYUP ALTAN, MEHMET ALTAN, MUSTAFA ALTAN, Off Naval Res Global, CemeCon Scandinavia, EBSO, Ford Otosan, Turk Otomobil Fabridasi, Egen Otomotiv Sanayi ve Ticaret A S, Kale Kahp Makina ve Kalp Sanayi A S, Canakkale Seramilk Kalevodur, Kale Grp, Ege Univ Sci & Technol Ctr, Mat Res Soc
DE ion implantation; osseointegration; dental implants; apoptosis
ID IN-VITRO; TITANIUM IMPLANTS; HUMAN OSTEOBLASTS; DENTAL IMPLANTS;
   ADHESION; BIOMATERIALS; CALCIUM; CELLS; IMPROVEMENT; PHOSPHORUS
AB The reaction of living tissues to foreign materials is a highly complex process that currently is insufficiently understood. Nevertheless, if specific reactions are to be promoted, this understanding is highly valuable and thus a significant research effort is being devoted to this issue. Typically, when a biomaterial is inserted in living tissue, proteins and other bio-molecules will adsorb to the surface. As this protein layer will mediate the interaction of the biomaterial with the living world, the consequent reactions will be highly dependant on this very first stage. Furthermore, different materials, i.e. surfaces, typically elicit a very different tissue response. It is commonly admitted that the primary adsorption depends heavily on the surface chemistry, surface topography and surface physical characteristics. Interactions between surface micro-topography and living cells have been widely studied, but protein specific reactions versus nano-topography have been barely explored. Ion beam modification of surfaces, which affect these key properties, can therefore be (i) a powerful tool to advance in the understanding of these nanoscale phenomena and (ii) useful as an industrial treatment of high value added medical devices. This work will explore the application of ion beam based surface treatments to cause specific reactions in hard tissue regeneration. A variety of in vitro and in vivo results are presented corresponding to ion implantation treatments promoting '' osseointegration '' or intimate binding between the biomaterial and the living tissue, without any soft tissue interlayer, and an overview of the mechanism behind is offered, i.e. among other behaviour of osteoblasts, signalling proteins as the integrins, nanotopographic parameters. (c) 2007 Elsevier B.V. All rights reserved.
C1 Lifenova Biomed SA, San Sebastian 20009, Spain.
   Fdn Inasmet, San Sebastian 20009, Spain.
RP Braceras, I (reprint author), Lifenova Biomed SA, Mikeletegi Pasealekua 2, San Sebastian 20009, Spain.
EM info@lifenova.com
RI Braceras, Inigo/I-1871-2015; Onate, J. Ignacio/I-1555-2015
OI Braceras, Inigo/0000-0001-9095-7663; Onate de la Presa, Jose
   Ignacio/0000-0002-9078-4480
CR Alava JI, 2005, STRUERS J MATERIALOG, V6, P1
   ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   Aubin JE, 1995, BONE, V17, P77
   Bigerelle M, 2002, BIOMATERIALS, V23, P1563, DOI 10.1016/S0142-9612(01)00271-X
   Braceras I, 2005, SURF COAT TECH, V196, P321, DOI 10.1016/j.surfcoat.2004.08.201
   Braceras I, 2002, SURF COAT TECH, V158, P28, DOI 10.1016/S0257-8972(02)00203-7
   Brett PM, 2004, BONE, V35, P124, DOI 10.1016/j.bone.2004.03.009
   Brizuela M, 2002, J MATER SCI-MATER M, V13, P1129, DOI 10.1023/A:1021129718737
   Castellani R, 1999, CLIN ORAL IMPLAN RES, V10, P369, DOI 10.1034/j.1600-0501.1999.100504.x
   Cochran DL, 1999, J PERIODONTOL, V70, P1523, DOI 10.1902/jop.1999.70.12.1523
   de Maeztu MA, 2003, CLIN ORAL IMPLAN RES, V14, P57, DOI 10.1034/j.1600-0501.2003.140108.x
   DEMAEZTU MA, 2007, INT J ORAL MAXILLOFA, V22
   Eisenbarth E, 1996, BIOMATERIALS, V17, P1399, DOI 10.1016/0142-9612(96)87281-4
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   GALLI G, 2002, COLLOID SURFACE B, V26, P255
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Giavaresi G, 2004, BIOMATERIALS, V25, P5583, DOI 10.1016/j.biomaterials.2004.01.017
   Hanawa T, 1997, J BIOMED MATER RES, V36, P131, DOI 10.1002/(SICI)1097-4636(199707)36:1<131::AID-JBM16>3.0.CO;2-L
   Hubler GK, 2002, SURF COAT TECH, V158, P449, DOI 10.1016/S0257-8972(02)00272-4
   Kasemo B, 1999, Adv Dent Res, V13, P8
   Katti KS, 2004, COLLOID SURFACE B, V39, P133, DOI 10.1016/j.colsurfb.2003.12.002
   Krupa D, 2005, BIOMATERIALS, V26, P2847, DOI 10.1016/j.biomaterials.2004.08.015
   Krupa D, 2002, BIOMATERIALS, V23, P3329, DOI 10.1016/S0142-9612(02)00020-0
   Links J, 1998, BIOMATERIALS, V19, P2219
   Maitz MF, 2005, BIOMATERIALS, V26, P5465, DOI 10.1016/j.biomaterials.2005.02.006
   Nayab S, 2003, J MATER SCI-MATER M, V14, P991, DOI 10.1023/A:1026358917896
   Nayab SN, 2005, BIOMATERIALS, V26, P4717, DOI 10.1016/j.biomaterials.2004.11.044
   Okabe Y, 2005, SURF COAT TECH, V196, P303, DOI 10.1016/j.surfcoat.2004.08.190
   Onate JI, 2001, SURF COAT TECH, V142, P1056, DOI 10.1016/S0257-8972(01)01074-X
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Rice JM, 2003, BIOMATERIALS, V24, P4799, DOI 10.1016/S0142-9612(03)00381-8
   Rupp F, 2004, BIOMATERIALS, V25, P1429, DOI 10.1016/j.biomaterials.2003.08.015
   Sul YT, 2005, BIOMATERIALS, V26, P6720, DOI 10.1016/j.biomaterials.2005.04.058
   Tan J, 2004, BIOMATERIALS, V25, P3593, DOI 10.1016/j.biomaterials.2003.10.034
   Viviente JL, 1999, APPL SURF SCI, V144-45, P249, DOI 10.1016/S0169-4332(98)00806-X
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Webster TJ, 2004, BIOMATERIALS, V25, P4731, DOI 10.1016/j.biomaterials.2003.12.002
   Xie YT, 2005, BIOMATERIALS, V26, P6129, DOI 10.1016/j.biomaterials.2005.03.032
   Yang YZ, 2002, BIOMATERIALS, V23, P1383, DOI 10.1016/S0142-9612(01)00259-9
   Zhu XL, 2004, BIOMATERIALS, V25, P4087, DOI 10.1016/j.biomaterials.2003.11.011
   ZIGNER O, 2004, BIOMATERIALS, V25, P2695
   Zreiqat H, 2005, BIOMATERIALS, V26, P7579, DOI 10.1016/j.biomaterials.2005.05.024
NR 43
TC 27
Z9 28
U1 1
U2 12
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD AUG 5
PY 2007
VL 201
IS 19-20
BP 8091
EP 8098
DI 10.1016/j.sur-fcoat.2006.03.052
PG 8
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 204HG
UT WOS:000249034000019
DA 2018-10-20
ER

PT J
AU Reichenberger, MA
   Stoff, A
   Richter, DF
AF Reichenberger, Matthias A.
   Stoff, Alexander
   Richter, Dirk F.
TI Polymethylmethacrylate for managing frontal bone deformities
SO AESTHETIC PLASTIC SURGERY
LA English
DT Article
DE alloplastic material; autogenous material; frontal bone deformity;
   polymethylmethacrylate
ID VAULT RECONSTRUCTIVE MATERIAL; RISK-FACTORS; CRANIOPLASTY; CHOICE
AB The correction of bony frontal deformities has been accomplished with a variety of autogenous and alloplastic materials. Of the various materials currently available, polymethylmethacrylate (PMMA), a valuable biomaterial, has proved to be effective in reconstructing deformities of the frontal bone. The authors present one case of acquired frontal bone deformity reconstructed by subperiostal application of PMMA through a minimally invasive coronal approach. Our preliminary experience with this method has been promising.
C1 Dreifaltigkeits Hosp, Dept Plast & Reconstruct Surg, D-50389 Wesseling, Germany.
RP Stoff, A (reprint author), Dreifaltigkeits Hosp, Dept Plast & Reconstruct Surg, Bonner Str 84, D-50389 Wesseling, Germany.
EM Alexander.Stoff@t-online.de
CR Azmi A, 2004, Med J Malaysia, V59, P418
   Eppley BL, 2005, J CRANIOFAC SURG, V16, P140, DOI 10.1097/00001665-200501000-00028
   KLEINSCHMIDT O, 1941, CHIRURGIE, V13, P273
   Lara WC, 1998, J LONG-TERM EFF MED, V8, P43
   MANSON PN, 1986, PLAST RECONSTR SURG, V77, P888, DOI 10.1097/00006534-198606000-00003
   Stelnicki EJ, 1996, J CRANIOFAC SURG, V7, P192, DOI 10.1097/00001665-199605000-00006
   Taub PJ, 2003, PLAST RECONSTR SURG, V111, P1233, DOI 10.1097/01.PRS.0000046048.77472.23
   WOLFE SA, 1986, PLAST RECONSTR SURG, V77, P901
   YAREMCHUK MJ, PLASTIC SURG 2, V3
NR 9
TC 6
Z9 7
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0364-216X
J9 AESTHET PLAST SURG
JI Aesthet. Plast. Surg.
PD AUG
PY 2007
VL 31
IS 4
BP 397
EP 400
DI 10.1007/s00266-007-0009-3
PG 4
WC Surgery
SC Surgery
GA 190GM
UT WOS:000248047000020
PM 17530325
DA 2018-10-20
ER

PT J
AU Yang, CL
   Guan, LT
   Zhao, YM
   Yan, YR
AF Yang, Chongling
   Guan, Litao
   Zhao, Yaoming
   Yan, Yurong
TI Sorption of Cu2+ and Zn2+ by natural biomaterial: Duck feather
SO APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
LA English
DT Article
DE feather fiber; tannic acid; metal adsorption; desorption; column
ID ANTIMICROBIAL PROPERTIES; METAL-CATIONS; WOOL; BINDING; ABSORPTION;
   BEHAVIOR; SALTS; IONS
AB Feather fibers were modified by treatment with 5% tannic acid ( TA) solution. Kinetics of the modification was investigated as a function of the reaction time. The maximum loading of TA on feather reached 8.3% after being treated by TA for 9 h. The adsorption of metal cations (Cu2+, Zn2+) by unmodified and TA-modified feather fibers was investigated as a function of fiber weight gain, temperature, and pH of the metal solution. The adsorption was enhanced at alkaline pH and ambient temperature and increased with the weight gain of TA. The maximum uptake of metal cations ( Cu2+, 0.77 mmol/g; Zn2+, 0.95 mmol/g) was obtained by TA-modified feather at weight gain: 8.3%, pH 11, while at the acidic pH, the adsorption of metal cations by either unmodified or TA-modified feather was negligible. The influence of anions on the adsorption of metal cations was also studied. The uptake of Cu2+ from chloride was higher and faster than that from nitrate. Desorption of the metals was performed at acidic pH 2.5 for 48 h. The feather-TA-metal complexes exhibited higher stability for metal cations than the feather-metal complexes. All these experiments reveal that TA-modified feather fibers have good adsorption to metal cations and can be used as metal adsorbent in wastewater treatment.
C1 S China Univ Technol, Coll Mat Sci & Engn, Guangzhou 510640, Peoples R China.
   S China Agr Univ, Coll Forestry, Guangzhou 510642, Peoples R China.
RP Zhao, YM (reprint author), S China Univ Technol, Coll Mat Sci & Engn, Guangzhou 510640, Peoples R China.
EM ygchem@126.com
CR Arai T, 2001, J APPL POLYM SCI, V80, P297, DOI 10.1002/1097-4628(20010411)80:2<297::AID-APP1099>3.3.CO;2-Q
   BRADY PR, 1974, TEXT RES J, P733
   Freddi G, 2001, J APPL POLYM SCI, V82, P3513, DOI 10.1002/app.2213.abs
   FRIEDMAN M, 1973, J APPL POLYM SCI, V17, P2183, DOI 10.1002/app.1973.070170717
   FRIEDMAN M, 1973, J APPL POLYM SCI, V17, P377, DOI 10.1002/app.1973.070170205
   Goto M, 2000, APPL BIOCHEM BIOTECH, V84-6, P1021, DOI 10.1385/ABAB:84-86:1-9:1021
   Khokhar S, 2003, FOOD CHEM, V81, P133, DOI 10.1016/S0308-8146(02)00394-1
   MASRI MS, 1974, J APPL POLYM SCI, V18, P2367, DOI 10.1002/app.1974.070180815
   MCPHEE JR, 1965, TEXT RES J, V35, P382, DOI 10.1177/004051756503500417
   Rintoul L, 2000, BIOPOLYMERS, V57, P19, DOI 10.1002/(SICI)1097-0282(2000)57:1<19::AID-BIP4>3.0.CO;2-Z
   SIMPSON WS, 1969, TEXT RES J, V39, P434
   Tsukada M, 2003, J APPL POLYM SCI, V89, P638, DOI 10.1002/app.11911
   Yu PQ, 2004, J AGR FOOD CHEM, V52, P7353, DOI 10.1021/jf0490955
NR 13
TC 3
Z9 3
U1 0
U2 6
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 0273-2289
J9 APPL BIOCHEM BIOTECH
JI Appl. Biochem. Biotechnol.
PD AUG
PY 2007
VL 142
IS 2
BP 168
EP 178
DI 10.1007/s12010-007-0015-6
PG 11
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 219FL
UT WOS:000250070000006
PM 18025578
DA 2018-10-20
ER

PT J
AU Prime, EL
   Hamid, ZAA
   Cooper-White, JJ
   Qiao, GG
AF Prime, Emma L.
   Hamid, Zuratul Ain Abdul
   Cooper-White, Justin J.
   Qiao, Greg G.
TI Addition of biological functionality to poly(epsilon-caprolactone) films
SO BIOMACROMOLECULES
LA English
DT Article
ID SURFACE MODIFICATION; IN-VITRO; PHYSICAL-PROPERTIES; CELL ATTACHMENT;
   RGD; ADHESION; PEPTIDE; ACID); POLYCAPROLACTONE; BIOMATERIAL
AB Biodegradable polyesters such as poly (E-caprolactone) (PCL) have a number of biomedical applications; however, their usage is often limited by a lack of biological functionality. In this paper, a PCL-based polymer containing pendent groups activated by 4-nitrophenyl chloroformate (NPC) and reactive toward primary amines has been cast into thin films. The reactivity of the films toward poly(L-lysine) and the cell adhesion peptide, GRGDS, was assessed, and their cell adhesive capabilities were characterized. ATR-FTIR analysis found that NPC functional groups were present on the surface of the cast film, and the synthesis, conjugation, and visualization of a fluorescent molecule on these films further demonstrated the success of this functionalization methodology. The immersion of these films into a solution of either poly(L-lysine) (PLL) or GRGDS in PBS (pH 7.4) and subsequent 3T3 fibroblast adhesion studies demonstrated significant improvement in cell adhesion and spreading over films cast from unmodified PCL. This investigation has shown that this novel NPC-containing polymer can be utilized in many applications where increased cellular adhesion is required, or the coupling of specific molecules to polymer surfaces is of interest.
C1 Univ Melbourne, Dept Chem & Biomol Engn, Polymer Sci Grp, Parkville, Vic 3010, Australia.
RP Qiao, GG (reprint author), Univ Melbourne, Dept Chem & Biomol Engn, Polymer Sci Grp, Parkville, Vic 3010, Australia.
EM gregghq@unimelb.edu.au
RI Cooper-White, Justin/B-2567-2010; Qiao, Greg/C-7674-2011
OI Qiao, Greg/0000-0003-2771-9675; Cooper-White,
   Justin/0000-0002-1920-8229; PRIME, EMMA/0000-0002-1410-6717
CR Cai KY, 2002, BIOMATERIALS, V23, P1603, DOI 10.1016/S0142-9612(01)00287-3
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Cook AD, 1997, J BIOMED MATER RES, V35, P513
   Croll TI, 2004, BIOMACROMOLECULES, V5, P463, DOI 10.1021/bm0343040
   Elbert DL, 2001, BIOMACROMOLECULES, V2, P430, DOI 10.1021/bm0056299
   Gabriel M, 2006, J BIOMAT SCI-POLYM E, V17, P567, DOI 10.1163/156856206776986288
   HEALY KE, 1992, MATER RES SOC SYMP P, V252, P109
   Hou QP, 2005, BIOMACROMOLECULES, V6, P734, DOI 10.1021/bm049420x
   Hu YH, 2003, J BIOMED MATER RES A, V64A, P583, DOI 10.1002/jbm.a.10438
   Hui S, 2004, BIOMACROMOLECULES, V5, P2275, DOI 10.1021/bm049703p
   Irvine DJ, 2001, BIOMACROMOLECULES, V2, P85, DOI 10.1021/bm005584b
   Ishaug-Riley SL, 1999, BIOMATERIALS, V20, P2245, DOI 10.1016/S0142-9612(99)00155-6
   Latere JP, 2002, MACROMOLECULES, V35, P7857, DOI 10.1021/ma020441y
   McConachie A, 1999, Biomed Sci Instrum, V35, P45
   Neff JA, 1999, BIOMATERIALS, V20, P2377, DOI 10.1016/S0142-9612(99)00166-0
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Prime EL, 2006, AUST J CHEM, V59, P534, DOI 10.1071/CH06144
   Quirk RA, 2001, BIOMATERIALS, V22, P865, DOI 10.1016/S0142-9612(00)00250-7
   Rohman G, 2007, BIOMATERIALS, V28, P2264, DOI 10.1016/j.biomaterials.2007.01.032
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Santiago LY, 2006, BIOMATERIALS, V27, P2962, DOI 10.1016/j.biomaterials.2006.01.011
   Schense JC, 2000, J BIOL CHEM, V275, P6813, DOI 10.1074/jbc.275.10.6813
   Tang ZG, 2005, BIOMATERIALS, V26, P6618, DOI 10.1016/j.biomaterials.2005.04.013
   Tang ZG, 2004, BIOMATERIALS, V25, P4741, DOI 10.1016/j.biomaterials.2003.12.003
   Taniguchi I, 2006, POLYM INT, V55, P1385, DOI 10.1002/pi.2139
   Yang J, 2002, BIOMATERIALS, V23, P2607, DOI 10.1016/S0142-9612(01)00400-8
NR 26
TC 11
Z9 11
U1 2
U2 18
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD AUG
PY 2007
VL 8
IS 8
BP 2416
EP 2421
DI 10.1021/bm0702962
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 200HR
UT WOS:000248755000012
PM 17591749
DA 2018-10-20
ER

PT J
AU Xu, LC
   Siedlecki, CA
AF Xu, Li-Chong
   Siedlecki, Christopher A.
TI Effects of surface wettability and contact time on protein adhesion to
   biomaterial surfaces
SO BIOMATERIALS
LA English
DT Article
DE AFM; protein; adhesion; wettability
ID ATOMIC-FORCE MICROSCOPY; SELF-ASSEMBLED MONOLAYERS; PLATELET-ADHESION;
   PLASMA-PROTEINS; CONFORMATIONAL-CHANGES; HYDROPHOBIC SURFACES;
   COMPETITIVE BEHAVIOR; RELAXATION KINETICS; ALBUMIN ADSORPTION; DEPENDENT
   CHANGES
AB Atomic force microscopy (AFNI) was used to directly measure the adhesion forces between three test proteins and low density polyethylene (LDPE) surfaces treated by glow discharge plasma to yield various levels of water wettability. The adhesion of proteins to the LDPE substrates showed a step dependence on the wettability of surfaces as measured by the water contact angle (theta). For LDPE surfaces with theta >-60-65 degrees, stronger adhesion forces were observed for bovine serum albumin, fibrinogen and human FXII than for the surfaces with theta < 60 degrees. Smaller adhesion forces were observed for FXII than for the other two proteins on all surfaces although trends were identical. Increasing the contact time from 0 to 50 s for each protein-surface combination increased the adhesion force regardless of surface wettability. Time varying adhesion data was fit to an exponential model and free energies of protein unfolding were calculated. This data, viewed in light of previously published studies, suggests a 2-step model of protein denaturation, an early stage on the order of seconds to minutes where the outer surface of the protein interacts with the substrate and a second stage involving movement of hydrophobic amino acids from the protein core to the protein/surface interface.
   Impact statement: The work described in this manuscript shows a stark transition between protein adherent and protein non-adherent materials in the range of water contact angles 60-65 degrees, consistent with known changes in protein adsorption and activity. Time-dependent changes in adhesion force were used to calculate unfolding energies relating to protein-surface interactions. This analysis provides justification for a 2-step model of protein denaturation on surfaces. (c) 2007 Elsevier Ltd. All rights reserved.
C1 Penn State Univ, Coll Med, Dept Bioengn, Biomed Engn Inst, Hershey, PA 17033 USA.
RP Siedlecki, CA (reprint author), Penn State Univ, Coll Med, Dept Surg, Biomed Engn Inst, Mail Code H151,500 Univ Dr, Hershey, PA 17033 USA.
EM csiedlecki@psu.edu
FU NHLBI NIH HHS [R01 HL69965, R01 HL069965]
CR Agashe M, 2005, LANGMUIR, V21, P1103, DOI 10.1021/la0478364
   Agnihotri A, 2005, ULTRAMICROSCOPY, V102, P257, DOI 10.1016/j.ultramic.2004.10.006
   Agnihotri A, 2004, LANGMUIR, V20, P8846, DOI 10.1021/la049239
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   BERG JM, 1994, LANGMUIR, V10, P1225, DOI 10.1021/la00016a041
   BOS MA, 1995, BIOPHYS J, V68, P2566, DOI 10.1016/S0006-3495(95)80439-X
   Buijs J, 1997, J COLLOID INTERF SCI, V190, P171, DOI 10.1006/jcis.1997.4876
   Cai KY, 2006, COLLOID SURFACE B, V49, P136, DOI 10.1016/j.colsurfb.2006.02.016
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   Choee JH, 2004, J APPL POLYM SCI, V92, P599, DOI 10.1002/app.20048
   Chowdhury PB, 1998, COLLOID SURFACE A, V143, P53, DOI 10.1016/S0927-7757(98)00408-7
   Dupont-Gillain CC, 2003, J BIOMED MATER RES A, V67A, P548, DOI 10.1002/jbm.a.10092
   Fang F, 2005, BIOPHYS J, V89, P1516, DOI 10.1529/biophysj.104.055079
   Faucheux N, 2004, BIOMATERIALS, V25, P2721, DOI 10.1016/j.biomaterials.2003.09.069
   GOLDBERG ME, 1991, TRENDS BIOCHEM SCI, V16, P358, DOI 10.1016/0968-0004(91)90148-O
   Greenfield NJ, 1999, TRAC-TREND ANAL CHEM, V18, P236, DOI 10.1016/S0165-9936(98)00112-5
   Hemmerle J, 1999, P NATL ACAD SCI USA, V96, P6705, DOI 10.1073/pnas.96.12.6705
   HEYNES CAN, 1994, BIOINTERFACES, V2, P517
   HORBETT TA, 1993, CARDIOVASC PATHOL, V2, pS137
   Hylton DM, 2005, J BIOMED MATER RES A, V73A, P349, DOI 10.1002/jbm.a.30295
   Israelachvili J, 1996, NATURE, V379, P219, DOI 10.1038/379219a0
   Kidoaki S, 1999, LANGMUIR, V15, P7639, DOI 10.1021/la990357k
   Kidoaki S, 2002, COLLOID SURFACE B, V23, P153, DOI 10.1016/S0927-7765(01)00232-6
   Lee JH, 1998, J BIOMED MATER RES, V41, P304, DOI 10.1002/(SICI)1097-4636(199808)41:2<304::AID-JBM16>3.0.CO;2-K
   LEE SJ, 1994, J VAC SCI TECHNOL A, V12, P2949, DOI 10.1116/1.578920
   Lhoest JB, 1998, J BIOMED MATER RES, V41, P95, DOI 10.1002/(SICI)1097-4636(199807)41:1<95::AID-JBM12>3.0.CO;2-G
   Lhoest JB, 2001, J BIOMED MATER RES, V57, P432, DOI 10.1002/1097-4636(20011205)57:3<432::AID-JBM1186>3.0.CO;2-G
   Mondon M, 2003, ANAL BIOANAL CHEM, V375, P849, DOI 10.1007/s00216-003-1751-2
   Montdargent B, 2000, INFECT CONT HOSP EP, V21, P404, DOI 10.1086/501782
   Noh H, 2006, BIOMATERIALS, V27, P5801, DOI 10.1016/j.biomaterials.2006.08.005
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   Rezwan K, 2004, LANGMUIR, V20, P10055, DOI 10.1021/la048459k
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Santore MM, 2005, LANGMUIR, V21, P10172, DOI 10.1021/la051059s
   Sethuraman A, 2004, LANGMUIR, V20, P7779, DOI 10.1021/la049454q
   Sethuraman A, 2004, PROTEINS, V56, P669, DOI 10.1002/prot.20183
   Sigal GB, 1998, J AM CHEM SOC, V120, P3464, DOI 10.1021/ja970819l
   Sit PS, 1999, THROMB HAEMOSTASIS, V82, P1053
   Sit PS, 2001, SURF SCI, V491, P421, DOI 10.1016/S0039-6028(01)01308-5
   TAN JS, 1990, J COLLOID INTERF SCI, V136, P415, DOI 10.1016/0021-9797(90)90389-6
   VOGLER EA, 1995, J BIOMED MATER RES, V29, P1005, DOI 10.1002/jbm.820290813
   Vogler EA, 1999, J BIOMAT SCI-POLYM E, V10, P1015, DOI 10.1163/156856299X00667
   Wertz CF, 2002, LANGMUIR, V18, P706, DOI 10.1021/la011075z
   Wertz CF, 1999, LANGMUIR, V15, P8884, DOI 10.1021/la990089q
   Wertz CF, 2001, LANGMUIR, V17, P3006, DOI 10.1021/la0017781
   Wu YG, 2005, J BIOMED MATER RES A, V74A, P722, DOI 10.1002/jbm.a.30381
   Xu LC, 2006, LANGMUIR, V22, P4720, DOI 10.1021/la053443v
   Xu LC, 2005, LANGMUIR, V21, P7491, DOI 10.1021/la0509091
   Xu LC, 2005, ENVIRON SCI TECHNOL, V39, P3592, DOI 10.1021/es048377i
   Yang Z, 2001, BIOCHEMISTRY-US, V40, P12515, DOI 10.1021/bi011394p
   Yoon RH, 1997, J COLLOID INTERF SCI, V185, P363, DOI 10.1006/jcis.1996.4583
NR 52
TC 283
Z9 286
U1 6
U2 134
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2007
VL 28
IS 22
BP 3273
EP 3283
DI 10.1016/j.biomaterials.2007.03.032
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 175WV
UT WOS:000247045600002
PM 17466368
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Weiss, P
   Layrolle, P
   Clergeau, LP
   Enckel, B
   Pilet, P
   Amouriq, Y
   Daculsi, G
   Giumelli, B
AF Weiss, Pierre
   Layrolle, Pierre
   Clergeau, Leon Philippe
   Enckel, Benedicte
   Pilet, Paul
   Amouriq, Yves
   Daculsi, Guy
   Giumelli, Bernard
TI The safety and efficacy of an injectable bone substitute in dental
   sockets demonstrated in a human clinical trial
SO BIOMATERIALS
LA English
DT Article
DE calcium phosphate; biomaterial; injectable bone substitute; human trial;
   bone healing
ID CALCIUM-PHOSPHATE BIOMATERIAL; CERAMIC RESORPTION; IMPLANT PLACEMENT;
   TIBIAL OSTEOTOMY; IN-VITRO; REGENERATION; CEMENT; AUGMENTATION;
   INGROWTH; BIOCERAMICS
AB This study is the first report of a clinical evaluation of an injectable bone substitute (IBS). This IBS was prepared by suspending biphasic calcium phosphate (BCP) particles with diameters ranging between 80 and 200 pm in a water-soluble cellulose polymer carrier phase. It was used for filling bone defects after tooth extractions in I I patients. The first objective of the study was to investigate the safety of the filler material. The second objective was to investigate the efficacy of the material for filling human tooth sockets and preventing alveolar bone loss. Radiographic density measurements of the surgical sites gradually increased to those of the surrounding host bone. Three years after surgery, small biopsies of the implanted areas were harvested and analyzed by using micro-computed tomography, non-decalcified histology and histomorphometry. The BCP granules appeared in direct contact with mineralized bone tissue, thereby supporting bone growth. A gradual substitution of the filler by bone tissue was observed thus preserving the height of the alveolar bone crest. (c) 2007 Elsevier Ltd. All rights reserved.
C1 Fac Chirurg Dentaire, INSERM U791, Lab Osteo Articular & Dent Tissue Engn, F-44042 Nantes, France.
   Univ Nantes, Fac Chirurg Dentaire, Equipe Rech Clin Odontol, ERT051, F-44042 Nantes, France.
   CHU Nantes, Serv Odontol Conservatrice Endodontie, F-44042 Nantes, France.
RP Weiss, P (reprint author), Fac Chirurg Dentaire, INSERM U791, Lab Osteo Articular & Dent Tissue Engn, 1 Pl Alexis Rivordeau,BP 84215, F-44042 Nantes, France.
EM pierre.weiss@univ-nantes.fr
RI LABOUX, OLIVIER/A-8270-2015; Weiss, Pierre/P-1372-2014; Layrolle,
   Pierre/K-9257-2015; Daculsi, Guy/P-1320-2014; Paul, Pilet/A-3755-2015
OI Weiss, Pierre/0000-0002-6159-8590; Layrolle, Pierre/0000-0001-9800-5210;
   Daculsi, Guy/0000-0003-1030-3446; 
CR Aho AJ, 2004, J MATER SCI-MATER M, V15, P1165, DOI 10.1023/B:JMSM.0000046401.50406.9b
   Amouriq Y, 2002, J MATER SCI-MATER M, V13, P149, DOI 10.1023/A:1013873828079
   Boix D, 2006, J MATER SCI-MATER M, V17, P1145, DOI 10.1007/s10856-006-0542-7
   Boix D, 2004, J PERIODONTOL, V75, P663, DOI 10.1902/jop.2004.75.5.663
   Brunel G, 2001, J PERIODONTOL, V72, P257, DOI 10.1902/jop.2001.72.2.257
   Carey LE, 2005, BIOMATERIALS, V26, P5002, DOI 10.1016/j.biomaterials.2005.01.015
   Cavagna R, 1999, J LONG-TERM EFF MED, V9, P403
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   DACULSI G, 1990, CALCIFIED TISSUE INT, V46, P20, DOI 10.1007/BF02555820
   DACULSI G, 1989, J BIOMED MATER RES, V23, P883, DOI 10.1002/jbm.820230806
   DACULSI G, 1990, BIOMATERIALS, V11, P86
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   Daculsi G, 2003, J MATER SCI-MATER M, V14, P195, DOI 10.1023/A:1022842404495
   DACULSI G, 1990, SCANNING MICROSCOPY, V4, P309
   DACULSI G, 1994, CNRS PATENT BIOMATER
   DEGROOT K, 1980, BIOMATERIALS, V1, P47, DOI 10.1016/0142-9612(80)90059-9
   DELECRIN J, 1994, CELL MATER, V4, P51
   Drissens F., 1994, J MATER SCI, V5, P164
   Gaasbeek RDA, 2005, BIOMATERIALS, V26, P6713, DOI 10.1016/j.biomaterials.2005.04.056
   Gauthier O, 1999, J BIOMED MATER RES, V47, P28, DOI 10.1002/(SICI)1097-4636(199910)47:1<28::AID-JBM4>3.0.CO;2-P
   Gauthier O, 1999, J PERIODONTOL, V70, P375, DOI 10.1902/jop.1999.70.4.375
   Gauthier O, 2005, BIOMATERIALS, V26, P5444, DOI 10.1016/j.biomaterials.2005.01.072
   Gauthier O, 2003, J BIOMED MATER RES A, V66A, P47, DOI 10.1002/jbm.a.10506
   Gordon P D, 1974, Dent Update, V1, P373
   Grimandi G, 1998, J BIOMED MATER RES, V39, P660, DOI 10.1002/(SICI)1097-4636(19980315)39:4<660::AID-JBM22>3.0.CO;2-9
   Horstmann WG, 2003, INJURY, V34, P141, DOI 10.1016/S0020-1383(02)00105-5
   LeGeros R Z, 1988, Adv Dent Res, V2, P164
   Lewandrowski KU, 2000, BIOMATERIALS, V21, P293, DOI 10.1016/S0142-9612(99)00180-5
   Li YW, 2000, J BIOMED MATER RES, V52, P164, DOI 10.1002/1097-4636(200010)52:1<164::AID-JBM21>3.3.CO;2-I
   Malard O, 1999, J BIOMED MATER RES, V46, P103, DOI 10.1002/(SICI)1097-4636(199907)46:1<103::AID-JBM12>3.0.CO;2-Z
   MALAWER MM, 1991, CLIN ORTHOP RELAT R, P42
   Merkx MAW, 2003, INT J ORAL MAX SURG, V32, P1, DOI 10.1054/ijom.2002.0346
   Moghadam HG, 2004, J ORAL MAXIL SURG, V62, P202, DOI 10.1016/j.joms.2003.10.002
   Nguyen H, 2003, BIOCHEM BIOPH RES CO, V311, P179, DOI 10.1016/j.bbrc.2003.09.192
   Paolantonio M, 2001, INT J PERIODONT REST, V21, P505
   PASSUTI N, 1989, CLIN ORTHOP RELAT R, P169
   Shanaman R, 2001, INT J PERIODONT REST, V21, P345
   Takechi M, 1998, J BIOMED MATER RES, V39, P308, DOI 10.1002/(SICI)1097-4636(199802)39:2<308::AID-JBM19>3.3.CO;2-F
   TAYLOR RS, 2007, EUR SPINE J
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Thorwarth M, 2005, J ORAL MAXIL SURG, V63, P1626, DOI 10.1016/j.joms.2005.06.010
   van Hemert WLW, 2004, KNEE, V11, P451, DOI 10.1016/j.knee.2004.08.004
   Verlaan JJ, 2006, BIOMATERIALS, V27, P290, DOI 10.1016/j.biomaterials.2005.07.028
   Weiss P, 2003, BIOMATERIALS, V24, P4591, DOI 10.1016/S0142-9612(03)00335-1
   WEISS P, 1999, BONE, V25, P67
   Wolff KD, 2004, J CRANIO MAXILL SURG, V32, P71, DOI 10.1016/S1010-5182(03)00134-3
   Yildirim M, 2000, CLIN ORAL IMPLAN RES, V11, P217, DOI 10.1034/j.1600-0501.2000.011003217.x
   Zerbo IR, 2005, BIOMATERIALS, V26, P1445, DOI 10.1016/j.biomaterials.2004.05.003
NR 48
TC 74
Z9 81
U1 0
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2007
VL 28
IS 22
BP 3295
EP 3305
DI 10.1016/j.biomaterials.2007.04.006
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 175WV
UT WOS:000247045600004
PM 17466366
DA 2018-10-20
ER

PT J
AU Cushing, MC
   Liao, JT
   Jaeggli, MP
   Anseth, KS
AF Cushing, Melinda C.
   Liao, Jo-Tsu
   Jaeggli, Michael P.
   Anseth, Kristi S.
TI Material-based regulation of the myofibroblast phenotype
SO BIOMATERIALS
LA English
DT Article
DE cardiac valve tissue engineering; cell signalling; fibroblast growth
   factor receptor; MAPK; heparin; hydrogel
ID FIBROBLAST-GROWTH-FACTOR; HEPARAN-SULFATE PROTEOGLYCANS; SMOOTH MUSCLE
   ACTIN; IN-VITRO; FACTOR-BETA; GENE-EXPRESSION; DIFFERENTIATION; BFGF;
   BINDING; PROTEIN
AB Fibroblast growth factor receptor (FGFR) activation by basic fibroblast growth factor (FGF-2) serves to naturally repress the myofibroblast activation of valvular interstitial cells (VICs). Co-receptors for FGF-2, the heparan sulfate proteoglycans (HSPGs), are key participants in the formation of active FGF-2 signaling complexes. Bioactive environments regulating the myofibroblast phenotype were created by utilizing heparin glycosaminoglycan as a competitive inhibitor of HSPGs. First, soluble heparin was delivered to compete with cell-surface HSPG for the binding of FGF-2. Exogenous soluble heparin prevented serum-dependent activation of the classic mitogen-activated protein kinase (MAPK) and induced myofibroblast alpha smooth muscle actin (alpha SMA) expression and collagen production. Next, heparin-functionalized hydrogel cell substrates were polymerized from vinyl-modified precursors and rendered adhesive through incorporation of RGDS peptide. Culture of VICs on heparin-modified gels induced aSMA expression and inhibited MAPK activity compared to control gel substrates lacking heparin. Additionally, heparin-functionalized gels continued to induce aSMA expression in serum-free culture conditions, suggesting that bioactivity was independent of exogenous soluble mediators. Biomaterial scaffolds targeting cell surface growth factor receptors are a promising new direction for regulating cell functions in tissue-engineering applications. (c) 2007 Elsevier Ltd. All rights reserved.
C1 Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA.
   Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA.
RP Anseth, KS (reprint author), Univ Colorado, Dept Chem & Biol Engn, ECCH 111,ECB 424, Boulder, CO 80309 USA.
EM kristi.anseth@Colorado.edu
FU NHLBI NIH HHS [R01 HL089260-02, R01 HL089260-01A1, R01 HL089260]
CR Abramoff MD, 2004, J BIOPHOTONICS INT, V11, P36
   Benoit DSW, 2005, ACTA BIOMATER, V1, P461, DOI 10.1016/j.actbio.2005.03.002
   CUSHING MC, 2006, THESIS U COLORADO
   ESCH F, 1985, P NATL ACAD SCI USA, V82, P6507, DOI 10.1073/pnas.82.19.6507
   Fannon M, 2000, BIOCHEMISTRY-US, V39, P1434, DOI 10.1021/bi991895z
   Franco R, 2003, TRENDS BIOCHEM SCI, V28, P238, DOI 10.1016/S0968-0004(03)00065-3
   Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427
   GOLDFARB M, 2001, SCI STKE, pPE37
   Gotlieb AI, 2002, J THORAC CARDIOV SUR, V124, P591, DOI 10.1067/mtc.2002.123812
   Greenberg RS, 2006, FASEB J, V20, P1006, DOI 10.1096/fj.05-4838fje
   Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681
   JOHNSON CM, 1987, J MOL CELL CARDIOL, V19, P1185, DOI 10.1016/S0022-2828(87)80529-1
   Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682
   KAN MK, 1993, SCIENCE, V259, P1918, DOI 10.1126/science.8456318
   Kawai-Kowase K, 2004, ARTERIOSCL THROM VAS, V24, P1384, DOI 10.1161/01.ATV.0000136548.17816.07
   KELLER KM, 1989, BIOCHEMISTRY-US, V28, P8100, DOI 10.1021/bi00446a021
   Khouw IMSL, 1999, BIOMATERIALS, V20, P1815, DOI 10.1016/S0142-9612(99)00077-0
   Krufka A, 1996, BIOCHEMISTRY-US, V35, P11131, DOI 10.1021/bi960125+
   Leicht M, 2003, MOL CELL BIOCHEM, V251, P119, DOI 10.1023/A:1025446302759
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   MAJNO G, 1971, SCIENCE, V173, P548, DOI 10.1126/science.173.3996.548
   Maltseva O, 2001, INVEST OPHTH VIS SCI, V42, P2490
   Masters KS, 2004, J BIOMED MATER RES A, V71A, P172, DOI 10.1002/jbm.a.30149
   Mattey DL, 1997, ANN RHEUM DIS, V56, P426, DOI 10.1136/ard.56.7.426
   MCCAFFREY TA, 1992, J CELL PHYSIOL, V152, P430, DOI 10.1002/jcp.1041520226
   MCCAFFREY TA, 1989, J CELL BIOL, V109, P441, DOI 10.1083/jcb.109.1.441
   Pike DB, 2006, BIOMATERIALS, V27, P5242, DOI 10.1016/j.biomaterials.2006.05.018
   QUARTO N, 1994, J CELL SCI, V107, P3201
   RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484
   REILAND J, 1993, J CELL SCI, V105, P1085
   RONNOVJESSEN L, 1993, LAB INVEST, V68, P696
   Rydholm AE, 2006, BIOMACROMOLECULES, V7, P2827, DOI 10.1021/bm0603793
   SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005
   Smeds KA, 2001, J BIOMED MATER RES, V55, P254, DOI 10.1002/1097-4636(200105)55:2<254::AID-JBM1012>3.0.CO;2-5
   Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809
   TSANG M, 2004, SCI STKE, pPE17, DOI DOI 10.1126/STKE.2282004PE17
   Verrecchia F, 2002, J INVEST DERMATOL, V118, P211, DOI 10.1046/j.1523-1747.2002.01641.x
   Walker GA, 2004, CIRC RES, V95, P253, DOI 10.1161/01.RES.0000136520.07995.aa
NR 38
TC 49
Z9 53
U1 3
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2007
VL 28
IS 23
BP 3378
EP 3387
DI 10.1016/j.biomaterials.2007.04.005
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 180KT
UT WOS:000247362700002
PM 17475322
DA 2018-10-20
ER

PT J
AU Wang, J
   Liu, CS
   Lu, X
   Yin, M
AF Wang, Jing
   Liu, Changsheng
   Lu, Xin
   Yin, Min
TI Co-polypeptides of 3,4-dihydroxyphenylalanine and L-lysine to mimic
   marine adhesive protein
SO BIOMATERIALS
LA English
DT Article
DE biomimetic material; copolymer; polyamino acid; tissue adhesive;
   swelling
ID MUSSEL ADHESIVE; CROSS-LINKING; STRENGTH; BIOMATERIALS; BYSSUS; DOPA
AB Co-polypeptides containing 3,4-dihydroxyphenylalanine (DOPA) and L-lysine were synthesized to mimic the marine adhesive proteins through ring-opening polymerizations. The effects of composition, molecular weight, and curing agents on the adhesive properties, swelling, and degradation behavior of synthetic polypeptide were investigated. Ferric ion was introduced to the system to optimize both adhesive strength and water resistance, simulating the specificity of metal-mediated cross-linking of the marine mussel adhesives. The polypeptide was used to bond on porcine skin and porcine bone in vitro to evaluate the adhesive properties. Furthermore, outcomes of the cell culture of both co-polypeptide and co-polypeptide-modified ethylene vinyl acetate (EVA) demonstrated good cell affinity, which would provide basic data for the application of the co-polypeptide in the biomaterial field. (c) 2007 Elsevier Ltd. All rights reserved.
C1 E China Univ Sci & Technol, Engn Res Ctr Biomed Mat Minist Educ, Key Lab Ultrafine Mat Minist Educ, Shanghai 200237, Peoples R China.
RP Liu, CS (reprint author), E China Univ Sci & Technol, Engn Res Ctr Biomed Mat Minist Educ, Key Lab Ultrafine Mat Minist Educ, Shanghai 200237, Peoples R China.
EM csliu@sh163.net
CR BENEDICT CV, 1988, Patent No. 5015677
   BOWNAM J, 2000, BIOMATERIALS BIOENGI
   Burzio LA, 2000, BIOCHEMISTRY-US, V39, P11147, DOI 10.1021/bi0002434
   Burzio LO, 1997, CURR OPIN BIOTECH, V8, P309, DOI 10.1016/S0958-1669(97)80008-0
   Burzio VA, 1996, ANAL BIOCHEM, V241, P190, DOI 10.1006/abio.1996.0398
   Carbon RT, 2003, BIOMATERIALS, V24, P1469, DOI 10.1016/S0142-9612(02)00522-7
   Chivers RA, 1997, INT J ADHES ADHES, V17, P127, DOI 10.1016/S0143-7496(96)00041-3
   Dalsin JL, 2003, J AM CHEM SOC, V125, P4253, DOI 10.1021/ja0284963
   DEMING T, 2003, Patent No. 6506577
   Deming TJ, 1999, CURR OPIN CHEM BIOL, V3, P100, DOI 10.1016/S1367-5931(99)80018-0
   GREEN K, 1995, SURG ADHESIVE SEALAN, P19
   Huang K, 2002, BIOMACROMOLECULES, V3, P397, DOI 10.1021/bm015650p
   HWANG J, 2002, THESIS U CALIFORNIA
   INOUE K, 1995, J BIOL CHEM, V270, P6698, DOI 10.1074/jbc.270.12.6698
   KOSOVSKY M, 2000, CELL, V10, P2
   KRICHELDORF HR, 1987, X AMINO ACID N CARBO
   Kuboe Y, 2004, BIOMACROMOLECULES, V5, P348, DOI 10.1021/bm034363d
   Lee BP, 2004, J BIOMAT SCI-POLYM E, V15, P449, DOI 10.1163/156856204323005307
   Monahan J, 2004, LANGMUIR, V20, P3724, DOI 10.1021/la0362728
   MONAHAN J, 2008, CHEM COMMUN, P1672
   Morikawa T, 2001, AM J SURG, V182, p29S, DOI 10.1016/S0002-9610(01)00774-7
   Ninan L, 2003, BIOMATERIALS, V24, P4091, DOI 10.1016/S0142-9612(03)00257-6
   O'Donnell J., 1991, US patent, Patent No. [5, 002,571, 5002571]
   Ohkawa K, 2001, BIOMACROMOLECULES, V2, P773, DOI 10.1021/bm010012s
   Reece TB, 2001, AM J SURG, V182, p40S, DOI 10.1016/S0002-9610(01)00742-5
   Sever MJ, 2004, ANGEW CHEM INT EDIT, V43, P448, DOI 10.1002/anie.200352759
   Sever MJ, 2001, TETRAHEDRON, V57, P6139, DOI 10.1016/S0040-4020(01)00601-9
   Tatehata H, 2001, J ADHES SCI TECHNOL, V15, P1003, DOI 10.1163/156856101317035459
   Vaccaro E, 2001, BIOMACROMOLECULES, V2, P906, DOI 10.1021/bm0100514
   Waite JH, 1998, MATRIX BIOL, V17, P93, DOI 10.1016/S0945-053X(98)90023-3
   WAITE JH, 1983, BIOL REV, V58, P209, DOI 10.1111/j.1469-185X.1983.tb00387.x
   Wake J., 1989, BIOL BULL, V176, P337
   WEBSTER I, 2000, POLYM BIOMATERIALS, P703
   Wilker JJ, 2003, J INORG BIOCHEM, V96, P67, DOI 10.1016/S0162-0134(03)80515-9
   Yamamoto H, 2000, BIOMACROMOLECULES, V1, P543, DOI 10.1021/bm000061p
   YU M, 1997, POLYM PREP-ACS, V38, P101
   Yu ME, 1998, MACROMOLECULES, V31, P4739, DOI 10.1021/ma980268z
   Yu ME, 1999, J AM CHEM SOC, V121, P5825, DOI 10.1021/ja990469y
NR 38
TC 51
Z9 53
U1 2
U2 54
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2007
VL 28
IS 23
BP 3456
EP 3468
DI 10.1016/j.biomaterials.2007.04.009
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 180KT
UT WOS:000247362700010
PM 17475323
DA 2018-10-20
ER

PT J
AU Ahmad, AA
   Alsaad, AM
AF Ahmad, A. A.
   Alsaad, A. M.
TI Adhesive B-doped DLC films on biomedical alloys used for bone fixation
SO BULLETIN OF MATERIALS SCIENCE
LA English
DT Article
DE boron-doped DLC; biomedical materials; adhesion strength; stainless
   steel; titanium alloys
ID DIAMOND-LIKE CARBON; WEAR PROTECTION; COATINGS; CORROSION; BIOMATERIALS;
   DEPOSITION; PROTEINS; STEEL
AB The long-term failure of the total hip and knee prostheses is attributed to the production of wear particles at the articulating interface between the metals, ceramics and polymers used for surgical implants and bone-fixtures. Therefore, finding an adhesive and inert coating material that has low frictional coefficient should dramatically reduce the production of wear particles and hence, prolong the life time of the surgical implants. The novel properties of the non-toxic diamond-like carbon (DLC) coatings have proven to be excellent candidates for biomedical applications. However, they have poor adhesion strength to the alloys and biomaterials. The addition of a thin interfacial layer such as Si, Ti, TiN, Mo and Cu/Cr and/or adding additives such as Si, F, N, O, W, V, Co, Mo, Ti or their combinations to the DLC films has been found to increase the adhesion strength substantially. In our study, grade 316L stainless steel and grade 5 titanium alloy (Ti-6Al-4V) were used as biomaterial substrates. They were coated with DLC films containing boron additives at various levels using various Si interfacial layer thicknesses. The best film adhesion was achieved at 8% and 20% on DLC coated Ti-6Al-4V and grade 316L substrates, respectively. It has been demonstrated that doping the DLC with boron increases their adhesion strength to both substrates even without silicon interfacial layer and increases it substantially with optimum silicon layer thickness. The adhesion strength is also correlated with the hydrogen contents in the B-DLC films. It is found to reach its maximum value of 700 kg/cm(2) and 390 kg/cm(2) at 2/7 and 3/6 for CH4/Ar partial pressures (in mTorr ratio) for Ti-6Al-4V and 316L substrates, respectively.
C1 [Ahmad, A. A.; Alsaad, A. M.] Jordan Univ Sci & Technol, Dept Phys Sci, Irbid 22110, Jordan.
RP Ahmad, AA (reprint author), Jordan Univ Sci & Technol, Dept Phys Sci, POB 3030, Irbid 22110, Jordan.
EM sema@just.edu.jo
CR AHMAD AA, 1996, THESIS U NEBRASKALIN
   BAKER NP, 1997, LAUR974984CONF971201
   BENTZON MD, 1994, SURF COAT TECH, V68, P651, DOI 10.1016/0257-8972(94)90232-1
   Bonfield W, 1997, MATER WORLD, V5, P18
   Box G. E. P., 1978, STAT EXPT
   Breusch SJ, 2003, ORTHOPADE, V32, P41, DOI 10.1007/s00132-002-0411-0
   Brown H. R., 2000, MATER FORUM, V24, P49
   CLARK GCF, 1982, J BIOMED MATER RES, V16, P125, DOI 10.1002/jbm.820160205
   Czarnowska E, 1999, J MATER SCI-MATER M, V11, P73
   Czernuszka J, 1996, MATER WORLD, V4, P452
   CZYRSKAFILEMONO.A, 2003, MICROSC MICRO ANAL, V9, P322
   DAVIDSON JA, 1994, BIO-MED MATER ENG, V4, P231
   Davies O. L., 1971, DESIGN ANAL IND EXPT
   DENG JG, 1995, DIAM RELAT MATER, V4, P936, DOI 10.1016/0925-9635(94)00256-8
   FRANKS J, 1989, J VAC SCI TECHNOL A, V7, P2307, DOI 10.1116/1.575933
   GRILL A, 1990, IBM J RES DEV, V34, P849, DOI 10.1147/rd.346.0849
   HARRIS SJ, 1993, SURF COAT TECH, V62, P550, DOI 10.1016/0257-8972(93)90298-3
   HARRIS WH, 1994, ACTA ORTHOP SCAND, V65, P113, DOI 10.3109/17453679408993734
   Hauert R, 2003, DIAM RELAT MATER, V12, P583, DOI 10.1016/S0925-9635(03)00081-5
   He XM, 2000, J PHYS-CONDENS MAT, V12, pL183, DOI 10.1088/0953-8984/12/8/105
   HE XM, 1955, MAT SCI ENG B, V31, P269
   Ianno NJ, 1995, THIN SOLID FILMS, V270, P275, DOI 10.1016/0040-6090(95)06710-8
   LEE HJ, 1992, SURF COAT TECH, V55, P552, DOI 10.1016/S0257-8972(07)80081-8
   Li DJ, 2002, B MATER SCI, V25, P7, DOI 10.1007/BF02704587
   MainilVarlet P, 1997, BIOMATERIALS, V18, P257, DOI 10.1016/S0142-9612(96)00126-3
   MIYOSHI K, 1992, SURF COAT TECH, V55, P428, DOI 10.1016/S0257-8972(07)80061-2
   Ronkainen H, 1996, SURF COAT TECH, V79, P87, DOI 10.1016/0257-8972(95)02433-6
   Sheeja D, 2001, DIAM RELAT MATER, V10, P1043, DOI 10.1016/S0925-9635(00)00413-1
   TAUBE K, 1996, SURF COAT TECH, V68, P662
   VENUGOPALAN R, 1999, 9901 PRINC APPL RES
   WILLIAMS RL, 1988, BIOMATERIALS, V9, P181, DOI 10.1016/0142-9612(88)90119-6
NR 31
TC 5
Z9 5
U1 4
U2 26
PU INDIAN ACAD SCIENCES
PI BANGALORE
PA C V RAMAN AVENUE, SADASHIVANAGAR, P B #8005, BANGALORE 560 080, INDIA
SN 0250-4707
EI 0973-7669
J9 B MATER SCI
JI Bull. Mat. Sci.
PD AUG
PY 2007
VL 30
IS 4
BP 301
EP 308
DI 10.1007/s12034-007-0050-5
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA 241TB
UT WOS:000251677600001
DA 2018-10-20
ER

PT J
AU Kiyozumi, T
   Kanatani, Y
   Ishihara, M
   Saitoh, D
   Shimizu, J
   Yura, H
   Suzuki, S
   Okada, Y
   Kikuchi, M
AF Kiyozumi, Tetsuro
   Kanatani, Yasuhiro
   Ishihara, Masayuki
   Saitoh, Daizoh
   Shimizu, Jun
   Yura, Hirofumi
   Suzuki, Shinya
   Okada, Yoshiaki
   Kikuchi, Makoto
TI The effect of chitosan hydrogel containing DMEM/F12 medium on
   full-thickness skin defects after deep dermal burn
SO BURNS
LA English
DT Article
DE deep dermal burn; chitosan hydrogel; DMEM/F12
ID PHOTOCROSSLINKABLE CHITOSAN; IN-VITRO; VEGF; NEOVASCULARIZATION;
   PROLIFERATION; INFECTION; ADHESIVE; EXCISION; SURVIVAL; SPONGE
AB Burn wound excision is considered necessary to prepare skin for grafting, and the success of graft "take" is thought to be dependent on the vascular supply to the wound. We previously showed that photocrosslinkable chitosan hydrogel containing DMEM/F12 medium (medium-Az-CH-LA) is a biocompatible and biodegradable biomaterial that promotes re-epithelialization and neovascularization. The current study was designed to determine the effect of medium-Az-CH-LA on deep dermal burn. Sixteen male Wistar rats were randomly divided into two groups that were treated with medium-Az-CH-LA (n = 5) or a collagen sponge (n = 5). Under anesthesia, the dorsal fur was shaved and the skin was exposed to water at 95 C for 10 s. After 2 h, damaged tissue was removed from the fascia and dressed with medium-Az-CH-LA or a collagen sponge. Specimens were obtained after 2, 4, 6, 8, 12, 16 and 32 days for histological analysis. There was no significant difference in the time required for wound closure between the two groups, but the thickness of the granulation tissue in the medium-Az-CH-LA-treated group was greater than that in the collagen sponge-treated group. Moreover, degradation and neovascularization occurred earlier in the group treated with medium-Az-CH-LA compared with the collagen sponge-treated group. These findings suggest that early degradative and angiogenic activities of medium-Az-CH-LA may be beneficial for granulation tissue formation in deep dermal burn wounds. (c) 2006 Elsevier Ltd and ISBI. All rights reserved.
C1 Natl Def Med Coll, Dept Traumatol & Crit Care Med, Tokorozawa, Saitama 3598513, Japan.
   Natl Def Med Coll, Res Inst, Tokorozawa, Saitama 3598513, Japan.
   Japan Def Agcy, Mil Med Res Unit, Ground Staff Off, Setagaya Ku, Tokyo 1548532, Japan.
   Netec Inc, Kawasaki, Kanagawa 2130012, Japan.
RP Kanatani, Y (reprint author), Natl Def Med Coll, Dept Traumatol & Crit Care Med, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.
EM ykanatan@ndmc.ac.jp
CR ABRAMO AC, 1992, BRIT J PLAST SURG, V45, P117, DOI 10.1016/0007-1226(92)90170-3
   Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964
   BROWNE EZ, 1986, HAND CLIN, V2, P353
   Djurickovic S, 2001, J BURN CARE REHABIL, V22, P1, DOI 10.1097/00004630-200101000-00002
   Fujita M, 2004, J SURG RES, V121, P135, DOI 10.1016/j.jss.2004.04.010
   Ishihara M, 2001, WOUND REPAIR REGEN, V9, P513, DOI 10.1046/j.1524-475x.2001.00513.x
   Ishihara T, 2001, J DERMATOL, V28, P360, DOI 10.1111/j.1346-8138.2001.tb00150.x
   KIYOZUMI T, 2006, J BIOMED MATER RES B, V798, P129
   LEVINE BA, 1979, J TRAUMA, V19, P670, DOI 10.1097/00005373-197909000-00006
   Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369
   Machens HG, 2000, CELLS TISSUES ORGANS, V167, P88, DOI 10.1159/000016772
   Mori T, 1997, BIOMATERIALS, V18, P947, DOI 10.1016/S0142-9612(97)00017-3
   NAVE M, 1992, Journal of Burn Care and Rehabilitation, V13, P147, DOI 10.1097/00004630-199201000-00033
   Ohki Y, 2005, FASEB J, V19, P2005, DOI 10.1096/fj.04-3496fje
   Ono K, 2000, J BIOMED MATER RES, V49, P289
   Ono K, 2001, SURGERY, V130, P844, DOI 10.1067/msy.2001.117197
   Osaki Ken-Ichi, 1996, Journal of Dermatology (Tokyo), V23, P83
   Scalise A, 2004, EXP DERMATOL, V13, P682
   Sung HW, 1999, J BIOMED MATER RES, V46, P520
   SUZUKI T, 1991, BURNS, V17, P443, DOI 10.1016/0305-4179(91)90069-S
   Unal S, 2005, ANN PLAS SURG, V55, P102, DOI 10.1097/01.sap.0000164531.23770.60
   VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270
   Xia YP, 2003, BLOOD, V102, P161, DOI 10.1182/blood-2002-12-3793
NR 23
TC 34
Z9 35
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0305-4179
J9 BURNS
JI Burns
PD AUG
PY 2007
VL 33
IS 5
BP 642
EP 648
DI 10.1016/j.burns.2006.09.010
PG 7
WC Critical Care Medicine; Dermatology; Surgery
SC General & Internal Medicine; Dermatology; Surgery
GA 189KJ
UT WOS:000247987500016
PM 17475411
DA 2018-10-20
ER

PT J
AU Northwood, E
   Fisher, J
AF Northwood, Ewen
   Fisher, John
TI A multi-directional in vitro investigation into friction, damage and
   wear of innovative chondroplasty materials against articular cartilage
SO CLINICAL BIOMECHANICS
LA English
DT Article
DE articular cartilage; lubrication; friction; degradation; chondroplasty;
   hydrogel
ID SURFACE AMORPHOUS LAYER; SYNOVIAL-FLUID; LUBRICATION; JOINTS;
   POLYETHYLENE; HYDROGELS; DEBRIS; METAL; ACID; TIME
AB Background. The wear of the biomaterial/cartilage interface is vital for the development of innovative chondroplasty therapies. The aim of this study was to investigate potential chondroplasty biomaterials when sliding against natural articular cartilage under uniaxial reciprocating and multi-directional, rotation/reciprocating motions.
   Method. Three biphasic hydrogels were compared to articular cartilage (negative control) and stainless steel (positive control). Friction was measured by means of a simple geometry friction and wear simulator. All tests were completed in 25% bovine serum at 20 degrees C. Mechanical alterations to the surface structure were quantified using surface topography.
   Findings. Articular cartilage produced a constant friction value of 0.05 (confidence interval = 0.0 15) with and without rotation. Stainless steel against articular cartilage produced an increase in friction over time resulting in a peak value of 0.7 (confidence interval = 0.02) without rotation, increasing to 0.88 (confidence interval = 0.03) with rotation. All biphasic hydrogels produced peak friction values lower than the positive control and demonstrated no difference between uni- and multi-directional motion. Degradation of the opposing cartilage surface showed a significant difference between the positive and negative controls, with the greater cartilage damage when sliding against stainless steel under uni-directional motion.
   Interpretation. The lower friction and reduction of opposing cartilage surface degradation with the potential chondroplasty biomaterials can be attributed to their biphasic properties. This study illustrated the importance of biphasic properties within the tribology of cartilage substitution materials and future work will focus on the optimisation of biphasic properties such that materials more closely mimic natural cartilage. (c) 2007 Elsevier Ltd. All rights reserved.
C1 Univ Leeds, Sch Mech Engn, Inst Med & Biol Engn, Leeds LS2 9JT, W Yorkshire, England.
RP Northwood, E (reprint author), Univ Leeds, Sch Mech Engn, Inst Med & Biol Engn, Leeds LS2 9JT, W Yorkshire, England.
EM men5ejn@leeds.ac.uk
CR ATESHIAN GA, 1995, J BIOMECH, V28, P1341, DOI 10.1016/0021-9290(95)00008-6
   Bell CJ, 2006, P I MECH ENG H, V220, P23, DOI 10.1243/095441105X69060
   BRAY JC, 1973, J BIOMED MATER RES, V7, P431, DOI 10.1002/jbm.820070506
   BULLOUGH P, 1968, Journal of Bone and Joint Surgery British Volume, V50-B, P852
   Corkhill P H, 1990, Proc Inst Mech Eng H, V204, P147, DOI 10.1243/PIME_PROC_1990_204_249_02
   Dowson D, 1991, Proc Inst Mech Eng H, V205, P59, DOI 10.1243/PIME_PROC_1991_205_269_02
   Dowson D, 1986, Eng Med, V15, P63
   Forster H, 1999, P I MECH ENG H, V213, P329, DOI 10.1243/0954411991535167
   Forster H, 1996, Proc Inst Mech Eng H, V210, P109, DOI 10.1243/PIME_PROC_1996_210_399_02
   Freeman M. A. R., 1979, ADULT ARTICULAR CART
   Freeman MAR, 2005, J BIOMECH, V38, P197, DOI 10.1016/j.jbiomech.2004.02.006
   Freeman ME, 2000, WEAR, V241, P129, DOI 10.1016/S0043-1648(00)00387-2
   Galvin A, 2006, J MATER SCI-MATER M, V17, P235, DOI 10.1007/s10856-006-7309-z
   Graindorge S, 2005, MED ENG PHYS, V27, P836, DOI 10.1016/j.medengphy.2005.05.001
   Graindorge SL, 2000, WEAR, V241, P143, DOI 10.1016/S0043-1648(00)00386-0
   Hills BA, 2000, P I MECH ENG H, V214, P83, DOI 10.1243/0954411001535264
   JAY GD, 1992, CONNECT TISSUE RES, V28, P71, DOI 10.3109/03008209209014228
   Jay GD, 1999, J RHEUMATOL, V26, P2454
   Jones ES, 1934, LANCET, V1, P1426
   KATTA JK, 2006, P WORLD C BIOM MUN
   KOBAYASHI S, 1995, J ANAT, V187, P429
   Krishnan R, 2004, J ORTHOPAED RES, V22, P565, DOI 10.1016/j.orthres.2003.07.002
   LAFORTUNE MA, 1992, J BIOMECH, V25, P347, DOI 10.1016/0021-9290(92)90254-X
   LEWIS PR, 1959, NATURE, V184, P1285, DOI 10.1038/1841285a0
   LIPSHITZ H, 1975, J BONE JOINT SURG AM, VA 57, P527, DOI 10.2106/00004623-197557040-00015
   McCutchen C, 1962, WEAR, V5, P1, DOI DOI 10.1016/0043-1648(62)90176-X
   MCCUTCHEN CW, 1969, LUBRICATION WEAR JOI
   MEACHIM G, 1974, J ANAT, V118, P101
   MOW VC, 1984, J BIOMECH, V17, P377, DOI 10.1016/0021-9290(84)90031-9
   MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73, DOI 10.1115/1.3138202
   MOW VC, 1980, BASIC BIOMECHANNICS
   OKA M, 1990, Clinical Materials, V6, P361, DOI 10.1016/0267-6605(90)90053-X
   Oka M, 2000, P I MECH ENG H, V214, P59, DOI 10.1243/0954411001535246
   Pickard JE, 1998, BIOMATERIALS, V19, P1807, DOI 10.1016/S0142-9612(98)00147-1
   SASADA T, 1985, J JPN SOC BIOMATERIA, V3, P151
   STACHOWIAK GW, 1994, WEAR, V171, P135, DOI 10.1016/0043-1648(94)90356-5
   Tipper JL, 1999, J MATER SCI-MATER M, V10, P353, DOI 10.1023/A:1026473723777
   VANDERSLUIJS JA, 1992, J ORTHOPAED RES, V10, P58, DOI 10.1002/jor.1100100107
   WALKER PS, 1971, WEAR, V17, P285, DOI 10.1016/0043-1648(71)90032-9
   Wang A, 2001, WEAR, V248, P38, DOI 10.1016/S0043-1648(00)00522-6
NR 40
TC 38
Z9 40
U1 2
U2 23
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0268-0033
J9 CLIN BIOMECH
JI Clin. Biomech.
PD AUG
PY 2007
VL 22
IS 7
BP 834
EP 842
DI 10.1016/j.clinbiomech.2007.03.008
PG 9
WC Engineering, Biomedical; Orthopedics; Sport Sciences
SC Engineering; Orthopedics; Sport Sciences
GA 199DV
UT WOS:000248677300013
PM 17521786
DA 2018-10-20
ER

PT J
AU Mei, Y
   Goldberg, M
   Anderson, D
AF Mei, Ying
   Goldberg, Michael
   Anderson, Daniel
TI The development of high-throughput screening approaches for stem cell
   engineering
SO CURRENT OPINION IN CHEMICAL BIOLOGY
LA English
DT Review
ID DRUG DISCOVERY; BIOMATERIALS; MICROARRAYS; POLYMER; DIFFERENTIATION;
   PROTEINS; LINES; SHAPE
AB It has become increasingly clear that both soluble factors, such as growth factors, and insoluble factors, including the surfaces on which cells grow, can have controlling effects on stem cell behavior and differentiation. While much progress has been made in biomaterial design and application, the rational design of biomaterial cues to direct stem cell behavior and differentiation remains challenging. Recent advances in automated, high-throughput methods for synthesizing and screening combinatorial biomaterial libraries and cellular microenvironments promise to accelerate the discovery of factors that control stem cell behavior. Specific examples include miniaturized, automated, combinatorial material synthesis and extracellular matrix screening methods as well microarrayed methods for creating local microenvironments of soluble factors, such as small molecules, siRNA, and other signaling molecules.
C1 MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
   MIT, Dept Chem, Cambridge, MA 02139 USA.
   MIT, Canc Res Ctr, Cambridge, MA 02139 USA.
RP Mei, Y (reprint author), MIT, Dept Chem Engn, 77 Massachusetts Ave,E25-342, Cambridge, MA 02139 USA.
EM ymei@mit.edu; dgander@mit.edu; dgander@mit.edu
FU NIBIB NIH HHS [R01 EB000244, R01 EB000244-27]
CR Amis EJ, 2004, NAT MATER, V3, P83, DOI 10.1038/nmat1064
   Anderson DG, 2005, BIOMATERIALS, V26, P4892, DOI 10.1016/j.biomaterials.2004.11.052
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Bailey SN, 2004, P NATL ACAD SCI USA, V101, P16144, DOI 10.1073/pnas.0404425101
   Bailey SN, 2006, NAT METHODS, V3, P117, DOI 10.1038/NMETH848
   Bhat RR, 2005, ADV MATER, V17, P2802, DOI 10.1002/adma.200500858
   Castel D, 2006, DRUG DISCOV TODAY, V11, P616, DOI 10.1016/j.drudis.2006.05.015
   Chen CS, 2003, BIOCHEM BIOPH RES CO, V307, P355, DOI 10.1016/S0006-291X(03)01165-3
   Ding S, 2004, NAT BIOTECHNOL, V22, P833, DOI 10.1038/nbt987
   ELLSSEEFF J, 2006, STEM CELLS DEV, V15, P295
   Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Hill E, 2006, P NATL ACAD SCI USA, V103, P2494, DOI 10.1073/pnas.0506004103
   Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598
   Jang JH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100079
   Jost MM, 2005, COMB CHEM HIGH T SCR, V8, P767, DOI 10.2174/138620705774962445
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   Kohn J, 2004, NAT MATER, V3, P745, DOI 10.1038/nmat1249
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   MacBeath G, 2000, SCIENCE, V289, P1760
   Mahoney MJ, 2006, TISSUE ENG, V12, P1915, DOI 10.1089/ten.2006.12.1915
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Mei Y, 2006, J BIOMED MATER RES A, V79A, P974, DOI 10.1002/jbm.a.30883
   NAKAJIMA M, 2007, BIOMATERIALS, P28
   Nelson CM, 2005, P NATL ACAD SCI USA, V102, P11594, DOI 10.1073/pnas.0502575102
   Odorico JS, 2001, STEM CELLS, V19, P193, DOI 10.1634/stemcells.19-3-193
   PEPERKOK R, 2006, NAT REV MOL CELL BIO, V7, P690
   Polak JM, 2006, ANN NY ACAD SCI, V1068, P352, DOI 10.1196/annals.1346.001
   Prang P, 2006, BIOMATERIALS, V27, P3560, DOI 10.1016/j.biomaterials.2006.01.053
   Pratt AB, 2004, BIOTECHNOL BIOENG, V86, P27, DOI 10.1002/bit.10897
   Ramstrom O, 2002, NAT REV DRUG DISCOV, V1, P26, DOI 10.1038/nrd704
   Riddle KW, 2007, MOL THER, V15, P361, DOI 10.1038/sj.mt.6300017
   Sanghvi AB, 2005, NAT MATER, V4, P496, DOI 10.1038/nmat1397
   Sniadecki N, 2006, ANN BIOMED ENG, V34, P59, DOI 10.1007/s10439-005-9006-3
   SOEN Y, 2006, MOL SYST BIOL, V2, P37
   Taqvi S, 2006, BIOMATERIALS, V27, P6024, DOI 10.1016/j.biomaterials.2006.05.052
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Tutter AV, 2006, CURR OPIN DRUG DISC, V9, P169
   Verfaillie Catherine M, 2002, Hematology Am Soc Hematol Educ Program, P369, DOI 10.1182/asheducation-2002.1.369
   Washburn NR, 2004, BIOMATERIALS, V25, P1215, DOI 10.1016/j.biomaterials.2003.08.043
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yoo PJ, 2006, NAT MATER, V5, P234, DOI 10.1038/nmat1596
NR 43
TC 26
Z9 27
U1 0
U2 2
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1367-5931
J9 CURR OPIN CHEM BIOL
JI Curr. Opin. Chem. Biol.
PD AUG
PY 2007
VL 11
IS 4
BP 388
EP 393
DI 10.1016/j.cbpa.2007.07.006
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 213QR
UT WOS:000249682700006
PM 17702642
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Chuang, VTG
   Otagiri, M
AF Chuang, Victor T. G.
   Otagiri, Masaki
TI Recombinant human serum albumin
SO DRUGS OF TODAY
LA English
DT Article
ID YEAST PICHIA-PASTORIS; LACTOSAMINATED HUMAN ALBUMIN; HEPARIN MULTILAYER
   COATINGS; FED-BATCH FERMENTATION; HIGH-LEVEL EXPRESSION; METHYLOTROPHIC
   YEAST; IN-VITRO; SACCHAROMYCES-CEREVISIAE; TRANSGENIC MICE; SYNTHETIC
   HEMES
AB Human serum albumin (HSA) is responsible for 80% of the colloid osmotic pressure of plasma (25-33 mmHg). Its main clinical use is in maintaining colloid oncotic pressure and increasing circulating plasma volume with the typical dosage in excess of 10 g per dose. HSA is isolated by fractionating human plasma, which entails possible contamination by viruses or prions. Recombinant HSA (rHSA) has been successfully produced using a methylotrophic yeast, Pichia pastoris. Due to the fact that the clinical usage of HSA infusion often exceeds 10 g, rHSA preparation requires a high level of purity. rHSA purified by means of Streamline technology is identical to plasma-derived HSA (pdHSA) with no detectable mannan component from P. pastoris. The structural and functional Preclinical and clinical trials have confirmed the safety and efficacy of using this rHSA preparation in different disease conditions, such as hemorrhagic shock, cirrhosis with ascites, and other critical clinical conditions related to plasma volume and oncotic pressure. In addition to its use as a plasma expander, rHSA has great potential as a biomaterial for other medical and pharmaceutically related applications. (c) 2007 Prous Science. All rights reserved.
C1 Kumamoto Univ, Grad Sch Pharmaceut Sci, Kumamoto 8620973, Japan.
   Univ Auckland, Sch Pharm, Fac Med & Hlth Sci, Auckland 1, New Zealand.
RP Otagiri, M (reprint author), Kumamoto Univ, Grad Sch Pharmaceut Sci, Kumamoto 8620973, Japan.
EM otagirim@gpo.kumamoto-u.ac.jp
RI Chuang, Victor/A-3644-2011
OI Chuang, Victor/0000-0003-4543-2256; Chuang, Victor Tuan
   Giam/0000-0002-2141-630X
CR ALDERSON P, 2004, HUMAN ALBUMIN SOLUTI
   Armstrong JS, 1998, J ANDROL, V19, P412
   BARASH I, 1994, TRANSGENIC RES, V3, P141, DOI 10.1007/BF01973981
   Bedrosian I, 1999, J NUCL MED, V40, P1143
   BENJAMIN PP, 1969, INT J APPL RADIAT IS, V20, P187, DOI 10.1016/0020-708X(69)90030-1
   BLONDEAU K, 1994, YEAST, V10, P1297, DOI 10.1002/yea.320101006
   Bosse D, 2005, J CLIN PHARMACOL, V45, P57, DOI 10.1177/0091270004269646
   BROWN JS, 1985, J ALLERGY CLIN IMMUN, V76, P808, DOI 10.1016/0091-6749(85)90753-5
   Brynda E, 2000, J BIOMED MATER RES, V51, P249, DOI 10.1002/(SICI)1097-4636(200008)51:2<249::AID-JBM14>3.3.CO;2-O
   Cai C, 2006, J DRUG TARGET, V14, P55, DOI 10.1080/10611860600613324
   CALLAHAN RJ, 1976, J NUCL MED, V17, P47
   Cha MK, 1996, BIOCHEM BIOPH RES CO, V222, P619, DOI 10.1006/bbrc.1996.0793
   Chen J, 2003, NUCLEIC ACIDS RES, V31, P474, DOI 10.1093/nar/gkg086
   Chuang VTG, 2002, PHARMACEUT RES, V19, P569
   Cochran A, 2007, BURNS, V33, P25, DOI 10.1016/j.burns.2006.10.005
   Di Stefano G, 2006, LIVER INT, V26, P726, DOI 10.1111/j.1478-3231.2006.01289.x
   Di Stefano G, 2004, EUR J PHARM SCI, V23, P393, DOI 10.1016/j.ejps.2004.09.005
   Di Stefano G, 2003, RAPID COMMUN MASS SP, V17, P2503, DOI 10.1002/rcm.1232
   Dosio F, 2001, J CONTROL RELEASE, V76, P107, DOI 10.1016/S0168-3659(01)00420-5
   EDENBRANDT CM, 1983, EUR J NUCL MED, V8, P332
   Farran I, 2002, TRANSGENIC RES, V11, P337, DOI 10.1023/A:1016356510770
   Finfer S, 2004, NEW ENGL J MED, V350, P2247
   Finfer S, 2006, BRIT MED J, V333, P1044, DOI 10.1136/bmj.38985.398704.7C
   FLEER R, 1991, BIO-TECHNOL, V9, P968, DOI 10.1038/nbt1091-968
   Halaby H, 2000, J NUCL MED, V41, P215
   Hara M, 1976, Rinsho Hoshasen, V21, P35
   HIGASHI J, 1997, PHASE 1 CLIN TRIAL G, P2841
   Hovatta O, 2005, REPROD BIOMED ONLINE, V10, P729, DOI 10.1016/S1472-6483(10)61116-9
   Huang LF, 2005, TRANSGENIC RES, V14, P569, DOI 10.1007/s11248-004-6481-5
   HURWITZ DR, 1994, TRANSGENIC RES, V3, P365, DOI 10.1007/BF01976768
   Hwang EH, 1999, J NUCL MED, V40, P1644
   Ichioka T, 2004, J NEURO-ONCOL, V67, P47, DOI 10.1023/B:NEON.0000021783.62610.1b
   Ikegaya K, 1997, ANAL CHEM, V69, P1986, DOI 10.1021/ac961316l
   Ishima Y, 2007, J PHARMACOL EXP THER, V320, P969, DOI 10.1124/jpet.106.114959
   Ito K, 1976, Radioisotopes, V25, P614
   KADEN R, 1985, ARCH ANDROLOGY, V14, P133, DOI 10.3109/01485018508988288
   KAMATA T, 1997, STUDY REPEATED DOSIN, P3128
   KAMATA T, 1997, MULTICENTER PHASE 2, P2884
   KAMATA T, 1997, PHASE 2 CLIN TRIAL G, P2856
   Kang HA, 2001, BIOTECHNOL BIOENG, V76, P175, DOI 10.1002/bit.1157
   Kinuya S, 1996, Ann Nucl Med, V10, P351
   Kobayashi K, 2006, BIOLOGICALS, V34, P55, DOI 10.1016/j.biologicals.2005.08.021
   Kobayashi K, 2000, J BIOSCI BIOENG, V89, P55, DOI 10.1016/S1389-1723(00)88050-0
   Kobayashi K, 2003, J BIOMED MATER RES A, V64A, P48, DOI 10.1002/jbm.a.10323
   Kobayashi K, 1998, Ther Apher, V2, P257, DOI 10.1111/j.1744-9987.1998.tb00118.x
   Kobayashi K, 2000, J BIOSCI BIOENG, V89, P479, DOI 10.1016/S1389-1723(00)89100-8
   Kobayashi K, 2000, J BIOSCI BIOENG, V90, P280, DOI 10.1016/S1389-1723(00)80082-1
   Komatsu T, 1999, BIOCONJUGATE CHEM, V10, P82, DOI 10.1021/bc980084p
   Komatsu T, 2000, BIOCONJUGATE CHEM, V11, P772, DOI 10.1021/bc000016e
   Komatsu T, 1998, ARTIF CELL BLOOD SUB, V26, P519, DOI 10.3109/10731199809117472
   KOSHIKAWA S, 1997, STUDY EFFICACY SAFET, P3138
   KOYANAGI H, 1997, RINSHO KENKYU, V74, P3196
   Kremer P, 2002, ANTI-CANCER DRUG, V13, P615, DOI 10.1097/00001813-200207000-00008
   Lane M, 2003, MOL REPROD DEV, V64, P70, DOI 10.1002/mrd.10210
   LAWN RM, 1981, NUCLEIC ACIDS RES, V9, P6103, DOI 10.1093/nar/9.22.6103
   Lee EJ, 2005, CRYOBIOLOGY, V50, P103, DOI 10.1016/j.cryobiol.2004.12.001
   Magoshi T, 2002, BIOMACROMOLECULES, V3, P976, DOI 10.1021/bm0200377
   Matsuo M, 1979, Radioisotopes, V28, P500
   Matsushita S, 2006, PHARM RES, V23, P882, DOI 10.1007/s11095-006-9933-1
   Matsushita S, 2004, PHARM RES, V21, P1924, DOI 10.1023/B:PHAM.0000045248.03337.0e
   Meyer TPH, 2006, CYTOTHERAPY, V8, P265, DOI 10.1080/14653240600735685
   MOTOKI R, 1997, GENERAL CLIN TRIAL G, V74, P3162
   Nakagawa A, 2006, BIOCONJUGATE CHEM, V17, P146, DOI 10.1021/bc050154+
   Ohi H, 1998, YEAST, V14, P895, DOI 10.1002/(SICI)1097-0061(199807)14:10<895::AID-YEA288>3.0.CO;2-9
   OHI H, 1994, MOL GEN GENET, V243, P489, DOI 10.1007/BF00284196
   Ohtani W, 1998, ANAL CHEM, V70, P425, DOI 10.1021/ac970596h
   Ohtani W, 1997, YAKUGAKU ZASSHI, V117, P220, DOI 10.1248/yakushi1947.117.4_220
   Ohya T, 2005, BIOTECHNOL BIOENG, V90, P876, DOI 10.1002/bit.20507
   Okizaki A, 2000, ANN NUCL MED, V14, P131, DOI 10.1007/BF02988593
   OTA M, 1997, RINSHO KENKYU, V74, P2916
   OTA M, 1997, PHASE 2 CLIN TRIAL G, P2874
   Ozawa T, 1988, Gan To Kagaku Ryoho, V15, P2479
   Park HS, 2002, CLIN EXP ALLERGY, V32, P551, DOI 10.1046/j.0954-7894.2002.01349.x
   PERKINS AC, 1994, EUR J NUCL MED, V21, P1231
   PORTER WC, 1976, J NUCL MED, V17, P704
   QUIRK AV, 1989, BIOTECHNOL APPL BIOC, V11, P273
   Sakai H, 2004, CRIT CARE MED, V32, P539, DOI 10.1097/01.CCM.0000109774.99665.22
   SAUNDERS CW, 1987, J BACTERIOL, V169, P2917, DOI 10.1128/jb.169.7.2917-2925.1987
   Schuh-Hofer S, 2006, CEPHALALGIA, V26, P1115, DOI 10.1111/j.1468-2982.2006.01170.x
   Sharma RI, 2006, BIOMATERIALS, V27, P3589, DOI 10.1016/j.biomaterials.2006.02.007
   Shechter Y, 2005, BIOCONJUGATE CHEM, V16, P913, DOI 10.1021/bc050055w
   Shimmura S, 2003, BRIT J OPHTHALMOL, V87, P1279, DOI 10.1136/bjo.87.10.1279
   SIJMONS PC, 1990, BIO-TECHNOL, V8, P217, DOI 10.1038/nbt0390-217
   SLEEP D, 1990, BIO-TECHNOL, V8, P42, DOI 10.1038/nbt0190-42
   Sperling C, 2006, J BIOMED MATER RES A, V76A, P681, DOI 10.1002/jbm.a.30519
   Stehle G, 1999, ANTI-CANCER DRUG, V10, P785, DOI 10.1097/00001813-199909000-00012
   Sumi A, 1998, BIOSEPARATION, V8, P195, DOI 10.1023/A:1008081314112
   Takeshima K, 1996, YAKUGAKU ZASSHI, V116, P622, DOI 10.1248/yakushi1947.116.8_622
   Tarelli E, 1998, BIOLOGICALS, V26, P331, DOI 10.1006/biol.1998.0163
   Thibaudeau K, 2005, BIOCONJUGATE CHEM, V16, P1000, DOI 10.1021/bc050102k
   Tsuchida E, 1999, BIOCONJUGATE CHEM, V10, P797, DOI 10.1021/bc990019v
   Tsuchida E, 2003, J BIOMED MATER RES A, V64A, P257, DOI 10.1002/jbm.a.10324
   Verbrugge SJC, 1996, CRIT CARE MED, V24, P1518, DOI 10.1097/00003246-199609000-00015
   Wartlick H, 2004, J CONTROL RELEASE, V96, P483, DOI 10.1016/j.jconrel.2004.01.029
   Watanabe H, 2001, PHARMACEUT RES, V18, P1775, DOI 10.1023/A:1013391001141
   Wong F, 2007, NAT CLIN PRACT GASTR, V4, P43, DOI 10.1038/ncpgasthep0680
   Wosikowski K, 2003, CLIN CANCER RES, V9, P1917
   YAGI M, 1997, RINSHO KENKYU, V74, P3178
NR 98
TC 37
Z9 39
U1 1
U2 16
PU PROUS SCIENCE, SA-THOMSON REUTERS
PI BARCELONA
PA PO BOX 540, PROVENZA 388, 08025 BARCELONA, SPAIN
SN 1699-3993
J9 DRUG TODAY
JI Drugs Today
PD AUG
PY 2007
VL 43
IS 8
BP 547
EP 561
DI 10.1358/dot.2007.43.8.1067343
PG 15
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 214QU
UT WOS:000249754000004
PM 17925886
DA 2018-10-20
ER

PT J
AU Todo, M
   Park, SD
   Takayama, T
   Arakawa, K
AF Todo, M.
   Park, S.-D.
   Takayama, T.
   Arakawa, K.
TI Fracture micromechanisms of bioabsorbable PLLA/PCL polymer blends
SO ENGINEERING FRACTURE MECHANICS
LA English
DT Article; Proceedings Paper
CT 1st International Conference on the Mechanics of Biomaterials and
   Tissues
CY DEC, 2005
CL HI
DE bioabsorbable; polymer blend; fracture toughness; toughening mechanism
ID BIODEGRADABLE POLY(LACTIC ACID); SOLUTION-CAST BLENDS; ALIPHATIC
   POLYESTERS; PHYSICAL-PROPERTIES; TOUGHNESS; BEHAVIOR;
   POLY(EPSILON-CAPROLACTONE); POLY(L-LACTIDE); CRYSTALLIZATION;
   POLYLACTIDE
AB Poly(L-lactide) (PLLA) has actively been used as a biomaterial for resorbable bone fixation devices for use in orthopedic and oral surgeries. Recently, in order to improve the fracture properties of brittle PLLA, polymer blends of PLLA and a ductile bioabsorbable polymer, poly(epsilon-caprolactone) (PCL), have been developed. The aim of the present study is to elucidate details of the fracture behavior and toughening mechanisms of PLLA/PCL blends. PLLA/PCL blends with different PCL contents were developed, and the critical energy release rate at crack initiation, G(in), was then measured to assess the effect of PCL content. It was shown that G(in) is dramatically improved by blending PCL with PLLA, and the maximum 51% of increase of G(in) is acheived with 5 wt% of PCL. Polarizing optical microscopy (POM) and scanning electron microscopy (SEM) of crack growth behavior were also performed to characterize the fracture mechanism. PLLA/PCL showed multiple craze formation in the crack-tip region, and elongated fibrils and voids construct the crazes. SEM of fracture surface also indicated that stretched fibril structures are formed on the surface as a result of elongation of PCL spherulites under high tensile stress condition in the crack-tip region. Thus, these damage formations are considered to be the primary energy dissipation mechanisms that resulted in the improvement of fracture energy. (C) 2006 Elsevier Ltd. All rights reserved.
C1 Kyushu Univ, Appl Mech Res Inst, Kasuga, Fukuoka 8168580, Japan.
RP Todo, M (reprint author), Kyushu Univ, Appl Mech Res Inst, 6-1 Kasuga Koen, Kasuga, Fukuoka 8168580, Japan.
EM todo@riam.kyushu-u.ac.jp
RI Kyushu, RIAM/F-4018-2015; U-ID, Kyushu/C-5291-2016
OI Kyushu, RIAM/0000-0002-3518-444X; 
CR Anderson KS, 2004, POLYMER, V45, P8809, DOI 10.1016/j.polymer.2004.10.047
   Anderson KS, 2003, J APPL POLYM SCI, V89, P3757, DOI 10.1002/app.12462
   *ASTM, 504191 ASTM D
   Chen CC, 2003, BIOMATERIALS, V24, P1167, DOI 10.1016/S0142-9612(02)00466-0
   Dell'Erba R, 2001, POLYMER, V42, P7831, DOI 10.1016/S0032-3861(01)00269-5
   HiljanenVainio M, 1996, MACROMOL CHEM PHYSIC, V197, P1503, DOI 10.1002/macp.1996.021970427
   Jiang L, 2006, BIOMACROMOLECULES, V7, P199, DOI 10.1021/bm050581q
   Ke TY, 2003, J APPL POLYM SCI, V88, P2947, DOI 10.1002/app.12112
   Kosaka M, 2003, J CRANIO MAXILL SURG, V31, P10, DOI 10.1016/s1010-5182(02)00166-X
   Maglio G, 1999, MACROMOL RAPID COMM, V20, P236, DOI 10.1002/(SICI)1521-3927(19990401)20:4<236::AID-MARC236>3.0.CO;2-V
   McCarthy SP, 1999, MACROMOL SYMP, V144, P63, DOI 10.1002/masy.19991440107
   Park JW, 2000, POLYM ENG SCI, V40, P2539, DOI 10.1002/pen.11384
   Park SD, 2005, J MATER SCI, V40, P1055, DOI 10.1007/s10853-005-6534-z
   Park SD, 2004, KEY ENG MAT, V261-263, P105, DOI 10.4028/www.scientific.net/KEM.261-263.105
   Park SD, 2004, J MATER SCI, V39, P1113, DOI 10.1023/B:JMSC.0000012957.02434.1e
   SHAFER BL, 2002, J ARTHROSC RELAT SUR, V18, P1
   Todo M, 2003, KOBUNSHI RONBUNSHU, V60, P644, DOI 10.1295/koron.60.644
   Todo M, 2002, J MATER SCI LETT, V21, P1203, DOI 10.1023/A:1016520518959
   Todo M, 1999, J REINF PLAST COMP, V18, P1415, DOI 10.1177/073168449901801505
   Todo M, 1999, JSME INT J A-SOLID M, V42, P585, DOI 10.1299/jsmea.42.585
   TODO M, 2004, P SEM X INT C EXPO E
   Tohdoh M, 1996, INT J FRACTURE, V75, P285, DOI 10.1007/BF00019610
   Tsuji H, 1996, J APPL POLYM SCI, V60, P2367, DOI 10.1002/(SICI)1097-4628(19960627)60:13<2367::AID-APP8>3.0.CO;2-C
   Tsuji H, 1998, J APPL POLYM SCI, V70, P2259, DOI 10.1002/(SICI)1097-4628(19981212)70:11<2259::AID-APP20>3.3.CO;2-A
   Tsuji H, 2003, POLYM INT, V52, P269, DOI 10.1002/pi.1093
   Wong S, 2004, MACROMOL MATER ENG, V289, P447, DOI 10.1002/mame.200300366
   Yuan YM, 1998, POLYM BULL, V40, P485, DOI 10.1007/s002890050280
NR 27
TC 78
Z9 79
U1 1
U2 46
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0013-7944
J9 ENG FRACT MECH
JI Eng. Fract. Mech.
PD AUG
PY 2007
VL 74
IS 12
BP 1872
EP 1883
DI 10.1016/j.engfracmech.2006.05.021
PG 12
WC Mechanics
SC Mechanics
GA 182ET
UT WOS:000247488600004
DA 2018-10-20
ER

PT J
AU Zhao, HP
   Feng, XQ
   Cui, WZ
   Zou, FZ
AF Zhao, Hong-Ping
   Feng, Xi-Qiao
   Cui, Wei-Zheng
   Zou, Feng-Zhu
TI Mechanical properties of silkworm cocoon pelades
SO ENGINEERING FRACTURE MECHANICS
LA English
DT Article; Proceedings Paper
CT 1st International Conference on the Mechanics of Biomaterials and
   Tissues
CY DEC, 2005
CL HI
DE silkworm cocoon; pelade; mechanical property; biomaterial; biomimetics
ID BOMBYX-MORI; TENSILE PROPERTIES; DENSITY; FIBERS; INSECT
AB The pelade, the innermost layer of silkworm cocoon next to the chrysalis, has special microstructures, mechanical properties and protective functions distinctly different from those of all the other layers. In the present paper, a series of static tensile tests and dynamic mechanical thermal analysis were performed for the first time to measure the mechanical properties of pelades, including Young's modulus, tensile strength and thermomechanical parameters. The fracture process of precracked pelade specimens was observed by in-situ scanning electron microscopy under tension. It is found that the Young's modulus, tensile strength, storage modulus and loss modulus of cocoon pelades are superior to the corresponding thickness-averaged values of a complete silkworm cocoon. The damage and fracture process of pelades involve delamination, silk breaking and damage localization band. The results indicate that silkworm caterpillars can be appreciated as sophisticated sewers to make anisotropic and optimized structures of cocoons with both protective functions and mechanical properties varying in their thickness direction. The present study might be helpful to guide biomimetic design of novel safe-guarding materials and structures from both the viewpoints of microstructures and spatial functional gradients. (C) 2006 Elsevier Ltd. All rights reserved.
C1 Tsing Hua Univ, Dept Engn Mech, Beijing 100084, Peoples R China.
   Shandong Agr Univ, Dept Sericulture, Tai An 271018, Peoples R China.
RP Feng, XQ (reprint author), Tsing Hua Univ, Dept Engn Mech, Beijing 100084, Peoples R China.
EM fengxq@tsinghua.edu.cn
RI Feng, Xi-Qiao/A-1696-2009
OI Feng, Xi-Qiao/0000-0001-6894-7979
CR Fox G., 1956, B AM PHYS SOC, V1, P123
   GEIER P. W., 1963, AUSTRALIAN JOUR ZOOL, V11, P323, DOI 10.1071/ZO9630323
   Jelinski LW, 1998, CURR OPIN SOLID ST M, V3, P237, DOI 10.1016/S1359-0286(98)80097-1
   Johnson CD, 2001, COLEOPTS BULL, V55, P37, DOI 10.1649/0010-065X(2001)055[0037:EOACRC]2.0.CO;2
   JONES D, 1985, J COMP PHYSIOL B, V155, P235, DOI 10.1007/BF00685218
   Karlou K, 2000, J THERM ANAL CALORIM, V59, P59, DOI 10.1023/A:1010119525345
   KAUFFMAN WC, 1989, J CHEM ECOL, V15, P2051, DOI 10.1007/BF01207437
   Kiyosawa M, 1999, ZOOL SCI, V16, P215, DOI 10.2108/zsj.16.215
   LEE YW, 1999, AGR SERVIES B UN, V136
   Liu G. K. C., 1952, Osiris Bruges, V10, P129, DOI 10.1086/368551
   Lyon BE, 1996, P ROY SOC B-BIOL SCI, V263, P1159, DOI 10.1098/rspb.1996.0169
   Mekky W, 2006, ENG FRACT MECH, V73, P571, DOI 10.1016/j.engfracmech.2005.09.005
   Miura Mikihiko, 1997, Journal of Sericultural Science of Japan, V66, P23
   Perez-Rigueiro J, 2002, J APPL POLYM SCI, V84, P1431, DOI 10.1002/app.10366
   Poursartip A, 1998, ENG FRACT MECH, V60, P173, DOI 10.1016/S0013-7944(98)00005-8
   Singh KP, 2002, PHARM BIOL, V40, P28, DOI 10.1076/phbi.40.1.28.5857
   TSUKADA M, 1993, J APPL POLYM SCI, V49, P1565, DOI 10.1002/app.1993.070490907
   Woesz A, 2004, ADV ENG MATER, V6, P134, DOI 10.1002/adem.200300529
   Zhang H, 2002, J APPL POLYM SCI, V86, P1817, DOI 10.1002/app.11089
   Zhang YL, 2003, J APPL POLYM SCI, V90, P2130, DOI 10.1002/app.12823
   Zhao HP, 2005, POLYMER, V46, P9192, DOI 10.1016/j.polymer.2005.07.004
   ZHAO HP, IN PRESS MAT SCI ENG
NR 22
TC 32
Z9 35
U1 0
U2 18
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0013-7944
J9 ENG FRACT MECH
JI Eng. Fract. Mech.
PD AUG
PY 2007
VL 74
IS 12
BP 1953
EP 1962
DI 10.1016/j.engfracmech.2006.06.010
PG 10
WC Mechanics
SC Mechanics
GA 182ET
UT WOS:000247488600011
DA 2018-10-20
ER

PT J
AU Dupont, L
   Jolly, G
   Aplincourt, M
AF Dupont, L.
   Jolly, G.
   Aplincourt, M.
TI Arsenic adsorption on lignocellulosic substrate loaded with ferric ion
SO ENVIRONMENTAL CHEMISTRY LETTERS
LA English
DT Article
DE lignocellulosic substrate; wheat bran; sorption; arsenite; arsenate
ID REMOVAL; OXIDE; GOETHITE
AB We loaded a lignocellulosic substrate extracted from wheat bran with ferric ions. This new low-cost adsorbent was prepared for the adsorption and removal of arsenate and arsenite ions from aqueous systems. The loading process of Fe in this biomaterial was done by hydrolization of a ferric salt while an alkaline solution was added dropwise. The new material obtained has a high sensivity to arsenite and arsenate species. Here, we investigated the effect of contact time, pH, and Fe content on the adsorption of both arsenic ions on the new material. This adsorption was found to be highly pH-dependent, which can be explained on the basis of electrostatic interactions between ionic species in solution and the  FeOH surface groups. The maximum adsorption capacity of arsenite and arsenate species vary linearly with the amount of Fe loaded on the lignocellulosic substrate.
C1 Univ Reims, GRECI, F-51687 Reims 2, France.
RP Dupont, L (reprint author), Univ Reims, GRECI, BP 1039, F-51687 Reims 2, France.
EM laurent.dupont@univ-reims.fr
CR Dupont L, 2005, ENVIRON CHEM LETT, V2, P165, DOI 10.1007/s10311-004-0095-2
   Dutta PK, 2004, J COLLOID INTERF SCI, V278, P270, DOI 10.1016/j.jcis.2004.06.015
   Guo XJ, 2005, ENVIRON SCI TECHNOL, V39, P6808, DOI 10.1021/es048080k
   Katsoyiannis IA, 2002, WATER RES, V36, P5141, DOI 10.1016/S0043-1354(02)00236-1
   Lakshmipathiraj P, 2006, J HAZARD MATER, V136, P281, DOI 10.1016/j.jhazmat.2005.12.015
   Raven KP, 1998, ENVIRON SCI TECHNOL, V32, P344, DOI 10.1021/es970421p
   Sherman DM, 2003, GEOCHIM COSMOCHIM AC, V67, P4223, DOI 10.1016/S0016-7037(03)00237-0
   Sun XH, 1996, SOIL SCI, V161, P865, DOI 10.1097/00010694-199612000-00006
   Wilkie JA, 1996, COLLOID SURFACE A, V107, P97, DOI 10.1016/0927-7757(95)03368-8
   Zhang FS, 2005, CHEMOSPHERE, V60, P319, DOI 10.1016/j.chemosphere.2004.12.019
NR 10
TC 23
Z9 24
U1 2
U2 5
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1610-3653
J9 ENVIRON CHEM LETT
JI Environ. Chem. Lett.
PD AUG
PY 2007
VL 5
IS 3
BP 125
EP 129
DI 10.1007/s10311-007-0092-3
PG 5
WC Chemistry, Multidisciplinary; Engineering, Environmental; Environmental
   Sciences
SC Chemistry; Engineering; Environmental Sciences & Ecology
GA 193UN
UT WOS:000248300800004
DA 2018-10-20
ER

PT J
AU Maev, RG
AF Maev, Roman Gr.
TI Introduction to the special issue on high resolution ultrasonic imaging
   in industrial, material and biomaterial applications
SO IEEE TRANSACTIONS ON ULTRASONICS FERROELECTRICS AND FREQUENCY CONTROL
LA English
DT Editorial Material
C1 Univ Windsor, Fac Sci, Daimler Chrysler NSERC Ind Res Chair Appl Solid S, Windsor, ON N9B 3P4, Canada.
RP Maev, RG (reprint author), Univ Windsor, Fac Sci, Daimler Chrysler NSERC Ind Res Chair Appl Solid S, Windsor, ON N9B 3P4, Canada.
NR 0
TC 0
Z9 0
U1 0
U2 3
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 0885-3010
J9 IEEE T ULTRASON FERR
JI IEEE Trans. Ultrason. Ferroelectr. Freq. Control
PD AUG
PY 2007
VL 54
IS 8
BP 1500
EP 1501
DI 10.1109/TUFFC.2007.419
PG 2
WC Acoustics; Engineering, Electrical & Electronic
SC Acoustics; Engineering
GA 194OA
UT WOS:000248352500001
DA 2018-10-20
ER

PT J
AU Gelinsky, M
   Eckert, M
   Despang, F
AF Gelinsky, Michael
   Eckert, Marlen
   Despang, Florian
TI Biphasic, but monolithic, scaffolds for the therapy of osteochondral
   defects
SO INTERNATIONAL JOURNAL OF MATERIALS RESEARCH
LA English
DT Article
DE biomaterial; collagen; alginate; calcium phosphate; tissue engineering
ID MINERALIZED COLLAGEN; ARTICULAR-CARTILAGE; POROUS SCAFFOLDS; TISSUE;
   CELLS; KNEE
AB For the regenerative therapy of osteochondral defects deep lesions of the articular cartilage in which the underlying bone tissue is already affected too - special implant materials and scaffolds are needed. In this study, two new approaches will be presented, leading to biphasic, but monolithic scaffold materials. Both consist of a mineralised layer for filling of the bony part of the defect and a non-mineralised one for the chondral part. Due to the preparation methods, both layers are fused together to give a unified whole without need of any artificial joining. The resulting materials, either based on collagen, hyaluronic acid and hydroxyapatite or calcium alginate gels and hydroxyapatite, seem to be suitable scaffolds for cultivating chondrocytes and osteoblasts - and therefore can act as matrices for tissue engineering of osteochondral grafts.
C1 Tech Univ Dresden, Inst Mat Sci, Max Bergmann Ctr Biomat, D-01069 Dresden, Germany.
RP Gelinsky, M (reprint author), Tech Univ Dresden, Inst Mat Sci, Max Bergmann Ctr Biomat, Budapesterstr 27, D-01069 Dresden, Germany.
EM gelinsky@tmfs.mpgfk.tu-dresden.de
RI Gelinsky, Michael/A-9680-2012; Despang, Florian/G-1815-2011
OI Gelinsky, Michael/0000-0001-9075-5121; 
CR BERNHARDT A, 2004, BIOMATERIALIEN, V5, P147
   BORNER A, 2004, BIOMATERIALIEN, V5, P151
   Bradt JH, 1999, CHEM MATER, V11, P2694, DOI 10.1021/cm991002p
   Burkart A C, 2001, Unfallchirurg, V104, P798, DOI 10.1007/s001130170049
   Darling EM, 2003, ANN BIOMED ENG, V31, P1114, DOI 10.1114/1.1603752
   Despang F, 2005, MATERIALWISS WERKST, V36, P761, DOI 10.1002/mawe.200500961
   Dittrich R., 2006, Advances in Science and Technology, V49, P159, DOI 10.4028/www.scientific.net/AST.49.159
   Dittrich R, 2007, J AM CERAM SOC, V90, P1703, DOI [10.1111/j.1551-2916.2007.01598.x, 10.1111/j.1 551-2916.2007.01598.x]
   ECKERT M, 2004, THESIS TU BRAUNSCHWE
   Gao JZ, 2001, TISSUE ENG, V7, P363, DOI 10.1089/10763270152436427
   Gelinsky M, 2004, MATERIALWISS WERKST, V35, P229, DOI 10.1002/mawe.200400732
   GELINSKY M, 2004, Patent No. 1020040441022
   GELINSKY M, 2004, BIOMATERIALIEN, V5, P164
   GELINSKY M, 2005, Patent No. 2006026981
   Gooding CR, 2006, KNEE, V13, P203, DOI 10.1016/j.knee.2006.02.011
   Hayes D W Jr, 2001, Clin Podiatr Med Surg, V18, P35
   Huch K, 2002, Z ORTHOP GRENZGEB, V140, P145, DOI 10.1055/s-2002-31532
   Martin I, 2007, J BIOMECH, V40, P750, DOI 10.1016/j.jbiomech.2006.03.008
   Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034
   Pompe W, 2003, MAT SCI ENG A-STRUCT, V362, P40, DOI 10.1016/S0921-5093(03)00580-X
   Quinn TM, 2005, OSTEOARTHR CARTILAGE, V13, P672, DOI 10.1016/j.joca.2005.04.011
   Redman S N, 2005, Eur Cell Mater, V9, P23
   Thiele H, 1967, HISTOLYSE HISTOGENES
   Waldman SD, 2003, J BONE JOINT SURG AM, V85A, P101, DOI 10.2106/00004623-200300002-00013
   WELZ P, 2006, THESIS TU DRESDEN
   Yokoyama A, 2005, J BIOMED MATER RES B, V75B, P464, DOI 10.1002/jbm.b.30331
NR 26
TC 33
Z9 33
U1 0
U2 6
PU CARL HANSER VERLAG
PI MUNICH
PA KOLBERGERSTRASSE 22, POSTFACH 86 04 20, D-81679 MUNICH, GERMANY
SN 1862-5282
J9 INT J MATER RES
JI Int. J. Mater. Res.
PD AUG
PY 2007
VL 98
IS 8
BP 749
EP 755
DI 10.3139/146.101520
PG 7
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 212QJ
UT WOS:000249611600013
DA 2018-10-20
ER

PT J
AU Ruszymah, BHI
   Lokman, BS
   Asma, A
   Munirah, S
   Chua, K
   Mazlyzma, AL
   Isa, MR
   Fuzina, NH
   Aminuddin, BS
AF Ruszymah, B. H. I.
   Lokman, B. S.
   Asma, A.
   Munirah, S.
   Chua, Kienhui
   Mazlyzma, A. L.
   Isa, M. R.
   Fuzina, N. H.
   Aminuddin, B. S.
TI Pediatric auricular chondrocytes gene expression analysis in monolayer
   culture and engineered elastic cartilage
SO INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY
LA English
DT Article
DE tissue engineering; elastic cartilage; auricular chondrocyte; human
   fibrin; gene expression analysis
ID NASAL SEPTAL CHONDROCYTES; FLOW-CYTOMETRY; CELL-SHAPE; IN-VITRO; TISSUE;
   SCAFFOLDS; ALGINATE; RECONSTRUCTION; CYTOSKELETON; MODULATION
AB Objectives: This study was aimed at regenerating autologous elastic cartilage for future use in pediatric ear reconstruction surgery. Specific attentions were to characterize pediatric auricular chondrocyte growth in a combination culture medium and to assess the possibility of elastic cartilage regeneration using human fibrin.
   Study design: Laboratory experiment using human pediatric auricular chondrocytes.
   Methods: Pediatric auricular chondrocytes growth kinetics and quantitative gene expression profile in three different types of media were compared in primary culture and subsequent three passages. Large-scale culture-expanded chondrocytes from the combination medium were then mixed with human fibrin for the formation of elastic cartilage via tissue engineering technique.
   Results: The equal mixture of Ham's F12 and Dulbecco's Modified Eagle Medium (FD) promoted the best chondrocyte growth at every passage compared to the individual media. Chondrocytes differentiation index; ratio of type II to type I collagen gene expression level, aggrecan and elastin expression gradually decreased white passaging but they were then restored in engineered tissues after implantation. The engineered cartilage was glistening white in color and firm in consistency. Histological evaluation, immunohistochemistry analysis and quantitative gene expression assessment demonstrated that the engineered cartilage resemble the features of native elastic cartilage.
   Conclusion: Pediatric auricular chondrocytes proliferate better in the combination medium (FD) and the utilization of human fibrin as a biomaterial hold promises for the regeneration of an autologous elastic cartilage for future application in ear reconstructive surgery. (c) 2007 Elsevier Ireland Ltd. All rights reserved.
C1 Univ Kebangsaan Malaysia, Fac Med, Dept Physiol, Kuala Lumpur 50300, Malaysia.
   Univ Kebangsaan Malaysia, Fac Med, Dept Otorhinolaryngol, Kuala Lumpur 50300, Malaysia.
   Univ Kebangsaan Malaysia, Fac Med, Dept Pathol, Kuala Lumpur 50300, Malaysia.
RP Ruszymah, BHI (reprint author), Univ Kebangsaan Malaysia, Fac Med, Dept Physiol, Jalan Raja Muda Abdul Aziz, Kuala Lumpur 50300, Malaysia.
RI Idrus, Ruszymah/F-1521-2010
CR Alexander TH, 2006, OTOLARYNG HEAD NECK, V135, P397, DOI 10.1016/j.otohns.2006.05.029
   AMINUDDIN BS, 2003, KPJ MED J, V1, P3
   AMINUDDIN BS, 2000, LARYNGOSCOPE, V110, P1694
   Arevalo-Silva CA, 2000, ARCH OTOLARYNGOL, V126, P1448, DOI 10.1001/archotol.126.12.1448
   Arevalo-Silva CA, 2000, ARCH OTOLARYNGOL, V126, P1234, DOI 10.1001/archotol.126.10.1234
   Azmi B, 2004, Med J Malaysia, V59 Suppl B, P13
   Baek CH, 2002, LARYNGOSCOPE, V112, P1050, DOI 10.1097/00005537-200206000-00021
   Cao YL, 1997, PLAST RECONSTR SURG, V100, P297, DOI 10.1097/00006534-199708000-00001
   Cao YL, 1998, J BIOMAT SCI-POLYM E, V9, P475
   Chia SH, 2005, J AM COLL SURGEONS, V200, P691, DOI 10.1016/j.jamcollsurg.2005.01.006
   Chua K H, 2004, Med J Malaysia, V59 Suppl B, P7
   Chua K H, 2004, Med J Malaysia, V59 Suppl B, P194
   CHUA KH, 2005, CUR CELL MAT, V9, P58
   DANIELS K, 1991, J CELL SCI, V100, P249
   Homicz MR, 2003, LARYNGOSCOPE, V113, P25, DOI 10.1097/00005537-200301000-00005
   Idrus RBH, 2005, INT J PEDIATR OTORHI, V69, P1489, DOI 10.1016/j.ijporl.2005.04.026
   Kamil SH, 2007, INT J PEDIATR OTORHI, V71, P71, DOI 10.1016/j.ijporl.2006.09.002
   Kamil SH, 2003, OTOLARYNG HEAD NECK, V129, P390, DOI 10.1016/S0194-5998(03)00710-1
   Kamil SH, 2003, LARYNGOSCOPE, V113, P90, DOI 10.1097/00005537-200301000-00017
   Kamil SH, 2002, TISSUE ENG, V8, P85, DOI 10.1089/107632702753503081
   LANGER R, 1993, TISSUE ENG SCI, V260, P920
   Lee CJ, 2002, J CARDIOVASC SURG, V43, P275
   Loty S, 2000, BIORHEOLOGY, V37, P117
   Melero-Martin JM, 2006, BIOMATERIALS, V27, P2970, DOI 10.1016/j.biomaterials.2006.01.023
   Munirah S, 2004, Med J Malaysia, V59 Suppl B, P9
   Munirah S, 2005, TISSUE ENG REGEN MED, V2, P347
   Nakata K, 2001, CLIN ORTHOP RELAT R, pS208
   Park K, 2007, ANN BIOMED ENG, V35, P419, DOI 10.1007/s10439-006-9219-0
   Park SH, 2005, ARTIF ORGANS, V29, P838, DOI 10.1111/j.1525-1594.2005.00137.x
   Patel NN, 2002, J LARYNGOL OTOL, V116, P165
   PUELACHER WC, 1994, INT J ORAL MAX SURG, V23, P49, DOI 10.1016/S0901-5027(05)80328-5
   Rodriguez A, 1999, PLAST RECONSTR SURG, V103, P1111, DOI 10.1097/00006534-199904040-00001
   RUSZYMAH BHI, 2003, INT MED J, V2
   RUSZYMAH BHI, 2005, MJIAS, V15, P5
   Samsudin O C, 2004, Med J Malaysia, V59 Suppl B, P15
   Sasano Y, 1996, ANAT EMBRYOL, V194, P247
   Shieh SJ, 2004, BIOMATERIALS, V25, P1545, DOI 10.1016/S0142-9612(03)00501-5
   VACANTI CA, 1991, PLAST RECONSTR SURG, V88, P753, DOI 10.1097/00006534-199111000-00001
   VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Xia WY, 2004, J BIOMED MATER RES B, V71B, P373, DOI 10.1002/jbm.b.30087
   Zheng Yi-xiong, 2006, J Zhejiang Univ Sci B, V7, P817, DOI 10.1631/jzus.2006.B0817
NR 42
TC 23
Z9 23
U1 0
U2 9
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0165-5876
EI 1872-8464
J9 INT J PEDIATR OTORHI
JI Int. J. Pediatr. Otorhinolaryngol.
PD AUG
PY 2007
VL 71
IS 8
BP 1225
EP 1234
DI 10.1016/j.ijporl.2007.04.014
PG 10
WC Otorhinolaryngology; Pediatrics
SC Otorhinolaryngology; Pediatrics
GA 196ZH
UT WOS:000248521700011
PM 17531328
DA 2018-10-20
ER

PT J
AU Ohtsu, N
   Sato, K
   Yanagawa, A
   Saito, K
   Imai, Y
   Kohgo, T
   Yokoyama, A
   Asami, K
   Hanawa, T
AF Ohtsu, Naofumi
   Sato, Kenji
   Yanagawa, Aya
   Saito, Kesami
   Imai, Yoshio
   Kohgo, Takao
   Yokoyama, Atsuro
   Asami, Katsuhiko
   Hanawa, Takao
TI CaTiO(3) coating on titanium for biomaterial application - Optimum
   thickness and tissue response
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomaterials; titanium; CaTiO(3) coating; biocompatibility; bone
   formation
ID CALCIUM-PHOSPHATE COATINGS; INTERFACE SHEAR-STRENGTH; ION-IMPLANTED
   TITANIUM; MECHANICAL-PROPERTIES; ANODIC POLARIZATION; BONE; ALLOYS;
   METAL; BEHAVIOR; CYTOCOMPATIBILITY
AB The objectives of this study were to determine the optimum thickness of a CaTiO(3) film for biomaterial applications and to investigate the biocompatibility and bone formation of titanium with a CaTiO(3) film. First, CaTiO(3) films of 10, 20, 30, and 50 nm in thickness were deposited on titanium substrates using ractiofrequency magnetron sputtering followed by annealing at 873 K in air for 7.2 ks. The optimum thickness of the CaTiO(3) film for bone formation was determined by comparison with its performance regarding calcium phosphate formation in Hanks' balanced saline solution (HBSS). Regarding calcium phosphate formation, the performance of the specimen with a 50-nm-thick CaTiO(3) film was superior to those of specimens with other thicknesses. A titanium prism with a CaTiO3 film of 50-nm in thickness was surgically inserted in both soft and hard rat tissues. The biocompatibility of CaTiO(3)-deposited titanium and bone formation on it was investigated by histological observations. A slight inflammatory reaction was observed around the titanium with the 50-nm-thick CaTiO(3) film, while no severe response, such as degeneration and necrosis, was observed in either soft or hard rat tissue. New bone formation on the titanium plate with the CaTiO(3) film was more active than that without the film. The 50-nm-thick CaTiO(3) film has biocompatibility and can facilitate new bone formation in vivo, and, consequently, it is an excellent surface modification method for biornaterial applications. (c) 2007 Wiley Periodicals, Inc. J Biomed Mater Res 82A: 304-315, 2007
C1 Tokyo Med & Dent Univ, Inst Biomat & Bioeng, Dept Met, Tokyo 1010062, Japan.
   Tohoku Univ, Adv Res Ctr Met Glasses, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
   Hokkaido Univ, Grad Sch Dent Med, Dept Oral Funct Sci, Sapporo, Hokkaido 0608586, Japan.
RP Ohtsu, N (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioeng, Dept Met, Tokyo 1010062, Japan.
EM nohtsu@imr.tohoku.ac.jp
RI Matsuda, Aya/F-8465-2012; Yokoyama, Atsuro/F-6418-2012; Ohtsu,
   Naofumi/L-6021-2018
OI Ohtsu, Naofumi/0000-0001-7935-3949
CR Brossa F., 1993, Bio-Medical Materials and Engineering, V3, P127
   De Lange G, 1993, J Oral Implantol, V19, P123
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   DENISSEN HW, 1980, J BIOMED MATER RES, V14, P713, DOI 10.1002/jbm.820140603
   DUCHEYNE P, 1993, J BIOMED MATER RES, V27, P25, DOI 10.1002/jbm.820270105
   GEESINK RGT, 1987, CLIN ORTHOP RELAT R, P147
   GEESINK RGT, 1988, J BONE JOINT SURG BR, V70, P17
   Hanawa T, 1997, J BIOMED MATER RES, V36, P131, DOI 10.1002/(SICI)1097-4636(199707)36:1<131::AID-JBM16>3.0.CO;2-L
   HANAWA T, 1994, AM SOC TEST MATER, V1196, P170, DOI 10.1520/STP25192S
   Hanawa T, 1996, CORROS SCI, V38, P1579, DOI 10.1016/0010-938X(96)00053-4
   HAYASHI K, 1994, BIOMATERIALS, V15, P1187, DOI 10.1016/0142-9612(94)90241-0
   INADOME T, 1995, J BIOMED MATER RES, V29, P19, DOI 10.1002/jbm.820290104
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   JASEN JA, 1991, J BIOMED MATER RES, V25, P1535
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   LIN JHC, 1994, J MATER SCI-MATER M, V5, P279
   LOCARDI B, 1993, BIOMATERIALS, V14, P437, DOI 10.1016/0142-9612(93)90146-S
   NAKAYAMA Y, 1989, BIOMATERIALS, V10, P420, DOI 10.1016/0142-9612(89)90134-8
   Ohtsu N, 2006, SURF COAT TECH, V200, P5455, DOI 10.1016/j.surfcoat.2005.07.003
   Ohtsu N, 2004, MATER TRANS, V45, P1778, DOI 10.2320/matertrans.45.1778
   Ohtsu N, 2004, MATER TRANS, V45, P550, DOI 10.2320/matertrans.45.550
   OHTSU N, IN PRESS J MAT SCI M
   Okazaki Y, 1998, MAT SCI ENG A-STRUCT, V243, P250, DOI 10.1016/S0921-5093(97)00809-5
   Okazaki Y, 1998, BIOMATERIALS, V19, P1197, DOI 10.1016/S0142-9612(97)00235-4
   Okazaki Y, 2005, BIOMATERIALS, V26, P11, DOI 10.1016/j.biomaterials.2004.02.005
   ONG JL, 1994, BIOMATERIALS, V15, P337, DOI 10.1016/0142-9612(94)90245-3
   Parker JATC, 2002, J BIOMED MATER RES, V61, P91, DOI 10.1002/jbm.10170
   RADIN SR, 1992, J MATER SCI-MATER M, V3, P33, DOI 10.1007/BF00702942
   SPECK KM, 1980, J DENT RES, V59, P1590, DOI 10.1177/00220345800590100601
   Tsui YC, 1998, BIOMATERIALS, V19, P2015, DOI 10.1016/S0142-9612(98)00103-3
   vanDijk K, 1996, BIOMATERIALS, V17, P405, DOI 10.1016/0142-9612(96)89656-6
   Yamamoto A, 1998, J BIOMED MATER RES, V39, P331, DOI 10.1002/(SICI)1097-4636(199802)39:2<331::AID-JBM22>3.0.CO;2-E
   Yamashita K, 1998, J BIOMED MATER RES, V43, P46, DOI 10.1002/(SICI)1097-4636(199821)43:1<46::AID-JBM5>3.0.CO;2-M
   Yokoyama A, 2003, J BIOMED MATER RES A, V64A, P491, DOI 10.1002/jbm.a.10398
   YOSHINARI M, 1994, BIOMATERIALS, V15, P529, DOI 10.1016/0142-9612(94)90019-1
NR 35
TC 37
Z9 38
U1 0
U2 15
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG
PY 2007
VL 82A
IS 2
BP 304
EP 315
DI 10.1002/jbm.a.31136
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 187GW
UT WOS:000247836600006
PM 17279562
DA 2018-10-20
ER

PT J
AU Nagai, N
   Mori, K
   Satoh, Y
   Takahashi, N
   Yunoki, S
   Tajima, K
   Munekata, M
AF Nagai, Nobuhiro
   Mori, Kazuo
   Satoh, Yasuharu
   Takahashi, Noritaka
   Yunoki, Shunji
   Tajima, Kenji
   Munekata, Masanobu
TI In vitro growth and differentiated activities of human periodontal
   ligament fibroblasts cultured on salmon collagen gel
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE salmon collagen; periodontal ligament fibroblasts; growth rate; alkaline
   phophatase activity; quantitative RT-PCR
ID TISSUE REGENERATION; CELLS; ATELOCOLLAGEN; INVITRO; PROLIFERATION;
   BIOMATERIAL; SCAFFOLD
AB Marine-derived collagen is expected to be a much safer alternative to calf collagen, which in medical applications carries the risk of bovine spongiform encephalopathy. In this study, acid-soluble collagen was extracted from salmon skin and crosslinked with 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide during fibril formation to produce a crosslinked salmon collagen (SC) gel. The growth rates and the differentiated functions of human periodontal ligament fibroblasts (HPdLFs) cultured on the SC gel were investigated. Growth was faster on the SC gel than on porcine collagen (PC) gel. In addition, the HPdLFs cultured on the SC gel exhibited higher alkaline phosphatase (ALP) activity than those cultured on the PC gel. Quantitative RT- PCR revealed higher mRNA expression of type I collagen, ALP, and osteocalcin in the HPdLFs cultured on the SC gel. HPdLFs had a flat shape on the SC gel and a spindle shape on the PC gel, as revealed by observation with scanning electron microscopy and immunostaining with cytoskeletal protein and vinculin. The results showed that HPdLFs could grow and show highly differentiated activity on the SC gel as well as on the PC gel. (c) 2007 Wiley Periodicals, Inc.
C1 Hokkaido Univ, Creat Res Initiat Sousei, Kita Ku, Sapporo, Hokkaido 0010021, Japan.
   Ihar & Co Ltd, Otaru, Hokkaido 0470261, Japan.
   Hokkaido Univ, Grad Sch Engn, Div Biotechnol & Macromol Chem, Kita Ku, Sapporo, Hokkaido 0608628, Japan.
   Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan.
RP Nagai, N (reprint author), Hokkaido Univ, Creat Res Initiat Sousei, Kita Ku, Sapporo, Hokkaido 0010021, Japan.
EM nagai@cris.hokudai.ac.jp
RI Satoh, Yasuharu/H-4174-2012; Tajima, Kenji/B-1379-2012
OI Satoh, Yasuharu/0000-0001-6671-7758; Tajima, Kenji/0000-0002-3238-813X
CR Akhouayri Omar, 1999, Journal of Cellular Biochemistry, V76, P217
   BOYKO GA, 1981, J PERIODONTAL RES, V16, P73, DOI 10.1111/j.1600-0765.1981.tb00951.x
   Burjanadze TV, 2000, BIOPOLYMERS, V53, P523, DOI 10.1002/(SICI)1097-0282(200005)53:6<523::AID-BIP8>3.0.CO;2-7
   Feng Z, 2003, ARTIF ORGANS, V27, P84, DOI 10.1046/j.1525-1594.2003.07187.x
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Iwasa J, 2003, ARTIF ORGANS, V27, P249, DOI 10.1046/j.1525-1594.2003.07073.x
   Kuzuya M, 1998, DIABETOLOGIA, V41, P491, DOI 10.1007/s001250050937
   MEPHERSON JM, 1986, J BIOMED MATER RES, V20, P93
   Nagai N, 2004, J BIOSCI BIOENG, V98, P493, DOI 10.1016/S1389-1723(05)00319-1
   Nagai N, 2004, J BIOSCI BIOENG, V97, P389, DOI 10.1263/jbb.97.389
   NISHIKAWA A, 1987, EXP CELL RES, V171, P164, DOI 10.1016/0014-4827(87)90259-X
   NISHIMURA K, 1995, J BIOMED MATER RES, V29, P227, DOI 10.1002/jbm.820290213
   NYMAN S, 1982, J CLIN PERIODONTOL, V9, P257, DOI 10.1111/j.1600-051X.1982.tb02065.x
   Saito Y, 2002, J CELL SCI, V115, P4191, DOI 10.1242/jcs.00098
   Semler EJ, 2000, BIOTECHNOL BIOENG, V69, P359, DOI 10.1002/1097-0290(20000820)69:4<359::AID-BIT2>3.0.CO;2-Q
   SOMERMAN MJ, 1990, ARCH ORAL BIOL, V35, P241, DOI 10.1016/0003-9969(90)90062-F
   Swatschek D, 2002, EUR J PHARM BIOPHARM, V53, P107, DOI 10.1016/S0939-6411(01)00192-8
   Takata T, 2001, J PERIODONTAL RES, V36, P322, DOI 10.1034/j.1600-0765.2001.360508.x
   Von den Hoff JW, 2003, J PERIODONTAL RES, V38, P449, DOI 10.1034/j.1600-0765.2003.00404.x
   Yamaguchi N, 2002, ARCH ORAL BIOL, V47, P465, DOI 10.1016/S0003-9969(02)00022-5
   YOSHIZATO K, 1984, ANN PLAS SURG, V13, P9, DOI 10.1097/00000637-198407000-00002
   Yunoki S, 2004, J BIOSCI BIOENG, V98, P40, DOI 10.1263/jbb.98.40
NR 22
TC 23
Z9 23
U1 0
U2 4
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG
PY 2007
VL 82A
IS 2
BP 395
EP 402
DI 10.1002/jbm.a.31110
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 187GW
UT WOS:000247836600015
PM 17295232
DA 2018-10-20
ER

PT J
AU Chen, J
   Mwenifumbo, S
   Langhammer, C
   McGovern, JP
   Li, M
   Beye, A
   Soboyejo, WO
AF Chen, J.
   Mwenifumbo, S.
   Langhammer, C.
   McGovern, J.-P.
   Li, M.
   Beye, A.
   Soboyejo, W. O.
TI Cell/surface interactions and adhesion on Ti-6Al-4V: Effects of surface
   texture
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE surface texture; cell spreading and adhesion; immunofluorescence
   staining; enzymatic detachment
ID TOTAL HIP-ARTHROPLASTY; HUMAN OSTEOBLAST ADHESION; CELL BEHAVIOR;
   TOPOGRAPHICAL CONTROL; BIOMATERIAL SURFACES; MORPHOLOGIC ASPECTS; TISSUE
   INTEGRATION; FEMORAL COMPONENTS; FAILURE MECHANISMS; TITANIUM SURFACES
AB This paper presents the results of an experimental study of the effects of surface texture on the interactions between human osteo-sarcoma (HOS) cells and Ti-6AI-4V. These include the Ti-6AI-4V with polished (smooth); AI(2)O(3) blasted (rough); and laser micro-grooved geometries with controlled spacings and depths. Immuno-fluorescence staining of adhesion proteins (actin and vinculin) was used to study the spreading and adhesion of HOS cells in 2 day culture experiments. Quantitative measures of adhesion were also obtained using an enzymatic detachment assay. The results are discussed within the context of existing theories of cell adhesion. The implications of the results are also examined for the design of textured surfaces in biomedical systems. (C) 2007 Wiley Periodicals, Inc.
C1 Princeton Univ, Princeton Inst Sci & Technol Mat, Princeton, NJ 08544 USA.
   Princeton Univ, Dept Mech & Aerosp Engn, Princeton, NJ 08544 USA.
   Spectra Phys Inc, Mountain View, CA 94043 USA.
   Cheikh Anta Diop Univ, Dept Phys, Dakar, Senegal.
RP Soboyejo, WO (reprint author), Princeton Univ, Princeton Inst Sci & Technol Mat, Princeton, NJ 08544 USA.
EM soboyejo@princeton.edu
CR ALBERTS B, 1995, MOL BIOL CELL
   *AM AC ORTH SURG, GROWTH RAT JOINT REP
   Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Anselme K, 1999, J MATER SCI-MATER M, V10, P815, DOI 10.1023/A:1008992109670
   Anselme K, 2000, BIOMATERIALS, V21, P1567, DOI 10.1016/S0142-9612(00)00042-9
   ASK M, 1989, APPL SURF SCI, V35, P283, DOI 10.1016/0169-4332(89)90013-5
   Aspenberg P, 1996, J BONE JOINT SURG BR, V78B, P641
   Baharloo B, 2005, J BIOMED MATER RES A, V74A, P12, DOI 10.1002/jbm.a.30321
   BOBYN JD, 1995, CLIN ORTHOP RELAT R, V311, P21
   Britland S, 1996, EXP CELL RES, V228, P313, DOI 10.1006/excr.1996.0331
   Brunette D. M., 2001, TITANIUM MED MAT SCI
   BRUNETTE DM, 1986, EXP CELL RES, V164, P11, DOI 10.1016/0014-4827(86)90450-7
   BRUNETTE DM, 1996, NANOFABRICATION BIOS
   Bugbee WD, 1997, J BONE JOINT SURG AM, V79A, P1007, DOI 10.2106/00004623-199707000-00006
   BURKE DW, 1991, J BONE JOINT SURG BR, V73, P33
   BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415
   CARPINTER, 1994, HDB FATIGUE CRACK PR, P81
   CHEHROUDI B, 1989, J BIOMED MATER RES, V23, P1067, DOI 10.1002/jbm.820230907
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1089, DOI 10.1002/jbm.820290909
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1101, DOI 10.1002/jbm.820290910
   CLARK P, 1987, DEVELOPMENT, V99, P439
   Cooke CC, 2003, J ARTHROPLASTY, V18, P827, DOI 10.1054/S0883-5403(03)00325-5
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   CURTIS ASG, 1990, CRIT REV BIOCOMPAT, V5, P343
   Dee KC, 2000, MATER TODAY, V3, P7
   DORR LD, 1997, CLIN ORTHOP RELAT R, V1, P157
   Dubey S, 1997, ACTA MATER, V45, P2777, DOI 10.1016/S1359-6454(96)00380-1
   Dumbleton JH, 2002, J ARTHROPLASTY, V17, P649, DOI 10.1054/arth.2002.33664
   DUNN GA, 1986, J CELL SCI, V83, P313
   Feng B, 2002, MATER CHARACT, V49, P129, DOI 10.1016/S1044-5803(02)00341-8
   Feng B, 2002, J MATER SCI-MATER M, V13, P457, DOI 10.1023/A:1014737831371
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GRUEN TA, 1979, CLIN ORTHOP RELAT R, P17
   HALL IW, 1978, MATER SCI ENG, V32, P241, DOI 10.1016/0025-5416(78)90138-6
   HARRIS WH, 1995, CLIN ORTHOP RELAT R, P46
   Ingber D, 2002, ANN NY ACAD SCI, V961, P162, DOI 10.1111/j.1749-6632.2002.tb03074.x
   Ingber DE, 1997, ANNU REV PHYSIOL, V59, P575, DOI 10.1146/annurev.physiol.59.1.575
   Kesteris U, 2003, J ARTHROPLASTY, V18, P10, DOI 10.1054/arth.2003.50011
   Kim HJ, 2005, J BIOMED MATER RES A, V74A, P366, DOI 10.1002/jbm.a.30327
   Kohilas K, 1999, J BIOMED MATER RES, V47, P95, DOI 10.1002/(SICI)1097-4636(199910)47:1<95::AID-JBM14>3.0.CO;2-8
   KOLEGA J, 1986, J CELL BIOL, V102, P1400, DOI 10.1083/jcb.102.4.1400
   KOLODNEY MS, 1992, J CELL BIOL, V117, P73, DOI 10.1083/jcb.117.1.73
   LAMIN M, 1997, J BIOMED MATER RES, V36, P99
   Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5
   LEWIN B, 2000, GENES, V7
   LI M, 2002, P SOC PHOTO-OPT INS, V4830, P206
   Martinesi M, 2005, J BIOMED MATER RES A, V74A, P197, DOI 10.1002/jbm.a.30366
   MENEZES GC, 2003, ACTA MICROSC, V12, P13
   Meyle J, 1993, J Biomater Appl, V7, P362, DOI 10.1177/088532829300700404
   Mostardi RA, 1999, J BIOMED MATER RES, V47, P60, DOI 10.1002/(SICI)1097-4636(199910)47:1<60::AID-JBM8>3.0.CO;2-X
   MWENIFUMBO S, 2003, SURFACE ENG MAT SCI, V2, P141
   MWENIFUMBO S, 2004, THESIS PRINCETON U, P41
   OAKLEY C, 1993, J CELL SCI, V106, P343
   Park BS, 2005, J BIOMED MATER RES A, V74A, P640, DOI 10.1002/jbm.a.30326
   Pioletti DP, 2003, J BIOMECH, V36, P131, DOI 10.1016/S0021-9290(02)00301-9
   RATNR BD, 1996, BIOMATERIALS SCI INT
   Ricci J.L., 2000, BONE ENG, P1
   Ricci JL, 2001, KEY ENG MAT, V198-1, P179, DOI 10.4028/www.scientific.net/KEM.198-199.179
   Ruoslahti E, 1996, EXP CELL RES, V227, P1, DOI 10.1006/excr.1996.0243
   SCHMALZRIED TP, 1992, CLIN ORTHOP RELAT R, P60
   Silver F. H., 1999, BIOMATERIALS SCI BIO
   Soboyejo WO, 2002, J BIOMED MATER RES, V62, P56, DOI 10.1002/jbm.10221
   Soboyejo WO, 2001, KEY ENG MAT, V198-1, P203, DOI 10.4028/www.scientific.net/KEM.198-199.203
   THORNHILL TS, 1998, REVISION TOTAL HIP A, P1
   Turner CH, 1998, BONE, V23, P399, DOI 10.1016/S8756-3282(98)00118-5
   VONRECUM AF, 1995, J BIOMAT SCI-POLYM E, V7, P181, DOI 10.1163/156856295X00698
   Walboomers X F, 2001, Odontology, V89, P2, DOI 10.1007/s10266-001-8178-z
   Walboomers XF, 1999, J BIOMED MATER RES, V46, P212, DOI 10.1002/(SICI)1097-4636(199908)46:2<212::AID-JBM10>3.0.CO;2-Y
   Wang JHC, 2000, J BIOMECH, V33, P729, DOI 10.1016/S0021-9290(00)00013-0
   Wieland M, 2005, BIOMATERIALS, V26, P1119, DOI 10.1016/j.biomaterials.2004.04.020
   WILLERT HG, 1999, EUROPEAN INSTRUCTION, V4, P58
   Zhu XL, 2004, BIOMATERIALS, V25, P4087, DOI 10.1016/j.biomaterials.2003.11.011
   Zhu Y H, 2001, J Orthop Surg (Hong Kong), V9, P91
NR 74
TC 29
Z9 31
U1 0
U2 13
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD AUG
PY 2007
VL 82B
IS 2
BP 360
EP 373
DI 10.1002/jbm.b.30741
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 192II
UT WOS:000248194100011
PM 17245741
DA 2018-10-20
ER

PT J
AU Laschke, MW
   Witt, K
   Pohlemann, T
   Menger, MD
AF Laschke, Matthias W.
   Witt, Kristina
   Pohlemann, Tim
   Menger, Michael D.
TI Injectable nanocrystalline hydroxyapatite paste for bone substitution:
   In vivo analysis of biocompatibility and vascularization
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE Ostim (R); hydroxyapatite; biocompatibility; angiogenesis; dorsal
   skinfold chamber
ID MICROVASCULAR RESPONSE; STRIATED-MUSCLE; TUMOR SURGERY; PHOSPHATE;
   NEOVASCULARIZATION; MICROCIRCULATION; ANGIOGENESIS; MICROSCOPY;
   CARTILAGE; DEFECTS
AB The nanocrystalline hydroxyapatite paste Ostim (R) represents a fully degradable synthetic bone substitute for the filling of bone defects. Herein, we investigated in vivo the inflammatory and angiogenic host tissue response to this biomaterial after implantation. For this purpose, Ostim was implanted into the dorsal skinfold chambers of Syrian golden hamsters. The hydroxyapatite ceramic Cerabone (R) and isogeneic transplanted cancellous bone served as controls. Angiogenesis, microhemodynamics, microvascular permeability, and leukocyte-endothelial cell interaction of the host tissue were analyzed over 2 weeks using intravital fluorescence microscopy. Ostim exhibited good biocompatibility comparable to that of Cerabone and cancellous bone, as indicated by a lack of venular leukocyte activation after implantation. Cancellous bone induced a more pronounced angiogenic response and an increased microvessel density when compared with the synthetic bone substitutes. In contrast to Cerabone, however, Ostim showed a guided neovascularization directed toward areas of degradation. Histology confirmed the ingrowth of proliferating vascularized tissue into the hydroxyapatite paste at sites of degradation, while the hydroxyapatite ceramic was not pierced by new microvessels. Thus, Ostim represents an injectable synthetic bone substitute, which may optimize the conditions for the formation of new bone at sites of bone defects by supporting a guided vascularization during biodegradation. (C) 2007 Wiley Periodicals, Inc.
C1 Univ Saarland, Inst Clin & Expt Surg, D-66421 Homburg, Germany.
   Univ Saarland, Dept Trauma Hand & Reconstruct Surg, D-66421 Homburg, Germany.
RP Laschke, MW (reprint author), Univ Saarland, Inst Clin & Expt Surg, D-66421 Homburg, Germany.
EM matthias.laschke@uniklinik-saarland.de
CR Aho AJ, 2004, J MATER SCI-MATER M, V15, P1165, DOI 10.1023/B:JMSM.0000046401.50406.9b
   Arrington ED, 1996, CLIN ORTHOP RELAT R, P300
   Arts JJC, 2005, CLIN ORTHOP RELAT R, P239, DOI 10.1097/01.blo.0000169081.61398.58
   BAKER M, 1974, MICROVASC RES, V7, P131, DOI 10.1016/0026-2862(74)90043-0
   BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012
   Bloemers FW, 2003, J BIOMED MATER RES B, V66B, P526, DOI 10.1002/jbm.b.10045
   Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651
   Cypher T J, 1996, J Foot Ankle Surg, V35, P413
   Deckers MML, 2000, ENDOCRINOLOGY, V141, P1667, DOI 10.1210/en.141.5.1667
   Druecke D, 2004, J BIOMED MATER RES A, V68A, P10, DOI 10.1002/jbm.a..20016
   Engstrand T, 2003, UPSALA J MED SCI, V108, P25
   Gauthier O, 2003, J BIOMED MATER RES A, V66A, P47, DOI 10.1002/jbm.a.10506
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Grimandi G, 1998, J BIOMED MATER RES, V39, P660, DOI 10.1002/(SICI)1097-4636(19980315)39:4<660::AID-JBM22>3.0.CO;2-9
   Hoffmann JN, 2002, ANESTHESIOLOGY, V97, P460, DOI 10.1097/00000542-200208000-00025
   Imaizumi H, 2006, CALCIFIED TISSUE INT, V78, P45, DOI 10.1007/s00223-005-0170-0
   Kraft CN, 2005, J BIOMED MATER RES A, V75A, P31, DOI 10.1002/jbm.a.30407
   Laschke MW, 2005, J BIOMED MATER RES A, V74A, P696, DOI 10.1002/jbm.a.30371
   Matsumine A, 2004, J BONE JOINT SURG BR, V86B, P719, DOI 10.1302/0301-620X.86B5.14242
   Menger MD, 2002, EUR SURG RES, V34, P83, DOI 10.1159/000048893
   MENGER MD, 1990, THORAC CARDIOV SURG, V38, P139, DOI 10.1055/s-2007-1014008
   MENGER MD, 1992, THORAC CARDIOV SURG, V40, P19, DOI 10.1055/s-2007-1020105
   Moore WR, 2001, AUST NZ J SURG, V71, P354, DOI 10.1046/j.1440-1622.2001.02128.x
   Nishikawa Tetsunari, 2005, Implant Dent, V14, P252, DOI 10.1097/01.id.0000173628.00705.d0
   Pennekamp PH, 2006, J ORTHOP RES, V24, P531, DOI 10.1002/jor.20066
   POSNER AS, 1969, PHYSIOL REV, V49, P760
   Ross N, 2000, BRIT J NEUROSURG, V14, P476
   RUBANYI GM, 1994, PHARMACOL REV, V46, P325
   Seiler J G 3rd, 2000, J South Orthop Assoc, V9, P91
   Thorwarth M, 2005, J ORAL MAXIL SURG, V63, P1626, DOI 10.1016/j.joms.2005.06.010
   UCHIDA A, 1990, J BONE JOINT SURG BR, V72, P298
   Zwaginga JJ, 2003, CLIN EXP PHARMACOL P, V30, P900, DOI 10.1046/j.1440-1681.2003.03931.x
NR 32
TC 74
Z9 79
U1 0
U2 19
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD AUG
PY 2007
VL 82B
IS 2
BP 494
EP 505
DI 10.1002/jbm.b.30755
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 192II
UT WOS:000248194100025
PM 17279565
DA 2018-10-20
ER

PT J
AU Hu, YC
   Wang, FH
AF Hu Ying-cheng
   Wang Feng-hu
TI Application of rheology in wood and other biomaterials science
SO JOURNAL OF CENTRAL SOUTH UNIVERSITY OF TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 4th Pacific Rim Conference on Rheology
CY AUG 07-11, 2005
CL Shanghai, PEOPLES R CHINA
SP Chinese Soc Theoret & Appl Mech, Chinese Chem Soc, Chinese Soc Rheol, Xiangtan Univ, E China Univ Sci & Technol, Fudan Univ, China Univ Petr, PetroChina Co Ltd, Langfang Branch Res Inst Petr E&D, Appl Rheol
DE rheology; wood; biomaterial; creep; mechano-sorptive behaviour
ID CHEMICALLY-MODIFIED WOOD; AMORPHOUS POLYMER; MOISTURE CHANGE; CREEP;
   MECHANISM; BEHAVIOR; MODEL; SIMULATION; DESORPTION
AB The research history, current situation of theology in wood and other biomaterials science in China and abroad were introduced. The applied prospects of rheology in wood and biomaterials science were also analyzed. The study of rheology can provide a scientific theory basis for the process and utilization of wood and other biomaterials.
C1 NE Forestry Univ, Coll Mat Sci & Engn, Key Lab Biobased Mat Sci & Technol, Minist Educ, Harbin 150040, Peoples R China.
RP Hu, YC (reprint author), NE Forestry Univ, Coll Mat Sci & Engn, Key Lab Biobased Mat Sci & Technol, Minist Educ, Harbin 150040, Peoples R China.
EM huyingcheng@yahoo.com.cn
CR Armstrong L. D., 1972, WOOD SCI, V5, P81
   BACK EL, 1983, SVENSK PAPPERSTIDNIN, P61
   BEACH L, 1968, PROF J, V18, P60
   Cao J., 2001, INTERACTION WATER WO
   Cao JinZhen, 1998, Journal of Beijing Forestry University, V20, P94
   CHEN SY, 1999, STUDY CREEP PERFORMA, V13, P3
   GROSSMAN PUA, 1976, WOOD SCI TECHNOL, V10, P163, DOI 10.1007/BF00355737
   Hearmon R. F. S., 1964, Forest Products Journal, V14, P357
   HOFFMEYER P, 1989, WOOD SCI TECHNOL, V23, P215, DOI 10.1007/BF00367735
   HUNT DG, 1987, J MATER SCI, V22, P313, DOI 10.1007/BF01160586
   KINGSTON R. S. T., 1961, AUSTRALIAN JOUR APPL SCI, V12, P211
   KOLLMANN F, 1961, RHEOLOGIE STRUKTURFE, V19, P73
   LU B, 1989, MECH ENG, V11, P41
   LU B, 1996, MECH ENG, V18, P36
   MACHIN D, 1973, J POLYM SCI POL PHYS, V11, P1535, DOI 10.1002/pol.1973.180110805
   MOSLCMI AA, 1964, B MICHIGAN AGR EXP S, V47, P271
   MUKUDAI J, 1986, WOOD SCI TECHNOL, V20, P335, DOI 10.1007/BF00351586
   MUKUDAI J, 1988, WOOD SCI TECHNOL, V22, P43, DOI 10.1007/BF00353227
   MUKUDAI J, 1987, WOOD SCI TECHNOL, V21, P49
   NAFA Z, 2003, J WOOD SCI, V49, P35
   NAKANO T, 1994, HOLZFORSCHUNG, V48, P318, DOI 10.1515/hfsg.1994.48.4.318
   Nakano T, 1996, WOOD SCI TECHNOL, V30, P117, DOI 10.1007/BF00224963
   NORIMOTO M, 1992, WOOD FIBER SCI, V24, P25
   RICE RW, 1990, HOLZ ROH WERKST, V48, P73, DOI 10.1007/BF02610711
   Shao ZP, 2005, WOOD SCI TECHNOL, V39, P19, DOI 10.1007/s00226-004-0265-1
   TOBOLSKY AV, 1963, J PHYS CHEM-US, V67, P1886, DOI 10.1021/j100803a038
   WANG FH, 1992, STRESS RELAXATION PH
   WANG FH, 1997, RHEOLOGY WOOD MAT
   WANG JZ, 1989, CONTEMPORARY ISSUES
   Wang P. Y., 1985, Scientia Silvae Sinicae, V21, P404
NR 30
TC 0
Z9 0
U1 0
U2 5
PU JOURNAL OF CENTRAL SOUTH UNIV TECHNOLOGY
PI HUNAN
PA EDITORIAL OFFICE, CHANGSHA, HUNAN 410083, PEOPLES R CHINA
SN 1005-9784
J9 J CENT SOUTH UNIV T
JI J. Cent. South Univ. Technol.
PD AUG
PY 2007
VL 14
SU 1
BP 484
EP 487
DI 10.1007/s11771-007-0312-9
PG 4
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 202PK
UT WOS:000248915300113
DA 2018-10-20
ER

PT J
AU Bengali, Z
   Rea, JC
   Shea, LD
AF Bengali, Zain
   Rea, Jennifer C.
   Shea, Lonnie D.
TI Gene expression and internalization following vector adsorption to
   immobilized proteins: dependence on protein identity and density
SO JOURNAL OF GENE MEDICINE
LA English
DT Article
DE gene delivery; reverse transfection; surface delivery; polyethylenimine
   (PEI); biomaterial; fibronectin; BSA
ID MULTILAYERED POLYELECTROLYTE FILMS; CAVEOLAE-MEDIATED ENDOCYTOSIS;
   TRANSFECTED CELL MICROARRAYS; DNA DELIVERY; IN-VIVO; FIBRONECTIN
   ADSORPTION; NEURITE EXTENSION; GOLGI-APPARATUS; SURFACE; SERUM
AB Background Gene delivery by non-specific adsorption of non-viral vectors to protein-coated surfaces can reduce the amount of DNA required, and also increase transgene expression and the number of cells expressing the transgene. The protein on the surface mediates cell adhesion and vector immobilization, and functions to colocalize the two to enhance gene delivery. This report investigates the mechanism and specificity by which the protein coating enhances gene transfer, and determines if the protein coating targets the vector for internalization by a specific pathway.
   Methods Proteins (FBS, BSA, fibronectin, collagen I, and laminin) were dried onto culture dishes, followed by PEI/DNA complex adsorption for surface delivery. Reporter genes were employed to characterize transfection as a function of the protein identity and density. Vector immobilization was measured using radiolabeled plasmid, and internalization was quantified in the presence and absence of the endocytosis inhibitors chlorpromazine and genistein.
   Results Fibronectin coating yielded the greatest expression for PEI/DNA polyplexes, with maximal expression at intermediate protein densities. Expression in control studies with bolus delivery was independent of the protein identity. Substrate binding was independent of the protein identity; however, internalization was greatest on surfaces coated with fibronectin and collagen I. Inhibition of caveolae-mediated endocytosis reduced gene expression more than clathrin-mediated endocytosis. Similarly, inhibition of caveolae-mediated endocytosis significantly reduced the intracellular levels of DNA.
   Conclusions Fibronectin at intermediate densities mediated the highest levels of transgene expression, potentially by targeting internalization through caveolae-mediated endocytosis. Substrate modifications, such as the identity and density of proteins, provide an opportunity for modification of biomaterials for enhancing gene expression. Copyright (c) 2007 John Wiley & Sons, Ltd.
C1 Northwestern Univ, Dept Chem Engn, Evanston, IL 60208 USA.
   Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.
   Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.
   Northwestern Univ, Ctr Comprehens Canc, Chicago, IL 60611 USA.
   Northwestern Univ, Dept Interdept Biol Sci, Evanston, IL 60208 USA.
RP Shea, LD (reprint author), Northwestern Univ, Dept Chem Engn, 2145 Sheridan Rd,E156, Evanston, IL 60208 USA.
EM l-shea@northwestern.edu
RI Shea, Lonnie/B-7615-2009
OI Rea, Jennifer/0000-0002-7405-6790
FU NIGMS NIH HHS [R01 GM066830, R01 GM066830-01A1]
CR AKIYAMA SK, 1987, ADV ENZYMOL RAMB, V59, P1
   Bailey SN, 2002, DRUG DISCOV TODAY, V7, pS113, DOI 10.1016/S1359-6446(02)02386-3
   Bajaj B, 2001, BIOTECHNOL PROGR, V17, P587, DOI 10.1021/bp010039n
   Bathori G, 2004, CRIT REV THER DRUG, V21, P67, DOI 10.1615/CritRevTherDrugCarrierSyst.v21.i2.10
   Bengali Z, 2005, BIOTECHNOL BIOENG, V90, P290, DOI 10.1002/bit.20393
   BENGALI Z, 2006, UNPUB CELLULAR ASS D
   Bielinska AU, 2000, BIOMATERIALS, V21, P877, DOI 10.1016/S0142-9612(99)00229-X
   BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297
   Boyd ND, 2003, BIOCHEM CELL BIOL, V81, P335, DOI 10.1139/O03-063
   BUCK CA, 1987, ANNU REV CELL BIOL, V3, P179, DOI 10.1146/annurev.cb.03.110187.001143
   Carrabino S, 2005, J GENE MED, V7, P1555, DOI 10.1002/jgm.799
   Cohen-Sacks H, 2004, J CONTROL RELEASE, V95, P309, DOI 10.1016/j.jconrel.2003.11.001
   Delehanty JB, 2004, ANAL CHEM, V76, P7323, DOI 10.1021/ac049259g
   Gekle M, 1997, AM J PHYSIOL-RENAL, V272, pF668
   HAYMAN EG, 1985, EXP CELL RES, V160, P245, DOI 10.1016/0014-4827(85)90173-9
   Houchin-Ray T, 2007, BIOMATERIALS, V28, P2603, DOI 10.1016/j.biomaterials.2007.01.042
   Houchin-Ray T, 2007, MOL THER, V15, P705, DOI 10.1038/mt.sj.6300106
   Jang JH, 2005, MOL THER, V12, P475, DOI 10.1016/j.ymrhe.2005.03.036
   Jang JH, 2003, J CONTROL RELEASE, V86, P157, DOI 10.1016/S0168-3659(02)00369-3
   JANG JH, 2005, J BIOMED MATER RES A, V77, P50
   Jewell CM, 2006, BIOMACROMOLECULES, V7, P2483, DOI 10.1021/bm0604808
   Jewell CM, 2005, J CONTROL RELEASE, V106, P214, DOI 10.1016/j.jconrel.2005.04.014
   Koenig AL, 2003, J BIOMED MATER RES A, V64A, P20, DOI 10.1002/jbm.a.10316
   Kowalczynska HM, 2005, J BIOMED MATER RES A, V72A, P228, DOI 10.1002/jbm.a.30238
   Le PU, 2003, J CELL SCI, V116, P1059, DOI 10.1242/jcs.00327
   LEWANDOWSKA K, 1989, J CELL PHYSIOL, V141, P334, DOI 10.1002/jcp.1041410215
   Luo D, 2000, NAT BIOTECHNOL, V18, P893, DOI 10.1038/78523
   Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059
   Pannier AK, 2005, ACTA BIOMATER, V1, P511, DOI 10.1016/j.actbio.2005.05.004
   Pannier AK, 2004, MOL THER, V10, P19, DOI 10.1016/j.ymthe.2004.03.020
   Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784
   Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x
   Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200
   PROCTOR RA, 1987, REV INFECT DIS S4, V9, P317
   Rejman J, 2005, MOL THER, V12, P468, DOI 10.1016/j.ymthe.2005.03.038
   Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253
   Rhaese S, 2003, J CONTROL RELEASE, V92, P199, DOI 10.1016/S0168-3659(03)00302-X
   Schaffer DV, 1998, J BIOL CHEM, V273, P28004, DOI 10.1074/jbc.273.43.28004
   Segura T, 2005, BIOMATERIALS, V26, P1575, DOI 10.1016/j.biomaterials.2004.05.007
   Segura T, 2003, J CONTROL RELEASE, V93, P69, DOI 10.1016/j.jconrel.2003.08.003
   Segura T, 2002, BIOCONJUGATE CHEM, V13, P621, DOI 10.1021/bc015575f
   Shea LD, 1999, NAT BIOTECHNOL, V17, P551
   Shen H, 2004, NAT MATER, V3, P569, DOI 10.1038/nmat1179
   Simoes S, 2000, BBA-BIOMEMBRANES, V1463, P459, DOI 10.1016/S0005-2736(99)00238-2
   SOFER A, 1995, J BIOL CHEM, V270, P12117, DOI 10.1074/jbc.270.20.12117
   Sottile J, 2005, MOL BIOL CELL, V16, P757
   STEELE JG, 1995, BIOMATERIALS, V16, P1057, DOI 10.1016/0142-9612(95)98901-P
   WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107
   White DJ, 2004, INT J BIOCHEM CELL B, V36, P1405, DOI 10.1016/j.biocel.2003.08.016
   Yoshikawa T, 2004, J CONTROL RELEASE, V96, P227, DOI 10.1016/j.jconrel.2004.01.024
   Ziauddin J, 2001, NATURE, V411, P107, DOI 10.1038/35075114
NR 51
TC 45
Z9 45
U1 2
U2 17
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 1099-498X
J9 J GENE MED
JI J. Gene. Med.
PD AUG
PY 2007
VL 9
IS 8
BP 668
EP 678
DI 10.1002/jgm.1058
PG 11
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine,
   Research & Experimental
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Research &
   Experimental Medicine
GA 206IB
UT WOS:000249176000004
PM 17533618
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Martinez, EC
   Ivirico, JLE
   Criado, IM
   Ribelles, JLG
   Pradas, MM
   Sanchez, MS
AF Costa Martinez, E.
   Escobar Ivirico, J. L.
   Munoz Criado, I.
   Gomez Ribelles, J. L.
   Monleon Pradas, M.
   Salmeron Sanchez, M.
TI Effect of poly(L-lactide) surface topography on the morphology of in
   vitro cultured human articular chondrocytes
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID BIOMATERIAL INTERFACE; CRYSTALLIZATION; OSTEOBLASTS; ADHESION; ACID);
   BONE; ROUGHNESS; INTEGRINS; FILMS; CELLS
AB Human articular chondrocytes were cultured in vitro on poly(L-lactic) acid, PLLA, substrates. Influence of the surface topography on cell morphology was found. Different surface microtopographies were obtained on PLLA by crystallizing at 120 degrees C after nucleation treatments that include isothermal stages at temperatures just below (55 degrees C) and just above (75 degrees C) the glass transition temperature (T-g = 65 degrees C). Isothermal crystallization from the melt gave rise to big spherulites (approx. 50 mu m diameter) with approx. 1 mu m depth. Crystallization after nucleation treatments results in smaller (approx. 5 mu m)-difficult to distinguish-spherulites. Cell viability was excellent and not affected by the surface roughness. Cell population on the nucleated samples resembles the result of culture on the reference tissue culture polystyrene (TCPS). However, cells cultured on big spherulites (PLLA isothermally crystallized without nucleation treatment) show a peculiar morphology, with a more isolated disposition and growth oriented in a characteristic direction.
C1 Ctr Invest Principe Felipe, Valencia 46013, Spain.
   Univ Politecn Valencia, Ctr Biomat, Valencia 46022, Spain.
   Casa De Salud Hosp, Valencia 46021, Spain.
RP Sanchez, MS (reprint author), Ctr Invest Principe Felipe, Autopista Saler 16, Valencia 46013, Spain.
EM masalsan@fis.upv.es
RI Escobar Ivirico, Jorge/G-9649-2012; Escobar Ivirico, Jorge
   Luis/M-1947-2013; Salmeron-Sanchez, Manuel/E-4680-2010; Escobar ivirico,
   Jorge/J-1203-2016; Gomez Ribelles, Jose Luis/L-5629-2014
OI Escobar Ivirico, Jorge Luis/0000-0002-1077-2333; Salmeron-Sanchez,
   Manuel/0000-0002-8112-2100; Escobar ivirico, Jorge/0000-0002-1077-2333;
   Gomez Ribelles, Jose Luis/0000-0001-9099-0885; MONLEON PRADAS,
   MANUEL/0000-0001-6457-0414
CR Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Bruinink A, 2005, ADV ENG MATER, V7, P411, DOI 10.1002/adem.200500065
   BRUNETTE DM, 1986, EXP CELL RES, V164, P11, DOI 10.1016/0014-4827(86)90450-7
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Di Lorenzo ML, 2001, POLYMER, V42, P9441, DOI 10.1016/S0032-3861(01)00499-2
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Iannace S, 1997, J APPL POLYM SCI, V64, P911, DOI 10.1002/(SICI)1097-4628(19970502)64:5<911::AID-APP11>3.0.CO;2-W
   Kenar H, 2006, BIOMATERIALS, V27, P885, DOI 10.1016/j.biomaterials.2005.07.001
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   Lee TM, 2002, J MATER SCI-MATER M, V13, P341, DOI 10.1023/A:1014393815923
   Miyata T, 1998, POLYMER, V39, P5515, DOI 10.1016/S0032-3861(97)10203-8
   OHARA PT, 1979, EXP CELL RES, V121, P235, DOI 10.1016/0014-4827(79)90002-8
   Rizzi G, 2004, INT J ARTIF ORGANS, V27, P649
   Sanchez FH, 2005, BIOMACROMOLECULES, V6, P3283, DOI 10.1021/bm050323t
   Sanchez MS, 2005, THERMOCHIM ACTA, V430, P201, DOI 10.1016/j.tca.2005.01.066
   Siebers MC, 2005, BIOMATERIALS, V26, P137, DOI 10.1016/j.biomaterials.2004.02.021
   Wan YQ, 2005, BIOMATERIALS, V26, P4453, DOI 10.1016/j.biomaterials.2004.11.016
   Wang Y, 2005, MACROMOLECULES, V38, P4712, DOI 10.1021/ma047934i
   Wong JY, 2004, SURF SCI, V570, P119, DOI 10.1016/j.susc.2004.06.186
   Yavuz H, 2002, POLYM DEGRAD STABIL, V75, P431, DOI 10.1016/S0141-3910(01)00242-7
   Zhu XL, 2004, BIOMATERIALS, V25, P4087, DOI 10.1016/j.biomaterials.2003.11.011
   Zinger O, 2005, BIOMATERIALS, V26, P1837, DOI 10.1016/j.biomaterials.2004.06.035
NR 22
TC 24
Z9 24
U1 0
U2 10
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD AUG
PY 2007
VL 18
IS 8
BP 1627
EP 1632
DI 10.1007/s10856-007-3038-1
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 192TW
UT WOS:000248226900020
PM 17483895
DA 2018-10-20
ER

PT J
AU Gyorgy, E
   Santiso, J
   Figueras, A
   Socol, G
   Mihailescu, IN
AF Gyoergy, Enikoe
   Santiso, Jose
   Figueras, Albert
   Socol, Gabriel
   Mihailescu, Ion N.
TI Biomolecular papain thin films growth by laser techniques
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID EVAPORATION MAPLE; DRUG DISCOVERY; MATRIX; DEPOSITION; VARIETY
AB Papain thin films were synthesised by matrix assisted and conventional pulsed laser deposition (PLD) techniques. The targets submitted to laser radiation consisted on a frozen composite obtained by dissolving the biomaterials in distilled water. For the deposition of the thin films by conventional PLD pressed biomaterial powder targets were submitted to laser irradiation. An UV KrF* excimer laser source was used in the experiments at 0.5 J/cm(2) incident fluence value, diminished one order of magnitude as compared to irradiation of inorganic materials. The surface morphology of the obtained thin films was studied by atomic force profilometry and atomic force microscopy. The investigations showed that the growth mode and surface quality of the deposited biomaterial thin filrns is strongly influenced by the target preparation procedure.
C1 Natl Inst Lasers Plasma & Radiat Phys, Bucharest 76900 V, Romania.
   CSIC, Inst Ciencia Mat Barcelona, E-08193 Barcelona, Spain.
RP Gyorgy, E (reprint author), Natl Inst Lasers Plasma & Radiat Phys, POB MG 36, Bucharest 76900 V, Romania.
EM eniko@ifin.nipne.ro
RI Mihailescu, Ion/A-5403-2011; Gyorgy, Eniko/C-4620-2012; Socol,
   Gabriel/A-5405-2011; Santiso, Jose/C-4423-2013
OI Socol, Gabriel/0000-0002-1992-7346; Santiso, Jose/0000-0003-4274-2101
CR BAUERLE D, 1996, LASER PROCESSING CHE, P63
   Borman S, 2000, CHEM ENG NEWS, V78, P31, DOI 10.1021/cen-v078n031.p031
   Brooks SA, 2000, ANAL CHEM, V72, P3253, DOI 10.1021/ac9914531
   Bubb DM, 2002, J APPL PHYS, V91, P2055, DOI 10.1063/1.1427138
   Chen L. C., 1994, PULSED LASER DEPOSIT, P167
   Cooper MA, 2002, NAT REV DRUG DISCOV, V1, P515, DOI 10.1038/nrd838
   Dong SJ, 2002, ELECTROANAL, V14, P7, DOI 10.1002/1521-4109(200201)14:1<7::AID-ELAN7>3.0.CO;2-V
   FUJIWARA I, 1992, LANGMUIR, V8, P2219, DOI 10.1021/la00045a025
   Gerritsen M, 2000, BIOMATERIALS, V21, P71, DOI 10.1016/S0142-9612(99)00136-2
   Gutierrez-Llorente A, 2004, ORG ELECTRON, V5, P29, DOI 10.1016/j.orgel.2003.11.003
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   Lee CS, 2003, BIOSENS BIOELECTRON, V18, P437, DOI 10.1016/S0956-5663(02)00147-1
   Leipner J, 2000, DRUGS, V59, P769, DOI 10.2165/00003495-200059040-00004
   Mihailescu IN, 1999, TRENDS OPTICS PHOTON, P201
   Miyachi H, 2000, BIOTECHNOL BIOENG, V69, P323, DOI 10.1002/1097-0290(20000805)69:3<323::AID-BIT10>3.0.CO;2-T
   Pique A, 1998, MATER RES SOC SYMP P, V526, P421, DOI 10.1557/PROC-526-421
   Pique A, 2003, SURF COAT TECH, V163, P293, DOI 10.1016/S0257-8972(02)00606-0
   Ringeisen BR, 2001, LANGMUIR, V17, P3472, DOI 10.1021/la0016874
   Toftmann B, 2004, THIN SOLID FILMS, V453, P177, DOI 10.1016/j.tsf.2003.11.099
   WAGNER P, 2002, CURR DRUG DISCOV, V5, P23
   WILLIAMS RA, 1994, BIOSENS BIOELECTRON, V9, P159, DOI 10.1016/0956-5663(94)80108-8
   Wu PK, 2003, REV SCI INSTRUM, V74, P2546, DOI 10.1063/1.1544081
NR 22
TC 7
Z9 7
U1 0
U2 6
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD AUG
PY 2007
VL 18
IS 8
BP 1643
EP 1647
DI 10.1007/s10856-007-3055-0
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 192TW
UT WOS:000248226900022
PM 17483884
DA 2018-10-20
ER

PT J
AU Baciut, M
   Baciut, G
   Simon, V
   Albon, C
   Coman, V
   Prodan, P
   Florian, S
   Bran, S
AF Baciut, M.
   Baciut, G.
   Simon, V.
   Albon, C.
   Coman, V.
   Prodan, P.
   Florian, St. I.
   Bran, S.
TI Investigation of deer antler as a potential bone regenerating
   biomaterial
SO JOURNAL OF OPTOELECTRONICS AND ADVANCED MATERIALS
LA English
DT Article
DE biomaterials; deer antler; SEM; EPR; ATIR; Raman spectroscopy
ID BIOACTIVITY
AB Bone regeneration using biomaterials has become a widely used technique for surgical restoration of bone defects. No biomaterial in use displays ideal characteristics and efficacy for bone formation. In search for new biomaterials, interest was focused on the remarkable regeneration properties of deer antler. The study compares the structural units identified in deer antler tissue, a tissue with unique capacity of self-regeneration, with clinically used Gen-Os biomaterial in order to evaluate the potential use of the deer antler as a bone regeneration biomaterial. These results can be the premises of a new development in the field of grafting materials, opening new perspectives towards future possible combinations of this material with other biomaterials used as bone substitutes.
C1 Univ Med & Pharm Iuliu, Dept Cranio Maxillofacial Surg, R-400029 Cluj Napoca, Romania.
   Univ Babes Bolyai, Fac Phys, R-400084 Cluj Napoca, Romania.
   Univ Bielefeld, Fac Phys, D-33615 Bielefeld, Germany.
   Inst Res Chem Raluca Ripan, R-400294 Cluj Napoca, Romania.
RP Baciut, M (reprint author), Univ Med & Pharm Iuliu, Dept Cranio Maxillofacial Surg, R-400029 Cluj Napoca, Romania.
EM mbaciut@yahoo.com
RI Baciut, Grigore/C-4966-2012; Florian, Ioan Stefan/D-5934-2016; Albon,
   Camelia/B-8438-2011
OI Florian, Ioan Stefan/0000-0001-7127-0946; 
CR BACIUT G, 1998, RECONSTRUCTION BONE
   Boyan BD, 2006, J PERIODONTOL, V77, P1555, DOI 10.1902/jop.2006.060019
   BRAN S, 2006, ACAD J MANUFACTURING, V2, P12
   COMAN V, 2006, P INT C BIOMAT MED D, P168
   COMAN V, 2006, 5 INT C S E EUR CHEM, P509
   HOLLINGER J, 1992, CELL MATER, V2, P143
   LI C, 2007, PLOS ONE, V10, pE148
   LI C, 2006, CELL TISSUE RES 1122
   Li CY, 2005, ANAT REC PART A, V282A, P163, DOI 10.1002/ar.a.20148
   Padilla S, 2006, ACTA BIOMATER, V2, P331, DOI 10.1016/j.actbio.2006.01.006
   Padilla S, 2005, BIOMATERIALS, V26, P475, DOI 10.1016/j.biomaterials.2004.02.054
   Paschalis EP, 2001, J BONE MINER RES, V16, P1821, DOI 10.1359/jbmr.2001.16.10.1821
   PLESHKO N, 1991, BIOPHYS J, V60, P786, DOI 10.1016/S0006-3495(91)82113-0
   SIMON V, 1995, ROM REP PHYS, V47, P815
   TURHANI D, 2005, J ORAL MAXILLOFAC SU, V34, P5430
   WEEKS RA, 1968, J CHEM PHYS, V48, P5, DOI 10.1063/1.1667952
NR 16
TC 15
Z9 15
U1 1
U2 8
PU NATL INST OPTOELECTRONICS
PI BUCHAREST-MAGURELE
PA 1 ATOMISTILOR ST, PO BOX MG-5, BUCHAREST-MAGURELE 76900, ROMANIA
SN 1454-4164
J9 J OPTOELECTRON ADV M
JI J. Optoelectron. Adv. Mater.
PD AUG
PY 2007
VL 9
IS 8
BP 2547
EP 2550
PG 4
WC Materials Science, Multidisciplinary; Optics; Physics, Applied
SC Materials Science; Optics; Physics
GA 197UY
UT WOS:000248583200048
DA 2018-10-20
ER

PT J
AU Kasuga, T
AF Kasuga, Toshihiro
TI Development of phosphate glass-ceramics for biomedical applications
SO JOURNAL OF THE CERAMIC SOCIETY OF JAPAN
LA English
DT Article
DE glass-ceramic; phosphate glass; bioactivity; bacteriostatic activity;
   machinable ceramic; coating; biomaterial; dental material
ID BETA-TITANIUM ALLOY; INVERT GLASSES; CRYSTALLIZATION; CYTOTOXICITY;
   SYSTEMS
AB Some recent developments of phosphate glass-ceramic biomaterials are briefly reviewed. Bioactive calcium pyrophosphate glass-ceramics can be prepared by including small amounts of TiO2 and Na2O (totally <= 10 mol%): they are easy to be machined using conventional tools and they are strongly coated on a beta-type titanium alloy using a conventional glazing technique. These materials are expected to be applicable to some surgical treatments such as custom-made implants, Kirschner-wires and so on. New types of dental materials using phosphate glass-ceramics are also discussed. Phosphate glass-ceramics containing a large amount of TiO2 (similar to 20 mol%) includes a functional Nasicon-type crystal, which has silver-ion exchangeability with excellent chemical durability: they are applied to a castable dental crown with bacteriostatic activity. Phosphate glass-ceramic fillers, which are rapidly sintered by CO2 laser irradiation, have been also newly developed for sealing fissures at the surface of a tooth crown.
C1 Nagoya Inst Technol, Dept Mat Sci & Engn, Grad Sch Engn, Showa Ku, Nagoya, Aichi 4668555, Japan.
RP Kasuga, T (reprint author), Nagoya Inst Technol, Dept Mat Sci & Engn, Grad Sch Engn, Showa Ku, Gokiso Cho, Nagoya, Aichi 4668555, Japan.
CR ABE Y, 1990, HDB BIOACTIVE CERAMI, V1, P109
   ADAIR PJ, 1984, INT J PERIODONT REST, V2, P33
   AOKI H, 1994, MED APPL HYDROXYAPAT, P286
   AONO H, 1989, J ELECTROCHEM SOC, V136, P590, DOI 10.1149/1.2096693
   CORBRIDGE DEC, 1957, ACTA CRYSTALLOGR, V10, P85, DOI 10.1107/S0365110X57000201
   Hench L. L., 1993, INTRO BIOCERAMICS, P1
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   HIYAMA K, 1997, J ANTIBACT ANTIFUNGA, V25, P679
   HOSONO H, 1994, MATER RES BULL, V29, P1157, DOI 10.1016/0025-5408(94)90185-6
   Kasuga T, 2005, KEY ENG MAT, V284-286, P243, DOI 10.4028/www.scientific.net/KEM.284-286.243
   Kasuga T, 2003, J CERAM SOC JPN, V111, P633, DOI 10.2109/jcersj.111.633
   Kasuga T, 2003, ADV ENG MATER, V5, P498, DOI 10.1002/adem.200300362
   Kasuga T, 2003, J AM CERAM SOC, V86, P1031, DOI 10.1111/j.1151-2916.2003.tb03415.x
   Kasuga T, 1999, J AM CERAM SOC, V82, P765
   Kasuga T, 2001, J MATER SCI LETT, V20, P1249, DOI 10.1023/A:1010939326541
   Kasuga T, 2001, J MATER RES, V16, P876, DOI 10.1557/JMR.2001.0107
   Kasuga T, 1998, J MATER RES, V13, P3357, DOI 10.1557/JMR.1998.0455
   Kasuga T, 2001, BIOMATERIALS, V22, P577, DOI 10.1016/S0142-9612(00)00216-7
   Kasuga T, 1997, J AM CERAM SOC, V80, P777, DOI 10.1111/j.1151-2916.1997.tb02898.x
   Kasuga T, 1999, BIOMATERIALS, V20, P1415, DOI 10.1016/S0142-9612(99)00047-2
   Kasuga T, 1999, J NON-CRYST SOLIDS, V243, P70, DOI 10.1016/S0022-3093(98)00820-5
   KASUGA T, 2001, KEY ENG MATER, P192
   KASUGA T, 1999, PHOSPHORUS RES B, V10, P534
   KASUGA T, 1995, P 8 INT S CER MED, P415
   KASUGA T, 2002, PHOSPHORUS RES B, V13, P153
   KASUGA T, 1998, P 18 INT CONG GLAS E, V4, P31
   Kasuga T, 2007, KEY ENG MATER, V330-332, P157, DOI 10.4028/www.scientific.net/KEM.330-332.157
   KIHARA S, 1984, J AM CERAM SOC, V67, pC100
   KISHIOKA A, 1974, B CHEM SOC JPN, V47, P2493, DOI 10.1246/bcsj.47.2493
   KOKUBO T, 1990, J NON-CRYST SOLIDS, V120, P138, DOI 10.1016/0022-3093(90)90199-V
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   MENTRE O, 1994, SOLID STATE IONICS, V72, P239
   MURTHY MK, 1961, J AM CERAM SOC, V44, P97, DOI 10.1111/j.1151-2916.1961.tb13721.x
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   NIINOMI M, 2001, RRD MET MAT SCI, V5, P1
   Obata A, 2007, MATER TRANS, V48, P313, DOI 10.2320/matertrans.48.313
   OYA A, 1992, APPL CLAY SCI, V6, P311
   Pilliar RM, 2001, BIOMATERIALS, V22, P963, DOI 10.1016/S0142-9612(00)00261-1
   UENO E, 2005, PHOSPHORUS RES B, V19, P280
   Uo M, 1998, BIOMATERIALS, V19, P2277, DOI 10.1016/S0142-9612(98)00136-7
   WEBB NC, 1966, ACTA CRYSTALLOGR, V21, P942, DOI 10.1107/S0365110X66004225
NR 41
TC 6
Z9 6
U1 0
U2 14
PU CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI
PI TOKYO
PA 22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN
SN 1882-0743
EI 1348-6535
J9 J CERAM SOC JPN
JI J. Ceram. Soc. Jpn.
PD AUG
PY 2007
VL 115
IS 1344
BP 455
EP 459
DI 10.2109/jcersj2.115.455
PG 5
WC Materials Science, Ceramics
SC Materials Science
GA 196ZW
UT WOS:000248523400001
OA Bronze
DA 2018-10-20
ER

PT J
AU Lee, SH
   Nomura, N
   Chiba, A
AF Lee, Sang-Hak
   Nomura, Naoyuki
   Chiba, Akihiko
TI Effect of Fe addition on microstructures and mechanical properties of
   Ni- and C-free Co-Cr-Mo alloys
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE cobalt chromium molybdenum alloy; biomaterial; nickel carbon free; iron
ID SURGICAL IMPLANTS; SUPERALLOYS; CAST
AB A series of Co-Cr-Mo alloys with Fe contents ranging from 5 to 20 mass% were prepared in order to study the effect of Fe addition on the microstructures and mechanical properties (tensile strength, yield strength, elongation, and Rockwell C scale hardness) of Ni- and C-free Co-Cr-Mo alloys. Fe was added with the composition of Co-29Cr-6Mo-xFe (where x = 0, 5, 10, and 20). Alloys were heat-treated at 1230 degrees C for 3 h and 1250 degrees C for 5 h. These heat treatment conditions were decided as considering pre-heat treatment followed by hot-forging process. An optical microscope and an XRD were used to determine the microstructure and identify the crystal structure. The volume ratio of gamma phase to epsilon phase increases not only with heat treatment temperature and time but also with Fe content. The tensile strength, yield strength, and elongation are significantly improved by Fe addition. However, the tendency toward a phase formation becomes higher as the Fe content increases, causing a deterioration of mechanical properties. From the viewpoint of mechanical properties, the amount of Fe addition should be less than 10 mass% in pre-heated condition of Co-29Cr-6Mo alloys.
C1 Iwate Univ, Ctr Reg Collaborat Res & Educ, Morioka, Iwate 0208551, Japan.
   Iwate Univ, Fac Engn, Dept Welfare Engn, Morioka, Iwate 0208551, Japan.
   Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
RP Lee, SH (reprint author), Iwate Univ, Ctr Reg Collaborat Res & Educ, Morioka, Iwate 0208551, Japan.
RI NOMURA, Naoyuki/L-7149-2017; Chiba, Akihiko/D-1326-2011
CR CLEMOW AJT, 1979, J BIOMED MATER RES, V13, P265, DOI 10.1002/jbm.820130208
   ERICSSON T, 1966, ACTA METALL MATER, V14, P853, DOI 10.1016/0001-6160(66)90006-X
   Garcia AD, 1999, SCRIPTA MATER, V40, P717
   Hsu HC, 2003, J MATER PROCESS TECH, V138, P231, DOI 10.1016/S0924-0136(03)00077-3
   Hsu RWW, 2005, MATER CHEM PHYS, V93, P531, DOI 10.1016/j.matchemphys.2005.04.007
   KILNER T, 1986, J MATER SCI, V21, P1349, DOI 10.1007/BF00553274
   KLARSTROM DL, 1993, J MATER ENG PERFORM, V2, P523, DOI 10.1007/BF02661736
   Lee SH, 2007, MATER TRANS, V48, P1084, DOI 10.2320/matertrans.48.1084
   Lee SH, 2006, MATER TRANS, V47, P287, DOI 10.2320/matertrans.47.287
   Lee SH, 2005, MATER TRANS, V46, P1790, DOI 10.2320/matertrans.46.1790
   MURPHY HJ, 1968, 1 INT S STRUCT STAB, P47
   SHI LQ, 1993, J MATER SCI, V28, P1312, DOI 10.1007/BF01191970
   Shin JC, 2003, SURF COAT TECH, V166, P117, DOI 10.1016/S0257-8972(02)00853-8
   WOODYATT LR, 1966, T METALL SOC AIME, V236, P519
   ZHUANG LZ, 1989, J MATER SCI, V24, P381, DOI 10.1007/BF01107415
NR 15
TC 9
Z9 9
U1 1
U2 5
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD AUG
PY 2007
VL 48
IS 8
BP 2207
EP 2211
DI 10.2320/matertrans.MRA2007004
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 211GH
UT WOS:000249511800043
OA Bronze
DA 2018-10-20
ER

PT J
AU Miura, E
   Kato, H
   Ogata, T
   Nishiyama, N
   Specht, ED
   Shiraishi, T
   Inoue, A
   Hisatsune, K
AF Miura, Eri
   Kato, Hidemi
   Ogata, Toshiaki
   Nishiyama, Nobuyuki
   Specht, Eliot D.
   Shiraishi, Takanobu
   Inoue, Akihisa
   Hisatsune, Kunihiro
TI Mechanical property and corrosion resistance evaluations of Ti-6Al-7Nb
   alloy brazed with bulk metallic glasses
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE bulk metallic glass; brazing filler; titanium-aluminum-niobium alloy;
   biomaterial; infrared joining; degradation test; artificial saliva;
   joint strength
ID BRAZING FILLER METALS; BEHAVIOR; TITANIUM; TI; NB
AB Exploitation of metallic glass as new brazing filler for Ti-based biomedical alloy was attempted. Ti-6Al-7Nb was used as a brazed material, and candidates of bulk metallic glass brazing filler were CU60Hf25Ti15, Mg65Cu25Gd10, Zr55Cu30Al10Ni5 and Pd40Cu30P20Ni10. Convergence infrared-ray brazing was conducted for brazing Ti-6Al-7Nb/metallic glass in Ar atmosphere. After brazing, hardness measurement, X-ray tomography, cross-sectional observation, artificial saliva immersion test and tensile test were performed to evaluate brazability, mechanical property and corrosion resistance of the obtained brazing joints.
   The results of brazing using these metallic glass fillers show that all the metallic glasses were brazable to Ti-6Al-7Nb except for Mg65Cu25Gd10. Mg65Cu25Gd10, Cu60Hf25Ti15 and their-joints collapsed rapidly during immersion test. Zr55Cu30Al10Ni5 joint was the best in terms of degradation resistance; however, tensile strength was inferior to the conventional one. Pd40Cu30Ni10P20 filler and Zr55Cu30Al10Ni5 filler and their joints did not show any collapse or tarnish during the immersion test. Pd40Cu30Ni10P20 joint showed the excellent properties in terms of both corrosion resistance and tensile strength, which were superior to a joint brazed using Ti-15Cu-25Ni conventional filler. X-ray tomograph indicates that fracture tends to occur in the vicinity of the brazing interface after tensile test.
   The brazed metallic glass fillers were fully crystallized, excluding Pd40Cu30Ni10P20 filler. Pd40Cu30Ni10P20 brazed filler contained maple-leaf like primary dendrite, peritectoid and a few microns interfacial reaction layer in glassy matrix. The results indicated that Pd40Cu30Ni10P20 is promising brazing filler for dental or biomaterial devices.
C1 Nagasaki Univ, Grad Sch Biomed Sci, Div Dent & Biomed Mat Sci, Nagasaki 8528588, Japan.
   Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
   Nagasaki Univ, Sch Dent, Nagasaki 8528588, Japan.
   RIMCOF Tohoku Univ Lab, Sendai, Miyagi 9808577, Japan.
   Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA.
RP Miura, E (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Div Dent & Biomed Mat Sci, Nagasaki 8528588, Japan.
RI Miura-Fujiwara, Eri/A-1023-2010; Kato, Hidemi/B-2492-2015; Nishiyama,
   Nobuyuki/C-8228-2015; Inoue, Akihisa/E-5271-2015
OI Miura-Fujiwara, Eri/0000-0002-7672-3534; Specht,
   Eliot/0000-0002-3191-2163
CR Asami K, 2004, MAT SCI ENG A-STRUCT, V375, P235, DOI 10.1016/j.msea.2003.10.034
   BOTSTEIN O, 1994, MAT SCI ENG A-STRUCT, V188, P305, DOI 10.1016/0921-5093(94)90386-7
   BOYER R, 1994, TITANIUM ALLOYS, P693
   Buzzi S, 2006, INTERMETALLICS, V14, P729, DOI 10.1016/j.intermet.2005.11.003
   DOI H, 1997, J JPN SOC DENT MAT D, V16, P182
   Gebert A, 2004, MAT SCI ENG A-STRUCT, V375, P280, DOI 10.1016/j.msea.2003.10.026
   HAMANAKE H, 1998, J DENT ENG, V124, P25
   HOWDEN DG, 1972, WELD J, V51, P31
   Inoue A, 2000, ACTA MATER, V48, P279, DOI 10.1016/S1359-6454(99)00300-6
   IWASE H, 2000, J J DENT MAT, V19, P397
   Kim JH, 2001, ACTA MATER, V49, P615, DOI 10.1016/S1359-6454(00)00353-0
   Kobayashi E., 1995, J JPN SOC DENT MAT D, V14, P406
   LAN SW, 1982, WELD J, V61, P23
   Liu L, 2005, J ALLOY COMPD, V399, P144, DOI 10.1016/j.jallcom.2005.03.016
   Miura E, 2007, MATER SCI FORUM, V539-543, P1983, DOI 10.4028/www.scientific.net/MSF.539-543.1983
   MIURA E, 2001, 4 PAC RIM INT C ADV, P261
   Nishiyama N, 1997, MATER T JIM, V38, P464, DOI 10.2320/matertrans1989.38.464
   Oda Y, 1996, DENT MATER, V12, P167, DOI 10.1016/S0109-5641(96)80016-9
   OHKAWA S, 1991, J J DENT MAT, V10, P1
   OKAZAKI M, 1992, MECH ENG LAB B, V45, P397
   OLSON DL, 1994, WELDING BRAZING SOLD, P941
   ONZAWA T, 1990, WELD J, V69, pS462
   Qiu CL, 2005, J BIOMED MATER RES A, V75A, P950, DOI 10.1002/jbm.a.30502
   RABINKIN A, 1991, SCRIPTA METALL MATER, V25, P399, DOI 10.1016/0956-716X(91)90200-K
   Raju VR, 2002, MATER LETT, V57, P173, DOI 10.1016/S0167-577X(02)00725-5
   *TEIJ FARM, 2003, INSTR MAN SALIVCHT
   Wu YF, 2006, MATER LETT, V60, P2416, DOI 10.1016/j.matlet.2006.01.068
   YAMAGUCHI Y, 1993, SOLDERING TECHNIQUE, P175
   Yao HB, 2003, ELECTROCHIM ACTA, V48, P2641, DOI 10.1016/S0013-4686(03)00310-4
NR 29
TC 11
Z9 11
U1 1
U2 16
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD AUG
PY 2007
VL 48
IS 8
BP 2235
EP 2243
DI 10.2320/matertrans.MER2007612
PG 9
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 211GH
UT WOS:000249511800048
OA Bronze
DA 2018-10-20
ER

PT J
AU Cohen, A
   Liu-Synder, P
   Storey, D
   Webster, TJ
AF Cohen, Ariel
   Liu-Synder, Peishan
   Storey, Dan
   Webster, Thomas J.
TI Decreased fibroblast and increased osteoblast functions on ionic plasma
   deposited nanostructured Ti coatings
SO NANOSCALE RESEARCH LETTERS
LA English
DT Article
DE nanometer; coatings; fibroblasts; osteoblasts; orthopedic
ID NANOPHASE CERAMICS; ADHESION; ALUMINA
AB Bioactive coatings are in high demand to control cellular functions for numerous medical devices. The objective of this in vitro study was to characterize for the first time fibroblast (fibrous scar tissue forming cells) adhesion and proliferation on an important polymeric biomaterial (silicone) coated with titanium using a novel ionic plasma deposition (IPD) process. Fibroblasts are one of the first anchorage-dependent cells to arrive at an implant surface during the wound healing process. Persistent excessive functions of fibroblasts have been linked to detrimental fibrous tissue formation which may cause implant failure. The IPD process creates a surface-engineered nanostructure (with features usually below 100 nm) by first using a vacuum to remove all contaminants, then guiding charged metallic ions or plasma to the surface of a medical device at ambient temperature. Results demonstrated that compared to currently used titanium and uncoated silicone, silicone coated with titanium using IPD significantly decreased fibroblast adhesion and proliferation. Results also showed competitively increased osteoblast (bone-forming cells) over fibroblast adhesion on silicone coated with titanium; in contrast, osteoblast adhesion was not competitively increased over fibroblast adhesion on uncoated silicone or titanium controls. In this manner, this study strongly suggests that IPD should be further studied for biomaterial applications in which fibrous tissue encapsulation is undesirable (such as for orthopedic implants, cardiovascular components, etc.).
C1 [Cohen, Ariel; Liu-Synder, Peishan; Webster, Thomas J.] Brown Univ, Div Engn & Orthopaed, Providence, RI 02912 USA.
   [Storey, Dan] Ion Fus, Longmont, CO 80501 USA.
RP Webster, TJ (reprint author), Brown Univ, Div Engn & Orthopaed, 184 Hope St, Providence, RI 02912 USA.
EM Thomas_Webster@Brown.edu
CR BAKER KC, IN PRESS MAT SCI E C
   Curtis ASG, 2004, IEEE T NANOBIOSCI, V3, P61, DOI 10.1109/TNB.2004.824276
   FURLONG R, 2001, J BONE JOINT SURG BR, V73, P741
   Karlsson M, 2003, BIOMATERIALS, V24, P3039, DOI 10.1016/S0142-9612(03)00146-7
   Popat KC, 2005, BIOMATERIALS, V26, P4516, DOI 10.1016/j.biomaterials.2004.11.026
   REISING A, 2007, IN PRESS J BIOMED MA
   Sato M, 2005, BIOMATERIALS, V26, P1349, DOI 10.1016/j.biomaterials.2004.04.044
   Valiev R.Z., 2004, MED DEVICE MAT, P362
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Webster TJ, 2004, BIOMATERIALS, V25, P4731, DOI 10.1016/j.biomaterials.2003.12.002
   Webster TJ, 2001, TISSUE ENG, V7, P291, DOI 10.1089/10763270152044152
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   YAO C, 2007, IN PRESS INT J NANOM
   Yao C, 2005, J BIOMED NANOTECHNOL, V1, P68, DOI 10.1166/jbn.2005.008
NR 14
TC 23
Z9 23
U1 0
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 1931-7573
J9 NANOSCALE RES LETT
JI Nanoscale Res. Lett.
PD AUG
PY 2007
VL 2
IS 8
BP 385
EP 390
DI 10.1007/s11671-007-9069-1
PG 6
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA 269NH
UT WOS:000253655300003
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Bradley, MP
   Fadale, PD
   Hulstyn, MJ
   Muirhead, WR
   Lifrak, JT
AF Bradley, Michael P.
   Fadale, Paul D.
   Hulstyn, Michael J.
   Muirhead, William R.
   Lifrak, Joseph T.
TI Porcine small intestine submucosa for repair of goat meniscal defects
SO ORTHOPEDICS
LA English
DT Article
ID AVASCULAR ZONE; KNEE; DOGS; TRANSPLANTATION; REGENERATION; MENISCECTOMY;
   TISSUE; BIOMATERIAL; ALLOGRAFTS; RABBITS
AB This study evaluated the effectiveness of small intestine submucosa used as a graft to fill surgically created meniscal defects in a large animal model. Four goats underwent unilateral interior subtotal meniscectomies (similar to 70%) within the avascular portion of the medial meniscus. The contralateral meniscus acted as a control. Grafts of porcine small intestine submucosa were trimmed to fill the resected defects and sutured into place. After surgery the operated knees were casted in partial flexion to limit weight bearing on the affected limb. All of the animals were sacrificed at 12 weeks at which point meniscal regeneration and articular cartilage degradation were evaluated by gross and histologic examination. Grossly, the defects in the small intestine submucosa-grafted goats were partially filled with meniscal-appearing connective tissue. Histologically, the replacement tissue was typified by the presence of dense, cellular, irregularly organized connective tissue. Evaluation of the articular cartilage displayed increased degeneration in the grafted compartment of the operative knees. Each of the operative menisci partially regenerated. The grafts were conducive to repopulation with host meniscal elements. Despite partial meniscal regeneration, comparatively more articular cartilage degeneration in the treated knees was observed than in the untreated contralateral controls.
C1 Brown Univ, Sch Med, Rhode Isl Hosp, Dept Orthoped Surg,Div Sports Med, Providence, RI 02905 USA.
RP Bradley, MP (reprint author), Brown Univ, Sch Med, Rhode Isl Hosp, Dept Orthoped Surg,Div Sports Med, 2 Dudley St,COOP 1st Fl, Providence, RI 02905 USA.
CR ARNOCZKY SP, 1982, AM J SPORT MED, V10, P90, DOI 10.1177/036354658201000205
   ARNOCZKY SP, 1988, J BONE JOINT SURG AM, V70A, P1209, DOI 10.2106/00004623-198870080-00012
   ARNOCZKY SP, 1988, J ORTHOP RES, V6, P1, DOI 10.1002/jor.1100060102
   ARNOCZKY SP, 1988, ORTHOP T, V12, P431
   ARNOCZKY SP, 1999, CLIN ORTHOP S, V367, P244
   Badylak S, 1999, CLIN ORTHOP RELAT R, pS333, DOI 10.1097/00003086-199910001-00032
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   BARATZ ME, 1986, AM J SPORT MED, V14, P270, DOI 10.1177/036354658601400405
   CISA J, 1995, ACTA ORTHOP SCAND, V66, P38, DOI 10.3109/17453679508994636
   Cook JL, 2001, TISSUE ENG, V7, P321, DOI 10.1089/10763270152044189
   Cook JL, 1999, AM J SPORT MED, V27, P658, DOI 10.1177/03635465990270051901
   DeHaven KE, 1999, AM J SPORT MED, V27, P242, DOI 10.1177/03635465990270022301
   Dejardin LM, 2001, AM J SPORT MED, V29, P175, DOI 10.1177/03635465010290021001
   DEJARDIN LM, 1992, AM J PATHOL, V140, P317
   Dora CD, 2004, J UROLOGY, V171, P1970, DOI 10.1097/01.ju.0000121377.61788.ad
   FAIRBANK TJ, 1948, J BONE JOINT SURG BR, V30, P664
   Gastel JA, 2001, ARTHROSCOPY, V17, P151, DOI 10.1053/jars.2001.20959
   Guisasola I, 2002, CLIN ORTHOP RELAT R, P227
   JACKSON DW, 1992, J BONE JOINT SURG AM, V74A, P112, DOI 10.2106/00004623-199274010-00014
   King D, 1936, J BONE JOINT SURG, V18, P333
   KRAUSE WR, 1976, J BONE JOINT SURG AM, V58, P599, DOI 10.2106/00004623-197658050-00003
   Kropp B P, 1995, Urology, V46, P396, DOI 10.1016/S0090-4295(99)80227-1
   Lantz G C, 1990, J Invest Surg, V3, P217, DOI 10.3109/08941939009140351
   LANTZ GC, 1992, J SURG RES, V53, P175, DOI 10.1016/0022-4804(92)90031-T
   LEVY IM, 1982, J BONE JOINT SURG AM, V64, P883, DOI 10.2106/00004623-198264060-00011
   MCGINTY JB, 1977, J BONE JOINT SURG AM, V59, P763, DOI 10.2106/00004623-197759060-00008
   MILACHOWSKI KA, 1989, INT ORTHOP, V13, P1
   PREVEL CD, 1995, ANN PLAS SURG, V35, P374, DOI 10.1097/00000637-199510000-00008
   Rath E, 2001, AM J SPORT MED, V29, P410, DOI 10.1177/03635465010290040401
   Rubman MH, 1998, AM J SPORT MED, V26, P87, DOI 10.1177/03635465980260013301
   SETTON LA, 1999, CLIN ORTHOP S, V367, P254
   Shaffer B, 2000, AM J SPORT MED, V28, P524, DOI 10.1177/03635465000280041301
   SHOEMAKER SC, 1986, J BONE JOINT SURG AM, V68A, P71, DOI 10.2106/00004623-198668010-00009
   Shrive N G, 1978, Clin Orthop Relat Res, P279
   SOMMERLATH K, 1992, AM J SPORT MED, V20, P73, DOI 10.1177/036354659202000117
   STONE KR, 1992, AM J SPORT MED, V20, P104, DOI 10.1177/036354659202000202
   STONE RK, 1999, CLIN ORTHOP RELAT R, V367, P273
   Walker P S, 1975, Clin Orthop Relat Res, P184, DOI 10.1097/00003086-197506000-00027
   Welch JA, 2002, AM J VET RES, V63, P427, DOI 10.2460/ajvr.2002.63.427
NR 39
TC 16
Z9 19
U1 2
U2 3
PU SLACK INC
PI THOROFARE
PA 6900 GROVE RD, THOROFARE, NJ 08086 USA
SN 0147-7447
EI 1938-2367
J9 ORTHOPEDICS
JI Orthopedics
PD AUG
PY 2007
VL 30
IS 8
BP 650
EP 656
PG 7
WC Orthopedics
SC Orthopedics
GA 199QM
UT WOS:000248710300014
PM 17727022
DA 2018-10-20
ER

PT J
AU Fischer, BM
   Helm, H
   Jepsen, PU
AF Fischer, Bernd M.
   Helm, Hanspeter
   Jepsen, Peter Uhd
TI Chemical recognition with broadband THz spectroscopy
SO PROCEEDINGS OF THE IEEE
LA English
DT Article
DE chemical recognition; THz-imaging; THz-TDS
ID TIME-DOMAIN SPECTROSCOPY; COLLECTIVE VIBRATIONAL-MODES;
   BIOLOGICAL-SYSTEMS; CRYSTAL-STRUCTURE; ARTIFICIAL RNA; TERAHERTZ;
   SPECTRA; MOLECULES; DENSITY; GLUCOSE
AB THz science is developing rapidly in Europe as well as the rest of the world. There is a strong interest in the exploitation of optical technologies in the THz frequency range in virtually all fields of basic and applied sciences of physics, chemistry, biology as well as medicine. Commercial interest in this field has also been growing, spurred by the potential of THz tools in quality control and the biotechnology sector. We will review some contrast mechanisms, which form the basis for real-world applications of THz technology, in particular in the fields of applied chemistry and biotechnology. Whereas narrow bandwidth THz technology may become important for, e.g., real-time imaging at larger standoff distances, we will concentrate on broad bandwidth THZ technologies for spectroscopic identification of various substances. It has recently been established that the 0.1-5 THz spectral range contains unique fingerprints of a very large number of crystalline materials, including explosives, illicit drugs as well as most other chemicals in powder form. Since many packaging materials are transparent to THz radiation this fundamental property of crystalline compounds allows remote (contact-free) sensing combined with chemical recognition. on the other hand, the THz spectrum of amorphous systems, including aqueous solutions, contains very little information about the detailed composition of the system. However, under certain conditions it is still possible to learn a great deal about amorphous systems with broadband THz spectroscopy. Amorphous systems of great biotechnological importance include DNA and proteins, both in aqueous solution and as dried matter. We will discuss methods for THz science and technology to attack the very complex problems involved in the extraction of useful new information, which may be difficult, expensive, or impossible to obtain with other methods, from minute amounts of biomaterial.
C1 Univ Freiburg, Freiburg Mat Res Ctr, Dept Mol Opt Phys, D-79104 Freiburg, Germany.
   Univ Adelaide, Ctr Biomed Engn, Sch Elect & Elect Engn, Adelaide, SA 5005, Australia.
RP Fischer, BM (reprint author), Univ Freiburg, Freiburg Mat Res Ctr, Dept Mol Opt Phys, Hugstetter Str 55, D-79104 Freiburg, Germany.
EM bernd.fischer@adelaide.edu.au
RI Helm, Hanspeter/G-4723-2011; Jepsen, Peter/G-5288-2010
OI Helm, Hanspeter/0000-0002-6761-5910; Jepsen, Peter
   Uhd/0000-0003-3915-1167
CR BARKER DH, 1975, P SOC PHOTO-OPT INS, V67, P27
   BROCK CP, 1991, J AM CHEM SOC, V113, P9811, DOI 10.1021/ja00026a015
   BROWN GM, 1979, ACTA CRYSTALLOGR B, V35, P656, DOI 10.1107/S0567740879004374
   Chen YQ, 2004, CHEM PHYS LETT, V400, P357, DOI 10.1016/j.cplett.2004.10.117
   Clarkson J, 2003, J MOL STRUCT, V648, P203, DOI 10.1016/S0022-2860(03)00024-3
   DAUCHEZ M, 1993, J COMPUT CHEM, V14, P263, DOI 10.1002/jcc.540140303
   Desseyn HO, 2001, SPECTROCHIM ACTA A, V57, P231, DOI 10.1016/S1386-1425(00)00370-X
   Doria A, 2004, INFRARED PHYS TECHN, V45, P339, DOI 10.1016/j.infrared.2004.01.014
   Federici JF, 2003, APPL PHYS LETT, V83, P2477, DOI 10.1063/1.1610799
   Federici JF, 2005, SEMICOND SCI TECH, V20, pS266, DOI 10.1088/0268-1242/20/7/018
   Ferguson B, 2002, MICROELECTRON J, V33, P1043, DOI 10.1016/S0026-2692(02)00109-X
   Fischer B, 2005, SEMICOND SCI TECH, V20, pS246, DOI 10.1088/0268-1242/20/7/015
   Fischer BM, 2007, PROC SPIE, V6416, DOI 10.1117/12.695726
   Fischer BM, 2005, OPT EXPRESS, V13, P5205, DOI 10.1364/OPEX.13.005205
   Fischer BM, 2002, PHYS MED BIOL, V47, P3807, DOI 10.1088/0031-9155/47/21/319
   Gervasio FL, 1998, J PHYS CHEM A, V102, P2131, DOI 10.1021/jp9724636
   Globus T, 2003, J PHYS D APPL PHYS, V36, P1314, DOI 10.1088/0022-3727/36/11/312
   GRUDZKOV YA, 2001, J PHYS CHEM A, V105, P6197
   HINENO M, 1974, SPECTROCHIM ACTA A, VA-30, P411, DOI 10.1016/0584-8539(74)80080-2
   HOUGH E, 1973, ACTA CRYSTALLOGR B, V29, P365, DOI 10.1107/S0567740873002529
   HU BB, 1995, OPT LETT, V20, P1716, DOI 10.1364/OL.20.001716
   Jepsen PU, 1996, ULTRAFAST PROCESSES IN SPECTROSCOPY, P645
   Jepsen PU, 2005, OPT LETT, V30, P29, DOI 10.1364/OL.30.000029
   Kawase K, 2003, OPT EXPRESS, V11, P2549, DOI 10.1364/OE.11.002549
   Knab J, 2006, BIOPHYS J, V90, P2576, DOI 10.1529/biophysj.105.069088
   Luner PE, 2002, ACTA CRYSTALLOGR C, V58, pO333, DOI 10.1107/S0108270102006650
   Markelz A, 2002, PHYS MED BIOL, V47, P3797, DOI 10.1088/0031-9155/47/21/318
   Mittleman D, 2003, SENSING TERAHERTZ RA
   OZEKI K, 1969, ACTA CRYSTALL B-STRU, VB 25, P1038, DOI 10.1107/S0567740869003505
   Pickwell E, 2004, APPL PHYS LETT, V84, P2190, DOI 10.1063/1.1688448
   SEKKAL M, 1992, SPECTROCHIM ACTA A, V48, P959, DOI 10.1016/0584-8539(92)80172-S
   Shen YC, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1946192
   Smye SW, 2001, PHYS MED BIOL, V46, pR101, DOI 10.1088/0031-9155/46/9/201
   Strachan CJ, 2004, CHEM PHYS LETT, V390, P20, DOI 10.1016/j.cplett.2004.03.117
   STRYER L, 1998, BIOCHEMISTRY
   Taday PF, 2003, J PHARM SCI, V92, P831, DOI 10.1002/jps.10358
   Takahashi M, 2005, CHEM PHYS LETT, V401, P475, DOI 10.1016/j.cplett.2004.11.108
   Upadhya PC, 2004, VIB SPECTROSC, V35, P139, DOI 10.1016/j.vibspec.2003.12.010
   Wallach O, 1895, LIEBIGS ANN CHEM, V286, P90
   Walther M, 2003, CHEM PHYS, V288, P261, DOI 10.1016/S0301-0104(03)00031-4
   Walther M, 2002, BIOPOLYMERS, V67, P310, DOI 10.1002/bip.10106
   Walther M, 2000, CHEM PHYS LETT, V332, P389, DOI 10.1016/S0009-2614(00)01271-9
   Wang QZ, 2005, DYNAM CONT DIS SER B, V1, P247
   Watanabe Y, 2003, APPL PHYS LETT, V83, P800, DOI 10.1063/1.1595132
   Whitmire SE, 2003, BIOPHYS J, V85, P1269, DOI 10.1016/S0006-3495(03)74562-7
   Woodward RM, 2003, J BIOL PHYS, V29, P257, DOI 10.1023/A:1024409329416
   Woolard DL, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.051903
   Yamaguchi M, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1857080
   Zhang XC, 1996, ULTRAFAST PROCESSES IN SPECTROSCOPY, P649
NR 49
TC 78
Z9 81
U1 3
U2 57
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 0018-9219
EI 1558-2256
J9 P IEEE
JI Proc. IEEE
PD AUG
PY 2007
VL 95
IS 8
BP 1592
EP 1604
DI 10.1109/JPROC.2007.898904
PG 13
WC Engineering, Electrical & Electronic
SC Engineering
GA 221GJ
UT WOS:000250215100009
DA 2018-10-20
ER

PT J
AU Guimard, NK
   Gomez, N
   Schmidt, CE
AF Guimard, Nathalie K.
   Gomez, Natalia
   Schmidt, Christine E.
TI Conducting polymers in biomedical engineering
SO PROGRESS IN POLYMER SCIENCE
LA English
DT Review
DE electroactive biomaterial; neural probes; biosensors; tissue
   engineering; polypyrrole; polythiophene
ID POLYPYRROLE-MODIFIED ELECTRODE; FREE ELECTROCHEMICAL DETECTION;
   GLUCOSE-OXIDASE BIOSENSOR; COATED POLYESTER FABRICS; CONTROLLED
   DRUG-DELIVERY; WALLED CARBON NANOTUBES; IN-VIVO; ARTIFICIAL MUSCLES;
   NERVE REGENERATION; POLYANILINE FILMS
AB Conducting polymers (CPs) were first produced in the mid-1970s as a novel generation of organic materials that have both electrical and optical properties similar to those of metals and inorganic semiconductors, but which also exhibit the attractive properties associated with conventional polymers, such as ease of synthesis and flexibility in processing. The fact that several tissues are responsive to electrical fields and stimuli has made CPs attractive for a number of biological and medical applications. This review provides information on desirable CP properties specific to biomedical applications and how CPs have been optimized to generate these properties. The manuscript first introduces different types of CPs, their unique properties and their synthesis. Then specific information is provided on their modification for use in applications such as biosensors, tissue engineering, and neural probes. Although there remain many unanswered questions, particularly regarding the mechanisms by which electrical conduction through CPs affects cells, there is already compelling evidence to demonstrate the significant impact that CPs are starting to make in the biomedical field. (C) 2007 Elsevier Ltd. All rights reserved.
C1 Univ Texas, Dept Biomed Engn, Austin, TX 78712 USA.
   Univ Texas, Dept Chem, Austin, TX 78712 USA.
   Univ Texas, Dept Chem Engn, Austin, TX 78712 USA.
RP Schmidt, CE (reprint author), Univ Texas, Dept Biomed Engn, Austin, TX 78712 USA.
EM schmidt@che.utexas.edu
RI Schmidt, Christine/P-1613-2016
CR Abidian MR, 2006, ADV MATER, V18, P405, DOI 10.1002/adma.200501726
   Abu-Rabeah K, 2005, BIOMACROMOLECULES, V6, P3313, DOI 10.1021/bm050339j
   Adeloju SB, 1996, ANAL CHIM ACTA, V323, P107, DOI 10.1016/0003-2670(95)00562-5
   AEBISCHER P, 1987, BRAIN RES, V436, P165, DOI 10.1016/0006-8993(87)91570-8
   Ahuja T, 2007, BIOMATERIALS, V28, P791, DOI 10.1016/j.biomaterials.2006.09.046
   Alves WA, 2006, BIOSENS BIOELECTRON, V22, P298, DOI 10.1016/j.bios.2006.01.009
   Arslan F, 2006, RUSS J ELECTROCHEM+, V42, P137, DOI 10.1134/S1023193506020042
   Arslan F, 2006, ARTIF CELL BLOOD SUB, V34, P113, DOI 10.1080/10731190500430289
   Azioune A, 2004, LANGMUIR, V20, P3350, DOI 10.1021/la030407s
   Bakker E, 2002, ANAL CHEM, V74, P2781, DOI 10.1021/ac0202278
   Bartlett PN, 2001, J MATER CHEM, V11, P849, DOI 10.1039/b006992m
   Bera-Aberem M, 2004, TETRAHEDRON, V60, P11169, DOI 10.1016/j.tet.2004.08.053
   Bhadani SN, 1997, J APPL POLYM SCI, V64, P1073
   Bidez PR, 2006, J BIOMAT SCI-POLYM E, V17, P199, DOI 10.1163/156856206774879180
   Biloivan OA, 2006, MAT SCI ENG C-BIO S, V26, P574, DOI 10.1016/j.msec.2005.10.011
   Bjork P, 2005, BIOSENS BIOELECTRON, V20, P1764, DOI 10.1016/j.bios.2004.07.001
   BOYLE A, 1990, J ELECTROANAL CHEM, V279, P179, DOI 10.1016/0022-0728(90)85175-5
   Brahim S, 2002, BIOSENS BIOELECTRON, V17, P53, DOI 10.1016/S0956-5663(01)00262-7
   Brahim S, 2005, ELECTROANAL, V17, P556, DOI 10.1002/elan.200403109
   BREDAS JL, 1986, HDB CONDUCTING POLYM, P859
   Cai H, 2003, ELECTROANAL, V15, P1864, DOI 10.1002/elan.200302755
   Campbell TE, 1999, ELECTROANAL, V11, P215, DOI 10.1002/(SICI)1521-4109(199904)11:4<215::AID-ELAN215>3.0.CO;2-#
   Carelli D, 2006, ANAL CHIM ACTA, V565, P27, DOI 10.1016/j.aca.2006.02.023
   Cassagneau T, 2002, ADV MATER, V14, P34, DOI 10.1002/1521-4095(20020104)14:1<34::AID-ADMA34>3.0.CO;2-M
   Castano H, 2004, MACROMOL BIOSCI, V4, P785, DOI 10.1002/mabi.200300123
   Cen L, 2003, BIOSENS BIOELECTRON, V18, P363, DOI 10.1016/S0956-5663(02)00149-5
   Cen L, 2002, LANGMUIR, V18, P8633, DOI 10.1021/la025979b
   CETE S, 2006, BIOTECHNOL, V34, P367
   Chaubey A, 2000, ANAL CHIM ACTA, V407, P97, DOI 10.1016/S0003-2670(99)00797-7
   Chaubey A, 2000, ELECTROCHIM ACTA, V46, P723
   CHEHIMI MM, 2003, SURFACTANT SCI SER, V115, P245
   Chen J, 2002, ELECTROCHIM ACTA, V47, P2715, DOI 10.1016/S0013-4686(02)00136-6
   Chen J, 2006, ELECTROCHEM SOLID ST, V9, pH68, DOI 10.1149/1.2201306
   Chen J, 2004, ELECTROCHIM ACTA, V49, P691, DOI 10.1016/j.electacta.2003.08.031
   Chen L, 2004, BIOMACROMOLECULES, V5, P238, DOI 10.1021/bm0344102
   Chen SJ, 2000, J MATER SCI LETT, V19, P2157, DOI 10.1023/A:1026799415199
   Chen Y, 2006, J PHYS CONF SER, V34, P204, DOI 10.1088/1742-6596/34/1/034
   Cheng DM, 2005, J NANOSCI NANOTECHNO, V5, P466, DOI [10.1166/jnn.2005.058, 10.1166/jnm.2005.058]
   Cheng GF, 2005, ANAL CHIM ACTA, V533, P11, DOI 10.1016/j.aca.2004.10.044
   Chronakis IS, 2006, POLYMER, V47, P1597, DOI 10.1016/j.polymer.2006.01.032
   CHUNG TC, 1984, PHYS REV B, V30, P702, DOI 10.1103/PhysRevB.30.702
   CLARK LC, 1962, ANN NY ACAD SCI, V102, P29, DOI 10.1111/j.1749-6632.1962.tb13623.x
   Collier JH, 2000, J BIOMED MATER RES, V50, P574, DOI 10.1002/(SICI)1097-4636(20000615)50:4<574::AID-JBM13>3.0.CO;2-I
   Cosnier S, 2003, ANAL BIOANAL CHEM, V377, P507, DOI 10.1007/s00216-003-2131-7
   Cosnier S, 2003, MICROCHIM ACTA, V143, P139, DOI 10.1007/s00604-003-0064-7
   Cosnier S, 2003, CHEM COMMUN, P414, DOI 10.1039/b211546h
   Cosnier S, 2006, ANAL CHEM, V78, P7054, DOI 10.1021/ac060926a
   Cristea C, 2005, ELECTROCHIM ACTA, V50, P3713, DOI 10.1016/j.electacta.2005.01.017
   Cui XY, 2003, SENSOR ACTUAT B-CHEM, V89, P92, DOI 10.1016/S0925-4005(02)00448-3
   Cui XY, 2001, J BIOMED MATER RES, V56, P261, DOI 10.1002/1097-4636(200108)56:2<261::AID-JBM1094>3.0.CO;2-I
   Cui XY, 2003, BIOMATERIALS, V24, P777, DOI 10.1016/S0142-9612(02)00415-5
   Cui XY, 2001, SENSOR ACTUAT A-PHYS, V93, P8, DOI 10.1016/S0924-4247(01)00637-9
   DALLOLIO A, 1968, CR ACAD SCI C CHIM, V267, P433
   De Giglio E, 1999, J BIOMAT SCI-POLYM E, V10, P845, DOI 10.1163/156856299X00919
   De Giglio E, 2000, J BIOMAT SCI-POLYM E, V11, P1073, DOI 10.1163/156856200743580
   DESHPANDE MV, 1990, BIOSENS BIOELECTRON, V5, P431, DOI 10.1016/0956-5663(90)80033-A
   DIAZ AF, 1979, J CHEM SOC CHEM COMM, P635, DOI 10.1039/c39790000635
   DIAZ AF, 1986, HDB CONDUCTING POLYM, V1, P81
   Dubus S, 2006, ANAL CHEM, V78, P4457, DOI 10.1021/ac060486n
   Dupont-Filliard A, 2004, ANAL CHIM ACTA, V515, P271, DOI 10.1016/j.aca.2004.03.072
   Ebarvia BS, 2005, TALANTA, V66, P145, DOI 10.1016/j.talanta.2004.10.009
   Entezami AA, 2006, IRAN POLYM J, V15, P13
   Evans SAG, 2005, ELECTROCHEM COMMUN, V7, P135, DOI 10.1016/j.elecom.2004.11.019
   Fabiano S, 2002, MAT SCI ENG C-BIO S, V21, P61, DOI 10.1016/S0928-4931(02)00060-7
   Feast W. J., 1986, HDB CONDUCTING POLYM, VI, P1
   Ferrer-Anglada N, 2006, PHYS STATUS SOLIDI B, V243, P3519, DOI 10.1002/pssb.200669220
   FINE EG, 1991, BIOMATERIALS, V12, P775, DOI 10.1016/0142-9612(91)90029-A
   Fiorito PA, 2006, TALANTA, V69, P403, DOI 10.1016/j.talanta.2005.09.040
   FORTIER G, 1990, BIOSENS BIOELECTRON, V5, P473, DOI 10.1016/0956-5663(90)80036-D
   FOULDS NC, 1986, J CHEM SOC FARAD T 1, V82, P1259, DOI 10.1039/f19868201259
   Fu YZ, 2006, ANAL LETT, V39, P467, DOI 10.1080/00032710500536102
   Gade VK, 2006, REACT FUNCT POLYM, V66, P1420, DOI 10.1016/j.reactfunctpolym.2006.04.005
   Gambhir A, 2001, APPL BIOCHEM BIOTECH, V96, P249, DOI 10.1385/ABAB:96:1-3:249
   GANDHI MR, 1995, SYNTHETIC MET, V73, P247, DOI 10.1016/0379-6779(95)80022-0
   Garner B, 1999, J MATER SCI-MATER M, V10, P19, DOI 10.1023/A:1008835925998
   Garner B, 1999, J BIOMED MATER RES, V44, P121, DOI 10.1002/(SICI)1097-4636(199902)44:2<121::AID-JBM1>3.0.CO;2-A
   Gautier C, 2006, J ELECTROANAL CHEM, V587, P276, DOI 10.1016/j.jelechem.2005.11.021
   George PM, 2006, ADV MATER, V18, P577, DOI 10.1002/adma.200501242
   George PM, 2005, BIOMATERIALS, V26, P3511, DOI 10.1016/j.biomaterials.2004.09.037
   Gerard M, 1999, ELECTROANAL, V11, P450, DOI 10.1002/(SICI)1521-4109(199905)11:6<450::AID-ELAN450>3.0.CO;2-R
   Gerard M, 2002, BIOSENS BIOELECTRON, V17, P345, DOI 10.1016/S0956-5663(01)00312-8
   GIAEVER I, 1984, P NATL ACAD SCI-BIOL, V81, P3761, DOI 10.1073/pnas.81.12.3761
   Gizdavic-Nikolaidis M, 2004, SYNTHETIC MET, V140, P225, DOI 10.1016/S0379-6779(03)00372-2
   Gomez N, 2007, J BIOMED MATER RES A, V81A, P135, DOI 10.1002/jbm.a.31047
   Guerrieri A, 2006, BIOSENS BIOELECTRON, V21, P1710, DOI 10.1016/j.bios.2005.08.005
   Guiseppi-Elie A, 2005, IEEE SENS J, V5, P345, DOI 10.1109/JSEN.2005.846173
   Gurunathan K, 1999, MATER CHEM PHYS, V61, P173, DOI 10.1016/S0254-0584(99)00081-4
   Guterman E., 2003, POLYM PREPR, V43, P766
   HABERMULLER L, 2000, J ANAL CHEM+, V366, P560
   Hakansson E, 2004, SYNTHETIC MET, V144, P21, DOI 10.1016/j.synthmet.2004.01.003
   Hamdi N, 2006, J ELECTROANAL CHEM, V591, P33, DOI [10.1016/j.jelechem.2006.03.022, 10.1016/j.jelechem.2006.06.022]
   Heeger AJ, 2001, ANGEW CHEM INT EDIT, V40, P2591, DOI 10.1002/1521-3773(20010716)40:14<2591::AID-ANIE2591>3.0.CO;2-0
   HEEGER AJ, 1986, HDB CONDUCTING POLYM, V2, P729
   Hiller M, 1996, ADV MATER, V8, P219, DOI 10.1002/adma.19960080306
   Ho HA, 2005, J AM CHEM SOC, V127, P12673, DOI 10.1021/ja053417j
   Hodgson AJ, 1996, PROC SPIE, V2716, P164, DOI 10.1117/12.232137
   HONG SY, 1992, MACROMOLECULES, V25, P4652, DOI 10.1021/ma00044a029
   HUANG J, 2005, R SOC CHEM, P1717
   Ionescu RE, 2006, ELECTROANAL, V18, P1041, DOI 10.1002/elan.200603506
   Ionescu RE, 2005, ELECTROCHEM COMMUN, V7, P1277, DOI 10.1016/j.elecom.2005.09.009
   JAFFE LF, 1979, J EXP ZOOL, V209, P115, DOI 10.1002/jez.1402090114
   Jakubiec B, 1998, J BIOMED MATER RES, V41, P519, DOI 10.1002/(SICI)1097-4636(19980915)41:4<519::AID-JBM2>3.0.CO;2-F
   JEFFRIESEL M, 2002, PMSE PREPRINTS, V86, P166
   Jiang XH, 2005, ANAL CHIM ACTA, V537, P145, DOI 10.1016/j.aca.2005.01.049
   Jiang XP, 2002, TISSUE ENG, V8, P635, DOI 10.1089/107632702760240553
   KANETO K, 1983, SOLID STATE COMMUN, V46, P389, DOI 10.1016/0038-1098(83)90454-4
   Kang SK, 2004, POLYM J, V36, P937, DOI 10.1295/polymj.36.937
   KERNS JM, 1987, J NEUROSCI METH, V19, P217, DOI 10.1016/S0165-0270(87)80005-5
   Kim DH, 2004, J BIOMED MATER RES A, V71A, P577, DOI 10.1002/jbm.a.30124
   Konry T, 2005, ANAL CHEM, V77, P1771, DOI 10.1021/ac048569w
   Korri-Youssoufi H, 2002, ANAL CHIM ACTA, V469, P85, DOI 10.1016/S0003-2670(02)00539-1
   Kotwal A, 2001, BIOMATERIALS, V22, P1055, DOI 10.1016/S0142-9612(00)00344-6
   KULINSKY L, 2006, P SPIE INT SOC OPT E, P6173
   Kumar A, 2001, J APPL POLYM SCI, V82, P3486, DOI 10.1002/app.2210
   Kundu K, 1996, J CHEM PHYS, V105, P11075, DOI 10.1063/1.472908
   Lassalle N, 2001, TALANTA, V55, P993, DOI 10.1016/S0039-9140(01)00491-X
   LaVan DA, 2003, ANGEW CHEM INT EDIT, V42, P1262, DOI 10.1002/anie.200390323
   Le Floch F, 2006, ANAL CHEM, V78, P4727, DOI 10.1021/ac0521955
   Le Floch F, 2005, ADV MATER, V17, P1251, DOI 10.1002/adma.200401474
   Lee JW, 2006, LANGMUIR, V22, P9816, DOI 10.1021/la062129d
   Lee JW, 2006, BIOMACROMOLECULES, V7, P1692, DOI 10.1021/bm060220q
   Lee K, 2002, SYNTHETIC MET, V128, P279, DOI 10.1016/S0379-6779(02)00006-1
   Li CM, 2005, FRONT BIOSCI, V10, P180, DOI 10.2741/1519
   Li JP, 2006, J CHIN CHEM SOC-TAIP, V53, P575, DOI 10.1002/jccs.200600075
   Li MY, 2006, BIOMATERIALS, V27, P2705, DOI 10.1016/j.biomaterials.2005.11.037
   Li YL, 2005, J BIOMED MATER RES A, V73A, P171, DOI 10.1002/jbm.a.30286
   Li YL, 2005, LANGMUIR, V21, P10702, DOI 10.1021/la0514314
   Li ZF, 2003, J COLLOID INTERF SCI, V264, P370, DOI 10.1016/S0021-9797(03)00442-9
   Liu JW, 2005, SENSOR ACTUAT B-CHEM, V106, P591, DOI 10.1016/j.snb.2004.07.027
   LIVACHE T, 1994, NUCLEIC ACIDS RES, V22, P2915, DOI 10.1093/nar/22.15.2915
   Llaudet E, 2003, BIOSENS BIOELECTRON, V18, P43, DOI 10.1016/S0956-5663(02)00106-9
   Low LM, 2000, SENSOR ACTUAT B-CHEM, V67, P149, DOI 10.1016/S0925-4005(00)00396-8
   Ludwig KA, 2006, J NEURAL ENG, V3, P59, DOI 10.1088/1741-2560/3/1/007
   Malhotra BD, 2006, ANAL CHIM ACTA, V578, P59, DOI 10.1016/j.aca.2006.04.055
   Marks RS, 2002, MAT SCI ENG C-BIO S, V21, P189, DOI 10.1016/S0928-4931(02)00085-1
   Mazzoldi A, 2000, PROC SPIE, V3987, P273, DOI 10.1117/12.387786
   Minett AI, 2002, REACT FUNCT POLYM, V53, P217, DOI 10.1016/S1381-5148(02)00175-X
   Minett AI, 2003, ANAL CHIM ACTA, V475, P37, DOI 10.1016/S0003-2670(02)01033-4
   Mottaghitalab V, 2006, SYNTHETIC MET, V156, P796, DOI 10.1016/j.synthmet.2006.03.016
   Mouffouk F, 2005, J MATER CHEM, V15, P1186, DOI 10.1039/b413974g
   Mousty C, 2001, ELECTROANAL, V13, P186, DOI 10.1002/1521-4109(200103)13:3<186::AID-ELAN186>3.0.CO;2-W
   Ngamna O, 2005, SYNTHETIC MET, V153, P185, DOI 10.1016/j.synthmet.2005.07.259
   Otero TF, 1997, BIOELECTROCH BIOENER, V42, P117, DOI 10.1016/S0302-4598(96)05112-4
   Otero TF, 2003, SENSOR ACTUAT B-CHEM, V96, P152, DOI 10.1016/S0925-4005(03)00518-5
   Ouerghi O, 2002, BIOELECTROCHEMISTRY, V56, P131, DOI 10.1016/S1567-5394(02)00029-4
   PALMISANO F, 2000, J ANAL CHEM+, V366, P586
   PANDEY PC, 1988, ANALYST, V113, P329, DOI 10.1039/an9881300329
   PARTHASARATHY RV, 1994, NATURE, V369, P298, DOI 10.1038/369298a0
   Patel N, 1997, LANGMUIR, V13, P6485, DOI 10.1021/la970933h
   PAUW LJ, 1958, PHILIPS RES REP, V13, P1
   PYO M, 1994, J ELECTROANAL CHEM, V368, P329, DOI 10.1016/0022-0728(93)03071-V
   Pyo M, 1996, CHEM MATER, V8, P128, DOI 10.1021/cm950299y
   QU L, 2005, P SPIE INT SOC OPT E, P5732
   Ramanathan K, 2005, J AM CHEM SOC, V127, P496, DOI 10.1021/ja044486l
   Ramanathan K, 1995, MAT SCI ENG C-BIOMIM, V3, P159, DOI 10.1016/0928-4931(95)00113-1
   Ramanathan K, 2000, J APPL POLYM SCI, V78, P662, DOI 10.1002/1097-4628(20001017)78:3<662::AID-APP220>3.0.CO;2-T
   Ramanavicius A, 2005, SENSOR ACTUAT B-CHEM, V111, P532, DOI 10.1016/j.snb.2005.03.038
   Razola SS, 2002, BIOSENS BIOELECTRON, V17, P921, DOI 10.1016/S0956-5663(02)00083-0
   Retama JR, 2005, COLLOID SURFACE A, V270, P239, DOI 10.1016/j.colsurfa.2005.06.007
   Riccardi CD, 2006, ANAL CHEM, V78, P1139, DOI 10.1021/ac051478u
   Richardson RT, 2007, BIOMATERIALS, V28, P513, DOI 10.1016/j.biomaterials.2006.09.008
   Richardson-Burns SM, 2007, BIOMATERIALS, V28, P1539, DOI 10.1016/j.biomaterials.2006.11.026
   Rivers TJ, 2002, ADV FUNCT MATER, V12, P33, DOI 10.1002/1616-3028(20020101)12:1<33::AID-ADFM33>3.0.CO;2-E
   Rodriguez MI, 2005, IEEE SENS J, V5, P733, DOI 10.1109/JSEN.2005.845518
   Sanghvi AB, 2005, NAT MATER, V4, P496, DOI 10.1038/nmat1397
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Schuhmann W., 2002, REV MOL BIOTECHNOL, V82, P425, DOI DOI 10.1016/S1389-0352(01)00058-7
   Shastri VR, 1996, MATER RES SOC SYMP P, V414, P113
   Shi GX, 2004, BIOMATERIALS, V25, P2477, DOI 10.1016/j.biomaterials.2003.09.032
   Shimomura M, 2001, POLYM J, V33, P629, DOI 10.1295/polymj.33.629
   SHIRAKAWA H, 1977, J CHEM SOC CHEM COMM, P578, DOI 10.1039/c39770000578
   SIDWELL JS, 1985, BIOTECHNOL LETT, V7, P419, DOI 10.1007/BF01166215
   Singh S, 2006, SENSOR ACTUAT B-CHEM, V115, P534, DOI 10.1016/j.snb.2005.10.025
   Singh S, 2004, J APPL POLYM SCI, V91, P3769, DOI 10.1002/app.13554
   Smela E, 2003, ADV MATER, V15, P481, DOI 10.1002/adma.200390113
   Smela E, 1999, ADV MATER, V11, P953
   Spinks GM, 2005, SMART MATER STRUCT, V14, P406, DOI 10.1088/0964-1726/14/2/015
   Spinks GM, 2006, ADV MATER, V18, P637, DOI 10.1002/adma.200502366
   Spinks GM, 2005, SYNTHETIC MET, V151, P85, DOI 10.1016/j.synthmet.2005.03.006
   Street GB, 1986, HDB CONDUCTING POLYM, VI, P265
   Tahhan M, 2003, SMART MATER STRUCT, V12, P626, DOI 10.1088/0964-1726/12/4/313
   TAMIYA E, 1989, SENSOR ACTUATOR, V18, P297, DOI 10.1016/0250-6874(89)87037-4
   Tessier D, 2000, J BIOMAT SCI-POLYM E, V11, P87, DOI 10.1163/156856200743517
   Thomas CA, 2000, ADV MATER, V12, P222, DOI 10.1002/(SICI)1521-4095(200002)12:3<222::AID-ADMA222>3.0.CO;2-D
   Torres-Rodrigez L-M., 2002, J ELECTROANAL CHEM, V523, P70
   Tourillon G., 1986, HDB CONDUCTING POLYM, V1, P293
   TROJANOWICZ M, 1990, BIOSENS BIOELECTRON, V5, P149, DOI 10.1016/0956-5663(90)80005-X
   Tsai YC, 2006, BIOSENS BIOELECTRON, V22, P495, DOI 10.1016/j.bios.2006.06.009
   Turner JN, 1999, EXP NEUROL, V156, P33, DOI 10.1006/exnr.1998.6983
   UMANA M, 1986, ANAL CHEM, V58, P2979, DOI 10.1021/ac00127a018
   VALENTINI RF, 1989, BRAIN RES, V480, P300, DOI 10.1016/0006-8993(89)90196-0
   Vidal JC, 2003, ANAL BIOANAL CHEM, V377, P273, DOI 10.1007/s00216-003-2120-x
   Wadhwa R, 2006, J CONTROL RELEASE, V110, P531, DOI 10.1016/j.jconrel.2005.10.027
   WALLACE G, 2004, ENCY BIOMATERIALS EN, P374
   Wang CH, 1999, SYNTHETIC MET, V102, P1313, DOI 10.1016/S0379-6779(98)01006-6
   Wang J, 2005, ANAL CHIM ACTA, V539, P209, DOI 10.1016/j.aca.2005.02.059
   Wang JJ, 2005, J ELECTROANAL CHEM, V575, P139, DOI 10.1016/j.jelechem.2004.08.023
   Wang XD, 2004, J BIOMED MATER RES A, V68A, P411, DOI 10.1002/jbm.a.20065
   Wang ZX, 2003, J BIOMED MATER RES A, V66A, P738, DOI 10.1002/jbm.a.10037
   Wang ZX, 2004, J BIOMED MATER RES A, V70A, P28, DOI 10.1002/jbm.a.30047
   Waugaman M, 2003, EUR POLYM J, V39, P1405, DOI 10.1016/S0014-3057(03)00035-1
   WEIDLAND JD, 2000, IEEE T BIOMED ENG, V47, P911
   Weiss Z, 2004, J POLYM SCI POL CHEM, V42, P1658, DOI 10.1002/pola.11097
   Welzel HP, 1996, MACROMOL CHEM PHYSIC, V197, P3355, DOI 10.1002/macp.1996.021971023
   WILCHEK M, 1988, ANAL BIOCHEM, V171, P1, DOI 10.1016/0003-2697(88)90120-0
   WILLIAMS RL, 1994, J MATER SCI-MATER M, V5, P429, DOI 10.1007/BF00058978
   WONG JY, 1994, P NATL ACAD SCI USA, V91, P3201, DOI 10.1073/pnas.91.8.3201
   Xiao YH, 2004, SENSOR ACTUAT B-CHEM, V99, P437, DOI 10.1016/j.snb.2003.12.067
   Xu Y, 2006, ELECTROANAL, V18, P1471, DOI 10.1002/elan.200603544
   Yamada T, 2003, ATHEROSCLEROSIS SUPP, V4, P163, DOI 10.1016/S1567-5688(03)90703-3
   YAMAGISHI FG, 2001, P ELECTROCHEM SOC, P213
   Yang JY, 2005, ACTA BIOMATER, V1, P125, DOI 10.1016/j.actbio.2004.09.006
   Zelikin AN, 2002, ANGEW CHEM INT EDIT, V41, P141, DOI 10.1002/1521-3773(20020104)41:1<141::AID-ANIE141>3.0.CO;2-V
   Zhang XY, 2005, CHEM COMMUN, P5328, DOI 10.1039/b511290g
   Zhang XY, 2004, J AM CHEM SOC, V126, P12714, DOI 10.1021/ja046359v
   Zhang Z, 2001, J BIOMED MATER RES, V57, P63, DOI 10.1002/1097-4636(200110)57:1<63::AID-JBM1142>3.0.CO;2-L
   ZHU L, 2005, GONGNENG CAILIAO, V36, P619
   Zhu MZ, 2005, SENSOR ACTUAT B-CHEM, V110, P382, DOI 10.1016/j.snb.2005.02.036
NR 218
TC 820
Z9 828
U1 35
U2 725
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0079-6700
J9 PROG POLYM SCI
JI Prog. Polym. Sci.
PD AUG-SEP
PY 2007
VL 32
IS 8-9
BP 876
EP 921
DI 10.1016/j.progpolymsci.2007.05.012
PG 46
WC Polymer Science
SC Polymer Science
GA 212ZP
UT WOS:000249635900006
DA 2018-10-20
ER

PT J
AU Vepari, C
   Kaplan, DL
AF Vepari, Charu
   Kaplan, David L.
TI Silk as a biomaterial
SO PROGRESS IN POLYMER SCIENCE
LA English
DT Review
DE silk; fibroin; spidroin; scaffold; tissue engineering; biomaterial
ID BOMBYX-MORI SILK; SPIDER DRAGLINE SILK; MESENCHYMAL STEM-CELLS; MARROW
   STROMAL CELL; IN-VITRO DEGRADATION; ORAL DOSAGE FORM;
   MECHANICAL-PROPERTIES; FIBROBLAST CELLS; FIBROIN FILMS;
   PHYSICAL-PROPERTIES
AB Silks are fibrous proteins with remarkable mechanical properties produced in fiber form by silkworms and spiders. Silk fibers in the form of sutures have been used for centuries. Recently regenerated silk solutions have been used to form a variety of biomaterials, such as gels, sponges and films, for medical applications. Silks can be chemically modified through amino acid side chains to alter surface properties or to immobilize cellular growth factors. Molecular engineering of silk sequences has been used to modify silks with specific features, such as cell recognition or mineralization. The degradability of silk biomaterials can be related to the mode of processing and the corresponding content of beta-sheet crystallinity. Several primary cells and cell lines have been successfully grown on different silk biomaterials to demonstrate a range of biological outcomes. Silk biomaterials are biocompatible when studied in vitro and in vivo. Silk scaffolds have been successfully used in wound healing and in tissue engineering of bone, cartilage, tendon and ligament tissues. (C) 2007 Elsevier Ltd. All rights reserved.
C1 Tufts Univ, Dept Chem & Biol Engn, Medford, MA 02155 USA.
   Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Chem & Biol Engn, 4 Colby St,Rm 153, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
FU NIBIB NIH HHS [R01 EB003210-04, R01 EB003210, P41 EB002520, P41
   EB002520-04S1, R01 EB003210-05]; NIDCR NIH HHS [R01 DE017207, R01
   DE017207-02, R01 DE013405-04, R01 DE013405]
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Aoki H, 2003, BIO-MED MATER ENG, V13, P309
   Arai T, 2004, J APPL POLYM SCI, V91, P2383, DOI 10.1002/app.13393
   Arai T, 2001, J APPL POLYM SCI, V80, P297, DOI 10.1002/1097-4628(20010411)80:2<297::AID-APP1099>3.3.CO;2-Q
   Arcidiacono S, 1998, APPL MICROBIOL BIOT, V49, P31, DOI 10.1007/s002530051133
   AYUB ZH, 1993, BIOSCI BIOTECH BIOCH, V57, P1910, DOI 10.1271/bbb.57.1910
   Ayutsede J, 2005, POLYMER, V46, P1625, DOI 10.1016/j.poplymer.2004.11.029
   Basu S, 2005, BIOMACROMOLECULES, V6, P1465, DOI 10.1016/bm049258y
   Bini E, 2004, J MOL BIOL, V335, P27, DOI 10.1016/j.jmb.2003.10.043
   BOWES JH, 1955, BIOCHEM J, V61, P143, DOI 10.1042/bj0610143
   Cai KY, 2002, BIOMATERIALS, V23, P1153, DOI 10.1016/S0142-9612(01)00230-7
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   Chiarini A, 2003, BIOMATERIALS, V24, P789, DOI 10.1016/S0142-9612(02)00417-9
   CUNNIFF PM, 1994, POLYM ADVAN TECHNOL, V5, P401
   Dal Pra I, 2005, BIOMATERIALS, V26, P1987, DOI 10.1016/j.biomaterials.2004.06.036
   DEMURA M, 1991, J MEMBRANE SCI, V59, P39, DOI 10.1016/S0376-7388(00)81220-X
   Dinerman AA, 2002, BIOMATERIALS, V23, P4203, DOI 10.1016/S0142-9612(02)00164-3
   Dinerman AA, 2002, J CONTROL RELEASE, V82, P277, DOI 10.1016/S0168-3659(02)00134-7
   ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P33, DOI 10.1007/s002530050884
   Fini M, 2005, BIOMATERIALS, V26, P3527, DOI 10.1016/j.biomaterials.2004.09.040
   Fisher JP, 2003, BIOMACROMOLECULES, V4, P1335, DOI 10.1021/bm0300296
   Foo CWP, 2006, APPL PHYS A-MATER, V82, P223, DOI 10.1007/s00339-005-3426-7
   Foo CWP, 2002, ADV DRUG DELIVER REV, V54, P1131
   FREDDI G, 1995, J APPL POLYM SCI, V56, P1537, DOI 10.1002/app.1995.070561203
   Fuchs S, 2006, BIOMATERIALS, V27, P5399, DOI 10.1016/j.biomaterials.2006.06.015
   Furuzono T, 2004, J MATER SCI-MATER M, V15, P19, DOI 10.1023/B:JMSM.0000010093.39298.5a
   GAGE LP, 1980, J BIOL CHEM, V255, P9444
   Gil ES, 2005, MACROMOL BIOSCI, V5, P702, DOI 10.1002/mabi.200500076
   Gil ES, 2005, BIOMACROMOLECULES, V6, P3079, DOI 10.1021/bm050396c
   Gotoh Y, 1997, BIOMATERIALS, V18, P267, DOI 10.1016/S0142-9612(96)00137-8
   Gotoh Y, 1998, J BIOMED MATER RES, V39, P351, DOI 10.1002/(SICI)1097-4636(19980305)39:3<351::AID-JBM2>3.0.CO;2-I
   HANAWA T, 1995, CHEM PHARM BULL, V43, P872
   Hanawa T, 2000, DRUG DEV IND PHARM, V26, P1091, DOI 10.1081/DDC-100100273
   Heijkants RGJC, 2006, J MATER SCI, V41, P2423, DOI 10.1007/s10853-006-7065-y
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Hou QP, 2003, J BIOMED MATER RES B, V67B, P732, DOI 10.1002/jbm.b.10066
   Hu K, 2006, J BIOACT COMPAT POL, V21, P23, DOI 10.1177/0883911506060455
   Huemmerich D, 2006, APPL PHYS A-MATER, V82, P219, DOI 10.1007/s00339-005-3428-5
   Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200
   Inouye K, 1998, J BIOCHEM BIOPH METH, V37, P159, DOI 10.1016/S0165-022X(98)00024-4
   JACKSON C, 1995, MACROMOLECULES, V28, P5975, DOI 10.1021/ma00121a042
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Kang GD, 2000, MACROMOL RAPID COMM, V21, P788, DOI 10.1002/1521-3927(20000701)21:11<788::AID-MARC788>3.0.CO;2-X
   KAPLAN DL, 1998, PROTEIN BASED MAT, P103
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Karageorgiou V, 2006, J BIOMED MATER RES A, V78A, P324, DOI 10.1002/jbm.a.30728
   KARATZAS CN, 2003, BIOPOLYMERS, V8, P97
   Kardestuncer T, 2006, CLIN ORTHOP RELAT R, P234, DOI 10.1097/01.blo.0000205879.50834.fe
   KAUG Y, 2006, J BIOMED MATER RES A, V77, P331
   Kim E.S., 2001, FIBER POLYM, V2, P64, DOI DOI 10.1007/BF02875260
   Kim HJ, 2005, AUST J CHEM, V58, P716, DOI 10.1071/CH05170
   Kim KH, 2005, J BIOTECHNOL, V120, P327, DOI 10.1016/j.jbiotec.2005.06.033
   Kim SJ, 2005, BIOPHARM DRUG DISPOS, V26, P21, DOI 10.1002/bdd.427
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Kino R, 2006, J APPL POLYM SCI, V99, P2822, DOI 10.1002/app.22910
   Kurioka A, 1999, EUR J BIOCHEM, V259, P120, DOI 10.1046/j.1432-1327.1999.00030.x
   Lanza R, 2000, PRINCIPLES TISSUE EN
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Lee MR, 2001, STRUCTURE, V9, P905, DOI 10.1016/S0969-2126(01)00660-8
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Li CM, 2005, J MATER RES, V20, P3374, DOI 10.1557/JMR.2005.0425
   Lv QA, 2005, POLYMER, V46, P12662, DOI 10.1016/j.polymer.2005.10.137
   MAROLT D, 2006, BIOMATERIALS
   MCCLAIN PE, 1972, J BIOL CHEM, V247, P692
   Megeed Z, 2004, J CONTROL RELEASE, V94, P433, DOI 10.1016/j.jconrel.2003.10.027
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4
   Meinel L, 2004, BIOTECHNOL BIOENG, V88, P379, DOI 10.1002/bit.20252
   MEINEL L, 2006, SILK BASED BIOMATERI
   Meinel L, 2006, BIOMATERIALS, V27, P4993, DOI 10.1016/j.biomaterials.2006.05.021
   Menassa R, 2004, PLANT BIOTECHNOL J, V2, P431, DOI 10.1111/j.1467-7652.2004.00087.x
   Meretoja VV, 2006, J BIOMED MATER RES A, V77A, P261, DOI 10.1002/jbm.a.30630
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   MINOURA N, 1990, POLYMER, V31, P265, DOI 10.1016/0032-3861(90)90117-H
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   Moran JM, 2003, TISSUE ENG, V9, P63, DOI 10.1089/107632703762687546
   Moreau JE, 2005, TISSUE ENG, V11, P1887, DOI 10.1089/ten.2005.11.1887
   MORI K, 1995, J MOL BIOL, V251, P217, DOI 10.1006/jmbi.1995.0429
   Morita Y, 2006, J BIOMECH, V39, P103, DOI 10.1016/j.jbiomech.2004.10.031
   Morita Y, 2002, BIO-MED MATER ENG, V12, P291
   Motta A, 2004, J BIOMAT SCI-POLYM E, V15, P851, DOI 10.1163/1568562041271075
   Motta A, 2002, MACROMOL CHEM PHYSIC, V203, P1658, DOI 10.1002/1521-3935(200207)203:10/11<1658::AID-MACP1658>3.0.CO;2-3
   MOY RL, 1991, AM FAM PHYSICIAN, V44, P2123
   Nam YS, 2000, J BIOMED MATER RES, V53, P1, DOI 10.1002/(SICI)1097-4636(2000)53:1<1::AID-JBM1>3.0.CO;2-R
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Nettles DL, 2004, ANN BIOMED ENG, V32, P391, DOI 10.1023/B:ABME.0000017552.65260.94
   Oh JE, 1999, J CONTROL RELEASE, V57, P269, DOI 10.1016/S0168-3659(98)00123-0
   Perez-Rigueiro J, 2000, J APPL POLYM SCI, V75, P1270, DOI 10.1002/(SICI)1097-4628(20000307)75:10<1270::AID-APP8>3.3.CO;2-3
   Petrini P, 2001, J MATER SCI-MATER M, V12, P849, DOI 10.1023/A:1012847301850
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Pins GD, 1997, BIOPHYS J, V73, P2164, DOI 10.1016/S0006-3495(97)78247-X
   Rammensee S., 2006, APPL PHYS A, P82261
   Reneker DH, 1996, NANOTECHNOLOGY, V7, P216, DOI 10.1088/0957-4484/7/3/009
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Scheibel T, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-14
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Solheim E, 2000, J BIOMED MATER RES, V49, P257, DOI 10.1002/(SICI)1097-4636(200002)49:2<257::AID-JBM15>3.0.CO;2-5
   Sugihara A, 2000, P SOC EXP BIOL MED, V225, P58, DOI 10.1046/j.1525-1373.2000.22507.x
   Swanson BO, 2006, APPL PHYS A-MATER, V82, P213, DOI 10.1007/s00339-005-3427-6
   Takeuchi A, 2005, KEY ENG MAT, V284-286, P329, DOI 10.4028/www.scientific.net/KEM.284-286.329
   Tamada Y, 2005, BIOMACROMOLECULES, V6, P3100, DOI 10.1021/bm050431f
   Tanaka K, 1999, INSECT BIOCHEM MOLEC, V29, P269, DOI 10.1016/S0965-1748(98)00135-0
   Teixeira JOC, 1998, ARCH ORTHOP TRAUM SU, V117, P27, DOI 10.1007/BF00703435
   Terada S, 2005, J BIOSCI BIOENG, V100, P667, DOI 10.1263/jbb.100.667
   Tsubouchi K, 2005, BIOSCI BIOTECH BIOCH, V69, P403, DOI 10.1271/bbb.69.403
   Unger RE, 2004, BIOMATERIALS, V25, P5137, DOI 10.1016/j.biomaterials.2003.12.040
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   VEPARI C, IN PRESS REGULATION
   Vepari CP, 2006, BIOTECHNOL BIOENG, V93, P1130, DOI 10.1002/bit.20833
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Wang M, 2004, MACROMOLECULES, V37, P6856, DOI 10.1021/ma048988v
   Wang XY, 2006, MATER TODAY, V9, P44, DOI 10.1016/S1369-7021(06)71742-4
   Wang XY, 2005, LANGMUIR, V21, P11335, DOI 10.1021/la051862m
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   YAMAGUCHI K, 1989, J MOL BIOL, V210, P127, DOI 10.1016/0022-2836(89)90295-7
   Yeo JH, 2000, BIOL PHARM BULL, V23, P1220
   Yoo MK, 2004, INT J BIOL MACROMOL, V34, P263, DOI 10.1016/j.ijbiomac.2004.06.002
   Zhang YQ, 2002, BIOTECHNOL ADV, V20, P91, DOI 10.1016/S0734-9750(02)00003-4
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
   Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078
NR 128
TC 1097
Z9 1147
U1 62
U2 735
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0079-6700
J9 PROG POLYM SCI
JI Prog. Polym. Sci.
PD AUG-SEP
PY 2007
VL 32
IS 8-9
BP 991
EP 1007
DI 10.1016/j.progpolymsci.2007.05.013
PG 17
WC Polymer Science
SC Polymer Science
GA 212ZP
UT WOS:000249635900010
PM 19543442
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Mendez-Vilas, A
   Bruque, JM
   Gonzalez-Martin, ML
AF Mendez-Vilas, A.
   Bruque, J. M.
   Gonzalez-Martin, M. L.
TI Sensitivity of surface roughness parameters to changes in the density of
   scanning points in multi-scale AFM studies. Application to a biomaterial
   surface
SO ULTRAMICROSCOPY
LA English
DT Article
DE AFM; surface roughness; morphology; cell-material interaction; surface
   structure; micro-topography; nano-topography; multi-scale; rms
   roughness; titanium alloy; Ti(6)A(14)V; biomaterial; skewness
ID ATOMIC-FORCE MICROSCOPY; OSTEOBLAST ADHESION; PROTEIN ADSORPTION;
   TITANIUM; TOPOGRAPHY; CELLS; TI
AB In the field of biomaterials surfaces, the ability of the atomic force microscope (AFM) to access the surface structure at unprecedented spatial (vertical and lateral) resolution, is helping in a better understanding on how topography affects the overall interaction of biological cells with the material surface. Since cells in a wide range of sizes are in contact with the biomaterial surface, a quantification of the surface structure in such a wide range of dimensional scales is needed. With the advent of the AFM, this can be routinely done in the lab. In this work, we show that even when it is clear that such a scale-dependent study is needed, AFM maps of the biomaterial surface taken at different scanning lengths are not completely consistent when they are taken at the same scanning resolution, as it is usually done: AFM images of different scanning areas have different point-to-point physical distances. We show that this effect influences the quantification of the average (R-a) and rms (R-q) roughness parameters determined at different length scales. This is the first time this inconsistency is reported and should be taken into account when roughness is measured in this way. Since differences will be in general in the range of nanometres, this is especially interesting for those processes involving the interaction of the biomaterial surface with small biocolloids as bacteria, while this effect should not represent any problems for larger animal cells. (C) 2007 Elsevier B.V. All rights reserved.
C1 Univ Extremadura, Dept Fis, E-06071 Badajoz, Spain.
RP Mendez-Vilas, A (reprint author), Univ Extremadura, Dept Fis, Avda Elvas SN, E-06071 Badajoz, Spain.
EM amvilas@formatex.org
RI Morales Bruque, Jose/N-2521-2014; Gonzalez Martin, Maria
   Luisa/L-3476-2014
OI Morales Bruque, Jose/0000-0002-9336-4350; Gonzalez Martin, Maria
   Luisa/0000-0002-9207-444X
CR Bigerelle M, 2002, BIOMOL ENG, V19, P79, DOI 10.1016/S1389-0344(02)00048-5
   Brant JA, 2002, J MEMBRANE SCI, V203, P257, DOI 10.1016/S0376-7388(02)00014-5
   Cai KY, 2006, COLLOID SURFACE B, V49, P136, DOI 10.1016/j.colsurfb.2006.02.016
   Cai KY, 2005, BIOMATERIALS, V26, P5960, DOI 10.1016/j.biomaterials.2005.03.020
   Cedelle J, 2006, SURF COAT TECH, V201, P1373, DOI 10.1016/j.surfcoat.2006.02.003
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   Jandt KD, 2001, SURF SCI, V491, P303, DOI 10.1016/S0039-6028(01)01296-1
   Linez-Bataillon P, 2002, BIOMOL ENG, V19, P133, DOI 10.1016/S1389-0344(02)00024-2
   Mendez-Vilas A, 2006, COLLOID SURFACE B, V52, P157, DOI 10.1016/j.colsurfb.2006.05.002
   Mendez-Vilas A, 2004, APPL SURF SCI, V238, P51, DOI 10.1016/j.apsusc.2004.05.212
   PRESS WH, 1992, NUMERICAL RECIPES FO
   Santiago Adriana Soares, 2005, Braz. oral res., V19, P203, DOI 10.1590/S1806-83242005000300009
   Scarano A, 2004, J PERIODONTOL, V75, P292, DOI 10.1902/jop.2004.75.2.292
   Shellenberger K, 2002, ENVIRON SCI TECHNOL, V36, P184, DOI 10.1021/es015515k
   Tayebi N, 2004, TRIBOL INT, V37, P491, DOI 10.1016/j.triboint.2003.11.010
   *TIT INF GROUP, 2004, TIT ALL MED APPL
   UNDERBOCK A, 1994, J MATER SCI-MATER M, V5, P434
   Wang WZ, 2006, TRIBOL INT, V39, P522, DOI 10.1016/j.triboint.2005.03.018
   Webster TJ, 2004, BIOMATERIALS, V25, P4731, DOI 10.1016/j.biomaterials.2003.12.002
   Yao C, 2005, J BIOMED NANOTECHNOL, V1, P68, DOI 10.1166/jbn.2005.008
   Zinger O, 2004, BIOMATERIALS, V25, P2695, DOI 10.1016/j.biomaterials.2003.09.111
NR 21
TC 40
Z9 42
U1 0
U2 26
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-3991
J9 ULTRAMICROSCOPY
JI Ultramicroscopy
PD AUG
PY 2007
VL 107
IS 8
BP 617
EP 625
DI 10.1016/j.ultramic.2006.12.002
PG 9
WC Microscopy
SC Microscopy
GA 174JA
UT WOS:000246937000008
PM 17292550
DA 2018-10-20
ER

PT J
AU Wieland, JA
   Houchin-Ray, TL
   Shea, LD
AF Wieland, Julie A.
   Houchin-Ray, Tiffany L.
   Shea, Lonnie D.
TI Non-viral vector delivery from PEG-hyaluronic acid hydrogels
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE gene therapy; tissue engineering; controlled release; plasmid;
   biomaterial
ID TISSUE ENGINEERING SCAFFOLDS; PLASMID DNA; GENE DELIVERY; IN-VITRO;
   CONTROLLED-RELEASE; DESIGN; VIVO; SYSTEMS; PROTEIN; COMPLEXES
AB Hydrogels have been widely used in tissue engineering as a support for tissue formation or to deliver non-viral gene therapy vectors locally. Hydrogels that combine these functionalities can provide a fundamental tool to promote specific cellular processes leading to tissue formation. This report investigates controlled release of gene therapy vectors from hydrogels as a function of the physical properties for both the hydrogel and the vector. Hydrogels were formed by photocrosslinking acryl-modified hyaluronic acid (HA) with a 4-arm poly(ethylene glycol) (PEG) acryl. The polymer content, and relative composition of HA and PEG modulated the swelling ratio, water content, and degradation, which can influence transport of the vector through the hydrogel. All hydrogels had a water content of 94% or higher, though the water content and swelling ratio increased with a decrease in the PEG:HA ratio. Plasmids were stably incorporated into the hydrogel, with a majority of the release occurring during the initial 2 days. For incubation in buffer, the cumulative release increased with a decreasing PEG or increasing HA content, with approximately 20% to 80% released during the first week depending on the hydrogel composition. Hydrogels incubated in hyaluronidase, an enzyme that degrades HA, significantly increased plasmid release for hydrogels containing 4% PEG and 4% HA-Acryl. The encapsulation of plasmid cornplexed with polyethylenimine had less than 14% of the complexes released from the hydrogel both in the presence and absence of hyaluronidase. The limited release of the complexes likely results from the complex size and interactions between the vector and hydrogel. These studies demonstrate the dependence of non-viral vector release on the physical properties of the hydrogel and the vector, suggesting vector and hydrogel designs for maximizing localized delivery of non-viral vectors. (c) 2007 Elsevier B.V. All rights reserved.
C1 Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.
   Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA.
RP Shea, LD (reprint author), Northwestern Univ, Dept Chem & Biol Engn, 2145 Sheridan Rd E156, Evanston, IL 60208 USA.
EM l-shea@northwestern.edu
RI Shea, Lonnie/B-7615-2009
FU NIGMS NIH HHS [R01 GM066830, R01 GM066830-01A1]
CR Andreopoulos FM, 1998, BIOMATERIALS, V19, P1343, DOI 10.1016/S0142-9612(97)00219-6
   Bengali Z, 2005, BIOTECHNOL BIOENG, V90, P290, DOI 10.1002/bit.20393
   BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7
   Bryant SJ, 2000, J BIOMAT SCI-POLYM E, V11, P439, DOI 10.1163/156856200743805
   Chen J, 1999, WOUND REPAIR REGEN, V7, P79
   Chun KW, 2005, BIOMATERIALS, V26, P3319, DOI 10.1016/j.biomaterials.2004.07.055
   Cowman MK, 2005, BIOPHYS J, V88, P590, DOI 10.1529/biophysj.104.049361
   Cruise GM, 1998, BIOMATERIALS, V19, P1287, DOI 10.1016/S0142-9612(98)00025-8
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/S0169-409X(01)00240-X
   Hiltunen ELJ, 2002, CANCER RES, V62, P6410
   Honore I, 2005, J CONTROL RELEASE, V107, P537, DOI 10.1016/j.jconrel.2005.06.018
   Jabbari E, 2004, J MICROENCAPSUL, V21, P525, DOI 10.1080/02652040410001729296
   Kasper FK, 2005, J CONTROL RELEASE, V104, P521, DOI 10.1016/j.jconrel.2005.03.008
   KREIL G, 1995, PROTEIN SCI, V4, P1666, DOI 10.1002/pro.5560040902
   Kuo CK, 2001, BIOMATERIALS, V22, P511, DOI 10.1016/S0142-9612(00)00201-5
   LAPCIK L, 1991, BIOPOLYMERS, V31, P1429
   LAURENT TC, 1963, BIOCHIM BIOPHYS ACTA, V78, P351, DOI 10.1016/0006-3002(63)91645-7
   LAURENT TC, 1955, J BIOL CHEM, V212, P325
   Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605
   Leach JB, 2005, BIOMATERIALS, V26, P125, DOI 10.1016/j.biomaterials.2004.02.018
   Ledley FD, 1996, PHARMACEUT RES, V13, P1595, DOI 10.1023/A:1016420102549
   LUI Y, 2005, BIOMATERIALS, V26, P4737
   Megeed Z, 2004, J CONTROL RELEASE, V94, P433, DOI 10.1016/j.jconrel.2003.10.027
   Meilander-Lin NJ, 2005, TISSUE ENG, V11, P546, DOI 10.1089/ten.2005.11.546
   Mellott MB, 2001, BIOMATERIALS, V22, P929, DOI 10.1016/S0142-9612(00)00258-1
   Nishikawa M, 1998, J PHARMACOL EXP THER, V287, P408
   Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775
   Pannier AK, 2004, MOL THER, V10, P19, DOI 10.1016/j.ymthe.2004.03.020
   Park H, 1996, ACS SYM SER, V627, P2
   Park YD, 2003, BIOMATERIALS, V24, P893, DOI 10.1016/S0142-9612(02)00420-9
   Price RD, 2005, AM J CLIN DERMATOL, V6, P393, DOI 10.2165/00128071-200506060-00006
   Quick DJ, 2004, J CONTROL RELEASE, V96, P341, DOI 10.1016/j.jconrel.2004.01.021
   Quick DJ, 2003, PHARM RES, V20, P1730, DOI 10.1023/B:PHAM.0000003368.66471.6a
   Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682
   Sakiyama-Elbert SE, 2001, ANN REV MATER RES, V31, P183, DOI 10.1146/annurev.matsci.31.1.183
   Salvay DM, 2006, MOL BIOSYST, V2, P36, DOI 10.1039/b514174p
   Scherer F, 2002, J GENE MED, V4, P634, DOI 10.1002/jgm.298
   Segura T, 2005, BIOMATERIALS, V26, P1575, DOI 10.1016/j.biomaterials.2004.05.007
   Segura T, 2005, BIOMATERIALS, V26, P359, DOI 10.1016/j.biomaterials.2004.02.067
   Segura T, 2003, J CONTROL RELEASE, V93, P69, DOI 10.1016/j.jconrel.2003.08.003
   Sershen S, 2002, ADV DRUG DELIVER REV, V54, P1225, DOI 10.1016/S0169-409X(02)00090-X
   Van Krevelen DW, 1990, PROPERTIES POLYM COR
NR 43
TC 82
Z9 85
U1 1
U2 38
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
J9 J CONTROL RELEASE
JI J. Control. Release
PD JUL 31
PY 2007
VL 120
IS 3
BP 233
EP 241
DI 10.1016/j.jconrel.2007.04.015
PG 9
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 201YI
UT WOS:000248868100011
PM 17582640
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Yang, Q
   Zhang, YY
   Liu, ML
   Zhang, YQ
   Yao, SZ
AF Yang, Qin
   Zhang, Youyu
   Liu, Meiling
   Zhang, YuQin
   Yao, Shouzhuo
TI Study of fibrinogen adsorption on hydroxyapatite and TiO2 surfaces by
   electrochemical piezoelectric quartz crystal impedance and FTIR-ATR
   spectroscopy
SO ANALYTICA CHIMICA ACTA
LA English
DT Article
DE electrochemical quartz crystal impedance; fourier transform infrared
   spectroscopy-attenuated total internal reflectance spectroscopy;
   adsorption kinetics; TiO2; hydroxyapatite; fibrinogen
ID HUMAN SERUM-ALBUMIN; CALCIUM-PHOSPHATE; CONFORMATIONAL-CHANGES;
   AQUEOUS-SOLUTION; PROTEINS; CHROMATOGRAPHY; BINDING; SENSOR; HSA
AB The electrochemical piezoelectric quartz crystal impedance (EQCI), a combined technique of piezoelectric quartz crystal impedance (PQCI), electrochemical impedance (EI), and Fourier transform infrared spectroscopy-attenuated total internal reflectance spectroscopy (FTIR-ATR) were used to in situ study the adsorption process of fibrinogen onto the surface of biomaterials-TiO2 and hydroxyapatite (Ca-5(PO4)(3)OH, HAP). The equivalent circuit parameters, the resonance frequencies and the half peak width of the conductance spectrum of the two biomaterial-modified piezoelectric quartz crystal (PQC) resonances as well as the FTIR-ATR spectra of fibrinogen during fibrinogen adsorption on TiO2 and HAP particles modified electrode surface were obtained. The adsorption kinetics and mechanism of fibrinogen were investigated and discussed as well. The results suggested that two consecutive steps occurred during the adsorption of fibrinogen onto TiO2 and hydroxyapatite (HAP) surface. The fibrinogen molecules were firstly adsorbed onto the surface, and then the rearrangement of adsorbed fibrinogen or multi-layered adsorption occurred. The FTIR-ATR spectroscopy investigations showed that the secondary structure of fibrinogen molecules was altered during the adsorption and the adsorption kinetics of fibrinogen related with the variety of biomaterials. These experimental results suggest a way for enriching biological analytical science and developing new applications of analytical techniques, such as PQCI, EI, and FTIR-ATR. (c) 2007 Published by Elsevier B.V.
C1 Hunan Normal Univ, Minist Educ, Coll Chem & Chem Engn, Key Lab Chem Biol & Tradit Chinese Med Res, Changsha 410081, Peoples R China.
RP Zhang, YY (reprint author), Hunan Normal Univ, Minist Educ, Coll Chem & Chem Engn, Key Lab Chem Biol & Tradit Chinese Med Res, Changsha 410081, Peoples R China.
EM zhangyy@hunnu.edu.cn
RI Zhang, Youyu/D-9617-2013
OI Zhang, Youyu/0000-0002-7502-6817
CR Bandey HL, 1996, J ELECTROANAL CHEM, V410, P219, DOI 10.1016/0022-0728(96)04556-1
   BERNABEU P, 1988, ELECTROCHIM ACTA, V33, P1129, DOI 10.1016/0013-4686(88)80204-4
   BERNARDI G, 1972, BIOCHIM BIOPHYS ACTA, V278, P409, DOI 10.1016/0005-2795(72)90001-3
   BRASH JL, 1986, ACS S SERIES, V343
   Buttry D.A., 1991, ELECTROANALYTICAL CH, V17, P1
   Chen YL, 1999, J COLLOID INTERF SCI, V214, P38
   DOUSSEAU F, 1989, APPL SPECTROSC, V43, P538, DOI 10.1366/0003702894202814
   Endo T, 2005, SCI TECHNOL ADV MAT, V6, P491, DOI 10.1016/j.stam.2005.03.019
   GORBUNOFF MJ, 1984, ANAL BIOCHEM, V136, P440, DOI 10.1016/0003-2697(84)90241-0
   Harding IS, 2005, BIOMATERIALS, V26, P6818, DOI 10.1016/j.biomaterials.2005.04.060
   Horbett TA, 1995, ACS S SERIES, V602
   Hou YX, 2006, BIOSENS BIOELECTRON, V21, P1393, DOI 10.1016/j.bios.2005.06.002
   Jiang DP, 2004, VACCINE, V23, P693, DOI 10.1016/j.vaccine.2004.06.029
   Kobson K. D., 1997, LANGMUIR, V13, P2614
   Lin Y, 2005, ULTRAMICROSCOPY, V105, P129, DOI 10.1016/j.ultramic.2005.06.028
   Liu Y, 2005, SPECTROCHIM ACTA A, V61, P2245, DOI 10.1016/j.saa.2004.09.004
   Long YM, 2003, J COLLOID INTERF SCI, V263, P106, DOI 10.1016/S0021-9797(03)00141-3
   Mao XL, 2006, BIOSENS BIOELECTRON, V21, P1178, DOI 10.1016/j.bios.2005.04.021
   MARGUERIE G, 1977, BIOCHIM BIOPHYS ACTA, V494, P172, DOI 10.1016/0005-2795(77)90145-3
   Moulton SE, 2003, COLLOID SURFACE A, V220, P159, DOI 10.1016/S0927-7757(03)00078-5
   MURAMATSU H, 1988, ANAL CHEM, V60, P2142, DOI 10.1021/ac00170a032
   NORDE W, 1986, ADV COLLOID INTERFAC, V25, P267, DOI 10.1016/0001-8686(86)80012-4
   Oliva FY, 2003, J COLLOID INTERF SCI, V261, P299, DOI 10.1016/S0021-9797(03)00029-8
   Ombelli M, 2005, J CHROMATOGR B, V826, P198, DOI 10.1016/j.jchromb.2005.09.002
   Parhi P, 2004, MATER LETT, V58, P3610, DOI 10.1016/j.matlet.2004.06.056
   PEI RJ, 2001, BIOSENS BIOELECTRON, V16, P55
   Raynaud S, 2002, BIOMATERIALS, V23, P1065, DOI 10.1016/S0142-9612(01)00218-6
   Roddick-Lanzilotta AD, 1998, LANGMUIR, V14, P6479, DOI 10.1021/la980425n
   Sato T, 1996, BBA-BIOMEMBRANES, V1285, P14, DOI 10.1016/S0005-2736(96)00138-1
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   Servagent-Noinville S, 2000, J COLLOID INTERF SCI, V221, P273, DOI 10.1006/jcis.1999.6576
   Su XD, 2005, BIOSENS BIOELECTRON, V21, P719, DOI 10.1016/j.bios.2005.01.006
   Su XL, 2005, BIOSENS BIOELECTRON, V21, P840, DOI 10.1016/j.bios.2005.01.021
   THOMPSON M, 1991, ANALYST, V116, P881, DOI 10.1039/an9911600881
   Tunc S, 2005, COLLOID SURFACE B, V42, P219, DOI 10.1016/j.colsurfb.2005.03.004
   Xie QJ, 2000, J ELECTROANAL CHEM, V484, P41, DOI 10.1016/S0022-0728(00)00047-4
   Yan YB, 2004, BIOPHYS J, V86, P1682, DOI 10.1016/S0006-3495(04)74237-X
   Zeng HT, 1999, BIOMATERIALS, V20, P377, DOI 10.1016/S0142-9612(98)00184-7
   Zhang XF, 2004, ANAL BIOCHEM, V325, P255, DOI 10.1016/j.ab.2003.11.001
   ZHANG YY, 2005, SENSOR ACTUAT B-CHEM, V10, P933
NR 40
TC 23
Z9 23
U1 0
U2 32
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0003-2670
J9 ANAL CHIM ACTA
JI Anal. Chim. Acta
PD JUL 30
PY 2007
VL 597
IS 1
BP 58
EP 66
DI 10.1016/j.aca.2007.06.025
PG 9
WC Chemistry, Analytical
SC Chemistry
GA 199BY
UT WOS:000248672400009
PM 17658313
DA 2018-10-20
ER

PT J
AU Kim, SY
   Kim, HJ
   Lee, KE
   Han, SS
   Sohn, YS
   Jeong, B
AF Kim, So Young
   Kim, Hyun Jeong
   Lee, Kyung Eun
   Han, Sung Sik
   Sohn, Youn Soo
   Jeong, Byeongmoon
TI Reverse thermal gelling PEG-PTMC diblock copolymer aqueous solution
SO MACROMOLECULES
LA English
DT Article
ID RING-OPENING POLYMERIZATION; DRUG-DELIVERY SYSTEMS; TRIBLOCK COPOLYMERS;
   BLOCK-COPOLYMERS; POLY(ETHYLENE GLYCOL); GELATION; BEHAVIOR; GEL;
   CARBONATE); TRANSITION
AB In the search for a new thermogelling biomaterial, we are reporting poly(ethylene glycol)-poly(trimethylene carbonate) (PEG-PTMC) diblock copolymers. The PEG-PTMC (550-2750) diblock copolymer aqueous solutions (> 25 wt %) underwent sol-to-gel-to-syneresis (macroscopic phase separation between the polymer and water) transition as the temperature increased. The sol-to-gel transition temperature could be controlled in a range of 20-75 degrees C by varying polymer concentration in water, molecular weight, and composition of the polymer. C-13 NMR spectra, a transmission electron microscopic image, and dynamic light scattering suggest that the micellar aggregation through the dehydration of PEG is involved in the sol-to-gel transition. The in-situ gel formation was confirmed by subcutaneous injection of the polymer aqueous solution (30 wt %, 0.5 mL) into rats. Because of the diffusion of the polymer with a low molecular weight out of the gel, mass loss of 15 wt % was observed over 20 days in in-vivo study. On the other hand, the polymer is so stable in phosphate buffer saline that any changes in molecular weight, pH, and gel mass were not observed over the same period of time in in-vitro study.
C1 Ewha Womans Univ, Dept Chem, Div Nano Sci, Seoul 120750, South Korea.
   Korea Univ, Coll Life Sci & Biotechnol, Div Life Sci, Seoul 136701, South Korea.
RP Jeong, B (reprint author), Ewha Womans Univ, Dept Chem, Div Nano Sci, Seoul 120750, South Korea.
EM bjeong@ewha.ac.kr
CR Albertsson AC, 2003, BIOMACROMOLECULES, V4, P1466, DOI 10.1021/bm034247a
   Arotcarena M, 2002, J AM CHEM SOC, V124, P3787, DOI 10.1021/ja012167d
   Bae SJ, 2006, MACROMOLECULES, V39, P4873, DOI 10.1021/ma060153s
   Behravesh E, 2002, BIOMACROMOLECULES, V3, P153, DOI 10.1021/bm010137x
   Bhattarai N, 2005, J CONTROL RELEASE, V103, P609, DOI 10.1016/j.jconrel.2004.12.019
   Brand L, 1971, PROBES STRUCTURE FUN, P17
   Choi BU, 2004, KOREAN J CHEM ENG, V21, P821, DOI 10.1007/BF02705527
   Chung YM, 2002, BIOMACROMOLECULES, V3, P511, DOI 10.1021/bm0156431
   Coulembier O, 2006, MACROMOLECULES, V39, P4001, DOI 10.1021/ma060552n
   Dang JM, 2006, BIOMATERIALS, V27, P406, DOI 10.1016/j.biomaterials.2005.07.033
   Dobrynin AV, 2000, MACROMOLECULES, V33, P8097, DOI 10.1021/ma000761m
   Huang K, 2002, BIOMACROMOLECULES, V3, P397, DOI 10.1021/bm015650p
   Hwang MJ, 2005, BIOMACROMOLECULES, V6, P885, DOI 10.1021/bm049347a
   Jeong B, 2003, J PHYS CHEM B, V107, P10032, DOI 10.1021/jp027339n
   Jeong B, 1999, MACROMOLECULES, V32, P7064, DOI 10.1021/ma9908999
   Jeong B, 2002, ADV DRUG DELIVER REV, V54, P37, DOI 10.1016/S0169-409X(01)00242-3
   Jeong B, 1999, COLLOID SURFACE B, V16, P185, DOI 10.1016/S0927-7765(99)00069-7
   Jeong B, 2000, J BIOMED MATER RES, V50, P171, DOI 10.1002/(SICI)1097-4636(200005)50:2<171::AID-JBM11>3.0.CO;2-F
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   Jo S, 2006, MACROMOL BIOSCI, V6, P923, DOI 10.1002/mabi.200600127
   Jun YJ, 2006, ANGEW CHEM INT EDIT, V45, P6173, DOI 10.1002/anie.200601108
   KIM C, 2000, MACROMOLECULES, V33, P7748
   Kim MS, 2006, MACROMOLECULES, V39, P3099, DOI 10.1021/ma052713d
   Lee BH, 2002, MACROMOLECULES, V35, P3876, DOI 10.1021/ma012093q
   Lee HJ, 2006, MACROMOLECULES, V39, P4938, DOI 10.1021/ma060198t
   Li H, 2003, LANGMUIR, V19, P1075, DOI 10.1021/la026464n
   Li XW, 2005, BIOMATERIALS, V26, P7002, DOI 10.1016/j.biomaterials.2005.05.094
   Packhaeuser CB, 2004, EUR J PHARM BIOPHARM, V58, P445, DOI 10.1016/uj.ejpb.2004.03.003
   Sangeetha NM, 2004, J PHYS CHEM B, V108, P16056, DOI 10.1021/jp047272z
   Sodergard A, 2002, PROG POLYM SCI, V27, P1123, DOI 10.1016/S0079-6700(02)00012-6
   Tu RS, 2004, ADV DRUG DELIVER REV, V56, P1537, DOI 10.1016/j.addr.2003.10.047
   Ueda H, 2003, ADV DRUG DELIVER REV, V55, P501, DOI 10.1016/S0169-409X(03)00037-1
   Verduin H, 1996, LANGMUIR, V12, P2947, DOI 10.1021/la951504r
   Wang H, 1998, J POLYM SCI POL CHEM, V36, P695, DOI 10.1002/(SICI)1099-0518(19980415)36:5<695::AID-POLA3>3.0.CO;2-L
   Yu L, 2006, ANGEW CHEM INT EDIT, V45, P2232, DOI 10.1002/anie.200503575
   Zhang Y, 2005, BIOMATERIALS, V26, P2089, DOI 10.1016/j.biomaterials.2004.06.004
   Zhang Z, 2006, J CONTROL RELEASE, V112, P57, DOI 10.1016/j.jconrel.2006.01.010
   Zhang Z, 2006, BIOMATERIALS, V27, P1741, DOI 10.1016/j.biomaterials.2005.09.017
   ZHU KJ, 1990, J APPL POLYM SCI, V39, P1, DOI 10.1002/app.1990.070390101
   ZHU KJ, 1991, MACROMOLECULES, V24, P1736, DOI 10.1021/ma00008a008
   Zupancich JA, 2006, MACROMOLECULES, V39, P4286, DOI 10.1021/ma060642s
NR 41
TC 76
Z9 76
U1 0
U2 40
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD JUL 24
PY 2007
VL 40
IS 15
BP 5519
EP 5525
DI 10.1021/ma070190z
PG 7
WC Polymer Science
SC Polymer Science
GA 190QI
UT WOS:000248073600037
DA 2018-10-20
ER

PT J
AU Ginalska, G
   Kowalczuk, D
   Osinska, M
AF Ginalska, Grazyna
   Kowalczuk, Dorota
   Osinska, Monika
TI Amikacin-loaded vascular prosthesis as an effective drug carrier
SO INTERNATIONAL JOURNAL OF PHARMACEUTICS
LA English
DT Article
DE amikacin; prosthetic biomaterial; antibacterial capabilities; drug
   release
ID GRAFT INFECTION; DACRON GRAFT; GENTAMICIN; RECONSTRUCTION; ANTIBIOTICS;
   RIFAMPIN
AB Strong covalent immobilization of amikacin on Uni-Graft (R) DV straight vascular prostheses made of gelatine-sealed poly(ethylene terephthalate) fibres was performed according to procedure described in the Polish Patent No. P-358934. The concentrations of amikacin in sample solutions were estimated either by HPLC or by UV spectroscopy method previously optimized for amikacin measurements. A high correlation was found between these two methods. It was found that the antibiotic was bound in mixed-type way via three types of interactions: strong covalent bonds (dominating amount: 81.84%) and weak interactions:,physical adsorption and ionic bonds (18.19%). Even when total amount of physically and ionically attached drug has been released, the remaining covalently bound amount still locally protected the prostheses in vitro against bacteria. The release test was conducted in PBS at pH 7.4 at 37 degrees C and showed that about 15% of total drug amount was eluted from the matrix during the first 7 days of shaking, then no more antibiotic was released. It suggested that about 85% of amikacin attached to prosthesis modified in mixed-type mode was bound via covalent interactions. A bacterial inhibition test on Escherichia coli ATCC 25922, Staphylococcus aureus ATCC 25923 and Pseudomonas aeruginosa ATCC 27853 showed inhibition of growth for all strains at low inoculum concentrations up to 30 days as well as high inoculum concentration for E. coli. At high concentrations of S. aureus and P. aeruginosa, the modified prostheses showed slight bacteriostatic effect since 10th day of experiment. Amikacin-modified vascular prostheses might therefore be protected against bacterial infection locally, without long-lasting drug release to human system. (C) 2007 Elsevier B.V. All rights reserved.
C1 Med Univ Lublin, Dept Biochem, PL-20093 Lublin, Poland.
   Med Univ Lublin, Dept Med Chem, PL-20090 Lublin, Poland.
   Marie Curie Sklodowska Univ, Dept Biochem, PL-20031 Lublin, Poland.
RP Ginalska, G (reprint author), Med Univ Lublin, Dept Biochem, Chodzki St 1, PL-20093 Lublin, Poland.
EM g.ginalska@am.lublin.pl
OI Ginalska, Grazyna/0000-0002-9961-4226; Osinska-Jaroszuk,
   Monika/0000-0002-3465-0461; Kowalczuk, Dorota/0000-0001-7458-5054
CR ANHALT JP, 1991, MANUAL CLIN MICROBIO, P1192
   AVRAMOVIC JR, 1991, AUST NZ J SURG, V61, P436, DOI 10.1111/j.1445-2197.1991.tb00258.x
   Belt H. V. D., 2001, BIOMATERIALS, V22, P1607
   Chiesa R, 1998, ANN VASC SURG, V12, P457, DOI 10.1007/s100169900184
   *DEPT QUAL MED, 1997, EUR PHARM, P104
   EARNSHAW JJ, 2000, EUR J VASC ENDOVASC, V20, P413
   Frutos P, 2000, J PHARMACEUT BIOMED, V21, P1149, DOI 10.1016/S0731-7085(99)00192-2
   GAHTAN V, 1995, J SURG RES, V58, P105, DOI 10.1006/jsre.1995.1017
   Galdbart JO, 1996, J SURG RES, V66, P174, DOI 10.1006/jsre.1996.0391
   Ginalska G, 2005, EUR J VASC ENDOVASC, V29, P419, DOI 10.1016/j.ejvs.2004.12.030
   Ginalska G, 2005, INT J PHARM, V288, P131, DOI 10.1016/j.ijpharm.2004.09.021
   GINALSKA G, 2004, Patent No. P358934
   GRINGAUZ A, 1997, INTRO MED CHEM
   HAVERICH A, 1992, J VASC SURG, V15, P187, DOI 10.1016/0741-5214(92)70027-I
   *HER MAJ STAT OFF, 1999, BRIT PHARM
   Hermanson GT, 1992, IMMOBILIZED AFFINITY
   Hernandez-Richter T, 2003, EUR J VASC ENDOVASC, V26, P550, DOI 10.1016/S1078-5884(03)00344-7
   Huh J, 1998, J SURG RES, V74, P54, DOI 10.1006/jsre.1997.5188
   Kikta M J, 1987, J Vasc Surg, V5, P566
   LOVERING AM, 1996, EUR J VASC ENDOVASC, V17, P347
   Lowdin E, 1998, ANTIMICROB AGENTS CH, V42, P2739, DOI 10.1128/AAC.42.10.2739
   MILLESIME L, 1995, J MEMBRANE SCI, V108, P143, DOI 10.1016/0376-7388(95)00158-X
   MOORE WS, 1991, VASCULAR SURG COMPRE, P598
   NEVELESTEN A, 1995, J VASC SURG, V2, P129
   Nevelsteen A, 1997, EUR J VASC ENDOVASC, V14, P88, DOI 10.1016/S1078-5884(97)80162-1
   NOVALI C, 2001, ANN ITAL CHIR, V2, P141
   Omri A, 1996, INT J ANTIMICROB AG, V7, P9, DOI 10.1016/0924-8579(96)00003-9
   Pipinos II, 2000, ANN VASC SURG, V14, P688, DOI 10.1007/s100169910124
   RISTUCCIA AM, 1985, THER DRUG MONIT, V7, P12, DOI 10.1097/00007691-198503000-00003
   Sanchez-Martinez ML, 2004, J PHARMACEUT BIOMED, V34, P1021, DOI 10.1016/j.jpba.2003.11.015
   Stigter M, 2004, J CONTROL RELEASE, V99, P127, DOI 10.1016/j.jconrel.2004.06.011
   Strachan C J, 1991, Eur J Vasc Surg, V5, P627, DOI 10.1016/S0950-821X(05)80896-5
   SZILAGYI DE, 1972, ANN SURG, V176, P321, DOI 10.1097/00000658-197209000-00008
   Vicaretti M, 1998, CARDIOVASC SURG, V6, P268, DOI 10.1016/S0967-2109(98)00003-9
NR 34
TC 10
Z9 10
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-5173
J9 INT J PHARM
JI Int. J. Pharm.
PD JUL 18
PY 2007
VL 339
IS 1-2
BP 39
EP 46
DI 10.1016/j.ijpharm.2007.02.016
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 195DC
UT WOS:000248391700006
PM 17376617
DA 2018-10-20
ER

PT J
AU Dong, Q
   Su, HL
   Zhang, D
   Cao, W
   Wang, N
AF Dong, Qun
   Su, Huilan
   Zhang, Di
   Cao, Wei
   Wang, Na
TI Biogenic synthesis of tubular SnO2 with hierarchical intertextures by an
   aqueous technique involving glycoprotein
SO LANGMUIR
LA English
DT Article
ID EGGSHELL MEMBRANES; STRUCTURAL-CHARACTERIZATION; NANOCRYSTALLINE SNO2;
   METAL-OXIDES; SILICA; REPLICATION; TEMPERATURE; FABRICATION; TEMPLATES;
   NANOWIRES
AB Tetragonal SnO2 with hierarchical interwoven structures was prepared by a convenient soaking technique followed by a calcination treatment over 823 K. On the basis of the biomaterial eggshell membrane (ESM) being immersed in aqueous Sn colloid medium and a calcination treatment in succession, SnO2 nanocrystallites with a size of about 5 nm were formed, assembled into tubular fibers, and further intertwisted to construct hollow interconnective fibrous meshworks. With the biomaterial ESM serving as the physical substrate, chemical revulsant, and capping agent, the formation and assembly of hierarchical SnO2 nanomaterials should be under the control of glycoprotein contained in the ESM fiber mantle and directed by the interactions between the glycoprotein macromolecules (containing carboxyl, hydroxyl, and amino groups, etc.) and Sn colloid ingredients of the Sn impregnant. The unique hierarchical SnO2 nanomaterials of structural particularity and complexity are expected to find potential applications in gas sensors, photocatalysts, and dye-sensitized solar cells, etc.
C1 Shanghai Jiao Tong Univ, State Key Lab Metal Matrix Composites, Shanghai 200030, Peoples R China.
RP Su, HL (reprint author), Shanghai Jiao Tong Univ, State Key Lab Metal Matrix Composites, Shanghai 200030, Peoples R China.
EM hlsu@sjtu.edu.cn
CR Abello L, 1998, J SOLID STATE CHEM, V135, P78, DOI 10.1006/jssc.1997.7596
   BERMAN A, 1993, SCIENCE, V259, P776, DOI 10.1126/science.259.5096.776
   Cha JN, 2000, NATURE, V403, P289, DOI 10.1038/35002038
   Clavier GM, 2000, J MATER CHEM, V10, P1725, DOI 10.1039/b000525h
   Cook G, 2003, ANGEW CHEM INT EDIT, V42, P557, DOI 10.1002/anie.200390160
   Dieguez A, 1999, SENSOR ACTUAT B-CHEM, V60, P125, DOI 10.1016/S0925-4005(99)00258-0
   Dong Q, 2005, J PHYS CHEM B, V109, P17429, DOI 10.1021/jp052826z
   Fernandez MS, 1997, MATRIX BIOL, V16, P13, DOI 10.1016/S0945-053X(97)90112-8
   Fujihara S, 2004, LANGMUIR, V20, P6476, DOI 10.1021/la0493060
   Hall SR, 2003, CHEM COMMUN, P2784, DOI 10.1039/b309877j
   Hazarika P, 2004, ANGEW CHEM INT EDIT, V43, P6469, DOI 10.1002/anie.200461887
   Hincke MT, 2000, MATRIX BIOL, V19, P443, DOI 10.1016/S0945-053X(00)00095-0
   Huang JG, 2003, J AM CHEM SOC, V125, P11834, DOI 10.1021/ja037419k
   Jimenez VM, 1999, SOLID STATE IONICS, V116, P117, DOI 10.1016/S0167-2738(98)00271-9
   Le JD, 2004, NANO LETT, V4, P2343, DOI 10.1021/nl048635+
   Lee SW, 2004, NANO LETT, V4, P387, DOI 10.1021/nl034911t
   Lee SW, 2002, SCIENCE, V296, P892, DOI 10.1126/science.1068054
   Liang CH, 2003, J PHYS CHEM B, V107, P9220, DOI 10.1021/jp0347466
   MANN S, 2000, ANGEW CHEM INT EDIT, V39, P3392, DOI DOI 10.1002/1521-3773(20001002)39:19<3392::AID-ANIE3392>3.0.CO;2-M
   MATOSSI F, 1951, J CHEM PHYS, V19, P1543, DOI 10.1063/1.1748119
   Mucic RC, 1998, J AM CHEM SOC, V120, P12674, DOI 10.1021/ja982721s
   Pan DC, 2005, ADV MATER, V17, P1991, DOI 10.1002/adma.200500174
   PEERCY PS, 1973, PHYS REV B, V7, P2779, DOI 10.1103/PhysRevB.7.2779
   Rambo CR, 2005, ADV MATER, V17, P1088, DOI 10.1002/adma.200401049
   Salas P, 1997, J MOL CATAL A-CHEM, V123, P149, DOI 10.1016/S1381-1169(97)00054-X
   Sellinger A, 1998, NATURE, V394, P256, DOI 10.1038/28354
   Seshadri R, 2000, ADV MATER, V12, P1149, DOI 10.1002/1521-4095(200008)12:15<1149::AID-ADMA1149>3.3.CO;2-Y
   Wang JX, 2004, SOLID STATE COMMUN, V130, P89, DOI 10.1016/j.ssc.2004.01.003
   Wang WZ, 2002, J APPL PHYS, V92, P2740, DOI 10.1063/1.1497718
   WONG M, 1984, DEV BIOL, V104, P28, DOI 10.1016/0012-1606(84)90033-2
   Wu NL, 1999, SCIENCE, V285, P1375, DOI 10.1126/science.285.5432.1375
   Yang D, 2002, ADV MATER, V14, P1543, DOI 10.1002/1521-4095(20021104)14:21<1543::AID-ADMA1543>3.0.CO;2-B
   Yang D, 2003, J MATER CHEM, V13, P1119, DOI 10.1039/b301077e
   Zhang DF, 2005, J AM CHEM SOC, V127, P13492, DOI 10.1021/ja054771k
   Zhang W, 2006, NANOTECHNOLOGY, V17, P840, DOI 10.1088/0957-4484/17/3/038
NR 35
TC 21
Z9 23
U1 2
U2 23
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD JUL 17
PY 2007
VL 23
IS 15
BP 8108
EP 8113
DI 10.1021/1a062653k
PG 6
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 188BN
UT WOS:000247893600036
PM 17580915
DA 2018-10-20
ER

PT J
AU Palocci, C
   Barbetta, A
   La Grotta, A
   Dentini, M
AF Palocci, Cleofe
   Barbetta, Andrea
   La Grotta, Angelo
   Dentini, Mariella
TI Porous biomaterials obtained using supercritical CO2-water emulsions
SO LANGMUIR
LA English
DT Article
ID CARBON-DIOXIDE; SURFACTANTS; POLYMERIZATION; COMPOSITES; MORPHOLOGY;
   STABILITY; SCAFFOLDS; HYDROGELS; DEXTRAN; FLUIDS
AB Highly porous, hydrophilic porous matrices were fabricated by using a high internal phase supercritical-CO2 (scCO(2)) emulsion templating technique. The novel aspect of the work resides in the combination of a natural biopolymer (dextran) as the building component of the matrices and of an environmentally benign solvent (supercritical-CO2) as the pore-generating phase. The synthetic route to the porous biomaterials involved the preliminary functionalization of the dextran chains with methacrylic moieties, formation of a scCO(2)-in-water concentrated emulsion, and curing of the external phase of the emulsion by radical polymerization. As the emulsion stabilizer a perfluoropolyether surfactant was chosen. The matrices obtained exhibit highly interconnected, trabecular morphologies. The porous biomaterial morphologies were qualitatively characterized by scanning electron microscopy (SEM) and the evaluation of void and interconnect sizes was carried out on the micrographs taken with the light microscope. To tailor the morphologies of the porous structures, the influence of the volume fraction of the internal phase and of the surfactant/internal phase ratio was investigated. It was established that the variation of the volume fraction of the internal phase exerted only a limited influence on void and interconnect sizes. On the contrary the increase of surfactant concentration alters dramatically the distribution of void size, a large proportion of the void space enclosed within the matrix being attributable to voids with a diameter exceeding 100 mu m. The free toxic solvent process of fabrication of the porous structures, the high water content, the expected biocompatibility, and the mechanical properties that resemble natural tissues make these porous hydrogels potentially useful for tissue engineering applications.
C1 Univ Roma La Sapienza, Dept Chem, I-00185 Rome, Italy.
RP Barbetta, A (reprint author), Univ Roma La Sapienza, Dept Chem, Piazzale Aldo Moro 5, I-00185 Rome, Italy.
EM andrea.barbetta@uniroma1.it
RI Dentini, Mariella/N-2653-2013
OI Dentini, Mariella/0000-0003-0783-0982; Barbetta,
   Andrea/0000-0001-9292-4734
CR ARONSON MP, 1993, J COLLOID INTERF SCI, V159, P134, DOI 10.1006/jcis.1993.1305
   Barbetta A, 2005, ADV FUNCT MATER, V15, P118, DOI 10.1002/adfm.200400072
   Barbetta A, 2006, BIOMACROMOLECULES, V7, P3059, DOI 10.1021/bm060533l
   Cameron NR, 1996, COLLOID POLYM SCI, V274, P592, DOI 10.1007/BF00655236
   Cooper AI, 2003, ADV MATER, V15, P1049, DOI 10.1002/adma.200300380
   Derjaguin B, 1936, ACTA PHYSICOCHIM URS, V5, P1
   Gibson L. J, 1997, CELLULAR SOLIDS STRU
   Hauthal WH, 2001, CHEMOSPHERE, V43, P123, DOI 10.1016/S0045-6535(00)00332-5
   Hoffmann H, 1997, J MOL LIQ, V72, P191, DOI 10.1016/S0167-7322(97)00039-1
   Howdle SM, 2001, CHEM COMMUN, P109, DOI 10.1039/b008188o
   Jenkins P, 1996, ADV COLLOID INTERFAC, V68, P57, DOI 10.1016/S0001-8686(96)90046-9
   Kissa E., 1994, FLUORINATED SURFACTA, V50
   Lee CT, 1999, LANGMUIR, V15, P6781, DOI 10.1021/la9903548
   Lee JY, 2007, MACROMOLECULES, V40, P1955, DOI 10.1021/ma0625197
   Ostwald W, 1910, Z CHEM IND KOLLOIDE, V6, P103
   OSTWALD W, 1910, Z CHEM IND KOLLOIDE, V7, P63
   Partap S, 2006, ADV MATER, V18, P501, DOI 10.1002/adma.200501423
   Rossi S, 2001, LANGMUIR, V17, P2340, DOI 10.1021/la001444b
   Rotureau E, 2007, COLLOID SURFACE A, V301, P229, DOI 10.1016/j.colsurfa.2006.12.062
   Tai H, 2001, POLYM ENG SCI, V41, P1540, DOI 10.1002/pen.10853
   Tan B, 2005, J AM CHEM SOC, V127, P8938, DOI 10.1021/ja052508d
   Tan B, 2007, MACROMOLECULES, V40, P1945, DOI 10.1021/ma062518e
   Taylor GI, 1932, P R SOC LOND A-CONTA, V138, P41, DOI 10.1098/rspa.1932.0169
   VANDIJKWOLTHUIS WNE, 1995, MACROMOLECULES, V28, P6317, DOI 10.1021/ma00122a044
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
NR 25
TC 48
Z9 49
U1 1
U2 35
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD JUL 17
PY 2007
VL 23
IS 15
BP 8243
EP 8251
DI 10.1021/la700947g
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 188BN
UT WOS:000247893600056
PM 17590033
DA 2018-10-20
ER

PT J
AU Ehrlich, H
   Krautter, M
   Hanke, T
   Simon, P
   Knieb, C
   Heinemann, S
   Worch, H
AF Ehrlich, Hermann
   Krautter, Manfred
   Hanke, Thomas
   Simon, Paul
   Knieb, Christiane
   Heinemann, Sascha
   Worch, Hartmut
TI First evidence of the presence of chitin in skeletons of marine sponges.
   Part II. glass sponges (Hexactinellida : porifera)
SO JOURNAL OF EXPERIMENTAL ZOOLOGY PART B-MOLECULAR AND DEVELOPMENTAL
   EVOLUTION
LA English
DT Article
ID SILICEOUS SPICULES; ALPHA-CHITIN; SILICON; TISSUES; ORIGIN;
   MICROORGANISMS; CHITOSAN; POSITION; METAZOA; BIOLOGY
AB Sponges (Porifera) are presently gaining increased scientific attention because of their secondary metabolites and specific skeleton structures. In contrast to demosponges, whose skeletons are formed from biopolymer spongin, glass sponges (hexactinellids) possess silica-organic composites as the main natural material for their skeletal fibres. Chitin has a crystalline structure and it constitutes a network of organized fibres. This structure confers rigidity and resistance to organisms that contain it, including monocellular (yeast, amoeba, diatoms) and multicellular (higher fungi, arthropods, nematodes, molluscs) organisms. In contrast to different marine invertebrates whose exoskeletons are built of chitin, this polysaccharide has not been found previously as an endogenous biopolymer within glass sponges (Hexactinellida). We hypothesized that glass sponges, which are considered to be the most basal lineage of multicellular animals, must possess chitin. Here, we present a detailed study of the structural and physico-chemical properties of skeletal fragments of the glass sponge Farrea occa. We show that these fibres have a layered design with specific compositional variations in the chitin/silica composite. We applied an effective approach for the demineralization of glass sponge skeletal formations based on an etching procedure using alkali solutions. The results show unambiguously that a-chitin is an essential component of the skeletal structures of Hexactinellida. This is the first report of a silica-chitin's composite biomaterial found in nature. From this perspective, the view that silica-chitin scaffolds may be key templates for skeleton formation also in ancestral unicellular organisms, rather than silica-protein composites, emerges as a viable alternative hypothesis.
C1 Tech Univ Dresden, Max Bergmann Ctr Biomat, D-061069 Dresden, Germany.
   Univ Stuttgart, Inst Geol & Palaeontol, D-70174 Stuttgart, Germany.
   Max Planck Inst Chem Phys Solids, D-01069 Dresden, Germany.
RP Ehrlich, H (reprint author), Tech Univ Dresden, Max Bergmann Ctr Biomat, Budapester Str 27, D-061069 Dresden, Germany.
EM hermann.ehrlich@mailbox.tu-dresden.de
RI Ehrlich, Hermann/J-6698-2012; Ehrlich, Hermann/I-5481-2015
OI Ehrlich, Hermann/0000-0003-3654-0810; Ehrlich,
   Hermann/0000-0003-3654-0810
CR Aizenberg J, 2005, SCIENCE, V309, P275, DOI 10.1126/science.1112255
   ANDERSON OR, 1994, PROTOPLASMA, V181, P61, DOI 10.1007/BF01666389
   BERGQUIST PR, 1985, PORIFEREAN RELATIONS, P14
   Borchiellini C, 2001, J EVOLUTION BIOL, V14, P171, DOI 10.1046/j.1420-9101.2001.00244.x
   Botting JP, 2005, P NATL ACAD SCI USA, V102, P1554, DOI 10.1073/pnas.0405867102
   Brasier M, 1997, GEOLOGY, V25, P303, DOI 10.1130/0091-7613(1997)025<0303:ESSCFS>2.3.CO;2
   CARLSTROM D, 1957, J BIOPHYS BIOCHEM CY, V3, P669, DOI 10.1083/jcb.3.5.669
   Croce G, 2004, BIOPHYS J, V86, P526, DOI 10.1016/S0006-3495(04)74131-4
   De La Rocha CL, 2003, GEOLOGY, V31, P423, DOI 10.1130/0091-7613(2003)031<0423:SIFBMS>2.0.CO;2
   DRUM RW, 1968, J ULTRA MOL STRUCT R, V22, P12, DOI 10.1016/S0022-5320(68)90046-4
   Ehrlich H., 2006, RUSS J MAR BIOL, V32, P217
   EHRLICH H, 2007, HDB BIOMINERALIZATIO
   Ehrlich H., 2005, BIOMATERIALIEN, V6, P297
   EHRLICH H, 2005, Patent No. 102005041414
   EHRLICH H, 2005, 1920 VDI, P163
   Ehrlich H, 2007, J EXP ZOOL PART B, V308B, P347, DOI 10.1002/jez.b.21156
   Einbu A, 2004, BIOMACROMOLECULES, V5, P2048, DOI 10.1021/bm049710d
   GARRONE R, 1978, PHYLOGENESIS CONNECT
   Gohel V, 2006, AFR J BIOTECHNOL, V5, P54
   HERTH W, 1980, J CELL BIOL, V87, P442, DOI 10.1083/jcb.87.2.442
   Herth W, 1977, J CELLULAR BIOL, V72, P311
   Iler R. K., 1979, CHEM SILICA
   KASTNER M, 1981, SEA
   Kidder DL, 2001, J GEOL, V109, P509, DOI 10.1086/320794
   Kim SS, 1996, J POLYM SCI POL PHYS, V34, P2367
   KOLB VM, 2004, INSTRUMENTS METHODS, V8, P116
   Krautter M, 2006, J PALEONTOL, V80, P38, DOI 10.1666/0022-3360(2006)080[0038:RHSRSM]2.0.CO;2
   Kruse M, 1998, J MOL EVOL, V46, P721, DOI 10.1007/PL00006353
   Kunike G., 1925, Zeitschrift fuer Vergleichende Physiologie Berlin, V2, P233, DOI 10.1007/BF00340513
   Leys SP, 2003, INTEGR COMP BIOL, V43, P19, DOI 10.1093/icb/43.1.19
   LEYS SP, 1995, BIOL BULL-US, V188, P241, DOI 10.2307/1542302
   Maldonado M, 2004, INVERTEBR BIOL, V123, P1
   Maliva RG, 2005, GEOL SOC AM BULL, V117, P835, DOI 10.1130/B25555.1
   MANN S, 1986, CIBA FDN S 121 SUSS
   Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709
   MINKE R, 1978, J MOL BIOL, V120, P167, DOI 10.1016/0022-2836(78)90063-3
   MULISCH M, 1989, PROTOPLASMA, V152, P77, DOI 10.1007/BF01323065
   Ogasawara W, 2000, CHEM MATER, V12, P2835, DOI 10.1021/cm0004376
   OKADA YAICHIRO, 1928, JOUR FAC SCI IMP UNIV TOKYO ZOOL, V2, P1
   Parker AR, 2001, NATURE, V409, P36, DOI 10.1038/35051168
   PREISIG HR, 1994, PROTOPLASMA, V181, P29, DOI 10.1007/BF01666387
   PRINGLE JR, 1991, METHOD ENZYMOL, V194, P732
   Ramirez MG, 2004, J MICROBIOL METH, V56, P213, DOI 10.1016/j.mimet.2003.10.011
   REISWIG HM, 1991, ZOOMORPHOLOGY, V110, P301, DOI 10.1007/BF01668020
   REISWIG HM, 2004, B MUS I BIOL U GEN, V68, P71
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   RUDALL KM, 1955, DISTRIBUTION COLLAGE
   SCHULZE FE, 1887, HEXACTINELLIDA, V21
   Shchipunov YA, 2005, J COLLOID INTERF SCI, V287, P373, DOI 10.1016/j.jcis.2005.02.004
   Shirosaki Y, 2005, BIOMATERIALS, V26, P485, DOI 10.1016/j.biomaterials.2004.02.056
   Sommer M, 2006, J PLANT NUTR SOIL SC, V169, P310, DOI 10.1002/jpln.200521981
   TRAVIS DF, 1967, J ULTRA MOL STRUCT R, V18, P519, DOI 10.1016/S0022-5320(67)80201-6
   Trevors JT, 1997, ANTON LEEUW INT J G, V71, P271, DOI 10.1023/A:1000183732698
   Uriz MJ, 2003, MICROSC RES TECHNIQ, V62, P279, DOI 10.1002/jemt.10395
   Vukusic P, 2003, NATURE, V424, P852, DOI 10.1038/nature01941
   Weaver JC, 2003, MICROSC RES TECHNIQ, V62, P356, DOI 10.1002/jemt.10401
NR 56
TC 81
Z9 83
U1 1
U2 22
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-5007
EI 1552-5015
J9 J EXP ZOOL PART B
JI J. Exp. Zool. Part B
PD JUL 15
PY 2007
VL 308B
IS 4
BP 473
EP 483
DI 10.1002/jez.b.21174
PG 11
WC Evolutionary Biology; Developmental Biology; Zoology
SC Evolutionary Biology; Developmental Biology; Zoology
GA 198QQ
UT WOS:000248643000013
PM 17520693
DA 2018-10-20
ER

PT J
AU Kavlock, KD
   Pechar, TW
   Hollinger, JO
   Guelcher, SA
   Goldstein, AS
AF Kavlock, Katherine D.
   Pechar, Todd W.
   Hollinger, Jeffrey O.
   Guelcher, Scott A.
   Goldstein, Aaron S.
TI Synthesis and characterization of segmented poly(esterurethane urea)
   elastomers for bone tissue engineering
SO ACTA BIOMATERIALIA
LA English
DT Article
DE polycaprolatone; tissue engineering; polyurethane; osteoblast; modulus
ID DEGRADABLE POLYURETHANE ELASTOMERS; MARROW STROMAL CELLS;
   SURFACE-CHEMISTRY; BIOMEDICAL POLYURETHANE; EPSILON-CAPROLACTONE;
   INTEGRIN BINDING; CHAIN EXTENDER; DIFFERENTIATION; SCAFFOLDS;
   1,4-BUTANEDIISOCYANATE
AB Segmented polyurethanes have been used extensively in implantable medical devices, but their tunable mechanical properties make them attractive for examining the effect of biomaterial modulus on engineered musculoskeletal tissue development. In this study, a family of segmented degradable poly(esterurethane urea)s (PEUURs) were synthesized from 1,4-diisocyanatobutane, a poly(F-caprolactone) (PCL) macrodiol soft segment and a tyramine-1,4-diisocyanatobutane-tyramine chain extender. By systematically increasing the PCL macrodiol molecular weight from I 100 to 2700 Da, the storage modulus, crystallinity and melting point of the PCL segment were systematically varied. In particular, the melting temperature, T-m, increased from 21 to 61 degrees C and the storage modulus at 37 degrees C increased from 52 to 278 MPa with increasing PCL macrodiol molecular weight, suggesting that the crystallinity of the PCL macrodiol contributed significantly to the mechanical properties of the polymers. Bone marrow stromal cells were cultured on rigid polymer films under osteogenic conditions for up to 21 days. Cell density, alkaline phosphatase activity, and osteopontin and osteocalcin expression were similar among PEUURs and comparable to poly(D,L-lactic-coglycolic acid). This study demonstrates the suitability of this family of PEUURs for tissue engineering applications, and establishes a foundation for determining the effect of biomaterial modulus on bone tissue development. (c) 2007 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 Virginia Polytech Inst & State Univ, Sch Biomed Engn & Sci, Blacksburg, VA 24061 USA.
   Virginia Polytech Inst & State Univ, Dept Chem Engn, Blacksburg, VA 24061 USA.
   Carnegie Mellon Univ, Bone Tissue Engn Ctr, Pittsburgh, PA 15213 USA.
   Vanderbilt Univ, Dept Chem Engn, Nashville, TN 37235 USA.
RP Goldstein, AS (reprint author), Virginia Polytech Inst & State Univ, Sch Biomed Engn & Sci, Blacksburg, VA 24061 USA.
EM goldst@vt.edu
FU NIAMS NIH HHS [R21 AR051945-02, R21 AR015945, R21 AR051945]
CR Badami AS, 2006, BIOMATERIALS, V27, P596, DOI 10.1016/j.biomaterials.2005.05.084
   Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180
   Blais P., 1990, J APPL BIOMATER, V1, P197
   Borkenhagen M, 1998, BIOMATERIALS, V19, P2155, DOI 10.1016/S0142-9612(98)00122-7
   BRUIN P, 1988, MAKROMOL CHEM-RAPID, V9, P589
   Capone C D, 1992, J Biomater Appl, V7, P108, DOI 10.1177/088532829200700202
   COURY A, 2004, BIOMATERIALS SCI INT, P411
   CRANE GM, 1995, NAT MED, V1, P1322, DOI 10.1038/nm1295-1322
   deGroot JH, 1997, POLYM BULL, V38, P211, DOI 10.1007/s002890050040
   deGroot JH, 1997, BIOMATERIALS, V18, P613, DOI 10.1016/S0142-9612(96)00169-X
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Fromstein JD, 2002, J BIOMAT SCI-POLYM E, V13, P391, DOI 10.1163/156856202320253929
   GISSELFAELT K, 2002, STRUCTURE DEPENDENT
   Gisselfalt K, 2002, BIOMACROMOLECULES, V3, P951, DOI 10.1021/bm025535u
   Goldstein AS, 2001, TISSUE ENG, V7, P817, DOI 10.1089/107632701753337753
   Guan JJ, 2004, BIOMATERIALS, V25, P85, DOI 10.1016/S0142-9612(03)00476-9
   Guan JJ, 2002, J BIOMED MATER RES, V61, P493, DOI 10.1002/jbm.10204
   Guelcher SA, 2005, ACTA BIOMATER, V1, P471, DOI 10.1016/j.actbio.2005.02.007
   Herrington R. M., 1997, FLEXIBLE POLYURETHAN
   HOFFMAN D, 1993, CLIN MATER, V13, P95
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Kreke MR, 2005, BONE, V36, P1047, DOI 10.1016/j.bone.2005.03.008
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LELAH MD, 1987, POLYURETHANES MED
   Liljensten E, 2002, J MATER SCI-MATER M, V13, P351, DOI 10.1023/A:1014380332762
   Lim JY, 2005, J ROY SOC INTERFACE, V2, P97, DOI 10.1098/rsif.2004.0019
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Meredith JC, 2003, J BIOMED MATER RES A, V66A, P483, DOI 10.1002/jbm.a.10004
   Michael KE, 2003, LANGMUIR, V19, P8033, DOI 10.1021/la034810a
   Oertel G., 1994, POLYURETHANE HDB
   Porter RM, 2003, J CELL BIOCHEM, V90, P13, DOI 10.1002/jcb.10592
   SAWHNEY AS, 1990, J BIOMED MATER RES, V24, P1397, DOI 10.1002/jbm.820241011
   Scotchford CA, 1998, J BIOMED MATER RES, V41, P431, DOI 10.1002/(SICI)1097-4636(19980905)41:3<431::AID-JBM13>3.0.CO;2-L
   Skarja GA, 2000, J APPL POLYM SCI, V75, P1522, DOI 10.1002/(SICI)1097-4628(20000321)75:12<1522::AID-APP11>3.3.CO;2-1
   Skarja GA, 1998, J BIOMAT SCI-POLYM E, V9, P271, DOI 10.1163/156856298X00659
   Spaans CJ, 2000, BIOMATERIALS, V21, P2453, DOI 10.1016/S0142-9612(00)00113-7
   Spaans CJ, 1998, POLYM BULL, V41, P131, DOI 10.1007/s002890050343
   Spaans CJ, 1998, J MATER SCI-MATER M, V9, P675, DOI 10.1023/A:1008922128455
   Sperling LH, 2006, INTRODUCTION TO PHYSICAL POLYMER SCIENCE, 4TH EDITION, P1
   Stankus JJ, 2004, J BIOMED MATER RES A, V70A, P603, DOI 10.1002/jbm.a.30122
   Szycher M, 1988, J Biomater Appl, V3, P297, DOI 10.1177/088532828800300207
   Szycher M, 1991, J Biomater Appl, V5, P323, DOI 10.1177/088532829100500404
   Szycher M, 1999, SZYCHERS HDB POLYURE
   Thomas V, 2001, BIOMACROMOLECULES, V2, P588, DOI 10.1021/bm010044f
   Zhang JY, 2002, TISSUE ENG, V8, P771, DOI 10.1089/10763270260424132
NR 47
TC 71
Z9 81
U1 8
U2 38
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL
PY 2007
VL 3
IS 4
BP 475
EP 484
DI 10.1016/j.actbio.2007.02.001
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 187RE
UT WOS:000247865100007
PM 17418651
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Lee, K
   Itharaju, RR
   Puleo, DA
AF Lee, K.
   Itharaju, R. R.
   Puleo, D. A.
TI Protein-imprinted polysiloxane scaffolds
SO ACTA BIOMATERIALIA
LA English
DT Article
DE molecular imprinting; silica; scaffold; sol-gel techniques; protein
   adsorption
ID SOL-GEL PROCESS; POROUS SILICA; POLYMERS; RECOGNITION; MATRICES;
   ENCAPSULATION; LYSOZYME; SURFACES; ANTIBODY; BULK
AB Molecular imprinting is a technique used to create specific recognition sites on the surface of materials. Although widely developed for chromatographic separation of small molecules, this approach has not been adequately investigated for biomaterial applications. Thus, the objective of these experiments was to explore the potential of molecular imprinting for creating biomaterials that preferentially bind specific proteins. Macroporous polysiloxane (silica) scaffolds were imprinted with either lysozyme or RNase A using sol-gel processing. The quantity of surface-accessible protein, which was related to the number of potential binding sites, was varied by changing the amount of protein loaded into the sol. Up to 62% of loaded protein was accessible. The amount of protein per unit surface area ranged from 0.3 mu g m(-2) for low loading of RNase to 152 mu g m(-2) for high loading of lysozyme. Protein-imprinted scaffolds were then evaluated for their ability to preferentially recognize the template biomolecule when incubated in mixtures containing both the imprinted protein and a competitor protein of comparable size (approximately 14 kD). In solutions containing a single protein, up to 3.6 times more template bound compared with the competitor. Furthermore, in solutions containing equal amounts of both molecules, the porous scaffolds bound up to three times more template than the competitor protein, which is a level of preferential binding similar to values reported in the molecular imprinting literature for both organic and inorganic materials. (c) 2007 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 Univ Kentucky, Ctr Biomed Engn, Lexington, KY 40506 USA.
RP Puleo, DA (reprint author), Univ Kentucky, Ctr Biomed Engn, Lexington, KY 40506 USA.
EM puleo@uky.edu
FU NIAMS NIH HHS [AR048700]; NIBIB NIH HHS [R21 EB002958, R21 EB002958-02,
   R21 EB002958-01, EB02958]
CR Batra D, 2003, CURR OPIN CHEM BIOL, V7, P434, DOI 10.1016/S1367-5931(03)00060-7
   Bruggemann Oliver, 2002, Adv Biochem Eng Biotechnol, V76, P127
   Buchmeiser MR, 2001, J CHROMATOGR A, V918, P233, DOI 10.1016/S0021-9673(00)00129-1
   Cummins W, 2005, ANAL CHIM ACTA, V542, P52, DOI 10.1016/j.aca.2005.01.042
   Dai S, 2001, CHEM-EUR J, V7, P763, DOI 10.1002/1521-3765(20010216)7:4<763::AID-CHEM763>3.0.CO;2-6
   Dave BC, 1997, J SOL-GEL SCI TECHN, V8, P629, DOI 10.1007/BF02436913
   Gill I, 2000, TRENDS BIOTECHNOL, V18, P282, DOI 10.1016/S0167-7799(00)01457-8
   GLAD M, 1985, J CHROMATOGR, V347, P11, DOI 10.1016/S0021-9673(01)95465-2
   Gore MA, 2004, J CHROMATOGR B, V804, P211, DOI 10.1016/j.jchromb.2003.12.028
   Hayden O, 2006, ANALYST, V131, P1044, DOI 10.1039/b608354b
   HORBETT TA, 1987, PROTEINS INTERFACES, P1
   Hunnius M, 1999, MICROPOR MESOPOR MAT, V29, P389, DOI 10.1016/S1387-1811(99)00008-6
   Ikegami T, 2004, ANAL BIOANAL CHEM, V378, P1898, DOI 10.1007/s00216-004-2490-8
   Jin W, 2002, ANAL CHIM ACTA, V461, P1, DOI 10.1016/S0003-2670(02)00229-5
   Katz A, 2000, NATURE, V403, P286, DOI 10.1038/35002032
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Kugimiya A, 2001, J CHROMATOGR A, V938, P131, DOI 10.1016/S0021-9673(01)01384-X
   Kunitake T, 2004, ANAL CHIM ACTA, V504, P1, DOI 10.1016/S0003-2670(03)00811-0
   Liu DM, 1999, ACTA MATER, V47, P4535, DOI 10.1016/S1359-6454(99)00335-3
   Moss A.J., 1991, USE SELECTED MED DEV
   Oral E, 2006, J BIOMED MATER RES A, V78A, P205, DOI 10.1002/jbm.a.30725
   Pembroke JT, 2000, BIOCHEM MOL BIOL EDU, V28, P297, DOI 10.1016/S1470-8175(00)00050-3
   Pooart J, 2005, BIOSCI BIOTECH BIOCH, V69, P103, DOI 10.1271/bbb.69.103
   Rachkov A, 2001, BBA-PROTEIN STRUCT M, V1544, P255, DOI 10.1016/S0167-4838(00)00226-0
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   Sellergren B, 1997, TRAC-TREND ANAL CHEM, V16, P310, DOI 10.1016/S0165-9936(97)00027-7
   Shi HQ, 2000, J BIOMED MATER RES, V49, P1
   Shi HQ, 1999, NATURE, V398, P593
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   TANFORD C, 1956, BIOCHIM BIOPHYS ACTA, V19, P535, DOI 10.1016/0006-3002(56)90477-2
   VENTON DL, 1995, BBA-PROTEIN STRUCT M, V1250, P126, DOI 10.1016/0167-4838(95)00080-E
   WETTER LR, 1951, J BIOL CHEM, V192, P237
   WULFF G, 1995, ANGEW CHEM INT EDIT, V34, P1812, DOI 10.1002/anie.199518121
   Ye L, 2004, ANAL BIOANAL CHEM, V378, P1887, DOI 10.1007/s00216-003-2450-8
NR 34
TC 28
Z9 31
U1 0
U2 17
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL
PY 2007
VL 3
IS 4
BP 515
EP 522
DI 10.1016/j.actbio.2007.01.003
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 187RE
UT WOS:000247865100011
PM 17363350
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Condie, R
   Bose, S
   Bandyopadhyay, A
AF Condie, Russell
   Bose, Susmita
   Bandyopadhyay, Amit
TI Bone cell-materials interaction on Si microchannels with bioinert
   coatings
SO ACTA BIOMATERIALIA
LA English
DT Article
DE osteoblast adhesion; osseointegration microchannel; bone tissue
   engineering
ID SCAFFOLDS; ALIGNMENT; LINE
AB Bone implant life is dependent upon integration of biomaterial surfaces with local ostcoblasts. This investigation studied the effects of various microchannel parameters and surface chemistry on immortalized osteoblast precursor cell (OPCI) adhesion. Cell-materials interactions were observed within channels of varying length, width, tortuosity, convergence, divergence and chemistry. Si wafers were used to create four distinct I cm 2 designs of varying channel dimensions. After anisotropic chemical etching to a depth of 120 mu m, wafers were sputter coated with gold and titanium; and on another surface SiO2 was grown to vary the surface chemistry of these microchannels. OPCI cells were seeded in the central cavity of each chip before incubation in tissue culture plates. On days 5, 11 and 16, samples were taken out, fixed and processed for microscopic analysis. Samples were visually characterized, qualitatively scored and analyzed. Channel walls did not contain OPCI migration, but showed locally interrupted adhesion. Scores for channels of floor widths as narrow as 350 Pm were significantly reduced. No statistically significant preference was detected for gold, titanium or SiO2 surfaces. Bands of OPC1 cells appeared to align with nearby channels, suggesting that cell morphology may be controlled by topography of the design to improve osseointegration. (c) 2006 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 Washington State Univ, WM Keck Biomed Mat Res Lab, Sch Mech & Mat Engn, Pullman, WA 99164 USA.
   Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.
RP Bandyopadhyay, A (reprint author), Washington State Univ, WM Keck Biomed Mat Res Lab, Sch Mech & Mat Engn, Pullman, WA 99164 USA.
EM amitband@wsu.edu
RI Bandyopadhyay, Amit/A-7780-2012
OI Bandyopadhyay, Amit/0000-0003-0992-5387
CR Bandyopadhyay A, 2006, J AM CERAM SOC, V89, P2675, DOI 10.1111/j.1551-2916.2006.01207.x
   Ber S, 2005, BIOMATERIALS, V26, P1977, DOI 10.1016/j.biomaterials.2004.07.007
   Bose S, 2003, MAT SCI ENG C-BIO S, V23, P479, DOI 10.1016/S0928-4931(02)00129-7
   DACULSI G, 1990, SCANNING MICROSCOPY, V4, P309
   Dalby MJ, 2006, BIOMATERIALS, V27, P1306, DOI 10.1016/j.biomaterials.2005.08.028
   DUNN GA, 1986, J CELL SCI, V83, P313
   Fredel MC, 1996, J MATER SCI, V31, P4375, DOI 10.1007/BF00356463
   Hall J., 2005, CLIN IMPLANT DENT S1, V7, P76
   Hedia HS, 2004, BIO-MED MATER ENG, V14, P133
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Kalita SJ, 2003, MAT SCI ENG C-BIO S, V23, P611, DOI 10.1016/S0928-4931(03)00052-3
   KLAWITTER JJ, 1971, J BIOMED MATER RES S, V2, P161, DOI DOI 10.1002/JBM.820050613
   Lenhert S, 2005, BIOMATERIALS, V26, P563, DOI 10.1016/j.biomaterials.2004.02.068
   Mayr-Wohlfart U, 2001, J BIOMED MATER RES, V57, P132, DOI 10.1002/1097-4636(200110)57:1<132::AID-JBM1152>3.0.CO;2-K
   Meyer U, 2004, INT J ORAL MAX SURG, V33, P325, DOI 10.1016/S0901-5027(03)00199-1
   RATNER BD, 2004, BIOMATERIALS SCI INT, P154
   William H, 1952, J AM STAT ASSOC, V47, P583
   Winn SR, 1999, J BONE MINER RES, V14, P1721, DOI 10.1359/jbmr.1999.14.10.1721
   Zinger O, 2005, BIOMATERIALS, V26, P1837, DOI 10.1016/j.biomaterials.2004.06.035
NR 19
TC 7
Z9 7
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL
PY 2007
VL 3
IS 4
BP 523
EP 530
DI 10.1016/j.actbio.2006.11.001
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 187RE
UT WOS:000247865100012
PM 17258518
DA 2018-10-20
ER

PT J
AU Algul, O
   Duran, N
AF Algul, Oztekin
   Duran, Nizami
TI Activity of bisbenzimidazoles derivatives to Staphylococcus epidermidis
SO ASIAN JOURNAL OF CHEMISTRY
LA English
DT Article
DE bis(benzimidazole); Staphylococcus epidermidis; antimicrobial activity;
   biofilm
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; BENZIMIDAZOLES; RESISTANCE
AB Biomaterial-associated infections, most frequently caused by Staphylococcus epidermidis and Staphylococcus aureus, are of increasing importance in modern medicine. The most important factor in the pathogenesis of biomaterial-associated staphylococcal infections is the formation of adherent, multilayered bacterial biofilms. The aim of this study was to synthesize bis(benzimidazole) derivatives and evaluate their in vitro antimicrobial activity against. the growth of gram positive (Enterococcus faecalis, methicillin resistant S. aureus, methicillin sensitive S.aureus, S. epidermidis and S. epidermidis RP12 (slime producing), gram-negative bacteria (Escherichia coli, Pseudomonas aeruginosa) and pathogenic fungi (Candida albicans, Candida krusei, Candida parapsilosis, Candida tropicalis and Candida glabrata). The antimicrobial activity of bis(benzimidazole) derivatives was higher in gram positive bacteria. Bis(benzimidazole) derivatives were inhibited gram positive bacteria at the concentration range of 12.5-100 mu g/ mL. All compounds were shown to be bacteriostatic as well as bacteriocidal for cultures of S. aureus and S. epidermidis strains, regardless of their antibiotic susceptibility profile. This was demonstrated by using simultaneously the optical density measuring method and 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide-reduction assay. The highest activity was shown by 1,2-di(1 H-benzo[d]imidazol-2-yl)ethane which demonstrated interesting activity regarding its effect on 24 h old staphylococcal biofilm cells viability.
C1 Mersin Univ, Fac Pharm, Dept Pharmaceut Chem, TR-33169 Mersin, Turkey.
RP Algul, O (reprint author), Mersin Univ, Fac Pharm, Dept Pharmaceut Chem, Yenisehir Campus, TR-33169 Mersin, Turkey.
EM oztekinalgul@mersin.edu.tr
CR Aghapoor K, 2005, Z NATURFORSCH B, V60, P901
   ARCHER GL, 1994, ANTIMICROB AGENTS CH, V38, P2231, DOI 10.1128/AAC.38.10.2231
   Cakir B., 1988, J FAC PHARM GAZI, V5, P71
   Demir AS, 2002, TETRAHEDRON LETT, V43, P6447, DOI 10.1016/S0040-4039(02)01362-X
   EMORI TG, 1993, CLIN MICROBIOL REV, V6, P428
   Fux Christoph A, 2003, Expert Rev Anti Infect Ther, V1, P667, DOI 10.1586/14787210.1.4.667
   Groziak MP, 1997, J MED CHEM, V40, P3336, DOI 10.1021/jm970301s
   Kaupp G, 2002, EUR J ORG CHEM, P1368
   KLOSS WE, 1994, CLIN MICROBIOL REV, V7, P117
   Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001
   NOBLE WC, 1997, STAPHYLOCOCCI HUMAN
   PFALLER M A, 1988, Clinical Microbiology Reviews, V1, P281
   Raad I, 1998, CLIN INFECT DIS, V26, P1182, DOI 10.1086/520285
   RUPP ME, 1994, CLIN INFECT DIS, V19, P231, DOI 10.1093/clinids/19.2.231
   Saluja S, 1996, J MED CHEM, V39, P881, DOI 10.1021/jm950556a
   SZYSZKA R, 1995, BIOCHEM BIOPH RES CO, V208, P418, DOI 10.1006/bbrc.1995.1354
   VVAS PC, 1980, CHEM IND, V7, P287
   Walencka Elzbieta, 2005, Polish Journal of Microbiology, V54, P191
   Zou RM, 1996, J MED CHEM, V39, P3477, DOI 10.1021/jm960157v
NR 19
TC 2
Z9 2
U1 0
U2 6
PU ASIAN JOURNAL OF CHEMISTRY
PI SAHIBABAD
PA 11/100 RAJENDRA NAGAR, SECTOR 3,, SAHIBABAD 201 005, GHAZIABAD, INDIA
SN 0970-7077
J9 ASIAN J CHEM
JI Asian J. Chem.
PD JUL-AUG
PY 2007
VL 19
IS 4
BP 3145
EP 3151
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA 238QU
UT WOS:000251463400098
DA 2018-10-20
ER

PT J
AU Clapper, JD
   Iverson, SL
   Guymon, CA
AF Clapper, Jason D.
   Iverson, Stephanie L.
   Guymon, C. Allan
TI Nanostructured biodegradable polymer networks using lyotropic liquid
   crystalline templates
SO BIOMACROMOLECULES
LA English
DT Article
ID TISSUE ENGINEERING APPLICATIONS; PEG HYDROGELS; SCAFFOLDS;
   PHOTOPOLYMERIZATION; PHASES; BEHAVIOR; CHONDROCYTES; MORPHOLOGY; DESIGN;
   GELS
AB The physical properties, porosity, and physiological behavior of synthetic biodegradable hydrogels have been identified as highly critical design parameters in most tissue engineering materials applications. Nanotechnology may provide the means to manipulate these parameters by accessing control over the network structure of the biomaterial, providing unique property relationships that often result from nanostructured materials. In this study, a lyotropic liquid crystal (LLC) was used as a polymerization template in the formation of a photopolymerizable biodegradable PLA-b-PEG-b-PLA (PEG = poly(ethylene glycol); PLA = poly(lactic acid)) material with nanoscale lamellar morphology. Through ordering of the biodegradable monomer within the liquid crystal assembly, a 2-fold increase in maximum polymerization rate and a 30% increase in double bond conversion were realized over isotropic monomer formulations. The resulting network structure of the templated PLA-b-PEG-b-PLA material has a dramatic affect on the physical properties of the hydrogel including an 80% increase in network swelling and an approximately 230% increase in diffusivity. This increase in permeability and solvent uptake leads to rapid degradation of the lamellar templated samples, further demonstrating the influence of the LLC directed network structure on the porosity and physical properties of the biodegradable material. The ability to control the porosity, physical properties, and behavior of a biodegradable hydrogel simply by imparting LLC network structure, without changing the chemistry or biocompatibility of the polymer, could prove highly advantageous in the design of synthetic biomaterials for potential medical applications.
C1 Univ Iowa, Iowa City, IA 52242 USA.
RP Guymon, CA (reprint author), Univ Iowa, Iowa City, IA 52242 USA.
EM Allan-guymon@uiowa.edu
CR ANDERSON DM, 1991, PHYSICA A, V176, P151, DOI 10.1016/0378-4371(91)90438-I
   Antonietti M, 1999, MACROMOLECULES, V32, P1383, DOI 10.1021/ma9812478
   BENOIT DSW, 2006, TISSUE ENG, V7, P1663
   Bryant SJ, 2004, BIOTECHNOL BIOENG, V86, P747, DOI 10.1002/bit.20160
   Bryant SJ, 2004, J ORTHOPAED RES, V22, P1143, DOI 10.1016/j.orthres.2004.02.001
   Burdick JA, 2005, BIOMACROMOLECULES, V6, P386, DOI 10.1021/bm049508a
   Chastain SR, 2006, J BIOMED MATER RES A, V78A, P73, DOI 10.1002/jbm.a.30686
   Clapper JD, 2007, MACROMOLECULES, V40, P1101, DOI 10.1021/ma0622377
   Clapper JD, 2006, ADV MATER, V18, P1575, DOI 10.1002/adma.200502608
   Coleman NRB, 2001, MICROPOR MESOPOR MAT, V44, P73, DOI 10.1016/S1387-1811(01)00170-6
   DEPIERRO MA, 2006, MACROMOLECULES, V39, P619
   DePierro MA, 2006, CHEM MATER, V18, P5609, DOI 10.1021/cm061969a
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Farokhzad OC, 2006, ADV DRUG DELIVER REV, V58, P1456, DOI 10.1016/j.addr.2006.09.011
   Gin DL, 2001, ACCOUNTS CHEM RES, V34, P973, DOI 10.1021/ar000140d
   Hacker MC, 2006, TISSUE ENG, V12, P2049, DOI 10.1089/ten.2006.12.2049
   Hentze HP, 2003, CURR OPIN COLLOID IN, V8, P164, DOI 10.1016/S1359-0294(03)00018-9
   Koyama S, 2006, SMALL, V2, P1406, DOI 10.1002/smll.200500416
   Landers R, 2002, BIOMATERIALS, V23, P4437, DOI 10.1016/S0142-9612(02)00139-4
   Lester CL, 2003, CHEM MATER, V15, P3376, DOI 10.1021/cm021703d
   Lester CL, 2003, LANGMUIR, V19, P9466, DOI 10.1021/la0300784
   Lester CL, 2001, MACROMOLECULES, V34, P8587, DOI 10.1021/ma011314p
   Mahmood TA, 2005, TISSUE ENG, V11, P1244, DOI 10.1089/ten.2005.11.1244
   McCormick DT, 2003, MACROMOLECULES, V36, P6549, DOI 10.1021/ma030037e
   Metters AT, 2000, POLYMER, V41, P3993, DOI 10.1016/S0032-3861(99)00629-1
   Mi YL, 2006, POLYMER, V47, P5124, DOI 10.1016/j.polymer.2006.04.063
   Moon JJ, 2007, BIOMACROMOLECULES, V8, P42, DOI 10.1021/bm060452p
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Perera DI, 1996, POLYM INT, V39, P121
   Pfister PM, 2007, BIOMATERIALS, V28, P567, DOI 10.1016/j.biomaterials.2006.09.016
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Price RL, 2004, NANOTECHNOLOGY, V15, P892, DOI 10.1088/0957-4484/15/8/004
   Rajagopalan P, 2006, TISSUE ENG, V12, P1553, DOI 10.1089/ten.2006.12.1553
   Rydholm AE, 2006, BIOMACROMOLECULES, V7, P2827, DOI 10.1021/bm0603793
   Sabino MA, 2004, J BIOMATER APPL, V19, P147, DOI 10.1177/0885328204045443
   Sarkar S, 2006, BIOMATERIALS, V27, P4775, DOI 10.1016/j.biomaterials.2006.04.038
   SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Shum AWT, 2005, POLYM DEGRAD STABIL, V87, P487, DOI 10.1016/j.polymdegradstab.2004.10.005
   Tan W, 2001, TISSUE ENG, V7, P203, DOI 10.1089/107632701300062831
   Van Nelson JA, 2002, LANGMUIR, V18, P5031, DOI 10.1021/la0118715
   von Burkersroda F, 2002, BIOMATERIALS, V23, P4221, DOI 10.1016/S0142-9612(02)00170-9
   Wadekar MN, 2005, CHEM MATER, V17, P2460, DOI 10.1021/cm048240r
   White TJ, 2006, POLYMER, V47, P2289, DOI 10.1016/j.polymer.2006.01.030
   Xie BJ, 2006, ADV FUNCT MATER, V16, P1685, DOI 10.1002/adfm.200500666
   Yih TC, 2006, J CELL BIOCHEM, V97, P1184, DOI 10.1002/jcb.20796
   Zhou MJ, 2005, ADV MATER, V17, P1850, DOI 10.1002/adma.200500444
NR 48
TC 22
Z9 22
U1 0
U2 32
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JUL
PY 2007
VL 8
IS 7
BP 2104
EP 2111
DI 10.1021/bm0701671
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 187AP
UT WOS:000247820000010
PM 17567168
DA 2018-10-20
ER

PT J
AU Robb, SA
   Lee, BH
   McLemore, R
   Vernon, BL
AF Robb, Stephanie A.
   Lee, Bae Hoon
   McLemore, Ryan
   Vernon, Brent L.
TI Simultaneously physically and chemically gelling polymer system
   utilizing a poly(NIPAAm-co-cysteamine)-based copolymer
SO BIOMACROMOLECULES
LA English
DT Article
ID MICHAEL-TYPE ADDITION; HYDROGELS; EMBOLIZATION; ALGINATE; THIOLS; GEL
AB The objective of this work was to create an in situ physically and chemically cross-linking hydrogel for in vivo applications. N-Isopropylacrylamide (NIPAAm) was copolymerized with N-acryloxysuccinimide (NASI) via free radical polymerization. Poly(NIPAAm-co-NASI) was further modified to obtain poly(NIPAAm-co-cysteamine) through a nucleophilic attack on the carbonyl group of the NASI by the amine group of the cysteamine. Modification was verified by nuclear magnetic resonance. In addition to thermoresponsive physical gelling due to the presence of NIPAAm, this system also chemically gels via a Michael-type addition reaction when mixed with poly(ethylene glycol) diacrylate. The presence of both physical and chemical gelation resulted in material properties that are much improved compared to purely physical gels. The chemical gelation time of the copolymers was not significantly affected by the amount of thiol present due to the increased pK(a) of the copolymer containing more thiols. In addition, the swelling of the copolymers was highly dependent on the temperature and thiol content. Last, the rate of nucleophilic attack in the Michael-type addition reaction was shown to be highly dependent on pH and on the mole ratio of thiol to acrylate. Due to the improved mechanical properties, this material may be better suited for long-term functional replacement applications than other thermosensitive physical gels. With further development and biocompatibility testing, this material could potentially be applied as a temperature-responsive injectable biomaterial for functional embolization.
C1 Arizona State Univ, Harrington Dept Bioengn, Ctr Intervent Biomat, Tempe, AZ 85287 USA.
RP Vernon, BL (reprint author), Arizona State Univ, Harrington Dept Bioengn, Ctr Intervent Biomat, ECG 334, Tempe, AZ 85287 USA.
EM Brent.Vernon@asu.edu
RI Vernon, Brent/F-2859-2010
FU NIGMS NIH HHS [GM065917, R01 GM065917-03, R01 GM065917]
CR ALARCON CH, 2005, CHEM SOC REV, V34, P267
   Becker TA, 2002, NEUROSURGERY, V51, P453, DOI 10.1227/01.NEU.0000020083.33150.81
   Cellesi F, 2004, BIOMATERIALS, V25, P5115, DOI 10.1016/j.biomaterials.2003.12.015
   DANEHY JP, 1968, J CHEM ENG DATA, V13, P386, DOI 10.1021/je60038a025
   ELLMAN GL, 1958, ARCH BIOCHEM BIOPHYS, V74, P443, DOI 10.1016/0003-9861(58)90014-6
   Gutowska A, 2001, ANAT RECORD, V263, P342, DOI 10.1002/ar.1115
   Heggli M, 2003, BIOCONJUGATE CHEM, V14, P967, DOI 10.1021/bc0340621
   Hoffman A. S., 2002, ADV DRUG DELIVERY RE, V43, P3, DOI DOI 10.1016/S0169-409X(01)00239-3
   Jeong B, 2002, ADV DRUG DELIVER REV, V54, P37, DOI 10.1016/S0169-409X(01)00242-3
   Jeong B, 2002, TRENDS BIOTECHNOL, V20, P305, DOI 10.1016/S0167-7799(02)01962-5
   Lee BH, 2006, BIOMACROMOLECULES, V7, P2059, DOI 10.1021/bm060211h
   Li XW, 2005, BIOMATERIALS, V26, P7002, DOI 10.1016/j.biomaterials.2005.05.094
   Lu YP, 2004, BIOMATERIALS, V25, P4393, DOI [10.1016/j.biomaterials.2003.08.014, 10.1016/j.biomaterials.2003.10.092]
   Lutolf MP, 2003, BIOMACROMOLECULES, V4, P713, DOI 10.1021/bm025744e
   Lutolf MP, 2001, BIOCONJUGATE CHEM, V12, P1051, DOI 10.1021/bc015519e
   McLemore R, 2006, J BIOMED MATER RES B, V79B, P398, DOI 10.1002/jbm.b.30554
   Ruel-Gariepy E, 2004, EUR J PHARM BIOPHARM, V58, P409, DOI 10.1016/j.ejpb.2004.03.019
   Shu XZ, 2004, J BIOMED MATER RES A, V68A, P365, DOI 10.1002/jbm.a.20002
   VERNON BL, 2002, J BIOMED MATER RES, V64, P447
   Weng YM, 2006, J PHYS CHEM B, V110, P11813, DOI 10.1021/jp0616922
   YANG HJ, 1990, J POLYM SCI POL CHEM, V28, P219, DOI 10.1002/pola.1990.080280116
   Zhao CR, 2005, CURR APPL PHYS, V5, P497, DOI 10.1016/j.cap.2005.01.019
NR 22
TC 68
Z9 68
U1 2
U2 34
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JUL
PY 2007
VL 8
IS 7
BP 2294
EP 2300
DI 10.1021/bm070267r
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 187AP
UT WOS:000247820000037
PM 17567067
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Ma, SF
   Lin, H
   Miao, YL
   Liu, XY
   Wang, B
   Dai, JW
AF Ma, Suofeng
   Lin, Hang
   Miao, Yiliang
   Liu, Xinyong
   Wang, Bin
   Dai, Jianwu
TI The effect of three-dimensional demineralized bone matrix on in vitro
   cumulus-free oocyte maturation
SO BIOMATERIALS
LA English
DT Article
DE co-culture; demineralized bone matrix; in vitro maturation; oocyte
ID MOUSE OOCYTES; MEIOTIC MATURATION; CORTICAL GRANULES; ZONA-PELLUCIDA;
   EXTRACELLULAR-MATRIX; DEVELOPMENTAL COMPETENCE; BOVINE OOCYTES;
   SOMATIC-CELLS; CULTURE; FERTILIZATION
AB The physiological role of cumulus cell surrounding oocytes is particularly important for normal cytoplasmic maturation of oocytes. Collagen-based demineralized bone matrix (DBM) is a valuable biomaterial for the three-dimensional (3-D) cell culture. The present study was designed to determine whether in vitro maturation (IVM) of cumulus-free oocytes in mice could be improved by using the 3-D DBM co-culture system. The results indicated that the denuded oocytes cultured in 3-D DBM co-culture system with cumulus cells showed close similarity of cortical granules (CGs) distribution pattern, had more normal maturation-promoting factor (MPF) level and zona pellucida (ZP) hardening level to the in vivo matured oocytes, and the best preimplantation development after being activated by in vitro fertilization (IVF) or parthenogenetic activation. Thus, 3-D DBM collagen scaffold could serve as a tool for fundamental in vitro studies of cells or tissues under the environment that closely assembles the in vivo conditions. (C) 2007 Elsevier Ltd. All rights reserved.
C1 Chinese Acad Sci, Inst Genet & Dev Biol, Beijing 100080, Peoples R China.
   Chinese Acad Sci, Grad Sch, Beijing, Peoples R China.
   Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China.
   Cent Hosp Taian, Med Ctr Reprod, Taian City, Shandong, Peoples R China.
RP Dai, JW (reprint author), Chinese Acad Sci, Inst Genet & Dev Biol, 3 Nanyitiao, Beijing 100080, Peoples R China.
EM jwdai@genetics.ac.cn
RI Lin, Hang/D-3003-2012
OI Lin, Hang/0000-0002-0781-6630
CR Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a
   Abir R, 1999, HUM REPROD, V14, P1299, DOI 10.1093/humrep/14.5.1299
   Bissell MJ, 1998, ANN NY ACAD SCI, V842, P1, DOI 10.1111/j.1749-6632.1998.tb09625.x
   BUCCIONE R, 1990, BIOL REPROD, V43, P543, DOI 10.1095/biolreprod43.4.543
   Cha KY, 1998, HUM REPROD UPDATE, V4, P103, DOI 10.1093/humupd/4.2.103
   CHEN B, 2006, J BIOMED MAT RES A
   Combelles CMH, 2005, HUM REPROD, V20, P1349, DOI 10.1093/humrep/deh750
   Combelles CMH, 2002, HUM REPROD, V17, P1006, DOI 10.1093/humrep/17.4.1006
   Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Damiani P, 1996, MOL REPROD DEV, V45, P521, DOI 10.1002/(SICI)1098-2795(199612)45:4<521::AID-MRD15>3.3.CO;2-H
   DUCIBELLA T, 1990, BIOL REPROD, V43, P870, DOI 10.1095/biolreprod43.5.870
   DUCIBELLA T, 1994, BIOL REPROD, V50, P467, DOI 10.1095/biolreprod50.3.467
   DUCIBELLA T, 1990, DEV BIOL, V137, P46, DOI 10.1016/0012-1606(90)90006-5
   DUCIBELLA T, 1988, DEV BIOL, V130, P184, DOI 10.1016/0012-1606(88)90425-3
   DUCIBELLA T, 1994, DEV BIOL, V165, P95, DOI 10.1006/dbio.1994.1237
   DUCIBELLA T, 1993, BIOL REPROD, V48, P1251, DOI 10.1095/biolreprod48.6.1251
   Eppig JJ, 2005, BIOL REPROD, V73, P351, DOI 10.1095/biolreprod.105.041798
   EPPIG JJ, 1979, J EXP ZOOL, V209, P345, DOI 10.1002/jez.1402090216
   EPPIG JJ, 1991, BIOESSAYS, V13, P569, DOI 10.1002/bies.950131105
   EPPIG JJ, 1982, DEV BIOL, V89, P268, DOI 10.1016/0012-1606(82)90314-1
   Gosden R, 1997, BIOESSAYS, V19, P875, DOI 10.1002/bies.950191007
   Hardy K, 2000, BRIT MED BULL, V56, P588, DOI 10.1258/0007142001903391
   HIRAO Y, 1994, J REPROD FERTIL, V100, P333
   Huet C, 2001, J ENDOCRINOL, V169, P347, DOI 10.1677/joe.0.1690347
   Hwang DH, 2000, ENDOCR J, V47, P177, DOI 10.1507/endocrj.47.177
   Kreeger PK, 2006, BIOMATERIALS, V27, P714, DOI 10.1016/j.biomaterials.2005.06.016
   Liu XY, 2005, HUM REPROD, V20, P3402, DOI 10.1093/humrep/dei265
   Ludwig SC, 1999, ORTHOP CLIN N AM, V30, P635, DOI 10.1016/S0030-5898(05)70116-4
   Ma SF, 2005, THERIOGENOLOGY, V64, P1142, DOI 10.1016/j.theriogenology.2005.03.002
   Mermillod P, 1999, J Reprod Fertil Suppl, V54, P449
   Miao YL, 2005, BIOL REPROD, V73, P1025, DOI 10.1095/biolreprod.105.043703
   Miki H, 2006, J REPROD DEVELOP, V52, P239, DOI 10.1262/jrd.17078
   Miyara F, 2003, HUM REPROD, V18, P1494, DOI 10.1093/humrep/deg272
   Moor R M, 1990, J Reprod Fertil Suppl, V40, P197
   OKADA A, 1986, J SUBMICR CYTOL PATH, V18, P233
   OKADA A, 1993, ANAT RECORD, V237, P518, DOI 10.1002/ar.1092370412
   Osaki S, 1997, REPROD FERT DEVELOP, V9, P781, DOI 10.1071/R97044
   QUINN P, 1982, J REPROD FERTIL, V66, P161
   Richardson MC, 2000, J ANAT, V196, P243, DOI 10.1046/j.1469-7580.2000.19620243.x
   Schouten CC, 2005, J MATER SCI-MATER M, V16, P149, DOI 10.1007/s10856-005-6034-3
   SCHROEDER AC, 1990, BIOL REPROD, V43, P891, DOI 10.1095/biolreprod43.5.891
   SIRARD MA, 1990, J REPROD FERTIL, V89, P459
   Sutton ML, 2003, HUM REPROD UPDATE, V9, P35, DOI 10.1093/humupd/dmg009
   Tanghe S, 2002, MOL REPROD DEV, V61, P414, DOI 10.1002/mrd.10102
   TORRANCE C, 1989, J REPROD FERTIL, V87, P367
   Trounson A, 2001, REPRODUCTION, V121, P51, DOI 10.1530/rep.0.1210051
   VANDESANDT JJM, 1990, MOL REPROD DEV, V25, P164, DOI 10.1002/mrd.1080250209
   Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231
   Zamboni L., 1970, Biol. Reprod., V2, P44, DOI 10.1095/biolreprod2.Supplement_2.44
NR 50
TC 6
Z9 7
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2007
VL 28
IS 21
BP 3198
EP 3207
DI 10.1016/j.biomaterials.2007.03.007
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 176BA
UT WOS:000247056500004
PM 17434580
DA 2018-10-20
ER

PT J
AU Reyes, CD
   Petrie, TA
   Burns, KL
   Schwartz, Z
   Garcia, AJ
AF Reyes, Catherine D.
   Petrie, Timothy A.
   Burns, Kellie L.
   Schwartz, Zvi
   Garcia, Andres J.
TI Biomolecular surface coating to enhance orthopaedic tissue healing and
   integration
SO BIOMATERIALS
LA English
DT Article
DE biomimetic material; cell adhesion; collagen; osseointegration; integrin
ID TOTAL JOINT ARTHROPLASTY; BONE-MARROW-CELLS; OSTEOBLASTIC
   DIFFERENTIATION; TITANIUM IMPLANTS; I COLLAGEN; TRANSCRIPTION FACTOR;
   GENE-EXPRESSION; MINERALIZATION; ADHESION; GROWTH
AB Implant osseointegration is a prerequisite for clinical success in orthopaedic and dental applications, many of which are restricted by loosening. Biomaterial surface modification approaches, including calcium-phosphate ceramic coatings and macro/microporosity, have had limited success in promoting integration. To improve osseointegration, titanium surfaces were coated with the glycine-phenylalanine-hydroxyproline-glycine-glutamate-arginine (GFOGER) collagen-mimetic peptide, selectively promoting alpha(2)beta(1) integrin binding, a crucial event for osteoblastic differentiation. Titanium surfaces presenting GFOGER triggered osteoblastic differentiation and mineral deposition in bone marrow stromal cells, leading to enhanced osteoblastic function compared to unmodified titanium. Furthermore, this integrin-targeted coating significantly improved in vivo peri-implant bone regeneration and osseointegration, as characterized by bone-implant contact and mechanical fixation, compared to untreated titanium in a rat cortical bone-implant model. GFOGER-modified implants also significantly enhanced osseointegration compared to surfaces modified with full-length type I collagen, highlighting the importance of presenting specific biofunctional domains within the native ligand. In addition, this biomimetic implant coating is generated using a simple, single-step procedure that readily translates to a clinical environment with minimal processing and cytotoxicity concerns. Therefore, this study establishes a biologically active and clinically relevant implant-coating strategy that enhances bone repair and orthopaedic implant integration. (C) 2007 Published by Elsevier Ltd.
C1 Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
   Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   Hebrew Univ Jerusalem, Dept Periodont, Jerusalem, Israel.
RP Garcia, AJ (reprint author), Georgia Inst Technol, George W Woodruff Sch Mech Engn, 315 Ferst Dr,Room 2314 IBB, Atlanta, GA 30332 USA.
EM andres.garcia@me.gatech.edu
FU NIBIB NIH HHS [R01 EB-004496, R01 EB004496, R01 EB004496-03]
CR Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   AUBIN JE, 1996, PRINCIPLES BONE BIOL, P69
   BARBER TA, 2006, J BIOMED MAT RES A
   Bauer TW, 1999, SKELETAL RADIOL, V28, P483, DOI 10.1007/s002560050552
   Bauer TW, 1999, SKELETAL RADIOL, V28, P423, DOI 10.1007/s002560050541
   Bernhardt R, 2005, BIOMATERIALS, V26, P3009, DOI 10.1016/j.biomaterials.2004.08.030
   Branemark R, 1997, BIOMATERIALS, V18, P969, DOI 10.1016/S0142-9612(97)00018-5
   Byers BA, 2004, TISSUE ENG, V10, P1623, DOI 10.1089/ten.2004.10.1623
   Byers BA, 2002, J BONE MINER RES, V17, P1931, DOI 10.1359/jbmr.2002.17.11.1931
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3
   Elmengaard B, 2005, J BIOMED MATER RES A, V75A, P249, DOI 10.1002/jbm.a.30301
   Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4
   Ferris DM, 1999, BIOMATERIALS, V20, P2323, DOI 10.1016/S0142-9612(99)00161-1
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Garcia AJ, 2005, J DENT RES, V84, P407, DOI 10.1177/154405910508400502
   Gronthos S, 1997, J BONE MINER RES, V12, P1189, DOI 10.1359/jbmr.1997.12.8.1189
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hubbell JA, 2004, NAT BIOTECHNOL, V22, P828, DOI 10.1038/nbt0704-828
   Jikko A, 1999, J BONE MINER RES, V14, P1075, DOI 10.1359/jbmr.1999.14.7.1075
   Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35
   Knight CG, 1998, J BIOL CHEM, V273, P33287, DOI 10.1074/jbc.273.50.33287
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   LYNCH MP, 1995, EXP CELL RES, V216, P35, DOI 10.1006/excr.1995.1005
   Mizuno M, 2001, J BIOCHEM-TOKYO, V129, P133, DOI 10.1093/oxfordjournals.jbchem.a002824
   Mizuno M, 2000, J CELL PHYSIOL, V184, P207, DOI 10.1002/1097-4652(200008)184:2<207::AID-JCP8>3.3.CO;2-L
   Petrie TA, 2006, BIOMATERIALS, V27, P5459, DOI 10.1016/j.biomaterials.2006.06.027
   Reyes CD, 2003, J BIOMED MATER RES A, V67A, P328, DOI 10.1002/jbm.a.10122
   Reyes CD, 2003, J BIOMED MATER RES A, V65A, P511, DOI 10.1002/jbm.a.10550
   Reyes CD, 2004, J BIOMED MATER RES A, V69A, P591, DOI 10.1002/jbm.a.30034
   Schliephake H, 2002, CLIN ORAL IMPLAN RES, V13, P312, DOI 10.1034/j.1600-0501.2002.130312.x
   Sporer SM, 2005, ORTHOP CLIN N AM, V36, P105, DOI 10.1016/j.ocl.2004.06.007
   Suzawa M, 2002, J BONE MINER RES, V17, P240, DOI 10.1359/jbmr.2002.17.2.240
   Takeuchi Y, 1997, J BIOL CHEM, V272, P29309, DOI 10.1074/jbc.272.46.29309
   Vreeland WN, 2002, CURR OPIN BIOTECH, V13, P87, DOI 10.1016/S0958-1669(02)00292-6
   Xiao GZ, 1998, J BIOL CHEM, V273, P32988, DOI 10.1074/jbc.273.49.32988
NR 37
TC 161
Z9 167
U1 3
U2 62
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2007
VL 28
IS 21
BP 3228
EP 3235
DI 10.1016/j.biomaterials.2007.04.003
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 176BA
UT WOS:000247056500007
PM 17448533
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Stephens, JS
   Cooper, JA
   Phelan, FR
   Dunkers, JP
AF Stephens, J. S.
   Cooper, J. A.
   Phelan, F. R., Jr.
   Dunkers, J. P.
TI Perfusion flow bioreactor for 3D in situ imaging: Investigating
   cell/biomaterials interactions
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE bioreactor; imaging; perfusion flow; tissue engineering
ID TISSUE ENGINEERING SCAFFOLDS; MARROW STROMAL CELLS; OSTEOBLAST RESPONSE;
   MATRIX DEPOSITION; LIGHT-MICROSCOPY; LONG-TERM; BONE; CULTURE; DESIGN;
   SYSTEM
AB The capability to image real tune cell/material interactions in a three-dimensional (3D) culture environment will aid in the advancement of tissue engineering. This paper describes a perfusion flow bioreactor designed to hold tissue engineering scaffolds and allow for in situ imaging using an upright microscope. The bioreactor can hold a scaffold of desirable thickness for implantation (>2 mm). Coupling 3D culture and perfusion flow leads to the creation of a more biomimetic environment. We examined the ability of the bioreactor to maintain cell viability outside of an incubator environment (temperature and pH stability), investigated the flow features of the system (flow induced shear stress), and determined the image quality in order to perform time-lapsed imaging of two-dimensional (2D) and 3D cell culture. In situ imaging was performed on 2D and 3D, culture samples and cell viability was measured under perfusion flow (2.5 mL/min, 0.016 Pa). The visualization of cell response to their environment, in real time, will help to further elucidate the influences of biomaterial surface features, scaffold architectures, and the influence of flow induced shear on cell response and growth of new tissue. (C) 2006 Wiley Periodicals, Inc.
C1 Natl Inst Stand & Technol, Div Polymers, Gaithersburg, MD 20899 USA.
RP Dunkers, JP (reprint author), Natl Inst Stand & Technol, Div Polymers, 1000 Bur Dr, Gaithersburg, MD 20899 USA.
EM joy.dunkers@nist.gov
CR Altman Greg, 2002, FASEB Journal, V16, P270
   Bancroft GN, 2003, TISSUE ENG, V9, P549, DOI 10.1089/107632703322066723
   Bancroft GN, 2002, P NATL ACAD SCI USA, V99, P12600, DOI 10.1073/pnas.202296599
   Beckman M, 2003, SCIENCE, V300, P76, DOI 10.1126/science.300.5616.76
   Botchwey EA, 2003, J BIOMED MATER RES A, V67A, P357, DOI 10.1002/jbm.a.10111
   Botchwey EA, 2001, J BIOMED MATER RES, V55, P242
   Cartmell SH, 2003, TISSUE ENG, V9, P1197, DOI 10.1089/10763270360728107
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Czirok A, 2002, MOL BIOL CELL, V13, p551A
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Focht DC, 1996, NAT BIOTECHNOL, V14, P361, DOI 10.1038/nbt0396-361
   Goldstein AS, 2001, BIOMATERIALS, V22, P1279, DOI 10.1016/S0142-9612(00)00280-5
   Gomes ME, 2003, J BIOMED MATER RES A, V67A, P87, DOI 10.1002/jbm.a.10075
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Griffith LG, 2002, ANN NY ACAD SCI, V961, P83, DOI 10.1111/j.1749-6632.2002.tb03056.x
   Heilshorn SC, 2005, BIOMACROMOLECULES, V6, P318, DOI 10.1021/bm049627q
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hing WA, 2000, J MICROSC-OXFORD, V199, P90, DOI 10.1046/j.1365-2818.2000.00727.x
   Hoerstrup SP, 2000, TISSUE ENG, V6, P75, DOI 10.1089/107632700320919
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Holmes TC, 2002, TRENDS BIOTECHNOL, V20, P16, DOI 10.1016/S0167-7799(01)01840-6
   Janssen FW, 2006, BIOMATERIALS, V27, P315, DOI 10.1016/j.biomaterials.2005.07.044
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Koegler WS, 2004, BIOMATERIALS, V25, P2819, DOI 10.1016/j.biomaterials.2003.09.064
   Landis FA, 2006, BIOMACROMOLECULES, V7, P1751, DOI 10.1021/bm0600466
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lauffenburger DA, 2001, P NATL ACAD SCI USA, V98, P4282, DOI 10.1073/pnas.081083698
   Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19
   Lichtenberg A, 2005, BIOMATERIALS, V26, P555, DOI 10.1016/j.biomaterials.2004.02.063
   Liebschner MAK, 2004, BIOMATERIALS, V25, P1697, DOI 10.1016/S0142-9612(03)00515-5
   Lu LC, 1996, MRS BULL, V21, P28
   Martin Y, 2005, BIOMATERIALS, V26, P7481, DOI 10.1016/j.biomaterials.2005.05.057
   Meredith JC, 2003, J BIOMED MATER RES A, V66A, P483, DOI 10.1002/jbm.a.10004
   Minuth WW, 2000, J BIOMAT SCI-POLYM E, V11, P495, DOI 10.1163/156856200743832
   Pathi P, 2005, BIOTECHNOL BIOENG, V89, P743, DOI 10.1002/bit.20367
   Porter B, 2005, J BIOMECH, V38, P543, DOI 10.1016/j.jbiomech.2004.04.011
   Powers MJ, 2002, BIOTECHNOL BIOENG, V78, P257, DOI 10.1002/bit.10143
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Sikavitsas VI, 2005, ANN BIOMED ENG, V33, P63, DOI 10.1007/s10439-005-8963-x
   Sikavitsas VI, 2001, BIOMATERIALS, V22, P2581, DOI 10.1016/S0142-9612(01)00002-3
   Simon CG, 2005, BIOMATERIALS, V26, P6906, DOI 10.1016/j.biomaterials.2005.04.050
   Stephens DJ, 2003, SCIENCE, V300, P82, DOI 10.1126/science.1082160
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Thomas C, 1996, SCIENCE, V273, P603, DOI 10.1126/science.273.5275.603
   Vance J, 2005, TISSUE ENG, V11, P1832, DOI 10.1089/ten.2005.11.1832
   Wang Y, 2002, J BONE MINER RES, V17, pS338
   Washburn NR, 2004, BIOMATERIALS, V25, P1215, DOI 10.1016/j.biomaterials.2003.08.043
   WEINBAUM S, 1994, J BIOMECH, V27, P339, DOI 10.1016/0021-9290(94)90010-8
   Williams C, 2004, TISSUE ENG, V10, P930, DOI 10.1089/1076327041348536
   Yu XJ, 2004, P NATL ACAD SCI USA, V101, P11203, DOI 10.1073/pnas.0402532101
   Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183
NR 53
TC 26
Z9 29
U1 1
U2 11
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0006-3592
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD JUL 1
PY 2007
VL 97
IS 4
BP 952
EP 961
DI 10.1002/bit.21252
PG 10
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 177NC
UT WOS:000247158800028
PM 17149772
DA 2018-10-20
ER

PT J
AU Kim, MD
   Hoppe, H
   Pavcnik, D
   Kaufman, JA
   Uchida, BT
   Correa, LO
   Timmermans, HA
   Park, WK
   Corless, CL
   Keller, FS
   Rosch, J
AF Kim, Man Deuk
   Hoppe, Hanno
   Pavcnik, Dusan
   Kaufman, John A.
   Uchida, Barry T.
   Correa, Luiz O.
   Timmermans, Hans A.
   Park, Won Kyu
   Corless, Christopher L.
   Keller, Frederick S.
   Roesch, Josef
TI Percutaneous vein occlusion with small intestinal submucosa: An
   experimental pilot study in swine and sheep
SO CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
LA English
DT Article
DE animal model; ablation; biomaterial; embolization; varicose veins
ID ABDOMINAL AORTIC-ANEURYSM; VARICOSE-VEINS; LONG-TERM; REPAIR; FOAM
AB The objective of this study was to investigate the feasibility, outcomes, and amount of small intestinal submucosa (SIS) material needed for embolization of jugular vein (JV) in a swine and sheep model. Our hypothesis was that SIS would cause vein occlusion.
   The external JVs (EJV) in swine (n = 6) and JVs in sheep (n = 6) were occluded with SIS fan-folded compressed strips. After percutaneous puncture of the peripheral portion of the EJV or JV, a TIPS set was used to exit their lumen centrally through the skin. The SIS strips were delivered into the isolated venous segment with a pull-through technique via a 10-Fr sheath. Follow-up venograms were done immediately after placement and at the time of sacrifice at 1 or 3 months. Gross examinations focused on the EJV or JV and their surrounding structures. Specimens were evaluated by histology.
   SIS strip(s) placement was successful in all cases, with immediate vein occlusion seen in 23 of 24 veins (95.8%). All EJVs treated with two strips and all JVs treated with three or four strips remained closed on 1- and 3-month follow-up venograms. Two EJVs treated with one strip and one JV treated with two strips were partially patent on venograms at 1 and 3 months. There has been one skin inflammatory reaction. Necropsies revealed excluded EJV or JV segments with SIS incorporation into the vein wall. Histology demonstrated various stages of SIS remodeling with fibrocytes, fibroblasts, endothelial cells, capillaries, and inflammatory cells.
   We conclude that EJV and JV ablation with SIS strips using percutaneous exit catheterization is feasible and effective in animal models. Further exploration of SIS as vein ablation material is recommended.
C1 Oregon Hlth & Sci Univ, Dotter Intervent Inst, Portland, OR 97239 USA.
RP Pavcnik, D (reprint author), Oregon Hlth & Sci Univ, Dotter Intervent Inst, 3181 SW Jackson Pk RD, Portland, OR 97239 USA.
EM pavcnikd@ohsu.edu
CR Badylak S, 2002, J SURG RES, V103, P190, DOI 10.1006/jsre.2001.6349
   CALLAM MJ, 1994, BRIT J SURG, V81, P167, DOI 10.1002/bjs.1800810204
   Chang CJ, 2002, LASER SURG MED, V31, P257, DOI 10.1002/lsm.10103
   DARKE SG, 1992, EUR J VASCULAR SURG, V6, P512, DOI 10.1016/S0950-821X(05)80626-7
   DOTTER CT, 1967, AMER J ROENTGENOL RA, V100, P459, DOI 10.2214/ajr.100.2.459
   Forlee MV, 2006, J VASC SURG, V43, P162, DOI 10.1016/j.jvs.2005.09.032
   Frullini A, 2002, DERMATOL SURG, V28, P11, DOI 10.1046/j.1524-4725.2002.01182.x
   Grossklaus DJ, 2001, J UROLOGY, V166, P636, DOI 10.1016/S0022-5347(05)66033-8
   Min RJ, 2003, J VASC INTERV RADIOL, V14, P991, DOI 10.1091/01.RVI.0000082864.05622.E4
   Morrison C, 2003, J VASC SURG, V38, P886, DOI 10.1016/S0741-5214(03)00790-0
   Pavcnik D, 2002, J VASC SURG, V35, P598, DOI 10.1067/mva.2002.118825
   PREVEL CD, 1995, ANN PLAS SURG, V35, P374, DOI 10.1097/00000637-199510000-00008
   Proebstle TM, 1998, DERMATOL SURG, V24, P149, DOI 10.1111/j.1524-4725.1998.tb04068.x
   Rautio TT, 2002, J VASC INTERV RADIOL, V13, P569, DOI 10.1016/S1051-0443(07)61649-2
   Schoder M, 2004, J VASC INTERV RADIOL, V15, P69, DOI 10.1097/01.RVI.0000106394.63463.10
   VANRAMSHORST B, 1994, J VASC SURG, V19, P1059, DOI 10.1016/S0741-5214(94)70218-7
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   Yamada K, 2001, CARDIOVASC INTER RAD, V24, P99, DOI 10.1007/s002700000400
NR 18
TC 3
Z9 3
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0174-1551
J9 CARDIOVASC INTER RAD
JI Cardiovasc. Interv. Radiol.
PD JUL
PY 2007
VL 30
IS 4
BP 725
EP 730
DI 10.1007/s00270-007-9070-1
PG 6
WC Cardiac & Cardiovascular Systems; Radiology, Nuclear Medicine & Medical
   Imaging
SC Cardiovascular System & Cardiology; Radiology, Nuclear Medicine &
   Medical Imaging
GA 201KU
UT WOS:000248831000022
PM 17533542
DA 2018-10-20
ER

PT J
AU Suvarnakuta, P
   Devahastin, S
   Mujumdar, AS
AF Suvarnakuta, Peamsuk
   Devahastin, Sakamon
   Mujumdar, Arun S.
TI A mathematical model for low-pressure superheated steam drying of a
   biomaterial
SO CHEMICAL ENGINEERING AND PROCESSING
LA English
DT Article
DE beta-carotene evolution; carrot; deformation; finite element method;
   heat and mass transfer; liquid diffusion model; shrinkage
ID PRODUCT; SIMULATION; KINETICS
AB Low-pressure superheated steam drying (LPSSD) has recently received much attention as an alternative drying technique for heat-sensitive biomaterials. Although there are a number of works that report studies of this drying technique experimentally, there are a very limited number of works that report attempts to model this drying process. The aim of the present study was therefore to propose the use of a simple three-dimensional liquid diffusion based model to predict the evolutions of the moisture content and temperature of a product undergoing LPSSD. The effect of the product shrinkage was also included directly in the model and the effect of this inclusion on the predictability of the model is shown. The model was found to be able to predict the heat and mass transfer behavior as well as the change of a selected chemical quality, i.e., beta-carotene, of a model biomaterial viz., carrot cube reasonably well over some range of moisture content if accurate values of the heat. transfer coefficient were used. (c) 2006 Elsevier B.V. All rights reserved.
C1 King Mongkuts Univ Technol Thonburi, Dept Food Engn, Bangkok 10140, Thailand.
   Thammasat Univ, Dept Food Sci & Technol, Pathum Thani 12121, Thailand.
   Natl Univ Singapore, Dept Mech Engn, Singapore 117576, Singapore.
RP Devahastin, S (reprint author), King Mongkuts Univ Technol Thonburi, Dept Food Engn, 126 Pracha U Tid Rd, Bangkok 10140, Thailand.
EM sakamon.dev@kmutt.ac.th
OI Devahastin, Sakamon/0000-0001-9582-1554
CR Braud LM, 2001, J FOOD ENG, V50, P121, DOI 10.1016/S0260-8774(00)00234-X
   Caixeta AT, 2002, J FOOD PROCESS ENG, V25, P63, DOI 10.1111/j.1745-4530.2002.tb00556.x
   Defo M, 2004, DRY TECHNOL, V22, P2231, DOI [10.1081/DRT-200039984, 10.1081/LDRT-200039984]
   Devahastin S, 2004, DEHYDRATION OF PRODUCTS OF BIOLOGICAL ORIGIN, P493
   Devahastin S, 2004, DRY TECHNOL, V22, P1845, DOI [10.1081/DRT-200032818, 10.1081/LDRT-200032818]
   Elustondo D, 2001, J FOOD ENG, V49, P15, DOI 10.1016/S0260-8774(00)00180-1
   Hasatani M, 1996, DRY TECHNOL, V14, P1011, DOI 10.1080/07373939608917138
   Islam R, 2003, INT COMMUN HEAT MASS, V30, P391, DOI 10.1016/S0735-1933(03)00057-5
   Iyota H, 2001, DRY TECHNOL, V19, P1425, DOI 10.1081/DRT-100105298
   Mihoubi D, 2004, DRY TECHNOL, V22, P91, DOI 10.1081/DRT-120028216
   Moreira RG, 2001, J FOOD ENG, V49, P291, DOI 10.1016/S0260-8774(00)00225-9
   Mujumdar A. S., 2000, MUJUMDARS PRACTICAL, P115
   MULET A, 1994, J FOOD ENG, V22, P329, DOI 10.1016/0260-8774(94)90038-8
   Panyawong S, 2007, J FOOD ENG, V78, P151, DOI 10.1016/j.jfoodeng.2005.09.012
   POTTER NN, 1998, FOOD SCI, P208
   POTTER OE, 1984, P 4 INT DRYING S, P51
   SEYEDYAGOOBI J, 1999, DRYING TECHNOLOGY, V17, P191
   Siebel E, 1982, ICE REFRIG, V2, P256
   Suvarnakuta P, 2005, J FOOD SCI, V70, pS520, DOI 10.1111/j.1365-2621.2005.tb11528.x
   Suvarnakuta P, 2005, IND ENG CHEM RES, V44, P1934, DOI 10.1021/ie049675r
   SWEAT VE, 1974, J FOOD SCI, V39, P1080, DOI 10.1111/j.1365-2621.1974.tb07323.x
NR 21
TC 30
Z9 33
U1 0
U2 6
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0255-2701
J9 CHEM ENG PROCESS
JI Chem. Eng. Process.
PD JUL
PY 2007
VL 46
IS 7
BP 675
EP 683
DI 10.1016/j.cep.2006.09.002
PG 9
WC Energy & Fuels; Engineering, Chemical
SC Energy & Fuels; Engineering
GA 162AS
UT WOS:000246059300009
DA 2018-10-20
ER

PT J
AU Forch, R
   Chifen, AN
   Bousquet, A
   Khor, HL
   Jungblut, M
   Chu, LQ
   Zhang, Z
   Osey-Mensah, I
   Sinner, EK
   Knoll, W
AF Foerch, Renate
   Chifen, Anye N.
   Bousquet, Angelique
   Khor, Hwei Ling
   Jungblut, Melanie
   Chu, Li-Qiang
   Zhang, Zhihong
   Osey-Mensah, Ivy
   Sinner, Eva-Katrin
   Knoll, Wolfgang
TI Recent and expected roles of plasma-polymerized films for biomedical
   applications
SO CHEMICAL VAPOR DEPOSITION
LA English
DT Review
DE adhesion; allylamine; cell adhesion; hexamethyldisiloxane; neurons;
   plasma deposition; protein adsorption
ID CHEMICAL-VAPOR-DEPOSITION; TISSUE-ENGINEERING SCAFFOLDS; SCANNING FORCE
   MICROSCOPY; GLYCOL DIMETHYL ETHER; ALLYL ALCOHOL FILMS; PULSED PLASMA;
   PROTEIN ADSORPTION; ACRYLIC-ACID; MALEIC-ANHYDRIDE; GLOW-DISCHARGE
AB This review aims to provide a summary of some of the challenges in correlating surface science and biology, with particular emphasis on areas where plasma polymerization has and will play an important role as a method to synthesize reproducible and well-defined surfaces. Since the range of possible applications of plasma polymer films in biomaterial applications is immense, this paper will focus on processes to develop various surface morphologies and chemical structures for the immobilization of proteins and cells. Functional, plasma-polymerized films are discussed as biosensitive interfaces that may ultimately be part of a multilayer system that aims at connecting inorganic/metallic transducers with biologically reactive surfaces. These topics will be reviewed with some experimental results taken from the authors' own work. Specific aspects such as adhesion improvement and solvent effects are also discussed.
C1 Max Planck Inst Polymer Res, D-55128 Mainz, Germany.
RP Forch, R (reprint author), Max Planck Inst Polymer Res, Ackermannweg 10, D-55128 Mainz, Germany.
EM foerch@mpip-mainz.mpg.de
RI Sinner, Eva/G-9616-2012; Foerch, Renate/B-8198-2011
OI Sinner, Eva/0000-0001-9201-268X; 
CR Alexander MR, 1999, POLYMER, V40, P5479, DOI 10.1016/S0032-3861(98)00784-8
   Balazs DJ, 2004, BIOMATERIALS, V25, P2139, DOI 10.1016/j.biomaterials.2003.08.053
   BALAZS DJ, 2004, PLASMA PROCESS POLYM, P351
   Barry JJA, 2006, ADV MATER, V18, P1406, DOI 10.1002/adma.200502719
   Barry JJA, 2005, ADV FUNCT MATER, V15, P1134, DOI 10.1005/adfm.200400562
   Bender K., 2005, PLASMA POLYM RELATED, P32
   BENSCH W, 1990, SEMICOND SCI TECH, V5, P421, DOI 10.1088/0268-1242/5/5/008
   Beyer D, 1997, J BIOMED MATER RES, V36, P181, DOI 10.1002/(SICI)1097-4636(199708)36:2<181::AID-JBM6>3.0.CO;2-G
   BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513
   Burns NL, 1996, PROG COLL POL SCI S, V100, P271
   Burns NL, 1996, J COLLOID INTERF SCI, V178, P116, DOI 10.1006/jcis.1996.0099
   Calderon JG, 1998, MACROMOLECULES, V31, P3216, DOI 10.1021/ma970924f
   Calderon JG, 1997, ABSTR PAP AM CHEM S, V213, P534
   Canavan HE, 2005, LANGMUIR, V21, P1949, DOI 10.1021/la048546c
   Candan S, 1998, J VAC SCI TECHNOL A, V16, P1702, DOI 10.1116/1.581288
   Chan K, 2005, LANGMUIR, V21, P8930, DOI 10.1021/la051004q
   Cheng XH, 2005, LANGMUIR, V21, P7833, DOI 10.1021/la050417o
   Chifen AN, 2007, MATER LETT, V61, P1722, DOI 10.1016/j.matlet.2006.07.118
   Choi JG, 2002, BIOCHEM BIOPH RES CO, V293, P1566, DOI 10.1016/S0006-291X(02)00420-5
   CHOUKOUROV A, 2005, J PHYS CHEM B, V109, P23089
   Chu LQ, 2006, PLASMA PROCESS POLYM, V3, P498, DOI 10.1002/ppap.200600010
   Defife KM, 1999, J BIOMAT SCI-POLYM E, V10, P1063, DOI 10.1163/156856299X00685
   Dennler G, 2003, PLASMAS POLYM, V8, P43, DOI 10.1023/A:1022865825205
   DESAI NP, 1991, J BIOMED MATER RES, V25, P829, DOI 10.1002/jbm.820250704
   Detomaso L, 2005, BIOMATERIALS, V26, P3831, DOI 10.1016/j.biomaterials.2004.10.011
   DICHTER MA, 1978, BRAIN RES, V149, P279, DOI 10.1016/0006-8993(78)90476-6
   DOOLITTLE RF, 1984, ANNU REV BIOCHEM, V53, P195, DOI 10.1146/annurev.bi.53.070184.001211
   Evenson SA, 2000, CHEM MATER, V12, P3038, DOI 10.1021/cm000223o
   Favia P, 2002, J PHOTOPOLYM SCI TEC, V15, P341
   Favia P., 2000, PLASMAS POLYM, DOI [10.1023/A:1009517408368, DOI 10.1023/A:1009517408368]
   Feng XF, 2003, SURF COAT TECH, V171, P96, DOI 10.1016/S0257-8972(03)00246-9
   Forch R, 2005, PLASMA PROCESS POLYM, V2, P351, DOI 10.1002/ppap.200400083
   Fraser S, 2002, J PHYS CHEM B, V106, P5596, DOI 10.1021/jp012406j
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   Haddow DB, 2006, PLASMA PROCESS POLYM, V3, P419, DOI 10.1002/ppap.200606608
   HARMELI P, 2003, BIOMATERIALS, V24, P3989
   Harsch A, 2000, J NEUROSCI METH, V98, P135, DOI 10.1016/S0165-0270(00)00196-5
   Hollander A, 2005, SURF COAT TECH, V200, P561, DOI 10.1016/j.surfcoat.2005.01.091
   Igarashi S, 2006, SENSOR ACTUAT B-CHEM, V117, P43, DOI 10.1016/j.snb.2005.11.001
   Jenkins ATA, 2000, LANGMUIR, V16, P6381, DOI 10.1021/la991649o
   JOHNSON SD, 1992, J BIOMED MATER RES, V26, P915, DOI 10.1002/jbm.820260707
   Johnston EE, 1997, NATO ADV SCI I E-APP, V346, P465
   Kim KJ, 1997, J MEMBRANE SCI, V134, P199, DOI 10.1016/S0376-7388(97)00113-0
   KIRK CT, 1988, PHYS REV B, V38, P1255, DOI 10.1103/PhysRevB.38.1255
   Knoll W, 1998, ANNU REV PHYS CHEM, V49, P569, DOI 10.1146/annurev.physchem.49.1.569
   KNOLL W, 1997, HDB OPTICAL PROPERTI
   Kretschmann E, 1971, Z PHYS, V241, P312
   Kumar R, 2005, J BIOMED MATER RES B, V75B, P311, DOI 10.1002/jbm.b.30306
   Kurosawa S, 2002, J PHOTOPOLYM SCI TEC, V15, P323, DOI 10.2494/photopolymer.15.323
   Kurosawa S, 1997, MAT SCI ENG C-BIOMIM, V4, P291, DOI 10.1016/S0928-4931(97)00013-1
   LANGE P, 1989, J APPL PHYS, V66, P201, DOI 10.1063/1.344472
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lassen B, 1997, J COLLOID INTERF SCI, V186, P9, DOI 10.1006/jcis.1996.4529
   LEE JH, 1989, J BIOMED MATER RES, V23, P351, DOI 10.1002/jbm.820230306
   Liu S, 2005, LANGMUIR, V21, P8572, DOI 10.1021/la051449e
   LOPEZ GP, 1992, J BIOMED MATER RES, V26, P415, DOI 10.1002/jbm.820260402
   Lopez LC, 2005, SURF COAT TECH, V200, P1000, DOI 10.1016/j.surfcoat.2005.02.003
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Malmsten M, 1996, J COLLOID INTERF SCI, V177, P70, DOI 10.1006/jcis.1996.0007
   MARQUART M, 1980, J MOL BIOL, V141, P369, DOI 10.1016/0022-2836(80)90252-1
   MCBURNEY MW, 1994, SOMAT CELL MOLEC GEN, V20, P529, DOI 10.1007/BF02255843
   Mitchell SA, 2004, SURF SCI, V561, P110, DOI 10.1016/j.susc.2004.05.001
   MORRA M, 2001, BIOMATERIALS SURFACE, P307
   Ohring M., 2002, MAT SCI THIN FILMS D
   Oran U, 2005, PLASMA PROCESS POLYM, V2, P563, DOI 10.1002/ppap.200400075
   Rinsch CL, 1996, LANGMUIR, V12, P2995, DOI 10.1021/la950685u
   SAHLI S, 1994, THIN SOLID FILMS, V250, P206, DOI 10.1016/0040-6090(94)90187-2
   Sardella E, 2006, PLASMA PROCESS POLYM, V3, P456, DOI 10.1002/ppap.200600041
   Schiller S, 2002, CHEM MATER, V14, P235, DOI 10.1021/cm011139r
   Schonherr H, 2000, CHEM COMMUN, P1303, DOI 10.1039/b003756g
   Schonherr H, 2000, CHEM MATER, V12, P3689, DOI 10.1021/cm0010351
   Shen MC, 2001, J BIOMAT SCI-POLYM E, V12, P961, DOI 10.1163/156856201753252507
   Smith D. L., 1995, THIN FILM DEPOSITION
   Susut C, 2005, INT J PHARM, V288, P253, DOI 10.1016/j.ijpharm.2004.10.004
   Swaraj S, 2005, PLASMA PROCESS POLYM, V2, P572, DOI 10.1002/ppap.200500022
   Szili E, 2004, BIOSENS BIOELECTRON, V19, P1395, DOI 10.1016/j.bios.2003.12.019
   TANG L, 1998, J BIOMED RES, V28, P156
   Tarducci C, 2002, MACROMOLECULES, V35, P8724, DOI 10.1021/ma020456w
   Teare DOH, 2005, J PHYS CHEM B, V109, P22407, DOI 10.1021/jp052869f
   Thissen H, 2006, BIOMATERIALS, V27, P35, DOI 10.1016/j.biomaterials.2005.05.037
   Truica-Marasescu F, 2004, PLASMA PROCESS POLYM, V1, P153, DOI 10.1002/ppap.200400020
   Tseng DY, 1998, J BIOMED MATER RES, V42, P188, DOI 10.1002/(SICI)1097-4636(199811)42:2<188::AID-JBM4>3.0.CO;2-L
   Vallee C, 2000, J NON-CRYST SOLIDS, V272, P163, DOI 10.1016/S0022-3093(00)00232-5
   van Os M. T., 1997, P 13 INT S PLASM CHE, V3, P1298
   van Os MT, 1999, CHEM MATER, V11, P3252, DOI 10.1021/cm991068k
   Whittle JD, 2000, CHEM MATER, V12, P2664, DOI 10.1021/cm0002158
   WIGREN R, 1991, FEBS LETT, V280, P225, DOI 10.1016/0014-5793(91)80298-H
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003
   WOBUS AM, 1984, EXP CELL RES, V152, P212, DOI 10.1016/0014-4827(84)90246-5
   Wu QG, 2005, PLASMA PROCESS POLYM, V2, P401, DOI 10.1002/ppap.200500024
   Wu YLJ, 2000, COLLOID SURFACE B, V18, P235, DOI 10.1016/S0927-7765(99)00150-2
   YAMAGUCHI T, 1994, J MEMBRANE SCI, V95, P39, DOI 10.1016/0376-7388(94)85027-5
   Yuan Y, 2005, CHINESE CHEM LETT, V16, P1641
   Zhang Z, 2003, SURF COAT TECH, V174, P588, DOI 10.1016/S0257-8972(03)00806-5
   Zhang Z, 2003, LANGMUIR, V19, P4765, DOI 10.1021/la026980d
   Zhang ZH, 2003, MACROMOLECULES, V36, P7689, DOI 10.1021/ma034673o
NR 97
TC 100
Z9 102
U1 4
U2 62
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0948-1907
J9 CHEM VAPOR DEPOS
JI Chem. Vapor Depos.
PD JUL
PY 2007
VL 13
IS 6-7
BP 280
EP 294
DI 10.1002/cvde.200604035
PG 15
WC Electrochemistry; Materials Science, Coatings & Films; Physics,
   Condensed Matter
SC Electrochemistry; Materials Science; Physics
GA 194ZH
UT WOS:000248381800003
DA 2018-10-20
ER

PT J
AU Guan, XL
   Liu, XY
   Su, ZX
AF Guan, Xiaolin
   Liu, Xinyu
   Su, Zhixing
TI Synthesis and photophysical behaviors of temperature/pH-sensitive
   polymeric materials. I. Vinyl monomer bearing 9-aminoacridine and
   polymers
SO EUROPEAN POLYMER JOURNAL
LA English
DT Article
DE acridine-9-N-acrylamide; poly(acridine-9-N-acrylamide);
   poly(acridine-9-N-acrylamide-co-acrylamide); fluorescence;
   temperature/pH-sensitive
ID DIFFERENTIAL SCANNING CALORIMETRY; POLY(VINYL ALCOHOL); PHOTOCHEMICAL
   BEHAVIOR; EXCIMER EMISSION; ENERGY-TRANSFER; FLUORESCENCE; MEMBRANE;
   ACRIDINE; CHITOSAN; BINDING
AB A novel acrylic monomer bearing acriclinyl group, acridine-9-N-acrylamide (Ac-9AA) was synthesized from 9-aminoacridine (9AA) and acryloyl chloride in the presence of triethylamine in dry dichloromethane (CCl2) at room temperature. The synthesized Ac-9AA was identified by IR, MS and H-1 NMR spectra. Homopolymer of Ac-9AA was obtained using AIBN as a thermal initiator in THF under 65-70 degrees C and the average molecular weights (M-w) of poly(Ac-9AA) obtained was very low, being in the order of ca. 10(3). Copolymer of Ac-9AA and acrylamide was synthesized with thermal initiator and poly(Ac-9AA-co-AM) was characterized by the method of IR, UV-vis and DSC. The photophysical behaviors of Ac-9AA and its polymers were explored by recording the fluorescence spectra in solution, solid and film. In addition, the pH and temperature dependence on fluorescence of the water-soluble poly(Ac-9AA-co-AM) were investigated in detail. The results showed that the relative fluorescence intensity of poly(Ac-9AA-co-AM) had an excellent linear response to temperature in the range of 0-60 degrees C. Moreover, the fluorescence intensity increased continuously from low pH to high pH while the excitation maxima at 388 nm and emission maxima at 400 nm had redshift after the addition of HCl or NaOH, which results from the fact that the predominance of tautomeric forms of Ac-9AA changed at different medium. This investigation may provide a convenient way to prepared multifunctional macromolecule biomaterial bearing aminoacridine to probe pH and temperature in biological system. (c) 2007 Elsevier Ltd. All rights reserved.
C1 Lanzhou Univ, Coll Chem & Chem Engn, Inst Polymer Sci Engn, Lanzhou 730000, Peoples R China.
RP Su, ZX (reprint author), Lanzhou Univ, Coll Chem & Chem Engn, Inst Polymer Sci Engn, Lanzhou 730000, Peoples R China.
EM suzx@lzu.edu.cn
CR Carvell M, 1998, POLYMER, V39, P393, DOI 10.1016/S0032-3861(97)00283-8
   CASADIO R, 1995, BBA-BIOMEMBRANES, V1237, P23, DOI 10.1016/0005-2736(95)00075-E
   CLARK JN, 1992, POLYMER, V33, P3137, DOI 10.1016/0032-3861(92)90225-L
   DEOLIVEIRA HPM, 2003, CHEM PHYS, V290, P52
   DIBBERNBRUNELLI D, 1995, J PHOTOCH PHOTOBIO A, V85, P285, DOI 10.1016/1010-6030(94)03915-H
   Dittmer JJ, 2000, ADV MATER, V12, P1270, DOI 10.1002/1521-4095(200009)12:17<1270::AID-ADMA1270>3.0.CO;2-8
   GABRIELLA S, 2003, INT J ANTIMICROB AG, V22, P223
   GAJIWALA HM, 1995, MACROMOLECULES, V28, P481, DOI 10.1021/ma00106a010
   GANGOLA P, 1981, CHEM PHYS LETT, V80, P418, DOI 10.1016/0009-2614(81)85049-X
   Ghirmai S, 2005, J LABELLED COMPD RAD, V48, P855, DOI 10.1002/jlcr.960
   GRZESIEK S, 1989, BIOPHYS J, V55, P1101, DOI 10.1016/S0006-3495(89)82907-8
   GRZESIEK S, 1988, BIOCHIM BIOPHYS ACTA, V938, P411, DOI 10.1016/0005-2736(88)90139-3
   Guan XL, 2006, REACT FUNCT POLYM, V66, P1227, DOI 10.1016/j.reactfunctpolym.2006.03.005
   Guan XL, 2006, CHEM J CHINESE U, V27, P1145
   HARGREAVES JS, 1985, MACROMOLECULES, V18, P734, DOI 10.1021/ma00146a027
   Jones G, 1998, J PHOTOCH PHOTOBIO A, V113, P125, DOI 10.1016/S1010-6030(97)00326-2
   Kim SR, 1997, EUR POLYM J, V33, P1009, DOI 10.1016/S0014-3057(96)00301-1
   Komatsu T, 1998, POLYMER, V39, P2169, DOI 10.1016/S0032-3861(97)00520-X
   Lee TS, 2000, MACROMOL RAPID COMM, V21, P951
   LEWIS OG, 1968, PHYS CONSTANTS LINEA, P57
   Li FM, 1996, J POLYM SCI POL CHEM, V34, P1881
   LI S, 2003, PHOTOCHEMICAL THEORY
   Machado JC, 2000, J POLYM SCI POL PHYS, V38, P1045, DOI 10.1002/(SICI)1099-0488(20000415)38:8<1045::AID-POLB5>3.3.CO;2-E
   MARTINSFRANCHETTI SM, 1995, EUR POLYM J, V31, P467, DOI 10.1016/0014-3057(94)00182-0
   Melucci M, 2004, MACROMOLECULES, V37, P5692, DOI 10.1021/ma049102q
   Mi FL, 2005, BIOMACROMOLECULES, V6, P975, DOI 10.1021/bm049335p
   MILLER KJ, 1980, BIOPOLYMERS, V19, P2091, DOI 10.1002/bip.1980.360191111
   Muravenko OV, 2003, CYTOM PART A, V51A, P52, DOI 10.1002/cyto.a.10002
   Murza A, 1998, BIOSPECTROSCOPY, V4, P327, DOI 10.1002/(SICI)1520-6343(1998)4:5<327::AID-BSPY4>3.3.CO;2-8
   Murza A, 2003, BIOPOLYMERS, V72, P174, DOI 10.1002/bip.10336
   NAKANISHI S, 1994, J CHEM PHYS, V100, P3442, DOI 10.1063/1.466387
   NAKASHIMA K, 1993, LANGMUIR, V9, P2825, DOI 10.1021/la00035a017
   Oliveira HPM, 2004, J MOL STRUC-THEOCHEM, V674, P213, DOI [10.1016/j.theochem.2004.01.011, 10.1016/j.theochem.2004.01.001]
   Pereira RV, 2005, SPECTROCHIM ACTA A, V61, P2926, DOI 10.1016/j.saa.2004.11.009
   RAK J, 1992, J PHOTOCH PHOTOBIO A, V67, P287, DOI 10.1016/1010-6030(92)87003-R
   Risbud MV, 2000, DRUG DELIV, V7, P69
   SCHULDINER S, 1972, EUR J BIOCHEM, V25, P64, DOI 10.1111/j.1432-1033.1972.tb01667.x
   Sebestik J, 2006, J PEPT SCI, V12, P472, DOI 10.1002/psc.752
   SENAIT G, 2004, EUR J ORG CHEM, P3719
   SERGEI F, 1995, POLYM J, V27, P712
   Skurski P, 2001, J CHEM PHYS, V115, P11193, DOI 10.1063/1.1419059
   Stomphorst RG, 2001, J PHYS CHEM A, V105, P4235, DOI 10.1021/jp0041813
   SURESHKUMAR GK, 1993, BIOTECHNOL BIOENG, V41, P118, DOI 10.1002/bit.260410116
   Talhavini M, 1998, J PHOTOCH PHOTOBIO A, V114, P65, DOI 10.1016/S1010-6030(97)00307-9
   Viswanathan K, 1996, J PHOTOCH PHOTOBIO A, V95, P245, DOI 10.1016/1010-6030(95)04260-1
   Wilde G, 2000, J APPL PHYS, V87, P1141, DOI 10.1063/1.371991
   WINNIK MA, 1985, ACCOUNTS CHEM RES, V18, P73, DOI 10.1021/ar00111a002
NR 47
TC 9
Z9 10
U1 2
U2 13
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0014-3057
EI 1873-1945
J9 EUR POLYM J
JI Eur. Polym. J.
PD JUL
PY 2007
VL 43
IS 7
BP 3094
EP 3105
DI 10.1016/j.eurpolymj.2006.12.014
PG 12
WC Polymer Science
SC Polymer Science
GA 198QA
UT WOS:000248641400034
DA 2018-10-20
ER

PT J
AU Alberti, C
AF Alberti, C.
TI Metabolic and histological complications in ileal urinary diversion -
   Challenges of tissue engineering technology to avoid them
SO EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
LA English
DT Article
DE heal urinary diversion; metabolism; malignancy; tissue engineering;
   urology
ID FOLLOW-UP; ORTHOTOPIC NEOBLADDER; BLADDER REPLACEMENT; STEM-CELLS;
   MORPHOLOGICAL-CHANGES; ACELLULAR MATRIX; UROTHELIAL CELLS; MUCIN
   SECRETION; RENAL-FUNCTION; SMOOTH-MUSCLE
AB Patients with ileal continent urinary diversion may present some awkward challenges to internists which have a considerable role in their long-term management. The potential metabolic complications result from both unphysiological exposure of the ileum to urine and decrease in absorbitive bowell capacity. Moreover, a variety of histopathomorphosic changes have been reported in ileal segment because of chronic exposure to urine. The risk of malignancy, particularly at ureteroileal anastomosis, is well documented in several large series but the mechanisms of development tumor in intestinal segments used for urinary diversion remain uncertain. In. order to avoid both metabolic and tumoral complications of ileal urinary diversion, research has been conducted into using tissues other than bowell for bladder augmentation or replacement. Tissue engineering technologies provide intriguing means for the development of tissue that can mimic the barrier properties of the urotheliurn together with functional aptitudes of the smooth muscle wall. Recent advances in biomaterial sciences pose significant challenges for tissue engineering.
C1 Univ Parma, LD Surg Semeiot, I-43100 Parma, Italy.
RP Alberti, C (reprint author), Univ Parma, LD Surg Semeiot, I-43100 Parma, Italy.
CR Akbal C, 2006, J UROLOGY, V176, P1706, DOI 10.1016/j.juro.2006.04.085
   Alberti C, 2000, Minerva Urol Nefrol, V52, P219
   ALBERTI C, 1974, UROLOGIA, V41, P369
   ALCINI E, 1993, J UROLOGY, V149, P735, DOI 10.1016/S0022-5347(17)36195-5
   Aragona F, 1998, BRIT J UROL, V81, P55
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Atala Anthony, 1997, P149
   Atala A, 2006, CURR OPIN UROL, V16, P305, DOI 10.1097/01.mou.0000232055.20084.f6
   BISTOLFI F, 1991, BIOSTRUCTURES RAD OR, P53
   Carini M, 1996, J SUBMICR CYTOL PATH, V28, P527
   CHENG EY, 2000, WORLD J UROL, V18, P19
   Chung SY, 2006, LANCET, V367, P1215, DOI 10.1016/S0140-6736(06)68481-X
   Chung SY, 2005, J UROLOGY, V174, P353, DOI 10.1097/01.ju.0000161592.00434.c1
   Cross WR, 2003, BJU INT, V92, P165, DOI 10.1046/j.1464-410X.2003.04280.x
   Cruz DN, 1997, AM J MED, V102, P477, DOI 10.1016/S0002-9343(97)00020-X
   De Coppi P, 2007, J UROLOGY, V177, P369, DOI 10.1016/j.juro.2006.09.103
   Di Tonno F, 2001, EUR UROL, V39, P15, DOI 10.1159/000052552
   Eberli D, 2006, METHOD ENZYMOL, V420, P287, DOI 10.1016/S0076-6879(06)20013-2
   Feil G, 2006, EUR UROL, V50, P1330, DOI 10.1016/j.eururo.2006.05.041
   Fichtner J, 1999, UROL INT, V63, P40, DOI 10.1159/000030417
   FILMER RB, 1990, J UROLOGY, V143, P671, DOI 10.1016/S0022-5347(17)40055-3
   Fontaine E, 2000, BJU INT, V86, P195, DOI 10.1046/j.1464-410x.2000.00769.x
   Freeman JA, 1996, J UROLOGY, V156, P1615, DOI 10.1016/S0022-5347(01)65462-4
   GATTEGNO B, 1999, CURRIC UROL, P1
   GATTEGNO B, 1999, EUR UROL, V36
   Gerharz EW, 2003, BJU INT, V91, P143, DOI 10.1046/j.1464-4096.2003.04000.x
   Gilbert SM, 2005, J UROLOGY, V173, P1080, DOI 10.1097/01.ju.0000155248.57049.4e
   Gough DCS, 2001, BJU INT, V88, P739, DOI 10.1046/j.1464-4096.2001.gough.2464.x
   Gschwend JE, 2003, CURR OPIN UROL, V13, P477, DOI 10.1097/01.mou.0000098070.73234.b7
   HALL MC, 1993, J UROLOGY, V149, P664, DOI 10.1016/S0022-5347(17)36175-X
   HANKE P, 1990, UROL INT, V45, P84, DOI 10.1159/000281675
   Harrison BS, 2007, BIOMATERIALS, V28, P344, DOI 10.1016/j.biomaterials.2006.07.044
   Hautmann RE, 2003, J UROLOGY, V169, P834, DOI 10.1097/01.ju.0000029010.97686.eb
   Hohenfellner M, 1999, Curr Opin Urol, V9, P309, DOI 10.1097/00042307-199907000-00006
   Kerfoot BP, 1999, J UROLOGY, V162, P1685, DOI 10.1016/S0022-5347(05)68200-6
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Kojima Y, 1998, BRIT J UROL, V82, P114
   Lai JY, 2002, J UROLOGY, V168, P1853, DOI 10.1097/01.ju.0000030040.76258.5a
   Lane T, 2000, UROL INT, V64, P31, DOI 10.1159/000030479
   MacDonald RA, 2005, J BIOMED MATER RES A, V74A, P489, DOI 10.1002/jbm.a.30386
   Malone MJ, 1997, UROL CLIN N AM, V24, P723, DOI 10.1016/S0094-0143(05)70414-6
   MARCHEGGIANO A, 1991, BRIT J UROL, V67, P477, DOI 10.1111/j.1464-410X.1991.tb15190.x
   MCDOUGAL WS, 1992, J UROLOGY, V147, P1199, DOI 10.1016/S0022-5347(17)37517-1
   Meyer JP, 2004, BJU INT, V94, P1317, DOI 10.1111/j.1464-410X.2004.05164.x
   Minervini A, 2005, J UROLOGY, V173, P144, DOI 10.1097/01.ju.0000146718.15786.e8
   OPERPENNING F, 1999, NAT BIOTECHNOL, V17, P149
   PAGANO F, 1990, EUR UROL, V17, P149
   Parenti A, 1999, EUR UROL, V35, P98, DOI 10.1159/000019826
   Piechota HJ, 1998, J UROLOGY, V159, P1717, DOI 10.1097/00005392-199805000-00100
   Poulsen AL, 1997, BRIT J UROL, V79, P339, DOI 10.1046/j.1464-410X.1997.00376.x
   Racioppi M, 1997, UROLOGY, V50, P888, DOI 10.1016/S0090-4295(97)00455-X
   Racioppi M, 1999, UROLOGY, V54, P629, DOI 10.1016/S0090-4295(99)00317-9
   Ram-Liebig G, 2004, BJU INT, V94, P922, DOI 10.1111/j.1464-410X.2004.05061.x
   SAKANO S, 1995, J UROLOGY, V153, P146, DOI 10.1097/00005392-199501000-00052
   SCHELZI S, 1995, ACTA UROL ITAL, V4, P137
   Senkul T, 2003, SCAND J UROL NEPHROL, V37, P202, DOI 10.1080/00365590310008046
   Shieh SJ, 2005, SURGERY, V137, P1, DOI 10.1016/j.surg.2004.04.002
   Sievert KD, 2000, WORLD J UROL, V18, P19, DOI 10.1007/s003450050004
   SIMEONE C, 1994, UROLOGIA, V61, P229
   Singh G, 1997, BRIT J UROL, V79, P328, DOI 10.1046/j.1464-410X.1997.03274.x
   THOMAS DJ, 1990, J ROY SOC MED, V83, P557
   Valentini G, 2002, Minerva Gastroenterol Dietol, V48, P81
   WOODHOUSE CRJ, 1994, EUR UROL UPDATE SER, V3, P10
   Zhang YY, 2006, BJU INT, V98, P1100, DOI 10.1111/j.1464-410X.2006.06447.x
NR 64
TC 9
Z9 10
U1 0
U2 2
PU VERDUCI PUBLISHER
PI ROME
PA VIA GREGORIO VII, ROME, 186-00165, ITALY
SN 1128-3602
J9 EUR REV MED PHARMACO
JI Eur. Rev. Med. Pharmacol. Sci.
PD JUL-AUG
PY 2007
VL 11
IS 4
BP 257
EP 264
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 232XR
UT WOS:000251055000006
PM 17876961
DA 2018-10-20
ER

PT J
AU Safina, MN
   Safronova, TV
   Lukin, ES
AF Safina, M. N.
   Safronova, T. V.
   Lukin, E. S.
TI Calcium phosphate based ceramic with a resorbable phase and low
   sintering temperature
SO GLASS AND CERAMICS
LA English
DT Article
AB The use of glasses with eutectic compositions in the system CaO-P2O5 as a sintering aid and as a source of a resorbable phase for obtaining a composite biomaterial for bone implants is examined. The use of such glass has made it possible not only to lower the sintering temperature by realization of the mechanism of liquid-phase sintering but also to form a ceramic material possessing bioresorbability. The material obtained consists of calcium hydroxyapatite, vitlokite, and calcium pyrophosphate phases.
C1 [Safina, M. N.; Safronova, T. V.; Lukin, E. S.] DI Mendeleev Russian Chem Engn Univ, Moscow, Russia.
   [Safina, M. N.; Safronova, T. V.; Lukin, E. S.] Moscow MV Lomonosov State Univ, Moscow, Russia.
RP Safina, MN (reprint author), DI Mendeleev Russian Chem Engn Univ, Moscow, Russia.
RI Safronova, Tatiana/D-7285-2012
OI Safronova, Tatiana/0000-0002-9799-5029
CR Barinov S.M., 2005, BIOCERAMICS BASED CA
   GARELIK EI, 2006, COLL P INT SCI C FUN, V1
   Grover LM, 2005, J AM CERAM SOC, V88, P3096, DOI [10.1111/j.1551-2916.2005.00558.x, 10.1111/j.1551-2916.2005.00566.x]
   Jalota S, 2007, J BIOMED MATER RES B, V80B, P304, DOI 10.1002/jbm.b.30598
   Kanazawa T., 1998, INORGANIC PHOSPHATE
   Knowles JC, 2003, J MATER CHEM, V13, P2395, DOI 10.1039/b307119g
   LUKIN ES, 2000, STEKLO KERAM, P22
   Putlyaev V. I., 2005, STEKLO KERAM, P30
   Raynaud S, 2002, BIOMATERIALS, V23, P1065, DOI 10.1016/S0142-9612(01)00218-6
   [САФРОНОВА Т.В. Safronova T.V.], 2007, [Стекло и керамика, Steklo i keramika], P31
   Safronova T. V., 2006, KONSTR KOMPOZIT MAT, P39
   SAFRONOVA TV, 2007, IAN SSSR NEORG MATER, P1
   Tago K, 2005, J CERAM SOC JPN, V113, P669, DOI 10.2109/jcersj.113.669
   1969, BINARY SYSTEMS, V1
NR 14
TC 10
Z9 10
U1 1
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0361-7610
J9 GLASS CERAM+
JI Glass Ceram.
PD JUL
PY 2007
VL 64
IS 7-8
BP 238
EP 243
DI 10.1007/s10717-007-0060-1
PG 6
WC Materials Science, Ceramics
SC Materials Science
GA 240MG
UT WOS:000251591100006
DA 2018-10-20
ER

PT J
AU Piconi, C
   Maccauro, G
   Angeloni, M
   Rossi, B
   Learmonth, ID
AF Piconi, C.
   Maccauro, G.
   Angeloni, M.
   Rossi, B.
   Learmonth, I. D.
TI Zirconia heads in perspective: a survey of zirconia outcomes in total
   hip replacement
SO HIP INTERNATIONAL
LA English
DT Review
DE zirconia; hip replacement; prosthesis; wear debris; degradation
ID CERAMIC FEMORAL-HEAD; LOW-TEMPERATURE DEGRADATION; Y-TZP CERAMICS;
   POLYETHYLENE WEAR; ENVIRONMENTAL DEGRADATION; CATASTROPHIC FAILURE;
   PHASE-TRANSFORMATION; COBALT-CHROME; FOLLOW-UP; ARTHROPLASTY
AB Zirconia ball heads have been implanted successfully from the late 1980s, but reports of wear and fractures have raised concerns about this ceramic biomaterial. This paper reviews the literature on clinical wear of zirconia-polyethylene bearings, zirconia head degradation and fractures, analysing the different factors that have led to clinical failure, such as material source, manufacturing process and type of polyethylene. The results underline the need for more homogeneous clinical series. Careful follow-up of patients with zirconia-polyethylene bearings is recommended.
C1 Univ Cattolica Sacro Cuore, Dept Orthopaed, Rome, Italy.
   Univ Bristol, Dept Orthopaed Surg, Bristol, Avon, England.
RP Piconi, C (reprint author), Univ Cattolica Sacro Cuore, Dept Orthopaed, Rome, Italy.
OI MACCAURO, Giulio/0000-0002-7359-268X
CR Allain J, 1999, J BONE JOINT SURG BR, V81B, P835, DOI 10.1302/0301-620X.81B5.9454
   *AM SOC TEST MAT, 2004, F2393 ASTM
   *AM SOC TEST MAT, 1998, F1873 ASTM
   ARNAUD JP, 1997, 30 M SOC OTH OU PONT
   ARNAUD JP, 2005, ANN ORTHOPEDIQUES QU, V37, P25
   BANON F, 2000, 6 WORLD BIOM C WORKS
   Bianchi A E, 2004, J Appl Biomater Biomech, V2, P143
   Blaine L., 2001, KEY ENG MATER, V192, P553
   CALANDRUCCIO JH, 1997, SEMINARS ARTROP, V82, P135
   CALES B, 2000, MAITRISE ORTHOP, V96, P26
   CALES B, 2002, 4 J ORTH TEINT CLERM
   CALES B, 1995, 4 EUROCERAMICS, V8, P45
   Cales Bernard, 1995, P415
   CATON J, 2000, P INT S CHARL 2000 L, P107
   CATON J, 2004, J BONE JOINT SURG S2, V87, P120
   Caton JH, 2006, Bioceramics and Alternative Bearings in Joint Arthroplasty, P293, DOI 10.1007/978-3-7985-1635-9_45
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Clarke IC, 2003, J BONE JOINT SURG AM, V85A, P73, DOI 10.2106/00004623-200300004-00009
   DAMBREVILLE A, 1999, MAITRISE ORTHOP, V78, P1
   Dietrich A, 1996, J MATER SCI-MATER M, V7, P559, DOI 10.1007/BF00122179
   Dumbleton JH, 2002, J ARTHROPLASTY, V17, P649, DOI 10.1054/arth.2002.33664
   Grant KL, 2001, J MATER SCI-MATER M, V12, P557, DOI 10.1023/A:1011284016483
   Guazzato M, 2005, J DENT, V33, P9, DOI 10.1016/j.jdent.2004.07.001
   Hannink RHJ, 2000, J AM CERAM SOC, V83, P461
   Haraguchi K, 2001, J BONE JOINT SURG BR, V83B, P996, DOI 10.1302/0301-620X.83B7.12122
   HERBERTS P, 2005, 2004 WED ARTHR REG
   Hernigou P, 2003, J BONE JOINT SURG BR, V85B, P504, DOI 10.1302/0301-620X.85B4.13397
   Herrera A, 2004, CLIN ORTHOP RELAT R, P129, DOI 10.1097/01.blo.0000128973.73132.0b
   HIRANO M, 1992, BRIT CERAM TRANS J, V91, P139
   Hummer CD, 1995, J ARTHROPLASTY, V10, P848, DOI 10.1016/S0883-5403(05)80085-3
   *INT STAND ORG, 1997, 13356 ISO
   Jenny JY, 1998, REV CHIR ORTHOP, V84, P111
   JOHNSONWALLS D, 1986, J AM CERAM SOC, V69, P44, DOI 10.1111/j.1151-2916.1986.tb04691.x
   Kakehashi V, 1998, INT J PERIODONT REST, V18, P587
   Kiely Paul D, 2005, Acta Orthop Belg, V71, P429
   Kim YH, 2001, J BONE JOINT SURG BR, V83B, P742, DOI 10.1302/0301-620X.83B5.10941
   Kim YH, 2005, J BONE JOINT SURG AM, V87A, P1769, DOI 10.2106/JBJS.D.02572
   Kohal RJ, 2002, INT J PROSTHODONT, V15, P189
   Kosmac T, 2000, J BIOMED MATER RES, V53, P304, DOI 10.1002/1097-4636(2000)53:4<304::AID-JBM4>3.0.CO;2-S
   LAWSON S, 1995, J EUR CERAM SOC, V15, P485, DOI 10.1016/0955-2219(95)00035-S
   LEPISTO TT, 1992, CORROSION GLASS CERA, P492
   Liang B, 2005, KEY ENG MAT, V284-286, P971, DOI 10.4028/www.scientific.net/KEM.284-286.971
   Luthardt R G, 1999, Eur J Prosthodont Restor Dent, V7, P113
   Luthardt RG, 2002, J DENT RES, V81, P487, DOI 10.1177/154405910208100711
   Maccauro G, 2004, J BONE JOINT SURG BR, V86B, P1192, DOI 10.1302/0301-620X.86B8.15012
   Masonis JL, 2004, J ARTHROPLASTY, V19, P898, DOI 10.1016/j.arth.2004.02.045
   Medical Devices Agency-Adverse Incident Centre, 1996, ZIRC CER HEADS MOD T
   *MIN EMPL SOL DEC, 2001, TEXTES GENERAUX, V200, P13884
   Nakamura T, 2004, KEY ENG MAT, V254-2, P607, DOI 10.4028/www.scientific.net/KEM.254-256.607
   Nakamura T, 2003, KEY ENG MAT, V240-2, P823, DOI 10.4028/www.scientific.net/KEM.240-242.823
   Norton MR, 2002, J BONE JOINT SURG BR, V84B, P631, DOI 10.1302/0301-620X.84B5.12679
   Oonishi H., 1999, RELIABILITY LONG TER, P7
   PAULE R, 2000, 6 WORLD BIOM C WORKS, P7
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Piconi C, 1998, BIOMATERIALS, V19, P1489, DOI 10.1016/S0142-9612(98)00064-7
   Rieger W., 2001, WORLD TRIBOLOGY FORU, P283
   Ross IM, 2001, SCRIPTA MATER, V45, P653, DOI 10.1016/S1359-6462(01)01076-4
   Santos EM, 2004, J ARTHROPLASTY, V19, P30, DOI 10.1016/j.arth.2004.06.017
   SATO T, 1985, J AM CERAM SOC, V68, P356, DOI 10.1111/j.1151-2916.1985.tb15239.x
   Scott DL, 2000, J ARTHROPLASTY, V15, P35, DOI 10.1016/S0883-5403(00)91103-3
   SHIMIZU K, 1993, J BIOMED MATER RES, V27, P729, DOI 10.1002/jbm.820270605
   Skyrme AD, 2005, HIP INT, V15, P63, DOI 10.5301/HIP.2008.2705
   Smith Harvey E, 2004, Neurosurg Focus, V17, pE3
   STEWART T, 2005, P 51 ORTH RES SOC M, P1167
   SWAB JJ, 1991, J MATER SCI, V26, P6706, DOI 10.1007/BF02402664
   TSUBAKINO H, 1991, J AM CERAM SOC, V74, P440, DOI 10.1111/j.1151-2916.1991.tb06905.x
   UENO M, 2000, 6 WORLD BIOM C WORKS
   Visentin M, 2006, J BIOMATER APPL, V21, P131, DOI 10.1177/0885328206058786
   von Schewelov T, 2005, J BONE JOINT SURG BR, V87B, P1631, DOI 10.1302/0301-620X.87B12.16873
   WEBER W, 2000, KEY ENG MATER, V192, P841
   Wroblewski BM, 2003, J BONE JOINT SURG BR, V85B, P376, DOI 10.1302/0301-620X.85B3.13817
   Wroblewski M, 2004, J ORTHOP SCI, V9, P253, DOI 10.1007/s00776-004-0777-4
   YOSHIMURA M, 1987, J MATER SCI LETT, V6, P465, DOI 10.1007/BF01756800
NR 73
TC 13
Z9 13
U1 0
U2 10
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 1120-7000
J9 HIP INT
JI Hip Int.
PD JUL-SEP
PY 2007
VL 17
IS 3
BP 119
EP 130
DI 10.5301/HIP.2008.2496
PG 12
WC Orthopedics
SC Orthopedics
GA 237RF
UT WOS:000251393400001
PM 19197856
DA 2018-10-20
ER

PT J
AU Gao, CJ
   Huo, SJ
   Li, XL
   You, XD
   Zhang, Y
   Gao, JP
AF Gao, Chunjuan
   Huo, Shujuan
   Li, Xiulan
   You, Xiudong
   Zhang, Yang
   Gao, Jianping
TI Characteristics of calcium sulfate/gelatin composite biomaterials for
   bone repair
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE calcium sulfate; gelatin; composite; bone repair
ID HYDROXYAPATITE; SULFATE; GELATIN; DEFECTS; PHOSPHATE; PLASTER; PARIS;
   COLLAGEN; REGENERATION; SUBSTITUTES
AB A novel hybrid biomaterial composed of calcium sulfate (CS) and gelatin (GEL) was prepared with the potential of being used as bone filler or scaffold owing to its osteoconduction. Such composite biomaterial, cross-linked or un-cross-linked, could provide a suitable absorbing rate and prevent the CS crystals migrating from the implant for tissue engineering. The structure of the composite was analyzed with infrared (IR) spectroscopy, X-ray diffraction (XRD) and scanning electron microscopy (SEM). The results indicated that the crystal pattern of CS was affected by the addition of GEL. The GEL part affected the development of the CS dihydrate (CSD) crystal by slowing the conversion from CS hemihydrate (CSH) to CSD; thus, the composite actually contained CSD, CSH and GEL. The compressive strength of the CS/CLGEL composite was also investigated. The compressive strength was correlated to the weight proportions of CS in the CS/cross-linked GEL (CS/CLGEL) composite, and the highest compressive strength of 82 MPa was obtained for the composite containing 40 wt% CS. The in vitro absorption test and the SEM results showed that a porous scaffold was formed in situ with the absorption of CS in the CS/CLGEL composite in a certain time. Therefore, the CS/CLGEL composite material can be used as an in situ porous scaffold with a high initial mechanical strength, and the remaining porous GEL scaffold will enable further in-growth of cells. Human osteoblasts were cultured in contact with the CS/CLGEL composite and the primary results suggested that human osteoblasts could attach and spread on the surface of CS/CLGEL films. The preliminary animal model experiment was operated for assessing the potential of the CS/CLGEL composite as a biodegradable bone substitute. The primary results showed that the CS/CLGEL composite filler could promote new bone in-growth, which will stimulate further study.
C1 Tianjin Univ, Sch Sci, Tianjin 300072, Peoples R China.
   Tianjin Univ, Sch Chem Engn, Tianjin 300072, Peoples R China.
   LG Chem Engn Plast Co, Tianjin, Peoples R China.
   Tianjin Orthoped Hosp, Tianjin 300211, Peoples R China.
   Acad Mil Med sci, Inst Med Equipment, Tianjin 300161, Peoples R China.
RP Gao, JP (reprint author), Tianjin Univ, Sch Sci, Tianjin 300072, Peoples R China.
EM chjg326@hotmail.com
CR Agrawal CM, 1997, J BIOMED MATER RES, V38, P105, DOI 10.1002/(SICI)1097-4636(199722)38:2<105::AID-JBM4>3.0.CO;2-U
   Al Ruhaimi KA, 2000, INT J ORAL MAX IMPL, V15, P859
   ALDERMAN NE, 1969, J PERIODONTOL, V40, P11, DOI 10.1902/jop.1969.40.1.11
   Alexander DI, 2001, CAN J SURG, V44, P262
   Bakos D, 1999, BIOMATERIALS, V20, P191, DOI 10.1016/S0142-9612(98)00163-X
   Bigi A, 1998, BIOMATERIALS, V19, P739, DOI 10.1016/S0142-9612(97)00194-4
   Bonfield W, 1988, Ann N Y Acad Sci, V523, P173, DOI 10.1111/j.1749-6632.1988.tb38510.x
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Chen GP, 2001, J BIOMED MATER RES, V57, P8, DOI 10.1002/1097-4636(200110)57:1<8::AID-JBM1135>3.0.CO;2-H
   Chen TM, 1998, MATER CHEM PHYS, V55, P44, DOI 10.1016/S0254-0584(98)00049-2
   COBDEN RH, 1976, J BONE JOINT SURG AM, V58, P70, DOI 10.2106/00004623-197658010-00012
   DAMIEN CJ, 1994, CALCIFIED TISSUE INT, V55, P151, DOI 10.1007/BF00297191
   DEGROOT K, 1983, BIOCERAMICS CALCIUM, P100
   EDWARDS MSB, 1987, NEUROSURGERY, V20, P273, DOI 10.1227/00006123-198702000-00013
   GEORGIADE NG, 1993, AESTHET PLAST SURG, V17, P85, DOI 10.1007/BF02274726
   Gitelis S, 2001, ORTHOPEDICS, V24, P162
   GURALNICK WC, 1948, ORAL SURG ORAL MED O, V1, P632, DOI 10.1016/0030-4220(48)90337-5
   HIGASHI S, 1986, BIOMATERIALS, V7, P183, DOI 10.1016/0142-9612(86)90099-2
   Ignjatovic N, 1999, BIOMATERIALS, V20, P809, DOI 10.1016/S0142-9612(98)00234-8
   Kasuga T, 2001, BIOMATERIALS, V22, P19, DOI 10.1016/S0142-9612(00)00091-0
   Khairoun I, 1997, BIOMATERIALS, V18, P1535, DOI 10.1016/S0142-9612(97)80005-1
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LATTES R, 1946, ANN SURG, V124, P28, DOI 10.1097/00000658-194607000-00002
   LIGHT RU, 1945, ARCH SURG-CHICAGO, V51, P69, DOI 10.1001/archsurg.1945.01230040074001
   Lin FH, 1998, BIOMATERIALS, V19, P905, DOI 10.1016/S0142-9612(97)00202-0
   Liu Q, 1997, BIOMATERIALS, V18, P1263, DOI 10.1016/S0142-9612(97)00069-0
   Mao JS, 2003, BIOMATERIALS, V24, P1067, DOI 10.1016/S0142-9612(02)00442-8
   Maragos P, 2002, INT J PERIODONT REST, V22, P493
   MCNEILL SR, 1999, J CLIN PERIODONTOL, V26, P239
   Meinig RP, 1997, J ORTHOP TRAUMA, V11, P551, DOI 10.1097/00005131-199711000-00002
   MIKI T, 2001, J CRANIOMAXILLOFAC S, V28, P294
   PELTIER LF, 1959, AM J SURG, V97, P311, DOI 10.1016/0002-9610(59)90305-8
   Pietrzak WS, 2000, J CRANIOFAC SURG, V11, P327, DOI 10.1097/00001665-200011040-00009
   PILCHER C, 1945, SURG GYNECOL OBSTET, V81, P365
   Ren L, 2002, BIOMATERIALS, V23, P4765, DOI 10.1016/S0142-9612(02)00226-0
   Rizzi SC, 2001, J BIOMED MATER RES, V55, P475, DOI 10.1002/1097-4636(20010615)55:4<475::AID-JBM1039>3.0.CO;2-Q
   SALYER KE, 1995, PLAST RECONSTR SURG, V96, P770, DOI 10.1097/00006534-199509001-00002
   Sato S, 1998, BIOMATERIALS, V19, P1895, DOI 10.1016/S0142-9612(98)00102-1
   Shikinami Y, 1999, BIOMATERIALS, V20, P859, DOI 10.1016/S0142-9612(98)00241-5
   SIDQUI M, 1995, BIOMATERIALS, V16, P1327, DOI 10.1016/0142-9612(95)91048-4
   TAHERI ZE, 1971, J NEUROSURG, V34, P438, DOI 10.3171/jns.1971.34.3.0438a
   Tamura H., 2000, POLYM PREPRINTS, V41, P1032
   Tay BKB, 1999, ORTHOP CLIN N AM, V30, P615, DOI 10.1016/S0030-5898(05)70114-0
   Wang M, 2001, BIOMATERIALS, V22, P1311, DOI 10.1016/S0142-9612(00)00283-0
   ZHENG CJ, 1996, 96 CHIN MRC P BEIJ, P85
NR 45
TC 17
Z9 20
U1 1
U2 16
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PD JUL
PY 2007
VL 18
IS 7
BP 799
EP 824
DI 10.1163/156856207781367710
PG 26
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 201GU
UT WOS:000248820300001
PM 17688742
DA 2018-10-20
ER

PT J
AU Takamoto, T
   Hiraoka, Y
   Tabata, Y
AF Takamoto, Tomoaki
   Hiraoka, Yosuke
   Tabata, Yasuhiko
TI Enhanced proliferation and osteogenic differentiation of rat mesenchymal
   stem cells in collagen sponge reinforced with different poly(ethylene
   terephthalate) fibers
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE mesenchymal stem cell; osteogenic differentiation; collagen sponge;
   three-dimensional scaffold; fiber reinforcement; poly(ethylene
   terephthalate)
ID STROMAL CELLS; POLY(LACTIC ACID-CO-LYSINE); FIBROBLAST-GROWTH;
   BONE-MARROW; IN-VITRO; TISSUE; BIOMATERIAL; REPLACEMENT; CULTURE; MUSCLE
AB The objective of this study was to investigate the feasibility of collagen sponges mechanically reinforced by the incorporation of poly(ethylene terephthalate) (PET) fibers in stem cell culture. A collagen solution with homogeneously dispersed PET fibers was freeze-dried, followed by dehydrothermal cross-linking to obtain the collagen sponge incorporating PET fibers. By scanning electron microscopy observation, the collagen sponges exhibited isotropic and interconnected pore structures with an average size of 200 mu m, irrespective of PET fiber incorporation. As expected, PET fibers incorporation significantly enhanced the compression strength of collagen sponge. When used for rat mesenchymal stem cells (MSC), the collagen sponge incorporating PET fibers was superior to the original collagen sponge without PET fibers incorporation in terms of the initial attachment, proliferation and osteogenic differentiation of cells, irrespective of the amount and diameter of fibers incorporated. The shrinkage of sponges during cell culture was significantly suppressed by the fiber incorporation. It is possible that the shrinkage suppression maintains the three-dimensional inner pore structure of collagen sponges without impairing the cell compatibility, resulting in the superior MSC attachment and the subsequent osteogenic differentiation in the sponge incorporating PET fiber.
C1 Kyoto Univ, Dept Biomat, Inst Frontier Med Sci, Field Tissue Engn,Sakyo Ku, Kyoto 6068507, Japan.
RP Tabata, Y (reprint author), Kyoto Univ, Dept Biomat, Inst Frontier Med Sci, Field Tissue Engn,Sakyo Ku, 53 Kawara Cho, Kyoto 6068507, Japan.
EM yasuhiko@frontier.kyoto-u.ac.jp
CR Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a
   BARRERA DA, 1993, J AM CHEM SOC, V115, P11010, DOI 10.1021/ja00076a077
   Carrier RL, 1999, BIOTECHNOL BIOENG, V64, P580, DOI 10.1002/(SICI)1097-0290(19990905)64:5<580::AID-BIT8>3.0.CO;2-X
   Chamberlain LJ, 2000, J NEUROSCI RES, V60, P666, DOI 10.1002/(SICI)1097-4547(20000601)60:5<666::AID-JNR12>3.0.CO;2-0
   Chen GP, 2005, BIOMATERIALS, V26, P2559, DOI 10.1016/j.biomaterials.2004.07.034
   Chen GP, 2000, J BIOMED MATER RES, V51, P273, DOI 10.1002/(SICI)1097-4636(200008)51:2<273::AID-JBM16>3.0.CO;2-O
   Cook AD, 1997, J BIOMED MATER RES, V35, P513
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Fujita M, 2005, TISSUE ENG, V11, P1346, DOI 10.1089/ten.2005.11.1346
   GRIGORIADIS AE, 1988, J CELL BIOL, V106, P2139, DOI 10.1083/jcb.106.6.2139
   Hiraoka Y, 2003, TISSUE ENG, V9, P1101, DOI 10.1089/10763270360728017
   Kim BS, 1998, BIOTECHNOL BIOENG, V57, P46
   Kim BS, 1999, EXP CELL RES, V251, P318, DOI 10.1006/excr.1999.4595
   Kimura Y, 2003, BIOMATERIALS, V24, P2513, DOI 10.1016/S0142-9612(03)00049-8
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LENNON DP, 1995, EXP CELL RES, V219, P211, DOI 10.1006/excr.1995.1221
   Lennon DP, 2000, DEV DYNAM, V219, P50, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1037>3.0.CO;2-7
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   MIYATA T, 1992, Clinical Materials, V9, P139, DOI 10.1016/0267-6605(92)90093-9
   NATSUME T, 1993, J BIOMED MATER RES, V27, P867, DOI 10.1002/jbm.820270705
   Quester R, 2003, BIOMATERIALS, V24, P711, DOI 10.1016/S0142-9612(02)00320-4
   RAO J, 1992, ANAL BIOCHEM, V207, P186, DOI 10.1016/0003-2697(92)90521-8
   Rault I, 1996, J MATER SCI-MATER M, V7, P215, DOI 10.1007/BF00119733
   STENZEL KH, 1974, ANNU REV BIOPHYS BIO, V3, P231, DOI 10.1146/annurev.bb.03.060174.001311
   Tabata Y, 2001, DRUG DISCOV TODAY, V6, P483, DOI 10.1016/S1359-6446(01)01753-6
   Takahashi Y, 2004, J BIOMAT SCI-POLYM E, V15, P41, DOI 10.1163/156856204322752228
   Takahashi Y, 2003, TISSUE ENG, V9, P931, DOI 10.1089/107632703322495574
   TAMADA Y, 1994, J BIOMED MATER RES, V28, P783, DOI 10.1002/jbm.820280705
   Teramachi M, 1997, ANN THORAC SURG, V64, P965, DOI 10.1016/S0003-4975(97)00755-8
   Vacanti JP, 1999, LANCET, V354, pSI32
   Yamamoto Y, 1999, ASAIO J, V45, P311, DOI 10.1097/00002480-199907000-00011
   YANNAS IV, 1982, SCIENCE, V215, P174, DOI 10.1126/science.7031899
   Yasuda K, 2004, TISSUE ENG, V10, P1587, DOI 10.1089/1076327042500418
NR 33
TC 16
Z9 16
U1 0
U2 6
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PD JUL
PY 2007
VL 18
IS 7
BP 865
EP 881
DI 10.1163/156856207781367738
PG 17
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 201GU
UT WOS:000248820300004
PM 17688745
DA 2018-10-20
ER

PT J
AU Zhang, M
   Pare, P
   King, R
   James, SP
AF Zhang, Min
   Pare, Philippe
   King, Richard
   James, Susan P.
TI A novel ultra high molecular polyethylene-hyaluronan micr use in total
   joint replacements. II. Mechanical and tribological property weight
   ocomposite for evaluation
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE UHMWPE; hyaluronan; microcomposites; wear; tensile test
AB The mechanical and tribological properties of a new biomaterial, an ultra high molecular weight polyethylene-hyaluronan (UHMWPE-HA) microcomposite, were investigated in this article, which is Part II of a two-part study. Part I presented the synthesis and physical/chemical characterization of the novel microcomposites. The microcomposite was developed for bearing surfaces of total joint replacements and was designed to enhance lubrication and improve wear resistance compared to noncrosslinked UHMWPE. Pin-on-flat wear tests with crosspath motion demonstrated significant decreases for both the wear and wear rate of UHMWPE with the presence of hyaluronan (HA) within and on the microcomposite. Compared to noncrosslinked UHMWPE, a maximum decrease of 56% in wear and a maximum decrease of 31% in wear rate were observed at 1.0 million cycles. Inferior tensile properties were observed for the microcomposites when compared to noncrosslinked UHMWPE, which resulted from poor intermolecular entanglement of the UHMWPE caused by low remolding temperature throughout microcomposite manufacturing. Similar results were observed for the sham control, which was processed in the same way as the microcomposite, except for the addition of HA. (c) 2007 Wiley Periodicals, Inc.
C1 Colorado State Univ, Biomed Engn Program, Dept Mech Engn, Ft Collins, CO 80523 USA.
   Zimmer Inc, Warsaw, IN 46581 USA.
   DePuy Orthopaed Inc, Warsaw, IN 46581 USA.
RP James, SP (reprint author), Colorado State Univ, Biomed Engn Program, Dept Mech Engn, Ft Collins, CO 80523 USA.
EM sjames@engr.colostate.edu
CR ASKELAND DR, 1994, SCI ENG MAT, P175
   Balazs E. A., 1970, CHEMISTRY MOLECULAR, P1241
   BENNETT AP, 1995, HSS POLY HISOLIDUR H
   BENNETT AP, 1996, T 42 ANN M ORTH RES, P472
   Bragdon C R, 1996, Proc Inst Mech Eng H, V210, P157, DOI 10.1243/PIME_PROC_1996_210_408_02
   Hoekstra D., 1999, MED DEVICES DIAGNOST, P51
   Kawate K, 1999, JOINT ARTHROPLASTY, P87
   KELLY JM, 2000, POLYM MODIFICATION, P273
   KING R, 2005, T 50 ANN M ORTH RES, P1682
   Kurtz SM, 1999, BIOMATERIALS, V20, P1659, DOI 10.1016/S0142-9612(99)00053-8
   Laurent TC, 1970, CHEMISTRY MOLECULAR, V2, P703, DOI DOI 10.1038/NRC3023
   Ogston AG, 1970, CHEMISTRY MOLECULAR, P1231
   Pruitt LA, 2005, BIOMATERIALS, V26, P905, DOI 10.1016/j.biomaterials.2004.03.022
   RENTFROW E, 1999, THESIS COLORADO STAT
   Unsworth A, 1995, TRIBOL INT, V28, P485, DOI 10.1016/0301-679X(95)00027-2
   UNSWORTH A, 1978, PHYS MED BIOL, V23, P253, DOI 10.1088/0031-9155/23/2/004
   Zhang M, 2005, POLYMER, V46, P3639, DOI 10.1016/j.polymer.2005.03.022
   ZHANG M, 2001, 27 ANN M T SOC BIOM, P479
   Zhang M, 2006, J BIOMED MATER RES A, V78A, P86, DOI 10.1002/jbm.a.30701
NR 19
TC 15
Z9 18
U1 0
U2 11
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2007
VL 82A
IS 1
BP 18
EP 26
DI 10.1002/jbm.a.31141
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 176MN
UT WOS:000247089500003
PM 17265440
DA 2018-10-20
ER

PT J
AU Cornwell, KG
   Pins, GD
AF Cornwell, Kevin G.
   Pins, George D.
TI Discrete crosslinked fibrin microthread scaffolds for tissue
   regeneration
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE fibrin; tissue regeneration; threads; wound healing
ID COLLAGEN-FIBERS; LINKING; GLUE; GEL; TRANSPLANTATION; EQUIVALENTS;
   MATRIX; REPAIR; CELLS
AB In this study, we report on the development of discrete fibrin microthreads as well as novel scaffolds composed of arrays of fibrin threads. These scaffolds exhibit mechanical properties that are significantly greater than fibrin gels and cellular responses suggesting that the materials are conducive to the development of organized, aligned tissues. Fibrin microthreads were produced by coextruding solutions of 70 mg/mL fibrinogen and 6 U/mL thrombin through small diameter polyethylene tubing. Uncrosslinked fibrin microthreads averaged 55-65 mu m in hydrated diameter and achieved ultimate tensile strengths approaching 4.5 MPa. The strengths and stiffnesses of the microthreads were approximately twofold greater when the materials were treated with exposure to ultraviolet (UV) light. Although UV crosslinking attenuated fibroblast proliferation, uncrosslinked fibrin microthreads supported fibroblast attachment, proliferation, and alignment, suggesting that they represent a viable biomaterial for the aligned regeneration of tissues. Because of the physiologic roles of fibrin matrices in the early phase of wound healing, we anticipate that these fibrin-based microthreads will direct the spatially and temporally complex processes of cell-mediated tissue ingrowth and regeneration. (c) 2007 Wiley Periodicals, Inc.
C1 Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01609 USA.
   Univ Massachusetts, Sch Med, Grad Sch Biomed Sci, Worcester, MA 01655 USA.
RP Pins, GD (reprint author), Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01609 USA.
EM gpins@wpi.edu
OI Pins, George/0000-0002-8844-8074; Cornwell, Kevin/0000-0002-9732-1788
CR Ameer GA, 2002, J ORTHOPAED RES, V20, P16, DOI 10.1016/S0736-0266(01)00074-2
   Bellincampi LD, 1997, J APPL POLYM SCI, V63, P1493, DOI 10.1002/(SICI)1097-4628(19970314)63:11<1493::AID-APP11>3.0.CO;2-3
   Billiar KL, 2005, J BIOMED MATER RES A, V73A, P182, DOI 10.1002/jbm.a.30282
   Clark RAF, 2000, EXPERT OPIN INV DRUG, V9, P2371, DOI 10.1517/13543784.9.10.2371
   Clark RAF, 2003, J INVEST DERMATOL, V121, pXXI, DOI 10.1046/j.1523-1747.2003.12575.x
   Clark RAF, 2001, ANN NY ACAD SCI, V936, P355
   Doillon CJ, 2002, METHODS TISSUE ENG, P555
   DUNN MG, 1995, J BIOMED MATER RES, V29, P1363, DOI 10.1002/jbm.820291107
   Fussenegger M, 2003, ANN PLAS SURG, V51, P493, DOI 10.1097/01.sap.0000067726.32731.E1
   Gorodetsky R, 1999, J INVEST DERMATOL, V112, P866, DOI 10.1046/j.1523-1747.1999.00600.x
   Hokugo A, 2006, BIOMATERIALS, V27, P61, DOI 10.1016/j.biomaterials.2005.05.030
   Hunter CJ, 2004, OSTEOARTHR CARTILAGE, V12, P117, DOI 10.1016/j.joca.2003.08.009
   Jockenhoevel S, 2001, EUR J CARDIO-THORAC, V19, P424, DOI 10.1016/S1010-7940(01)00624-8
   Lee CR, 2005, TISSUE ENG, V11, P1562, DOI 10.1089/ten.2005.11.1562
   Long JL, 2003, MATRIX BIOL, V22, P339, DOI 10.1016/S0945-053X(03)00052-0
   Mol A, 2005, BIOMATERIALS, V26, P3113, DOI 10.1016/j.biomaterials.2004.08.007
   Pins GD, 2000, J INVEST DERMATOL, V114, P647, DOI 10.1046/j.1523-1747.2000.00858.x
   Pins GD, 1997, BIOPHYS J, V73, P2164, DOI 10.1016/S0006-3495(97)78247-X
   Ross JJ, 2003, MATRIX BIOL, V22, P477, DOI 10.1016/S0945-053X(03)00078-7
   ROVENSKY YA, 1994, J CELL SCI, V107, P1255
   SILVER FH, 1995, BIOMATERIALS, V16, P891, DOI 10.1016/0142-9612(95)93113-R
   Sims CD, 1998, PLAST RECONSTR SURG, V101, P1580, DOI 10.1097/00006534-199805000-00022
   Spotnitz William D, 2005, J Long Term Eff Med Implants, V15, P245, DOI 10.1615/JLongTermEffMedImplants.v15.i3.20
   Swartz DD, 2005, AM J PHYSIOL-HEART C, V288, pH1451, DOI 10.1152/ajpheart.00479.2004
   van Griensven M, 2002, EXP TOXICOL PATHOL, V54, P25, DOI 10.1078/0940-2993-00231
   WEADOCK KS, 1995, J BIOMED MATER RES, V29, P1373, DOI 10.1002/jbm.820291108
   Weadock KS, 1996, J BIOMED MATER RES, V32, P221, DOI 10.1002/(SICI)1097-4636(199610)32:2<221::AID-JBM11>3.0.CO;2-M
   Wechselberger G, 2002, PLAST RECONSTR SURG, V110, P123, DOI 10.1097/00006534-200207000-00022
   Ye Q, 2000, EUR J CARDIO-THORAC, V17, P587, DOI 10.1016/S1010-7940(00)00373-0
NR 29
TC 24
Z9 24
U1 0
U2 4
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2007
VL 82A
IS 1
BP 104
EP 112
DI 10.1002/jbm.a.31057
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 176MN
UT WOS:000247089500011
PM 17269139
DA 2018-10-20
ER

PT J
AU Hacking, SA
   Zuraw, M
   Harvey, EJ
   Tanzer, M
   Krygier, JJ
   Bobyn, JD
AF Hacking, S. A.
   Zuraw, M.
   Harvey, E. J.
   Tanzer, M.
   Krygier, J. J.
   Bobyn, J. D.
TI A physical vapor deposition method for controlled evaluation of
   biological response to biomaterial chemistry and topography
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE hydroxyapatite; surface chemistry; physical vapor deposition;
   biomaterial; surface topography
ID CALCIUM-PHOSPHATE COATINGS; SPUTTER-COATED IMPLANTS; OSTEOBLAST-LIKE
   CELLS; POROUS TANTALUM; STAINLESS-STEEL; TRABECULAR BONE; SURFACE
   CHARACTERISTICS; CORROSION-RESISTANCE; TITANIUM IMPLANTS; NITRIDE
   COATINGS
AB The purpose of this study was to characterize a technique to effectively mask surface chemistry without modifying surface topography. A thin layer of titanium was deposited by physical vapor deposition (PVD) onto different biomaterial surfaces. Commercially pure titanium disks were equally divided into three groups. Disks were either polished to a mirror finish, grit blasted with alumina particles, or grit blasted and subsequently plasma sprayed with a commercial grade of hydroxyapatite (HA). A subgroup of each of these treatment types was further treated by masking the entire disk surface with a thin layer of commercially pure titanium deposited by PVD. A comparison of surface topography and chemical composition was carried out between disks within each treatment group. Canine marrow cells were seeded on all disk surfaces to determine the stability of the PVD Ti mask under culture conditions. The PVD process did not significantly alter the surface topography of any samples. The thin titanium layer completely masked the underlying chemistry of the plasma sprayed HA surface and the chemistry of the plasma vapor deposited titanium layer did not differ from that of the commercially pure titanium disks. Aliquots obtained from the media during culture did not indicate any significant differences in Ti concentration amongst the Ti and Ti-masked surfaces. The PVD application of a Ti layer on HA coatings formed a stable, durable, and homogenous layer that effectively masked the underlying surface chemistry without altering the surface topography. (c) 2007 Wiley Periodicals, Inc.
C1 McGill Univ, Jo Miller Orthopaed Res Lab, Montreal, PQ, Canada.
   McGill Univ, Div Orthopaed, Montreal, PQ, Canada.
   McGill Univ, Dept Biomed Engn, Montreal, PQ, Canada.
   McGill Univ, Dept Surg, Montreal, PQ H3A 2T5, Canada.
   Fused Met Inc, Georgetown, PE, Canada.
RP Hacking, SA (reprint author), McGill Univ, Jo Miller Orthopaed Res Lab, Montreal, PQ, Canada.
EM ahacking@yahoo.com
RI Hacking, Adam/F-3645-2010
OI harvey, edward/0000-0003-3934-8920
CR Abrahamsson I, 2002, J CLIN PERIODONTOL, V29, P448, DOI 10.1034/j.1600-051X.2002.290510.x
   ALBREKTSSON T, 1986, BIOMATERIALS, V7, P201, DOI 10.1016/0142-9612(86)90103-1
   ARAKI T, 1987, HISTOCHEMISTRY, V87, P331, DOI 10.1007/BF00492587
   Arweiler-Harbeck D, 2001, ACTA OTO-LARYNGOL, V121, P643, DOI 10.1080/000164801316878971
   Auditore A, 2002, BIOMOL ENG, V19, P85, DOI 10.1016/S1389-0344(02)00042-4
   Bigerelle M, 2002, BIOMOL ENG, V19, P79, DOI 10.1016/S1389-0344(02)00048-5
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 1999, J ARTHROPLASTY, V14, P347, DOI 10.1016/S0883-5403(99)90062-1
   Boyan B D, 1993, J Oral Implantol, V19, P116
   BRANEMARK P I, 1969, Scandinavian Journal of Plastic and Reconstructive Surgery, V3, P81
   CHEHROUDI B, 1991, J BIOMED MATER RES, V25, P387, DOI 10.1002/jbm.820250310
   CLARK P, 1990, DEVELOPMENT, V108, P635
   CLARK P, 1991, J CELL SCI, V99, P73
   CLARK P, 1987, DEVELOPMENT, V99, P439
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   CURTIS A, 1999, BIOCH SOC S, V65, P15
   Curtis ASG, 1998, J BIOMAT SCI-POLYM E, V9, P1313, DOI 10.1163/156856298X00415
   Degasne I, 1999, CALCIFIED TISSUE INT, V64, P499, DOI 10.1007/s002239900640
   den Braber ET, 1998, J BIOMED MATER RES, V40, P291, DOI 10.1002/(SICI)1097-4636(199805)40:2<291::AID-JBM14>3.3.CO;2-8
   Ding SJ, 1999, J BIOMED MATER RES, V44, P266, DOI 10.1002/(SICI)1097-4636(19990305)44:3<266::AID-JBM5>3.0.CO;2-4
   Duncan AC, 2002, BIOSENS BIOELECTRON, V17, P413, DOI 10.1016/S0956-5663(01)00281-0
   Dunlap D, 1996, FEBS LETT, V382, P65, DOI 10.1016/0014-5793(96)00147-0
   Hacking SA, 2000, J BIOMED MATER RES, V52, P631
   Hacking SA, 2002, CLIN ORTHOP RELAT R, P24, DOI 10.1097/01.blo.0000038469.05771.3d
   Hacking SA, 1999, CLIN ORTHOP RELAT R, P240
   HAMBLETON J, 1994, J ORTHOPAED RES, V12, P542, DOI 10.1002/jor.1100120411
   Hendry JA, 2001, J BIOMED MATER RES, V58, P156, DOI 10.1002/1097-4636(2001)58:2<156::AID-JBM1002>3.3.CO;2-8
   Hulshoff JEG, 1997, J BIOMED MATER RES, V36, P75, DOI 10.1002/(SICI)1097-4636(199707)36:1<75::AID-JBM9>3.0.CO;2-I
   KASEMO B, 1983, J PROSTHET DENT, V49, P832, DOI 10.1016/0022-3913(83)90359-1
   Keller J C, 1998, Implant Dent, V7, P331, DOI 10.1097/00008505-199807040-00012
   KEMMENOE BH, 1983, J MICROSC-OXFORD, V132, P153, DOI 10.1111/j.1365-2818.1983.tb04267.x
   Kieswetter K, 1996, CRIT REV ORAL BIOL M, V7, P329, DOI 10.1177/10454411960070040301
   Koontz CS, 1998, J BIOMED MATER RES, V42, P238, DOI 10.1002/(SICI)1097-4636(199811)42:2<238::AID-JBM8>3.3.CO;2-Y
   LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7
   Lappalainen R, 1998, CLIN ORTHOP RELAT R, P118
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   Locci P, 1997, CELL BIOCHEM FUNCT, V15, P163
   Massaro C, 2001, J BIOMED MATER RES, V58, P651, DOI 10.1002/jbm.1065
   Meyle J, 1993, J Biomater Appl, V7, P362, DOI 10.1177/088532829300700404
   MEZGER PR, 1992, J DENT, V20, P342, DOI 10.1016/0300-5712(92)90021-4
   Mohanty M, 2002, BIOMOL ENG, V19, P125, DOI 10.1016/S1389-0344(02)00026-6
   Nan H., 1998, BIOMATERIALS, V19, P771
   Ozeki K, 2001, BIO-MED MATER ENG, V11, P63
   Pan J, 1997, J BIOMED MATER RES, V35, P309, DOI 10.1002/(SICI)1097-4636(19970605)35:3<309::AID-JBM5>3.3.CO;2-N
   Park JY, 2001, BIOMATERIALS, V22, P2671, DOI 10.1016/S0142-9612(01)00009-6
   Ruddell DE, 2000, J BIOMED MATER RES, V51, P316, DOI 10.1002/1097-4636(20000905)51:3<316::AID-JBM4>3.0.CO;2-G
   Schwartz Z, 1997, J PERIODONTAL RES, V32, P166, DOI 10.1111/j.1600-0765.1997.tb01399.x
   Staia MH, 1995, SURF COAT TECH, V76, P231
   TREGLIO JR, 1995, SURF COAT TECH, V76, P815
   van Dijk K, 1998, J BIOMED MATER RES, V42, P266, DOI 10.1002/(SICI)1097-4636(199811)42:2<266::AID-JBM11>3.3.CO;2-U
   Vercaigne S, 2000, CLIN ORAL IMPLAN RES, V11, P314, DOI 10.1034/j.1600-0501.2000.011004314.x
   Wang CX, 2001, J BIOMED MATER RES, V55, P587, DOI 10.1002/1097-4636(20010615)55:4<587::AID-JBM1052>3.0.CO;2-2
   Ward LP, 1998, P I MECH ENG H, V212, P303, DOI 10.1243/0954411981534088
   WISBEY A, 1987, BIOMATERIALS, V8, P477, DOI 10.1016/0142-9612(87)90085-8
   Wolke JGC, 1997, BIOMATERIALS, V18, P483, DOI 10.1016/S0142-9612(96)00164-0
   WONG M, 1995, J BIOMED MATER RES, V29, P1567, DOI 10.1002/jbm.820291213
   Zhang F, 1998, J BIOMED MATER RES, V42, P128, DOI 10.1002/(SICI)1097-4636(199810)42:1<128::AID-JBM16>3.0.CO;2-H
NR 57
TC 14
Z9 18
U1 0
U2 7
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2007
VL 82A
IS 1
BP 179
EP 187
DI 10.1002/jbm.a.31131
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 176MN
UT WOS:000247089500020
PM 17269149
DA 2018-10-20
ER

PT J
AU Aggarwal, D
   Matthew, HWT
AF Aggarwal, Dinesh
   Matthew, Howard W. T.
TI Branched chitosans: Effects of branching parameters on rheological and
   mechanical properties
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE chitosan; hydrogels; mechanical properties; intrinsic viscosity; gel
   permeation chromatography; cell adhesion; FTIR spectroscopy; branched
   polymers
ID MOLECULAR-WEIGHT MANIPULATION; CHEMICAL-MODIFICATION; POLYMER SURFACES;
   CELL-ADHESION; NITROUS-ACID; CHAIN; DERIVATIVES; SCAFFOLDS; CHITIN;
   FILMS
AB Chitosan continues to be studied as a promising biomaterial for tissue repair and regeneration applications. However, chitosan structures show a large reduction in tensile strength in the wet state. Methods for improving the wet strength of chitosan materials may broaden its applicability as a tissue scaffold for applications requiring significant load bearing capacity. In this study, the role of molecular architecture in defining the mechanical properties of hydrated chitosan membranes was examined. Specifically, branched chitosan molecules were synthesized with a range of branch lengths and branch densities. Physical and mechanical properties were characterized using viscometry, FTIR spectroscopy, and tensile testing measurements, and the results were correlated with the postulated architecture of the linear and branched chitosan materials. Both branch density and branch length were found to influence the mechanical properties of chitosan membranes. For example, high-molecular-weight (600 kDa) chitosans grafted with 80 kDa branches exhibited up to twofold increases in both tensile strength and extensibility. FTIR results indicated that these increases correlated with enhanced levels of hydrogen bonding in the branched materials. Vascular smooth muscle cells cultured on cast membranes of the branched chitosans exhibited no differences in adhesion or spreading as compared to the linear polymer. The results indicate that the mechanical properties of chitosan materials can be improved by the induction of a branched molecular architecture. (c) 2007 Wiley Periodicals, Inc.
C1 Wayne State Univ, Dept Chem Engn & Mat Sci, Detroit, MI 48202 USA.
RP Matthew, HWT (reprint author), Wayne State Univ, Dept Chem Engn & Mat Sci, Detroit, MI 48202 USA.
EM hmatthew@wayne.edu
OI Matthew, Howard/0000-0001-6033-9258
CR Alexeev VL, 2000, POLYM ENG SCI, V40, P1211, DOI 10.1002/pen.11248
   ALLAN GG, 1995, CARBOHYD RES, V277, P273, DOI 10.1016/0008-6215(95)00208-B
   ALLAN GG, 1995, CARBOHYD RES, V277, P257, DOI 10.1016/0008-6215(95)00207-A
   Bernkop-Schnurch A, 2004, EUR J PHARM BIOPHARM, V57, P9, DOI 10.1016/s0939-6411(03)00147-4
   BLAIR HS, 1987, J APPL POLYM SCI, V33, P641, DOI 10.1002/app.1987.070330226
   Chung TW, 2003, ARTIF ORGANS, V27, P155, DOI 10.1046/j.1525-1594.2003.07045.x
   Chupa JM, 2000, BIOMATERIALS, V21, P2315, DOI 10.1016/S0142-9612(00)00158-7
   Davis DH, 2002, BIOMATERIALS, V23, P4019, DOI 10.1016/S0142-9612(02)00152-7
   Desbrieres J, 1996, INT J BIOL MACROMOL, V19, P21, DOI 10.1016/0141-8130(96)01095-1
   HALL LD, 1980, J CHEM SOC CHEM COMM, P1153, DOI 10.1039/c39800001153
   Han YK, 2001, J POLYM SCI POL CHEM, V39, P2143, DOI 10.1002/pola.1190.abs
   Haque M.I., 2001, CURR SURG, V58, P77
   HOLME KR, 1992, CARBOHYD RES, V225, P307, DOI 10.1016/S0008-6215(00)90503-2
   ITO M, 1991, BIOMATERIALS, V12, P41, DOI 10.1016/0142-9612(91)90130-3
   Kassal M.R., 2000, J POLYM SCI POL LETT, V38, P2591
   KNUAL JZ, 1998, CAN J CHEM, V76, P1699
   KUO CY, 1990, J LIQ CHROMATOGR, V13, P3177, DOI 10.1080/01483919008049095
   Kurita K, 1998, MACROMOLECULES, V31, P4764, DOI 10.1021/ma980272a
   LEE JH, 1994, BIOMATERIALS, V15, P705, DOI 10.1016/0142-9612(94)90169-4
   Lee SB, 2004, BIOMATERIALS, V25, P2309, DOI 10.1016/j.biomaterials.2003.09.016
   Li JL, 2003, BIOMATERIALS, V24, P2317, DOI 10.1016/S0142-9612(03)00048-6
   MANIAR M, 1990, BIOMATERIALS, V11, P690, DOI 10.1016/0142-9612(90)90028-O
   MIMA S, 1983, J APPL POLYM SCI, V28, P1909, DOI 10.1002/app.1983.070280607
   Ming Larng Tsaih, 1997, International Journal of Biological Macromolecules, V20, P233, DOI 10.1016/S0141-8130(97)01165-3
   NGUYEN TQ, 1999, MECH PROPERTIES TEST, P151
   PAINTER PC, 1997, FUNDAMENTALS POLYM S, P145
   Qaqish RB, 1999, CARBOHYD POLYM, V38, P99, DOI 10.1016/S0144-8617(98)00109-X
   QURASHI MT, 1992, J APPL POLYM SCI, V46, P255, DOI 10.1002/app.1992.070460206
   RODRIGUEZ F, 1996, BASIC STRUCTURES POL, P27
   Rong Huei Chen, 1994, Carbohydrate Polymers, V24, P41, DOI 10.1016/0144-8617(94)90115-5
   Rong Huei Chen, 1996, Carbohydrate Polymers, V29, P353, DOI 10.1016/S0144-8617(96)00007-0
   Sashiwa H, 2000, CHEM COMMUN, P909, DOI 10.1039/b001861i
   Sashiwa H, 1999, CARBOHYD POLYM, V39, P127, DOI 10.1016/S0144-8617(98)00167-2
   SMIDSROD O, 1971, BIOPOLYMERS, V10, P1213, DOI 10.1002/bip.360100711
   STEELE JG, 1992, J BIOMED MATER RES, V26, P861, DOI 10.1002/jbm.820260704
   TAMADA Y, 1993, POLYMER, V34, P2208, DOI 10.1016/0032-3861(93)90752-V
   VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270
   WANG W, 1994, INT J BIOL MACROMOL, V16, P149, DOI 10.1016/0141-8130(94)90042-6
   YALPANI M, 1984, MACROMOLECULES, V17, P272, DOI 10.1021/ma00133a003
   Yamaguchi I, 2000, KEY ENG MAT, V192-1, P673
   Yan XL, 2001, J BIOMED MATER RES, V58, P358, DOI 10.1002/jbm.1029
   Zhang M, 2002, BIOMATERIALS, V23, P2641, DOI 10.1016/S0142-9612(01)00403-3
   Zhang Y, 2001, J BIOMED MATER RES, V55, P304, DOI 10.1002/1097-4636(20010605)55:3<304::AID-JBM1018>3.0.CO;2-J
NR 43
TC 9
Z9 9
U1 1
U2 9
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2007
VL 82A
IS 1
BP 201
EP 212
DI 10.1002/jbm.a.31133
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 176MN
UT WOS:000247089500023
PM 17266018
DA 2018-10-20
ER

PT J
AU Chen, F
   Lam, WM
   Lin, CJ
   Qiu, GX
   Wu, ZH
   Luk, KDK
   Lu, WW
AF Chen, F.
   Lam, W. M.
   Lin, C. J.
   Qiu, G. X.
   Wu, Z. H.
   Luk, K. D. K.
   Lu, W. W.
TI Biocompatibility of electrophoretical deposition of nanostructured
   hydroxyapatite coating on roughen titanium surface: In vitro evaluation
   using mesenchymal stem cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE hydroxyapatite; nanocoating; electrophoretic deposition; MSCs; adhesion
ID CALCIUM-PHOSPHATE COATINGS; OSTEOBLASTIC PHENOTYPE; NANOPHASE CERAMICS;
   BOND STRENGTH; MARROW; EXPRESSION; PARTICLES; CULTURES; SCAFFOLD; GROWTH
AB A nano hydroxyapatite (HAp) layer was coated on a roughen titanium surface by means of electrophoretic deposition with an acetic anhydride solvent system. The objectives of this current study are to investigate whether nano-HAp can improve mechanical strength at a lower sintering temperature and biocompatibility. Densification temperature was lowered from usual 1000 to 800 degrees C. The coating interfacial bonding strength, phase purity, microstructure, and biocompatibility were investigated. Degradation of HA phase was not detected in XRD. A porous TiO2 layer acts as a gradient coating layer with an intermediate thermal expansion coefficient between hydroxyapatite and titanium that reduces the thermal stress. From SEM image, the coating does not contain any crack. Mesenchymal stem cell (MSC) is the progenitor cell for various tissues in mature animals, which can improve integration of bone tissue into implant. In this in vitro study, rabbit MSCs culture indicated that the HAp/Ti nanocomposite biomaterial had good biocompatibillity and bioactivity. Around materials and on its surface cell grew well with good morphology. Proliferation of the MSC on the nano-HAp coating was higher than its micron counterpart in XTT assay. These properties show potential for the orthopaedic and dental applications. (c) 2006 Wiley Periodicals, Inc.
C1 Xiamen Univ, Dept Chem, State Key Lab Phys Chem Solid Surfaces, Xiamen 361005, Peoples R China.
   Beijing Union Med Coll Hosp, Dept Orthopaed Surg, Beijing, Peoples R China.
   Univ Hong Kong, Dept Orthopaed Surg & Traumatol, Hong Kong, Hong Kong, Peoples R China.
RP Lin, CJ (reprint author), Xiamen Univ, Dept Chem, State Key Lab Phys Chem Solid Surfaces, Xiamen 361005, Peoples R China.
EM cjlin@xmu.edu.cn; wwlu@hkusua.hku.hk
RI Lin, CJ/G-3392-2010
CR BAN SJ, 1995, BIOMATERIALS, V16, P977, DOI 10.1016/0142-9612(95)94904-Y
   Boccaccini AR, 2002, CURR OPIN SOLID ST M, V6, P251, DOI 10.1016/S1359-0286(02)00080-3
   BRUDER SP, 1994, J CELL BIOCHEM, V56, P283, DOI 10.1002/jcb.240560303
   Campoccia D, 2003, BIOMATERIALS, V24, P587, DOI 10.1016/S0142-9612(02)00373-3
   Chai CS, 1999, J MATER SCI-MATER M, V10, P465, DOI 10.1023/A:1008992807888
   Chen F, 2002, MATER LETT, V57, P858, DOI 10.1016/S0167-577X(02)00885-6
   de Sena LA, 2002, J BIOMED MATER RES, V60, P1
   Driessens FCM, 2002, BIOMATERIALS, V23, P4011, DOI 10.1016/S0142-9612(02)00151-5
   Ferrero D, 1998, BONE MARROW TRANSPL, V21, P409, DOI 10.1038/sj.bmt.1701094
   Jansen J A, 1993, Clin Oral Implants Res, V4, P28, DOI 10.1034/j.1600-0501.1993.040104.x
   JI HX, 1993, BIOMATERIALS, V14, P64, DOI 10.1016/0142-9612(93)90077-F
   Keller R, 2002, IMMUNOL LETT, V83, P1, DOI 10.1016/S0165-2478(02)00065-2
   Knowles JC, 1996, BIOMATERIALS, V17, P639, DOI 10.1016/0142-9612(96)88715-1
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Ma J, 2003, J MATER SCI-MATER M, V14, P797, DOI 10.1023/A:1025092506583
   Ma J, 2003, BIOMATERIALS, V24, P3505, DOI 10.1016/S0142-9612(03)00203-5
   Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415
   Manso M, 2002, BIOMATERIALS, V23, P3985, DOI 10.1016/S0142-9612(02)00142-4
   Mao CB, 1999, J CRYST GROWTH, V206, P308, DOI 10.1016/S0022-0248(99)00315-2
   Midy V, 2001, J MATER SCI-MATER M, V12, P259, DOI 10.1023/A:1008971317544
   Murugan R, 2005, J CRYST GROWTH, V274, P209, DOI 10.1016/j.jcrysgro.2004.09.069
   Narasaraju TSB, 1996, J MATER SCI, V31, P1, DOI 10.1007/BF00355120
   Nie X, 2001, J BIOMED MATER RES, V57, P612, DOI 10.1002/1097-4636(20011215)57:4<612::AID-JBM1208>3.0.CO;2-H
   Okumura M, 1997, J BIOMED MATER RES, V37, P122, DOI 10.1002/(SICI)1097-4636(199710)37:1<122::AID-JBM15>3.0.CO;2-I
   ONG JL, 1992, BIOMATERIALS, V13, P249, DOI 10.1016/0142-9612(92)90192-Q
   SAUTIER JM, 1991, CELL MATER, V1, P209
   Simon SP, 1994, ORTHOPAEDIC BASIC SC, P127
   SOBALLE K, 1993, J BONE JOINT SURG BR, V75, P681
   Sridhar TM, 2003, CORROS SCI, V45, P237, DOI 10.1016/S0010-938X(02)00091-4
   Stoch A, 2001, J MOL STRUCT, V596, P191, DOI 10.1016/S0022-2860(01)00716-5
   Tadic D, 2002, BIOMATERIALS, V23, P2553, DOI 10.1016/S0142-9612(01)00390-8
   Wang C, 2002, MATER LETT, V57, P99, DOI 10.1016/S0167-577X(02)00706-1
   Wang ML, 2002, J ORTHOPAED RES, V20, P1175, DOI 10.1016/S0736-0266(02)00076-1
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Webster TJ, 1999, NANOSTRUCT MATER, V12, P983, DOI 10.1016/S0965-9773(99)00283-4
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Wei M, 2001, J SOL-GEL SCI TECHN, V21, P39, DOI 10.1023/A:1011201414651
   Wei M, 1999, J BIOMED MATER RES, V45, P11, DOI 10.1002/(SICI)1097-4636(199904)45:1<11::AID-JBM2>3.0.CO;2-7
   Wei M, 1999, J MATER SCI-MATER M, V10, P401, DOI 10.1023/A:1008923029945
   Wen HB, 1998, J CRYST GROWTH, V186, P616, DOI 10.1016/S0022-0248(97)00824-5
   Wen HB, 1998, J MATER SCI-MATER M, V9, P121, DOI 10.1023/A:1008859417664
   Wilke A, 1998, J BIOMED MATER RES, V40, P301, DOI 10.1002/(SICI)1097-4636(199805)40:2<301::AID-JBM15>3.0.CO;2-O
   Yamada Y, 2003, J CRANIO MAXILL SURG, V31, P27, DOI 10.1016/S1010-5182
   YANKEE SJ, 1990, THERMAL SPRAY RES AP, P433
   ZHANG ZT, S P, V703
NR 45
TC 69
Z9 72
U1 0
U2 26
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JUL
PY 2007
VL 82B
IS 1
BP 183
EP 191
DI 10.1002/jbm.b.30720
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 184AD
UT WOS:000247612600024
PM 17106895
DA 2018-10-20
ER

PT J
AU Ogushi, Y
   Sakai, S
   Kawakami, K
AF Ogushi, Yuko
   Sakai, Shinji
   Kawakami, Koei
TI Synthesis of enzymatically-gellable carboxymethylcellulose for
   biomedical applications
SO JOURNAL OF BIOSCIENCE AND BIOENGINEERING
LA English
DT Article
DE carboxymethylcellulose; peroxidase; biomaterial; gelation; tyramine
ID CELLULOSE; BIOCOMPATIBILITY; POLYMERIZATION; HYDROGELS
AB We synthesized a carboxymethylcellulose with phenol moieties by covalently incorporating tyramine into carboxymethylcellulose using aqueous-phase carbodiimide activation chemistry. The resulting hydrogel was obtained from an aqueous solution of the conjugate via the horseradish peroxidase-catalyzed oxidation reaction of phenols by Consuming H2O2, where the gelation speed depended on the concentrations of enzyme and H2O2. The viability of the mammalian cells enclosed within the hydrogel prepared from 1.5% (w/v) conjugate solution containing 5 units/ml horseradish peroxidase and 1 mM H2O2, was 80% after 24 h. These results demonstrate that this carboxymethylcellulose with phenol moieties has potential for biomedical applications including tissue-engineering.
C1 Kyushu Univ, Fac Engn, Dept Chem Engn, Nishi Ku, Fukuoka 8190395, Japan.
RP Sakai, S (reprint author), Kyushu Univ, Fac Engn, Dept Chem Engn, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.
EM sakai@chem-eng.kyushu-u.ac.jp
RI Sakai, Shinji/F-9463-2016; U-ID, Kyushu/C-5291-2016
OI Sakai, Shinji/0000-0002-1041-4798; 
CR Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d
   Fricain JC, 2002, BIOMATERIALS, V23, P971, DOI 10.1016/S0142-9612(01)00152-1
   Fukuoka T, 2004, BIOMACROMOLECULES, V5, P977, DOI 10.1021/bm034490
   Gross RA, 2001, CHEM REV, V101, P2097, DOI 10.1021/cr0002590
   Gutowska A, 2001, ANAT RECORD, V263, P342, DOI 10.1002/ar.1115
   Heinze T, 2005, MACROMOL SYMP, V223, P13, DOI 10.1002/masy.200550502
   KIM SW, 1992, PHARMACEUT RES, V9, P283, DOI 10.1023/A:1015887213431
   Kobayashi S, 2001, CHEM REV, V101, P3793, DOI 10.1021/cr990121l
   Kurisawa M, 2005, CHEM COMMUN, P4312, DOI 10.1039/b506989k
   Martson M, 1999, BIOMATERIALS, V20, P1989, DOI 10.1016/S0142-9612(99)00094-0
   Orive G, 2002, BIOMATERIALS, V23, P3825, DOI 10.1016/S0142-9612(02)00118-7
   SAKAI S, 2007, J BIOMED MAT RES A
   Sakai S, 2007, ACTA BIOMATER, V3, P495, DOI 10.1016/j.actbio.2006.12.002
NR 13
TC 90
Z9 90
U1 0
U2 26
PU SOC BIOSCIENCE BIOENGINEERING JAPAN
PI OSAKA
PA OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871,
   JAPAN
SN 1389-1723
J9 J BIOSCI BIOENG
JI J. Biosci. Bioeng.
PD JUL
PY 2007
VL 104
IS 1
BP 30
EP 33
DI 10.1263/jbb.104.30
PG 4
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA 208MF
UT WOS:000249322700005
PM 17697980
DA 2018-10-20
ER

PT J
AU Webb, JCJ
   Spencer, RF
AF Webb, J. C. J.
   Spencer, R. F.
TI The role of polymethylmethacrylate bone cement in modern orthopaedic
   surgery
SO JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME
LA English
DT Review
ID TOTAL HIP-REPLACEMENT; TOTAL JOINT REPLACEMENT; PERCUTANEOUS
   VERTEBROPLASTY; ACRYLIC CEMENT; IMPREGNATED CEMENT; GENTAMICIN RELEASE;
   STRESS-RELAXATION; FEMORAL COMPONENT; CREEP-BEHAVIOR; FOLLOW-UP
AB Polymethylmethacrylate remains one of the most enduring materials in orthopaedic surgery. It has a central role in the success of total joint replacement and is also used in newer techniques such as percutaneous vertebroplasty and kyphoplasty.
   This article describes the current uses and limitations of polymethylmethacrylate in orthopaedic surgery. It focuses on its mechanical and chemical properties and links these to its clinical performance. The behaviour of antibiotic- loaded bone cement are discussed, together with areas of research that are now shedding light upon the behaviour of this unique biomaterial.
C1 Southmead Hosp, Avon Orthopaed Ctr, Bristol BS10 5NB, Avon, England.
RP Webb, JCJ (reprint author), Southmead Hosp, Avon Orthopaed Ctr, Bristol BS10 5NB, Avon, England.
EM jcjwebb@doctors.org.uk
CR Abdel-Kader KFM, 2001, J ARTHROPLASTY, V16, P811, DOI 10.1054/arth.2001.25561
   Armstrong M, 2002, Hip Int, V12, P23, DOI 10.5301/HIP.2008.2065
   Barker DS, 2000, J BONE JOINT SURG BR, V82B, P1182, DOI 10.1302/0301-620X.82B8.9864
   BEECHING NJ, 1986, J ANTIMICROB CHEMOTH, V17, P173, DOI 10.1093/jac/17.2.173
   Belkoff SM, 2002, J BIOMED MATER RES, V63, P396, DOI 10.1002/jbm.10258
   BUCHHOLZ HW, 1970, CHIRURG, V41, P511
   CHARNLEY J, 1979, LOW FRICTION ARTHROP
   CHARNLEY J, 1970, ACRYLIC CEMENT ORHTO
   CHWIRUT DJ, 1984, J BIOMED MATER RES, V18, P25, DOI 10.1002/jbm.820180105
   DiPisa J A, 1976, Clin Orthop Relat Res, P95
   Eden OR, 2002, P I MECH ENG H, V216, P195, DOI 10.1243/0954411021536405
   FOWLER JL, 1988, ORTHOP CLIN N AM, V19, P477
   FURNES O, 2005, PROSPOECTIVE STUDIES, P23
   GALIBERT P, 1987, NEUROCHIRURGIE, V33, P166
   Gheduzzi S, 2006, J MATER SCI-MATER M, V17, P421, DOI 10.1007/s10856-006-8469-6
   GHEDUZZI S, 2006, J BONE JOINT SURG BR, V88, P65
   HABOUSH E J, 1953, Bull Hosp Joint Dis, V14, P242
   Hansen E, 2003, J BIOMECH, V36, P787, DOI 10.1016/S0021-9290(03)00012-5
   HARRIGAN TP, 1992, J ORTHOPAED RES, V10, P134, DOI 10.1002/jor.1100100116
   HARVING S, 1991, ACTA ORTHOP SCAND, V62, P546, DOI 10.3109/17453679108994493
   Hendriks JGE, 2004, BIOMATERIALS, V25, P545, DOI 10.1016/S0142-9612(03)00554-4
   HOLM NJ, 1980, ACTA ORTHOP SCAND, V51, P727, DOI 10.3109/17453678008990867
   Hook S, 2006, J BONE JOINT SURG BR, V88B, P1584, DOI 10.1302/0301-620X.88B12.18345
   HOPE PG, 1989, J BONE JOINT SURG BR, V71, P851
   Howie DW, 1998, J BONE JOINT SURG BR, V80B, P573, DOI 10.1302/0301-620X.80B4.8629
   Ingham E, 2000, P I MECH ENG H, V214, P21, DOI 10.1243/0954411001535219
   JIRANEK WA, 2004, COMM BIOL IMPL ORTH
   JOSEFSSON G, 1990, CLIN ORTHOP RELAT R, P173
   JUDET J, 1950, J BONE JOINT SURG BR, V32, P166
   KINDTLARSEN T, 1995, J APPL BIOMATER, V6, P75, DOI 10.1002/jab.770060111
   KUHN KD, 2005, WELL CEMENTED TOTAL, P52, DOI DOI 10.1007/3-540-28924-0_5
   KUKN KD, 2000, BONE CEMENT UP TO DA
   LAUTENSCHLAGER EP, 1976, J BIOMED MATER RES, V10, P837, DOI 10.1002/jbm.820100603
   Lee AJC, 2002, J MATER SCI-MATER M, V13, P723, DOI 10.1023/A:1016150403665
   LEE AJC, 1978, ARCH ORTHOP TRAUM SU, V92, P1, DOI 10.1007/BF00381635
   Lee AJC, 2000, INTERFACES TOTAL HIP, P11
   Lewis G, 1997, J BIOMED MATER RES, V38, P155, DOI 10.1002/(SICI)1097-4636(199722)38:2<155::AID-JBM10>3.0.CO;2-C
   Lewis G, 1998, BIOMATERIALS, V19, P117, DOI 10.1016/S0142-9612(97)00165-8
   Lewis G, 2006, ACTA ORTHOP, V77, P622, DOI 10.1080/17453670610012700
   LINDER L, 1977, J BONE JOINT SURG AM, V59, P82, DOI 10.2106/00004623-197759010-00015
   Liu C, 2002, J MATER SCI-MATER M, V13, P1021, DOI 10.1023/A:1020328218520
   Malchau H, 2002, J BONE JOINT SURG AM, V84A, P2, DOI 10.2106/00004623-200200002-00002
   MARKS KE, 1976, J BONE JOINT SURG AM, V58, P358, DOI 10.2106/00004623-197658030-00011
   Mathis JM, 2003, J VASC INTERV RADIOL, V14, P953
   McGraw JK, 2002, J VASC INTERV RADIOL, V13, P883, DOI 10.1016/S1051-0443(07)61770-9
   MEYER PR, 1973, J BONE JOINT SURG AM, VA 55, P149, DOI 10.2106/00004623-197355010-00015
   MILES AW, 1990, IMPLANT BONE INTERFA, P137
   MILLER MD, 2004, REV ORTHOPAEDICS, P127
   MJOBERG B, 1984, ACTA ORTHOP SCAND, V55, P597, DOI 10.3109/17453678408992403
   MUNSON FT, 1941, AM J SURG, V3, P291
   Nussbaum DA, 2004, J VASC INTERV RADIOL, V15, P121, DOI 10.1097/01.RVI.0000109394.74740.56
   OGA M, 1992, ACTA ORTHOP SCAND, V63, P301, DOI 10.3109/17453679209154787
   PAL S, 1982, BIOMATERIALS, V3, P93
   Persson C, 2006, ACTA ORTHOP, V77, P617, DOI 10.1080/17453670610012692
   PICKNELL B, 1977, J BONE JOINT SURG BR, V59, P302
   Pilliar RM, 1982, J BIOMED MATER RES, V21, P145
   Powles JW, 1998, J BONE JOINT SURG BR, V80B, P607, DOI 10.1302/0301-620X.80B4.8555
   RECKLING FW, 1977, J BONE JOINT SURG AM, V59, P80, DOI 10.2106/00004623-197759010-00014
   RIGGS BL, 1995, BONE, V17, pS505, DOI 10.1016/8756-3282(95)00258-4
   RIMNAC CM, 1986, J BONE JOINT SURG AM, V68A, P281, DOI 10.2106/00004623-198668020-00014
   SCALES JF, 1945, BMJ-BRIT MED J, P245
   SLOOF TJJH, 1971, ACTA ORTHOP SCAND, V42, P465, DOI 10.3109/17453677108989064
   SUTHERLAND CJ, 1982, J BONE JOINT SURG AM, V64, P970, DOI 10.2106/00004623-198264070-00002
   TORHOLM C, 1983, CLIN ORTHOP RELAT R, V181, P99
   Truumees Eeric, 2004, Spine J, V4, P218, DOI 10.1016/j.spinee.2003.08.029
   van de Belt H, 2000, ACTA ORTHOP SCAND, V71, P625, DOI 10.1080/000164700317362280
   van de Belt H, 2001, ACTA ORTHOP SCAND, V72, P557
   Verdonschot N, 1998, BIOMATERIALS, V19, P1773, DOI 10.1016/S0142-9612(98)00088-X
   VERDONSCHOT N, 2000, INTERFACE TOTAL HIP, P21
   WAHLIG H, 1980, ACTA ORTHOP SCAND, V51, P49, DOI 10.3109/17453678008990768
   WAHLIG H, 1984, J BONE JOINT SURG BR, V66, P175
   WEBB JCJ, 2006, HIP INT, V14, P76
   WEBB JCJ, 2006, BRIT ORTH RES SOC M
   WEIGHTMAN B, 1987, J BONE JOINT SURG BR, V69, P558
   WHELTON A, 1984, CLIN ORTHOP RELAT R, P66
   Williams HDW, 2002, J BONE JOINT SURG BR, V84B, P324, DOI 10.1302/0301-620X.84B3.12261
   Wininger DA, 1996, ANTIMICROB AGENTS CH, V40, P2675, DOI 10.1128/AAC.40.12.2675
   YOUNG RJ, 1991, INTRO POLYM, P322
   58332002 BS ISO
NR 79
TC 129
Z9 135
U1 6
U2 42
PU BRITISH EDITORIAL SOC BONE JOINT SURGERY
PI LONDON
PA 22 BUCKINGHAM STREET, LONDON WC2N 6ET, ENGLAND
SN 0301-620X
EI 2044-5377
J9 J BONE JOINT SURG BR
JI J. Bone Joint Surg.-Br. Vol.
PD JUL
PY 2007
VL 89B
IS 7
BP 851
EP 857
DI 10.1302/0301-620X.89B7.19148
PG 7
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 197PT
UT WOS:000248568700002
PM 17673574
OA Bronze
DA 2018-10-20
ER

PT J
AU Ueno, T
   Oga, A
   Takahashi, T
   Pappas, TN
AF Ueno, Tomio
   Oga, Atsunori
   Takahashi, Toku
   Pappas, Theodore N.
TI Small intestinal submucosa (SIS) in the repair of a cecal wound in
   unprepared bowel in rats
SO JOURNAL OF GASTROINTESTINAL SURGERY
LA English
DT Article
DE small intestinal submucosa (SIS); acellular matrix; cecum defect repair
ID EXTRACELLULAR-MATRIX; DOG-MODEL; BIOSCAFFOLD; GROWTH; BIOMATERIAL;
   SCAFFOLD; DEFECTS; BLADDER; GRAFT
AB Purpose Porcine-derived small intestinal submucosa (SIS) has been accepted as an acellular matrix for tissue regeneration. However, its use for remodeling gastrointestinal defects has been poorly investigated. Our previous study of the rodent stomach has demonstrated that the SIS stimulates regeneration of native tissue under acidic conditions. The purpose of this paper was to investigate the feasibility of using SIS as a bioscaffold for a colonic defect in unprepared bowel.
   Methods A 1x1-cm whole layer was excised on the anterior wall of the cecum in 24 rats, followed by onlay repair with SIS. Measurement outcomes included animal survival, mesh stability in situ, and histologic evaluation at 3 weeks and 6 months.
   Results Rats showed a significant weight gain and had no evidence of postoperative leakage. All wounds were secured and associated with either omental or other fatty adhesions. Histological findings revealed that intact mucosa covered the area of the graft in all cases 6 months after surgery and that the defect was completely replaced by the normal constituents (mucosa, muscle, and nerve cells) of the bowel wall.
   Conclusions SIS was largely successful in promoting healing in a cecal wound in unprepared bowel and serving as a bioscaffold for regeneration of the native colonic tissue. Small intestinal submucosa may be useful in surgical anastomoses to promote healing and presumably prevent leakage.
C1 Yamaguchi Univ, Dept Surg 2, Grad Sch Med, Yamaguchi 7558505, Japan.
   Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA.
   Yamaguchi Univ, Dept Pathol 2, Grad Sch Med, Yamaguchi, Japan.
RP Ueno, T (reprint author), Yamaguchi Univ, Dept Surg 2, Grad Sch Med, 1-1-1 Minami Kogushi, Yamaguchi 7558505, Japan.
EM tommy@yamaguchi-u.ac.jp
CR Badylak S, 2000, J PEDIATR SURG, V35, P1097, DOI 10.1053/jpsu.2000.7834
   Badylak SE, 2002, SEMIN CELL DEV BIOL, V13, P377, DOI 10.1016/S1084-9521(02)00094-0
   BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   Badylak SF, 1998, TISSUE ENG, V4, P379, DOI 10.1089/ten.1998.4.379
   Brown-Etris M, 2002, WOUNDS, V14, P150
   Chen MK, 2001, J SURG RES, V99, P352, DOI 10.1006/jsre.2001.6199
   Clarke KM, 1996, J SURG RES, V60, P107, DOI 10.1006/jsre.1996.0018
   Dalla Vecchia LD, 1999, J PEDIATR SURG, V34, P167, DOI 10.1016/S0022-3468(99)90250-6
   de la Fuente SG, 2003, J GASTROINTEST SURG, V7, P96, DOI 10.1016/S1091-255X(02)00050-1
   HILES MC, 1995, J BIOMED MATER RES, V29, P883, DOI 10.1002/jbm.820290714
   Hodde JP, 2001, ENDOTHELIUM-NEW YORK, V8, P11, DOI 10.3109/10623320109063154
   Hodde JP, 2001, WOUNDS, V13, P195
   Hurst RE, 2001, J BIOMAT SCI-POLYM E, V12, P1267, DOI 10.1163/156856201753395798
   Pope JC, 1997, J UROLOGY, V158, P1105, DOI 10.1016/S0022-5347(01)64398-2
   PREVEL CD, 1995, ANN PLAS SURG, V35, P374, DOI 10.1097/00000637-199510000-00008
   Record RD, 2001, BIOMATERIALS, V22, P2653, DOI 10.1016/S0142-9612(01)00007-2
   Rosen M, 2002, SURGERY, V132, P480, DOI 10.1067/msy.2002.126505
   SANDUSKY GE, 1995, J SURG RES, V58, P415, DOI 10.1006/jsre.1995.1064
   Ueno T, 2004, J GASTROINTEST SURG, V8, P109, DOI 10.1016/j.gassur.2003.09.025
   Voytik-Harbin SL, 1998, TISSUE ENG, V4, P157, DOI 10.1089/ten.1998.4.157
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
NR 21
TC 21
Z9 21
U1 0
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 1091-255X
J9 J GASTROINTEST SURG
JI J. Gastrointest. Surg.
PD JUL
PY 2007
VL 11
IS 7
BP 918
EP 922
DI 10.1007/s11605-007-0171-6
PG 5
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA 184PF
UT WOS:000247653300017
PM 17476557
DA 2018-10-20
ER

PT J
AU Tiwari, A
AF Tiwari, Ashutosh
TI Gum arabic-graft-polyaniline: An electrically active redox biomaterial
   for sensor applications
SO JOURNAL OF MACROMOLECULAR SCIENCE PART A-PURE AND APPLIED CHEMISTRY
LA English
DT Article
DE gum arabic; polyaniline; graft copolymer; conducting biomaterial; redox
   behavior; sensor
ID POLYMERIZATION; POLYMERS; ACID; POLYACRYLAMIDE; ELECTRODE; CHITOSAN;
   FILMS
AB The radical copolymerization of gum Arabic and polyaniline was done using peroxydisulfate as oxidant and initiator. The produced copolymer was electrically active, water-soluble and has redox property. The redox behavior of the copolymer was studied using cyclic voltammetry and compared with the pure polyaniline. The UV-vis, FTIR, H-1-NMR, XRD, TGA and SEM techniques have been used for the characterization of grafted biomaterial. The copolymerization was systematically optimized and it was observed that solubility of the copolymers in water decreased with an increase in % G. The intrinsic viscosity of the copolymer has been estimated to be 10.8 dL/g, which indicates an appreciably high molecular weight for the copolymer. The shelf life and electrical conductivity of the copolymer were monitored to evaluate their potential application in the fabrication of semiconductor sensor devices. Results are discussed and proposed a plausible mechanism for the copolymerization.
C1 Natl Phys Lab, Div Engn Mat, New Delhi 110012, India.
RP Tiwari, A (reprint author), Natl Phys Lab, Div Engn Mat, Dr KS Krishnan Marg, New Delhi 110012, India.
EM ashunpl@gmail.com
CR Ahmeda A. A., 2004, SYNTHETIC MET, V144, P29
   COOPER JC, 1993, ELECTROANAL, V5, P385, DOI 10.1002/elan.1140050504
   GANG L, 1997, MACROMOLECULES, V30, P5660
   Ghosh P, 1999, EUR POLYM J, V35, P803, DOI 10.1016/S0014-3057(98)00065-2
   Gospodinova N, 1998, PROG POLYM SCI, V23, P1443, DOI 10.1016/S0079-6700(98)00008-2
   GOSPODINOVA N, 1994, POLYMER, V35, P3102, DOI 10.1016/0032-3861(94)90425-1
   Hua MY, 2000, POLYMER, V41, P813, DOI 10.1016/S0032-3861(99)00452-8
   KANETO K, 1995, SYNTHETIC MET, V71, P2211, DOI 10.1016/0379-6779(94)03226-V
   KHOR E, 1995, CARBOHYD POLYM, V26, P183, DOI 10.1016/0144-8617(95)00004-Q
   MACDIARMID AG, 1991, MAKROMOL CHEM-M SYMP, V51, P11, DOI 10.1002/masy.19910510104
   Mallik H, 2004, SOLID STATE IONICS, V175, P769, DOI 10.1016/j.ssi.2004.03.043
   OSMAN ME, 1993, J AGR FOOD CHEM, V41, P71, DOI 10.1021/jf00025a016
   RUIZHITZKY E, 1993, ADV MATER, V5, P334, DOI 10.1002/adma.19930050503
   Sanchez C, 2002, FOOD HYDROCOLLOID, V16, P257, DOI 10.1016/S0268-005X(01)00096-0
   SIN SR, 2005, SYNTHETIC MET, V15, P213
   Singh V, 2005, J APPL POLYM SCI, V98, P1652, DOI 10.1002/app.22333
   Singh V, 2005, BIOMACROMOLECULES, V6, P453, DOI 10.1021/bm049518b
   SKOTHEIM TA, 1997, HDB CONDUCTING POLYM
   STREET CA, 1983, TALANTA, V30, P887, DOI 10.1016/0039-9140(83)80206-9
   Sviridov DV, 1995, SOL ENERG MAT SOL C, V39, P49, DOI 10.1016/0927-0248(95)00039-9
   Xiang Q, 1996, EUR POLYM J, V32, P865, DOI 10.1016/0014-3057(96)00010-9
   YANG S, 1989, SYNTHETIC MET, V32, P191, DOI 10.1016/0379-6779(89)90841-2
   YANG Y, 1994, APPL PHYS LETT, V64, P1245, DOI 10.1063/1.110853
   Yang YS, 2005, POLYM ADVAN TECHNOL, V16, P24, DOI 10.1002/pat.541
NR 24
TC 51
Z9 52
U1 4
U2 15
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 1060-1325
J9 J MACROMOL SCI A
JI J. Macromol. Sci. Part A-Pure Appl. Chem.
PD JUL-SEP
PY 2007
VL 44
IS 7-9
BP 735
EP 745
DI 10.1080/10601320701353116
PG 11
WC Polymer Science
SC Polymer Science
GA 185QB
UT WOS:000247724400011
DA 2018-10-20
ER

PT J
AU Hoglund, A
   Hakkarainen, M
   Albertsson, AC
AF Hoglund, Anders
   Hakkarainen, Minna
   Albertsson, Ann-Christine
TI Degradation profile of poly(epsilon-caprolactone) - the influence of
   macroscopic and macromolecular biomaterial design
SO JOURNAL OF MACROMOLECULAR SCIENCE PART A-PURE AND APPLIED CHEMISTRY
LA English
DT Article
DE degradation; hydrolysis; poly(epsilon-caprolactone); macromolecular
   design
ID FILM-BLOWN POLY(EPSILON-CAPROLACTONE); IN-VITRO DEGRADATION;
   EPSILON-CAPROLACTONE; ALIPHATIC POLYESTERS; SCAFFOLDS;
   1,5-DIOXEPAN-2-ONE; POLYCAPROLACTONE; BIODEGRADATION; COPOLYMERS;
   PRODUCTS
AB Macroscopic and macromolecular material design and their influence on hydrolysis mechanism of poly(epsilon-caprolactone) (PCL) was evaluated. Homogoenous discs of linear PCL, porous scaffolds of linear PCL and crosslinked PCL networks were subjected to hydrolytic degradation for up to 364 days in 37 degrees C and pH 7.4 phosphate buffer solution. After different hydrolysis times, mass loss and changes in molecular weight and thermal properties were determined in parallel to extraction and analysis of the formed degradation products. Size exclusion chromatography (SEC), differential scanning calorimetry (DSC) and gas chromatography-mass spectrometry (GC-MS) were used for the analyses. The results clearly demonstrated different degradation profiles and susceptibilities towards hydrolysis depending on the macroscopic and macromolecular biomaterial design.
C1 Royal Inst Technol, Dept Fibre & Polymer Technol, Sch Chem Sci & Engn, S-10044 Stockholm, Sweden.
RP Albertsson, AC (reprint author), Royal Inst Technol, Dept Fibre & Polymer Technol, Sch Chem Sci & Engn, S-10044 Stockholm, Sweden.
EM aila@polymer.kth.se
RI Hoglund, Anders/B-8040-2013; Albertsson, Ann-Christine/Q-6107-2016
OI Hoglund, Anders/0000-0002-0139-9485; Albertsson,
   Ann-Christine/0000-0001-8696-9143; Hakkarainen,
   Minna/0000-0002-7790-8987
CR Agrawal CM, 2000, BIOMATERIALS, V21, P2443, DOI 10.1016/S0142-9612(00)00112-5
   Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A
   Albertsson AC, 1998, J APPL POLYM SCI, V70, P61, DOI 10.1002/(SICI)1097-4628(19981003)70:1<61::AID-APP8>3.0.CO;2-S
   ALBERTSSON AC, 1995, POLYMER, V36, P1009, DOI 10.1016/0032-3861(95)93601-H
   Andronova N, 2005, POLYMER, V46, P6746, DOI 10.1016/j.polymer.2005.06.038
   Chen DR, 2000, POLYM DEGRAD STABIL, V67, P455, DOI 10.1016/S0141-3910(99)00145-7
   CRESCENZI V, 1972, EUR POLYM J, V8, P449, DOI 10.1016/0014-3057(72)90109-7
   Edlund U, 2002, ADV POLYM SCI, V157, P67
   Eldsater C, 2000, POLYMER, V41, P1297, DOI 10.1016/S0032-3861(99)00278-5
   Hakkarainen M, 2002, ADV POLYM SCI, V157, P113
   Hakkarainen M, 2002, MACROMOL CHEM PHYSIC, V203, P1357, DOI 10.1002/1521-3935(200207)203:10/11<1357::AID-MACP1357>3.0.CO;2-R
   Hakkarainen M, 2007, J AM CHEM SOC, V129, P6308, DOI 10.1021/ja0702871
   HOGLUND A, 2007, BIOMACROMOLECULES, V8
   Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.3.CO;2-Z
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Odelius K, 2005, BIOMACROMOLECULES, V6, P2718, DOI 10.1021/bm050190b
   Palmgren R, 1997, J POLYM SCI POL CHEM, V35, P1635, DOI 10.1002/(SICI)1099-0518(19970715)35:9<1635::AID-POLA5>3.0.CO;2-Q
   PITT C G, 1987, Journal of Controlled Release, V4, P283, DOI 10.1016/0168-3659(87)90020-4
   PITT CG, 1981, J APPL POLYM SCI, V26, P3779, DOI 10.1002/app.1981.070261124
   Stridsberg K, 1999, J POLYM SCI POL CHEM, V37, P3407, DOI 10.1002/(SICI)1099-0518(19990815)37:16<3407::AID-POLA40>3.3.CO;2-O
   Sun HF, 2006, BIOMATERIALS, V27, P1735, DOI 10.1016/j.biomaterials.2005.09.019
   Sung HJ, 2004, BIOMATERIALS, V25, P5735, DOI 10.1016/j.biomaterials.2004.01.066
   van Tienen TG, 2002, BIOMATERIALS, V23, P1731, DOI 10.1016/S0142-9612(01)00280-0
   Wu LB, 2005, J BIOMED MATER RES A, V75A, P767, DOI 10.1002/jbm.a.30487
NR 24
TC 15
Z9 15
U1 2
U2 26
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 1060-1325
J9 J MACROMOL SCI A
JI J. Macromol. Sci. Part A-Pure Appl. Chem.
PD JUL-SEP
PY 2007
VL 44
IS 7-9
BP 1041
EP 1046
DI 10.1080/10601320701424487
PG 6
WC Polymer Science
SC Polymer Science
GA 185QB
UT WOS:000247724400050
DA 2018-10-20
ER

PT J
AU Pan, YS
   Xiong, DS
   Chen, XL
AF Pan, Yusong
   Xiong, Dangsheng
   Chen, Xiaolin
TI Mechanical properties of nanohydroxyapatite reinforced poly(vinyl
   alcohol) gel composites as biomaterial
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Article
ID ARTIFICIAL ARTICULAR-CARTILAGE; PVA-HYDROGEL
AB Nanohydroxyapatite reinforced poly(vinyl alcohol) gel (nano-HA/PVA gel) composites has been proposed as a promising biomaterial, especially used as an articular cartilage repair biomaterial. In this paper, nano-HA/PVA gel composites were prepared from mixing nano-HA particles modified by silicon coupling agent, with physiological saline solution (PSS) of PVA by freezing-thawing, method. The effects of various factors on the mechanical properties of nano-HA/PVA gel composites were evaluated. It was shown that the mechanical behavior of nano-HA/PVA gel composites was similar to that of natural articular cartilage, which held special viscoelastic characteristics. The tensile strength and tensile modulus of the composites improved correspondingly with the increase of freezing-thawing times and concentration of PVA solution. The more concentration of PVA solution, the higher influence degree of concentration on the tensile strength of composites is. The tensile strength and tensile modulus of nano-HA/PVA hydrogel composites increased first and then decreased with the rising nano-HA content of the composites. The tensile modulus of the composites improved remarkably with the increase of elongation ratio.
C1 Nan Jing Univ Sci & Technol, Dept Mat Sci & Engn, Nanjing 210094, Jiangsu, Peoples R China.
RP Xiong, DS (reprint author), Nan Jing Univ Sci & Technol, Dept Mat Sci & Engn, No 200 Xiaolingwei St, Nanjing 210094, Jiangsu, Peoples R China.
EM xiongds@163.com
RI xiong, dangsheng/B-1823-2015
OI xiong, dangsheng/0000-0003-3210-3728
CR Ahn ES, 2001, NANO LETT, V1, P149, DOI 10.1021/nl0055299
   Covert RJ, 2003, WEAR, V255, P1064, DOI 10.1016/S0043-1648(03)00113-3
   Huang H. Y., 1997, CLIN NEUROL NEUROSUR, V99, P20
   Kobayashi M, 2005, BIOMATERIALS, V26, P3243, DOI 10.1016/j.biomaterials.2004.08.028
   Liu Q, 1997, BIOMATERIALS, V18, P1263, DOI 10.1016/S0142-9612(97)00069-0
   Muta H, 2001, J MOL STRUC-THEOCHEM, V536, P219, DOI 10.1016/S0166-1280(00)00632-1
   Nebahat D., 2006, COLLOID SURFACE B, V48, P42
   NOGUCHI T, 1991, J APPL BIOMATER, V2, P101, DOI 10.1002/jab.770020205
   Rosa R., 2004, MACROMOLECULES, V37, P1921
   SAWAE Y, 1996, T JPN SOC MECH ENG-C, V62, P2343
   Stammen JA, 2001, BIOMATERIALS, V22, P799, DOI 10.1016/S0142-9612(00)00242-8
   Suciu AN, 2004, JSME INT J C-MECH SY, V47, P199, DOI 10.1299/jsmec.47.199
   Zheng YD, 2005, CHEM J CHINESE U, V26, P1735
   Zheng-Qiu G, 1998, BIO-MED MATER ENG, V8, P75
NR 14
TC 36
Z9 38
U1 3
U2 34
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0022-2461
J9 J MATER SCI
JI J. Mater. Sci.
PD JUL
PY 2007
VL 42
IS 13
BP 5129
EP 5134
DI 10.1007/s10853-006-1264-4
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 186YP
UT WOS:000247814800054
DA 2018-10-20
ER

PT J
AU Yunoki, S
   Mori, K
   Suzuki, T
   Nagai, N
   Munekata, M
AF Yunoki, Shunji
   Mori, Kazuo
   Suzuki, Takeshi
   Nagai, Nobuhiro
   Munekata, Masanobu
TI Novel elastic material from collagen for tissue engineering
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID PHYSICAL CROSS-LINKING; FIBRIL FORMATION; MATRIX; CHONDROCYTES;
   BIOMATERIAL; INVITRO; REPAIR; SPONGE; GEL
AB Elastic collagen gel (e-gel) was prepared from salmon atelocollagen fibrillar gel reinforced by 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC) mediated cross-linking (f-gel). The preparation consisted of a simple heat treatment of the f-gel at 80 degrees C, in which the f-gel drastically shrank and the collagen fibril structure was deformed. The e-gel obtained showed rubber-like elasticity; its stress-strain behavior little changed through repeated stretching. The elongation at the breaking point was approximately 230%. Furthermore, normal human osteoblasts showed good attachment and proliferation on the e-gel. These results suggest its potential to be utilized for the development of tissue engineering.
C1 Hokkaido Univ, Div Mol Chem, Grad Sch Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan.
   Ihara & Co Ltd, Otaru, Hokkaido 0470261, Japan.
RP Yunoki, S (reprint author), Hokkaido Univ, Div Mol Chem, Grad Sch Engn, Kita Ku, Kita 13,Nishi 8, Sapporo, Hokkaido 0608628, Japan.
EM yunoki@cris.hokudai.ac.jp
CR Daamen WF, 2003, BIOMATERIALS, V24, P4001, DOI 10.1016/S0142-9612(03)00273-4
   DAMINK LHHO, 1995, J MATER SCI-MATER M, V6, P460, DOI 10.1007/BF00123371
   GORHAM SD, 1992, INT J BIOL MACROMOL, V14, P129, DOI 10.1016/S0141-8130(05)80002-9
   GROSS J, 1958, J BIOL CHEM, V233, P355
   Hafemann B, 2001, J MATER SCI-MATER M, V12, P437, DOI 10.1023/A:1011205221972
   HELSETH DL, 1981, J BIOL CHEM, V256, P7118
   HOLMES M, 1975, SURG FORUM, V26, P511
   Katsube K, 2000, ARCH ORTHOP TRAUM SU, V120, P121, DOI 10.1007/PL00021232
   KOIDE M, 1993, J BIOMED MATER RES, V27, P79, DOI 10.1002/jbm.820270111
   Koide T, 1997, Dent Mater J, V16, P1
   MATSUDA K, 1995, J BIOMAT SCI-POLYM E, V7, P221
   Mizuno S, 2001, J BIOMED MATER RES, V56, P368, DOI 10.1002/1097-4636(20010905)56:3<368::AID-JBM1105>3.0.CO;2-V
   Ochi M, 2001, ARTIF ORGANS, V25, P172, DOI 10.1046/j.1525-1594.2001.025003172.x
   Wang XH, 2003, BIOMATERIALS, V24, P3213, DOI 10.1016/S0142-9612(03)00170-4
   WEADOCK KS, 1995, J BIOMED MATER RES, V29, P1373, DOI 10.1002/jbm.820291108
   Weadock KS, 1996, J BIOMED MATER RES, V32, P221, DOI 10.1002/(SICI)1097-4636(199610)32:2<221::AID-JBM11>3.0.CO;2-M
   WILLIAMS BR, 1978, J BIOL CHEM, V253, P6578
   Yunoki S, 2004, J BIOSCI BIOENG, V98, P40, DOI 10.1263/jbb.98.40
NR 18
TC 17
Z9 17
U1 1
U2 8
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUL
PY 2007
VL 18
IS 7
BP 1369
EP 1375
DI 10.1007/s10856-007-0121-6
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 184PL
UT WOS:000247653900013
PM 17277984
DA 2018-10-20
ER

PT J
AU Kang, CK
   Lee, YS
AF Kang, Chan-Koo
   Lee, Yoon-Sik
TI The surface modification of stainless steel and the correlation between
   the surface properties and protein adsorption
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
DE stainless steel; surface modification; surface roughness;
   hydrophilicity; protein adsorption
ID SELF-ASSEMBLED MONOLAYERS; FIBRINOGEN ADSORPTION; POLY(ETHYLENE GLYCOL);
   MODEL; BIOMATERIALS; DESIGN; POLYMERS; STENTS
AB Protein adsorption on a biomaterial surface is of great importance as it usually induces unfavorable biological cascades, with the result that much surface modification research has had to be performed in an effort to prevent this. In this study, we developed surface modification methods for stainless steel, which is a representative metal for biomedical device. The stainless steels were first smoothened to different extents by electropolishing, in order to obtain a rough or smooth surface. On these two kinds of substrates, we introduced epoxide groups to the metal surface by silanization with 3-glycidoxypropyltrimethoxysilane (GPTS). Then, various polymers such as poly(ethylene glycol) (PEG), poly(tetrahydrofuran glycol) (PTG), poly(propylene glycol) (PPG) and poly(dimethylsiloxane) (PDMS) were grafted on the silanized stainless steels. Each surface modification step was confirmed by various analytical methods. Contact angle measurement revealed that the surface hydrophilicity was controllable by polymer grafting. Root-mean-square (RMS) data of atomic force microscopy showed that surface roughness was dramatically changed by electropolishing. Based on these results, the correlation between surface properties and protein adsorption was investigated. In the protein adsorption study, we observed that all of the polymer-grafted stainless steels exhibited lower protein adsorption, when compared with bare stainless steel. Moreover, a hydrophilic and smooth surface was found to be the best of choice for decreasing the protein adsorption.
C1 Seoul Natl Univ, Organ Synth Lab, Sch Chem Engn, Seoul 151742, South Korea.
RP Lee, YS (reprint author), Seoul Natl Univ, Organ Synth Lab, Sch Chem Engn, Seoul 151742, South Korea.
EM westhill@empal.com; yslee@snu.ac.kr
CR Bertelsen CM, 2001, PROG ORG COAT, V41, P239, DOI 10.1016/S0300-9440(01)00135-7
   Bertrand OF, 1998, J AM COLL CARDIOL, V32, P562, DOI 10.1016/S0735-1097(98)00289-7
   Cacciafesta P, 2001, SURF SCI, V491, P405, DOI 10.1016/S0039-6028(01)01303-6
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   COURTNEY JM, 1994, BIOMATERIALS, V15, P737, DOI 10.1016/0142-9612(94)90026-4
   Denis FA, 2002, LANGMUIR, V18, P819, DOI 10.1021/la011011o
   Eidelman Rachel S, 2003, Eur Heart J, V24, P499, DOI 10.1016/S0195-668X(02)00810-2
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   Halperin A, 1999, LANGMUIR, V15, P2525, DOI 10.1021/la981356f
   Harris J.M., 1992, POLYETHYLENE GLYCOL
   Helsen J.A., 1998, METALS BIOMATERIALS
   HERRWERTH S, 2003, J AM CHEM SOC, V125, P9459
   Huang NP, 2001, LANGMUIR, V17, P489, DOI 10.1021/la000736+
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   Kim YH, 2003, BIOMATERIALS, V24, P2213, DOI 10.1016/S0142-9612(03)00023-1
   Lewis AL, 2002, BIOMATERIALS, V23, P1697, DOI 10.1016/S0142-9612(01)00297-6
   Martins MCL, 2003, BIOMATERIALS, V24, P2067, DOI 10.1016/S0142-9612(03)00002-4
   Martz EO, 1997, J BIOMED MATER RES, V38, P267, DOI 10.1002/(SICI)1097-4636(199723)38:3<267::AID-JBM12>3.0.CO;2-8
   Nanci A, 1998, J BIOMED MATER RES, V40, P324
   Palmaz JC, 2002, J VASC SURG, V36, P1031, DOI 10.1067/MVA.2002.129113
   Piehler J, 1996, BIOSENS BIOELECTRON, V11, P579, DOI 10.1016/0956-5663(96)83293-3
   Plueddemann EP, 1982, SILANE COUPLING AGEN
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   Shin DS, 2003, BIOSENS BIOELECTRON, V19, P485, DOI 10.1016/S0956-5663(03)00228-8
   Sofia SJ, 1998, MACROMOLECULES, V31, P5059, DOI 10.1021/ma971016l
   Tegoulia VA, 2001, LANGMUIR, V17, P4396, DOI 10.1021/la001790t
   Thierry B, 2002, BIOMATERIALS, V23, P2997, DOI 10.1016/S0142-9612(02)00030-3
   Tirrell M, 2002, SURF SCI, V500, P61, DOI 10.1016/S0039-6028(01)01548-5
   Tsuruta T., 1993, BIOMEDICAL APPL POLY
   Ulman A, 1996, CHEM REV, V96, P1533, DOI 10.1021/cr9502357
   Yang ZH, 1999, LANGMUIR, V15, P8405, DOI 10.1021/la990260y
   Zhang F, 2001, BIOMATERIALS, V22, P1541, DOI 10.1016/S0142-9612(00)00310-0
   Zhao H, 2002, J MATER SCI-MATER M, V13, P911, DOI 10.1023/A:1019831808503
   Zhdanov VP, 2001, LANGMUIR, V17, P5407, DOI 10.1021/la0104222
NR 35
TC 40
Z9 42
U1 2
U2 42
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUL
PY 2007
VL 18
IS 7
BP 1389
EP 1398
DI 10.1007/s10856-006-0079-9
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 184PL
UT WOS:000247653900015
PM 17277988
DA 2018-10-20
ER

PT J
AU Castaneda-Munoz, DF
   Sundaram, PA
   Ramirez, N
AF Castaneda-Munoz, Diego F.
   Sundaram, Paul Antony
   Ramirez, Norman
TI Bone tissue reaction to Ti-48Al-2Cr-2Nb (at.%) in a rodent model: a
   preliminary SEM study
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID IMPLANTS; ALLOYS; CORROSION
AB A variety of metals have been used to replace the skeletal framework of human beings. Gamma titanium aluminide (gamma TiAl) has been recently developed as a prospective material for turbine applications. In this preliminary study, the potential of gamma TiAl as a biomaterial was evaluated using an in vivo rat model. Sprague-Dawley rats were implanted with gamma TiAl cylinders in the femur and observed for an experimental period lasting up to 180 days. The rats were sacrificed after periods of 45, 90 and 180 days. The femurs with the gamma TiAl implants were extracted and examined using scanning electron microscopy (SEM). Normal bone growth processes were observed as early as 45 days after gamma TiAl cylinder implantation. No signs of rejection of the implant metal were observed. In fact, a layered bone growth was observed on the implant metal surface. The bone-metal interface showed signs of tissue growth from original bone to the metal surface. gamma TiAl appears to elicit a normal bone tissue reaction and hence, has potential as a metallic implant material.
C1 Univ Puerto Rico, Dept Mech Engn, Mayaguez, PR 00680 USA.
   Univ Puerto Rico, Dept Orthoped, San Juan, PR 00926 USA.
   Hosp Concepc, Dept Pediat Orthoped, San German, PR 00683 USA.
RP Sundaram, PA (reprint author), Univ Puerto Rico, Dept Mech Engn, Mayaguez, PR 00680 USA.
EM psundaram@me.uprm.edu
CR ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   AUSTIN CM, 1997, INT S STRUCT IT, P413
   Bartolotta PA, 1999, GAMMA TITANIUM ALUMINIDES 1999, P3
   Bouchard PR, 1996, J BIOMED MATER RES, V32, P37, DOI 10.1002/(SICI)1097-4636(199609)32:1<37::AID-JBM5>3.0.CO;2-Q
   BRANEMARK P I, 1969, Scandinavian Journal of Plastic and Reconstructive Surgery, V3, P81
   BREME HJ, 1998, METABOLLIC BIOMATERI, P135
   Charnley J, 1968, Physiotherapy, V54, P406
   Guther V, 1999, GAMMA TITANIUM ALUMINIDES 1999, P225
   HIERHOLZER S, 1984, ARCH ORTHOP TRAUM SU, V102, P198, DOI 10.1007/BF00575233
   Jacobs JJ, 1996, CLIN ORTHOP RELAT R, pS256
   JEE WSS, 1983, SKELETAL TISSUES HIS, P212
   KIM YW, 1989, JOM-J MIN MET MAT S, V41, P24
   Lipsitt H.A., 1985, MATER RES SOC S P, V39, P351
   McQuay PA, 1999, GAMMA TITANIUM ALUMINIDES 1999, P197
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   ROCK M, 1998, HDB BIOMATERIAL PROP, P528
   Rugg D, 1999, GAMMA TITANIUM ALUMINIDES 1999, P11
   SOLAR RJ, 1979, J BIOMED MATER RES, V13, P217, DOI 10.1002/jbm.820130206
   SUNDERMAN FW, 1977, ANN CLIN LAB SCI, V7, P377
   TARR RR, 1986, CLIN ORTHOP RELAT R, P10
   Williams D.F., 1992, ADV BIOMATER, V10, P525
NR 21
TC 9
Z9 9
U1 0
U2 2
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUL
PY 2007
VL 18
IS 7
BP 1433
EP 1438
DI 10.1007/s10856-006-0095-9
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 184PL
UT WOS:000247653900020
PM 17387593
DA 2018-10-20
ER

PT J
AU Stancu, IC
   Layrolle, P
   Libouban, H
   Filmon, R
   Legeay, G
   Cincu, C
   Basle, MF
   Chappard, D
AF Stancu, I. C.
   Layrolle, P.
   Libouban, H.
   Filmon, R.
   Legeay, G.
   Cincu, C.
   Basle, M. F.
   Chappard, D.
TI Preparation of macroporous poly (2-hydroxyethyl) methacrylate with
   interconnected porosity
SO JOURNAL OF OPTOELECTRONICS AND ADVANCED MATERIALS
LA English
DT Article
DE biomaterial; macroporous methacrylate; X-ray microtomography; SEM
ID POLY(L-LACTIC ACID) FOAMS; INDUCED PHASE-SEPARATION; SCAFFOLDS; BONE;
   FABRICATION; MATRICES
AB The design of a macromolecular bone graft with interconnected macroporosity represents a major challenge in the field of orthopaedic biomaterials. Such a synthetic graft would combine the biocompatibility and the biomechanical behavior with a micro-architecture allowing the osteoconduction through the colonization of the implant by bony cells and blood vessels. Macroporous pHEMA blocks were obtained by polymerizing 2-hydroxyethyl methacrylate around polystyrene beads of four diameters (600, 800, 1200, 1600 mu m). X-ray microtomography (microCT) and scanning electron microscopy were used to evaluate the porosity and the interconnectivity. Porosity did not differ whatever the size of the beads used as porogen. Porosity was in the range of 58-66%, close to that of calf trabecular bone, a material used for preparing bone xenografts. Chromatographic analysis was performed in order to check the presence of residual monomer. The biomechanical characteristics of these porous materials were measured in compression and appeared close to those of calf bone used for xenografts.
C1 INSERM, EMI 0335, LHEA Fac Med, F-49045 Angers, France.
   Polytech Univ, Fac Ind Chem, Dept Macromol Chem, Bucharest, Romania.
   Technopole Univ, CTTM, F-72000 Le Mans, France.
RP Stancu, IC (reprint author), INSERM, EMI 0335, LHEA Fac Med, F-49045 Angers, France.
EM Izabela.Stancu@UGent.be
RI Stancu, Izabela-Cristina/D-3788-2014; Layrolle, Pierre/K-9257-2015
OI Stancu, Izabela-Cristina/0000-0003-0685-3947; Layrolle,
   Pierre/0000-0001-9800-5210
CR Burdick JA, 2003, BIOMATERIALS, V24, P1613, DOI 10.1016/S0142-9612(02)00538-0
   Cartmell S, 2004, J BIOMED MATER RES A, V69A, P97, DOI 10.1002/jbm.a.20118
   CHAPPARD D, 1993, BIOMATERIALS, V14, P507, DOI 10.1016/0142-9612(93)90238-W
   CHAPPARD D, 2005, MICROSC ANAL, V19, P17
   Chen VJ, 2004, BIOMATERIALS, V25, P2065, DOI 10.1016/j.biomaterials.2003.08.058
   Cornell C.N., 1998, CLIN ORTHOP S, V355, P267
   COURPRON P, 1973, REV RHUM, V40, P469
   Filmon R, 2002, BONE, V30, P152, DOI 10.1016/S8756-3282(01)00634-2
   Filmon R., 1996, Cells and Materials, V6, P11
   Filmon R, 2002, J BIOMAT SCI-POLYM E, V13, P1105, DOI 10.1163/156856202320813828
   GRENGA TE, 1989, PLAST RECONSTR SURG, V84, P245, DOI 10.1097/00006534-198908000-00009
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   Jaecques SVN, 2004, BIOMATERIALS, V25, P1683, DOI 10.1016/S0142-9612(03)00516-7
   KENTEPOZIDOU A, 1995, J MICROENCAPSUL, V12, P627, DOI 10.3109/02652049509006793
   Kujala S, 2003, BIOMATERIALS, V24, P4691, DOI 10.1016/S0142-9612(03)00359-4
   Legrand E, 2000, J BONE MINER RES, V15, P13, DOI 10.1359/jbmr.2000.15.1.13
   Lin ASP, 2003, BIOMATERIALS, V24, P481, DOI 10.1016/S0142-9612(02)00361-7
   Lo H, 1996, J BIOMED MATER RES, V30, P475, DOI 10.1002/(SICI)1097-4636(199604)30:4<475::AID-JBM5>3.0.CO;2-M
   Lozinsky VI, 1998, ENZYME MICROB TECH, V23, P227, DOI 10.1016/S0141-0229(98)00036-2
   MIKOS AG, 1993, BIOMATERIALS, V14, P323, DOI 10.1016/0142-9612(93)90049-8
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   MONTHEARD JP, 1992, J MACROMOL SCI R M C, VC32, P1, DOI 10.1080/15321799208018377
   MONTHEARD JP, 1997, DESK REFERENCE FUNCT, P699
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Nam YS, 1999, J BIOMED MATER RES, V47, P8, DOI 10.1002/(SICI)1097-4636(199910)47:1<8::AID-JBM2>3.0.CO;2-L
   Nam YS, 2000, J BIOMED MATER RES, V53, P1, DOI 10.1002/(SICI)1097-4636(2000)53:1<1::AID-JBM1>3.0.CO;2-R
   Nam YS, 1999, BIOMATERIALS, V20, P1783, DOI 10.1016/S0142-9612(99)00073-3
   Schiraldi C, 2004, BIOMATERIALS, V25, P3645, DOI 10.1016/j.biomaterials.2003.10.059
   SCHLIEPHAKE H, 1991, INT J ORAL MAX SURG, V20, P52, DOI 10.1016/S0901-5027(05)80698-8
   SCHLIEPHAKE H, 1991, International Journal of Oral and Maxillofacial Implants, V6, P168
   Spaans CJ, 2000, BIOMATERIALS, V21, P2453, DOI 10.1016/S0142-9612(00)00113-7
   Tancred DC, 1998, BIOMATERIALS, V19, P2303, DOI 10.1016/S0142-9612(98)00141-0
   Turner CH, 2002, OSTEOPOROSIS INT, V13, P97, DOI 10.1007/s001980200000
   van Lenthe GH, 2002, J BIOMECH, V35, P1191, DOI 10.1016/S0021-9290(02)00081-7
   WHANG K, 1995, POLYMER, V36, P837, DOI 10.1016/0032-3861(95)93115-3
   ZAKI HS, 1976, J DENT RES, V55, P272, DOI 10.1177/00220345760550021901
NR 36
TC 5
Z9 5
U1 0
U2 6
PU NATL INST OPTOELECTRONICS
PI BUCHAREST-MAGURELE
PA 1 ATOMISTILOR ST, PO BOX MG-5, BUCHAREST-MAGURELE 76900, ROMANIA
SN 1454-4164
EI 1841-7132
J9 J OPTOELECTRON ADV M
JI J. Optoelectron. Adv. Mater.
PD JUL
PY 2007
VL 9
IS 7
BP 2125
EP 2129
PG 5
WC Materials Science, Multidisciplinary; Optics; Physics, Applied
SC Materials Science; Optics; Physics
GA 197UX
UT WOS:000248583100034
DA 2018-10-20
ER

PT J
AU Zdolsek, J
   Eaton, JW
   Tang, L
AF Zdolsek, Johann
   Eaton, John W.
   Tang, Liping
TI Histamine release and fibrinogen adsorption mediate acute inflammatory
   responses to biomaterial implants in humans
SO JOURNAL OF TRANSLATIONAL MEDICINE
LA English
DT Article
ID IDENTIFICATION
AB Background: Medical implants often fail as a result of so-called foreign body reactions during which inflammatory cells are recruited to implant surfaces. Despite the clinical importance of this phenomenon, the mechanisms involved in these reactions to biomedical implants in humans are not well understood. The results from animal studies suggest that both fibrinogen adsorption to the implant surface and histamine release by local mast cells are involved in biomaterial-mediated acute inflammatory responses. The purpose of this study was to test this hypothesis in humans.
   Methods: Thirteen male medical student volunteers (Caucasian, 21-30 years of age) were employed for this study. To assess the importance of fibrinogen adsorption, six volunteers were implanted with polyethylene teraphthalate disks pre-coated with their own (fibrinogen-containing) plasma or (fibrinogen-free) serum. To evaluate the importance of histamine, seven volunteers were implanted with uncoated disks with or without prior oral administration of histamine receptor antagonists. The acute inflammatory response was estimated 24 hours later by measuring the activities of implant-associated phagocyte-specific enzymes.
   Results: Plasma coated implants accumulated significantly more phagocytes than did serum coated implants and the recruited cells were predominantly macrophage/monocytes. Administration of both H1 and H2 histamine receptor antagonists greatly reduced the recruitment of macrophages/monocytes and neutrophils on implant surfaces.
   Conclusion: In humans - as in rodents - biomaterial-mediated inflammatory responses involve at least two crucial events: histamine-mediated phagocyte recruitment and phagocyte accumulation on implant surfaces engendered by spontaneously adsorbed host fibrinogen. Based on these results, we conclude that reducing fibrinogen: surface interactions should enhance biocompatibility and that administration of histamine receptor antagonists prior to, and shortly after, medical device implantation should improve the functionality and longevity of medical implants.
C1 Univ Hosp, Dept Hand & Plast Surg, SE-58185 Linkoping, Sweden.
   Univ Louisville, James Graham Brown Canc Ctr, Mol Targets Program, Louisville, KY 40202 USA.
   Univ Texas, Dept Bioengn, Arlington, TX 76019 USA.
RP Zdolsek, J (reprint author), Univ Hosp, Dept Hand & Plast Surg, SE-58185 Linkoping, Sweden.
EM johann.zdolsek@lio.se; eatonredox@aol.com; ltang@uta.edu
FU NIGMS NIH HHS [R01 GM074021]
CR ALTIERI DC, 1990, J BIOL CHEM, V265, P12119
   BOZEMAN PM, 1990, J IMMUNOL METHODS, V126, P125, DOI 10.1016/0022-1759(90)90020-V
   CHRISTENSON L, 1989, J BIOMED MATER RES, V23, P705, DOI 10.1002/jbm.820230704
   COLEMAN RW, 1984, J CLIN INVEST, V73, P1249
   CRADDOCK PR, 1977, J CLIN INVEST, V59, P879, DOI 10.1172/JCI108710
   DOMANSKIS EJ, 1976, PLAST RECONSTR SURG, V58, P689, DOI 10.1097/00006534-197612000-00006
   FAUL F, 2007, IN PRESS BEHAV RES M
   GENG JG, 1990, NATURE, V343, P757, DOI 10.1038/343757a0
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Jansen B, 1988, J Biomater Appl, V2, P520
   Kozinn S C, 1986, J Arthroplasty, V1, P249, DOI 10.1016/S0883-5403(86)80015-8
   KUBES P, 1994, J IMMUNOL, V152, P3570
   PICHA GJ, 1990, PLAST RECONSTR SURG, V85, P903, DOI 10.1097/00006534-199006000-00011
   Reiner E., 1989, ENZYMES HYDROLYSING
   SUTHERLAND K, 1993, J CLIN INVEST, V92, P2360, DOI 10.1172/JCI116841
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841
   TORRES JL, 1988, ARCH BIOCHEM BIOPHYS, V267, P271, DOI 10.1016/0003-9861(88)90032-X
   TRUMPY IG, 1993, J ORAL MAXIL SURG, V51, P624, DOI 10.1016/S0278-2391(10)80259-9
   Ugarova TP, 1998, J BIOL CHEM, V273, P22519, DOI 10.1074/jbc.273.35.22519
   YAM LT, 1971, AM J CLIN PATHOL, V55, P283
NR 23
TC 53
Z9 56
U1 0
U2 5
PU BIOMED CENTRAL LTD
PI LONDON
PA MIDDLESEX HOUSE, 34-42 CLEVELAND ST, LONDON W1T 4LB, ENGLAND
SN 1479-5876
J9 J TRANSL MED
JI J. Transl. Med.
PD JUL 1
PY 2007
VL 5
AR 31
DI 10.1186/1479-5876-5-31
PG 6
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 194MS
UT WOS:000248349100001
PM 17603911
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Christensen, LD
   Moser, C
   Jensen, PO
   Rasmussen, TB
   Christophersen, L
   Kielleberg, S
   Kumar, N
   Hoiby, N
   Givskov, M
   Bjarnsholt, T
AF Christensen, Louise D.
   Moser, Claus
   Jensen, Peter O.
   Rasmussen, Thomas B.
   Christophersen, Lars
   Kielleberg, Staffan
   Kumar, Naresh
   Hoiby, Niels
   Givskov, Michael
   Bjarnsholt, Thomas
TI Impact of Pseudomonas aeruginosa quorum sensing on biofilm persistence
   in an in vivo intraperitoneal foreign-body infection model
SO MICROBIOLOGY-SGM
LA English
DT Article
ID CYSTIC-FIBROSIS; POLYMORPHONUCLEAR LEUKOCYTES; MICROBIAL ADHESION;
   BACTERIAL BIOFILM; HYDROGEN-PEROXIDE; STATIONARY-PHASE; VIRULENCE GENES;
   LUNG INFECTION; EXPRESSION; BIOMATERIAL
AB Pseudomonas aeruginosa is an opportunistic human pathogen that causes chronic biofilm-based infections in host organisms. P. aeruginosa employs quorum sensing (OS) to control expression of its virulence, and to establish and maintain chronic infections. Under such conditions, the biofilm mode of growth contributes significantly to P. aeruginosa tolerance to the action of the innate and adaptive defence system and numerous antibiotics. In the present study, an in vivo foreign-body infection model was established in the peritoneal cavity of mice. Experimental data showed that QS-deficient P. aeruginosa are cleared more rapidly from silicone implants as compared to their wild-type counterparts. Concurrently, treatment with the QS inhibitor furanone C-30 of mice harbouring implants colonized with the wild-type P. aeruginosa resulted in a significantly faster clearing of the implants as compared to the placebo-treated group. These results were obtained with both an inbred (BALB/c) and an outbred (NMRI) mouse strain. The present results support a model by which functional QS systems play a pivotal role in the ability of bacteria to resist clearing by the innate immune system and strongly suggest that the efficiency of the mouse innate defence against biofilm-forming P. aeruginosa is improved when the bacteria are treated with QS drugs that induce QS deficiency.
C1 Tech Univ Denmark, Bio Centrum, DK-2800 Lyngby, Denmark.
   Rigshosp, Dept Clin Microbiol, DK-2100 Copenhagen, Denmark.
   Genom & Strain Dev, DK-2970 Horsholm, Denmark.
   Univ New S Wales, Ctr Marine Biofouling & Bioinnovat, Sydney, NSW 2052, Australia.
   Univ New S Wales, Sch Chem, Sydney, NSW 2052, Australia.
RP Bjarnsholt, T (reprint author), Tech Univ Denmark, Bio Centrum, DK-2800 Lyngby, Denmark.
EM tbj@biocentrum.dtu.dk
RI Hultqvist, Louise/M-1352-2015
OI Givskov, Michael/0000-0001-5004-8609; Hoiby, Niels/0000-0002-1347-725X;
   Bjarnsholt, Thomas/0000-0002-8003-7414; Jensen, Peter
   Ostrup/0000-0003-1648-7186; Hultqvist, Louise Dahl/0000-0003-0256-892X
CR Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x
   Bjarnsholt T, 2005, MICROBIOL-SGM, V151, P3873, DOI 10.1099/mic.0.27955-0
   Bjarnsholt T, 2005, MICROBIOL-SGM, V151, P373, DOI 10.1099/mic.0.27463-0
   Braxton EE, 2005, NEUROSURG REV, V28, P249, DOI 10.1007/s10143-005-0403-8
   BURET A, 1991, J BIOMED MATER RES, V25, P865, DOI 10.1002/jbm.820250706
   CHERNEY DL, 1983, J BONE JOINT SURG AM, V65, P1256, DOI 10.2106/00004623-198365090-00006
   Clegg CD, 1996, J APPL BACTERIOL, V81, P19, DOI 10.1111/j.1365-2672.1996.tb03277.x
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295
   Diggle SP, 2003, MOL MICROBIOL, V50, P29, DOI 10.1046/j.1365-2958.2003.03672.x
   Emerson RJ, 2004, APPL ENVIRON MICROB, V70, P6012, DOI 10.1128/AEM.70.10.6012-6022.2004
   FUQUA WC, 1994, J BACTERIOL, V176, P269
   GIVSKOV M, 1994, J BACTERIOL, V176, P7, DOI 10.1128/jb.176.16.4816-4824.1994
   Goldsby RA, 2003, IMMUNOLOGY
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Hassett DJ, 1999, MOL MICROBIOL, V34, P1082, DOI 10.1046/j.1365-2958.1999.01672.x
   Hentzer M, 2003, EMBO J, V22, P3803, DOI 10.1093/emboj/cdg366
   Hentzer M, 2002, MICROBIOL-SGM, V148, P87, DOI 10.1099/00221287-148-1-87
   Hentzer M, 2005, BIOFILMS, V2, P37, DOI DOI 10.1017/S1479050505001699
   HOIBY N, 1974, ACTA PATH MICRO IM B, VB 82, P541
   Hoiby N, 2001, MICROBES INFECT, V3, P23, DOI 10.1016/S1286-4579(00)01349-6
   Hooi DSW, 2004, INFECT IMMUN, V72, P6463, DOI 10.1128/IAI.72.11.6463.6470.2004
   Jensen PO, 2007, MICROBIOL-SGM, V153, P1329, DOI 10.1099/mic.0.2006/003863-0
   Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x
   Koch B, 2001, J MICROBIOL METH, V45, P187, DOI 10.1016/S0167-7012(01)00246-9
   LAPPINSCOTT HM, 1988, J APPL BACTERIOL, V64, P541, DOI 10.1111/j.1365-2672.1988.tb02445.x
   Latifi A, 1996, MOL MICROBIOL, V21, P1137, DOI 10.1046/j.1365-2958.1996.00063.x
   Matz C, 2004, ENVIRON MICROBIOL, V6, P218, DOI 10.1111/j.1462-2920.2004.00556.x
   Middleton B, 2002, FEMS MICROBIOL LETT, V207, P1
   Neut D, 2005, ACTA ORTHOP, V76, P109, DOI 10.1080/00016470510030427
   OCHSNER UA, 1995, P NATL ACAD SCI USA, V92, P6424, DOI 10.1073/pnas.92.14.6424
   PASSADOR L, 1993, SCIENCE, V260, P1127, DOI 10.1126/science.8493556
   PEARSON JP, 1994, P NATL ACAD SCI USA, V91, P197, DOI 10.1073/pnas.91.1.197
   PEARSON JP, 1995, P NATL ACAD SCI USA, V92, P1490, DOI 10.1073/pnas.92.5.1490
   PEDERSEN SS, 1990, APMIS, V98, P203, DOI 10.1111/j.1699-0463.1990.tb01023.x
   Pesci EC, 1997, J BACTERIOL, V179, P3127, DOI 10.1128/jb.179.10.3127-3132.1997
   Rasmussen TB, 2005, J BACTERIOL, V187, P1799, DOI 10.1128/JB.187.5.1799-1814.2005
   Rasmussen TB, 2005, MICROBIOL-SGM, V151, P1325, DOI 10.1099/mic.0.27715-0
   Saiman L, 2004, CURR OPIN PULM MED, V10, P515, DOI 10.1097/01.mcp.0000142101.53084.f0
   Singh PK, 2002, NATURE, V417, P552, DOI 10.1038/417552a
   Southern KW, 2004, EUR RESPIR J, V24, P834, DOI 10.1183/09031936.04.00084304
   Tateda K, 2003, INFECT IMMUN, V71, P5785, DOI 10.1128/IAI.71.10.5785-5793.2003
   Tateda K, 2001, ANTIMICROB AGENTS CH, V45, P1930, DOI 10.1128/AAC.45.6.1930-1933.2001
   Telford G, 1998, INFECT IMMUN, V66, P36
   Van Delden C, 1998, EMERG INFECT DIS, V4, P551, DOI 10.3201/eid0404.980405
   Verkerke GJ, 1997, ARTIF ORGANS, V21, P413
   Wu H, 2004, J ANTIMICROB CHEMOTH, V53, P1054, DOI 10.1093/jac/dkh223
NR 47
TC 83
Z9 92
U1 3
U2 13
PU SOC GENERAL MICROBIOLOGY
PI READING
PA MARLBOROUGH HOUSE, BASINGSTOKE RD, SPENCERS WOODS, READING RG7 1AG,
   BERKS, ENGLAND
SN 1350-0872
J9 MICROBIOL-SGM
JI Microbiology-(UK)
PD JUL
PY 2007
VL 153
BP 2312
EP 2320
DI 10.1099/mic.0.2007/006122-0
PN 7
PG 9
WC Microbiology
SC Microbiology
GA 191TM
UT WOS:000248154900031
PM 17600075
OA Bronze
DA 2018-10-20
ER

PT J
AU Simon, CG
   Stephens, JS
   Dorsey, SM
   Becker, ML
AF Simon, Carl G., Jr.
   Stephens, Jean S.
   Dorsey, Shauna M.
   Becker, Matthew L.
TI Fabrication of combinatorial polymer scaffold libraries
SO REVIEW OF SCIENTIFIC INSTRUMENTS
LA English
DT Article
ID NERVE GROWTH-FACTOR; CONCENTRATION GRADIENTS; NEURITE OUTGROWTH;
   CELL-INTERACTIONS; NATURAL BONE; GEL ASSAY; MATRIX; SURFACES; ADHESION;
   CULTURE
AB We have designed a novel combinatorial research platform to help accelerate tissue engineering research. Combinatorial methods combine many samples into a single specimen to enable accelerated experimentation and discovery. The platform for fabricating combinatorial polymer scaffold libraries can be used to rapidly identify scaffold formulations that maximize tissue formation. Many approaches for screening cell-biomaterial interactions utilize a two-dimensional format such as a film or surface to present test substrates to cells. However, cells in vivo exist in a three-dimensional milieu of extracellular matrix and cells in vitro behave more naturally when cultured in a three-dimensional environment than when cultured on a two-dimensional surface. Thus, we have designed a method for fabricating combinatorial biomaterial libraries where the materials are presented to cells in the form of three-dimensional, porous, salt-leached, polymer scaffolds. Many scaffold variations and compositions can be screened in a single experiment so that optimal scaffold formulations for tissue formation can be rapidly identified. In summary, we have developed a platform technology for fabricating combinatorial polymer scaffold libraries that can be used to screen cell response to materials in a three-dimensional, scaffold format. (c) 2007 American Institute of Physics.
C1 Natl Inst Stand & Technol, Div Polymers, Gaithersburg, MD 20899 USA.
RP Simon, CG (reprint author), Natl Inst Stand & Technol, Div Polymers, Gaithersburg, MD 20899 USA.
EM carl.simon@nist.gov
CR Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a
   Anderson DG, 2005, BIOMATERIALS, V26, P4892, DOI 10.1016/j.biomaterials.2004.11.052
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Barry JJA, 2006, ADV MATER, V18, P1406, DOI 10.1002/adma.200502719
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Brocchini S, 1998, J BIOMED MATER RES, V42, P66, DOI 10.1002/(SICI)1097-4636(199810)42:1<66::AID-JBM9>3.0.CO;2-M
   Burdick JA, 2004, LANGMUIR, V20, P5153, DOI 10.1021/la049298n
   Cao X, 2003, NEUROSCIENCE, V122, P381, DOI 10.1016/j.neuroscience.2003.08.018
   Cao X, 2001, NEUROSCIENCE, V103, P831, DOI 10.1016/S0306-4522(01)00029-X
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Disney MD, 2004, CHEM BIOL, V11, P1701, DOI 10.1016/j.chembiol.2004.10.011
   DOOLEY CT, 1994, SCIENCE, V266, P2019, DOI 10.1126/science.7801131
   DUNN JCY, 1989, FASEB J, V3, P174
   Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736
   Gunawan RC, 2005, LANGMUIR, V21, P3061, DOI 10.1021/la048303k
   HADDOX JL, 1991, J IMMUNOL METHODS, V141, P41, DOI 10.1016/0022-1759(91)90208-W
   HALL HG, 1982, P NATL ACAD SCI-BIOL, V79, P4672, DOI 10.1073/pnas.79.15.4672
   Harley BA, 2006, BIOMATERIALS, V27, P866, DOI 10.1016/j.biomaterials.2005.07.012
   ISHIYAMA M, 1993, CHEM PHARM BULL, V41, P1118
   Kang CE, 2004, J BIOMED MATER RES A, V71A, P403, DOI 10.1002/jbm.a.30137
   Kennedy SB, 2006, BIOMATERIALS, V27, P3817, DOI 10.1016/j.biomaterials.2006.02.044
   Knapp DM, 1999, EXP CELL RES, V247, P543, DOI 10.1006/excr.1998.4364
   Lanza R, 2000, PRINCIPLES TISSUE EN
   LETOURNEAU PC, 1978, DEV BIOL, V66, P183, DOI 10.1016/0012-1606(78)90283-X
   Li B, 2005, BIOMATERIALS, V26, P1487, DOI 10.1016/j.biomaterials.2004.05.004
   Lysaght MJ, 2004, TISSUE ENG, V10, P309, DOI 10.1089/107632704322791943
   Lysaght MJ, 1998, TISSUE ENG, V4, P231, DOI 10.1089/ten.1998.4.231
   Mei Y, 2005, LANGMUIR, V21, P12309, DOI 10.1021/la050668x
   Meredith JC, 2003, J BIOMED MATER RES A, V66A, P483, DOI 10.1002/jbm.a.10004
   MOGHE PV, 1995, J IMMUNOL METHODS, V180, P193, DOI 10.1016/0022-1759(94)00314-M
   Moore K, 2006, TISSUE ENG, V12, P267, DOI 10.1089/ten.2006.12.267
   Rohrer SP, 1998, SCIENCE, V282, P737, DOI 10.1126/science.282.5389.737
   Roy TD, 2003, J BIOMED MATER RES A, V66A, P283, DOI 10.1002/jbm.a.10582
   RUARDY TG, 1995, J BIOMED MATER RES, V29, P1415, DOI 10.1002/jbm.820291113
   Schwarz K, 1998, MACROMOL RAPID COMM, V19, P613, DOI 10.1002/(SICI)1521-3927(19981201)19:12<613::AID-MARC613>3.3.CO;2-D
   Shea LD, 2000, TISSUE ENG, V6, P605, DOI 10.1089/10763270050199550
   Simon CG, 2005, BIOMATERIALS, V26, P6906, DOI 10.1016/j.biomaterials.2005.04.050
   Simon CG, 2002, J ORTHOPAED RES, V20, P473, DOI 10.1016/S0736-0266(01)00140-1
   Smith JT, 2004, LANGMUIR, V20, P8279, DOI 10.1021/la0489763
   Stegemann JP, 2003, EXP CELL RES, V283, P146, DOI 10.1016/S0014-4827(02)00041-1
   SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191
   Tampieri A, 2001, BIOMATERIALS, V22, P1365, DOI 10.1016/S0142-9612(00)00290-8
   Washburn NR, 2004, BIOMATERIALS, V25, P1215, DOI 10.1016/j.biomaterials.2003.08.043
   Webb K, 2003, BIOMATERIALS, V24, P4681, DOI 10.1016/S0142-9612(03)00368-5
NR 44
TC 25
Z9 25
U1 1
U2 8
PU AMER INST PHYSICS
PI MELVILLE
PA CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1,
   MELVILLE, NY 11747-4501 USA
SN 0034-6748
J9 REV SCI INSTRUM
JI Rev. Sci. Instrum.
PD JUL
PY 2007
VL 78
IS 7
AR 072207
DI 10.1063/1.2755761
PG 7
WC Instruments & Instrumentation; Physics, Applied
SC Instruments & Instrumentation; Physics
GA 196MI
UT WOS:000248486300008
PM 17672738
DA 2018-10-20
ER

PT J
AU Suehiro, A
   Kanemaru, S
   Umeda, H
   Amano, Y
   Omori, K
   Ito, J
AF Suehiro, A.
   Kanemaru, S.
   Umeda, H.
   Amano, Y.
   Omori, K.
   Ito, J.
TI Bacterial cellulose: A new biomaterial for mucosal regeneration of
   trachea
SO TISSUE ENGINEERING
LA English
DT Meeting Abstract
CT Conference of the
   Tissue-Engineering-and-Regenerative-Medicine-International-Society
   (TERMIS-EU)
CY SEP 04-07, 2007
CL London, ENGLAND
SP Tissue Engn & Regenerat Med Int Soc, European Chapter, UK Tissue & Cell Engn Soc
C1 Kyoto Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Sakyo Ku, Kyoto 6068507, Japan.
NR 0
TC 3
Z9 3
U1 0
U2 3
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD JUL
PY 2007
VL 13
IS 7
MA 22
BP 1642
EP 1642
PG 1
WC Cell & Tissue Engineering
SC Cell Biology
GA 190CL
UT WOS:000248035500045
DA 2018-10-20
ER

PT J
AU Lisignoli, G
   Grigolo, B
   Manferdini, C
   Codeluppi, K
   Cavallo, C
   Desando, G
   Facchini, A
AF Lisignoli, G.
   Grigolo, B.
   Manferdini, C.
   Codeluppi, K.
   Cavallo, C.
   Desando, G.
   Facchini, A.
TI Hyaluronan-based biomaterial modulates catabolic factors expressed by
   human chondrocytes and mesenchymal stem cells
SO TISSUE ENGINEERING
LA English
DT Meeting Abstract
CT Conference of the
   Tissue-Engineering-and-Regenerative-Medicine-International-Society
   (TERMIS-EU)
CY SEP 04-07, 2007
CL London, ENGLAND
SP Tissue Engn & Regenerat Med Int Soc, European Chapter, UK Tissue & Cell Engn Soc
C1 Ist Ortoped Rizzoli, Lab Immunol & Genet, Bologna, Italy.
RI Grigolo, Brunella/J-5417-2016
OI Grigolo, Brunella/0000-0002-3990-6745
NR 0
TC 0
Z9 0
U1 0
U2 2
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD JUL
PY 2007
VL 13
IS 7
MA 220
BP 1707
EP 1708
PG 2
WC Cell & Tissue Engineering
SC Cell Biology
GA 190CL
UT WOS:000248035500240
DA 2018-10-20
ER

PT J
AU Edwards, FC
   Di, Y
   Dye, JF
AF Edwards, F. C.
   Di, Y.
   Dye, J. F.
TI In vitro analysis of the inflammatory potential of a prototype
   biomaterial scaffold
SO TISSUE ENGINEERING
LA English
DT Meeting Abstract
CT Conference of the
   Tissue-Engineering-and-Regenerative-Medicine-International-Society
   (TERMIS-EU)
CY SEP 04-07, 2007
CL London, ENGLAND
SP Tissue Engn & Regenerat Med Int Soc, European Chapter, UK Tissue & Cell Engn Soc
C1 Mt Vernon Hosp, Royal Free Hosp NHS Trust, RAFT Inst, Northwood HA6 2RN, Middx, England.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD JUL
PY 2007
VL 13
IS 7
MA 231
BP 1711
EP 1711
PG 1
WC Cell & Tissue Engineering
SC Cell Biology
GA 190CL
UT WOS:000248035500251
DA 2018-10-20
ER

PT J
AU Marcacci, M
   Kon, E
   Zaffagnini, S
   Delcogliano, M
   Filardo, G
   Giardino, R
   Fini, M
   Pressato, D
   Arcangeli, E
   Quarto, R
AF Marcacci, M.
   Kon, E.
   Zaffagnini, S.
   Delcogliano, M.
   Filardo, G.
   Giardino, R.
   Fini, M.
   Pressato, D.
   Arcangeli, E.
   Quarto, R.
TI Novel nano-composite biomaterial for osteochondral tissue engineering
SO TISSUE ENGINEERING
LA English
DT Meeting Abstract
CT Conference of the
   Tissue-Engineering-and-Regenerative-Medicine-International-Society
   (TERMIS-EU)
CY SEP 04-07, 2007
CL London, ENGLAND
SP Tissue Engn & Regenerat Med Int Soc, European Chapter, UK Tissue & Cell Engn Soc
C1 Rizzoli Orthopaed Inst, I-40135 Bologna, Italy.
RI Fini, Milena/J-4808-2016
OI Fini, Milena/0000-0002-3732-3570
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD JUL
PY 2007
VL 13
IS 7
MA 306
BP 1736
EP 1736
PG 1
WC Cell & Tissue Engineering
SC Cell Biology
GA 190CL
UT WOS:000248035500326
DA 2018-10-20
ER

PT J
AU Zhao, Q
   Liu, Y
   Wang, C
   Wang, S
AF Zhao, Q.
   Liu, Y.
   Wang, C.
   Wang, S.
TI Evaluation of bacterial adhesion on Si-doped diamond-like carbon films
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE anti-adhesion; anti-bacterial; bacterial adhesion; Si-doped DLC; surface
   energy; surface treatment
ID STAPHYLOCOCCUS-AUREUS; THERMAL-STABILITY; SILICON; INFECTIONS;
   DEPOSITION; COATINGS
AB Diamond-like carbon (DLC) films as biomaterial for medical devices have been attracting great interest due to their excellent properties such as hardness, low friction and chemical inertness. It has been demonstrated that the properties of DLC films can be further improved by the addition of silicon into DLC films, such as thermal stability, compressive stress, etc. However no research work on anti-bacterial properties of silicon-doped diamond-like carbon films has been reported. In this paper the surface physical and chemical properties of Si-doped diamond-like carbon films with various Si contents on 316 stainless steel substrate prepared by a magnetron sputtering technique were investigated, including surface topography, surface chemistry, the sp(3)/sp(2) ratio, contact angle, surface free energy, etc. Bacterial adhesion to Si-doped DLC films was evaluated with Pseudomonas aeruginosa, Staphylococcus epidermidis and Staphylococcus aureus which frequently cause medical device-associated infections. The experimental results showed that bacterial adhesion decreased with increasing the silicon content in the films. All the Si-doped DLC films performed much better than stainless steel 316L on reducing bacterial attachment. (c) 2007 Elsevier B.V. All rights reserved.
C1 Univ Dundee, Dept Mech Engn, Dundee DD1 4HN, Scotland.
RP Zhao, Q (reprint author), Univ Dundee, Dept Mech Engn, Dundee DD1 4HN, Scotland.
EM q.zhao@dundee.ac.uk
CR BARTH E, 1989, BIOMATERIALS, V10, P325, DOI 10.1016/0142-9612(89)90073-2
   Butter R. S., 1995, Journal of Chemical Vapor Deposition, V3, P182
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   De Scheerder I, 2000, J INVASIVE CARDIOL, V12, P389
   DEMICHELIS F, 1992, MAT SCI ENG B-SOLID, V11, P313, DOI 10.1016/0921-5107(92)90231-W
   Flock JI, 1999, TRENDS MICROBIOL, V7, P140, DOI 10.1016/S0966-842X(99)01483-3
   Gago R, 1999, THIN SOLID FILMS, V338, P88, DOI 10.1016/S0040-6090(98)01002-5
   Gangopadhyay AK, 1997, TRIBOL INT, V30, P9, DOI 10.1016/0301-679X(96)00017-5
   GOOD RJ, 1992, J ADHES SCI TECHNOL, V6, P1269, DOI 10.1163/156856192X00629
   GRILL A, 1993, DIAM RELAT MATER, V2, P1519, DOI 10.1016/0925-9635(93)90023-U
   GRILL A, 1993, WEAR, V168, P143, DOI 10.1016/0043-1648(93)90210-D
   Kim MG, 1999, SURF COAT TECH, V112, P204, DOI 10.1016/S0257-8972(98)00770-1
   LASCOVICH JC, 1994, APPL SURF SCI, V78, P17, DOI 10.1016/0169-4332(94)90026-4
   Lee KR, 1997, THIN SOLID FILMS, V308, P263, DOI 10.1016/S0040-6090(97)00411-2
   Lin CR, 2001, MATER CHEM PHYS, V72, P126, DOI 10.1016/S0254-0584(01)00420-5
   Singh A, 2003, BIOMATERIALS, V24, P5083, DOI 10.1016/S0142-9612(03)00424-1
   TALLANT DR, 1995, DIAM RELAT MATER, V4, P191, DOI 10.1016/0925-9635(94)00243-6
   THRELKELD MG, 1994, PRINCIPLES PRACTICE, P783
   VANOSS CJ, 1988, LANGMUIR, V4, P884, DOI 10.1021/la00082a018
   von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3
   Weinstein RA, 2001, CLIN INFECT DIS, V33, P1386, DOI 10.1086/324190
   Wu WJ, 1999, SURF COAT TECH, V111, P134, DOI 10.1016/S0257-8972(98)00719-1
NR 22
TC 36
Z9 39
U1 1
U2 17
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD JUN 30
PY 2007
VL 253
IS 17
BP 7254
EP 7259
DI 10.1016/j.apsusc.2007.03.011
PG 6
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 187SC
UT WOS:000247867700046
DA 2018-10-20
ER

PT J
AU Bhattarai, SR
   Badahur, KCR
   Aryal, S
   Khil, MS
   Kim, HY
AF Bhattarai, Shanta Raj
   Bahadur, K. C. Remant
   Aryal, Santosh
   Khil, Myung Seob
   Kim, Hak Yong
TI N-Acylated chitosan stabilized iron oxide nanoparticles as a novel
   nano-matrix and ceramic modification
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE biomineralization; biomaterial; chitosan; nanoparticles; hydroxyapatite
ID MAGNETIC NANOPARTICLES; GOLD NANOPARTICLES; IN-VIVO; HYDROXYAPATITE;
   BIOMEDICINE; ADSORBENT; RESONANCE
AB The present study dealt with the use of hydrophobically modified polycations (N-acylated chitosan, Nac) stabilized iron oxide nanoparticles (IOPs) as a three dimensional (3D) nano-matrix for the controlled fabrication of hydroxyapatite (HAP). Among three different fatty acid chlorides (hexanoyl, octanoyl, and myristoyl chloride) modified chitosan (Nac-6, Nae-8, and Nac-14, respectively), we demonstrated the Nac-6-IOPs as a novel 3D nano-matrix for the controlled fabrication of HAP due to its well dispersibility and stability in aqueous medium (pH 7.4). Thermogravimetric analysis (TGA) estimated that an average two Nac-6 molecules could interact with one IOPs when the weight ratio of Nac-6 to IOPs was 0.16. Fourier transforms infrared (FT-IR) spectroscopic showed that the interaction of the polymer with IOPs was through the amide group of Nac-6. Transmission electron microscopy (TEM) revealed that the Nac-6-IOPs were well stable, uniform and mono-disperse in aqueous medium (pH 7.4), with average size of 10 nm. X-ray diffraction (XRD) and FT-IR analysis showed the evidence of HAP formation on the surface of Nac-6-IOPs. Scanning electron microscope (SEM) equipped with energy dispersive X-ray (EDX) analysis showed that the HAP on the surface of 3D Nac-640Ps nanomatrix looks an interesting morphology like quasi-spherical structured with a significant rough surface and highly compact configuration. EDX data analysis confirmed that Ca/P ratio is in excellent agreement with the closer theoretical value of 1.67 for natural HAP. Our investigation for the growth of HAP on the surface of Nac-640Ps approved that the functional groups and the geometry of the nano-matrix play a key role for inducing and directing the growth of HAP crystals mimicking to that of natural apatite. (C) 2007 Elsevier Ltd. All rights reserved.
C1 Chonbuk Natl Univ, Dept Text Engn, Jeonju 561756, South Korea.
   Chonbuk Natl Univ, Dept Bionanosyst Engn, Jeonju 561756, South Korea.
   Chonbuk Natl Univ, Ctr Healthcare Technol Dev, Jeonju 561756, South Korea.
RP Kim, HY (reprint author), Chonbuk Natl Univ, Dept Text Engn, Jeonju 561756, South Korea.
EM khy@moak.chonbuk.ac.kr
RI Kim, Hak Yong/G-3826-2013
OI Kim, Hak Yong/0000-0002-4133-124X; KC, Remant/0000-0002-3554-7247
CR Arbab AS, 2005, NMR BIOMED, V18, P383, DOI 10.1002/nbm.970
   Aryal S, 2006, SCRIPTA MATER, V54, P131, DOI 10.1016/j.scriptamat.2005.09.050
   AYER B, 2000, TURKEY J MED SCI, V30, P341
   Beppu M, 2001, KEY ENG MATER, V192-195, P31
   Beppu Marisa M., 2002, Mat. Res., V5, P47, DOI 10.1590/S1516-14392002000100008
   Berry CC, 2003, J PHYS D APPL PHYS, V36, pR198, DOI 10.1088/0022-3727/36/13/203
   Berry CC, 2004, BIOMATERIALS, V25, P5405, DOI 10.1016/j.biomaterials.2003.12.046
   Bhattarai N, 2005, BIOMATERIALS, V26, P6176, DOI 10.1016/j.biomaterials.2005.03.027
   Brewer SH, 2002, LANGMUIR, V18, P4460, DOI 10.1021/la025613z
   Bulte JWM, 2001, NAT BIOTECHNOL, V19, P1141, DOI 10.1038/nbt1201-1141
   Cartmell Sarah H, 2002, IEEE Trans Nanobioscience, V1, P92, DOI 10.1109/TNB.2002.806945
   Chang YC, 2005, MACROMOL BIOSCI, V5, P254, DOI 10.1002/mabi.200400153
   Cheng FY, 2005, BIOMATERIALS, V26, P729, DOI 10.1016/j.biomaterials.2004.03.016
   Choi CY, 2007, CARBOHYD POLYM, V68, P122, DOI 10.1016/j.carbol.2006.07.018
   Coche-Guerente L, 2005, ELECTROCHIM ACTA, V50, P2865, DOI 10.1016/j.electacta.2004.11.040
   Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+
   FOCHER B, 1986, MAKROMOL CHEM, V187, P2609
   Gupta AK, 2003, IEEE T NANOBIOSCI, V2, P256
   Heras A, 2001, CARBOHYD POLYM, V44, P1, DOI 10.1016/S0144-8617(00)00195-8
   Holme KR, 1997, CARBOHYD RES, V302, P7, DOI 10.1016/S0008-6215(97)00117-1
   Jain TK, 2005, MOL PHARMACEUT, V2, P194, DOI 10.1021/mp0500014
   Jia ZS, 2001, CARBOHYD RES, V333, P1, DOI 10.1016/S0008-6215(01)00112-4
   KC RB, 2006, STABILIZATION GOLD N, V7, P579
   KC RB, 2006, CERAMIC MODIFICATION, V54, P2029
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kim DK, 2003, CHEM MATER, V15, P1617, DOI 10.1021/cm021349j
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   Lee HS, 2005, J MAGN MAGN MATER, V293, P102, DOI 10.1016/j.jmmm.2005.01.049
   LI PJ, 1993, BIOMATERIALS, V14, P963, DOI 10.1016/0142-9612(93)90186-6
   Liao MH, 2002, J MATER CHEM, V12, P3654, DOI 10.1039/b207158d
   Lillo LE, 1997, CARBOHYD POLYM, V34, P397, DOI 10.1016/S0144-8617(97)00117-3
   MARGUERITE R, 1992, INT J BIOL MACROMOL, V14, P122
   MUZZARELLI RAA, 1988, CARBOHYD POLYM, V8, P1, DOI 10.1016/0144-8617(88)90032-X
   MUZZARELLI RAA, 1982, CARBOHYD RES, V107, P199, DOI 10.1016/S0008-6215(00)80539-X
   NEAMNARK, 2006, CARBOHYDRATE POLYMER, V66, P298
   Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201
   Peesan M, 2005, CARBOHYD POLYM, V60, P343, DOI 10.1016/j.carbpol.2005.01.008
   Ramay HR, 2005, J BIOMED NANOTECHNOL, V1, P151, DOI 10.1166/jbn.2005.026
   Rautaray D, 2005, LANGMUIR, V21, P5185, DOI 10.1021/la048541f
   ROBERT E, 1977, SCIENCE, V277, P1078
   SATO T, 1987, J MAGN MAGN MATER, V65, P252, DOI 10.1016/0304-8853(87)90044-8
   Scherer F, 2002, GENE THER, V9, P102, DOI 10.1038/sj/gt/3301624
   Shchukin DG, 2003, CHEM MATER, V15, P3947, DOI 10.1021/cm0341585
   Silva SS, 2005, J MATER CHEM, V15, P3952, DOI 10.1039/b505875a
   Song J, 2005, J AM CHEM SOC, V127, P3366, DOI 10.1021/ja043776z
   TIEN CL, 2003, J CONTROL RELEASE, V93, P1, DOI DOI 10.1016/S0168-3659
   Woo K, 2004, CHEM MATER, V16, P2814, DOI 10.1021/cm049552x
   Wyrna D., 2002, NANO LETT, V2, P419
   Xie WM, 2002, CARBOHYD POLYM, V50, P35, DOI 10.1016/S0144-8617(01)00370-8
   Zhang C, 2003, EUR POLYM J, V39, P1629, DOI 10.1016/S0014-3057(03)00068-5
   Zhang Y, 2002, BIOMATERIALS, V23, P1553, DOI 10.1016/S0142-9612(01)00267-8
NR 51
TC 62
Z9 63
U1 2
U2 36
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JUN 25
PY 2007
VL 69
IS 3
BP 467
EP 477
DI 10.1016/j.carbpol.2007.01.006
PG 11
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 174JQ
UT WOS:000246938600008
DA 2018-10-20
ER

PT J
AU Zhu, SL
   Wang, XM
   Qin, FX
   Inoue, A
AF Zhu, S. L.
   Wang, X. M.
   Qin, F. X.
   Inoue, A.
TI A new Ti-based bulk glassy alloy with potential for biomedical
   application
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE Ti-Zr-Cu-Pd; bulk glassy alloy; biomaterial; glass-forming ability
ID STRESS-STRAIN BEHAVIOR; AMORPHOUS-ALLOYS; METALLIC GLASSES; FORMING
   ABILITY; CRITERION
AB The thermal properties, glass forming ability (GFA) and mechanical properties of a series of Ti40Zr10Cu40-xPd10+x (x=0, 2, 4, 6, 8, 10) bulk glassy alloys were examined by differential scanning calorimetry (DSC), differential thermal analysis (DTA), X-ray diffractometry (XRD) and compressive test. The series of bulk glassy alloys are expected to be used as biomedical materials because of the absence of toxic elements such as Ni, Al and Be. The Ti40Zr10Cu36Pd14 alloy exhibits the highest GFA, resulting in a maximum diameter of 6 mm, and high thermal stability with a supercooled liquid region (Delta T-x) of 49 K. The bulk glassy alloy has higher specific strength of 2.7 x 10(5) Nm/kg and lower Young's modulus of 82 GPa than those of conventional biomedical Ti alloys. These are favorable for application to biomaterials. (C) 2007 Elsevier B.V. All rights reserved.
C1 Tohoku Univ, Mat Res Inst, Sendai, Miyagi 9808577, Japan.
RP Zhu, SL (reprint author), Tohoku Univ, Mat Res Inst, Sendai, Miyagi 9808577, Japan.
EM slzhu@imr.tohoku.ac.jp
RI Zhu, Shengli/D-5281-2009; zhu, shengli/A-8818-2011; BAI,
   JIE/D-7448-2016; Inoue, Akihisa/E-5271-2015; Qin, Fengxiang/A-8359-2011
OI Zhu, Shengli/0000-0002-0190-2626; 
CR Cai YL, 2006, SCRIPTA MATER, V54, P89, DOI 10.1016/j.scriptamat.2005.09.001
   Chen QJ, 2005, CHINESE PHYS LETT, V22, P1736, DOI 10.1088/0256-307X/22/7/048
   Cui CX, 2005, MATER LETT, V59, P3144, DOI 10.1016/j.matlet.2005.05.037
   HAY CC, 2002, APPL PHYS LETT, V80, P3096
   He G, 2003, BIOMATERIALS, V24, P5115, DOI 10.1016/S0142-9612(03)00440-X
   Helsen J.A., 1998, METALS BIOMATERIALS
   Inoue A, 2000, ACTA MATER, V48, P279, DOI 10.1016/S1359-6454(99)00300-6
   Inoue A, 2002, MATER TRANS, V43, P1892, DOI 10.2320/matertrans.43.1892
   INOUE A, 1995, MATER T JIM, V36, P866, DOI 10.2320/matertrans1989.36.866
   INOUE A, 1993, J NONCRYST SOLIDS, V473, P156
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Li BY, 2000, INTERMETALLICS, V8, P643, DOI 10.1016/S0966-9795(99)00140-5
   LIN XH, 1995, J APPL PHYS, V78, P6514, DOI 10.1063/1.360537
   Lu ZP, 2002, ACTA MATER, V50, P3501, DOI 10.1016/S1359-6454(02)00166-0
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Noort R. V, 1987, J MATER SCI, V22, P3801, DOI DOI 10.1007/BF01133326
   Takeuchi A, 2000, MATER T JIM, V41, P1372, DOI 10.2320/matertrans1989.41.1372
   Zhu SL, 2005, MAT SCI ENG A-STRUCT, V408, P264, DOI 10.1016/j.msea.2005.08.012
NR 18
TC 103
Z9 109
U1 2
U2 53
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD JUN 25
PY 2007
VL 459
IS 1-2
BP 233
EP 237
DI 10.1016/j.msea.2007.01.044
PG 5
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 171IL
UT WOS:000246729300033
DA 2018-10-20
ER

PT J
AU Metcalfe, AD
   Ferguson, MWJ
AF Metcalfe, Anthony D.
   Ferguson, Mark W. J.
TI Tissue engineering of replacement skin: the crossroads of biomaterials,
   wound healing, embryonic development, stem cells and regeneration
SO JOURNAL OF THE ROYAL SOCIETY INTERFACE
LA English
DT Review
DE skin; regeneration; stem cells; tissue engineering; scarring
ID HEPATOCYTE GROWTH-FACTOR; HUMAN EPIDERMAL KERATINOCYTES; VERTEBRATE LENS
   REGENERATION; PERIPHERAL-BLOOD FIBROCYTES; AMPHIBIAN LIMB REGENERATION;
   TRANSIT AMPLIFYING CELLS; IN-VIVO; GENE-EXPRESSION; RETINOIC ACID;
   FACTOR-BETA
AB Advanced therapies combating acute and chronic skin wounds are likely to be brought about using our knowledge of regenerative medicine coupled with appropriately tissue-engineered skin substitutes. At the present time, there are no models of an artificial skin that completely replicate normal uninjured skin. Natural biopolymers such as collagen and fibronectin have been investigated as potential sources of biomaterial to which cells can attach. The first generation of degradable polymers used in tissue engineering were adapted from other surgical uses and have drawbacks in terms of mechanical and degradation properties. This has led to the development of synthetic degradable gels primarily as a way to deliver cells and/or molecules in situ, the so-called smart matrix technology. Tissue or organ repair is usually accompanied by fibrotic reactions that result in the production of a sear. Certain mammalian tissues, however, have a capacity for complete regeneration without scarring; good examples include embryonic or foetal skin and the ear of the MRL/MpJ mouse. Investigations of these model systems reveal that in order to achieve such complete regeneration, the inflammatory response is altered such that the extent of fibrosis and scarring is diminished. From studies on the limited examples of mammalian regeneration, it may also be possible to exploit such models to further clarify the regenerative process. The challenge is to identify the factors and cytokines expressed during regeneration and incorporate them to create a smart matrix for use in a skin equivalent. Recent advances in the use of DNA microarray and proteomic technology are likely to aid the identification of such molecules. This, coupled with recent advances in non-viral gene delivery and stem cell technologies, may also contribute to novel approaches that would generate a skin replacement whose materials technology was based not only upon intelligent design, but also upon the molecules involved in the process of regeneration.
C1 Univ Manchester, Fac Life Sci, UK Ctr Tissue Engn, Manchester M13 9PT, Lancs, England.
RP Ferguson, MWJ (reprint author), Univ Manchester, Fac Life Sci, UK Ctr Tissue Engn, 3-239 Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.
EM mark.w.ferguson@manchester.ac.uk
OI Metcalfe, Anthony/0000-0002-1633-6831
CR Abe R, 2001, J IMMUNOL, V166, P7556, DOI 10.4049/jimmunol.166.12.7556
   ADZICK NS, 1991, J SURG RES, V51, P216, DOI 10.1016/0022-4804(91)90097-6
   Ahsan T, 2005, Orthod Craniofac Res, V8, P134, DOI 10.1111/j.1601-6343.2005.00326.x
   Allen SP, 2002, DEV BIOL, V251, P409, DOI 10.1006/dbio.2002.0816
   Alonso L, 2003, GENE DEV, V17, P1189, DOI 10.1101/gad.1086903
   ARMSTRONG JR, 1995, DEV BIOL, V169, P242, DOI 10.1006/dbio.1995.1141
   Ashcroft GS, 1997, J ANAT, V190, P351, DOI 10.1046/j.1469-7580.1997.19030351.x
   Auger FA, 2004, BIOTECHNOL APPL BIOC, V39, P263
   Badiavas EV, 2003, ARCH DERMATOL, V139, P510, DOI 10.1001/archderm.139.4.510
   Bayat A, 2003, BRIT MED J, V326, P88, DOI 10.1136/bmj.326.7380.88
   Beausang E, 1998, PLAST RECONSTR SURG, V102, P1954, DOI 10.1097/00006534-199811000-00022
   BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274
   Benest AV, 2006, MICROCIRCULATION, V13, P423, DOI 10.1080/10739680600775940
   Bevan D, 2004, J PATHOL, V203, P831, DOI 10.1002/path.1578
   BOROS P, 1995, LANCET, V345, P293, DOI 10.1016/S0140-6736(95)90279-1
   Boyce ST, 2002, AM J SURG, V183, P445, DOI 10.1016/S0002-9610(02)00813-9
   Boyce ST, 1996, J INVEST DERMATOL, V107, P82, DOI 10.1111/1523-1747.ep12298286
   Boyce ST, 2001, BURNS, V27, P523, DOI 10.1016/S0305-4179(01)00019-5
   BOYCE ST, 1993, J INVEST DERMATOL, V100, P360, DOI 10.1111/1523-1747.ep12471822
   Broadley K N, 1989, Biotechnol Ther, V1, P55
   Brockes JP, 2005, SCIENCE, V310, P1919, DOI 10.1126/science.1115200
   Brockes JP, 1997, SCIENCE, V276, P81, DOI 10.1126/science.276.5309.81
   Brouard M, 2003, CURR OPIN BIOTECH, V14, P520, DOI 10.1016/j.copbio.2003.09.005
   BUCALA R, 1994, MOL MED, V1, P71
   Burd A, 2005, CLIN DERMATOL, V23, P376, DOI 10.1016/j.clindermatol.2004.07.019
   Butler CE, 2005, ADV BIOCHEM ENG BIOT, V94, P23, DOI 10.1007/b99998
   Caplan Arnold I, 2003, Novartis Found Symp, V249, P17
   Chai Y, 2003, MICROSC RES TECHNIQ, V60, P469, DOI 10.1002/jemt.10287
   Chesney J, 1997, P NATL ACAD SCI USA, V94, P6307, DOI 10.1073/pnas.94.12.6307
   CHETTIBI S, 1999, INFLAMMATION BASIC P, P864
   CHIN GS, 2000, SCARLESS WOUND HEALI, P239
   Clark LD, 1998, CLIN IMMUNOL IMMUNOP, V88, P35, DOI 10.1006/clin.1998.4519
   Clark R., 1996, Mezhdunarodnyi Sel'skokhozyaistvennyi Zhurnal, P3
   Cole J, 2001, WOUND REPAIR REGEN, V9, P360, DOI 10.1046/j.1524-475x.2001.00360.x
   Cooper L, 2005, GENOME BIOL, V6
   Cordeiro MF, 2003, GENE THER, V10, P59, DOI 10.1038/sj.gt.3301865
   CORDEIRO MF, 2002, CIRCULATION, V106, P130, DOI DOI 10.1161/01.CIR.0000020689.12472.EO
   Cowin AJ, 1998, DEV DYNAM, V212, P385
   Cowin AJ, 2001, CELL TISSUE RES, V306, P239, DOI 10.1007/s004410100443
   Cowin AJ, 2001, EUR J DERMATOL, V11, P424
   Currie LJ, 2001, PLAST RECONSTR SURG, V108, P1713, DOI 10.1097/00006534-200111000-00045
   Dang CM, 2003, PLAST RECONSTR SURG, V111, P1969, DOI 10.1097/01.PRS.0000054837.47432.E7
   DESAI NP, 1991, J BIOMED MATER RES, V25, P829, DOI 10.1002/jbm.820250704
   Dmetrichuk JM, 2005, DEV BIOL, V281, P112, DOI 10.1016/j.ydbio.2005.02.019
   Donohue KG, 2005, J DERMATOL, V32, P626, DOI 10.1111/j.1346-8138.2005.tb00811.x
   DOUGLAS BS, 1972, AUST PAEDIATR J, V8, P86
   Doukas J, 2002, MOL THER, V5, P517, DOI 10.1006/mthe.2002.0579
   DUNPHY J. ENGLEBERT, 1967, CAN J SURG, V10, P281
   Ehrenreich Michael, 2006, Acta Dermatovenerol Croat, V14, P172
   FALANGA V, 1992, J DERMATOL SURG ONC, V18, P604, DOI 10.1111/j.1524-4725.1992.tb03514.x
   Falanga V, 1999, WOUND REPAIR REGEN, V7, P201, DOI 10.1046/j.1524-475X.1999.00201.x
   Fallon JF, 2003, DEV DYNAM, V226, P161, DOI 10.1002/dvdy.10252
   FAUSTO N, 2000, HEPATOLOGY, V32, P19
   Ferguson M W J, 2002, Br Dent J, V192, P475, DOI 10.1038/sj.bdj.4801404a
   Ferguson MWJ, 1996, PLAST RECONSTR SURG, V97, P854, DOI 10.1097/00006534-199604000-00029
   Ferguson MWJ, 2004, PHILOS T ROY SOC B, V359, P839, DOI 10.1098/rstb.2004.1475
   FERRARI G, 1998, SCIENCE, V279, P514, DOI DOI 10.1126/SCIENCE.279.5356.1528
   FERRETTI P, 2001, INT J DEV BIOL, V45, P127
   FRANK S, 1995, J BIOL CHEM, V270, P12607, DOI 10.1074/jbc.270.21.12607
   Gambardella L, 2003, CURR OPIN CELL BIOL, V15, P771, DOI 10.1016/j.ceb.2003.10.011
   Gardiner DM, 1996, INT J DEV BIOL, V40, P797
   Gardiner DM, 2002, SEMIN CELL DEV BIOL, V13, P345, DOI 10.1016/S1084-9521(02)00090-3
   GARG HG, 2000, SCARLESS WOUND HEALI
   Gawronska-Kozak B, 2004, TISSUE ENG, V10, P1251, DOI 10.1089/ten.2004.10.1251
   Gawronska-Kozak B, 2006, WOUND REPAIR REGEN, V14, P265, DOI 10.1111/j.1743-6109.2006.00121.x
   Gillitzer R, 2001, J LEUKOCYTE BIOL, V69, P513
   Godwin AR, 1998, GENE DEV, V12, P11, DOI 10.1101/gad.12.1.11
   Godwin JW, 2006, J ANAT, V209, P423, DOI 10.1111/j.1469-7580.2006.00626.x
   Gosiewska A, 2001, WOUND REPAIR REGEN, V9, P213, DOI 10.1046/j.1524-475x.2001.00213.x
   GOSS RJ, 1995, ANAT REC, V241, P291, DOI 10.1002/ar.1092410302
   GOSS RJ, 1992, J EXP ZOOL, V261, P451, DOI 10.1002/jez.1402610412
   GOSS RJ, 1975, J MORPHOL, V146, P533, DOI 10.1002/jmor.1051460408
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   Griffith LG, 2002, ANN NY ACAD SCI, V961, P83, DOI 10.1111/j.1749-6632.2002.tb03056.x
   Gu DL, 2004, MOL THER, V9, P699, DOI 10.1016/j.ymthe.2004.02.018
   Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43922
   Gwak SJ, 2005, CELL TRANSPLANT, V14, P809, DOI 10.3727/000000005783982521
   Hachiya A, 2005, J INVEST DERMATOL, V125, P364, DOI 10.1111/j.0022-202X.2005.23832
   Han Manjong, 2005, Anatomical Record Part B:The New Anatomist, V287, P14, DOI 10.1002/ar.b.20082
   Hansbrough John F., 1992, Journal of Burn Care and Rehabilitation, V13, P519, DOI 10.1097/00004630-199209000-00004
   Harlan DM, 2002, ANN NY ACAD SCI, V961, P323, DOI 10.1111/j.1749-6632.2002.tb03114.x
   Hartlapp I, 2001, FASEB J, V15, P2215, DOI 10.1096/fj.01-0049com
   Harty M, 2003, DEV DYNAM, V226, P268, DOI 10.1002/dvdy.10239
   Hayen W, 1999, J CELL SCI, V112, P2241
   HEIKINHEIMO M, 1994, MECH DEVELOP, V48, P129, DOI 10.1016/0925-4773(94)90022-1
   Hojo M, 2003, PLAST RECONSTR SURG, V111, P1638, DOI 10.1097/01.PRS.0000053842.90564.26
   Hudon V, 2003, BRIT J DERMATOL, V148, P1094, DOI 10.1046/j.1365-2133.2003.05298.x
   Hynes RO, 1990, FIBRONECTINS, P546
   ILLINGWORTH CM, 1974, J PEDIATR SURG, V9, P853, DOI 10.1016/S0022-3468(74)80220-4
   Imokawa Y, 2004, PHILOS T R SOC B, V359, P765, DOI 10.1098/rstb.2004.1467
   Imokawa Y, 2003, CURR BIOL, V13, P877, DOI 10.1016/S0960-9822(03)00294-X
   Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823
   Jahoda CAB, 1996, J INVEST DERMATOL, V107, P804, DOI 10.1111/1523-1747.ep12330565
   JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K
   Kanda T, 1999, INT J DEV NEUROSCI, V17, P191, DOI 10.1016/S0736-5748(99)00026-X
   Kano MR, 2005, J CELL SCI, V118, P3759, DOI 10.1242/jcs.02483
   Kaur P, 2000, J INVEST DERMATOL, V114, P413, DOI 10.1046/j.1523-1747.2000.00884.x
   Kawai K, 2000, BIOMATERIALS, V21, P489, DOI 10.1016/S0142-9612(99)00207-0
   Kimura Y, 2003, J IMMUNOL, V170, P2331, DOI 10.4049/jimmunol.170.5.2331
   Kitano Y, 2001, ARCH DERMATOL RES, V293, P515, DOI 10.1007/PL00007466
   Kivinen PK, 1999, ARCH DERMATOL RES, V291, P217, DOI 10.1007/s004030050397
   KOBAYASHI K, 1989, J INVEST DERMATOL, V92, P278, DOI 10.1111/1523-1747.ep12276858
   Komuves LG, 2002, DEV DYNAM, V224, P58, DOI 10.1002/dvdy.10085
   KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9
   Kunisada T, 2000, MECH DEVELOP, V94, P67, DOI 10.1016/S0925-4773(00)00308-7
   Kuntz RM, 1997, BIOPHYS J, V72, P1472, DOI 10.1016/S0006-3495(97)78793-9
   Larocca david, 2002, Current Pharmaceutical Biotechnology, V3, P45, DOI 10.2174/1389201023378490
   LERNER AB, 1987, J INVEST DERMATOL, V89, P219, DOI 10.1111/1523-1747.ep12470973
   LEVINE JH, 1993, AM J PATHOL, V143, P368
   Li A, 1998, P NATL ACAD SCI USA, V95, P3902, DOI 10.1073/pnas.95.7.3902
   Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030
   Li X, 2000, BBA-GEN SUBJECTS, V1524, P102, DOI 10.1016/S0304-4165(00)00118-5
   Li XM, 2001, MAMM GENOME, V12, P52, DOI 10.1007/s003350010230
   LINBLAD WJ, 1998, WOUND REPAIR REGEN, V6, P186, DOI DOI 10.1046/J.1524-475X.1998.60304.X
   Lingen MW, 2001, ARCH PATHOL LAB MED, V125, P67
   LONGAKER MT, 1994, ANN SURG, V219, P65, DOI 10.1097/00000658-199401000-00011
   Luu YK, 2003, J CONTROL RELEASE, V89, P341, DOI 10.1016/S0168-3659(03)00097-X
   Mack JA, 2005, J BIOL CHEM, V280, P29904, DOI 10.1074/jbc.M505262200
   Mack JA, 2003, FASEB J, V17, P1352, DOI 10.1096/fj.02-0959fje
   Maden M, 2003, DEV DYNAM, V226, P237, DOI 10.1002/dvdy.10222
   MANAK JR, 1994, DEVELOPMENT, P61
   Mansbridge J, 2006, J ANAT, V209, P527, DOI 10.1111/j.1469-7580.2006.00631.x
   Masinde G, 2005, BIOCHEM BIOPH RES CO, V330, P117, DOI 10.1016/j.bbrc.2005.02.143
   Mastellos D, 2001, J IMMUNOL, V166, P2479, DOI 10.4049/jimmunol.166.4.2479
   MATSUMOTO K, 1991, EXP CELL RES, V196, P114, DOI 10.1016/0014-4827(91)90462-4
   MATSUMOTO K, 1995, EXP CELL RES, V220, P71, DOI 10.1006/excr.1995.1293
   McCallion RL, 1996, MOL CELLULAR BIOL WO, P561
   Mendez MV, 1998, J VASC SURG, V28, P876, DOI 10.1016/S0741-5214(98)70064-3
   Metcalfe AD, 2005, BIOCHEM SOC T, V33, P413, DOI 10.1042/BST0330413
   Metcalfe AD, 2006, J ANAT, V209, P439, DOI 10.1111/j.1469-7580.2006.00632.x
   Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60
   Mironov V, 2003, TRENDS BIOTECHNOL, V21, P157, DOI 10.1016/S0167-7799(03)00033-7
   Mori L, 2005, EXP CELL RES, V304, P81, DOI 10.1016/j.yexcr.2004.11.011
   MORRIS RJ, 1994, CELL PROLIFERAT, V27, P279, DOI 10.1111/j.1365-2184.1994.tb01425.x
   Murray EW, 1998, J BIOL CHEM, V273, P25279, DOI 10.1074/jbc.273.39.25279
   NISWANDER L, 1992, DEVELOPMENT, V114, P755
   NISWANDER L, 1993, NATURE, V361, P68, DOI 10.1038/361068a0
   O'Ceallaigh S, 2006, PLAST RECONSTR SURG, V117, P140, DOI 10.1097/01.prs.0000185611.87601.b8
   OHUCHI H, 1994, BIOCHEM BIOPH RES CO, V204, P882, DOI 10.1006/bbrc.1994.2542
   OKane S, 1997, INT J BIOCHEM CELL B, V29, P63, DOI 10.1016/S1357-2725(96)00120-3
   Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2
   OTTO WR, 1995, PLAST RECONSTR SURG, V96, P166, DOI 10.1097/00006534-199507000-00025
   Packer AI, 2000, MECH DEVELOP, V99, P153, DOI 10.1016/S0925-4773(00)00471-8
   Pandit A, 1999, J INVEST SURG, V12, P89
   PARENTEAU NL, 1992, CYTOTECHNOLOGY, V9, P163, DOI 10.1007/BF02521744
   Peled ZM, 2001, ANN PLAS SURG, V47, P417, DOI 10.1097/00000637-200110000-00010
   Peterson DA, 2002, CURR OPIN PHARMACOL, V2, P34, DOI 10.1016/S1471-4892(01)00118-7
   PHILIPSON L, 1983, CURR TOP MICROBIOL, V109, P1
   Phillips TJ, 1998, ARCH DERMATOL, V134, P344, DOI 10.1001/archderm.134.3.344
   Pienimaki JP, 2001, J BIOL CHEM, V276, P20428, DOI 10.1074/jbc.M007601200
   PIERCE GF, 1991, J CELL BIOCHEM, V45, P319, DOI 10.1002/jcb.240450403
   PIERCE GF, 1989, J CELL BIOL, V109, P429, DOI 10.1083/jcb.109.1.429
   Powers PS, 1999, J BURN CARE REHABIL, V20, P54, DOI 10.1097/00004630-199901001-00011
   Quan Timothy E, 2006, Curr Rheumatol Rep, V8, P145, DOI 10.1007/s11926-006-0055-x
   Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682
   Raffetto JD, 1999, AM J SURG, V178, P107, DOI 10.1016/S0002-9610(99)00134-8
   Rajnoch C, 2003, DEV DYNAM, V226, P388, DOI 10.1002/dvdy.10242
   Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530
   RAPPOLEE DA, 1994, DEVELOPMENT, V120, P2259
   RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8
   RHEINWALD JG, 1977, NATURE, V265, P421, DOI 10.1038/265421a0
   ROBERTS AB, 1990, PHILOS T R SOC B, V327, P145, DOI 10.1098/rstb.1990.0050
   ROBERTS AB, 1990, ANN NY ACAD SCI, V580, P225, DOI 10.1111/j.1749-6632.1990.tb17931.x
   Ronfard V, 2000, TRANSPLANTATION, V70, P1588, DOI 10.1097/00007890-200012150-00009
   Rosso F, 2005, J CELL PHYSIOL, V203, P465, DOI 10.1002/jcp.20270
   RUDOLPH R, 1976, SURG GYNECOL OBSTET, V142, P49
   RUOSLAHTI E, 1991, J CLIN INVEST, V87, P1, DOI 10.1172/JCI114957
   Sandulache VC, 2003, ARCH OTOLARYNGOL, V129, P345, DOI 10.1001/archotol.129.3.345
   SATO C, 1995, J INVEST DERMATOL, V104, P958, DOI 10.1111/1523-1747.ep12606221
   Schaffer CJ, 1996, INT REV CYTOL, V169, P151, DOI 10.1016/S0074-7696(08)61986-5
   Segre JA, 1999, NAT GENET, V22, P356
   Seitz H, 2005, J BIOMED MATER RES B, V74B, P782, DOI 10.1002/jbm.b.30291
   Seliktar D, 2004, J BIOMED MATER RES A, V68A, P704, DOI 10.1002/jbm.a.20091
   Sethi KK, 2002, WOUND REPAIR REGEN, V10, P397, DOI 10.1046/j.1524-475X.2002.10609.x
   SHAH FH, 1994, ASIA-PAC J MOL BIOL, V2, P107
   SHAH M, 1995, J CELL SCI, V108, P985
   SHAH M, 1992, LANCET, V339, P213, DOI 10.1016/0140-6736(92)90009-R
   SHURE D, 1992, BIOCHEM BIOPH RES CO, V186, P1510, DOI 10.1016/S0006-291X(05)81577-3
   SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0
   Slack JMW, 2003, DEV DYNAM, V226, P162, DOI 10.1002/dvdy.10232
   Spyrou GE, 2002, BRIT J PLAST SURG, V55, P275, DOI 10.1054/bjps.2002.3831
   Stelnicki EJ, 1997, DIFFERENTIATION, V62, P33, DOI 10.1046/j.1432-0436.1997.6210033.x
   Stenn KS, 2005, CURR OPIN BIOTECH, V16, P493, DOI 10.1016/j.copbio.2005.08.002
   Stenn KS, 2003, INT J DERMATOL, V42, P40, DOI 10.1046/j.1365-4362.2003.01726.x
   Sun X, 2002, NATURE, V418, P501, DOI 10.1038/nature00902
   Supp DM, 2005, CLIN DERMATOL, V23, P403, DOI 10.1016/j.clindermatol.2004.07.023
   Sweitzer SM, 2006, DIABETES EDUCATOR, V32, P197, DOI 10.1177/0145721706286897
   Swope VB, 1997, J INVEST DERMATOL, V109, P289, DOI 10.1111/1523-1747.ep12335766
   Tagashira S, 1997, GENE, V197, P399, DOI 10.1016/S0378-1119(97)00187-X
   Tanaka EM, 1999, CURR BIOL, V9, P792, DOI 10.1016/S0960-9822(99)80362-5
   Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7
   Toyoda M, 2001, FEBS LETT, V509, P95, DOI 10.1016/S0014-5793(01)03126-X
   Tran KT, 2005, J DERMATOL SCI, V40, P11, DOI 10.1016/j.jdermsci.2005.05.001
   Tremblay PL, 2005, AM J TRANSPLANT, V5, P1002, DOI 10.1111/j.1600-6143.2005.00790.x
   Trentin D, 2006, P NATL ACAD SCI USA, V103, P2506, DOI 10.1073/pnas.0505964102
   Tsai Chih-Cheng, 1999, Kaohsiung Journal of Medical Sciences, V15, P651
   Tsonis PA, 2006, J ANAT, V209, P433, DOI 10.1111/j.1469-7580.2006.00634.x
   Tsonis PA, 2006, ADV EXP MED BIOL, V586, P63
   Tuan RS, 2003, ARTHRITIS RES THER, V5, P32, DOI 10.1186/ar614
   van de Wetering P, 2005, J CONTROL RELEASE, V102, P619, DOI 10.1016/j.jconrel.2004.10.029
   Vande Berg Jerry S., 1998, Wound Repair and Regeneration, V6, P38, DOI 10.1046/j.1524-475X.1998.60107.x
   Vats A, 2003, CLIN OTOLARYNGOL, V28, P165, DOI 10.1046/j.1365-2273.2003.00686.x
   Vogel V, 2003, ANNU REV BIOMED ENG, V5, P441, DOI 10.1146/annurev.bioeng.5.040202.121615
   Ward R S, 1989, J Burn Care Rehabil, V10, P536, DOI 10.1097/00004630-198911000-00015
   WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0
   Watt FM, 1998, PHILOS T R SOC B, V353, P831, DOI 10.1098/rstb.1998.0247
   WERNER S, 1992, P NATL ACAD SCI USA, V89, P6896, DOI 10.1073/pnas.89.15.6896
   WHITBY DJ, 1991, DEV BIOL, V147, P207, DOI 10.1016/S0012-1606(05)80018-1
   WHITBY DJ, 1991, DEVELOPMENT, V112, P651
   WILCOX JN, 1988, MOL CELL BIOL, V8, P3415, DOI 10.1128/MCB.8.8.3415
   WU C, 1996, J CELL SCI, V108, P821
   Yang LJ, 2005, WOUND REPAIR REGEN, V13, P398, DOI 10.1111/j.1067-1927.2005.130407.x
   Yang LJ, 2002, LAB INVEST, V82, P1183, DOI 10.1097/01.LAB.0000027841.50269.61
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108
   Yoshida S, 2003, J INVEST DERMATOL, V120, P335, DOI 10.1046/j.1523-1747.2003.12039.x
   ZARNEGAR R, 1995, J CELL BIOL, V129, P1177, DOI 10.1083/jcb.129.5.1177
   Zenjari C, 1996, INT J DEV BIOL, V40, P965
   Zheng Y, 2005, J INVEST DERMATOL, V124, P867, DOI 10.1111/j.0022-202X.2005.23716.x
NR 218
TC 343
Z9 353
U1 10
U2 192
PU ROYAL SOCIETY
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1742-5689
J9 J R SOC INTERFACE
JI J. R. Soc. Interface
PD JUN 22
PY 2007
VL 4
IS 14
BP 413
EP 437
DI 10.1098/rsif.2006.0179
PG 25
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 179SZ
UT WOS:000247311700001
PM 17251138
OA Green Published
DA 2018-10-20
ER

PT J
AU Fukui, S
   Fukatsu, T
   Ikegami, T
   Shimada, M
AF Fukui, Shin
   Fukatsu, Takema
   Ikegami, Takashi
   Shimada, Masakazu
TI Endosymblosis as a compact ecosystem with material cycling: Parasitism
   or mutualism?
SO JOURNAL OF THEORETICAL BIOLOGY
LA English
DT Article
DE turnover flow; autophagy; decomposing process; metabolic system;
   evolution
ID TIT-FOR-TAT; ADAPTIVE IMMUNITY; AUTOPHAGY; EVOLUTION; SYMBIOSIS; INNATE;
   ORIGIN; TRANSMISSION; STRATEGY; PROTEIN
AB To discover the evolutionary logic of intracellular endosymbiosis, we investigated a theoretical model (simultaneous ordinary differential equations) of a material-cycling system inside a host cell. In the model, we introduced a recently developed cell biology concept called "autophagy", which is a decomposing-recycle process of self-compiled materials found universally among eukaryote cells. Our model is based on traditional simultaneous ODE for natural ecosystems that involve producing, grazing, and decomposing processes in material cycling. In the basic intracellular metabolic system, several enzymes regulate metabolism by synthesizing and converting metabolites into biomolecules that are precursors for enzymes involved in the producing process. Symbionts are involved in grazing processes and autophagosomes that degrade materials are involved in decomposing recycles. We compared and analyzed the local stability of ODE systems in three cases: (1) the independent, free-living cell (the basal state of a cell), (2) the case where symbionts invade and exploit macrobiomaterials as parasites inside a host cell, and (3) the combination where symbionts assist the host's metabolism. We conclude that: (i) as consumers, symbionts are required to have a growth rate that is higher than the rate of autophagosome decomposition, (ii) the host cell with a biomass larger than the threshold size would realize the mutualistic relationship with its symbiont, and (iii) this partnership accelerates the biomaterial turnover flow on the basis of biomaterials. (C) 2007 Elsevier Ltd. All rights reserved.
C1 Univ Tokyo, Grad Sch Arts & Sci, Dept Gen Syst Studies, Meguro Ku, Tokyo 1538902, Japan.
   AIST, Inst Biol Resources & Funct, Tsukuba, Ibaraki 3058566, Japan.
RP Fukui, S (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Gen Syst Studies, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.
EM shinsunm@dolphin.c.u-tokyo.ac.jp
OI Fukui, Shin/0000-0003-4452-2559
CR Andersen T., 1997, PELAGIC NUTR CYCLES
   Andersson SGE, 2003, PHILOS T ROY SOC B, V358, P165, DOI 10.1098/rstb.2002.1193
   Axelrod R., 1984, EVOLUTION COOPERATIO
   Bourtzis K., 2006, INSECT SYMBIOSIS, V2nd
   BUCHNER P, 1965, ENDOSYMBIOSIS ANIMAL
   DEANGELIS DL, 1992, DYNAMICS NUTR CYCLIN
   Deretic V, 2005, TRENDS IMMUNOL, V26, P523, DOI 10.1016/j.it.2005.08.003
   Eigen M., 1979, HYPERCYCLE PRINCIPLE
   EWALD PW, 1987, ANN NY ACAD SCI, V503, P295, DOI 10.1111/j.1749-6632.1987.tb40616.x
   FENNER F, 1983, PROC R SOC SER B-BIO, V218, P259, DOI 10.1098/rspb.1983.0039
   FENNER F, 1965, GENETICS COLONIZING, P485
   FRANK SA, 1993, EVOLUTION, V47, P1721, DOI 10.1111/j.1558-5646.1993.tb01264.x
   FRANK SA, 1995, J THEOR BIOL, V176, P403, DOI 10.1006/jtbi.1995.0208
   Gantmacher F. R., 1960, THEORY MATRICES, V1
   HASSELL MP, 1978, DYNAMICS ANTHROPOD P
   HERRE EA, 1993, SCIENCE, V259, P1142
   ISHIKAWA H, 1985, INSECT BIOCHEM, V15, P155, DOI 10.1016/0020-1790(85)90003-4
   JOHN P, 1975, NATURE, V254, P495, DOI 10.1038/254495a0
   LEVIN S, 1981, AM NAT, V117, P308, DOI 10.1086/283708
   Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1
   LOREAU M, 1995, AM NAT, V145, P22, DOI 10.1086/285726
   Loreau M, 1998, P ROY SOC B-BIOL SCI, V265, P33, DOI 10.1098/rspb.1998.0260
   Lotka AJ, 1922, P NATL ACAD SCI USA, V8, P147, DOI 10.1073/pnas.8.6.147
   Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660
   MARGALEF R, 1963, AM NAT, V97, P357, DOI 10.1086/282286
   Margulis L, 1981, SYMBIOSIS CELL EVOLU
   Matsuda H, 1993, MUTUALISM COMMUNITY, P228
   May R.M., 1983, P186
   MAYNARDSMITH J, 1995, MAJOR TRANSITIONS EV
   MAYNARDSMITH J, 1989, NATURE, V341, P284
   Mizushima N, 2005, CELL DEATH DIFFER, V12, P1535, DOI 10.1038/sj.cdd.4401728
   Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966
   NOWAK M, 1993, NATURE, V364, P56, DOI 10.1038/364056a0
   NOWAK MA, 1992, NATURE, V355, P250, DOI 10.1038/355250a0
   Odum E. P., 1971, FUNDAMENTALS ECOLOGY
   ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262
   Odum HT, 1983, SYSTEMS ECOLOGY
   Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036
   Otsuka Jinya, 2004, Ecological Complexity, V1, P237, DOI 10.1016/j.ecocom.2004.04.002
   Pimm S. L., 1991, BALANCE NATURE ECOLO
   ROUGHGARDEN J, 1975, ECOLOGY, V56, P1201, DOI 10.2307/1936160
   SASAKI A, 1999, P ROY SOC LOND B BIO, V266, P1455
   Schmid D, 2006, J MOL MED-JMM, V84, P194, DOI 10.1007/s00109-005-0014-4
   Seay M, 2006, CELL MICROBIOL, V8, P899, DOI 10.1111/j.1462-5822.2006.00715.x
   Ulanowicz R.E., 1983, MATH BIOSCI, V65, P210
   van Baalen M, 1998, P ROY SOC B-BIOL SCI, V265, P317
   Yamamura N, 1996, RES POPUL ECOL, V38, P211, DOI 10.1007/BF02515729
   YAMAMURA N, 1993, THEOR POPUL BIOL, V44, P95, DOI 10.1006/tpbi.1993.1020
   Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765
NR 49
TC 1
Z9 1
U1 0
U2 2
PU ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-5193
J9 J THEOR BIOL
JI J. Theor. Biol.
PD JUN 21
PY 2007
VL 246
IS 4
BP 746
EP 754
DI 10.1016/j.jtbi.2007.01.002
PG 9
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA 176PI
UT WOS:000247097000012
PM 17379250
OA Green Accepted, Green Published
DA 2018-10-20
ER

PT J
AU Fathima, NN
   Suresh, R
   Rao, JR
   Nair, BU
AF Fathima, Nishtar Nishad
   Suresh, Raju
   Rao, Jonnalagadda Raghava
   Nair, Balachandran Unni
TI Effect of UV irradiation on the physicochemical properties of collagen
   stabilized using aldehydes
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE collagen; UV radiation; conformational analysis; viscosity;
   fluorescence; absorption
ID RAT TAIL TENDON; ULTRAVIOLET-IRRADIATION; CIRCULAR-DICHROISM; SKIN;
   CONFORMATION
AB Collagen is an important biomaterial, finding immense application in the field of wound healing. In this study, effect of UV irradiation on aldehydes crosslinked collagen has been carried out. Aldehydes find predominant application in crosslinking of collagen for various end uses. The physical and optical properties of aldehydes crosslinked collagen affected by UV irradiation have been detailed. Viscosity measurements have shown that aldehydes crosslinked collagen has better stability against UV radiation than native collagen. Circular dichroic studies showed that prolonged exposure to UV radiation changes the triple helical structure of collagen into random coil conformation. The difference spectra for both emission and absorption show that formaldehyde brings about more stability to collagen against UV irradiation than gluteraldehyde. (c) 2007 Wiley Periodicals, Inc.
C1 Cent Leather Res Inst, Chem Lab, Madras 20, Tamil Nadu, India.
RP Rao, JR (reprint author), Cent Leather Res Inst, Chem Lab, Madras 20, Tamil Nadu, India.
EM jrrao_dri@yahoo.com.in; bcunchem@rediffmail.com
RI Rao, Jonnalagadda/B-8486-2009; Nair, Balachandran/D-1508-2010; Fathima,
   Nishad/B-7919-2009
CR BROWN FR, 1972, J MOL BIOL, V63, P85, DOI 10.1016/0022-2836(72)90523-2
   CHANDRAKASAN G, 1976, J BIOL CHEM, V251, P6062
   COHEN RG, 1986, J SURG RES, V41, P352, DOI 10.1016/0022-4804(86)90048-X
   COOPER DR, 1965, BIOCHEM J, V97, P139, DOI 10.1042/bj0970139
   de Gruijl FR, 1999, EUR J CANCER, V35, P2003, DOI 10.1016/S0959-8049(99)00283-X
   Fathima NN, 2004, INT J BIOL MACROMOL, V34, P241, DOI 10.1016/j.ijbiomac.2004.05.004
   Feng YB, 1996, J AM CHEM SOC, V118, P10351, DOI 10.1021/ja961260c
   Figueiro SD, 2006, BIOPHYS CHEM, V120, P154, DOI 10.1016/j.bpc.2005.11.001
   FRASER RDB, 1979, J MOL BIOL, V129, P463, DOI 10.1016/0022-2836(79)90507-2
   FUJIMORI E, 1966, BIOCHEMISTRY-US, V5, P1034, DOI 10.1021/bi00867a032
   KATO Y, 1992, J AGR FOOD CHEM, V40, P373, DOI 10.1021/jf00015a003
   Kollias N, 1998, J INVEST DERMATOL, V111, P776, DOI 10.1046/j.1523-1747.1998.00377.x
   Ramachandran G.N., 1967, TREATISE COLLAGEN
   RICH A, 1961, J MOL BIOL, V3, P483, DOI 10.1016/S0022-2836(61)80016-8
   Sionkowska A, 1999, INT J BIOL MACROMOL, V24, P337, DOI 10.1016/S0141-8130(99)00047-1
   Sionkowska A, 2005, INT J BIOL MACROMOL, V35, P145, DOI 10.1016/j.ijbiomac.2005.01.009
   Sionkowska A, 2004, INT J BIOL MACROMOL, V34, P9, DOI 10.1016/j.ijbiomac.2003.10.001
   Sionkowska A, 2000, POLYM DEGRAD STABIL, V68, P147, DOI 10.1016/S0141-3910(99)00176-7
   TIFFANY ML, 1968, BIOPOLYMERS, V6, P1767, DOI 10.1002/bip.1968.360061212
   TORIKAI A, 1999, J APPL POLYM SCI, V73, P1257
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
NR 21
TC 13
Z9 13
U1 2
U2 5
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD JUN 15
PY 2007
VL 104
IS 6
BP 3642
EP 3648
DI 10.1002/app.26129
PG 7
WC Polymer Science
SC Polymer Science
GA 162ZP
UT WOS:000246128400018
DA 2018-10-20
ER

PT J
AU Guan, XL
   Liu, XY
   Su, ZX
AF Guan, Xiaolin
   Liu, Xinyu
   Su, Zhixing
TI Preparation and photophysical behaviors of fluorescent chitosan bearing
   fluorescein: Potential biomaterial as temperature/pH probes
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE 3-epoxypropoxy fluorescein; chitosan; fluorescence; temperature/pH
   sensitivity
ID POLY(VINYL ALCOHOL); WATER; DERIVATIVES; CONDUCTION; POLYMERS
AB A novel method for attaching fluorescein (via its epoxy derivative) to water-soluble chitosan, and the temperature /pH-sensitive qualities of fluorescence were investigated. 3-Epoxypropoxy fluorescein (EPF) was firstly synthesized by the reaction between fluorescein and epichlorohydrin, and then water-soluble chitosan bearing fluorescein (CS-EPF) was prepared via ring-opening reaction with EPF. They were characterized by the methods of H-1 NMR, MS, IR, UV-Vis, and luminescence spectra, respectively. The chemiluminescent and photophysical behaviors of EPF and CS-EPF were studied in detail. The results showed that the fluorescent chitosan could still provide temperature and pH sensitivities similar to that of fluorescein, achieving better long-term stability and fast equilibrium response. CS-EPF had an excellent linear response between relative fluorescence intensity and temperature in the range of 0-60 degrees C and two linear relationships between relative fluorescence intensity and pH in 0.0-4.14 and 8.15-13.20, respectively. This investigation may provide a convenient way to prepare low-cost and multifunctional macromolecule biomaterial to probe pH and temperature in biological systems. (C) 2007 Wiley Periodicals, Inc.
C1 Lanzhou Univ, Coll Chem & Chem Engn, Inst Polymer Sci & Engn, Lanzhou 730000, Peoples R China.
RP Su, ZX (reprint author), Lanzhou Univ, Coll Chem & Chem Engn, Inst Polymer Sci & Engn, Lanzhou 730000, Peoples R China.
EM suzx@lzu.edu.cn
CR Calzaferri G, 1997, P INDIAN AS-CHEM SCI, V109, P429
   Carvell M, 1998, POLYMER, V39, P393, DOI 10.1016/S0032-3861(97)00283-8
   Chen CA, 2002, J AM CHEM SOC, V124, P3840, DOI 10.1021/ja017530v
   DIBBERNBRUNELLI D, 1995, J PHOTOCH PHOTOBIO A, V85, P285, DOI 10.1016/1010-6030(94)03915-H
   EUGENE L, 1991, EUR POLYM J, V27, P311
   Fang Y, 2000, J PHOTOCH PHOTOBIO A, V135, P141, DOI 10.1016/S1010-6030(00)00305-1
   FLEMING GR, 1977, J AM CHEM SOC, V99, P4306, DOI 10.1021/ja00455a017
   FWULONG M, 2005, BIOMACROMOLECULES, V6, P975
   GABRIEL B, 1991, J AM CHEM SOC, V113, P8818, DOI 10.1021/ja00023a033
   Garcia-Martinez JM, 1998, J APPL POLYM SCI, V70, P689, DOI 10.1002/(SICI)1097-4628(19981024)70:4<689::AID-APP7>3.0.CO;2-M
   Guan XL, 2006, REACT FUNCT POLYM, V66, P1227, DOI 10.1016/j.reactfunctpolym.2006.03.005
   GUILFORD J, 1998, J PHOTOCH PHOTOBIO A, V113, P125
   HARGREAVES JS, 1985, MACROMOLECULES, V18, P734, DOI 10.1021/ma00146a027
   Hirano T, 2002, J AM CHEM SOC, V124, P6555, DOI 10.1021/ja025567p
   Kristoffer T., 2001, CARBOHYD RES, V336, P291
   LI XH, 2003, CHEM J CHINESE U, V11, P1984
   LIN YW, 2000, HE CHEN HUA XUE, V8, P167
   Liu ZH, 2005, J POLYM SCI POL CHEM, V43, P1019, DOI 10.1002/pola.20576
   M Monique M, 1975, CHEM PHY LETT, V35, p105~111
   MANUELA M, 2004, MACROMOLECULES, V37, P5692
   MARTINSFRANCHETTI SM, 1995, EUR POLYM J, V31, P467, DOI 10.1016/0014-3057(94)00182-0
   MATTINGLY PG, 1992, BIOCONJUGATE CHEM, V3, P430, DOI 10.1021/bc00017a013
   Mehata MS, 2001, J LUMIN, V93, P275, DOI 10.1016/S0022-2313(01)00205-8
   MONIQUE MM, 1976, CHEM PHY LETT, V43, P332
   NAKANISHI S, 1994, J CHEM PHYS, V100, P3442, DOI 10.1063/1.466387
   Neckers D. C., 1993, ADV PHOTOCHEM, V18, P315, DOI DOI 10.1002/9780470133491.CH4
   PRATS M, 1986, NATURE, V322, P756, DOI 10.1038/322756a0
   Qu X, 2000, POLYMER, V41, P4589, DOI 10.1016/S0032-3861(99)00685-0
   REGIEN GS, 2001, J PHYS CHEM A, V105, P4235
   ROB Z, 2003, J PHYS CHEM A, V107, P6770
   ROULA BQ, 1999, CARBOHYD POLYM, V38, P99
   SETSUKINAI S, 2003, J BIOL CHEM, V278, P3170
   Shapiro HH, 2000, J MICROBIOL METH, V42, P3, DOI 10.1016/S0167-7012(00)00167-6
   SHIPCHANDLER MT, 1987, ANAL BIOCHEM, V162, P89, DOI 10.1016/0003-2697(87)90013-3
   Sjoback R., 1995, SPECTROCHIM ACTA A, V51, pL7
   Talhavini M, 1998, J PHOTOCH PHOTOBIO A, V114, P65, DOI 10.1016/S1010-6030(97)00307-9
   TASUKU U, 2004, J AM CHEM SOC, V126, P14079
   VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270
   WOLFF NE, 1963, APPL PHYS LETT, V2, P152, DOI 10.1063/1.1753821
NR 39
TC 20
Z9 22
U1 0
U2 17
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD JUN 15
PY 2007
VL 104
IS 6
BP 3960
EP 3966
DI 10.1002/app.26200
PG 7
WC Polymer Science
SC Polymer Science
GA 162ZP
UT WOS:000246128400061
DA 2018-10-20
ER

PT J
AU Rai, B
   Oest, ME
   Dupont, KM
   Ho, KH
   Teoh, SH
   Guldberg, RE
AF Rai, Bina
   Oest, Megan E.
   Dupont, Ken M.
   Ho, Kee H.
   Teoh, Swee H.
   Guldberg, Robert E.
TI Combination of platelet-rich plasma with polycaprolactone-tricalcium
   phosphate scaffolds for segmental bone defect repair
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE bone regeneration; vascularization; polycaprolactone; scaffold; growth
   factors
ID MICROCOMPUTED TOMOGRAPHY ANALYSIS; TISSUE-ENGINEERED BONE; IN-VITRO;
   POLYMER SCAFFOLDS; DELIVERY-SYSTEMS; DRUG-DELIVERY; RECONSTRUCTION;
   REGENERATION; ANGIOGENESIS; COMPOSITES
AB Porous scaffold biomaterials may offer a clinical alternative to bone grafts; however, scaffolds alone are typically insufficient to heal large bone defects. Numerous studies have demonstrated that osteoinductive growth factor or gene delivery significantly improves bone repair. However, given the important role of vascularization during bone regeneration, it may also be beneficial to incorporate factors that promote vascular ingrowth into constructs. In this study, a strategy combining structural polycaprolactone-20% tricalcium phosphate (PCL-TCP) composite scaffolds with platelet-rich plasma (PRP) was tested. Following bilateral implantation of constructs into 8 mm rat nonunion femoral defects, 3D vascular and bone ingrowth were quantified at 3 and 12 weeks using contrast-enhanced microcomputed tomography (micro-CT) imaging. At week 3, PRP-treated femurs displayed 70.3% higher vascular volume fraction than control femurs. Interestingly, bone volume fraction (BVF) was significantly higher for the empty scaffold group at the early time point. At 12 weeks, BVF measurements between the two groups were statiscally equivalent. However, a greater proportion of PRP-treated femurs (83%) achieved bone union as compared to empty scaffold controls (33%). Consistent with this observation, biomechanical evaluation of functional integration also revealed a significantly higher torsional stiffness observed for PRP-treated defects compared to empty scaffolds. Ultimate torque at failure was not improved, however, perhaps due to the slow resorption profile of the scaffold material. Histological evaluation illustrated infiltration of vascularized connective tissue and bone in both groups. Given that bone ingrowth into untreated defects in this model is minimal, PCL-TCP scaffolds were clearly able to promote bone ingrowth but failed to consistently bridge the defect. The addition of PRP to PCL-TCP scaffolds accelerated early vascular ingrowth and improved longer-term functional integration. Taken together, the results of this study suggest that the use of PRP, alone or in combination with other bioactive components, may be an effective approach to augment the ability of porous biomaterial scaffolds to repair orthotopic defects. (c) 2007 Wiley Periodicals, Inc. J Biomed Mater Res 81A: 888-899, 2007.
C1 Natl Univ Singapore, Dept Mech Engn, Singapore 117548, Singapore.
   Natl Univ Singapore, Dept Oral & Maxillofacial Surg, Singapore 117548, Singapore.
   Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA.
   Georgia Inst Technol, Sch Mech Engn, Atlanta, GA 30332 USA.
RP Teoh, SH (reprint author), Natl Univ Singapore, Dept Mech Engn, Singapore 117548, Singapore.
EM mpetsh@nus.edu.sg; robert.guldberg@me.gatech.edu
OI Oest, Megan/0000-0002-7609-730X
FU NIAMS NIH HHS [AR051336]
CR Aghaloo TL, 2005, CLIN ORAL IMPLAN RES, V16, P250, DOI 10.1111/j.1600-0501.2004.01075.x
   BARREY BH, 1990, J BONE JOINT SURG AM, V72, P825
   BENTLEY MD, 2002, AM J PHYSIOL-REG I, V282, P1267
   Boccaccini A. R., 2002, Ceramic Engineering and Science Proceedings, V23, P805
   Cao T, 2003, TISSUE ENG, V9, pS103, DOI 10.1089/10763270360697012
   Cartmell S, 2004, J BIOMED MATER RES A, V69A, P97, DOI 10.1002/jbm.a.20118
   Duvall CL, 2004, AM J PHYSIOL-HEART C, V287, pH302, DOI 10.1152/ajpheart.00928.2003
   Fennis JPM, 2005, INT J ORAL MAX SURG, V34, P158, DOI 10.1016/j.ijom.2004.06.004
   Fennis JPM, 2004, INT J ORAL MAX SURG, V33, P48, DOI 10.1054/ijom.2003.0452
   Fratzl P, 2004, J MATER CHEM, V14, P2115, DOI 10.1039/b402005g
   Freymiller EG, 2004, J ORAL MAXIL SURG, V62, P484, DOI 10.1016/j.joms.2003.08.021
   Huang YC, 2005, J BONE MINER RES, V20, P848, DOI 10.1359/JBMR.041226
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Ito K, 2005, J BIOMED MATER RES A, V73A, P63, DOI 10.1002/jbm.a.30248
   Jones AC, 2004, BIOMATERIALS, V25, P4947, DOI 10.1016/j.biomatcrials.2004.01.047
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim HW, 2004, BIOMATERIALS, V25, P1279, DOI 10.1016/j.biomaterials.2003.07.003
   Koefoed M, 2005, MOL THER, V12, P212, DOI 10.1016/j.ymthe.2005.02.026
   Kokubu T, 2003, J ORTHOP RES, V21, P503, DOI 10.1016/S0736-0266(02)00209-7
   Lin ASP, 2003, BIOMATERIALS, V24, P481, DOI 10.1016/S0142-9612(02)00361-7
   Liu Y, 2005, BONE, V36, P745, DOI 10.1016/j.bone.2005.02.005
   Marx RE, 2004, J ORAL MAXIL SURG, V62, P489, DOI 10.1016/j.joms.2003.12.003
   Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4
   Murphy WL, 2004, J DENT RES, V83, P204, DOI 10.1177/154405910408300304
   OEST ME, UNPUB EVALUATION MIN
   Oyama T, 2004, J ORAL MAXIL SURG, V62, P555, DOI 10.1016/j.joms.2003.08.023
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Rai B, 2005, J CONTROL RELEASE, V107, P330, DOI 10.1016/j.jconrel.2005.07.002
   Rai B, 2005, BIOMATERIALS, V26, P3739, DOI 10.1016/j.biomaterials.2004.09.052
   Rai B, 2004, BIOMATERIALS, V25, P5499, DOI 10.1016/j.biomaterials.2004.01.007
   Rohner D, 2003, J BIOMED MATER RES B, V66B, P574, DOI 10.1002/jbm.b.10037
   SCANTZ JT, 2002, CELL TRANSPLANT, V11, P125
   SCHANTZ JT, 2003, NEUROSURGERY, V9, pS127
   Sun QH, 2005, PHARM RES, V22, P1110, DOI 10.1007/s11095-005-5644-2
   Tozum Tolga Fikret, 2003, J Can Dent Assoc, V69, P664
   Tsay RC, 2005, J ORAL MAXIL SURG, V63, P521, DOI 10.1016/j.joms.2004.09.012
   YANG L, IN PRESS MAT SCI E C
   Zein I, 2002, BIOMATERIALS, V23, P1169, DOI 10.1016/S0142-9612(01)00232-0
   Zhang XP, 2005, J BONE MINER RES, V20, P2124, DOI 10.1359/JBMR.050806
NR 39
TC 132
Z9 137
U1 2
U2 38
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN 15
PY 2007
VL 81A
IS 4
BP 888
EP 899
DI 10.1002/jbm.a.31142
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 170BQ
UT WOS:000246636600013
PM 17236215
DA 2018-10-20
ER

PT J
AU Teixeira, S
   Monteiro, FJ
   Ferraz, MP
   Vilar, R
   Eugenio, S
AF Teixeira, S.
   Monteiro, F. J.
   Ferraz, M. P.
   Vilar, R.
   Eugenio, S.
TI Laser surface treatment of hydroxyapatite for enhanced tissue
   integration: surface characterization and osteoblastic interaction
   studies
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE hydroxyapatite; excimer laser; cell adhesion; surface modification
ID BONE-MARROW-CELLS; IMPLANT SURFACES; TITANIUM-ALLOY; COATINGS;
   ROUGHNESS; DIFFERENTIATION; PROLIFERATION; TOPOGRAPHY; DEPOSITION;
   BEHAVIOR
AB Biocompatibility has long been associated with surface microtopography, microtexture, and microchemistry. The surface topography eventually affects the nature and the intensity of the interactions that occur at biomaterial-biological interface (cell adhesion, mobility, spreading, and proliferation). Therefore, it is necessary to produce and work with controlled microtopographical surfaces that present reproducible microdomains of a dimension similar to that of the biological elements of interest (in this case, osteoblasts). There are a number of substrates that already have been studied in terms of surface topography; however, few studies are related to hydroxyapatite (HA) substrates. As it is well established, HA is a well-known ceramic that is extremely used in medical applications, namely implants and coatings. In this work, the surface topography of dense HA substrates was altered by using KFr excimer laser. The surface was characterized by atomic force microscopy and contact angle measurements, while the cell distribution and morphology was assessed by scanning electron microscopy and confocal laser scanning microscopy. Results revealed that the surface is characterized by a homogeneous columnar structure with high specific area. Moreover, cells were able to attach and spread on the surface of the samples, and gradually grow into nearly confluent monolayers. (c) 2007 Wiley Periodicals, Inc. J Biomed Mater Res 81A: 920-929, 2007.
C1 INEB, Inst Biomed Engn, Lab Biomat, P-4150180 Oporto, Portugal.
   Univ Porto, Fac Engn, Dept Mat & Met Engn, P-4100 Oporto, Portugal.
   Univ Fernando Pessoa, Fac Ciencias Saude, P-4200150 Oporto, Portugal.
   Inst Super Tecn, IST, Dept Mat Engn, P-1049001 Lisbon, Portugal.
RP Teixeira, S (reprint author), INEB, Inst Biomed Engn, Lab Biomat, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.
EM smsilva@ineb.up.pt
RI Eugenio, Sonia/B-2254-2013; Vilar, Rui/C-1079-2011; Ferraz,
   Maria/M-6316-2013; Xu, Qingguo/C-1962-2014
OI Eugenio, Sonia/0000-0002-1386-5236; Ferraz, Maria/0000-0002-0274-106X;
   Xu, Qingguo/0000-0003-3191-0771; Vilar, Rui/0000-0003-1167-6164;
   Monteiro, Fernando/0000-0002-1361-4605
CR Ahmad M, 1999, BIOMATERIALS, V20, P211, DOI 10.1016/S0142-9612(98)00152-5
   Anselme K, 2005, ACTA BIOMATER, V1, P211, DOI 10.1016/j.actbio.2004.11.009
   Anselme K, 1999, J MATER SCI-MATER M, V10, P815, DOI 10.1023/A:1008992109670
   Anselme K, 2000, BIOMATERIALS, V21, P1567, DOI 10.1016/S0142-9612(00)00042-9
   Boyan B. D., 2003, European Cells & Materials, V6, P22
   Carvalho P, 2003, J DENT RES, V82, P573
   Cleries L, 2000, J BIOMED MATER RES, V49, P43, DOI 10.1002/(SICI)1097-4636(200001)49:1<43::AID-JBM6>3.0.CO;2-G
   Cleries L, 2001, J BIOMED MATER RES, V57, P473, DOI 10.1002/1097-4636(20011205)57:3<473::AID-JBM1191>3.0.CO;2-H
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   dos Santos EA, 2007, MAT SCI ENG C-BIO S, V27, P61, DOI 10.1016/j.msec.2006.02.003
   Duncan AC, 2002, BIOSENS BIOELECTRON, V17, P413, DOI 10.1016/S0956-5663(01)00281-0
   Fernandez-Pradas JM, 2001, BIOMATERIALS, V22, P2171, DOI 10.1016/S0142-9612(00)00408-7
   Fernandez-Pradas JM, 2001, APPL PHYS A-MATER, V72, P613, DOI 10.1007/s003390100726
   FOLTYN SR, 1991, APPL PHYS LETT, V59, P594, DOI 10.1063/1.106386
   Galli C, 2005, J PERIODONTOL, V76, P364, DOI 10.1902/jop.2005.76.3.364
   Hao L, 2004, J LASER APPL, V16, P55, DOI 10.2351/1.1642634
   Khor KA, 1999, MAT SCI ENG A-STRUCT, V266, P1, DOI 10.1016/S0921-5093(99)00049-0
   Kieswetter K, 1996, CRIT REV ORAL BIOL M, V7, P329, DOI 10.1177/10454411960070040301
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   Martin JY, 1996, CLIN ORAL IMPLAN RES, V7, P27, DOI 10.1034/j.1600-0501.1996.070104.x
   Matsuura T, 2000, BIOMATERIALS, V21, P1121, DOI 10.1016/S0142-9612(99)00264-1
   Noth U, 1999, BIOMED TECH, V44, P6, DOI 10.1515/bmte.1999.44.1-2.6
   Oliveira V, 2001, ADV ENG MATER, V3, P75, DOI 10.1002/1527-2648(200101)3:1/2<75::AID-ADEM75>3.0.CO;2-Z
   Ponsonnet L, 2003, MAT SCI ENG C-BIO S, V23, P551, DOI 10.1016/S0928-4931(03)00033-X
   Ramires PA, 2001, BIOMATERIALS, V22, P1467, DOI 10.1016/S0142-9612(00)00269-6
   Redey SA, 2000, J BIOMED MATER RES, V50, P353, DOI 10.1002/(SICI)1097-4636(20000605)50:3<353::AID-JBM9>3.0.CO;2-C
   Ricci JL, 2001, KEY ENG MAT, V198-1, P179, DOI 10.4028/www.scientific.net/KEM.198-199.179
   Rosa AL, 2003, DENT MATER, V19, P768, DOI 10.1016/S0109-5641(03)00024-1
   Saldana L, 2006, J BIOMED MATER RES A, V77A, P608, DOI 10.1002/jbm.a.30671
   Schmidt C, 2001, J BIOMED MATER RES, V54, P209, DOI 10.1002/1097-4636(200102)54:2<209::AID-JBM7>3.0.CO;2-7
   Schwartz Z, 1997, J PERIODONTAL RES, V32, P166, DOI 10.1111/j.1600-0765.1997.tb01399.x
   Schwartz Z, 1996, J BIOMED MATER RES, V30, P145
   Serra P, 1998, THIN SOLID FILMS, V335, P43, DOI 10.1016/S0040-6090(98)00874-8
   SERRA P, 1997, APPL SURF SCI, V110, P384
   TEIXEIRA S, 2006, BIOCERAMICS 1, V18, P105
   TEIXEIRA S, 2006, BIOCERAMICS 2, V18, P309
   Torricelli P, 2003, BIOMED PHARMACOTHER, V57, P57, DOI 10.1016/S0753-3322(02)00329-3
   Walboomers XF, 1999, J BIOMED MATER RES, V47, P204, DOI 10.1002/(SICI)1097-4636(199911)47:2<204::AID-JBM10>3.0.CO;2-H
   Wang J, 2004, J DENT RES, V83, P296, DOI 10.1177/154405910408300405
   Xavier SP, 2003, J DENT, V31, P173, DOI 10.1016/S0300-5712(03)00027-7
NR 40
TC 7
Z9 7
U1 0
U2 10
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN 15
PY 2007
VL 81A
IS 4
BP 920
EP 929
DI 10.1002/jbm.a.31073
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 170BQ
UT WOS:000246636600016
PM 17252543
DA 2018-10-20
ER

PT J
AU Niki, Y
   Matsumoto, H
   Otani, T
   Tomatsu, T
   Toyama, Y
AF Niki, Yasuo
   Matsumoto, Hideo
   Otani, Toshiro
   Tomatsu, Taisuke
   Toyama, Yoshiaki
TI Five types of inflammatory arthritis following total knee arthroplasty
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomaterial-related arthritis; total knee arthroplasty; synovial fluid
   leukocyte; rheumatoid arthritis; osteoarthritis
ID SYNOVIAL-FLUID ANALYSIS; RHEUMATOID-ARTHRITIS; T-CELLS; CHEMOTACTIC
   CYTOKINES; CHEMOKINES; PHENOTYPE
AB Joint effusion after total knee arthroplasty (TKA) is considered as a manifestation of certain inflammatory reactions within prosthetic joints. This study investigated causes of joint effusion following TKA and analyzed phenotypic characteristics of synovial fluid leukocytes for each cause. Forty-six TKAs for rheumatoid arthritis (RA) and 49 TKAs for osteoarthritis (OA) displaying joint effusion were investigated. Causes of joint effusion were clinically identified and frequencies of each cause were compared between RA and CA. Synovial fluid cell phenotypes were analyzed using a fluorescence-activated cell sorter. Clinical diagnoses for joint effusion were classified into five different groups: deep infection (DI); increased activity of RA (IRA); particle-induced synovitis (PS); metal sensitivity (MS); and nonspecific synovitis (NS). The most frequent cause of post-TKA effusion was IRA in RA, and NS in OA. Biomaterial-related arthritis such as PS and MS were more frequent with OA than with RA. Analysis of synovial fluid cell phenotypes revealed that the characteristic cells for each diagnosis were CD16(+)CD14(-) neutrophils in IRA and DI, CD14(+) macrophages in PS, and CD3(+)CD45RO(+) T cells in MS. Post-TKA joint effusion is clinically caused by five different types of arthritis. Phenotypic characteristics of synovial fluid leukocytes reflect joint pathology and contribute to diagnosis and exclusion of biomaterial-related arthritis. (c) 2007 Wiley Periodicals, Inc.
C1 Keio Univ, Dept Orthopaed Surg, Shinjuku Ku, Tokyo 1608582, Japan.
   Tokyo Womens Med Univ, Inst Rheumatol, Shinjuku Ku, Tokyo 1620054, Japan.
RP Niki, Y (reprint author), Keio Univ, Dept Orthopaed Surg, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.
EM y.niki@lib.bekkoame.ne.jp
RI Matsumoto, Hideo/A-2304-2014; Toyama, Yoshiaki/K-5743-2013
CR BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97
   Bauer TW, 2006, J BONE JOINT SURG AM, V88A, P869, DOI 10.2106/JBJS.E.01149
   Brannan SR, 2006, J EMERG MED, V30, P331, DOI 10.1016/j.jemermed.2005.05.029
   DELECRIN J, 1994, CLIN ORTHOP RELAT R, P240
   Dombrecht EJ, 2006, CLIN EXP RHEUMATOL, V24, P31
   FREEMONT AJ, 1991, ANN RHEUM DIS, V50, P101, DOI 10.1136/ard.50.2.101
   FREW AJ, 1991, CLIN EXP IMMUNOL, V84, P270
   GREIS PE, 1994, J ORTHOPAED RES, V12, P286, DOI 10.1002/jor.1100120219
   Hallab N, 2001, J BONE JOINT SURG AM, V83A, P428, DOI 10.2106/00004623-200103000-00017
   Johnston A, 2005, CLIN IMMUNOL, V114, P154, DOI 10.1016/j.clim.2004.09.001
   Lind M, 1999, J BIOMED MATER RES, V48, P246, DOI 10.1002/(SICI)1097-4636(1999)48:3<246::AID-JBM7>3.0.CO;2-X
   Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706
   Niki Y, 2003, J ARTHROPLASTY, V18, P1071, DOI 10.1016/S0883-5403(03)00328-0
   Niki Y, 2005, BIOMATERIALS, V26, P1019, DOI 10.1016/j.biomaterials.2004.03.038
   Niki Y, 2003, BIOMATERIALS, V24, P3715, DOI 10.1016/S0142-9612(03)00246-1
   Niki Y, 2003, BIOMATERIALS, V24, P1447, DOI 10.1016/S0142-9612(02)00531-8
   PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107
   Pridgeon C, 2003, RHEUMATOLOGY, V42, P870, DOI 10.1093/rheumatology/keg240
   SCHALL TJ, 1990, NATURE, V347, P669, DOI 10.1038/347669a0
   SHMERLING RH, 1994, RHEUM DIS CLIN N AM, V20, P503
   SINIGAGLIA F, 1994, J INVEST DERMATOL, V102, P398, DOI 10.1111/1523-1747.ep12372149
   Verhoef CM, 1998, ANN RHEUM DIS, V57, P275, DOI 10.1136/ard.57.5.275
   WILLERT HG, 1993, BRIS MYER Z, P87
NR 23
TC 6
Z9 6
U1 1
U2 2
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN 15
PY 2007
VL 81A
IS 4
BP 1005
EP 1010
DI 10.1002/jbm.a.31152
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 170BQ
UT WOS:000246636600026
PM 17265437
DA 2018-10-20
ER

PT J
AU Klaver, CL
   Caplan, MR
AF Klaver, Christopher L.
   Caplan, Michael R.
TI Bioactive surface for neural electrodes: Decreasing astrocyte
   proliferation via transforming growth factor-beta 1
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE astrocytes; transforming growth factor-beta 1; biomaterial; cell
   proliferation inhibition; gliosis
ID GROWTH-FACTOR-BETA; RGD PEPTIDES; REACTIVE ASTROCYTES; COMB POLYMERS;
   GLIAL SCAR; INTERFACES; COATINGS; BRAIN; CELLS
AB Implantation of deep-brain recording devices is a traumatic event, which inevitably elicits reactive gliosis. The ensuing glial scar encapsulating the implanted device impedes the long-term functional recording capability of the microelectrode. In this work, a bioactive surface is prepared by conjugation of transforming growth factor-beta one (TGF-beta 1) and laminin to dextran, which is in turn conjugated to a biomaterial substrate. Poly-L-lysine coated surfaces are treated with oxidized dextran, and the dextran is re-oxidized with sodium metaperiodate to generate hemiacetal structures to which TGF-beta 1) and laminin are covalently bound. Covalent conjugation of the ligand is confirmed by enzyme-linked immunosorbent assay. A primary cell line of astrocytes is incubated on a surface conjugated with laminin and TGF-beta 1 and a surface only conjugated with laminin. Proliferation on the laminin plus TGF-beta 1 surface is 57%, less (p < 0.002) than the control surface (laminin alone). The results demonstrate that conjugated TGF-beta 1 retains its efficacy toward astrocyte proliferation and represents a potential strategy for reducing glial scar formation in vivo. (c) 2007 Wiley Periodicals, Inc.
C1 Arizona State Univ, Harrington Dept Bioengn, Tempe, AZ 85287 USA.
   Arizona State Univ, Dept Chem & Mat Engn, Tempe, AZ 85287 USA.
RP Caplan, MR (reprint author), Arizona State Univ, Harrington Dept Bioengn, POB 879709, Tempe, AZ 85287 USA.
EM michael.caplan@asu.edu
FU NIDCR NIH HHS [K22 DE014846]
CR *BRAINBITS LLC, PRIM RAT BRAIN ASTR
   Cui XY, 2003, BIOMATERIALS, V24, P777, DOI 10.1016/S0142-9612(02)00415-5
   Donoghue JP, 2002, NAT NEUROSCI, V5, P1085, DOI 10.1038/nn947
   EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X
   Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6
   He W, 2005, BIOMATERIALS, V26, P2983, DOI 10.1016/j.biomaterials.2004.08.021
   Heiduschka P, 1998, PROG NEUROBIOL, V55, P433, DOI 10.1016/S0301-0082(98)00013-6
   Hinck AP, 1996, BIOCHEMISTRY-US, V35, P8517, DOI 10.1021/bi9604946
   HUNTER KE, 1993, GLIA, V7, P203, DOI 10.1002/glia.440070303
   Irvine DJ, 2001, BIOMACROMOLECULES, V2, P85, DOI 10.1021/bm005584b
   Irvine DJ, 2001, BIOMACROMOLECULES, V2, P545, DOI 10.1021/bm015510f
   LINDHOLM D, 1992, J CELL BIOL, V117, P395, DOI 10.1083/jcb.117.2.395
   Mann BK, 2001, BIOMATERIALS, V22, P439, DOI 10.1016/S0142-9612(00)00196-4
   Massia SP, 2000, BIOMATERIALS, V21, P2253, DOI 10.1016/S0142-9612(00)00151-4
   MASSIA SP, 1990, ANAL BIOCHEM, V187, P292, DOI 10.1016/0003-2697(90)90459-M
   Massia SP, 2004, J BIOMED MATER RES A, V68A, P177, DOI 10.1002/jbm.a.20009
   Massia SP, 2001, J BIOMED MATER RES, V56, P390, DOI 10.1002/1097-4636(20010905)56:3<390::AID-JBM1108>3.0.CO;2-L
   MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890
   McGraw J, 2001, J NEUROSCI RES, V63, P109, DOI 10.1002/1097-4547(20010115)63:2<109::AID-JNR1002>3.0.CO;2-J
   McKenzie JL, 2004, BIOMATERIALS, V25, P1309, DOI 10.1016/j.biomaterials.2003.08.006
   McKeon RJ, 1999, J NEUROSCI, V19, P10778
   *PROM CORP, ASS TECHN B PROM COR
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   Seliktar D, 2004, J BIOMED MATER RES A, V68A, P704, DOI 10.1002/jbm.a.20091
   SPORN MB, 1986, SCIENCE, V233, P532, DOI 10.1126/science.3487831
   TORUDELBAUFFE D, 1990, J NEUROCHEM, V54, P1056, DOI 10.1111/j.1471-4159.1990.tb02357.x
   *WORTH BIOCH CORP, TISS DISS GUID
NR 27
TC 11
Z9 11
U1 0
U2 6
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN 15
PY 2007
VL 81A
IS 4
BP 1011
EP 1016
DI 10.1002/jbm.a.31153
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 170BQ
UT WOS:000246636600027
PM 17265435
DA 2018-10-20
ER

PT J
AU Connors, RC
   Muir, JJ
   Liu, YC
   Reiss, GR
   Kouretas, PC
   Whitten, MG
   Sorenson, TK
   Prestwich, GD
   Bull, DA
AF Connors, Rafe C.
   Muir, Jeffery J.
   Liu, Yanchun
   Reiss, G. Russell
   Kouretas, Peter C.
   Whitten, Matthew G.
   Sorenson, Tyler K.
   Prestwich, Glenn D.
   Bull, David A.
TI Postoperative pericardial adhesion prevention using Carbylan-SX in a
   rabbit model
SO JOURNAL OF SURGICAL RESEARCH
LA English
DT Article; Proceedings Paper
CT 2nd Annual Academic Surgical Congress of the
   Association-for-Academic-Surgery
CY FEB 09-12, 2007
CL Phoenix, AZ
SP Assoc Acad Surg, Soc Univ Surg
DE retrosternal adhesions; pericardial adhesions; adhesion prevention;
   Carbylan; Seprafilm
ID ABSORBABLE POLYMER PATCHES; CARBOXYMETHYLCELLULOSE MEMBRANE; SURGICAL
   MEMBRANE; MEDIAN STERNOTOMY; CARDIAC-SURGERY; MURINE MODEL; CLOSURE;
   REOPERATION; OPERATIONS; REDUCTION
AB Introduction. The presence of dense adhesions within the pericardial space complicates reoperative cardiac surgery. Prior attempts to reduce adhesion formation after primary cardiac surgery using medications or biomaterials have had variable success. Carbylan-SX (Carbylan Biosurgery Inc., Palo Alto, CA) is a hyaluronan-based biomaterial, which has been shown to be effective at reducing adhesions in a non-thoracic rat model. This study evaluates whether Carbylan-SX can effectively reduce postoperative adhesions within the pericardial cavity.
   Methods. Thirty-eight New Zealand white rabbits underwent a left lateral thoracotomy. A pericardiotomy was made and epicardial adhesions were induced on the anterior surface of the heart using a Dremel device (Racine, WI). The rabbits were divided into four groups: controls with abrasions only receiving no treatment (n = 10), Carbylan-SX films (n = 10), Carbylan-SX aerosolized hydrogel (n = 10), and Seprafilm (n = 8). The pericardial sac and chest were subsequently closed. Rabbits were sacrificed at a mean of 15 days. For histological analysis, each heart was divided into 12 separate 1 mm sections. Computer imaging software was used to measure the adhesion thickness and the mean of 12 random measurements for each animal was recorded and statistical analysis performed.
   Results. Histological analysis revealed all treatment groups to be significantly better than the control (2159 mu m thickness, P < 0.0001) at preventing adhesions. The Carbylan-SX film and Carbylan-SX aerosolized hydrogel both proved to be better at preventing adhesions than Seprafilm (Genzyme Corp., Cambridge, MA) with an average adhesion thickness of 454 and 577 pm, respectively, compared with 1319 mu m for Seprafilm (P < 0.0001 and P < 0.0005, respectively). The Carbylan-SX film and Carbylan-SX aerosolized hydrogel were equally effective at preventing adhesion formation.
   Conclusion. Carbylan-SX film and Carbylan-SX aerosolized crosslinkable hydrogel are equally effective methods of reducing postoperative pericardial adhesions within the pericardial. cavity. Both the Carbylan-SX film and aerosolized hydrogel showed a significantly greater reduction in adhesions than Seprafilm. Clinical application of Carbylan-SX could have significant therapeutic implications in the future. (C) 2007 Elsevier Inc. All rights reserved.
C1 Univ Utah, Sch Med, Div Cardiothorac Surg, Dept Surg, Salt Lake City, UT 84132 USA.
RP Connors, RC (reprint author), Univ Utah, Sch Med, Div Cardiothorac Surg, Dept Surg, 30 N 1900 E,Room 3C 145 SOM, Salt Lake City, UT 84132 USA.
EM rafe.connors@hsc.utah.edu
CR Arnold PB, 2000, FERTIL STERIL, V73, P157, DOI 10.1016/S0015-0282(99)00464-1
   Beck D E, 1997, Eur J Surg Suppl, P49
   BROWN AH, 1969, J THORAC CARDIOV SUR, V58, P189
   Buckenmaier CC, 1999, AM SURGEON, V65, P274
   BUNTON RW, 1990, J THORAC CARDIOV SUR, V100, P99
   CULLIFORD AT, 1979, J THORAC CARDIOV SUR, V78, P633
   DIAMOND M P, 1987, Microsurgery, V8, P103, DOI 10.1002/micr.1920080215
   Diamond MP, 1996, FERTIL STERIL, V66, P904, DOI 10.1016/S0015-0282(16)58716-0
   DOBELL ARC, 1984, ANN THORAC SURG, V37, P273, DOI 10.1016/S0003-4975(10)60728-X
   Duflo S, 2006, TISSUE ENG, V12, P2171, DOI 10.1089/ten.2006.12.2171
   DUNCAN DA, 1988, J SURG RES, V45, P44, DOI 10.1016/0022-4804(88)90019-4
   Edwards GA, 1997, J BIOMED MATER RES, V34, P291
   ENGLISH TAH, 1978, J THORAC CARDIOV SUR, V76, P56
   GABBAY S, 1989, ANN THORAC SURG, V48, P803, DOI 10.1016/0003-4975(89)90674-7
   GALLO JI, 1978, ANN THORAC SURG, V26, P149, DOI 10.1016/S0003-4975(10)63658-2
   HANEY AF, 1992, AM J OBSTET GYNECOL, V166, P1137, DOI 10.1016/S0002-9378(11)90600-0
   Hellebrekers BWJ, 2000, FERTIL STERIL, V74, P203, DOI 10.1016/S0015-0282(00)00656-7
   HEYDORN WH, 1987, J THORAC CARDIOV SUR, V94, P291
   Kobayashi M, 2001, J BIOMED MATER RES, V58, P344
   LAKS H, 1981, J THORAC CARDIOV SUR, V82, P88
   Liu GK, 2005, SPRINGER SERIES MATE, V83, P1, DOI 10.1007/3-540-28209-2_1
   Liu YC, 2007, FERTIL STERIL, V87, P940, DOI 10.1016/j.fertnstert.2006.07.1532
   LONDE S, 1974, ANN THORAC SURG, V17, P157, DOI 10.1016/S0003-4975(10)65627-5
   MACMANUS Q, 1975, J THORAC CARDIOV SUR, V69, P138
   MALM T, 1992, J THORAC CARDIOV SUR, V104, P600
   MALM T, 1992, SCAND J THORAC CARD, V26, P15, DOI 10.3109/14017439209099048
   MATHISEN SR, 1986, J THORAC CARDIOV SUR, V92, P92
   Matsuda S, 2002, BIOMATERIALS, V23, P2901, DOI 10.1016/S0142-9612(01)00418-5
   MERAV AD, 1979, ANN THORAC SURG, V28, P399, DOI 10.1016/S0003-4975(10)63142-6
   MEUS PJ, 1983, J THORAC CARDIOV SUR, V85, P54
   MITCHELL JD, 1994, J THORAC CARDIOV SUR, V107, P1481
   Mueller POE, 2000, VET SURG, V29, P48, DOI 10.1111/j.1532-950X.2000.00048.x
   Okuyama N, 1999, ANN THORAC SURG, V68, P913, DOI 10.1016/S0003-4975(99)00556-1
   Oncel M, 2003, DIS COLON RECTUM, V46, P187, DOI 10.1097/01.DCR.0000049342.17762.16
   Osada H, 1999, J INT MED RES, V27, P292, DOI 10.1177/030006059902700605
   Park AH, 2006, OTOL NEUROTOL, V27, P1170, DOI 10.1097/01.mao.0000227893.50162.9e
   PARR GVS, 1977, ANN THORAC SURG, V23, P319, DOI 10.1016/S0003-4975(10)64132-X
   Prestwich GD, 2006, ADV EXP MED BIOL, V585, P125
   Proctor M, 2006, AM J RHINOL, V20, P206, DOI 10.1177/194589240602000218
   REVUELTA JM, 1985, J THORAC CARDIOV SUR, V89, P451
   SCHAFF HV, 1983, J THORAC CARDIOV SUR, V85, P508
   SEIFER DB, 1990, J GYNECOL SURG, V6, P3, DOI 10.1089/gyn.1990.6.3
   Shu XZ, 2002, BIOMACROMOLECULES, V3, P1304, DOI 10.1021/bm025603c
   Sondrup C, 2006, OTOLARYNG HEAD NECK, V135, P28, DOI 10.1016/j.otohns.2006.01.018
   Trew G, 2006, REV GYNAECOL PERINAT, V6, P47, DOI [10.1016/j.rigapp.2006.02.001, DOI 10.1016/J.RIGAPP.2006.02.001]
   WISEMAN DM, 1992, J SURG RES, V53, P362, DOI 10.1016/0022-4804(92)90062-5
   Wiseman DM, 1999, J INVEST SURG, V12, P141
   Wiseman DM, 1994, POLYM SITE SPECIFIC, P369
   Yamaoka T, 2001, J BIOMED MATER RES, V54, P470, DOI 10.1002/1097-4636(20010315)54:4<470::AID-JBM20>3.3.CO;2-O
   YOUNG RL, 1991, FERTIL STERIL, V55, P624
NR 50
TC 18
Z9 19
U1 0
U2 7
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0022-4804
J9 J SURG RES
JI J. Surg. Res.
PD JUN 15
PY 2007
VL 140
IS 2
BP 237
EP 242
DI 10.1016/j.jss.2007.03.014
PG 6
WC Surgery
SC Surgery
GA 172AQ
UT WOS:000246776900015
PM 17509269
DA 2018-10-20
ER

PT J
AU Ayoub, NA
   Garb, JE
   Tinghitella, RM
   Collin, MA
   Hayashi, CY
AF Ayoub, Nadia A.
   Garb, Jessica E.
   Tinghitella, Robin M.
   Collin, Matthew A.
   Hayashi, Cheryl Y.
TI Blueprint for a High-Performance Biomaterial: Full-Length Spider
   Dragline Silk Genes
SO PLOS ONE
LA English
DT Article
ID AMINO-ACID-COMPOSITION; NEPHILA-CLAVIPES TETRAGNATHIDAE;
   ARANEUS-BICENTENARIUS ARANEIDAE; UTR SEQUENCE MOTIF; BLACK-WIDOW SPIDER;
   EGG CASE SILK; MECHANICAL-PROPERTIES; LATRODECTUS-HESPERUS; COMPARATIVE
   GENOMICS; REGULATORY ELEMENTS
AB Spider dragline (major ampullate) silk outperforms virtually all other natural and manmade materials in terms of tensile strength and toughness. For this reason, the mass-production of artificial spider silks through transgenic technologies has been a major goal of biomimetics research. Although all known arthropod silk proteins are extremely large (> 200 kiloDaltons), recombinant spider silks have been designed from short and incomplete cDNAs, the only available sequences. Here we describe the first full-length spider silk gene sequences and their flanking regions. These genes encode the MaSp1 and MaSp2 proteins that compose the black widow's high-performance dragline silk. Each gene includes a single enormous exon (> 9000 base pairs) that translates into a highly repetitive polypeptide. Patterns of variation among sequence repeats at the amino acid and nucleotide levels indicate that the interaction of selection, intergenic recombination, and intragenic recombination governs the evolution of these highly unusual, modular proteins. Phylogenetic footprinting revealed putative regulatory elements in non-coding flanking sequences. Conservation of both upstream and downstream flanking sequences was especially striking between the two paralogous black widow major ampullate silk genes. Because these genes are co-expressed within the same silk gland, there may have been selection for similarity in regulatory regions. Our new data provide complete templates for synthesis of recombinant silk proteins that significantly improve the degree to which artificial silks mimic natural spider dragline fibers.
C1 [Ayoub, Nadia A.; Garb, Jessica E.; Tinghitella, Robin M.; Collin, Matthew A.; Hayashi, Cheryl Y.] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA.
RP Ayoub, NA (reprint author), Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA.
EM nadiaa@ucr.edu
RI Garb, Jessica/J-4566-2015
OI Ayoub, Nadia/0000-0003-4404-1472; Tinghitella, Robin/0000-0002-0049-5539
FU Army Research Office [DAAD19-02-1-0358, W911NF-06-1-0455]; National
   Science Foundation [DEB-0236020]
FX The research was funded by the Army Research Office (DAAD19-02-1-0358
   and W911NF-06-1-0455) and the National Science Foundation (DEB-0236020).
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
   ANDERSEN SO, 1970, COMP BIOCHEM PHYSIOL, V35, P705, DOI 10.1016/0010-406X(70)90988-6
   Arcidiacono S, 1998, APPL MICROBIOL BIOT, V49, P31, DOI 10.1007/s002530051133
   Arnason U, 2000, HEREDITAS, V133, P217, DOI 10.1111/j.1601-5223.2000.00217.x
   Ayoub NA, 2007, MOL PHYLOGENET EVOL, V42, P394, DOI 10.1016/j.ympev.2006.07.018
   BECKWITT R, 1994, J BIOL CHEM, V269, P6661
   Beckwitt R, 1998, INSECT BIOCHEM MOLEC, V28, P121, DOI 10.1016/S0965-1748(97)00083-0
   BENTON MJ, 1990, J MOL EVOL, V30, P409, DOI 10.1007/BF02101113
   Bini E, 2006, BIOMACROMOLECULES, V7, P3139, DOI 10.1021/bm0607877
   Blackledge TA, 2006, J EXP BIOL, V209, P2452, DOI 10.1242/jeb.02275
   Blackledge TA, 2005, ZOOLOGY, V108, P41, DOI 10.1016/j.zool.2004.11.001
   Boffelli D, 2003, SCIENCE, V299, P1391, DOI 10.1126/science.1081331
   Bram A, 1997, J APPL CRYSTALLOGR, V30, P390, DOI 10.1107/S0021889896012344
   Bray N, 2003, GENOME RES, V13, P97, DOI 10.1101/gr.789803
   CABRERA CV, 1991, EMBO J, V10, P2965, DOI 10.1002/j.1460-2075.1991.tb07847.x
   Casem ML, 1999, INT J BIOL MACROMOL, V24, P103, DOI 10.1016/S0141-8130(98)00078-6
   Castillo-Davis CI, 2002, NAT GENET, V31, P415, DOI 10.1038/ng1011
   Chaw SM, 2004, J MOL EVOL, V58, P424, DOI 10.1007/s00239-003-2564-9
   Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337
   Coy JF, 1999, HUM MOL GENET, V8, P1253, DOI 10.1093/hmg/8.7.1253
   Craig CL, 2000, MOL BIOL EVOL, V17, P1904, DOI 10.1093/oxfordjournals.molbev.a026292
   De Bodt S, 2006, MOL BIOL EVOL, V23, P1293, DOI 10.1093/molbev/msk016
   DELIDAKIS C, 1992, P NATL ACAD SCI USA, V89, P8731, DOI 10.1073/pnas.89.18.8731
   Dicko C, 2004, BIOMACROMOLECULES, V5, P704, DOI 10.1021/bm034307c
   DONG ZY, 1991, ARCH BIOCHEM BIOPHYS, V284, P53, DOI 10.1016/0003-9861(91)90262-H
   Foelix R.F., 1996, BIOL SPIDERS, P336
   Foo CWP, 2006, APPL PHYS A-MATER, V82, P193, DOI 10.1007/s00339-005-3425-8
   Foo CWP, 2002, ADV DRUG DELIVER REV, V54, P1131
   Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458
   Garb JE, 2005, P NATL ACAD SCI USA, V102, P11379, DOI 10.1073/pnas.0502473102
   Garb JE, 2006, SCIENCE, V312, P1762, DOI 10.1126/science.1127946
   Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561
   Goodwin EB, 1997, DEVELOPMENT, V124, P749
   Gosline J, 2002, PHILOS T ROY SOC B, V357, P121, DOI 10.1098/rstb.2001.1022
   GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   GRAUR D, 2000, FUNDAMENTALS MOL EVO
   Gregory TR, 2003, J HERED, V94, P285, DOI 10.1093/jhered/esg070
   Griswold CE, 1998, ZOOL J LINN SOC-LOND, V123, P1
   Guerette PA, 1996, SCIENCE, V272, P112, DOI 10.1126/science.272.5258.112
   Hardison RC, 2003, PLOS BIOL, V1, P156, DOI 10.1371/journal.pbio.0000058
   HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   Hayashi CY, 2004, MOL BIOL EVOL, V21, P1950, DOI 10.1093/molbev/msh204
   Hayashi CY, 2000, SCIENCE, V287, P1477, DOI 10.1126/science.287.5457.1477
   Hayashi CY, 1998, J MOL BIOL, V275, P773, DOI 10.1006/jmbi.1997.1478
   HINMAN M, 1992, SPIDER SILK MYSTERY, P227
   HINMAN MB, 1992, J BIOL CHEM, V267, P19320
   Hinman MB, 2000, TRENDS BIOTECHNOL, V18, P374, DOI 10.1016/S0167-7799(00)01481-5
   Huemmerich D, 2004, BIOCHEMISTRY-US, V43, P13604, DOI 10.1021/bi048983q
   Inada DC, 2003, GENOME RES, V13, P2030, DOI 10.1101/gr.1280703
   Ittah S, 2006, BIOMACROMOLECULES, V7, P1790, DOI 10.1021/bm060120k
   Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644
   Kohler K, 2005, DNA CELL BIOL, V24, P371, DOI 10.1089/dna.2005.24.371
   Kummerlen J, 1996, MACROMOLECULES, V29, P2920, DOI 10.1021/ma951098i
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   Lai EC, 1997, DEVELOPMENT, V124, P4847
   Lai EC, 1998, DEVELOPMENT, V125, P4077
   Lawrence BA, 2004, BIOMACROMOLECULES, V5, P689, DOI 10.1021/bm0342640
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Lee MSY, 1999, J MOL EVOL, V49, P385, DOI 10.1007/PL00006562
   Leviten MW, 1997, DEVELOPMENT, V124, P4039
   LOMBARDI SJ, 1990, J ARACHNOL, V18, P297
   Marais G, 2005, GENETICS, V170, P481, DOI 10.1534/genetics.104.037333
   Margulies EH, 2003, GENOME RES, V13, P2507, DOI 10.1101/gr.1602203
   Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143
   Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046
   Motriuk-Smith D, 2005, BIOMACROMOLECULES, V6, P3152, DOI 10.1021/bm050472b
   O'Brien JP, 1998, ADV MATER, V10, P1185, DOI 10.1002/(SICI)1521-4095(199810)10:15<1185::AID-ADMA1185>3.3.CO;2-K
   Parkhe AD, 1997, J MOL RECOGNIT, V10, P1, DOI 10.1002/(SICI)1099-1352(199701/02)10:1<1::AID-JMR338>3.0.CO;2-7
   Pollard DA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-376
   Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817
   Prakash A, 2005, NAT BIOTECHNOL, V23, P1249, DOI 10.1038/nbt1140
   Rising A, 2006, BIOMACROMOLECULES, V7, P3120, DOI 10.1021/bm060693x
   Rombauts S, 2003, PLANT PHYSIOL, V132, P1162, DOI 10.1104/pp.102.017715
   Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180
   Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359
   RUIZGOMEZ M, 1993, EMBO J, V12, P1121, DOI 10.1002/j.1460-2075.1993.tb05753.x
   Sakharkar MK, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-67
   Sakharkar MK, 2002, BIOINFORMATICS, V18, P1266, DOI 10.1093/bioinformatics/18.9.1266
   Sambrook J, 2001, MOL CLONING LAB MANU
   Scheller J, 2004, TRANSGENIC RES, V13, P51, DOI 10.1023/B:TRAG.0000017175.78809.7a
   Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335
   Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577
   Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403
   SELDEN PA, 1990, PALAEONTOLOGY, V33, P257
   SIMMONS A, 1994, MACROMOLECULES, V27, P5235, DOI 10.1021/ma00096a060
   Simmons AH, 1996, SCIENCE, V271, P84, DOI 10.1126/science.271.5245.84
   Sinha S, 2005, MOL BIOL EVOL, V22, P874, DOI 10.1093/molbev/rnsi090
   Sponner A, 2005, BIOCHEM BIOPH RES CO, V338, P897, DOI 10.1016/j.bbrc.2005.10.048
   Sponner A, 2005, NAT MATER, V4, P772, DOI 10.1038/nmat1493
   Sponner A, 2005, BIOCHEMISTRY-US, V44, P4727, DOI 10.1021/bi047671k
   SPRAGUE KU, 1975, BIOCHEMISTRY-US, V14, P925, DOI 10.1021/bi00676a008
   Swanson BO, 2006, APPL PHYS A-MATER, V82, P213, DOI 10.1007/s00339-005-3427-6
   Swofford DL, 2002, PAUP PHYLOGENETIC AN
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512
   Thomas JW, 2003, NATURE, V424, P788, DOI 10.1038/nature01858
   Tian MZ, 2005, BIOCHEMISTRY-US, V44, P8006, DOI 10.1021/bi050366u
   Urrutia AO, 2003, GENOME RES, V13, P2260, DOI 10.1101/gr.641103
   van Beek JD, 2002, P NATL ACAD SCI USA, V99, P10266, DOI 10.1073/pnas.152162299
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6
   Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782
   Wong WSW, 2004, GENETICS, V167, P949, DOI 10.1534/genetics.102.010959
   Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441
   XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120
   Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8
   Zhao AC, 2006, BIOCHEMISTRY-US, V45, P3348, DOI 10.1021/bi052414g
NR 108
TC 182
Z9 198
U1 2
U2 53
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 13
PY 2007
VL 2
IS 6
AR e514
DI 10.1371/journal.pone.0000514
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA V10GD
UT WOS:000207451600002
PM 17565367
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU McGuigan, AP
   Sefton, MV
AF McGuigan, Alison P.
   Sefton, Michael V.
TI The influence of biomaterials on endothelial cell thrombogenicity
SO BIOMATERIALS
LA English
DT Review
DE endothelial cells; thrombogenicity
ID TUMOR-NECROSIS-FACTOR; TISSUE FACTOR EXPRESSION; FACTOR PATHWAY
   INHIBITOR; FLUID SHEAR-STRESS; ADHESIVE PROTEIN EXPRESSION;
   PLATELET-ACTIVATING-FACTOR; BLOOD-FLOW CONDITIONS; SMOOTH-MUSCLE-CELLS;
   THROMBIN-STIMULATED PLATELETS; PROSTHETIC VASCULAR GRAFTS
AB Driven by tissue engineering and regenerative medicine, endothelial cells are being used in combination with biomaterials in a number of applications for the purpose of improving blood compatibility and host integration. Endothelialized vascular grafts are beginning to be used clinically with some success in some centers, while endothelial seeding is being explored as a means of creating a vasculature within engineered tissues. The underlying assumption of this strategy is that when cultured on artificial biomaterials, a confluent layer of endothelial cells maintain their non-thrombogenic phenotype. In this review the existing knowledge base of endothelial cell thrombogenicity cultured on a number of different biomaterials is summarized. The importance of selecting appropriate endpoint measures that are most reflective of overall surface thrombogenicity is the focus of this review. Endothelial cells inhibit thrombosis through three interconnected regulatory systems (1) the coagulation cascade, (2) the cellular components of the blood such as leukocytes and platelets and (3) the complement cascade, and also through effects on fibrinolysis and vascular tone, the latter which influences blood flow. Thus, in order to demonstrate the thrombogenic benefit of seeding a biomaterial with EC, the conditions under which EC surfaces are more likely to exhibit lower thrombogenicity than unseeded biomaterial surfaces need to be consistent with the experimental context. The endpoints selected should be appropriate for the dominant thrombotic process that occurs under the given experimental conditions. (c) 2007 Elsevier Ltd. All rights reserved.
C1 Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3G8, Canada.
   Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G8, Canada.
RP Sefton, MV (reprint author), Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3G8, Canada.
EM sefton@chem-eng.utoronto.ca
RI McGuigan, Alison/B-4744-2010
FU NIBIB NIH HHS [EB001013, R21 EB001013, R21 EB001013-01]
CR ALLEN BT, 1984, J VASC SURG, V1, P224, DOI 10.1067/mva.1984.avs0010224
   ANDOH K, 1990, THROMB HAEMOSTASIS, V63, P298
   Andrews RK, 2004, THROMB RES, V114, P447, DOI 10.1016/j.thromres.2004.07.020
   ANTONOV AS, 1992, THROMB RES, V67, P135, DOI 10.1016/0049-3848(92)90133-U
   Aoki J, 2005, J AM COLL CARDIOL, V45, P1574, DOI 10.1016/j.jacc.2005.01.048
   BAKER KS, 1985, AM J SURG, V150, P197, DOI 10.1016/0002-9610(85)90118-7
   Balcells M, 2002, J CELL PHYSIOL, V191, P155, DOI 10.1002/jcp.10087
   Berge N, 1999, CELL ADHES COMMUN, V7, P29, DOI 10.3109/15419069909034390
   BHAGYALAKSHMI A, 1989, BIOCHEM BIOPH RES CO, V158, P31, DOI 10.1016/S0006-291X(89)80172-X
   Bhatt A D, 1997, J Assoc Physicians India, V45, P868
   BIEDERMANN B, 1994, J LAB CLIN MED, V124, P339
   BIZIOS R, 1988, J CELL PHYSIOL, V134, P275, DOI 10.1002/jcp.1041340214
   BLAJCHMAN MA, 1986, PROG HEMATOL, V14, P149
   Bombeli T, 1996, J LAB CLIN MED, V127, P621, DOI 10.1016/S0022-2143(96)90153-5
   Bos GW, 1999, J BIOMED MATER RES, V47, P279, DOI 10.1002/(SICI)1097-4636(19991205)47:3<279::AID-JBM1>3.0.CO;2-W
   Bos GW, 1999, THROMB HAEMOSTASIS, V82, P1757
   Budd J S, 1991, Eur J Vasc Surg, V5, P397, DOI 10.1016/S0950-821X(05)80171-9
   Burmeister JS, 1996, J BIOMED MATER RES, V30, P13, DOI 10.1002/(SICI)1097-4636(199601)30:1<13::AID-JBM3>3.0.CO;2-U
   CANFIELD AE, 1992, J CELL SCI, V102, P807
   Cenni E, 1996, BIOMATERIALS, V17, P2071, DOI 10.1016/0142-9612(96)00037-3
   CENNI E, 1995, BIOMATERIALS, V16, P1223, DOI 10.1016/0142-9612(95)98128-2
   Cenni E, 1997, BIOMATERIALS, V18, P489, DOI 10.1016/S0142-9612(96)00160-3
   CENNI E, 1992, ATLA-ALTERN LAB ANIM, V20, P61
   CENNI E, 1993, J BIOMED MATER RES, V27, P1161, DOI 10.1002/jbm.820270906
   Chan BP, 2004, BIOMATERIALS, V25, P3951, DOI 10.1016/j.biomaterials.2003.10.077
   CHAZOV EI, 1981, P NATL ACAD SCI-BIOL, V78, P5603, DOI 10.1073/pnas.78.9.5603
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chi JT, 2003, P NATL ACAD SCI USA, V100, P10623, DOI 10.1073/pnas.1434429100
   Chien S, 1998, HYPERTENSION, V31, P162, DOI 10.1161/01.HYP.31.1.162
   Chiquet M, 1996, BIOCHEM CELL BIOL, V74, P737, DOI 10.1139/o96-080
   Cines DB, 1998, BLOOD, V91, P3527
   CLAGETT GP, 1984, CIRCULATION, V69, P632, DOI 10.1161/01.CIR.69.3.632
   Colman RW, 2006, HEMOSTASIS THROMBOSI
   CONWAY EM, 1988, MOL CELL BIOL, V8, P5588, DOI 10.1128/MCB.8.12.5588
   CROSSMAN DC, 1990, J BIOL CHEM, V265, P9782
   CURWEN KD, 1982, J LAB CLIN MED, V100, P425
   Dardik R, 2000, THROMB HAEMOSTASIS, V83, P338
   DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001
   Davies P F, 1981, Dev Biol Stand, V50, P125
   DEKKER A, 1989, THROMB HAEMOSTASIS, V61, P402
   Dekker RJ, 2006, BLOOD, V107, P4354, DOI 10.1182/blood-2005-08-3465
   DIAMOND SL, 1989, SCIENCE, V243, P1483, DOI 10.1126/science.2467379
   DIAMOND SL, 1990, J CELL PHYSIOL, V143, P364, DOI 10.1002/jcp.1041430222
   DIQUELOU A, 1994, BLOOD, V84, P2206
   DIQUELOU A, 1995, THROMB HAEMOSTASIS, V74, P778
   Dong QG, 1997, ARTERIOSCL THROM VAS, V17, P1599, DOI 10.1161/01.ATV.17.8.1599
   DUBOSE DA, 1987, LIFE SCI, V40, P447, DOI 10.1016/0024-3205(87)90109-3
   Esmon CT, 2006, CURR OPIN HEMATOL, V13, P382, DOI 10.1097/01.moh.0000239712.93662.35
   Esmon CT, 2005, BIOCHEM SOC T, V33, P401, DOI 10.1042/BST0330401
   ESMON CT, 1995, FASEB J, V9, P946
   Esmon CT, 2000, BBA-PROTEIN STRUCT M, V1477, P349, DOI 10.1016/S0167-4838(99)00266-6
   Fish JE, 2006, CELL MOL LIFE SCI, V63, P144, DOI 10.1007/s00018-005-5421-8
   Fisher A. B., 2001, AM J PHYSIOL-LUNG C, V281, P529
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   FORD JW, 1981, IN VITRO CELL DEV B, V17, P44, DOI 10.1007/BF02618029
   FORM DM, 1986, LAB INVEST, V55, P521
   FRANGOS JA, 1985, SCIENCE, V227, P1477, DOI 10.1126/science.3883488
   FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0
   Galbusera M, 1997, BLOOD, V90, P1558
   Garlanda C, 1997, ARTERIOSCL THROM VAS, V17, P1193, DOI 10.1161/01.ATV.17.7.1193
   Geiger M, 1997, AM J PHYSIOL-LUNG C, V273, pL275
   Gillis C, 1996, EUR J VASC ENDOVASC, V11, P127, DOI 10.1016/S1078-5884(96)80040-2
   GillisHaegerstrand C, 1996, J VASC SURG, V24, P226
   GIMBRONE MA, 1982, ANN NY ACAD SCI, V401, P171, DOI 10.1111/j.1749-6632.1982.tb25716.x
   GIRARD PR, 1995, J CELL PHYSIOL, V163, P179, DOI 10.1002/jcp.1041630121
   GLASSBERG MK, 1992, J APPL PHYSIOL, V72, P1681
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   GRABOWSKI EF, 1995, THROMB HAEMOSTASIS, V74, P123
   Grabowski EF, 2001, ARTERIOSCL THROM VAS, V21, P157, DOI 10.1161/01.ATV.21.1.157
   Granchi D, 1998, BIOMATERIALS, V19, P93, DOI 10.1016/S0142-9612(97)00161-0
   Guidollet J, 1999, J BIOMED MATER RES, V44, P156, DOI 10.1002/(SICI)1097-4636(199902)44:2<156::AID-JBM5>3.0.CO;2-H
   Gulino D, 1998, J BIOL CHEM, V273, P29786, DOI 10.1074/jbc.273.45.29786
   Hackeng TM, 1996, BIOCHEM J, V319, P399, DOI 10.1042/bj3190399
   HAJJAR KA, 1995, THROMB HAEMOSTASIS, V74, P294
   HAMILTON KK, 1990, BLOOD, V76, P2572
   HEWETT PW, 1993, IN VITRO CELL DEV-AN, V29A, P823
   Ho M, 2003, PHYSIOL GENOMICS, V13, P249, DOI 10.1152/physiolgenomics.00186.2002
   Hordijk PL, 1999, J CELL SCI, V112, P1915
   Hristov M, 2004, J CELL MOL MED, V8, P498, DOI 10.1111/j.1582-4934.2004.tb00474.x
   Imbert E, 2001, J BIOMED MATER RES, V56, P376, DOI 10.1002/1097-4636(20010905)56:3<376::AID-JBM1106>3.0.CO;2-R
   Imbert E, 1998, BIOMATERIALS, V19, P2285, DOI 10.1016/S0142-9612(98)00137-9
   INGBER D, 1991, J CELL BIOCHEM, V47, P236, DOI 10.1002/jcb.240470309
   Ingber DE, 2002, CIRC RES, V91, P877, DOI 10.1161/01.RES.0000039537.73816.E5
   INGBER DE, 1987, IN VITRO CELL DEV B, V23, P387
   IVES CL, 1986, IN VITRO CELL DEV B, V22, P500
   Iwata H, 2000, COLLOID SURFACE B, V19, P219, DOI 10.1016/S0927-7765(00)00159-4
   JAFFE EA, 1974, P NATL ACAD SCI USA, V71, P1906, DOI 10.1073/pnas.71.5.1906
   Jensen N, 1996, ANN VASC SURG, V10, P530, DOI 10.1007/BF02000441
   Jensen N, 1997, BRIT J SURG, V84, P52
   JESTY J, 1993, BIOCHEMISTRY-US, V32, P6266, DOI 10.1021/bi00075a021
   Joosten PAH, 1999, J VASC RES, V36, P91
   Joosten PPAH, 1998, J VASC SURG, V28, P1094, DOI 10.1016/S0741-5214(98)70036-9
   JORGENSEN L, 1986, LAB INVEST, V54, P408
   KAIBARA M, 1991, BIORHEOLOGY, V28, P263
   Kaihara S, 2000, J PEDIATR SURG, V35, P1287, DOI 10.1053/jpsu.2000.9298
   KAPLAN JE, 1989, AM J PHYSIOL, V257, pH423
   Kesler K A, 1986, Ann Vasc Surg, V1, P60, DOI 10.1007/BF02732457
   KIRCHHOFER D, 1993, BLOOD, V81, P2050
   KIRCHHOFER D, 1994, J CLIN INVEST, V93, P2073, DOI 10.1172/JCI117202
   KIRKPATRICK CJ, 1990, PATHOBIOLOGY, V58, P221
   KNEDLER A, 1989, IN VITRO CELL DEV B, V25, P863
   Knudsen HL, 1997, AM J PHYSIOL-HEART C, V273, pH347
   KOHLER HP, 1995, THROMB HAEMOSTASIS, V73, P719
   KottkeMarchant K, 1996, J BIOMED MATER RES, V30, P209
   KOVEKER GB, 1988, J VASC SURG, V7, P600
   KOVEKER GB, 1991, SURGERY, V109, P313
   KUMAR S, 1987, DIFFERENTIATION, V36, P57, DOI 10.1111/j.1432-0436.1987.tb00181.x
   Lang I, 2003, EUR J CELL BIOL, V82, P163, DOI 10.1078/0171-9335-00306
   Laszik Z, 1997, CIRCULATION, V96, P3633
   Levin EG, 1997, J CELL SCI, V110, P139
   LI JM, 1992, J VASC SURG, V15, P1010, DOI 10.1016/0741-5214(92)90457-J
   LIAW L, 1993, ARTERIOSCLER THROMB, V13, P985, DOI 10.1161/01.ATV.13.7.985
   Lidington EA, 2000, BLOOD, V96, P2784
   Lopesmartins R, 1996, EUR J PHARMACOL, V308, P287, DOI 10.1016/0014-2999(96)00310-X
   Lu A, 2001, BIOMATERIALS, V22, P1439, DOI 10.1016/S0142-9612(00)00302-1
   Luscher TF, 1997, CLIN CARDIOL, V20, P3
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lwaleed BA, 2006, J PATHOL, V208, P327, DOI 10.1002/path.1871
   MACARAK EJ, 1983, J CELL PHYSIOL, V116, P76, DOI 10.1002/jcp.1041160112
   MADRI JA, 1983, J CELL BIOL, V97, P153, DOI 10.1083/jcb.97.1.153
   MADRI JA, 1988, AM J PATHOL, V132, P18
   MALEK AM, 1994, CIRC RES, V74, P852, DOI 10.1161/01.RES.74.5.852
   MARCUM JA, 1984, J CLIN INVEST, V74, P341, DOI 10.1172/JCI111429
   MARGIOTTA M, 1994, J AM COLL SURGEONS, V179, P689
   Margiotta M S, 1995, J Am Coll Surg, V181, P215
   MARGIOTTA MS, 1992, ANN SURG, V216, P600, DOI 10.1097/00000658-199211000-00013
   MARSDEN PA, 1991, J AM SOC NEPHROL, V1, P931
   Mateo AO, 1997, PHARMACOL RES, V36, P339, DOI 10.1006/phrs.1997.0246
   MAYNARD JR, 1977, BLOOD, V50, P387
   McCormick SM, 2001, P NATL ACAD SCI USA, V98, P8955, DOI 10.1073/pnas.171259298
   McGuigan AP, 2006, P NATL ACAD SCI USA, V103, P11461, DOI 10.1073/pnas.0602740103
   MCINTYRE TM, 1985, J CLIN INVEST, V76, P271, DOI 10.1172/JCI111957
   MONCADA S, 1982, BRIT J PHARMACOL, V76, P3, DOI 10.1111/j.1476-5381.1982.tb09186.x
   MONCADA S, 1991, PHARMACOL REV, V43, P109
   MOORE KL, 1989, BLOOD, V73, P159
   MOORE KL, 1987, J CLIN INVEST, V79, P124, DOI 10.1172/JCI112772
   MORRISSEY JH, 1993, BLOOD, V81, P734
   MULDER AB, 1995, THROMB RES, V80, P399, DOI 10.1016/0049-3848(95)00192-T
   MULDER AB, 1994, BLOOD, V84, P1559
   Murugesan G, 2000, J BIOMED MATER RES, V49, P396, DOI 10.1002/(SICI)1097-4636(20000305)49:3<396::AID-JBM13>3.0.CO;2-H
   Nadar S, 2004, CURR PHARM DESIGN, V10, P3591, DOI 10.2174/1381612043382765
   NAJABBENHAYOUN M, 1993, J BIOMED MATER RES, V27, P511, DOI 10.1002/jbm.820270412
   NAWROTH PP, 1986, J EXP MED, V163, P740, DOI 10.1084/jem.163.3.740
   Noria S, 1999, CIRC RES, V85, P504, DOI 10.1161/01.RES.85.6.504
   Ong ATL, 2005, TEX HEART I J, V32, P372
   ORTENWALL P, 1987, J VASC SURG, V6, P17
   PALMER RMJ, 1988, NATURE, V333, P664, DOI 10.1038/333664a0
   PARSONS TJ, 1986, THROMB RES, V43, P435, DOI 10.1016/0049-3848(86)90088-5
   PATRICK CW, 1995, BLOOD PURIFICAT, V13, P112
   Pearson JD, 1999, BEST PRACT RES CL HA, V12, P329, DOI 10.1053/beha.1999.0028
   PENHOAT J, 1993, BIOMATERIALS, V14, P503, DOI 10.1016/0142-9612(93)90237-V
   Petri B, 2006, FEBS J, V273, P4399, DOI 10.1111/j.1742-4658.2006.05439.x
   POHLMAN TH, 1986, J IMMUNOL, V136, P4548
   Pompe T, 2003, J BIOMED MATER RES A, V67A, P647, DOI 10.1002/jbm.a.10130
   PRATT BM, 1984, AM J PATHOL, V117, P349
   RADOMSKI MW, 1987, BIOCHEM BIOPH RES CO, V148, P1482, DOI 10.1016/S0006-291X(87)80299-1
   Raines EW, 2000, INT J EXP PATHOL, V81, P173, DOI 10.1046/j.1365-2613.2000.00155.x
   Remy M, 1998, MED BIOL ENG COMPUT, V36, P256, DOI 10.1007/BF02510755
   Remy-Zolghadri M, 2004, J VASC SURG, V39, P613, DOI 10.1016/j.jvs.2003.08.007
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   RIJKEN DC, 1982, J BIOL CHEM, V257, P2920
   RISAU W, 1995, FASEB J, V9, P926
   Rose SL, 2005, J BIOMED MATER RES A, V72A, P269, DOI 10.1002/jbm.a.30222
   Rubens FD, 1997, J SURG RES, V72, P22, DOI 10.1006/jsre.1997.5149
   RYAN J, 1992, BLOOD, V80, P966
   SAGE H, 1981, ARTERIOSCLEROSIS, V1, P427, DOI 10.1161/01.ATV.1.6.427
   Salacinski HJ, 2001, MED BIOL ENG COMPUT, V39, P609, DOI 10.1007/BF02345431
   SAMPATH R, 1995, ANN BIOMED ENG, V23, P247, DOI 10.1007/BF02584426
   Sandset PM, 1996, HAEMOSTASIS, V26, P154
   SCARPATI EM, 1989, J BIOL CHEM, V264, P20705
   SCHLEEF RR, 1988, J BIOL CHEM, V263, P5797
   SCHLEEF RR, 1990, J CELL BIOL, V110, P155, DOI 10.1083/jcb.110.1.155
   SCHNAPER HW, 1993, PEDIATR NEPHROL, V7, P96, DOI 10.1007/BF00861587
   SCHORER AEM, 1988, PRODUCTION TISSUE FA
   SCHWARTZ SM, 1990, PHYSIOL REV, V70, P1177
   Scott W J, 1990, ASAIO Trans, V36, pM737
   SHAREFKIN JB, 1982, SURGERY, V92, P385
   She MY, 2007, J BIOMED MATER RES A, V80A, P497, DOI 10.1002/jbm.a.31083
   SHEPARD AD, 1986, SURGERY, V99, P318
   Shirota T, 2003, TISSUE ENG, V9, P127, DOI 10.1089/107632703762687609
   Slupsky JR, 1998, THROMB HAEMOSTASIS, V80, P1008
   Smyth JV, 1995, ANN VASC SURG, V9, P542, DOI 10.1007/BF02018827
   SNEDDON JM, 1988, P NATL ACAD SCI USA, V85, P2800, DOI 10.1073/pnas.85.8.2800
   SOLBERG S, 1985, IN VITRO CELL DEV B, V21, P612
   SPEISER W, 1987, BLOOD, V69, P964
   SPEISER W, 1988, THROMB HAEMOSTASIS, V60, P463
   Stevens T, 2000, AM J PHYSIOL-LUNG C, V279, pL419
   Storck J, 1996, BIOMATERIALS, V17, P1791, DOI 10.1016/0142-9612(95)00360-6
   Szmitko PE, 2003, CIRCULATION, V107, P3093, DOI 10.1161/01.CIR.0000074242.66719.4A
   TAKADA Y, 1994, BIOCHEM BIOPH RES CO, V205, P1345, DOI 10.1006/bbrc.1994.2813
   Tassiopoulos AK, 2000, J BIOMAT SCI-POLYM E, V11, P1275, DOI 10.1163/156856200744200
   Tedesco F, 1999, MOL IMMUNOL, V36, P261, DOI 10.1016/S0161-5890(99)90054-8
   THOMSON GJL, 1991, SURGERY, V109, P20
   THOUMINE O, 1995, LAB INVEST, V73, P565
   TUNSTALL A, 1994, J BIOMED MATER RES, V28, P1233, DOI 10.1002/jbm.820281013
   TUNSTALL A, 1995, J BIOMED MATER RES, V29, P1193, DOI 10.1002/jbm.820291006
   Tzima E, 2001, EMBO J, V20, P4639, DOI 10.1093/emboj/20.17.4639
   UNDERWOOD PA, 1993, EXP CELL RES, V205, P311, DOI 10.1006/excr.1993.1091
   Underwood PA, 2002, INT J BIOCHEM CELL B, V34, P55, DOI 10.1016/S1357-2725(01)00100-5
   UNDERWOOD PA, 1989, J CELL SCI, V93, P641
   Underwood PA, 2001, J CELL BIOCHEM, V82, P98, DOI 10.1002/jcb.1112
   Van de Wouwer M, 2004, ARTERIOSCL THROM VAS, V24, P1374, DOI 10.1161/01.ATV.0000134298.25489.92
   van der Zijpp YJT, 2003, J BIOMED MATER RES A, V65A, P51, DOI 10.1002/jbm.a.10327
   VANWACHEM PB, 1987, BIOMATERIALS, V8, P323, DOI 10.1016/0142-9612(87)90001-9
   VANWACHEM PB, 1988, BIOMATERIALS, V9, P121, DOI 10.1016/0142-9612(88)90083-X
   VLODAVSKY I, 1982, THROMB RES, V28, P179, DOI 10.1016/0049-3848(82)90260-2
   WECHEZAK AR, 1979, BLOOD VESSELS, V16, P35
   WEKSLER BB, 1977, P NATL ACAD SCI USA, V74, P3922, DOI 10.1073/pnas.74.9.3922
   Westmuckett AD, 2000, ARTERIOSCL THROM VAS, V20, P2474, DOI 10.1161/01.ATV.20.11.2474
   Wileman SM, 2000, BRIT J OPHTHALMOL, V84, P417, DOI 10.1136/bjo.84.4.417
   WILLIAMS SK, 1995, CELL TRANSPLANT, V4, P401, DOI 10.1016/0963-6897(95)00023-Q
   Wissink MJB, 2000, THROMB HAEMOSTASIS, V84, P325
   Wissink MJB, 2001, BIOMATERIALS, V22, P2283, DOI 10.1016/S0142-9612(00)00417-8
   Wissink MJB, 2000, J CONTROL RELEASE, V67, P141, DOI 10.1016/S0168-3659(00)00202-9
   WOJTA J, 1989, J BIOL CHEM, V264, P2846
   YOSHIZUMI M, 1989, BIOCHEM BIOPH RES CO, V161, P859, DOI 10.1016/0006-291X(89)92679-X
   ZETTER BR, 1988, ENDOTHELIAL HETEROGE
   ZHANG JC, 1995, J THORAC CARDIOV SUR, V109, P1059, DOI 10.1016/S0022-5223(95)70188-5
   ZIMMERMAN GA, 1990, J CELL BIOL, V110, P529, DOI 10.1083/jcb.110.2.529
   ZIMMERMANN H, 1998, CARDIOVASCULAR BIOL, P342
   ZWAGINGA JJ, 1990, ARTERIOSCLEROSIS, V10, P437, DOI 10.1161/01.ATV.10.3.437
   Zwahlen R D, 1994, Zentralbl Veterinarmed A, V41, P671
NR 222
TC 133
Z9 137
U1 1
U2 48
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2007
VL 28
IS 16
BP 2547
EP 2571
DI 10.1016/j.biomaterials.2007.01.039
PG 25
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 157AV
UT WOS:000245691900003
PM 17316788
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Roman, I
   Vilalta, M
   Rodriguez, J
   Matthies, AM
   Srouji, S
   Livne, E
   Hubbell, JA
   Rubio, N
   Blanco, J
AF Roman, Irene
   Vilalta, Marta
   Rodriguez, Julio
   Matthies, Annette M.
   Srouji, Samer
   Livne, Erella
   Hubbell, Jeffrey A.
   Rubio, Nuria
   Blanco, Jeronimo
TI Analysis of progenitor cell-scaffold combinations by in vivo
   non-invasive photonic imaging
SO BIOMATERIALS
LA English
DT Article
DE in vivo imaging; cell proliferation; scaffold; luciferase; enhanced
   green fluorescent protein (EGFP)
ID MESENCHYMAL STEM-CELLS; HUMAN PROSTATE TUMORS; MARROW STROMAL CELLS;
   TISSUE; LUCIFERASE; GENE; DIFFERENTIATION; EXPRESSION; METASTASES;
   MICROSCOPY
AB Recent developments in stem cell research have promoted a flourishing of new biomaterials and scaffolds for tissue repair. However, there is a scarcity of procedures to monitor the performance of scaffold-stem cell combinations implanted in live animals, avoiding the inherent artefacts associated with in vitro assay conditions. We report the implementation of a procedure based on the use of the luciferase gene as a cell proliferation tracer to monitor, by in vivo non-invasive imaging, the performance of stem cell-biomaterial combinations used for tissue regeneration. In a model system using immunodepressed mice we show preference of a mouse embryonic mesenchymal cell line (C3H/10T1/2) for specific implantation sites and biomaterials during a prolonged in vivo growth period (3 months). Moreover, we analyzed the safety of implanted cells using a sensitive luminometric procedure and showed that the implanted cells did not spread to other organs. Our results demonstrate the utility of this simple and resource-saving procedure in the development and screening of biomaterials for tissue engineering. (c) 2007 Elsevier Ltd. All rights reserved.
C1 Hosp Sant Pau, CSIC, Cardiovasc Res Ctr, ICCC, Barcelona, Spain.
   Ecole Polytech Fed Lausanne, Inst Bioengn, CH-1015 Lausanne, Switzerland.
   Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn, CH-1015 Lausanne, Switzerland.
   Carmel Hosp, Dept Maxillofacial Surg, Haifa, Israel.
   Technion Israel Inst Technol, Fac Med, Haifa, Israel.
RP Blanco, J (reprint author), Hosp Sant Pau, CSIC, Cardiovasc Res Ctr, ICCC, Barcelona, Spain.
EM jbiancof@csic-iccc.santpau.es
RI Blanco, Jeronimo/H-2764-2015; Hubbell, Jeffrey/A-9266-2008; Roman
   Degano, Irene/C-1826-2012; Rubio, Nuria/H-3156-2015
OI Blanco, Jeronimo/0000-0003-3765-0640; Hubbell,
   Jeffrey/0000-0003-0276-5456; Rubio, Nuria/0000-0003-2471-4684; R. BAGO,
   JULI/0000-0002-2862-4048; Degano, Irene R./0000-0003-1914-6934
CR Benaron DA, 1997, SCIENCE, V276, P2002, DOI 10.1126/science.276.5321.2002
   Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180
   CAMPBELL A, 1996, FLUORESCENT LUMINESC, P58
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Ciapetti G, 2006, BIOMATERIALS, V27, P6150, DOI 10.1016/j.biomaterials.2006.08.025
   Contag CH, 1997, PHOTOCHEM PHOTOBIOL, V66, P523, DOI 10.1111/j.1751-1097.1997.tb03184.x
   de Boer J, 2006, BIOMATERIALS, V27, P1851, DOI 10.1016/j.biomaterials.2005.09.034
   El Hilali N, 2005, CLIN CANCER RES, V11, P1253
   El Hilali N, 2002, LAB INVEST, V82, P1563, DOI 10.1097/01.LAB.0000036877.36379.1F
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Klump H, 2001, GENE THER, V8, P811, DOI 10.1038/sj.gt.3301447
   Krishnan M., 2006, FASEB J, V20, P106, DOI DOI 10.1096/FJ.05-4551FJE
   Lange C, 2005, STEM CELLS DEV, V14, P70, DOI 10.1089/scd.2005.14.70
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee HS, 2006, TISSUE ENG, V12, P2835, DOI 10.1089/ten.2006.12.2835
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Magne D, 2005, TRENDS MOL MED, V11, P519, DOI 10.1016/j.molmed.2005.09.002
   MATSUMOTO K, 1994, MOL REPROD DEV, V39, P136, DOI 10.1002/mrd.1080390203
   MULLER G, 1993, MED OPTICAL TOMOGRAP
   Niklason LE, 2001, JAMA-J AM MED ASSOC, V285, P573, DOI 10.1001/jama.285.5.573
   Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Polak J, 2005, GENE THER, V12, P1725, DOI 10.1038/sj.gt.3302651
   Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Rubio N, 2000, PROSTATE, V44, P133, DOI 10.1002/1097-0045(20000701)44:2<133::AID-PROS6>3.0.CO;2-N
   Srouji S, 2005, MICROSC RES TECHNIQ, V66, P132, DOI 10.1002/jemt.20144
   Sweeney TJ, 1999, P NATL ACAD SCI USA, V96, P12044, DOI 10.1073/pnas.96.21.12044
   THOMPSON EM, 1995, P NATL ACAD SCI USA, V92, P1317, DOI 10.1073/pnas.92.5.1317
   Zheng B, 2006, TISSUE ENG, V12, P1891, DOI 10.1089/ten.2006.12.1891
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 32
TC 23
Z9 27
U1 3
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2007
VL 28
IS 17
BP 2718
EP 2728
DI 10.1016/j.biomaterials.2007.02.011
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 162OM
UT WOS:000246097300003
PM 17346789
DA 2018-10-20
ER

PT J
AU Vermette, M
   Trottier, V
   Menard, V
   Saint-Pierre, L
   Roy, A
   Fradette, J
AF Vermette, Melanie
   Trottier, Valerie
   Menard, Vincent
   Saint-Pierre, Lucie
   Roy, Alphonse
   Fradette, Julie
TI Production of a new tissue-engineered adipose substitute from human
   adipose-derived stromal cells
SO BIOMATERIALS
LA English
DT Article
DE adipose tissue engineering; extracellular matrix (ECM); mesenchymal stem
   cell; cell culture; scanning electron microscopy (SEM); autologous cell
ID MESENCHYMAL STEM-CELLS; ADIPOCYTE PRECURSOR CELLS;
   FIBROBLAST-GROWTH-FACTOR; IN-VITRO; HUMAN SKIN; FAT; PREADIPOCYTES;
   VIVO; DIFFERENTIATION; CONVERSION
AB Adipose tissue is an accessible and abundant source of mesenchymal stem cells for soft-tissue reconstruction. In an attempt to create a novel, entirely autologous tissue-engineered adipose substitute, we extracted human stromal cells from either lipoaspirated or resected fat, and assessed their capacity to produce a three-dimensional adipose tissue using an adapted "self-assembly" culture methodology. This strategy involved a concomitant induction of adipogenic differentiation whilst ascorbic acid supplementation stimulated the stromal cells to produce and organize their own "biomaterial" in the form of extracellular matrix, forming manipulatable sheets that are then assembled into thicker reconstructed adipose tissues. When compared to resected fat, lipoaspiration-derived cells featured an increased adipogenic potential and the enhanced ability to recreate an adipose substitute in vitro. When viewed by scanning electron microscopy, the appearance of these reconstructed adipose tissues was strikingly similar to subcutaneous fat. Furthermore, these substitutes secreted adipokines and mediated beta-adrenergic receptor-stimulated lipolysis, hence reproducing known major biological functions of white adipose tissue. Therefore, our cell-based tissue engineering strategy led to the production of a functional and entirely natural reconstructed adipose tissue, which offers the potential to be used for specific in vitro applications as well as for autologous soft-tissue reconstruction. (C) 2007 Elsevier Ltd. All rights reserved.
C1 Univ Quebec, Ctr Hosp Affilie, Hop St Sacrement, LOEX, Ste Foy, PQ G1S 4L8, Canada.
   Univ Laval, Fac Med, Dept Surg, Quebec City, PQ G1S 4L8, Canada.
RP Fradette, J (reprint author), Univ Quebec, Ctr Hosp Affilie, Hop St Sacrement, LOEX, 1050 Chemin St Foy, Ste Foy, PQ G1S 4L8, Canada.
EM julie.fradette@chg.ulaval.ca
CR Alhadlaq A, 2005, TISSUE ENG, V11, P556, DOI 10.1089/ten.2005.11.556
   Auger FA, 2000, J REGENERATIVE MED, V1, P75
   BILLINGS E, 1989, PLAST RECONSTR SURG, V83, P368, DOI 10.1097/00006534-198902000-00033
   Black AF, 1998, FASEB J, V12, P1331
   Cho SW, 2006, BIOCHEM BIOPH RES CO, V345, P588, DOI 10.1016/j.bbrc.2006.04.089
   Cho SW, 2005, BIOMATERIALS, V26, P3577, DOI 10.1016/j.biomaterials.2004.09.013
   Choi YS, 2005, BIOMATERIALS, V26, P5855, DOI 10.1016/j.biomaterials.2005.02.022
   De Ugarte DA, 2003, ANN PLAS SURG, V50, P215, DOI 10.1097/01.SAP.0000029661.38066.15
   Fischbach C, 2004, TISSUE ENG, V10, P215, DOI 10.1089/107632704322791862
   Fischbach C, 2004, EXP CELL RES, V300, P54, DOI 10.1016/j.yexcr.2004.05.036
   Germain L, 2000, J INVEST DERMATOL, V115, P860, DOI 10.1046/j.1523-1747.2000.00024.x
   Gomillion CT, 2006, BIOMATERIALS, V27, P6052, DOI 10.1016/j.biomaterials.2006.07.033
   Halbleib M, 2003, BIOMATERIALS, V24, P3125, DOI 10.1016/S0142-9612(03)00156-X
   HAUNER H, 1989, J CLIN INVEST, V84, P1663, DOI 10.1172/JCI114345
   Hong L, 2005, ANN BIOMED ENG, V33, P511, DOI 10.1007/s10439-005-2510-7
   Kimura Y, 2003, BIOMATERIALS, V24, P2513, DOI 10.1016/S0142-9612(03)00049-8
   Kral JG, 1999, PLAST RECONSTR SURG, V104, P1732, DOI 10.1097/00006534-199911000-00018
   KURIHARCUCH W, 1978, P NATL ACAD SCI USA, V75, P6107, DOI 10.1073/pnas.75.12.6107
   L'Heureux N, 1998, FASEB J, V12, P47
   Marler JJ, 2000, PLAST RECONSTR SURG, V105, P2049, DOI 10.1097/00006534-200005000-00020
   Michel M, 1999, IN VITRO CELL DEV-AN, V35, P318
   Neubauer M, 2005, TISSUE ENG, V11, P1840, DOI 10.1089/ten.2005.11.1840
   Oedayrajsingh-Varma MJ, 2006, CYTOTHERAPY, V8, P166, DOI 10.1080/14653240600621125
   ONO M, 1990, EXP CELL RES, V187, P309, DOI 10.1016/0014-4827(90)90096-S
   Patrick CW, 1999, TISSUE ENG, V5, P139, DOI 10.1089/ten.1999.5.139
   Patrick CW, 2001, ANAT RECORD, V263, P361, DOI 10.1002/ar.1113
   Patrick CW, 2002, TISSUE ENG, V8, P283, DOI 10.1089/107632702753725049
   Pouliot R, 2002, TRANSPLANTATION, V73, P1751, DOI 10.1097/00007890-200206150-00010
   RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069
   Rohrich RJ, 2004, PLAST RECONSTR SURG, V113, P391, DOI 10.1097/01.PRS.0000097293.56504.00
   Rohrich RJ, 2004, PLAST RECONSTR SURG, V113, P396
   Sierra-Honigmann MR, 1998, SCIENCE, V281, P1683, DOI 10.1126/science.281.5383.1683
   Strem BM, 2005, TRENDS BIOTECHNOL, V23, P64, DOI 10.1016/j.tibtech.2004.12.003
   Tremblay PL, 2005, AM J TRANSPLANT, V5, P1002, DOI 10.1111/j.1600-6143.2005.00790.x
   von Heimburg D, 2001, BIOMATERIALS, V22, P429, DOI 10.1016/S0142-9612(00)00186-1
   von Heimburg D, 2004, CELLS TISSUES ORGANS, V178, P87, DOI 10.1159/000081719
   von Heimburg D, 2001, PLAST RECONSTR SURG, V108, P411, DOI 10.1097/00006534-200108000-00020
   von Heimburg D, 2001, PLAST RECONSTR SURG, V108, P421
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 40
TC 98
Z9 112
U1 0
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2007
VL 28
IS 18
BP 2850
EP 2860
DI 10.1016/j.biomaterials.2007.02.030
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 173IZ
UT WOS:000246868000007
PM 17374391
DA 2018-10-20
ER

PT J
AU Lai, SK
   Hida, K
   Man, ST
   Chen, C
   Machamer, C
   Schroer, TA
   Hanes, J
AF Lai, Samuel K.
   Hida, Kaoru
   Man, Stan T.
   Chen, Clive
   Machamer, Carolyn
   Schroer, Trina A.
   Hanes, Justin
TI Privileged delivery of polymer nanoparticles to the perinuclear region
   of live cells via a non-clathrin, non-degradative pathway
SO BIOMATERIALS
LA English
DT Article
DE intracellular delivery; trafficking; size; gene delivery; non-clathrin;
   non-caveolae
ID COATED PIT FORMATION; MEDIATED ENDOCYTOSIS; GENE DELIVERY;
   DRUG-DELIVERY; SECRETORY PATHWAY; GOLGI-APPARATUS; IN-VIVO; DNA;
   CAVEOLAE; TRANSPORT
AB The efficacy of many therapeutic molecules could be greatly enhanced by polymer-based nanoparticle systems capable of delivering them to the direct vicinity of the cell nucleus. However, degradation of the particles and encapsulated drugs within the enzyme-rich and low-pH environments of the endo/lysosomal pathway of cells has dramatically limited the efficacy of such systems. In this paper, we discovered that small polymeric particles (< 25 nm) but not larger particles (> 42 nm) enter live cells via a novel mechanism that leads to trafficking outside the endo/lysosomal pathway. Sub-25 nm particles rapidly transport to the perinuclear region of cells in vesicles that never acidify. The pathway is non-degradative, cholesterol independent, and non-clathrin and non-caveolae mediated. This privileged non-acidic pathway may be general since our results are surprisingly obtained with standard latex polymer beads without addition of ligands and may, therefore, provide a promising route for drug and gene delivery using biomaterial-based nanodevices. (C) 2007 Elsevier Ltd. All rights reserved.
C1 Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA.
   Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.
   Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.
   Johns Hopkins Univ, Inst NanobioTechnol, Baltimore, MD 21218 USA.
   Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Care Ctr, Dept Oncol, Baltimore, MD 21231 USA.
   Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21231 USA.
RP Hanes, J (reprint author), Johns Hopkins Univ, Dept Chem & Biomol Engn, 3400 N Charles St, Baltimore, MD 21218 USA.
EM hanes@jhu.edu
OI Schroer, Trina/0000-0002-5065-1835
CR Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833
   Burdick M. M., 2003, AM J PHYSIOL-CELL PH, V284, P977
   Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451
   Dawson M, 2003, J BIOL CHEM, V278, P50393, DOI 10.1074/jbc.M309026200
   DIWU Z, 1994, CYTOMETRY, P77
   Du H, 1998, MOL GENET METAB, V64, P126, DOI 10.1006/mgme.1998.2707
   Duncan R, 2003, NAT REV DRUG DISCOV, V2, P347, DOI 10.1038/nrd1088
   Evans CJ, 2003, GENE, V322, P1, DOI 10.1016/j.gene.2003.08.022
   Fink TL, 2006, GENE THER, V13, P1048, DOI 10.1038/sj.gt.3302761
   Gaborik Z, 2004, TRENDS ENDOCRIN MET, V15, P286, DOI 10.1016/j.tem.2004.06.009
   Garver WS, 2000, J LIPID RES, V41, P673
   HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389
   KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250
   Kircheis R, 2001, J CONTROL RELEASE, V72, P165, DOI 10.1016/S0168-3659(01)00272-3
   Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038
   Langer R, 1998, NATURE, V392, P5
   Le PU, 2003, J CELL SCI, V116, P1059, DOI 10.1242/jcs.00327
   Lechardeur D, 2005, ADV DRUG DELIVER REV, V57, P755, DOI 10.1016/j.addr.2004.12.008
   Liu G, 2003, J BIOL CHEM, V278, P32578, DOI 10.1074/jbc.M305776200
   Lungwitz U, 2005, EUR J PHARM BIOPHARM, V60, P247, DOI 10.1016/j.ejpb.2004.11.011
   Luo D, 2000, NAT BIOTECHNOL, V18, P33
   Maag RS, 2005, MOL BIOL CELL, V16, P3019, DOI 10.1091/ebc.E04-11-0971
   Meier O, 2004, J GENE MED, V6, pS152, DOI 10.1002/jgm.553
   Mineo C, 2001, HISTOCHEM CELL BIOL, V116, P109
   Mousavi SA, 2004, BIOCHEM J, V377, P1, DOI 10.1042/BJ20031000
   Nagamatsu S, 2001, J CELL SCI, V114, P219
   Ogris Manfred, 2002, Somatic Cell and Molecular Genetics, V27, P85, DOI 10.1023/A:1022988008131
   OHTANI Y, 1989, EUR J BIOCHEM, V186, P17, DOI 10.1111/j.1432-1033.1989.tb15171.x
   Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775
   Pelham HRB, 1996, CELL STRUCT FUNCT, V21, P413, DOI 10.1247/csf.21.413
   Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784
   Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539
   Pichler H, 2004, BBA-BIOMEMBRANES, V1666, P51, DOI 10.1016/j.bbamem.2004.05.011
   Pietiainen V, 2004, MOL BIOL CELL, V15, P4911, DOI 10.1091/mbc.E04-01-0070
   Pillay CS, 2002, BIOCHEM J, V363, P417, DOI 10.1042/0264-6021:3630417
   Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253
   Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961
   ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z
   Sandvig K, 2002, HISTOCHEM CELL BIOL, V117, P131, DOI 10.1007/s00418-001-0346-2
   Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042
   SCHNITZER JE, 1994, J CELL BIOL, V127, P1217, DOI 10.1083/jcb.127.5.1217
   Sieczkarski SB, 2002, J VIROL, V76, P10455, DOI 10.1128/JVI.76.20.10455-10464.2002
   Sieczkarski SB, 2002, J GEN VIROL, V83, P1535, DOI 10.1099/vir.O.18346-O
   SOFER A, 1995, J BIOL CHEM, V270, P12117, DOI 10.1074/jbc.270.20.12117
   Sotgia F, 2003, BIOCHEMISTRY-US, V42, P7110, DOI 10.1021/bi0271289
   Sugii S, 2003, J BIOL CHEM, V278, P27180, DOI 10.1074/jbc.M300542200
   Suh J, 2005, ADV DRUG DELIVER REV, V57, P63, DOI 10.1016/j.addr.2004.06.001
   Suh J, 2003, P NATL ACAD SCI USA, V100, P3878, DOI 10.1073/pnas.0636277100
   Suk JS, 2006, BIOMATERIALS, V27, P5143, DOI 10.1016/j.biomaterials.2006.05.013
   Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233
   WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107
   Wattiaux R, 2000, ADV DRUG DELIVER REV, V41, P201, DOI 10.1016/S0169-409X(99)00066-6
   Widera A, 2003, ADV DRUG DELIVER REV, V55, P1439, DOI 10.1016/j.addr.2003.07.004
   ZHANG YZ, 1994, MOL BIOL CELL, P5
NR 54
TC 172
Z9 175
U1 3
U2 44
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2007
VL 28
IS 18
BP 2876
EP 2884
DI 10.1016/j.biomaterials.2007.02.021
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 173IZ
UT WOS:000246868000010
PM 17363053
DA 2018-10-20
ER

PT J
AU Azzarello, J
   Ihnat, MA
   Kropp, BP
   AWarnke, L
   Lin, HK
AF Azzarello, Joseph
   Ihnat, Michael A.
   Kropp, Bradley P.
   AWarnke, Linda
   Lin, Hsueh-Kung
TI Assessment of angiogenic properties of biomaterials using the chicken
   embryo chorioallantoic membrane assay
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID SMALL-INTESTINAL SUBMUCOSA; BIODEGRADABLE POLYMER SCAFFOLDS; BLADDER
   AUGMENTATION; URINARY-BLADDER; IN-VIVO; TISSUE; MESH; REGENERATION;
   INHIBITION; DENSITY
AB The angiogenic potential of a biomaterial is a critical factor for successful graft intake in tissue engineering. We developed a modified, rapid and reproducible chicken embryo chorioallantoic membrane ( CAM) assay to evaluate the ability of biomaterials in inducing blood vessel density. Five biomaterials including one-layer porcine small intestinal submucosa ( SIS), two-layer SIS, four-layer vacuum pressed (VP) SIS, polyglycolic acid ( PGA) and PGA modified with poly( lactic-co-glycolic acid) ( PLGA) were analyzed. A circular section ( 1.2 mm diameter) of each biomaterial was placed near a group of blood vessels in the CAM. Blood vessels around the biomaterials were captured with black and white images at 96 h post implantation; and the images were subjected to densitometry evaluation. One-layer SIS induced a significant increase in blood vessel density as compared to the cellulose nitrate negative control, and had the greatest increase in blood vessel density as compared to four-layer VP SIS, PGA, or PLGA modified PGA. Although two-layer SIS has enhanced physical structure for surgical manipulation, its induction in blood vessel density was significantly lower than the one-layer SIS. Stripping the SIS proteins or incubating one-layer SIS with neutralizing antibodies against basic fibroblast growth factor ( bFGF) or vascular endothelial growth factor ( VEGF) resulted in decreased angiogenesis. Consistent with results obtained from bladder augmentation animal models, these results confirmed that angiogenic growth factors were present in SIS and affected the angiogenic potential of biomaterials. These data also demonstrated that the CAM assay can be used to ascertain methodically the angiogenic potential of biomaterials.
C1 Univ Oklahoma, Hlth Sci Ctr, Dept Urol, Oklahoma City, OK 73190 USA.
   Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK 73190 USA.
   Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73190 USA.
RP Azzarello, J (reprint author), Univ Oklahoma, Hlth Sci Ctr, Dept Urol, Oklahoma City, OK 73190 USA.
EM hk-lin@ouhsc.edu
FU NCRR NIH HHS [RR017703]; NIDDK NIH HHS [DK056968]
CR Abraham GA, 2000, J BIOMED MATER RES, V51, P442, DOI 10.1002/1097-4636(20000905)51:3<442::AID-JBM19>3.3.CO;2-W
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   ATALA A, 1992, J UROLOGY, V148, P658, DOI 10.1016/S0022-5347(17)36685-5
   Atala A, 2001, Curr Urol Rep, V2, P83, DOI 10.1007/s11934-001-0030-z
   Auerbach R, 2003, CLIN CHEM, V49, P32, DOI 10.1373/49.1.32
   AUERBACH R, 1975, INT J CANCER, V15, P241, DOI 10.1002/ijc.2910150209
   AUERBACH R, 1974, DEV BIOL, V41, P391, DOI 10.1016/0012-1606(74)90316-9
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   Borges J, 2003, TISSUE ENG, V9, P441, DOI 10.1089/107632703322066624
   Clarke KM, 1996, J SURG RES, V60, P107, DOI 10.1006/jsre.1996.0018
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Hidaka C, 2002, TISSUE ENG, V8, P93, DOI 10.1089/107632702753503090
   Hurst RE, 2001, J BIOMAT SCI-POLYM E, V12, P1267, DOI 10.1163/156856201753395798
   Kropp BP, 1996, J UROLOGY, V156, P599, DOI 10.1016/S0022-5347(01)65761-6
   Kropp BP, 1998, UROLOGY, V52, P138, DOI 10.1016/S0090-4295(98)00114-9
   Kropp BP, 1998, WORLD J UROL, V16, P262, DOI 10.1007/s003450050064
   Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2
   Lantz G C, 1990, J Invest Surg, V3, P217, DOI 10.3109/08941939009140351
   Marks MG, 2002, BIOL PHARM BULL, V25, P597, DOI 10.1248/bpb.25.597
   Misseri R, 2005, J UROLOGY, V174, P1680, DOI 10.1097/01.ju.0000176421.95997.6f
   Nakanishi Y, 2003, J PEDIATR SURG, V38, P1781, DOI 10.1016/S0022-3468(03)00632-8
   Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149
   Parsons-Wingerter P, 1998, MICROVASC RES, V55, P201, DOI 10.1006/mvre.1998.2073
   Paterson RF, 2002, J UROLOGY, V168, P2253, DOI 10.1097/01.ju.0000024629.58795.43
   Pope JC, 1997, J UROLOGY, V158, P1105, DOI 10.1016/S0022-5347(01)64398-2
   PREVEL CD, 1995, ANN PLAS SURG, V35, P381, DOI 10.1097/00000637-199510000-00009
   Puccio F, 2005, INT SURG, V90, pS21
   Raghavan D, 2005, J BIOMED MATER RES A, V73A, P90, DOI 10.1002/jbm.a.30268
   RIABATTI D, 2000, CURR PHARM BIOTECHNO, V1, P73
   RIBATTI D, 1987, ACTA ANAT, V130, P257
   Soucy NV, 2003, TOXICOL SCI, V76, P271, DOI 10.1093/toxsci/kfg231
   Steffens GCM, 2004, TISSUE ENG, V10, P1502, DOI 10.1089/ten.2004.10.1502
   Valdes TI, 2002, J BIOMED MATER RES, V62, P273, DOI 10.1002/jbm.10152
   Vance RJ, 2004, BIOMATERIALS, V25, P2095, DOI 10.1016/j.biomaterials.2003.08.064
   Vaught JD, 1996, J UROLOGY, V155, P374, DOI 10.1016/S0022-5347(01)66663-1
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
NR 36
TC 19
Z9 20
U1 2
U2 12
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
J9 BIOMED MATER
JI Biomed. Mater.
PD JUN
PY 2007
VL 2
IS 2
BP 55
EP 61
DI 10.1088/1748-6041/2/2/001
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 212LJ
UT WOS:000249597500003
PM 18458436
DA 2018-10-20
ER

PT J
AU Machado, CB
   Ventura, JMG
   Lemos, AF
   Ferreira, JMF
   Leite, MF
   Goes, AM
AF Machado, C. B.
   Ventura, J. M. G.
   Lemos, A. F.
   Ferreira, J. M. F.
   Leite, M. F.
   Goes, A. M.
TI 3D chitosan-gelatin-chondroitin porous scaffold improves osteogenic
   differentiation of mesenchymal stem cells
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID HUMAN BONE-MARROW; POLYMETHYLMETHACRYLATE PARTICLES; COLLAGEN SCAFFOLDS;
   ADHESION; CULTURES; MATRIX; FIBROBLASTS; BIOMATERIAL; CARTILAGE; MARKERS
C1 Univ Fed Minas Gerais, Dept Biochem & Immunol, Inst Biol Sci, Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Dept Physiol & Biophys, Inst Biol Sci, Belo Horizonte, MG, Brazil.
   Univ Aveiro, Dept Ceram & Glass Engn, P-3800 Aveiro, Portugal.
RP Machado, CB (reprint author), Univ Fed Minas Gerais, Dept Biochem & Immunol, Inst Biol Sci, Belo Horizonte, MG, Brazil.
EM goes@mono.icb.ufmg.br
OI Ferreira, Jose/0000-0002-7520-2809; Barcellos Machado,
   Carolina/0000-0003-4420-6097; Lemos, Alexandra/0000-0002-0065-7606
CR BOUVIER M, 1996, DIFFERENTIATION, V158, P25
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Chiu R, 2006, J BIOMED MATER RES A, V77A, P850, DOI 10.1002/jbm.a.30697
   Christenson RH, 1997, CLIN BIOCHEM, V30, P573, DOI 10.1016/S0009-9120(97)00113-6
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Fakhry A, 2004, BIOMATERIALS, V25, P2075, DOI 10.1016/j.biomaterials.2003.08.068
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   GIE GA, 1993, J BONE JOINT SURG BR, V75, P14
   Hung SC, 2002, STEM CELLS, V20, P249, DOI 10.1634/stemcells.20-3-249
   Ishii M, 2005, BIOCHEM BIOPH RES CO, V332, P297, DOI 10.1016/j.bbrc.2005.04.118
   Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870
   Kang SW, 2006, J BIOMED MATER RES A, V77A, P659, DOI 10.1002/jbm.a.30579
   Kas HS, 1997, J MICROENCAPSUL, V14, P689, DOI 10.3109/02652049709006820
   KASSEM M, 1993, J BONE MINER RES, V8, P1453
   Kiberstis P, 2000, SCIENCE, V289, P1497, DOI 10.1126/science.289.5484.1497
   KleinNulend J, 1997, J CELL PHYSIOL, V170, P174, DOI 10.1002/(SICI)1097-4652(199702)170:2<174::AID-JCP9>3.0.CO;2-L
   Lapasin R., 1995, RHEOLOGY IND POLYSAC, p[398, 400]
   Le Trong I, 2003, ACTA CRYSTALLOGR D, V59, P828, DOI 10.1107/S0907444903004153
   Liu F, 2003, J CELL SCI, V116, P1787, DOI 10.1242/jcs.00376
   LURIA EA, 1971, TRANSFUSION, V11, P345, DOI 10.1111/j.1537-2995.1971.tb04426.x
   Manjubala I, 2005, J MATER SCI-MATER M, V16, P1111, DOI 10.1007/s10856-005-4715-6
   McCarthy JB, 1996, BIOPOLYMERS, V40, P371, DOI 10.1002/(SICI)1097-0282(1996)40:4<371::AID-BIP3>3.0.CO;2-T
   Meier P, 2000, NATURE, V407, P796, DOI 10.1038/35037734
   Moreira PL, 2004, J BIOMED MATER RES B, V71B, P229, DOI 10.1002/jbm.b.30026
   Olhero SM, 2000, J EUR CERAM SOC, V20, P423, DOI 10.1016/S0955-2219(99)00182-X
   Otto WR, 2004, CELL PROLIFERAT, V37, P97, DOI 10.1111/j.1365-2184.2004.00303.x
   Parfitt AM, 1997, J BONE MINER RES, V12, P1864, DOI 10.1359/jbmr.1997.12.11.1864
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Ramachandran R, 2006, J BIOMED MATER RES A, V77A, P512, DOI 10.1002/jbm.a.30649
   Rickard DJ, 1996, J BONE MINER RES, V11, P312
   Rocha LB, 2002, BIOMATERIALS, V23, P449, DOI 10.1016/S0142-9612(01)00126-0
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Subramanian A, 2005, J BIOMED MATER RES A, V75A, P742, DOI 10.1002/jbm.a.30489
   Taravel MN, 1996, BIOMATERIALS, V17, P451, DOI 10.1016/0142-9612(96)89663-3
   TAYLOR MS, 1994, J APPL BIOMATER, V5, P151, DOI 10.1002/jab.770050208
   Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504
   THELLIN O, 1997, J BIOTECHNOL, V75, P291
   Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4
   WERKMEISTER J A, 1992, Clinical Materials, V9, P137
   Wollenweber M, 2006, TISSUE ENG, V12, P345, DOI 10.1089/ten.2006.12.345
   Yan JH, 2006, ARTIF CELL BLOOD SUB, V34, P27, DOI [10.1080/10731190500430024, 10.1080/107311090500430024]
   Yang XBB, 2004, TISSUE ENG, V10, P1148, DOI 10.1089/1076327041887871
   Yudoh K, 2000, ARTHRITIS RHEUM, V43, P2178, DOI 10.1002/1529-0131(200010)43:10<2178::AID-ANR5>3.0.CO;2-Z
NR 43
TC 34
Z9 34
U1 2
U2 17
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD JUN
PY 2007
VL 2
IS 2
BP 124
EP 131
DI 10.1088/1748-6041/2/2/010
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 212LJ
UT WOS:000249597500012
PM 18458445
DA 2018-10-20
ER

PT J
AU Minuth, WW
   Strehl, R
AF Minuth, Will W.
   Strehl, Raimund
TI Technical and theoretical considerations about gradient perfusion
   culture for epithelia used in tissue engineering, biomaterial testing
   and pharmaceutical research
SO BIOMEDICAL MATERIALS
LA English
DT Review
ID BLOOD-RETINA BARRIER; LONG-TERM CULTURE; IN-VITRO; CELL-CULTURE;
   TRACHEAL EPITHELIUM; CORNEAL EPITHELIUM; BRAIN-BARRIER; STEM-CELLS;
   MODEL; DIFFERENTIATION
AB Epithelia act as biological barriers, which are exposed to different environments at the luminal and basal sides. To simulate this situation and to improve functional features an in vitro gradient perfusion culture technique was developed in our laboratory. This innovative technique appears to be simple at first sight, but the performance needs practical and theoretical knowledge. To harvest intact epithelia after a long-term gradient culture period of many days, leakage, edge damage and pressure differences in the system have to be avoided so that the epithelial barrier function is maintained continuously. Unexpectedly, one of the major obstacles are micro-injuries in the epithelia caused by gas bubbles, which arise during transportation of the medium or due to respiration of the cultured tissue. Gas bubbles randomly accumulate either at the luminal or basal fluid flow of the gradient perfusion culture container. This phenomenon results in fluid pressure differences between the luminal and basal perfusion compartments of the gradient container, which in turn leads to damage of the barrier function. Consequently, the content of gas bubbles in the transported culture medium has to be minimized. Thus, our technical concept is the reduction of gas bubbles while keeping the content of oxygen constant. To follow this strategy we developed a new type of screw cap for media bottles specifically designed to allow fluid contact only with tube and not with cap material. Furthermore, a gas expander module separates gas bubbles from the liquid phase during transportation of the medium. Finally, a new type of gradient culture container allows a permanent elimination of transported gas bubbles. Application of this innovative equipment optimizes the parallel transportation of fluid in the luminal and basal compartments of a gradient culture container.
C1 Univ Regensburg, Dept Mol & Cellular Anat, D-93053 Regensburg, Germany.
   Cellartis AB, S-41346 Gothenburg, Sweden.
RP Minuth, WW (reprint author), Univ Regensburg, Dept Mol & Cellular Anat, Univ St 31, D-93053 Regensburg, Germany.
EM will.minuth@vkl.uni-regensburg.de
CR Bhadriraju K, 2000, BIOMATERIALS, V21, P267, DOI 10.1016/S0142-9612(99)00175-1
   Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181
   Cho EH, 2005, J BIOMAT SCI-POLYM E, V16, P775, DOI 10.1163/1568562053992441
   Evans MDM, 2005, BIOMATERIALS, V26, P1703, DOI 10.1016/j.biomaterials.2004.05.023
   Ferrari S, 2005, CLIN DERMATOL, V23, P430, DOI 10.1016/j.clindermatol.2004.07.017
   Framme C, 2002, OPHTHALMOLOGICA, V216, P320, DOI 10.1159/000066184
   Gusic RJ, 2005, J BIOMECH, V38, P1760, DOI 10.1016/j.jbiomech.2004.10.030
   Hayashi K, 2004, ASAIO J, V50, P261, DOI 10.1097/01.MAT.0000123688.45717.A4
   Hollande E, 2004, BIOL CELL, V96, P429, DOI 10.1016/j.biolcel.2004.04.005
   Humes HD, 2000, SEMIN NEPHROL, V20, P71
   Hyatt BA, 2004, AM J PHYSIOL-LUNG C, V287, pL1116, DOI 10.1152/ajplung.00033.2004
   Iwaguro H, 2005, METH MOLEC MED, V112, P239
   Jahoda CAB, 2001, LANCET, V358, P1445, DOI 10.1016/S0140-6736(01)06532-1
   JENNINGS ML, 1997, Patent No. 3923279
   Jockenhoevel S, 2002, ASAIO J, V48, P8, DOI 10.1097/00002480-200201000-00003
   Kavvada KM, 2005, J BIOMOL SCREEN, V10, P495, DOI 10.1177/1087057105276035
   Kilgour JD, 2000, TOXICOLOGY, V145, P39, DOI 10.1016/S0300-483X(99)00180-8
   Kremer M, 2001, LANGENBECK ARCH SURG, V386, P357, DOI 10.1007/s004230100227
   Kurosawa H, 2003, J BIOSCI BIOENG, V95, P59, DOI 10.1263/jbb.95.59
   Lacorre DA, 2004, BLOOD, V103, P4164, DOI 10.1082/blood-2003-10-3537
   Langer RS, 1999, SCI AM, V280, P86, DOI 10.1038/scientificamerican0499-86
   Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922
   Masungi C, 2004, J PHARM SCI-US, V93, P2507, DOI 10.1002/jps.20149
   MINUTH WW, 1990, CYTOTECHNOLOGY, V4, P181, DOI 10.1007/BF00365099
   Minuth WW, 2005, BIO-MED MATER ENG, V15, P51
   Minuth WW, 2001, J BIOMAT SCI-POLYM E, V12, P353, DOI 10.1163/156856201750180861
   Minuth WW, 1997, PEDIATR NEPHROL, V11, P140, DOI 10.1007/s004670050245
   MINUTH WW, 1994, IN VITRO CELL DEV-AN, V30A, P12
   Minuth WW, 1999, EXP NEPHROL, V7, P394
   MINUTH WW, 2006, Patent No. 19952847
   Monga SPS, 2005, AM J PATHOL, V167, P1279, DOI 10.1016/S0002-9440(10)61215-1
   Mrsny RJ, 2005, CRIT REV THER DRUG, V22, P331, DOI 10.1615/CritRevTherDrugCarrierSyst.v22.i4.10
   Nerem RM, 2001, ANNU REV BIOMED ENG, V3, P225, DOI 10.1146/annurev.bioeng.3.1.225
   Ojeh NO, 2001, TISSUE ENG, V7, P457, DOI 10.1089/10763270152436508
   Pariente JL, 2000, BIOMATERIALS, V21, P835, DOI 10.1016/S0142-9612(99)00253-7
   Pilot F, 2005, DEV DYNAM, V232, P685, DOI 10.1002/dvdy.20334
   Pins GD, 2000, FASEB J, V14, P593
   Poumay Y, 2004, ARCH DERMATOL RES, V296, P203, DOI 10.1007/s00403-004-0507-y
   Schmalz G, 1996, J ENDODONT, V22, P249, DOI 10.1016/S0099-2399(06)80142-1
   Schumacher K, 2002, BIOMATERIALS, V23, P805, DOI 10.1016/S0142-9612(01)00186-7
   Shurman DL, 2005, INVEST OPHTH VIS SCI, V46, P1957, DOI 10.1167/iovs.04-1364
   Steuer H, 2005, INVEST OPHTH VIS SCI, V46, P1047, DOI 10.1167/iovs.04-0925
   Steuer H, 2004, BRAIN RES PROTOC, V13, P26, DOI 10.1016/j.brainresprot.2003.12.002
   Stockmann M, 1999, PFLUG ARCH EUR J PHY, V438, P107, DOI 10.1007/s004240050886
   Strehl R, 2004, TISSUE ENG, V10, P1196, DOI 10.1089/1076327041887853
   Suzuki M, 2005, J EXP MED, V202, P1235, DOI 10.1084/jem.20051027
   Toimela T, 2004, TOXICOL APPL PHARM, V195, P73, DOI 10.1016/j.taap.2993.11.002
   VACANTI JP, 1999, LANCET S1, V354, pS132
   van Vranken BE, 2005, TISSUE ENG, V11, P1177
   Vogt F, 2004, EUR HEART J, V25, P1330, DOI 10.1016/j.ehj.2004.06.010
   Widdicombe JH, 2005, BIOTECHNIQUES, V39, P249, DOI 10.2144/05392RR02
   Ziegelaar BW, 2002, BIOMATERIALS, V23, P1425, DOI 10.1016/S0142-9612(01)00264-2
NR 52
TC 11
Z9 11
U1 0
U2 8
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
J9 BIOMED MATER
JI Biomed. Mater.
PD JUN
PY 2007
VL 2
IS 2
BP R1
EP R11
DI 10.1088/1748-6041/2/R01
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 212LJ
UT WOS:000249597500001
PM 18458434
DA 2018-10-20
ER

PT J
AU Caner, H
   Yilmaz, E
   Yimaz, O
AF Caner, Hamit
   Yilmaz, Elvan
   Yimaz, Osman
TI Synthesis, characterization and antibacterial activity of
   poly(N-vinylimidazole) grafted chitosan
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE 1-vinylimidazole; CAN; cerium; enzymes; water-soluble polymers
ID COMPLEX-FORMATION; GLUCOSE-OXIDASE; METAL-IONS; COPOLYMERS; HYDROGELS;
   1-VINYLIMIDAZOLE; 4-VINYLPYRIDINE; METHACRYLATE; BIOMATERIAL; ADSORPTION
AB Poly(N-vinylimidazole) has been grafted onto chitosan in dilute acetic acid solution via ceric ion initiation. The effect of the amounts of N-vinylimidazole monomer, cerium(IV) ammonium nitrate initiator, chitosan substrate, as well as chitosan molecular weight, temperature and reaction time on the grafting yield has been investigated. The maximum grafting yield achieved was 140% in 1.0% (w/V) chitosan solution at 0.2 M N-vinylimidazole, 70 degrees C within 3 It under nitrogen atmosphere. The grafted products were characterized by gravimetric methods, FTIR and DSC. Grafted chitosans with lower grafting yields less than 108% were completely soluble in neutral water. Products with higher % grafting values swell in aqueous solution. Grafted products have improved antibacterial activity. (C) 2007 Published by Elsevier Ltd.
C1 Eastern Mediterranean Univ, Fac Arts & Sci, Dept Chem, Gazimagusa, N Cyprus, Turkey.
   Eastern Mediterranean Univ, Fac Educ, Dept Educ Sci, Gazimagusa, N Cyprus, Turkey.
RP Yimaz, O (reprint author), Eastern Mediterranean Univ, Fac Arts & Sci, Dept Chem, Via Mersin 10, Gazimagusa, N Cyprus, Turkey.
EM osman.yilmaz@emu.edu.tr
RI YILMAZ, OSMAN/A-3285-2008; Yilmaz, Elvan/A-8528-2008
CR Ajji Z, 2005, NUCL INSTRUM METH B, V236, P580, DOI 10.1016/j.nimb.2005.04.046
   Allcock HR, 1999, MACROMOL SYMP, V144, P33, DOI 10.1002/masy.19991440105
   BAMFORD CH, 1981, POLYMER, V22, P1227, DOI 10.1016/0032-3861(81)90138-5
   Bojanic V, 1996, J APPL POLYM SCI, V60, P1719, DOI 10.1002/(SICI)1097-4628(19960606)60:10<1719::AID-APP24>3.0.CO;2-Y
   Chauhan GS, 2006, J APPL POLYM SCI, V100, P1522, DOI 10.1002/app.23651
   DOMSZY JG, 1985, MAKROMOL CHEM, V186, P1671
   Dutta PK, 2002, J MACROMOL SCI-POL R, VC42, P307, DOI 10.1081/MC-120006451
   Gorochovceva N, 2004, EUR POLYM J, V40, P685, DOI 10.1016/j.eurpolymj.2003.12.005
   HASIPOGLU HN, 2005, J POLYM ANAL CHARACT, V10, P313
   HUMMEL DO, 1990, ATLAS POLYM PLASTIC
   Kumar G, 1999, BIOTECHNOL BIOENG, V63, P154, DOI 10.1002/(SICI)1097-0290(19990420)63:2<154::AID-BIT4>3.3.CO;2-I
   Lee JW, 2004, J BIOMAT SCI-POLYM E, V15, P1065, DOI 10.1163/1568562041526496
   Liang J, 2004, J MACROMOL SCI PURE, VA41, P685, DOI 10.1081/MA-120034199
   Pekel N, 2000, RADIAT PHYS CHEM, V59, P485, DOI 10.1016/S0969-806X(00)00308-X
   Pekel N, 2002, COLLOID POLYM SCI, V280, P46, DOI 10.1007/s003960200006
   Pekel N, 2003, J MOL CATAL B-ENZYM, V21, P273, DOI 10.1016/S1381-1177(02)00232-1
   Pekel N, 2003, COLLOID SURFACE A, V212, P155, DOI 10.1016/S0927-7757(02)00297-2
   Pekel N, 2001, MACROMOL SYMP, V169, P329, DOI 10.1002/1521-3900(200105)169:1<329::AID-MASY329>3.0.CO;2-E
   Pekel N, 1999, COLLOID POLYM SCI, V277, P570, DOI 10.1007/s003960050426
   Qu X, 1999, J APPL POLYM SCI, V74, P3193, DOI 10.1002/(SICI)1097-4628(19991220)74:13<3193::AID-APP23>3.0.CO;2-V
   Rivas BL, 1998, J APPL POLYM SCI, V67, P1109, DOI 10.1002/(SICI)1097-4628(19980207)67:6<1109::AID-APP19>3.0.CO;2-V
   Salih B, 2001, J APPL POLYM SCI, V82, P446, DOI 10.1002/app.1870
   Saravanan S, 2005, ARCH PHARM, V338, P488, DOI 10.1002/ardp.200400944
   Sashiwa H, 2004, PROG POLYM SCI, V29, P887, DOI 10.1016/j.progpolymsci.2004.04.001
   Soykan C, 2005, J MACROMOL SCI PURE, VA42, P1603, DOI 10.1080/10601320500246693
   Takafuji M, 2004, CHEM MATER, V16, P1977, DOI 10.1021/cm030334y
   Wang WC, 2004, POLYM ENG SCI, V44, P362, DOI 10.1002/pen.20033
   WEI W, 1991, INT J BIOL MACROMOL, V13, P281, DOI 10.1016/0141-8130(91)90027-R
   Xie WM, 2002, CARBOHYD POLYM, V50, P35, DOI 10.1016/S0144-8617(01)00370-8
   Yilmaz E, 2004, ADV EXP MED BIOL, V553, P59
NR 30
TC 48
Z9 49
U1 2
U2 45
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JUN 1
PY 2007
VL 69
IS 2
BP 318
EP 325
DI 10.1016/j.carbpol.2006.10.008
PG 8
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 173VQ
UT WOS:000246901000016
DA 2018-10-20
ER

PT J
AU Schedle, A
   Ortengren, U
   Eidler, N
   Gabauer, M
   Hensten, A
AF Schedle, Andreas
   Ortengren, Ulf
   Eidler, Nicole
   Gabauer, Michael
   Hensten, Arne
TI Do adverse effects of dental materials exist? What are the consequences,
   and how can they be diagnosed and treated?
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article; Proceedings Paper
CT 1st European Workshop on Evidence-Based Reconstructive Dentistry
CY NOV 04-07, 2006
CL Hunigen, SWITZERLAND
SP Swiss Soc Reconstruct Dentistry
DE adverse effects; dental materials; hypersensitivity; mouth
   diseases/etiology; occupational diseases/epidemiology
ID ORAL LICHENOID REACTIONS; OCCUPATIONAL-HEALTH PROBLEMS; RANDOMIZED
   CLINICAL-TRIAL; NATURAL-RUBBER LATEX; RESIN COMPOSITE RESTORATIONS;
   BONDED AMALGAM RESTORATIONS; POWDER-FREE GLOVES; WORK-RELATED SKIN;
   CONTACT ALLERGY; POSTOPERATIVE SENSITIVITY
AB Objectives: All dental biomaterials release substances into the oral environment to a varying degree. Various preclinical biocompatibility test systems have been introduced, aiming at an evaluation of the potential risks of dental materials. Potential pathogenic effects of released substances from dental materials have been demonstrated. For the biocompatibility of a biomaterial, it is not only important that minimal diffusable substances are released when it is in body contact - the material must also fulfill the function for which it has been designed. This is also very much dependent on the material properties and its handling properties. The aim of this review was to generate an overview of the present status concerning adverse reactions among patients and personnel.
   Materials and methods: A systematic review was performed using a defined search strategy in order to evaluate all MEDLINE-literature published between 1996 and 2006.
   Results: The compilation of the literature available has revealed that the majority of studies have been carried out on patients compared with personnel. Adverse reactions towards dental materials do occur, but the prevalence and incidence are difficult to obtain. The results were essentially based on cohort studies. Clinical trials, especially randomized-control led trials, are in the minority of all studies investigated, with the exception of composite and bonding studies, where clinical trials, but not randomized-controlled trials, represent the majority of studies. Patients and personnel were treated separately in the manuscript. Amalgam studies show the lowest degree of verified material-related diagnosis. Even if objective symptoms related to adverse reactions with polymer resin-based materials have been reported, postoperative sensitivity dominates reports concerning composites/bondings. Verified occupational effects among dental personnel show a low frequency of allergy/toxic reactions. Irritative hand eczema seemed to be more common than in the general population.
   Conclusions: Patient- and personnel-related studies are of variable quality and can be improved. There is a need for a better description of the content of materials. A registry for adverse effects of dental materials would be useful to detect the occurrence of low-incidence events.
C1 Med Univ Vienna, Bemhard Gottlieb Univ, Clin Dent, Cent Res Unit, Vienna, Austria.
   Univ Gothenburg, Sahgrenska Acad, Inst Odontol, Dept Prosthet Dent Dent Mat Sci, Gothenburg, Sweden.
   Univ Tromso, Fac Med, Inst Clin Dent, Tromso, Norway.
RP Schedle, A (reprint author), Med Univ Vienna, Bemhard Gottlieb Univ, Clin Dent, Waehringerstrasse 25A, A-1090 Vienna, Austria.
EM andreas.schedle@meduniwien.ac.at
CR About I, 2001, OPER DENT, V26, P336
   Ahlgren C, 2002, ACTA DERM-VENEREOL, V82, P41, DOI 10.1080/000155502753600876
   Ahlqwist M, 1999, ACTA ODONTOL SCAND, V57, P168
   Ahnlide I, 2002, ACTA ODONTOL SCAND, V60, P301, DOI 10.1080/00016350260248283
   Al-Omari WM, 2006, OPER DENT, V31, P165, DOI 10.2341/05-8
   Alanko K, 2004, CONTACT DERMATITIS, V50, P77, DOI 10.1111/j.0105-1873.2004.00304.x
   Alanko K, 1996, CONTACT DERMATITIS, V34, P263, DOI 10.1111/j.1600-0536.1996.tb02197.x
   Andreasson H, 2001, ACTA ODONTOL SCAND, V59, P267, DOI 10.1080/000163501750541110
   [Anonymous], 1999, 1099351999 ISO
   Anveden I, 2006, CONTACT DERMATITIS, V54, P272, DOI 10.1111/j.0105-1873.2006.00823.x
   Apostoli P, 2002, SCI TOTAL ENVIRON, V289, P13, DOI 10.1016/S0048-9697(01)01013-0
   Archbold GP, 2004, ANN CLIN BIOCHEM, V41, P233, DOI 10.1258/000456304323019622
   Athavale PN, 2003, CONTACT DERMATITIS, V49, P264, DOI 10.1111/j.0105-1873.2003.0225g.x
   Attin T, 1998, Clin Oral Investig, V2, P115, DOI 10.1007/s007840050055
   Aw TC, 2005, J AM DENT ASSOC, V136, P311, DOI 10.14219/jada.archive.2005.0171
   BagedahlStrindlund M, 1997, ACTA PSYCHIAT SCAND, V96, P475, DOI 10.1111/j.1600-0447.1997.tb09950.x
   Bailer J, 2001, PSYCHOL MED, V31, P255, DOI 10.1017/S0033291701003233
   Baker PS, 2006, J PROSTHET DENT, V95, P190, DOI 10.1016/j.prosdent.2006.01.008
   Bangsi D, 1998, INT J EPIDEMIOL, V27, P667, DOI 10.1093/ije/27.4.667
   Barregard Lars, 1998, Tidsskrift for den Norske Laegeforening, V118, P58
   Bellinger DC, 2006, JAMA-J AM MED ASSOC, V295, P1775, DOI 10.1001/jama.295.15.1775
   Bergdahl IA, 1998, ENVIRON RES, V77, P20, DOI 10.1006/enrs.1997.3820
   Berglund A, 1996, EUR J ORAL SCI, V104, P56, DOI 10.1111/j.1600-0722.1996.tb00046.x
   Biocina-Lukenda D, 2004, J EUR ACAD DERMATOL, V18, P227, DOI 10.1111/j.1468-3083.2004.00874.x
   Bleiker TO, 1998, CONTACT DERMATITIS, V38, P112, DOI 10.1111/j.1600-0536.1998.tb05667.x
   Blomgren J, 1996, J ORAL PATHOL MED, V25, P311, DOI 10.1111/j.1600-0714.1996.tb00268.x
   Bratel J, 1997, EUR J ORAL SCI, V105, P234, DOI 10.1111/j.1600-0722.1997.tb00206.x
   Bratel J, 1996, J DENT, V24, P41, DOI 10.1016/0300-5712(95)00004-6
   Braun A R, 2001, Clin Oral Investig, V5, P139, DOI 10.1007/s007840100116
   Browning WD, 1997, OPER DENT, V22, P66
   Casetta I, 2001, NEUROEPIDEMIOLOGY, V20, P134, DOI 10.1159/000054773
   Chong BS, 2005, ORAL SURG ORAL MED O, V100, P762, DOI 10.1016/j.tripleo.2005.01.010
   Collins CJ, 1998, J DENT, V26, P311, DOI 10.1016/S0300-5712(97)00019-5
   Dalen K, 2003, ACTA ODONTOL SCAND, V61, P310, DOI 10.1080/00016350310006762
   Dalen K, 2003, J DENT, V31, P487, DOI 10.1016/S0300-5712(03)00086-1
   de Souza Costa Carlos Alberto, 2002, Dent Mater, V18, P543, DOI 10.1016/S0109-5641(01)00089-6
   DELOURDES RAM, 2006, QUINTESSENCE INT, V37, P205
   DeRouen TA, 2006, JAMA-J AM MED ASSOC, V295, P1784, DOI 10.1001/jama.295.15.1784
   Dohrn N, 2001, PSYCHOTHER PSYCH MED, V51, P153, DOI 10.1055/s-2001-12380
   Dunne SM, 2005, BRIT DENT J, V198, P355, DOI 10.1038/sj.bdj.4812175
   Dunne SM, 2000, BRIT DENT J, V189, P310, DOI 10.1038/sj.bdj.4800755a
   Dunsche A, 2003, BRIT J DERMATOL, V148, P70, DOI 10.1046/j.1365-2133.2003.04936.x
   Eden S E, 2002, J Orthod, V29, P51, DOI 10.1093/ortho/29.1.51
   Estlander T, 1996, ALLERGY, V51, P56, DOI 10.1111/j.1398-9995.1996.tb00011.x
   *EUR COMM, 2001, 2121 MEDDEV EUR COMM
   Faccioni F, 2003, AM J ORTHOD DENTOFAC, V124, P687, DOI 10.1016/j.ajodo.2003.09.010
   Factor-Litvak P, 2003, ENVIRON HEALTH PERSP, V111, P719, DOI 10.1289/ehp.5879
   Fernandes L M, 1998, J Orofac Orthop, V59, P331, DOI 10.1007/BF01299769
   FERRACANE JL, 1994, J ORAL REHABIL, V21, P441, DOI 10.1111/j.1365-2842.1994.tb01158.x
   Fletcher R, 1996, CLIN EPIDEMIOLOGY ES
   Franz A, 2003, DENT MATER, V19, P382, DOI 10.1016/S0109-5641(02)00081-7
   Ganss C, 2000, Clin Oral Investig, V4, P206, DOI 10.1007/s007840000089
   Garhammer P, 2001, Clin Oral Investig, V5, P240
   Gaworski M, 1999, AM J ORTHOD DENTOFAC, V116, P518, DOI 10.1016/S0889-5406(99)70182-4
   Gebhardt M, 1996, CONTACT DERMATITIS, V34, P191, DOI 10.1111/j.1600-0536.1996.tb02172.x
   Geukens S, 2001, CONTACT DERMATITIS, V44, P153, DOI 10.1034/j.1600-0536.2001.044003153.x
   Geurtsen W, 1998, EUR J ORAL SCI, V106, P687, DOI 10.1046/j.0909-8836.1998.eos10602ii04.x
   Gordan VV, 2002, OPER DENT, V27, P543
   Gottwald B, 2001, INT J HYG ENVIR HEAL, V204, P223, DOI 10.1078/1438-4639-00097
   Grandjean P, 1997, J OCCUP ENVIRON MED, V39, P707, DOI 10.1097/00043764-199708000-00004
   Hagberg S, 2005, J OCCUP ENVIRON HYG, V2, P302, DOI 10.1080/15459620590958732
   Hamann CP, 2005, J AM DENT ASSOC, V136, P500, DOI 10.14219/jada.archive.2005.0207
   Hamann CP, 1998, J AM DENT ASSOC, V129, P43, DOI 10.14219/jada.archive.1998.0021
   Hamid A, 1997, DENT MATER, V13, P98, DOI 10.1016/S0109-5641(97)80018-8
   Hayashi M, 2003, OPER DENT, V28, P681
   Henningsson M, 1996, ACTA ODONTOL SCAND, V54, P176, DOI 10.3109/00016359609003520
   Hensten-Pettersen A, 1991, Int Dent J, V41, P265
   Hensten-Pettersen A, 1998, EUR J ORAL SCI, V106, P707
   HENSTENPETTERSE.A, 2001, OPER DENT S, V6, P229
   Herrstrom P, 1996, SCI TOTAL ENVIRON, V191, P277, DOI 10.1016/S0048-9697(96)05270-9
   Herrstrom P, 1997, INT ARCH OCC ENV HEA, V69, P339, DOI 10.1007/s004200050157
   Hill JG, 1998, J AM DENT ASSOC, V129, P212, DOI 10.14219/jada.archive.1998.0180
   Hol PJ, 2001, ENVIRON RES, V87, P141, DOI 10.1006/enrs.2001.4308
   *IARC, 1999, IARC MON EV CARC RIS, V74, P253
   Ibbotson SH, 1996, BRIT J DERMATOL, V134, P420, DOI 10.1046/j.1365-2133.1996.25760.x
   *ISO, 1999, 74051997 ISO
   Issa Y, 2005, BRIT DENT J, V198, P361, DOI 10.1038/sj.bdj.4812176
   JACOBSEN N, 1989, J CLIN PERIODONTOL, V16, P428, DOI 10.1111/j.1600-051X.1989.tb01671.x
   JACOBSEN N, 1989, EUR J ORTHODONT, V11, P254, DOI 10.1093/oxfordjournals.ejo.a035993
   Jacobsen N, 2003, EUR J ORTHODONT, V25, P591, DOI 10.1093/ejo/25.6.591
   JACOBSEN N, 1991, COMMUNITY DENT ORAL, V19, P155, DOI 10.1111/j.1600-0528.1991.tb00132.x
   Janson GRP, 1998, AM J ORTHOD DENTOFAC, V113, P655, DOI 10.1016/S0889-5406(98)70226-4
   Jokstad A, 1996, J DENT, V24, P309, DOI 10.1016/0300-5712(95)00076-3
   Jones KP, 2004, ANN OCCUP HYG, V48, P455, DOI 10.1093/annhyg/mch038
   KALLUS T, 1991, SCAND J DENT RES, V99, P236
   Kanerva L, 1999, CONTACT DERMATITIS, V40, P104, DOI 10.1111/j.1600-0536.1999.tb06000.x
   Kanerva L, 1997, CLIN DERMATOL, V15, P533, DOI 10.1016/S0738-081X(97)00006-0
   Kern M, 1996, J PROSTHET DENT, V75, P159, DOI 10.1016/S0022-3913(96)90093-1
   Khamaysi Z, 2006, CONTACT DERMATITIS, V55, P216, DOI 10.1111/j.1600-0536.2006.00905.x
   Kim TS, 2002, IND HEALTH, V40, P260, DOI 10.2486/indhealth.40.260
   Koch P, 1999, J AM ACAD DERMATOL, V41, P422, DOI 10.1016/S0190-9622(99)70116-7
   Kosugi Munehiro, 2003, Bull Tokyo Dent Coll, V44, P149, DOI 10.2209/tdcpublication.44.149
   Kuijs RH, 2006, INT J PROSTHODONT, V19, P349
   Laeijendecker R, 2004, ARCH DERMATOL, V140, P1434, DOI 10.1001/archderm.140.12.1434
   Laine J, 1997, J ORAL PATHOL MED, V26, P362, DOI 10.1111/j.1600-0714.1997.tb00231.x
   Laine J, 1999, J ORAL PATHOL MED, V28, P117
   Laine J, 1997, CONTACT DERMATITIS, V36, P141, DOI 10.1111/j.1600-0536.1997.tb00396.x
   Langworth S, 2002, J ORAL REHABIL, V29, P705, DOI 10.1046/j.1365-2842.2002.00963.x
   Lee JY, 2001, CONTACT DERMATITIS, V45, P13, DOI 10.1034/j.1600-0536.2001.045001013.x
   Leggat PA, 2006, INT DENT J, V56, P154
   Lindberg M, 2000, CONTACT DERMATITIS, V43, P4, DOI 10.1034/j.1600-0536.2000.043001004.x
   Lindh U, 2002, NEUROENDOCRINOL LETT, V23, P459
   Lindh U, 2001, CLIN CHEM LAB MED, V39, P134, DOI 10.1515/CCLM.2001.023
   Lindow SW, 2003, BJOG-INT J OBSTET GY, V110, P287, DOI 10.1016/S1470-0328(02)02957-9
   Lonnroth EC, 1998, SWED DENT J, V22, P33
   Lonnroth EC, 1998, SWED DENT J, V22, P23
   Lopez-Jornet P, 2004, CONTACT DERMATITIS, V51, P210, DOI 10.1111/j.0105-1873.2004.0424a.x
   Luglie Pier Franca, 2005, Archives of Gynecology and Obstetrics, V271, P138, DOI 10.1007/s00404-003-0578-6
   Lundin SA, 2004, QUINTESSENCE INT, V35, P758
   Lygre GB, 2005, COMMUNITY DENT ORAL, V33, P227, DOI 10.1111/j.1600-0528.2005.00223.x
   Lygre GB, 2003, COMMUNITY DENT ORAL, V31, P200, DOI 10.1034/j.1600-0528.2003.00037.x
   Mach Z, 2002, J AM DENT ASSOC, V133, P460, DOI 10.14219/jada.archive.2002.0204
   Magnin Pierre, 2003, Schweiz Monatsschr Zahnmed, V113, P143
   Malt UF, 1997, PSYCHOSOM MED, V59, P32, DOI 10.1097/00006842-199701000-00005
   Marcusson JA, 1998, CONTACT DERMATITIS, V38, P297, DOI 10.1111/j.1600-0536.1998.tb05758.x
   Marcusson JA, 1999, CONTACT DERMATITIS, V41, P60, DOI 10.1111/j.1600-0536.1999.tb06225.x
   Marcusson JA, 1996, CONTACT DERMATITIS, V34, P320, DOI 10.1111/j.1600-0536.1996.tb02215.x
   Meding B, 2000, CONTACT DERMATITIS, V43, P65, DOI 10.1034/j.1600-0536.2000.043002065.x
   Meding B, 2001, CONTACT DERMATITIS, V45, P341, DOI 10.1034/j.1600-0536.2001.450604.x
   MEDING B, 1990, CONTACT DERMATITIS, V23, P154, DOI 10.1111/j.1600-0536.1990.tb04776.x
   Mehulic M, 2005, Minerva Stomatol, V54, P303
   Melchart D, 1998, EUR J ORAL SCI, V106, P770, DOI 10.1046/j.0909-8836.1998.eos106303.x
   Merte Ilka, 2004, Schweiz Monatsschr Zahnmed, V114, P1124
   Michelsen VB, 2003, EUR J ORAL SCI, V111, P263, DOI 10.1034/j.1600-0722.2003.00033.x
   Monaco C, 2001, INT J PROSTHODONT, V14, P81
   Munksgaard EC, 1996, EUR J ORAL SCI, V104, P396, DOI 10.1111/j.1600-0722.1996.tb00098.x
   MUNKSGAARD EC, 1990, SCAND J DENT RES, V98, P261
   *NAT BOARD HLTH WE, 2002, SWED REG ADV REACT A, P125
   Nerdrum P, 2004, J PSYCHOSOM RES, V57, P103, DOI 10.1016/S0022-3999(03)00542-7
   Ohlson CG, 2002, SWED DENT J, V26, P141
   Ohlson CG, 2001, SWED DENT J, V25, P13
   Olsson H, 2005, INT ENDOD J, V38, P186, DOI 10.1111/j.1365-2591.2004.00932.x
   Opdam NJM, 1998, AM J DENT, V11, P229
   Opdam NJM, 1998, J DENT, V26, P555, DOI 10.1016/S0300-5712(97)00042-0
   Ortengren U, 2001, J ORAL REHABIL, V28, P1106, DOI 10.1046/j.1365-2842.2001.00802.x
   Ortengren U, 2001, J DENT, V29, P35, DOI 10.1016/S0300-5712(00)00055-5
   Ortengren U, 1999, EUR J ORAL SCI, V107, P496, DOI 10.1046/j.0909-8836.1999.eos107612.x
   ORTENGREN U, 2000, SWED DENT J S, V141, P1
   Osborne JW, 1996, AM J DENT, V9, P191
   Ostman PO, 1996, ORAL SURG ORAL MED O, V81, P459, DOI 10.1016/S1079-2104(96)80024-2
   Pecegueiro M, 1999, CONTACT DERMATITIS, V40, P333, DOI 10.1111/j.1600-0536.1999.tb06091.x
   Perdigao J, 2003, J AM DENT ASSOC, V134, P1621, DOI 10.14219/jada.archive.2003.0109
   Peumans M, 1998, QUINTESSENCE INT, V29, P211
   PHILLIPS RW, 1991, SCI DENT MAT, P65
   Piirila P, 2002, INT ARCH OCC ENV HEA, V75, P209, DOI 10.1007/s00420-001-0302-4
   Prochazkova J, 2004, NEUROENDOCRINOL LETT, V25, P211
   Rao R, 2004, CONTACT DERMATITIS, V50, P252, DOI 10.1111/j.0105-1873.2004.0301a.x
   Rasanen L, 1996, BRIT J DERMATOL, V134, P673, DOI 10.1111/j.1365-2133.1996.tb06968.x
   Reitemeier B, 2002, J PROSTHET DENT, V87, P167, DOI 10.1067/mpr.2002.121585
   Ritchie KA, 2002, OCCUP ENVIRON MED, V59, P287, DOI 10.1136/oem.59.5.287
   Rodvall Y, 1998, ORAL ONCOL, V34, P265, DOI 10.1016/S1368-8375(97)00096-1
   Rosin Michael, 2003, Clin Oral Investig, V7, P20
   Rustemeyer T, 1996, CONTACT DERMATITIS, V34, P125, DOI 10.1111/j.1600-0536.1996.tb02144.x
   SALLSTEN G, 1996, J DENT RES, V68, P345
   Santosh V, 1999, CONTACT DERMATITIS, V40, P50, DOI 10.1111/j.1600-0536.1999.tb05980.x
   Schedle A, 2003, J CHROMATOGR A, V990, P231, DOI 10.1016/S0021-9673(02)01966-0
   Schedle A, 1998, DENT MATER, V14, P429, DOI 10.1016/S0300-5712(99)00018-4
   Schmalz G, 2000, EUR J ORAL SCI, V108, P442, DOI 10.1034/j.1600-0722.2000.108005442.x
   Schmid K, 2002, CONTACT DERMATITIS, V47, P103, DOI 10.1034/j.1600-0536.2002.470209.x
   Schnuch A, 1998, ACTA DERM-VENEREOL, V78, P358
   Schuster Gabriele, 2004, J Orofac Orthop, V65, P48, DOI 10.1007/s00056-004-0312-4
   Schuurs A, 2000, EUR J ORAL SCI, V108, P511, DOI 10.1034/j.1600-0722.2000.00880.x
   Schwartz RS, 1998, J PROSTHET DENT, V80, P269, DOI 10.1016/S0022-3913(98)70126-X
   Scott A, 2004, BRIT DENT J, V196, P471, DOI 10.1038/sj.bdj.4811176
   Scott A, 2003, BRIT DENT J, V195, P686, DOI 10.1038/sj.bdj.4810821
   Setcos J C, 1999, J Adhes Dent, V1, P323
   Sinclair Neil A., 2004, New Zealand Dental Journal, V100, P38
   Stejskal VDM, 1996, J CLIN IMMUNOL, V16, P31, DOI 10.1007/BF01540970
   Stenman S, 1997, SCAND J WORK ENV HEA, V23, P59
   Stromberg Rolf, 1999, European Journal of Oral Sciences, V107, P208, DOI 10.1046/j.0909-8836.1999.eos1070308.x
   Subay RK, 2005, J ENDODONT, V31, P201
   Swift EJ, 2001, J DENT, V29, P1, DOI 10.1016/S0300-5712(00)00050-6
   THOMHILL MH, 2003, ORAL SURG ORAL MED O, V95, P291
   TILLBERG A, 2005, COMMUNITY DENTISTRY, V33, P327
   Tsuruta K, 2001, CONTACT DERMATITIS, V44, P55
   Turkun LS, 2001, J AM DENT ASSOC, V132, P196
   Unemori M, 2001, J DENT, V29, P7, DOI 10.1016/S0300-5712(00)00037-3
   Vamnes JS, 2004, COMMUNITY DENT ORAL, V32, P150, DOI 10.1111/j.0301-5661.2004.00148.x
   Vamnes JS, 2000, J DENT RES, V79, P868, DOI 10.1177/00220345000790031401
   van Dijken JWV, 1999, J DENT RES, V78, P1319, DOI 10.1177/00220345990780070601
   van Dijken JWV, 2003, ACTA ODONTOL SCAND, V61, P235, DOI 10.1080/00016350310004575
   van Noort R, 2004, J DENT, V32, P351, DOI 10.1016/j.jdent.2004.02.001
   Vilaplana J, 2000, CONTACT DERMATITIS, V43, P183
   Vilkinis V, 2000, Clin Oral Investig, V4, P133, DOI 10.1007/s007840000075
   Wallenhammar LM, 2000, CONTACT DERMATITIS, V43, P192, DOI 10.1034/j.1600-0536.2000.043004192.x
   Wataha JC, 2004, J BIOMED MATER RES B, V69B, P11, DOI 10.1002/jbm.b.20029
   Whitworth JM, 2005, INT ENDOD J, V38, P409, DOI 10.1111/j.1365-2591.2005.00962.x
   Williams DF, 1986, P CONS C EUR SOC BIO
   Wirz Jakob, 2003, Schweiz Monatsschr Zahnmed, V113, P284
   Wong L, 2003, CONTACT DERMATITIS, V48, P74, DOI 10.1034/j.1600-0536.2003.480204.x
   Wrangsjo K, 2001, BRIT J DERMATOL, V145, P32, DOI 10.1046/j.1365-2133.2001.04278.x
   Yiannias JA, 2000, J AM ACAD DERMATOL, V42, P177, DOI 10.1016/S0190-9622(00)90123-3
NR 192
TC 20
Z9 21
U1 0
U2 6
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0905-7161
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD JUN
PY 2007
VL 18
SU 3
BP 232
EP 256
DI 10.1111/j.1600-0501.2007.01481.x
PG 25
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 188IW
UT WOS:000247914600022
PM 17594385
DA 2018-10-20
ER

PT J
AU Dong, Q
   Su, HL
   Cao, W
   Zhang, D
   Guo, QX
   Zhang, FY
AF Dong, Qun
   Su, Huilan
   Cao, Wei
   Zhang, Di
   Guo, Qixin
   Zhang, Fangying
TI Assembly and formation of biomorphic tin dioxide by a biomimetic sol-gel
   approach involving glycoprotein
SO EUROPEAN JOURNAL OF INORGANIC CHEMISTRY
LA English
DT Article
DE biomimetic synthesis; colloids; hierarchy; nanotubes; sol-gel processes
ID EGGSHELL MEMBRANES; METAL-OXIDES; SOLUTION-PHASE; FILMS; NANOCRYSTALS;
   REPLICATION; NETWORKS; SILICA; TIO2; NANOPARTICLES
AB Three diverse layers of eggshell membrane (ESM) were introduced in a biogenic sol-gel technique for the synthesis of hierarchical SnO(2) nanomaterials with corresponding configurations. Typically, the biomorphic replication of the interwoven inner eggshell membrane was systematically investigated by controlling synthesis conditions such as pH value, dipping time, and calcination temperature. The as-prepared SnO(2) tubes consisting of interconnected 5-nm nanocrystallite units were successfully interwoven into ESM-morphic films. Herein, the biomaterial ESM served both as the physical substrate and the functional macromolecule template to realize the precision replication, by the interactions between ESM macromolecules (containing carboxyl, hydroxy, amino groups, etc.) and Sri colloid ingredients, Moreover, some biomacro-molecules also acted as the surfactant to yield small-scaled and well-distributed SnO(2) nanocrystallites based on the strong bondage of short-chained amino acids within ESM glycoprotein with SnO(2) nuclei. This technique can be attributed to a biomimetic sol-gel process and is widely applicable to the synthesis of other functional material systems. ((c) Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2007).
C1 Shanghai Jiao Tong Univ, State Key Lab Met Matrix Composities, Shanghai 200030, Peoples R China.
   Saga Univ, Dept Elect & Elect Engn, Saga 8408502, Japan.
   Fudan Univ, Natl Key Lab Surface Phys, Shanghai 200433, Peoples R China.
RP Su, HL (reprint author), Shanghai Jiao Tong Univ, State Key Lab Met Matrix Composities, Shanghai 200030, Peoples R China.
EM hlsu@sjtu.edu.cn
CR Antonietti M, 2004, CHEM-EUR J, V10, P28, DOI 10.1002/chem.200305009
   Brinker C. J., 1990, SOL GEL SCI PHYS CHE
   Caruso RA, 2004, ANGEW CHEM INT EDIT, V43, P2746, DOI 10.1002/anie.200301747
   Caruso RA, 2001, CHEM MATER, V13, P3272, DOI 10.1021/cm001257z
   Cha JN, 2000, NATURE, V403, P289, DOI 10.1038/35002038
   Cheng B, 2004, J AM CHEM SOC, V126, P5972, DOI 10.1021/ja0493244
   Chiang Y. M., 1997, PHYS CERAMICS PRINCI
   Colfen H, 2003, ANGEW CHEM INT EDIT, V42, P2350, DOI 10.1002/anie.200200562
   Cook G, 2003, ANGEW CHEM INT EDIT, V42, P557, DOI 10.1002/anie.200390160
   Dieguez A, 1999, SENSOR ACTUAT B-CHEM, V60, P125, DOI 10.1016/S0925-4005(99)00258-0
   Dong Q, 2005, J PHYS CHEM B, V109, P17429, DOI 10.1021/jp052826z
   Fernandez MS, 1997, MATRIX BIOL, V16, P13, DOI 10.1016/S0945-053X(97)90112-8
   Ferrere S, 1997, J PHYS CHEM B, V101, P4490, DOI 10.1021/jp970683d
   Gaal DA, 2000, J AM CHEM SOC, V122, P10956, DOI 10.1021/ja0024744
   Ginley DS, 2000, MRS BULL, V25, P15, DOI 10.1557/mrs2000.256
   Hincke MT, 2000, MATRIX BIOL, V19, P443, DOI 10.1016/S0945-053X(00)00095-0
   Huang JG, 2003, J AM CHEM SOC, V125, P11834, DOI 10.1021/ja037419k
   Ichinose I, 1997, CHEM MATER, V9, P1296, DOI 10.1021/cm970008g
   Ichinose I, 1998, ADV MATER, V10, P535, DOI 10.1002/(SICI)1521-4095(199805)10:7<535::AID-ADMA535>3.3.CO;2-H
   Jimenez VM, 1999, SOLID STATE IONICS, V116, P117, DOI 10.1016/S0167-2738(98)00271-9
   Jones W., 2002, SUPRAMOLECULAR ORG M
   Kamat S, 2000, NATURE, V405, P1036
   Kim Y, 2003, BIOMACROMOLECULES, V4, P908, DOI 10.1021/bm0257558
   Kolmakov A, 2003, ADV MATER, V15, P997, DOI 10.1002/adma.200304889
   Kunitake T, 2004, ANAL CHIM ACTA, V504, P1, DOI 10.1016/S0003-2670(03)00811-0
   Lee SW, 2002, SCIENCE, V296, P892, DOI 10.1126/science.1068054
   Li GJ, 1999, SENSOR ACTUAT B-CHEM, V60, P64, DOI 10.1016/S0925-4005(99)00245-2
   Liang CH, 2003, J PHYS CHEM B, V107, P9220, DOI 10.1021/jp0347466
   Lowenstam HA, 1989, BIOMINERALIZATION
   Mann K, 2003, MATRIX BIOL, V22, P397, DOI 10.1016/S0945-053X(03)00072-6
   Mann S, 2001, BIOMINERALIZATION PR
   Mann S., 1996, BIOMIMETIC MAT CHEM
   Moss JM, 1997, ARCH BIOCHEM BIOPHYS, V339, P172, DOI 10.1006/abbi.1996.9828
   Mucic RC, 1998, J AM CHEM SOC, V120, P12674, DOI 10.1021/ja982721s
   OGAWA H, 1981, J ELECTROCHEM SOC, V128, P2020, DOI 10.1149/1.2127787
   Pan DC, 2005, ADV MATER, V17, P1991, DOI 10.1002/adma.200500174
   Pan ZW, 2001, SCIENCE, V291, P1947, DOI 10.1126/science.1058120
   Pang GS, 2001, NANO LETT, V1, P723, DOI 10.1021/nl0156181
   Poon S, 2002, J BIOL CHEM, V277, P39532, DOI 10.1074/jbc.M204855200
   Rambo CR, 2005, ADV MATER, V17, P1088, DOI 10.1002/adma.200401049
   Rubner M, 2003, NATURE, V423, P925, DOI 10.1038/423925a
   Salas P, 1997, J MOL CATAL A-CHEM, V123, P149, DOI 10.1016/S1381-1169(97)00054-X
   Sellinger A, 1998, NATURE, V394, P256, DOI 10.1038/28354
   Shirahata N, 2004, ADV FUNCT MATER, V14, P580, DOI 10.1002/adfm.200305060
   Srivastava DN, 2002, LANGMUIR, V18, P4160, DOI 10.1021/la015761+
   Vukusic P, 2003, NATURE, V424, P852, DOI 10.1038/nature01941
   Wainwright SA, 1976, MECH DESIGN ORGANISM
   Wang Y, 2005, CHEM MATER, V17, P3899, DOI 10.1021/cm050724f
   Wang YL, 2003, J AM CHEM SOC, V125, P16176, DOI 10.1021/ja037743f
   Weatherspoon MR, 2005, CHEM COMMUN, P651, DOI 10.1039/b409466b
   WONG M, 1984, DEV BIOL, V104, P28, DOI 10.1016/0012-1606(84)90033-2
   Wu NL, 1999, SCIENCE, V285, P1375, DOI 10.1126/science.285.5432.1375
   Yang D, 2002, ADV MATER, V14, P1543, DOI 10.1002/1521-4095(20021104)14:21<1543::AID-ADMA1543>3.0.CO;2-B
   Yang D, 2003, J MATER CHEM, V13, P1119, DOI 10.1039/b301077e
   Zhang DF, 2005, J AM CHEM SOC, V127, P13492, DOI 10.1021/ja054771k
   Zhang DY, 2005, CHEM COMMUN, P2735, DOI 10.1039/b501933h
NR 56
TC 3
Z9 3
U1 1
U2 17
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1434-1948
J9 EUR J INORG CHEM
JI Eur. J. Inorg. Chem.
PD JUN
PY 2007
IS 16
BP 2265
EP 2273
DI 10.1002/ejic.200601176
PG 9
WC Chemistry, Inorganic & Nuclear
SC Chemistry
GA 178UU
UT WOS:000247246400003
DA 2018-10-20
ER

PT J
AU Nguyen-Vu, TDB
   Chen, H
   Cassell, AM
   Andrews, RJ
   Meyyappan, M
   Li, J
AF Nguyen-Vu, T. D. Barbara
   Chen, Hua
   Cassell, Alan M.
   Andrews, Russell J.
   Meyyappan, M.
   Li, Jun
TI Vertically aligned carbon nanofiber architecture as a multifunctional
   3-D neural electrical interface
SO IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING
LA English
DT Article
DE neural electrical interface; neural stimulation; neuromodulation;
   vertically aligned carbon nanofibers
ID CONDUCTING-POLYMER; MAMMALIAN-CELLS; PC12 CELLS; NANOTUBE; STIMULATION;
   STIFFNESS; ADHESION; RELEASE; GROWTH; FILMS
AB Developing biomaterial constructs that closely mimic the natural tissue microenvironment with its complex chemical and physical cues is essential for improving the function and reliability of implantable devices, especially those that require direct neural-electrical interfaces. Here we demonstrate that free-standing vertically aligned carbon nanofiber (VACNF) arrays can be used as a multifunctional 3-D brush-like nanoengineered matrix that interpenetrates the neuronal network of PC12 cells. We found that PC12 neuron cells cultured on VACNF substrates can form extended neural network upon proper chemical and biochemical modifications. The soft 3-D VACNF architecture provides a new platform to fine-tune the topographical, mechanical, chemical, and electrical cues at subcellular nanoscale. This new biomaterial platform can be used for both fundamental studies of material-cell interactions and the development of chronically stable implantable neural devices. Micropatterned multiplex VACNF arrays can be selectively controlled by electrical and electrochemical methods to provide localized stimulation with extraordinary spatiotemporal resolution. Further development of this technology may potentially result in a highly multiplex closed-loop system with multifunctions for neuromodulation and neuroprostheses.
C1 NASA, Ames Res Ctr, Univ Affiliated Res Ctr, Moffett Field, CA 94035 USA.
   Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA.
   NASA, Ames Res Ctr, ELORET, Moffett Field, CA 94035 USA.
RP Li, J (reprint author), NASA, Ames Res Ctr, Univ Affiliated Res Ctr, MS 229-1, Moffett Field, CA 94035 USA.
EM bnguyenv@stanford.edu; hchen@mail.arc.nasa.gov;
   acassell@mail.arc.nasa.gov; rja@russelljandrews.org;
   mmeyyappan@mail.arc.nasa.gov; jh@mail.arc.nasa.gov
RI Li, Jun/H-7771-2013
OI Li, Jun/0000-0002-3689-8946; Nguyen-Vu, T.D. Barbara/0000-0002-4708-1982
FU NINDS NIH HHS [5 R21 NS047721, R21 NS047721]
CR Abidian MR, 2006, ADV MATER, V18, P405, DOI 10.1002/adma.200501726
   ARREGUI CO, 1994, J NEUROSCI, V14, P6967
   Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1
   Bico J, 2004, NATURE, V432, P690, DOI 10.1038/432690a
   Brock A, 2003, LANGMUIR, V19, P1611, DOI 10.1021/la026394k
   Chen CS, 2005, MRS BULL, V30, P194, DOI 10.1557/mrs2005.52
   Chen J. H., 2002, SYNTHETIC MET, V125, P289
   Cruden BA, 2003, J APPL PHYS, V94, P4070, DOI 10.1063/1.1601293
   CRUDEN BA, 2007, IN PRESS IEEE T NANO
   CUI X, 2003, BIOMATERIALS, V24, P177
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Elliott JT, 2003, LANGMUIR, V19, P1506, DOI 10.1021/la026216r
   Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103
   Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970
   Karuri NW, 2004, J CELL SCI, V117, P3153, DOI 10.1242/jcs.01146
   Kim HM, 2004, CURR APPL PHYS, V4, P577, DOI 10.1016/j.cap.2004.01.022
   Lang F, 2000, CELL PHYSIOL BIOCHEM, V10, P417, DOI 10.1159/000016367
   Li J, 2003, NANO LETT, V3, P597, DOI 10.1021/nl0340677
   Li J, 2003, APPL PHYS LETT, V82, P2491, DOI 10.1063/1.1566791
   Liu H, 2004, ANGEW CHEM INT EDIT, V43, P1146, DOI 10.1002/anie.200351988
   Liu WF, 2005, MATER TODAY, V8, P28, DOI 10.1016/S1369-7021(05)71222-0
   Lovat V, 2005, NANO LETT, V5, P1107, DOI 10.1021/nl050637m
   MANIVANNAN S, 1994, J NEUROSCI, V14, P5917
   Mattson MP, 2000, J MOL NEUROSCI, V14, P175, DOI 10.1385/JMN:14:3:175
   McKenzie JL, 2004, BIOMATERIALS, V25, P1309, DOI 10.1016/j.biomaterials.2003.08.006
   Meyyappan M., 2005, CARBON NANOTUBES SCI
   Nguyen-Vu TDB, 2006, SMALL, V2, P89, DOI 10.1002/smll.200500175
   Nicolelis MAL, 2003, NAT REV NEUROSCI, V4, P417, DOI 10.1038/nrn1105
   Rutten WLC, 2002, ANNU REV BIOMED ENG, V4, P407, DOI 10.1146/annurev.bioeng.4.020702.153427
   Santhanam G, 2006, NATURE, V442, P195, DOI 10.1038/nature04968
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Spinks GM, 2002, ADV FUNCT MATER, V12, P437, DOI 10.1002/1616-3028(20020618)12:6/7<437::AID-ADFM437>3.0.CO;2-I
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   Wadhwa R, 2006, J CONTROL RELEASE, V110, P531, DOI 10.1016/j.jconrel.2005.10.027
   Webster TJ, 2004, NANOTECHNOLOGY, V15, P48, DOI 10.1088/0957-4484/15/1/009
   WONG JY, 1994, P NATL ACAD SCI USA, V91, P3201, DOI 10.1073/pnas.91.8.3201
   Yu MF, 2000, SCIENCE, V287, P637, DOI 10.1126/science.287.5453.637
NR 39
TC 94
Z9 96
U1 0
U2 24
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 0018-9294
J9 IEEE T BIO-MED ENG
JI IEEE Trans. Biomed. Eng.
PD JUN
PY 2007
VL 54
IS 6
BP 1121
EP 1128
DI 10.1109/TBME.2007.891169
PN 1
PG 8
WC Engineering, Biomedical
SC Engineering
GA 172RK
UT WOS:000246821500017
PM 17554831
DA 2018-10-20
ER

PT J
AU Chung, AS
   Gao, Q
   Kao, WJ
AF Chung, Amy S.
   Gao, Qiang
   Kao, Weiyuan John
TI Either integrin subunit beta 1 or beta 3 is involved in mediating
   monocyte adhesion, IL-1 beta protein and mRNA expression in response to
   surfaces functionalized with fibronectin-derived peptides
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE arginine-glycine-aspartic acid (RGD); integrin; interleukin-1 beta (IL-1
   beta); interpenetrating network (IPN); polyethylene glycol (PEG)
ID INTERLEUKIN-1 RECEPTOR ANTAGONIST; POLY(ETHYLENE GLYCOL) DIACRYLATE;
   INTERPENETRATING NETWORKS; MACROPHAGE ADHESION; EPITHELIAL-CELLS;
   GELATIN; MIGRATION; TISSUE; RGD; MECHANISMS
AB We synthesized gelatin-based, interpenetrating network (IPN) scaffolds immobilized with fibronectin (FN)-derived peptides to assess monocyte-biomaterial interaction. Human primary monocytes were seeded onto peptide-grafted IPN or tissue-culture polystyrene (TCPS) pre-adsorbed with FN or FN-derived peptides. Monocyte cell density on both TCPS and IPN surfaces was higher in the presence of the arginine-glycine-aspartic acid (RGD) peptide. Pretreatment with anti-integrin beta 1 or beta 3 antibody decreased monocyte density on all ligand-modified TCPS and IPN. Interleukin-1 beta (IL-1 beta) protein levels of cells on modified TCPS decreased over time. IL-1 beta expression of monocytes in the presence of IPNs peaked at 24 h and then decreased through 168 h. Ligand identity did not affect IL-1 beta expression in either TCPS or IPN samples. Pretreatment with anti-integrin beta 1 or beta 3 antibody reduced IL-1 beta levels from both TCPS and IPN samples in a ligand-independent manner, particularly at 24 h. Monocytic IL-1 beta mRNA expression in IPN samples without antibody pretreatment was highest at 2 h and decreased over time. IL-1 beta mRNA expression in cells with anti-integrin beta 1 or beta 3 antibody pretreatment was similar to those without antibody pretreatment, except for methoxygrafted IPN samples. The change in IL-1 beta mRNA expression did not correlate with changes in protein expression. The results indicate that monocyte adhesion was affected by the substrate and the RGD sequence and beta 1 or beta 3 containing integrin receptors. beta 1-or beta 3-containing integrin receptors were also involved in IL-1 beta gene and protein expression in monocytes adhered to gelatin-based biomaterial surfaces.
C1 Univ Wisconsin, Sch Pharm, Madison, WI 53705 USA.
   Univ Wisconsin, Dept Biomed Engn, Madison, WI 53705 USA.
RP Kao, WJ (reprint author), Univ Wisconsin, Sch Pharm, Madison, WI 53705 USA.
EM wjkao@pharmacy.wisc.edu
FU NIBIB NIH HHS [R01EB6613]; NHLBI NIH HHS [R01HL77825]
CR AOTA S, 1994, J BIOL CHEM, V269, P24756
   Arend WP, 1998, ANNU REV IMMUNOL, V16, P27, DOI 10.1146/annurev.immunol.16.1.27
   AREND WP, 1993, ADV IMMUNOL, V54, P167, DOI 10.1016/S0065-2776(08)60535-0
   Arend WR, 2002, CYTOKINE GROWTH F R, V13, P323, DOI 10.1016/S1359-6101(02)00020-5
   Benoit DSW, 2005, BIOMATERIALS, V26, P5209, DOI 10.1016/j.biomaterials.2005.01.045
   Burmania JA, 2003, J BIOMED MATER RES A, V67A, P224, DOI 10.1002/jbm.a.10106
   Cabrero A, 2005, MOL CELL BIOCHEM, V275, P173, DOI 10.1007/s11010-005-1353-8
   Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014
   Chen XX, 2005, BIOMATERIALS, V26, P873, DOI 10.1016/j.biomaterials.2004.04.002
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   Cox EA, 1998, MICROSC RES TECHNIQ, V43, P412, DOI 10.1002/(SICI)1097-0029(19981201)43:5<412::AID-JEMT7>3.0.CO;2-F
   Dinarello CA, 2005, CRIT CARE MED, V33, pS460, DOI 10.1097/01-CCM.0000185500.11080.91
   Elisseeff J, 2000, J BIOMED MATER RES, V51, P164, DOI 10.1002/(SICI)1097-4636(200008)51:2<164::AID-JBM4>3.0.CO;2-W
   Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010
   HONIG J, 1989, J PERIODONTAL RES, V24, P362, DOI 10.1111/j.1600-0765.1989.tb00883.x
   Humphries MJ, 2004, BIOCHEM SOC T, V32, P822, DOI 10.1042/BST0320822
   Imhof BA, 2004, NAT REV IMMUNOL, V4, P432, DOI 10.1038/nri1375
   ISSEKUTZ TB, 1995, J IMMUNOL, V154, P6533
   JOHANSSON S, 1997, FRONT BIOSCI, V2, P126
   Kao WUJ, 2002, J BIOMED MATER RES, V62, P478, DOI 10.1002/jbm.10317
   KLINGEMANN HG, 1989, BLOOD, V74, P1348
   Lafrenie RM, 1998, J CELL PHYSIOL, V175, P163, DOI 10.1002/(SICI)1097-4652(199805)175:2<163::AID-JCP6>3.0.CO;2-M
   Li J, 2003, BIOMACROMOLECULES, V4, P1055, DOI 10.1021/bm034069l
   Liu YP, 2002, CELL SIGNAL, V14, P145, DOI 10.1016/S0898-6568(01)00246-7
   Mayadas TN, 2005, TRENDS IMMUNOL, V26, P388, DOI 10.1016/j.it.2005.05.002
   McNally AK, 2002, AM J PATHOL, V160, P621, DOI 10.1016/S0002-9440(10)64882-1
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   Miyamoto S, 1998, ANN NY ACAD SCI, V857, P119, DOI 10.1111/j.1749-6632.1998.tb10112.x
   Mohri H, 1997, PEPTIDES, V18, P899, DOI 10.1016/S0196-9781(97)00027-2
   Mould AP, 1997, J BIOL CHEM, V272, P17283, DOI 10.1074/jbc.272.28.17283
   Nakayama Y, 1999, J BIOMED MATER RES, V48, P511, DOI 10.1002/(SICI)1097-4636(1999)48:4<511::AID-JBM17>3.3.CO;2-M
   Okino H, 2002, J BIOMED MATER RES, V59, P233, DOI 10.1002/jbm.1237
   Phillips JM, 2005, TISSUE ENG, V11, P964, DOI 10.1089/ten.2005.11.964
   Ronni T, 1997, J IMMUNOL, V158, P2363
   Rosenwasser LJ, 1998, J ALLERGY CLIN IMMUN, V102, P344
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   Stevens KR, 2002, J BIOMAT SCI-POLYM E, V13, P1353, DOI 10.1163/15685620260449741
   WALDECK H, 2007, IN PRESS J BIOMED MA
   Weerasinghe D, 1998, J CELL BIOL, V142, P595, DOI 10.1083/jcb.142.2.595
   Zilinski JL, 2004, J BIOMED MATER RES A, V68A, P392, DOI 10.1002/jbm.a.20079
NR 41
TC 13
Z9 13
U1 0
U2 5
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PD JUN
PY 2007
VL 18
IS 6
BP 713
EP 729
DI 10.1163/156856207781034179
PG 17
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 189DS
UT WOS:000247970200006
PM 17623553
DA 2018-10-20
ER

PT J
AU Yamane, S
   Iwasaki, N
   Kasahara, Y
   Harada, K
   Majima, T
   Monde, K
   Nishimura, SI
   Minami, A
AF Yamane, Shintaro
   Iwasaki, Norimasa
   Kasahara, Yasuhiko
   Harada, Kazuo
   Majima, Tokifumi
   Monde, Kenji
   Nishimura, Shin-ichiro
   Minami, Akio
TI Effect of pore size on in vitro cartilage formation using chitosan-based
   hyaluronic acid hybrid polymer fibers
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE chitosan; chondrocyte; hyaluronic acid/hyaluronan; cell culture;
   scaffold
ID TISSUE-ENGINEERED CARTILAGE; CHONDROCYTES; SCAFFOLD; TRANSPLANTATION;
   FEASIBILITY; BIOMATERIAL; DERIVATIVES; ALGINATE; CHITIN; KNEE
AB In this study, we successfully developed three-dimensional scaffolds fabricated from the chitosan-based hyaluronic acid hybrid polymer fibers, which can control the porous structure. To determine the adequate pore size for enhancing the chondrogenesis of cultured cells, we compared the behaviors of rabbit chondrocytes in scaffolds comprising different pore sizes (100, 200, and 400 mu m pore size). Regarding the cell proliferation, there was no significant difference among the three groups. On the other hand, glycosaminoglycan contents in the 400 pm group significantly increased during the culture period, compared with those in the other groups. The ratio of type II to type I collagen mRNA level was also significantly higher in the 400 mu m group than in the other groups. These results indicate that our scaffold with 400 mu m pore size significantly enhances the extracellular matrix synthesis by chondrocytes. Additionally, the current scaffolds showed high mechanical properties, compared with liquid and gel materials. The data derived from this study suggest great promise for the future of a novel fabricated material with relatively large pore size as a scaffold for cartilage regeneration. The biological and mechanical advantages presented here will make it possible to apply our scaffold to relatively wide cartilaginous lesions. (C) 2006 Wiley Periodicals, Inc. J Biomed Mater Res 81A: 586-593, 2007.
C1 Hokkaido Univ, Sch Med, Dept Orthopaed Surg, Sapporo, Hokkaido 060, Japan.
   Hokkaido Univ, Frontier Res Ctr Post Genom Sci & Technol, Sapporo, Hokkaido, Japan.
   Inst Biol Chem, Sapporo, Hokkaido, Japan.
   Hokkaido Univ, Grad Sch Sci, Div Biol Sci, Lab Biomacromol, Sapporo, Hokkaido, Japan.
RP Iwasaki, N (reprint author), Hokkaido Univ, Sch Med, Dept Orthopaed Surg, Sapporo, Hokkaido 060, Japan.
EM niwasaki@med.hokudai.ac.jp
RI Iwasaki, Norimasa/D-6448-2012; Monde, Kenji/F-5286-2011; Nishimura,
   Shinichiro/F-5277-2011
CR Bhardwaj T, 2001, J BIOMED MATER RES, V57, P190, DOI 10.1002/1097-4636(200111)57:2<190::AID-JBM1158>3.0.CO;2-J
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Brittberg M, 2003, J BONE JOINT SURG AM, V85A, P109, DOI 10.2106/00004623-200300003-00017
   BRITTBERG M, 2001, CLIN ORTHOP S, V391, P337
   Bryant SJ, 2004, BIOTECHNOL BIOENG, V86, P747, DOI 10.1002/bit.20160
   Chen GP, 2003, J BIOMED MATER RES A, V67A, P1170, DOI 10.1002/jbm.a.10164
   Denuziere A, 1998, BIOMATERIALS, V19, P1275, DOI 10.1016/S0142-9612(98)00036-2
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   HAUSELMANN HJ, 1994, J CELL SCI, V107, P17
   Hoemann CD, 2005, OSTEOARTHR CARTILAGE, V13, P318, DOI 10.1016/j.joca.2004.12.001
   Iwasaki N, 2004, BIOMACROMOLECULES, V5, P828, DOI 10.1021/bm0400067
   KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5
   KIMURA T, 1984, CLIN ORTHOP RELAT R, P231
   Lu JX, 1999, BIOMATERIALS, V20, P1937
   Malda J, 2005, BIOMATERIALS, V26, P63, DOI 10.1016/j.biomaterials.2004.02.046
   Muzzarelli RAA, 1997, CELL MOL LIFE SCI, V53, P131, DOI 10.1007/PL00000584
   Nehrer S, 1997, J BIOMED MATER RES, V38, P95
   Ochi M, 2002, J BONE JOINT SURG BR, V84B, P571, DOI 10.1302/0301-620X.84B4.11947
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270
   Waldman SD, 2003, J ORTHOPAED RES, V21, P132, DOI 10.1016/S0736-0266(02)00105-5
   Woodfield TBF, 2004, BIOMATERIALS, V25, P4149, DOI 10.1016/j.biomaterials.2003.10.056
   Yamane S, 2005, BIOMATERIALS, V26, P611, DOI 10.1016/j.biomaterials.2004.03.013
NR 25
TC 84
Z9 85
U1 5
U2 15
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN 1
PY 2007
VL 81A
IS 3
BP 586
EP 593
DI 10.1002/jbm.a.31095
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 165AS
UT WOS:000246276800008
PM 17177288
DA 2018-10-20
ER

PT J
AU Moreau, JL
   Kesselman, D
   Fisher, JP
AF Moreau, Jennifer L.
   Kesselman, Dafna
   Fisher, John P.
TI Synthesis and properties of cyclic acetal biomaterials
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomaterials; cyclic acetal; scaffolds; osteoprogenitor cells
ID POLYESTER POLY(PROPYLENE FUMARATE); PHOTOINITIATED CROSS-LINKING;
   IN-VITRO DEGRADATION; MECHANICAL-PROPERTIES; LACTIC ACID; BONE;
   POLYMERS; POLYCAPROLACTONE; COMPOSITE; SCAFFOLDS
AB There is an increasing need to develop new biomaterials as tissue engineering scaffolds. Unfortunately, many of the materials that have been studied for these purposes are polyesters that hydrolytically degrade into acidic products, which may harm the surrounding tissue, and lead to accelerated degradation of the biomaterial. To overcome this disadvantage, a novel class of biomaterials based on a cyclic acetal unit has been created. Specifically, materials based upon the monomer 5-ethyl-5-(hydroxymethyl)-beta, beta-dimethyl-1,3-dioxane-2-ethanol diacrylate (EHD) is examined. This study investigates the effects of fabrication parameters, including initiator content, volume of diluent, and volume of accelerant, on several properties of EHD networks. Twelve different formulations were fabricated by varying the three parameters in a factorial design. The effects of the fabrication parameters on properties of the EHD networks were examined. Results show that the volume of accelerant most affected the EHD network gelation time, while the volume of diluent most affected the maximum reaction temperature, sol fraction, and degree of swelling. Cell viability on the EHD networks varied between (18 +/- 6)% and (57 10)% of the control at 4 h, and between (36 +/- 14)% and (140 +/- 50)% of the control at 8 h. These results indicate that it is possible to control the properties of the EHD networks by varying the fabrication parameters, and that EHD networks support a viable cell population. (C) 2006 Wiley Periodicals, Inc. J Biomed Mater Res SIA: 594-602, 2007.
C1 Univ Maryland, Dept Chem & Biomol Engn, College Pk, MD 20742 USA.
   Univ Maryland, Dept Biol Resources Engn, College Pk, MD 20742 USA.
   Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
RP Fisher, JP (reprint author), Univ Maryland, Dept Chem & Biomol Engn, College Pk, MD 20742 USA.
EM jpfisher@umd.edu
RI Fisher, John/F-8078-2012
CR Bala I, 2004, CRIT REV THER DRUG, V21, P387, DOI 10.1615/CritRevTherDrugCarrierSyst.v21.i5.20
   Barralet JE, 2003, TISSUE ENG, V9, P1037, DOI 10.1089/107632703322495673
   COOK WD, 1983, J BIOMED MATER RES, V17, P275, DOI 10.1002/jbm.820170206
   Dai NT, 2004, BIOMATERIALS, V25, P4263, DOI 10.1016/j.biomaterials.2003.11.022
   Fisher JP, 2003, BIOMACROMOLECULES, V4, P1335, DOI 10.1021/bm0300296
   Fisher JP, 2003, BIOMACROMOLECULES, V4, P1327, DOI 10.1021/bm030028d
   Heino A, 1996, J BIOMED MATER RES, V30, P187, DOI 10.1002/(SICI)1097-4636(199602)30:2<187::AID-JBM8>3.0.CO;2-N
   Ishaug-Riley SL, 1999, BIOMATERIALS, V20, P2245, DOI 10.1016/S0142-9612(99)00155-6
   Lu L, 1999, J BIOMED MATER RES, V46, P236, DOI 10.1002/(SICI)1097-4636(199908)46:2<236::AID-JBM13>3.0.CO;2-F
   Papisov MI, 2005, BIOMACROMOLECULES, V6, P2659, DOI 10.1021/bm0502157
   Park YJ, 2002, BIOMATERIALS, V23, P873, DOI 10.1016/S0142-9612(01)00196-X
   Peter SJ, 1999, J BIOMED MATER RES, V44, P314
   Reyes JMG, 2005, INVEST OPHTH VIS SCI, V46, P1247, DOI 10.1167/iovs.04-1192
   Saulnier B, 2004, MACROMOL BIOSCI, V4, P232, DOI 10.1002/mabi.200300087
   SUGANUMA J, 1993, J APPL BIOMATER, V4, P13, DOI 10.1002/jab.770040103
   Suuronen R, 2000, J Craniomaxillofac Trauma, V6, P19
   SUURONEN R, 2000, J CRANIOMAXILLOFAC T, V6, P28
   TAYLOR MS, 1994, J APPL BIOMATER, V5, P151, DOI 10.1002/jab.770050208
   VANSLIEDREGT A, 1994, BIOMATERIALS, V15, P251, DOI 10.1016/0142-9612(94)90047-7
   Vert M, 1998, J CONTROL RELEASE, V53, P85, DOI 10.1016/S0168-3659(97)00240-X
   Wu LB, 2006, J BIOMED MATER RES A, V76A, P264, DOI 10.1002/jbm.a.30544
   Yang JM, 1996, J BIOMED MATER RES, V33, P83, DOI 10.1002/(SICI)1097-4636(199622)33:2<83::AID-JBM4>3.0.CO;2-H
NR 22
TC 22
Z9 23
U1 0
U2 9
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN 1
PY 2007
VL 81A
IS 3
BP 594
EP 602
DI 10.1002/jbm.a.31104
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 165AS
UT WOS:000246276800009
PM 17177269
DA 2018-10-20
ER

PT J
AU Ozturk, O
   Sudagidan, M
   Turkan, U
AF Ozturk, Orhan
   Sudagidan, Mert
   Turkan, Ugur
TI Biofilm formation by Staphylococcus epidermidis on nitrogen ion
   implanted CoCrMo alloy material
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE CoCrMo alloy; nitrogen ion implantation; biofilm formation; X-ray
   diffraction; atomic force microscopy
ID STAINLESS-STEEL; BACTERIAL ADHESION; SURFACES
AB Staphylococcus epidermidis is the primary cause of medical device-related infections due to its adhesion and biofilm forming abilities on biomaterial surfaces. For this reason development of new materials and surfaces to prevent bacterial adhesion is inevitable. In this study, the adhesion of biofilm forming S. epidermidis strain YT-169a on nitrogen (N) ion implanted as well as on as-polished CoCrMo alloy materials were investigated. A medical grade CoCrMo alloy was ion implanted with 60 keV N ions to a high dose of 1.9 x 10(18) ions/cm(2) at substrate temperatures of 200 and 400 degrees C. The near-surface implanted layer crystal structures, implanted layer thicknesses, and roughnesses were characterized by XRD, SEM and AFM. The number of adherent bacteria on the surfaces of N implanted specimens was found to be 191 x 10(6) CFU/cm(2) for the 200 degrees C and 70 x 10(6) CFU/cm(2) for the 400 degrees C specimens compared to the as-polished specimen (3 x 10(6) CFU/cm(2)). The adhesion test results showed that S. epidermidis strain YT-169a adhere much more efficiently to the N implanted surfaces than to the as-polished CoCrMo alloy surface. This was attributed mainly to the rougher surfaces associated with the N implanted specimens in comparison with the relatively smooth surface of the as-polished specimen. (C) 2006 Wiley Periodicals, Inc. J Biomed Mater Res 81A: 663-668, 2007.
C1 Izmir Inst Technol, Dept Phys, TR-35430 Izmir, Turkey.
   Izmir Inst Technol, Dept Biol, TR-35430 Izmir, Turkey.
   Izmir Inst Technol, Mat Sci & Engn Program, TR-35430 Izmir, Turkey.
RP Ozturk, O (reprint author), Izmir Inst Technol, Dept Phys, TR-35430 Izmir, Turkey.
EM orhinozturk@iyte.edu.tr
CR An YH, 1997, J MICROBIOL METH, V30, P141, DOI 10.1016/S0167-7012(97)00058-4
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Arciola CR, 2005, BIOMATERIALS, V26, P6530, DOI 10.1016/j.biomaterials.2005.04.031
   Cui FZ, 1999, SURF COAT TECH, V112, P278, DOI 10.1016/S0257-8972(98)00763-4
   Cullity B. D., 1978, ELEMENTS XRAY DIFFRA
   Flint SH, 2000, J FOOD ENG, V43, P235, DOI 10.1016/S0260-8774(99)00157-0
   Hashimoto H, 2001, J JAPANESE ASS INFEC, V75, P678
   Klueh U, 2000, J BIOMED MATER RES, V53, P621, DOI 10.1002/1097-4636(2000)53:6<621::AID-JBM2>3.0.CO;2-Q
   Mandl S, 2002, SURF COAT TECH, V156, P276, DOI 10.1016/S0257-8972(02)00085-3
   Ozturk O, 2006, SURF COAT TECH, V200, P5687, DOI 10.1016/j.surfcoat.2005.08.113
   OZTURK O, 1995, J APPL PHYS, V77, P3839, DOI 10.1063/1.358561
   RUPP ME, 1994, CLIN INFECT DIS, V19, P231, DOI 10.1093/clinids/19.2.231
   SMIDT FA, 1993, NUCL INSTRUM METH B, V80-1, P207, DOI 10.1016/0168-583X(93)96108-O
   VANHAECKE E, 1990, APPL ENVIRON MICROB, V56, P788
   WILBUR PJ, 1986, VACUUM, V36, P5, DOI 10.1016/0042-207X(86)90259-9
   Wirtanen G., 1995, T INT CHEM ENG, V73, P1
   ZOLTAI PT, 1981, J FOOD PROTECT, V44, P204, DOI 10.4315/0362-028X-44.3.204
NR 17
TC 9
Z9 9
U1 0
U2 9
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN 1
PY 2007
VL 81A
IS 3
BP 663
EP 668
DI 10.1002/jbm.a.31037
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 165AS
UT WOS:000246276800016
PM 17187392
DA 2018-10-20
ER

PT J
AU Bruns, S
   Stark, Y
   Wieland, M
   Stahl, F
   Kasper, C
   Scheper, T
AF Bruns, Stephanie
   Stark, Yvonne
   Wieland, Martin
   Stahl, Frank
   Kasper, Cornelia
   Scheper, Thomas
TI Fast and efficient screening system for new biomaterials in tissue
   engineering: a model for peripheral nerve regeneration
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomaterial; biocompatibility testing; screening; tissue engineering;
   peripheral nerve regeneration
ID ARTICULAR-CARTILAGE; SCIATIC-NERVE; GROWTH-FACTOR; IN-VITRO; SCAFFOLDS;
   COLLAGEN; CHAMBERS; GUIDANCE; REPAIR; GRAFT
AB The use of three-dimensional biodegradable matrices is one major issue in tissue engineering. Numerous materials, fabrication techniques, and modifications have been used and tested in different areas of tissue engineering recently. But nevertheless, technology is far from being optimized and optimal constructs with bioidentical and mechanical properties have not been described in the literature so far. Hence, there is great demand of new suitable biomaterials for tissue engineering applications. In this study, a fast and efficient screening system for initial testing of biomaterials for cell culture application was developed. The set up for the screening system and the decision criteria applied for the determination of suitability of new materials are presented. Hep-G2 and PC-12 cells were seeded onto different matrices and cultured over a period of 2 weeks. The viability of the cells was monitored via the MTT assay. Cell spreading was investigated by DAPI-staining of cell nuclei. Furthermore, the adhesion of the cells on the different matrices was examined by counting the number of attached cells. With these general assays a classification of materials is possible with regard to their suitability. Optimal cell models must be chosen for the defined applications and at least two cell lines are necessary for a differentiating interpretation. (C) 2007 Wiley Periodicals, Inc. J Biomed Mater Res 81A: 736-747, 2007.
C1 Leibniz Univ Hannover, Inst Tech Chem, D-30167 Hannover, Germany.
   Dr Suwelack Skin & Hlth Care AG, D-48727 Billerberk, Germany.
RP Scheper, T (reprint author), Leibniz Univ Hannover, Inst Tech Chem, Callinstr 3, D-30167 Hannover, Germany.
EM scheper@iftc.uni-hannover.de
RI Scheper, Thomas/H-8143-2013
CR ARCHIBALD SJ, 1995, J NEUROSCI, V15, P4109
   BEHRENS P, 2003, HOST GUEST SYSTEMS B, P7
   Belkas JS, 2005, BIOMATERIALS, V26, P1741, DOI 10.1016/j.biomaterials.2004.05.031
   BELLAMKONDA R, 1994, BIOTECHNOL BIOENG, V43, P543, DOI 10.1002/bit.260430703
   Bini TB, 2005, J MATER SCI-MATER M, V16, P367, DOI 10.1007/s10856-005-0637-6
   Buti M, 1996, EXP NEUROL, V137, P26, DOI 10.1006/exnr.1996.0003
   Cai J, 2005, J BIOMED MATER RES A, V75A, P374, DOI 10.1002/jbm.a.30432
   Chen YS, 2000, BIOMATERIALS, V21, P1541, DOI 10.1016/S0142-9612(00)00028-4
   DEMIZOT F, 1986, J IMMUNOL METHODS, V89, P271
   Gomez N, 1996, RESTOR NEUROL NEUROS, V10, P187, DOI 10.3233/RNN-1996-10401
   Grande DA, 1997, J BIOMED MATER RES, V34, P211, DOI 10.1002/(SICI)1097-4636(199702)34:2<211::AID-JBM10>3.0.CO;2-L
   GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424
   Grimpe B, 2002, PROG BRAIN RES, V137, P333
   Grothe C, 2001, ANAT EMBRYOL, V204, P171, DOI 10.1007/s004290100205
   Gugala Z, 2000, J BIOMED MATER RES, V49, P183, DOI 10.1002/(SICI)1097-4636(200002)49:2<183::AID-JBM5>3.0.CO;2-D
   Haastert K, 2006, NEUROBIOL DIS, V21, P138, DOI 10.1016/j.nbd.2005.06.020
   Harley BA, 2006, BIOMATERIALS, V27, P866, DOI 10.1016/j.biomaterials.2005.07.012
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Hutmacher DW, 2001, ANN ACAD MED SINGAP, V30, P183
   Itoh S, 2003, ARTIF ORGANS, V27, P1079, DOI 10.1111/j.1525-1594.2003.07208.x
   Itoh S, 2003, BRAIN RES, V993, P111, DOI 10.1016/j.brainres.2003.09.003
   Jansen K, 2004, J BIOMED MATER RES A, V69A, P334, DOI 10.1002/jbm.a.30004
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lin H, 2006, J BIOMED MATER RES A, V79A, P591, DOI 10.1002/jbm.a.30862
   LUNDBORG G, 1982, EXP NEUROL, V76, P361, DOI 10.1016/0014-4886(82)90215-1
   Lundborg G, 1997, J HAND SURG-BRIT EUR, V22B, P299, DOI 10.1016/S0266-7681(97)80390-7
   MACKINNON S E, 1990, Journal of Reconstructive Microsurgery, V6, P117, DOI 10.1055/s-2007-1006810
   Oberdoerster J, 1998, J PHARMACOL EXP THER, V287, P359
   ONKINSON JL, 2002, FRONT BIOSCI, V7, pC1
   Prang P, 2006, BIOMATERIALS, V27, P3560, DOI 10.1016/j.biomaterials.2006.01.053
   Riesle J, 1998, J CELL BIOCHEM, V71, P313, DOI 10.1002/(SICI)1097-4644(19981201)71:3<313::AID-JCB1>3.0.CO;2-C
   Rutishauser U, 1993, Curr Opin Neurobiol, V3, P709, DOI 10.1016/0959-4388(93)90142-L
   Saltzman WM, 2002, NAT REV DRUG DISCOV, V1, P177, DOI 10.1038/nrd744
   SALTZMAN WM, 1998, ADV DRUG DELIV REV, V33, P71
   Sanghvi A., 2004, ENCY BIOMATERIALS BI, P1613
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   SLATER TF, 1963, BIOCHIM BIOPHYS ACTA, V77, P383, DOI 10.1016/0006-3002(63)90513-4
   Stark Y, 2006, EXP TOXICOL PATHOL, V57, P305, DOI 10.1016/j.etp.2005.10,005
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Vats A, 2003, CLIN OTOLARYNGOL, V28, P165, DOI 10.1046/j.1365-2273.2003.00686.x
   Vlakh EG, 2005, J BIOMED MATER RES A, V75A, P333, DOI 10.1002/jbm.a.30428
   Wen XJ, 2006, J BIOMED MATER RES A, V76A, P626, DOI 10.1002/jbm.a.30520
   WHITWORTH IH, 1995, J HAND SURG-BRIT EUR, V20B, P429, DOI 10.1016/S0266-7681(05)80148-2
   Yoshii S, 2001, J HAND SURG-AM, V26A, P52, DOI 10.1053/jhsu.2001.20968
   Yoshikawa Hideki, 2005, J Artif Organs, V8, P131, DOI 10.1007/s10047-005-0292-1
   Yu XJ, 2003, TISSUE ENG, V9, P421, DOI 10.1089/107632703322066606
   Zhang N, 2005, J BIOMED MATER RES A, V75A, P941, DOI 10.1002/jbm.a.30495
NR 49
TC 12
Z9 16
U1 0
U2 5
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN 1
PY 2007
VL 81A
IS 3
BP 736
EP 747
DI 10.1002/jbm.a.31120
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 165AS
UT WOS:000246276800025
PM 17226811
DA 2018-10-20
ER

PT J
AU Nayak, SR
   McShane, MJ
AF Nayak, Suman R.
   McShane, Michael J.
TI Encapsulation of peroxidase by polymerizing acrylic acid monomers in
   "clean" polyelectrolyte microcapsules
SO JOURNAL OF BIOMEDICAL NANOTECHNOLOGY
LA English
DT Article
DE layer-by-layer self-assembly; enzyme encapsulation; free radical
   polymerization; polyelectrolyte microcapsules; horseradish peroxidase
ID CARBONATE MICROPARTICLES; HORSERADISH-PEROXIDASE; COLLOIDAL PARTICLES;
   MULTILAYER CAPSULES; FABRICATION; NANOCAPSULES; NANOSENSORS; ADSORPTION;
   TEMPLATES; STABILITY
AB Encapsulation of macromolecules in microscale carriers has numerous applications in biotechnology, medicine, and chemical processing. Stability of encapsulated biomaterial is a significant drawback especially for biosensor applications, which can be compensated by immobilization of a large quantity of biomaterial. A facile method for electrostatically-driven attraction and encapsulation of large quantities of macromolecules via in situ polymerization of charged monomers in polyelectrolyte microcapsules is described. The technique is based on fabrication of hollow microcapsules using the versatile Layer-by-Layer self assembly method, followed by loading and polymerization of acrylic acid monomeric units within the capsule cavity. Anionic acrylic acid monomers were polymerized by free-radical polymerization to form an anionic interior, and cationic horseradish peroxidase (HRP) was spontaneously loaded from the exterior solution. Using confocal microscopy, the loading was studied using fluorescent-labeled enzyme, from which it was observed that the protein was rapidly attracted through the capsule walls and stably entrapped in the interior. With an increase in the quantities of monomers and initiator, the quantity of HRP encapsulated and corresponding catalytic activity also increased. This methodology can be applied towards efficient and stable encapsulation of other charged macromolecules within hollow templates by selection of appropriate charged monomers with reactive groups that provide a stable environment to support the native function of the encapsulated species.
C1 Louisiana Tech Univ, Inst Micromfg, Ruston, LA 71272 USA.
   Louisiana Tech Univ, Biomed Engn Program, Ruston, LA 71272 USA.
   Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77843 USA.
RP McShane, MJ (reprint author), Louisiana Tech Univ, Inst Micromfg, Ruston, LA 71272 USA.
RI McShane, Mike/D-3489-2009
OI McShane, Mike/0000-0001-6838-3982
CR Antipov AA, 2003, COLLOID SURFACE A, V224, P175, DOI 10.1016/S0927-7757(03)00195-X
   Balabushevitch NG, 2001, BIOTECHNOL BIOENG, V76, P207, DOI 10.1002/bit.1184
   Blandino A, 2000, ENZYME MICROB TECH, V27, P319, DOI 10.1016/S0141-0229(00)00204-0
   BULUKIN E, 2004, IAEAC 6 WORKSH BIOS
   Caruso F, 1998, SCIENCE, V282, P1111, DOI 10.1126/science.282.5391.1111
   Caruso F, 2000, LANGMUIR, V16, P1485, DOI 10.1021/la991161n
   Clark HA, 1999, ANAL CHEM, V71, P4831, DOI 10.1021/ac990629o
   Dahne L, 2001, J AM CHEM SOC, V123, P5431, DOI 10.1021/ja002911e
   DECHER G, 1992, THIN SOLID FILMS, V210, P831, DOI 10.1016/0040-6090(92)90417-A
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   ERDEM A, 2000, J MED SCI, V30, P349
   Gao CY, 2002, CHEM COMMUN, P1928, DOI 10.1039/b204583d
   GEMEINER P, 1992, ENZYME ENG IMMOBILIZ
   Gittins DI, 2000, ADV MATER, V12, P1947, DOI 10.1002/1521-4095(200012)12:24<1947::AID-ADMA1947>3.0.CO;2-8
   Hernandez-Ruiz J, 2001, BIOCHEM J, V354, P107, DOI 10.1042/0264-6021:3540107
   Leporatti S, 2000, LANGMUIR, V16, P4059, DOI 10.1021/la991429a
   Livage J, 2001, J PHYS-CONDENS MAT, V13, pR673, DOI 10.1088/0953-8984/13/33/202
   McNamara KP, 1998, ANAL CHEM, V70, P4853, DOI 10.1021/ac9803232
   MOHWALD H, 2001, MACROMOL RAPID COMMN, V22, P44
   Moya S, 2000, MACROMOLECULES, V33, P4538, DOI 10.1021/ma9914974
   Moya S., 2001, COLLOID SURF A, V27, P183
   OLSEN LF, 2003, EUR J BIOCHEM, V270, P27964
   Premachandran RS, 1996, MACROMOLECULES, V29, P6452, DOI 10.1021/ma960468f
   Radtchenko IL, 2000, J COLLOID INTERF SCI, V230, P272, DOI 10.1006/jcis.2000.7068
   RENNEBERG R, 2003, BIOSENS BIOELECTRONS, V18, P1491
   Shchukin DG, 2004, J AM CHEM SOC, V126, P3374, DOI 10.1021/ja036952x
   Singh A, 2000, BIOMACROMOLECULES, V1, P592, DOI 10.1021/bm005537j
   Sukhorukov G, 2000, ADV MATER, V12, P112, DOI 10.1002/(SICI)1521-4095(200001)12:2<112::AID-ADMA112>3.3.CO;2-G
   Sukhorukov GB, 2001, MACROMOL RAPID COMM, V22, P44, DOI 10.1002/1521-3927(20010101)22:1<44::AID-MARC44>3.0.CO;2-U
   Sukhorukov GB, 1998, POLYM ADVAN TECHNOL, V9, P759, DOI 10.1002/(SICI)1099-1581(1998100)9:10/11<759::AID-PAT846>3.0.CO;2-Q
   SVENSSON HP, 1992, BIOCONJUGATE CHEM, V3, P176, DOI 10.1021/bc00014a013
   Taylor R., 1991, PROTEIN IMMOBILIZATI
   ZHU H, 2004, UNPUB CHEM MAT
   Zhu HG, 2005, CHEM MATER, V17, P2323, DOI 10.1021/cm048229r
NR 34
TC 10
Z9 10
U1 1
U2 11
PU AMER SCIENTIFIC PUBLISHERS
PI STEVENSON RANCH
PA 25650 NORTH LEWIS WAY, STEVENSON RANCH, CA 91381-1439 USA
SN 1550-7033
J9 J BIOMED NANOTECHNOL
JI J. Biomed. Nanotechnol.
PD JUN
PY 2007
VL 3
IS 2
BP 170
EP 177
DI 10.1166/jbn.2007.014
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Biomaterials
SC Science & Technology - Other Topics; Materials Science
GA 180YQ
UT WOS:000247404300008
DA 2018-10-20
ER

PT J
AU Peng, HT
   Martineau, L
   Shek, PN
AF Peng, Henry T.
   Martineau, Lucie
   Shek, Pang N.
TI Hydrogel-elastomer composite biomaterials: 1. Preparation of
   interpenetrating polymer networks and in vitro characterization of
   swelling stability and mechanical properties
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID BIOMEDICAL APPLICATIONS; SEGMENTED POLYURETHANE; GELATIN; RELEASE;
   TISSUE; DEGRADATION; VIVO; BIODEGRADATION; BIOSTABILITY; TEMPERATURE
AB We prepared interpenetrating polymer networks (IPNs) composed of a gelatin hydrogel and a HydroThane(TM) elastomer to combine the advantages of both polymers into one biomaterial. Fourier transform Infrared (FTIR) spectroscopy and Differential Scanning Calorimetry (DSC) confirmed the co-existence of the two polymers in the IPNs. Optical light microscopy confirmed hydrogel domains were interspaced into an elastomer network. Hydration and stability studies in aqueous solution showed that, although the IPN biomaterials exhibited stable swelling for more than 30 days, approximately 10% and 50% loss of the hydrogel component were confirmed at room temperature and 37 degrees C, respectively, using gel permeation chromatography (GPC). The swelling study in the serum-containing medium indicated the biomaterials maintained their swelling stability for different periods, depending on the extent of gelatin methacrylation, photoinitiator concentration and incubation temperature. Lastly, the biomaterials exhibited higher failure stress and lower failure strain in a dry state than in a swollen state, and showed limited changes in both stress and strain at room temperature and at 37 degrees C, in contrast with a decrease at 50 degrees C. No significant effects of gelatin methacrylation on mechanical properties were noticed. The preparation and characterization methods were well established and formed the basis of further developing the biomaterials.
C1 Def Res & Dev Canada Toronto, Toronto, ON M3M 3B9, Canada.
RP Peng, HT (reprint author), Def Res & Dev Canada Toronto, 1133 Sheppard Ave W,POB 2000, Toronto, ON M3M 3B9, Canada.
EM henry.peng@drdc-rddc.gc.ca
OI Peng, Henry/0000-0001-5276-9573
CR Abbasi F, 2001, POLYM INT, V50, P1279, DOI 10.1002/pi.783
   Anderson JM, 1998, POLYM INT, V46, P163, DOI 10.1002/(SICI)1097-0126(199807)46:3<163::AID-PI972>3.0.CO;2-9
   Bajpai AK, 2003, J MATER SCI-MATER M, V14, P347, DOI 10.1023/A:1022983932548
   Bigi A, 2002, BIOMATERIALS, V23, P4827, DOI 10.1016/S0142-9612(02)00235-1
   Changez M, 2004, BIOMATERIALS, V25, P139, DOI 10.1016/S0142-9612(03)00466-6
   CLARK RC, 1977, SCI TECHNOLOGY GELAT, P213
   Djagny KB, 2001, CRIT REV FOOD SCI, V41, P481, DOI 10.1080/20014091091904
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Dupont AL, 2002, J CHROMATOGR A, V950, P113, DOI 10.1016/S0021-9673(02)00010-9
   Einerson NJ, 2003, BIOMATERIALS, V24, P509, DOI 10.1016/S0142-9612(02)00369-1
   Frisch HL, 1996, PROG ORG COAT, V27, P67, DOI 10.1016/0300-9440(95)00521-8
   Griffith LG, 2002, ANN NY ACAD SCI, V961, P83, DOI 10.1111/j.1749-6632.2002.tb03056.x
   Guignot C, 2002, J APPL POLYM SCI, V85, P1970, DOI 10.1002/app.10760
   GUPTA N, 1994, POLYM INT, V35, P109, DOI 10.1002/pi.1994.210350201
   Gursel I, 1998, BIOMATERIALS, V19, P1137, DOI 10.1016/S0142-9612(98)00009-X
   HAN X, 1997, IPNS WORLD, P241
   Hasirci V, 2001, J BIOTECHNOL, V86, P135, DOI 10.1016/S0168-1656(00)00409-0
   Hu ZB, 2000, ASAIO J, V46, P431, DOI 10.1097/00002480-200007000-00012
   KIM H, 1988, KC FRISCH S U DETR 1, P29
   Lee DI, 2004, J UROLOGY, V171, P575, DOI 10.1097/01.ju.0000103501.98597.b7
   Lee SB, 2003, BIOMATERIALS, V24, P2503, DOI 10.1016/S0142-9612(03)00003-6
   Liu L, 2005, BIOMATERIALS, V26, P233, DOI 10.1016/j.biomaterials.2004.02.025
   Martens PJ, 2003, BIOMACROMOLECULES, V4, P283, DOI 10.1021/bm025666v
   MARTINEAU L, 2005201 TR DRDC
   Miller RG, 1998, J BIOMED MATER RES, V41, P237, DOI 10.1002/(SICI)1097-4636(199808)41:2<237::AID-JBM8>3.0.CO;2-J
   Miyawaki O, 2003, BIOPOLYMERS, V70, P482, DOI 10.1002/bip.10473
   Morimoto N, 2002, BIOMATERIALS, V23, P4881, DOI 10.1016/S0142-9612(02)00246-6
   Nho YC, 2002, J APPL POLYM SCI, V85, P1787, DOI 10.1002/app.10812
   PENG H, 2004, P 2 WORLD UN WOUND H, P185
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   REICH MH, 2001, Patent No. 6177523
   Renier ML, 1997, J BIOMED MATER RES, V34, P95, DOI 10.1002/(SICI)1097-4636(199701)34:1<95::AID-JBM13>3.0.CO;2-O
   Santin M, 1996, BIOMATERIALS, V17, P1459, DOI 10.1016/0142-9612(96)89769-9
   Santin M, 2003, J Appl Biomater Biomech, V1, P67
   SCHACHT E, 2002, Patent No. 6458386
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Seifalian AM, 2003, BIOMATERIALS, V24, P2549, DOI 10.1016/S0142-9612(02)00608-7
   Tabata Y, 1998, ADV DRUG DELIVER REV, V31, P287, DOI 10.1016/S0169-409X(97)00125-7
   Teoh SH, 1999, J MATER SCI-MATER M, V10, P343, DOI 10.1023/A:1026421606939
   van den Bosch E, 2003, INT J BIOL MACROMOL, V32, P129, DOI 10.1016/S0141-8130(03)00046-1
   Wang NG, 2004, J APPL POLYM SCI, V91, P332, DOI 10.1002/app.13293
   Zdrahala RJ, 1999, J BIOMATER APPL, V14, P67, DOI 10.1177/088532829901400104
NR 42
TC 28
Z9 28
U1 0
U2 25
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 2007
VL 18
IS 6
BP 975
EP 986
DI 10.1007/s10856-006-0088-8
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 169UZ
UT WOS:000246618900002
PM 17243001
DA 2018-10-20
ER

PT J
AU Tanaka, K
   Mutter, D
   Inoue, H
   Lindner, V
   Bouras, G
   Forgione, A
   Leroy, J
   Aprahamian, M
   Marescaux, J
AF Tanaka, Keitaro
   Mutter, Didier
   Inoue, Harutaka
   Lindner, Veronique
   Bouras, George
   Forgione, Antonello
   Leroy, Joel
   Aprahamian, Marc
   Marescaux, Jacques
TI In vivo evaluation of a new composite mesh (10% polypropylene/90%
   poly-L-lactic acid) for hernia repair
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID ABDOMINAL-WALL HERNIAS; CHRONIC PAIN; TERM; LICHTENSTEIN; REGENERATION;
   SHOULDICE; QUESTIONNAIRE; IMPLANTATION; MACROPHAGE; CELLS
AB The increasing use of mesh insertion for groin hernia repair is dashed by a worrying prevalence of chronic pain frequently related as a reaction to the biomaterial implantation. Thus, new biocompatible prosthesis, designed as a composite material associating polypropylene (PP) and long-term absorbable material, are now under development. In the present study, the typical commercially available Prolene(R) mesh has been compared to two new meshes designed with 3-fold less PP, either alone (light PP) or associated with poly-L-lactic acid (PP-PLA) accounting for 90% of the mesh weight. These PP-mesh variants were implanted in an extraperitoneal position within the abdominal wall of 90 rats. Mesh adhesion and size were determined at autopsy 2, 4 and 8 weeks after implantation (10 animals per group) and morphometric parameters of the host tissues by light microscopy. Prolene(R) and light PP-meshes presented intra-corporeal shrinkage and tissue adhesion, both more pronounced with light-PP, whilst PP-PLA meshes were not affected in spite of a strongest fibrosis. In contrast to Prolene(R) and even more with light PP meshes, inflammation and cell-mediated immune responses were reduced without occurrence of angiogenesis or oedema. All these findings advocate together for a better tolerance of this new composite biomaterial, more likely due to a low macrophage response that appeared statistically correlated to the absence of mesh shrinkage and to a decreased adhesion to the tissue. On the basis of these experimental observations, it could be expected that the better tolerance of this composite biomaterial may avoid both long-term pain and recurrence when used as plug in groin hernia repair.
C1 Univ Strasbourg, IRCAD EITS, F-67091 Strasbourg, France.
   Hop Civil, Inst Pathol, F-67000 Strasbourg, France.
RP Marescaux, J (reprint author), Univ Strasbourg, IRCAD EITS, 1 Pl Hop, F-67091 Strasbourg, France.
EM Jacques.marescaux@ircad.u-strasbg.fr
CR Amid PK, 1997, HERNIA, V1, P15, DOI DOI 10.1007/BF02426382
   ARNAUD JP, 1977, AM J SURG, V133, P338, DOI 10.1016/0002-9610(77)90542-6
   Bay-Nielsen M, 2001, ANN SURG, V233, P1, DOI 10.1097/00000658-200101000-00001
   BELLON JM, 1995, BIOMATERIALS, V16, P381, DOI 10.1016/0142-9612(95)98855-8
   Bringman Sven, 2004, Hernia, V8, P127
   Courtney CA, 2002, BRIT J SURG, V89, P1310, DOI 10.1046/j.1365-2168.2002.02206.x
   DABROWIECKI S, 1991, EUR SURG RES, V23, P240, DOI 10.1159/000129159
   Evans GRD, 2002, BIOMATERIALS, V23, P841, DOI 10.1016/S0142-9612(01)00190-9
   FASHID T, 2000, ANN R COLL SURG ENGL, V82, P396
   Fuchs JR, 2003, J PEDIATR SURG, V38, P1348, DOI 10.1016/S0022-3468(03)00394-4
   Furukawa KS, 2002, CELL TRANSPLANT, V11, P475
   Goldstein H., 1999, HERNIA, V3, P23
   HAY JM, 1995, ANN SURG, V222, P719, DOI 10.1097/00000658-199512000-00005
   Holzheimer RG, 2004, EUR J MED RES, V9, P323
   Junge K, 2002, WORLD J SURG, V26, P1472, DOI 10.1007/s00268-002-6444-z
   Kellomaki M, 2000, BIOMATERIALS, V21, P2495, DOI 10.1016/S0142-9612(00)00117-4
   Klinge U, 1999, EUR J SURG, V165, P665
   Klinge U, 1998, EUR J SURG, V164, P965
   Klinge U, 2001, BIOMATERIALS, V22, P1415, DOI 10.1016/S0142-9612(00)00299-4
   Klosterhalfen B, 2002, BRIT J SURG, V89, P1043, DOI 10.1046/j.1365-2168.2002.02149.x
   Klosterhalfen B, 1998, BIOMATERIALS, V19, P2235, DOI 10.1016/S0142-9612(98)00115-X
   Klosterhalfen B, 2000, CHIRURG, V71, P43
   Koninger J, 2004, LANGENBECK ARCH SURG, V389, P361, DOI 10.1007/s00423-004-0496-5
   LAMB JP, 1983, SURGERY, V93, P643
   LEIBOVICH SJ, 1975, AM J PATHOL, V78, P71
   LICHTENSTEIN IL, 1989, AM J SURG, V157, P188, DOI 10.1016/0002-9610(89)90526-6
   Lowham AS, 1997, ANN SURG, V225, P422, DOI 10.1097/00000658-199704000-00012
   Mayagoitia J C, 2004, Hernia, V8, P64, DOI 10.1007/s10029-003-0180-7
   McGillicuddy JE, 1998, ARCH SURG-CHICAGO, V133, P974, DOI 10.1001/archsurg.133.9.974
   PELISSIER EP, 1999, HERNIA, V4, P201
   Read Raymond C, 2004, Hernia, V8, P8, DOI 10.1007/s10029-003-0169-2
   Rives J, 1967, Int Surg, V47, P360
   Rosch R, 2003, EUR SURG RES, V35, P445, DOI 10.1159/000072230
   STOPPA R, 1975, INT SURG, V60, P411
   TYRELL J, 1989, SURG GYNECOL OBSTET, V168, P227
   USHER F C, 1958, Am Surg, V24, P969
NR 36
TC 11
Z9 11
U1 1
U2 6
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 2007
VL 18
IS 6
BP 991
EP 999
DI 10.1007/s10856-006-0090-1
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 169UZ
UT WOS:000246618900004
PM 17243000
DA 2018-10-20
ER

PT J
AU Kurotobi, K
   Yamamoto, A
   Kikuta, A
   Hanawa, T
AF Kurotobi, Kimi
   Yamamoto, Akiko
   Kikuta, Akemi
   Hanawa, Takao
TI Short term evaluation of material blood compatibility using a
   microchannel array
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID SHORT-TIME EXPOSURE; PROTEIN ADSORPTION; IN-VITRO; PLATELET-ADHESION;
   WHOLE-BLOOD; BIOMATERIAL SURFACES; FLOW CONDITIONS; HEART-VALVES;
   TITANIUM; HEMOCOMPATIBILITY
AB New short-term evaluation of material blood compatibility was attempted using a microchannel array with human blood under a flow condition. The microchannel array chips were made of silicon, having 8,736 microchannels of 10 mu m-wide, 30 mu m-long, and 4.5 mu m-deep on the average, as the models of capillary blood vessels. Titanium, chromium, albumin and collagen were coated onto the chips to examine the difference of material blood compatibility and the effect of protein adsorption on it. The time for the first 100 mu l portion of whole blood to pass through the channels (blood pass-through time, BPT) was measured under a pressure difference of 20 cmH(2)O. Simultaneously, the flow behavior of blood cells was observed by an optical microscope. The BPT tends to correlate well with the level of platelet adhesion. The highest BPT as well as platelet adhesion was observed on collagen, followed by titanium, chromium, silicon, and albumin. These results indicate that the BPT can detect the different levels of platelet adhesion and thrombus formation on microchannel surface and that the protein adsorption onto chip surface can influence BPT. We concluded that this method could be applied to evaluate initial blood compatibility of materials within several minutes in vitro.
C1 NIMS, Ctr Biomat, Tsukuba, Ibaraki 3050044, Japan.
RP Yamamoto, A (reprint author), NIMS, Ctr Biomat, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.
EM yamamoto.akiko@nims.go.jp
CR FUJIMAKI M, 1998, KANAIS MANUAL CLIN L, P369
   GROOT PG, 1999, METHOD MOL BIOL, V96, P159
   HANAWA T, 1991, SHIKAZAIRYO KIKA S17, V10, P201
   Hanson S., 2004, BIOMATERIALS SCI INT, P332
   Hansson KM, 2005, BIOMATERIALS, V26, P861, DOI 10.1016/j.biomaterials.2004.03.036
   Hong J, 1999, THROMB HAEMOSTASIS, V82, P58
   HONG J, 2005, BIOMATERIALS, V26, P1307
   ISHIHARA K, 1994, J BIOMED MATER RES, V28, P1347, DOI 10.1002/jbm.820281113
   Jones MI, 2000, J BIOMED MATER RES, V52, P413, DOI 10.1002/1097-4636(200011)52:2<413::AID-JBM23>3.0.CO;2-U
   KAGAKUKAI N, 1984, KAGAKU BINRAN, P96
   KAMATH KR, 1994, COLLOID SURFACE B, V2, P471
   Kanagaraja S, 1996, BIOMATERIALS, V17, P2225, DOI 10.1016/0142-9612(95)00311-8
   KIKUCHI Y, 1994, MICROVASC RES, V47, P126, DOI 10.1006/mvre.1994.1008
   Klinger A, 1997, J BIOMED MATER RES, V36, P387, DOI 10.1002/(SICI)1097-4636(19970905)36:3<387::AID-JBM13>3.0.CO;2-B
   KREIS T, 1999, GUIDEBOOK EXTRACELLU, P498
   LAMBRECHT LK, 1986, THROMB RES, V41, P99, DOI 10.1016/0049-3848(86)90283-5
   Nan H., 1998, BIOMATERIALS, V19, P771
   Otto M, 2004, J MATER SCI-MATER M, V15, P35, DOI 10.1023/B:JMSM.0000010095.19693.67
   Otto M, 2003, J MATER SCI-MATER M, V14, P263, DOI 10.1023/A:1022840909038
   Otto M, 1997, J MATER SCI-MATER M, V8, P119, DOI 10.1023/A:1018515001850
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Schaub RD, 2000, J BIOMED MATER RES, V49, P460, DOI 10.1002/(SICI)1097-4636(20000315)49:4<460::AID-JBM4>3.0.CO;2-3
   SEFTON MV, 2004, BIOMATERIALS SCI INT, P456
   Streller U, 2003, J BIOMED MATER RES B, V66B, P379, DOI 10.1002/jbm.b.10016
   SUNDGREN JE, 1986, J COLLOID INTERF SCI, V113, P530, DOI 10.1016/S0021-9797(86)90446-7
   Sunny M C, 1991, J Biomater Appl, V6, P89, DOI 10.1177/088532829100600107
   WALIVAARA B, 1994, BIOMATERIALS, V15, P827, DOI 10.1016/0142-9612(94)90038-8
   Wang XH, 2000, SURF COAT TECH, V128, P36, DOI 10.1016/S0257-8972(00)00659-9
   Weisenberg BA, 2002, J BIOMED MATER RES, V60, P283, DOI 10.1002/jbm.10076
   WOJCIECHOWSKI PW, 1993, COLLOID SURFACE B, V1, P107, DOI 10.1016/0927-7765(93)80041-V
   Yahyapour N, 2004, BIOMATERIALS, V25, P3171, DOI 10.1016/j.biomaterials.2003.10.011
   Yang YQ, 1996, J HEART VALVE DIS, V5, P532
   Zhang F, 1998, J BIOMED MATER RES, V42, P128, DOI 10.1002/(SICI)1097-4636(199810)42:1<128::AID-JBM16>3.0.CO;2-H
NR 33
TC 3
Z9 5
U1 0
U2 7
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 2007
VL 18
IS 6
BP 1175
EP 1184
DI 10.1007/s10856-007-0120-7
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 169UZ
UT WOS:000246618900027
PM 17277985
DA 2018-10-20
ER

PT J
AU Efimov, AE
   Tonevitsky, AG
   Dittrich, M
   Matsko, NB
AF Efimov, Anton E.
   Tonevitsky, Alexander G.
   Dittrich, Maria
   Matsko, Nadezda B.
TI Atomic force microscope (AFM) combined with the ultramicrotome: a novel
   device for the serial section tomography and AFM/TEM complementary
   structural analysis of biological and polymer samples
SO JOURNAL OF MICROSCOPY-OXFORD
LA English
DT Article
DE AFM; cells; microtomy; polymers; TEM; 3D serial section tomography
ID ELECTRON-MICROSCOPY; EPOXY-RESIN; CELL; SUBSTITUTION; BILAYERS; TISSUE
AB A new device (NTEGRA Tomo) that is based on the integration of the scanning probe microscope (SPM) (NT-MDT NTEGRA SPM) and the Ultramicrotome (Leica UC6NT) is presented. This integration enables the direct monitoring of a block face surface immediately following each sectioning cycle of ultramicrotome sectioning procedure. Consequently, this device can be applied for a serial section tomography of the wide range of biological and polymer materials. The automation of the sectioning/scanning cycle allows one to acquire up to 10 consecutive sectioned layer images per hour. It also permits to build a 3-D nanotomography image reconstructed from several tens of layer images within one measurement session. The thickness of the layers can be varied from 20 to 2000 nm, and can be controlled directly by its interference colour in water.
   Additionally, the NTEGRA Tomo with its nanometer resolution is a valid instrument narrowing and highlighting an area of special interest within volume of the sample. For embedded biological objects the ultimate resolution of SPM mostly depends on the quality of macromolecular preservation of the biomaterial during sample preparation procedure. For most polymer materials it is comparable to transmission electron microscopy (TEM).
   The NTEGRA Tomo can routinely collect complementary AFM and TEM images. The block face of biological or polymer sample is investigated by AFM, whereas the last ultrathin section is analyzed with TEM after a staining procedure. Using the combination of both of these ultrastructural methods for the analysis of the same particular organelle or polymer constituent leads to a breakthrough in AFM/TEM image interpretation. Finally, new complementary aspects of the object's ultrastructure can be revealed.
C1 Sci Res Inst Transplantol & Artificial Organ, Moscow, Russia.
   EAWAG, Swiss Fed Inst Aquat Sci & Technol, Kastanienbaum, Switzerland.
   ETH, EMEZ, Electron Microscopy Ctr Zurich, CH-8006 Zurich, Switzerland.
RP Matsko, NB (reprint author), ZVE, FELMI, Forsch Inst Elektronenmikroskopie & Feinstrukfors, Steyrergasse 17, A-8010 Graz, Austria.
EM nadejda.matsko@felmi-zfe.at
RI Dittrich, Maria/H-3203-2014; Efimov, Anton/A-9229-2012
OI Dittrich, Maria/0000-0002-8112-2661; Efimov, Anton/0000-0002-0769-301X
CR Biel SS, 2003, J MICROSC-OXFORD, V212, P91, DOI 10.1046/j.1365-2818.2003.01227.x
   Chen Y, 2005, ULTRAMICROSCOPY, V103, P173, DOI 10.1016/j.ultramic.2004.11.019
   Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329
   Dittrich M, 2005, J COLLOID INTERF SCI, V286, P487, DOI 10.1016/j.jcis.2005.01.029
   HAYAT M, 2000, PRINCIPLES TECHNIQUE
   Heymann JAW, 2006, J STRUCT BIOL, V155, P63, DOI 10.1016/j.jsb.2006.03.006
   HOHENBERG H, 1994, J MICROSC-OXFORD, V175, P34, DOI 10.1111/j.1365-2818.1994.tb04785.x
   Holzer L, 2004, J MICROSC-OXFORD, V216, P84, DOI 10.1111/j.0022-2720.2004.01397.x
   KAESTNER A, 2003, GEOPH RES ABSTR, V5, P11095
   Koguchi M, 2001, J ELECTRON MICROSC, V50, P235, DOI 10.1093/jmicro/50.3.235
   Matsko N, 2004, J STRUCT BIOL, V146, P334, DOI 10.1016/j.jsb.2004.01.010
   Matsko N, 2005, J STRUCT BIOL, V152, P92, DOI 10.1016/j.jsb.2005.07.005
   Matsko NB, 2007, ULTRAMICROSCOPY, V107, P95, DOI 10.1016/j.ultramic.2006.05.009
   Midgley PA, 2003, ULTRAMICROSCOPY, V96, P413, DOI 10.1016/S0304-3991(03)00105-0
   Miller MK, 2000, ATOM PROBE TOMOGRAPH
   MOU JX, 1995, J MOL BIOL, V248, P507, DOI 10.1006/jmbi.1995.0238
   Obst M, 2006, GEOCHEM GEOPHY GEOSY, V7, P1
   Reimer L, 1993, IMAGE FORMATION LOW
   Reviakine I, 1998, J STRUCT BIOL, V121, P356, DOI 10.1006/jsbi.1998.4003
   REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208
   ROESSLER F, 1991, LARYNGOSCOPE, V101, P473
   SAWYER LC, 1996, POLYM MICROSCOPY
   SCHEURING S, 1999, Z EMBO J, V18, P4981
   Schmitt L, 2000, BIOPHYS J, V78, P3275, DOI 10.1016/S0006-3495(00)76863-9
   SCHWARZ H, 1994, ELECT MICROSCOPY 199, V3, P233
   Sutton S.R., 2003, GEOPH RES ABSTR, V5, P13260
   VANHARREVELD A, 1964, ANAT REC, V149, P381, DOI 10.1002/ar.1091490307
   Walters DA, 1996, REV SCI INSTRUM, V67, P3583, DOI 10.1063/1.1147177
   Walz T, 1996, J MOL BIOL, V264, P907, DOI 10.1006/jmbi.1996.0686
NR 29
TC 43
Z9 46
U1 0
U2 41
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0022-2720
J9 J MICROSC-OXFORD
JI J. Microsc.-Oxf.
PD JUN
PY 2007
VL 226
IS 3
BP 207
EP 217
DI 10.1111/j.1365-2818.2007.01773.x
PG 11
WC Microscopy
SC Microscopy
GA 171UZ
UT WOS:000246762200003
PM 17535260
OA Bronze
DA 2018-10-20
ER

PT J
AU Duan, D
   Zheng, QX
   Hao, J
   Guo, XD
AF Duan Deyu
   Zheng Qixin
   Hao Jie
   Guo Xiaodong
TI Biocompatibility of tri-block bone-matrix material in vitro
SO JOURNAL OF WUHAN UNIVERSITY OF TECHNOLOGY-MATERIALS SCIENCE EDITION
LA English
DT Article
DE tissue engineering; biomaterial; polylactic acid(PLA); biocompatibility
AB To evaluate the biocompatibility of poly(lactic acid/glycolic acid/ asparagic acid-co-polyethylene glycol)(PLGA-[ASP-PEG]) tri-block copolymer in vitro, L929 fibroblast was co-cultured with the copolymer for cytotoxicity, hemolysis and pyrogen tests. And, compared with PLGA, the adhesiveness rate of the copolymer was calculated. The experimental results show that the toxicity gradation of the material was 0-1; L929 fibroblasts had a good cell morphology and proliferated rapidly on the surface of the material; hemolysis ratio was 3.08%; there was no pyrogen reaction. The adhesiveness of PLGA-[ASP-PEG] was better than that of the PLGA's(P < 0.05). The results confirm that the PLGA-[ASP-PEG] has a good biocompatibility.
C1 Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Orthoped, Wuhan 430022, Peoples R China.
RP Duan, D (reprint author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Orthoped, Wuhan 430022, Peoples R China.
EM duandeyu@21cn.com
RI guo, xiaodong/K-2600-2013
CR [Anonymous], 1992, 10993 ISO
   Fialkov JA, 2003, J CRANIOFAC SURG, V14, P324, DOI 10.1097/00001665-200305000-00010
   Karp JM, 2003, J BIOMED MATER RES A, V64A, P388, DOI 10.1002/jbm.a.10420
   Lieb E, 2003, TISSUE ENG, V9, P71, DOI 10.1089/107632703762687555
   [罗丙红 Luo Binghong], 2005, [功能高分子学报, Journal of Functional Polymer], V18, P295
   Mallol C, 2003, J ALGEBRA, V261, P1, DOI 10.1016/S0021-8693(02)00681-6
   Saito N, 2003, BIOMATERIALS, V24, P2287, DOI 10.1016/S0142-9612(03)00040-1
NR 7
TC 2
Z9 2
U1 0
U2 3
PU JOURNAL WUHAN UNIV TECHNOLOGY
PI WUHAN
PA WUHAN UNIV TECHNOLOGY, WUHAN 430070, PEOPLES R CHINA
SN 1000-2413
J9 J WUHAN UNIV TECHNOL
JI J. Wuhan Univ. Technol.-Mat. Sci. Edit.
PD JUN
PY 2007
VL 22
IS 2
BP 284
EP 287
DI 10.1007/s11595-005-2384-7
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA 182II
UT WOS:000247497900025
DA 2018-10-20
ER

PT J
AU Albrecht, DR
   Underhill, GH
   Mendelson, A
   Bhatia, SN
AF Albrecht, Dirk R.
   Underhill, Gregory H.
   Mendelson, Avital
   Bhatia, Sangeeta N.
TI Multiphase electropatterning of cells and biomaterials
SO LAB ON A CHIP
LA English
DT Article
ID LIVING CELLS; HYDROGELS; ALGINATE; DIELECTROPHORESIS; DIFFERENTIATION;
   MICROCAPSULES; MANIPULATION; HEPATOCYTES; CULTURE; LINES
AB Tissues formed by cells encapsulated in hydrogels have uses in biotechnology, cell-based assays, and tissue engineering. We have previously presented a 3D micropatterning technique that rapidly localizes live cells within hydrogels using dielectrophoretic (DEP) forces, and have demonstrated the ability to modulate tissue function through the control of microscale cell architecture. A limitation of this method is the requirement that a single biomaterial must simultaneously harbor biological properties that support cell survival and function and material properties that permit efficient dielectrophoretic patterning. Here, we resolve this issue by forming multiphase tissues consisting of microscale tissue sub-units in a 'local phase' biomaterial, which, in turn, are organized by DEP forces in a separate, mechanically supportive 'bulk phase' material. We first define the effects of medium conductivity on the speed and quality of DEP cell patterning. As a case study, we then produce multiphase tissues with microscale architecture that combine high local hydrogel conductivity for enhanced survival of sensitive liver progenitor cells with low bulk conductivity required for efficient DEP micropatterning. This approach enables an expanded range of studies examining the influence of 3D cellular architecture on diverse cell types, and in the future may improve the biological function of inhomogeneous tissues assembled from a variety of modular tissue sub-units.
C1 MIT, Harvard MIT Div Hlth Sci & Technol Elect Engn & C, Cambridge, MA 02139 USA.
   Brigham & Womens Hosp, Div Med, Boston, MA 02115 USA.
RP Bhatia, SN (reprint author), MIT, Harvard MIT Div Hlth Sci & Technol Elect Engn & C, 77 Massachusetts Ave,E19-502D, Cambridge, MA 02139 USA.
EM sbhatia@mit.edu
RI Albrecht, Dirk/B-9941-2011
CR Albrecht DR, 2005, LAB CHIP, V5, P111, DOI 10.1039/b406953f
   Albrecht DR, 2006, NAT METHODS, V3, P369, DOI 10.1038/NMETH873
   Albrecht DR, 2004, BIOPHYS J, V87, P2131, DOI 10.1529/biophysj.104.039511
   Bhatia SN, 1999, FASEB J, V13, P1883
   Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217
   Collier JH, 2001, J AM CHEM SOC, V123, P9463, DOI 10.1021/ja011535a
   Dang SM, 2004, STEM CELLS, V22, P275, DOI 10.1634/stemcells.22-3-275
   Esch M, 1999, BIOPOLYMERS, V50, P227
   FUHR G, 1994, BBA-GEN SUBJECTS, V1201, P353, DOI 10.1016/0304-4165(94)90062-0
   HAUSER O, 2004, CURR OPIN MOL THER, V6, P12
   Huang Y, 1997, BIOPHYS J, V73, P1118, DOI 10.1016/S0006-3495(97)78144-X
   Jones T., 1995, ELECTROMECHANICS PAR
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Khetani SR, 2006, CURR OPIN BIOTECH, V17, P524, DOI 10.1016/j.copbio.2006.08.009
   Kong HJ, 2003, BIOMATERIALS, V24, P4023, DOI 10.1016/S0142-9612(03)00295-3
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   Liu VA, 2002, BIOMED MICRODEVICES, V4, P257, DOI 10.1023/A:1020932105236
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McGuigan AP, 2006, P NATL ACAD SCI USA, V103, P11461, DOI 10.1073/pnas.0602740103
   Patz TM, 2006, J BIOMED MATER RES B, V78B, P124, DOI 10.1002/jbm.b.30473
   Peirone M, 1998, J BIOMED MATER RES, V42, P587, DOI 10.1002/(SICI)1097-4636(19981215)42:4<587::AID-JBM15>3.0.CO;2-X
   Ringeisen Bradley R., 2006, Biotechnology Journal, V1, P930, DOI 10.1002/biot.200600058
   Robitaille R, 2000, J BIOMED MATER RES, V50, P420, DOI 10.1002/(SICI)1097-4636(20000605)50:3<420::AID-JBM17>3.0.CO;2-S
   Smeds KA, 2001, J BIOMED MATER RES, V54, P115, DOI 10.1002/1097-4636(200101)54:1<115::AID-JBM14>3.0.CO;2-Q
   SMIDSROD O, 1990, TRENDS BIOTECHNOL, V8, P71, DOI 10.1016/0167-7799(90)90139-O
   Strick-Marchand H, 2004, P NATL ACAD SCI USA, V101, P8360, DOI 10.1073/pnas.0401092101
   Strick-Marchand H, 2002, HEPATOLOGY, V36, P794, DOI 10.1053/jhep.2002.36123
   Underhill GH, 2007, BIOMATERIALS, V28, P256, DOI 10.1016/j.biomaterials.2006.08.043
   Voldman J, 2006, ANNU REV BIOMED ENG, V8, P425, DOI 10.1146/annurev.bioeng.8.061505.095739
   Yeh J, 2006, BIOMATERIALS, V27, P5391, DOI 10.1016/j.biomaterials.2006.06.005
NR 30
TC 58
Z9 58
U1 0
U2 18
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1473-0197
J9 LAB CHIP
JI Lab Chip
PD JUN
PY 2007
VL 7
IS 6
BP 702
EP 709
DI 10.1039/b701306j
PG 8
WC Biochemical Research Methods; Chemistry, Multidisciplinary; Chemistry,
   Analytical; Nanoscience & Nanotechnology
SC Biochemistry & Molecular Biology; Chemistry; Science & Technology -
   Other Topics
GA 183IL
UT WOS:000247566400017
PM 17538711
DA 2018-10-20
ER

PT J
AU D'Acunto, M
   Napolitano, S
   Pingue, P
   Giusti, P
   Rolla, P
AF D'Acunto, M.
   Napolitano, S.
   Pingue, P.
   Giusti, P.
   Rolla, P.
TI Fast formation of ripples induced by AFM. A new method for patterning
   polymers on nanoscale
SO MATERIALS LETTERS
LA English
DT Article
DE ripples; patterned surfaces; atomic force microscopy; poly(ethylene
   terephtlialate); poly(epsilon-caprolactone)
ID ATOMIC-FORCE MICROSCOPE; SURFACES; FILMS; DEFORMATION; SOLVENT; SCALE;
   TIP
AB The possibility to control the assembly of molecules on a given substrate is particularly important for polymeric systems. Self-assembly of polymer chains on a substrate can be controlled by modifying selectively the chemistry of the substrate surface and/or the polymer itself in order to create patterned polymer films with tailored length scales. A novel tool to change the polymer morphology in order to achieve the requested superficial structures and textures is the atomic force microscopy (AFM). In this paper, we shall demonstrate how to obtain ordered ripple structures induced by an AFM tip on a polymer thin film. It is well known that a polymer surface scanned by a probe tip can change its morphology assuming typical ripple structures. These structures however are expected to be formed for high applied loads (> 10 nN) and after many scanning cycles (> 10). On the contrary, we shall show how to obtain the ripple formation just by a single AFM scan and for relatively low applied loads. Such ripple structures can be modulated and modified by changing the applied load, scanning velocity and angle. In this way, it is possible to obtain sinusoidal structures with suitable amplitude, periodicity and orientation. Beyond the general contribution to the development of nanolithography, the patterns obtained by this method can find many applications in biomaterial polymer science (such as scaffolds for cell proliferation in tissue engineering). (c) 2006 Elsevier B.V. All rights reserved.
C1 Univ Pisa, Dept Chem Engn & Mat Sci, I-56126 Pisa, Italy.
   Univ Pisa, Dept Phys, I-56127 Pisa, Italy.
   CNR, INFM PolyLab, I-56127 Pisa, Italy.
   Katholieke Univ Leuven, Dept Phys & Astron, Lab Acoust & Thermal Phys, B-3001 Heverlee, Belgium.
   CNR, INFM, NEST, I-56100 Pisa, Italy.
   Scuola Normale Super Pisa, I-56100 Pisa, Italy.
   CNR, Inst Composite & Biocompatible Mat, Pisa, Italy.
RP D'Acunto, M (reprint author), Univ Pisa, Dept Chem Engn & Mat Sci, Via Diotisalvi 2, I-56126 Pisa, Italy.
EM m.dacunto@ing.unipi.it
RI Pingue, Pasqualantonio/C-7045-2008; Napolitano, Simone/J-9359-2012
CR Bormashenko E, 2005, MATER LETT, V59, P2461, DOI 10.1016/j.matlet.2005.03.015
   Cheng X, 2002, J VAC SCI TECHNOL B, V20, P2877, DOI 10.1116/1.1515307
   Dalby MJ, 2002, EXP CELL RES, V276, P1, DOI 10.1006/EXCR.2002.5498
   ELKAAKOUR Z, 1994, PHYS REV LETT, V73, P3231, DOI 10.1103/PhysRevLett.73.3231
   Gotsmann B, 2004, LANGMUIR, V20, P1495, DOI 10.1021/la036112w
   Granone F, 2005, NUCL INSTRUM METH B, V230, P545, DOI 10.1016/j.nimb.2004.12.098
   Ikkala O, 2002, SCIENCE, V295, P2407, DOI 10.1126/science.1067794
   Johannsmann D, 2002, EUR PHYS J E, V8, P257, DOI 10.1140/epje/i2002-10013-5
   Johnson K. L., 1985, CONTACT MECH
   Kung LA, 2000, LANGMUIR, V16, P6773, DOI 10.1021/la000653t
   Lawrence JR, 2002, APPL PHYS LETT, V81, P1955, DOI 10.1063/1.1502187
   LAZZERI L, 2006, TRIBOTEST, V12, P257
   Leach RN, 2003, LANGMUIR, V19, P10225, DOI 10.1021/la035289n
   LEUNG OM, 1992, SCIENCE, V255, P64, DOI 10.1126/science.255.5040.64
   MOLTAU M, 1998, NATURE, V391, P877
   NAPOLITANO S, UNPUB
   NAPOLITANO S, 2005, THESIS U PISA
   Noel O, 2004, EUR POLYM J, V40, P965, DOI 10.1016/j.eurpolymj.2004.01.014
   Schmidt RH, 2003, LANGMUIR, V19, P898, DOI 10.1021/la015769j
   Surtchev M, 2005, NANOTECHNOLOGY, V16, P1213, DOI 10.1088/0957-4484/16/8/040
   Valbusa U, 2002, J PHYS-CONDENS MAT, V14, P8153, DOI 10.1088/0953-8984/14/35/301
   Yizhaq H, 2005, PHYSICA A, V357, P57, DOI 10.1016/j.physa.2005.05.070
NR 22
TC 21
Z9 21
U1 2
U2 19
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD JUN
PY 2007
VL 61
IS 14-15
BP 3305
EP 3309
DI 10.1016/j.matlet.2006.11.067
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 179WH
UT WOS:000247320500118
DA 2018-10-20
ER

PT J
AU Kumagai, K
   Nomura, N
   Chiba, A
AF Kumagai, Kazushige
   Nomura, Naoyuki
   Chiba, Akihiko
TI Effect of dissolved oxygen content on pin-on-disc wear Behavior of
   biomedical Co-Cr-Mo alloys in a like-on-like configuration in distilled
   water
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE biomaterial; medical implants; cobalt-chromium-molybdenum alloy; wear;
   wear behavior; wear mechanism; pin-on-disc; metal-on-metal; adhesion;
   oxidation; three-body abrasion
ID TOTAL HIP-ARTHROPLASTY; FORGED LOW-NI; FOLLOW-UP; CORROSION BEHAVIOR;
   TRIBOCORROSION; CAST
AB The wear behavior of a forged Co-29Cr-6Mo alloy without any Ni and C added has been investigated by using a tribosystem consisting of a pin-on-disc type wear testing machine in distilled water containing different dissolved oxygen content. Dissolved oxygen content in the distilled water was controlled by aerating with oxygen or by deaerating with argon. Wear volume in the distilled water containing high oxygen content is approximately two times larger than in that containing low oxygen content. Accordingly, it is deduced that the overall wear volume is significantly affected by the dissolved oxygen content in the distilled water surrounding the tribosystem. Although abrasive wear, caused by wear debris, is operative as a wear mechanism in the present tribosystem irrespective of oxygen content, the transfer of the wear debris to sliding surfaces, as well its the aggregation of the wear debris on the sliding Surfaces, is more prone to occur during the wear process with the lower oxygen content. Therefore, in the present tribosystem with the lower oxygen content, since the transfer of the wear debris to the disc or the pin readily occurs, the generation of the wear debris does not directly contribute to the wear volume, leading to the apparently lower wear volume in the tribosystem with lower oxygen content than in that with higher oxygen content; the transfer of the wear debris is not counted as wear loss because the wear volume is estimated based on the loss in disc and pin weight that occurs during the wear test.
C1 Iwate Univ, Ctr Reg Collaborat Res & Educ, Morioka, Iwate 0208551, Japan.
   Iwate Univ, Fac Engn, Dept Welfare Engn, Morioka, Iwate 0208551, Japan.
   Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808557, Japan.
RP Kumagai, K (reprint author), Iwate Univ, Ctr Reg Collaborat Res & Educ, Morioka, Iwate 0208551, Japan.
RI NOMURA, Naoyuki/L-7149-2017; Chiba, Akihiko/D-1326-2011
CR AARTIK S, 1999, J IMMUNOL, V136, P1143
   Chiba A, 2005, MATER SCI FORUM, V475-479, P2317, DOI 10.4028/www.scientific.net/MSF.475-479.2317
   Chiba A, 2007, ACTA MATER, V55, P1309, DOI 10.1016/j.actamat.2006.10.005
   Clarke MT, 2005, J ARTHROPLASTY, V20, P542, DOI 10.1016/j.arth.2004.09.063
   DAWSON D, 2004, J ARTHOPLASTY, V19, P118
   DDMBLETON JH, 1981, TRIBOLOGY NATURAL AR, P223
   Dorr LD, 2000, J BONE JOINT SURG AM, V82A, P789, DOI 10.2106/00004623-200006000-00005
   Higuchi F, 1997, ARCH ORTHOP TRAUM SU, V116, P121, DOI 10.1007/s004020050084
   Hiromoto S, 2005, BIOMATERIALS, V26, P4912, DOI 10.1016/j.biomaterials.2005.01.028
   Howie DW, 2005, J ARTHROPLASTY, V20, P350, DOI 10.1016/j.arth.2004.09.028
   Iwabuchi A, 1999, WEAR, V225, P181, DOI 10.1016/S0043-1648(98)00357-3
   Kumagai K, 2005, MATER TRANS, V46, P1578, DOI 10.2320/matertrans.46.1578
   Landolt D, 2004, WEAR, V256, P517, DOI 10.1016/S0043-1648(03)00561-1
   Landolt D, 2001, ELECTROCHIM ACTA, V46, P3913, DOI 10.1016/S0013-4686(01)00679-X
   Mischler S, 2001, WEAR, V251, P1295, DOI 10.1016/S0043-1648(01)00754-2
   Rieker CB, 2004, J ARTHROPLASTY, V19, P5, DOI 10.1016/j.arth.2004.09.017
   Rieker CB, 1998, AM SOC TEST MATER, V1346, P144, DOI 10.1520/STP12836S
   Saldivar-Garcia AJ, 2005, J BIOMED MATER RES A, V74A, P269, DOI 10.1002/jbm.a.30392
   Scholes SC, 2001, J MATER SCI-MATER M, V12, P299, DOI 10.1023/A:1011238902803
   SCHULTE KR, 1993, J BONE JOINT SURG AM, V75A, P961, DOI 10.2106/00004623-199307000-00002
   Sims C. T., 1987, SUPER ALLOYS, P135
   WILLERT HG, 1990, CLIN ORTHOP RELAT R, P95
   Yokozeki Hiroo, 1992, Journal of Dermatology (Tokyo), V19, P964
   ZICHNER LP, 1993, CLIN OTHOP, V282, P961
NR 24
TC 1
Z9 1
U1 3
U2 10
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD JUN
PY 2007
VL 48
IS 6
BP 1511
EP 1516
DI 10.2320/matertrans.MRA2007601
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 187BW
UT WOS:000247823300058
OA Bronze
DA 2018-10-20
ER

PT J
AU Kurosu, S
   Nomura, N
   Chiba, A
AF Kurosu, Shingo
   Nomura, Naoyuki
   Chiba, Akihiko
TI Microstructure and mechanical properties of Co-29Cr-Wo alloy aged at
   1023K
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE cobalt-chromium-molybdenum alloy; biomaterial; mechanical property;
   sigma phase (sigma); aging treatment
ID IMPLANT ALLOY; NI; PHASE; TRANSFORMATION; CORROSION
AB Mechanical properties of Co-29Cr-6Mo alloys consisting of epsilon phase and sigma phase were examined at room temperature. Solution treatment at 1523 K for 7.2 ks was carried out for cast Co-29Cr-6Mo alloy, followed by various aging treatments at 1023 K for up to 21.6 ks. The area fraction of the sigma phase in the aged alloys increases with the aging time at 1023 K and reaches 0.6% after aging at 1023 K for 21.6 ks. However, mechanical properties such as 0.2% proof strength, ultimate tensile strength and plastic elongation of the aged alloys do not depend on the aging time. It is found that the or phase less than 0.6% does not cause the deterioration of mechanical properties of the aged Co-29Cr-6Mo alloy.
C1 Iwate Univ, Grad Sch Engn, Dept Mat Sci, Morioka, Iwate 0208551, Japan.
   Iwate Univ, Fac Engn, Dept Welfare Engn, Morioka, Iwate 0208551, Japan.
   Tohoku Univ, Mat Res Inst, Sendai, Miyagi 9808577, Japan.
RP Kurosu, S (reprint author), Iwate Univ, Grad Sch Engn, Dept Mat Sci, Morioka, Iwate 0208551, Japan.
RI Chiba, Akihiko/D-1326-2011; NOMURA, Naoyuki/L-7149-2017
CR Borgenstam A, 2000, ACTA MATER, V48, P2765, DOI 10.1016/S1359-6454(00)00102-6
   Cheng WC, 2006, SCRIPTA MATER, V55, P783, DOI 10.1016/j.scriptamat.2006.07.023
   Chiba A, 2005, MATER SCI FORUM, V475-479, P2317, DOI 10.4028/www.scientific.net/MSF.475-479.2317
   GARCIA AJS, 2005, J BIOMED MATER RES A, V74, P269
   Kurosu S, 2005, J JPN I MET, V69, P886, DOI 10.2320/jinstmet.69.886
   Kurosu S, 2006, MATER TRANS, V47, P1961, DOI 10.2320/matertrans.47.1961
   Lee SH, 2006, MATER TRANS, V47, P287, DOI 10.2320/matertrans.47.287
   Lee SH, 2005, MATER TRANS, V46, P1790, DOI 10.2320/matertrans.46.1790
   Park CJ, 2006, MAT SCI ENG A-STRUCT, V418, P211, DOI 10.1016/j.msea.2005.11.053
   RAJAN K, 1982, METALL TRANS A, V13, P1161, DOI 10.1007/BF02645497
NR 10
TC 7
Z9 7
U1 0
U2 5
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD JUN
PY 2007
VL 48
IS 6
BP 1517
EP 1522
DI 10.2320/matertrans.MRA2007606
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 187BW
UT WOS:000247823300059
OA Bronze
DA 2018-10-20
ER

PT J
AU Truy, E
   Naiman, AN
   Pavillon, C
   Abedipour, D
   Lina-Granade, G
   Rabilloud, M
AF Truy, Eric
   Naiman, Anna Nuca
   Pavillon, Clemence
   Abedipour, Darius
   Lina-Granade, Genevieve
   Rabilloud, Muriel
TI Hydroxyapatite versus titanium ossiculoplasty
SO OTOLOGY & NEUROTOLOGY
LA English
DT Article
DE hydroxyapatite; ossiculoplasty; prosthesis; titanium
ID MIDDLE-EAR SURGERY; OSSICULAR REPLACEMENT; PROSTHESES; IMPLANTS;
   RECONSTRUCTION; TYMPANOPLASTY; HYDROXYLAPATITE; EXTRUSION; CARTILAGE;
   CHAIN
AB Objective: To compare the results of ossicular chain reconstruction using hydroxyapatite (HA) and titanium (TI) prostheses.
   Study Design: Retrospective study and case series.
   Setting: Tertiary referral center.
   Patients: One hundred sixty-eight patients presenting chronic otitis media with or without cholesteatoma.
   Intervention: Ossiculoplasty using partial or total HA and TI ossicular replacement prostheses (TORP and PORP, respectively).
   Main Outcome Measures: Patients were assessed at 2 months postoperatively to establish short-term results. Results of treatment for conductive hearing loss were reported according to guidelines. Available audiometric data at 1, 2, 3, and 5 years were used to assess prosthesis stability. Average postoperative air-conduction gain, air-bone gap, and sensorineural hearing level were measured at four frequencies: 0.5, 1, 2, and 4 kHz. Statistical analyses compared outcomes for HA TORP versus TI TORP and HA PORP versus TI PORP.
   Results: Postoperative air-bone gap of less than 20 dB was obtained in 50% of HA TORP versus 45.8% of TI TORP cases and in 63.2% of HA PORP versus 72% of TI PORP cases. Preoperative middle ear status and presence/absence of malleus significantly influenced postoperative audiometric results. All types of prosthesis demonstrated significant postoperative air-conduction gain decrease on follow-up. Prosthesis exclusion was observed in three cases (1.78%).
   Conclusion: Prostheses using both types of biomaterial gave good functional results and stability with low exclusion rates, with no statistically significant differences between the two. Trends could be observed for slightly better results for HA in total reconstruction and for TI in partial reconstruction. The degradation in postoperative functional gain seemed to be independent of prosthesis type.
C1 Hop Edouard Herriot, Dept Otolaryngol, F-67437 Lyon, France.
   Univ Lyon 1, Lab Biostat Sante, F-69365 Lyon, France.
RP Truy, E (reprint author), Hop Edouard Herriot, Dept Otolaryngol, 5 Pl Arsonval, F-67437 Lyon, France.
EM eric.truy@chu-lyon.fr
RI truy, eric/J-9097-2017
OI truy, eric/0000-0002-1769-8623
CR Albu S, 1998, AM J OTOL, V19, P136
   Begall K, 2000, LARYNGO RHINO OTOL, V79, P139
   Black B, 2003, OTOL NEUROTOL, V24, P534, DOI 10.1097/00129492-200307000-00002
   *COMM HEAR EQ, 1995, OTOLARYNGOL HEAD NEC, V113, P186, DOI DOI 10.1016/S0194-5998(95)70103-6
   Dalchow CV, 2001, OTOLARYNG HEAD NECK, V125, P628, DOI 10.1067/mhn.2001.120397
   Goldenberg RA, 2001, OTOL NEUROTOL, V22, P145, DOI 10.1097/00129492-200103000-00005
   GROTE JJ, 1981, ORL J OTO-RHINO-LARY, V43, P248, DOI 10.1159/000275544
   GROTE JJ, 1990, ANN OTO RHINOL LARYN, V144, P12
   Ho SY, 2003, OTOL NEUROTOL, V24, P149, DOI 10.1097/00129492-200303000-00005
   House JW, 2001, OTOLARYNG HEAD NECK, V125, P135, DOI 10.1067/mhn.2001.117163
   Kobayashi T, 2002, AM J OTOLARYNG, V23, P222, DOI 10.1053/ajot.2002.124191
   Krueger WWO, 2002, OTOL NEUROTOL, V23, P836, DOI 10.1097/00129492-200211000-00004
   MIESTER H, 1999, EUR ARCH OTO-RHINO-L, V256, P122
   Neff BA, 2003, LARYNGOSCOPE, V113, P1525, DOI 10.1097/00005537-200309000-00021
   PASHA R, 2000, OTOLARYNGOL HEAD NEC, V122, P425
   Rondini-Gilli E, 2003, OTOL NEUROTOL, V24, P543, DOI 10.1097/00129492-200307000-00003
   SANNA M, 1982, AM J OTOL, V4, P138
   Schwager K, 1998, EUR ARCH OTO-RHINO-L, V255, P396, DOI 10.1007/s004050050086
   SHELTON C, 1990, LARYNGOSCOPE, V100, P679
   Shinohara T, 2000, CLIN OTOLARYNGOL, V25, P287, DOI 10.1046/j.1365-2273.2000.00364.x
   SMYTH GDL, 1982, OTOLARYNG HEAD NECK, V90, P343
   Stupp CH, 1999, LARYNGO RHINO OTOL, V78, P299, DOI 10.1055/s-2007-996875
   VANBLITTERSWIJK CA, 1990, J BIOMED MATER RES, V24, P433, DOI 10.1002/jbm.820240403
   Vrabec JT, 2002, OTOL NEUROTOL, V23, P653, DOI 10.1097/00129492-200209000-00008
   Wang XJ, 1999, OTOLARYNG HEAD NECK, V121, P606, DOI 10.1016/S0194-5998(99)70066-5
   Zenner HP, 2001, OTOL NEUROTOL, V22, P582, DOI 10.1097/00129492-200109000-00004
   ZOLLNER C, 1997, ANN OTO RHINOL LARYN, V96, P207
NR 27
TC 41
Z9 45
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1531-7129
J9 OTOL NEUROTOL
JI Otol. Neurotol.
PD JUN
PY 2007
VL 28
IS 4
BP 492
EP 498
DI 10.1097/01.mao.0000265203.92743.d1
PG 7
WC Clinical Neurology; Otorhinolaryngology
SC Neurosciences & Neurology; Otorhinolaryngology
GA 173DP
UT WOS:000246854000011
PM 17529851
DA 2018-10-20
ER

PT J
AU Nicolau, PJ
AF Nicolau, Pierre J.
TI Long-lasting and permanent fillers: Biomaterial influence over host
   tissue response
SO PLASTIC AND RECONSTRUCTIVE SURGERY
LA English
DT Article; Proceedings Paper
CT International Master Course on Aging Skin
CY AUG   24, 2004
CL Boston, MA
ID INJECTABLE AESTHETIC MICROIMPLANTS; AUTOLOGOUS CULTURED FIBROBLASTS;
   PMMA-MICROSPHERES ARTECOLL; FOREIGN-BODY GRANULOMAS; COSMETIC SURGERY;
   SILICONE FLASH; AUGMENTATION; COMPLICATIONS; IMPLANTATION; SKIN
AB Background: The purpose of this study was to attempt to understand why some injectable fillers produce frequent ill effects and some do not, by reviewing the available agents and analyzing them through the knowledge of biomaterial studies, which show clearly what type of reactions can be expected according to the chemical used.
   Methods: A study of long-lasting and permanent fillers was performed in an attempt to understand the specific reactions induced by each agent. Agents were then compared with manufacturers' allegations and published data on complications.
   Results: All the available products have a potential for complications. However, the difference between the normal healing process and true inflammatory granuloma must be established. For a volume effect, the implant, although deep, should induce the smallest inflammatory reaction, to avoid any long-term side effects. Particulate implants with porous or irregular surfaces are potentially more reactive than spherical, smooth-surface particles. Gels and oils have a potential for fragmentation, and each droplet will start a new inflammatory phase. For a superficial treatment, is seems better to use a "passive" filler, which should have no inflammatory reaction. The problem remains for combined indications: volume and smoothing, deep and superficial. After hyaluronic acid injections in areas previously treated with a nonresorbable agent, severe inflammatory granulomas have appeared, and it is not possible to state whether they are attributable to the new product, even a resorbable one, or to reactivation of the sleeping reaction from the previous implant.
   Conclusion: There is an obvious need for serious, precise, and objective studies on most of the available fillers, which have not been properly scientifically studied on human skin.
C1 Assistance Publ Hop Paris, Paris, France.
RP Nicolau, PJ (reprint author), 8 Rue Marignan, F-75008 Paris, France.
EM pjnicolau@mageos.com
CR ADAMYAN AA, 2001, ANN PLAST RECONSTR A, V4, P20
   ALLEN O, 1992, AESTHET PLAST SURG, V16, P227, DOI 10.1007/BF00190068
   Alster TS, 2000, PLAST RECONSTR SURG, V105, P2515, DOI 10.1097/00006534-200006000-00034
   Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008
   BECKER DW, 1988, PLAST RECONSTR SURG, V81, P600, DOI 10.1097/00006534-198804000-00020
   Bergeret-Galley C, 2001, AESTHET PLAST SURG, V25, P249, DOI 10.1007/s002660010131
   Boss WK, 2000, CLIN PLAST SURG, V27, P613
   Boss WK, 2000, ANN PLAS SURG, V44, P536, DOI 10.1097/00000637-200044050-00013
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   Cheng NX, 2002, AESTHET PLAST SURG, V26, P375, DOI 10.1007/s00266-002-2052
   Christensen LH, 2004, PLAST RECONSTR SURG, V113, P1878, DOI 10.1097/01.PRS.0000119877.63517.8B
   Christensen LH, 2003, PLAST RECONSTR SURG, V111, P1883, DOI 10.1097/01.PRS.0000056873.87165.5A
   Cohen SR, 2004, PLAST RECONSTR SURG, V114, P964, DOI 10.1097/01.PRS.0000133169.16467.5F
   DIEGELMANN RF, 2004, J P C, V44, P51
   DROBECK HP, 1984, J ORAL MAXIL SURG, V42, P143, DOI 10.1016/S0278-2391(84)80024-5
   DUNCAN DI, 2003, AESTHETIC SURG J, V23, P186
   Duranti F, 1998, DERMATOL SURG, V24, P1317, DOI 10.1111/j.1524-4725.1998.tb00007.x
   EPPLEY BL, 1994, AESTHET PLAST SURG, V18, P413, DOI 10.1007/BF00451350
   EPPLEY BL, 1995, AESTHET PLAST SURG, V19, P445, DOI 10.1007/BF00453878
   Evstatiev D, 2004, PLAST RECONSTR SURG, V113, P1878, DOI 10.1097/01.PRS.0000119877.63517.8B
   Fagien S, 2000, PLAST RECONSTR SURG, V105, P2526
   Flint PW, 1997, ANN OTO RHINOL LARYN, V106, P399, DOI 10.1177/000348949710600508
   Formigli L, 2004, PLAST RECONSTR SURG, V113, P1104, DOI 10.1097/01.PRS.0000107746.58665.0A
   Furuzono T, 2003, J BIOMED MATER RES B, V65B, P217, DOI 10.1002/jbm.b.10002
   GELB H, 1994, J ORTHOP RES, V12, P83, DOI 10.1002/jor.1100120111
   Hertzog B., 1997, J MED ESTH CHIR DERM, V24, P253
   HONIG JF, 2003, J CRANIOFAC SURG, V14
   [霍孟华 Huo Menghua], 2002, [中华整形外科杂志, Chinese Journal of Plastic Surgery], V18, P79
   Jirouskova M, 1997, J MATER SCI-MATER M, V8, P19, DOI 10.1023/A:1018534111419
   Jordan DR, 2002, OPHTHALMIC PLAST REC, V18, P342, DOI 10.1097/01.IOP.0000019288.50184.8F
   KESSLER JPA, 1997, CIR PLAST IBERO LATI, V23, P389
   LAM WW, 2003, CLIN RADIOL EXTRA, V58, P61
   Lemperle G, 2004, PLAST RECONSTR SURG, V113, P1380, DOI 10.1097/01.PRS.0000112764.22839.7A
   LEMPERLE G, 1991, ANN PLAS SURG, V26, P57, DOI 10.1097/00000637-199101000-00009
   Lemperle G, 2003, AESTHET PLAST SURG, V27, P354, DOI 10.1007/s00266-003-3022-1
   Lemperle G, 2003, DERMATOL SURG, V29, P573, DOI 10.1046/j.1524-4725.2003.29140.x
   Lemperle G, 1999, PLAST RECONSTR SURG, V103, P338, DOI 10.1097/00006534-199901000-00079
   Lemperle G, 1998, AESTHET PLAST SURG, V22, P356, DOI 10.1007/s002669900217
   LEMPERLE G, 1995, PLAST RECONSTR SURG, V96, P627, DOI 10.1097/00006534-199509000-00015
   LEMPERLE G, 1992, PLASTIC SURG 2
   Lemperle Gottfried, 2003, Aesthet Surg J, V23, P469, DOI 10.1016/j.asj.2003.09.002
   Li DJ, 1999, J BIOMED MATER RES, V45, P322, DOI 10.1002/(SICI)1097-4636(19990615)45:4<322::AID-JBM6>3.3.CO;2-U
   Maas CS, 1997, DERMATOL SURG, V23, P871, DOI 10.1111/j.1524-4725.1997.tb00738.x
   MATLAGA BF, 1976, J BIOMED MATER RES, V10, P391, DOI 10.1002/jbm.820100308
   MAUBER E, 2003, ANN DERMATOL VENER, V130, P257
   McClelland M, 1997, PLAST RECONSTR SURG, V100, P1466, DOI 10.1097/00006534-199711000-00014
   Milanov NO, 2000, ANN PLAST RECONSTR A, V4, P63
   MISIEK DJ, 1984, J ORAL MAXIL SURG, V42, P150, DOI 10.1016/S0278-2391(84)80025-7
   Morhenn VB, 2002, DERMATOL SURG, V28, P484, DOI 10.1046/j.1524-4725.2002.01273.x
   MUSTOE TA, 1992, PLAST RECONSTR SURG, V89, P891, DOI 10.1097/00006534-199205000-00018
   NICOLAU PJ, 2000, P 1O NAT C SOC FRANC
   Niechajev I, 2000, PLAST RECONSTR SURG, V105, P1173, DOI 10.1097/00006534-200003000-00055
   Novaes WD, 2003, AESTHET PLAST SURG, V27, P376, DOI 10.1007/s00266-003-2119-x
   Okada Y, 1999, J BIOMED MATER RES, V45, P277, DOI 10.1002/(SICI)1097-4636(19990615)45:4<277::AID-JBM1>3.0.CO;2-0
   Pacini S, 2003, PLAST RECONSTR SURG, V111, P489, DOI 10.1097/00006534-200301000-00092
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Pannek J, 2001, J UROLOGY, V166, P1350, DOI 10.1016/S0022-5347(05)65767-9
   Pons-Guiraud A, 2003, NOUV DERMATOL, V22, P205
   PROTOPAPA C, 2003, J COSMET LASER THERA, V5, P1
   Pshenisnov K, 2001, ANN PLAST RECONSTR A, V2, P41
   Reisberger EM, 2003, ARCH DERMATOL, V139, P17, DOI 10.1001/archderm.139.1.17
   Requena C, 2001, AM J DERMATOPATH, V23, P197, DOI 10.1097/00000372-200106000-00006
   Rizzi SC, 2001, J BIOMED MATER RES, V55, P475, DOI 10.1002/1097-4636(20010615)55:4<475::AID-JBM1039>3.0.CO;2-Q
   Rubin JP, 1997, PLAST RECONSTR SURG, V100, P1336, DOI 10.1097/00006534-199710000-00043
   Rudolph CM, 1999, AM J SURG PATHOL, V23, P113, DOI 10.1097/00000478-199901000-00013
   SANGER JR, 1992, PLAST RECONSTR SURG, V89, P931, DOI 10.1097/00006534-199205000-00025
   Saylan Ziya, 2003, Aesthet Surg J, V23, P221, DOI 10.1067/maj.2003.45
   Shinzato S, 2003, J BIOMED MATER RES B, V65B, P262, DOI 10.1002/jbm.b.10008
   Sklar JA, 2004, DERMATOL SURG, V30, P764, DOI 10.1111/j.1524-4725.2004.30214.x
   SMETANA K, 1993, BIOMATERIALS, V14, P1046, DOI 10.1016/0142-9612(93)90203-E
   Smetana K, 1997, BIOMATERIALS, V18, P1009, DOI 10.1016/S0142-9612(97)00037-9
   SPENLEHAUER G, 1989, BIOMATERIALS, V10, P557, DOI 10.1016/0142-9612(89)90063-X
   TAYLOR SR, 1983, J BIOMED MATER RES, V17, P205, DOI 10.1002/jbm.820170202
   Tomazic-Jezic VJ, 2001, J BIOMED MATER RES, V55, P523, DOI 10.1002/1097-4636(20010615)55:4<523::AID-JBM1045>3.0.CO;2-G
   VANWACHEM PB, 1989, BIOMATERIALS, V10, P532, DOI 10.1016/0142-9612(89)90058-6
   Zager W, 2001, ARCH OTOLARYNGOL, V127, P418, DOI 10.1001/archotol.127.4.418
   Zide Barry M, 2003, Aesthet Surg J, V23, P495, DOI 10.1016/j.asj.2003.08.004
NR 77
TC 47
Z9 49
U1 0
U2 11
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0032-1052
J9 PLAST RECONSTR SURG
JI Plast. Reconstr. Surg.
PD JUN
PY 2007
VL 119
IS 7
BP 2271
EP 2286
DI 10.1097/01.prs.0000260710.30934.a1
PG 16
WC Surgery
SC Surgery
GA 170NB
UT WOS:000246669000043
PM 17519731
DA 2018-10-20
ER

PT J
AU Feng, YK
   Zhang, L
   Wu, ZZ
AF Feng Yakai
   Zhang Li
   Wu Zhenzhen
TI Biodegradable polyurethanes in medical applications
SO RESEARCH JOURNAL OF CHEMISTRY AND ENVIRONMENT
LA English
DT Review
DE biodegradable; biomaterial; polyurethane; polyesterurethane;
   shape-memory
ID ENDOTHELIAL-CELLS; ADSORPTION; POLYMERS; GROWTH
AB Biodegradable polyurethane materials, which possess excellent properties such as biocompatibility and mechanical strength, facile formation etc. have been widely used in medical applications. The new applications and research progresses in this area are introduced in, this paper Histocompatibility, blood compatibility and degradation of polyurethanes are also discussed. In addition, the multifunctional biodegradable polyurethanes are also reviewed.
C1 [Feng Yakai; Zhang Li; Wu Zhenzhen] Tianjin Univ, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China.
RP Feng, YK (reprint author), Tianjin Univ, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China.
EM yakaifeng@hot.mail.com
RI feng, yakai/F-3854-2015
OI feng, yakai/0000-0002-4511-0874
CR Alteheld A, 2005, ANGEW CHEM INT EDIT, V44, P1188, DOI 10.1002/anie.200461360
   Borkenhagen M, 1998, BIOMATERIALS, V19, P2155, DOI 10.1016/S0142-9612(98)00122-7
   BRUIN P, 1990, BIOMATERIALS, V11, P291, DOI 10.1016/0142-9612(90)90013-G
   CHEN DJ, 1997, CHINA SYNTHETIC RUBB, V20, P244
   CLAPPER DL, 1992, IMPL RETR S SOC BIOM, P17
   [杜民慧 Du Minhui], 2003, [生物医学工程学杂志, Journal of Biomedical Engineering], V20, P273
   [傅皓 Fu Hao], 2003, [生物医学工程学杂志, Journal of Biomedical Engineering], V20, P348
   Gao CY, 2002, CHEM J CHINESE U, V23, P1210
   GE JJ, 2002, BIODEGRADABLE POLYM, P283
   GE JJ, 1998, ZIRAN ZAZHI, V20, P98
   Howard GT, 2002, INT BIODETER BIODEGR, V49, P245, DOI 10.1016/S0964-8305(02)00051-3
   HUANG SW, 1996, FOREIGN MED BLOOD TR, V19, P99
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   Kawamoto Y, 1997, J MATER SCI-MATER M, V8, P551, DOI 10.1023/A:1018598714996
   [孔桦 Kong Hua], 2002, [基础医学与临床, Basic Medical Sciences and Clinics], V22, P113
   Lee PC, 1996, J BIOMED MATER RES, V32, P645, DOI 10.1002/(SICI)1097-4636(199612)32:4<645::AID-JBM18>3.0.CO;2-C
   Lee SI, 2001, POLYM DEGRAD STABIL, V72, P81, DOI 10.1016/S0141-3910(00)00205-6
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Li Baoqiang, 2003, PUBLIC PRIVATE PARTN, P1
   LIU BH, 2002, POLYURETHANE IND, V17, P6
   LIU LB, 2003, CHINA ELASTOMERICS, V13, P53
   LU Q, 2003, CHINESE HIGH TECHNOL, V10, P58
   Mahkam M, 2003, POLYM DEGRAD STABIL, V80, P199, DOI 10.1016/S0141-3910(02)00388-9
   Matheson LA, 2002, J BIOMED MATER RES, V61, P505, DOI 10.1002/jbm.10286
   [孟舒献 Meng Shuxian], 2004, [生物医学工程学杂志, Journal of Biomedical Engineering], V21, P597
   PENNINGS AJ, 1990, COLLOID POLYM SCI, V268, P2, DOI 10.1007/BF01410416
   PINCHUK L, 1994, J BIOMAT SCI-POLYM E, V6, P225, DOI 10.1163/156856294X00347
   POOLEWARREN LA, 1997, MATER FORUM, V21, P241
   Spaans CJ, 2000, BIOMATERIALS, V21, P2453, DOI 10.1016/S0142-9612(00)00113-7
   SYCHER M, 1983, J ELASTOM PLAST, V15, P81
   Tai NR, 2000, BRIT J SURG, V87, P1516, DOI 10.1046/j.1365-2168.2000.01566.x
   TAKAHISA M, 1990, AM SOC ARTIF INT ORG, V36, P161
   Tang YW, 2001, J BIOMED MATER RES, V57, P597, DOI 10.1002/1097-4636(20011215)57:4<597::AID-JBM1207>3.0.CO;2-T
   van der Heiden AP, 1998, J BIOMED MATER RES, V40, P195, DOI 10.1002/(SICI)1097-4636(199805)40:2<195::AID-JBM4>3.0.CO;2-G
   XIE XY, 2000, POLYM MAT SCI ENG, V16, P22
   [许海燕 Xu Haiyan], 2002, [中国医学科学院学报, Acta Academiae Medicinae Sinicae], V24, P114
   XU HY, 2003, J BIOMEDICAL ENG, V22, P533
   Yoon SS, 2005, POLYM BULL, V53, P339, DOI 10.1007/s00289-005-0355-8
NR 38
TC 4
Z9 4
U1 3
U2 15
PU DR JYOTI GARG
PI INDORE MP
PA SECTOR A/80 SCHEME NO 54, VIJAY NAGAR, A B ROAD, INDORE MP, 452 010,
   INDIA
SN 0972-0626
J9 RES J CHEM ENVIRON
JI Res. J. Chem. Environ.
PD JUN
PY 2007
VL 11
IS 2
BP 78
EP 83
PG 6
WC Chemistry, Multidisciplinary; Environmental Sciences
SC Chemistry; Environmental Sciences & Ecology
GA 289EW
UT WOS:000255038800016
DA 2018-10-20
ER

PT J
AU Takezawa, T
   Ozaki, K
   Takabayashi, C
AF Takezawa, Toshiaki
   Ozaki, Katsuyuki
   Takabayashi, Chiyuki
TI Reconstruction of a hard connective tissue utilizing a pressed silk
   sheet and type-1 collagen as the scaffold for fibroblasts
SO TISSUE ENGINEERING
LA English
DT Article
ID ANTERIOR CRUCIATE LIGAMENT; IN-VIVO; CELLS; BIOMATERIALS; VIABILITY;
   RESPONSES; CULTURE; MODEL
AB A pressed silk sheet is a new biomaterial composed of a network of numerous cocoon filaments and having excellent mechanical strength and shape stability compared to a cotton-gauze sheet. To reconstruct a hard connective tissue using the silk sheet and type-I collagen as the scaffold for fibroblasts, three different three-dimensional floating culture systems were designed. "On sheet" system: fibroblasts were seeded on the silk sheet coated with collagen and the cell-attached sheet was cultured. "In gel" system: fibroblasts and the silk sheet were co-embedded in a collagen gel and the gel was cultured. "On vitrigel" system: fibroblasts were seeded on both sides of a collagen vitrigel involving the silk sheet and the vitrigel was cultured. The fibroblasts in all culture systems grew and formed disk-shaped connective tissue models involving the silk sheet by 14 days of culture. The "on sheet" and "on vitrigel" models retained a maximum elastic load of about 23 kgf and an ultimate tensile load of about 3.6 kgf, which were almost the same as for the individual silk sheet. However, the "in gel" system showed a low value for the tensile load. Cell damage following application of mechanical stress was lowest in the "on vitrigel" system. These data demonstrated the advantage of the "on vitrigel" system in reconstructing hard connective tissues. Such a novel culture method would contribute to a regenerative medicine for the failure of ligaments, tendons, and other connective tissues.
C1 Natl Inst Agrobiol Sci, Lab Anim Cell Biol, Tsukuba, Ibaraki 3050901, Japan.
   Natl Inst Agrobiol Sci, Lab New Silk Mat, Nagano, Japan.
RP Takezawa, T (reprint author), Natl Inst Agrobiol Sci, Lab Anim Cell Biol, Ikenodai 2, Tsukuba, Ibaraki 3050901, Japan.
EM t.takezawa@affrc.go.jp
OI Takezawa, Toshiaki/0000-0002-1825-838X
CR Abe M, 2004, TISSUE ENG, V10, P585, DOI 10.1089/107632704323061942
   Aigner J, 1998, J BIOMED MATER RES, V42, P172, DOI 10.1002/(SICI)1097-4636(199811)42:2<172::AID-JBM2>3.0.CO;2-M
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274
   BESSETTE GC, 1990, ORTHOPEDICS, V13, P551
   Bourke SL, 2004, TISSUE ENG, V10, P43, DOI 10.1089/107632704322791682
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   Dal Pra I, 2005, BIOMATERIALS, V26, P1987, DOI 10.1016/j.biomaterials.2004.06.036
   DECKER T, 1988, J IMMUNOL METHODS, V115, P61, DOI 10.1016/0022-1759(88)90310-9
   Grad S, 2003, BIOMATERIALS, V24, P5163, DOI 10.1016/S0142-9612(03)00462-9
   GREGOIRE M, 1984, EXP CELL RES, V152, P38, DOI 10.1016/0014-4827(84)90228-3
   Ishiyama M, 1996, BIOL PHARM BULL, V19, P1518
   Liu LR, 2003, ARTIF CELL BLOOD SUB, V31, P435, DOI 10.1081/BIO-120025414
   Ouyang HW, 2003, TISSUE ENG, V9, P431, DOI 10.1089/107632703322066615
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Robinson Dror, 1993, Bulletin Hospital for Joint Diseases, V53, P75
   Shimbara N, 1996, CYTOTECHNOLOGY, V21, P31, DOI 10.1007/BF00364835
   Sikavitsas VI, 2003, J BIOMED MATER RES A, V67A, P944, DOI 10.1002/jbm.a.10126
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Subramanian Anu, 2004, Biomed Sci Instrum, V40, P117
   Takezawa T, 1997, TISSUE ENG, V3, P329, DOI 10.1089/ten.1997.3.329
   Takezawa T, 2004, CELL TRANSPLANT, V13, P463, DOI 10.3727/000000004783983882
   TAKEZAWA T, 1993, EXP CELL RES, V208, P430, DOI 10.1006/excr.1993.1265
   Takezawa T, 2003, BIOMATERIALS, V24, P2267, DOI 10.1016/S0142-9612(03)00038-3
   van den Dolder J, 2003, TISSUE ENG, V9, P315, DOI 10.1089/107632703764664783
   Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022
   Xu HHK, 2004, BIOMATERIALS, V25, P1029, DOI 10.1016/S0142-9612(03)00608-2
NR 28
TC 21
Z9 21
U1 0
U2 13
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD JUN
PY 2007
VL 13
IS 6
BP 1357
EP 1366
DI 10.1089/ten.2006.0248
PG 10
WC Cell & Tissue Engineering
SC Cell Biology
GA 178RK
UT WOS:000247237600021
PM 17518702
DA 2018-10-20
ER

PT J
AU Boyde, A
AF Boyde, Alan
TI Higher archetypical imaging of biomaterial-bone tissue interactions
SO TISSUE ENGINEERING
LA English
DT Meeting Abstract
CT 17th Interdisciplinary Research Conference on Biomaterials
CY APR 02-03, 2007
CL Oxford, ENGLAND
C1 Queen Mary Univ London, Ctr Oral Growth & Dev, Biophys Sect, London, England.
EM a.boyde@qmul.ac.uk
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD JUN
PY 2007
VL 13
IS 6
BP 1371
EP 1371
PG 1
WC Cell & Tissue Engineering
SC Cell Biology
GA 178RK
UT WOS:000247237600030
DA 2018-10-20
ER

PT J
AU Lykomitros, V
   Konstandinidis, A
   Anagnostidis, K
   Potoupnis, M
   Kapetanos, G
AF Lykomitros, V.
   Konstandinidis, A.
   Anagnostidis, K.
   Potoupnis, M.
   Kapetanos, G.
TI Biomaterial injection under local anesthesia in a case of vertebral
   compression fracture (VCF)
SO TISSUE ENGINEERING
LA English
DT Meeting Abstract
CT 17th Interdisciplinary Research Conference on Biomaterials
CY APR 02-03, 2007
CL Oxford, ENGLAND
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD JUN
PY 2007
VL 13
IS 6
BP 1375
EP 1375
PG 1
WC Cell & Tissue Engineering
SC Cell Biology
GA 178RK
UT WOS:000247237600042
DA 2018-10-20
ER

PT J
AU Wang, ZQ
   Jing, B
AF Wang, Zhiqiang
   Jing, Bo
TI Preliminary studies on a novel injectable biomaterial for the repair of
   cartilage; High viscous chitosan/glycerol phosphate-demineralized bone
   matrix
SO TISSUE ENGINEERING
LA English
DT Meeting Abstract
CT 17th Interdisciplinary Research Conference on Biomaterials
CY APR 02-03, 2007
CL Oxford, ENGLAND
C1 Second Hosp Tangshan, Tangshan, Peoples R China.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD JUN
PY 2007
VL 13
IS 6
BP 1387
EP 1387
PG 1
WC Cell & Tissue Engineering
SC Cell Biology
GA 178RK
UT WOS:000247237600082
DA 2018-10-20
ER

PT J
AU Xia, ZD
   Triffitt, JT
AF Xia, Zhidao
   Triffitt, James T.
TI Tissue responses to mesenchymal stem cells and biomaterial implants
SO TISSUE ENGINEERING
LA English
DT Meeting Abstract
CT 17th Interdisciplinary Research Conference on Biomaterials
CY APR 02-03, 2007
CL Oxford, ENGLAND
C1 Univ Oxford, Inst Musculoskeletal Sci, Botnar Res Ctr, Nuffield Orthopaed Ctr, Oxford, England.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD JUN
PY 2007
VL 13
IS 6
BP 1389
EP 1389
PG 1
WC Cell & Tissue Engineering
SC Cell Biology
GA 178RK
UT WOS:000247237600088
DA 2018-10-20
ER

PT J
AU Simion, M
   Kleps, I
   Neghina, T
   Angelescu, A
   Miu, M
   Bragaru, A
   Danila, M
   Condac, E
   Costache, M
   Savu, L
AF Simion, Monica
   Kleps, Irina
   Neghina, Teodora
   Angelescu, Anca
   Miu, Mihaela
   Bragaru, Adina
   Danila, Mihai
   Condac, Eduard
   Costache, Marieta
   Savu, Lorand
TI Nanoporous silicon matrix used as biomaterial
SO JOURNAL OF ALLOYS AND COMPOUNDS
LA English
DT Article; Proceedings Paper
CT 12th International Symposium on Metastable and Nano-Materials
   (ISMANAM-2005)
CY JUL 03-07, 2005
CL Paris, FRANCE
DE nanostructured material; thin films; nanofabrications; X-ray
   diffraction; DNA immobilization
ID POROUS SILICON
AB In the last years due to porous silicon (PS) biocompatible properties, PS layers were investigated as support for cell adhesion, as matrix for drug delivery, or for bio (optical) sensors. In this paper we have investigated different types of surface modification of nanoporous silicon in order to be used as support for immobilization of DNA molecules. Good results were obtained by DNA immobilization on Au/PS layer. (C) 2006 Elsevier B.V. All rights reserved.
C1 Natl Inst Res & Dev Microtechnol, Bucharest, Romania.
   Univ Bucharest, Fac Biol, Bucharest, Romania.
   Dextercom SRL, Bucharest, Romania.
RP Simion, M (reprint author), Natl Inst Res & Dev Microtechnol, 32B Iancu Nicole St,POB 38-60, Bucharest, Romania.
EM monicas@imt.ro; econdac@bio.bio.umboc.ro; lorand_savu@yahoo.com
RI Costache, Marieta/F-2806-2016; Bragaru, Adina/C-6440-2012; Simion,
   Monica/D-4842-2011; Savu, Lorand/S-8150-2016; Kusko,
   Mihaela/C-4964-2012; Boldeiu, Adina/H-9179-2016
OI Costache, Marieta/0000-0002-8103-3693; Kusko,
   Mihaela/0000-0001-6773-8745; 
CR CULLIS AG, 1994, J APPL PHYS, V75, P493, DOI 10.1063/1.355827
   Kleps I, 2000, NATO SCI S PRT 3 HI, V78, P337
   KLEPS I, 2004, P 11 EUR C COMP MAT
   Maubach G, 2003, NANOTECHNOLOGY, V14, P546, DOI 10.1088/0957-4484/14/5/312
   MIU M, 2004, P 27 INT SEM C CAS S, P63
   MIU M, 2003, CAS 2003 P OCT 8 12, V1, P99
   MIU M, 2005, P 3 WORLD C DRUG ABS, P18
   MOLLER R, 2005, IEE P-NANOBIOTECHNOL, V152, P47
   SIMION M, 2004, P INT C IND TECHN IE
NR 9
TC 16
Z9 17
U1 1
U2 16
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-8388
J9 J ALLOY COMPD
JI J. Alloy. Compd.
PD MAY 31
PY 2007
VL 434
SI SI
BP 830
EP 832
DI 10.1016/j.jallcom.2006.08.093
PG 3
WC Chemistry, Physical; Materials Science, Multidisciplinary; Metallurgy &
   Metallurgical Engineering
SC Chemistry; Materials Science; Metallurgy & Metallurgical Engineering
GA 165EN
UT WOS:000246286900211
DA 2018-10-20
ER

PT J
AU De Laporte, L
   Shea, LD
AF De Laporte, Laura
   Shea, Lonnie D.
TI Matrices and scaffolds for DNA delivery in tissue engineering
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE gene therapy; regenerative medicine; biomaterials
ID NONVIRAL GENE DELIVERY; SPINAL-CORD-INJURY; MULTILAYERED POLYELECTROLYTE
   FILMS; NANOSTRUCTURED CALCIUM PHOSPHATES; BONE MORPHOGENETIC PROTEIN-2;
   SELF-ASSEMBLED MONOLAYERS; CUTANEOUS WOUND REPAIR; GROWTH-FACTOR
   DELIVERY; FLUID SHEAR-STRESS; PLASMID DNA
AB Regenerative medicine aims to create functional tissue replacements, typically through creating a controlled environment that promotes and directs the differentiation of stem or progenitor cells, either endogenous or transplanted. Scaffolds serve a central role in many strategies by providing the means to control the local environment. Gene delivery from the scaffold represents a versatile approach to manipulating the local environment for directing cell function. Research at the interface of biomaterials, gene therapy, and drug delivery has identified several design parameters for the vector and the biomaterial scaffold that must be satisfied. Progress has been made towards achieving gene delivery within a tissue engineering scaffold, though the design principles for the materials and vectors that produce efficient delivery require further development. Nevertheless, these advances in obtaining transgene expression with the scaffold have created opportunities to develop greater control of either delivery or expression and to identify the best practices for promoting tissue formation. Strategies to achieve controlled, localized expression within the tissue engineering scaffold will have broad application to the regeneration of many tissues, with great promise for clinical therapies. (c) 2007 Elsevier B.V. All rights reserved.
C1 Northwestern Univ, Dept Biol & Chem Engn, Evanston, IL 60208 USA.
   Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA.
RP Shea, LD (reprint author), Northwestern Univ, Dept Biol & Chem Engn, 2145 Sheridan Rd,E156, Evanston, IL 60208 USA.
EM l-shea@northwestern.edu
RI De Laporte, Laura/B-9980-2014; Shea, Lonnie/B-7615-2009
OI De Laporte, Laura/0000-0002-9438-0977; 
FU NIGMS NIH HHS [R01 GM066830-05, R01 GM066830, R01 GM066830-04]; NIBIB
   NIH HHS [R01 EB005678-02, R01 EB005678-01A1, R01 EB003806, R01 EB005678,
   R01 EB003806-03]
CR Alden TD, 1999, HUM GENE THER, V10, P2245, DOI 10.1089/10430349950017220
   Anderson DG, 2003, ANGEW CHEM INT EDIT, V42, P3153, DOI 10.1002/anie.200351244
   Anderson WF, 1998, NATURE, V392, P25
   Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7
   ASAYAMA A, 2004, NUCL ACIDS S SER OXF, P229
   Bajaj B, 2001, BIOTECHNOL PROGR, V17, P587, DOI 10.1021/bp010039n
   Batycky RP, 1997, J PHARM SCI, V86, P1464, DOI 10.1021/js9604117
   Bengali Z, 2005, BIOTECHNOL BIOENG, V90, P290, DOI 10.1002/bit.20393
   BENGALI Z, UNPUB CELLULAR ASS D
   BENGALI Z, IN PRESS J GENE MED
   Berry M, 2001, MOL CELL NEUROSCI, V17, P706, DOI 10.1006/mcne.2001.0975
   Bessis N, 2004, GENE THER, V11, pS10, DOI 10.1038/sj.gt.3302364
   Bonadio J, 1999, NAT MED, V5, P753, DOI 10.1038/10473
   Breen A, 2006, J BIOMED MATER RES A, V78A, P702, DOI 10.1002/jbm.a.30735
   Bumcrot D, 2006, NAT CHEM BIOL, V2, P711, DOI 10.1038/nchembio839
   Bunge MB, 2003, J REHABIL RES DEV, V40, P55, DOI 10.1682/JRRD.2003.08.0055
   Cao RH, 2003, NAT MED, V9, P604, DOI 10.1038/nm848
   Cao X, 2003, NEUROSCIENCE, V122, P381, DOI 10.1016/j.neuroscience.2003.08.018
   Cao X, 2001, NEUROSCIENCE, V103, P831, DOI 10.1016/S0306-4522(01)00029-X
   CARLSON BM, 1999, HUMAN EMBRYOLOGY DEV
   Chachisvilis M, 2006, P NATL ACAD SCI USA, V103, P15463, DOI 10.1073/pnas.0607224103
   Chandler LA, 2000, MOL THER, V2, P153, DOI 10.1006/mthe.2000.0102
   Chandler LA, 2004, WOUNDS, V16, P23
   Chandler LA, 2000, WOUND REPAIR REGEN, V8, P473, DOI 10.1046/j.1524-475x.2000.00473.x
   Chen CP, 2006, BIOCONJUGATE CHEM, V17, P1057, DOI 10.1021/bc060028l
   Chen Y, 2001, GENE THER, V8, P1024, DOI 10.1038/sj.gt.3301482
   Chun KW, 2005, BIOMATERIALS, V26, P3319, DOI 10.1016/j.biomaterials.2004.07.055
   Chun KW, 2004, J BIOMAT SCI-POLYM E, V15, P1341, DOI 10.1163/1568562042368103
   Cohen-Sacks H, 2004, J CONTROL RELEASE, V95, P309, DOI 10.1016/j.jconrel.2003.11.001
   Croyle MA, 2001, J VIROL, V75, P4792, DOI 10.1128/JVI.75.10.4792-4801.2001
   Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   De Laporte L, 2006, BIOMATERIALS, V27, P947, DOI 10.1016/j.biomaterials.2005.09.036
   Dean DA, 2005, GENE THER, V12, P881, DOI 10.1038/sj.gt.3302534
   Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695
   DELAPORTE L, UNPUB DNA LOADED MUL
   DeLong SA, 2005, BIOMATERIALS, V26, P3227, DOI 10.1016/j.biomaterials.2004.09.021
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Doody A, 2006, CRIT REV THER DRUG, V23, P137
   Doukas J, 2002, MOL THER, V5, P517, DOI 10.1006/mthe.2002.0579
   Doukas J, 2001, HUM GENE THER, V12, P783, DOI 10.1089/104303401750148720
   Eliaz RE, 2002, GENE THER, V9, P1230, DOI 10.1038/sj.gt.3301786
   Elisseeff J, 2001, J ORTHOPAED RES, V19, P1098, DOI 10.1016/S0736-0266(01)00054-7
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0
   Fang JM, 1996, P NATL ACAD SCI USA, V93, P5753, DOI 10.1073/pnas.93.12.5753
   Fukunaka Y, 2002, J CONTROL RELEASE, V80, P333, DOI 10.1016/S0168-3659(02)00026-3
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Georges PC, 2005, J APPL PHYSIOL, V98, P1547, DOI 10.1152/japplphysiol.01121.2004
   Glushakova LG, 2006, INVEST OPHTH VIS SCI, V47, P3505, DOI 10.1167/iovs.05-1670
   Gruneich JA, 2004, GENE THER, V11, P668, DOI 10.1038/sj.gt.3302214
   Gudi S, 1998, P NATL ACAD SCI USA, V95, P2515, DOI 10.1073/pnas.95.5.2515
   GURDON JB, 1994, NATURE, V371, P487, DOI 10.1038/371487a0
   Hammond PT, 2004, ADV MATER, V16, P1271, DOI 10.1002/adma.200400760
   Hanai K, 2006, ANN NY ACAD SCI, V1082, P9, DOI 10.1196/annals.1348.010
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   Harris SS, 2005, GENE THER, V12, P512, DOI 10.1038/sj.gt.3302397
   He WJ, 2006, HUM GENE THER, V17, P949, DOI 10.1089/hum.2006.17.949
   Heron PM, 2007, J NEUROSCI METH, V159, P203, DOI 10.1016/j.jneumeth.2006.07.013
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Honma K, 2001, BIOCHEM BIOPH RES CO, V289, P1075, DOI 10.1006/bbrc.2001.6133
   Houchin-Ray T, 2007, MOL THER, V15, P705, DOI 10.1038/mt.sj.6300106
   Hsiong SX, 2006, PERIODONTOL 2000, V41, P109, DOI 10.1111/j.1600-0757.2006.00158.x
   Huang YC, 2005, GENE THER, V12, P418, DOI 10.1038/sj.gt.3302439
   Huang YC, 2003, J BIOMED MATER RES A, V67A, P1384, DOI 10.1002/jbm.a.20036
   Huang YC, 2005, HUM GENE THER, V16, P609, DOI 10.1089/hum.2005.16.609
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Iwanaga S, 2005, BIOMATERIALS, V26, P5395, DOI 10.1016/j.biomaterials.2005.01.021
   Jabbari E, 2004, J MICROENCAPSUL, V21, P525, DOI 10.1080/02652040410001729296
   Jackson DA, 2006, MOL THER, V14, P613, DOI 10.1016/j.ymthe.2006.03.026
   Jang JH, 2005, MOL THER, V12, P475, DOI 10.1016/j.ymrhe.2005.03.036
   Jang JH, 2006, J BIOMED MATER RES A, V77A, P50, DOI 10.1002/jbm.a.30643
   Jang JH, 2004, EXPERT REV MED DEVIC, V1, P127, DOI 10.1586/17434440.1.1.127
   Jang JH, 2003, J CONTROL RELEASE, V86, P157, DOI 10.1016/S0168-3659(02)00369-3
   Jewell CM, 2006, BIOMACROMOLECULES, V7, P2483, DOI 10.1021/bm0604808
   Jewell CM, 2005, J CONTROL RELEASE, V106, P214, DOI 10.1016/j.jconrel.2005.04.014
   Kao WYJ, 1999, BIOMATERIALS, V20, P2213, DOI 10.1016/S0142-9612(99)00152-0
   Kapur TA, 2004, J BIOMED MATER RES A, V68A, P235, DOI 10.1002/jbm.a.10168
   Kasper FK, 2005, J CONTROL RELEASE, V104, P521, DOI 10.1016/j.jconrel.2005.03.008
   Kikuchi A, 2002, ADV DRUG DELIVER REV, V54, P53, DOI 10.1016/S0169-409X(01)00243-5
   Knoller N, 2005, J NEUROSURG-SPINE, V3, P173, DOI 10.3171/spi.2005.3.3.0173
   Kong HJ, 2005, NAT MATER, V4, P460, DOI 10.1038/nmat1392
   Kootstra NA, 2003, ANNU REV PHARMACOL, V43, P413, DOI 10.1146/annurev.pharmtox.43.100901.140257
   Krebsbach PH, 2000, HUM GENE THER, V11, P1201, DOI 10.1089/10430340050015248
   Kreeger PK, 2006, BIOMATERIALS, V27, P714, DOI 10.1016/j.biomaterials.2005.06.016
   KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0
   Kumta PN, 2005, ACTA BIOMATER, V1, P65, DOI 10.1016/j.actbio.2004.09.008
   Kushibiki T, 2003, J CONTROL RELEASE, V90, P207, DOI 10.1016/S0168-3659(03)00197-4
   Langer R, 2001, SCIENCE, V293, P58, DOI 10.1126/science.1063273
   Langer R, 1998, NATURE, V392, P5
   LARSEN WJ, 1997, HUMAN EMBRYOLOGY
   LEDLEY FD, 1995, HUM GENE THER, V6, P1129, DOI 10.1089/hum.1995.6.9-1129
   Levy RJ, 2001, GENE THER, V8, P659, DOI 10.1038/sj.gt.3301452
   Li S., 1999, AM J PHYSIOL, V276, P796
   Liang DH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gnil171
   Luo D, 1999, PHARMACEUT RES, V16, P1300, DOI 10.1023/A:1014870102295
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Luu YK, 2003, J CONTROL RELEASE, V89, P341, DOI 10.1016/S0168-3659(03)00097-X
   Maheshri N, 2006, NAT BIOTECHNOL, V24, P198, DOI 10.1038/nbt1182
   Martin I, 2001, J CELL BIOCHEM, V83, P121, DOI 10.1002/jcb.1203
   McKenzie DL, 2000, BIOCONJUGATE CHEM, V11, P901, DOI 10.1021/bc000056i
   Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883
   Megeed Z, 2004, J CONTROL RELEASE, V94, P433, DOI 10.1016/j.jconrel.2003.10.027
   Megeed Z, 2002, PHARMACEUT RES, V19, P954, DOI 10.1023/A:1016406120288
   Middaugh CR, 1998, J PHARM SCI, V87, P130, DOI 10.1021/js970367a
   Mikos AG, 1998, ADV DRUG DELIV REV, V33, P111
   Minakuchi Y, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh093
   Moon LDF, 2001, NAT NEUROSCI, V4, P465
   Nazir SA, 2005, J INVEST MED, V53, P292, DOI 10.2310/6650.2005.53605
   Nie Y, 2006, DRUG DELIV, V13, P441, DOI 10.1080/10717540600640302
   Nishimura I, 2003, TISSUE ENG, V9, pS77
   NORDE W, 1991, Journal of Biomaterials Science Polymer Edition, V2, P183
   Ochiya T, 1999, NAT MED, V5, P707
   Oishi M, 2006, BIOCONJUGATE CHEM, V17, P677, DOI 10.1021/bc050364m
   Okubo Y, 2000, BIOCHEM BIOPH RES CO, V267, P382, DOI 10.1006/bbrc.1999.1975
   Olton D, 2007, BIOMATERIALS, V28, P1267, DOI 10.1016/j.biomaterials.2006.10.026
   Oupicky D, 2001, GENE THER, V8, P713, DOI 10.1038/sj.gt.3301446
   Ozawa CR, 2004, J CLIN INVEST, V113, P516, DOI 10.1172/JCI200418420
   Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775
   Pannier AK, 2005, ACTA BIOMATER, V1, P511, DOI 10.1016/j.actbio.2005.05.004
   Pannier AK, 2004, MOL THER, V10, P19, DOI 10.1016/j.ymthe.2004.03.020
   PANNIER AK, UNPUB INCORPORATION
   PARKER LE, 1998, P 4 INT C INF SYST A, V3, P89
   Paszek MJ, 2004, J MAMMARY GLAND BIOL, V9, P325, DOI 10.1007/s10911-004-1404-x
   Perabo L, 2006, J GENE MED, V8, P155, DOI 10.1002/jgm.849
   Powers MJ, 2002, BIOTECHNOL BIOENG, V78, P257, DOI 10.1002/bit.10143
   PROCTOR RA, 1987, REV INFECT DIS, V9, pS317
   Quick DJ, 2004, J CONTROL RELEASE, V96, P341, DOI 10.1016/j.jconrel.2004.01.021
   Quick DJ, 2003, PHARM RES, V20, P1730, DOI 10.1023/B:PHAM.0000003368.66471.6a
   Rebar EJ, 2002, NAT MED, V8, P1427, DOI 10.1038/nm795
   Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Ritter T, 2002, BIODRUGS, V16, P3, DOI 10.2165/00063030-200216010-00001
   Romanczuk H, 1999, HUM GENE THER, V10, P2615, DOI 10.1089/10430349950016654
   Rosoff WJ, 2005, BIOTECHNOL BIOENG, V91, P754, DOI 10.1002/bit.20564
   Roth CM, 2004, ANNU REV BIOMED ENG, V6, P397, DOI 10.1146/annurev.bioeng.6.040803.140203
   Roy K, 2003, MOL THER, V7, P401, DOI 10.1016/1525-0016(03)00008-X
   SAKAMOTO H, 1994, P NATL ACAD SCI USA, V91, P12368, DOI 10.1073/pnas.91.26.12368
   Sakiyama-Elbert SE, 2001, ANN REV MATER RES, V31, P183, DOI 10.1146/annurev.matsci.31.1.183
   Saltzman WM, 2002, NAT REV DRUG DISCOV, V1, P177, DOI 10.1038/nrd744
   Salvay DM, 2006, MOL BIOSYST, V2, P36, DOI 10.1039/b514174p
   Schek RM, 2004, MOL THER, V9, P130, DOI 10.1016/j.ymthe.2003.10.002
   Scherer F, 2002, J GENE MED, V4, P634, DOI 10.1002/jgm.298
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Schwartz M, 2005, ACTA NEUROCHIR SUPPL, V93, P147
   Segura T, 2005, BIOMATERIALS, V26, P1575, DOI 10.1016/j.biomaterials.2004.05.007
   Segura T, 2002, BIOCONJUGATE CHEM, V13, P621, DOI 10.1021/bc015575f
   Shea LD, 2000, TISSUE ENG, V6, P605, DOI 10.1089/10763270050199550
   Shea LD, 1999, NAT BIOTECHNOL, V17, P551
   SHEA LD, UNPUB
   Shen H, 2004, NAT MATER, V3, P569, DOI 10.1038/nmat1179
   Siemens DR, 2000, J NATL CANCER I, V92, P403, DOI 10.1093/jnci/92.5.403
   Simmons CA, 2004, BONE, V35, P562, DOI 10.1016/j.bone.2004.02.027
   Singh M, 2006, INT J PHARM, V327, P1, DOI 10.1016/j.ijpharm.2006.07.033
   Song S, 2005, NAT CELL BIOL, V7, P870, DOI 10.1038/ncb1288
   Spagnou S, 2004, BIOCHEMISTRY-US, V43, P13348, DOI 10.1021/bi048950a
   Stachelek SJ, 2004, GENE THER, V11, P15, DOI 10.1038/sj.gt.3302129
   Storrie H, 2006, ADV DRUG DELIVER REV, V58, P500, DOI 10.1016/j.addr.2006.03.004
   Streicher J, 2001, TRENDS BIOTECHNOL, V19, P145, DOI 10.1016/S0167-7799(00)01571-7
   SUKHAREV SI, 1994, NATURE, V368, P265, DOI 10.1038/368265a0
   Tanabe Y, 1996, SCIENCE, V274, P1115, DOI 10.1126/science.274.5290.1115
   TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123
   Trentin D, 2006, P NATL ACAD SCI USA, V103, P2506, DOI 10.1073/pnas.0505964102
   Tseng WC, 1999, BBA-GENE STRUCT EXPR, V1445, P53, DOI 10.1016/S0167-4781(99)00039-1
   Tyrone JW, 2000, J SURG RES, V93, P230, DOI 10.1006/jsre.2000.5912
   Varady P, 2001, HUM GENE THER, V12, P697, DOI 10.1089/104303401300057423
   Varga CM, 2005, GENE THER, V12, P1023, DOI 10.1038/sj.gt.3302495
   Vilaboa N, 2006, CURR GENE THER, V6, P421, DOI 10.2174/156652306777934829
   Wang XP, 2006, WORLD J SURG, V30, P1543, DOI 10.1007/s00268-005-0688-3
   Weaver VM, 1996, BIOCHEM CELL BIOL, V74, P833, DOI 10.1139/o96-089
   WIELAND J, IN PRESS J CONTROL R
   Wood KC, 2005, ANGEW CHEM INT EDIT, V44, P6704, DOI 10.1002/anie.200502152
   Wood KC, 2006, P NATL ACAD SCI USA, V103, P10207, DOI 10.1073/pnas.0602884103
   Wright A, 2005, HUM GENE THER, V16, P881, DOI 10.1089/hum.2005.16.881
   Xie YB, 2001, TISSUE ENG, V7, P585, DOI 10.1089/107632701753213200
   Xu M, 2006, BIOL REPROD, V75, P916, DOI 10.1095/biolreprod.106.054833
   Yamauchi F, 2005, LANGMUIR, V21, P8360, DOI 10.1021/la0505059
   Yamauchi F, 2004, BBA-GEN SUBJECTS, V1672, P138, DOI 10.1016/j.bbagen.2004.03.008
   Yang J, 2006, P NATL ACAD SCI USA, V103, P13872, DOI 10.1073/pnas.0601455103
   YANG YP, 1994, IMMUNITY, V1, P433, DOI 10.1016/1074-7613(94)90074-4
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
   Yew NS, 2000, MOL THER, V1, P255, DOI 10.1006/mthe.2000.0036
   Yick LW, 2000, NEUROREPORT, V11, P1063, DOI 10.1097/00001756-200004070-00032
   Zhang JT, 2004, LANGMUIR, V20, P8015, DOI 10.1021/la048888i
   Zhang XJ, 2006, ADV DRUG DELIVER REV, V58, P515, DOI 10.1016/j.addr.2006.03.006
   Zheng J, 2000, BIOTECHNOL PROGR, V16, P254, DOI 10.1021/bp990150h
   ZHOU BY, 2006, STEM CELLS, V25, P779
   Ziauddin J, 2001, NATURE, V411, P107, DOI 10.1038/35075114
NR 188
TC 171
Z9 171
U1 1
U2 41
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD MAY 30
PY 2007
VL 59
IS 4-5
BP 292
EP 307
DI 10.1016/j.addr.2007.03.017
PG 16
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 185MJ
UT WOS:000247714800008
PM 17512630
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Moioli, EK
   Clark, PA
   Xin, XJ
   Lal, S
   Mao, JJ
AF Moioli, Eduardo K.
   Clark, Paul A.
   Xin, Xuejun
   Lal, Shan
   Mao, Jeremy J.
TI Matrices and scaffolds for drug delivery in dental, oral and
   craniofacial tissue engineering
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE teeth; dental pulp; periodontium; cranial sutures; temporomandibular
   joint; implant dentistry
ID BONE MORPHOGENETIC PROTEIN-2; FIBROBLAST-GROWTH-FACTOR; MESENCHYMAL
   STEM-CELLS; HUMAN OSTEOGENIC PROTEIN-1; SINUS FLOOR ELEVATION; IN-VITRO;
   PULP CELLS; HYALURONIC-ACID; PERIODONTAL REGENERATION; PROTEOGLYCAN
   SYNTHESIS
AB Current treatments for diseases and trauma of dental, oral and craniofacial (DOC) structures rely on durable materials such as amalgam and synthetic materials, or autologous tissue grafts. A paradigm shift has taken place to utilize tissue engineering and drug delivery approaches towards the regeneration of these structures. Several prototypes of DOC structures have been regenerated such as temporomandibular joint (TMJ) condyle, cranial sutures, tooth structures and periodontium components. However, many challenges remain when taking in consideration the high demand for esthetics of DOC structures, the complex environment and yet minimal scar formation in the oral cavity, and the need for accommodating multiple tissue phenotypes. This review highlights recent advances in the regeneration of DOC structures, including the tooth, periodontium, TMJ, cranial sutures and implant dentistry, with specific emphasis on controlled release of signaling cues for stem cells, biomaterial matrices and scaffolds, and integrated tissue engineering approaches. (c) 2007 Elsevier B.V. All rights reserved.
C1 Columbia Univ, Med Ctr, TERML, Coll Dent Med,Fu Fdn Sch Engn & Appl Sci,Dept Bio, New York, NY 10032 USA.
   Univ Wisconsin, UW Hosp & Clin, Dept Neurol Surg, Madison, WI 53792 USA.
RP Mao, JJ (reprint author), Columbia Univ, Med Ctr, TERML, Coll Dent Med,Fu Fdn Sch Engn & Appl Sci,Dept Bio, 630 W 168 St,PH7E, New York, NY 10032 USA.
EM jmao@columbia.edu
FU NIBIB NIH HHS [EB02332, R01 EB002332]; NIDCR NIH HHS [DE13964, RC2
   DE020767-02, DE15391, RC2 DE020767, R01 DE013964, R01 DE015391]
CR AGRAWAL CM, 2001, J BIOMED MAT RES, V55
   Alhadlaq A, 2005, J BONE JOINT SURG AM, V87A, P936, DOI 10.2106/JBJS.D.02104
   Alhadlaq A, 2004, STEM CELLS DEV, V13, P436, DOI 10.1089/1547328041797552
   Alhadlaq A, 2004, ANN BIOMED ENG, V32, P911, DOI 10.1023/B:ABME.0000032454.53116.ee
   Alhadlaq A, 2003, J DENT RES, V82, P951, DOI 10.1177/154405910308201203
   ALHADLAQ A, 2005, J BONE JOINT SURG AM, V87
   ALMARZA AJ, 2006, ARCH ORAL BIOL, V51
   Anusaksathien O, 2004, J PERIODONTOL, V75, P429, DOI 10.1902/jop.2004.75.3.429
   ASHLEY ET, 2003, J CONTEMP DENT PRACT, V4, P1915
   Athanasiou K. A., 1996, BIOMATERIALS, V17
   BADAMI AS, 2006, BIOMATERIALS, V27
   BAUMGARTEN PK, 1971, J COLLOID INTERF SCI, V36, P71, DOI 10.1016/0021-9797(71)90241-4
   BECKER J, 2006, CLIN ORAL INVESTIG, V10
   BEGUEKIRN C, 1992, INT J DEV BIOL, V36, P491
   BEHRAVESH E, 1999, CLIN ORTHOP RELAT S, V367
   Bergenholtz G, 2005, ORAL SURG ORAL MED O, V100, pS102, DOI 10.1016/j.tripleo.2005.03.032
   BLUMENFELD I, 2000, CELLS TISSUES ORGANS, V167
   BRANEMARK PI, 1969, SCAND J PLAST RECONS, V3
   Bulpitt P, 1999, J BIOMED MATER RES, V47, P152
   BUSER D, 1997, CLIN ORAL IMPLANTS R, V8
   Caplan AI, 2001, TRENDS MOL MED, V7, P259, DOI 10.1016/S1471-4914(01)02016-0
   Chai Y, 1998, DEV DYNAM, V213, P500, DOI 10.1002/(SICI)1097-0177(199812)213:4<500::AID-AJA14>3.0.CO;2-A
   Chen FM, 2006, J CONTROL RELEASE, V114, P209, DOI 10.1016/hj.jconrel.2006.05.014
   Chou CH, 2006, J BIOMED MATER RES B, V77B, P338, DOI 10.1002/jbm.b.30432
   CLARKE SA, 2004, J BONE JOINT SURG BR, V86
   CLOKIE CM, 2003, J CRANIOFAC SURG, V14
   COCHRAN DL, 1999, J PERIODONTOL, V70
   COOK SD, 1995, J ORAL IMPLANTOL, V21
   Cooke JW, 2006, TISSUE ENG, V12, P1441, DOI 10.1089/ten.2006.12.1441
   COX CF, 1986, INT ENDOD J, V19, P113, DOI 10.1111/j.1365-2591.1986.tb00463.x
   CRAIG R. G., 1958, JOUR DENTAL RES, V37, P710, DOI 10.1177/00220345580370041801
   CRAIG RG, 1961, J DENT RES, V40, P936, DOI 10.1177/00220345610400051901
   CVEK M, 1987, J DENT RES, V66, P1166, DOI 10.1177/00220345870660061501
   DAMRONGSRI D, 2006, CLIN ORAL IMPLANTS R, V17
   Decup F, 2000, Clin Oral Investig, V4, P110, DOI 10.1007/s007840050126
   Denholm IA, 1998, INT ENDOD J, V31, P251
   DETAMORE MS, 2003, TISSUE ENG, V6
   DETAMORE MS, 2005, ANN BIOMED ENG, V33
   DETAMORE MS, 2004, ARCH ORAL BIOL, V49
   DETAMORE MS, 2005, TISSUE ENG, V11
   Dimitriou R, 2005, INJURY, V36, P1392, DOI 10.1016/j.injury.2005.07.019
   Dobie K, 2002, CONNECT TISSUE RES, V43, P387, DOI 10.1080/03008200290000574
   FISHER JP, 2004, J BIOMED MATER RES A, V71, P1901
   FONTANA S, 2004, IMPLANT DENT, V13
   GAO J, 2001, TISSUE ENG, V7
   GERSTENFELD LC, 2003, J CELL BIOCHEM, V88, P1901
   Giannobile WV, 1998, J PERIODONTOL, V69, P129, DOI 10.1902/jop.1998.69.2.129
   Goldberg Michel, 2006, Dent Clin North Am, V50, P277, DOI 10.1016/j.cden.2005.11.008
   GOODMAN S, 2002, J ORTHOP RES, V20
   Gronthos S, 2002, J DENT RES, V81, P531, DOI 10.1177/154405910208100806
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   Haase HR, 1998, J CELL PHYSIOL, V174, P353, DOI 10.1002/(SICI)1097-4652(199803)174:3<353::AID-JCP9>3.0.CO;2-N
   HANAOKA K, 2006, ANGLE ORTHOD, V76
   HARROP TJ, 1968, ARCH ORAL BIOL, V13, P365, DOI 10.1016/0003-9969(68)90165-9
   HOLLAND TA, 2005, J BIOMED MATER RES A, V75, P1901
   HONDA MJ, 2007, BIOMATERIALS, V28
   HORSTED P, 1981, ORAL SURG ORAL MED O, V52, P531, DOI 10.1016/0030-4220(81)90366-2
   Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878
   Hu JCC, 1995, INT J DEV BIOL, V39, P939
   Huang GTJ, 2006, CELL TISSUE RES, V324, P225, DOI 10.1007/s00441-005-0117-9
   Iohara K, 2004, J DENT RES, V83, P590, DOI 10.1177/154405910408300802
   Isogai N, 1999, J BONE JOINT SURG AM, V81A, P306, DOI 10.2106/00004623-199903000-00002
   JABER L, 1991, J ORAL PATHOL MED, V20, P502, DOI 10.1111/j.1600-0714.1991.tb00413.x
   Jansen JA, 2005, J CONTROL RELEASE, V101, P127, DOI 10.1016/j.jconrel.2004.07.005
   KAKEHASHI S, 1965, ORAL SURG ORAL MED O, V20, P340, DOI 10.1016/0030-4220(65)90166-0
   KANG SW, 2006, J BIOMATER SCI POLYM, V17
   KIENAPFEL H, 1999, J ARTHROPLAST, V14
   Kim HD, 2002, J BIOMED MATER RES, V59, P573, DOI 10.1002/jbm.10011
   Kimble KM, 2004, J PERIODONTOL, V75, P210, DOI 10.1902/jop.2004.75.2.210
   King GN, 1998, J PERIODONTOL, V69, P561, DOI 10.1902/jop.1998.69.5.561
   King GN, 1998, J PERIODONTAL RES, V33, P226, DOI 10.1111/j.1600-0765.1998.tb02194.x
   Kitasako Y, 2002, INT ENDOD J, V35, P996, DOI 10.1046/j.1365-2591.2002.00606.x
   Kocher T, 2000, J CLIN PERIODONTOL, V27, P866, DOI 10.1034/j.1600-051x.2000.027011866.x
   KREKLAU B, 1999, BIOMATERIALS, V20
   Landes CA, 2006, PLAST RECONSTR SURG, V117, P2347, DOI 10.1097/01.prs.0000218787.49887.73
   Landes CA, 2006, J BIOMED MATER RES B, V76B, P403, DOI 10.1002/jbm.b.30388
   Lee JE, 2004, ARTIF ORGANS, V28, P829, DOI 10.1111/j.1525-1594.2004.00020.x
   Lee JY, 2002, J CONTROL RELEASE, V78, P187, DOI 10.1016/S0168-3659(01)00498-9
   LI WJ, 2002, J BIOMED MATER RES, V60, P1915
   LI WJ, 2005, BIOMATERIALS, V26
   LIND M, 1998, ACTA ORTHOP SCAND S, V283
   LIU Y, 2006, METHOD ENZYMOL, V419, P99
   LIU Y, 2004, TISSUE ENG, V10
   Longaker MT, 2001, J CRANIOFAC SURG, V12, P389, DOI 10.1097/00001665-200107000-00016
   LU L, 2000, J BIOMED MATER RES, V50, P1905
   MA Z, 2005, TISSUE ENG, V11
   Mao JJ, 2006, J DENT RES, V85, P966, DOI 10.1177/154405910608501101
   Mao JJ, 2005, BIOL CELL, V97, P289, DOI 10.1042/BC20040100
   Marcopoulou C E, 2003, J Int Acad Periodontol, V5, P63
   Marion NW, 2006, METHOD ENZYMOL, V420, P339, DOI 10.1016/S0079-6879(06)20016-8
   Mellonig JT, 2000, INT J PERIODONT REST, V20, P19
   MERICKSESTERN R, 2001, CLIN ORAL IMPLANTS R, V12
   MJOR IA, 1991, J ORAL PATHOL MED, V20, P496, DOI 10.1111/j.1600-0714.1991.tb00412.x
   MO XM, 2004, BIOMATERIALS, V25
   Moioli EK, 2006, TISSUE ENG, V12, P537, DOI 10.1089/ten.2006.12.537
   MOIOLI EK, 2006, TISSUE ENG, V12
   Mooney MP, 2001, CLEFT PALATE-CRAN J, V38, P206, DOI 10.1597/1545-1569(2001)038<0206:COCSSU>2.0.CO;2
   Moses O, 2005, CLIN ORAL IMPLAN RES, V16, P210, DOI 10.1111/j.1600-0501.2004.01100.x
   Murakami S, 2003, J PERIODONTAL RES, V38, P97, DOI 10.1034/j.1600-0765.2003.00640.x
   NA K, 2006, J BIOTECHNOL, P1912
   Nakahara T, 2003, TISSUE ENG, V9, P153, DOI 10.1089/107632703762687636
   NAKASHIMA M, 1994, ARCH ORAL BIOL, V39, P1085, DOI 10.1016/0003-9969(94)90062-0
   Nakashima M, 2003, NAT BIOTECHNOL, V21, P1025, DOI 10.1038/nbt864
   NAKASHIMA M, 1992, ARCH ORAL BIOL, V37, P231, DOI 10.1016/0003-9969(92)90093-N
   Nakashima M, 2005, J ENDODONT, V31, P711, DOI 10.1097/01.don.0000164138.49923.e5
   Nevins M L, 2000, Int J Periodontics Restorative Dent, V20, P458
   NOH HK, 2006, BIOMATERIALS, V27
   OATES TW, 1993, J PERIODONTOL, V64, P142, DOI 10.1902/jop.1993.64.2.142
   Okuda K, 2003, J PERIODONTOL, V74, P849, DOI 10.1902/jop.2003.74.6.849
   Opperman LA, 2000, DEV DYNAM, V219, P237, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1044>3.0.CO;2-F
   Opperman LA, 2002, ANAT REC, V267, P120, DOI 10.1002/ar.10094
   Opperman LA, 1998, J CRAN GENET DEV BIO, V18, P150
   PAIGE KT, 1995, PLAST RECONSTR SURG, V96
   PARALKAR VM, 1990, J BIOL CHEM, V265, P17281
   Park H, 2005, BIOMATERIALS, V26, P7095, DOI 10.1016/j.biomaterials.2005.05.083
   Park YJ, 2000, BIOMATERIALS, V21, P153
   Parkar MH, 2001, ARCH ORAL BIOL, V46, P275, DOI 10.1016/S0003-9969(00)00099-6
   PRICE RL, 2004, J BIOMED MATER RES A, V70, P1901
   PRITCHARD JJ, 1956, J ANAT, V90, P73
   PROBST A, 1997, J INVEST SURG, V10
   Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71
   Rahaman MN, 2005, BIOTECHNOL BIOENG, V91, P261, DOI 10.1002/bit.20292
   RAHAMAN MN, 2005, BIOTECHNOL BIOENG, V91, P1905
   Ramseier Christoph A, 2006, Dent Clin North Am, V50, P245, DOI 10.1016/j.cden.2005.12.001
   Reddi AH, 2001, ARTHRITIS RES, V3, P1
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Ripamonti U, 2001, EUR J ORAL SCI, V109, P241, DOI 10.1034/j.1600-0722.2001.00041.x
   Rosing CK, 2005, J PERIODONTOL, V76, P129, DOI 10.1902/jop.2005.76.1.129
   Rowe A H, 1967, Br Dent J, V123, P543
   Rutherford R B, 1992, Int J Oral Maxillofac Implants, V7, P297
   RUTHERFORD RB, 1992, ARCH ORAL BIOL, V37, P139, DOI 10.1016/0003-9969(92)90009-W
   Sae-Lim V, 2004, J PERIODONTOL, V75, P1570, DOI 10.1902/jop.2004.75.12.1570
   Saito T, 2004, J ENDODONT, V30, P205, DOI 10.1097/00004770-200404000-00005
   SANCHEZ AR, 2005, J PERIODONTOL, V76
   SASAKI T, 1995, ARCH ORAL BIOL, V40, P209, DOI 10.1016/0003-9969(95)98810-L
   SCHAEFER D, 2002, ARTHRITIS RHEUM, V46
   SCHEK RM, 2005, ORTHOD CRANIOFAC RES, V8
   Scheuhammer AM, 1999, ECOTOXICOLOGY, V8, P49, DOI 10.1023/A:1008936910823
   SCHIERANO G, 2005, J PERIODONTOL, V76
   SCHINDLER M, 2005, BIOMATERIALS, V26
   SCHMIDMAIER G, 2001, J BIOMED MAT RES, V58
   Sculean A, 2005, J CLIN PERIODONTOL, V32, P111, DOI 10.1111/j.1600-051X.2004.00635.x
   SHARPE PT, 2005, SCI AM, V293
   Shi ST, 2002, NAT BIOTECHNOL, V20, P587, DOI 10.1038/nbt0602-587
   Sloan AJ, 1999, ARCH ORAL BIOL, V44, P149, DOI 10.1016/S0003-9969(98)00106-X
   Sloan AJ, 2000, ARCH ORAL BIOL, V45, P173, DOI 10.1016/S0003-9969(99)00131-4
   SOLCHAGA LA, 2005, OSTEOARTHR CARTIL, V13
   SONOYAMA W, 2006, PLOS ONE, V1
   Stavropoulos Andreas, 2004, Clin Oral Investig, V8, P226, DOI 10.1007/s00784-004-0277-0
   SUMNER DR, 1995, J BONE JOINT SURG AM, V77
   SUMNER DR, 2006, J BONE JOINT SURG AM, V88
   SUZUKI T, 2002, BR J ORAL MAXILLOFAC, V40
   Sykaras Nikitas, 2003, J Oral Sci, V45, P57
   Takayama S, 2002, J PERIODONTOL, V73, P1467, DOI 10.1902/jop.2002.73.12.1467
   TANIMOTO K, 2004, J DENT RES, V83
   THELEN S, 2004, J BIOMED MATER RES A, V69, P1915
   Thesleff I, 2003, QUINTESSENCE INT, V34, P613
   Tozum Tolga Fikret, 2003, J Can Dent Assoc, V69, P664
   Trombelli L, 2002, J CLIN PERIODONTOL, V29, P117, DOI 10.1034/j.1600-051X.29.s3.7.x
   Tziafas D, 1998, ARCH ORAL BIOL, V43, P431, DOI 10.1016/S0003-9969(98)00026-0
   Tziafas D, 2000, J DENT, V28, P77, DOI 10.1016/S0300-5712(99)00047-0
   UEKI K, 2003, J CRANIOMAXILLOFAC S, V31
   URIST MR, 1965, SCIENCE, V150, P1912
   van den Bergh JPA, 2000, J CLIN PERIODONTOL, V27, P627, DOI 10.1034/j.1600-051x.2000.027009627.x
   VEHOF JW, 2002, CLIN ORAL IMPLANTS R, V13
   WALSH WR, 1995, BIOMATERIALS, V16, P1319
   WAYNE JS, 2005, TISSUE ENG, V11
   Wei GB, 2006, J CONTROL RELEASE, V112, P103, DOI 10.1016/j.jconrel.2006.01.011
   Wikesjo UME, 2004, J CLIN PERIODONTOL, V31, P662, DOI 10.1111/j.1600-051X.2004.00541.x
   XU C, 2004, TISSUE ENG, V10
   YAMAMOTO M, 2000, J CONTROL RELEASE, V64, P1914
   YELICK PC, 2006, DENT CLIN N AM, V50
   Yokose S, 2000, CALCIFIED TISSUE INT, V66, P139, DOI 10.1007/s002230010028
   Yokose S, 2004, CELL TISSUE RES, V315, P375, DOI 10.1007/s00441-003-0839-5
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   YOUNG CS, 2002, J DENT RES, V81
   Zerbo IR, 2005, BIOMATERIALS, V26, P1445, DOI 10.1016/j.biomaterials.2004.05.003
   ZHANG R, 2004, J BIOMED MATER RES B, V71, P1915
   ZHANG W, IN PRESS TISSUE ENG
   Zhang WB, 2006, BIOMATERIALS, V27, P5658, DOI 10.1016/j.biomaterials.2006.07.013
   Zhang YF, 2006, BIOCHEM BIOPH RES CO, V344, P362, DOI 10.1016/j.bbrc.2006.03.106
   ZHANG YZ, 2005, BIOMACROMOLECULES, V6
NR 182
TC 94
Z9 94
U1 2
U2 50
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD MAY 30
PY 2007
VL 59
IS 4-5
BP 308
EP 324
DI 10.1016/j.addr.2007.03.019
PG 17
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 185MJ
UT WOS:000247714800009
PM 17499385
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Gaspard, S
   Oujja, A
   de Nalda, R
   Abrusci, C
   Catalina, F
   Banares, L
   Castillejo, M
AF Gaspard, S.
   Oujja, A.
   de Nalda, R.
   Abrusci, C.
   Catalina, F.
   Banares, L.
   Castillejo, M.
TI Submicron foaming in gelatine by nanosecond and femtosecond pulsed laser
   irradiation
SO APPLIED SURFACE SCIENCE
LA English
DT Article; Proceedings Paper
CT 5th International Conference on Photo-Excited Processes and Applications
CY SEP, 2006
CL Charlotteville, VA
SP Univ Virginia, US Natl Sci Fdn, US Off Naval Res Global, Thomas Jefferson Natl Accelerat Fac
DE gelatine; biopolymers; femtosecond laser processing; nanostructuring
ID FREE-ELECTRON-LASER; ABLATION; MECHANISMS; COLLAGEN; TISSUES; FILMS
AB We compare the foaming characteristics induced by irradiation with single ns and fs laser pulses of UV, VIS and IR wavelengths on gelatines differing in gel strength (bloom values 75 and 225) and in crosslinking degree. We have observed that while laser irradiation with nanoseconds leads to the formation of a microfoam layer at 266 run, and melting and crater formation at longer wavelengths (532 and 1064 nm), fs pulse irradiation leads to submicron foaming at all wavelengths studied (266, 400 and 800 nm). These results show the possibility of controlling the submicrometric foam structure in this biomaterial and can shed light into the working mechanisms of fs laser nanoprocessing in biomaterials, where increase of temperature, thermoelastic stress generation, and stress-induced bubble formation are mediated by the generated plasma. (C) 2007 Elsevier B.V. All rights reserved.
C1 CSIC, Inst Phys Chem Rocasolano, E-28006 Madrid, Spain.
   CSIC, Inst Polymer Sci & Technol, Madrid 28006, Spain.
   Univ Complutense Madrid, Fac Chem, Dept Phys Chem, Madrid 28040, Spain.
RP Castillejo, M (reprint author), CSIC, Inst Phys Chem Rocasolano, Serrano 119, E-28006 Madrid, Spain.
EM marta.castillejo@iqfr.csic.es
RI Banares, Luis/B-7922-2014; de Nalda, Rebeca/E-9098-2015; Castillejo,
   Marta/D-7448-2014
OI Banares, Luis/0000-0002-0777-2375; de Nalda, Rebeca/0000-0002-9720-6106;
   Castillejo, Marta/0000-0002-5870-4380; Oujja,
   Mohamed/0000-0003-3757-4043; Catalina, Fernando/0000-0002-4620-8582
CR Abrusci C, 2004, J PHOTOCH PHOTOBIO A, V163, P537, DOI 10.1016/j.jphotochem.2004.02.010
   Ball MD, 2004, J MATER SCI-MATER M, V15, P447, DOI 10.1023/B:JMSM.0000021118.85955.4a
   BRANNONPEPPAS L, 1990, BIOMATERIALS, V11, P635, DOI 10.1016/0142-9612(90)90021-H
   *BRIT STAND I, 1975, 757 BRIT STAND
   CASTILLEJO M, 2006, P SPIE, V6261
   HEITZ J, 2006, P SOC PHOTO-OPT INS, V6261, pI6261
   Heya M, 2003, NUCL INSTRUM METH A, V507, P564, DOI 10.1016/S0168-9002(03)00921-5
   Jandeleit J, 1996, APPL PHYS A-MATER, V63, P117, DOI 10.1007/BF01567638
   Lazare S, 2005, APPL PHYS A-MATER, V81, P465, DOI 10.1007/s00339-005-3260-y
   LAZARE S, IN PRESS J LASER MIC
   LIU WG, 2000, POLYMER, V75, P89
   Maatz G, 2000, J OPT A-PURE APPL OP, V2, P59, DOI 10.1088/1464-4258/2/1/311
   Malyshev A, 2004, APPL PHYS A-MATER, V79, P1175, DOI 10.1007/s00339-004-2698-7
   MAXWELL I, 2005, MED LASER APPL, V20, P193, DOI DOI 10.1016/J.MLA.2005.07.005
   Nolte S, 2000, ADV ENG MATER, V2, P23, DOI 10.1002/(SICI)1527-2648(200002)2:1/2<23::AID-ADEM23>3.0.CO;2-L
   OUJJA M, IN PRESS J PHYS C SE
   Ramakrishna S, 2006, MATER TODAY, V9, P40, DOI 10.1016/S1369-7021(06)71389-X
   Shoichet MS, 1998, POLYM TISSUE ENG
   Tribble J, 1997, PHYS REV E, V55, P7385, DOI 10.1103/PhysRevE.55.7385
   Tsunoda K, 2001, J PHOTOCH PHOTOBIO A, V145, P195, DOI 10.1016/S1010-6030(01)00582-2
   Vogel A, 2005, APPL PHYS B-LASERS O, V81, P1015, DOI 10.1007/s00340-005-2036-6
   Vogel A, 2003, CHEM REV, V103, P577, DOI 10.1021/cr010379n
   Ward A. G., 1977, SCI TECHNOLOGY GELAT
   Yoshikawa HY, 2006, CRYST GROWTH DES, V6, P302, DOI 10.1021/cg050190v
NR 24
TC 21
Z9 21
U1 0
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD MAY 30
PY 2007
VL 253
IS 15
SI SI
BP 6420
EP 6424
DI 10.1016/j.apsusc.2007.01.083
PG 5
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 178KX
UT WOS:000247220700030
DA 2018-10-20
ER

PT J
AU El Mhammedi, MA
   Achak, M
   Bakasse, M
   Chtaini, A
AF El Mhammedi, M. A.
   Achak, M.
   Bakasse, M.
   Chtaini, A.
TI Physico-chemical characterization of electrochemical deposit of
   Ca-10(PO4)(6)(OH)(2) on copper surfaces
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE electrodeposition; apatite; X-ray diffraction; copper; carbon paste;
   square wave voltammetry
ID CALCIUM-PHOSPHATE CRYSTALS; HYDROXYAPATITE; OSTEOBLASTS; OXIDATION;
   CERAMICS; PROTEINS; TITANIUM; BONE
AB Surface modification of biomaterials to improve biocompatibility without changing their bulk properties is desired for many clinical applications and has become an emerging technology in biomaterial research and industry. In the present study, a sample electrochemical method of coating the solid surfaces of copper, with a film of apatite, was developed. Thin layer of calcium phosphate crystals formed on the surfaces of copper, was carried out by electrochemical methods, and characterized by XRD, infrared spectroscopy and chemical analysis. (c) 2007 Elsevier B.V. All rights reserved.
C1 Univ Cadi Ayyad, Equipe Electrochim & Mat Inorgan, Fac Sci & Tech, Beni Mellal, Morocco.
   Univ Cadi Ayyad, Lab Hydrobiol & Algol, Marrakech, Morocco.
   Univ Chouaib Doukkali, Fac Sci, Equipe Anal Micropollants Organ, El Jadida, Morocco.
RP El Mhammedi, MA (reprint author), Univ Cadi Ayyad, Equipe Electrochim & Mat Inorgan, Fac Sci & Tech, BP 523, Beni Mellal, Morocco.
EM elmhammedi@yahoo.fr
CR AMLER MH, 1988, J PERIODONTOL, V58, P759
   BAGAMBISA F B, 1990, International Journal of Oral and Maxillofacial Implants, V5, P217
   Benmoussa H, 1999, MATER RES BULL, V34, P1429, DOI 10.1016/S0025-5408(99)00147-6
   CHEUNG HS, 1989, BIOMATERIALS, V10, P63, DOI 10.1016/0142-9612(89)90012-4
   Clark J.H., 1992, SUPPORTED REAGENTS P
   CLARK JH, 1994, CATLAYSIS ORGANIC RE
   Combes C, 2002, BIOMATERIALS, V23, P2817, DOI 10.1016/S0142-9612(02)00073-X
   Cornell C.N., 1998, CLIN ORTHOP S, V355, P267
   Davies JE, 1997, J BIOMED MATER RES, V36, P429, DOI 10.1002/(SICI)1097-4636(19970915)36:4<429::AID-JBM1>3.0.CO;2-G
   ELLIOTT J. C., 1994, STUDIES INORGANIC CH, V18, P111
   ELMHAMMEDI MA, 2005, ITE LETT BATTERIES N, V6, pB18
   FOWLER BO, 1974, INORG CHEM, V13, P194, DOI 10.1021/ic50131a039
   GALGUT P N, 1990, Clinical Materials, V6, P105, DOI 10.1016/0267-6605(90)90002-D
   Gregorie M., 1990, J BIOMED MATER RES, V24, P163
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Ito A, 2000, J BIOMED MATER RES, V50, P178, DOI 10.1002/(SICI)1097-4636(200005)50:2<178::AID-JBM12>3.0.CO;2-5
   Izumi Y., 1992, ZEOLITE CLAY HETEROP
   Kakiuchi N, 2001, B CHEM SOC JPN, V74, P165, DOI 10.1246/bcsj.74.165
   Kilpadi KL, 2001, J BIOMED MATER RES, V57, P258, DOI 10.1002/1097-4636(200111)57:2<258::AID-JBM1166>3.0.CO;2-R
   KIM HM, 1995, J BONE MINER RES, V10, P1589
   KIM HM, 1984, HYDROXYAPATITE RELAT, P331
   KIM HM, 1996, CALCIFIED TISSUE INT, V59, P63
   KUHNSPEARING L, 1996, P ANN M MIN MET MAT
   Lacefield W R, 1998, Implant Dent, V7, P315, DOI 10.1097/00008505-199807040-00010
   LACOUT JL, 1983, THESIS INPT TOULOUSE
   LeGeros R. Z., 1993, INTRO BIOCERAMICS, P139
   LEGEROS RZ, 1991, CALCIUM PHOSPHATES O, P108
   LeGeros RZ, 1993, INTRO BIOCERAMICS
   MHAMMEDI MAE, 2005, ITE LETT BATTERIES N, V6, pC40
   MONMA H, 1982, J CATAL, V75, P200, DOI 10.1016/0021-9517(82)90137-3
   Mori K, 2002, J AM CHEM SOC, V124, P11572, DOI 10.1021/ja020444q
   NADIR S, 1986, THESIS U MOHAMED RAB
   NERY EB, 1992, J PERIODONTOL, V63, P729, DOI 10.1902/jop.1992.63.9.729
   Nishimura T, 2004, B CHEM SOC JPN, V77, P1765, DOI 10.1246/bcsj.77.1765
   Nishimura T, 2000, APPL CATAL A-GEN, V194, P415, DOI 10.1016/S0926-860X(99)00387-7
   Nishimura T, 2000, CATAL SURV JPN, V4, P135
   OWADA H, 1989, SOLID STATE IONICS, V35, P401, DOI 10.1016/0167-2738(89)90327-5
   REY C, 1995, J BONE MINER RES, V10, P1577
   RHLALOU T, 1991, THESIS U MOHAMED RAB
   Soballe K, 1999, J LONG-TERM EFF MED, V9, P131
   Stoch A, 2001, J MOL STRUCT, V596, P191, DOI 10.1016/S0022-2860(01)00716-5
   TATEIWA J, 1997, J JPN PETROL INST, V40, P327
   Yamaguchi K, 2000, J AM CHEM SOC, V122, P7144, DOI 10.1021/ja001325i
NR 43
TC 13
Z9 13
U1 0
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD MAY 15
PY 2007
VL 253
IS 14
BP 5925
EP 5930
DI 10.1016/j.apsusc.2007.01.085
PG 6
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 169OJ
UT WOS:000246601200001
DA 2018-10-20
ER

PT J
AU Su, Y
   Zeng, BF
   Zhang, CQ
   Zhang, KG
   Xie, XT
AF Su, Yan
   Zeng, Bing-Fang
   Zhang, Chang-Qing
   Zhang, Kai-Gang
   Xie, Xue-Tao
TI Study of biocompatibility of small intestinal submucosa (SIS) with
   Schwann cells in vitro
SO BRAIN RESEARCH
LA English
DT Article
DE Schwann cell; biocompatibility; small intestinal submucosa.; peripheral
   nerve regeneration
ID PERIPHERAL-NERVE REGENERATION; ADULT-RAT; BIOSCAFFOLD; MATRIX; REPAIR;
   RECONSTRUCTION; PROTEINS; CULTURE; GRAFTS
AB No satisfactory method currently exists for repairing long peripheral nerve defects. Efforts have been made to fabricate bioactive artificial nerve conduits, comprised of a biomaterial pre-seeded with Schwann cells (SCs), which creating a favorable micro-environment for axonal regeneration, to be an alternative to autografting by means of tissue engineering. Small intestinal submucosa (SIS) possesses special biological characteristics and is comprehensively researched for tissue repairing at varied tissues and organs. This study investigated the biocompatibility of SIS with SCs in vitro. Cultured rat SCs were seeded on SIS. Cell morphology was observed by light microscopy, scanning electron microscopy and transmission electron microscope. The viability of SCs was measured by MTT assay. Secretion of NGF-beta and BDNF was quantitatively assessed by ELISA, and NGF-beta mRNA and BDNF mRNA were semi-quantitatively assessed by RT-PCR. The results indicated that SCs could adhere, migrate and proliferate on the surface of SIS in good condition with productive function of secreting growth factors. SIS has a good biocompatibility with SCs and SIS pre-seeded with SCs has potential to be an alternate candidate of autografting for repairing long peripheral nerve defects. (c) 2007 Elsevier B.V. All rights reserved.
C1 Shanghai Jiao Tong Univ, Dept Orthopaed, Affiliated Peoples Hosp 6, Shanghai 200233, Peoples R China.
RP Zeng, BF (reprint author), Shanghai Jiao Tong Univ, Dept Orthopaed, Affiliated Peoples Hosp 6, 600 Yishan Rd, Shanghai 200233, Peoples R China.
EM yansu2004@yahoo.com.cn
CR Abraham GA, 2000, J BIOMED MATER RES, V51, P442, DOI 10.1002/1097-4636(20000905)51:3<442::AID-JBM19>3.3.CO;2-W
   Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024
   Badylak S, 1999, BIOMATERIALS, V20, P2257, DOI 10.1016/S0142-9612(99)00156-8
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   Bellamkonda RV, 2006, BIOMATERIALS, V27, P3515, DOI 10.1016/j.biomaterials.2006.02.030
   Campodonico F, 2004, EUR UROL, V46, P531, DOI 10.1016/j.eururo.2004.04.019
   Evans GRD, 2002, BIOMATERIALS, V23, P841, DOI 10.1016/S0142-9612(01)00190-9
   Fansa H, 2004, NEUROL RES, V26, P167, DOI 10.1179/016164104225013842
   FAWCETT JW, 1990, ANNU REV NEUROSCI, V13, P43, DOI 10.1146/annurev.neuro.13.1.43
   Greca Fernando H., 2004, Int. braz j urol., V30, P327, DOI 10.1590/S1677-55382004000400013
   Hadlock TA, 2001, MICROSURG, V21, P96, DOI 10.1002/micr.1016
   Hudson TW, 1999, CLIN PLAST SURG, V26, P617
   Hurst RE, 2001, J BIOMAT SCI-POLYM E, V12, P1267, DOI 10.1163/156856201753395798
   Keilhoff G, 2003, BIOMATERIALS, V24, P2779, DOI 10.1016/S0142-9612(03)00084-X
   Lindberg K, 2001, BURNS, V27, P254, DOI 10.1016/S0305-4179(00)00113-3
   Lundborg G, 2000, J HAND SURG-AM, V25A, P391, DOI 10.1053/jhsu.2000.4165
   LUNDBORG G, 1988, NERVE INJURY REPAIR, P163
   MACHINNON SE, 1990, PLAST RECONSTR SURG, V85, P419
   MACKINNON SE, 1990, PLAST RECONSTR SURG, V85, P419, DOI 10.1097/00006534-199003000-00015
   MARTINI R, 1994, J NEUROCYTOL, V23, P1, DOI 10.1007/BF01189813
   Mauritz C, 2004, J NEUROSCI RES, V77, P453, DOI 10.1002/jnr.20166
   Rochkind S, 2004, NEUROL RES, V26, P161, DOI 10.1179/016164104225013905
   Schicho R, 1999, BRAIN RES, V815, P60, DOI 10.1016/S0006-8993(98)01094-4
   Serpe CJ, 2005, BRAIN BEHAV IMMUN, V19, P173, DOI 10.1016/j.bbi.2004.07.005
   Smith RM, 2004, J INVEST SURG, V17, P339, DOI 10.1080/08941930490524417
   Suckow MA, 1999, J INVEST SURG, V12, P277, DOI 10.1080/089419399272395
   Sulaiman OAR, 2002, GLIA, V37, P206, DOI 10.1002/glia.10022
   Terzis JK, 1997, J RECONSTR MICROSURG, V13, P215, DOI 10.1055/s-2007-1006407
   Thompson DM, 2004, ANN BIOMED ENG, V32, P1120
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   Zhang F, 2003, PLAST RECONSTR SURG, V112, P565, DOI 10.1097/01.PRS.0000070966.74429.03
NR 31
TC 20
Z9 27
U1 0
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0006-8993
J9 BRAIN RES
JI Brain Res.
PD MAY 11
PY 2007
VL 1145
BP 41
EP 47
DI 10.1016/j.brainres.2007.01.138
PG 7
WC Neurosciences
SC Neurosciences & Neurology
GA 164UR
UT WOS:000246260600005
PM 17367764
DA 2018-10-20
ER

PT J
AU Gimble, JM
   Katz, AJ
   Bunnell, BA
AF Gimble, Jeffrey M.
   Katz, Adam J.
   Bunnell, Bruce A.
TI Adipose-derived stem cells for regenerative medicine
SO CIRCULATION RESEARCH
LA English
DT Review
DE adipose tissue; adult stem cells; bone marrow stromal cell;
   differentiation; tissue engineering
ID PROGRESSIVE OSSEOUS HETEROPLASIA; PROCESSED LIPOASPIRATE CELLS; ISOLATED
   FAT CELLS; IMPROVE POSTNATAL NEOVASCULARIZATION; CARBOXYPEPTIDASE-LIKE
   PROTEIN; HUMAN ADIPOCYTE PRECURSORS; ACTIVATED RECEPTOR-GAMMA;
   PERFRINGENS ALPHA TOXIN; HUMAN-BONE-MARROW; MUSCLE-LIKE CELLS
AB The emerging field of regenerative medicine will require a reliable source of stem cells in addition to biomaterial scaffolds and cytokine growth factors. Adipose tissue represents an abundant and accessible source of adult stem cells with the ability to differentiate along multiple lineage pathways. The isolation, characterization, and preclinical and clinical application of adipose-derived stem cells (ASCs) are reviewed in this article.
C1 Pennington Biomed Res Ctr, Stem Cell Biol Lab, Baton Rouge, LA 70808 USA.
   Pennington Biomed Res Ctr, Clin Nutr Res Unit, Baton Rouge, LA 70808 USA.
   Louisiana State Univ Syst, Baton Rouge, LA USA.
   Univ Virginia, Dept Plast & Maxillofacial Surg, Charlottesville, VA USA.
   Tulane Univ, Primate Res Ctr, Covington, LA USA.
RP Gimble, JM (reprint author), Pennington Biomed Res Ctr, Stem Cell Biol Lab, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.
EM gimblejm@pbrc.edu
FU NCRR NIH HHS [RR00164, P51 RR000164]; NIDDK NIH HHS [P30 DK072476]
CR Abderrahim-Ferkoune A, 2004, EXP CELL RES, V293, P219, DOI [10.1016/j.yexcr.2003.10.020, 10.1016/j.yexer.2003.10.020]
   Aoki S, 2003, CELL STRUCT FUNCT, V28, P55
   Ashjian PH, 2003, PLAST RECONSTR SURG, V111, P1922, DOI 10.1097/01.PRS.0000055043.62589.05
   Aust L, 2004, CYTOTHERAPY, V6, P7, DOI 10.1080/14653240310004539
   Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X
   BJORNTORP P, 1978, J LIPID RES, V19, P316
   Bray GA, 2004, J CLIN ENDOCR METAB, V89, P2583, DOI 10.1210/jc.2004-0535
   Burks CA, 2006, TISSUE ENG, V12, P2591, DOI 10.1089/ten.2006.12.2591
   Butler DL, 2000, J BIOMECH ENG-T ASME, V122, P570, DOI 10.1115/1.1318906
   Cao Y, 2005, BIOCHEM BIOPH RES CO, V332, P370, DOI 10.1016/j.bbrc.2005.04.135
   Case J, 2005, ANN NY ACAD SCI, V1044, P183, DOI 10.1196/annals.1349.024
   Casteilla L, 2006, DIABETES METAB, V32, P393, DOI 10.1016/S1262-3636(07)70297-5
   CASTROMALASPINA H, 1980, BLOOD, V56, P289
   Celis JE, 2005, MOL CELL PROTEOMICS, V4, P492, DOI 10.1074/mcp.M500030-MCP200
   Chan I, 2004, CLIN EXP DERMATOL, V29, P77, DOI 10.1111/j.1365-2230.2004.01439.x
   Chen XL, 2005, J PROTEOME RES, V4, P570, DOI 10.1021/pr049772a
   Cone RD, 1999, TRENDS ENDOCRIN MET, V10, P211, DOI 10.1016/S1043-2760(99)00153-8
   CORNELIUS P, 1994, ANNU REV NUTR, V14, P99, DOI 10.1146/annurev.nu.14.070194.000531
   Corre J, 2006, J CELL PHYSIOL, V208, P282, DOI 10.1002/jcp.20655
   Crossno JT, 2006, J CLIN INVEST, V116, P3220, DOI 10.1172/JCI285510
   Cui Lei, 2005, Zhonghua Yi Xue Za Zhi, V85, P1890
   Debrock G, 2003, BRIT J CANCER, V89, P1409, DOI 10.1038/sj.bjc.6601306
   DeLany JP, 2005, MOL CELL PROTEOMICS, V4, P731, DOI 10.1074/mcp.M400198-MCP200
   Demetri GD, 1999, P NATL ACAD SCI USA, V96, P3951, DOI 10.1073/pnas.96.7.3951
   DESLEX S, 1987, INT J OBESITY, V11, P19
   Dicker A, 2005, EXP CELL RES, V308, P283, DOI 10.1016/j.yexcr.2005.04.029
   Eddy MC, 2000, J BONE MINER RES, V15, P2074, DOI 10.1359/jbmr.2000.15.11.2074
   Erickson GR, 2002, BIOCHEM BIOPH RES CO, V290, P763, DOI 10.1006/bbrc.2001.6270
   Estes BT, 2006, ARTHRITIS RHEUM, V54, P1222, DOI 10.1002/art.21779
   Estes RT, 2006, J CELL PHYSIOL, V209, P987, DOI 10.1002/jcp.20808
   FAUST IM, 1977, SCIENCE, V197, P391, DOI 10.1126/science.877563
   Fraser JK, 2006, TRENDS BIOTECHNOL, V24, P150, DOI 10.1016/j.tibtech.2006.01.010
   Fraser John K, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS33, DOI 10.1038/ncpcardio0444
   Fukumura D, 2003, CIRC RES, V93, pE88, DOI 10.1161/01.RES.0000099243.20096.FA
   Gagnon A, 2002, ENDOCRINOLOGY, V143, P2478, DOI 10.1210/en.143.7.2478
   Gaustad KG, 2004, BIOCHEM BIOPH RES CO, V314, P420, DOI 10.1016/j.bbrc.2003.12.109
   Gimble JM, 2003, CURR TOP DEV BIOL, V58, P137, DOI 10.1016/S0070-2153(03)58005-X
   Gimble JM, 2003, EXPERT OPIN BIOL TH, V3, P705, DOI 10.1517/14712598.3.5.705
   Gronthos S, 2001, J CELL PHYSIOL, V189, P54, DOI 10.1002/jcp.1138
   Halvorsen YC, 2000, INT J OBESITY, V24, pS41, DOI 10.1038/sj.ijo.0801503
   Halvorsen YDC, 2001, TISSUE ENG, V7, P729, DOI 10.1089/107632701753337681
   Halvorsen YDC, 2001, METABOLISM, V50, P407, DOI 10.1053/meta.2001.21690
   HAUNER H, 1989, J CLIN INVEST, V84, P1663, DOI 10.1172/JCI114345
   Hauner H, 1988, Horm Metab Res Suppl, V19, P35
   Hausman GJ, 2006, J ANIM SCI, V84, P1666, DOI 10.2527/jas.2005-539
   Hausman GJ, 2006, J CLIN INVEST, V116, P3103, DOI 10.1172/JCI30666
   Hausman GJ, 2004, J ANIM SCI, V82, P925
   Hicok KC, 2004, TISSUE ENG, V10, P371, DOI 10.1089/107632704323061735
   Huang JI, 2002, PLAST RECONSTR SURG, V109, P1033, DOI 10.1097/00006534-200203000-00037
   Hutley LJ, 2001, AM J PHYSIOL-ENDOC M, V281, pE1037
   ILLOUZ YG, 1983, PLAST RECONSTR SURG, V72, P591, DOI 10.1097/00006534-198311000-00001
   Izadpanah R, 2006, J CELL BIOCHEM, V99, P1285, DOI 10.1002/jcb.20904
   Jack GS, 2005, J UROLOGY, V174, P2041, DOI 10.1097/01.ju.0000176489.96993.84
   Jeon ES, 2006, J CELL SCI, V119, P4994, DOI 10.1242/jcs.03281
   Juppner H, 2002, NEW ENGL J MED, V346, P128, DOI 10.1056/NEJM200201103460212
   Kang SK, 2004, J CELL SCI, V117, P4289, DOI 10.1242/jcs.01264
   Kaplan FS, 1994, J AM ACAD ORTHOP SUR, V2, P288
   Katz AJ, 1999, CLIN PLAST SURG, V26, P587
   Katz AJ, 2005, STEM CELLS, V23, P412, DOI 10.1634/stemcells.2004-0021
   Katz AJ, 2001, PLAST RECONSTR SURG, V107, P595, DOI 10.1097/00006534-200102000-00047
   KATZ AJ, IN PRESS ADIPOCYTES
   KILROY GE, IN PRESS J CELL PHYS
   Krampera M, 2007, BONE, V40, P382, DOI 10.1016/j.bone.2006.09.006
   Kratchmarova I, 2002, MOL CELL PROTEOMICS, V1, P213, DOI 10.1074/mcp.M200006-MCP200
   KURITA MMD, IN PRESS PLAST RECON
   Lalikos JF, 1997, J SURG RES, V70, P95, DOI 10.1006/jsre.1997.5090
   Lee JH, 2006, BIOCHEM BIOPH RES CO, V341, P882, DOI 10.1016/j.bbrc.2006.01.038
   LEE WC, IN PRESS BIOMECH MOD
   Lee WCC, 2006, CELLS TISSUES ORGANS, V183, P80, DOI 10.1159/000095512
   Liu TM, 2007, STEM CELLS, V25, P750, DOI 10.1634/stemcells.2006-0394
   Martin RJ, 1998, P SOC EXP BIOL MED, V219, P200
   Martinez-Estrada OM, 2005, CARDIOVASC RES, V65, P328, DOI 10.1016/j.cardiores.2004.11.015
   McIntosh K, 2006, STEM CELLS, V24, P1246, DOI 10.1634/stemcells.2005-0235
   Millington GWM, 2006, CLIN EXP DERMATOL, V31, P681, DOI 10.1111/j.1365-2230.2006.02233.x
   Millis K, 1999, MAGNET RESON MED, V41, P257, DOI 10.1002/(SICI)1522-2594(199902)41:2<257::AID-MRM8>3.3.CO;2-E
   Miranville A, 2004, CIRCULATION, V110, P349, DOI 10.1161/01.CIR.0000135466.16823.D0
   Mitchell JB, 2006, STEM CELLS, V24, P376, DOI 10.1634/stemcells.2005-0234
   Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391
   Mizuno H, 2002, PLAST RECONSTR SURG, V109, P199, DOI 10.1097/00006534-200201000-00030
   Moon MH, 2006, CELL PHYSIOL BIOCHEM, V17, P279, DOI 10.1159/000094140
   MOORE JH, 1995, AESTHET PLAST SURG, V19, P335, DOI 10.1007/BF00451659
   Moseley TA, 2006, PLAST RECONSTR SURG, V118, p121S, DOI 10.1097/01.prs.0000234609.74811.2e
   Nakagami H, 2006, J ATHEROSCLER THROMB, V13, P77, DOI 10.5551/jat.13.77
   Nakagami H, 2005, ARTERIOSCL THROM VAS, V25, P2542, DOI 10.1161/01.ATV.0000190701.92007.6d
   Neese RA, 2002, P NATL ACAD SCI USA, V99, P15345, DOI 10.1073/pnas.232551499
   *NIH, 2006, FACT BOOK FISC YEAR
   NNODIM JO, 1987, ANAT RECORD, V219, P331, DOI 10.1002/ar.1092190402
   Oedayrajsingh-Varma MJ, 2006, CYTOTHERAPY, V8, P166, DOI 10.1080/14653240600621125
   Parker AM, 2006, EXPERT OPIN BIOL TH, V6, P567, DOI 10.1517/14712598.6.6.567
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Planat-Benard V, 2004, CIRCULATION, V109, P656, DOI 10.1161/01.CIR.0000114522.38265.61
   Planat-Benard V, 2004, CIRC RES, V94, P223, DOI 10.1161/01.RES.0000109792.43271.47
   Prunet-Marcassus B, 2006, EXP CELL RES, V312, P727, DOI 10.1016/j.yexcr.2005.11.021
   Puissant N, 2005, BRIT J HAEMATOL, V129, P118, DOI 10.1111/j.1365-2141.2005.05409.x
   Rangappa S, 2003, J THORAC CARDIOV SUR, V126, P124, DOI 10.1016/S0022-5223(03)00074-6
   Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1
   RODBELL M, 1966, J BIOL CHEM, V241, P3909
   RODBELL M, 1966, J BIOL CHEM, V241, P130
   RODBELL M, 1966, J BIOL CHEM, V241, P140
   Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145
   Rubio D, 2005, CANCER RES, V65, P3035, DOI 10.1158/0008-5472.CAN-04-4194
   Safford KA, 2005, CURR DRUG TARGETS, V6, P57, DOI 10.2174/1389450053345028
   Safford KM, 2002, BIOCHEM BIOPH RES CO, V294, P371, DOI 10.1016/S0006-291X(02)00469-2
   Safford KM, 2004, EXP NEUROL, V187, P319, DOI 10.1016/j.expneurol.2004.01.027
   SCHIPPER B, 2006, 4 ANN INT FAT APPL T
   Sen A, 2001, J CELL BIOCHEM, V81, P312, DOI 10.1002/1097-4644(20010501)81:2<312::AID-JCB1046>3.0.CO;2-Q
   Sengenes C, 2005, J CELL PHYSIOL, V205, P114, DOI 10.1002/jcp.20381
   Seo MJ, 2005, BIOCHEM BIOPH RES CO, V328, P258, DOI 10.1016/j.bbrc.2004.12.158
   Shore EM, 2002, NEW ENGL J MED, V346, P99, DOI 10.1056/NEJMoa011262
   Shore EM, 2000, CLIN ORTHOP RELAT R, P303
   SIMMONS PJ, 1991, BLOOD, V78, P55
   Song YH, 2007, BIOCHEM BIOPH RES CO, V354, P999, DOI 10.1016/j.bbrc.2007.01.095
   Spees JL, 2006, P NATL ACAD SCI USA, V103, P1283, DOI 10.1073/pnas.0510511103
   Stashower M, 1999, DERMATOL SURG, V25, P945, DOI 10.1046/j.1524-4725.1999.99098.x
   Strawford A, 2004, AM J PHYSIOL-ENDOC M, V286, pE577, DOI 10.1152/ajpendo.00093.2003
   Strem BM, 2005, CYTOTHERAPY, V7, P282, DOI 10.1080/14653240510027226
   Sun HJ, 2006, J ORTHOP RES, V24, P2059, DOI 10.1002/jor.20273
   Talens-Visconti R, 2007, TOXICOL IN VITRO, V21, P324, DOI 10.1016/j.tiv.2006.08.009
   Timper K, 2006, BIOCHEM BIOPH RES CO, V341, P1135, DOI 10.1016/j.bbrc.2006.01.072
   Tontonoz P, 1997, P NATL ACAD SCI USA, V94, P237, DOI 10.1073/pnas.94.1.237
   van Harmelen V, 2004, METABOLISM, V53, P632, DOI 10.1016/j.metabol.2003.11.012
   VAN RLR, 1976, J CLIN INVEST, V58, P699, DOI 10.1172/JCI108516
   Wang DJ, 2004, J BIOL CHEM, V279, P43725, DOI 10.1074/jbc.M407368200
   Wang MJ, 2006, AM J PHYSIOL-REG I, V291, pR880, DOI 10.1152/ajpregu.00280.2006
   Welsh GI, 2004, PROTEOMICS, V4, P1042, DOI 10.1002/pmic.200300675
   Wessells H, 1999, J UROLOGY, V162, P2162, DOI 10.1016/S0022-5347(05)68152-9
   Wickham MQ, 2003, CLIN ORTHOP RELAT R, P196, DOI 10.1097/01.blo.0000072467.53786.ca
   Williams S K, 1989, Ann Vasc Surg, V3, P146, DOI 10.1016/S0890-5096(06)62008-6
   WILLIAMS SK, 1995, CELL TRANSPLANT, V4, P281, DOI 10.1016/0963-6897(95)00006-J
   WILLIAMS SK, 1994, J VASC SURG, V19, P916, DOI 10.1016/S0741-5214(94)70019-2
   Winter A, 2003, ARTHRITIS RHEUM, V48, P418, DOI 10.1002/art.10767
   WRIGHT JT, 1990, J ANIM SCI, V68, P1170
   WRIGHT JT, 1990, INT J OBESITY, V14, P395
   Yamada Y, 2006, BIOCHEM BIOPH RES CO, V342, P662, DOI 10.1016/j.bbrc.2006.01.181
   Yeh GL, 2000, J BONE MINER RES, V15, P2063, DOI 10.1359/jbmr.2000.15.11.2063
   Yoshimura K, 2006, J CELL PHYSIOL, V208, P64, DOI 10.1002/jcp.20636
   Young C, 1992, Cell Transplant, V1, P293
   Young HE, 1999, P SOC EXP BIOL MED, V221, P63, DOI 10.1046/j.1525-1373.1999.d01-55.x
   Zeng Q, 2007, BONE, V40, P374, DOI 10.1016/j.bone.2006.09.022
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
   Zvonic S, 2007, MOL CELL PROTEOMICS, V6, P18, DOI 10.1074/mcp.M600217-MCP200
NR 142
TC 1263
Z9 1350
U1 19
U2 312
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0009-7330
EI 1524-4571
J9 CIRC RES
JI Circ.Res.
PD MAY 11
PY 2007
VL 100
IS 9
BP 1249
EP 1260
DI 10.1161/01.RES.0000265074.83288.09
PG 12
WC Cardiac & Cardiovascular Systems; Hematology; Peripheral Vascular
   Disease
SC Cardiovascular System & Cardiology; Hematology
GA 166SA
UT WOS:000246399100003
PM 17495232
OA Green Published, Green Accepted, Bronze
DA 2018-10-20
ER

PT J
AU Gelain, F
   Horii, A
   Zhang, SG
AF Gelain, Fabrizio
   Horii, Akihiro
   Zhang, Shuguang
TI Designer self-assembling peptide scaffolds for 3-D tissue cell cultures
   and regenerative medicine
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Review
DE 3D scaffolds; bioengineering; biomimetic; microenvironment; molecular
   self-assembly; nanofibers; nanobiotechnology; tissue engineering
ID BETA-SHEET PEPTIDE; COMPLEMENTARY OLIGOPEPTIDE; NANOFIBER SCAFFOLD;
   MATRIX; MEMBRANE; REPAIR
AB Biomaterial science has made enormous progress in the last few decades. Nonetheless, innovative biomaterials are still urgently needed to provide in vitro cell-culture models that more closely resemble three-dimensional (3-D) cell interactions and cyto-architectures in bodies and tissues. In this review, the recent advanced toward this goal through molecular engineering of various designer self-assembling peptide scaffolds are discussed. These peptide scaffolds can be commercially and custom-tailor synthesized materials with high purity and may be not only useful for specific 3-D tissue cell cultures but also for tissue repair and regenerative therapies. Furthermore, these designer self-assembling peptide scaffolds have recently become powerful tools for regenerative medicine to repair nervous tissue, to stop bleeding in seconds, to repair infarctuated myocardia, as well as being useful medical devices for slow drug release.
C1 MIT, Ctr Biomed Engn, Cambridge, MA 02139 USA.
   Univ Milan, Dept Biosci & Biotechnol, I-20126 Milan, Italy.
   Olympus Amer Inc, Center Valley, PA 18034 USA.
RP Zhang, SG (reprint author), MIT, Ctr Biomed Engn, NE47-379, Cambridge, MA 02139 USA.
EM Shuguang@mit.edu
RI Gelain, Fabrizio/K-5069-2012
OI Gelain, Fabrizio/0000-0002-2624-5853
CR Ashammakhi N, 2006, J NANOSCI NANOTECHNO, V6, P2693, DOI 10.1166/jnn.2006.485
   ATALA A, 2001, METHODS TISSUE ENG
   Ayad S., 1998, EXTRACELLULAR MATRIX
   Caplan MR, 2000, BIOMACROMOLECULES, V1, P627, DOI 10.1021/bm005586w
   Caplan MR, 2002, BIOMATERIALS, V23, P219, DOI 10.1016/S0142-9612(01)00099-0
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   GELAIN F, 2007, J NANOSCI, V11, P424
   Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Horii A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000190
   Hwang WM, 2003, J CHEM PHYS, V118, P389, DOI 10.1063/1.1524618
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   KLEINMAN HK, 1986, BIOCHEMISTRY-US, V25, P312, DOI 10.1021/bi00350a005
   Kreis T, 1999, GUIDE BOOK EXTRACELL
   Lanza R, 2000, PRINCIPLES TISSUE EN
   Leon EJ, 1998, J BIOMAT SCI-POLYM E, V9, P297, DOI 10.1163/156856298X00668
   LI WJ, 2006, J BIOMECH
   Marini DM, 2002, NANO LETT, V2, P295, DOI 10.1021/nl015697g
   Nowakowski GS, 2004, STEM CELLS, V22, P1030, DOI 10.1634/stemcells.22-6-1030
   PALSSON B, 2003, TISSUE ENG PRINCIPLE
   Ricard-Blum S., 2000, UNCONVENTIONAL COLLA
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Yokoi H, 2005, P NATL ACAD SCI USA, V102, P8414, DOI 10.1073/pnas.0407843102
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zhang SG, 2002, BIOTECHNOL ADV, V20, P321, DOI 10.1016/S0734-9750(02)00026-5
NR 31
TC 171
Z9 177
U1 2
U2 71
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD MAY 10
PY 2007
VL 7
IS 5
BP 544
EP 551
DI 10.1002/mabi.200700033
PG 8
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 169ZS
UT WOS:000246631200002
PM 17477441
DA 2018-10-20
ER

PT J
AU Nebe, JGB
   Luethen, F
   Lange, R
   Beck, U
AF Nebe, J. G. Barbara
   Luethen, Frank
   Lange, Regina
   Beck, Ulrich
TI Interface interactions of osteoblasts with structured titanium and the
   correlation between physicochemical characteristics and cell biological
   parameters
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Review
DE microstructure; osteoblast adhesion; theory; tissue engineering;
   titanium
ID SURFACE-ROUGHNESS; ADHESION MOLECULES; MATRIX ADHESION; FOCAL ADHESION;
   DYNAMICS; ORGANIZATION; TOPOGRAPHY; GROWTH; 1-ALPHA,25-(OH)(2)D-3;
   MECHANOTRANSDUCTION
AB Cellular behavior at the interface of an implant is influenced by the material's topography. However, little is known about the correlation between the biological parameters and the physicochemical characteristics of the biomaterial. We therefore modified pure titanium surfaces by polishing, machining, blasting with glass spheres, blasting with corundum particles, and vacuum plasma spraying to give progressively higher surface roughness. The material surface was characterized by SEM, surface profiling, and electrochemical methods. We revealed a correlation for integrin expression and formation, adhesion, spreading, proliferation, and bone sialo protein expression with the physicochemical parameters of the titanium surfaces.
C1 Univ Rostock, Dept Internal Med, BMFZ, D-18057 Rostock, Germany.
   Univ Rostock, Dept Elect Engn & Informat Technol, D-18051 Rostock, Germany.
RP Nebe, JGB (reprint author), Univ Rostock, Dept Internal Med, BMFZ, Schillingallee 69, D-18057 Rostock, Germany.
EM barbara.nebe@med.uni-rostock.de
CR Abramson SD, 2005, J BIOMED MATER RES A, V73A, P116, DOI 10.1002/jbm.a.30266
   Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Anselme K, 2006, J MATER SCI-MATER M, V17, P471, DOI 10.1007/s10856-006-8475-8
   Anselme K, 2006, BIOMATERIALS, V27, P1187, DOI 10.1016/j.biomaterials.2005.10.009
   Anselme K, 2000, BIOMATERIALS, V21, P1567, DOI 10.1016/S0142-9612(00)00042-9
   Aplin AE, 1999, CURR OPIN CELL BIOL, V11, P737, DOI 10.1016/S0955-0674(99)00045-9
   Bigerelle M, 2005, ACTA BIOMATER, V1, P499, DOI 10.1016/j.actbio.2005.06.001
   Bigerelle M, 2005, J BIOMED MATER RES A, V72A, P36, DOI 10.1002/jbm.a.30212
   Bissell MJ, 1999, CURR OPIN CELL BIOL, V11, P537, DOI 10.1016/S0955-0674(99)00029-0
   Boyan BD, 1998, J BIOMED MATER RES, V39, P77, DOI 10.1002/(SICI)1097-4636(199801)39:1<77::AID-JBM10>3.0.CO;2-L
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Cohen M, 2003, BIOPHYS J, V85, P1996, DOI 10.1016/S0006-3495(03)74627-X
   Dalby MJ, 2007, J CELL BIOCHEM, V100, P326, DOI 10.1002/jcb.21058
   Dalby MJ, 2005, MED ENG PHYS, V27, P730, DOI 10.1016/j.medengphy.2005.04.005
   DAVIES JE, 2000, BONE ENG
   Degasne I, 1999, CALCIFIED TISSUE INT, V64, P499, DOI 10.1007/s002239900640
   Diener A, 2005, BIOMATERIALS, V26, P383, DOI [10.1016/j.biomaterials.2004.02.038, 10.1016/j.biomaterials.2004.02.019]
   FAUCHEUX N, 2000, BIOMATERIALIEN, V4, P101
   Frank O, 2002, J CELL BIOCHEM, V85, P737, DOI 10.1002/jcb.10174
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Gronowicz G, 1996, J ORTHOPAED RES, V14, P878, DOI 10.1002/jor.1100140606
   Hall A, 2000, PHILOS T R SOC B, V355, P965, DOI 10.1098/rstb.2000.0632
   Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343
   Ideker T, 2004, ADV EXP MED BIOL, V547, P21
   Ingber DE, 2003, J CELL SCI, V116, P1397, DOI 10.1242/jcs.00360
   Ingber D, 1991, CURR OPIN CELL BIOL, V3, P841, DOI 10.1016/0955-0674(91)90058-7
   JOYCE AR, 2007, PROG DRUG RES, V64, P267
   Kirbs A, 2003, MAT SCI ENG C-BIO S, V23, P413, DOI 10.1016/S0928-4931(02)00313-2
   Kirbs A, 2003, MAT SCI ENG C-BIO S, V23, P425, DOI 10.1016/S0928-4931(02)00315-6
   Lange R, 2002, BIOMOL ENG, V19, P255, DOI 10.1016/S1389-0344(02)00047-3
   LANGE R, 2004, BIOMATERIALIEN, V5, P74
   LANGE R, 2007, IN PRESS BIOMOL ENG
   Lee TM, 2002, J MATER SCI-MATER M, V13, P341, DOI 10.1023/A:1014393815923
   Lim JY, 2007, BIOMATERIALS, V28, P1787, DOI 10.1016/j.biomaterials.2006.12.020
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   Luthen F, 2005, BIOMATERIALS, V26, P2423, DOI 10.1016/j.biomaterials.2004.07.054
   Meredith JC, 2003, J BIOMED MATER RES A, V66A, P483, DOI 10.1002/jbm.a.10004
   NEBE B, 1995, EXP CELL RES, V218, P479, DOI 10.1006/excr.1995.1181
   Nebe B, 2004, MAT SCI ENG C-BIO S, V24, P619, DOI 10.1016/j.msec.2004.08.034
   NEBE B, 2007, IN PRESS BIOMOL ENG
   NEBE B, 2005, BIOMATERIALIEN, V6, P35
   Pommerenke H, 1996, EUR J CELL BIOL, V70, P157
   Raz P, 2004, J BIOMED MATER RES A, V71A, P217, DOI 10.1002/jbm.a.30134
   Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175
   Rychly J, 1998, CELL BIOL INT, V22, P7, DOI 10.1006/cbir.1997.0210
   Schneider GB, 2001, J DENT RES, V80, P1540, DOI 10.1177/00220345010800061201
   Schwartz Z, 2001, J BIOMED MATER RES, V56, P417, DOI 10.1002/1097-4636(20010905)56:3<417::AID-JBM1111>3.0.CO;2-K
   Shapiro HM, 1988, PRACTICAL FLOW CYTOM
   Webster T. J., 1999, BIOMATERIALS, V20, P1231
   Yamada KM, 2003, BRAZ J MED BIOL RES, V36, P959, DOI 10.1590/S0100-879X2003000800001
   Zaidel-Bar R, 2004, BIOCHEM SOC T, V32, P416, DOI 10.1042/BST0320416
   Zamir E, 2000, NAT CELL BIOL, V2, P191
   Zimmerman E, 2002, BIOPHYS J, V82, P1848, DOI 10.1016/S0006-3495(02)75535-5
NR 53
TC 42
Z9 43
U1 1
U2 10
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD MAY 10
PY 2007
VL 7
IS 5
BP 567
EP 578
DI 10.1002/mabi.200600293
PG 12
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 169ZS
UT WOS:000246631200004
PM 17457937
DA 2018-10-20
ER

PT J
AU Kim, HJ
   Kim, UJ
   Leisk, GG
   Bayan, C
   Georgakoudi, I
   Kaplan, DL
AF Kim, Hyeon Joo
   Kim, Ung-Jin
   Leisk, Gary G.
   Bayan, Christopher
   Georgakoudi, Irene
   Kaplan, David L.
TI Bone regeneration on macroporous aqueous-derived silk 3-D scaffolds
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE bone; osteogenesis; silk; spinner flask; stem cells
ID MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; IN-VITRO; FLUID-FLOW;
   MECHANICAL-PROPERTIES; PROTEIN SCAFFOLDS; TISSUE; STRESS;
   DIFFERENTIATION; BIOMATERIALS
AB Spinner flask culture under osteogenic conditions was used to study osteogenic outcomes from human bone marrow-derived mesenchymal stem cells (hMSCs) seeded on aqueous-derived porous silk scaffolds. Of particular novelty was the use of larger sized scaffolds (15 mm diameter, 5 mm thick) and large pore sizes (approximate to 900-1000 micron diameter). Cultures were maintained for 84 d in the spinner flasks and compared to static controls under otherwise similar conditions. The spinner flask cultures demonstrated enhanced cell proliferation compared to static cultures and the improved fluid flow promoted significantly improved osteogenic related outcomes based on elevated alkaline phosphatase (ALP) activity and the deposition of mineralized matrix. The expression of osteogenic differentiation associated markers based on real time PCR also demonstrated increased responses under the dynamic spinner flask culture conditions. Histological analysis showed organized bone-like structures in the constructs cultured in the spinner flasks after 56 d of culture. These structures stained intensely with von Kossa. The combination of improved transport due to spinner flask culture and the use of macroporous 3D aqueous-derived silk scaffolds with large pore sizes resulted in enhanced outcomes related to bone tissue engineering, even with the use of large sized scaffolds in the study. These results suggest the importance of the structure of the silk biomaterial substrate (water vs. solvent based preparation) and large pore sizes in improved bone-like outcomes during dynamic cultivation.
C1 Tufts Univ, Ctr Biotechnol, Dept Biomed Engn, Medford, MA 02155 USA.
   Tufts Univ, Ctr Biotechnol, Dept Chem Engn, Medford, MA 02155 USA.
   Tufts Univ, Ctr Biotechnol, Dept Biol Engn, Medford, MA 02155 USA.
   Tufts Univ, Ctr Biotechnol, Dept Mech Engn, Medford, MA 02155 USA.
   Tufts Univ, Ctr Biotechnol, Dept Bioengn, Medford, MA 02155 USA.
   Samsung Fine Chem Co, R&D Ctr, Mecellose R&D Team, Taejon 305380, South Korea.
RP Kaplan, DL (reprint author), Tufts Univ, Ctr Biotechnol, Dept Biomed Engn, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
CR Abedi M, 2004, EXP HEMATOL, V32, P426, DOI 10.1016/j.exphem.2004.02.007
   Akhouayri Omar, 1999, Journal of Cellular Biochemistry, V76, P217
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Aubin JE, 1995, BONE, V17, P77
   BERESFORD JN, 1992, J CELL SCI, V102, P341
   CHAMBERS TJ, 1993, BONE MINER, V20, P167, DOI 10.1016/S0169-6009(08)80025-6
   CHEN JK, 1993, MATRIX, V13, P113, DOI 10.1016/S0934-8832(11)80070-3
   Cooper LF, 1998, INT J ORAL MAX IMPL, V13, P163
   Davisson T, 2002, J ORTHOPAED RES, V20, P842, DOI 10.1016/S0736-0266(01)00160-7
   Elliott JA, 2002, J MATER SCI, V37, P1547, DOI 10.1023/A:1014920902712
   Estes BT, 2004, CURR TOP DEV BIOL, V60, P91
   Gong SJ, 2006, BIOMATERIALS, V27, P3793, DOI 10.1016/j.biomaterials.2006.02.019
   Heng BC, 2004, J BONE MINER RES, V19, P1379, DOI 10.1359/JBMR.040714
   Ignatius A, 2005, BIOMATERIALS, V26, P311, DOI 10.1016/j.biomaterials.2004.02.045
   Kim HJ, 2005, AUST J CHEM, V58, P716, DOI 10.1071/CH05170
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   KLEINNULEND J, 1995, FASEB J, V9, P441
   Kobayashi N, 2004, EXP HEMATOL, V32, P1238, DOI 10.1016/j.exphem.2004.08.011
   KUFAHL RH, 1990, J BIOMECH, V23, P171, DOI 10.1016/0021-9290(90)90350-C
   Lee SJ, 2006, BIOMATERIALS, V27, P3466, DOI 10.1016/j.biomaterials.2006.01.059
   LEHUEC JC, 1995, BIOMATERIALS, V16, P113, DOI 10.1016/0142-9612(95)98272-G
   Lian J B, 1998, J Cell Biochem Suppl, V30-31, P62
   Lian J B, 1993, J Oral Implantol, V19, P95
   LIAN JB, 1992, CRIT REV ORAL BIOL M, V3, P269, DOI 10.1177/10454411920030030501
   LONNERDAL B, 1987, J NUTR, V117, P1385
   MARTIN RB, 1993, BIOMATERIALS, V14, P341, DOI 10.1016/0142-9612(93)90052-4
   Mauney JR, 2004, CALCIFIED TISSUE INT, V74, P458, DOI 10.1007/s00223-003-0104-7
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4
   Meinel L, 2004, BIOTECHNOL BIOENG, V88, P379, DOI 10.1002/bit.20252
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   Ochi K, 2003, J CELL PHYSIOL, V194, P45, DOI 10.1002/jcp.10185
   OZAWA H, 1990, J CELL PHYSIOL, V142, P177, DOI 10.1002/jcp.1041420122
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Park JS, 2004, BIOTECHNOL BIOENG, V88, P359, DOI 10.1002/bit.20250
   Rocha LB, 2002, BIOMATERIALS, V23, P449, DOI 10.1016/S0142-9612(01)00126-0
   Sikavitsas VI, 2001, BIOMATERIALS, V22, P2581, DOI 10.1016/S0142-9612(01)00002-3
   Sikavitsas VI, 2002, J BIOMED MATER RES, V62, P136, DOI 10.1002/jbm.10150
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Takano Y, 1999, J ORTHOP RES, V17, P59, DOI 10.1002/jor.1100170110
   Tanck E, 2001, BONE, V28, P650, DOI 10.1016/S8756-3282(01)00464-1
   Tate MLK, 1998, AM J MED SCI, V316, P189, DOI 10.1097/00000441-199809000-00007
   Thi MM, 2003, AM J PHYSIOL-CELL PH, V284, pC389, DOI 10.1152/ajpcell.00052.2002
   Turner CH, 1996, AM J PHYSIOL-ENDOC M, V270, pE634
   TURNER CH, 1994, FASEB J, V8, P875
   Vuola J, 1998, BIOMATERIALS, V19, P223, DOI 10.1016/S0142-9612(97)00211-1
   Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022
   WEINBAUM S, 1994, J BIOMECH, V27, P339, DOI 10.1016/0021-9290(94)90010-8
   Wierzbicki T, 2003, J APPL MECH-T ASME, V70, P204, DOI 10.1115/1.1546242
   Wiesmann Anne, 2006, Head Face Med, V2, P8, DOI 10.1186/1746-160X-2-8
   Yamada Y, 2003, J CRANIO MAXILL SURG, V31, P27, DOI 10.1016/S1010-5182
NR 53
TC 91
Z9 95
U1 2
U2 29
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD MAY 10
PY 2007
VL 7
IS 5
BP 643
EP 655
DI 10.1002/mabi.200700030
PG 13
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 169ZS
UT WOS:000246631200012
PM 17477447
DA 2018-10-20
ER

PT J
AU Zhang, SF
   Wright, JEI
   Ozber, N
   Uludag, H
AF Zhang, Sufeng
   Wright, Jennifer E. I.
   Ozber, Natali
   Uludag, Hasan
TI The interaction of cationic polymers and their bisphosphonate
   derivatives with hydroxyapatite
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE bisphosphonates; hydroxyapatite; mineral affinity; poly(ethylenimine);
   poly(L-lysine)
ID RAT ECTOPIC MODEL; BIOMATERIAL CARRIERS; MINERAL AFFINITY; BONE
   AFFINITY; GENE DELIVERY; IN-VITRO; PROTEINS; POLYETHYLENIMINE;
   ADSORPTION; CALCIUM
AB Conjugating proteins with bisphosphonates (BPs), a class of molecules with exceptional affinity to hydroxyapatite (HA), is a feasible means to impart bone affinity to protein-based therapeutic agents. To increase the targeting effectiveness while minimizing protein modification, a polymeric linker containing multiple copies of BPs could be constructed for protein conjugation and targeting to bone. Towards this goal, poly(L-lysine) (PLL) and poly(ethylenimine) (PEI) were utilized as the polymeric backbones to incorporate a BP, namely 2-(3-mercaptopropylsulfanyl) -ethyl-1,1-bisphosphonic acid (thioIBP), by using N-hydroxysuccinimidyl polyethylene glycol maleimide and succinimidyl-4-(N-maleimidomethyl)-cydohexane-1-carboxylate, respectively. In vitro and in vivo mineral affinity of the polymer-BP conjugates were determined in comparison with the unmodified polymers. The in vitro results indicated strong binding of the cationic polymers to HA in their unmodified form. BP conjugation did not enhance the inherent mineral affinity of the polymers; in contrast, certain modifications negatively affected the polymers' binding to the HA. In vivo results from a subcutaneous implant model in rats also showed no significant difference in mineral affinity of the BP modified and unmodified PEI. We conclude that thiolBP conjugation to the cationic polymers PLL and PEI was not beneficial for increasing the mineral affinity of the polymeric molecules. The strong interaction between the cationic polymers and HA may make the polymers suitable for imparting mineral affinity to bone-acting therapeutics.
C1 Univ Alberta, Fac Engn, Dept Chem & Mat Engn, Edmonton, AB T6G 2G6, Canada.
   Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada.
   Univ Alberta, Fac Med & Dent, Dept Biomed Engn, Edmonton, AB T6G 2N8, Canada.
   Koc Univ, Coll Engn, Dept Biol & Chem Engn, Istanbul, Turkey.
RP Uludag, H (reprint author), Univ Alberta, Fac Engn, Dept Chem & Mat Engn, Edmonton, AB T6G 2G6, Canada.
EM hasan.uludag@ualberta.ca
CR Akari S, 1996, BER BUNSEN PHYS CHEM, V100, P1014, DOI 10.1002/bbpc.19961000652
   AMES BN, 1966, METHOD ENZYMOL, V8, P115, DOI DOI 10.1016/0076-6879(66)08014-5
   Aydin HM, 2006, INT J ARTIF ORGANS, V29, P873
   Bansal G, 2005, J BIOMED MATER RES A, V74A, P618, DOI 10.1002/jbm.a.30334
   Bansal G, 2005, ANGEW CHEM INT EDIT, V44, P3710, DOI 10.1002/anie.200500350
   Bansal G, 2004, J PHARM SCI-US, V93, P2788, DOI 10.1002/jps.20186
   Bernardi G., 1971, METHOD ENZYMOL, V21, P95
   BOHMER MR, 1990, MACROMOLECULES, V23, P2288, DOI 10.1021/ma00210a027
   BOSKEY AL, 2005, BONE TISSUE ENG, P111
   Bullock J, 1997, ANAL BIOCHEM, V254, P254, DOI 10.1006/abio.1997.2405
   DALEYYATES PT, 1992, CHEM-BIOL INTERACT, V81, P79, DOI 10.1016/0009-2797(92)90028-J
   Davis ME, 2002, J INCL PHENOM MACRO, V44, P17, DOI 10.1023/A:1023063117423
   Duncan R, 2003, NAT REV DRUG DISCOV, V2, P347, DOI 10.1038/nrd1088
   Durrieu MC, 2004, J MATER SCI-MATER M, V15, P779, DOI 10.1023/B:JMSM.0000032818.09569.d9
   FLEISCH H, 1966, NATURE, V212, P901, DOI 10.1038/212901a0
   FREITAG R, 1995, J CHROMATOGR A, V691, P101, DOI 10.1016/0021-9673(94)01000-5
   Gittens SA, 2003, PHARMACEUT RES, V20, P978, DOI 10.1023/A:1024445903306
   Gittens SA, 2005, MOL PHARMACEUT, V2, P392, DOI 10.1021/mp050017u
   GORBUNOFF MJ, 1984, ANAL BIOCHEM, V136, P425, DOI 10.1016/0003-2697(84)90239-2
   HALL HK, 1957, J AM CHEM SOC, V79, P5441, DOI 10.1021/ja01577a030
   Harding IS, 2005, BIOMATERIALS, V26, P6818, DOI 10.1016/j.biomaterials.2005.04.060
   Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033
   HERMANSON GT, 1996, BIOCONJUGATE TECHNIQ, P605
   Hu M, 2000, TISSUE ENG, V6, P585, DOI 10.1089/10763270050199532
   Itoh D, 2002, J BIOMED MATER RES, V62, P292, DOI 10.1002/jbm.10338
   Lin JH, 1996, BONE, V18, P75, DOI 10.1016/8756-3282(95)00445-9
   LINDQUIST GM, 1976, J COLLOID INTERF SCI, V55, P45, DOI 10.1016/0021-9797(76)90007-2
   Majoros IJ, 2003, MACROMOLECULES, V36, P5526, DOI 10.1021/ma021540e
   Meszaros R, 2002, LANGMUIR, V18, P6164, DOI 10.1021/la011776w
   Muller M, 2006, BIOMACROMOLECULES, V7, P1285, DOI 10.1021/bm050631r
   ONG CP, 1994, J BIOTECHNOL, V34, P259, DOI 10.1016/0168-1656(94)90061-2
   PERRINE TD, 1967, J POLYM SCI A1, V5, P1993, DOI 10.1002/pol.1967.150050816
   Pessela BCC, 2005, ENZYME MICROB TECH, V37, P295, DOI 10.1016/j.enzmictec.2005.04.021
   PIMM MV, 1995, J CONTROL RELEASE, V37, P161, DOI 10.1016/0168-3659(95)00080-R
   Radeva T, 1997, J COLLOID INTERF SCI, V196, P87, DOI 10.1006/jcis.1997.5166
   Sawyer AA, 2005, BIOMATERIALS, V26, P7046, DOI 10.1016/j.biomaterials.2005.05.006
   Soukos NS, 1998, ANTIMICROB AGENTS CH, V42, P2595, DOI 10.1128/AAC.42.10.2595
   Suh J, 1997, BIOORG CHEM, V25, P221, DOI 10.1006/bioo.1997.1066
   TISELIUS A, 1956, ARCH BIOCHEM BIOPHYS, V65, P132, DOI 10.1016/0003-9861(56)90183-7
   Uludag H, 2000, BIOTECHNOL PROGR, V16, P258, DOI 10.1021/bp990154m
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 2002, BIOTECHNOL PROGR, V18, P604, DOI 10.1021/bp0200447
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   VANDESTEEG HGM, 1992, LANGMUIR, V8, P2538, DOI 10.1021/la00046a030
   Varkey M, 2006, CLIN ORTHOP RELAT R, P113, DOI 10.1097/01.blo.0000200236.84189.87
   Vogt AK, 2003, BIOTECHNOL PROGR, V19, P1562, DOI 10.1021/bp034016f
   von Harpe A, 2000, J CONTROL RELEASE, V69, P309, DOI 10.1016/S0168-3659(00)00317-5
   Wang D, 2005, ADV DRUG DELIVER REV, V57, P1049, DOI 10.1016/j.addr.2004.12.011
   Wang L, 2006, CHEM COMMUN, P2795, DOI 10.1039/b605365c
   Wright JEI, 2006, BIOMATERIALS, V27, P769, DOI 10.1016/j.biomaterials.2005.06.012
   ZHANG S, 2006, CHEM SOC REV, V36, P507
   Zhang SF, 2005, BIOMACROMOLECULES, V6, P2800, DOI 10.1021/bm050273s
NR 52
TC 23
Z9 23
U1 0
U2 21
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD MAY 10
PY 2007
VL 7
IS 5
BP 656
EP 670
DI 10.1002/mabi.200600286
PG 15
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 169ZS
UT WOS:000246631200013
PM 17457941
DA 2018-10-20
ER

PT J
AU Ritz, R
   Roser, F
   Morgalla, M
   Dietz, K
   Tatagiba, M
   Will, BE
AF Ritz, Rainer
   Roser, Florian
   Morgalla, Matthias
   Dietz, Klaus
   Tatagiba, Marcos
   Will, Bernd E.
TI Do antibiotic-impregnated shunts in hydrocephalus therapy reduce the
   risk of infection? An observational study in 258 patients
SO BMC INFECTIOUS DISEASES
LA English
DT Article
ID CEREBROSPINAL-FLUID SHUNT; CHILDREN; CATHETERS; MENINGITIS;
   COMPLICATIONS; BIOMATERIAL; EXPERIENCE; DURATION; ADHESION; INFANTS
AB Background: Shunt infection in hydrocephalus patients is a severe, even life-threatening complication. Antibiotic-impregnated shunts (AIS) have been developed in an attempt to reduce rate of shunt infection. The study was performed to analyze if AIS can diminish the rate of shunt infection. The pathogenic nature of shunt infection in patients with AIS systems and those without antibiotic impregnated shunts (non-AIS) was compared.
   Methods: Over a period of 24 months in the Department of Neurosurgery at University Hospital of Tubingen shunt surgery was performed in 258 patients. In 86 patients AIS systems were implanted. Shunt catheters were commercially impregnated with clindamycin and rifampicin. Analysis of the clinical data included sex, age, classification of hydrocephalus, shunt types and risk factors for shunt infection [ age (< 1 year and > 80 years), prematurely born patients, external ventricular drainage, former shunt infection, former systemic infection, disturbance of consciousness, former radiation-/chemotherapy]. Infection rates and underlying bacterial pathogens of patients with AIS were compared to patients with implanted non-AIS systems ( 172 patients).
   Results: AIS and non-AIS patients did not differ in sex, etiology of hydrocephalus and the shunt type. In the AIS group 72 out of 86 patients had at least one risk factor (83.7%), compared to 126 patients in the non-AIS group (73.3%). There was no significant difference between the two groups ( p = 0.0629; Fisher's exact test). In patients with no risk factors, only one patient with non-AIS suffered from shunt infection. In patients with one or more risk factors the rate for shunt infection was 7.14% in patients with non-AIS and 6.94% in patients with AIS. Former shunt infection ( p = 0.0124) was related to higher risk for shunt infection. The use of AIS had therefore no significant advantage ( p = 0.8611; multiple logistic regression).
   Significantly related to a shunt infection was the number of shunt surgeries. 190 interventions in the AIS group ( 2.21 interventions per patient) and 408 in the non-AIS group ( 2.37 interventions per patient) had been performed ( p = 0.3063; Wilcoxon). There was no shunt infection in the group of patients on whom only one shunt surgery was performed. In patients with at least two shunt surgeries the infection rate was 9%. The infection rate in AIS patients was 5/52 (9.6%) and in the non-AIS 10/114 (8.77%), ( p = 1.0; Fisher's exact test). Staphylococcus epidermidis was the most frequent pathogen for shunt infection. Fourteen out of 15 infections occurred within the first 6 months of surgery. The most frequent pathogen for shunt infection was S. epidermidis. No toxic or allergic complications were seen using the AIS shunt systems. The presented data show a remarkably low infection rate of 5.8% in the non-AIS group compared to other studies which demonstrated a significant decrease in the infection rate by AIS.
   Conclusion: AIS did not significantly reduce shunt infection in hydrocephalus patients in the presented study. In the AIS group three patients suffered from shunt infections caused by skin ulceration or neurosurgical procedures with exposure of the cerebrospinal liquor after shunt implantation. AIS was not developed to prevent infection in such cases, therefore an advantage of AIS can not be excluded. In view of the presented data and the small number of reported studies a prospective randomized multicenter study is required.
C1 Univ Tubingen Hosp, Dept Neurosurg, D-72076 Tubingen, Germany.
   Univ Tubingen, Dept Med Biometry, D-72070 Tubingen, Germany.
RP Ritz, R (reprint author), Univ Tubingen Hosp, Dept Neurosurg, Hoppe Seyler Str 3, D-72076 Tubingen, Germany.
EM rainer.ritz@med.uni-tuebingen.de; f.roser@gmx.de;
   matthias.morgalla@med.unituebingen.de; klaus.dietz@uni-tuebingen.de;
   marcos.tatagiba@med.uni-tuebingen.de; bernd.will@med.uni-tuebingen.de
RI Dietz, Klaus/R-9268-2016
OI Dietz, Klaus/0000-0001-8503-9737
CR AMMIRATI M, 1987, CHILD NERV SYST, V3, P106, DOI 10.1007/BF00271135
   Aryan HE, 2005, CHILD NERV SYST, V21, P56, DOI 10.1007/s00381-004-1052-x
   Bayston R, 2004, J ANTIMICROB CHEMOTH, V53, P778, DOI 10.1093/jac/dkh183
   BAYSTON R, 1974, DEV MED CHILD NEUROL, V16, P16
   Bayston R, 1997, J NEUROSURG, V87, P247, DOI 10.3171/jns.1997.87.2.0247
   BORGBJERG BM, 1995, ACTA NEUROCHIR, V136, P1, DOI 10.1007/BF01411427
   Brown EM, 2002, CLIN INFECT DIS, V34, P556, DOI 10.1086/338019
   Choksey MS, 2004, J NEUROL NEUROSUR PS, V75, P87
   CHOUX M, 1992, J NEUROSURG, V77, P875, DOI 10.3171/jns.1992.77.6.0875
   Davis SE, 1999, PEDIATR NEUROSURG, V30, P253, DOI 10.1159/000028806
   Ersahin Y, 1994, J Neurosurg Sci, V38, P161
   FAILLACE WJ, 1995, SURG NEUROL, V43, P344, DOI 10.1016/0090-3019(95)80060-T
   Filka J, 1999, ACTA PAEDIATR, V88, P576, DOI 10.1080/08035259950169620
   Forgacs P, 2001, CLIN INFECT DIS, V32, P179, DOI 10.1086/318471
   FORWARD KR, 1983, J NEUROSURG, V59, P389, DOI 10.3171/jns.1983.59.3.0389
   GEORGE R, 1979, J NEUROSURG, V51, P804, DOI 10.3171/jns.1979.51.6.0804
   Govender ST, 2003, J NEUROSURG, V99, P831, DOI 10.3171/jns.2003.99.5.0831
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GUEVARA JA, 1987, J NEUROSURG, V67, P438, DOI 10.3171/jns.1987.67.3.0438
   Kanev PM, 2003, PEDIATR NEUROSURG, V39, P285, DOI 10.1159/000075255
   KESTLE JRW, 1993, CHILD NERV SYST, V9, P163
   Kulkarni AV, 2001, J NEUROSURG, V94, P195, DOI 10.3171/jns.2001.94.2.0195
   Mancao M, 1998, ACTA PAEDIATR, V87, P667, DOI 10.1080/080352598750014085
   Pattavilakom A, 2006, NEUROSURGERY, V58, P930, DOI 10.1227/01.NEU.0000210155.65102.E7
   POPLE IK, 1992, J NEUROSURG, V77, P29, DOI 10.3171/jns.1992.77.1.0029
   QUIGLEY MR, 1989, PEDIATR NEUROSCI, V15, P111, DOI 10.1159/000120455
   SCHIFF SJ, 1989, PEDIATR NEUROSCI, V15, P131, DOI 10.1159/000120458
   Sciubba DM, 2005, J NEUROSURG, V103, P131, DOI 10.3171/ped.2005.103.2.0131
   SERLO W, 1990, CHILD NERV SYST, V6, P92, DOI 10.1007/BF00307928
   SHAPIRO S, 1988, NEUROSURGERY, V22, P868, DOI 10.1227/00006123-198805000-00009
   SHURTLEF.DB, 1973, AM J DIS CHILD, V125, P688, DOI 10.1001/archpedi.1973.04160050042008
   Wang KW, 2004, JPN J INFECT DIS, V57, P44
   ZENTNER J, 1995, NEUROSURG REV, V18, P169, DOI 10.1007/BF00383721
   2007, POWERSAMPLESIZE
NR 34
TC 58
Z9 60
U1 0
U2 3
PU BIOMED CENTRAL LTD
PI LONDON
PA MIDDLESEX HOUSE, 34-42 CLEVELAND ST, LONDON W1T 4LB, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD MAY 8
PY 2007
VL 7
AR 38
DI 10.1186/1471-2334-7-38
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA 175LF
UT WOS:000247014400001
PM 17488498
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Maeda, Y
   Vaizey, CJ
   Kamm, MA
AF Maeda, Y.
   Vaizey, C. J.
   Kamm, M. A.
TI Long-term results of perianal silicone injection for faecal incontinence
SO COLORECTAL DISEASE
LA English
DT Article
DE passive faecal incontinence; silicone biomaterial; injection; long term
ID ANAL-SPHINCTER DYSFUNCTION; CROSS-LINKED COLLAGEN;
   POLYTETRAFLUOROETHYLENE INJECTION; URINARY-INCONTINENCE; FOLLOW-UP;
   BIOMATERIAL; MIGRATION; COMPLICATIONS; BEADS
AB Objective Perianal injection of bulking agents is a simple method for treating passive faecal incontinence. To date only short-term results of treatment are available. This study is the first to determine the efficacy of silicone biomaterial (PTQ(TM); Uroplasty BV, Geleen, The Netherlands) injection in the long term.
   Method Six patients, median age 53 years at the time of injection with PTQ, were followed up at 61 months. A validated faecal incontinence score, treatment-specific questionnaire and SF-36 health survey questionnaire were completed.
   Results At 61-month follow up one patient had undergone a colostomy for faecal incontinence. In the remaining five patients the incontinence score was little changed: 11 (8-20) vs 13 (9-19) [pre v at 61 months, median (range)]. However, there was a substantial improvement in physical and social function on the SF-36 scores. Satisfaction scores were high at a median 7 of 10 (range: 0-8). Subjectively, three patients were improved; one of these had undergone a further set of injections and one improved after a course of biofeedback. After the follow-up period one of the five patients had a colostomy for recto-vaginal fistula.
   Conclusion The results of perianal injection of PTQ for passive faecal incontinence are variable in the long term. More extensive evaluation in the short term, and possibly repeated treatment, may be required.
C1 St Marks Hosp, Harrow HA1 3UJ, Middx, England.
RP Vaizey, CJ (reprint author), St Marks Hosp, Watford Rd, Harrow HA1 3UJ, Middx, England.
EM carolynne.vaizey@nwlh.nhs.uk
RI Maeda, Yasuko/B-6123-2016
OI Maeda, Yasuko/0000-0002-4081-4741
CR Aragona F, 1997, J UROLOGY, V158, P1539, DOI 10.1016/S0022-5347(01)64275-7
   Bano F, 2005, INT UROGYNECOL J, V16, P147, DOI 10.1007/s00192-004-1216-y
   Chrouser KL, 2004, J UROLOGY, V171, P1152, DOI 10.1097/01.ju.0000103688.83606.06
   Currie I, 1997, Int Urogynecol J Pelvic Floor Dysfunct, V8, P377, DOI 10.1007/BF02765599
   Davis K, 2003, ALIMENT PHARM THERAP, V18, P237, DOI 10.1046/j.0269-2813.2003.01668.x
   Dewan PA, 1996, AUST NZ J SURG, V66, P57, DOI 10.1111/j.1445-2197.1996.tb00708.x
   Gorton E, 1999, BJU INT, V84, P966
   Kenefick NJ, 2002, GUT, V51, P225, DOI 10.1136/gut.51.2.225
   Kumar D, 1998, BRIT J SURG, V85, P978
   MALIZIA AA, 1984, JAMA-J AM MED ASSOC, V251, P3277, DOI 10.1001/jama.251.24.3277
   Malouf AJ, 2001, DIS COLON RECTUM, V44, P595, DOI 10.1007/BF02234337
   Pannek J, 2001, J UROLOGY, V166, P1350, DOI 10.1016/S0022-5347(05)65767-9
   SHAFIK A, 1993, INT SURG, V78, P159
   SHAFIK A, 1995, DIS COLON RECTUM, V38, P583, DOI 10.1007/BF02054115
   Stenberg AM, 2003, INT UROGYNECOL J PEL, V14, P335, DOI 10.1007/s00192-003-1075-y
   Sweat SD, 1999, J UROLOGY, V161, P93, DOI 10.1016/S0022-5347(01)62074-3
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
   Vaizey CJ, 1999, GUT, V44, P77, DOI 10.1136/gut.44.1.77
   WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002
   Zarini E, 2004, PLAST RECONSTR SURG, V114, P934, DOI 10.1097/01.PRS.0000133125.22598
NR 20
TC 30
Z9 31
U1 0
U2 1
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 1462-8910
J9 COLORECTAL DIS
JI Colorectal Dis.
PD MAY 4
PY 2007
VL 9
IS 4
BP 357
EP 361
DI 10.1111/j.1463-1318.2006.01164.x
PG 5
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA 154KE
UT WOS:000245505100013
PM 17432990
DA 2018-10-20
ER

PT J
AU Pataro, AL
   Oliveira, MF
   Teixeira, KIR
   Turchetti-Maia, RMM
   Lopes, MTP
   Wykrota, FHL
   Sinisterra, RD
   Cortes, ME
AF Pataro, Andre L.
   Oliveira, Michele F.
   Teixeira, Karina I. R.
   Turchetti-Maia, Regina M. M.
   Lopes, Miriam T. P.
   Wykrota, Francisco H. L.
   Sinisterra, Ruben D.
   Cortes, Maria E.
TI Polymer: Bioceramic composites optimization by tetracycline addition
SO INTERNATIONAL JOURNAL OF PHARMACEUTICS
LA English
DT Article
DE tetracycline; bioceramic; polymer; composite; biocompatibility
ID MINOCYCLINE; INHIBITION; BONE; DOXYCYCLINE; BIOMATERIAL; ACTIVATION;
   THERAPY; RELEASE; DENTIN; CELLS
AB The aim of this study was to evaluate the biocompatibility of composites of poly-lactic acid polymer (PLA) and copolymer of lactic and glycolic acid (PLGA), dispersed in a bioceramic matrix, Osteosynt (R) (BC), to which tetracycline ITC) was added. The in vitro test used direct contact test (ASTM F-813) and elution test (USP-XXIII, ISO 10993-5), and in vivo evaluation was performed after subcutaneous implantation in outbread Swiss mice. The 0.01% (w/w) TC addition did not affect composite cytotoxicity in vitro. The macroscopic and histologic evaluation in vivo after 1, 7, 13, 21, 28 and 56 days showed an initial intense infiltrate of inflammatory cells for most of the groups. The tissue showed normal pattern after 21 days for all the groups. TC addition exhibited significantly larger reduction of inflammation signs (Mann-Whitney test, p < 0.05) in the critical period of the resolution of the inflammatory process. Angiogenesis, cellular adsorption and fibrous deposit were observed on SEM evaluation. In conclusion, TC addition optimized composites polymer/bioceramic biocompatibility, contributing to anti-inflammatory response during the early phases of the wound healing process. (C) 2006 Elsevier B.V. All rights reserved.
C1 Hosp Sao Bento, Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, ICB, Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Dept Quim, Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Dept Odontol Restauradora, Fac Odontol, Belo Horizonte, MG, Brazil.
RP Cortes, ME (reprint author), Av Antonio Carlos,6627, BR-31270901 Belo Horizonte, MG, Brazil.
EM mecortes@yahoo.com
RI Lopes, Miriam/A-7732-2015
CR Abrams L, 1994, Biomed Sci Instrum, V30, P169
   Amin AR, 1997, FEBS LETT, V410, P259, DOI 10.1016/S0014-5793(97)00605-4
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   Bajpai P. K., 1992, BIOCERAMICS, V3, P87
   Brundula V, 2002, BRAIN, V125, P1297, DOI 10.1093/brain/awf133
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Chtarto A, 2003, NEUROSCI LETT, V352, P155, DOI 10.1016/S0304-3940(03)01077-2
   ELATTAR TM, 1998, J PERIODONTAL RES, V23, P285
   *END INC, 1991, 91042208 PI BR
   Esposito E, 1997, J MICROENCAPSUL, V14, P175, DOI 10.3109/02652049709015331
   ESTERLY NB, 1978, J INVEST DERMATOL, V70, P51, DOI 10.1111/1523-1747.ep12543487
   GOODSON JM, 1989, J DENT RES, V68, P1625
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   HOLLINGER JO, 1986, CLIN ORTHOP RELAT R, V207, P290
   Ignjatovic N, 2004, APPL SURF SCI, V238, P314, DOI 10.1016/j.apsusc.2004.05.227
   Ignjatovic N, 2007, J EUR CERAM SOC, V27, P1589, DOI 10.1016/j.jeurceramsoc.2006.04.104
   ISO 10993-5, 1999, 109935 ISO
   Kalish RS, 2004, CLIN IMMUNOL, V113, P270, DOI 10.1016/j.clim.2004.07.012
   KLOPPENBURG M, 1994, ARTHRITIS RHEUM, V37, P629, DOI 10.1002/art.1780370505
   Lin FH, 1998, BIOMATERIALS, V19, P905, DOI 10.1016/S0142-9612(97)00202-0
   LOBO SH, 2002, THESIS U FEDERAL MIN
   MARTIN RR, 1974, J INFECT DIS, V129, P110, DOI 10.1093/infdis/129.2.110
   Nasr HF, 1999, PERIODONTOL 2000, V19, P74, DOI 10.1111/j.1600-0757.1999.tb00148.x
   Pataro AL, 2003, BIOMATERIALS, V24, P1075, DOI 10.1016/S0142-9612(02)00403-9
   Popovic N, 2002, ANN NEUROL, V51, P215, DOI 10.1002/ana.10092
   PRUZANSKI W, 1992, BIOCHEM PHARMACOL, V44, P1165, DOI 10.1016/0006-2952(92)90381-R
   Ripamonti U, 1999, S AFR J SCI, V95, P335
   RIPAMONTI U, 1999, BONE ENG, P215
   Ritchlin CT, 2000, ARTHRITIS RHEUM, V43, pS345
   Rodrigues CVM, 2003, BIOMATERIALS, V24, P4987, DOI 10.1016/S0142-9612(03)00410-1
   Ryan Maria E., 1996, Current Opinion in Rheumatology, V8, P238, DOI 10.1097/00002281-199605000-00013
   Sapadin AN, 2006, J AM ACAD DERMATOL, V54, P258, DOI 10.1016/j.jaad.2005.10.004
   Scarabelli TM, 2004, J AM COLL CARDIOL, V43, P865, DOI 10.1016/j.jacc.2003.09.050
   SEYMOUR RA, 1995, J CLIN PERIODONTOL, V22, P22
   Shikinami Y, 1999, BIOMATERIALS, V20, P859, DOI 10.1016/S0142-9612(98)00241-5
   SINISTERRA RD, 2006, PROCESSO PREPARACAO
   THONG YH, 1979, CLIN EXP IMMUNOL, V35, P443
   *US PHARM CONV, 1995, US PHARM, P1697
   Vandekerckhove BNA, 1997, J PERIODONTOL, V68, P353, DOI 10.1902/jop.1997.68.4.353
   WIKESJO UME, 1986, J PERIODONTAL RES, V21, P322, DOI 10.1111/j.1600-0765.1986.tb01466.x
   Wong W.H., 1997, SYNTHETIC BIODEGRADA, P51
   WYKROTA LL, 1999, BONE ENG, P516
NR 42
TC 12
Z9 18
U1 1
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-5173
EI 1873-3476
J9 INT J PHARMACEUT
JI Int. J. Pharm.
PD MAY 4
PY 2007
VL 336
IS 1
BP 75
EP 81
DI 10.1016/j.ijpharm.2006.11.038
PG 7
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 167ZJ
UT WOS:000246491100009
PM 17174495
DA 2018-10-20
ER

PT J
AU Meier, S
   Jensen, PR
   Adamczyk, P
   Bachinger, HP
   Holstein, TW
   Engel, J
   Ozbek, S
   Grzesiek, S
AF Meier, Sebastian
   Jensen, Pernille Rose
   Adamczyk, Patrizia
   Bachinger, Hans Peter
   Holstein, Thomas W.
   Engel, Juergen
   Oezbek, Suat
   Grzesiek, Stephan
TI Sequence-structure and structure-function analysis in cysteine-rich
   domains forming the ultrastable nematocyst wall
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE molecular evolution; conformational diversity; NMR structure;
   cysteine-rich; dihedral angle preference
ID HYDRA NEMATOCYSTS; CIS/TRANS ISOMERIZATION; DISULFIDE LINKAGE; PROLINE
   RESIDUES; REFLEX RESPONSE; NMR STRUCTURE; PROTEIN; MINICOLLAGEN;
   ALIGNMENT; PEPTIDES
AB The nematocyst wall of cnidarians is a unique biomaterial that withstands extreme osmotic pressures, allowing an ultrafast discharge of the nematocyst capsules. Assembly of the highly robust nernatocyst wall is achieved by covalent linkage of cysteine-rich domains (CRDs) from two main protein components, minicollagens and nematocyst outer wall antigen (NOWA). The bipolar minicollagens have different disulfide patterns and topologies in their N and C-terminal CRDs. The functional significance of this polarity has been elusive. Here, we show by NMR structural analysis that all representative cysteine-rich domains of NOWA are structurally related to N-terminal minicollagen domains. Natural sequence insertions in NOWA CRDs have very little effect on the tightly knit domain structures, nor do they preclude the efficient folding to a single native conformation. The different folds in NOWA CRDs and the atypical C-terminal minicollagen domain on the other hand can be directly related to different conformational preferences in the reduced states. Ultrastructural analysis in conjunction with aggregation studies argues for an association between the similar NOWA and N-terminal minicollagen domains in early stages of the nernatocyst wall assembly, which is followed by the controlled association between the unusual structures of C-terminal minicollagen domains. (c) 2007 Elsevier Ltd. All rights reserved.
C1 Univ Basel, Biozentrum, Dept Biol Struct, CH-4056 Basel, Switzerland.
   Univ Heidelberg, Inst Zool, Dept Mol Evolut & Genom, D-69120 Heidelberg, Germany.
   Oregon Hlth & Sci Univ, Shriners Hosp Children, Portland, OR 97201 USA.
   Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA.
   Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
RP Meier, S (reprint author), Univ Copenhagen, Inst Mol Biol & Physiol, August Krogh Bldg,Universitetsparken 13, DK-2100 Copenhagen, Denmark.
EM smeier@aki.ku.dk; stephan.grzesiek@unibas.ch
RI Meier, Sebastian/A-4279-2015; Ozbek, Suat/D-3701-2014; Jensen, Pernille
   Rose/J-8648-2016
OI Jensen, Pernille Rose/0000-0003-4359-848X; Grzesiek,
   Stephan/0000-0003-1998-4225; Meier, Sebastian/0000-0003-3761-3217
CR BLANQUET R, 1966, SCIENCE, V154, P152, DOI 10.1126/science.154.3745.152
   Bornberg-Bauer E, 1999, P NATL ACAD SCI USA, V96, P10689, DOI 10.1073/pnas.96.19.10689
   Boulegue C, 2006, J MOL BIOL, V358, P846, DOI 10.1016/j.jmb.2006.02.031
   BRANDTS JF, 1975, BIOCHEMISTRY-US, V14, P4953, DOI 10.1021/bi00693a026
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254
   Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740
   Cornilescu G, 1998, J AM CHEM SOC, V120, P6836, DOI 10.1021/ja9812610
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Engel U, 2002, J CELL SCI, V115, P3923, DOI 10.1242/jcs.00084
   Engel U, 2001, EMBO J, V20, P3063, DOI 10.1093/emboj/20.12.3063
   Fasman G. D., 1975, CRC HDB BIOCH MOL BI
   Ferraro DM, 2006, J MOL BIOL, V359, P390, DOI 10.1016/j.jmb.2006.03.047
   Ferraro DM, 2005, J MOL BIOL, V352, P575, DOI 10.1016/j.jmb.2005.07.012
   FISCHER S, 1994, J AM CHEM SOC, V116, P11931, DOI 10.1021/ja00105a036
   GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P
   Grishin NV, 2001, J STRUCT BIOL, V134, P167, DOI 10.1006/jsbi.2001.4335
   HAWKINS HC, 1991, BIOCHEM J, V275, P341, DOI 10.1042/bj2750341
   HOLSTEIN T, 1984, SCIENCE, V223, P830, DOI 10.1126/science.6695186
   HUTCHINSON EG, 1994, PROTEIN SCI, V3, P2207, DOI 10.1002/pro.5560031206
   Huth JR, 1997, PROTEIN SCI, V6, P2359
   Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4
   KURZ EM, 1991, J CELL BIOL, V115, P1159, DOI 10.1083/jcb.115.4.1159
   Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148
   Louhivuori M, 2003, J AM CHEM SOC, V125, P15647, DOI 10.1021/ja035427v
   Meier S, 2004, FEBS LETT, V569, P112, DOI 10.1016/j.febslet.2004.05.034
   Meier S, 2007, CURR BIOL, V17, P173, DOI 10.1016/j.cub.2006.10.063
   Milbradt AG, 2005, J MOL BIOL, V354, P591, DOI 10.1016/j.jmb.2005.09.080
   Nuchter T, 2006, CURR BIOL, V16, pR316, DOI 10.1016/j.cub.2006.03.089
   Ozbek S, 2004, J BIOL CHEM, V279, P52016, DOI 10.1074/jbc.M407613200
   Ozbek S, 2002, J BIOL CHEM, V277, P49200, DOI 10.1074/jbc.M209401200
   Ozbek S, 2002, J STRUCT BIOL, V137, P11, DOI 10.1006/jsbi.2002.4436
   Pokidysheva E, 2004, J BIOL CHEM, V279, P30395, DOI 10.1074/jbc.M403734200
   Reimer U, 1998, J MOL BIOL, V279, P449, DOI 10.1006/jmbi.1998.1770
   Renner C, 2001, ANGEW CHEM INT EDIT, V40, P923, DOI 10.1002/1521-3773(20010302)40:5<923::AID-ANIE923>3.0.CO;2-#
   Sass HJ, 2000, J BIOMOL NMR, V18, P303, DOI 10.1023/A:1026703605147
   Sass HJ, 2001, J BIOMOL NMR, V21, P275, DOI 10.1023/A:1012998006281
   Shi T, 2006, ANGEW CHEM INT EDIT, V45, P1780, DOI 10.1002/anie.200503470
   Tycko R, 2000, J AM CHEM SOC, V122, P9340, DOI 10.1021/ja002133q
   ZHANG RM, 1989, J BIOL CHEM, V264, P18472
NR 39
TC 16
Z9 17
U1 1
U2 4
PU ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
J9 J MOL BIOL
JI J. Mol. Biol.
PD MAY 4
PY 2007
VL 368
IS 3
BP 718
EP 728
DI 10.1016/j.jmb.2007.02.026
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 162BB
UT WOS:000246060200009
PM 17362991
DA 2018-10-20
ER

PT J
AU Horna, D
   Semino, CE
   Agullo, N
   Borros, S
AF Horna, David
   Semino, Carlos E.
   Agullo, Nuria
   Borros, Salvador
TI Biodegradable elastomers for applications in tissue engineering and
   regenerative medicine
SO AFINIDAD
LA English
DT Article
DE biodegradability; bioelastomers; tissue engineering; drug delivery;
   regenerative medicine
ID DRUG-DELIVERY APPLICATIONS; IN-VITRO DEGRADATION; BONE-CEMENT;
   THERMOPLASTIC ELASTOMERS; VIVO DEGRADATION; COPOLYMERS; SCAFFOLD;
   COMPOSITE; POLYMERS; BIOMATERIAL
AB This paper reviews the different types of biodegradable elastomers described in the literature. The major classes of bioelastomers are briefly described in terms of their synthesis, properties and biodegradability. The classification of the materials has been done regarding their chemical structure. Their use in contact with cells are also highlighted.
C1 [Horna, David; Semino, Carlos E.; Agullo, Nuria; Borros, Salvador] Univ Ramon Llull, Barcelona Bioengn Ctr, Inst Quim Sarria, Barcelona 08017, Spain.
   [Semino, Carlos E.] MIT, Ctr Biomed Engn, Cambridge, MA USA.
RP Borros, S (reprint author), Univ Ramon Llull, Barcelona Bioengn Ctr, Inst Quim Sarria, Barcelona 08017, Spain.
RI Borros, Salvador/A-3950-2016
OI Borros, Salvador/0000-0002-4003-0381; Agullo, Nuria/0000-0002-7712-0049
CR ALLCOCK HR, 1966, INORG CHEM, V5, P1709, DOI 10.1021/ic50044a016
   ALLCOCK HR, 1965, J AM CHEM SOC, V87, P4216, DOI 10.1021/ja01096a056
   Aroca AS, 2004, POLYMER, V45, P8949, DOI 10.1016/j.polymer.2004.10.033
   AUSTIN P, 2002, NEUENSCHWANDER MACRO, V35, P4946
   Bogdanov B, 1998, POLYMER, V39, P1631, DOI 10.1016/S0032-3861(97)00444-8
   CATO T, POLYPHOSPHAZENE NANO
   Chen SC, 1999, INT POLYM PROC, V14, P90
   Cohn D, 2005, POLYMER, V46, P2068, DOI 10.1016/j.polymer.2005.01.012
   Cohn D, 2005, BIOMATERIALS, V26, P2297, DOI 10.1016/j.biomaterials.2004.07.052
   Deng XM, 2002, EUR POLYM J, V38, P1435, DOI 10.1016/S0014-3057(02)00017-4
   Diego RB, 2005, J MATER SCI-MATER M, V16, P693, DOI 10.1007/s10856-005-2604-7
   Ding T, 2006, POLYM DEGRAD STABIL, V91, P733, DOI 10.1016/j.polymdegradstab.2005.06.007
   Domb AJ, 1996, BIOMATERIALS, V17, P411, DOI 10.1016/0142-9612(96)89657-8
   Dupaix RB, 2007, MECH MATER, V39, P39, DOI 10.1016/j.mechmat.2006.02.006
   El Fray M, 2006, BIOMACROMOLECULES, V7, P844, DOI 10.1021/bm050971c
   ESTES GM, 1971, MACROMOLECULES, V4, P452, DOI 10.1021/ma60022a018
   Flynn L, 2003, BIOMATERIALS, V24, P4265, DOI 10.1016/S0142-9612(03)00334-X
   Fromstein JD, 2002, J BIOMAT SCI-POLYM E, V13, P391, DOI 10.1163/156856202320253929
   GERHART TN, 1988, J ORTHOPAED RES, V6, P585, DOI 10.1002/jor.1100060417
   GERHART TN, 1988, RES, V6, P58592
   GLERIA M, 2001, J INORGANIC ORGANOME, V11
   GRESSER JD, 1995, J BIOMED MATER RES, V29, P1241, DOI 10.1002/jbm.820291011
   Guan JJ, 2004, BIOMATERIALS, V25, P85, DOI 10.1016/S0142-9612(03)00476-9
   Han DK, 1997, MACROMOLECULES, V30, P6077, DOI 10.1021/ma970302u
   HELLER J, 1992, MACROMOLECULES, V25, P3362, DOI 10.1021/ma00039a007
   HELLER J, 1993, ADV POLYM SCI, V107, P41
   HELLER J, 1990, BIOMATERIALS, V11, P659, DOI 10.1016/0142-9612(90)90024-K
   HEROLD DA, 1989, BIOCHEM PHARMACOL, V38, P73, DOI 10.1016/0006-2952(89)90151-2
   KELLOMAKI J, 2000, J MATER SCI-MATER M, P345
   KENNEDY JP, 2004, THERMOPLASTIC ELASTO, P285
   KORLEY LTJ, 2006, POLYMER, V47, P3037
   Kylma J, 1997, MACROMOLECULES, V30, P2876, DOI 10.1021/ma961569g
   Lakshmi S, 2003, ADV DRUG DELIVER REV, V55, P467, DOI 10.1016/S0169-409X(03)00039-5
   Lee SH, 2003, J BIOMED MATER RES A, V66A, P29, DOI 10.1002/jbm.a.10497
   Luo N, 1997, MACROMOLECULES, V30, P4405
   MERRILL EW, 1982, J AM SOC ARTIF INT O, V6, P60
   METER SJ, 1997, J BIOMED MATER RES, V41, P1
   MIKOS AG, 2001, SCI POLYM, V12, P673
   MODY PC, 1981, J APPL POLYM SCI, V26, P2853, DOI 10.1002/app.1981.070260904
   MONTHEARD JP, 1992, J MACROMOL SCI R M C, VC32, P1, DOI 10.1080/15321799208018377
   Nagata M, 2003, J POLYM SCI POL CHEM, V41, P2930, DOI 10.1002/pola.10884
   Nerem RM, 2001, ANNU REV BIOMED ENG, V3, P225, DOI 10.1146/annurev.bioeng.3.1.225
   PATRICK CW, 1995, BLOOD PURIFICAT, V13, P112
   Peter SJ, 1998, J BIOMED MATER RES, V41, P1
   Peter SJ, 1997, TISSUE ENG, V3, P207, DOI 10.1089/ten.1997.3.207
   Peter SJ, 1999, J BIOMED MATER RES, V44, P314
   Pol BJM, 1996, J BIOMED MATER RES, V32, P307
   Ranade SV, 2005, ACTA BIOMATER, V1, P137, DOI 10.1016/j.actbio.2004.09.004
   Rezgui F, 2005, POLYMER, V46, P7370, DOI 10.1016/j.polymer.2005.03.116
   RICHTER AW, 1983, INT ARCH ALLER A IMM, V70, P124, DOI 10.1159/000233309
   SEYMOUR RW, 1970, MACROMOLECULES, V3, P579, DOI 10.1021/ma60017a021
   SHYLIN HE, 2000, BIOMATERIALS, V21, P2389
   Sodian R, 2000, TISSUE ENG, V6, P183, DOI 10.1089/107632700320793
   Stegemann JP, 2003, ANN BIOMED ENG, V31, P391, DOI 10.1114/1.1558031
   SUNG P, 1970, MACROMOLECULES, V3, P117
   Wang YD, 2003, J BIOMED MATER RES A, V66A, P192, DOI 10.1002/jbm.a.10534
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Yang J, 2004, ADV MATER, V16, P511, DOI 10.1002/adma.200306264
   Yang J, 2006, BIOMATERIALS, V27, P1889, DOI 10.1016/j.biomaterials.2005.05.106
   Yaszemski M J, 1995, Tissue Eng, V1, P41, DOI 10.1089/ten.1995.1.41
   Zdrahala RJ, 1999, J BIOMATER APPL, V14, P67, DOI 10.1177/088532829901400104
   THESIS FACULTY SCI T, P268
NR 62
TC 0
Z9 0
U1 2
U2 4
PU ASOC QUIMICOS
PI BARCELONA
PA INST QUIMICO SARRIA, 17 BARCELONA, SPAIN
SN 0001-9704
J9 AFINIDAD
JI Afinidad
PD MAY-JUN
PY 2007
VL 64
IS 529
BP 404
EP 414
PG 11
WC Chemistry, Multidisciplinary
SC Chemistry
GA 261TU
UT WOS:000253103700013
DA 2018-10-20
ER

PT J
AU Siproudhis, L
   Morcet, J
   Laine, F
AF Siproudhis, L.
   Morcet, J.
   Laine, F.
TI Elastomer implants in faecal incontinence: a blind, randomized
   placebo-controlled study
SO ALIMENTARY PHARMACOLOGY & THERAPEUTICS
LA English
DT Article
ID INTERNAL ANAL-SPHINCTER; INJECTABLE SILICONE BIOMATERIAL;
   CONTROLLED-TRIAL; TOPICAL PHENYLEPHRINE; ANORECTAL PHYSIOLOGY;
   STIMULATION; DYSFUNCTION; PRESSURE; AGENTS
AB Background To test efficacy and safety of polydimethylsiloxane elastomer implants, a silicone biomaterial, in patients with severe faecal incontinence related to an impaired internal anal sphincter.
   Methods Subjects were randomized to receive three injections of 2.5 mL of either physiological saline or polydimethylsiloxane elastomer. After local anaesthesia, an 18 gauge, 2.5-in needle was inserted through the perianal skin and laid down into the intersphincteric space. Treatment (saline or polydimethylsiloxane elastomer) was administered by means of a ratchet gun. Three injections of 2.5 mL each were performed in the area of the internal anal sphincter at 3, 7 and 11 o'clock positions. Main end point was the percentage of subjects in each treatment arm experiencing a successful treatment, defined as a Cleveland Clinic Florida-Faecal Incontinence score < 8, 3 months after treatment. Secondary end points were quality of life scores, weekly number of faecal incontinence episodes, subject acceptance and adverse events rate. Both patients and end point assessments were blinded to treatment.
   Results 44 women (64.3 +/- 9 years) with a baseline Cleveland Clinic Florida-Faecal Incontinence score >= 8 were enrolled prospectively; 22 received polydimethylsiloxane elastomer and 22 saline treatment. Treatment was well tolerated. At 3 months, the percentage of subjects experiencing a successful treatment was not different between polydimethylsiloxane elastomer and saline groups (23% vs. 27%, respectively, P = 0.73). Moreover, Cleveland Clinic Florida-Faecal Incontinence score was not significantly different between polydimethylsiloxane elastomer and saline groups (11.7 +/- 4.7 vs. 11.4 +/- 4.5, respectively, P = 0.79).
   Conclusions Polydimethylsiloxane elastomer implants cannot be recommended for treatment of severe faecal incontinence related to impaired internal anal sphincter.
C1 CHU Pontchaillou, Serv Malad Appareil Digestif, F-35033 Rennes, France.
   CHU Pontchaillou, Ctr Invest Clin, F-35033 Rennes, France.
RP Siproudhis, L (reprint author), CHU Pontchaillou, Serv Malad Appareil Digestif, Rue Henri Le Guillou, F-35033 Rennes, France.
EM laurent.siproudhis@chu-rennes.fr
CR Carapeti EA, 2000, BRIT J SURG, V87, P38, DOI 10.1046/j.1365-2168.2000.01306.x
   Chan MKY, 2006, DIS COLON RECTUM, V49, P433, DOI 10.1007/s10350-005-0307-2
   Cheetham MJ, 2001, GUT, V48, P356, DOI 10.1136/gut.48.3.356
   Cheetham MJ, 2003, COCHRANE DB SYST REV, V3
   DUTHIE HL, 1965, GUT, V6, P64, DOI 10.1136/gut.6.1.64
   Efron JE, 2003, DIS COLON RECTUM, V46, P1606, DOI 10.1097/01.DCR.0000098927.47914.D0
   FRENCKNER B, 1975, GUT, V16, P482, DOI 10.1136/gut.16.6.482
   IPROUDHIS L, 2006, DIS COLON RECTUM, V49, P219
   Kenefick NJ, 2002, GUT, V51, P225, DOI 10.1136/gut.51.2.225
   Leroi AM, 2005, ANN SURG, V242, P662, DOI 10.1097/01.sla.0000186281.09475.db
   Leroi AM, 1997, INT J COLORECTAL DIS, V12, P243, DOI 10.1007/s003840050098
   Malouf AJ, 2001, DIS COLON RECTUM, V44, P595, DOI 10.1007/BF02234337
   MATZEL KE, 2004, LANCET, V17, P363
   Norton C, 2006, DIS COLON RECTUM, V49, P190, DOI 10.1007/s10350-005-0251-1
   Norton C, 2003, GASTROENTEROLOGY, V125, P1320, DOI 10.1053/S0016-5085(03)01368-4
   Norton C, 2006, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD002111.PUB2
   Perry S, 2002, GUT, V50, P480, DOI 10.1136/gut.50.4.480
   Rullier E, 2004, GASTROEN CLIN BIOL, V28, P562, DOI 10.1016/S0399-8320(04)95012-9
   Siproudhis L, 1998, CLIN PHARMACOL THER, V64, P424, DOI 10.1016/S0009-9236(98)90073-X
   Siproudhis L, 2004, ALIMENT PHARM THERAP, V20, P689, DOI 10.1111/j.1365-2036.2004.02151.x
   Siproudhis L, 1998, ALIMENT PHARM THERAP, V12, P747
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
   Uludag O, 2005, BRIT J SURG, V92, P1017, DOI 10.1002/bjs.4977
   Vaizey CJ, 1997, LANCET, V349, P612, DOI 10.1016/S0140-6736(96)09188-X
   Vaizey CJ, 2005, BRIT J SURG, V92, P521, DOI 10.1002/bjs.4997
   Vaizey CJ, 1999, GUT, V44, P77, DOI 10.1136/gut.44.1.77
NR 26
TC 43
Z9 45
U1 0
U2 1
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0269-2813
J9 ALIMENT PHARM THERAP
JI Aliment. Pharmacol. Ther.
PD MAY 1
PY 2007
VL 25
IS 9
BP 1125
EP 1132
DI 10.1111/j.1365-2036.2007.03293.x
PG 8
WC Gastroenterology & Hepatology; Pharmacology & Pharmacy
SC Gastroenterology & Hepatology; Pharmacology & Pharmacy
GA 155TX
UT WOS:000245602300014
PM 17439514
OA Bronze
DA 2018-10-20
ER

PT J
AU Griesshaber, E
   Schmahl, WW
   Neuser, R
   Pettke, T
   Blum, M
   Mutterlose, J
   Brand, U
AF Griesshaber, Erika
   Schmahl, Wolfgang W.
   Neuser, Rolf
   Pettke, Thomas
   Bluem, Michael
   Mutterlose, Joerg
   Brand, Uwe
TI Crystallographic texture and microstructure of terebratulide brachiopod
   shell calcite: An optimized materials design with hierarchical
   architecture
SO AMERICAN MINERALOGIST
LA English
DT Article
DE biomineralization of brachiopod shell calcite; EBSD; texture;
   microstructure; cathodoluminescence; Vickers microhardness; hybrid
   biomaterial; fiber composite material
ID CRYSTAL-GROWTH; ISOTOPIC COMPOSITION; SEA-URCHIN; BIOMINERALIZATION;
   PROTEINS; MACROMOLECULES; DELTA-O-18; DELTA-C-13; SEAWATER; OXYGEN
AB We analyzed the microstructure, microchemistry, and microhardness variations across the architectural elements of the shells of the brachiopod species Megerlia truncata and Terebratalia transversa with scanning electron microscopy (SEM), electron backscatter diffraction (EBSD), laser-ablation inductively coupled plasma mass-spectrometry (LA-ICP-MS), and Vickers microhardness indentation (VMHI). The brachiopod valves consist of two principal layers of distinct calcite biomineralization: a thin, nanocrystalline, outer, hard protective layer with VMHI values exceeding 200 HV and a much thicker, inner, secondary layer of a hybrid organic-inorganic fiber composite material. The secondary layer is further structured into two sublayers, an outer part with VMHI values varying between 110 and 140 HV, and a softer inner part (70 < HV < 110). Whereas the size of the calcite crystals within the primary layer varies between a few tens of nanometers and 2 mu m, calcite crystals within the secondary layer are fibrous, commonly reaching lengths exceeding 150 mu m. Cross sections of these fibrous crystals are spade shaped, their dimensions being about 5 x 20 gm. The fibers are aligned parallel to each other. They are single crystals with their morphological fiber axes pointing almost parallel to the shell vault. The crystallographic orientation of the morphological fiber axes, however, is arbitrary within the a-b plane of the calcite lattice, whereas the c-axis (hexagonal unit-cell setting) is perpendicular to the morphological fiber axes and thus parallel to the radial vector of the valve vault. This morphology strongly indicates that fibrous growth is controlled by confinement within a cell in an organic matrix and not by attachment of biomolecules to specific crystallographic faces. We observe inhomogeneous Sr2+ and Mg2+ concentrations in the shell calcite within the 0.1-0.9 wt% range. Design of the shell appears to be highly optimized for mechanical performance. Crystal morphology and orientation as well as incorporated organic matter are structured hierarchially at different length levels forming a hybrid organic-inorganic fiber composite architecture.
C1 Ruhr Univ Bochum, Inst Geol Mineral & Geophys, D-44780 Bochum, Germany.
   Univ Munich, Dept Earth & Environm Sci, D-80333 Munich, Germany.
   ETH Zentrum, Dept Earth Sci, CH-8092 Zurich, Switzerland.
   Ruhr Univ Bochum, Inst Werkstoffe, D-44780 Bochum, Germany.
   Brock Univ, Dept Earth Sci, St Catharines, ON L2S 3A1, Canada.
RP Griesshaber, E (reprint author), Inst Geol Sci, Baltzerstr 1-3, CH-3012 Bern, Switzerland.
EM erika.griesshaber@rub.de
RI Pettke, Thomas/M-5834-2018; Schmahl, Wolfgang/J-7571-2012
OI Pettke, Thomas/0000-0002-5784-0639; Schmahl,
   Wolfgang/0000-0002-0165-5952; Mutterlose, Joerg/0000-0003-3449-4507
CR ADDADI L, 1986, MOL CRYST LIQ CRYST, V134, P305, DOI 10.1080/00268948608079592
   ADDADI L, 1985, P NATL ACAD SCI USA, V82, P4110, DOI 10.1073/pnas.82.12.4110
   Agarwal BD, 1990, ANAL PERFORMANCE FIB, P449
   Alexander R.R., 2001, BRACHIOPODS ANCIENT, V7, P145
   Auclair AC, 2003, CHEM GEOL, V202, P59, DOI 10.1016/S0009-2541(03)00233-X
   BARBIN V, 1991, GEOL MAG, V128, P19, DOI 10.1017/S001675680001801X
   Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0
   Brand U, 2003, CHEM GEOL, V198, P305, DOI 10.1016/S0009-2541(03)00032-9
   Brown S, 2000, J MOL BIOL, V299, P725, DOI 10.1006/jmbi.2000.3682
   Bruckschen P, 1999, CHEM GEOL, V161, P127, DOI 10.1016/S0009-2541(99)00084-4
   Buening Nancy, 2001, Paleontological Society Papers, V7, P117
   CARPENTER SJ, 1995, GEOCHIM COSMOCHIM AC, V59, P3749, DOI 10.1016/0016-7037(95)00291-7
   Chateigner D, 2000, J STRUCT GEOL, V22, P1723, DOI 10.1016/S0191-8141(00)00088-2
   Collins M.J., 1988, Historical Biology, V1, P207
   COLLINS MJ, 1991, LETHAIA, V24, P387, DOI 10.1111/j.1502-3931.1991.tb01491.x
   CURREY D, 1990, SKELETAL BIOMINERALI, P11
   CURREY JD, 1977, PROC R SOC SER B-BIO, V196, P443, DOI 10.1098/rspb.1977.0050
   CURRY GB, 1991, PHILOS T ROY SOC B, V333, P359, DOI 10.1098/rstb.1991.0085
   CURRY GB, 1991, LETHAIA, V24, P399, DOI 10.1111/j.1502-3931.1991.tb01493.x
   Curry GB, 2002, PALAEOGEOGR PALAEOCL, V182, P133, DOI 10.1016/S0031-0182(01)00456-4
   CUSACK M, 1992, COMP BIOCHEM PHYS B, V102, P93, DOI 10.1016/0305-0491(92)90278-Y
   Cusack M, 2001, PALAEONTOLOGY, V44, P875, DOI 10.1111/1475-4983.00206
   Cusack Maggie, 2001, Paleontological Society Papers, V7, P105
   DREXLER KE, 1994, ANNU REV BIOPH BIOM, V23, P337
   Eggins S, 2003, EARTH PLANET SC LETT, V212, P291, DOI 10.1016/S0012-821X(03)00283-8
   Engler O., 2000, INTRO TEXTURE ANAL
   FALLINI G, 1996, SCIENCE, V271, P667
   Graham T, 2000, MAT SCI ENG C-BIO S, V11, P145, DOI 10.1016/S0928-4931(00)00202-2
   GREGOIRE C, 1957, J BIOPHYS BIOCHEM CY, V3, P797, DOI 10.1083/jcb.3.5.797
   Griesshaber E, 2005, MATER RES SOC SYMP P, V844, P99
   Griesshaber E, 2005, MATER RES SOC SYMP P, V844, P93
   Grossman EL, 1996, J SEDIMENT RES, V66, P1011
   Gunther D, 1997, J ANAL ATOM SPECTROM, V12, P939, DOI 10.1039/a701423f
   Harris P. J. F., 1999, CARBON NANOTUBES REL
   HEINRICH CA, 2003, GEOCHIMICA COSMOCHIM, V67, P1
   Kamat S, 2004, ACTA MATER, V52, P2395, DOI 10.1016/j.actamat.2004.01.030
   LARAIA VJ, 1990, MATER RES SOC SYMP P, V174, P125
   Levi-Kalisman Y, 2001, J STRUCT BIOL, V135, P8, DOI 10.1006/jsbi.2001.4372
   Lohkamper THK, 2003, CONTRIB MINERAL PETR, V146, P263, DOI 10.1007/s00410-003-0498-2
   LOWENSTAM HA, 1961, J GEOL, V69, P241, DOI 10.1086/626740
   Lowenstam HA, 1989, BIOMINERALIZATION
   Magdans U, 2004, EUR J MINERAL, V16, P261, DOI 10.1127/0935-1221/2004/0016-0261
   Mayer G, 2002, EXP MECH, V42, P395, DOI 10.1007/BF02412144
   MIDDLETON PD, 1991, EVIDENCE ISOTOPIC CH, P313
   MII H, 1999, GEOLOGICAL SOC AM B, V7, P960
   Muller B, 2001, SURF REV LETT, V8, P169, DOI 10.1016/S0218-625X(01)00085-9
   Niemeyer CM, 2001, ANGEW CHEM INT EDIT, V40, P4128, DOI 10.1002/1521-3773(20011119)40:22<4128::AID-ANIE4128>3.0.CO;2-S
   Nys Y, 2004, CR PALEVOL, V3, P549, DOI 10.1016/j.crpv.2004.08.002
   Okumura K, 2001, EUR PHYS J E, V4, P121, DOI 10.1007/s101890170150
   Parkinson D, 2005, CHEM GEOL, V219, P193, DOI 10.1016/j.chemgeo.2005.02.002
   Pettke T, 2004, LITHOS, V78, P333, DOI 10.1016/j.lithos.2004.06.011
   Pojeta J. Jr, 1987, P270
   Rowell A.J., 1987, P445
   Rudwick M. J. S., 1959, Geological Magazine, V96, P1
   Rudwick Martin J S, 1970, LIVING FOSSIL BRACHI
   RUSH PF, 1990, J SEDIMENT PETROL, V60, P968
   Samtleben C, 2001, CHEM GEOL, V175, P61, DOI 10.1016/S0009-2541(00)00364-8
   Sarikaya M, 2004, ANNU REV MATER RES, V34, P373, DOI 10.1146/annurev.matsci.34.040203.121025
   SARIKAYA M, 1994, MICROSC RES TECHNIQ, V27, P360, DOI 10.1002/jemt.1070270503
   Scheel HJ, 2000, J CRYST GROWTH, V211, P1, DOI 10.1016/S0022-0248(99)00780-0
   Schmahl WW, 2004, EUR J MINERAL, V16, P693, DOI 10.1127/0935-1221/2004/0016-0693
   SCHMIDT NH, 1989, CAN MINERAL, V27, P15
   SILYNROBERTS H, 1986, PROC R SOC SER B-BIO, V227, P303, DOI 10.1098/rspb.1986.0025
   VANDERWAL P, 1983, J ULTRA MOL STRUCT R, V85, P139, DOI 10.1016/S0022-5320(83)90103-X
   Veizer J, 1999, CHEM GEOL, V161, P59, DOI 10.1016/S0009-2541(99)00081-9
   Wang RZ, 1997, PHILOS T ROY SOC B, V352, P469, DOI 10.1098/rstb.1997.0034
   WEFER G, 1991, MAR GEOL, V100, P207, DOI 10.1016/0025-3227(91)90234-U
   Weiner S, 2003, REV MINERAL GEOCHEM, V54, P1, DOI 10.2113/0540001
   WEISS A, 2003, REV MINERALOGY PETRO, V54, P249
   WEISSBUCH I, 1991, SCIENCE, V253, P637, DOI 10.1126/science.253.5020.637
   Wenzel B, 1996, PALAEOGEOGR PALAEOCL, V122, P143, DOI 10.1016/0031-0182(95)00094-1
   WILKINSON BH, 1979, GEOLOGY, V7, P425
   Williams A., 1968, Special Papers in Palaeontology, VNo. 2, P1
   WILLIAMS A, 1970, LETHAIA, V3, P329, DOI 10.1111/j.1502-3931.1970.tb00827.x
   Williams A., 1965, TREATISE INVERTEBRAT
   Williams A., 1956, BIOL REV, V28, P261
   WILLIAMS A, 1997, TREATISE INVERTEBR H, P265
   WILLIAMS A, 1979, SPECIAL PAPERS PALEO, V7, P1
NR 78
TC 70
Z9 71
U1 3
U2 50
PU MINERALOGICAL SOC AMER
PI CHANTILLY
PA 3635 CONCORDE PKWY STE 500, CHANTILLY, VA 20151-1125 USA
SN 0003-004X
J9 AM MINERAL
JI Am. Miner.
PD MAY-JUN
PY 2007
VL 92
IS 5-6
BP 722
EP 734
DI 10.2138/am.2007.2220
PG 13
WC Geochemistry & Geophysics; Mineralogy
SC Geochemistry & Geophysics; Mineralogy
GA 170RR
UT WOS:000246682200002
DA 2018-10-20
ER

PT J
AU Ataka, K
   Heberle, J
AF Ataka, Kenichi
   Heberle, Joachim
TI Biochemical applications of surface-enhanced infrared absorption
   spectroscopy
SO ANALYTICAL AND BIOANALYTICAL CHEMISTRY
LA English
DT Review
DE FTIR; protein; membrane; electron transfer; self-assembled monolayer
ID CYTOCHROME-C-OXIDASE; GOLD ELECTRODE; DIFFERENCE SPECTROSCOPY; MEMBRANE
   RECONSTITUTION; ORIENTED ATTACHMENT; SILVER ELECTRODE; NUCLEIC-ACIDS;
   ATR-SEIRAS; ADSORPTION; SPECTRA
AB An overview is presented on the application of surface-enhanced infrared absorption (SEIRA) spectroscopy to biochemical problems. Use of SEIRA results in high surface sensitivity by enhancing the signal of the adsorbed molecule by approximately two orders of magnitude and has the potential to enable new studies, from fundamental aspects to applied sciences. This report surveys studies of DNA and nucleic acid adsorption to gold surfaces, development of immunoassays, electron transfer between metal electrodes and proteins, and protein-protein interactions. Because signal enhancement in SEIRA uses surface properties of the nano-structured metal, the biomaterial must be tethered to the metal without hampering its functionality. Because many biochemical reactions proceed vectorially, their functionality depends on proper orientation of the biomaterial. Thus, surface-modification techniques are addressed that enable control of the proper orientation of proteins on the metal surface.
C1 Univ Bielefeld, Dept Chem Biophys Chem PC 3, D-33615 Bielefeld, Germany.
RP Ataka, K (reprint author), Univ Bielefeld, Dept Chem Biophys Chem PC 3, D-33615 Bielefeld, Germany.
EM kenichi.ataka@uni-bielefeld.de
RI Heberle, Joachim/D-8605-2016
OI Heberle, Joachim/0000-0001-6321-2615
CR Aroca R, 1999, VIB SPECTROSC, V19, P11, DOI 10.1016/S0924-2031(99)00003-X
   AROCA RF, 2004, APPL SPECTROSC, V58, P324
   Ataka K, 1998, LANGMUIR, V14, P951, DOI 10.1021/la971110v
   Ataka K, 2006, J PHYS CHEM B, V110, P9339, DOI 10.1021/jp0534131
   Ataka K, 2004, J AM CHEM SOC, V126, P16199, DOI 10.1021/ja045951h
   Ataka K, 2004, J AM CHEM SOC, V126, P9445, DOI 10.1021/ja048346n
   BADURA A, 2006, PHOTOCHEM PHOTOBIOL
   Berna A, 2006, LANGMUIR, V22, P7192, DOI 10.1021/la0604001
   Brown CW, 1998, ANAL CHEM, V70, P2991, DOI 10.1021/ac980058k
   Chekhun VF, 2002, J EXP CLIN CANC RES, V21, P599
   Dovbeshko GI, 2002, BIOPOLYMERS, V67, P470, DOI 10.1002/bip.10165
   Fedurco M, 2000, COORDIN CHEM REV, V209, P263, DOI 10.1016/S0010-8545(00)00292-7
   FLEISCHMANN M, 1974, CHEM PHYS LETT, V26, P163, DOI 10.1016/0009-2614(74)85388-1
   Friedrich MG, 2004, CHEM COMMUN, P2376, DOI 10.1039/b410998h
   Garczarek F, 2006, NATURE, V439, P109, DOI 10.1038/nature04231
   HARTSTEIN A, 1980, PHYS REV LETT, V45, P201, DOI 10.1103/PhysRevLett.45.201
   Haynes CL, 2005, J CHEM EDUC, V82, p768A, DOI 10.1021/ed082p768A
   Haynes CL, 2002, J PHYS CHEM B, V106, P1898, DOI 10.1021/jp013570+
   Hellwig P, 1999, BIOCHEMISTRY-US, V38, P14683, DOI 10.1021/bi991267h
   Hrabakova J, 2006, PHYS CHEM CHEM PHYS, V8, P759, DOI 10.1039/b513379n
   JEANMAIRE DL, 1977, J ELECTROANAL CHEM, V84, P1, DOI 10.1016/S0022-0728(77)80224-6
   Kamnev AA, 2002, BIOSCIENCE REP, V22, P541, DOI 10.1023/A:1022077920527
   Mayer D, 2005, LANGMUIR, V21, P8580, DOI 10.1021/la051195x
   Miyake H, 2002, ELECTROCHEM COMMUN, V4, P973, DOI 10.1016/S1388-2481(02)00510-6
   MOSS D, 1990, EUR J BIOCHEM, V187, P565, DOI 10.1111/j.1432-1033.1990.tb15338.x
   NISHIKAWA Y, 1993, ANAL SCI, V9, P811, DOI 10.2116/analsci.9.811
   NISHIKAWA Y, 1993, VIB SPECTROSC, V6, P43, DOI 10.1016/0924-2031(93)87021-K
   NISHIKAWA Y, 1993, ANAL CHEM, V65, P556, DOI 10.1021/ac00053a011
   Osawa M, 1997, B CHEM SOC JPN, V70, P2861, DOI 10.1246/bcsj.70.2861
   OSAWA M, 1993, APPL SPECTROSC, V47, P1497, DOI 10.1366/0003702934067478
   Osawa M, 2001, TOP APPL PHYS, V81, P163
   Pronkin S, 2003, J ELECTROANAL CHEM, V550, P131, DOI 10.1016/S0022-0728(02)01472-9
   Rodes A, 2003, ELECTROCHEM COMMUN, V5, P56, DOI 10.1016/S1388-2481(02)00532-5
   Rodig C, 1999, BIOPHYS J, V76, P2687
   Sato Y, 2004, ANAL CHEM, V76, P5564, DOI 10.1021/ac049303s
   Seelenbinder JA, 1999, ANAL CHEM, V71, P1963, DOI 10.1021/ac981170l
   Willner I, 2000, ANGEW CHEM INT EDIT, V39, P1180, DOI 10.1002/(SICI)1521-3773(20000403)39:7<1180::AID-ANIE1180>3.0.CO;2-E
   Zhen YJ, 1999, J BIOL CHEM, V274, P38032, DOI 10.1074/jbc.274.53.38032
NR 38
TC 132
Z9 135
U1 4
U2 105
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1618-2642
J9 ANAL BIOANAL CHEM
JI Anal. Bioanal. Chem.
PD MAY
PY 2007
VL 388
IS 1
BP 47
EP 54
DI 10.1007/s00216-006-1071-4
PG 8
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 151LQ
UT WOS:000245292200007
PM 17242890
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Sanchez, DM
   Gaitan, DM
   Leon, AF
   Mugnier, J
   Briceno, JC
AF Sanchez, Diana M.
   Gaitan, Diana M.
   Leon, Andres F.
   Mugnier, Jacqueline
   Briceno, Juan C.
TI Fixation of vascular grafts with increased glutaraldehyde concentration
   enhances mechanical properties without increasing calcification
SO ASAIO JOURNAL
LA English
DT Article
ID BOVINE PERICARDIUM; VALVULAR BIOPROSTHESES; OSTRICH PERICARDIUM; VALVE
AB Our objective was to study the effect of glutaraldehyde (GLU) concentration, heat, and photooxidation on mechanical properties and calcification of bovine pericardium grafts in an in vivo model. Fresh pericardia were treated as follows: 0.625% GLU for 7 days (standard); 0.625%, 1 %, and 3% GLU at VC for 20 days and 50 degrees C for additional 20 days; irradiation in cross-linking medium with metilene blue at 0 degrees C for 8 hours. Tissues were subjected to tensile mechanical tests (n = 76). Fixed patches were subcutaneously implanted in mice for 50 days (n = 16 per treatment). Calcification was assessed by atomic absorption spectrophotometry (n = 55) and von Kossa staining (n = 28). Analysis of variance and Tukey's test were used for statistical analysis. The 3% GLU and 3% GLU + heat treatments showed an enhancement of the mechanical properties above standard treatment. No significant difference was found in calcification between treatments. The 3% GLU treatment enhances the mechanical properties of the tissue above standard treatment without increasing calcification and without applying heat; therefore it is recommended for high-strength applications. Supplementary treatments to decrease calcification could be combined with this methodology to obtain a high-strength-low-calcification biomaterial for manufacturing of long-term cardiovascular grafts.
C1 Univ Los Andes, Grp Biomed Engn, Bogota, Colombia.
   Fdn CardioInfantil, Dept Res, Bogota, Colombia.
   Fdn CardioInfantil, Dept Pathol, Bogota, Colombia.
RP Sanchez, DM (reprint author), Univ Los Andes, Grp Biomed Engn, Off Z115,POB 4976, Bogota, Colombia.
RI Briceno Triana, Juan Carlos/O-1931-2017
CR Abolhoda A, 1996, ANN THORAC SURG, V62, P169, DOI 10.1016/0003-4975(96)00277-9
   Arcidiacono G, 2005, J BIOMECH, V38, P1483, DOI 10.1016/j.jbiomech.2004.07.007
   Arenaz B, 2004, BIOMATERIALS, V25, P3359, DOI 10.1016/j.biomaterials.2003.09.105
   Carpentier SM, 2001, ANN THORAC SURG, V71, pS410, DOI 10.1016/S0003-4975(01)02494-8
   Carpentier SM, 1998, ANN THORAC SURG, V66, pS264, DOI 10.1016/S0003-4975(98)01101-1
   CHANDA J, 1995, ANN THORAC SURG, V60, pS339, DOI 10.1016/0003-4975(95)00256-K
   Dardik H, 2002, J VASC SURG, V35, P64, DOI 10.1067/mva.2002.121053
   Driessen NJB, 2007, J BIOMECH, V40, P325, DOI 10.1016/j.jbiomech.2006.01.009
   GAITAN DM, 2002, DISENO METODOLOGIA O
   GARCIA JM, 2001, BIOMATERIALS, V22, P2759
   Grande KJ, 1998, ANN BIOMED ENG, V26, P534, DOI 10.1114/1.122
   Jorge-Herrero E, 1999, BIOMATERIALS, V20, P539, DOI 10.1016/S0142-9612(98)90205-8
   Lee Y.H., 1989, BIOTECHNOL LETT, V1, P23
   Liao Kangxiong, 1995, Annals of Thoracic Surgery, V60, P343
   Maestro MM, 2006, ACTA BIOMATER, V2, P213, DOI 10.1016/j.actbio.2005.11.004
   Neuenschwander S, 2004, TRANSPL IMMUNOL, V12, P359, DOI 10.1016/S0966-3274(03)00116-3
   SHEN M, 2001, ANN THORAC SURG, V71, P413
   Stradins P, 2004, EUR J CARDIO-THORAC, V26, P634, DOI 10.1016/j.ejcts.2004.05.043
   TROWBRIDGE EA, 1985, J MATER SCI, V20, P114, DOI 10.1007/BF00555905
NR 19
TC 4
Z9 5
U1 2
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1058-2916
J9 ASAIO J
JI Asaio J.
PD MAY-JUN
PY 2007
VL 53
IS 3
BP 257
EP 262
DI 10.1097/MAT.0b013e318033a68f
PG 6
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 172GW
UT WOS:000246793100001
PM 17515713
DA 2018-10-20
ER

PT J
AU Watanabe, H
   Tsumoto, K
   Taguchi, S
   Yamashita, K
   Doi, Y
   Nishimiya, Y
   Kondo, H
   Umetsu, M
   Kumagai, I
AF Watanabe, Hideki
   Tsumoto, Kouhei
   Taguchi, Seiichi
   Yamashita, Koichi
   Doi, Yoshiharu
   Nishimiya, Yoshiyuki
   Kondo, Hidemasa
   Umetsu, Mitsuo
   Kumagai, Izumi
TI A human antibody fragment with high affinity for biodegradable polymer
   film
SO BIOCONJUGATE CHEMISTRY
LA English
DT Article
ID LEUCINE-LEUCINE-TYROSINE; POLYHYDROXYBUTYRATE DEPOLYMERASE; CHIRAL
   SURFACES; RECOGNITION; CELLULOSE; ADSORPTION; POLYPEPTIDES; SUBSTRATE;
   SELECTION; PEPTIDES
AB Antibodies with high affinity for the surface of a solid material would be advantageous in biomaterial science as a protein device. A human antibody fragment that binds to poly(hydroxybutyrate) (PHB), a biodegradable polymer matter, was generated by a phage display system. Clone PH7-3d3 was isolated after several rounds of selection and prepared as a fragment of immunoglobulin variable regions (Fv). The quartz crystal microbalance technique showed that PH7-3d3 Fv completely inhibited PHB enzymatic degradation by competing with PHB depolymerase. Kinetic analysis based on surface plasmon resonance demonstrated that PH7-3d3 Fv bound to the PHB film with an equilibrium dissociation constant of 14 nM. The three-dimensional structure of PH7-3d3 Fv was resolved to 1.7 angstrom, revealing that the complementarity determining regions (CDRs) in the Fv fragment form a relatively flat surface on which uncharged polar and aromatic amino acids are distributed in clusters. The structure of PH7-3d3 Fv was similar to that of PHB depolymerase in the orientation of aromatic residues in the binding sites. Alanine scanning mutagenesis demonstrated that these aromatic residues, especially tryptophan residues in CDRs, were critical in the interaction between PH7-3d3 Fv and PHB. Our results suggest the possible selection of an antibody fragment that binds a material surface in a manner similar to protein - ligand interaction.
C1 Tohoku Univ, Dept Biomol Engn, Grad Sch Engn, Sendai, Miyagi 9808579, Japan.
   Riken Inst Phys & Chem Res, Polymer Chem Lab, Wako, Saitama 3510198, Japan.
   Natl Inst Adv Ind Sci & Technol, RIGB, Funct Prot Res Grp, Sapporo, Hokkaido 0628517, Japan.
RP Watanabe, H (reprint author), Tohoku Univ, Dept Biomol Engn, Grad Sch Engn, Aoba Yama 6-6-11-606, Sendai, Miyagi 9808579, Japan.
EM kmiz@mail.tains.tohoku.ac.jp
RI Watanabe, Hideki/M-2711-2018; Kondo, Hidemasa/M-7465-2018; Nishimiya,
   Yoshiyuki/M-4173-2018
OI Watanabe, Hideki/0000-0002-9561-4077; Kondo,
   Hidemasa/0000-0003-2799-1775; Nishimiya, Yoshiyuki/0000-0002-0701-7775
CR BELDMAN G, 1987, BIOTECHNOL BIOENG, V30, P251, DOI 10.1002/bit.260300215
   Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843
   Bothwell MK, 1997, BIORESOURCE TECHNOL, V60, P169, DOI 10.1016/S0960-8524(96)00179-4
   Braden BC, 1998, IMMUNOL REV, V163, P45, DOI 10.1111/j.1600-065X.1998.tb01187.x
   Braun R, 2002, J BIOMAT SCI-POLYM E, V13, P747, DOI 10.1163/156856202760197384
   Brown S, 1997, NAT BIOTECHNOL, V15, P269, DOI 10.1038/nbt0397-269
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254
   Geva M, 2004, PROTEINS, V55, P862, DOI 10.1002/prot.20042
   Geva M, 2003, J AM CHEM SOC, V125, P696, DOI 10.1021/ja027942j
   GILKES NR, 1992, J BIOL CHEM, V267, P6743
   Hisano T, 2006, J MOL BIOL, V356, P993, DOI 10.1016/j.jmb.2005.12.028
   Huang RP, 1996, J BIOL CHEM, V271, P22196, DOI 10.1074/jbc.271.36.22196
   Kasuya K, 1999, INT J BIOL MACROMOL, V24, P329, DOI 10.1016/S0141-8130(99)00046-X
   Lee SW, 2002, SCIENCE, V296, P892, DOI 10.1126/science.1068054
   Lemoigne M., 1927, ANN I PASTEUR, V41, P148
   Livingstone JR, 1996, NATURE, V384, P491, DOI 10.1038/384491a0
   Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002
   MacCallum RM, 1996, J MOL BIOL, V262, P732, DOI 10.1006/jmbi.1996.0548
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   Naik RR, 2002, NAT MATER, V1, P169, DOI 10.1038/nmat758
   Ohura T, 1999, APPL ENVIRON MICROB, V65, P189
   Papanastasiou D, 1999, J NEUROIMMUNOL, V94, P182, DOI 10.1016/S0165-5728(98)00249-5
   Reusch RN, 1997, FEBS LETT, V412, P592, DOI 10.1016/S0014-5793(97)00863-6
   Sarikaya M, 2003, NAT MATER, V2, P577, DOI 10.1038/nmat964
   STAHLBERG J, 1991, BIO-TECHNOL, V9, P286, DOI 10.1038/nbt0391-286
   Todorovska A, 2001, J IMMUNOL METHODS, V248, P47, DOI 10.1016/S0022-1759(00)00342-2
   TSUMOTO K, 1994, J BIOL CHEM, V269, P28777
   Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766
   van Oss CJ, 1997, J MOL RECOGNIT, V10, P203, DOI 10.1002/(SICI)1099-1352(199709/10)10:5<203::AID-JMR366>3.0.CO;2-Z
   Vincken QJJP, 2003, PLANT MOL BIOL, V51, P789, DOI 10.1023/A:1022528705590
   Wang SQ, 2003, NAT MATER, V2, P196, DOI 10.1038/nmat833
   Watanabe H, 2002, BIOCHEM BIOPH RES CO, V295, P31, DOI 10.1016/S0006-291X(02)00616-2
   Whaley SR, 2000, NATURE, V405, P665
   Worn A, 2001, J MOL BIOL, V305, P989, DOI 10.1006/jmbi.2000.4265
   Yamane M, 2003, INST GLOB ENVIRONM S, V3, P3
   Yamashita K, 2001, BIOMACROMOLECULES, V2, P25, DOI 10.1021/bm0000844
   Zemlin M, 2003, J MOL BIOL, V334, P733, DOI 10.1016/j/jmb.2003.10.007
   1994, ACTA CRYSTALLOGR D, V50, P760
NR 38
TC 16
Z9 16
U1 2
U2 13
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1043-1802
J9 BIOCONJUGATE CHEM
JI Bioconjugate Chem.
PD MAY-JUN
PY 2007
VL 18
IS 3
BP 645
EP 651
DI 10.1021/bc060203y
PG 7
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Multidisciplinary; Chemistry, Organic
SC Biochemistry & Molecular Biology; Chemistry
GA 167XJ
UT WOS:000246485500007
PM 17385839
DA 2018-10-20
ER

PT J
AU Huang, J
   Wong, C
   George, A
   Kaplan, DL
AF Huang, Jia
   Wong, Cheryl
   George, Anne
   Kaplan, David L.
TI The effect of genetically engineered spider silk-dentin matrix protein 1
   chimeric protein on hydroxyapatite nucleation
SO BIOMATERIALS
LA English
DT Article
DE silk; hydroxyapatite; apatite; composites; dentin matrix protein 1;
   mineralization
ID DRAGLINE SILK; IN-VITRO; ESCHERICHIA-COLI; APATITE; BONE; EXPRESSION;
   SPECTROSCOPY; DEPOSITION; IMPLANTS; PURIFICATION
AB Spider silks exhibit remarkable mechanical properties while dentin matrix protein I provides controlled nucleation and hydroxyapatite growth. In the present work, these two attributes were combined via genetic engineering to form a chimera, a clone encoding consensus repeats from the major protein in the spider dragline silk of Nephila clavipes fused to the carboxyl terminal domain of dentin matrix protein 1 (CDMP1). The objective was to exploit the self-assembly and material properties of silk proteins with controlled hydroxyapatite (HA) formation from CDMP1, for novel biomaterial composites. The purified recombinant protein retained native-silk like self-assembly properties and beta-sheet structure when formed into films and treated with methanol. When the chimeric protein in solution was incubated with CaCl2, the secondary structure shifted from random coil to a-helix and beta-sheet, due to the interactions between the CDMP1 domain and Ca2+. The control protein without the CDMP1 domain did not undergo a similar transition. Films formed from the recombinant protein were mineralized using simulated body fluids and induced the formation of calcium-deficient carbonated HA, Ca-10(PO4)(6)(OH)(2) based on SEM, EDS, FTIR and TEM analysis. This mineral phase was not formed on the films formed from the control spider silk protein without the CDMP1 domain. Considering the osteoconductivity of HA and the novel material features of spider silks, these new hybrid systems offer potential as biomaterials for a number of potential applications. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Tufts Univ, Dept Chem & Biol Engn, Medford, MA 02155 USA.
   Tufts Univ, Dept Biomed Engn & Chem, Medford, MA 02155 USA.
   Univ Illinois, Dept Oral Biol, Chicago, IL 60680 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Chem & Biol Engn, Medford, MA 02155 USA.
EM david.Kaplan@tufts.edu
RI Xu, Qingguo/C-1962-2014
OI Xu, Qingguo/0000-0003-3191-0771; GEORGE, ANNE/0000-0002-9008-7642
FU NIDCR NIH HHS [DE 16533]
CR Agathopoulos S, 2006, BIOMATERIALS, V27, P1832, DOI 10.1016/j.biomaterials.2005.10.033
   Arcidiacono S, 1998, APPL MICROBIOL BIOT, V49, P31, DOI 10.1007/s002530051133
   Barrere F, 2003, J BIOMED MATER RES B, V67B, P655, DOI 10.1002/jbm.b.10057
   Bini E, 2006, BIOMACROMOLECULES, V7, P3139, DOI 10.1021/bm0607877
   Bogush V.G., 2001, BIOTEKHNOLOGIYA, P11
   Cassella JP, 2000, J BONE MINER METAB, V18, P291, DOI 10.1007/PL00010645
   Chou YF, 2005, J BIOMED MATER RES B, V75B, P81, DOI 10.1002/jbm.b.30261
   Fahnestock S R, 2000, J Biotechnol, V74, P105, DOI 10.1016/S1389-0352(00)00008-8
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P23, DOI 10.1007/s002530050883
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P33, DOI 10.1007/s002530050884
   Fratzl P, 2004, J MATER CHEM, V14, P2115, DOI 10.1039/b402005g
   Fukushima Y, 1998, BIOPOLYMERS, V45, P269, DOI 10.1002/(SICI)1097-0282(19980405)45:4<269::AID-BIP1>3.0.CO;2-J
   Furuzono T, 2000, J BIOMED MATER RES, V50, P344, DOI 10.1002/(SICI)1097-4636(20000605)50:3<344::AID-JBM8>3.0.CO;2-D
   Gineste L, 1999, J BIOMED MATER RES, V48, P224, DOI 10.1002/(SICI)1097-4636(1999)48:3<224::AID-JBM5>3.0.CO;2-A
   He G, 2003, NAT MATER, V2, P552, DOI 10.1038/nmat945
   He G, 2005, J BIOL CHEM, V280, P33109, DOI 10.1074/jbc.M500159200
   He G, 2004, J BIOL CHEM, V279, P11649, DOI 10.1074/jbc.M309296200
   He G, 2003, CONNECT TISSUE RES, V44, P240, DOI 10.1080/03008200390181726
   Huang J, 2003, J BIOL CHEM, V278, P46117, DOI 10.1074/jbc.M307792200
   Huemmerich D, 2006, APPL PHYS A-MATER, V82, P219, DOI 10.1007/s00339-005-3428-5
   JACKSON M, 1995, CRIT REV BIOCHEM MOL, V30, P95, DOI 10.3109/10409239509085140
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Lewis RV, 1996, PROTEIN EXPRES PURIF, V7, P400, DOI 10.1006/prep.1996.0060
   Li PJ, 2003, J BIOMED MATER RES A, V66A, P79, DOI 10.1002/jbm.a.10519
   Markovic M, 2004, J RES NATL INST STAN, V109, P553, DOI 10.6028/jres.109.042
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Oroudjev E, 2002, P NATL ACAD SCI USA, V99, P6460, DOI 10.1073/pnas.082526499
   PLESHKO N, 1991, BIOPHYS J, V60, P786, DOI 10.1016/S0006-3495(91)82113-0
   POSNER AS, 1969, PHYSIOL REV, V49, P760
   PRINCE JT, 1995, BIOCHEMISTRY-US, V34, P10879, DOI 10.1021/bi00034a022
   Rammensee S, 2006, APPL PHYS A-MATER, V82, P261, DOI 10.1007/s00339-005-3431-x
   Rossler S, 2003, J BIOMED MATER RES A, V64A, P655, DOI 10.1002/jbm.a.10330
   Scheibel T, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-14
   Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335
   Srinivasan R, 1999, CONNECT TISSUE RES, V40, P251, DOI 10.3109/03008209909000703
   SUREWICZ WK, 1993, BIOCHEMISTRY-US, V32, P389, DOI 10.1021/bi00053a001
   Szela S, 2000, BIOMACROMOLECULES, V1, P534, DOI 10.1021/bm0055697
   Takeuchi A, 2003, J BIOMED MATER RES A, V65A, P283, DOI 10.1002/jbm.a.10456
   Valluzzi R, 1999, J PHYS CHEM B, V103, P11382, DOI 10.1021/jp991363s
   Winkler S, 2000, BIOCHEMISTRY-US, V39, P12739, DOI 10.1021/bi001335w
   Winkler S, 1999, INT J BIOL MACROMOL, V24, P265, DOI 10.1016/S0141-8130(98)00088-9
   Yan WQ, 1997, BIOMATERIALS, V18, P1185, DOI 10.1016/S0142-9612(97)00057-4
   Zhang K, 2003, J BIOMED MATER RES A, V66A, P860, DOI 10.1002/jbm.a.10093
NR 44
TC 87
Z9 91
U1 4
U2 42
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2007
VL 28
IS 14
BP 2358
EP 2367
DI 10.1016/j.biomaterials.2006.11.021
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 152YC
UT WOS:000245397200011
PM 17289141
DA 2018-10-20
ER

PT J
AU Tyler, BJ
   Rayal, G
   Castner, DG
AF Tyler, Bonnie J.
   Rayal, Gaurav
   Castner, David G.
TI Multivariate analysis strategies for processing ToF-SIMS images of
   biomaterials
SO BIOMATERIALS
LA English
DT Article
DE image analysis; molecular imaging; SIMS; surface analysis;
   micro-patterning
ID ION MASS-SPECTROMETRY; POLY(L-LYSINE)-G-POLY(ETHYLENE GLYCOL) LAYERS;
   PRINCIPAL COMPONENT ANALYSIS; METAL-OXIDE SURFACES; PROTEIN ADSORPTION;
   SPECTRAL IMAGES; INFORMATION; RESISTANCE; POISSON; NOISE
AB Time-of-flight secondary ion mass spectrometry (ToF-SIMS) is a hyperspectral imaging technique. Each pixel in a two-dimensional ToF-SIMS image (or each voxel in a three-dimensional (3-D) ToF-SIMS image) contains a full mass spectrum. Thus, multivariate analysis methods are being increasingly used to process biomaterial ToF-SIMS images so the maximum amount of information can be extracted from the images. This study examines the use of principal component analysis (PCA) and maximum autocorrelation factors (MAF) on four different ToF-SIMS images. These images were selected because they represent significant challenges for biomedical ToF-SIMS image processing (topographical features, low count rates, surface contaminants, etc.). With PCA four different types of scaling methods (auto, root mean, filter, and shift variance scaling) were used. The effect of two preprocessing methods (normalization and mean centering) was also examined for both PCA and MAF. The more computational intense MAF provided the best results for all the images investigated in this study, doing the best job of reducing the number of variables required to describe the image, enhancing image contrast and recovering key spectral features. MAF was particularly good at identifying subtle features that were often lost in PCA and impossible to visualize in single peak images. However, the combination of PCA with either root mean or shift variance scaling provided similar results to MAF. Thus, these combinations offer promising alternatives to MAF for working with large data sets encountered in 3-D imaging. Also, the new method of filter scaling is promising for processing low count rate images with salt and pepper noise. Normalization proved an important tool for deconvoluting chemical effects from topographic and/or matrix effects. Mean centering aided in reducing the dimensionality of the data, but in one case resulted in a loss of information. (c) 2007 Elsevier Ltd. All rights reserved.
C1 Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA.
   Univ Washington, Natl ESCA & Surface Anal Ctr Biomed Problems, Seattle, WA 98195 USA.
   Univ Utah, Dept Chem & Fuels Engn, Salt Lake City, UT 84112 USA.
   Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
RP Castner, DG (reprint author), Univ Washington, Dept Chem Engn, Box 351750, Seattle, WA 98195 USA.
EM castner@nb.engr.washington.edu
FU NIBIB NIH HHS [EB-002027, P41 EB002027]
CR Belu AM, 2003, BIOMATERIALS, V24, P3635, DOI 10.1016/S0142-9612(03)00159-5
   Biesinger MC, 2002, ANAL CHEM, V74, P5711, DOI 10.1021/ac020311n
   Gillen G, 2003, APPL SURF SCI, V203, P209, DOI 10.1016/S0169-4332(02)00627-X
   Goessl A, 2001, J BIOMAT SCI-POLYM E, V12, P721, DOI 10.1163/156856201750411620
   Graham DJ, 2006, APPL SURF SCI, V252, P6860, DOI 10.1016/j.apsusc.2006.02.149
   GREEN AA, 1988, IEEE T GEOSCI REMOTE, V26, P65, DOI 10.1109/36.3001
   Huang NP, 2001, LANGMUIR, V17, P489, DOI 10.1021/la000736+
   Keenan MR, 2004, SURF INTERFACE ANAL, V36, P203, DOI 10.1002/sia.1657
   Kenausis GL, 2000, J PHYS CHEM B, V104, P3298, DOI 10.1021/jp993359m
   Larsen R, 2002, J CHEMOMETR, V16, P427, DOI 10.1002/cem.743
   MCCULLAGH P, 1989, GEN LINEAR MODELS, pCH6
   MCLACHLAN GJ, 1992, DISCRIMINANT ANAL ST, pCH13
   Michel R, 2002, LANGMUIR, V18, P3281, DOI 10.1021/la011715y
   Nygren H, 2004, J MICROSC-OXFORD, V215, P156, DOI 10.1111/j.0022-2720.2004.01374.x
   Postawa Z, 2004, J PHYS CHEM B, V108, P7831, DOI 10.1021/jp049936a
   Rangarajan S, 2004, APPL SURF SCI, V231, P406, DOI 10.1016/j.apsusc.2004.03.148
   RAYAL G, 2006, THESIS U WASHINTON
   Smentkowski VS, 2005, ANAL CHEM, V77, P1530, DOI 10.1021/ac048468y
   Sosnik A, 2006, BIOMATERIALS, V27, P2340, DOI 10.1016/j.biomaterials.2005.11.028
   TYLER BJ, 2006, UNPUB
   Tyler BJ, 2006, APPL SURF SCI, V252, P6875, DOI 10.1016/j.apsusc.2006.02.160
   Veiseh M, 2004, BIOMATERIALS, V25, P3315, DOI 10.1016/j.biomaterials.2003.10.014
   Veiseh M, 2001, BIOMED MICRODEVICES, V3, P45, DOI 10.1023/A:1011477319971
   Wagner MS, 2006, APPL SURF SCI, V252, P6575, DOI 10.1016/j.apsusc.2006.02.073
   Wagner MS, 2004, SURF SCI, V570, P78, DOI 10.1016/j.susc.2004.06.184
   Weibel D, 2003, ANAL CHEM, V75, P1754, DOI 10.1021/ac026338o
   Willse A, 2002, ANAL CHEM, V74, P6314, DOI 10.1021/ac025561i
   WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9
   Wolkenstein M, 1997, ANAL CHEM, V69, P777, DOI 10.1021/ac9605105
   Zhang ZP, 2005, BIOMACROMOLECULES, V6, P3388, DOI 10.1021/bm050446d
   Zhang ZP, 2005, BIOMATERIALS, V26, P47, DOI 10.1016/j.biomaterials.2004.02.004
NR 31
TC 114
Z9 114
U1 1
U2 40
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2007
VL 28
IS 15
BP 2412
EP 2423
DI 10.1016/j.biomaterials.2007.02.002
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 157AT
UT WOS:000245691700005
PM 17335898
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Huebsch, ND
   Mooney, DJ
AF Huebsch, Nathaniel D.
   Mooney, David J.
TI Fluorescent resonance energy transfer: A tool for probing molecular
   cell-biomaterial interactions in three dimensions
SO BIOMATERIALS
LA English
DT Review
DE extracellular matrix (ECM); integrin; fibronectin (FN); fluorescence;
   green fluorescent protein (GFP)
ID SMOOTH-MUSCLE-CELLS; EXTRACELLULAR-MATRIX; INTEGRIN BINDING;
   SURFACE-CHEMISTRY; FOCAL ADHESIONS; FIBROBLAST TRACTION; LIGAND
   ORGANIZATION; IMAGING MICROSCOPY; ALGINATE HYDROGELS; FORCE MICROSCOPY
AB The current paradigm in designing biomaterials is to optimize material chemical and physical parameters based on correlations between these parameters and downstream biological responses, whether in vitro or in vivo. Extensive developments in molecular design of biomaterials have facilitated identification of several biophysical and biochemical variables (e.g. adhesion peptide density, substrate elastic modulus) as being critical to cell response. However, these empirical observations do not indicate whether different parameters elicit cell responses by modulating redundant variables of the cell-material interface (e.g. number of cell-material bonds, cell-matrix mechanics). Recently, fluorescence resonance energy transfer (FRET) has been applied to quantitatively analyze parameters of the cell-material interface for both two- and three-dimensional adhesion substrates. Tools based on FRET have been utilized to quantify several parameters of the cell-material interface relevant to cell response, including molecular changes in matrix proteins induced by interactions both with surfaces and cells, the number of bonds between integrins and their adhesion ligands, and changes in the crosslink density of hydrogel synthetic extracellular matrix analogs. As such techniques allow both dynamic and 3-D analyses they will be useful to quantitatively relate downstream cellular responses (e.g. gene expression) to the composition of this interface. Such understanding will allow bioengineers to fully exploit the potential of biomaterials engineered on the molecular scale, by optimizing material chemical and physical properties to a measurable set of interfacial parameters known to elicit a predictable response in a specific cell population. This will facilitate the rational design of complex, multi-functional biomaterials used as model systems for studying diseases or for clinical applications. (c) 2007 Elsevier Ltd. All rights reserved.
C1 Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA.
   MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
RP Mooney, DJ (reprint author), Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA.
EM mooneyd@deas.harvard.edu
OI Huebsch, Nathaniel/0000-0002-3329-0214
FU NIDCR NIH HHS [R37 DE013033]
CR Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7
   Asthagiri AR, 1999, J BIOL CHEM, V274, P27119, DOI 10.1074/jbc.274.38.27119
   Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Bacskai BJ, 2003, J BIOMED OPT, V8, P368, DOI 10.1117/1.1584442
   Baker SC, 2006, BIOMATERIALS, V27, P3136, DOI 10.1016/j.biomaterials.2006.01.026
   Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532
   Ballestrem C, 2006, J CELL SCI, V119, P866, DOI 10.1242/jcs.02794
   Baneyx G, 2002, P NATL ACAD SCI USA, V99, P5139, DOI 10.1073/pnas.072650799
   Baneyx G, 2001, P NATL ACAD SCI USA, V98, P14464, DOI 10.1073/pnas.251422998
   Bao G, 2003, NAT MATER, V2, P715, DOI 10.1038/nmat1001
   Baugh L, 2004, J BIOMED MATER RES A, V69A, P525, DOI 10.1002/jbm.a.30026
   BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575
   Bischofs IB, 2006, ACTA BIOMATER, V2, P253, DOI 10.1016/j.actbio.2006.01.002
   Blum JS, 2004, BIOMATERIALS, V25, P5809, DOI 10.1016/j.biomaterials.2004.01.035
   Brinkerhoff CJ, 2005, TISSUE ENG, V11, P865, DOI 10.1089/ten.2005.11.865
   Brown XQ, 2005, BIOMATERIALS, V26, P3123, DOI 10.1016/j.biomaterials.2004.08.009
   Burdick JA, 2004, LANGMUIR, V20, P5153, DOI 10.1021/la049298n
   Cavalcanti-Adam EA, 2006, EUR J CELL BIOL, V85, P219, DOI 10.1016/j.ejcb.2005.09.011
   Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Cherniavskaya O, 2005, J VAC SCI TECHNOL B, V23, P2972, DOI 10.1116/1.2132332
   Chigaev A, 2003, BIOPHYS J, V85, P3951, DOI 10.1016/S0006-3495(03)74809-7
   Chigaev A, 2001, J BIOL CHEM, V276, P48670, DOI 10.1074/jbc.M103194200
   Comisar WA, 2006, BIOMATERIALS, V27, P2322, DOI 10.1016/j.biomaterials.2005.10.037
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Cunningham JJ, 2002, ANN BIOMED ENG, V30, P927, DOI 10.1114/1.1500408
   CURTIS ASG, 1991, MEASURING CELL ADHES
   DEMBO M, 1988, PROC R SOC SER B-BIO, V234, P55, DOI 10.1098/rspb.1988.0038
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Ecker RC, 2004, CYTOM PART A, V59A, P172, DOI 10.1002/cyto.a.20053
   Eggeling C, 2005, BIOPHYS J, V89, P605, DOI 10.1529/biophysj.104.052753
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55
   FORSTER T, 1959, DISCUSS FARADAY SOC, P7
   Friedl P, 2004, HISTOCHEM CELL BIOL, V122, P183, DOI 10.1007/s00418-004-0682-0
   FUNG BKK, 1978, BIOCHEMISTRY-US, V17, P5241, DOI 10.1021/bi00617a025
   Galbraith CG, 1997, P NATL ACAD SCI USA, V94, P9114, DOI 10.1073/pnas.94.17.9114
   Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153
   Gallant ND, 2005, MOL BIOL CELL, V16, P4329, DOI 10.1091/mbc.E05-02-0170
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Garcia-Alloza M, 2004, NEUROMOL MED, V6, P65, DOI 10.1385/NMM:6:1:065
   Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618
   Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   Gu JH, 2004, J AM CHEM SOC, V126, P8098, DOI 10.1021/ja048405x
   GUIDO S, 1993, J CELL SCI, V105, P317
   HANSEN LK, 1994, MOL BIOL CELL, V5, P967
   Harbers GM, 2005, J BIOMED MATER RES A, V75A, P855, DOI 10.1002/jbm.a.30482
   HARRIS AK, 1981, NATURE, V290, P249, DOI 10.1038/290249a0
   Horbett T., 2004, BIOMATERIALS SCI INT
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   INGBER DE, 1994, INT REV CYTOL, V150, P173
   INGBER DE, 1990, P NATL ACAD SCI USA, V87, P3579, DOI 10.1073/pnas.87.9.3579
   Irvine DJ, 2002, BIOPHYS J, V82, P120, DOI 10.1016/S0006-3495(02)75379-4
   Itaka K, 2002, BIOMACROMOLECULES, V3, P841, DOI 10.1021/bm025527d
   Jiang GY, 2006, BIOPHYS J, V90, P1804, DOI 10.1529/biophysj.105.072462
   Johnson AE, 2005, TRAFFIC, V6, P1078, DOI 10.1111/j.1600-0854.2005.00340.x
   Kato M, 2004, BIOCHEMISTRY-US, V43, P2699, DOI 10.1021/bi0352670
   Keppler A, 2004, P NATL ACAD SCI USA, V101, P9955, DOI 10.1073/pnas.0401923101
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Kim H, 2003, ULTRAMICROSCOPY, V97, P359, DOI 10.1016/S0304-3991(03)00061-5
   Kirchner J, 2003, J CELL SCI, V116, P975, DOI 10.1242/jcs.00284
   Koblinski JE, 2005, J CELL SCI, V118, P2965, DOI 10.1242/jcs.02411
   Kong HJ, 2003, MACROMOLECULES, V36, P7887, DOI 10.1021/ma034865j
   Kong HJ, 2005, P NATL ACAD SCI USA, V102, P4300, DOI 10.1073/pnas.0405873102
   Kong HJ, 2005, NAT MATER, V4, P460, DOI 10.1038/nmat1392
   Kong HJ, 2006, P NATL ACAD SCI USA, V103, P18534, DOI 10.1073/pnas.0605960103
   Krammer A, 1999, P NATL ACAD SCI USA, V96, P1351, DOI 10.1073/pnas.96.4.1351
   Krishnan RV, 2001, J FLUORESC, V11, P211, DOI 10.1023/A:1012201201651
   LAI CS, 1993, J MOL BIOL, V230, P625, DOI 10.1006/jmbi.1993.1174
   Lakowicz J. R., 2006, PRINCIPLES FLUORESCE
   Lauffenburger DA, 1993, RECEPTORS MODELS BIN
   Laukaitis CM, 2001, J CELL BIOL, V153, P1427, DOI 10.1083/jcb.153.7.1427
   LECKBAND D, 1995, NATURE, V376, P617, DOI 10.1038/376617a0
   Leckband D, 2001, Q REV BIOPHYS, V34, P105, DOI 10.1017/S0033583501003687
   Lee KB, 2002, SCIENCE, V295, P1702, DOI 10.1126/science.1067172
   Lee KY, 2004, NANO LETT, V4, P1501, DOI 10.1021/nl0493592
   Lee KY, 2003, ADV MATER, V15, P1828, DOI 10.1002/adma.200305406
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lee SH, 2005, BIOTECHNOL PROGR, V21, P1736, DOI 10.1021/bp0502429
   Lehenkari PP, 1999, BIOCHEM BIOPH RES CO, V259, P645, DOI 10.1006/bbrc.1999.0827
   Lichtman JW, 2005, NAT METHODS, V2, P910, DOI 10.1038/NMETH817
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   Merkel R, 1999, NATURE, V397, P50, DOI 10.1038/16219
   MIDWOOD KS, 2002, METHODS CELL BIOL, V69
   Miura K, 2005, ADV BIOCHEM ENG BIOT, V95, P267, DOI 10.1007/b102218
   Model MA, 2000, J BIOMED MATER RES, V50, P90, DOI 10.1002/(SICI)1097-4636(200004)50:1<90::AID-JBM13>3.0.CO;2-3
   MOONEY DJ, 1995, J CELL SCI, V108, P2311
   Munevar S, 2004, J CELL SCI, V117, P85, DOI 10.1242/jcs.00795
   Munevar S, 2001, BIOPHYS J, V80, P1744, DOI 10.1016/S0006-3495(01)76145-0
   Neher RA, 2004, MICROSC RES TECHNIQ, V64, P185, DOI 10.1002/jemt.20078
   Oberhauser AF, 2002, J MOL BIOL, V319, P433, DOI 10.1016/S0022-2836(02)00306-6
   Ohashi T, 1999, P NATL ACAD SCI USA, V96, P2153, DOI 10.1073/pnas.96.5.2153
   Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   Putnam AJ, 1998, J CELL SCI, V111, P3379
   Remaut K, 2005, J CONTROL RELEASE, V103, P259, DOI 10.1016/j.jconrel.2004.11.019
   Roberts C, 1998, J AM CHEM SOC, V120, P6548, DOI 10.1021/ja972467o
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Rowley JA, 2002, ADV MATER, V14, P886, DOI 10.1002/1521-4095(20020618)14:12<886::AID-ADMA886>3.0.CO;2-I
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   Stockholm D, 2005, J MOL BIOL, V346, P215, DOI 10.1016/j.jmb.2004.11.039
   STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719
   Stupack DG, 2002, J CELL SCI, V115, P3729, DOI 10.1242/jcs.00071
   Suehiro K, 2000, J BIOCHEM-TOKYO, V128, P705, DOI 10.1093/oxfordjournals.jbchem.a022804
   Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x
   Tamada M, 2004, DEV CELL, V7, P709, DOI 10.1016/j.devcel.2004.08.021
   Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100
   Thomas CH, 2002, P NATL ACAD SCI USA, V99, P1972, DOI 10.1073/pnas.032668799
   Wang M, 2004, IEEE ELECTR INSUL M, V20, P5, DOI 10.1109/MEI.2004.1342427
   WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161
   Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469
   WARD MD, 1993, BIOPHYS J, V64, P936, DOI 10.1016/S0006-3495(93)81456-5
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wiseman PW, 2004, J CELL SCI, V117, P5521, DOI 10.1242/jcs.01416
   WOLBER PK, 1979, BIOPHYS J, V28, P197, DOI 10.1016/S0006-3495(79)85171-1
   Wu D, 2004, BIOTECHNOL BIOENG, V85, P406, DOI 10.1002/bit.10902
   Zamir E, 1999, J CELL SCI, V112, P1655
   ZIMET DB, 1995, BIOPHYS J, V68, P1592, DOI 10.1016/S0006-3495(95)80332-2
   Zimmermann T, 2005, ADV BIOCHEM ENG BIOT, V95, P245, DOI 10.1007/b102216
NR 128
TC 49
Z9 50
U1 4
U2 66
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2007
VL 28
IS 15
BP 2424
EP 2437
DI 10.1016/j.biomaterials.2007.01.023
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 157AT
UT WOS:000245691700006
PM 17270268
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Jones, AC
   Arns, CH
   Sheppard, AP
   Hutmacher, DW
   Milthorpe, BK
   Knackstedt, MA
AF Jones, Anthony C.
   Arns, Christoph H.
   Sheppard, Adrian P.
   Hutmacher, Dietmar W.
   Milthorpe, Bruce K.
   Knackstedt, Mark A.
TI Assessment of bone ingrowth into porous biomaterials using MICRO-CT
SO BIOMATERIALS
LA English
DT Article
DE micro-CT; bone ingrowth; hydroxyapatite; scaffolds; pore structure
ID TRABECULAR BONE; TOMOGRAPHIC-IMAGES; MICROTOMOGRAPHIC IMAGES;
   COMPUTED-TOMOGRAPHY; ELASTIC PROPERTIES; NETWORK MODELS; SCAFFOLDS;
   IMPLANTS; MEDIA; SEGMENTATION
AB The three-dimensional (313) structure and architecture of biomaterial scaffolds play a critical role in bone formation as they affect the functionality of the tissue-engineered constructs. Assessment techniques for scaffold design and their efficacy in bone ingrowth studies require an ability to accurately quantify the 3D structure of the scaffold and an ability to visualize the bone regenerative processes within the scaffold structure. In this paper, a 3D micro-CT imaging and analysis study of bone ingrowth into tissue-engineered scaffold materials is described. Seven specimens are studied in this paper; a set of three specimens with a cellular structure, varying pore size and implant material, and a set of four scaffolds with two different scaffold designs investigated at early (4 weeks) and late (12 weeks) explantation times. The difficulty in accurately phase separating the multiple phases within a scaffold undergoing bone regeneration is first highlighted. A sophisticated three-phase segmentation approach is implemented to develop high-quality phase separation with minimal artifacts. A number of structural characteristics and bone ingrowth characteristics of the scaffolds are quantitatively measured on the phase separated images. Porosity, pore size distributions, pore constriction sizes, and pore topology are measured on the original pore phase of the scaffold volumes. The distribution of bone ingrowth into the scaffold pore volume is also measured. For early explanted specimens we observe that bone ingrowth occurs primarily at the periphery of the scaffold with a constant decrease in bone mineralization into the scaffold volume. Pore size distributions defined by both the local pore geometry and by the largest accessible pore show distinctly different behavior. The accessible pore size is strongly correlated to bone ingrowth. In the specimens studied a strong enhancement of bone ingrowth is observed for pore diameters > 100 mu m. Little difference in bone ingrowth is measured with different scaffold design. This result illustrates the benefits of microtomography for analyzing the 3D structure of scaffolds and the resultant bone ingrowth. (c) 2007 Elsevier Ltd. All rights reserved.
C1 Australian Natl Univ, Res Sch Phys Sci & Engn, Dept Appl Math, Canberra, ACT 0200, Australia.
   Natl Univ Singapore, Div Bioengn, Singapore 117576, Singapore.
   Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Orthoped Surg, Singapore 117576, Singapore.
   Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia.
   UNSW Asia, Singapore 248922, Singapore.
RP Knackstedt, MA (reprint author), Australian Natl Univ, Res Sch Phys Sci & Engn, Dept Appl Math, Canberra, ACT 0200, Australia.
EM Mark.knackstedt@anu.edu.au
RI Sheppard, Adrian/A-7410-2008; Arns, Christoph/A-5036-2009; Milthorpe,
   Bruce/A-7014-2008
OI Sheppard, Adrian/0000-0001-9792-4143; Arns,
   Christoph/0000-0003-1721-3996; Hutmacher, Dietmar
   Werner/0000-0001-5678-2134
CR Arns CH, 2004, J PETROL SCI ENG, V45, P41, DOI 10.1016/j.petrol.2004.05.001
   Arns CH, 2002, GEOPHYSICS, V67, P1396, DOI 10.1190/1.1512785
   Blunt MJ, 2001, CURR OPIN COLLOID IN, V6, P197, DOI 10.1016/S1359-0294(01)00084-X
   Bohner M, 2004, BIOMATERIALS, V25, P3569, DOI 10.1016/j.biomaterials.2003.10.032
   BOSKEY AI, 2001, BONE MECH HDB
   Boyde A, 1999, BONE, V24, P579, DOI 10.1016/S8756-3282(99)00083-6
   Cioffi M, 2006, BIOTECHNOL BIOENG, V93, P500, DOI 10.1002/bit.20740
   Cormen T. H., 2001, INTRO ALGORITHMS, P947
   Currey J.D., 2002, BONES STRUCTURE MECH, P124
   Gauthier O, 2005, BIOMATERIALS, V26, P5444, DOI 10.1016/j.biomaterials.2005.01.072
   Gonzalez R., 2002, DIGITAL IMAGE PROCES
   Hara T, 2002, BONE, V31, P107, DOI 10.1016/S8756-3282(02)00782-2
   Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x
   Hilpert M, 2001, ADV WATER RESOUR, V24, P243, DOI 10.1016/S0309-1708(00)00056-7
   Hing KA, 2005, INT J APPL CERAM TEC, V2, P184, DOI 10.1111/j.1744-7402.2005.02020.x
   Ho ST, 2006, BIOMATERIALS, V27, P1362, DOI 10.1016/j.biomaterials.2005.08.035
   HOSHEN J, 1976, PHYS REV B, V14, P3438, DOI 10.1103/PhysRevB.14.3438
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Issever AS, 2002, ACAD RADIOL, V9, P1395, DOI 10.1016/S1076-6332(03)80667-0
   Jones AC, 2004, J MATER SCI-MATER M, V15, P529, DOI 10.1023/B:JMSM.0000021133.48661.62
   Jones AC, 2004, BIOMATERIALS, V25, P4947, DOI 10.1016/j.biomatcrials.2004.01.047
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   KASS M, 1987, INT J COMPUT VISION, V1, P321
   Kinney J H, 1998, Technol Health Care, V6, P339
   Kinney JH, 1998, J BONE MINER RES, V13, P839, DOI 10.1359/jbmr.1998.13.5.839
   KLAWITTER JJ, 1971, J BIOMED MATER RES S, V2, P161, DOI DOI 10.1002/JBM.820050613
   Knackstedt MA, 2006, BIOMATERIALS, V27, P2776, DOI 10.1016/j.biomaterials.2005.12.016
   Koerten HK, 1999, J BIOMED MATER RES, V44, P78, DOI 10.1002/(SICI)1097-4636(199901)44:1<78::AID-JBM9>3.0.CO;2-6
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Otsuki B, 2006, BIOMATERIALS, V27, P5892, DOI 10.1016/j.biomaterials.2006.08.013
   Porter B, 2005, J BIOMECH, V38, P543, DOI 10.1016/j.jbiomech.2004.04.011
   Pothuaud L, 2002, J BIOMECH, V35, P1091, DOI 10.1016/S0021-9290(02)00060-X
   Prendergast P., 2001, BONE MECH HDB
   Rajagopalan S, 2005, J BIOMED MATER RES A, V75A, P877, DOI 10.1002/jbm.a.30498
   Sakellariou A, 2004, PHYSICA A, V339, P152, DOI 10.1016/j.physa.2004.03.055
   SAKELLARIOU A, 2004, P SOC PHOTO-OPT INS, V5535, P166
   Schriefer JL, 2005, J BIOMECH, V38, P1838, DOI 10.1016/j.jbiomech.2004.08.017
   SERRA J, 1982, IMAGE ANAL MATH MORP, P375
   Sheppard AP, 2004, PHYSICA A, V339, P145, DOI 10.1016/j.physa.2004.03.057
   SHEPPARD AP, 2005, P SOC COR AN TOR 21
   Sok RM, 2002, TRANSPORT POROUS MED, V46, P345, DOI 10.1023/A:1015034924371
   Stock SR, 2003, DEV DYNAM, V226, P410, DOI 10.1002/dvdy.10241
   THOVERT JF, 2001, PHYS REV E, V63, P61307
NR 43
TC 186
Z9 191
U1 2
U2 53
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2007
VL 28
IS 15
BP 2491
EP 2504
DI 10.1016/j.biomaterials.2007.01.046
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 157AT
UT WOS:000245691700012
PM 17335896
DA 2018-10-20
ER

PT J
AU Yildirim, S
   Alacam, A
   Saritas, ZK
   Oygur, T
AF Yildirim, S.
   Alacam, A.
   Saritas, Z. Kadir
   Oygur, T.
TI In vivo effect of calcium phosphate biomaterials on dog dental pulp
SO BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT
LA English
DT Article
DE calcium phosphate biomaterials; dog teeth; hydroxyapatite; pulp capping;
   reparative dentinogenesis; tricalcium phosphate
ID HUMAN OSTEOGENIC PROTEIN-1; TRICALCIUM PHOSPHATE; REPARATIVE DENTIN;
   CAPPING AGENTS; GROWTH-FACTORS; TISSUE; HYDROXYAPATITE; INDUCTION;
   HYDROXIDE; MONKEYS
AB Exogenous ideal delivery system for biologically active molecules is under intensive investigation. In the present study it was aimed to test the availability of different calcium phosphate biomaterials (CPBs), hydroxyapatite (HA), beta tricalcium phosphate (TCP), and a combination of these (TCP+HA) as dental pulp capping systems on healing of dog dental pulp. Experimentally perforated dental pulps of 16 premolar and molar teeth in a beagle dog were capped with CPBs. Calcium hydroxide (CH) was used as positive control. Thirty days after the operation, teeth were extracted and examined by routine histological techniques. While in HA and TCP group the pulp tissue displayed severe inflammatory response, prompted healing of the pulp tissue in TCP+HA group was seen. Complete bridge of reparative dentin formation was obvious in TCP+HA and CH groups.
   This study suggested that TCP+HA induced dentinogenic effect in the pulp cells of dog teeth. TCP+HA might serve as an ideal calcium phosphate pulp capping biomaterial to induce initial healing response and it might has a capacity for being a good carrier for biologically active dentinogenic molecules.
C1 [Yildirim, S.] Univ Selcuk, Fac Dent, Dept Pedodont, Konya, Turkey.
   [Alacam, A.] Gazi Univ, Fac Dent, Dept Pedodont, Emek, Turkey.
   [Saritas, Z. Kadir] Univ Afyon Kocatepe, Fac Vet Med, Dept Surg, Afyon, Turkey.
   [Oygur, T.] Gazi Univ, Fac Dent, Dept Oral Pathol, Emek, Turkey.
RP Yildirim, S (reprint author), Univ Selcuk, Fac Dent, Dept Pedodont, Konya, Turkey.
EM ysibel@msn.com
CR ALLIOTLICHT B, 1994, ARCH ORAL BIOL, V39, P481, DOI 10.1016/0003-9969(94)90144-9
   BAUME LJ, 1980, BIOL PULP DENTINE, P159
   BOWERS GM, 1986, J PERIODONTOL, V57, P286, DOI 10.1902/jop.1986.57.5.286
   BROWNE RM, 1983, INT ENDOD J, V16, P147, DOI 10.1111/j.1365-2591.1983.tb01318.x
   CHOHAYEB AA, 1991, ORAL SURG ORAL MED O, V71, P343, DOI 10.1016/0030-4220(91)90312-Z
   DACULSI G, 1989, J BIOMED MATER RES, V23, P883, DOI 10.1002/jbm.820230806
   dos Santos LA, 2002, BIOMATERIALS, V23, P2035, DOI 10.1016/S0142-9612(01)00333-7
   FINKELMAN RD, 1990, J BONE MINER RES, V5, P717
   HASHIMOTOUOSHIMA M, 1995, INT J PERIODONT REST, V15, P205
   HAUSCHKA PV, 1986, J BIOL CHEM, V261, P2665
   Heller A L, 1975, J Endod, V1, P95, DOI 10.1016/S0099-2399(75)80025-2
   HEYS DR, 1981, J DENT RES, V60, P1371, DOI 10.1177/00220345810600071401
   Higashi T, 1996, J ENDODONT, V22, P168, DOI 10.1016/S0099-2399(96)80094-X
   JABER L, 1992, ORAL SURG ORAL MED O, V73, P2
   JEAN A, 1998, J ENDODONT, V14, P83
   Kivrak N, 1998, J AM CERAM SOC, V81, P2245
   LEGEROS RZ, 1993, INTRO BIOCERAMICS, V1, P139
   MISIEK DJ, 1984, J ORAL MAXIL SURG, V42, P150, DOI 10.1016/S0278-2391(84)80025-7
   NAKASHIMA M, 1990, ARCH ORAL BIOL, V35, P493, DOI 10.1016/0003-9969(90)90078-O
   NAKASHIMA M, 1994, J DENT RES, V73, P1515, DOI 10.1177/00220345940730090601
   NERY EB, 1992, J PERIODONTOL, V63, P729, DOI 10.1902/jop.1992.63.9.729
   OGILVIE A, 1987, J PERIODONTAL RES, V22, P270, DOI 10.1111/j.1600-0765.1987.tb01585.x
   OGUNTEBI B, 1993, J DENT RES, V72, P484, DOI 10.1177/00220345930720020301
   RUTHERFORD B, 1995, CRIT REV ORAL BIOL M, V6, P218, DOI 10.1177/10454411950060030401
   RUTHERFORD RB, 1994, ARCH ORAL BIOL, V39, P833, DOI 10.1016/0003-9969(94)90014-0
   RUTHERFORD RB, 1993, ARCH ORAL BIOL, V38, P571, DOI 10.1016/0003-9969(93)90121-2
   SASANO Y, 1996, CONNECT TISSUE RES, V35, P292
   SUBAY RK, 1993, ORAL SURG ORAL MED O, V76, P485, DOI 10.1016/0030-4220(93)90018-Y
   Suwa Fumihiko, 1993, Okajimas Folia Anatomica Japonica, V70, P195
   THESLEFF I, 1995, INT J DEV BIOL, V39, P35
   TIAN WD, 1997, ORAL SURG ORAL MED O, V53, P112
   URIST MR, 1994, BONE GRAFTS, DERIVATIVES AND SUBSTITUTES, P315
   URIST MR, 1984, CLIN ORTHOP RELAT R, V187, P277
   WADA T, 1989, J PERIODONTAL RES, V24, P391, DOI 10.1111/j.1600-0765.1989.tb00888.x
   YOSHIBA K, 1994, ENDOD DENT TRAUMATOL, V10, P113
NR 35
TC 2
Z9 2
U1 0
U2 5
PU DIAGNOSIS PRESS LTD
PI SOFIA
PA 67 DONDUKOV BLVD, 1504 SOFIA, BULGARIA
SN 1310-2818
J9 BIOTECHNOL BIOTEC EQ
JI Biotechnol. Biotechnol. Equip.
PD MAY
PY 2007
VL 21
IS 2
BP 198
EP 204
PG 7
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 284KC
UT WOS:000254704300015
DA 2018-10-20
ER

PT J
AU Ehrenpreis, ED
   Chang, D
   Eichenwald, E
AF Ehrenpreis, Eli D.
   Chang, David
   Eichenwald, Elad
TI Pharmacotherapy for fecal incontinence: A review
SO DISEASES OF THE COLON & RECTUM
LA English
DT Article; Proceedings Paper
CT International Symposium on Colorectal Disease
CY FEB 17-19, 2005
CL Ft Lauderdale, FL
DE incontinence; feces; bulking agents; anal sphincter; fiber;
   biomaterials; constipation; fecal impaction; fecal incontinence; fecal
   disimpaction
ID IRRITABLE-BOWEL-SYNDROME; INJECTABLE SILICONE BIOMATERIAL;
   ANAL-SPHINCTER DYSFUNCTION; AUTOLOGOUS FAT INJECTION; CHRONIC DIARRHEA;
   CONTROLLED-TRIAL; TOPICAL PHENYLEPHRINE; BIOFEEDBACK TREATMENT; DIETARY
   FIBER; LOPERAMIDE
AB Fecal incontinence is a common clinical problem that often is frustrating to the patient and treating physician. Nonsurgical management for fecal incontinence includes dietary manipulation, Kegel exercises, perianal skin care, and biofeedback therapy. Pharmacotherapies often are used to assist in management of fecal incontinence. A variety of pharmacotherapies have been utilized for the management of fecal incontinence; limited data from randomized, placebo-controlled trials are available. This is a review of the existing literature on clinical trials of several classes of drugs and other medical therapies that may be beneficial for patients with fecal incontinence. The information in this article was obtained by a MEDLINE search for all clinical trials of drug therapy for fecal incontinence. These treatments and the existing data on their use are summarized. Treatments reviewed include stool bulking agents, with an emphasis on the most promising effect obtained with calcium polycarbophil, constipating agents, including loperamide, codeine, amitriptyline, atropine, and diphenoxylate agents injected into the anal sphincter, drugs to enhance anal sphincter function, including topical phenylepherine and oral sodium valproate, and trials of fecal disimpaction. A new classification to easily remember the treatment categories for this condition, based on the "ABCs of treatment for fecal incontinence," has been introduced into the structure of this review.
C1 Rush Presbyterian St Lukes Med Ctr, Div Gastroenterol, Chicago, IL USA.
   Univ Penn, Philadelphia, PA 19104 USA.
   Semmelweis Univ, Budapest, Hungary.
RP Ehrenpreis, ED (reprint author), 1538 N Arlington Heights Rd, Arlington Hts, IL 60004 USA.
EM ehrenpreis@gipharm.net
CR Bliss Donna Zimmaro, 2005, J Gerontol Nurs, V31, P35
   Bliss DZ, 2001, NURS RES, V50, P203, DOI 10.1097/00006199-200107000-00004
   Carapeti EA, 2000, BRIT J SURG, V87, P38, DOI 10.1046/j.1365-2168.2000.01306.x
   Carapeti EA, 2000, DIS COLON RECTUM, V43, P1059, DOI 10.1007/BF02236550
   Chassagne P, 2000, AGE AGEING, V29, P159, DOI 10.1093/ageing/29.2.159
   Chassagne P, 1999, AM J MED, V106, P185, DOI 10.1016/S0002-9343(98)00407-0
   CHEETHAM M, 2003, COCHRANE DB SYST REV, V4, P1
   Cheetham MJ, 2001, GUT, V48, P356, DOI 10.1136/gut.48.3.356
   Davis K, 2003, ALIMENT PHARM THERAP, V18, P237, DOI 10.1046/j.0269-2813.2003.01668.x
   DROSSMAN DA, 1989, AM J GASTROENTEROL, V84, P365
   EHRENPREIS ED, 2003, AFP GUIDE DIAGNOSIS
   Ehrenpreis S., 2001, CLIN HDB PRESCRIPTIO
   ENCK P, 1991, INT J COLORECTAL DIS, V6, P143, DOI 10.1007/BF00341234
   Feinendegen DL, 1998, AESTHET PLAST SURG, V22, P163, DOI 10.1007/s002669900185
   Fine KD, 1997, GASTROENTEROLOGY, V112, P1830, DOI 10.1053/gast.1997.v112.pm9178673
   FRIZELLE F, 2004, CLIN EVID, V12, P610
   Fynes MM, 1999, DIS COLON RECTUM, V42, P753, DOI 10.1007/BF02236930
   Goode PS, 2005, J AM GERIATR SOC, V53, P629, DOI 10.1111/j.1532-5415.2005.53211.x
   HALLGREN T, 1994, DIGEST DIS SCI, V39, P2612, DOI 10.1007/BF02087698
   HARFORD WV, 1980, GASTROENTEROLOGY, V78, P440
   Kenefick NJ, 2002, GUT, V51, P225, DOI 10.1136/gut.51.2.225
   Kumar D, 1998, BRIT J SURG, V85, P978
   KUSUNOKI M, 1990, SURGERY, V107, P311
   Lee PE, 2001, J UROLOGY, V165, P153, DOI 10.1097/00005392-200101000-00037
   Lembo TJ, 2002, J CLIN GASTROENTEROL, V35, pS31, DOI 10.1097/00004836-200207001-00007
   Nelson RL, 2004, GASTROENTEROLOGY, V126, pS3, DOI 10.1053/j.gastro.2003.10.010
   Olden KW, 2002, GASTROENTEROLOGY, V122, P1701, DOI 10.1053/gast.2002.33741
   Pager CK, 2002, DIS COLON RECTUM, V45, P997, DOI 10.1097/01.DCR.0000019495.92696.34
   PALMER KR, 1980, GASTROENTEROLOGY, V79, P1272
   Palsson OS, 2004, APPL PSYCHOPHYS BIOF, V29, P153, DOI 10.1023/B:APBI.0000039055.18609.64
   Quander CR, 2005, AM J GASTROENTEROL, V100, P905, DOI 10.1111/j.1572-0241.2005.30511.x
   READ M, 1982, DIGEST DIS SCI, V27, P807, DOI 10.1007/BF01391374
   Saito T, 2000, JPN J PHARMACOL, V83, P206, DOI 10.1254/jjp.83.206
   Saito T, 2002, JPN J PHARMACOL, V89, P133, DOI 10.1254/jjp.89.133
   Santoro GA, 2000, DIS COLON RECTUM, V43, P1676, DOI 10.1007/BF02236848
   Scarlett Y, 2004, GASTROENTEROLOGY, V126, pS55, DOI 10.1053/j.gastro.2003.10.007
   Schaefer DC, 1998, AM FAM PHYSICIAN, V58, P907
   SCHILLER LR, 1984, GASTROENTEROLOGY, V86, P1475
   Schuster MM, 2001, AM J MANAG CARE, V7, pS246
   SHAFIK A, 1993, INT SURG, V78, P159
   SHAFIK A, 1995, DIS COLON RECTUM, V38, P583, DOI 10.1007/BF02054115
   SHANKARDASS K, 1990, JPEN-PARENTER ENTER, V14, P508, DOI 10.1177/0148607190014005508
   SOLIANI P, 1992, DIS COLON RECTUM, V35, P969, DOI 10.1007/BF02253500
   Solomon MJ, 2003, DIS COLON RECTUM, V46, P703, DOI 10.1097/01.DCR.0000070034.58255.06
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
   Vaizey CJ, 2005, BRIT J SURG, V92, P521, DOI 10.1002/bjs.4997
   Vaizey CJ, 1999, GUT, V44, P77, DOI 10.1136/gut.44.1.77
   Vandewoude MFJ, 2005, AGE AGEING, V34, P120, DOI 10.1093/ageing/afh242
   Wald A, 2005, DRUG AGING, V22, P131, DOI 10.2165/00002512-200522020-00004
NR 49
TC 24
Z9 27
U1 1
U2 15
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0012-3706
J9 DIS COLON RECTUM
JI Dis. Colon Rectum
PD MAY
PY 2007
VL 50
IS 5
BP 641
EP 649
DI 10.1007/s10350-006-0778-9
PG 9
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA 168KG
UT WOS:000246522900009
PM 17205204
DA 2018-10-20
ER

PT J
AU Tjandra, J
   Chan, M
   Yeh, C
AF Tjandra, J.
   Chan, M.
   Yeh, C.
TI Injectable silicone biomaterial is more effective than Durasphere (R) in
   treating passive fecal incontinence - A randomized trial
SO DISEASES OF THE COLON & RECTUM
LA English
DT Meeting Abstract
CT Annual Meeting of the Amerian-Society-of-Colon-and-Rectal-Surgeons
CY JUN 02-06, 2007
CL St Louis, MO
SP Amer Soc Colon & Rectal Surg
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0012-3706
J9 DIS COLON RECTUM
JI Dis. Colon Rectum
PD MAY
PY 2007
VL 50
IS 5
BP 740
EP 741
PG 2
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA 168KG
UT WOS:000246522900105
DA 2018-10-20
ER

PT J
AU Tan, Q
   Steiner, R
   Yang, L
   Welti, M
   Neuenschwander, P
   Hillinger, S
   Weder, W
AF Tan, Qiang
   Steiner, Rudolf
   Yang, Lin
   Welti, Manfred
   Neuenschwander, Peter
   Hillinger, Sven
   Weder, Walter
TI Accelerated angiogenesis by continuous medium flow with vascular
   endothelial growth factor inside tissue-engineered trachea
SO EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
LA English
DT Article; Proceedings Paper
CT World Congress on Tissue Engineering and Regenerative Medicine
CY APR 27, 2006
CL Pittsburgh, PA
DE tissue engineering; tracheal prosthesis; reepithetialization;
   revascularization; bioreactor
ID IN-VITRO; BIOREACTOR; SKIN
AB Objective: To test the effects of a continuous medium flow inside DegraPol (R) scaffolds on the reepithelialization and revascularization processes of a tissue-engineered trachea prosthesis.
   Methods: In this proof-of-principle study a continuous medium flow was maintained within a tubular DegraPol (R) scaffold by an inserted porous catheter connected to a pump system. The impact of the intra-scaffold medium flow on the survival of a tracheal epithelial sheet wrapped around and on chondrocyte delivery to the DegraPol (R) scaffold was studied. In the chick embryo, chorioallantoic membrane (CAM) model angiogenesis within the biomaterial was investigated.
   Results: Scanning electronic microscopy (SEM) images showed an intact epithelial layer after a 2-week support by continuous medium flow underneath. On histology, three-dimensional cell growth was detected in the continuous delivery group. The CAM assay showed that angiogenesis was enhanced within the DegraPol (R) scaffolds when vascular endothelial. growth factor/vascular permeability factor (VEGF/VPF) was added to the perfusate.
   Conclusions: Taken together, these results demonstrated that the built-in perfusion system within DegraPol (R) scaffolds was able to maintain an intact tracheal epithelial layer, allowed a continuous delivery of cells, and kept an efficient VEGF/VPF expression level which accelerated angiogenic response in the CAM assay. This design combines the in vitro and in vivo parts of tissue engineering and offers the possibility to be used as an in vivo bioreactor implanted for the tissue-engineered reconstruction of trachea and of other organs. (c) 2007 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
C1 Univ Zurich Hosp, Clin Thorac Surg, Div Thorac Surg, CH-8091 Zurich, Switzerland.
   Univ Zurich Hosp, Div Oncol, CH-8091 Zurich, Switzerland.
   ETHZ, Swiss Fed Inst Technol, Polymer Res Inst, CH-8093 Zurich, Switzerland.
   Fudan Univ, Shanghai Chest Hosp, Med Ctr, Shanghai, Peoples R China.
RP Tan, Q (reprint author), Univ Zurich Hosp, Clin Thorac Surg, Div Thorac Surg, Raemistr 100, CH-8091 Zurich, Switzerland.
EM tqiang@hotmail.com
CR Dragowska WH, 2004, MOL CANCER RES, V2, P606
   Ehrhardt C, 2002, CELL TISSUE RES, V308, P391, DOI 10.1007/s00441-002-0548-5
   Fantini MC, 2005, EXPERT REV ANTICANC, V5, P681, DOI 10.1586/14737140.5.4.681
   Feng XS, 2006, BURNS, V32, P293, DOI 10.1016/j.burns.2005.10.006
   Grillo HC, 2002, ANN THORAC SURG, V73, P1995, DOI 10.1016/S0003-4975(02)03564-6
   Grillo Hermes C, 2003, Chest Surg Clin N Am, V13, P175, DOI 10.1016/S1052-3359(03)00002-4
   Horch RE, 2005, J CELL MOL MED, V9, P592, DOI 10.1111/j.1582-4934.2005.tb00491.x
   Kanzaki M, 2006, TISSUE ENG, V12, P1275, DOI 10.1089/ten.2006.12.1275
   Kojima K, 2002, J THORAC CARDIOV SUR, V123, P1177, DOI 10.1067/mtc.2002.121161
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   NAGAYA N, 2005, AM J PHYSIOL-REG I, V288, P1432
   Portner R, 2005, J BIOSCI BIOENG, V100, P235, DOI 10.1263/jbb.100.235
   Qu N, 2005, J HEART LUNG TRANSPL, V24, P882, DOI 10.1016/j.healun.2004.04.020
   Radisic M, 2005, AM J PHYSIOL-HEART C, V288, pH1278, DOI 10.1152/ajpheart.00787.2004
   Saad B, 1997, J BIOMED MATER RES, V36, P65, DOI 10.1002/(SICI)1097-4636(199707)36:1<65::AID-JBM8>3.3.CO;2-#
   Saad B, 1999, INT J BIOL MACROMOL, V25, P293, DOI 10.1016/S0141-8130(99)00044-6
   Sahota PS, 2004, WOUND REPAIR REGEN, V12, P635, DOI 10.1111/j.1067-1927.2004.12608.x
   Scheidegger P, 1999, BIOL CHEM, V380, P1449, DOI 10.1515/BC.1999.187
   Shin M, 2004, BIOMED MICRODEVICES, V6, P269, DOI 10.1023/B:BMMD.0000048559.29932.27
   Steiner R., 1992, ANGIOGENESIS KEY PRI, P449
   Stevens MM, 2005, P NATL ACAD SCI USA, V102, P11450, DOI 10.1073/pnas.0504705102
   Szanto Z, 2001, Magy Seb, V54, P320
   Tan Qian, 2003, Zhonghua Zheng Xing Wai Ke Za Zhi, V19, P291
   Yang L, 2003, EUR J CARDIO-THORAC, V24, P201, DOI 10.1016/S1010-7940(03)00263-X
   Yao C, 2004, CELLS TISSUES ORGANS, V178, P189, DOI 10.1159/000083730
NR 25
TC 23
Z9 23
U1 1
U2 15
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1010-7940
EI 1873-734X
J9 EUR J CARDIO-THORAC
JI Eur. J. Cardio-Thorac. Surg.
PD MAY
PY 2007
VL 31
IS 5
BP 806
EP 811
DI 10.1016/j.ejcts.2007.01.045
PG 6
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 196FY
UT WOS:000248468300018
PM 17320405
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Rodriguez-Navarro, AB
   Yebra, A
   Nys, Y
   Jimenez-Lopez, C
   Garcia-Ruiz, JM
AF Rodriguez-Navarro, Alejandro B.
   Yebra, Africa
   Nys, Yves
   Jimenez-Lopez, Concepcion
   Garcia-Ruiz, Juan Manuel
TI Analysis of avian eggshell microstructure using X-ray area detectors
SO EUROPEAN JOURNAL OF MINERALOGY
LA English
DT Article
DE biomineralization; calcite; eggshell; microtexture; CCD detector;
   Debye-Scherrer ring
ID DIFFRACTION; SHELL; SIZE
AB Avian eggshell is a relatively simple model of biomineralization processes, This biomaterial consists mainly of a mineral part made of columnar calcite crystals and a pervading organic matrix. The organization of eggshell microstructure is determined by genetic, physiological and external factors. Eggshell microstructural characteristics can inform us about biological and physicochemical processes affecting its formation. Quantitative microstructure information can be efficiently determined from two-dimensional diffraction patterns of polycrystalline samples. The present paper analyses the potential of this methodology as applied to microstructure characterization of fully dense polycrystalline materials such as avian eggshell. High correlation was found between parameters determined by X-ray diffraction, such as the number, size and intensity of reflection spots in Debye rings, and crystal size dimensions determined by means of optical microscopy. Crystal sizes can be calculated from these parameters following calibration using samples of the same material whose sizes are already known. Estimated error in crystal size measurements was within 5 %. In comparison with traditional methodologies (e.g., optical microscopy), this technique enabled much faster and more precise determination of microstructural information.
C1 Univ Granada, Dept Mineral & Petrol, E-18002 Granada, Spain.
   Univ Jaen, Dept Geol, Granada, Spain.
   INRA, Ctr Tours, Stn Rech Avicoles, F-37380 Nouzilly, France.
   Univ Granada, Dept Microbiol, E-18002 Granada, Spain.
   Univ Granada, CSIC, Inst Andaluz Ciencias Terra, Lab Estudios Cristallog, E-18002 Granada, Spain.
RP Rodriguez-Navarro, AB (reprint author), Univ Granada, Dept Mineral & Petrol, E-18002 Granada, Spain.
EM anava@ugr.es
RI Garcia-Ruiz, Juan Manuel/C-4389-2015; Yebra-Rodriguez,
   Africa/K-4662-2013
OI Garcia-Ruiz, Juan Manuel/0000-0002-4743-8718; Yebra-Rodriguez,
   Africa/0000-0002-1452-1136; Jimenez-Lopez,
   Concepcion/0000-0002-5645-2079
CR ANDREWS KW, 1959, J APPL PHYS, V10, P321
   Azaroff L. V., 1968, ELEMENTS XRAY CRYSTA, P549
   BUERGER JM, 1942, XRAY CRYSTALLOGRAPHY, P179
   CAIN CJ, 1964, BIOPHYS J, V4, P23, DOI 10.1016/S0006-3495(64)86767-9
   CULLITY BD, 1977, ELEMENTS XRAY DIFFRA, P281
   GALLEGO MR, 1982, DIFRACCION RAYOS, V10
   He BBP, 2003, POWDER DIFFR, V18, P71, DOI 10.1154/1.1577355
   HIRSCH PB, 1952, ACTA CRYSTALLOGR, V5, P162, DOI 10.1107/S0365110X52000496
   Ichikawa F, 1996, MATER SCI FORUM, V210-2, P195, DOI 10.4028/www.scientific.net/MSF.210-213.195
   Kurzydlowski K.J., 1995, QUANTITATIVE DESCRIP
   Nys Y, 1999, POULT AVIAN BIOL REV, V10, P143
   Rodriguez-Enriquez S, 2006, AUTOPHAGY, V2, P39, DOI 10.4161/auto.2229
   Rodriguez-Navarro A, 2002, BRIT POULTRY SCI, V43, P395, DOI 10.1080/00071660120103675
   Rodriguez-Navarro AB, 2006, J AM CERAM SOC, V89, P2232, DOI 10.1111/j.1551-2916.2006.00998.x
   SULYANOV SN, 1994, J APPL CRYSTALLOGR, V27, P934, DOI 10.1107/S002188989400539X
NR 15
TC 12
Z9 12
U1 0
U2 12
PU E SCHWEIZERBARTSCHE VERLAGS
PI STUTTGART
PA NAEGELE U OBERMILLER, SCIENCE PUBLISHERS, JOHANNESSTRASSE 3A, D 70176
   STUTTGART, GERMANY
SN 0935-1221
J9 EUR J MINERAL
JI Eur. J. Mineral.
PD MAY-JUN
PY 2007
VL 19
IS 3
BP 391
EP 398
DI 10.1127/0935-1221/2007/0019-1724
PG 8
WC Mineralogy
SC Mineralogy
GA 188RZ
UT WOS:000247938300012
DA 2018-10-20
ER

PT J
AU Varshosaz, J
AF Varshosaz, Jaleh
TI The promise of chitosan microspheres in drug delivery systems
SO EXPERT OPINION ON DRUG DELIVERY
LA English
DT Review
DE bioadhesive; biocompatible; chitosan microspheres
ID IN-VITRO EVALUATION; SPRAY-DRYING METHOD; H-PYLORI THERAPY; LOADED
   CHITOSAN; CONTROLLED-RELEASE; NASAL DELIVERY; MUCOADHESIVE MICROSPHERES;
   ALGINATE MICROPARTICLES; ARTICULAR-CARTILAGE; FORMULATION FACTORS
AB Chitosan is a partially deacetylated polymer obtained from the alkaline deacetylation of chitin, which is a glucose-based, unbranched polysaccharide that occurs widely in nature as the principal component of exoskeletons of crustaceans and insects, as well as of the cell walls of some bacteria and fungi. Chitosan exhibits a variety of physicochemical and biological properties resulting in numerous applications in fields such as waste water treatment, agriculture, fabric and textiles, cosmetics, nutritional enhancement and food processing. In addition to its lack of toxicity and allergenicity, its biocompatibility, biodegradability and bioactivity make it a very attractive substance for diverse applications as a biomaterial in the pharmaceutical and medical fields. This review takes a closer look at the biomedical applications of chitosan microspheres. Based on recent research and existing products, some new and potential future approaches in this fascinating area are discussed.
C1 [Varshosaz, Jaleh] Isfahan Univ Med Sci, Sch Pharm, Dept Pharmaceut, Esfahan, Iran.
RP Varshosaz, J (reprint author), Isfahan Univ Med Sci, Sch Pharm, Dept Pharmaceut, Esfahan, Iran.
EM varshosaz@pharm.mui.ac.ir
RI varshosaz, jaleh/V-6124-2017; Varshosaz, Jaleh/W-2290-2017
OI , Jaleh/0000-0001-9333-5798
CR Agnihotri SA, 2004, J CONTROL RELEASE, V100, P5, DOI 10.1016/j.jconrel.2004.08.010
   Agnihotri SA, 2006, INT J PHARM, V324, P103, DOI 10.1016/j.ijpharm.2006.05.061
   Akbuga J, 2004, EUR J PHARM BIOPHARM, V58, P501, DOI 10.1016/j.ejpb.2004.04.015
   Anal AK, 2006, INT J PHARM, V312, P166, DOI 10.1016/j.ijpharm.2006.01.043
   Ansell RJ, 1998, ANALYST, V123, P1611, DOI 10.1039/a801903g
   Aral C, 2003, J PHARM PHARM SCI, V6, P321
   Bai AP, 2006, POSTGRAD MED J, V82, P376, DOI 10.1136/pgmj.2005.040899
   Bivas-Benita M, 2004, VACCINE, V22, P1609, DOI 10.1016/j.vaccine.2003.09.044
   Blanco MD, 2000, INT J PHARM, V202, P29, DOI 10.1016/S0378-5173(00)00408-7
   BODMEIER R, 1991, J CONTROL RELEASE, V15, P65, DOI 10.1016/0168-3659(91)90104-L
   BRAMBLE JL, 1990, BIOTECHNOL PROGR, V6, P452, DOI 10.1021/bp00006a008
   Cabana MD, 2006, CLIN PEDIATR, V45, P405, DOI 10.1177/0009922806289614
   Celik O, 2007, EUR J PHARM BIOPHARM, V66, P42, DOI 10.1016/j.ejpb.2006.08.016
   Cerchiara T, 2005, EUR J PHARM BIOPHARM, V61, P195, DOI 10.1016/j.ejpb.2005.05.005
   Cerchiara T, 2003, J MICROENCAPSUL, V20, P473, DOI 10.1080/0265204031000094329
   Cevher E, 2006, INT J PHARM, V317, P127, DOI 10.1016/j.ijpharm.2006.03.014
   Cho BC, 2004, J CRANIOFAC SURG, V15, P299, DOI 10.1097/00001665-200403000-00028
   Coppi G, 2004, J MICROENCAPSUL, V21, P829, DOI 10.1080/02652040400015437
   Denkbas EB, 2002, REACT FUNCT POLYM, V50, P225, DOI 10.1016/S1381-5148(01)00115-8
   DUNNILL P, 1974, BIOTECHNOL BIOENG, V16, P987, DOI 10.1002/bit.260160710
   El-Gibaly I, 2002, INT J PHARM, V249, P7, DOI 10.1016/S0378-5173(02)00396-4
   Elcin YM, 1996, ARTIF CELL BLOOD SUB, V24, P257, DOI 10.3109/10731199609117438
   Eroglu M, 2006, J MICROENCAPSUL, V23, P367, DOI 10.1080/02652040500286318
   FU X, IN PRESS CARBOHYDRAT
   Gagnon M, 2006, INT J FOOD MICROBIOL, V111, P26, DOI 10.1016/j.ijfoodmicro.2006.04.041
   Gavini E, 2006, INT J PHARM, V307, P9, DOI 10.1016/j.ijpharm.2005.09.013
   Gavini E, 2005, J PHARM PHARMACOL, V57, P287, DOI 10.1211/0022357055623
   Genta I, 1997, J PHARM PHARMACOL, V49, P737, DOI 10.1111/j.2042-7158.1997.tb06103.x
   Giunchedi P, 1998, BIOMATERIALS, V19, P157, DOI 10.1016/S0142-9612(97)00181-6
   Giunchedi P, 2002, EUR J PHARM BIOPHARM, V53, P233, DOI 10.1016/S0939-6411(01)00237-5
   Govender S, 2005, INT J PHARM, V306, P24, DOI 10.1016/j.ijpharm.2005.07.026
   Grant J, 2005, J PHARM SCI-US, V94, P1512, DOI 10.1002/jps.20379
   Grenha A, 2005, EUR J PHARM SCI, V25, P427, DOI 10.1016/j.ejps.2005.04.009
   Guliyeva U, 2006, EUR J PHARM BIOPHARM, V62, P17, DOI 10.1016/j.ejpb.2005.08.006
   Haghighi HR, 2006, CLIN VACCINE IMMUNOL, V13, P975, DOI 10.1128/CVI.00161-06
   HALLING PJ, 1979, BIOTECHNOL BIOENG, V21, P2359, DOI 10.1002/bit.260211217
   Han Gang, 2006, Yao Xue Xue Bao, V41, P493
   Harikarnpakdee Saraporn, 2006, AAPS PharmSciTech, V7, pE12
   He P, 1998, INT J PHARMACEUT, V166, P75, DOI 10.1016/S0378-5173(98)00027-1
   Hejazi R, 2002, INT J PHARM, V235, P87, DOI 10.1016/S0378-5173(01)00985-1
   Hejazi R, 2004, INT J PHARM, V272, P99, DOI 10.1016/j.ijpharm.2003.12.001
   Huang YC, 2003, J MICROENCAPSUL, V20, P459, DOI 10.1080/0265204021000058456
   Huang YC, 2003, J MICROENCAPSUL, V20, P247, DOI 10.1080/02652040210162522
   Huang YC, 2002, INT J PHARM, V242, P239, DOI 10.1016/S0378-5173(02)00164-3
   Illum L, 2002, J PHARMACOL EXP THER, V301, P391, DOI 10.1124/jpet.301.1.391
   Illum L, 2001, ADV DRUG DELIVER REV, V51, P81, DOI 10.1016/S0169-409X(01)00171-5
   Jaganathan KS, 2005, INT J PHARM, V294, P23, DOI 10.1016/j.ijpharm.2004.12.026
   Jain SK, 2004, DRUG DELIV, V11, P113, DOI 10.1080/10717540490280750
   Jameela SR, 1998, J CONTROL RELEASE, V52, P17, DOI 10.1016/S0168-3659(97)00187-9
   Jiang DS, 2005, BIOCHEM ENG J, V25, P15, DOI 10.1016/j.bej.2005.03.007
   Jiang HL, 2004, EUR J PHARM BIOPHARM, V58, P471, DOI 10.1016/j.ejpb.2004.05.006
   Jiang T, 2006, BIOMATERIALS, V27, P4894, DOI 10.1016/j.biomaterials.2006.05.025
   Kang ML, 2006, EUR J PHARM BIOPHARM, V63, P215, DOI 10.1016/j.ejpb.2006.01.010
   Kim DK, 2001, J MAGN MAGN MATER, V225, P256, DOI 10.1016/S0304-8853(00)01255-5
   KIM EH, IN PRESS J ALLOYS CO
   Kofuji K, 2005, INT J PHARM, V303, P95, DOI 10.1016/j.ijpharm.2005.07.011
   Kosaraju SL, 2006, CARBOHYD POLYM, V64, P163, DOI 10.1016/j.carbpol.2005.11.027
   Krauland AH, 2006, INT J PHARMACEUT, V307, P270, DOI 10.1016/j.ijphann.2005.10.016
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Lameiro MH, 2006, J BIOTECHNOL, V126, P152, DOI 10.1016/j.jbiotec.2006.04.030
   LAUWO JAK, 1990, DRUG DEV IND PHARM, V16, P1375, DOI 10.3109/03639049009115967
   Lee HS, 2005, J MAGN MAGN MATER, V293, P102, DOI 10.1016/j.jmmm.2005.01.049
   Lee JE, 2004, BIOMATERIALS, V25, P4163, DOI 10.1016/j.biomaterials.2003.10.057
   Lee JE, 2004, ARTIF ORGANS, V28, P829, DOI 10.1111/j.1525-1594.2004.00020.x
   Lee JS, 2004, J AGR FOOD CHEM, V52, P7300, DOI 10.1021/jf040235k
   Lee JY, 2004, PHARM RES, V21, P1790, DOI 10.1023/B:PHAM.0000045230.14287.73
   Lim S, 2001, AAPS PHARMSCITECH, V2, pe20
   Liu LS, 1997, J CONTROL RELEASE, V43, P65, DOI 10.1016/S0168-3659(96)01471-X
   Ljungh Asa, 2006, Current Issues in Intestinal Microbiology, V7, P73
   Machida Y, 1986, Drug Des Deliv, V1, P119
   Majithiya Rita J., 2005, Current Drug Delivery, V2, P235, DOI 10.2174/1567201054367995
   Marrache F, 2007, BRIT J CANCER, V96, P49, DOI 10.1038/sj.bjc.6603526
   Martinac A, 2005, J MICROENCAPSUL, V22, P549, DOI 10.1080/02652040500098960
   Martins AO, 2004, TALANTA, V63, P397, DOI 10.1016/j.talanta.2003.11.011
   Mi FL, 1999, BIOMATERIALS, V20, P1603, DOI 10.1016/S0142-9612(99)00064-2
   Minas T, 1997, ORTHOPEDICS, V20, P525
   Misirli Y, 2005, J MICROENCAPSUL, V22, P167, DOI 10.1080/02652040400026368
   Mitra S, 2001, J CONTROL RELEASE, V74, P317, DOI 10.1016/S0168-3659(01)00342-X
   Moore A, 1998, BBA-MOL CELL RES, V1402, P239, DOI 10.1016/S0167-4889(98)00002-0
   Morales MP, 2003, J MAGN MAGN MATER, V266, P102, DOI 10.1016/S0304-8853(03)00461-X
   Nsereko S, 2002, BIOMATERIALS, V23, P2723, DOI 10.1016/S0142-9612(02)00005-4
   Orhan Z, 2006, J BONE JOINT SURG BR, V88B, P270, DOI 10.1302/0301-620X.88B2.16328
   Ozbas-Turan S, 2003, J PHARM PHARM SCI, V6, P27
   Pandey R, 2004, J ANTIMICROB CHEMOTH, V53, P635, DOI 10.1093/jac/dkh139
   Peng XH, 2005, LANGMUIR, V21, P1091, DOI 10.1021/la047689w
   Portero A, 2002, J MICROENCAPSUL, V19, P797, DOI 10.1080/0265204021000022761
   Rai G, 2005, PHARMAZIE, V60, P131
   ROKHADE AP, IN PRESS CARBOHYDRAT
   Saha TK, 2006, CARBOHYD RES, V341, P2835, DOI 10.1016/j.carres.2006.09.016
   Salminen S, 2006, J PEDIATR-US, V149, pS115, DOI 10.1016/j.jpeds.2006.06.062
   Schally AV, 1999, GYNECOL ENDOCRINOL, V13, P401, DOI 10.3109/09513599909167587
   Shentu JL, 2005, INT J BIOL MACROMOL, V37, P42, DOI 10.1016/j.ijbiomac.2005.08.004
   Singh UV, 1998, J MICROENCAPSUL, V15, P581, DOI 10.3109/02652049809008242
   TAKAHASHI K, 1987, BIOCHEM BIOPH RES CO, V142, P291, DOI 10.1016/0006-291X(87)90271-3
   Takishima J, 2002, BIOL PHARM BULL, V25, P1498, DOI 10.1248/bpb.25.1498
   Tanyolac D, 2000, REACT FUNCT POLYM, V43, P279, DOI 10.1016/S1381-5148(99)00054-1
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Turkoglu OF, 2005, SURG NEUROL, V64, P11, DOI 10.1016/j.surneu.2005.07.041
   Van der Lubben IM, 2002, J DRUG TARGET, V10, P449, DOI 10.1080/1061186021000038319
   Van der Lubben IM, 2001, J DRUG TARGET, V9, P39, DOI 10.3109/10611860108995631
   Varshosaz J, 2006, J MICROENCAPSUL, V23, P329, DOI 10.1080/0265040600612405
   Varshosaz J, 2004, J MICROENCAPSUL, V21, P761, DOI 10.1080/02652040400015403
   Wang LY, 2006, COLLOID SURFACE B, V50, P126, DOI 10.1016/j.colsurfb.2006.05.006
   Wang Y. M., 1995, Yaoxue Xuebao, V30, P891
   Wang YM, 1997, J APPL POLYM SCI, V64, P1843, DOI 10.1002/(SICI)1097-4628(19970531)64:9<1843::AID-APP21>3.0.CO;2-X
   Williams RO, 1998, INT J PHARM, V174, P209, DOI 10.1016/S0378-5173(98)00266-X
   Wittaya-areekul S, 2006, INT J PHARM, V312, P113, DOI 10.1016/j.ijpharm.2006.01.003
   Wu Y, 2006, POLYMER, V47, P5287, DOI 10.1016/j.polymer.2006.05.017
   Xue ZX, 2006, REACT FUNCT POLYM, V66, P893, DOI 10.1016/j.reactfunctpolym.2006.04.009
   Yamamoto H, 2005, J CONTROL RELEASE, V102, P373, DOI 10.1016/j.jconrel.2004.10.010
   Yin Chenghui, 2004, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V21, P350
   YOSHIMOTO T, 1987, BIOCHEM BIOPH RES CO, V145, P908, DOI 10.1016/0006-291X(87)91051-5
   Yun YH, 2005, J BIOMAT SCI-POLYM E, V16, P1359, DOI 10.1163/156856205774472281
   Zhao HP, 2006, BIOTECHNOL LETT, V28, P1299, DOI 10.1007/s10529-006-9086-7
NR 114
TC 64
Z9 68
U1 1
U2 52
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1742-5247
EI 1744-7593
J9 EXPERT OPIN DRUG DEL
JI Expert Opin. Drug Deliv.
PD MAY
PY 2007
VL 4
IS 3
BP 263
EP 273
DI 10.1517/17425247.4.3.263
PG 11
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 258GR
UT WOS:000252856900006
PM 17489653
DA 2018-10-20
ER

PT J
AU Tiwari, A
   Singh, V
AF Tiwari, A.
   Singh, V.
TI Synthesis and characterization of electrical conducting
   chitosan-graft-polyaniline
SO EXPRESS POLYMER LETTERS
LA English
DT Article
DE biopolymers; biocomposites; material testing; thermal properties;
   industrial applications
AB A mucopolysaccharide, chitosan was grafted with polyaniline through oxidative-radical copolymerization using ammonium persulfate in acidic medium. The grafting conditions were extensively studied by varying grafting parameters. All the findings have been discussed and proposed a plausible mechanism for the graft copolymerization. The representative chitosan-graft-polyaniline (Ch-g-PANI) was characterized using UV-vis, FTIR, TGA, X-ray diffraction and Scanning electron microscopy taking chitosan as reference. Ch-g-PANI exhibited electrical conductivity, which increases with the extent of grafting onto chitosan backbone. Its electrical conductivity is further influenced by pH and showed pH switching electrical conduction behavior when exposed to NN(3)/HCl vapors. The application of conducting biomaterial such as Ch-g-PANI in the electronic devices especially for the fabrication of sensor devices would be attractive not only in terms of product cost and environmental safety but also from a materials science point of view.
C1 [Tiwari, A.] Natl Phys Lab, Div Engn Mat, New Delhi 110012, India.
   [Singh, V.] Univ Allahabad, Dept Chem, Allahabad 211002, Uttar Pradesh, India.
RP Tiwari, A (reprint author), Natl Phys Lab, Div Engn Mat, Dr KS Krishnan Marg, New Delhi 110012, India.
EM ashunpl@gmail.com
FU Department of Science and Technology, Govt. of India
FX The authors are thankful to the Department of Science and Technology,
   Govt. of India for generous financial support and to the Director,
   National Physical Laboratory, New Delhi, India for providing
   infrastructure facilities to carry out this work.
CR Adhikari B, 2004, PROG POLYM SCI, V29, P699, DOI 10.1016/j.progpolymsci.2004.03.002
   Albuquerque JE, 2000, SYNTHETIC MET, V113, P19, DOI 10.1016/S0379-6779(99)00299-4
   Gosh M, 1999, PHYS LETT A, V260, P138, DOI 10.1016/S0375-9601(99)00501-0
   Gospodinova N, 1998, PROG POLYM SCI, V23, P1443, DOI 10.1016/S0079-6700(98)00008-2
   Kahol PK, 2003, SYNTHETIC MET, V139, P191, DOI 10.1016/S0379-6779(02)01321-8
   Kang YK, 2004, MAT SCI ENG C-BIO S, V24, P39, DOI 10.1016/j.msec.2003.09.047
   Karami H, 2003, J POWER SOURCES, V117, P255, DOI 10.1016/S0378-7753(03)00168-X
   Kim SJ, 2005, J APPL POLYM SCI, V96, P867, DOI 10.1002/app.21524
   Lu XH, 2003, SYNTHETIC MET, V138, P429, DOI 10.1016/S0379-6779(02)00471-X
   Luthra V, 2003, CURR APPL PHYS, V3, P219, DOI 10.1016/S1567-1739(02)00205-5
   Matsuguchi M, 2002, SYNTHETIC MET, V128, P15, DOI 10.1016/S0379-6779(01)00504-5
   Peniche C, 1999, BIOMATERIALS, V20, P1869, DOI 10.1016/S0142-9612(99)00048-4
   Prokes J, 2004, POLYM DEGRAD STABIL, V86, P187, DOI 10.1016/j.polymdegradstab.2004.04.012
   Sengupta PP, 2006, MATER MANUF PROCESS, V21, P263, DOI 10.1080/10426910500464602
   Shin SR, 2005, SYNTHETIC MET, V154, P213, DOI 10.1016/j.synthmet.2005.07.054
   Singh V, 2007, EXPRESS POLYM LETT, V1, P51, DOI 10.3144/expresspolymlett.2007.10
   Singh V, 2006, POLYMER, V47, P254, DOI 10.1016/j.polymer.2005.10.101
   Singh V, 2005, J APPL POLYM SCI, V98, P1652, DOI 10.1002/app.22333
   Singh V, 2005, BIOMACROMOLECULES, V6, P453, DOI 10.1021/bm049518b
   Singh V, 2004, CARBOHYD POLYM, V58, P1, DOI 10.1016/j.carbpol.2004.04.010
   Singh V, 2004, J APPL POLYM SCI, V92, P1569, DOI 10.1002/app.20099
   Singh V., 2004, J APPL POLYM SCI, V95, P820
   Singh V, 2006, REACT FUNCT POLYM, V66, P1306, DOI 10.1016/j.reactfunctpolym.2006.03.013
   Takahashi K, 2002, SYNTHETIC MET, V128, P27, DOI 10.1016/S0379-6779(01)00660-9
   Tan CK, 2000, SENSOR ACTUAT B-CHEM, V71, P184, DOI 10.1016/S0925-4005(00)00615-8
   Tiwari A, 2007, MATER LETT, V61, P4587, DOI 10.1016/j.matlet.2007.02.076
   Tiwari A, 2007, J MACROMOL SCI A, V44, P735, DOI 10.1080/10601320701353116
NR 27
TC 73
Z9 73
U1 6
U2 29
PU BUDAPEST UNIV TECHNOL & ECON
PI BUDAPEST
PA DEPT POLYMER ENG, MUEGYETEM RKP 3, BUDAPEST, H-1111, HUNGARY
SN 1788-618X
J9 EXPRESS POLYM LETT
JI Express Polym. Lett.
PD MAY
PY 2007
VL 1
IS 5
BP 308
EP 317
DI 10.3144/expresspolymlett.2007.44
PG 10
WC Polymer Science
SC Polymer Science
GA V91OF
UT WOS:000206188500007
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Trabuco, EC
   Klingele, CJ
   Gebhart, JB
AF Trabuco, Emanuel C.
   Klingele, Christopher J.
   Gebhart, John B.
TI Xenograft use in reconstructive pelvic surgery: a review of the
   literature
SO INTERNATIONAL UROGYNECOLOGY JOURNAL
LA English
DT Review
DE biomaterial; dermal collagen; uterine; prolapse; reconstructive surgical
   procedures; small-intestine submucosa; surgical mesh; heterologous;
   transplantation
ID SMALL-INTESTINAL SUBMUCOSA; PORCINE DERMAL COLLAGEN; ABDOMINAL-WALL
   DEFECTS; ORGAN PROLAPSE; URINARY-INCONTINENCE; STRESS-INCONTINENCE;
   POLYPROPYLENE MESH; RECTOCELE REPAIR; RANDOMIZED TRIAL; ACELLULAR MATRIX
AB Xenografts, bovine or porcine acellular collagen bioprostheses derived from dermis, pericardium, or small-intestine submucosa, were introduced to overcome synthetic mesh-related complications. Although there are eight commercially available xenografts, there is a paucity of empiric information to justify their use instead of the use of synthetic grafts. In addition, limited data are available about which graft characteristics are important and whether graft-reinforced repairs reduce recurrences and improve outcomes. To address these knowledge gaps, we conducted a Medline search of published reports on xenografts in animal and human trials. Histologic host response to implanted xenograft material depends primarily on chemical cross-linking and porosity, and it is limited to four responses: resorption, incorporation, encapsulation, and mixed. No clinical data unequivocally demonstrate an improved benefit to graft-reinforced repair.
C1 Mayo Clin & Mayo Fdn, Dept Obstet & Gynecol, Rochester, MN 55905 USA.
   Mayo Clin & Mayo Fdn, Div Gynecol Surg, Rochester, MN 55905 USA.
RP Gebhart, JB (reprint author), Mayo Clin & Mayo Fdn, Dept Obstet & Gynecol, 200 1st St SW, Rochester, MN 55905 USA.
EM gebhart.john@mayo.edu
CR Altman D, 2005, DIS COLON RECTUM, V48, P1233, DOI 10.1007/s10350-005-0023-y
   Amid PK, 1997, HERNIA, V1, P15, DOI DOI 10.1007/BF02426382
   Ansaloni Luca, 2003, Acta Biomed, V74 Suppl 2, P10
   Badylak S, 2002, J SURG RES, V103, P190, DOI 10.1006/jsre.2001.6349
   Badylak S, 2001, J SURG RES, V99, P282, DOI 10.1006/jsre.2001.6176
   Baessler K, 2005, OBSTET GYNECOL, V106, P713, DOI 10.1097/01.AOG.0000177970.52037.0a
   Bafghi A, 2005, BJOG-INT J OBSTET GY, V112, P376, DOI 10.1111/j.147-0528.2004.00415.x
   Bellon JM, 2004, WORLD J SURG, V28, P461, DOI 10.1007/s00268-004-7299-2
   Bellon JM, 1998, BIOMATERIALS, V19, P669, DOI 10.1016/S0142-9612(97)00162-2
   Bemelmans BLH, 2003, CURR OPIN UROL, V13, P301, DOI 10.1097/01.mou.0000079414.62186.e1
   Birch C, 2002, CURR OPIN OBSTET GYN, V14, P527, DOI 10.1097/00001703-200210000-00015
   BOBYN JD, 1982, J BIOMED MATER RES, V16, P571, DOI 10.1002/jbm.820160505
   Burger JWA, 2004, ANN SURG, V240, P578
   Cervigni M, 2001, Curr Opin Urol, V11, P429, DOI 10.1097/00042307-200107000-00016
   Clarke KM, 1996, J SURG RES, V60, P107, DOI 10.1006/jsre.1996.0018
   Cole E, 2003, J UROLOGY, V170, P1950, DOI 10.1097/01.ju.0000086484.41789.b7
   Dell JR, 2005, INT UROGYNECOL J, V16, P44, DOI 10.1007/s00192-004-1217-x
   Derwin K, 2004, CLIN ORTHOP RELAT R, P245, DOI 10.1097/01.blo.0000131235.91264.d7
   Gandhi S, 2005, AM J OBSTET GYNECOL, V192, P1643, DOI 10.1016/j.ajog.2004.11.044
   Gomelsky A, 2004, J UROLOGY, V171, P1581, DOI 10.1097/01.ju.0000115956.25769.0a
   Helstrom L, 2005, ACTA OBSTET GYN SCAN, V84, P79, DOI 10.1111/j.0001-6349.2005.00668.x
   Iglesia C B, 1997, Int Urogynecol J Pelvic Floor Dysfunct, V8, P105, DOI 10.1007/BF02764826
   Konstantinovic ML, 2005, BJOG-INT J OBSTET GY, V112, P1554, DOI 10.1111/j.1471-0528.2005.00688.x
   LeBoeuf L, 2004, UROLOGY, V64, P282, DOI 10.1016/j.urology.2004.03.044
   Mantovani F, 2003, EUR UROL, V44, P600, DOI 10.1016/S0302-2838(03)00212-4
   MESCHIA M, MULTICENTRE RANDOMIZ
   Nygaard I, 2004, OBSTET GYNECOL, V104, P489, DOI 10.1097/01.AOG.0000136100.10818.d8
   O'Connor RC, 2002, UROLOGY, V60, P906, DOI 10.1016/S0090-4295(02)01965-9
   Olsen AL, 1997, OBSTET GYNECOL, V89, P501, DOI 10.1016/S0029-7844(97)00058-6
   Record RD, 2001, BIOMATERIALS, V22, P2653, DOI 10.1016/S0142-9612(01)00007-2
   Salomon L, 2004, EUR UROL, V45, P219, DOI 10.1016/j.eururo.2003.09.005
   Samuelsson EC, 1999, AM J OBSTET GYNECOL, V180, P299, DOI 10.1016/S0002-9378(99)70203-6
   Sand PK, 2001, AM J OBSTET GYNECOL, V184, P1357, DOI 10.1067/mob.2001.115118
   Subak LL, 2001, OBSTET GYNECOL, V98, P646, DOI 10.1016/S0029-7844(01)01472-7
   SUNG VW, PORCINE DERIVED SMAL
   VERLEYEN P, PROSPECTIVE RANDOMIS
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   Weber AM, 2001, AM J OBSTET GYNECOL, V185, P1299, DOI 10.1067/mob.2001.119081
   Wiedemann A, 2004, J UROLOGY, V172, P215, DOI 10.1097/01.ju.0000132148.56211.af
   Zheng F, 2005, NEUROUROL URODYNAM, V24, P362, DOI 10.1002/nau.20148
   Zheng F, 2004, AM J OBSTET GYNECOL, V191, P1961, DOI 10.1016/j.ajog.2004.01.091
NR 41
TC 51
Z9 56
U1 1
U2 7
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0937-3462
EI 1433-3023
J9 INT UROGYNECOL J
JI Int. Urogynecol. J.
PD MAY
PY 2007
VL 18
IS 5
BP 555
EP 563
DI 10.1007/s00192-006-0288-2
PG 9
WC Obstetrics & Gynecology; Urology & Nephrology
SC Obstetrics & Gynecology; Urology & Nephrology
GA 153TK
UT WOS:000245457900013
PM 17225930
DA 2018-10-20
ER

PT J
AU Awang-Hazmi, AJ
   Zuki, ABZ
   Noordin, MM
   Jalila, A
   Norimah, Y
AF Awang-Hazmi, A. J.
   Zuki, A. B. Z.
   Noordin, M. M.
   Jalila, A.
   Norimah, Y.
TI Mineral composition of the cockle (Anadara granosa) shells of West Coast
   of Peninsular Malaysia and it's potential as biomaterial for use in bone
   repair
SO JOURNAL OF ANIMAL AND VETERINARY ADVANCES
LA English
DT Article
DE cockle (Anadara granosa) shells; mineral compositions; biomaterial;
   corals
ID GRAFT SUBSTITUTE; CORAL
AB The study was conducted to determine the composition of mineral content of cockle (Anadara granosa) shells from 3 major cockle cultivation of West Coast of Malaysia. Three samples of cockle shells from three different sources were evaluated to determine the content of 12 macro-and micro-elements (Calcium (Ca), Carbon (C), Magnesium (Mg), Sodium (Na), Phosphorus (P), Potassium (K), Ferum (Fe), Copper (Cu), Nickel (Ni), Zink (Zn), Boron and Silica (Si)). For convenience and ease of reference, Ca and C were combine into one unit (Calcium Carbonate, CaC) while Mg, Na, P and K was evaluated individually and Fe, Cu, Ni, Zn, B and Si were evaluated as one group (others). Analysis of elements content was done using inductively Coupled plasma, Auto Analyzer, an Atomic Absorption Spectrophotometer and Carbon Analyzer. Results in this study revealed that the mineral compositions of cockle shells from 3 different sources in West Coast of Peninsular Malaysia were consistence almost in all the samples. The percentage of CaC comprises of more than 98.7% of the total minerals content of the cockle shells of the 3 sources. About 1.3 % of the composition are comprises of Mg, Na, P, K and others (Fe, Cu, Ni, B, Zn and Si). Overall, the minerals composition of cockle shells of West Coast of Peninsular Malaysia are as followed: CaC 98.7 %, Mg 0.05%, Na 0.9%, p 0.02 and others 0.2%.
C1 [Awang-Hazmi, A. J.; Zuki, A. B. Z.; Noordin, M. M.; Jalila, A.] Univ Putras Malaysia, Fac Vet Med, Serdang 43400, Selangor Darul, Malaysia.
   [Norimah, Y.] Malaysia Inst Nucl Technol Res, Kajang 43000, Selangor, Malaysia.
RP Awang-Hazmi, AJ (reprint author), Univ Putras Malaysia, Fac Vet Med, Serdang 43400, Selangor Darul, Malaysia.
CR ALZIEU C, 1989, MAR POLLUT BULL, V20, P22, DOI 10.1016/0025-326X(89)90272-5
   BEUKEMA J J, 1974, Netherlands Journal of Sea Research, V8, P94, DOI 10.1016/0077-7579(74)90028-3
   BEUKEMA JJ, 1992, NETH J SEA RES, V30, P73, DOI 10.1016/0077-7579(92)90047-I
   CHIROFF RT, 1975, J BIOMED MATER RES, V9, P29, DOI 10.1002/jbm.820090407
   Copenhaver W, 1978, BAILEYS TXB HISTOLOG, P170
   DARRACOTT A, 1975, T ROY SOC S AFR, V41, P325, DOI 10.1080/00359197509519447
   Demers C, 2002, BIO-MED MATER ENG, V12, P15
   Din ZB, 1995, MAR POLLUT BULL, V31, P406, DOI 10.1016/0025-326X(95)00143-B
   *DOE, 1994, ENV QUAL REP
   GUILLEMIN G, 1987, J BIOMED MATER RES, V21, P557, DOI 10.1002/jbm.820210503
   HOLMES RE, 1979, PLAST RECONSTR SURG, V63, P626, DOI 10.1097/00006534-197905000-00004
   KALFAS IH, 2002, NEOUROSURG FOC, V10, P1
   Muschler GF, 1990, SPINAL FUSION SCI TE, P9
   NOORDIN I, 1994, FOOD CHEM, V54, P133
   Recker RR, 1992, DISORDERS BONE MINER, P219
   VUOLA J, 2001, NATURAL CORAL HYDROX
   YAHYA MN, 1987, UNPUB ENV BASELINE S
   ZUKI ABZ, 2004, J ANIM VET ADV, V3, P445
NR 18
TC 23
Z9 23
U1 0
U2 4
PU MEDWELL ONLINE
PI FAISALABAD
PA ANSINET BUILDING, 308-LASANI TOWN, SARGODHA RD, FAISALABAD, 38090,
   PAKISTAN
SN 1680-5593
J9 J ANIM VET ADV
JI J. Anim. Vet. Adv.
PD MAY
PY 2007
VL 6
IS 5
BP 591
EP 594
PG 4
WC Veterinary Sciences
SC Veterinary Sciences
GA 263CR
UT WOS:000253195700001
DA 2018-10-20
ER

PT J
AU Draghi, L
   Cigada, A
AF Draghi, L.
   Cigada, A.
TI Nanostructured surfaces for biomedical applications. Part I:
   nanotopography
SO JOURNAL OF APPLIED BIOMATERIALS & BIOMECHANICS
LA English
DT Article
DE biomaterial; nanotopography; nanolithography; soft lithography
ID CORNEAL EPITHELIAL-CELLS; CONTACT-GUIDANCE; SCALE TOPOGRAPHY; GROWTH;
   ADHESION; FIBROBLASTS; LITHOGRAPHY; FABRICATION; ALIGNMENT; MOTILITY
AB The natural cell environment provides a variety of chemical, topographical and mechanical stimuli that contribute in regulating cell behavior and function. If considerable effort has been traditionally dedicated to exploring the chemical side of cell regulation, it was more recently demonstrated that topographic cues might be equally important. Cell substratum interactions are particularly crucial in determining the reaction of cells to biomaterials, which was also shown to be strongly determined by topographical cues. A significant acceleration in investigating this aspect came from the availability of techniques for microstructured surfaces, and is now well known that cells can react to topographical features at their own scale (1-100 micron). Nevertheless, cells possess many nanoscaled features such as filopodia and a cytoskeleton, and the extracellular matrix (ECM) itself possess quite a few nanoscale details. Therefore, the capability of controlling the surface structure of materials in the nanoscale has offered the possibility of adding another level in the hierarchical understanding of cell/biomaterial interactions. Nanofabrication methods, mainly developed out of the semiconductor industries, are a technological driver for addressing the nanotopography related aspects of cell behavior. General concepts regarding some of the more widely utilized techniques that enable the achievement of ordered and well-defined nanoscale features for the investigation of cell reaction to topography are presented together with a few examples of the practical applications available in the literature.
C1 [Draghi, L.; Cigada, A.] Politecn Milan, Dept Chem Mat & Chem Engn, I-20131 Milan, Italy.
RP Draghi, L (reprint author), Politecn Milan, Dept Chem Mat & Chem Engn, Via Mancinelli,7, I-20131 Milan, Italy.
EM lorenza.draghi@polimi.it
RI Draghi, Lorenza/C-1092-2013
OI Cigada, Alberto/0000-0002-0925-5558; Draghi, Lorenza/0000-0003-4744-7777
CR Abrams GA, 2000, CELL TISSUE RES, V299, P39, DOI 10.1007/s004410050004
   [Anonymous], 2004, SYSTEMS BIOL, V1, P54, DOI 10.1049/sb:20045001
   Anselme K, 2004, BIO-MED MATER ENG, V14, P545
   Bettinger CJ, 2006, BIOMATERIALS, V27, P2558, DOI 10.1016/j.biomaterials.2005.11.029
   Biggs MJP, 2007, J ORTHOP RES, V25, P273, DOI 10.1002/jor.20319
   Britland S, 1996, EXP CELL RES, V228, P313, DOI 10.1006/excr.1996.0331
   Brueck SRJ, 1999, J VAC SCI TECHNOL B, V17, P908, DOI 10.1116/1.590669
   Bunk R, 2003, BIOCHEM BIOPH RES CO, V301, P783, DOI 10.1016/S0006-291X(03)00027-5
   CARTER SB, 1967, NATURE, V213, P256, DOI 10.1038/213256a0
   Charest JL, 2004, BIOMATERIALS, V25, P4767, DOI 10.1016/j.biomaterials.2003.12.011
   Choi CH, 2007, BIOMATERIALS, V28, P1672, DOI 10.1016/j.biomaterials.2006.11.031
   Curtis A, 1999, BIOCHEM SOC SYMP, V65, P15
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Curtis A S G, 2005, Eur Cell Mater, V9, P50
   Curtis ASG, 1998, J BIOMAT SCI-POLYM E, V9, P1313, DOI 10.1163/156856298X00415
   Curtis ASG, 2004, IEEE T NANOBIOSCI, V3, P61, DOI 10.1109/TNB.2004.824276
   Curtis ASG, 2001, BIOPHYS CHEM, V94, P275, DOI 10.1016/S0301-4622(01)00247-2
   Cyster LA, 2003, J BIOMED MATER RES A, V67A, P138, DOI 10.1002/jbm.a.10087
   Gallagher JO, 2002, IEEE T NANOBIOSCI, V1, P24, DOI 10.1109/TNB.2002.806918
   Geissler M, 2004, ADV MATER, V16, P1249, DOI 10.1002/adma.200400835
   He W, 2003, BIOMED MICRODEVICES, V5, P101, DOI 10.1023/A:1024531010086
   Hesjedal T, 2003, NANOTECHNOLOGY, V14, P91, DOI 10.1088/0957-4484/14/1/320
   Hsu SH, 2005, BIOTECHNOL BIOENG, V92, P579, DOI 10.1002/bit.20634
   Johansson F, 2006, BIOMATERIALS, V27, P1251, DOI [10.1016/j.biomaterials.2005.07.047, 10.1016/j.niomaterials.2005.07.047]
   Johnson WE, 2006, EUR SPINE J, V15, pS389, DOI 10.1007/s00586-006-0125-9
   Karuri NW, 2004, J CELL SCI, V117, P3153, DOI 10.1242/jcs.01146
   Kenar H, 2006, BIOMATERIALS, V27, P885, DOI 10.1016/j.biomaterials.2005.07.001
   Kikuchi A, 2005, J CONTROL RELEASE, V101, P69, DOI 10.1016/j.jconrel.2004.08.026
   Kim DH, 2005, P ANN INT IEEE EMBS, P4091
   Kim DH, 2006, LANGMUIR, V22, P5419, DOI 10.1021/la060283u
   Kim E, 1996, J AM CHEM SOC, V118, P5722, DOI 10.1021/ja960151v
   KIM E, 1995, NATURE, V376, P581, DOI 10.1038/376581a0
   Liliensiek SJ, 2006, J BIOMED MATER RES A, V79A, P185, DOI 10.1002/jbm.a.30744
   Lim JY, 2005, J ROY SOC INTERFACE, V2, P97, DOI 10.1098/rsif.2004.0019
   Manwaring ME, 2004, BIOMATERIALS, V25, P3631, DOI 10.1016/j.biomaterials.2003.10.043
   Marero DM, 2006, NUCL INSTRUM METH B, V249, P253, DOI 10.1016/j.nimb.2006.04.009
   MEYLE J, 1995, J BIOMED MATER RES, V29, P81, DOI 10.1002/jbm.820290112
   MICHLER A, 1989, J HIRNFORSCH, V30, P473
   Miller C, 2001, BIOMATERIALS, V22, P1263, DOI 10.1016/S0142-9612(00)00278-7
   Mills CA, 2006, J BIOMED MATER RES A, V76A, P781, DOI 10.1002/jbm.a.30539
   Neumann T, 2003, TISSUE ENG, V9, P995, DOI 10.1089/107632703322495637
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Raghavan S, 2004, ADV MATER, V16, P1303, DOI 10.1002/adma.200400594
   Recknor JB, 2006, BIOMATERIALS, V27, P4098, DOI 10.1016/j.biomaterials.2006.03.029
   Sammons RL, 2005, CLIN ORAL IMPLAN RES, V16, P657, DOI 10.1111/j.1600-0501.2005.01168.x
   Sarkar S, 2006, BIOMATERIALS, V27, P4775, DOI 10.1016/j.biomaterials.2006.04.038
   Schwartz Zvi, 2005, Alpha Omegan, V98, P9
   Schwarz US, 2005, MED ENG PHYS, V27, P763, DOI 10.1016/j.medengphy.2005.04.007
   Shin H, 2007, BIOMATERIALS, V28, P126, DOI 10.1016/j.biomaterials.2006.08.007
   Sutherland J, 2005, J ANAT, V206, P581, DOI 10.1111/j.1469-7580.2005.00415.x
   Vernon RB, 2005, BIOMATERIALS, V26, P3131, DOI 10.1016/j.biomateriasl.2004.08.011
   Vieu C, 2000, APPL SURF SCI, V164, P111, DOI 10.1016/S0169-4332(00)00352-4
   Walboomers XF, 1999, J BIOMED MATER RES, V47, P204, DOI 10.1002/(SICI)1097-4636(199911)47:2<204::AID-JBM10>3.0.CO;2-H
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
   WojciakStothard B, 1996, EXP CELL RES, V223, P426, DOI 10.1006/excr.1996.0098
   WOOD A, 1988, J CELL SCI, V90, P667
   Xia YN, 1997, ADV MATER, V9, P147, DOI 10.1002/adma.19970090211
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
   Yim EKF, 2005, NANOMED-NANOTECHNOL, V1, P10, DOI 10.1016/j.nano.2004.11.008
   Zhu BS, 2005, TISSUE ENG, V11, P825, DOI 10.1089/ten.2005.11.825
   Zhu BS, 2004, BIOMATERIALS, V25, P4215, DOI 10.1016/j.biomaterials.2003.11.020
NR 62
TC 14
Z9 14
U1 0
U2 10
PU WICHTIG PUBLISHING
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 1722-6899
EI 1724-6024
J9 J APPL BIOMATER BIOM
JI J. Appl. Biomater. Biomech.
PD MAY-AUG
PY 2007
VL 5
IS 2
BP 61
EP 69
PG 9
WC Biophysics; Engineering, Biomedical; Materials Science, Biomaterials
SC Biophysics; Engineering; Materials Science
GA 298ZT
UT WOS:000255726300001
PM 20799175
DA 2018-10-20
ER

PT J
AU Brochhausen, C
   Zehbe, R
   Gross, U
   Schubert, H
   Kirkpatrick, CJ
AF Brochhausen, C.
   Zehbe, R.
   Gross, U.
   Schubert, H.
   Kirkpatrick, C. J.
TI Perspectives for the tissue engineering of cartilage from a biological
   and biomaterial point of view
SO JOURNAL OF APPLIED BIOMATERIALS & BIOMECHANICS
LA English
DT Article
DE articular cartilage; tissue engineering; growth plate
ID GROWTH-PLATE CHONDROCYTES; PROSTAGLANDIN E-2; X COLLAGEN;
   PARATHYROID-HORMONE; ARTICULAR-CARTILAGE; IN-SITU; BONE;
   DIFFERENTIATION; PROLIFERATION; SCAFFOLD
AB Tissue engineering has become a fast growing interdisciplinary branch of research at the interface between life and engineering sciences with important clinical end-points. In this context the regeneration of articular cartilage represents an exciting challenge since hyaline cartilage has a limited capacity for self-repair. Today the use of different scaffold materials combined with in vitro expanded chondrocytes and signalling molecules poses great hopes for an optimal treatment of articular cartilage defects. However, until today the optimal construct of scaffolds, cells and signalling molecules has not yet been found. Since repair and regeneration recapitulate in part ontogenetic processes, the present paper summarizes the regulative mechanisms of endochondral ossification in the growth plate of the long bones to identify possible new signalling molecules for the improvement of tissue engineering-based solutions in the treatment of cartilage defects. The growth plate represents a highly organized structure of chondrocytes and extracellular matrix components in distinguishable proliferation and differentiation stages. It is regulated by various paracrine and hormonal factors. In a second part we present actual trends in scaffold design based on synthetic polymers and natural polymers, stressing their potential use in the regeneration of cartilage defects from the point of view of bioactivity and biocompatibility. In conclusion, both new signalling molecules from basic research and innovative scaffold materials with variable physico-chemical properties open up new and interesting perspectives for the research in optimized tissue engineered-based therapeutic strategies to treat cartilage defects.
C1 [Brochhausen, C.; Kirkpatrick, C. J.] Johannes Gutenberg Univ Mainz, Inst Pathol, REPAIRlab, D-55101 Mainz, Germany.
   [Zehbe, R.; Schubert, H.] Tech Univ Berlin, Inst Mat Sci & Technol, Berlin, Germany.
   [Gross, U.] Charite Univ Med Berlin, Lab Biomat Res, Dept Expt Dent Oral Biol, D-13353 Berlin, Germany.
RP Brochhausen, C (reprint author), Johannes Gutenberg Univ Mainz, Inst Pathol, REPAIRlab, Langenbeckstr 1, D-55101 Mainz, Germany.
EM brochhausen@pathologie.klinik.uni-mainz.de
OI Zehbe, Rolf/0000-0002-0169-9058
CR Abad V, 2002, ENDOCRINOLOGY, V143, P1851, DOI 10.1210/en.143.5.1851
   Anderson H Clarke, 2003, Curr Rheumatol Rep, V5, P222, DOI 10.1007/s11926-003-0071-z
   ANDERSON HC, 1995, CLIN ORTHOP RELAT R, P266
   Aszodi A, 2003, GENE DEV, V17, P2465, DOI 10.1101/gad.277003
   Bailon-Plaza A, 1999, BONE, V24, P211, DOI 10.1016/S8756-3282(98)00171-9
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Boyan BD, 2001, STEROIDS, V66, P363, DOI 10.1016/S0039-128X(00)00162-8
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   BROCHHAUSEN C, 2005, ARCH PHARM, V371, P146
   BROCHHAUSEN C, 2006, BIOMATERIALIEN, V7, P53
   BROCHHAUSEN CH, 2005, BIOMATERIALIEN, V6, P218
   BROCHHAUSEN CH, 2006, BIOMATERIALIEN, V7, P128
   Brochhausen C, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1948
   Brouwers JEM, 2006, J BIOMECH, V39, P2774, DOI 10.1016/j.jbiomech.2005.10.004
   Buckland RA, 1998, MECH DEVELOP, V71, P143, DOI 10.1016/S0925-4773(98)00008-2
   Chang CH, 2003, BIOMATERIALS, V24, P4853, DOI 10.1016/S0142-9612(03)00383-1
   CHENG Z, 2006, ENDOCRINOLOGY, P25
   de Crombrugghe B, 2001, CURR OPIN CELL BIOL, V13, P721, DOI 10.1016/S0955-0674(00)00276-3
   DeLise AM, 2000, OSTEOARTHR CARTILAGE, V8, P309, DOI 10.1053/joca.1999.0306
   Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006
   Erdmann S, 1996, J CELL BIOL, V135, P1179, DOI 10.1083/jcb.135.4.1179
   FLANAGAN AM, 1992, ENDOCRINOLOGY, V130, P443, DOI 10.1210/en.130.1.443
   Fodor William L, 2003, Reprod Biol Endocrinol, V1, P102, DOI 10.1186/1477-7827-1-102
   Frost HM, 2000, J BONE MINER METAB, V18, P305, DOI 10.1007/s007740070001
   GABLER F, 2007, IN PRESS BIOMOLECULA
   Gafni RI, 2001, PEDIATR RES, V50, P618, DOI 10.1203/00006450-200111000-00014
   Gerber HP, 1999, NAT MED, V5, P623
   Gigante A, 2003, J MATER SCI-MATER M, V14, P713, DOI 10.1023/A:1024915817061
   Harper J, 1999, NAT MED, V5, P617, DOI 10.1038/9460
   Homicz MR, 2003, LARYNGOSCOPE, V113, P25, DOI 10.1097/00005537-200301000-00005
   Hong Y, 2005, BIOMATERIALS, V26, P6305, DOI 10.1016/j.biomaterials.2005.03.038
   Jackson D., 2001, CLIN ORTHOP RELAT R, V133, P14
   Jakob M, 2004, RHEUMATOLOGY, V43, P852, DOI 10.1093/rheumatology/keh197
   Kaab MJ, 1998, J ANAT, V193, P23, DOI 10.1046/j.1469-7580.1998.19310023.x
   Kang SW, 2005, TISSUE ENG, V11, P438, DOI 10.1089/ten.2005.11.438
   Kirsch T, 2000, J BIOL CHEM, V275, P35577, DOI 10.1074/jbc.M005648200
   KLAUS G, 1994, ENDOCRINOLOGY, V135, P1307, DOI 10.1210/en.135.4.1307
   Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657
   Lee DA, 2003, ACTA ORTHOP SCAND, V74, P6, DOI 10.1080/00016470310013581
   Li WJ, 2003, J BIOMED MATER RES A, V67A, P1105, DOI 10.1002/jbm.a.10101
   Lynn AK, 2004, J BONE JOINT SURG BR, V86B, P1093, DOI 10.1302/0301-620X.86B8.15609
   Minina E, 2002, DEV CELL, V3, P439, DOI 10.1016/S1534-5807(02)00261-7
   MINUTH WW, 2003, TISSUE ENG
   Miyamoto M, 2003, OSTEOARTHR CARTILAGE, V11, P644, DOI 10.1016/S1063-4584(03)00118-3
   Mizoguchi I, 1997, ANAT EMBRYOL, V196, P291, DOI 10.1007/s004290050098
   Narumiya S, 1999, PHYSIOL REV, V79, P1193
   OKEEFE RJ, 1994, J BONE MINER RES, V9, P1713
   OKEEFE RJ, 1992, J BONE MINER RES, V7, P397
   Pavesio Alessandra, 2003, Novartis Found Symp, V249, P203
   Perka C, 2001, TISSUE ENG, V7, P359, DOI 10.1089/10763270152044215
   Perka C, 2000, ORTHOPADE, V29, P112
   PETERSON L, 2003, J BONE JOINT SURG S2, V85, pS17
   POOLE AR, 2001, CLIN ORTHOP S, V391, P26
   Reddi AH, 2000, TISSUE ENG, V6, P351, DOI 10.1089/107632700418074
   Roberts S, 2003, ARTHRITIS RES THER, V5, pR60, DOI 10.1186/ar613
   Schwartz Z, 1998, ENDOCRINOLOGY, V139, P1825, DOI 10.1210/en.139.4.1825
   Sharma B, 2004, ANN BIOMED ENG, V32, P148, DOI 10.1023/B:ABME.0000007799.60142.78
   Shum L, 2002, ARTHRITIS RES, V4, P94, DOI 10.1186/ar396
   Simon AM, 2002, J BONE MINER RES, V17, P963, DOI 10.1359/jbmr.2002.17.6.963
   Smith GD, 2005, J BONE JOINT SURG BR, V87B, P445, DOI 10.1302/0301-620X.87B4
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   SYLVIA VL, 2001, J CELL BIOCHEM, V81, P32
   Tuan R.S., 2004, CLIN ORTHOP RELAT R, V427, P105
   UEDA K, 1980, J PEDIATR-US, V97, P834, DOI 10.1016/S0022-3476(80)80282-4
   van der Eerden BCJ, 2003, ENDOCR REV, V24, P782, DOI 10.1210/er.2002-0033
   Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97
   WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8
   Wang W, 2003, J BIOL CHEM, V278, P3762, DOI 10.1074/jbc.M208868200
   Weinreb M, 1997, BONE, V20, P347, DOI 10.1016/S8756-3282(97)00011-2
   Wozney J M, 1989, Prog Growth Factor Res, V1, P267, DOI 10.1016/0955-2235(89)90015-X
   YANG RS, 1993, CALCIFIED TISSUE INT, V52, P57, DOI 10.1007/BF00675627
   YI S, 1999, DEVELOPMENT, V127, P621
   Yoon BS, 2004, J CELL BIOCHEM, V93, P93, DOI 10.1002/jcb.20211
   Zehbe R, 2005, BIO-MED MATER ENG, V15, P445
   ZEHBE R, 2006, BIOMATERIALIEN, V7, P249
   Zou HY, 1997, GENE DEV, V11, P2191, DOI 10.1101/gad.11.17.2191
NR 76
TC 16
Z9 16
U1 0
U2 2
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 1722-6899
J9 J APPL BIOMATER BIOM
JI J. Appl. Biomater. Biomech.
PD MAY-AUG
PY 2007
VL 5
IS 2
BP 70
EP 81
PG 12
WC Biophysics; Engineering, Biomedical; Materials Science, Biomaterials
SC Biophysics; Engineering; Materials Science
GA 298ZT
UT WOS:000255726300002
PM 20799176
DA 2018-10-20
ER

PT J
AU Siriphannon, P
   Monvisade, P
   Jinawath, S
   Hemachandra, K
AF Siriphannon, Punnama
   Monvisade, Pathavuth
   Jinawath, Supatra
   Hemachandra, Khemchai
TI Preparation and characterization of hydroxyapatite/poly(ethylene
   glutarate) biomaterials
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE hydroxyapatite; poly(ethylene glutarate); ring-opening polymerization;
   biomaterials; nanocrystals
ID SIMULATED BODY-FLUID; BONE-REPLACEMENT; POLYMERIZATION; BIODEGRADATION;
   POLYESTERS; CERAMICS; APATITE
AB Hydroxyapatite/poly(ethylene glutarate) (HAp/PEG) biomaterial composites were prepared by ring-opening polymerization (ROP) of cyclic oligo(ethylene glutarate) (C-PEG) in porous HAp scaffolds. The HAp/C-PEG precomposites were prepared by immersing the porous HAp scaffolds in the mixture solution of C-PEG and dibutyl tin-oxide catalyst overnight and polymerizing at 200 degrees C for 24, 48, and 72 h under vacuum. The successful ROP of C-PEG in the porous HAp scaffolds was corroborated by the signals of hydroxyl end-group of PEG shown in the H-1 NMR spectrum of the ROP-products extracted from the composites. PEG in the composites was present as a thin layer coating on the HAp grains and was evenly distributed throughout the samples. The PEG content was about 13-16 wt % and decreased with increasing polymerization time. Its molecular weight (M-w, weight average) measured by gel permeation chromatography was in the range of 4300-6800 g/mol. Compressive strength of the HAp/PEG composites was significantly increased from 3 MPa of the porous HAp scaffold to 11-15 MPa, depending on the PEG content in the composites. In vitro bioactivity of the HAp/PEG composites was studied by soaking in simulated body fluid (SBF) at 36.5 degrees C for 7-28 days. After prolonged soaking, the HAp nanocrystals precipitated from the SBF solution and formed as a layer of globular aggregates, coated on the composite surfaces. This result suggested that the HAp/PEG composite was a bioactive material. (c) 2006 Wiley Periodicals, Inc.
C1 King Mongkuts Inst Technol, Fac Sci, Dept Chem, Bangkok 10520, Thailand.
   Chulalongkorn Univ, Fac Sci, Dept Mat Sci, Bangkok 10330, Thailand.
RP Siriphannon, P (reprint author), King Mongkuts Inst Technol, Fac Sci, Dept Chem, Chalongkrung Rd, Bangkok 10520, Thailand.
EM kspunnam@kmitl.ac.th
CR Amass W, 1998, POLYM INT, V47, P89, DOI 10.1002/(SICI)1097-0126(1998100)47:2<89::AID-PI86>3.0.CO;2-F
   AOKI H, 1994, APPL HYDROXYAPATITE, P1
   BONFIELD W, 1988, J BIOMED ENG, V10, P522, DOI 10.1016/0141-5425(88)90110-0
   BONFIELD W, 1981, BIOMATERIALS, V2, P185, DOI 10.1016/0142-9612(81)90050-8
   Chang BS, 2000, BIOMATERIALS, V21, P1291, DOI 10.1016/S0142-9612(00)00030-2
   Furukawa T, 2000, BIOMATERIALS, V21, P889, DOI 10.1016/S0142-9612(99)00232-X
   GEN S, 1985, KOBUNSHI RONBUNSHU, V42, P771
   Helwig E, 2001, BIOMATERIALS, V22, P2695, DOI 10.1016/S0142-9612(01)00015-1
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Ignjatovic N, 1999, BIOMATERIALS, V20, P809, DOI 10.1016/S0142-9612(98)00234-8
   Jamshidi K, 1988, ASAIO Trans, V34, P755
   JARCHO M, 1977, J BIOENG, V1, P79
   KOKUBO T, 1990, J NON-CRYST SOLIDS, V120, P138, DOI 10.1016/0022-3093(90)90199-V
   Kokubo T., 1993, INTRO BIOCERAMICS, P75
   LeGeros R. Z., 1993, INTRO BIOCERAMICS, P140
   Monvisade P, 1999, CHEM COMMUN, P1987, DOI 10.1039/a905685h
   SHORS CE, 1993, INTRO BIOCERAMICS, P181
   Siriphannon P, 2002, J BIOMED MATER RES, V60, P175, DOI 10.1002/jbm.10056
   Siriphannon P, 1999, J MATER RES, V14, P529, DOI 10.1557/JMR.1999.0076
   Siriphannon P, 2000, J BIOMED MATER RES, V52, P30, DOI 10.1002/1097-4636(200010)52:1<30::AID-JBM5>3.0.CO;2-Z
   Walsh D, 2001, BIOMATERIALS, V22, P1205, DOI 10.1016/S0142-9612(00)00268-4
NR 22
TC 7
Z9 7
U1 0
U2 7
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY
PY 2007
VL 81A
IS 2
BP 381
EP 391
DI 10.1002/jbm.a.31032
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 156ZN
UT WOS:000245688500014
PM 17542004
DA 2018-10-20
ER

PT J
AU Le Nihouannen, D
   Goyenvalle, E
   Aguado, E
   Pilet, P
   Bilban, M
   Daculsi, G
   Layrolle, P
AF Le Nihouannen, Damien
   Goyenvalle, Eric
   Aguado, Eric
   Pilet, Paul
   Bilban, Melitta
   Daculsi, Guy
   Layrolle, Pierre
TI Hybrid composites of calcium phosphate granules, fibrin glue, and bone
   marrow for skeletal repair
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biphasic calcium phosphate granules; fibrin glue; bone marrow; bone
   reconstruction
ID RECONSTRUCTION; SEALANT; TRANSPLANTATION; CERAMICS; SURGERY; DEFECTS;
   GRAFTS
AB Synthetic bone substitutes, such as calcium phosphate ceramics, give good results in clinical applications. In order to adapt to surgical sites, bioceramics come in the form of blocks or granules, and are either dense or porous. Combining these bioceramics with fibrin glue provides a mouldable and self-hardening composite biomaterial with the biochemical properties of each component. Critical-sized defects in the femoral condyle of rabbits were filled with TricOs/fibrin glue/bone marrow hybrid/composite material. The TricOs granules (1-2 mm) were composed of hydroxyapatite and beta tricalcium phosphate (60/40 in weight). The fibrin glue was composed of fibrinogen, thrombin and other biological factors and mixed with MBCP granules either simultaneously or sequentially. Bone marrow was also added to the MBCP/fibrin composite prior to filling the defects. After 3, 6, 12, and 24 weeks of implantation, the newly-formed bone was analysed with histology, histomorphometry and mechanical tests. The newly-formed bone had grown centripetally. Simultaneous application of fibrin glue showed better results for mechanical properties than sequential application after 6 weeks. Around 40% of bone had formed after 24 weeks in the three groups. Although the addition of bone marrow did not improve bone formation, the MBCP/fibrin material could be used in clinical bone filling applications. (c) 2006 Wiley Periodicals, Inc.
C1 INSERM, Lab Ingn Osteo Articulaire & Dent, LIOAD, U791, Nantes, France.
   Univ Nantes, Fac Chirurg Dent, F-44042 Nantes 1, France.
   Ecole Natl Vet Nantes, F-44307 Nantes, France.
   Univ Nantes, SC3M, Fac Chirurg Dent, F-44042 Nantes, France.
   Baxter Biosci Biosurg, Vienna, Austria.
RP Daculsi, G (reprint author), INSERM, Lab Ingn Osteo Articulaire & Dent, LIOAD, U791, Nantes, France.
EM guy.daculsi@univ-nantes.fr
RI Layrolle, Pierre/K-9257-2015; Paul, Pilet/A-3755-2015; Daculsi,
   Guy/P-1320-2014
OI Layrolle, Pierre/0000-0001-9800-5210; Daculsi, Guy/0000-0003-1030-3446
CR Albala DM, 2003, CARDIOVASC SURG, V11, P5, DOI 10.1016/S0967-2109(03)00065-6
   BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012
   Becker S, 2006, SPINE, V31, P11, DOI 10.1097/01.brs.0000192762.40274.57
   BIEBER EJ, 1986, CLIN PLAST SURG, V13, P645
   Bluteau G, 2006, BIOMATERIALS, V27, P2934, DOI 10.1016/j.biomaterials.2006.01.004
   BURCHARDT H, 1987, ORTHOP CLIN N AM, V18, P187
   Burstein FD, 2000, PLAST RECONSTR SURG, V105, P34, DOI 10.1097/00006534-200001000-00006
   Currie LJ, 2001, PLAST RECONSTR SURG, V108, P1713, DOI 10.1097/00006534-200111000-00045
   D'Arc MB, 2004, ANN OTO RHINOL LARYN, V113, P711, DOI 10.1177/000348940411300907
   Delloye C, 2003, Chir Organi Mov, V88, P335
   FRAYSSINET P, 1993, BIOMATERIALS, V14, P423, DOI 10.1016/0142-9612(93)90144-Q
   FRIEDENSTEIN AJ, 1976, INT REV CYTOL, V47, P327, DOI 10.1016/S0074-7696(08)60092-3
   FROST HM, 1969, CALC TISS RES, V3, P211, DOI 10.1007/BF02058664
   Hollinger J O, 1990, J Craniofac Surg, V1, P60, DOI 10.1097/00001665-199001000-00011
   KRUYT MC, 2006, BIOMATERIALS, V2, P75099
   KURZ LT, 1989, SPINE, V14, P1324, DOI 10.1097/00007632-198912000-00009
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Le Guehennec L, 2004, Eur Cell Mater, V8, P1
   Le Guehennec L, 2005, J MATER SCI-MATER M, V16, P29, DOI 10.1007/s10856-005-6443-3
   Le Guehennec L, 2005, J BIOMED MATER RES B, V72B, P69, DOI 10.1002/jbm.b.30118
   Le Guehennec L, 2004, EUR CELLS MATER, V8, P10
   Le Nihouannen D, 2006, BIOMATERIALS, V27, P2716, DOI 10.1016/j.biomaterials.2005.11.038
   LEGUEHENNEC L, 2004, EUR CELL MAT, V8, P11
   Logeart-Avramoglou D, 2005, J CELL MOL MED, V9, P72, DOI 10.1111/j.1582-4934.2005.tb00338.x
   Malard O, 2005, BONE, V36, P323, DOI 10.1016/j.bone.2004.07.018
   MATRAS H, 1985, J ORAL MAXIL SURG, V43, P605, DOI 10.1016/0278-2391(85)90129-6
   Monaco Anthony P, 2004, Exp Clin Transplant, V2, P153
   NERY EB, 1990, J PERIODONTOL, V61, P166, DOI 10.1902/jop.1990.61.3.166
   PEARSON OM, 2004, AM J PHYS ANTHR S, V39, P63
   Pfister RR, 2005, CORNEA, V24, P593, DOI 10.1097/01.ico.0000157402.89032.ad
   RAMRAKHIANI M, 1979, ACTA ANAT, V103, P358
   SALTZ R, 1991, PLAST RECONSTR SURG, V88, P1005, DOI 10.1097/00006534-199112000-00009
   Tan K K, 2005, Med J Malaysia, V60 Suppl C, P53
   Yokosaki Y, 2005, MATRIX BIOL, V24, P418, DOI 10.1016/j.matbio.2005.05.005
NR 34
TC 18
Z9 18
U1 0
U2 3
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY
PY 2007
VL 81A
IS 2
BP 399
EP 408
DI 10.1002/jbm.a.31058
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 156ZN
UT WOS:000245688500016
PM 17117470
DA 2018-10-20
ER

PT J
AU Gorustovich, AA
   Sivak, MG
   Guglielmotti, MB
AF Gorustovich, Alejandro A.
   Sivak, Matias G.
   Guglielmotti, Maria B.
TI A novel methodology for imaging new bone formation around bioceramic
   bone substitutes
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE confocal laser scanning microscopy; bone; bioceramics
ID CALCIUM-PHOSPHATE BIOMATERIAL; BIOACTIVE GLASS PARTICLES; RATS;
   MICRODAMAGE
AB In this study, Frost's bulk-staining in combination with confocal laser scanning microscopy (CLSM) was used to image and characterize ground sections of undecalcified rat bone tissue with in situ bioceramic implants. This was addressed by bulk staining specimens in alcohol-soluble basic fuchsin dye. The ground sections were imaged using CLSM in the confocal fluorescence mode. Confocal images revealed that the newly formed bone could be clearly distinguished from bone marrow and cortical bone, as well as from the implant material. (c) 2006 Wiley Periodicals, Inc.
C1 Natl Atom Energy Commiss, CNEA Reg Noroeste, Res Lab, Salta, Argentina.
   Consejo Nacl Invest Cient & Tecn, Natl Res Council, RA-1033 Buenos Aires, DF, Argentina.
   Univ Buenos Aires, Sch Dent, Dept Oral Pathol, Buenos Aires, DF, Argentina.
RP Gorustovich, AA (reprint author), Natl Atom Energy Commiss, CNEA Reg Noroeste, Res Lab, A4408FTV, Salta, Argentina.
EM alegorustov@ciudad.com.ar
CR Bentolila V, 1998, BONE, V23, P275, DOI 10.1016/S8756-3282(98)00104-5
   Blouin S, 2006, J BIOMED MATER RES A, V78A, P570, DOI 10.1002/jbm.a.30721
   BURR DB, 1990, CLIN ORTHOP RELAT R, P305
   Frost H.M., 1960, H FORD HOSP B, V8, P25
   Gauthier O, 2005, BIOMATERIALS, V26, P5444, DOI 10.1016/j.biomaterials.2005.01.072
   Gauthier O, 2003, J BIOMED MATER RES A, V66A, P47, DOI 10.1002/jbm.a.10506
   Gerstenfeld LC, 2005, J BONE MINER RES, V20, P1715, DOI 10.1359/JBMR.050702
   Gorustovich A, 2005, KEY ENG MAT, V284-286, P913, DOI 10.4028/www.scientific.net/KEM.284-286.913
   Gorustovich A, 2002, INT J ORAL MAX IMPL, V17, P644
   Gorustovich AA, 2006, BIOMED MATER, V1, P100, DOI 10.1088/1748-6041/1/3/002
   JOHANSSON CB, 1995, BIOMATERIALS, V16, P91, DOI 10.1016/0142-9612(95)98268-J
   Lee TC, 2003, J ANAT, V203, P161, DOI 10.1046/j.1469-7580.2003.00211.x
   Qiu SJ, 2005, BONE, V37, P10, DOI 10.1016/j.bone.2005.01.023
NR 13
TC 6
Z9 8
U1 0
U2 5
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY
PY 2007
VL 81A
IS 2
BP 443
EP 445
DI 10.1002/jbm.a.31071
PG 3
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 156ZN
UT WOS:000245688500021
PM 17117473
DA 2018-10-20
ER

PT J
AU Rodrigues, L
   Banat, IM
   Teixeira, J
   Oliveira, R
AF Rodrigues, Ligia
   Banat, Ibrahim M.
   Teixeira, Jose
   Oliveira, Rosario
TI Strategies for the prevention of microbial biofilm formation on silicone
   rubber voice prostheses
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE voice prosthesis; biofilm; prophylactic treatment; surface
   modifications; biosurfactants
ID AIR-FLOW RESISTANCES; SURFACE-FREE-ENERGY; IN-VITRO; PROBIOTIC BACTERIA;
   ANTIFUNGAL AGENTS; ANTIMICROBIAL ACTIVITY; DAIRY-PRODUCTS;
   STREPTOCOCCUS-THERMOPHILUS; POSTLARYNGECTOMY PATIENTS; BIOSURFACTANT
   PRODUCTION
AB Total laryngectomy, a surgical treatment for extensive cancer of larynx, which alters swallowing and respiration in patients, is followed up with a surgical voice restoration procedure comprising tracheoesophageal puncture techniques with insertion of a "voice prosthesis" to improve successful voice rehabilitation. However, microbial colonization is a major drawback of these devices. Antimicrobials are usually used to prevent the colonization of silicone rubber voice prostheses by microorganisms. However, long-term medication induces the development of resistant strains with all associated risks and the development of alternative prophylactic and therapeutic agents, including probiotics and biosurfactants, have been suggested. The inhibition of microbial growth on surfaces can also be achieved by several other techniques involving the modification of physicochemical properties of the biomaterial surface or the covalently binding of antimicrobial agents to the biomaterial surface. An overview of the different approaches investigated to date and future perspectives to reduce the frequent replacements of voice prostheses in laryngectomized patients through microbial biofilm retardation is presented and discussed. (c) 2006 Wiley Periodicals, Inc.
C1 Univ Minho, Ctr Engn Biol, P-4710057 Braga, Portugal.
   Univ Ulster, Sch Biomed Sci, Coleraine VT52 1SA, Londonderry, North Ireland.
RP Rodrigues, L (reprint author), Univ Minho, Ctr Engn Biol, Campus Gualtar, P-4710057 Braga, Portugal.
EM lrmr@deb.uminho.pt
RI Banat, Ibrahim/C-1910-2013; Rodrigues, Ligia/C-3151-2009; Teixeira, Jose
   Antonio/A-6268-2012
OI Banat, Ibrahim/0000-0001-8964-2840; Rodrigues,
   Ligia/0000-0001-9265-0630; Teixeira, Jose Antonio/0000-0002-4918-3704
CR Abbasi F, 2002, POLYM INT, V51, P882, DOI 10.1002/pi.1069
   Ackerstaff AH, 1999, ARCH OTOLARYNGOL, V125, P167, DOI 10.1001/archotol.125.2.167
   Andriole VT, 1999, J ANTIMICROB CHEMOTH, V44, P151, DOI 10.1093/jac/44.2.151
   Angelova N, 1999, TRENDS BIOTECHNOL, V17, P409, DOI 10.1016/S0167-7799(99)01356-6
   Arweiler-Harbeck D, 2001, ACTA OTO-LARYNGOL, V121, P643, DOI 10.1080/000164801316878971
   Balazs DJ, 2004, BIOMATERIALS, V25, P2139, DOI 10.1016/j.biomaterials.2003.08.053
   BANAT IM, 1991, WORLD J MICROB BIOT, V7, P80, DOI 10.1007/BF02310921
   Banat IM, 1995, ACTA BIOTECHNOL, V15, P251, DOI 10.1002/abio.370150302
   BANAT IM, 1995, BIORESOURCE TECHNOL, V51, P1, DOI 10.1016/0960-8524(94)00101-6
   Banat IM, 2000, APPL MICROBIOL BIOT, V53, P495, DOI 10.1007/s002530051648
   BATISH VK, 1990, AUST J DAIRY TECHNOL, V45, P74
   Bauters TGM, 2002, LARYNGOSCOPE, V112, P708, DOI 10.1097/00005537-200204000-00021
   BLOM E, 2000, FOLIA PHONIATR LOGO, V52, P1
   BODEY GP, 1988, MED CLIN N AM, V72, P637, DOI 10.1016/S0025-7125(16)30763-5
   BUSSCHER HJ, 1992, FEMS MICROBIOL LETT, V88, P199, DOI 10.1111/j.1574-6968.1992.tb04988.x
   Busscher HJ, 1997, APPL ENVIRON MICROB, V63, P3810
   BUSSCHER HJ, 1994, APPL MICROBIOL BIOT, V41, P4, DOI 10.1007/s002530050098
   Busscher HJ, 1997, J BIOMED MATER RES, V34, P201, DOI 10.1002/(SICI)1097-4636(199702)34:2<201::AID-JBM9>3.0.CO;2-U
   Busscher HJ, 1998, EUR ARCH OTO-RHINO-L, V255, P410, DOI 10.1007/s004050050088
   Busscher HJ, 1999, MICROBIAL ECOLOGY AND INFECTIOUS DISEASE, P66
   Busscher HJ, 2000, J DAIRY SCI, V83, P641, DOI 10.3168/jds.S0022-0302(00)74924-1
   Busscher HJ, 1999, CARIES RES, V33, P403, DOI 10.1159/000016541
   Dijk F, 2000, J BIOMED MATER RES, V51, P408, DOI 10.1002/1097-4636(20000905)51:3<408::AID-JBM15>3.0.CO;2-M
   Douglas LJ, 2003, TRENDS MICROBIOL, V11, P30, DOI 10.1016/S0966-842X(02)00002-1
   Eerenstein SEJ, 1999, CLIN OTOLARYNGOL, V24, P398, DOI 10.1046/j.1365-2273.1999.00245.x
   Ell SR, 1996, INT CONGR SER, V1112, P363
   Elving GJ, 2002, ANN OTO RHINOL LARYN, V111, P200, DOI 10.1177/000348940211100302
   Elving GJ, 2001, J BIOMED MATER RES, V58, P421
   Elving GJ, 2000, LARYNGOSCOPE, V110, P321, DOI 10.1097/00005537-200002010-00027
   Everaert EPJM, 1999, ARCH OTOLARYNGOL, V125, P1329, DOI 10.1001/archotol.125.12.1329
   Everaert EPJM, 1997, EUR ARCH OTO-RHINO-L, V254, P261, DOI 10.1007/BF02905983
   Everaert EPJM, 1998, COLLOID SURFACE B, V10, P179, DOI 10.1016/S0927-7765(98)00003-4
   Everaert EPJM, 1998, J MATER SCI-MATER M, V9, P147, DOI 10.1023/A:1008867619481
   Flemming RG, 2000, BIOMATERIALS, V21, P273, DOI 10.1016/S0142-9612(99)00176-3
   Foley I, 1996, BIOFOULING, V10, P331, DOI 10.1080/08927019609386290
   Free RH, 2000, ACTA OTO-LARYNGOL, V120, P92
   Free RH, 2000, BIOFOULING, V16, P69, DOI 10.1080/08927010009378431
   Free RH, 2001, ANN OTO RHINOL LARYN, V110, P946, DOI 10.1177/000348940111001010
   Georgopapadakou NH, 1996, ANTIMICROB AGENTS CH, V40, P279, DOI 10.1128/AAC.40.2.279
   Gottenbos B, 2002, BIOMATERIALS, V23, P1417, DOI 10.1016/S0142-9612(01)00263-0
   Gottenbos B, 2002, J MATER SCI-MATER M, V13, P717, DOI 10.1023/A:1016175502756
   Gottenbos B, 2001, J ANTIMICROB CHEMOTH, V48, P7, DOI 10.1093/jac/48.1.7
   GRAYBILL J, 2000, REV IBEROAM MICROL, V17, P168
   Helmerhorst EJ, 1999, ANTIMICROB AGENTS CH, V43, P702, DOI 10.1128/AAC.43.3.702
   HILGERS FJM, 1993, EUR ARCH OTO-RHINO-L, V250, P375
   HILGERS JM, 1990, LARYNGOSCOPE, V100, P1202
   Hoght A.H., 1986, J BIOMED MATER RES, V20, P533
   Kenawy ER, 1998, J CONTROL RELEASE, V50, P145, DOI 10.1016/S0168-3659(97)00126-0
   KEOGH JR, 1994, J LAB CLIN MED, V124, P537
   Laccourreye O, 1997, LARYNGOSCOPE, V107, P527, DOI 10.1097/00005537-199704000-00018
   Leunisse C, 2001, J BIOMED MATER RES, V58, P556, DOI 10.1002/jbm.1054.abs
   MAHIEU HF, 1986, ARCH OTOLARYNGOL, V112, P321
   Millsap KW, 2001, ANTON LEEUW INT J G, V79, P337, DOI 10.1023/A:1012013101862
   NEU TR, 1992, CELL MATER, V2, P261
   NEU TR, 1993, BIOMATERIALS, V14, P459, DOI 10.1016/0142-9612(93)90149-V
   NEU TR, 1994, J APPL BACTERIOL, V76, P521, DOI 10.1111/j.1365-2672.1994.tb01111.x
   Neu TR, 1996, MICROBIOL REV, V60, P151
   NEU TR, 1994, MICROB ECOL HEALTH D, V7, P27, DOI 10.3109/08910609409141571
   NIJDAM HF, 1982, ARCH OTO-RHINO-LARYN, V237, P27, DOI 10.1007/BF00453713
   NIJDAM HF, 1990, CLIN OTOLARYNGOL, V15, P561
   Oosterhof JJH, 2003, BIOFOULING, V19, P347, DOI 10.1080/08927010310001612054
   PALMER MD, 1993, LARYNGOSCOPE, V103, P910
   PANJE WR, 1981, ANN OTO RHINOL LARYN, V90, P116, DOI 10.1177/000348948109000204
   PERDIGON G, 1986, INFECT IMMUN, V53, P404
   PerezGiraldo C, 1997, J ANTIMICROB CHEMOTH, V39, P643, DOI 10.1093/jac/39.5.643
   PRATTTERPSTRA IH, 1989, J COLLOID INTERF SCI, V129, P568, DOI 10.1016/0021-9797(89)90471-2
   PRESS RI, 1992, LANCET, V340, P1304, DOI 10.1016/0140-6736(92)92491-W
   QUIRYNEN M, 1995, J CLIN PERIODONTOL, V22, P1, DOI 10.1111/j.1600-051X.1995.tb01765.x
   QUIRYNEN M, 1989, J DENT RES, V68, P796, DOI 10.1177/00220345890680050801
   Ramakrishnan A, 2002, MACROMOL RAPID COMM, V23, P612, DOI 10.1002/1521-3927(20020701)23:10/11<612::AID-MARC612>3.0.CO;2-9
   REID G, 1992, CELL MATER, V2, P253
   Reid G, 1998, INT DAIRY J, V8, P555, DOI 10.1016/S0958-6946(98)00075-2
   Reid G, 1999, METHOD ENZYMOL, V310, P426
   REID G, 1984, J DAIRY SCI, V84, P164
   Rodrigues L, 2006, J ANTIMICROB CHEMOTH, V57, P609, DOI 10.1093/jac/dkl024
   Rodrigues L, 2006, FEMS IMMUNOL MED MIC, V46, P107, DOI 10.1111/j.1574-695X.2005.00006.x
   Rodrigues L, 2004, APPL MICROBIOL BIOT, V66, P306, DOI 10.1007/s00253-004-1674-7
   Rodrigues L, 2004, APPL ENVIRON MICROB, V70, P4408, DOI 10.1128/AEM.70.7.4408-4410.2004
   RODRIGUES LR, 2000, J APPL MICROBIOL, V100, P470
   Ruissen ALA, 1999, J CONTROL RELEASE, V60, P49, DOI 10.1016/S0168-3659(99)00052-8
   Sheehan DJ, 1999, CLIN MICROBIOL REV, V12, P40
   SINGER MI, 1980, ANN OTO RHINOL LARYN, V89, P529, DOI 10.1177/000348948008900608
   STAFFIERI M, 1988, LARYNGOSCOPE, V98, P1027
   Tenovuo J, 1998, ACTA ODONTOL SCAND, V56, P250, DOI 10.1080/000163598428400
   Traissac L, 1987, Rev Laryngol Otol Rhinol (Bord), V108, P157
   van de Belt H, 2000, BIOMATERIALS, V21, P1981, DOI 10.1016/S0142-9612(00)00082-X
   van der Mei HC, 2000, J MED MICROBIOL, V49, P713, DOI 10.1099/0022-1317-49-8-713
   Van der Mei HC, 1999, FOOD BIOPROD PROCESS, V77, P156, DOI 10.1205/096030899532303
   van Hoogmoed CG, 2000, APPL ENVIRON MICROB, V66, P659, DOI 10.1128/AEM.66.2.659-663.2000
   VANDENHOOGEN F, 1996, ACTA OTOLARYNGOL, V16, P119
   vanDie I, 1996, GLYCOBIOLOGY, V6, P157, DOI 10.1093/glycob/6.2.157
   VANLITHBIJL JT, 1992, EUR ARCH OTO-RHINO-L, V249, P354, DOI 10.1007/BF00179389
   vanWeissenbruch R, 1997, ACTA OTO-LARYNGOL, V117, P452, DOI 10.3109/00016489709113420
   vanWeissenbruch R, 1997, ANN OTO RHINOL LARYN, V106, P329, DOI 10.1177/000348949710600413
   Velraeds MMC, 1996, APPL ENVIRON MICROB, V62, P1958
   Velraeds MMC, 1998, J MED MICROBIOL, V47, P1081, DOI 10.1099/00222615-47-12-1081
   Wagner RD, 1997, INFECT IMMUN, V65, P4165
NR 97
TC 44
Z9 44
U1 1
U2 20
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD MAY
PY 2007
VL 81B
IS 2
BP 358
EP 370
DI 10.1002/jbm.b.30673
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 161HC
UT WOS:000246004400010
PM 17022068
DA 2018-10-20
ER

PT J
AU Arimura, SI
   Kawahara, KI
   Biswas, KK
   Abeyama, K
   Tabata, M
   Shimoda, T
   Ogomi, D
   Matsusaki, M
   Kato, S
   Ito, T
   Sugihara, K
   Akashi, M
   Hashiguchi, T
   Maruyama, I
AF Arimura, Shin-ichiro
   Kawahara, Ko-ichi
   Biswas, Kamal Krishna
   Abeyama, Kazuhiro
   Tabata, Masashi
   Shimoda, Toru
   Ogomi, Daisuke
   Matsusaki, Michiya
   Kato, Shinya
   Ito, Takashi
   Sugihara, Kazumasa
   Akashi, Mitsuru
   Hashiguchi, Teruto
   Maruyama, Ikuro
TI Hydroxyapatite formed on/in agarose gel induces activation of blood
   coagulation and platelets aggregation
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE adsorption; coagulation; crystallinity; hemostatis; hydroxyl(L)lapatite
ID ALCOHOL) HYDROGEL MATRICES; ALTERNATE SOAKING PROCESS; BONE-GRAFTING
   MATERIAL; APATITE FORMATION; VITRONECTIN; HYDROXYLAPATITE; RECEPTORS;
   CERAMICS; DEFECTS; BIOMATERIAL
AB We reported earlier that hydroxyapatite (HA) formed on/in agarose gels (HA/ agarose) produced by alternate soaking process is a bone-filling material possessing osteoconductive and hemostatic effects. This process could allow us to make bone-like apatite that was formed on/in organic polymer hydrogel matrices. Here, we investigated the mechanism of hemostasis induced by HA/agarose and found that HA/agarose, but not agarose or HA powder, significantly shortened activated partial thromboplastin time (APTT). While HA/agarose did not show significant platelet aggregation, it markedly enhanced adenosine diphosphate (ADP)-induced platelet aggregation. Moreover, Western blot analysis revealed selective adsorption of vitronectin onto HA/agarose. We also observed marked differences between HA powder and HA/agarose in their XRD patterns. The crystallinity of HA powder was much higher compared to that of HA/agarose. Furthermore, 50-100 nm of tube-form aggregations was observed in HA powder on the other hand 100-200 nm of particles was observed in HA/agarose by SEM observation. Thus 100-200 urn of low crystallized particles on the surface structure of HA/agarose may play an important role in hemostasis. Our results demonstrated a crucial role of HA/agarose in the mechanism of hemostasis and suggested a potential role for HA/agarose as a bone-grafting material. (c) 2006 Wiley Periodicals, Inc.
C1 Kagoshima Univ, Grad Sch Med & Dent Sci, Lab Vasc Med, Cardiovasc & Resp Disorders Adv Therapies, Kagoshima 8908520, Japan.
   Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Maxillofacial Diagnost & Surg Sci, Dev Therapeut Course Oral & Maxillofacial Rehabil, Kagoshima 8908544, Japan.
   Miyakonojyo Hosp, Dept Oral Maxillofacial Surg, Miyakonojo, Miyazaki 8850014, Japan.
   Natl Sanatorium Hosizukakeiaien, Dept Dent, Kagoshima 8938502, Japan.
   Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan.
   Kagoshima Univ, Ctr Res & Dev, BioMed Technol Hybrid Ltd, Kagoshima 8900065, Japan.
RP Maruyama, I (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Lab Vasc Med, Cardiovasc & Resp Disorders Adv Therapies, 8-35-1 Sakuragaoka, Kagoshima 8908520, Japan.
EM rinken@m3.kufm.kagoshima-u.ac.jp
RI Matsusaki, Michiya/E-2476-2011
OI Matsusaki, Michiya/0000-0003-4294-9313
CR ASCH E, 1990, J CLIN INVEST, V85, P1372, DOI 10.1172/JCI114581
   BAUER G, 1990, BIOCH ASPECTS OSSEOI, P81
   BELL R, 1988, J ORAL MAXIL SURG, V46, P589, DOI 10.1016/0278-2391(88)90150-4
   Biswas KK, 2003, HEPATOLOGY, V38, P1167, DOI 10.1053/jhep.2003.50459
   BYRD HS, 1993, PLAST RECONSTR SURG, V91, P15, DOI 10.1097/00006534-199301000-00003
   Chou TC, 2003, BIOCHEM BIOPH RES CO, V302, P480, DOI 10.1016/S0006-291X(03)00173-6
   COBB CM, 1990, J ORAL MAXIL SURG, V48, P268, DOI 10.1016/0278-2391(90)90392-F
   Denissen H W, 1991, Int Dent J, V41, P17
   GINSBURG D, 1986, J CLIN INVEST, V78, P1673, DOI 10.1172/JCI112761
   GUETTIER C, 1989, VIRCHOWS ARCH A, V414, P309, DOI 10.1007/BF00734084
   Jang YC, 2000, SURGERY, V127, P696, DOI 10.1067/msy.2000.105858
   Jang YC, 1998, J SURG RES, V80, P9, DOI 10.1006/jsre.1998.5355
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   JARCHO M, 1986, DENT CLIN N AM, V30, P25
   KATO K, 1979, BIOMATER ARTIF CELL, V7, P291, DOI 10.3109/10731197909117584
   LONGENECKER GL, 1985, PLATELETS PHYSL PHAR
   MARANO RPC, 1995, EXP EYE RES, V60, P5
   Matsusaki M, 2003, J BIOMED MATER RES B, V66B, P429, DOI 10.1002/jbm.b.10030
   MEFFERT RM, 1985, J PERIODONTOL, V56, P63, DOI 10.1902/jop.1985.56.2.63
   Misch C E, 1993, Implant Dent, V2, P158, DOI 10.1097/00008505-199309000-00003
   NAGAHARA K, 1992, International Journal of Oral and Maxillofacial Implants, V7, P72
   PETTIS GY, 1990, J ORAL MAXIL SURG, V48, P1068, DOI 10.1016/0278-2391(90)90291-9
   Podor TJ, 2002, J BIOL CHEM, V277, P7520, DOI 10.1074/jbc.M109677200
   Preissner KT, 1998, THROMB RES, V89, P1, DOI 10.1016/S0049-3848(97)00298-3
   PREISSNER KT, 1989, BLUT, V59, P419, DOI 10.1007/BF00349063
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   Sato R, 1994, J Atheroscler Thromb, V1 Suppl 1, pS50
   Tabata M, 2005, J BIOMED MATER RES B, V75B, P378, DOI 10.1002/jbm.b.30316
   Tabata M, 2003, J BIOMED MATER RES B, V67B, P680, DOI 10.1002/jbm.b.10063
   Taguchi T, 1999, J BIOMAT SCI-POLYM E, V10, P331, DOI 10.1163/156856299X00397
   Taguchi T, 1998, CHEM LETT, P711, DOI 10.1246/cl.1998.711
   Taguchi T, 1999, J BIOMAT SCI-POLYM E, V10, P795, DOI 10.1163/156856299X00883
   WILSON J, 1992, J APPL BIOMATER, V3, P123, DOI 10.1002/jab.770030208
NR 33
TC 5
Z9 5
U1 0
U2 25
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD MAY
PY 2007
VL 81B
IS 2
BP 456
EP 461
DI 10.1002/jbm.b.30684
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 161HC
UT WOS:000246004400021
PM 17022065
DA 2018-10-20
ER

PT J
AU Reach, JS
   Dickey, ID
   Zobitz, ME
   Adams, JE
   Scully, SP
   Lewallen, DG
AF Reach, John S., Jr.
   Dickey, Ian D.
   Zobitz, Mark E.
   Adams, Julie E.
   Scully, Sean P.
   Lewallen, David G.
TI Direct tendon attachment and healing to porous tantalum: An experimental
   animal study
SO JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
LA English
DT Article
ID CRUCIATE LIGAMENT RECONSTRUCTION; PATELLAR TENDON; FIBROUS TISSUE;
   CANINE MODEL; BONE; FIXATION; REPAIR; METAL; ANTERIOR; SURGERY
AB Background: The ability to directly attach soft-tissue to metal would have broad clinical application. Previous attempts to obtain normal tendon-to-bone attachment strength have been unsuccessful. In the present study, we hypothesized that when the initial interface mechanical environment is carefully controlled, a highly porous form of tantalum metal would allow the ingrowth of tendon tissue with clinically relevant tendon-to-implant fixation strength approaching that of an intact tendon-to-bone insertion.
   Methods: Supraspinatus tendons from forty skeletally mature dogs were reattached to the greater tuberosity between two custom-designed porous tantalum washers. Clinical function as judged on the basis of gait analysis, reattachment fixation strength and stiffness, and tendon function as seen through muscle volume were evaluated preoperatively, immediately postoperatively, and at three, six, and twelve weeks after surgery. Qualitative and quantitative histomorphologic evaluation was performed at three, six, and twelve weeks after surgery.
   Results: Gait analysis with use of force-plate measurements demonstrated return to a normal gait pattern by three weeks after surgery. Tendon-implant strength as a percentage of normal, contralateral controls increased significantly, from 39% at the time of surgery to 67% at three weeks, 99% at six weeks, and 140% at twelve weeks (p < 0.0014). The stiffness of the construct also increased and approached that of normal tendon, measuring 47% at the time of surgery, 62% at three weeks, 94% at six weeks, and 130% at twelve weeks (p < 0.0299). Supraspinatus muscle volume initially decreased by 33% but recovered to 92% of normal by twelve weeks (p < 0.01). Histomorphologic evaluation showed Sharpey-like fibers inserting onto the surface of the porous tantalum. Quantitative histomorphometric analysis revealed a time-dependent increase in the density of the collagen tissue filling the metal voids below the implant surface of first the bottom washer and then the top washer.
   Conclusions: Robust biologic ingrowth of tendon into a porous tantalum implant surface can be achieved under conditions of secure initial mechanical fixation. The strength and stiffness of the tendon-implant construct reached normal levels by six to twelve weeks in this animal model.
   Clinical Relevance: Our results demonstrate the potential utility of highly porous metals in general and this specific form of porous tantalum in particular as a biomaterial for soft-tissue reconstruction. The ability to achieve healing of tendon and possibly other soft tissues directly to metallic devices should offer opportunities for the development of novel and potentially more physiologic orthopaedic implants.
C1 Mayo Clin, Rochester, MN USA.
RP Reach, JS (reprint author), Yale Univ, Sch Med, Yale Phys Bldg,800 Howard Ave, New Haven, CT 06520 USA.
EM john.reach@aya.yale.edu; SScully@med.miami.edu; lewallen.david@mayo.edu
CR Aoki M, 2001, J SHOULDER ELB SURG, V10, P123, DOI 10.1067/mse.2001.111963
   ARKIN AM, 1953, AM J SURG, V85, P795, DOI 10.1016/0002-9610(53)90571-6
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 1999, J ARTHROPLASTY, V14, P347, DOI 10.1016/S0883-5403(99)90062-1
   BOBYN JD, 1982, J BIOMED MATER RES, V16, P571, DOI 10.1002/jbm.820160505
   Boyer MI, 2001, J BONE JOINT SURG AM, V83A, P891, DOI 10.2106/00004623-200106000-00011
   Brand J, 2000, ARTHROSCOPY, V16, P805, DOI 10.1053/jars.2000.18240
   CAMERON HU, 1978, INT J ARTIF ORGANS, V1, P104
   Carlstedt C A, 1987, Acta Orthop Scand Suppl, V224, P1
   CARLSTEDT CA, 1986, PROSTAGLANDINS, V32, P353, DOI 10.1016/0090-6980(86)90004-3
   CHRISTIE MJ, 1998, ANN M INT SOC TECHN
   Cohen Robert, 2002, Am J Orthop (Belle Mead NJ), V31, P216
   Dion N, 2002, J BONE JOINT SURG AM, V84A, P644, DOI 10.2106/00004623-200204000-00024
   EVANS RB, 1989, PHYS THER, V69, P1041, DOI 10.1093/ptj/69.12.1041
   FERNIE GR, 1977, J BIOMED MATER RES, V11, P883, DOI 10.1002/jbm.820110608
   Forslund C, 2003, ACTA ORTHOP SCAND, V74, P465, DOI 10.1080/00016470310017802
   Gottsauner-Wolf F, 1999, CLIN ORTHOP RELAT R, P101
   GOTTSAUNERWOLF F, 1994, J ORTHOPAED RES, V12, P814, DOI 10.1002/jor.1100120609
   GOTTSAUNERWOLF F, 1995, J ORTHOPAED RES, V13, P90, DOI 10.1002/jor.1100130114
   GOTTSAUNERWOLF F, 1994, ACTA ORTHOP SCAND, V65, P179, DOI 10.3109/17453679408995430
   Grant I, 2002, J HAND SURG-BRIT EUR, V27B, P337, DOI 10.1054/jhsb.2002.0768
   Guide for the Care and Use of Laboratory Animals, GUID CAR US LAB AN
   Hacking SA, 2000, J BIOMED MATER RES, V52, P631
   HOLT GE, 2001, ANN M MUSC TUM SOC M
   Inoue N, 2002, J ORTHOPAED RES, V20, P957, DOI 10.1016/S0736-0266(02)00037-2
   Janis L, 2000, J Foot Ankle Surg, V39, P49
   JONES JR, 1987, J HAND SURG-BRIT EUR, V12B, P306, DOI 10.1016/0266-7681(87)90179-3
   Kannus P, 1997, SCAND J MED SCI SPOR, V7, P67
   KRACKOW KA, 1986, J BONE JOINT SURG AM, V68A, P764, DOI 10.2106/00004623-198668050-00020
   Kumar K, 1999, ARTHROSCOPY, V15, P422, DOI 10.1016/S0749-8063(99)70061-7
   Langlais F, 2003, CLIN ORTHOP RELAT R, P197, DOI 10.1097/01.blo.0000079270.91782.23
   LEVI AD, 1988, SPINE, V23, P1245
   Maffulli N, 2003, J SPORT MED PHYS FIT, V43, P367
   Melican MC, 2001, J BIOMED MATER RES, V55, P194, DOI 10.1002/1097-4636(200105)55:2<194::AID-JBM1006>3.0.CO;2-K
   Nelson CL, 2003, J ARTHROPLASTY, V18, P37, DOI 10.1054/S0883-5403(03)00290-0
   Noyes FR, 2001, J BONE JOINT SURG AM, V83A, P1131, DOI 10.2106/00004623-200108000-00001
   Panni AS, 1997, CLIN ORTHOP RELAT R, P203
   Park MJ, 2001, INT ORTHOP, V25, P35, DOI 10.1007/s002640000199
   Piazza SJ, 2003, J BONE JOINT SURG AM, V85A, P858, DOI 10.2106/00004623-200305000-00013
   PIERMATTEI D.L., 1993, ATLAS SURG APPROACHE
   Piermattei DL, 1997, BRINKER PIERMATTEI F
   POGGIE R, 1998, SOC BIOM M SAN DIEG, P472
   POWELL ES, 1989, J BIOMED ENG, V11, P215, DOI 10.1016/0141-5425(89)90144-1
   Seiler JG, 1997, CLIN ORTHOP RELAT R, P239
   SHARKEY NA, 1995, J BIOMECH, V28, P631, DOI 10.1016/0021-9290(94)00100-I
   TALAC R, 2004, ANN M MID ORTH ASS A
   Wigfield C, 2003, BRIT J NEUROSURG, V17, P418, DOI 10.1080/02688690310001611206
   Zardiackas LD, 2001, J BIOMED MATER RES, V58, P180, DOI 10.1002/1097-4636(2001)58:2<180::AID-JBM1005>3.0.CO;2-5
NR 48
TC 22
Z9 25
U1 1
U2 10
PU JOURNAL BONE JOINT SURGERY INC
PI NEEDHAM
PA 20 PICKERING ST, NEEDHAM, MA 02192 USA
SN 0021-9355
J9 J BONE JOINT SURG AM
JI J. Bone Joint Surg.-Am. Vol.
PD MAY
PY 2007
VL 89A
IS 5
BP 1000
EP 1009
DI 10.2106/JBJS.E.00886
PG 10
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 166KK
UT WOS:000246377400012
PM 17473137
DA 2018-10-20
ER

PT J
AU Oak, JJ
   Louzguine-Luzgin, DV
   Inoue, A
AF Oak, Jeong-Jung
   Louzguine-Luzgin, Dmitri V.
   Inoue, Akihisa
TI Fabrication of Ni-free Ti-based bulk-metallic glassy alloy having
   potential for application as biomaterial, and investigation of its
   mechanical properties, corrosion, and crystallization behavior
SO JOURNAL OF MATERIALS RESEARCH
LA English
DT Article
ID SUPERCOOLED LIQUID REGION; AMORPHOUS-ALLOYS; FORMING ABILITY;
   SUPERCONDUCTING PROPERTIES; SURFACE CHARACTERIZATION; TITANIUM-ALLOYS;
   CERCLAGE WIRE; PHASES; NANOCRYSTALLIZATION; FIXATION
AB A new Ti-based bulk-metallic glassy (BMG) alloy without Ni was developed in various forms such as melt-spun ribbon and cylindrical rods. Ti metal and Ti-based alloys are well known as biomaterials because Ti has good biocompatibility with the human body. We examined mechanical and chemical properties of a newly developed Ti-based BMG alloy in comparison with pure Ti metal and Ti-6Al-4V alloy, which are used for biornaterials. The new Ti-based BMG (Ti45Zr10Pd10CU31Sn4) alloy does not contain Ni, Al, and Be elements, which are known to be toxic. The Ti45Zr10Pd10CU31Sn4 BMG alloy rod with a diameter of 3 mm, which is produced by copper mold casting, exhibits a compressive strength of 1970 MPa and a Young's modulus of 95 GPa. In addition, the Ti45Zr10Pd10CU31Sn4, BMG alloy shows a supercooled liquid region of 56 K and a reduced glass-transition temperature, T-rg (=T-g/T-1), of 0.56. The high thermal stability of supercooled liquid has enabled the fabrication of a cylindrical rod specimen with a diameter of 4 mm. This alloy exhibits precipitation of a primary nanoscale icosahedral phase upon devitrification followed by the formation of a metastable unidentified phase. Ti2Cu and Ti3Sn are stable phases formed in this alloy. The Ti45Zr10Pd10Cu31Sn4 BMG alloy has a high corrosion resistance and is passivated at a lower passive current density of approximately 10(-2) A/m(2) compared to those of pure titanium and the Ti-6Al-4V alloy in 1 mass% lactic acid and phosphate-buffered saline solutions at 310 K.
C1 Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
   Tohoku Univ, Dept Mat Sci, Sendai, Miyagi 9808577, Japan.
RP Oak, JJ (reprint author), Tohoku Univ, Inst Mat Res, Katahira 2-1-1, Sendai, Miyagi 9808577, Japan.
EM ojj69@imr.tohoku.ac.jp
RI BAI, JIE/D-7448-2016; Inoue, Akihisa/E-5271-2015; LOUZGUINE,
   Dmitri/D-2492-2010
OI LOUZGUINE, Dmitri/0000-0001-5716-4987
CR Aziz-Kerrzo M, 2001, BIOMATERIALS, V22, P1531, DOI 10.1016/S0142-9612(00)00309-4
   Chen N, 2005, ACTA MATER, V53, P759, DOI 10.1016/j.actamat.2004.10.027
   Disegi JA, 2000, INJURY, V31, pSD14
   Hattori K, 2001, MAT SCI ENG C-BIO S, V17, P27, DOI 10.1016/S0928-4931(01)00331-9
   Hiromoto S, 2002, MATER TRANS, V43, P261, DOI 10.2320/matertrans.43.261
   INOUE A, 1982, SCRIPTA METALL MATER, V16, P1141, DOI 10.1016/0036-9748(82)90083-7
   INOUE A, 1984, J NON-CRYST SOLIDS, V68, P63, DOI 10.1016/0022-3093(84)90034-6
   INOUE A, 1980, SCRIPTA METALL MATER, V14, P1077, DOI 10.1016/0036-9748(80)90209-4
   Inoue A, 2000, ACTA MATER, V48, P279, DOI 10.1016/S1359-6454(99)00300-6
   INOUE A, 1981, MATER SCI ENG, V47, P59, DOI 10.1016/0025-5416(81)90041-0
   JAMES D, 1986, MOL CELL BIOL, P731
   Kim YC, 2003, J NON-CRYST SOLIDS, V325, P242, DOI 10.1016/S0022-3093(03)00327-2
   Kim YC, 2002, MATER TRANS, V43, P1243, DOI 10.2320/matertrans.43.1243
   KROOVESSIS P, 2002, J ORTHOP SURG TRAMUA, V12, P61
   LIN XH, 1995, J APPL PHYS, V78, P6514, DOI 10.1063/1.360537
   Liu AM, 1997, J ARTHROPLASTY, V12, P772, DOI 10.1016/S0883-5403(97)90007-3
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Louzguine DV, 2000, SCRIPTA MATER, V43, P371, DOI 10.1016/S1359-6462(00)00425-5
   Louzguine DV, 2000, J MATER SCI, V35, P4159, DOI 10.1023/A:1004815112497
   Louzguine DV, 1999, J MATER RES, V14, P4426, DOI 10.1557/JMR.1999.0599
   Louzguine DV, 2001, J NANOSCI NANOTECHNO, V1, P185, DOI 10.1166/jnn.2001.033
   Meyer DC, 2003, CLIN BIOMECH, V18, P975, DOI 10.1016/S0268-0033(03)00181-5
   Oak JJ, 2007, MAT SCI ENG A-STRUCT, V449, P220, DOI 10.1016/j.msea.2006.02.307
   Pang SJ, 2000, MATER T JIM, V41, P1490, DOI 10.2320/matertrans1989.41.1490
   Raju VR, 2002, MATER LETT, V57, P173, DOI 10.1016/S0167-577X(02)00725-5
   ROCKWOOD CA, 1996, FRACTURES ADULTS, P177
   SACHDEV S, 1985, PHYS REV B, V32, P4592, DOI 10.1103/PhysRevB.32.4592
   Sheng WB, 2005, J NON-CRYST SOLIDS, V351, P3081, DOI 10.1016/j.jnoncrysol.2005.07.021
   STEINEMAN GS, 1985, TI 84 SCI TECHN, P1373
   Steinemann G.S., 1980, EVALUATION BIOMATERI, P1
   STEINEMANN GS, 1985, TI 84 SCI TECHN, P1327
   SURYANARAYANA C, 1980, J MATER SCI, V15, P1993, DOI 10.1007/BF00550625
   Takeuchi A, 2005, MATER TRANS, V46, P2817, DOI 10.2320/matertrans.46.2817
   Takeuchi A, 2004, MAT SCI ENG A-STRUCT, V375, P449, DOI 10.1016/j.msea.2003.10.199
   TELFORD A, 2004, MATER TODAY, V7, P36
   Velten D, 2002, J BIOMED MATER RES, V59, P18, DOI 10.1002/jbm.1212
   Wang K, 1996, MAT SCI ENG A-STRUCT, V213, P134, DOI 10.1016/0921-5093(96)10243-4
   Wang LM, 2003, J ALLOY COMPD, V361, P234, DOI 10.1016/S0925-8388(03)00430-4
   Wang WH, 2004, MAT SCI ENG R, V44, P45, DOI 10.1016/j.mser.2004.03.001
   Wever DJ, 1998, BIOMATERIALS, V19, P761, DOI 10.1016/S0142-9612(97)00210-X
   Zhang T, 1999, MATER T JIM, V40, P301, DOI 10.2320/matertrans1989.40.301
   Zhang T, 1998, MATER T JIM, V39, P1001, DOI 10.2320/matertrans1989.39.1001
   Zhang T, 2001, MAT SCI ENG A-STRUCT, V304, P771, DOI 10.1016/S0921-5093(00)01592-6
NR 44
TC 73
Z9 77
U1 1
U2 44
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DR, WARRENDALE, PA 15086 USA
SN 0884-2914
J9 J MATER RES
JI J. Mater. Res.
PD MAY
PY 2007
VL 22
IS 5
BP 1346
EP 1353
DI 10.1557/JMR.2007.0154
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA 164TV
UT WOS:000246258300033
DA 2018-10-20
ER

PT J
AU Sun, WB
   Chu, CL
   Wang, J
   Zhao, HT
AF Sun, Weibin
   Chu, Chenlin
   Wang, Juan
   Zhao, Huating
TI Comparison of periodontal ligament cells responses to dense and
   nanophase hydroxyapatite
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID ALKALINE-PHOSPHATASE; MINERALIZATION; BEHAVIOR; CALCIUM; BONE
AB Hydroxyapatite, a synthetic calcium phosphate ceramic, is used as a biomaterial for the restoration of human hard tissue as well as in techniques which aim to regenerate periodontal tissues. Generally, hydroxyapatite is believed to have osteoconductive effects and to be non-bioresorbable but not to induce to periodontal tissue regeneration. No report has been found on responses of periodontal ligament cells (PDLC), the main contributor to periodontal tissue regeneration, to nanoparticles of hydroxyapatite. The objective of this study was to investigate the possible effects of nanophase powder of hydroxyapatite on proliferation of periodontal ligament cells. Using a sol-gel method, the nanophase hydroxyapatite powders were fabricated. These powders were proved to comprise nanoparticles by transmission electron microscope examination. The primary periodontal ligament cells were cultured on dense particle hydroxyapatite and nanometer particle hydroxyapatite. The effects on proliferation of periodontal ligament cells on dense and nanoparticle hydroxyapatite were examined in vitro using a methyl thiazolil tetracolium (MTT) test. The intercellular effects were studied with scanning electron microscopy (SEM), transmission electron microscopy (TEM) and energy dispersive X-ray (EDX). In addition, the influence of the two materials on osteogenic differentiation was determined through measurement of alkaline phosphatase activity and flow cytometry. About 2, 3, and 4 days after treatment with nanoparticles of hydroxyapatite, the proliferation activity of the PDLC increased significantly compared with those proliferating on dense hydroxyapatite and of control PDLC, but no significant difference was found between the PDLC proliferation on dense hydroxyapatite and the control PDLCs. After 3 and 5 days' incubation with nanoparticles of hydroxyapatite, alkaline phosphatase activity was significantly increased as compared to PDLCs incubated with dense hydroxyapatite and control PDLCs. Intracellular engulfment was found in the cultured cells with nanophase hydroxyapatite under electron microscopy. The results suggest that nanophase hydroxyapatite can promote proliferation and osteogenic differentiation of periodontal ligament cells and further that it may be used as a bioresorbable agent in osseous restoration.
C1 Nanjing Med Univ, Coll Stomatol, Dept Periodontol, Nanjing 210029, Peoples R China.
   SE Univ, Dept Mat Sci & Engn, Nanjing 210018, Peoples R China.
RP Sun, WB (reprint author), Nanjing Med Univ, Coll Stomatol, Dept Periodontol, Nanjing 210029, Peoples R China.
EM wbsun@njmu.edu.cn
CR AlliotLicht B, 1997, J PERIODONTOL, V68, P158, DOI 10.1902/jop.1997.68.2.158
   Bartold PM, 2000, PERIODONTOL 2000, V24, P253, DOI 10.1034/j.1600-0757.2000.2240113.x
   BEERTSEN W, 1992, J CLIN INVEST, V89, P1974, DOI 10.1172/JCI115805
   Chu CL, 2002, J MATER SCI LETT, V21, P1793, DOI 10.1023/A:1020997510289
   Devecioglu D, 2004, J BIOMATER APPL, V19, P107, DOI 10.1177/0885328204043818
   Ehara A, 2003, BIOMATERIALS, V24, P831, DOI 10.1016/S0142-9612(02)00411-8
   Galkowska Ewa, 2003, Ann Univ Mariae Curie Sklodowska Med, V58, P231
   GENGE BR, 1988, J BIOL CHEM, V263, P18513
   Giannobile WV, 2002, INT J PERIODONT REST, V22, P6
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Knabe C, 2000, J BIOMED MATER RES, V52, P498, DOI 10.1002/1097-4636(20001205)52:3<498::AID-JBM8>3.0.CO;2-P
   LUO D, 2004, J NANJING MED U, V18, P172
   NEWMAN MG, 2002, CARRANZAS CLIN PERIO, P75
   Scabbia A, 2004, J CLIN PERIODONTOL, V31, P348, DOI 10.1111/j.1600-051X.2004.00483.x
   Urabe M, 2000, J BIOMED MATER RES, V49, P17, DOI 10.1002/(SICI)1097-4636(200001)49:1<17::AID-JBM3>3.0.CO;2-G
   WOLTGENS JHM, 1982, J BIOL BUCCALE, V10, P191
NR 16
TC 44
Z9 48
U1 0
U2 12
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAY
PY 2007
VL 18
IS 5
BP 677
EP 683
DI 10.1007/s10856-006-0019-8
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 169AD
UT WOS:000246564200002
PM 17143736
DA 2018-10-20
ER

PT J
AU Paez, JMG
   Carrera, A
   Jorge, E
   Millan, I
   Cordon, A
   Rocha, A
   Maestro, M
   Castillo-Olivares, JL
AF Garcia Paez, J. M.
   Carrera, A.
   Jorge, E.
   Millan, I.
   Cordon, A.
   Rocha, A.
   Maestro, M.
   Castillo-Olivares, J. L.
TI Hysteresis of a biomaterial: Influence of sutures and biological
   adhesives
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID BIOPROSTHETIC HEART-VALVES; TISSUE SELECTION SITES; BOVINE PERICARDIUM;
   MECHANICAL-BEHAVIOR; FIBER ARCHITECTURE; LEAFLETS; PROSTHESES;
   ANISOTROPY; FRESH
AB We studied the changes in energy consumption of samples of calf pericardium, when joined or not joined by sutures and adhesives, by means of hysteretic cycles. Sixty-four samples were subsequently subjected to tensile stress until rupture. An overlapping suture sewn in the form of a rectangle presented an acceptable mean resistance to rupture of over 10 MPa, although lower than the mean values in an unsutured control series where the mean resistance surpassed 15 MPa. The contribution of an acrylic adhesive to the resistance to rupture was negligible. The sutured samples that were reinforced with adhesives and had not been subjected to hysteretic cycles prior to rupture showed an anisotropic behavior. This behavior appeared to be lost in all the samples that underwent hysteretic cycles. We found an inflection point in the stress/strain curve following the stepwise increase in the load, with a value greater than and proximate to the final load applied. This inflection should be analyzed by means of microscopy. Finally, the mathematical relationship between the energy consumed and the stress applied, the strain or deformation produced and the number of cycles of hysteresis to which the samples were subjected was established as the ultimate objective of this study. The bonding systems provoked a greater consumption of energy, with the greatest consumption corresponding to the first cycle in all the series assayed. An equation relating the energy consumption in a sample to the number of hysteretic cycles to which it was subjected was obtained. Its asymptote on the x-axis indicates the energy consumption for a theoretical number of cycles, making it possible to estimate the durability of the sample.
C1 Clin Puerta Hierro, Serv Cirugia Expt, Madrid 28035, Spain.
   Escuela Tecn Super Ingenieros Ind, Dept Mecan Estructural & Resistencia Mat, Madrid 28006, Spain.
   Clin Puerta Hierro, Serv Bioestadist, Madrid 28035, Spain.
RP Paez, JMG (reprint author), Clin Puerta Hierro, Serv Cirugia Expt, San Martin de Porres 4, Madrid 28035, Spain.
EM josempaez@telefonica.net
RI Jorge Herrero, EDUARDO/F-7240-2010
CR Braile DM, 1998, J HEART VALVE DIS, V7, P202
   Burriesci G, 1999, J MED ENG TECHNOL, V23, P203
   Butany J, 2001, J Long Term Eff Med Implants, V11, P115
   Butterfield M, 2001, J HEART VALVE DIS, V10, P105
   CANNEGIETER SC, 1994, CIRCULATION, V89, P635, DOI 10.1161/01.CIR.89.2.635
   Carrera San Martin A, 1998, J Biomed Mater Res, V39, P568
   CHRISTIE GW, 1982, FINITE ELEMENTS BIOM, P153
   CLARK RE, 1973, J THORAC CARDIOV SUR, V66, P202
   CLARK RE, 1974, J THORAC CARDIOV SUR, V67, P792
   Ellsmere JC, 1999, BIOMATERIALS, V20, P1143, DOI 10.1016/S0142-9612(99)00013-7
   Grabenwoger M, 2000, J HEART VALVE DIS, V9, P104
   GUYTON A, 1971, TRATADO FISIOLOGIA M, P160
   Hiester ED, 1998, J BIOMED MATER RES, V39, P215, DOI 10.1002/(SICI)1097-4636(199802)39:2<215::AID-JBM7>3.0.CO;2-S
   Hiester ED, 1998, J BIOMED MATER RES, V39, P207, DOI 10.1002/(SICI)1097-4636(199802)39:2<207::AID-JBM6>3.0.CO;2-T
   Jennings LM, 2002, ANN THORAC SURG, V74, P63, DOI 10.1016/S0003-4975(02)03617-2
   Kent PD, 1998, CARDIOVASC PATHOL, V7, P9, DOI 10.1016/S1054-8807(97)00040-9
   Munro AI, 1995, ANN THORAC SURG, V59, pS470
   Oxenham H, 2003, HEART, V89, P715, DOI 10.1136/heart.89.7.715
   Paez JMG, 2001, BIOMATERIALS, V22, P2731
   Paez JMG, 1996, BIOMATERIALS, V17, P1677, DOI 10.1016/0142-9612(96)87647-2
   PAEZ JMG, 1994, BIOMATERIALS, V5, P172
   PAEZ JMG, 2002, J MATER SCI MAT MED, V13, P1
   Sacks M S, 1994, ASAIO J, V40, pM632, DOI 10.1097/00002480-199407000-00075
   Sacks MS, 2002, J BIOMED MATER RES, V62, P359, DOI 10.1002/jbm.10293
   Talman EA, 1996, J HEART VALVE DIS, V5, P152
   TYERS GFO, 1995, ANN THORAC SURG, V60, pS464
   Vesely I, 2001, J Long Term Eff Med Implants, V11, P137
   VONFRAUNHOFER JA, 1992, BIOMATERIALS, V13, P715, DOI 10.1016/0142-9612(92)90133-9
   VONFRAUNHOFER JA, 1988, BIOMATERIALS, V9, P324, DOI 10.1016/0142-9612(88)90027-0
   Vongpatanasin W, 1996, NEW ENGL J MED, V335, P407, DOI 10.1056/NEJM199608083350607
   ZIOUPOS P, 1992, MED BIOL ENG COMPUT, V30, P76, DOI 10.1007/BF02446197
NR 31
TC 6
Z9 6
U1 2
U2 4
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAY
PY 2007
VL 18
IS 5
BP 715
EP 724
DI 10.1007/s10856-006-0009-x
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 169AD
UT WOS:000246564200007
PM 17136602
DA 2018-10-20
ER

PT J
AU Traini, T
   Valentini, P
   Iezzi, G
   Piattelli, A
AF Traini, Tonino
   Valentini, Pascal
   Iezzi, Giovanna
   Piattelli, Adriano
TI A histologic and histomorphometric evaluation of anorganic bovine bone
   retrieved 9 years after a sinus augmentation procedure
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE bio-oss; maxillary sinus
ID HUMAN CORTICAL BONE; OSTEOCYTE DENSITY; BIO-OSS; MORPHOMETRIC-ANALYSIS;
   FLOOR AUGMENTATION; IMPLANT PLACEMENT; AUTOGENOUS BONE; DENTAL IMPLANTS;
   SUBSTITUTE; HUMANS
AB Background: Anorganic bovine bone (ABB) has been shown to have osteoconductiue properties and no inflammatory or adverse responses as grafting materials used in sinus augmentation procedures. Despite these successful results, histologic data in humans over the long-term period are scarce. The purpose of this study was to analyze the histomorphometric data 9 years after surgery in a case of maxillary sinus augmentation using ABB.
   Methods: The histologic evaluation was performed in flue different thin sections of the specimen, comparing histomorphometric measures for newly formed bone, marrow spaces, biomaterial particles remnants, and number of osteocytes embedded in both trabecular bone and bone tissue near the ABB. The investigation was carried out by means of scanning electron microscopy and brightfleld and circularly polarized light microscopy.
   Results: We observed a mean amount of newly formed bone of 46.0% +/- 4.67%, ABB remnants of 16.0% +/- 5.89%, and marrow spaces of 38.0% +/- 8.93%. The osteocyte index was 4.43 for bone around ABB and 3.27 in the trabecular bone at a distance from the particles.
   Conclusions: After 9 years, the tissue pattern appeared composed by residual ABB particles in close contact to the newly formed bone. The bone mineralized matrix around the ABB had collagen fibers randomly oriented and more osteocytes embedded. The results demonstrate both a high level of osteoconductivity and a '' biomimetic '' behavior over the long term.
C1 Univ G dAnnunzio, Sch Dent, Chieti, Italy.
RP Traini, T (reprint author), Via F Sciucchi 63, I-66100 Chieti, Italy.
OI Traini, Tonino/0000-0002-0265-8709; Valentini,
   Pascal/0000-0002-2712-8819
CR Artzi Z, 2004, INT J ORAL MAX IMPL, V19, P357
   Artzi Z, 2003, J PERIODONTOL, V74, P1153, DOI 10.1902/jop.2003.74.8.1153
   Artzi Z, 2002, CLIN ORAL IMPLAN RES, V13, P420, DOI 10.1034/j.1600-0501.2002.130411.x
   Blokhuis TJ, 2000, J TRAUMA, V48, P179, DOI 10.1097/00005373-200001000-00037
   Cullinane D. M., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P242
   Ewers R, 2004, CLIN ORAL IMPLAN RES, V15, P96, DOI 10.1111/j.1600-0501.2004.00987.x
   Hallman M, 2002, INT J ORAL MAX IMPL, V17, P635
   Hammerle CHF, 1998, CLIN ORAL IMPLAN RES, V9, P151, DOI 10.1034/j.1600-0501.1998.090302.x
   Hernandez CJ, 2004, BONE, V35, P1095, DOI 10.1016/j.bone.2004.07.002
   Hurzeler MB, 1997, CLIN ORAL IMPLAN RES, V8, P476, DOI 10.1034/j.1600-0501.1997.080606.x
   Jardini MAN, 2005, ORAL SURG ORAL MED O, V100, P666, DOI 10.1016/j.tripleo.2005.03.020
   JENSEN J, 1991, J ORAL MAXIL SURG, V49, P1277, DOI 10.1016/0278-2391(91)90303-4
   John HD, 2004, INT J ORAL MAX IMPL, V19, P199
   Merkx MAW, 2003, INT J ORAL MAX SURG, V32, P1, DOI 10.1054/ijom.2002.0346
   Merkx MAW, 1999, BIOMATERIALS, V20, P2029, DOI 10.1016/S0142-9612(99)00105-2
   Mullender MG, 2005, CALCIFIED TISSUE INT, V77, P291, DOI 10.1007/s00223-005-0043-6
   Piattelli M, 1999, INT J ORAL MAX IMPL, V14, P835
   Power J, 2002, BONE, V30, P859, DOI 10.1016/S8756-3282(02)00731-7
   Qiu S, 2002, BONE, V31, P709, DOI 10.1016/S8756-3282(02)00907-9
   Qiu SJ, 2005, BONE, V37, P10, DOI 10.1016/j.bone.2005.01.023
   Qiu SJ, 2003, J BONE MINER RES, V18, P1657, DOI 10.1359/jbmr.2003.18.9.1657
   Ramaswamy Y, 2005, J MATER SCI-MATER M, V16, P1199, DOI 10.1007/s10856-005-4729-0
   Rosenlicht J L, 1999, J Oral Implantol, V25, P7, DOI 10.1563/1548-1336(1999)025<0007:HHEOIO>2.3.CO;2
   Sartori S, 2003, CLIN ORAL IMPLAN RES, V14, P369, DOI 10.1034/j.1600-0501.2003.140316.x
   Scarano A, 2004, J PERIODONTOL, V75, P1161, DOI 10.1902/jop.2004.75.8.1161
   Schlegel AK, 1998, J LONG-TERM EFF MED, V8, P201
   Seeman E, 2006, OSTEOPOROSIS INT, V17, P1443, DOI 10.1007/s00198-006-0220-0
   Skoglund A, 1997, INT J ORAL MAX IMPL, V12, P194
   Tadjoedin ES, 2003, J CLIN PERIODONTOL, V30, P261, DOI 10.1034/j.1600-051X.2003.01099.x
   Valentini P, 2000, INT J PERIODONT REST, V20, P245
   Valentini P, 1998, CLIN ORAL IMPLAN RES, V9, P59, DOI 10.1034/j.1600-0501.1998.090108.x
   Valentini P, 1997, INT J PERIODONT REST, V17, P233
   Vance GS, 2004, INT J ORAL MAX IMPL, V19, P491
   Vashishth D, 2002, ANAT REC, V267, P292, DOI 10.1002/ar.10114
   Vashishth D, 2000, BONE, V26, P375, DOI 10.1016/S8756-3282(00)00236-2
   Verhoeven JW, 2000, CLIN ORAL IMPLAN RES, V11, P583, DOI 10.1034/j.1600-0501.2000.011006583.x
   Wallace SS, 1996, INT J PERIODONT REST, V16, P47
   Yildirim M, 2000, CLIN ORAL IMPLAN RES, V11, P217, DOI 10.1034/j.1600-0501.2000.011003217.x
   Zaffe D, 2005, J MATER SCI-MATER M, V16, P789, DOI 10.1007/s10856-005-3574-5
NR 39
TC 95
Z9 97
U1 1
U2 9
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA
SN 0022-3492
EI 1943-3670
J9 J PERIODONTOL
JI J. Periodont.
PD MAY
PY 2007
VL 78
IS 5
BP 955
EP 961
DI 10.1902/jop.2007.060308
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 167RF
UT WOS:000246468100023
PM 17470032
DA 2018-10-20
ER

PT J
AU Shekunov, BY
   Chattopadhyay, P
   Tong, HHY
   Chow, AHL
   Grossmann, JG
AF Shekunov, Boris Y.
   Chattopadhyay, Pratibhash
   Tong, Henry H. Y.
   Chow, Albert H. L.
   Grossmann, J. Gunter
TI Structure and drug release in a crosslinked poly(ethylene oxide)
   hydrogel
SO JOURNAL OF PHARMACEUTICAL SCIENCES
LA English
DT Article
DE poly(ethylene oxide) gels; small- and wide-angle X-ray scattering
   (SAXS/WAXS); small-angle neutron scattering (SANS); atomic force
   microscopy (AFM); hydration; polymer crystallinity; drug loading;
   release
ID BLOCK-COPOLYMERS; X-RAY; POLYURETHANE; BIOMATERIAL; SYSTEMS; BLENDS
AB Hydrogels are a continuously expanding class of pharmaceutical polymers designed for sustained or controlled drug release. The structure and intermolecular interactions in such systems define their macroscopic properties. The aim of this study was to investigate the mechanism of swelling, drug impregnation, and drug release from poly(ethylene oxide) (PEO) gel crosslinked by urethane bonds. A combination of SAXS/WAXS/SANS techniques enabled us to determine the phase transition between lamellar and extended gel network, and to apply different descriptions of crystallinity, based on lamellar and crystal lattice structures. It is shown that even low (1-7% w/w) loading of model drugs acetaminophen and caffeine, produced significant disorder in the polymer matrix. This effect was particularly pronounced for acetaminophen due to its specific ability to form complexes with PEO. The drug-release profiles were analyzed using a general cubic equation, proposed for this work, which allowed us to determine the gel hydration velocity. The results indicate that the release profiles correlate inversely with the polymer crystallinity. (c) 2007 Wiley-Liss, Inc. and the American Pharmacists Association.
C1 Ferro Pfanstiehl Labs, Independence, OH 44131 USA.
   Macao Polytech Inst, Sch Hlth Sci, Macao, Peoples R China.
   Chinese Univ Hong Kong, Sch Pharm, Shatin, Hong Kong, Peoples R China.
   CCLRC, Daresbury Lab, Synchrotron Radiat Dept, Warrington WA4 4AD, Cheshire, England.
RP Shekunov, BY (reprint author), Ferro Pfanstiehl Labs, Independence, OH 44131 USA.
EM shekunovb@ferro.com
RI Tong, Henry/A-2327-2014
CR CARELLI V, 1993, INT J PHARM, V94, P103, DOI 10.1016/0378-5173(93)90014-7
   Chan-Park MB, 2004, J ADHES SCI TECHNOL, V18, P1663, DOI 10.1163/1568561042411303
   Edwards AD, 2001, J PHARM SCI, V90, P1106, DOI 10.1002/jps.1064
   Gorman SP, 1998, J BIOMED MATER RES, V39, P642, DOI 10.1002/(SICI)1097-4636(19980315)39:4<642::AID-JBM20>3.0.CO;2-7
   Gorna K, 2003, J BIOMED MATER RES A, V67A, P813, DOI 10.1002/jbm.a.10148
   GRAHAM NB, 1982, POLYMER, V23, P1345, DOI 10.1016/0032-3861(82)90276-2
   HEY MJ, 1991, J CHEM SOC FARADAY T, V87, P3671, DOI 10.1039/ft9918703671
   Jamzad S, 2006, INT J PHARM, V312, P24, DOI 10.1016/j.ijpharm.2005.12.037
   Lee JH, 2000, BIOMATERIALS, V21, P683, DOI 10.1016/S0142-9612(99)00197-0
   Park JH, 2002, J BIOMAT SCI-POLYM E, V13, P527, DOI 10.1163/15685620260178382
   Paternostre L, 1996, MACROMOLECULES, V29, P2046, DOI 10.1021/ma9506288
   Peppas N. A., 1987, HYDROGELS MED PHARM, V2
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   Petrini P, 2003, J MATER SCI-MATER M, V14, P683, DOI 10.1023/A:1024955531173
   Pissis P, 1996, J POLYM SCI POL PHYS, V34, P1529, DOI 10.1002/(SICI)1099-0488(19960715)34:9<1529::AID-POLB1>3.0.CO;2-G
   Ryan AJ, 1997, POLYMER, V38, P759, DOI 10.1016/S0032-3861(96)00583-6
   Shekunov BY, 1999, J CRYST GROWTH, V198, P1335, DOI 10.1016/S0022-0248(98)01020-3
   Silverstein B, 1997, REGUL TOXICOL PHARM, V25, P60, DOI 10.1006/rtph.1996.1057
   TARCHA PJ, 1991, POLYMERS CONTROLLED
   Turner S, 2004, DRUG DEV IND PHARM, V30, P797, DOI 10.1081/DDC-200026747
   Yoo HJ, 2004, J APPL POLYM SCI, V91, P2348, DOI 10.1002/app.13377
   ZULFIQAR M, 1995, J APPL POLYM SCI, V55, P1301, DOI 10.1002/app.1995.070550903
NR 22
TC 10
Z9 10
U1 0
U2 28
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0022-3549
J9 J PHARM SCI-US
JI J. Pharm. Sci.
PD MAY
PY 2007
VL 96
IS 5
BP 1320
EP 1330
DI 10.1002/jps.20950
PG 11
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology &
   Pharmacy
SC Pharmacology & Pharmacy; Chemistry
GA 163BF
UT WOS:000246132800030
PM 17455363
DA 2018-10-20
ER

PT J
AU Mudera, V
   Morgan, M
   Cheema, U
   Nazhat, S
   Brown, R
AF Mudera, Vivek
   Morgan, Mary
   Cheema, Umber
   Nazhat, Showan
   Brown, Robert
TI Ultra-rapid engineered collagen constructs tested in an in vivo nursery
   site
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE plastic compression; nano-microstructure; collagen; spiral assembly;
   biomimetic materials; in vivo integration; flexor tendon cells;
   vascularization; CD45; CD31
ID TISSUE; SCAFFOLD; GELS
AB Collagen is a naturally occurring structural protein, highly conserved across species. Conventionally, tissue engineering aims to convert cell-seeded constructs into a tissue-like architecture with biomimetic function. However, cell-mediated remodelling of biomaterial scaffolds in vitro has proved to be slow, costly and difficult to control. We have recently developed a novel process for ultra-rapid engineering of tissue-like constructs without the need for cell-based remodelling. Using plastic compression of type I collagen gels, the densities of collagen and cells together with mechanical properties can be brought controllably to near-tissue levels in minutes rather than weeks/months. We have now implanted these constructs in a test site across intercostal spaces in a rabbit model designed to provide cyclical tensile loading in vivo, to test their integration, cell ingrowth and angiogenic response over 5 weeks. Post-implanted constructs were recovered and tested for host vascularization, inflammatory response and mechanical integrity. Copyright (C) 2007 John Wiley & Sons, Ltd.
C1 [Mudera, Vivek; Morgan, Mary; Cheema, Umber; Brown, Robert] UCL Tissue Repair & Engn Ctr, Inst Orthopaed & Musculoskeletal Sci, London, England.
   [Nazhat, Showan] McGill Univ, Dept Min Met & Mat Engn, Montreal, PQ, Canada.
RP Mudera, V (reprint author), UCL Tissue Regenerat & Engn Ctr, Inst Orthopaed & Musculoskeletal Sci, Stanmore Campus, London HA7 4LP, England.
EM v.mudera@ucl.ac.uk
RI Mudera, Vivek/C-9383-2009; Cheema, Umber/E-5927-2010
CR Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   Brown R. A., 2002, FUTURE STRATEGIES TI, P51
   Brown RA, 2005, ADV FUNCT MATER, V15, P1762, DOI 10.1002/adfm.200500042
   Brown Robert A., 1997, Wound Repair and Regeneration, V5, P212, DOI 10.1046/j.1524-475X.1997.50304.x
   BURT AM, 1992, ANIMAL CELL BIOTECHN, P150
   Eastwood M, 1998, CELL MOTIL CYTOSKEL, V40, P13, DOI 10.1002/(SICI)1097-0169(1998)40:1<13::AID-CM2>3.0.CO;2-G
   Feng Z, 2003, ARTIF ORGANS, V27, P84, DOI 10.1046/j.1525-1594.2003.07187.x
   Hu SS, 2006, WOUND REPAIR REGEN, V14, P427, DOI 10.1111/j.1743-6109.2006.00148.x
   HUANG D, 1993, ANN BIOMED ENG, V21, P289, DOI 10.1007/BF02368184
   Jones ME, 2000, J HAND SURG-BRIT EUR, V25B, P552, DOI 10.1054/jhsb.2000.0458
   Krishnan L, 2004, TISSUE ENG, V10, P241, DOI 10.1089/107632704322791880
   Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109
   Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Warnke PH, 2004, LANCET, V364, P766, DOI 10.1016/S0140-6736(04)16935-3
NR 15
TC 39
Z9 39
U1 0
U2 9
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD MAY-JUN
PY 2007
VL 1
IS 3
BP 192
EP 198
DI 10.1002/term.25
PG 7
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 310HP
UT WOS:000256519800005
PM 18038411
DA 2018-10-20
ER

PT J
AU Linares, CF
   Quintero, J
   Martinez, L
   Gonzalez, G
AF Linares, Carlos F.
   Quintero, Jose
   Martinez, Lesbia
   Gonzalez, Gema
TI A new antacid drug from activated carbon modified with calcium carbonate
SO MATERIALS LETTERS
LA English
DT Article
DE microstructure; powder technology; impregnation; biomaterial; calcium
   carbonate; antacid
AB Activated carbons were previously modified with different sodium carbonate solutions and then, they were soaked in a calcium nitrate solution. This procedure allowed to precipitate calcium carbonate on the microporous carbons. Then, these solids were washed with abundant distillated water. These modified carbons were characterized by means of XRD, SEM, HRTEM and BET surface area measurements. XRD confirmed the presence of calcium carbonate species, while the surface area measurements indicated that microporous solids were partially blocked. SEM and HRTEM showed that precipitated calcium carbonate crystals were found on the surface of the activated carbon. These solids were tested as antacids in a synthetic gastric juice and they were able to neutralize it. A commercial compound formulated with calcium carbonate was used as a reference system. (c) 2006 Elsevier B.V. All rights reserved.
C1 Univ Carabobo, Fac Ciencias & Tecnol, Dept Quim, Lab Catalisis & Met Trans, Valencia, Edo Carabobo, Venezuela.
   Inst Venezolano Invest Cient, Dept Mat, Lab Ciencias & Ing Mat, Caracas 1020A, Venezuela.
RP Linares, CF (reprint author), Univ Carabobo, Fac Ciencias & Tecnol, Dept Quim, Lab Catalisis & Met Trans, Apartado Postal 3336, Valencia, Edo Carabobo, Venezuela.
EM clinares@thor.uc.edu.ve
CR Beers M H, 1999, MERK MANUAL, P221
   DISCHER C, 1966, QUIMICA INORGANICA F, P389
   FORDTRAN JS, 1973, NEW ENGL J MED, V288, P923, DOI 10.1056/NEJM197305032881801
   Linares C. F., 2004, Journal of Applied Sciences, V4, P472
   Linares CF, 2005, STUD SURF SCI CATAL, V158, P2073
   Linares CF, 2006, MATER LETT, V60, P439, DOI 10.1016/j.matlet.2005.09.020
   Linares CF, 2005, MICROPOR MESOPOR MAT, V77, P215, DOI 10.1016/j.micromeso.2004.08.030
NR 7
TC 6
Z9 6
U1 1
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD MAY
PY 2007
VL 61
IS 11-12
BP 2362
EP 2364
DI 10.1016/j.matlet.2006.09.012
PG 3
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 163KK
UT WOS:000246158300061
DA 2018-10-20
ER

PT J
AU Hayami, T
   Matsumura, K
   Kusunoki, M
   Nishikawa, H
   Hontsu, S
AF Hayami, Takashi
   Matsumura, Kazuaki
   Kusunoki, Masanobu
   Nishikawa, Hiroaki
   Hontsu, Shigeki
TI Imparting cell adhesion to poly(vinyl alcohol) hydrogel by coating with
   hydroxyapatite thin film
SO MATERIALS LETTERS
LA English
DT Article
DE hydrogel; cell adhesion; hydroxyapatite; thin films; laser processing;
   biomaterial
ID LASER DEPOSITION
AB To impart good cell adhesion to poly(vinyl alcohol) hydrogel (PVA-H) as an artificial articular cartilage, hydroxyapatite thin film 300 nm thick was deposited by a pulsed laser deposition technique on PVA-H, which has virtually no cell adhesion. A cell culture method was used to study the effect of hydroxyapatite deposition on PVA-H upon cell adhesion among mouse fibroblasts. The cell adhesion of water content 33% PVA-H coated with the amorphous hydroxyapatite film showed a maximum as high as that of commonly used tissue culture dishes. This technique was also effective for improving cell adhesion, even on a higher water content (53%) PVA-H. This is a novel technique to improve the biocompatibility and attachment of PVA-H and with the underlying bone and natural cartilage. (C) 2006 Elsevier B.V. All rights reserved.
C1 Kinki Univ, Sch Biol Oriented Sci & Technol, Wakayama 6496493, Japan.
   Kyoto Univ, Inst Frontier Med Sci, Sakyo Ku, Kyoto 6068507, Japan.
RP Hayami, T (reprint author), Kinki Univ, Sch Biol Oriented Sci & Technol, 930 Nishimitani, Wakayama 6496493, Japan.
EM hayami@waka.kindai.ac.jp
RI Matsumura, Kazuaki/I-1627-2014
OI Matsumura, Kazuaki/0000-0001-9484-3073; Nishikawa,
   Hiroaki/0000-0001-7753-3866
CR Chang Yong-Shun, 1995, Clinical Materials, V17, P181
   Dbaibo GS, 1998, J CLIN INVEST, V102, P329, DOI 10.1172/JCI1180
   Hontsu S, 1996, JPN J APPL PHYS 2, V35, pL1208
   MONT MA, 1995, J BONE JOINT SURG AM, V77A, P459, DOI 10.2106/00004623-199503000-00018
   SINGH RK, 1994, BIOMATERIALS, V15, P522, DOI 10.1016/0142-9612(94)90018-3
   Taguchi T, 1998, CHEM LETT, P711, DOI 10.1246/cl.1998.711
   TAMADA Y, 1993, J COLLOID INTERF SCI, V155, P334, DOI 10.1006/jcis.1993.1044
   TANAHASHI M, 1994, J APPL BIOMATER, V5, P339, DOI 10.1002/jab.770050409
   Ushio K, 2004, J BIOMED MATER RES B, V68B, P59, DOI 10.1002/jbm.b.10076
   Yamauchi K, 1998, J BIOMAT SCI-POLYM E, V9, P259, DOI 10.1163/156856298X00640
NR 10
TC 23
Z9 23
U1 0
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD MAY
PY 2007
VL 61
IS 13
BP 2667
EP 2670
DI 10.1016/j.matlet.2006.10.019
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 166VD
UT WOS:000246407800017
DA 2018-10-20
ER

PT J
AU Hamdi, M
   Ide-Ektessabi, A
AF Hamdi, M.
   Ide-Ektessabi, A.
TI Dissolution behavior of simultaneous vapor deposited calcium phosphate
   coatings in vitro
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article
DE calcium phosphate coating; hydroxyapatite; simultaneous vapor
   deposition; dissolution
ID SPUTTER-DEPOSITION; COMPOSITE COATINGS; HANKS SOLUTION; THIN-FILMS;
   CERAMICS; BIOMATERIALS; IMPLANTS; VIVO
AB Solubility is one of the most important properties in the field of biomaterial. The present paper evaluated the dissolution behavior of simultaneous vapor deposited calcium phosphate coatings in vitro. The coatings were immersed in calcium-free Hank's solution at different periods of time. Characterization of the coatings was performed using scanning electron microscopy, X-ray diffraction, Fourier transform infrared spectroscopy and Rutherford backscattering spectroscopy, prior to and after immersion. Amorphous coatings showed complete dissolution. Crystalline coatings showed that alpha tricalcium phosphate (alpha-TCP) phase dissolved steadily throughout the testing time leaving the stable hydroxyapatite phase undegraded. The increased in calcium and phosphate ions due to dissolution of alpha-TCP provided the means for reprecipitation of apatite on the coating, which became apparent after 7days of immersion. (C) 2006 Elsevier B.V. All rights reserved.
C1 Univ Malaya, Fac Engn, Dept Engn Design & Manufacture, Kuala Lumpur 50603, Malaysia.
   Kyoto Univ, Int Innovat Ctr, Sakyo Ku, Kyoto 6068501, Japan.
RP Hamdi, M (reprint author), Univ Malaya, Fac Engn, Dept Engn Design & Manufacture, Kuala Lumpur 50603, Malaysia.
EM hamdi@um.edu.my
RI shukor, hamdi/B-9093-2010
CR Cleries L, 1999, BIOMATERIALS, V20, P1401, DOI 10.1016/S0142-9612(99)00045-9
   Cleries L, 1998, BIOMATERIALS, V19, P1483, DOI 10.1016/S0142-9612(98)00063-5
   DACULSI G, 1989, J BIOMED MATER RES, V23, P883, DOI 10.1002/jbm.820230806
   DUCHEYNE P, 1990, BIOMATERIALS, V11, P531
   DUCHEYNE P, 1993, J BIOMED MATER RES, V27, P25, DOI 10.1002/jbm.820270105
   Ektessabi AM, 1997, NUCL INSTRUM METH B, V127, P1008, DOI 10.1016/S0168-583X(97)00049-9
   Hamdi M, 2001, J VAC SCI TECHNOL A, V19, P1566, DOI 10.1116/1.1380228
   Hamdi M, 2000, THIN SOLID FILMS, V377, P484, DOI 10.1016/S0040-6090(00)01276-1
   HYAKUNA K, 1990, J BIOMED MATER RES, V24, P471, DOI 10.1002/jbm.820240406
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   KLEIN CPA, 1991, BIOMATERIALS, V11, P509
   KOCH B, 1990, J BIOMED MATER RES, V24, P655, DOI 10.1002/jbm.820240603
   Lee TM, 2001, J BIOMED MATER RES, V55, P360, DOI 10.1002/1097-4636(20010605)55:3<360::AID-JBM1040>3.0.CO;2-Q
   Legeros Racquel Z., 1993, Clinical Materials, V14, P65, DOI 10.1016/0267-6605(93)90049-D
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   LIN JHC, 1994, J BIOMED MATER RES, V28, P723, DOI 10.1002/jbm.820280609
   Lin JHC, 2000, MATER CHEM PHYS, V64, P229, DOI 10.1016/S0254-0584(00)00209-1
   Luo ZS, 2000, SURF COAT TECH, V131, P192, DOI 10.1016/S0257-8972(00)00824-0
   POURBAIX M, 1984, BIOMATERIALS, V5, P122, DOI 10.1016/0142-9612(84)90046-2
   RADIN SR, 1992, J MATER SCI-MATER M, V3, P33, DOI 10.1007/BF00702942
   Yang YZ, 2005, BIOMATERIALS, V26, P327, DOI 10.1016/j.biomaterials.2004.02.029
   Zeng H, 1999, BIOMATERIALS, V20, P443, DOI 10.1016/S0142-9612(98)00190-2
   ZYMAN Z, 1993, BIOMATERIALS, V14, P225, DOI 10.1016/0142-9612(93)90027-Y
NR 23
TC 7
Z9 7
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD MAY
PY 2007
VL 27
IS 4
BP 670
EP 674
DI 10.1016/j.msee.2006.06.008
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 169ZM
UT WOS:000246630600011
DA 2018-10-20
ER

PT J
AU Bouafsoun, A
   Ponsonnet, L
   Kerkeni, A
   Jaffrezic, N
   Othmane, A
AF Bouafsoun, Amira
   Ponsonnet, Laurence
   Kerkeni, Abdelhamid
   Jaffrezic, Nicole
   Othmane, Ali
TI Comparative wettability study of polystyrene functionalized with
   different proteins
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article
DE biomaterial; Wilhelmy balance; sessile drop; captive bubble; proteins
ID CONTACT-ANGLE HYSTERESIS; CELL-ADHESION; SURFACE-PROPERTIES;
   HYDROPHOBICITY; BIOSURFACES; ADSORPTION
AB Protein adsorption plays a part in the interfacial interactions needed for improving implants biospecificity. In this study, we functionalize polystyrene, which is a biomaterial commonly used for vascular implants, by different adhesion proteins such as fibronectin, collagen, albumin, heparin and immunoglobulin G. Each surface layer is characterized by three techniques: the Wilhelmy technique, the sessile drop and the captive bubble methods. Each technique provides complementary information. Wetting measurements provide a comparative study between the physicochemical states of different proteins. (C) 2006 Elsevier B.V. All rights reserved.
C1 CNRS, UMR 6522, Lab Polymeres Biopolymeres Membranes, F-76821 Mont St Aignan, France.
   Fac Med Monastir, Lab Biophys, Monastir, Tunisia.
   CNRS, Ecole Cent Lyon, UMR 5005, Lab Ingn & Fonctionnarisat Surfaces Cegely, F-69134 Ecully, France.
RP Ponsonnet, L (reprint author), CNRS, UMR 6522, Lab Polymeres Biopolymeres Membranes, F-76821 Mont St Aignan, France.
EM laurence.ponsonnet@univ-rouen.fr
CR ANDRADE JD, 1979, J POLYM SCI POL SYM, P313
   Buijs J, 1997, J COLLOID INTERF SCI, V190, P171, DOI 10.1006/jcis.1997.4876
   Cai JY, 2003, MOLECULES, V8, P86, DOI 10.3390/80100086
   CUNANAN CM, 1991, J CATARACT REFR SURG, V17, P767
   HAIDER L, 2002, ACUSTICUM SEVILLA, P16
   Hallab NJ, 2001, TISSUE ENG, V7, P55, DOI 10.1089/107632700300003297
   Hermitte L, 2004, J COLLOID INTERF SCI, V272, P82, DOI 10.1016/j.jcis.2003.08.055
   Lam CNC, 2002, ADV COLLOID INTERFAC, V96, P169, DOI 10.1016/S0001-8686(01)00080-X
   LANDER LM, 1993, LANGMUIR, V9, P2237, DOI 10.1021/la00032a055
   Rupp F, 2002, CHEM ENG TECHNOL, V25, P877, DOI 10.1002/1521-4125(20020910)25:9<877::AID-CEAT877>3.0.CO;2-D
   Sapsford KE, 2004, BIOSENS BIOELECTRON, V19, P1045, DOI 10.1016/j.bios.2003.10.002
   SCHAMBERGER PC, 1994, COLLOID SURFACE B, V2, P209, DOI 10.1016/0927-7765(94)80036-7
   Sefiane K, 2003, INT J HEAT MASS TRAN, V46, P4527, DOI 10.1016/S0017-9310(03)00267-9
   VANKOOTEN TG, 2003, BIOMATERIALS, P1
   VANOSS CJ, 1995, COLLOID SURFACE B, V5, P91, DOI 10.1016/0927-7765(95)01217-7
   vanOss CJ, 1997, CURR OPIN COLLOID IN, V2, P503, DOI 10.1016/S1359-0294(97)80099-4
   VANOSS CJ, 1996, FORCES INTERFACIALES
   VANWACHEM PB, 1987, BIOMATERIALS, V8, P323, DOI 10.1016/0142-9612(87)90001-9
   VOGLER EA, 1993, LANGMUIR, V9, P2470, DOI 10.1021/la00033a033
NR 19
TC 13
Z9 13
U1 1
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD MAY
PY 2007
VL 27
IS 4
BP 709
EP 715
DI 10.1016/j.msec.2006.06.038
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 169ZM
UT WOS:000246630600017
DA 2018-10-20
ER

PT J
AU Tanaka, T
   Hirose, M
   Kotobuki, N
   Ohgushi, H
   Furuzono, T
   Sato, J
AF Tanaka, Toshimitsu
   Hirose, Motohiro
   Kotobuki, Noriko
   Ohgushi, Hajime
   Furuzono, Tsutomu
   Sato, Junichi
TI Nano-scaled hydroxyapatite/silk fibroin sheets support osteogenic
   differentiation of rat bone marrow mesenchymal cells
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article
DE osteogenic differentiation; tissue engineering; marrow mesenchymal
   cells; hydroxyapatite; silk fibroin
ID STEM-CELLS; CERAMICS; CALCIUM; PROTEIN; MATRIX; MINERALIZATION;
   PROLIFERATION; VISUALIZATION; REGENERATION; INTEGRINS
AB A novel biomaterial that was composed of nano-scaled sintered hydroxyapatite (HAP) and silk fibroin (SF) was fabricated. We cultured rat marrow mesenchymal cells (MMCs) on this biomaterial (nano-HAp/SF sheet), on bare SF sheets, and on tissue culture polystyrene (TCPS) dishes as controls, then evaluated cell adhesion, proliferation, and differentiation of the MMCs. After 1 h of culture, a large number of viable cells were observed on the nano-HAp/SF sheets in comparison to the controls. In addition, after 3 hof culture, the morphology of the cells on the nano-HAp/ SF sheets was quite different from that on the SF sheets. MMCs extrude their cytoplasmic processes to nano-HAp particles and are well attached to the sheets. After 14 days of culture, under osteogenic conditions, the alkaline phosphatase (ALP) activity and bone-specific osteocalcin secretion of the cells on nano-HAp/SF sheets were higher than were those on the controls. These results indicated that the surface of the nano-HAp/SF sheets is covered with appropriate HAp crystal for MMC adhesion/proliferation and that the sheets effectively support the osteogenic differentiation of MMCs. Therefore, the nano-HAp/SF sheet is an effective biomaterial that is applicable in bone reconstruction surgery. (C) 2006 Elsevier B.V. All rights reserved.
C1 Natl Inst Adv Ind Sci & Technol, AIST, RICE, Amagasaki, Hyogo 6610974, Japan.
   Natl Cardiovasc Ctr, Res Inst, Dept Biomed Engn, Suita, Osaka 5658565, Japan.
   Japan Sci & Technol Agcy, JST, Osaka 5941194, Japan.
   Tsurumi Univ, Sch Dent Med, Dept Oral & Maxillofacial Surg, Tsurumi Ku, Yokohama, Kanagawa 2300063, Japan.
RP Hirose, M (reprint author), Natl Inst Adv Ind Sci & Technol, AIST, RICE, 3-11-46 Nakoji, Amagasaki, Hyogo 6610974, Japan.
EM motohiro-hirose@aist.go.jp
RI Hirose, Motohiro/M-4959-2018
OI Hirose, Motohiro/0000-0001-9010-0125
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Ayers RA, 1998, J ORAL MAXIL SURG, V56, P1297, DOI 10.1016/S0278-2391(98)90613-9
   Chang YL, 2000, J BIOMED MATER RES, V52, P270, DOI 10.1002/1097-4636(200011)52:2<270::AID-JBM5>3.0.CO;2-1
   DAVIES JE, 1991, CELL MATER, V1, P3
   DAVIS GE, 1992, BIOCHEM BIOPH RES CO, V182, P1025, DOI 10.1016/0006-291X(92)91834-D
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   DOHI Y, 1992, J BONE MINER RES, V7, P1173
   FINN RA, 1980, J MAXILLOFAC SURG, V8, P217, DOI 10.1016/S0301-0503(80)80104-4
   Furuzono T, 2004, J MATER SCI-MATER M, V15, P19, DOI 10.1023/B:JMSM.0000010093.39298.5a
   FURUZONO T, 2004, ORGANS, V7, P137
   Hench L L, 1988, Ann N Y Acad Sci, V523, P54, DOI 10.1111/j.1749-6632.1988.tb38500.x
   Hott M, 1997, J BIOMED MATER RES, V37, P508, DOI 10.1002/(SICI)1097-4636(19971215)37:4<508::AID-JBM9>3.0.CO;2-P
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Kihara T, 2004, BIOCHEM BIOPH RES CO, V316, P943, DOI 10.1016/j.bbrc.2004.02.134
   Kilpadi KL, 2001, J BIOMED MATER RES, V57, P258, DOI 10.1002/1097-4636(200111)57:2<258::AID-JBM1166>3.0.CO;2-R
   Kim KH, 2005, J BIOTECHNOL, V120, P327, DOI 10.1016/j.jbiotec.2005.06.033
   Kitamura S, 2004, ARTIF ORGANS, V28, P72, DOI 10.1111/j.1525-1594.2004.07325.x
   Kotobuki N, 2004, ARTIF ORGANS, V28, P33, DOI 10.1111/j.1525-1594.2004.07320.x
   Kotobuki N, 2005, BIOMATERIALS, V26, P779, DOI 10.1016/j.biomaterials.2004.03.020
   LEBOY PS, 1991, J CELL PHYSIOL, V146, P370, DOI 10.1002/jcp.1041460306
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   Matsuoka H, 1999, J BIOMED MATER RES, V47, P176, DOI 10.1002/(SICI)1097-4636(199911)47:2<176::AID-JBM7>3.0.CO;2-Z
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   Morishita T, 2006, ARTIF ORGANS, V30, P115, DOI 10.1111/j.1525-1594.2006.00190.x
   Ohgushi H, 1999, J BIOMED MATER RES, V48, P913, DOI 10.1002/(SICI)1097-4636(1999)48:6<913::AID-JBM22>3.0.CO;2-0
   Ohgushi H, 2005, BIOMATERIALS, V26, P4654, DOI 10.1016/j.biomaterials.2004.11.055
   Ozawa S, 1996, BIOMATERIALS, V17, P23, DOI 10.1016/0142-9612(96)80751-4
   PRICE PA, 1980, J CLIN INVEST, V66, P878, DOI 10.1172/JCI109954
   PRICE PA, 1981, J BIOL CHEM, V256, P3781
   UCHIDA A, 1990, J BONE JOINT SURG BR, V72, P298
   Uchimura E, 2003, CALCIFIED TISSUE INT, V73, P575, DOI 10.1007/s00223-002-1052-3
   XIAO G, 1998, J BIOL CHEM, V273, P120
NR 32
TC 35
Z9 36
U1 0
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD MAY
PY 2007
VL 27
IS 4
BP 817
EP 823
DI 10.1016/j.msec.2006.09.019
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 169ZM
UT WOS:000246630600035
DA 2018-10-20
ER

PT J
AU Kalita, SJ
   Bhatt, HA
AF Kalita, Samar J.
   Bhatt, Himesh A.
TI Nanocrystalline hydroxyapatite doped with magnesium and zinc: Synthesis
   and characterization
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article
DE nanostructured bioceramics; nanocrystalline hydroxyapatite; nano-powder;
   sol-gel; calcium phosphate; biomaterial
ID GLASS-REINFORCED HYDROXYAPATITE; MECHANICAL-PROPERTIES; LOW-TEMPERATURE;
   CERAMICS; POWDERS; COMPOSITES; STRENGTH; BIOCERAMICS; PARTICLES;
   ADDITIVES
AB During recent years, there have been efforts in developing nanocrystalline bioceramics, to enhance their mechanical and biological properties for use in tissue engineering applications. In this research, we made an attempt to synthesize nanocrystalline bioactive hydroxyapatite (Ca-10(PO4)(6) (OH)(2), HAp) ceramic powder in the lower-end of nano-range (2-10 mn), using a simple low-temperature sol-gel technique and studied its densification behavior. We further studied the effects of metal ion dopants during synthesis on powder morphology, and the properties of the sintered structures. Calcium nitrate and triethyl phosphite were used as precursors for calcium and phosphorous, respectively, for sol-gel synthesis. Calculated quantities of magnesium oxide and zinc oxide were incorporated as dopants into amorphous dried powder, prior to calcination at 250-550 degrees C. The synthesized powders were analyzed for their phases using X-ray diffraction technique and characterized for powder morphology and particle size using transmission electron microscopy (TEM). TEM analysis showed that the average particle size of the synthesized powders were in the range of 2-10 nm. The synthesized nano-powders were uniaxially compacted and then sintered at 1250 degrees C and 1300 degrees C for 6 h, separately, in air. A maximum average sintered density of 3.29 g/cm(3) was achieved in structures sintered at 1300 degrees C, developed from nano-powder doped with magnesium. Vickers hardness testing was performed to determine the hardness of the sintered structures. Uniaxial compression tests were performed to evaluate the mechanical properties. Bioactivity and biodegradation behavior of the sintered structures were assessed in simulated body fluid (SBF) and maintained in a dynamic state. (C) 2006 Elsevier B.V. All rights reserved.
C1 Univ Cent Florida, Dept Mech Mat & Aerosp Engn, Orlando, FL 32816 USA.
RP Kalita, SJ (reprint author), Univ Cent Florida, Dept Mech Mat & Aerosp Engn, Orlando, FL 32816 USA.
EM samar@mail.ucf.edu
RI Liu, Yifei/L-7828-2014
OI Liu, Yifei/0000-0002-1087-9827
CR Ahn ES, 2001, NANO LETT, V1, P149, DOI 10.1021/nl0055299
   Ahn ES, 2005, J AM CERAM SOC, V88, P3374, DOI 10.1111/j.1551-2916.2005.00636.x
   AKAO M, 1981, J MATER SCI, V16, P809, DOI 10.1007/BF02402799
   Anee TK, 2003, MATER CHEM PHYS, V80, P725, DOI 10.1016/S0254-0584(03)00116-0
   BEST S, 1994, J MATER SCI-MATER M, V5, P516, DOI 10.1007/BF00124883
   DRIESSENS FCM, 1978, CALC TISS RES, V26, P127, DOI 10.1007/BF02013247
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Georgiou G, 2001, BIOMATERIALS, V22, P2811, DOI 10.1016/S0142-9612(01)00025-4
   Groot K. D., 1990, HDB BIOACTIVE CERAMI, V2, P3
   Gutwein LG, 2004, BIOMATERIALS, V25, P4175, DOI 10.1016/j.biomaterials.2003.10.090
   Han YC, 2004, MATER RES BULL, V39, P25, DOI 10.1016/j.materresbull.2003.09.022
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HEUGHEBAERT M, 1988, J BIOMED MATER RES-A, V22, P257, DOI 10.1002/jbm.820221406
   Itokazu M, 1998, BIOMATERIALS, V19, P817, DOI 10.1016/S0142-9612(97)00237-8
   Kalita SJ, 2004, J BIOMED MATER RES A, V71A, P35, DOI 10.1002/jbm.a.30118
   Kalita SJ, 2004, BIOMATERIALS, V25, P2331, DOI 10.1016/j.biomaterials.2003.09.012
   KARCH J, 1987, NATURE, V330, P556, DOI 10.1038/330556a0
   Knowles JC, 1996, BIOMATERIALS, V17, P1437, DOI 10.1016/0142-9612(96)87287-5
   KNOWLES JC, 1993, J BIOMED MATER RES, V27, P1591, DOI 10.1002/jbm.820271217
   KOKUBO T, 1990, J NON-CRYST SOLIDS, V120, P138, DOI 10.1016/0022-3093(90)90199-V
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   Kong YM, 2005, BIOMATERIALS, V26, P509, DOI 10.1016/j.biomaterials.2004.02.061
   Kuriakose TA, 2004, J CRYST GROWTH, V263, P517, DOI 10.1016/j.jcrysgro.2003.11.057
   LeGeros R. Z., 2002, INT S NEW WAV CER 21
   LEGEROS RZ, 1978, CALC TISS RES, V26, P111, DOI 10.1007/BF02013245
   Li J, 1996, BIOMATERIALS, V17, P1787, DOI 10.1016/0142-9612(95)00356-8
   Lim GK, 1997, BIOMATERIALS, V18, P1433, DOI 10.1016/S0142-9612(97)00081-1
   Liou SC, 2004, BIOMATERIALS, V25, P189, DOI 10.1016/S0142-9612(03)00479-4
   Liu DM, 2002, BIOMATERIALS, V23, P1679, DOI 10.1016/S0142-9612(01)00295-2
   Lopes MA, 1999, BIOMATERIALS, V20, P2085, DOI 10.1016/S0142-9612(99)00112-X
   Lopes MA, 1999, J BIOMED MATER RES, V48, P734, DOI 10.1002/(SICI)1097-4636(1999)48:5<734::AID-JBM20>3.0.CO;2-2
   Lopes MA, 1998, J BIOMED MATER RES, V39, P244, DOI 10.1002/(SICI)1097-4636(199802)39:2<244::AID-JBM11>3.0.CO;2-D
   Luo P, 1995, MAT SCI ENG C-BIOMIM, V3, P75, DOI 10.1016/0928-4931(95)00089-5
   Ramachandra R. R., 1997, J MATER SCI-MATER M, V8, P511
   RUYS AJ, 1995, BIOMATERIALS, V16, P409, DOI 10.1016/0142-9612(95)98859-C
   Santos JD, 1996, J MATER SCI-MATER M, V7, P187, DOI 10.1007/BF00121259
   SANTOS JD, 1995, J MAT SCI MAT MED, V6
   Sarig S, 2002, J CRYST GROWTH, V237, P55, DOI 10.1016/S0022-0248(01)01850-4
   Tas AC, 2000, BIOMATERIALS, V21, P1429
   Varma HK, 1998, CERAM INT, V24, P467, DOI 10.1016/S0272-8842(97)00038-2
   Webster TJ, 2001, BIOMATERIALS, V22, P1327, DOI 10.1016/S0142-9612(00)00285-4
   XU JL, 2005, BIOMATERIALS, V26, P1297
   Yeong KCB, 2001, BIOMATERIALS, V22, P2705, DOI 10.1016/S0142-9612(00)00257-X
   YOUNG RA, 1974, J DENT RES, V53, P193, DOI 10.1177/00220345740530020601
NR 44
TC 88
Z9 91
U1 0
U2 56
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD MAY
PY 2007
VL 27
IS 4
BP 837
EP 848
DI 10.1016/j.msec.2006.09.036
PG 12
WC Materials Science, Multidisciplinary
SC Materials Science
GA 169ZM
UT WOS:000246630600038
DA 2018-10-20
ER

PT J
AU Wan, YZ
   Huang, Y
   Yuan, CD
   Raman, S
   Zhu, Y
   Jiang, HJ
   He, F
   Gao, C
AF Wan, Y. Z.
   Huang, Y.
   Yuan, C. D.
   Raman, S.
   Zhu, Y.
   Jiang, H. J.
   He, F.
   Gao, C.
TI Biomimetic synthesis of hydroxyapatite/bacterial cellulose
   nanocomposites for biomedical applications
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article
DE bacterial cellulose; hydroxyapatite; nanocomposite; surface treatment;
   biomineralization
ID SELF-ORGANIZATION MECHANISM; SIMULATED BODY-FLUID; CALCIUM-PHOSPHATE;
   BACTERIAL CELLULOSE; APATITE FORMATION; BONELIKE APATITE; IN-VITRO;
   COLLAGEN; BIOCOMPATIBILITY; COMPOSITE
AB Hydroxyapatite (HAp) and bacterial cellulose (BC) are both excellent materials for use in biomaterial areas. The former has outstanding osteoconductivity and bioactivity and the latter is a high-strength nano-fibrous and extensively used biomaterial. In this work, the HAp/BC nanocomposites with a 3-dimensional (3-D) network were synthesized via a biological route by soaking both phosphorylated and unphosphorylated BCs in 1.5 simulated body fluid (SBF). Scanning electron microscopy (SEM), X-ray diffraction (XRD), Fourier transformed infrared spectroscopy (FTIR), and transmission electron microscopy (TEM) were employed to characterize the HAp/BC nanocomposites. SEM observations demonstrated that HAp crystals were uniformly formed on the phosphorylated BC fibers after soaking in 1.5 SBF whereas little HAp was observed on individual unphosphorylated BC fibers. Our experimental results suggested that the unphosphorylated BC did not induce HAp growth and that phosphorylation effectively triggered HAp formation on BC. Mechanisms were proposed for the explanation of the experimental observations. XRD and FTIR results revealed that the HAp crystals formed on the phosphorylated BC fibers were carbonate-containing with nano-sized crystallites and crystallinities less than 1%. These structural features were close to those of biological apatites. (C) 2006 Elsevier B.V. All rights reserved.
C1 Tianjin Univ, Sch Mat Sci & Engn, Tianjin 300072, Peoples R China.
   Tianjin Univ, Sch Chem Engn, Tianjin 300072, Peoples R China.
   Queens Univ, Dept Epidemiol & Community Hlth, Kingston, ON K7L 3N6, Canada.
   Wendeng Hosp Orthopaed, Shandong 264400, Peoples R China.
RP Wan, YZ (reprint author), Tianjin Univ, Sch Mat Sci & Engn, Tianjin 300072, Peoples R China.
EM yzwantju@yahoo.com
CR Angele P, 2004, BIOMATERIALS, V25, P2831, DOI 10.1016/j.biomaterials.2003.09.066
   BUNKER BC, 1994, SCIENCE, V264, P48, DOI 10.1126/science.264.5155.48
   Cao LY, 2005, MATER LETT, V59, P1902, DOI 10.1016/j.matlet.2005.02.007
   Chang MC, 2003, BIOMATERIALS, V24, P2853, DOI 10.1016/S0142-9612(03)00115-7
   Cho SB, 1998, J MATER SCI-MATER M, V9, P279, DOI 10.1023/A:1008808828567
   Choi YJ, 2004, J CHEM TECHNOL BIOT, V79, P79, DOI 10.1002/jctb.942
   Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035
   Derek E.G., 1993, SCIENCE, V259, P1439
   EBRAHIMPOUR A, 1993, J COLLOID INTERF SCI, V159, P158, DOI 10.1006/jcis.1993.1307
   Fan YW, 2005, BIOMATERIALS, V26, P1623, DOI 10.1016/j.biomaterials.2004.06.019
   FONTANA JD, 1990, APPL BIOCHEM BIOTECH, V24-5, P253, DOI 10.1007/BF02920250
   Fontana JD, 1997, APPL BIOCHEM BIOTECH, V63-5, P327, DOI 10.1007/BF02920434
   Fricain JC, 2002, BIOMATERIALS, V23, P971, DOI 10.1016/S0142-9612(01)00152-1
   Furuzono T, 2000, J BIOMED MATER RES, V50, P344, DOI 10.1002/(SICI)1097-4636(20000605)50:3<344::AID-JBM8>3.0.CO;2-D
   Gonzalez M, 2003, J MATER CHEM, V13, P2948, DOI 10.1039/b306846n
   Granja PL, 2001, J MATER SCI-MATER M, V12, P785, DOI 10.1023/A:1013960601330
   Hu QL, 2004, BIOMATERIALS, V25, P779, DOI 10.1016/S0142-9612(03)00582-9
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Itoh S, 2001, J BIOMED MATER RES, V54, P445, DOI 10.1002/1097-4636(20010305)54:3<445::AID-JBM190>3.0.CO;2-9
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   Kikuchi M, 2004, COMPOS SCI TECHNOL, V64, P819, DOI 10.1016/j.compscitech.2003.09.002
   Kikuchi M, 2004, BIOMATERIALS, V25, P63, DOI 10.1016/S0142-9612(03)00472-1
   Kim HM, 1997, J BIOMED MATER RES, V38, P121
   Kong XD, 2004, J CRYST GROWTH, V270, P197, DOI 10.1016/j.jcrysgro.2004.06.007
   Koutsopoulos S, 2002, J BIOMED MATER RES, V62, P600, DOI 10.1002/jbm.10280
   Liao SS, 2003, SPINE, V28, P1954, DOI 10.1097/01.BRS.0000083240.13332.F6
   Martson M, 1998, EUR SURG RES, V30, P426, DOI 10.1159/000008609
   MIYAMOTO T, 1989, J BIOMED MATER RES, V23, P125, DOI 10.1002/jbm.820230110
   MUCALO MR, 1995, J MATER SCI-MATER M, V6, P658, DOI 10.1007/BF00123448
   MUCALO MR, 1995, J MATER SCI-MATER M, V6, P597, DOI 10.1007/BF00121284
   Muller FA, 2005, KEY ENG MAT, V284-286, P183
   Muller FA, 2004, KEY ENG MAT, V254-2, P1111
   NISHI Y, 1990, J MATER SCI, V25, P2997, DOI 10.1007/BF00584917
   Pang YX, 2003, J EUR CERAM SOC, V23, P1697, DOI 10.1016/S0955-2219(02)00413-2
   Risbud MV, 2001, J BIOMED MATER RES, V54, P436, DOI 10.1002/1097-4636(20010305)54:3<436::AID-JBM180>3.3.CO;2-#
   Roveri N, 2003, MAT SCI ENG C-BIO S, V23, P441, DOI 10.1016/S0928-4931(02)00318-1
   Rusu VM, 2005, BIOMATERIALS, V26, P5414, DOI 10.1016/j.biomaterials.2005.01.051
   Sato K, 2001, J COLLOID INTERF SCI, V240, P133, DOI 10.1006/jcis.2001.7617
   Sosnik A, 2005, BIOMATERIALS, V26, P7425, DOI 10.1016/j.biomaterials.2005.05.086
   Suetsugu Y, 1998, J AM CERAM SOC, V81, P746
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   Tachibana A, 2005, BIOMATERIALS, V26, P297, DOI 10.1016/j.biomaterials.2004.02.032
   Tampieri A, 2003, J BIOMED MATER RES A, V67A, P618, DOI 10.1002/jbm.a.10039
   Tanahashi M, 1997, J BIOMED MATER RES, V34, P305
   TANAHASHI M, 1995, J BIOMED MATER RES, V29, P349, DOI 10.1002/jbm.820290310
   Tokoh C, 1998, CELLULOSE, V5, P249, DOI 10.1023/A:1009211927183
   Varma HK, 1999, BIOMATERIALS, V20, P879, DOI 10.1016/S0142-9612(98)00243-9
   Wan ACA, 1997, J BIOMED MATER RES, V38, P235, DOI 10.1002/(SICI)1097-4636(199723)38:3<235::AID-JBM8>3.0.CO;2-Q
   Watanabe K, 1998, CELLULOSE, V5, P187, DOI 10.1023/A:1009272904582
   YAMANAKA S, 1994, CELLULOSIC POLYM BLE, P207
   Yano H, 2005, ADV MATER, V17, P153, DOI 10.1002/adma.200400597
   Yin YJ, 2004, MACROMOL BIOSCI, V4, P971, DOI 10.1002/mabi.200400063
   Yokogawa Y, 1997, J MATER SCI-MATER M, V8, P407, DOI 10.1023/A:1018549404092
NR 53
TC 196
Z9 213
U1 7
U2 114
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD MAY
PY 2007
VL 27
IS 4
BP 855
EP 864
DI 10.1016/j.msec.2006.10.002
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA 169ZM
UT WOS:000246630600040
DA 2018-10-20
ER

PT J
AU Lee, SH
   Uchikanezaki, T
   Nomura, N
   Nakamura, M
   Chiba, A
AF Lee, Sang-Hak
   Uchikanezaki, Tomo
   Nomura, Naoyuki
   Nakamura, Mitsuru
   Chiba, Akihiko
TI Effects of zirconium addition on microstructures and mechanical
   properties of Co-29Cr-6Mo alloy
SO MATERIALS TRANSACTIONS
LA English
DT Article; Proceedings Paper
CT 6th Japanese-Polish Seminar on Materials Analysis
CY SEP 11-13, 2006
CL Toyama, JAPAN
DE cobalt chromium molybdenum alloy; microstructure; mechanical properties;
   heat treatment; biomaterial; zirconium
ID IMPLANT ALLOY; NI; BEHAVIOR; RELEASE; SYSTEM; CAST
AB Co-29Cr-6Mo alloys consisting of 0 similar to 1.76% Zr were prepared and heat-treated at 1210 degrees C for 2 h or 1230 degrees C for 3 h. Three types of precipitates were identified. With more than 0.37% Zr content, precipitates are mixtures of or phase and (Zr, Mo)-rich phase. The sigma phase dissolves into a matrix and the (Zr, Mo)-rich phases change its composition into a Zr-rich phase with heat treatment. An alloy with a solid solution containing 0.01% Zr exhibits improved mechanical properties.
C1 Iwate Univ, Ctr Reg Collaborat Res & Educ, Morioka, Iwate 0208551, Japan.
   Iwate Univ, Grad Sch Engn, Dept Welfare Engn, Morioka, Iwate 0208551, Japan.
   Iwate Univ, Grad Sch Engn, Dept Welfare Engn, Morioka, Iwate 0208551, Japan.
   Iwate Univ, Fac Engn, Dept Welfare Engn, Morioka, Iwate 0208551, Japan.
   Iwate Univ, Fac Engn, Dept Die Mold & Casting Engn, Morioka, Iwate 0208551, Japan.
   Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
RP Lee, SH (reprint author), Iwate Univ, Ctr Reg Collaborat Res & Educ, Morioka, Iwate 0208551, Japan.
RI NOMURA, Naoyuki/L-7149-2017; Chiba, Akihiko/D-1326-2011
CR CHART T, 1980, NPL ALLOYDATA BANK, V34, P235
   Chiba A, 2005, MATER SCI FORUM, V475-479, P2317, DOI 10.4028/www.scientific.net/MSF.475-479.2317
   CHIBA A, 1994, MATER T JIM, V35, P286, DOI 10.2320/matertrans1989.35.286
   de la Garza Z, 2001, J MATER ENG PERFORM, V10, P153, DOI 10.1361/105994901770345150
   ERICSSON T, 1966, ACTA METALL MATER, V14, P853, DOI 10.1016/0001-6160(66)90006-X
   Granchi D, 1999, BIOMATERIALS, V20, P1079, DOI 10.1016/S0142-9612(99)00004-6
   Huang P, 1999, MATER SCI TECH SER, V15, P1324, DOI 10.1179/026708399101505284
   KLARSTROM DL, 1993, J MATER ENG PERFORM, V2, P523, DOI 10.1007/BF02661736
   Kurosu S, 2005, J JPN I MET, V69, P886, DOI 10.2320/jinstmet.69.886
   Lee SH, 2006, MATER TRANS, V47, P287, DOI 10.2320/matertrans.47.287
   LUCAS LC, 1982, J BIOMED MATER RES, V16, P799, DOI 10.1002/jbm.820160606
   MOHAMMED H, 1974, J DENT RES, V53, P7, DOI 10.1177/00220345740530013301
   TAYLOR RNJ, 1983, J MATER SCI, V18, P3265, DOI 10.1007/BF00544151
   Yun YH, 1996, J BIOMED MATER RES, V32, P77, DOI 10.1002/(SICI)1097-4636(199609)32:1<77::AID-JBM9>3.0.CO;2-M
   ZHUANG LZ, 1989, J MATER SCI, V24, P381, DOI 10.1007/BF01107415
NR 15
TC 13
Z9 13
U1 0
U2 1
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD MAY
PY 2007
VL 48
IS 5
BP 1084
EP 1088
DI 10.2320/matertrans.48.1084
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 179FC
UT WOS:000247274100036
OA Bronze
DA 2018-10-20
ER

PT J
AU Lee, DW
   Lee, YL
   Kang, JH
AF Lee, Dong-Weon
   Lee, Yong-Lok
   Kang, Jung-Ho
TI Fabrication and evaluation of a novel protein sensor based on Lorentz
   force
SO MICROELECTRONIC ENGINEERING
LA English
DT Article; Proceedings Paper
CT 32nd International Conference on Micro- and Nano-Engineering
CY SEP 17-20, 2006
CL Barcelona, SPAIN
SP La Caixa
DE protein chip; electromotive force; resonator; actuator; biotin; avidin
AB An array (4 by 4) of a novel bio-sensor has been designed, fabricated and evaluated for biomedical applications. Each array element consists of two resonators of different sizes, a small resonator for sensing and a big resonator for actuation. The big resonator structure with integrated coils is placed in a transverse magnetic field. An alternating current is then applied through a metal line on the resonator surface to drive the resonator by means of the Lorentz force. The resulting motion of the small resonator through the magnetic field generates an electromotive force to a metal loop. By measuring the change of the induced electromotive force, the small resonator can be used for bio-sensor applications. We also developed a novel polymer monolayer to prevent biofouling effects on the silicon substrate. Basic characteristics of the monolayer and the new biomaterial are evaluated by using avidin-biotin interaction. (c) 2007 Elsevier B.V. All rights reserved.
C1 Chonnam Natl Univ, MEMS, Sch Mech Syst Engn, Kwangju, South Korea.
   Chonnam Natl Univ, Nanotechnol Lab, Sch Mech Syst Engn, Kwangju, South Korea.
   Dong A Univ, MEMS Lab, Div Mech Engn, Pusan, South Korea.
RP Lee, DW (reprint author), Chonnam Natl Univ, MEMS, Sch Mech Syst Engn, 300 Yongbong, Kwangju, South Korea.
EM mems@chonnam.ac.kr; Kangjh@donga.ac.kr
CR Lee DW, 2000, SENSOR ACTUAT A-PHYS, V83, P11, DOI 10.1016/S0924-4247(99)00378-7
   LEE DW, 2001, T IEE JPN E, V121, P113
NR 2
TC 4
Z9 4
U1 1
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-9317
J9 MICROELECTRON ENG
JI Microelectron. Eng.
PD MAY-AUG
PY 2007
VL 84
IS 5-8
BP 1719
EP 1723
DI 10.1016/j.mee.2007.01.193
PG 5
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology;
   Optics; Physics, Applied
SC Engineering; Science & Technology - Other Topics; Optics; Physics
GA 177WF
UT WOS:000247182500243
DA 2018-10-20
ER

PT J
AU Wang, DA
   Varghese, S
   Sharma, B
   Strehin, I
   Fermanian, S
   Gorham, J
   Fairbrother, DH
   Cascio, B
   Elisseeff, JH
AF Wang, Dong-An
   Varghese, Shyni
   Sharma, Blanka
   Strehin, Iossif
   Fermanian, Sara
   Gorham, Justin
   Fairbrother, D. Howard
   Cascio, Brett
   Elisseeff, Jennifer H.
TI Multifunctional chondroitin sulphate for cartilage tissue-biomaterial
   integration
SO NATURE MATERIALS
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; ARTICULAR-CARTILAGE; BONE-MARROW; IN-VITRO;
   ADHESIVE; REPAIR; CHONDROCYTES; HYDROGELS; TRANSPLANTATION;
   OSTEOARTHROSIS
AB A biologically active, high-strength tissue adhesive is needed for numerous medical applications in tissue engineering and regenerative medicine. Integration of biomaterials or implants with surrounding native tissue is crucial for both immediate functionality and long-term performance of the tissue. Here, we use the biopolymer chondroitin sulphate (CS), one of the major components of cartilage extracellular matrix, to develop a novel bioadhesive that is readily applied and acts quickly. CS was chemically functionalized with methacrylate and aldehyde groups on the polysaccharide backbone to chemically bridge biomaterials and tissue proteins via a twofold covalent link. Three-dimensional hydrogels (with and without cells) bonded to articular cartilage defects. In in vitro and in vivo functional studies this approach led to mechanical stability of the hydrogel and tissue repair in cartilage defects.
C1 Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.
   Nanyang Technol Univ, Sch Chem & Biomed Engn, Div Bioengn, Singapore 637457, Singapore.
   Cartilix Inc, Foster City, CA 94404 USA.
   Johns Hopkins Univ, Dept Chem, Baltimore, MD 21218 USA.
   Johns Hopkins Univ, Dept Orthoped, Baltimore, MD 21218 USA.
RP Wang, DA (reprint author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.
EM jhe@jhu.edu
RI Wang, Dong-an/G-6195-2010; Gorham, Justin/C-1236-2009
OI Gorham, Justin/0000-0002-0569-297X
FU NIBIB NIH HHS [R01 EB05517-01, R21 EB002369-01]
CR Ahsan T, 1999, OSTEOARTHR CARTILAGE, V7, P29, DOI 10.1053/joca.1998.0160
   Bryant SJ, 2005, ACTA BIOMATER, V1, P243, DOI 10.1016/j.actbio.2004.11.003
   Buckwalter JA, 1998, ARTHRITIS RHEUM-US, V41, P1331, DOI 10.1002/1529-0131(199808)41:8<1331::AID-ART2>3.0.CO;2-J
   Buckwalter JA, 1997, J BONE JOINT SURG AM, V79A, P612, DOI 10.2106/00004623-199704000-00022
   DiMicco MA, 2001, J ORTHOPAED RES, V19, P1105, DOI 10.1016/S0736-0266(01)00037-7
   Dunn CJ, 1999, DRUGS, V58, P863, DOI 10.2165/00003495-199958050-00010
   Elisseeff J, 2000, J BIOMED MATER RES, V51, P164, DOI 10.1002/(SICI)1097-4636(200008)51:2<164::AID-JBM4>3.0.CO;2-W
   FREED LE, 1994, J BIOMED MATER RES, V28, P891, DOI 10.1002/jbm.820280808
   GUO JF, 1989, CONNECT TISSUE RES, V19, P277, DOI 10.3109/03008208909043901
   Herget GW, 2001, EUR J CARDIO-THORAC, V19, P4, DOI 10.1016/S1010-7940(00)00613-8
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Hwang NS, 2006, TISSUE ENG, V12, P2695, DOI 10.1089/ten.2006.12.2695
   KERZBERG EM, 1987, SCAND J RHEUMATOL, V16, P377, DOI 10.3109/03009748709102512
   KJAERGARD HK, 1992, EUR J CARDIO-THORAC, V6, P52, DOI 10.1016/1010-7940(92)90100-C
   Kramer J, 2006, CELL MOL LIFE SCI, V63, P616, DOI 10.1007/s00018-005-5527-z
   LEAHEY AB, 1993, OPHTHALMOLOGY, V100, P173
   Li Q, 2006, BIOMATERIALS, V27, P1027, DOI 10.1016/j.biomaterials.2005.07.019
   Li Q, 2004, J BIOMED MATER RES A, V68A, P28, DOI 10.1002/jbm.a.20007
   Menon NG, 2003, ANN PLAS SURG, V50, P639, DOI 10.1097/01.SAP.0000054182.47311.17
   Mithoefer K, 2006, J BONE JOINT SURG AM, V88A, P729, DOI 10.2106/JBJS.E.00336
   Mohai M, 2004, SURF INTERFACE ANAL, V36, P805, DOI 10.1002/sia.1769
   MOSS M, 1965, ORAL SURG ORAL MED O, V20, P795, DOI 10.1016/0030-4220(65)90143-X
   Obradovic B, 2001, J ORTHOPAED RES, V19, P1089, DOI 10.1016/S0736-0266(01)00030-4
   Owen RJT, 2000, CARDIOVASC INTER RAD, V23, P389, DOI 10.1007/s002700010088
   PIPITONE VR, 1991, DRUG EXP CLIN RES, V17, P3
   Reyes JMG, 2005, INVEST OPHTH VIS SCI, V46, P1247, DOI 10.1167/iovs.04-1192
   Ronca F, 1998, OSTEOARTHR CARTILAGE, V6, P14, DOI 10.1016/S1063-4584(98)80006-X
   ROVETTA G, 1991, DRUG EXP CLIN RES, V17, P53
   Singer AJ, 1998, ACAD EMERG MED, V5, P94, DOI 10.1111/j.1553-2712.1998.tb02590.x
   Solchaga LA, 2002, TISSUE ENG, V8, P333, DOI 10.1089/107632702753725085
   Werner C, 1999, INT J ARTIF ORGANS, V22, P160
   Williams CG, 2005, BIOMATERIALS, V26, P1211, DOI 10.1016/j.biomaterials.2004.04.024
   Williams CG, 2003, TISSUE ENG, V9, P679, DOI 10.1089/107632703768247377
   WOODWARD SC, 1965, ANN SURG, V162, P113, DOI 10.1097/00000658-196507000-00017
   Zhang ZJ, 2005, J ORTHOP RES, V23, P433, DOI 10.1016/j.orthres.2004.08.028
   ZHAO H, 1991, PHARMACEUT RES, V8, P400, DOI 10.1023/A:1015866104055
NR 36
TC 326
Z9 330
U1 13
U2 198
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1476-1122
EI 1476-4660
J9 NAT MATER
JI Nat. Mater.
PD MAY
PY 2007
VL 6
IS 5
BP 385
EP 392
DI 10.1038/nmat1890
PG 8
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 163FF
UT WOS:000246143500022
PM 17435762
DA 2018-10-20
ER

PT J
AU Kannan, RY
   Salacinski, HJ
   Ghanavi, JE
   Narula, A
   Odlyha, M
   Peirovi, H
   Butler, PE
   Seifalian, AM
AF Kannan, Ruben Y.
   Salacinski, Henryk J.
   Ghanavi, Jalal-edin
   Narula, Ashish
   Odlyha, Marianne
   Peirovi, Habiballah
   Butler, Peter E.
   Seifalian, Alexander M.
TI Silsesquioxane nanocomposites as tissue implants
SO PLASTIC AND RECONSTRUCTIVE SURGERY
LA English
DT Article
ID SILICONE BREAST IMPLANTS; PROSTHESES; CAPSULES; BIODEGRADATION;
   BIOSTABILITY; ADSORPTION
AB Background: Silicone implants are being used increasingly worldwide, especially in breast augmentation procedures. The most common morbidity observed is capsular contracture, which occurs in 15 percent of cases. To overcome this problem, the authors have developed a novel nanocomposite based on polyhedral oligomeric silsesquioxane-poly(carbonate-urea) urethane (POSS-PCU) for use as tissue implants.
   Methods: These polymers were implanted in six healthy sheep (n = 6) for 36 months and a siloxane served as the positive control. After explantation, these polymers were extracted, as was the surrounding capsule, if any. Attenuated total reflectance Fourier transform infrared spectroscopy analysis was performed to look for signs of surface degradation on the polymers and histopathologic and electron microscopic examinations were performed to study the interaction between the biomaterial and the host environment in greater detail.
   Results: After implantation, the authors observed minimal inflammation of the nanocomposite within the sheep model as compared with the siloxane control. Contact angle measurements and fibrinogen enzyme-linked immunosorbent assay tests were then conducted on the POSS-PCU nanocomposite to determine the reason for this behavior. The increased fibrinogen adsorption on POSS-PCU, its amphilicity, and large contact-angle hysteresis indicated that POSS-PCU inhibits inflammation by adsorbing and inactivating fibrinogen on its surface. In complete contrast, the control siloxane in the same setting demonstrated very significant inflammation and degradation, resulting in capsular formation. Naturally, there was no evidence of degradation of the nanocomposite compared with the siloxane control.
   Conclusions: POSS-PCU nanocomposites have enhanced interfacial biocompatibility and better biological stability as compared with conventional silicone biomaterials, thus making them safer as tissue implants.
C1 UCL, Acad Div Surg & Intervent Sci, Biomat & Tissue Engn Ctr, London NW3 2PF, England.
   Univ London, Birbeck Coll, Dept Mat Chem, London NW3, England.
RP Seifalian, AM (reprint author), UCL, Acad Div Surg & Intervent Sci, Biomat & Tissue Engn Ctr, Rolland Hill St, London NW3 2PF, England.
EM a.seifalian@medsch.ucl.ac.uk
RI Seifalian, Alexander/I-6028-2013; ghanavi, jalaledin/G-7394-2017
OI Seifalian, Alexander/0000-0002-1180-3322; ghanavi,
   jalaledin/0000-0002-4415-4840; Butler, Peter/0000-0001-7419-1493
CR Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933
   BARMEIR E, 1995, J AUTOIMMUN, V8, P267, DOI 10.1006/jaut.1995.0020
   BERRINO P, 1986, BRIT J PLAST SURG, V39, P549, DOI 10.1016/0007-1226(86)90133-5
   BRINTON LA, 1995, J CLIN EPIDEMIOL, V48, P557, DOI 10.1016/0895-4356(94)00213-A
   BROHIM RM, 1992, ANN PLAS SURG, V28, P354, DOI 10.1097/00000637-199204000-00010
   Carpaneda CA, 1997, AESTHET PLAST SURG, V21, P110, DOI 10.1007/s002669900094
   Cohney BC, 1997, AESTHET PLAST SURG, V21, P191, DOI 10.1007/s002669900108
   COPELAND M, 1994, PLAST RECONSTR SURG, V94, P628, DOI 10.1097/00006534-199410000-00009
   Deng JJ, 2002, J AM CHEM SOC, V124, P15194, DOI 10.1021/ja027860v
   EBERHART RC, 1987, ANN NY ACAD SCI, V516, P78, DOI 10.1111/j.1749-6632.1987.tb33032.x
   Englert H, 2004, INTERN MED J, V34, P668, DOI 10.1111/j.1445-5994.2004.00670.x
   Freitas R.A., 2003, NANOMEDICINE
   Friemann J, 1997, ZBL CHIR, V122, P551
   Gao HJ, 2003, P NATL ACAD SCI USA, V100, P5597, DOI 10.1073/pnas.0631609100
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Kamel M, 2001, J BIOMED MATER RES, V58, P88, DOI 10.1002/1097-4636(2001)58:1<88::AID-JBM130>3.0.CO;2-7
   Katzin WE, 2005, AM J SURG PATHOL, V29, P506, DOI 10.1097/01.pas.0000155145.60670.e4
   Lesesne CP, 1997, AESTHET PLAST SURG, V21, P93, DOI 10.1007/s002669900091
   Liu L G, 1992, Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi, V8, P174
   Luke JL, 1997, PLAST RECONSTR SURG, V100, P1558, DOI 10.1097/00006534-199711000-00029
   Marcolli C, 1999, APPL ORGANOMET CHEM, V13, P213, DOI 10.1002/(SICI)1099-0739(199904)13:4<213::AID-AOC841>3.3.CO;2-7
   Mathur AB, 1997, J BIOMED MATER RES, V36, P246, DOI 10.1002/(SICI)1097-4636(199708)36:2<246::AID-JBM14>3.3.CO;2-9
   MCCARTHY D J, 1988, Journal of Foot Surgery, V27, P418
   MENA EA, 1995, J INVEST SURG, V8, P31, DOI 10.3109/08941939509015389
   MIKHAIL G, 1981, LAVRENTYEV POLYHEDRA
   Muller B, 2001, J VAC SCI TECHNOL B, V19, P1715, DOI 10.1116/1.1392402
   Muller G H, 1996, Ann Chir Plast Esthet, V41, P666
   PENNISI VR, 1990, PLAST RECONSTR SURG, V86, P368, DOI 10.1097/00006534-199008000-00033
   Peters W, 2001, PLAST RECONSTR SURG, V107, P356, DOI 10.1097/00006534-200102000-00010
   Riedel M, 2001, BIOMATERIALS, V22, P2307, DOI 10.1016/S0142-9612(01)00011-4
   Rubino C, 2001, ANN PLAS SURG, V46, P95, DOI 10.1097/00000637-200102000-00001
   SALACINSKI HJ, 2005, Patent No. 2005000189
   Seifalian AM, 2003, BIOMATERIALS, V24, P2549, DOI 10.1016/S0142-9612(02)00608-7
   Shanklin DR, 1999, EXP MOL PATHOL, V67, P26, DOI 10.1006/exmp.1999.2269
   SINCLAIR TM, 1993, PLAST RECONSTR SURG, V92, P1003, DOI 10.1097/00006534-199311000-00001
   Tanaka K, 2002, J BIOMED MATER RES, V63, P262, DOI 10.1002/jbm.10182
   van Tienen TG, 2002, BIOMATERIALS, V23, P1731, DOI 10.1016/S0142-9612(01)00280-0
   WAGNER H, 1977, PLAST RECONSTR SURG, V60, P49, DOI 10.1097/00006534-197707000-00007
   WEIWEI DU, 2000, THESIS VIRGINIA POLY
   Wiggins MJ, 2001, J BIOMED MATER RES, V58, P302
   Yeoh G, 1996, PATHOLOGY, V28, P232, DOI 10.1080/00313029600169044
   Zhang Y, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.195504
NR 42
TC 66
Z9 71
U1 2
U2 39
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0032-1052
EI 1529-4242
J9 PLAST RECONSTR SURG
JI Plast. Reconstr. Surg.
PD MAY
PY 2007
VL 119
IS 6
BP 1653
EP 1662
DI 10.1097/01.prs.0000246404.53831.4c
PG 10
WC Surgery
SC Surgery
GA 161RC
UT WOS:000246032200003
PM 17440337
DA 2018-10-20
ER

PT J
AU Yoon, SJ
   Park, KS
   Kim, MS
   Rhee, JM
   Khang, G
   Lee, HB
AF Yoon, Sun Jung
   Park, Ki Suk
   Kim, Moon Suk
   Rhee, John M.
   Khang, Gilson
   Lee, Hai Bang
TI Repair of diaphyseal bone defects with calcitriol-loaded PLGA scaffolds
   and marrow stromal cells
SO TISSUE ENGINEERING
LA English
DT Article
ID TISSUE ENGINEERED BONE; MESENCHYMAL STEM-CELLS; POROUS HYDROXYAPATITE;
   IN-VIVO; DIFFERENTIATION; IMPLANTS; GROWTH
AB Calcitriol (1,25(OH)(2)D-3)-loaded porous poly(D,L-lactide-co-glycolide) (PLGA) scaffolds prepared by solvent casting/ salt leaching method were used to repair a 1.5 cm diaphyseal segmental bone defect as a fully absorbable osteogenic biomaterial. The in vitro release of sulforhodamine B (SRB) from PLGA scaffold was measured using spectrophotometer, considering SRB as a model drug. The SRB released from SRB-incorporated PLGA scaffold during 3 months was with relatively low initial burst. The calcitriol-loaded PLGA scaffolds with or without marrow stromal cells (MSCs) were implanted in a critical- sized intercalated bone defect in rabbit femur. Defects were assessed by radiographs until 9 weeks. The bony union of the defect was observed only in the calcitriol-loaded groups. RT-PCR results indicated that MSCs, which were seeded into calcitriol-loaded scaffold, expressed an increased level of alkaline phosphatase, osteonectin, and type I collagen mRNA at day 10. After 2 and 4 weeks, the implanted scaffolds were evaluated by histology. New osteoid matrix and direct calcium deposits were more evident in calcitriol/PLGA/MSC group. Three-dimensional computed tomography and frontal tomographic images of repaired femur showed that normal femur anatomy had been restored with cortical bone with no implanted PLGA remnants at 20 weeks. It can be concluded that the porous calcitriol-loaded PLGA scaffold combined with MSCs may be a novel method for repairing the large loaded bone defect.
C1 Chonbuk Natl Univ, Dept Adv Organ Mat Engn, BK21 BIN Polymer Fus Res Team, Jeonju 561756, South Korea.
   Korea Res Inst Chem Technol, Nanobiomat Lab, Taejon 305606, South Korea.
RP Khang, G (reprint author), Chonbuk Natl Univ, Dept Adv Organ Mat Engn, BK21 BIN Polymer Fus Res Team, Jeonju 561756, South Korea.
EM gskhang@chonbuk.ac.kr
RI Khang, Gilson/B-2109-2013
OI Yoon, Sun-Jung/0000-0003-3487-6863
CR Al-Khaldi A, 2003, GENE THER, V10, P621, DOI 10.1038/sj.gt.3301934
   BALTZER AW, 2000, GENE THER, V7, P743
   BOSTMAN OM, 1991, J BONE JOINT SURG AM, V73A, P148
   Bruder SP, 1998, CLIN ORTHOP RELAT R, pS247
   Bruder SP, 1997, BONE, V21, P225, DOI 10.1016/S8756-3282(97)00127-0
   CARL AG, 2005, EXP CELL RES, V306, P330
   Cho JC, 1999, KOREA POLYM J, V7, P79
   Dong J, 2001, J BIOMED MATER RES, V57, P208, DOI 10.1002/1097-4636(200111)57:2<208::AID-JBM1160>3.0.CO;2-N
   FRAZZA E J, 1971, Journal of Biomedical Materials Research Biomedical Materials Symposium, V1, P43
   Hicok KC, 1998, J BONE MINER RES, V13, P205, DOI 10.1359/jbmr.1998.13.2.205
   HOOGENDOORN HA, 1984, CLIN ORTHOP RELAT R, P281
   Jang JW, 2003, POLYM-KOREA, V27, P226
   Jorgensen NR, 2004, STEROIDS, V69, P219, DOI 10.1016/j.steroids.2003.12.005
   KHANG G, 2001, METHODS TISSUE ENG, P771
   KHANG G, 2006, ENCY MED DEVICES INS, P366
   KHANG G, 2007, IN PRESS PRINCIPLES
   KIM HS, 2002, J KOREA SOC ENDOCRIN, V17, P206
   Kim MS, 2005, INT J BIOL MACROMOL, V36, P54, DOI 10.1016/j/ijbiomac.2005.03.013
   Kim SH, 2006, POLYM-KOREA, V30, P14
   Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57
   Lee R, 2002, J WILDLIFE REHABIL, V25, P3
   Lee SJ, 2004, BIOMATERIALS, V25, P4699, DOI 10.1016/j.biomaterials.2003.11.034
   LEE SJ, 2002, MACROMOL CHEM S, V15, P201
   LIAN JB, 1992, CRIT REV ORAL BIOL M, V3, P269, DOI 10.1177/10454411920030030501
   Lieberman JR, 2002, J BONE JOINT SURG AM, V84A, P1032, DOI 10.2106/00004623-200206000-00022
   Lohmann CH, 2000, J BONE MINER RES, V15, P1169, DOI 10.1359/jbmr.2000.15.6.1169
   Masahiro Y., 2005, BIOMATERIALS, V26, P5145
   Tatebe M, 2005, CYTOTHERAPY, V7, P520, DOI 10.1080/14653240500361350
   Vehof JWM, 2001, PLAST RECONSTR SURG, V108, P434, DOI 10.1097/00006534-200108000-00024
NR 29
TC 36
Z9 44
U1 0
U2 11
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD MAY
PY 2007
VL 13
IS 5
BP 1125
EP 1133
DI 10.1089/ten.2006.0287
PG 9
WC Cell & Tissue Engineering
SC Cell Biology
GA 165XN
UT WOS:000246340800020
PM 17394384
DA 2018-10-20
ER

PT J
AU Akasaka, Y
   Ono, I
   Tominaga, A
   Ishikawa, Y
   Ito, K
   Suzuki, T
   Imaizumi, R
   Ishiguro, S
   Jimbow, K
   Ishii, T
AF Akasaka, Yoshikiyo
   Ono, Ichiro
   Tominaga, Akihiro
   Ishikawa, Yukio
   Ito, Kinji
   Suzuki, Takeya
   Imaizumi, Risa
   Ishiguro, Shigeki
   Jimbow, Kowichi
   Ishii, Toshiharu
TI Basic fibroblast growth factor in an artificial dermis promotes
   apoptosis and inhibits expression of alpha-smooth muscle actin, leading
   to reduction of wound contraction
SO WOUND REPAIR AND REGENERATION
LA English
DT Article
ID IMPREGNATED GELATIN MICROSPHERES; GRANULATION-TISSUE; MYOFIBROBLAST
   APOPTOSIS; COLLAGEN MATRIX; SCAR FORMATION; SKIN; MICE; REGENERATION;
   REPAIR; BIOMATERIAL
AB To clarify the mechanisms underlying declines in wound contraction caused by basic fibroblast growth factor (bFGF) and the role of autologous fibroblasts in modulating wound healing, we have examined the expression of alpha-smooth muscle actin (alpha-SMA) and apoptosis in a model of wound healing using collagen sponges with and without bFGF (1 mu g) and/or fibroblasts (1x10(6)cells/cm(2)) applied to experimentally produced full-thickness skin wounds in rats (n=10 for each group). At 7 days postoperatively, wounds filled with a fibroblast-seeded collagen sponge (fibroblast-seeded group) displayed a greater area of collagen sponge and a smaller area of fibroblasts compared with control wounds filled with collagen sponge alone (control group). Therefore, seeding of fibroblasts in the dermal substitute might retard degradation of the collagen sponge, inhibiting fibroblast infiltration into the substitute. By day 14, wounds filled with bFGF-treated collagen sponge without fibroblast seeding (bFGF group) displayed decreased alpha-SMA expression and significantly increased apoptosis compared with other wounds. Double staining revealed that apoptosis in alpha-SMA-positive fibroblastic cells was significantly increased in the bFGF group, suggesting that bFGF treatment is a potent stimulator of myofibroblast apoptosis. Furthermore, morphometric analysis demonstrated the significant decrease in the level of wound contraction and the degree of mature collagen bundle formation in the bFGF group by day 42. The bFGF group also showed increased bFGF expression in macrophages by day 28. These results suggest that bFGF administration to an artificial dermis promotes apoptosis of alpha-SMA-positive fibroblastic cells and inhibits alpha-SMA expression in the treated wound, thus reducing wound contraction.
C1 Toho Univ, Sch Med, Dept Pathol, Ohta City, Tokyo 1438540, Japan.
   Sapporo Med Univ, Sch Med, Dept Dermatol, Sapporo, Hokkaido, Japan.
RP Akasaka, Y (reprint author), Toho Univ, Sch Med, Dept Pathol, 5-21-16 Omori Nishi, Ohta City, Tokyo 1438540, Japan.
EM akasakay@med.toho-u.ac.jp
CR Akasaka Y, 2004, J PATHOL, V203, P710, DOI 10.1002/path.1574
   ARORA PD, 1994, J CELL PHYSIOL, V159, P161, DOI 10.1002/jcp.1041590120
   Desmouliere A, 2005, WOUND REPAIR REGEN, V13, P7, DOI 10.1111/j.1067-1927.2005.130102.x
   DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103
   DESMOULIERE A, 1995, AM J PATHOL, V146, P56
   DEVRIES HJC, 1995, LAB INVEST, V73, P532
   Dugina V, 1998, EXP CELL RES, V238, P481, DOI 10.1006/excr.1997.3868
   Ehrlich HP, 1999, ARCH SURG-CHICAGO, V134, P494, DOI 10.1001/archsurg.134.5.494
   El-Ghalbzouri A, 2002, BRIT J DERMATOL, V147, P230, DOI 10.1046/j.1365-2133.2002.04871.x
   Erdag G, 2004, BURNS, V30, P322, DOI 10.1016/j.burns.2003.12.007
   Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427
   GRIERSON I, 1988, EYE, V2, P135, DOI 10.1038/eye.1988.27
   Hewitson TD, 2000, METH MOL B, V123, P157
   Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730
   Hinz B, 2003, CURR OPIN BIOTECH, V14, P538, DOI 10.1016/j.copbio.2003.08.006
   Hinz B, 2001, AM J PATHOL, V159, P1009, DOI 10.1016/S0002-9440(10)61776-2
   Kawai K, 2005, BRIT J PLAST SURG, V58, P1115, DOI 10.1016/j.bjps.2005.04.010
   Kawai K, 2000, BIOMATERIALS, V21, P489, DOI 10.1016/S0142-9612(99)00207-0
   Khouw IMSL, 1999, BIOMATERIALS, V20, P1815, DOI 10.1016/S0142-9612(99)00077-0
   KOIDE M, 1993, J BIOMED MATER RES, V27, P79, DOI 10.1002/jbm.820270111
   Kubo K, 2004, ARTIF ORGANS, V28, P182, DOI 10.1111/j.1525-1594.2004.47219.x
   Lamme EN, 2000, J PATHOL, V190, P595, DOI 10.1002/(SICI)1096-9896(200004)190:5<595::AID-PATH572>3.0.CO;2-V
   Lamme EN, 2002, WOUND REPAIR REGEN, V10, P152, DOI 10.1046/j.1524-475X.2002.10901.x
   LEIPZIGER LS, 1985, J AM ACAD DERMATOL, V12, P409, DOI 10.1016/S0190-9622(85)80004-9
   Maltseva O, 2001, INVEST OPHTH VIS SCI, V42, P2490
   MARKS MG, 1991, J BIOMED MATER RES, V25, P683, DOI 10.1002/jbm.820250510
   Matsui R, 1996, BIOMATERIALS, V17, P989, DOI 10.1016/0142-9612(96)84673-4
   Matsui R, 1996, BIOMATERIALS, V17, P995, DOI 10.1016/0142-9612(96)84674-6
   Mizuno S, 2005, FASEB J, V19, P580, DOI 10.1096/fj.04-1535fje
   Ono I, 1999, J BIOMED MATER RES, V48, P621, DOI 10.1002/(SICI)1097-4636(1999)48:5<621::AID-JBM5>3.0.CO;2-1
   RAMOS C, 2006, AM J PHYSIOL-LUNG C, V291, P871
   RonnovJessen L, 1996, J CELL BIOL, V134, P67, DOI 10.1083/jcb.134.1.67
   SPORN MB, 1993, J CLIN INVEST, V92, P2565, DOI 10.1172/JCI116868
   Spyrou GE, 2002, BRIT J PLAST SURG, V55, P275, DOI 10.1054/bjps.2002.3831
   STENZEL KH, 1974, ANNU REV BIOPHYS BIO, V3, P231, DOI 10.1146/annurev.bb.03.060174.001311
   Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809
   Wrobel LK, 2002, CELL MOTIL CYTOSKEL, V52, P82, DOI 10.1002/cm.10034
   Yang JW, 2002, J AM SOC NEPHROL, V13, P2464, DOI 10.1097/01.ASN.0000031827.16102.C1
   Zagorodniuk I, 2005, INT J DERMATOL, V44, P541, DOI 10.1111/j.1365-4632.2004.02541.x
   Zhang HY, 1999, AM J RESP CELL MOL, V21, P658, DOI 10.1165/ajrcmb.21.6.3720
NR 40
TC 43
Z9 45
U1 4
U2 7
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 1067-1927
J9 WOUND REPAIR REGEN
JI Wound Repair Regen.
PD MAY-JUN
PY 2007
VL 15
IS 3
BP 378
EP 389
DI 10.1111/j.1524-475X.2007.00240.x
PG 12
WC Cell Biology; Dermatology; Medicine, Research & Experimental; Surgery
SC Cell Biology; Dermatology; Research & Experimental Medicine; Surgery
GA 172IH
UT WOS:000246797000014
PM 17537125
DA 2018-10-20
ER

PT J
AU Cringus-Fundeanu, I
   Luijten, J
   van der Mei, HC
   Busscher, HJ
   Schouten, AJ
AF Cringus-Fundeanu, Irina
   Luijten, Jeroen
   van der Mei, Henny C.
   Busscher, Henk J.
   Schouten, Arend J.
TI Synthesis and characterization of surface-grafted polyacrylamide brushes
   and their inhibition of microbial adhesion
SO LANGMUIR
LA English
DT Article
ID SILICONE-RUBBER; RADICAL POLYMERIZATION; LAYERS; BIOMATERIAL;
   ATTACHMENT; MONOLAYER; BACTERIA; DENSITY; YEASTS; GLASS
AB A method is presented to prevent microbial adhesion to solid surfaces exploiting the unique properties of polymer brushes. Polyacrylamide (PAAm) brushes were grown from silicon wafers by atom transfer radical polymerization (ATRP) using a three-step reaction procedure consisting of immobilization of a coupling agent gamma-aminopropyltriethoxysilane, anchoring of an ATRP initiator 4-(chloromethyl)benzoyl chloride, and controlled radical polymerization of acrylamide. The surfaces were characterized by X-ray photoelectron spectroscopy, Fourier transform infrared spectroscopy, ellipsometry, and contact-angle measurements. The calculated grafting density pointed to the presence of a dense and homogeneous polymer brush. Initial deposition rates, adhesion after 4 h, and detachment of two bacterial strains (Staphylococcus aureus ATCC 12600 and Streptococcus salivarius GB 24/9) and one yeast strain (Candida albicans GB 1/2) to both PAAm-coated and untreated silicon surfaces were investigated in a parallel plate flow chamber. A high reduction (70-92%) in microbial adhesion to the surface-grafted PAAm brush was observed, as compared with untreated silicon surfaces. Application of the proposed grafting method to silicone rubbers may offer great potential to prevent biomaterials-centered infection of implants.
C1 Univ Groningen, Dept Polymer Chem & Mat Sci, NL-9747 AG Groningen, Netherlands.
   Univ Groningen, Med Ctr, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
RP van der Mei, HC (reprint author), Univ Groningen, Dept Polymer Chem & Mat Sci, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.
EM h.c.van.der.mei@med.umcg.nl
CR Archambault JG, 2004, COLLOID SURFACE B, V33, P111, DOI 10.1016/j.colsurfb.2003.09.004
   AUROY P, 1991, PHYS REV LETT, V66, P719, DOI 10.1103/PhysRevLett.66.719
   Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2
   Cecchet F, 2004, J PHYS CHEM B, V108, P15192, DOI 10.1021/jp048621s
   DEFIFE MK, 1999, J BIOMED MATER RES, V44, P298
   EVERAERT EP, 1995, J ADHES SCI TECHNOL, V9, P1263, DOI 10.1163/156856195X01030
   Everaert EPJM, 1998, COLLOID SURFACE B, V10, P179, DOI 10.1016/S0927-7765(98)00003-4
   Farhan T, 2004, EUR POLYM J, V40, P1599, DOI 10.1016/j.eurpolymj.2004.05.001
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Halperin A, 1999, LANGMUIR, V15, P2525, DOI 10.1021/la981356f
   Hermansson M, 1999, COLLOID SURFACE B, V14, P105, DOI 10.1016/S0927-7765(99)00029-6
   Huang XY, 1998, ANAL CHEM, V70, P4023, DOI 10.1021/ac980231c
   Jones DM, 2002, LANGMUIR, V18, P1265, DOI 10.1021/la011365f
   Kim JB, 2000, J AM CHEM SOC, V122, P7616, DOI 10.1021/ja001652q
   Lee JH, 1998, J BIOMED MATER RES, V40, P314, DOI 10.1002/(SICI)1097-4636(199805)40:2<314::AID-JBM17>3.0.CO;2-L
   Luzinov I, 2000, MACROMOLECULES, V33, P1043, DOI 10.1021/ma990926v
   Mark HF, 1985, ENCY POLYM SCI ENG, V1, P169
   Matyjaszewski K, 2001, CHEM REV, V101, P2921, DOI 10.1021/cr940534g
   Mi YL, 2003, MACROMOLECULES, V36, P7560, DOI 10.1021/ma030127j
   MIRZADEH H, 1995, BIOMATERIALS, V16, P641, DOI 10.1016/0142-9612(95)93862-8
   Moon JH, 1996, LANGMUIR, V12, P4621, DOI 10.1021/la9604339
   Morra M, 2000, J BIOMAT SCI-POLYM E, V11, P547, DOI 10.1163/156856200743869
   Roosjen A, 2003, MICROBIOL-SGM, V149, P3239, DOI 10.1099/mic.0.26519-0
   Silver JH, 1999, BIOMATERIALS, V20, P1533, DOI 10.1016/S0142-9612(98)00173-2
   Simon A, 2002, J COLLOID INTERF SCI, V251, P278, DOI 10.1006/jcis.2002.8385
   Sofia SJ, 1998, J BIOMED MATER RES, V40, P153, DOI 10.1002/(SICI)1097-4636(199804)40:1<153::AID-JBM18>3.0.CO;2-P
   Steiner U, 2005, J POLYM SCI POL PHYS, V43, P3395, DOI 10.1002/polb.20631
   Wieringa RH, 2001, LANGMUIR, V17, P6477, DOI 10.1021/la001769s
   Wu T, 2002, J AM CHEM SOC, V124, P9394, DOI 10.1021/ja027412n
   Xiao SJ, 1998, LANGMUIR, V14, P5507, DOI 10.1021/la980257z
   ZAFONTE L, 1984, P SOC PHOTO-OPT INST, V470, P164
   ZHURAVLEV LT, 1987, LANGMUIR, V3, P316, DOI 10.1021/la00075a004
NR 32
TC 79
Z9 80
U1 1
U2 44
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD APR 24
PY 2007
VL 23
IS 9
BP 5120
EP 5126
DI 10.1021/la063531v
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 157QX
UT WOS:000245736400065
PM 17388616
OA Green Published
DA 2018-10-20
ER

PT J
AU Nagahama, K
   Nishimura, Y
   Ohya, Y
   Ouchi, T
AF Nagahama, Koji
   Nishimura, Yoshihiro
   Ohya, Yuichi
   Ouchi, Tatsuro
TI Impacts of stereoregularity and stereocomplex formation on
   physicochemical, protein adsorption and cell adhesion behaviors of
   star-shaped 8-arms poly(ethylene glycol)-poly(lactide) block copolymer
   films
SO POLYMER
LA English
DT Article
DE stereocomplex; polylactide; 8-arms poly(ethylene glycol)
ID ENANTIOMERIC LACTIC-ACID; TRIBLOCK COPOLYMERS; BIODEGRADABLE HYDROGELS;
   IN-VITRO; DELIVERY; POLY(LACTIDE)S; POLYMERIZATION; NANOPARTICLES;
   POLYMERS; MELT
AB Biodegradable stereocomplex film exhibiting soft and stretchy character was prepared by simply blending between enantiomeric 8-arms poly(ethylene glycol)-block-poly(L-lactide) (8-arms PEG-b-PLLA) and 8-arms PEG-b-PDLA copolymers with star-shaped structure. The stereocomplex film exhibited higher T-g and PLA crystallinity than those of original copolymer films. Effects of stereoregularity and stereocomplexation on protein adsorption and L929 cells attachment/proliferation behaviors onto the films were analyzed from the viewpoint to design a new class of implantable soft biomaterial. The stereocomplex film was found to exhibit large amount of protein adsorption than original films. Furthermore, cell attachment efficiency and proliferation rate on the film were significantly enhanced by stereocomplexation. This stereocomplex material is expected to be applicable as degradable temporary scaffold for soft tissue regeneration. Consequently, it was indicated that the stereocomplex formation could be proposed to be a novel method to control the protein- and cell-adhesive properties of biodegradable matrix composed of PEG-PLA copolymer. (c) 2007 Elsevier Ltd. All rights reserved.
C1 Kansai Univ, Dept Appl Chem, Fac Engn, Suita, Osaka 5648680, Japan.
   Kansai Univ, High Technol Res Ctr, Suita, Osaka 5648680, Japan.
RP Ohya, Y (reprint author), Kansai Univ, Dept Appl Chem, Fac Engn, Suita, Osaka 5648680, Japan.
EM yohya@ipcku.kansai-u.ac.jp; touchi@ipcku.kansai-u.ac.jp
CR Breitenbach A, 2000, J CONTROL RELEASE, V64, P167, DOI 10.1016/S0168-3659(99)00134-0
   de Jong SJ, 2000, MACROMOLECULES, V33, P3680, DOI 10.1021/ma992067g
   Dong YC, 2004, BIOMATERIALS, V25, P2843, DOI 10.1016/j.biomaterials.2003.09.055
   ECHEVERR.E, 1970, SURG GYNECOL OBSTETR, V131, P1
   FRAZZA E J, 1971, Journal of Biomedical Materials Research Biomedical Materials Symposium, V1, P43
   Gessner A, 2003, J BIOMED MATER RES A, V65A, P319, DOI 10.1002/jbm.a.10371
   Hiemstra C, 2006, BIOMACROMOLECULES, V7, P2790, DOI 10.1021/bm060630e
   IKADA Y, 1987, MACROMOLECULES, V20, P904, DOI 10.1021/ma00170a034
   ISHIHARA K, 1992, J BIOMED MATER RES, V26, P1543, DOI 10.1002/jbm.820261202
   ISHIHARA K, 1991, J BIOMED MATER RES, V25, P1397, DOI 10.1002/jbm.820251107
   Kricheldorf HR, 2005, MACROMOLECULES, V38, P7018, DOI 10.1021/ma047836x
   Li SM, 2003, MACROMOLECULES, V36, P8008, DOI 10.1021/ma034734i
   LI SM, 1994, MACROMOLECULES, V27, P3107, DOI 10.1021/ma00089a031
   Lieb E, 2003, TISSUE ENG, V9, P71, DOI 10.1089/107632703762687555
   Lim DW, 2000, J APPL POLYM SCI, V75, P1615, DOI 10.1002/(SICI)1097-4628(20000328)75:13<1615::AID-APP7>3.0.CO;2-L
   Lim DW, 2000, MACROMOL RAPID COMM, V21, P464, DOI 10.1002/(SICI)1521-3927(20000501)21:8<464::AID-MARC464>3.0.CO;2-#
   Mukose T, 2004, MACROMOL BIOSCI, V4, P361, DOI 10.1002/mabi.200300112
   Nagahama K, 2006, MACROMOL BIOSCI, V6, P412, DOI 10.1002/mabi.200500249
   Nagahama K, 2006, POLYM J, V38, P852, DOI 10.1295/polymj.PJ2005240
   ODELIUS K, 2005, J POLYM SCI A, V44, P596
   OGAWA Y, 1988, CHEM PHARM BULL, V36, P1095
   Otsuka H, 2000, BIOMACROMOLECULES, V1, P39, DOI 10.1021/bm990005s
   Serizawa T, 2001, MACROMOLECULES, V34, P1996, DOI 10.1021/ma001705o
   Slivniak R, 2002, BIOMACROMOLECULES, V3, P754, DOI 10.1021/bm0200128
   Soltys-Robitaille CE, 2001, BIOMATERIALS, V22, P3257, DOI 10.1016/S0142-9612(01)00163-6
   Steinbuechel A., 2001, BIOPOLYMERS, V4
   Steinbuechel A., 2001, BIOPOLYMERS, V3
   Tsuji H, 1996, POLYMER, V37, P595, DOI 10.1016/0032-3861(96)83146-6
   TSUJI H, 1993, MACROMOLECULES, V26, P6918, DOI 10.1021/ma00077a032
   Tsuruta T., 1993, BIOMEDICAL APPL POLY
   Vert M, 2000, MACROMOL SYMP, V153, P333, DOI 10.1002/1521-3900(200003)153:1<333::AID-MASY333>3.0.CO;2-9
   Wise D L, 1979, DRUG CARRIERS BIOL M, P237
   Yamaoka T, 2001, J BIOMED MATER RES, V54, P470, DOI 10.1002/1097-4636(20010315)54:4<470::AID-JBM20>3.3.CO;2-O
NR 33
TC 37
Z9 41
U1 2
U2 25
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
J9 POLYMER
JI Polymer
PD APR 24
PY 2007
VL 48
IS 9
BP 2649
EP 2658
DI 10.1016/j.polymer.2007.03.017
PG 10
WC Polymer Science
SC Polymer Science
GA 165TS
UT WOS:000246329300026
DA 2018-10-20
ER

PT J
AU Yang, P
   Huang, N
   Leng, YX
   Wan, GJ
   Zhao, AS
   Chen, JY
   Wang, J
   Sun, H
AF Yang, Ping
   Huang, Nan
   Leng, Yongxiang
   Wan, Guojiang
   Zhao, Ansha
   Chen, Junying
   Wang, Jin
   Sun, Hong
TI Functional inorganic films fabricated by PIII(-D) for surface
   modification of blood contacting biomaterials: Fabrication parameters,
   characteristics and antithrombotic properties
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 8th International Workshop on Plasma-Based Ion Implantation and
   Deposition
CY SEP 18-22, 2005
CL SW Jiaotong Univ, Chengdu, PEOPLES R CHINA
SP Key Lab Adv Technol Mat
HO SW Jiaotong Univ
DE biomaterials; functional inorganic film; PIII-D
ID IMMERSION ION-IMPLANTATION; THIN-FILMS; NITROGEN; SILICON;
   HEMOCOMPATIBILITY; PLATELETS
AB One of the important considerations of antithrombotic biomaterial improvement is to control the response of blood cells and plasma proteins to the materials. Material surface characteristics can be suggested as the important factors that influence the response of blood to materials. Thus, modifying the surface characteristics of a material becomes an important way to endue it with the antithrombotic function of preventing blood cell/ plasma protein activation. This article is going to summarize results from previous studies on functional inorganic films coated with blood contacting biomaterials, including fabricating condition, characteristics and antithrombotic function. The functional inorganic films of Ti-O, a-C: N:H and Si-N synthesized using PIII-D on the surface of a biomaterial can endue it with the antithrombotic function of preventing platelet adhesion/activation. The characteristics of the films changed with alteration of the fabrication condition and influenced their antithrombotic function strongly. The in vitro test results showed that improved biomaterial surfaces with special antithrombotic function can be obtained from the optimization of the fabrication condition according to the understanding of the blood-materials interaction. (c) 2006 Elsevier B.V. All rights reserved.
C1 SW Jiaotong univ, Chinese Educ Minist, Lab Adv Technol Mat, Key Lab Surface Modificar Artificial Organs, Chengdu 610031, Peoples R China.
RP Huang, N (reprint author), SW Jiaotong univ, Chinese Educ Minist, Lab Adv Technol Mat, Key Lab Surface Modificar Artificial Organs, Chengdu 610031, Peoples R China.
EM nhuang@263.net
RI Leng, Yongxiang/G-5488-2010; Wan, Guojiang/A-6651-2013
OI Wan, Guojiang/0000-0002-1636-5405; Leng, Y.X./0000-0001-6823-1233
CR ALLEN RD, 1979, J CELL BIOL, V83, P126, DOI 10.1083/jcb.83.1.126
   BAURSCHMIDT P, 1980, MED BIOL ENG COMPUT, V18, P496, DOI 10.1007/BF02443327
   BUSTARRET E, 1988, PHYS REV B, V38, P8171, DOI 10.1103/PhysRevB.38.8171
   Chen JY, 2002, BIOMATERIALS, V23, P2545, DOI 10.1016/S0142-9612(01)00389-1
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Huang N, 2003, BIOMATERIALS, V24, P2177, DOI 10.1016/S0142-9612(03)00046-2
   Lattemann M, 2003, SURF COAT TECH, V174, P365, DOI 10.1016/S0257-8972(03)00695-9
   Rzany A, 1998, Biomed Tech (Berl), V43 Suppl, P388, DOI 10.1515/bmte.1998.43.s1.388
   Ueda M, 2001, SURF COAT TECH, V136, P244, DOI 10.1016/S0257-8972(00)01023-9
   Wan GJ, 2006, NUCL INSTRUM METH B, V242, P296, DOI 10.1016/j.nimb.2005.08.034
   Yang P, 2006, NUCL INSTRUM METH B, V242, P22, DOI 10.1016/j.nimb.2005.08.081
   Yang P, 2005, KEY ENG MATER, V288-289, P335, DOI 10.4028/www.scientific.net/KEM.288-289.335
   Yang P, 2003, BIOMATERIALS, V24, P2821, DOI 10.1016/S0142-9612(03)00091-7
NR 13
TC 3
Z9 3
U1 0
U2 6
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD APR 23
PY 2007
VL 201
IS 15
BP 6828
EP 6832
DI 10.1016/j.surfcoat.2006.09.014
PG 5
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 156HZ
UT WOS:000245640000082
DA 2018-10-20
ER

PT J
AU Lu, XY
   Li, DJ
   Huang, Y
   Zhang, YY
AF Lu, Xiaoying
   Li, Dejun
   Huang, Yan
   Zhang, Yiyun
TI Application of a modified Coomassie brilliant blue protein assay in the
   study of protein adsorption on carbon thin films
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 8th International Workshop on Plasma-Based Ion Implantation and
   Deposition
CY SEP 18-22, 2005
CL SW Jiaotong Univ, Chengdu, PEOPLES R CHINA
SP Key Lab Adv Technol Mat
HO SW Jiaotong Univ
DE Coomassie brilliant blue protein assay; protein adsorption; carbon thin
   films; biomaterial
AB The aim of this study is to investigate the adsorptive property of proteins on surfaces of three kinds of carbon films (DLC, CN0.088, and CN0.15) and the medical origin of PMMA. The carbon films were first synthesized by magnetron sputtering with different deposition parameters. The surface characteristics of both the carbon films and the original samples were then measured using a contact-angle meter. A modified Coomassie brilliant blue (CBB) protein assay (or Bradford method) was used to detect the amount of proteins adsorbed on the material surfaces after the pilot research for the optimal ratio of protein- to CBB-solution had been performed. The results of the pilot research show that the optimal ratio of protein- to CBB-solution is 1:3, and the protein adsorption results show that the sequence amounts of proteins adsorbed on four kinds of surfaces are DLC > CN0.088 > PMMA > CN0.15. This was the same as the hydrophobicity sequence of four kinds of surfaces obtained from the contact-angle test. However, the ratio of albumin to IgG (R-A/I) adsorbed on the four surfaces has an order of PMMA > CN0.15 > DLC > CN0.088, which indicates the anti-thrombogenicity property of the four kinds of surfaces. (c) 2006 Elsevier B.V. All rights reserved.
C1 Se Univ, State Key Lab bioelect, Dept Biomed Engn, Nanjing 210096, Peoples R China.
   Tianjin Normal Univ, Coll Phys & Elect Informat Sci, Tianjin 300074, Peoples R China.
RP Lu, XY (reprint author), Se Univ, State Key Lab bioelect, Dept Biomed Engn, Nanjing 210096, Peoples R China.
EM luxy@seu.edu.cn; dejunli@mail.tjnu.edu.cn
RI Zhang, Yiyun/H-7526-2013
OI Zhang, Yiyun/0000-0002-2358-9271
CR Barbucci R, 2005, BIOMACROMOLECULES, V6, P638, DOI 10.1021/bm049642v
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   Delgado AD, 2001, LANGMUIR, V17, P4386, DOI 10.1021/la001701c
   GU HQ, 1993, BIOMEDICAL MAT, P142
   HUANG HY, 1998, ACTA MED SIN, V11, P258
   LIN SC, 1998, J MACROMOL, V1, P1
   Pashova V, 2004, J AGR FOOD CHEM, V52, P1558, DOI 10.1021/jf034966g
   Rezwan K, 2004, LANGMUIR, V20, P10055, DOI 10.1021/la048459k
   SADANA A, 1992, CHEM REV, V92, P1799, DOI 10.1021/cr00016a006
   Xu ZK, 2003, MACROMOLECULES, V36, P2441, DOI 10.1021/ma021393k
   ZHOU XW, 2003, BIOCH INSTRUMENT ANA, P24
   ZHU HT, 2000, ACTA ACAD MED SUZHOU, V20, P39
   1998, BIO RAD PROTEIN ASSA
NR 13
TC 19
Z9 21
U1 0
U2 11
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD APR 23
PY 2007
VL 201
IS 15
BP 6843
EP 6846
DI 10.1016/j.surfcoat.2006.09.019
PG 4
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 156HZ
UT WOS:000245640000085
DA 2018-10-20
ER

PT J
AU Tangkuaram, T
   Ponchio, C
   Kangkasomboon, T
   Katikawong, P
   Veerasai, W
AF Tangkuaram, Tanin
   Ponchio, Chatchai
   Kangkasomboon, Thippayawadee
   Katikawong, Panadda
   Veerasai, Waret
TI Design and development of a highly stable hydrogen peroxide biosensor on
   screen printed carbon electrode based on horseradish peroxidase bound
   with gold nanoparticles in the matrix of chitosan
SO BIOSENSORS & BIOELECTRONICS
LA English
DT Article; Proceedings Paper
CT 9th World Congress on Biosensors
CY MAY 10-12, 2006
CL Toronto, CANADA
DE screen printed carbon electrode; chitosan; gold nanoparticles;
   electrodeposition; H2O2 biosensors
ID GLUCOSE-OXIDASE; DIRECT ELECTROCHEMISTRY; PRUSSIAN-BLUE; AMPEROMETRIC
   DETECTION; NANOTUBE ELECTRODE; IMMOBILIZATION; SENSOR; CONSTRUCTION;
   HEMOGLOBIN; BULK
AB The design and development of a screen printed carbon electrode (SPCE) on a polyvinyl chloride substrate as a disposable sensor is described. Six configurations were designed on silk screen frames. The SPCEs were printed with four inks: silver ink as the conducting track, carbon ink as the working and counter electrodes, silver/silver chloride ink as the reference electrode and insulating ink as the insulator layer. Selection of the best configuration was done by comparing slopes from the calibration plots generated by the cyclic voltammograms at 10, 20 and 30 rum K3Fe(CN)(6) for each configuration. The electrodes with similar configurations gave similar slopes. The 5th configuration was the best electrode that gave the highest slope.
   Modifying the best SPCE configuration for use as a biosensor, horseradish peroxidase (HRP) was selected as a biomaterial bound with gold nanoparticles (AuNP) in the matrix of chitosan (HRP/AuNP/CHIT). Biosensors of HRP/SPCE, HRP/CHIT/SPCE and HRP/AuNP/CHIT/SPCE were used in the amperometric detection of H2O2 in a solution of 0.1 M citrate buffer, pH 6.5, by applying a potential of -0.4 V at the working electrode. All the biosensors showed an immediate response to H2O2. The effect of HRP/AuNP incorporated with CHIT (HRP/AuNP/CHIT/SPCE) yielded the highest performance. The amperometric response of HPP/AuNP/CHIT/SPCE retained over 95% of the initial current of the 1st day up to 30 days of storage at 4 degrees C. The biosensor showed a linear range of 0.01-11.3 mM H2O2, with a detection limit of 0.65 mu M H2O2 (S/N = 3). The low detection limit, long storage life and wide linear range of this biosensor make it advantageous in many applications, including bioreactors and biosensors. (c) 2006 Elsevier B.V. All fights reserved.
C1 Mahidol Univ, Fac Sci, Dept Chem, Bangkok 10400, Thailand.
RP Tangkuaram, T (reprint author), Mahidol Univ, Fac Sci, Dept Chem, Bangkok 10400, Thailand.
EM pengtangkua@yahoo.com; scwvr@mahidol.ac.th
CR Abad JM, 2005, J AM CHEM SOC, V127, P5689, DOI 10.1021/ja042717i
   Cai CX, 2004, ANAL BIOCHEM, V325, P285, DOI 10.1016/j.ab.2003.10.040
   Cai H, 2001, J ELECTROANAL CHEM, V510, P78, DOI 10.1016/S0022-0728(01)00548-4
   Clark L C Jr, 1979, Methods Enzymol, V56, P448
   Delvaux M, 2004, ANAL CHIM ACTA, V525, P221, DOI 10.1016/j.aca.2004.08.054
   Gu HY, 2001, J ELECTROANAL CHEM, V516, P119, DOI 10.1016/S0022-0728(01)00669-6
   Gu HY, 2004, BIOMATERIALS, V25, P3445, DOI 10.1016/j.biomaterials.2003.10.048
   Jia NQ, 2005, J ELECTROANAL CHEM, V580, P213, DOI 10.1016/j.jelechem.2005.03.029
   KAMIN RA, 1980, ANAL CHEM, V52, P1198, DOI 10.1021/ac50058a010
   Khanna PK, 2005, MATER CHEM PHYS, V92, P229, DOI 10.1016/j.matchemphys.2005.01.016
   Kong YT, 2003, BIOSENS BIOELECTRON, V19, P227, DOI 10.1016/S0956-5663(03)00216-1
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Ledru S, 2006, BIOSENS BIOELECTRON, V21, P1591, DOI 10.1016/j.bios.2005.07.020
   Lei CX, 2003, TALANTA, V59, P981, DOI 10.1016/S0039-9140(02)00641-0
   Lindgren A, 2000, BIOSENS BIOELECTRON, V15, P491, DOI 10.1016/S0956-5663(00)00110-X
   Liu HY, 1996, J ELECTROANAL CHEM, V417, P59, DOI 10.1016/S0022-0728(96)04756-0
   Liu SQ, 2002, ANAL BIOCHEM, V307, P110, DOI 10.1016/S0003-2697(02)00014-3
   Lu XB, 2006, ELECTROCHEM COMMUN, V8, P874, DOI 10.1016/j.elecom.2006.03.026
   Luo XL, 2005, BIOSENS BIOELECTRON, V21, P190, DOI 10.1016/j.bios.2004.07.029
   Luo XL, 2004, ANAL BIOCHEM, V334, P284, DOI 10.1016/j.ab.2004.07.005
   Miao Y, 2001, ANAL CHIM ACTA, V437, P87, DOI 10.1016/S0003-2670(01)00986-2
   Miserere S, 2006, ELECTROCHEM COMMUN, V8, P238, DOI 10.1016/j.elecom.2005.11.016
   Morrin A, 2003, ANAL LETT, V36, P2021, DOI 10.1081/AL-120023627
   NAGATA R, 1995, ANAL CHIM ACTA, V304, P157, DOI 10.1016/0003-2670(94)00612-P
   Neiman B, 2001, ANAL CHEM, V73, P5220, DOI 10.1021/ac0104375
   O'Halloran MP, 2001, TALANTA, V55, P605, DOI 10.1016/S0039-9140(01)00469-6
   QIAN JH, 1995, J ELECTROANAL CHEM, V397, P157, DOI 10.1016/0022-0728(95)04158-1
   Ricci F, 2003, ANAL CHIM ACTA, V485, P111, DOI 10.1016/S0003-2670(03)00403-3
   Tseng KS, 2005, SENSOR ACTUAT B-CHEM, V108, P738, DOI 10.1016/j.snb.2004.12.031
   Vo-Dinh T, 2001, SENSOR ACTUAT B-CHEM, V74, P2, DOI 10.1016/S0925-4005(00)00705-X
   VREEKE M, 1995, ANAL CHEM, V67, P303, DOI 10.1021/ac00098a012
   WANG J, 1992, ANAL CHEM, V64, P1285, DOI 10.1021/ac00035a016
   Wang MJ, 2004, BIOSENS BIOELECTRON, V19, P575, DOI 10.1016/S0956-5663(03)00252-5
   Wu LQ, 2002, LANGMUIR, V18, P8620, DOI 10.1021/la020381p
   Xu XX, 2003, SENSORS, V3, P350, DOI 10.3390/s30900350
   Yang MH, 2006, BIOSENS BIOELECTRON, V21, P1791, DOI 10.1016/j.bios.2005.09.004
   Yang WW, 2006, ELECTROCHEM COMMUN, V8, P665, DOI 10.1016/j.elecom.2005.11.014
   Zhang CX, 2001, ANAL CHIM ACTA, V426, P33, DOI 10.1016/S0003-2670(00)01158-2
   Zhang JD, 2004, ELECTROCHIM ACTA, V50, P85, DOI 10.1016/j.electacta.2004.07.026
   Zhang SX, 2005, SENSOR ACTUAT B-CHEM, V109, P367, DOI 10.1016/j.snb.2005.01.003
   Zhang ZE, 1996, ANAL CHEM, V68, P1632, DOI 10.1021/ac950431d
NR 41
TC 133
Z9 138
U1 4
U2 62
PU ELSEVIER ADVANCED TECHNOLOGY
PI OXFORD
PA OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON,
   OXFORD OX5 1GB, OXON, ENGLAND
SN 0956-5663
J9 BIOSENS BIOELECTRON
JI Biosens. Bioelectron.
PD APR 15
PY 2007
VL 22
IS 9-10
BP 2071
EP 2078
DI 10.1016/j.bios.2006.09.011
PG 8
WC Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical;
   Electrochemistry; Nanoscience & Nanotechnology
SC Biophysics; Biotechnology & Applied Microbiology; Chemistry;
   Electrochemistry; Science & Technology - Other Topics
GA 154XN
UT WOS:000245541600035
PM 17046233
DA 2018-10-20
ER

PT J
AU Eggert, K
   Wullner, U
   Antony, G
   Gasser, T
   Janetzky, B
   Klein, C
   Schols, L
   Oertel, W
AF Eggert, Karla
   Wuellner, Ullrich
   Antony, Gisela
   Gasser, Thomas
   Janetzky, Bernd
   Klein, Christine
   Schoels, Ludger
   Oertel, Wolfgang
TI Data protection in biomaterial banks for Parkinson's disease research:
   The model of GEPARD (Gene Bank Parkinson's Disease Germany)
SO MOVEMENT DISORDERS
LA English
DT Article
DE gene bank; data protection; standardized documentation; remote data
   entry system; German Competence Network on Parkinson's disease;
   Parkinson's disease
AB Parkinson's disease (PD) is the second most common neurodegenerative disease. Although 10 gene loci have been identified to cause a Parkinsonian syndrome, these loci account only for a minority of PD patients. Large, systematic research programs are required to collect, store, and analyze DNA samples and clinical information to support further discovery of additional genetic components of PD or other movement disorders. Such programs facilitate research into the relationship between genotype and phenotype. The German Competence Network on Parkinson's disease (CNP) initiated the Gene Bank Parkinson's Disease Germany (GEPARD), providing an administrative and scientific infrastructure for the Storage of DNA and clinical data that are electronically accessible and protective of patient rights. In this article, we offer guidance on how to establish a framework for a clinical genetic data and DNA bank, and describe GEPARD as a model that may be useful to other local, national, and international research groups developing similar programs. (c) 2007 Movement Disorder Society.
C1 Univ Marburg, Dept Neurol, D-35039 Marburg, Germany.
   Univ Bonn, Dept Neurol, D-5300 Bonn, Germany.
   Univ Tubingen, Dept Neurol, D-7400 Tubingen, Germany.
   Univ Tubingen, Hertie Inst Clin Brain Res, D-7400 Tubingen, Germany.
   Univ Dresden, Dept Neurol, Dresden, Germany.
   Univ Lubeck, Dept Neurol, Lubeck, Germany.
RP Eggert, K (reprint author), Univ Marburg, Dept Neurol, Rudolf Bultmann Str 8, D-35039 Marburg, Germany.
EM eggert@med.uni-marburg.de
CR Gasser T, 2005, CURR OPIN NEUROL, V18, P363, DOI 10.1097/01.wco.0000170951.08924.3d
   Hofer A, 2004, J MOL NEUROSCI, V24, P417, DOI 10.1385/JMN:24:3:417
   KNOPPERS BM, 1999, GENOMICS HEALTHCARE, P58
   RENG M, 2003, DTSCH ARZTEBLATT, V33, P2134
   SCHULTE J, 2002, DATENSCHUTZ DATENSIC, V26, P605
   SEMLER SC, 2005, TELEMEDIZINISCHER FU, V3, P198
   Wellbrock R, 2004, DUD DATENSCHUTZ DATE, V28, P561
   Wellbrock R, 2003, MEDIZINRECHT, V21, P77
NR 8
TC 7
Z9 7
U1 0
U2 0
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0885-3185
J9 MOVEMENT DISORD
JI Mov. Disord.
PD APR 15
PY 2007
VL 22
IS 5
BP 611
EP 618
DI 10.1002/mds.21331
PG 8
WC Clinical Neurology
SC Neurosciences & Neurology
GA 164DK
UT WOS:000246213100002
PM 17230444
DA 2018-10-20
ER

PT J
AU Castro, LG
   Thompson, DW
   Tiwald, T
   Berberov, EM
   Woollam, JA
AF Castro, Leon G.
   Thompson, Daniel W.
   Tiwald, Thomas
   Berberov, Emil M.
   Woollam, John A.
TI Repeatability of ellipsometric data in cholera toxin G(M1)-ELISA
   structures
SO SURFACE SCIENCE
LA English
DT Article
DE cholera toxin; ELISA; ellipsometry; repeatability; surface reactions
ID DEACTIVATION; MODEL
AB The need for repeated measurements in a wide range of biological testing due to statistical variations is well known. In this paper, we discuss a specific example in which the measurement probe is a spectroscopic ellipsometer. Repeatable results are needed in a wide range of applications such as drug testing, inummoassays and other tests for disease, and fundamental biomaterial research. The present paper seeks to help reduce the non-meaningful causes of lack of repeatability by identifying a large number of externally controllable factors. Another goal of this work was to quantify the effects of many of these factors on ellipsometric measurements. By exploiting the sensitivity of spectroscopic ellipsometry to ultrathin layers, improved ways to detect and quantitatively differentiate biological events can be explored. This initial work was motivated from an interest to distinguish one disease from another or discern effects of one drug from another using the high surface sensitivity of spectroscopic ellipsometry. In this paper, we investigate the example biological system of cholera toxin (CT) in an ELISA structure with monosialoganglioside (G(M1)). (c) 2007 Elsevier B.V. All rights reserved.
C1 Univ Nebraska, Lincoln Elect Engn Dept, Lincoln, NE 68588 USA.
   JA Woollam Co, Lincoln, NE 68508 USA.
   Univ Saskatchewan, Vaccine & Infect Dis Organ, Saskatoon, SK S7N 5E3, Canada.
RP Woollam, JA (reprint author), Univ Nebraska, Lincoln Elect Engn Dept, 209N WSEC, Lincoln, NE 68588 USA.
EM jwoollam@jawoollam.com
CR Adachi S., 1999, OPTICAL CONSTANTS CR
   Arwin H, 2000, THIN SOLID FILMS, V377, P48, DOI 10.1016/S0040-6090(00)01385-7
   Asuero AG, 2006, CRIT REV ANAL CHEM, V36, P41, DOI 10.1080/10408340500526766
   Azzam R. M. A., 1977, ELLIPSOMETRY POLARIZ
   Chen J, 2003, NUCLEIC ACIDS RES, V31, P474, DOI 10.1093/nar/gkg086
   Devlin T, 1997, TXB BIOCH CLIN CORRE
   Elwing H, 1998, BIOMATERIALS, V19, P397, DOI 10.1016/S0142-9612(97)00112-9
   Herzinger CM, 1998, THIN SOLID FILMS, V313, P281, DOI 10.1016/S0040-6090(97)00833-X
   Jellison GE, 1998, THIN SOLID FILMS, V313, P33, DOI 10.1016/S0040-6090(97)00765-7
   JOHS B, 1999, CRIT REV OPT SCI CR, V72, P29
   KING CA, 1973, J INFECT DIS, V127, P639, DOI 10.1093/infdis/127.6.639
   MERRITT EA, 1994, PROTEIN SCI, V3, P166
   Palik E.D., 1991, HDB OPTICAL CONSTANT
   Palik E. D., 1998, HDB OPTICAL CONSTANT
   Palik E. D., 1985, HDB OPTICAL CONSTANT
   Press WH, 1992, NUMERICAL RECIPES C
   Snopok BA, 2006, ANAL BIOCHEM, V348, P222, DOI 10.1016/j.ab.2005.11.009
   THOMPSON DW, 2003, P SOC PHOTO-OPT INS, P138
   Tompkins H. G., 1999, SPECTROSCOPIC ELLIPS
   VANHEYNINGEN WE, 1971, J INFECT DIS, V124, P415, DOI 10.1093/infdis/124.4.415
   VanTassel PR, 1997, J CHEM PHYS, V106, P761, DOI 10.1063/1.473164
   Wang YL, 2003, MACROMOLECULES, V36, P6503, DOI 10.1021/ma034092z
   WOLLAM JA, 1999, CRITICAL REV OPTICAL, P3
NR 23
TC 5
Z9 5
U1 1
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0039-6028
J9 SURF SCI
JI Surf. Sci.
PD APR 15
PY 2007
VL 601
IS 8
BP 1795
EP 1803
DI 10.1016/j.susc.2007.02.005
PG 9
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA 165OD
UT WOS:000246313900004
DA 2018-10-20
ER

PT J
AU Hsu, SH
   Tang, CM
   Chiu, JJ
   Liao, TC
   Lin, CC
   Iwata, H
AF Hsu, Shan-hui
   Tang, Cheng-Ming
   Chiu, Jeng-Jiann
   Liao, Tien-Chi
   Lin, Chu-Chieh
   Iwata, Hiroo
TI Cell migration rate on poly(epsilon-caprolactone)/poly(ethylene glycol)
   diblock copolymers and correlation with the material sliding angle
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE cell migration; microphase separation; nanotopography; PCL/PEG diblock
   copolymer; sliding angle
ID COLLOIDAL LITHOGRAPHY; FIBROBLAST ADHESION; POLYMER; NANOTOPOGRAPHY;
   MORPHOLOGY
AB The nanostructure of a biomaterial surface has strong influence on cell behavior. The migration of cells on nanostructured surfaces, however, has not been investigated so far. In this study, we used PCL/PEG diblock copolymers as model surfaces to examine the effect of nanoislands on migration of different cells, including fibroblasts and endothelial cells. The water sliding angle of the substrates was measured. The cell migration rate was examined under a real-time optical microscope. It was found that a greater cell migration rate correlated with the smaller sliding angle of the substrate.
C1 Natl Chung Hsing Univ, Dept Chem Engn, Taichung 40227, Taiwan.
   Natl Chung Hsing Univ, Inst Biomed Engn, Taichung 40227, Taiwan.
   Natl Hlth Res Inst, Div Med Engn Res, Miaoli, Taiwan.
   Natl Chung Hsing Univ, Dept Chem, Taichung, Taiwan.
   Kyoto Univ, Inst Frontier Med Sci, Kyoto, Japan.
RP Hsu, SH (reprint author), Natl Chung Hsing Univ, Dept Chem Engn, Taichung 40227, Taiwan.
EM shhsu@nchu.edu.tw
RI Chiu, Jeng-Jiann/E-3980-2010
OI Hsu, Shan-hui/0000-0003-3399-055X
CR Aplin AE, 1999, J CELL SCI, V112, P695
   ARIMA Y, 2000, J JPN SOC COLOUR MAT, V73, P485
   Athanassiou A, 2006, LANGMUIR, V22, P2329, DOI 10.1021/la052122g
   CARRELL NA, 1985, J BIOL CHEM, V260, P1743
   CONDEELIS J, 1998, BIOCH ANIMAL CELL CR, P85
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Curtis A, 2001, TRENDS BIOTECHNOL, V19, P97, DOI 10.1016/S0167-7799(00)01536-5
   Dalby M J, 2004, IEE Proc Nanobiotechnol, V151, P53, DOI 10.1049/ip-nbt:20040534
   Dalby MJ, 2002, IEEE T NANOBIOSCI, V1, P12, DOI 10.1109/TNB.2002.806930
   Dalby MJ, 2002, EXP CELL RES, V276, P1, DOI 10.1006/EXCR.2002.5498
   Dalby MJ, 2006, BIOMATERIALS, V27, P1306, DOI 10.1016/j.biomaterials.2005.08.028
   Dalby MJ, 2004, BIOMATERIALS, V25, P5415, DOI 10.1016/j.biomaterials.2003.12.049
   Dalby MJ, 2004, EXP CELL RES, V295, P387, DOI 10.1016/j.yexcr.2004.02.004
   Dalby MJ, 2004, BIOMATERIALS, V25, P77, DOI 10.1016/S0142-9612(03)00475-7
   Dalton BA, 1998, J BIOMAT SCI-POLYM E, V9, P781, DOI 10.1163/156856298X00154
   Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148
   FISCHER EG, 1990, J IMMUNOL METHODS, V128, P235, DOI 10.1016/0022-1759(90)90215-H
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Hsu SH, 2004, BIOMATERIALS, V25, P5593, DOI 10.1016/j.biomaterials.2004.01.061
   LEE J, 1993, NATURE, V362, P167, DOI 10.1038/362167a0
   MCNAMEE HP, 1993, J CELL BIOL, V121, P673, DOI 10.1083/jcb.121.3.673
   Paku S, 2003, EXP CELL RES, V290, P246, DOI 10.1016/S0014-4827(03)00334-3
   Parra-Barraza H, 2005, BIOMACROMOLECULES, V6, P2416, DOI 10.1021/bm050106s
   PRESTON T, 1990, CELL SURFACE MOTILIT, P158
   Renshaw MW, 1997, EMBO J, V16, P5592, DOI 10.1093/emboj/16.18.5592
   Steele JG, 2000, J BIOMED MATER RES, V50, P475, DOI 10.1002/(SICI)1097-4636(20000615)50:4<475::AID-JBM2>3.0.CO;2-G
   SU W, IN PRESS MICRON
   TSAI W, 2005, INTERACTIONS CELLS B, P359
   Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670
   Wood MA, 2006, IEEE T NANOBIOSCI, V5, P20, DOI 10.1109/TNB.2005.864015
   Yim EKF, 2005, NANOMED-NANOTECHNOL, V1, P10, DOI 10.1016/j.nano.2004.11.008
NR 31
TC 11
Z9 12
U1 2
U2 15
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD APR 10
PY 2007
VL 7
IS 4
BP 482
EP 490
DI 10.1002/mabi.200600248
PG 9
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 161FV
UT WOS:000246000800011
PM 17429810
DA 2018-10-20
ER

PT J
AU Sun, W
   Puzas, JE
   Sheu, TJ
   Liu, X
   Fauchet, PM
AF Sun, Wei
   Puzas, J. Edward
   Sheu, Tzong-Jen
   Liu, Xi
   Fauchet, Philippe M.
TI Nano- to microscale porous silicon as a cell interface for bone-tissue
   engineering
SO ADVANCED MATERIALS
LA English
DT Article
ID DELIVERY; MICROCAVITIES
AB Porous Si (PSi) is shown to support and promote primary osteoblast growth (shown in the figure), protein-matrix synthesis, and mineralization. It is also shown that the osteoconductivity of PSi and other cellular responses can be controlled by altering the micro-/nanoarchitecture of the porous interface. This material has the potential to be a functional biomaterial with both osteoconductivity and drug-delivery functions.
C1 Univ Rochester, Dept Biomed Engn, Rochester, NY 14627 USA.
   Univ Rochester, Dept Elect & Comp Engn, Rochester, NY 14627 USA.
   Univ Rochester, Dept Orthopaed, Rochester, NY 14627 USA.
RP Fauchet, PM (reprint author), Univ Rochester, Dept Biomed Engn, Rochester, NY 14627 USA.
EM fauchet@ece.rochester.edu
CR Bayliss SC, 1999, ADV MATER, V11, P318, DOI 10.1002/(SICI)1521-4095(199903)11:4<318::AID-ADMA318>3.0.CO;2-Z
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Buriak J.M., 2002, CHEM REV, V102, P1272
   Canham L., 1997, PROPERTIES POROUS SI
   Canham LT, 1996, ADV MATER, V8, P850, DOI 10.1002/adma.19960081020
   Canham LT, 1995, ADV MATER, V7, P1033, DOI 10.1002/adma.19950071215
   Canham LT, 1999, ADV MATER, V11, P1505, DOI 10.1002/(SICI)1521-4095(199912)11:18<1505::AID-ADMA1505>3.3.CO;2-3
   Chan S, 2001, J AM CHEM SOC, V123, P11797, DOI 10.1021/ja016555r
   Chin V, 2001, ADV MATER, V13, P1877, DOI 10.1002/1521-4095(200112)13:24<1877::AID-ADMA1877>3.0.CO;2-4
   Foraker AB, 2003, PHARMACEUT RES, V20, P110, DOI 10.1023/A:1022211127890
   FROMHERZ P, 1995, PHYS REV LETT, V75, P1670, DOI 10.1103/PhysRevLett.75.1670
   GOLDBERG VM, 2004, ORTHOPEDIC TISSUE EN, pCH1
   Heiduschka P, 1998, PROG NEUROBIOL, V55, P433, DOI 10.1016/S0301-0082(98)00013-6
   Hing KA, 2004, PHILOS T R SOC A, V362, P2821, DOI 10.1098/rsta.2004.1466
   Lai W, 2002, BIOMATERIALS, V23, P213, DOI 10.1016/S0142-9612(01)00097-7
   Letant SE, 2003, NAT MATER, V2, P391, DOI 10.1038/nmat888
   Li X, 2000, BIOMED MICRODEVICES, V2, P265, DOI 10.1023/A:1009951121205
   Li YY, 2003, SCIENCE, V299, P2045, DOI 10.1126/science.1081298
   Moore WR, 2001, AUST NZ J SURG, V71, P354, DOI 10.1046/j.1440-1622.2001.02128.x
   Ouyang H, 2005, ADV FUNCT MATER, V15, P1851, DOI 10.1002/adfm.200500218
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Stewart MP, 2000, ADV MATER, V12, P859, DOI 10.1002/1521-4095(200006)12:12<859::AID-ADMA859>3.0.CO;2-0
   Voskerician G, 2003, BIOMATERIALS, V24, P1959, DOI 10.1016/S0142-9612(02)00565-3
NR 23
TC 92
Z9 93
U1 2
U2 29
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0935-9648
J9 ADV MATER
JI Adv. Mater.
PD APR 6
PY 2007
VL 19
IS 7
BP 921
EP +
DI 10.1002/adma.200600319
PG 5
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 157LC
UT WOS:000245720200005
DA 2018-10-20
ER

PT J
AU Xia, W
   Zhang, DM
   Chang, J
AF Xia, Wei
   Zhang, Daming
   Chang, Jiang
TI Fabrication and in vitro biomineralization of bioactive glass (BG)
   nanofibres
SO NANOTECHNOLOGY
LA English
DT Article
ID ELECTROSPUN NANOFIBERS; MEDICAL APPLICATIONS; TISSUE REGENERATION;
   POLYMER NANOFIBERS; FIBERS; BIOCERAMICS; SYSTEM
AB Bioactive glass nanofibres have excellent bioactivity and cell compatibility, and are regarded as a promising next-generation biomaterial in the bone-regeneration field. This paper is concentrated on the effect of electrospinning parameters on the diameter and morphology of bioactive glass nanofibres, and the process of in vitro biomineralization. In this work, sol-gel glass nanofibres with high bioactivity were prepared by electrospinning processing in the presence of poly( vinyl pyrrolidone) (PVP) and pluronic P123 (EO20-PO70-EO20) as chain entanglements. The influence of the polymer concentration, types of polymer and electric field strength on the fibre diameter was examined. The average diameter of these BG nanofibres could be controlled in the range from 85 to 400 nm. The addition of PVP resulted in sufficient chain entanglement and the formation of smooth BG nanofibres, and the addition of P123 led to a further decrease of the diameter with appropriate electric field strength, which held the balance between the electrostatic repulsive force and surface tension of the electrospinning solution. Furthermore, the early stage of in vitro biomineralization of the BG nanofibres in the simulated body fluid (SBF) was studied in this work. The behaviour of in vitro biomineralization of bioactive glass nanofibres was different to the conventional ones, and the structure of bioactive glasses contributed to the formation process of hydroxyapatite.
C1 Chinese Acad Sci, Shanghai Inst Ceram, Biomat & Tissue Engn Res Ctr, Shanghai 200050, Peoples R China.
   Chinese Acad Sci, Grad Sch, Shanghai 200050, Peoples R China.
RP Chang, J (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, Biomat & Tissue Engn Res Ctr, 1295 Dingxi Rd, Shanghai 200050, Peoples R China.
CR Ahmed I, 2004, BIOMATERIALS, V25, P501, DOI 10.1016/S0142-9612(03)00547-7
   Brunner TJ, 2006, CHEM COMMUN, P1384, DOI 10.1039/b517501a
   Clupper DC, 2003, J BIOMED MATER RES A, V67A, P285, DOI 10.1002/jbm.a.10040
   DAVIS TA, 1984, SCIENCE, V67, P226
   De Diego MA, 2000, J BIOMED MATER RES, V53, P199, DOI 10.1002/(SICI)1097-4636(2000)53:3<199::AID-JBM2>3.0.CO;2-J
   Deitzel JM, 2001, POLYMER, V42, P261, DOI 10.1016/S0032-3861(00)00250-0
   Domingues RZ, 2001, J BIOMED MATER RES, V55, P468, DOI 10.1002/1097-4636(20010615)55:4<468::AID-JBM1038>3.0.CO;2-T
   Fong H, 1999, POLYMER, V40, P4585, DOI 10.1016/S0032-3861(99)00068-3
   Frenot A, 2003, CURR OPIN COLLOID IN, V8, P64, DOI 10.1016/S1359-0294(03)00004-9
   Hench LL, 2004, J BIOMAT SCI-POLYM E, V15, P543, DOI 10.1163/156856204323005352
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Kim HW, 2006, ADV FUNCT MATER, V16, P1529, DOI 10.1002/adfm.200500750
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Li D, 2004, ADV MATER, V16, P1151, DOI 10.1002/adma.200400719
   Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   LIN ST, 1994, BIOMATERIALS, V15, P1057, DOI 10.1016/0142-9612(94)90091-4
   Lopez-Noriega A, 2006, CHEM MATER, V18, P3137, DOI 10.1021/cm060488o
   Ma PX, 2004, MATER TODAY, V7, P30, DOI 10.1016/S1369-7021(04)00233-0
   Marcolongo M, 1997, J BIOMED MATER RES, V37, P440
   McKee MG, 2006, SCIENCE, V311, P353, DOI 10.1126/science.1119790
   OHTSUKI C, 1992, J NON-CRYST SOLIDS, V143, P84, DOI 10.1016/S0022-3093(05)80556-3
   Ramakrishna S, 2006, MATER TODAY, V9, P40, DOI 10.1016/S1369-7021(06)71389-X
   Reneker DH, 1996, NANOTECHNOLOGY, V7, P216, DOI 10.1088/0957-4484/7/3/009
   Shenoy SL, 2005, POLYMER, V46, P3372, DOI 10.1016/j.polymer.2005.03.011
   Vallet-Regi M, 2003, EUR J INORG CHEM, P1029
   Vallet-Regi MA, 2006, J MATER CHEM, V16, P26, DOI 10.1039/b509744d
   Xia W, 2006, J CONTROL RELEASE, V110, P522, DOI 10.1016/j.jconrel.2005.11.002
   YAN XX, 2006, BIOMATERIALS, V37, P3396
NR 33
TC 45
Z9 45
U1 4
U2 55
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 0957-4484
J9 NANOTECHNOLOGY
JI Nanotechnology
PD APR 4
PY 2007
VL 18
IS 13
AR 135601
DI 10.1088/0957-4484/18/13/135601
PG 7
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA 150TL
UT WOS:000245241500008
PM 21730379
DA 2018-10-20
ER

PT J
AU Latella, BA
   Gan, BK
   Li, H
AF Latella, B. A.
   Gan, B. K.
   Li, H.
TI Fracture toughness and adhesion of thermally grown titanium oxide on
   medical grade pure titanium
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE titanium oxide; thermal oxide; adhesion; biomaterial
ID THIN-FILMS; MECHANICAL-PROPERTIES; COATINGS; CRACKING; DECOHESION;
   OXIDATION; SYSTEMS; LAYERS; TI
AB The mechanical properties and adhesion characteristics of a thin thermally grown titanium oxide film on commercially pure titanium were examined. Tensile tests were used to introduce controlled strains in the thermally grown oxide (TGO), through the titanium substrate, to study the damage evolution and to quantitatively evaluate the intrinsic strength and fracture toughness of the TGO layer. Details of the TGO adhesion behaviour were explored. Nanoindentation was used to determine the Young's modulus and hardness of the TGO. Tensile loading resulted in multiple cracking to occur in the TGO layer along with distinctive inclined cracking driven by shear band deformation in the titanium substrate. The fracture toughness of the TGO was determined to be 1.8 +/- 0.6 MPa m(1/2). Localised delamination of the TGO was observed but only when the titanium substrate was strained well within the plastic deformation region by more than about 2.5%. (c) 2007 Elsevier B.V. All rights reserved.
C1 Australian Nucl Sci & Technol Org, Inst Mat Sci & Engn, Menai, NSW 2234, Australia.
   Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia.
RP Latella, BA (reprint author), Australian Nucl Sci & Technol Org, Inst Mat Sci & Engn, Private Mail Bag 1, Menai, NSW 2234, Australia.
EM bal@ansto.gov.au
RI Gan, Bee/B-3818-2009
CR AGRAWAL DC, 1989, ACTA METALL MATER, V37, P1265, DOI 10.1016/0001-6160(89)90120-X
   Atanacio AJ, 2005, SURF COAT TECH, V192, P354, DOI 10.1016/j.surfcoat.2004.06.004
   Bendavid A, 2000, THIN SOLID FILMS, V360, P241, DOI 10.1016/S0040-6090(99)00937-2
   Beuth JL, 1996, J MECH PHYS SOLIDS, V44, P1411, DOI 10.1016/0022-5096(96)00042-7
   Birch JR, 2000, CORROSION, V56, P1233, DOI 10.5006/1.3280511
   Bordet H, 1998, THIN SOLID FILMS, V315, P207, DOI 10.1016/S0040-6090(97)00755-4
   Fischer-Cripps AC, 2006, SURF COAT TECH, V200, P4153, DOI 10.1016/j.surfcoat.2005.03.018
   HU MS, 1989, ACTA METALL MATER, V37, P917, DOI 10.1016/0001-6160(89)90018-7
   Latella BA, 2007, THIN SOLID FILMS, V515, P3138, DOI 10.1016/j.tsf.2006.08.022
   Latella BA, 2006, SURF COAT TECH, V200, P3605, DOI 10.1016/j.surfcoat.2004.09.008
   Latella BA, 2004, J SOL-GEL SCI TECHN, V31, P143, DOI 10.1023/B:JSST.0000047976.41395.51
   Latella BA, 2004, J MATER SCI, V39, P4321, DOI 10.1023/B:JMSC.0000033417.79101.27
   Ogwu AA, 2003, ACTA MATER, V51, P3455, DOI 10.1016/S1359-6454(03)00166-6
   Pouilleau J, 1997, MAT SCI ENG B-SOLID, V47, P235, DOI 10.1016/S0921-5107(97)00043-3
   Poulingue M, 1999, THIN SOLID FILMS, V348, P215, DOI 10.1016/S0040-6090(99)00137-6
   Qasmi M, 2006, SURF COAT TECH, V201, P1191, DOI 10.1016/j.surfcoat.2006.01.058
   Roest R, 2006, KEY ENG MAT, V306-308, P1307, DOI 10.4028/www.scientific.net/KEM.306-308.1307
   Roest R, 2004, KEY ENG MAT, V254-2, P455, DOI 10.4028/www.scientific.net/KEM.254-256.455
   Ting CC, 2000, J APPL PHYS, V88, P4628, DOI 10.1063/1.1309039
   Velten D, 2002, J BIOMED MATER RES, V59, P18, DOI 10.1002/jbm.1212
   Zywitzki O, 2004, SURF COAT TECH, V180, P538, DOI 10.1016/j.surfcoat.2003.10.115
NR 21
TC 18
Z9 18
U1 2
U2 12
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD APR 2
PY 2007
VL 201
IS 14
BP 6325
EP 6331
DI 10.1016/j.surfcoat.2006.11.037
PG 7
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 148HL
UT WOS:000245065200020
DA 2018-10-20
ER

PT J
AU Muller, R
   Groger, G
   Hiller, KA
   Schmalz, G
   Ruhl, S
AF Mueller, Rainer
   Groeger, Gerhard
   Hiller, Karl-Anton
   Schmalz, Gottfried
   Ruhl, Stefan
TI Fluorescence-based bacterial overlay method for simultaneous in situ
   quantification of surface-attached bacteria
SO APPLIED AND ENVIRONMENTAL MICROBIOLOGY
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; MICROBIAL ADHESION; STREPTOCOCCUS-GORDONII;
   FLOW CHAMBER; BIOMATERIAL SURFACES; SILICA SURFACES; IDENTIFICATION;
   BINDING; FIBRONECTIN; RECEPTORS
AB For quantification of bacterial adherence to biomaterial surfaces or to other surfaces prone to biofouling, there is a need for methods that allow a comparative analysis of small material specimens. A new method for quantification of surface-attached biotinylated bacteria was established by in situ detection with fluorescence-labeled avidin-D. This method was evaluated utilizing a silicon wafer model system to monitor the influences of surface wettability and roughness on bacterial adhesion. Furthermore, the effects of protein preadsorption from serum, saliva, human serum albumin, and fibronectin were investigated. Streptococcus gordonii, Streptococcus mitis, and Staphylococcus aureus were chosen as model organisms because of their differing adhesion properties and their clinical relevance. To verify the results obtained by this new technique, scanning electron microscopy and agar replica plating were employed. Oxidized and poly(ethylene glycol)-modified silicon wafers were found to be more resistant to bacterial adhesion than wafers coated with hydrocarbon and fluorocarbon moieties. Roughening of the chemically modified surfaces resulted in an overall increase in bacterial attachment. Preadsorption of proteins affected bacterial adherence but did not fully abolish the influence of the original surface chemistry. However, in certain instances, mostly with saliva or serum, masking of the underlying surface chemistry became evident. The new bacterial overlay method allowed a reliable quantification of surface-attached bacteria and could hence be employed for measuring bacterial adherence on material specimens in a variety of applications.
C1 Univ Regensburg, Dept Operat Dent & Periodontol, Sch Dent, D-93053 Regensburg, Germany.
   Univ Regensburg, Dept Prosthodont, Sch Dent, D-93053 Regensburg, Germany.
   Univ Regensburg, Inst Phys & Theoret Chem, D-8400 Regensburg, Germany.
RP Ruhl, S (reprint author), Univ Regensburg, Dept Operat Dent & Periodontol, Sch Dent, Franz Josef Str Allee 11, D-93053 Regensburg, Germany.
EM stefan.ruhl@klinik.uni-regensburg.de
RI Mueller, Rainer/D-3326-2009
OI Mueller, Rainer/0000-0001-9641-7780; Ruhl, Stefan/0000-0003-3888-4908
CR An YH, 1997, J MICROBIOL METH, V30, P141, DOI 10.1016/S0167-7012(97)00058-4
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   An YHH, 2001, METHOD ENZYMOL, V337, P79, DOI 10.1016/S0076-6879(01)37008-8
   Busscher HJ, 1997, J BIOMED MATER RES, V34, P201, DOI 10.1002/(SICI)1097-4636(199702)34:2<201::AID-JBM9>3.0.CO;2-U
   BUSSCHER HJ, 1995, METHOD ENZYMOL, V253, P455
   Chandra J, 2005, APPL ENVIRON MICROB, V71, P8795, DOI 10.1128/AEM.71.12.8795-8801.2005
   Christie J, 2002, MICROBIOL-SGM, V148, P1615, DOI 10.1099/00221287-148-6-1615
   Cunliffe D, 1999, APPL ENVIRON MICROB, V65, P4995
   EDGERTON M, 1993, J PROSTHET DENT, V69, P406, DOI 10.1016/0022-3913(93)90190-Y
   Fijan S, 2005, J HOSP INFECT, V61, P30, DOI 10.1016/j.jhin.2005.02.005
   Flemming HC, 2002, APPL MICROBIOL BIOT, V59, P629, DOI 10.1007/s00253-002-1066-9
   FRANDSEN EVG, 1991, ORAL MICROBIOL IMMUN, V6, P129, DOI 10.1111/j.1399-302X.1991.tb00466.x
   Glantz POJ, 1999, ACTA ODONTOL SCAND, V57, P238, DOI 10.1080/000163599428634
   GRINNELL F, 1987, ANN NY ACAD SCI, V516, P280, DOI 10.1111/j.1749-6632.1987.tb33048.x
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   Heuberger M, 2005, BIOPHYS J, V88, P495, DOI 10.1529/biophysj.104.045443
   KARLSSON KA, 1987, METHOD ENZYMOL, V138, P220
   Lendenmann U, 2000, Adv Dent Res, V14, P22
   Li J, 2004, J APPL MICROBIOL, V97, P1311, DOI 10.1111/j.1365-2672.2004.02420.x
   Mrksich M, 1996, ANNU REV BIOPH BIOM, V25, P55, DOI 10.1146/annurev.bb.25.060196.000415
   Muller R, 2006, ANAL BIOCHEM, V359, P194, DOI 10.1016/j.ab.2006.09.032
   PAULSSON M, 1993, BIOMATERIALS, V14, P845, DOI 10.1016/0142-9612(93)90006-N
   PRAKOBPHOL A, 1987, ANAL BIOCHEM, V164, P5, DOI 10.1016/0003-2697(87)90359-9
   PRINGLE JH, 1986, APPL ENVIRON MICROB, V51, P1321
   Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384
   QUIRYNEN M, 1993, J DENT RES, V72, P1304, DOI 10.1177/00220345930720090801
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Rickard AH, 2003, TRENDS MICROBIOL, V11, P94, DOI 10.1016/S0966-842X(02)00034-3
   Roosjen A, 2005, COLLOID SURFACE B, V46, P1, DOI 10.1016/j.colsurtb.2005.08.009
   Roosjen A, 2004, LANGMUIR, V20, P10949, DOI 10.1021/la0484691
   Ruhl S, 2000, INFECT IMMUN, V68, P6346, DOI 10.1128/IAI.68.11.6346-6354.2000
   Ruhl S, 2004, J DENT RES, V83, P505, DOI 10.1177/154405910408300614
   Sbordone L, 2003, CLIN ORAL INVEST, V7, P181, DOI 10.1007/s00784-003-0236-1
   Schwarz-Linek U, 2004, MOL MICROBIOL, V52, P631, DOI 10.1111/j.1365-2958.2004.04027.x
   SILBERZAN P, 1991, LANGMUIR, V7, P1647, DOI 10.1021/la00056a017
   SLACK SM, 1995, PROTEINS INTERFACES, V2, P112
   Takahashi Y, 2002, INFECT IMMUN, V70, P1209, DOI 10.1128/IAI.70.3.1209-1218.2002
   Taylor RL, 1998, J MATER SCI-MATER M, V9, P17, DOI 10.1023/A:1008874326324
   Tegoulia VA, 2002, COLLOID SURFACE B, V24, P217, DOI 10.1016/S0927-7765(01)00240-5
   VANPELT AWJ, 1985, APPL ENVIRON MICROB, V49, P1270
   VERGNAT M, 1995, THIN SOLID FILMS, V255, P231, DOI 10.1016/0040-6090(94)05660-6
   von Eiff C, 2005, DRUGS, V65, P179, DOI 10.2165/00003495-200565020-00003
   Walz A, 2005, GLYCOBIOLOGY, V15, P700, DOI 10.1093/glycob/cwi049
NR 44
TC 22
Z9 24
U1 0
U2 10
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0099-2240
EI 1098-5336
J9 APPL ENVIRON MICROB
JI Appl. Environ. Microbiol.
PD APR
PY 2007
VL 73
IS 8
BP 2653
EP 2660
DI 10.1128/AEM.02884-06
PG 8
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA 168RT
UT WOS:000246542400029
PM 17308176
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Lee, KW
   Wang, SF
   Fox, BC
   Ritman, EL
   Yaszemski, MJ
   Lu, LC
AF Lee, Kee-Won
   Wang, Shanfeng
   Fox, Bradley C.
   Ritman, Erik L.
   Yaszemski, Michael J.
   Lu, Lichun
TI Poly(propylene fumarate) bone tissue engineering scaffold fabrication
   using stereolithography: Effects of resin formulations and laser
   parameters
SO BIOMACROMOLECULES
LA English
DT Article
ID CROSS-LINKING CHARACTERISTICS; BIODEGRADABLE SCAFFOLDS;
   MECHANICAL-PROPERTIES; COMPUTED-TOMOGRAPHY; PHYSICAL-PROPERTIES; DESIGN;
   DIFFUSION; CEMENT; ARCHITECTURE; COPOLYMER
AB Stereolithography using photo-cross-linkable polymeric biomaterials is an effective technique for fabricating highly complex three-dimensional (3D) scaffolds with controlled microstructures for tissue engineering applications. In this study, we have optimized the UV curable polymer solution composition and laser parameters for the stereolithography machine. Poly(propylene fumarate) (PPF) was used as the biomaterial, diethyl fumarate (DEF) was used as the solvent, and bisacrylphosphrine oxide (BAPO) was used as the photoinitiator. Three different weight ratios of PPF/DEF and BAPO contents were characterized by measuring the viscosities and thermal properties of the un-cross-linked solutions and the mechanical properties of the formed scaffolds. After optimizing the resin composition by satisfying both the viscosity limitation and the mechanical requirement, laser parameters such as critical exposure (E-c) and penetration depth (D-p) were determined from the working curve and the relationship between laser speed and energy by measuring the thickness of predesigned windows fabricated in stereolithography with different ranges of E-c and D-p. Three-dimensional scaffolds with various pore sizes, pore shapes, and porosities were designed in computer-aided design (CAD) software and were fabricated in stereolithography. The fabricated scaffolds were characterized by measuring external dimensions, porosities, mean pore sizes, and compressive moduli and were compared to the CAD models. Feature accuracy in the xy-plane was achieved and overcuring of the resin in z-axis was minimized. The stereolithographically fabricated scaffolds with controlled microstructures can be useful in diverse tissue engineering applications.
C1 Mayo Clin, Coll Med, Dept Orthoped Surg, Rochester, MN 55905 USA.
   Mayo Clin, Coll Med, Dept Biomed Engn, Rochester, MN 55905 USA.
RP Lu, LC (reprint author), Mayo Clin, Coll Med, Dept Orthoped Surg, 200 1st St SW, Rochester, MN 55905 USA.
EM lu.lichun@mayo.edu
OI Lee, Kee-Won/0000-0002-1571-276X
FU NIBIB NIH HHS [R01 EB003060, R01 EB000305]; NIAMS NIH HHS [R01 AR45871]
CR Bibb R, 2002, RAPID PROTOTYPING J, V8, P25, DOI 10.1108/13552540210413275
   Chen GP, 2002, MACROMOL BIOSCI, V2, P67, DOI 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F
   Cooke MN, 2003, J BIOMED MATER RES B, V64B, P65, DOI 10.1002/jbm.b.10485
   COOKE MN, 2004, THESIS CASE W RESERV
   Dhariwala B, 2004, TISSUE ENG, V10, P1316, DOI 10.1089/1076327042500256
   FELDKAMP LA, 1989, J BONE MINER RES, V4, P3, DOI 10.1002/jbmr.5650040103
   Fisher JP, 2002, J BIOMED MATER RES, V59, P547, DOI 10.1002/jbm.1268
   Fisher JP, 2002, BIOMATERIALS, V23, P4333, DOI 10.1016/S0142-9612(02)00178-3
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   Harrysson OLA, 2003, RAPID PROTOTYPING J, V9, P37, DOI 10.1108/13552540310455647
   He S, 2001, POLYMER, V42, P1251, DOI 10.1016/S0032-3861(00)00479-1
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Hutmacher DW, 2004, TRENDS BIOTECHNOL, V22, P354, DOI 10.1016/j.tibtech.2004.05.006
   Jacobs PF, 1992, RAPID PROTOTYPING MA
   Jorgensen S.M., 1998, AM J PHYSIOL, V275, P1103
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Karande TS, 2004, ANN BIOMED ENG, V32, P1728, DOI 10.1007/s10439-004-7825-2
   Kharas GB, 1997, J APPL POLYM SCI, V66, P1123
   Lee KW, 2006, TISSUE ENG, V12, P2801, DOI 10.1089/ten.2006.12.2801
   Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9
   Lewandrowski KU, 2000, BIOMATERIALS, V21, P293, DOI 10.1016/S0142-9612(99)00180-5
   Mapili G, 2005, J BIOMED MATER RES B, V75B, P414, DOI 10.1002/jbm.b.30325
   Moore MJ, 2004, J BIOMED MATER RES A, V71A, P258, DOI 10.1002/jbm.a.30138
   Murugan R, 2005, COMPOS SCI TECHNOL, V65, P2385, DOI 10.1016/j.compscitech.2005.07.022
   Naumann A, 2003, EUR ARCH OTO-RHINO-L, V260, P568, DOI 10.1007/s00405-003-0636-5
   Peter SJ, 1998, J BIOMED MATER RES, V43, P422, DOI 10.1002/(SICI)1097-4636(199824)43:4<422::AID-JBM9>3.3.CO;2-T
   Peter SJ, 1999, J BIOMED MATER RES, V44, P314
   Sodian R, 2002, ASAIO J, V48, P12, DOI 10.1097/00002480-200201000-00004
   Tsang VL, 2004, ADV DRUG DELIVER REV, V56, P1635, DOI 10.1016/j.addr.2004.05.001
   Wang SF, 2006, BIOMACROMOLECULES, V7, P1976, DOI 10.1021/bm060096a
   Wang SF, 2006, BIOMATERIALS, V27, P832, DOI 10.1016/j.biomaterials.2005.07.013
   Wang SF, 2005, MACROMOLECULES, V38, P7358, DOI 10.1021/ma050884c
   Wang SF, 2004, MACROMOLECULES, V37, P1641, DOI 10.1021/ma034835g
   Wang SF, 2003, MACROMOLECULES, V36, P5355, DOI 10.1021/ma0210426
   Wang WL, 1996, MATER DESIGN, V17, P205, DOI 10.1016/S0261-3069(97)00008-3
   Yang SF, 2002, TISSUE ENG, V8, P1, DOI 10.1089/107632702753503009
   Yaszemski M J, 1995, Tissue Eng, V1, P41, DOI 10.1089/ten.1995.1.41
NR 38
TC 116
Z9 120
U1 7
U2 47
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD APR
PY 2007
VL 8
IS 4
BP 1077
EP 1084
DI 10.1021/bm060834v
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 154LY
UT WOS:000245510100005
PM 17326677
DA 2018-10-20
ER

PT J
AU Au, A
   Boehm, CA
   Mayes, AM
   Muschler, GF
   Griffith, LG
AF Au, Ada
   Boehm, Cynthia A.
   Mayes, Anne M.
   Muschler, George F.
   Griffith, Linda G.
TI Formation of osteogenic colonies on well-defined adhesion peptides by
   freshly isolated human marrow cells
SO BIOMATERIALS
LA English
DT Article
DE connective tissue progenitors; bone marrow; peptide; biomaterial; bone
   graft; mesenchymal stem cells
ID HUMAN BONE-MARROW; MESENCHYMAL STEM-CELLS; OSTEOBLAST-LIKE CELLS;
   STROMAL CELLS; RGD PEPTIDES; IN-VITRO; 3-DIMENSIONAL CULTURE; TITANIUM
   IMPLANTS; PROGENITOR CELLS; SPINAL-FUSION
AB Bone graft performance can be enhanced by addition of connective tissue progenitors (CTPs) from fresh bone marrow in a manner that concentrates the CTP cell population within the graft. Here, we used small peptide adhesion ligands presented against an otherwise adhesion-resistant synthetic polymer background in order to illuminate the molecular basis for the attachment and colony formation by osteogenic CTPs from fresh human marrow, and contrast the behavior of fresh marrow to many commonly used osteogenic cell sources. The linear GRGDSPY ligand was as effective as tissue culture polystyrene in fostering attachment of culture-expanded porcine CTPs. Although this GRGDSPY peptide was more effective than control peptides in fostering alkaline phosphatase (AP)-positive colony formation from primary human marrow in 5 of the 7 patients tested, GRGDSPY was as effective as the control glass substrate in only one patient of 7. Thus, the peptide appears capable of enabling osteoblastic development from only a subpopulation of CTPs in marrow. The bone sialoprotein-derived peptide FHRRIKA was ineffective in fostering attachment of primary culture-expanded pig CTPs, although it was as effective as GRGDSPY in fostering AP-positive colonies from fresh human marrow. This study provides insights into integrin-mediated behaviors of CTPs and highlights differences between freshly isolated marrow and culture-expanded cells. (c) 2006 Elsevier Ltd. All rights reserved.
C1 MIT, Dept Biol Engn, Cambridge, MA 02139 USA.
   MIT, Dept Mech Engn, Cambridge, MA 02139 USA.
   MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.
   Cleveland Clin Fdn, Dept Orthopaed Surg & Biomed Engn, Cleveland, OH 44195 USA.
   MIT, Dept Biol Engn, Cambridge, MA 02139 USA.
RP Griffith, LG (reprint author), MIT, Dept Biol Engn, 16-429,77 Massachusetts Ave, Cambridge, MA 02139 USA.
EM griff@mit.edu
FU NIAMS NIH HHS [R01-AR42997, R01 AR042997]; NIGMS NIH HHS [U54 GM064346,
   R01-GM59870, R01 GM059870]
CR Abukawa H, 2004, J ORAL MAXIL SURG, V62, P601, DOI 10.1016/j.joms.2003.11.010
   Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501
   Aubin J E, 1998, J Cell Biochem Suppl, V30-31, P73
   BELLOWS CG, 1986, CALCIFIED TISSUE INT, V38, P143, DOI 10.1007/BF02556874
   Brodke D, 2006, J ORTHOP RES, V24, P857, DOI 10.1002/jor.20094
   Cavalcanti-Adam EA, 2002, J BONE MINER RES, V17, P2130, DOI 10.1359/jbmr.2002.17.12.2130
   Chastain SR, 2006, J BIOMED MATER RES A, V78A, P73, DOI 10.1002/jbm.a.30686
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   CLOVER J, 1992, J CELL SCI, V103, P267
   Conget PA, 1999, J CELL PHYSIOL, V181, P67, DOI 10.1002/(SICI)1097-4652(199910)181:1<67::AID-JCP7>3.3.CO;2-3
   Cutler SM, 2003, BIOMATERIALS, V24, P1759, DOI 10.1016/S0142-9612(02)00570-7
   Deschaseaux F, 2000, J CELL PHYSIOL, V184, P319, DOI 10.1002/1097-4652(200009)184:3<319::AID-JCP5>3.0.CO;2-N
   Eid K, 2001, J BIOMED MATER RES, V57, P224, DOI 10.1002/1097-4636(200111)57:2<224::AID-JBM1162>3.0.CO;2-F
   Elmengaard B, 2005, J BIOMED MATER RES A, V75A, P249, DOI 10.1002/jbm.a.30301
   Fleming JE, 2000, ORTHOP CLIN N AM, V31, P357, DOI 10.1016/S0030-5898(05)70156-5
   FRIEDENSTEIN AJ, 1987, CELL TISSUE KINET, V20, P263, DOI 10.1111/j.1365-2184.1987.tb01309.x
   Giacomelli CE, 1997, J COLLOID INTERF SCI, V188, P387, DOI 10.1006/jcis.1996.4750
   Glowacki J, 1998, CELL TRANSPLANT, V7, P319, DOI 10.1016/S0963-6897(98)00003-7
   Grayson WL, 2006, J CELL PHYSIOL, V207, P331, DOI 10.1002/jcp.20571
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   Grigoriou V, 2005, J BIOL CHEM, V280, P1733, DOI 10.1074/jbc.M402550200
   GUPTA V, 1987, EXP HEMATOL, V15, P1153
   Harbers GM, 2005, J BIOMED MATER RES A, V75A, P855, DOI 10.1002/jbm.a.30482
   HARRIS JM, 1997, POLY ETHYLENE GLYCOL
   Holy CE, 2000, J BIOMED MATER RES, V51, P376, DOI 10.1002/1097-4636(20000905)51:3<376::AID-JBM11>3.0.CO;2-G
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Irvine DJ, 2001, BIOMACROMOLECULES, V2, P85, DOI 10.1021/bm005584b
   Irvine DJ, 2001, BIOMACROMOLECULES, V2, P545, DOI 10.1021/bm015510f
   Ishaug-Riley SL, 1998, BIOMATERIALS, V19, P1405, DOI 10.1016/S0142-9612(98)00021-0
   Jiang XS, 2006, BIOMATERIALS, V27, P2723, DOI 10.1016/j.biomaterials.2005.12.001
   Jo S, 2001, BIOMACROMOLECULES, V2, P255, DOI 10.1021/bm000107e
   Kilpadi KL, 2004, J BIOMED MATER RES A, V68A, P273, DOI 10.1002/jbm.a.20043
   Klees RF, 2005, MOL BIOL CELL, V16, P881
   Koo LY, 2002, J CELL SCI, V115, P1423
   Kroese-Deutman HC, 2005, TISSUE ENG, V11, P1867, DOI 10.1089/ten.2005.11.1867
   Kuhlman WA, 2006, MACROMOLECULES, V39, P5122, DOI 10.1021/ma060132y
   Lennon DP, 2001, J CELL PHYSIOL, V187, P345, DOI 10.1002/jcp.1081
   LOPEZ GP, 1992, J BIOMED MATER RES, V26, P415, DOI 10.1002/jbm.820260402
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Majors AK, 1997, J ORTHOPAED RES, V15, P546, DOI 10.1002/jor.1100150410
   Matsukura Y, 2000, J BONE MINER RES, V15, pS504
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   Mizuno M, 2000, J CELL PHYSIOL, V184, P207, DOI 10.1002/1097-4652(200008)184:2<207::AID-JCP8>3.3.CO;2-L
   Moursi AM, 1997, J CELL SCI, V110, P2187
   Muschler GE, 2004, J BONE JOINT SURG AM, V86A, P1541, DOI 10.2106/00004623-200407000-00029
   Muschler GF, 2003, J BIOMED BIOTECHNOL, P170
   Muschler GF, 1997, J BONE JOINT SURG AM, V79A, P1699, DOI 10.2106/00004623-199711000-00012
   Muschler GF, 2001, J ORTHOPAED RES, V19, P117, DOI 10.1016/S0736-0266(00)00010-3
   Muschler GF, 2005, CLIN ORTHOP RELAT R, P242, DOI 10.1097/01.blo.0000149812.32857.8b
   Muschler GF, 2003, CLIN ORTHOP RELAT R, P102, DOI 10.1097/01.blo.0000030504.43495.46
   Nuttelman CR, 2005, MATRIX BIOL, V24, P208, DOI 10.1016/j.matbio.2005.03.004
   Owen M, 1985, J CELL SCI S, V10, P63
   PETERS T, 1985, ADV PROTEIN CHEM, V37, P161, DOI 10.1016/S0065-3233(08)60065-0
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   Reyes CD, 2004, J BIOMED MATER RES A, V69A, P591, DOI 10.1002/jbm.a.30034
   Rezania A, 1999, BIOTECHNOL PROGR, V15, P19, DOI 10.1021/bp980083b
   Rezania A, 2000, J BIOMED MATER RES, V52, P595, DOI 10.1002/1097-4636(20001215)52:4<595::AID-JBM3>3.0.CO;2-3
   Roche P, 1999, EXP CELL RES, V250, P465, DOI 10.1006/excr.1999.4518
   Roy V, 1999, EXP HEMATOL, V27, P302, DOI 10.1016/S0301-472X(98)00031-9
   Sawyer AA, 2005, BIOMATERIALS, V26, P1467, DOI 10.1016/j.biomaterials.2004.05.008
   Scaglione S, 2006, BIOTECHNOL BIOENG, V93, P181, DOI 10.1002/bit.20677
   Schaffner P, 2003, CELL MOL LIFE SCI, V60, P119, DOI 10.1007/s000180300008
   SCHOOLEY JC, 1985, INT J CELL CLONING, V3, P2, DOI 10.1002/stem.5530030103
   Shin H, 2005, BIOMATERIALS, V26, P3645, DOI 10.1016/j.biomaterials.2004.09.050
   Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x
   Tuan RS, 2003, ARTHRITIS RES THER, V5, P32, DOI 10.1186/ar614
   Verrier S, 2002, BIOMATERIALS, V23, P585, DOI 10.1016/S0142-9612(01)00145-4
   Yang F, 2005, BIOMATERIALS, V26, P5991, DOI 10.1016/j.biomaterials.2005.03.018
   Yang XB, 2001, BONE, V29, P523, DOI 10.1016/S8756-3282(01)00617-2
NR 70
TC 19
Z9 26
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2007
VL 28
IS 10
BP 1847
EP 1861
DI 10.1016/j.biomaterials.2006.12.009
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 139MM
UT WOS:000244436000012
PM 17222453
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Lee, M
   Chen, TT
   Iruela-Arispe, ML
   Wu, BM
   Dunn, JCY
AF Lee, Min
   Chen, Tom T.
   Iruela-Arispe, M. Luisa
   Wu, Benjamin M.
   Dunn, James C. Y.
TI Modulation of protein delivery from modular polymer scaffolds
SO BIOMATERIALS
LA English
DT Article
DE growth factors; controlled release; scaffolds; collagen; PLGA
   microspheres
ID ENDOTHELIAL GROWTH-FACTOR; FACTOR RELEASE; TISSUE; MICROSPHERES;
   COLLAGEN; REGENERATION; MATRICES; GELATIN
AB Growth factors are increasingly employed to promote tissue regeneration with various biomaterial scaffolds. In vitro release kinetics of protein growth factors from tissue engineering scaffolds are often investigated in aqueous environment, which is significantly different from in vivo environment. This study investigates the release of model proteins with net-positive (histone) and net-negative charge (bovine serum albumin, BSA) from various scaffolding surfaces and from encapsulated microspheres in the presence of ions, proteins, and cells. The release kinetics of proteins in media with varying concentrations of ions (NaCl) suggests stronger electrostatic interaction between the positively charged histone with the negatively charged substrates. While both proteins released slowly from hydrophobic PCL surfaces, plasma etching resulted in rapid release of BSA, but not histone. Interestingly, although negatively charged BSA released readily from negatively charged collagen (col), BSA released slowly from col-coated PCL scaffolds. Such electrostatic interaction effects were abolished in the presence of serum proteins and cells as evidenced by the rapid release of proteins from col-coated scaffolds. To achieve sustained release in the complex environment of serum proteins and cells, the model proteins were encapsulated into poly(D,L-lactic- co-glycolic acid) (PLGA) microspheres, which were embedded within col-coated PCL scaffolds. Protein release from microspheres was modulated by changing the lactide-to-glycolide ratio of PLGA polymer. BSA adsorbed to col released faster than histone encapsulated in microspheres in the presence of serum and cells. Collectively, the data suggest that growth factor release is highly influenced by scaffold surface and the presence of ions, proteins, and cells in the media. Strategies to deliver multiple growth factors and studies which investigate their release should consider these important variables. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Calif Los Angeles, Div Pediat Surg, Dept Bioengn, Los Angeles, CA 90095 USA.
   Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.
   Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90095 USA.
   Univ Calif Los Angeles, Dept Surg, Los Angeles, CA 90095 USA.
RP Dunn, JCY (reprint author), Univ Calif Los Angeles, Div Pediat Surg, Dept Bioengn, Box 709818,10833 Le Conte Ave, Los Angeles, CA 90095 USA.
EM jdunn@mednet.ucla.edu
RI Xu, Qingguo/C-1962-2014
OI Xu, Qingguo/0000-0003-3191-0771
CR ALNAFUSSI AI, 1982, VIRCHOWS ARCH B, V40, P63, DOI 10.1007/BF02932851
   Anderson JM, 1997, ADV DRUG DELIVER REV, V28, P5, DOI 10.1016/S0169-409X(97)00048-3
   BARNARD JA, 1989, P NATL ACAD SCI USA, V86, P1578, DOI 10.1073/pnas.86.5.1578
   BURGESS AW, 1990, J GASTROEN HEPATOL, V5, P10, DOI 10.1111/j.1440-1746.1990.tb01778.x
   Chen RR, 2003, PHARMACEUT RES, V20, P1103, DOI 10.1023/A:1025034925152
   Dimitriou R, 2005, INJURY, V36, P1392, DOI 10.1016/j.injury.2005.07.019
   DOUGHERVERMAZEN M, 1994, BIOCHEM BIOPH RES CO, V205, P728, DOI 10.1006/bbrc.1994.2726
   ELDRIDGE JH, 1992, RES IMMUNOL, V143, P557, DOI 10.1016/0923-2494(92)80069-W
   Ennett AB, 2006, J BIOMED MATER RES A, V79A, P176, DOI 10.1002/jbm.a.30771
   FUNATSU M, 1972, PROTEINS STRUCTURE F
   Gu F, 2004, J CONTROL RELEASE, V96, P463, DOI 10.1016/j.jconrel.2004.02.021
   Holland TA, 2005, J CONTROL RELEASE, V101, P111, DOI 10.1016/j.jconrel.2004.07.004
   Jain RA, 2000, BIOMATERIALS, V21, P2475, DOI 10.1016/S0142-9612(00)00115-0
   Kanematsu A, 2004, BIOMATERIALS, V25, P4513, DOI 10.1016/j.biomaterials.2003.11.035
   Kanematsu A, 2004, J CONTROL RELEASE, V99, P281, DOI 10.1016/j.jconrel.2004.07.008
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   MIHALYI E, 1972, APPL PROTEOLYTIC ENZ
   MIKOS AG, 1993, BIOMATERIALS, V14, P323, DOI 10.1016/0142-9612(93)90049-8
   MISSIRLIS Y, 1991, MODERN ASPECTS PROTE
   Murphy WL, 2000, BIOMATERIALS, V21, P2521, DOI 10.1016/S0142-9612(00)00120-4
   Oyane A, 2005, J BIOMED MATER RES A, V75A, P138, DOI 10.1002/jbm.a.30397
   Rai B, 2005, BIOMATERIALS, V26, P3739, DOI 10.1016/j.biomaterials.2004.09.052
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   SIOUSSAT TM, 1993, ARCH BIOCHEM BIOPHYS, V301, P15, DOI 10.1006/abbi.1993.1109
   Suh H, 2001, BIOMATERIALS, V22, P219, DOI 10.1016/S0142-9612(00)00177-0
   Tabata Y, 2003, TISSUE ENG, V9, pS5, DOI 10.1089/10763270360696941
   Tabata Y, 1998, ADV DRUG DELIVER REV, V31, P287, DOI 10.1016/S0169-409X(97)00125-7
   Tamber H, 2005, ADV DRUG DELIVER REV, V57, P357, DOI 10.1016/j.addr.2004.09.002
   Thompson JS, 2000, MICROSC RES TECHNIQ, V51, P129, DOI 10.1002/1097-0029(20001015)51:2<129::AID-JEMT4>3.0.CO;2-Y
   Whitaker MJ, 2001, J PHARM PHARMACOL, V53, P1427, DOI 10.1211/0022357011777963
   Yang J, 2002, BIOMATERIALS, V23, P2607, DOI 10.1016/S0142-9612(01)00400-8
   Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023
NR 32
TC 61
Z9 62
U1 0
U2 17
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2007
VL 28
IS 10
BP 1862
EP 1870
DI 10.1016/j.biomaterials.2006.12.006
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 139MM
UT WOS:000244436000013
PM 17184836
DA 2018-10-20
ER

PT J
AU Daneshvar, N
   Ayazloo, M
   Khataee, AR
   Pourhassan, M
AF Daneshvar, N.
   Ayazloo, M.
   Khataee, A. R.
   Pourhassan, M.
TI Biological decolorization of dye solution containing Malachite Green by
   microalgae Cosmarium sp.
SO BIORESOURCE TECHNOLOGY
LA English
DT Article
DE biodegradation; triphenylmethane; malachite green; dyeing waste;
   microalgae; Cosmarium
ID WASTE-WATER; CHLORELLA-VULGARIS; AZO-DYE; BOTTOM ASH; PHOTOCATALYTIC
   DEGRADATION; AQUEOUS-SOLUTIONS; REMOVAL; BIOSORPTION; BIODEGRADATION;
   TEXTILE
AB The potential of Cosmarium species, belonging to green algae, was investigated as a viable biomaterial for biological treatment of triphenylmethane dye, Malachite Green (MG). The results obtained from the batch experiments revealed the ability of algal species in removing dye. The effects of operational parameters (temperature, pH, dye concentration and algal concentration) on decolorization were examined. Optimal initial pH was determined 9. The stability and efficiency of the algae in long-term repetitive operations were also examined. Michaelis-Menten kinetics was used to describe the apparent correlation between the decolorization rate and the dye concentration. The optimal kinetic parameters, v(max) and K-m are 7.63 mg dye g cell(-1) h(-1) and 164.57 ppm, respectively. All assays were conducted in triplicates. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Tabriz, Fac Chem, Dept Appl Chem, Water & Wastewater Treatment Res Lab, Tabriz, Iran.
   Univ Tabriz, Fac Sci, Dept Biol, Lab Ecol Res, Tabriz, Iran.
RP Daneshvar, N (reprint author), Univ Tabriz, Fac Chem, Dept Appl Chem, Water & Wastewater Treatment Res Lab, Tabriz, Iran.
EM nezam_daneshvar@yahoo.com; ayazloo@yahoo.com; ar_khataee@yahoo.com;
   minoopourhassan@yahoo.com
RI Khataee, Alireza/E-2874-2015
OI Khataee, Alireza/0000-0002-4673-0223; Pourhassan shamchi,
   Minoo/0000-0003-1764-0453
CR Acuner E, 2004, PROCESS BIOCHEM, V39, P623, DOI 10.1016/S0032-9592(03)00138-9
   Aksu Z, 2005, PROCESS BIOCHEM, V40, P1347, DOI 10.1016/j.procbio.2004.06.007
   Aksu Z, 2005, PROCESS BIOCHEM, V40, P997, DOI 10.1016/j.procbio.2004.04.008
   Aksu Z, 2003, CHEMOSPHERE, V50, P1075, DOI 10.1016/S0045-6535(02)00623-9
   Chang JS, 2000, BIORESOURCE TECHNOL, V75, P107, DOI 10.1016/S0960-8524(00)00049-3
   Chang JS, 2000, BIOTECHNOL LETT, V22, P807, DOI 10.1023/A:1005624707777
   Chang JS, 2001, PROCESS BIOCHEM, V36, P757, DOI 10.1016/S0032-9592(00)00274-0
   Chen KC, 2003, J BIOTECHNOL, V101, P57, DOI 10.1016/S0168-1656(02)00303-6
   Daneshvar N, 2005, CHEMOSPHERE, V59, P761, DOI 10.1016/j.chemosphere.2004.11.012
   Daneshvar N, 2004, J ENVIRON SCI HEAL B, V39, P285, DOI 10.1081/PFC-120030242
   Daneshvar N, 2004, J PHOTOCH PHOTOBIO A, V162, P317, DOI 10.1016/s1010-6030(03)00378-2
   de-Bashan LE, 2002, WATER RES, V36, P2941, DOI 10.1016/S0043-1354(01)00522-X
   Fournier D, 2004, ENVIRON SCI TECHNOL, V38, P4130, DOI 10.1021/es049671d
   Fu YZ, 2002, BIORESOURCE TECHNOL, V82, P139, DOI 10.1016/S0960-8524(01)00172-9
   Gupta VK, 2006, J COLLOID INTERF SCI, V296, P59, DOI 10.1016/j.jcis.2005.08.033
   Gupta VK, 2005, IND ENG CHEM RES, V44, P3655, DOI 10.1021/ie0500220
   Gupta VK, 2005, J COLLOID INTERF SCI, V284, P89, DOI 10.1016/j.jcis.2004.09.055
   Gupta VK, 2004, IND ENG CHEM RES, V43, P1740, DOI 10.1021/ie034218g
   Gupta VK, 2004, SEP PURIF TECHNOL, V40, P87, DOI 10.1016/j.seppur.2004.01.008
   Gupta VK, 2003, J COLLOID INTERF SCI, V265, P257, DOI 10.1016/S0021-9797(03)00467-3
   Jain AK, 2003, J HAZARD MATER, V101, P31, DOI 10.1016/S0304-3894(03)00146-8
   Kumar KV, 2005, PROCESS BIOCHEM, V40, P2865, DOI 10.1016/j.procbio.2005.01.007
   Kumar KV, 2006, DYES PIGMENTS, V69, P74
   Mittal A, 2005, J HAZARD MATER, V117, P171, DOI 10.1016/j.jhazmat.2004.09.016
   Mohan SV, 2002, WASTE MANAGE, V22, P575
   Robinson T, 2001, BIORESOURCE TECHNOL, V77, P247, DOI 10.1016/S0960-8524(00)00080-8
   Saikia N, 2004, J AGR FOOD CHEM, V52, P1220, DOI 10.1021/jf0349580
   Sani RK, 1999, ENZYME MICROB TECH, V24, P433, DOI 10.1016/S0141-0229(98)00159-8
   Valderrama LT, 2002, WATER RES, V36, P4185, DOI 10.1016/S0043-1354(02)00143-4
   Vashishta B.R., 2005, BOT DEGREE STUDENTS
   Walker GM, 2000, ENVIRON POLLUT, V108, P219, DOI 10.1016/S0269-7491(99)00187-6
   Yan H, 2004, CHEMOSPHERE, V55, P1281, DOI 10.1016/j.chemosphere.2003.12.019
NR 32
TC 222
Z9 240
U1 2
U2 62
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0960-8524
J9 BIORESOURCE TECHNOL
JI Bioresour. Technol.
PD APR
PY 2007
VL 98
IS 6
BP 1176
EP 1182
DI 10.1016/j.biortech.2006.05.025
PG 7
WC Agricultural Engineering; Biotechnology & Applied Microbiology; Energy &
   Fuels
SC Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels
GA 134GO
UT WOS:000244071700004
PM 16844368
DA 2018-10-20
ER

PT J
AU Gong, RM
   Zhang, XP
   Liu, HJ
   Sun, YZ
   Liu, BR
AF Gong, Renmin
   Zhang, Xiaoping
   Liu, Huijun
   Sun, Yingzhi
   Liu, Birong
TI Uptake of cationic dyes from aqueous solution by biosorption onto
   granular kohlrabi peel
SO BIORESOURCE TECHNOLOGY
LA English
DT Article
DE biosorption; methylene blue; neutral red; acridine orange; kohlrabi peel
ID PALM-FRUIT BUNCH; ACTIVATED CARBONS; COLOR REMOVAL; WASTE-WATER;
   ADSORPTION; EFFLUENTS; PHENOLS; COST; RED
AB A new, low cost, locally available biomaterial was tested for its ability to remove cationic dyes from aqueous solution. Granules prepared from kohlrabi peel had been utilized as a sorbent for uptake of three cationic dyes, methylene blue (MB), neutral red (NR) and acridine orange (AO). The effects of various experimental parameters (e.g., dye concentration, particle size, initial pH, contact time and other factors) were investigated and optimal experimental conditions were ascertained. Above the value of initial pH 4, three dyes studied could be removed effectively. The isothermal data fitted the Langmuir model in the case of NR sorption and the Freundlich model for all three dyes sorption. The biosorption processes followed the pseudo-first-order rate kinetics. The results in this study indicated that kohlrabi peel was an attractive candidate for removing cationic dyes from the dye wastewater. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Anhui Normal Univ, Coll Life Sci, Wuhu 241000, Peoples R China.
RP Gong, RM (reprint author), Anhui Normal Univ, Coll Life Sci, Wuhu 241000, Peoples R China.
EM rmgong.nju@163.com
CR Aksu Z, 2001, WASTE MANAGE, V21, P695, DOI 10.1016/S0956-053X(01)00006-X
   Balasubramanian M. R., 1987, INDIAN J TECHNOL, V29, P471
   Bhattacharyya KG, 2003, DYES PIGMENTS, V57, P211, DOI 10.1016/S0143-7208(03)00009-3
   Chen KC, 2003, J BIOTECHNOL, V101, P241, DOI 10.1016/S0168-1656(02)00362-0
   Ciardelli G, 2000, RES CONSERVATION REC, V31, P189
   Garg VK, 2003, BIORESOURCE TECHNOL, V89, P121, DOI 10.1016/S0960-8524(03)00058-0
   HEISS GS, 1992, FEMS MICROBIOL LETT, V99, P221, DOI 10.1016/0378-1097(92)90030-R
   Juang RS, 2000, J COLLOID INTERF SCI, V227, P437, DOI 10.1006/jcis.2000.6912
   Koch M, 2002, CHEMOSPHERE, V46, P109, DOI 10.1016/S0045-6535(01)00102-3
   Low K. S., 1993, ENVIRON TECHNOL, V14, P115
   LOW KS, 1995, BIORESOURCE TECHNOL, V52, P79, DOI 10.1016/0960-8524(95)00007-2
   Malik PK, 2003, SEP PURIF TECHNOL, V31, P241, DOI 10.1016/S1383-5866(02)00200-9
   MCKAY G, 1986, WATER AIR SOIL POLL, V29, P273, DOI 10.1007/BF00158759
   Mishra G, 1993, COLOURAGE, V40, P35
   Morais LC, 1999, WATER RES, V33, P979, DOI 10.1016/S0043-1354(98)00294-2
   NAMASIVAYAM C, 1994, BIORESOURCE TECHNOL, V48, P79, DOI 10.1016/0960-8524(94)90141-4
   Namasivayam C, 1996, BIORESOURCE TECHNOL, V57, P37, DOI 10.1016/0960-8524(96)00044-2
   Namasivayam C, 1998, BIORESOURCE TECHNOL, V64, P77, DOI 10.1016/S0960-8524(97)86722-3
   Nassar MM, 1995, WATER SCI TECHNOL, V32, P27, DOI 10.1016/0273-1223(96)00114-X
   Nassar MM, 1999, WATER SCI TECHNOL, V40, P133, DOI 10.1016/S0273-1223(99)00592-2
   NASSAR MM, 1991, J CHEM TECHNOL BIOT, V50, P257
   Nigam P, 2000, BIORESOURCE TECHNOL, V72, P219, DOI 10.1016/S0960-8524(99)00123-6
   PANSWAD T, 1986, WATER SCI TECHNOL, V18, P139
   Rajeshwarisivaraj, 2001, BIORESOURCE TECHNOL, V80, P233
   Rao B. Venkata, 1987, INDIAN J ENV PROT, V7, P363
   Robinson T, 2002, WATER RES, V36, P2824, DOI 10.1016/S0043-1354(01)00521-8
   Wu FC, 1999, J ENVIRON SCI HEAL A, V34, P1753, DOI 10.1080/10934529909376927
NR 27
TC 84
Z9 90
U1 1
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0960-8524
J9 BIORESOURCE TECHNOL
JI Bioresour. Technol.
PD APR
PY 2007
VL 98
IS 6
BP 1319
EP 1323
DI 10.1016/j.biortech.2006.04.034
PG 5
WC Agricultural Engineering; Biotechnology & Applied Microbiology; Energy &
   Fuels
SC Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels
GA 134GO
UT WOS:000244071700024
PM 16790346
DA 2018-10-20
ER

PT J
AU Ogawa, S
   Osanai, S
AF Ogawa, Shigesaburo
   Osanai, Shuichi
TI Inhibition effect of sugar-based amphiphiles on eutectic formation in
   the freezing-thawing process of aqueous NaCl solution
SO CRYOBIOLOGY
LA English
DT Article
DE sugar; sugar-based amphiphile; DSC; XRD-DSC; eutectic; NaCl hydrate;
   inhibition effect; aqueous NaCl solution; freezing thawing
ID DIFFERENTIAL SCANNING CALORIMETRY; BIOMATERIAL STABILIZATION;
   AMINO-ACIDS; XRD-DSC; BEHAVIOR; CRYSTALLIZATION; SYSTEMS; WATER;
   H2O-NACL-GLYCEROL; CRYOPROTECTANTS
AB DSC and simultaneous XRD-DSC measurements were carried out to clarify the interaction among the ingredients in a ternary aqueous solution composed of NaCl, a sugar-based amphiphile or free sugar, and water. Two aspects of the inhibition of eutectic formation were suggested through the addition of the sugar amphiphile. One was the retention of the glass state of the eutectic phase, and the other was the trapping of NaCl hydrate into the sugar moiety of the amphiphilic aggregate. The difference between the free sugar and the amphiphilic one in terms of the trapping of NaCl hydrate was attributable to their dissimilarity in the dissolution state. The results indicated that the free sugars in water could interact with NaCl hydrate on the basis of their various hydroxyl groups. On the other hand, the sugar-based amphiphiles generated a self-assembly aggregate in the system, and interacted with NaCl hydrate by a salting-in effect with their sugar moiety in the freezing thawing process. It was confirmed that the number of sugar units played an important role in trapping NaCl hydrate in the system. The effects of the structural isomerism in the sugars were slight with regard to the inhibition of eutectic formation. (c) 2007 Elsevier Inc. All rights reserved.
C1 Keio Univ, Grad Sch Sci & Technol, Dept Appl Chem, Yokohama, Kanagawa 223, Japan.
RP Osanai, S (reprint author), Keio Univ, Grad Sch Sci & Technol, Dept Appl Chem, 3-14-1 Hiyoshi, Yokohama, Kanagawa 223, Japan.
EM osanai@applc.keio.ac.jp
CR Akinari A., 2004, J SURFACTANTS DETERG, V7, P297
   [Anonymous], 1984, ULLMANNS ENCY IND CH, V33, P208
   Aveyard R, 1998, LANGMUIR, V14, P4699, DOI 10.1021/la980519x
   BEEVERS CA, 1946, NATURE, V157, P872, DOI 10.1038/157872a0
   Chen N, 2005, THERMOCHIM ACTA, V431, P106, DOI 10.1016/j.tca.2005.01.050
   Chen NJ, 2005, CRYOBIOLOGY, V50, P264, DOI 10.1016/j.crybiol.2005.02.004
   COOK WJ, 1973, CARBOHYD RES, V31, P265, DOI 10.1016/S0008-6215(00)86191-1
   DESROSIERS NM, 1991, J CHEM SOC FARADAY T, V87, P2173
   Ferrer M, 2005, ENZYME MICROB TECH, V36, P391, DOI 10.1016/j.enzmictec.2004.02.009
   Goff MJ, 2005, FLUID PHASE EQUILIBR, V238, P149, DOI 10.1016/j.fluid.2005.09.018
   Han B, 2004, CRYOBIOLOGY, V48, P8, DOI 10.1016/j.cryobiol.2003.11.002
   Hancock BC, 1997, J PHARM SCI, V86, P1, DOI 10.1021/js9601896
   HER LM, 1995, PHARMACEUT RES, V12, P768, DOI 10.1023/A:1016280113800
   IZUTSU K, 1995, CHEM PHARM BULL, V43, P1804
   Izutsu K, 1996, PHARMACEUT RES, V13, P1393, DOI 10.1023/A:1016086319851
   JOCHEM M, 1987, CRYOBIOLOGY, V24, P513, DOI 10.1016/0011-2240(87)90055-1
   Kajiwara K, 2001, CRYOLETTERS, V22, P311
   Kishi A, 2002, COLLOID SURFACE B, V25, P281, DOI 10.1016/S0927-7765(01)00290-9
   Longinotti MP, 2002, PHYS CHEM CHEM PHYS, V4, P533, DOI 10.1039/b107746e
   Mazzobre MF, 2001, CRYOBIOLOGY, V43, P199, DOI 10.1006/cryo.2001.2345
   Miller DP, 1998, PHARM RES-DORDR, V15, P1215, DOI 10.1023/A:1011987707515
   NICOLAJSEN H, 1994, CRYOBIOLOGY, V31, P199, DOI 10.1006/cryo.1994.1024
   Nishimoto Y, 2004, ANAL SCI, V20, P1079, DOI 10.2116/analsci.20.1079
   RIAHI HAT, 1988, CARBOHYD RES, V183, P35
   SHEPARD ML, 1976, CRYOBIOLOGY, V13, P9, DOI 10.1016/0011-2240(76)90154-1
   Tanaka M, 2000, POLYM INT, V49, P1709, DOI 10.1002/1097-0126(200012)49:12<1709::AID-PI601>3.0.CO;2-L
   TYANKOVA L, 1972, BIOCHIM BIOPHYS ACTA, V274, P75, DOI 10.1016/0005-2736(72)90282-9
   Vill V, 2000, CHEM PHYS LIPIDS, V104, P75, DOI 10.1016/S0009-3084(99)00119-X
NR 28
TC 7
Z9 7
U1 1
U2 9
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0011-2240
J9 CRYOBIOLOGY
JI Cryobiology
PD APR
PY 2007
VL 54
IS 2
BP 173
EP 180
DI 10.1016/j.cryobiol.2007.01.005
PG 8
WC Biology; Physiology
SC Life Sciences & Biomedicine - Other Topics; Physiology
GA 162OF
UT WOS:000246096500005
PM 17391663
DA 2018-10-20
ER

PT J
AU Scheideler, L
   Rupp, F
   Wendel, HP
   Sathe, S
   Geis-Gerstorfer, J
AF Scheideler, Lutz
   Rupp, Frank
   Wendel, Hans P.
   Sathe, Shila
   Geis-Gerstorfer, Juergen
TI Photocoupling of fibronectin to titanium surfaces influences
   keratinocyte adhesion, pellicle formation and thrombogenicity
SO DENTAL MATERIALS
LA English
DT Article
DE dental implants; titanium biofunctionalization; fibronectin;
   anthraquinone photocoupling; epithelial seal; keratinocyte adhesion;
   platelet activation; pellicle formation; QCM-D
ID QUARTZ-CRYSTAL MICROBALANCE; CELL-ADHESION; ADSORBED FIBRONECTIN;
   PLATELET-ADHESION; ESCHERICHIA-COLI; IMPLANT SURFACES; EPITHELIAL-CELLS;
   DENTAL IMPLANTS; ADSORPTION; PROTEIN
AB Objectives. Coating of implant surfaces with biomolecules can influence basic host responses and enhance subsequent tissue integration. The biological factors have to be immobilized on the implant material. Human fibronectin (Fn) was used as a model protein and covalently coupled to titanium (Ti) surfaces via silanization and an anthraquinone linker. The impact on several aspects of initial host/biomaterial interactions (keratinocyte adhesion, platelet interactions and pellicle formation) was studied.
   Methods. Coupling efficiency was characterized by immunological techniques. The effects of coupled Fn on initial host/biomaterial interactions were assessed. Cell adhesion and spreading were investigated by fluorescent staining, pellicle formation by an acoustic sensor system (quartz crystal microbalance with dissipation, QCM-D), and platelet adhesion as one parameter mediating the inflammatory response by scanning electron microscopy (SEM) and immunological assays.
   Results. Coupling efficiency was related to irradiation time used for photochemical coupling of the UV-activated anthraquinone to the silanized Ti surface. With an optimized protocol, the amount of Fn coupled to the surface could be almost doubled compared to standard dip-coating methods. On the anthraquinone-coupled Fn coatings, cell adhesion and spreading of human keratinocytes was significantly enhanced. Online detection of pellicle formation revealed strong reversibility of saliva protein adhesion on Fn coated surfaces compared to the pure Ti surface. Furthermore, the Fn coated Ti showed a low thrombogenicity.
   Significance. This study suggests that anthraquinone-coupled biological coatings may be useful for biofunctionalization of Ti dental implants by enhancement of soft tissue reintegration (restoration of the epithelial seal) combined with diminished pellicle formation. (C) 2006 Academy of Dental Materials. Published by Elsevier Ltd. All rights reserved.
C1 Univ Tubingen, Dept Prosthodont, Sect Med Mat & Technol, Ctr Dent Oral & Maxillofacial Med, D-72074 Tubingen, Germany.
   Univ Tubingen, Dept Thorac Cardiac & Vasc Surg, D-72074 Tubingen, Germany.
RP Scheideler, L (reprint author), Univ Tubingen, Dept Prosthodont, Sect Med Mat & Technol, Ctr Dent Oral & Maxillofacial Med, D-72074 Tubingen, Germany.
EM lutz.scheideler@med.uni-tuebingen.de
RI Rupp, Frank/G-4725-2012; Wendel, Hans/C-5687-2009
CR Ahn SJ, 2003, AM J ORTHOD DENTOFAC, V124, P198, DOI 10.1016/S0889-5406(03)00346-9
   Andersson AS, 2003, J BIOMED MATER RES A, V64A, P622, DOI 10.1002/jbm.a.10442
   Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Boyan BD, 2001, ANN REV MATER RES, V31, P357, DOI 10.1146/annurev.matsci.31.1.357
   Brown MJ, 1996, CELL MOTIL CYTOSKEL, V34, P185, DOI 10.1002/(SICI)1097-0169(1996)34:3<185::AID-CM2>3.0.CO;2-9
   Burmeister JS, 1996, J BIOMED MATER RES, V30, P13, DOI 10.1002/(SICI)1097-4636(199601)30:1<13::AID-JBM3>3.0.CO;2-U
   BUSSCHER HJ, 1995, FEMS MICROBIOL LETT, V128, P229, DOI 10.1016/0378-1097(95)00103-C
   CALVETE JJ, 1990, FEBS LETT, V263, P43, DOI 10.1016/0014-5793(90)80701-J
   Carlen A, 1996, ARCH ORAL BIOL, V41, P1133, DOI 10.1016/S0003-9969(96)00094-5
   Cho MI, 1999, TISSUE ENGINEERING, P161
   Davies John E, 2003, J Dent Educ, V67, P932
   Dean J W 3rd, 1995, Int J Oral Maxillofac Implants, V10, P721
   Decker Eva-Maria, 2003, Clin Oral Investig, V7, P98, DOI 10.1007/s00784-003-0202-y
   Edgerton M, 1996, Int J Oral Maxillofac Implants, V11, P443
   Geissler U, 2000, J BIOMED MATER RES, V51, P752, DOI 10.1002/1097-4636(20000915)51:4<752::AID-JBM25>3.0.CO;2-7
   Grossner-Schreiber B, 2001, CLIN ORAL IMPLAN RES, V12, P543, DOI 10.1034/j.1600-0501.2001.120601.x
   Grunkemeier JM, 2000, BIOMATERIALS, V21, P2243, DOI 10.1016/S0142-9612(00)00150-2
   Hong J, 1999, THROMB HAEMOSTASIS, V82, P58
   Hook F, 2002, COLLOID SURFACE B, V24, P155, DOI 10.1016/S0927-7765(01)00236-3
   Hook F, 2001, LANGMUIR, V17, P8305, DOI 10.1021/la0107704
   Hook F, 2001, ANAL CHEM, V73, P5796, DOI 10.1021/ac0106501
   Kieswetter K, 1996, CRIT REV ORAL BIOL M, V7, P329, DOI 10.1177/10454411960070040301
   KOHAVI D, 1995, J PROSTHET DENT, V74, P531, DOI 10.1016/S0022-3913(05)80357-9
   KREIKEMEYER B, 1995, MOL MICROBIOL, V17, P137, DOI 10.1111/j.1365-2958.1995.mmi_17010137.x
   Lange K, 2004, DENT MATER, V20, P814, DOI 10.1016/j.dental.2003.10.010
   Lee SJ, 2001, AM J ORTHOD DENTOFAC, V119, P59, DOI 10.1067/mod.2001.110583
   Lee VA, 1996, J BIOMED MATER RES, V31, P51, DOI 10.1002/(SICI)1097-4636(199605)31:1<51::AID-JBM7>3.0.CO;2-P
   Lendenmann U, 2000, Adv Dent Res, V14, P22
   McCarty OJT, 2004, J THROMB HAEMOST, V2, P1823, DOI 10.1111/j.1538-7836.2004.00925.x
   Michael KE, 2003, LANGMUIR, V19, P8033, DOI 10.1021/la034810a
   Otto K, 1999, J BACTERIOL, V181, P5210
   Park JC, 1998, INT J ORAL MAX IMPL, V13, P826
   Park JY, 2000, CLIN ORAL IMPLAN RES, V11, P530, DOI 10.1034/j.1600-0501.2000.011006530.x
   PETTIT DK, 1994, J BIOMED MATER RES, V28, P685, DOI 10.1002/jbm.820280605
   Pilliar R M, 1998, Implant Dent, V7, P305, DOI 10.1097/00008505-199807040-00009
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Reiss B, 2003, LANGMUIR, V19, P1816, DOI 10.1021/la0261747
   Rodahl M, 1997, FARADAY DISCUSS, V107, P229, DOI 10.1039/a703137h
   ROZALSKA B, 1995, FEMS IMMUNOL MED MIC, V11, P307, DOI 10.1111/j.1574-695X.1995.tb00161.x
   Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227
   Sardin S, 2004, J ORAL REHABIL, V31, P140, DOI 10.1046/j.0305-182X.2003.01136.x
   Sauberlich S, 1999, CLIN ORAL IMPLAN RES, V10, P379, DOI 10.1034/j.1600-0501.1999.100505.x
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   Scheideler L, 2003, MAT SCI ENG C-BIO S, V23, P455, DOI 10.1016/S0928-4931(02)00321-1
   SCHEIDELER L, 2001, 14 AACH C BIOM MARCH, P73
   SCHEIDELER L, 2002, 15 AACH C BIOM FEBR, P50
   SCHEIDELER L, 2004, BIOMATERIALIEN, V5, P84
   SCHEIDELER L, 2003, BIOMATERIALIEN, V4, P146
   Schneider GB, 2003, J DENT RES, V82, P372, DOI 10.1177/154405910308200509
   TALAY SR, 1994, MOL MICROBIOL, V13, P531, DOI 10.1111/j.1365-2958.1994.tb00448.x
   Tamura RN, 1997, J PERIODONTAL RES, V32, P287, DOI 10.1111/j.1600-0765.1997.tb00536.x
   Tsai WB, 1999, J BIOMAT SCI-POLYM E, V10, P163, DOI 10.1163/156856299X00117
   Tsai WB, 2004, J BIOMAT SCI-POLYM E, V15, P817, DOI 10.1163/1568562041271093
   Wozney JM, 1999, TISSUE ENGINEERING, P103
   YU JL, 1994, J MED MICROBIOL, V41, P133, DOI 10.1099/00222615-41-2-133
NR 55
TC 34
Z9 34
U1 1
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0109-5641
J9 DENT MATER
JI Dent. Mater.
PD APR
PY 2007
VL 23
IS 4
BP 469
EP 478
DI 10.1016/j.dental.2006.03.005
PG 10
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA 149KF
UT WOS:000245145100012
PM 16624401
DA 2018-10-20
ER

PT J
AU Hasebe, T
   Ishimaru, T
   Kamijo, A
   Yoshimoto, Y
   Yoshimura, T
   Yohena, S
   Kodama, H
   Hotta, A
   Takahashi, K
   Suzuki, T
AF Hasebe, T.
   Ishimaru, T.
   Kamijo, A.
   Yoshimoto, Y.
   Yoshimura, T.
   Yohena, S.
   Kodama, H.
   Hotta, A.
   Takahashi, K.
   Suzuki, T.
TI Effects of surface roughness on anti-thrombogenicity of diamond-like
   carbon films
SO DIAMOND AND RELATED MATERIALS
LA English
DT Article; Proceedings Paper
CT 17th European Conference on Diamond, Diamond-Like Materials, Carbon
   Nanotubes, Nitrides and Silicon Carbide
CY SEP 03-08, 2006
CL Estoril, PORTUGAL
SP AIXTRON AG, Elsevier Ltd, Iplas Innovat Plasma Syst GmbH, Lambda Technologies, Seki Technotron Corp
DE diamond-like carbon; fluorine; surface roughness; thrombogenicity
ID PLATELET-ADHESION; COATINGS; STENTS; PERFORMANCE; GUIDEWIRES; ACTIVATION
AB The mechanism of biomaterial-associated thrombosis has not been fully elucidated. It is believed that surface roughness of biomaterials is a key factor in influencing thrombogenicity. Diamond-like carbon (DLC) is being considered for widespread clinical use as a surface coating for cardiovascular devices. We previously reported that fluorine doping in DLC films (F-DLC) markedly inhibits platelet adhesion and activation in human blood. To evaluate the effects of surface roughness of coatings on thrombus formation, DLC and F-DLC films were deposited on the three different roughness-controlled polycarbonate (PC) substrates, and platelet adhesion and activation was investigated on each substrate. The surface roughness of DLC-coated PC and F-DLC-coated PC ranged from 4.1 nm to 97 nm. In this range, there were no significant differences in the platelet-covered area among the three grades of differing surface roughness for each coated surface. However, evaluation of the F-DLC films showed significant reductions in platelet adhesion and activation when compared with DLC films for every grade of roughness, suggesting that the inherent chemical characteristics of the surface, such as wettability, interfacial free energy and higher ratios of albumin/fibrinogen adsorption, might be more important in the mechanism of F-DLC non-thrombogenicity. (c) 2006 Elsevier B.V. All rights reserved.
C1 Tachikawa Hosp, Dept Radiol, Tokyo 1908531, Japan.
   Keio Univ, Fac Sci & Technol, Ctr Sci Environm Resource & Energy, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan.
   Tachikawa Hosp, Dept Radiol, Tokyo 1908531, Japan.
   Tokyo Univ Hosp, Dept Transfus Med, Bunkyo Ku, Tokyo 1138655, Japan.
RP Hasebe, T (reprint author), Tachikawa Hosp, Dept Radiol, 4-2-22 Nishiki Cho, Tokyo 1908531, Japan.
EM teru_hasebe@hotmail.com
RI Hotta, Atsushi/E-9302-2014
OI Hotta, Atsushi/0000-0001-9516-2739
CR Chepurov A K, 1977, Med Tekh, P25
   Frank RD, 2000, J BIOMED MATER RES, V52, P374, DOI 10.1002/1097-4636(200011)52:2<374::AID-JBM18>3.3.CO;2-Q
   GOODMAN SL, 1989, J BIOMED MATER RES, V23, P105, DOI 10.1002/jbm.820230109
   Gutensohn K, 2000, THROMB RES, V99, P577, DOI 10.1016/S0049-3848(00)00295-4
   Haidopoulos M, 2006, J MATER SCI-MATER M, V17, P647, DOI 10.1007/s10856-006-9228-4
   Hasebe T, 2006, J BIOMED MATER RES A, V76A, P86, DOI 10.1002/jbm.a.30512
   Hasebe T, 2006, DIAM RELAT MATER, V15, P129, DOI 10.1016/j.diamond.2005.08.025
   HECKER JF, 1981, J BIOMED MATER RES, V15, P1, DOI 10.1002/jbm.820150104
   HECKER JF, 1985, J BIOMED MATER RES, V19, P381, DOI 10.1002/jbm.820190404
   Kihara S, 2003, ARTIF ORGANS, V27, P188, DOI 10.1046/j.1525-1594.2003.t01-2-06993.x
   Kwok SCH, 2005, DIAM RELAT MATER, V14, P78, DOI 10.1016/j.diamond.2004.07.019
   Maguire PD, 2005, DIAM RELAT MATER, V14, P1277, DOI 10.1016/j.diamond.2004.12.023
   Maitz MF, 2006, J BIOMED MATER RES B, V77B, P179, DOI 10.1002/jbm.b.30435
   McNicol A, 2003, J PHARMACOL SCI, V93, P381, DOI 10.1254/jphs.93.381
   Okpalugo TIT, 2004, BIOMATERIALS, V25, P239, DOI 10.1016/S0142-9612(03)00494-0
   Saito T, 2005, DIAM RELAT MATER, V14, P1116, DOI 10.1016/j.diamond.2004.09.017
   Tepe G, 2006, BIOMATERIALS, V27, P643, DOI 10.1016/j.biomaterials.2005.06.004
   Tsunoda N, 1999, ASAIO J, V45, P418, DOI 10.1097/00002480-199909000-00010
   Yang P, 2003, BIOMATERIALS, V24, P2821, DOI 10.1016/S0142-9612(03)00091-7
   ZINGG W, 1982, CAN J SURG, V25, P16
NR 20
TC 68
Z9 69
U1 3
U2 66
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-9635
J9 DIAM RELAT MATER
JI Diam. Relat. Mat.
PD APR-JUL
PY 2007
VL 16
IS 4-7
BP 1343
EP 1348
DI 10.1016/j.diamond.2006.12.009
PG 6
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 169RB
UT WOS:000246608200146
DA 2018-10-20
ER

PT J
AU Schultz, P
   Vautier, D
   Charpiot, A
   Lavalle, P
   Debry, C
AF Schultz, P.
   Vautier, D.
   Charpiot, A.
   Lavalle, P.
   Debry, C.
TI Development of tracheal prostheses made of porous titanium: a study on
   sheep
SO EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
LA English
DT Article
DE porous titanium; pracheal prostheses; sheep
ID SURVIVAL ANALYSIS; RECONSTRUCTION; REPLACEMENT; SURGERY; GRAFT; MESH
AB Authors report the development of a biomaterial to be used for tracheal and laryngeal reconstruction. This experimentation follows the replacement of trachea in rats with porous titanium implants. The aim of the study is to test this type of prosthesis on sheep, whose trachea is of comparable size to that of humans. Six ewes were implanted with porous titanium implants after resection of 5 cm of trachea. The planned period for the implantation was from 3 to 6 months before the sacrifice of the animals for histological analysis. After a simple immediate postoperative course, the implantations developed complications of tracheal patency, responsible for four deaths (tracheal obstruction by mucous plug n = 2, inferior necrosis of trachea n = 1, pneumopathy n = 1). The two remaining sheep presented no complications. The mechanical performance of the prostheses was good. The histological results showed an inflammatory stenosis of the tracheo-prosthetic junctions, which was not the direct result of death. The protheses were integrated by the surrounding tissue, but endoprosthetic colonisation by pseudostratified ciliated columnar epithelium was low or nil. The absence of endoprosthetic lining was responsible for the complications. The biocompatibility of the biomaterial is not in question, but the surgical procedure will have to be modified by an endoprosthetic mucous graft before implantation so as to accelerate healing process.
C1 CHU Hautepierre, Dept Otorhinolaryngol, F-67098 Strasbourg, France.
   CHU Hautepierre, Tech Res Team, F-67098 Strasbourg, France.
   ERT 10 61, F-67098 Strasbourg, France.
   INSERM 595, Dept Res, F-67085 Strasbourg, France.
   INSERM 595, Tech Res Team, F-67085 Strasbourg, France.
   ERT 10 61, F-67085 Strasbourg, France.
RP Schultz, P (reprint author), CHU Hautepierre, Dept Otorhinolaryngol, Ave Moliere, F-67098 Strasbourg, France.
EM philippe.schultz@chru-strasbourg.fr
RI Lavalle, Philippe/E-6328-2016
OI Lavalle, Philippe/0000-0001-8798-912X
CR BOTTEMA JR, 1986, J SURG RES, V41, P16, DOI 10.1016/0022-4804(86)90003-X
   Boura C, 2003, BIOMATERIALS, V24, P3521, DOI 10.1016/S0142-9612(03)00214-X
   Bucheler M, 2003, DNA CELL BIOL, V22, P549, DOI 10.1089/104454903322405446
   Bucheler M, 2000, LARYNGO RHINO OTOL, V79, P160
   CULL DL, 1990, ANN THORAC SURG, V50, P899, DOI 10.1016/0003-4975(90)91116-S
   Debry C, 2003, J LARYNGOL OTOL, V117, P113
   Grillo HC, 2003, ANN THORAC SURG, V75, P1039, DOI 10.1016/S0003-4975(02)04109-7
   Grillo HC, 2003, ANN THORAC SURG, V75, P610, DOI 10.1016/S0003-4975(02)04108-5
   Grillo HC, 2002, ANN THORAC SURG, V73, P1995, DOI 10.1016/S0003-4975(02)03564-6
   Kanzaki M, 2006, TISSUE ENG, V12, P1275, DOI 10.1089/ten.2006.12.1275
   KOJIMA K, 2003, FASEB J, V17, P8283
   Martinod E, 2003, ANN THORAC SURG, V75, P1572, DOI 10.1016/S0003-4975(03)00120-6
   MENDAK SH, 1984, ANN THORAC SURG, V38, P488, DOI 10.1016/S0003-4975(10)64190-2
   NELSON RJ, 1983, J THORAC CARDIOV SUR, V86, P800
   NEVILLE WE, 1990, J THORAC CARDIOV SUR, V99, P604
   OKUMURA N, 1994, J THORAC CARDIOV SUR, V108, P337
   SCHERER MA, 1986, ARCH OTO-RHINO-LARYN, V243, P215, DOI 10.1007/BF00464433
   Schultz P, 2005, BIOMATERIALS, V26, P2621, DOI 10.1016/j.biomaterials.2004.06.049
   Schultz P, 2004, EUR ARCH OTO-RHINO-L, V261, P484, DOI 10.1007/s00405-003-0717-5
   Schultz P, 2002, ANN THORAC SURG, V73, P1747, DOI 10.1016/S0003-4975(02)03569-5
   SHAHA A, 1988, AM J SURG, V156, P306, DOI 10.1016/S0002-9610(88)80299-X
   Suh SW, 2001, ASAIO J, V47, P496
   ten Hallers EJO, 2004, BIOMATERIALS, V25, P1533, DOI 10.1016/S0142-9612(03)00500-3
   Teramachi M, 1997, ANN THORAC SURG, V64, P965, DOI 10.1016/S0003-4975(97)00755-8
   Teramachi M, 1997, J THORAC CARDIOV SUR, V113, P701, DOI 10.1016/S0022-5223(97)70227-7
   Walles T, 2004, EXPERT REV MED DEVIC, V1, P241, DOI 10.1586/14734440.1.2.241
   ZIEGELAAR BW, 2001, BIOMATERIALS, V23, P1425
NR 27
TC 20
Z9 22
U1 0
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0937-4477
J9 EUR ARCH OTO-RHINO-L
JI Eur. Arch. Oto-Rhino-Laryn.
PD APR
PY 2007
VL 264
IS 4
BP 433
EP 438
DI 10.1007/s00405-006-0195-7
PG 6
WC Otorhinolaryngology
SC Otorhinolaryngology
GA 142VD
UT WOS:000244677800018
PM 17123095
DA 2018-10-20
ER

PT J
AU Luna, AS
   da Costa, ACA
   Henriques, CA
   Herbst, MH
AF Luna, Aderval S.
   da Costa, Antonio Carlos A.
   Henriques, Chistiane A.
   Herbst, Marcelo H.
TI Electron paramagnetic resonance and atomic absorption spectrometry as
   tools for the investigation of Cu(II) biosorption by Sargassum
   filipendula
SO HYDROMETALLURGY
LA English
DT Article
DE copper; biosorption; kinetics; equilibrium; Sargassum filipendula;
   electron paramagnetic resonance
ID AQUEOUS-SOLUTIONS; COPPER BIOSORPTION; PRETREATED BIOMASS;
   RHIZOPUS-ARRHIZUS; CADMIUM(II); ADSORPTION; REMOVAL; IONS; TEMPERATURE;
   EQUILIBRIUM
AB A basic investigation into the removal of copper ions from aqueous solutions by Sargassum filipendula was conducted in batch conditions. The influence of different experimental parameters such as initial pH, sorption time, equilibrium conditions, and initial concentrations of copper ions on copper uptake was evaluated. Results indicated that copper uptake capacity increased from pH 2.0 to 3.0, being constant at pH values 4.0 and 5.0. Electron Paramagnetic Resonance proved to be a useful tool for studying the mechanism involved in copper biosorption by S. filipendula. For initial copper concentrations smaller than 250 mu g mL(-1) axial type spectra were obtained, typical of isolated immobilized copper ions, and a hyperfine structure was observed (A(parallel to) = 150(2)G, g(parallel to) =2.31 (1)). For initial copper concentrations greater than 250 mu g mL(-1), (q(e)= 53.3 mg g(-1)), a distorted line, typical of aggregates, was observed, due to dipole-dipole magnetic interactions.
   The Langmuir model better represented the sorption process, as compared to the model of Freundlich. The process followed a second-order kinetics, and equilibrium was reached after 10 min of contact between the biomass and the metal solution. Due to its outstanding copper uptake capacity (1.30 mmol g(-1) biomass), S. filipendula proved to be an excellent biomaterial for accumulating and recovering copper from industrial solutions. The results show that the biomass has sorption capacities comparable to other biomasses and conventional ion-exchange materials. (C) 2006 Elsevier B.V. All rights reserved.
C1 Univ Estado Rio de Janeiro, Programa Posgrad Engn Quim, BR-20550013 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Inst Fis, Dept Fis Solidos, BR-21941590 Rio De Janeiro, Brazil.
RP Luna, AS (reprint author), Univ Estado Rio de Janeiro, Programa Posgrad Engn Quim, Rua Sao Francisco Xavier 524, BR-20550013 Rio De Janeiro, Brazil.
EM asluna@uerj.br
RI DA COSTA, ANTONIO CARLOS/G-3460-2012
OI Luna, Aderval/0000-0001-6772-0182
CR Aksu Z, 2001, SEP PURIF TECHNOL, V21, P285, DOI 10.1016/S1383-5866(00)00212-4
   Antunes WM, 2003, ELECTRON J BIOTECHN, V6, P174, DOI 10.4067/S0717-34582003000300003
   Benguella B, 2002, WATER RES, V36, P2463, DOI 10.1016/S0043-1354(01)00459-6
   Chang JS, 1997, WATER RES, V31, P1651, DOI 10.1016/S0043-1354(97)00008-0
   DACOSTA ACA, 2001, EJB ELECT J BIOTECHN, V4, P1
   de Carvalho RP, 2003, HYDROMETALLURGY, V71, P277, DOI 10.1016/S0304-386X(03)00166-X
   de Carvalho RP, 2001, HYDROMETALLURGY, V59, P407, DOI 10.1016/S0304-386X(00)00170-5
   Fernadez NA, 1995, BIORESOURCE TECHNOL, V54, P111, DOI 10.1016/0960-8524(95)00000-3
   Freire-Nordi CS, 2005, PROCESS BIOCHEM, V40, P2215, DOI 10.1016/j.procbio.2004.09.003
   Ho YS, 1996, ENVIRON TECHNOL, V17, P71, DOI 10.1080/09593331708616362
   KIVELSON D, 1961, J CHEM PHYS, V35, P149, DOI 10.1063/1.1731880
   LEWIS WB, 1966, J CHEM PHYS, V44, P2409, DOI 10.1063/1.1727057
   Matheickal JT, 1999, WATER RES, V33, P335, DOI 10.1016/S0043-1354(98)00237-1
   Matheickal JT, 1999, BIORESOURCE TECHNOL, V69, P223, DOI 10.1016/S0960-8524(98)00196-5
   MCGARVEY R, 1966, TRANSITION METAL CHE, V3
   Mehta SK, 2001, ECOL ENG, V18, P1, DOI 10.1016/S0925-8574(00)00174-9
   MURALEEDHARAN TR, 1995, APPL ENVIRON MICROB, V61, P3507
   Nakajima A, 2001, WORLD J MICROB BIOT, V17, P343, DOI 10.1023/A:1016638230043
   Nuhoglu Y, 2002, BIORESOURCE TECHNOL, V85, P331, DOI 10.1016/S0960-8524(02)00098-6
   PEISACH J, 1974, ARCH BIOCHEM BIOPHYS, V165, P691, DOI 10.1016/0003-9861(74)90298-7
   Philip L, 2000, WATER AIR SOIL POLL, V119, P11, DOI 10.1023/A:1005123624184
   Sag Y, 1998, HYDROMETALLURGY, V50, P297, DOI 10.1016/S0304-386X(98)00065-6
   Sag Y, 2002, BIOCHEM ENG J, V12, P143, DOI 10.1016/S1369-703X(02)00068-2
   Say R, 2001, BIORESOURCE TECHNOL, V76, P67, DOI 10.1016/S0960-8524(00)00071-7
   Veglio F, 1997, HYDROMETALLURGY, V44, P301, DOI 10.1016/S0304-386X(96)00059-X
   Volesky B., 2003, SORPTION BIOSORPTION
NR 26
TC 13
Z9 13
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-386X
J9 HYDROMETALLURGY
JI Hydrometallurgy
PD APR
PY 2007
VL 86
IS 1-2
BP 105
EP 113
DI 10.1016/j.hydromet.2006.11.008
PG 9
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 144LO
UT WOS:000244797700014
DA 2018-10-20
ER

PT J
AU Shiji, Y
   Muramoto, Y
   Shimizu, N
AF Shiji, Yuhei
   Muramoto, Yuji
   Shimizu, Noriyuki
TI AC breakdown properties of bamboo pulp-ice composite system at cryogenic
   temperature
SO IEEE TRANSACTIONS ON DIELECTRICS AND ELECTRICAL INSULATION
LA English
DT Article
DE bamboo pulp-ice composite system; biomaterial; ac breakdown; cryogenic
   temperature
AB In recent years, biomaterials have attracted attention in various fields in response to environmental problems. We pay attention to bamboo because it naturally decomposes and is characterized by its excellent elasticity and water absorption properties. We had proposed a bamboo-ice composite system as a substitute for the glass fiber reinforced plastics (GFRP) in electrical insulation systems at cryogenic temperatures. In this paper we will report the ac breakdown properties of a bamboo pulp-ice composite system at liquid nitrogen temperature. The bamboo pulp-ice composite system had ac breakdown strength comparable with GFRP and can be easily molded in various shapes. We consider that the bamboo pulp-ice composite system is promising as a substitute for the GFRP in the electrical insulating systems at cryogenic temperatures.
C1 Meijo Univ, Dept Elect & Elect Engn, Tempaku Ku, Nagoya, Aichi 4688502, Japan.
RP Shiji, Y (reprint author), Meijo Univ, Dept Elect & Elect Engn, Tempaku Ku, Nagoya, Aichi 4688502, Japan.
CR SHIJI Y, 2006, IEEE INT S EL INS IS, P354
   SHIJI Y, 2003, IEEE 7 ICPADM, V2, P703
   SHIJI Y, 2006, IEEJ T A, V126, P310
   SHIJI Y, 2003, IEEE C EL INS DIEL P, P48
   SHIJI Y, 2004, IEEE ICSD, V1, P470
   SHIJI Y, 2006, J CRYOGENIC SOC JAPA, V41, P405
   SONODA K, 1988, IEEJ T, V108, P97
NR 7
TC 8
Z9 8
U1 0
U2 1
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 1070-9878
J9 IEEE T DIELECT EL IN
JI IEEE Trns. Dielectr. Electr. Insul.
PD APR
PY 2007
VL 14
IS 2
BP 296
EP 301
DI 10.1109/TDEI.2007.344606
PG 6
WC Engineering, Electrical & Electronic; Physics, Applied
SC Engineering; Physics
GA 155SR
UT WOS:000245598900004
DA 2018-10-20
ER

PT J
AU Coburn, JC
   Brody, S
   Billiar, KL
   Pandit, A
AF Coburn, James C.
   Brody, Sarah
   Billiar, Kristen L.
   Pandit, Abhay
TI Biaxial mechanical evaluation of cholecyst-derived extracellular matrix:
   A weakly anisotropic potential tissue engineered biomaterial
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
ID SMALL-INTESTINAL SUBMUCOSA; FIBER ARCHITECTURE; BLADDER REGENERATION;
   POLARIZED-LIGHT; BEHAVIOR; PERICARDIUM; MICROSCOPY; STRAIN; DEVICE;
   TENDON
AB A new acellular, natural, biodegradable matrix has been discovered in the cholecyst-derived extracellular matrix (CEM). This matrix is rich in collagen and contains several other macromolecules useful in tissue remodeling. In this study, the principal material axes, collagen fiber orientations, and biaxial mechanical properties in a physiological loading regime were characterized. Fiber direction was determined by polarized light microscopy, and the principal axes and degree of anisotropy were determined mechanically. Macroscopic equibiaxial strain tests were then conducted on preconditioned specimens. While 13% of the area of CEM contains collagen fibers oriented between 50 degrees and 60 degrees from the neck-fundus axis, the principal material axis was oriented 63 degrees +/- 13.7 degrees, with an aspect ratio of 0.11 +/- 0.06, indicating a weak anisotropy in that direction. Under biaxial loading, CEM exhibited a large toe region followed by an exponential rise in stress in both principal and perpendicular axis directions, similar to other materials currently under research. There was no significant difference between the biaxial stress-strain profile and the burst stress-strain profile. The results demonstrate that CEM is weakly anisotropic and it has the ability to support large strains across a physiological loading regime. (c) 2007 Wiley Periodicals, Inc.
C1 Natl Univ Ireland Univ Coll Galway, Natl Ctr Biomed Engn Serv, Galway, Ireland.
   Natl Univ Ireland Univ Coll Galway, Dept Mech & Biomed Engn, Galway, Ireland.
   Worchester Polytech Inst, Dept Biomed Engn, Worcester, MA USA.
RP Pandit, A (reprint author), Natl Univ Ireland Univ Coll Galway, Natl Ctr Biomed Engn Serv, Galway, Ireland.
EM abhay.pandit@nuigalway.ie
RI Pandit, Abhay/B-6187-2008
OI Pandit, Abhay/0000-0002-6292-4933
CR ANILKUMAR T, 2005, EUR SOC BIOM C SOR I
   Arokoski JPA, 1996, ANN RHEUM DIS, V55, P253, DOI 10.1136/ard.55.4.253
   Badylak S, 2002, J SURG RES, V103, P190, DOI 10.1006/jsre.2001.6349
   Bigi A, 1998, J BIOMED MATER RES, V41, P289, DOI 10.1002/(SICI)1097-4636(199808)41:2<289::AID-JBM14>3.0.CO;2-G
   Billiar KL, 1997, J BIOMECH, V30, P753, DOI 10.1016/S0021-9290(97)00019-5
   Billiar KL, 2000, J BIOMECH ENG-T ASME, V122, P327, DOI 10.1115/1.1287158
   BRODY S, IN PRESS TISSUE ENG
   BURUGAPALLI K, 2005, P TISS ENG SOC INT, P121
   CHOI HS, 1990, J BIOMECH ENG-T ASME, V112, P153, DOI 10.1115/1.2891166
   Dejardin LM, 2001, AM J SPORT MED, V29, P175, DOI 10.1177/03635465010290021001
   Driessen NJB, 2003, J BIOMECH ENG-T ASME, V125, P549, DOI 10.1115/1.1590361
   Franklin M E Jr, 2004, Hernia, V8, P186
   Freytes DO, 2004, BIOMATERIALS, V25, P2353, DOI 10.1016/j.biomaterials.2003.09.015
   Freytes DO, 2005, BIOMATERIALS, V26, P5518, DOI 10.1016/j.biomaterials.2005.01.070
   Gloeckner DC, 2000, J BIOMED MATER RES, V52, P365, DOI 10.1002/1097-4636(200011)52:2<365::AID-JBM17>3.0.CO;2-3
   Hiester ED, 1998, J BIOMED MATER RES, V39, P207, DOI 10.1002/(SICI)1097-4636(199802)39:2<207::AID-JBM6>3.0.CO;2-T
   Hodde JP, 2002, TISSUE ENG, V8, P225, DOI 10.1089/107632702753724996
   Jacques SL, 2000, LASER SURG MED, V26, P119, DOI 10.1002/(SICI)1096-9101(2000)26:2<119::AID-LSM3>3.3.CO;2-P
   Kropp BP, 2004, J UROLOGY, V172, P1710, DOI 10.1097/01.ju.0000139952.64753.27
   Langdon SE, 1999, BIOMATERIALS, V20, P137, DOI 10.1016/S0142-9612(98)00142-2
   LANIR Y, 1974, J BIOMECH, V7, P171, DOI 10.1016/0021-9290(74)90058-X
   Lantz G C, 1993, J Invest Surg, V6, P297, DOI 10.3109/08941939309141619
   Ledet Eric H, 2002, Spine J, V2, P188, DOI 10.1016/S1529-9430(02)00182-1
   Lu SH, 2005, BIOMATERIALS, V26, P443, DOI 10.1016/j.biomaterials.2004.05.006
   Sacks MS, 1999, J BIOMED MATER RES, V46, P1, DOI 10.1002/(SICI)1097-4636(199907)46:1<1::AID-JBM1>3.0.CO;2-7
   Sacks MS, 1998, ANN BIOMED ENG, V26, P892, DOI 10.1114/1.135
   SACKS MS, 1992, J BIOMECH ENG-T ASME, V114, P183, DOI 10.1115/1.2891370
   Waldman SD, 2005, BIOMATERIALS, V26, P7504, DOI 10.1016/j.biomaterials.2005.05.056
   Wells SM, 2002, BIOMATERIALS, V23, P2389, DOI 10.1016/S0142-9612(01)00375-1
   Whitson BA, 1998, J BIOMED MATER RES, V43, P277, DOI 10.1002/(SICI)1097-4636(199823)43:3<277::AID-JBM8>3.3.CO;2-M
   Zhang YY, 2004, TISSUE ENG, V10, P181, DOI 10.1089/107632704322791835
NR 31
TC 17
Z9 17
U1 0
U2 3
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2007
VL 81A
IS 1
BP 250
EP 256
DI 10.1002/jbm.a.30943
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 145PC
UT WOS:000244876000026
PM 17269134
DA 2018-10-20
ER

PT J
AU Taqvi, S
   Dixit, L
   Roy, K
AF Taqvi, Sabia
   Dixit, Lena
   Roy, Krishnendu
TI Biomaterial-based notch signaling for the differentiation of
   hematopoietic stem cells into T cells (vol 79A, pg 689, 2006)
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Correction
C1 Univ Texas, Dept Biomed Engn, Austin, TX 78712 USA.
RP Taqvi, S (reprint author), Univ Texas, Dept Biomed Engn, Austin, TX 78712 USA.
CR Taqvi S, 2006, J BIOMED MATER RES A, V79A, P689, DOI 10.1002/jbm.a.30916
NR 1
TC 0
Z9 0
U1 1
U2 4
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2007
VL 81A
IS 1
BP 257
EP 258
DI 10.1002/jbm.a.31266
PG 2
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 145PC
UT WOS:000244876000027
OA Bronze
DA 2018-10-20
ER

PT J
AU Wei, JH
   Yoshinari, M
   Takemoto, S
   Hattori, M
   Kawada, E
   Liu, BL
   Oda, Y
AF Wei, Jianhua
   Yoshinari, Masao
   Takemoto, Shinji
   Hattori, Masayuki
   Kawada, Eiji
   Liu, Baolin
   Oda, Yutaka
TI Adhesion of mouse fibroblasts on hexamethyidisiloxane surfaces with wide
   range of wettability
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; GLOW-DISCHARGE PLASMA; PROTEIN-ADSORPTION;
   FIBRONECTIN ADSORPTION; CELL ATTACHMENT; ENDOTHELIAL-CELLS;
   ION-IMPLANTATION; POLYMER SURFACES; THIN-FILMS; TOF-SIMS
AB Surface wettability is an important physicochemical property of biomaterials, and it would be more helpful for understanding this property if a wide range of wettability are employed. This study focused on the effect of surface wettability on fibroblast adhesion over a wide range of wettability using a single material without changing surface topography. Plasma polymerization with hexamethyldisiloxane followed by oxygen (O-2)-plasma treatment was employed to modify the surfaces. The water contact angle of sample surfaces varied from 106 degrees (hydrophobicity) to almost 0 degrees (super-hydrophilicity). O-2 functional groups were introduced on polymer surfaces during O-2-plasma treatment. The cell attachment study confirmed that the more hydrophilic the surface, the more fibroblasts adhered in the initial stage that includes super-hydrophilic surfaces. Cells spread much more widely on the hydrophilic surfaces than on the hydrophobic surfaces. There was no significant difference in fibroblast proliferation, but cell spreading was much greater on the hydrophilic surfaces. The fibronectin adsorbed much more on a hydrophilic surface while albumin dominated on a hydrophobic surface in a competing mode. These findings suggest the importance of the surface wettability of biomaterials on initial cell attachment and spreading. The degree of wettability should be taken into account when a new biomaterial is to be employed.
C1 Tokyo Dent Coll, Dept Dent Mat Sci, Mihama Ku, Chiba 2618502, Japan.
   Tokyo Dent Coll, Oral Hlth Sci Ctr, Mihama Ku, Chiba 2618502, Japan.
   Fourth Mil Med Univ, Dept Oral & Maxillofacial Surg, Qindu Stomatol Coll, Xian 710032, Peoples R China.
RP Yoshinari, M (reprint author), Tokyo Dent Coll, Dept Dent Mat Sci, Mihama Ku, 1-2-2 Masago, Chiba 2618502, Japan.
EM yosinari@tdc.ac.jp
CR Altankov G, 1996, J BIOMED MATER RES, V30, P385, DOI 10.1002/(SICI)1097-4636(199603)30:3<385::AID-JBM13>3.0.CO;2-J
   Andersson AS, 2003, J BIOMED MATER RES A, V64A, P622, DOI 10.1002/jbm.a.10442
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Brunette D.M., 2001, TITANIUM MED, P485
   Bumgardner JD, 2003, J BIOMAT SCI-POLYM E, V14, P1401, DOI 10.1163/156856203322599734
   Chen M, 2003, J BIOMAT SCI-POLYM E, V14, P917, DOI 10.1163/156856203322381410
   Chen SF, 2005, J AM CHEM SOC, V127, P14473, DOI 10.1021/ja054169u
   DEKKER A, 1991, BIOMATERIALS, V12, P130, DOI 10.1016/0142-9612(91)90191-C
   Dupont-Gillain CC, 1999, J COLLOID INTERF SCI, V220, P163, DOI 10.1006/jcis.1999.6524
   El Sayegh TY, 2002, J BIOMED MATER RES, V61, P482, DOI 10.1002/jbm.10217
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   Groth T, 1996, BIOMATERIALS, V17, P1227, DOI 10.1016/0142-9612(96)84943-X
   Hao L, 2006, P I MECH ENG H, V220, P47, DOI 10.1243/095441105X68999
   Hao L, 2004, J BIOMED MATER RES A, V69A, P748, DOI 10.1002/jbm.a.30055
   Hayakawa T, 2004, BIOMATERIALS, V25, P119, DOI 10.1016/S0142-9612(03)00484-8
   Howlett C. R., 1993, Clinical Materials, V14, P57, DOI 10.1016/0267-6605(93)90048-C
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   Khang G, 1997, BIO-MED MATER ENG, V7, P357
   Lee JH, 1998, J COLLOID INTERF SCI, V205, P323, DOI 10.1006/jcis.1998.5688
   Lee SH, 1998, THIN SOLID FILMS, V325, P83, DOI 10.1016/S0040-6090(98)00492-1
   Lhoest JB, 1998, J BIOMED MATER RES, V41, P95, DOI 10.1002/(SICI)1097-4636(199807)41:1<95::AID-JBM12>3.0.CO;2-G
   Morra M, 1999, J BIOMAT SCI-POLYM E, V10, P1107, DOI 10.1163/156856299X00711
   Nakao A, 1996, SURF INTERFACE ANAL, V24, P252, DOI 10.1002/(SICI)1096-9918(199604)24:4<252::AID-SIA113>3.0.CO;2-R
   Ozdemir Y, 2002, J MATER SCI-MATER M, V13, P1147, DOI 10.1023/A:1021185803716
   Scotchford CA, 2002, J BIOMED MATER RES, V59, P84, DOI 10.1002/jbm.1220
   SERRO AP, 1999, J BIOMED MATER RES, V46, P376
   Shen MC, 2001, J BIOMAT SCI-POLYM E, V12, P961, DOI 10.1163/156856201753252507
   Shi FF, 1996, SURF COAT TECH, V82, P1, DOI 10.1016/0257-8972(95)02621-5
   Swart K M, 1992, J Oral Implantol, V18, P130
   TAMADA Y, 1994, J BIOMED MATER RES, V28, P783, DOI 10.1002/jbm.820280705
   Tan JL, 2004, TISSUE ENG, V10, P865, DOI 10.1089/1076327041348365
   van Kooten TG, 2004, BIOMATERIALS, V25, P1735, DOI 10.1016/j.biomaterials.2003.08.071
   VANWACHEM PB, 1987, BIOMATERIALS, V8, P323, DOI 10.1016/0142-9612(87)90001-9
   Wagner MS, 2002, J BIOMAT SCI-POLYM E, V13, P407, DOI 10.1163/156856202320253938
   Wang YW, 2003, BIOMATERIALS, V24, P4621, DOI 10.1016/S0142-9612(03)00356-9
   Wang YX, 2004, PHARM RES, V21, P1362, DOI 10.1023/B:PHAM.0000036909.41843.18
   Yoshinari M, 2006, J BIOMED MATER RES B, V77B, P47, DOI 10.1002/jbm.b.30393
   Yoshinari M, 2004, J ORAL TISSUE ENG, V1, P69
   Zhang MQ, 1998, BIOMATERIALS, V19, P953, DOI 10.1016/S0142-9612(98)00026-X
   Zhu BS, 2004, J BIOMED MATER RES B, V70B, P43, DOI 10.1002/jbm.b.30011
NR 42
TC 125
Z9 129
U1 2
U2 21
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2007
VL 81B
IS 1
BP 66
EP 75
DI 10.1002/jbm.b.30638
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 149IN
UT WOS:000245140700008
PM 16924616
DA 2018-10-20
ER

PT J
AU Janorkar, AV
   Fritz, EW
   Burg, KJL
   Metters, AT
   Hirt, DE
AF Janorkar, Arnol V.
   Fritz, Edward W., Jr.
   Burg, Karen J. L.
   Metters, Andrew T.
   Hirt, Douglas E.
TI Grafting amine-terminated branched architectures from poly(L-lactide)
   film surfaces for improved cell attachment
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE cell culture; photografting; poly(L-lactide); surface modification
ID DIFFERENT POLYMERIC BIOMATERIALS; PLASMA TREATMENT; POLY(LACTIC ACID);
   FUNCTIONAL-GROUPS; CARBOXYL GROUPS; ADHESION; POLYLACTIDE; OSTEOBLAST;
   AFFINITY; BIOCOMPATIBILITY
AB Poly (L-lactide) (PLL) has been used as a bioabsorbable material in the medical and pharmaceutical fields. The unmodified hydrophobic PLL surface generally has low cell affinity; thus, modification of PLL film surface properties is necessary to improve its use as a biomaterial. Our surface modification method involved the use of photografting and typical wet chemistry to create branched architectures containing amine functionalities on the periphery of the grafted layers. Amine (-NH2) groups were first introduced on the PLL film surface by photoinduced grafting of 4,4'-diaminobenzophenone and the grafted branched architectures were created by subsequent reactions with succinic acid and tris(2-aminoethyl) amine. The resulting film surface was analyzed using contact angle goniometry and X-ray photoelectron spectroscopy. MC3T3 fibroblasts were cultured on unmodified PLL film and PLL films grafted with the branched structures and the films were subsequently analyzed by optical microscopy. The contact angle goniometry results showed an initial decrease and subsequent plateau in the water contact angles for the PLL films with each successive generation of the branched architectures. The X-ray photoelectron spectroscopy data provided insight into the structure of the grafted layer and revealed an increase in the nitrogen content with each generation. Optical micrographs showed enhanced cell attachment and viability on the surface-modified PLL films. (c) 2006 Wiley Periodicals, Inc.
C1 Clemson Univ, Dept Chem Engn, Ctr Adv Engn Fibers & Films, Clemson, SC 29634 USA.
   Clemson Univ, Dept Bioengn, Ctr Adv Engn Fibers & Films, Clemson, SC 29634 USA.
RP Hirt, DE (reprint author), Clemson Univ, Dept Chem Engn, Ctr Adv Engn Fibers & Films, Clemson, SC 29634 USA.
EM hirtd@clemson.edu
CR ANDERSON GW, 1964, J AM CHEM SOC, V86, P1839, DOI 10.1021/ja01063a037
   Barndup J, 1988, POLYM HDB
   Burg KJL, 1999, J BIOMAT SCI-POLYM E, V10, P147, DOI 10.1163/156856299X00108
   Cai KY, 2002, J BIOMED MATER RES, V60, P398, DOI 10.1002/jbm.10008
   Cai Q, 2003, BIOMATERIALS, V24, P3555, DOI 10.1016/S0142-9612(03)00199-6
   Daw R, 1998, BIOMATERIALS, V19, P1717, DOI 10.1016/S0142-9612(98)00080-5
   Dong J, 2004, BIOMATERIALS, V25, P4691, DOI 10.1016/j.biomaterials.2003.10.084
   FOERCH R, 1992, J POLYM SCI POL CHEM, V30, P279, DOI 10.1002/pola.1992.080300212
   Garric X, 2005, J BIOMED MATER RES A, V72A, P180, DOI 10.1002/jbm.a.30216
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Irvine DJ, 2001, BIOMACROMOLECULES, V2, P545, DOI 10.1021/bm015510f
   Janorkar AV, 2004, MACROMOLECULES, V37, P9151, DOI 10.1021/ma049056u
   Janorkar AV, 2004, LANGMUIR, V20, P7151, DOI 10.1021/la049715w
   KIMURA Y, 1988, MACROMOLECULES, V21, P3338, DOI 10.1021/ma00189a037
   LEE JH, 1994, BIOMATERIALS, V15, P705, DOI 10.1016/0142-9612(94)90169-4
   LIN CC, 2004, BIOMATERIALS, V26, P3655
   Lombello CB, 2002, J MATER SCI-MATER M, V13, P867, DOI 10.1023/A:1016552413295
   Ma HM, 2000, MACROMOLECULES, V33, P331, DOI 10.1021/ma990821s
   Ma ZW, 2003, BIOMATERIALS, V24, P3725, DOI 10.1016/S0142-9612(03)00247-3
   Ma ZW, 2002, J APPL POLYM SCI, V85, P2163, DOI 10.1002/app.10803
   MIKOLAJCZYK M, 1981, TETRAHEDRON, V37, P233, DOI 10.1016/S0040-4020(01)92010-1
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   Nikolovski J, 2000, BIOMATERIALS, V21, P2025, DOI 10.1016/S0142-9612(00)00079-X
   Noh I, 1997, J POLYM SCI POL CHEM, V35, P3467, DOI 10.1002/(SICI)1099-0518(19971130)35:16<3467::AID-POLA14>3.0.CO;2-D
   Ouchi T, 2002, J POLYM SCI POL CHEM, V40, P1218, DOI 10.1002/pola.10211
   Palsson B.O., 2004, TISSUE ENG
   Patolsky F, 1998, J ELECTROANAL CHEM, V454, P9, DOI 10.1016/S0022-0728(98)00257-5
   Quirk RA, 2000, MACROMOLECULES, V33, P258, DOI 10.1021/ma9916133
   Ranby B, 1999, INT J ADHES ADHES, V19, P337, DOI 10.1016/S0143-7496(98)00066-9
   RATNER BD, 1995, BIOSENS BIOELECTRON, V10, P797, DOI 10.1016/0956-5663(95)99218-A
   Schroder K, 2002, PLASMAS POLYM, V7, P103, DOI 10.1023/A:1016239302194
   SHELTON RM, 1988, BIOMATERIALS, V9, P24, DOI 10.1016/0142-9612(88)90065-8
   Steffens GCM, 2002, BIOMATERIALS, V23, P3523, DOI 10.1016/S0142-9612(02)00091-1
   Wagner CD, 1979, HDB XRAY PHOTOELECTR
   Walboomers XF, 1999, J BIOMED MATER RES, V47, P204, DOI 10.1002/(SICI)1097-4636(199911)47:2<204::AID-JBM10>3.0.CO;2-H
   Wang YW, 2005, BIOMATERIALS, V26, P755, DOI 10.1016/j.biomaterials.2004.03.023
   Washburn NR, 2004, BIOMATERIALS, V25, P1215, DOI 10.1016/j.biomaterials.2003.08.043
   Watanabe J, 2003, SCI TECHNOL ADV MAT, V4, P539, DOI 10.1016/j.stam.2003.09.018
   Webb K, 1998, J BIOMED MATER RES, V41, P422, DOI 10.1002/(SICI)1097-4636(19980905)41:3<422::AID-JBM12>3.0.CO;2-K
   Yan HS, 2000, BIOTECHNOL APPL BIOC, V31, P15, DOI 10.1042/BA19990039
   Yan L, 1997, LANGMUIR, V13, P6704, DOI 10.1021/la970762g
   Yang J, 2002, BIOMATERIALS, V23, P2607, DOI 10.1016/S0142-9612(01)00400-8
   Yang J, 2002, POLYM ADVAN TECHNOL, V13, P220, DOI 10.1002/pat.177
   Yang XS, 2002, BIOMATERIALS, V23, P1391, DOI 10.1016/S0142-9612(01)00260-5
NR 45
TC 26
Z9 26
U1 2
U2 17
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2007
VL 81B
IS 1
BP 142
EP 152
DI 10.1002/jbm.b.30647
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 149IN
UT WOS:000245140700017
PM 16941600
DA 2018-10-20
ER

PT J
AU Teng, XR
   Ren, J
   Gu, SY
AF Teng, Xinrong
   Ren, Jie
   Gu, Shuying
TI Preparation and characterization of porous PDLLA/HA composite foams by
   supercritical carbon dioxide technology
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE PDLLA/HA; supercritical carbon dioxide; composite foams; porosity
ID HYDROXYLAPATITE POLY(L-LACTIDE) COMPOSITES; BIODEGRADABLE POLYMER
   SCAFFOLDS; GROWTH-FACTOR DELIVERY; HYDROXYAPATITE; PLASTICIZATION;
   REGENERATION; GENERATION; STRENGTH; BEHAVIOR; ACID)
AB A composite poly(D,L) lactic acid (PDLLA)/hydroxvapatite (HA) biomaterial was prepared by in situ polymerization of D,L-lactide monomer and HA. Supercritical CO2 (SC CO2) technology was developed to prepare the biodegradable composite foams for use in tissue regeneration. In this technology, NaCl particles were used as porogen to produce an open-pore structure. Organic solvents were not used and high temperature was not necessary. The problem with pore interconnectivity was resolved. High-porosity composite foams (up to 90% +/- 2% porosity) were obtained with pore sizes ranging from 100 to 300 pm suitable for cell seeding. The microstructure and morphology of the composite foams could be controlled by saturation pressure, saturation time, and temperature as well as amount of NaCl particles. The compressive strength and water absorbability of the composite foams were also determined. With an increase in HA amount, the molecular weight of PDLLA/HA composite foams decreased, but the mechanical strength and hydrophilicity increased slightly. (c) 2006 Wiley Periodicals, Inc.
C1 Tongji Univ, Inst Nano & Biopolymer Mat, Sch Mat Sci & Engn, Shanghai 200092, Peoples R China.
RP Teng, XR (reprint author), Tongji Univ, Inst Nano & Biopolymer Mat, Sch Mat Sci & Engn, Shanghai 200092, Peoples R China.
EM txr@mail.tongji.edu.cn
RI Ren, Jie/J-2811-2012
CR CHIOU JS, 1985, J APPL POLYM SCI, V30, P2633, DOI 10.1002/app.1985.070300626
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Furukawa T, 2000, BIOMATERIALS, V21, P889, DOI 10.1016/S0142-9612(99)00232-X
   GOEL SK, 1993, POLYMER, V34, P1410, DOI 10.1016/0032-3861(93)90853-3
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   HIGASHI S, 1986, BIOMATERIALS, V7, P183, DOI 10.1016/0142-9612(86)90099-2
   Hile DD, 2000, J CONTROL RELEASE, V66, P177, DOI 10.1016/S0168-3659(99)00268-0
   Ignjatovic N, 1999, BIOMATERIALS, V20, P809, DOI 10.1016/S0142-9612(98)00234-8
   Kasuga T, 2001, BIOMATERIALS, V22, P19, DOI 10.1016/S0142-9612(00)00091-0
   Liu Q, 1998, BIOMATERIALS, V19, P1067, DOI 10.1016/S0142-9612(98)00033-7
   Lo H, 1995, Tissue Eng, V1, P15, DOI 10.1089/ten.1995.1.15
   Maquet V, 2001, BIOMATERIALS, V22, P1137, DOI 10.1016/S0142-9612(00)00357-4
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Nam YS, 2000, J BIOMED MATER RES, V53, P1, DOI 10.1002/(SICI)1097-4636(2000)53:1<1::AID-JBM1>3.0.CO;2-R
   REFE ZG, 1995, BIOMATERIALS, V16, P397
   RUYS AJ, 1995, BIOMATERIALS, V16, P409, DOI 10.1016/0142-9612(95)98859-C
   Sheridan MH, 2000, J CONTROL RELEASE, V64, P91, DOI 10.1016/S0168-3659(99)00138-8
   Singh L, 2004, BIOMATERIALS, V25, P2611, DOI 10.1016/j.biomaterials.2003.09.040
   Thomson RC, 1998, BIOMATERIALS, V19, P1935, DOI 10.1016/S0142-9612(98)00097-0
   VERHEYEN CCPM, 1993, J BIOMED MATER RES, V27, P433, DOI 10.1002/jbm.820270404
   VERHEYEN CCPM, 1993, J MATER SCI-MATER M, V4, P58, DOI 10.1007/BF00122979
   VERHEYEN CCPM, 1992, J BIOMED MATER RES, V26, P1277, DOI 10.1002/jbm.820261003
   VERT M, 1994, BIOMATERIALS, V15, P1209, DOI 10.1016/0142-9612(94)90271-2
   Wang J, 2001, POLYMER, V42, P8265
   Xu Q, 2004, J APPL POLYM SCI, V94, P593, DOI 10.1002/app.20726
   Yoon JJ, 2001, J BIOMED MATER RES, V55, P401, DOI 10.1002/1097-4636(20010605)55:3<401::AID-JBM1029>3.0.CO;2-H
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
   Zhang RY, 1999, J BIOMED MATER RES, V45, P285
NR 29
TC 41
Z9 44
U1 0
U2 18
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2007
VL 81B
IS 1
BP 185
EP 193
DI 10.1002/jbm.b.30652
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 149IN
UT WOS:000245140700022
PM 16924605
DA 2018-10-20
ER

PT J
AU Dizerega, GS
   Cortese, S
   Rodgers, KE
   Block, KM
   Falcone, SJ
   Juarez, TG
   Berg, R
AF diZerega, Gere S.
   Cortese, Stephanie
   Rodgers, Kathleen E.
   Block, Kathleen M.
   Falcone, Samuel J.
   Juarez, Thomas G.
   Berg, Richard
TI A modern biomaterial for adhesion prevention
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE absorbable; viscoelastic; fibrin; bioresorbable; adhesion
ID UTERINE HORN MODEL; LAPAROSCOPIC GYNECOLOGICAL SURGERY; LUMBAR DISC
   HERNIATION; SODIUM CARBOXYMETHYLCELLULOSE; POSTOPERATIVE ADHESIONS;
   POSTSURGICAL ADHESIONS; EPIDURAL FIBROSIS; PERIDURAL SCAR;
   CLINICAL-TRIAL; UNITED-STATES
AB A biomaterial composed of carboxymetbylcellulose, poly(ethylene oxide), and calcium can be prepared in a variety of ways to reduce fibrin deposition and adhesion formation. This biomaterial platform can be formulated into a flowable gel with tissue adherence appropriate for use in minimally invasive surgery. The device remains at the site of placement even in gravitationally dependent areas. A peridural formulation was shown in preclinical studies to be safe and effective in reducing adhesions to dura following spinal surgery. A peritoneal formulation used on pelvic organs following peritoneal cavity surgery was also shown to be safe and effective. A clinical feasibility study showed that patients with severe back pain and lower extremity weakness treated with the peridural formulation, applied over their nerve roots following laminectomy or laminotomy, experienced significantly reduced symptoms when compared with surgery-only controls. The peritoneal formulation was shown in two multicenter feasibility studies of women undergoing pelvic surgery to significantly reduce adhesion formation when compared with surgery-only controls. Confirmation of the feasibility studies awaits results from pivotal clinical trials. These formulations were safe, effective, and easy to use. This biomaterial provided a benefit to patients undergoing surgery where postsurgical adhesion formation is a concern. (c) 2006 Wiley Periodicals, Inc.
C1 Keck USC, Sch Med, Livingston Reprod Biol Labs, Dept Obstet & Gynecol, Los Angeles, CA USA.
   FzioMed Inc, San Luis Obispo, CA USA.
RP Dizerega, GS (reprint author), Keck USC, Sch Med, Livingston Reprod Biol Labs, Dept Obstet & Gynecol, Los Angeles, CA USA.
EM dizerega@usc.edu
CR ABRAMOVITZ JN, 1991, NEUROSURGERY, V29, P301, DOI 10.1227/00006123-199108000-00027
   Ahmad CS, 1998, AM J SPORT MED, V26, P715, DOI 10.1177/03635465980260051901
   Al-Musawi D, 2001, GYNAECOL ENDOSC, V10, P123, DOI 10.1046/j.1365-2508.2001.00422.x
   Almeida O D Jr, 1997, J Am Assoc Gynecol Laparosc, V4, P587, DOI 10.1016/S1074-3804(05)80093-3
   American Fertility Society, 1988, FERTIL STERIL, V49, P944
   ARAKAWA T, 1985, BIOCHEMISTRY-US, V24, P6756, DOI 10.1021/bi00345a005
   Atlas SJ, 2001, SPINE, V26, P1179, DOI 10.1097/00007632-200105150-00017
   AZZIZ R, 1993, SURG GYNECOL OBSTET, V177, P135
   Beck DE, 2003, DIS COLON RECTUM, V46, P1310, DOI 10.1097/01.DCR.0000089117.62296.E4
   Becker JM, 1996, J AM COLL SURGEONS, V183, P297
   BenDebba M, 1999, NEUROL RES, V21, pS37, DOI 10.1080/01616412.1999.11741025
   BenDebba M, 2002, J SPINAL DISORD TECH, V15, P2, DOI 10.1097/00024720-200202000-00002
   BenDebba M, 2002, SPINE, V27, P2116, DOI 10.1097/01.BRS.0000025729.35559.28
   BENDEBBA M, 2006, IN PRESS SPINE
   Canis M, 2001, GYNAECOL ENDOSC, V10, P99, DOI 10.1046/j.1365-2508.2001.00426.x
   COOK SD, 1994, SPINE, V19, P1815, DOI 10.1097/00007632-199408150-00005
   Danielsen JM, 2000, SPINE, V25, P1015, DOI 10.1097/00007632-200004150-00017
   DeBruyne F, 1997, HUM REPROD, V12, P266, DOI 10.1093/humrep/12.2.266
   DECHERNEY AH, 1984, FERTIL STERIL, V41, P643
   Di Zerega G.S., 2003, INFERTIL REPROD MED, V14, P431
   Diamond MP, 1996, FERTIL STERIL, V66, P904, DOI 10.1016/S0015-0282(16)58716-0
   DIAMOND MP, 1987, FERTIL STERIL, V47, P864
   Diamond MP, 2003, FERTIL STERIL, V80, P631, DOI 10.1016/S0015-0282(03)00759-3
   DIAMOND MP, 1988, INT J FERTIL, V33, P278
   DIAMOND MP, 1988, INT J FERTIL, V33, P372
   diZerega GS, 2002, HUM REPROD, V17, P1031, DOI 10.1093/humrep/17.4.1031
   DIZEREGA GS, 2006, IN PRESS FERTIL STER
   DIZEREGA GS, 1992, PERITONEUM, P33
   diZerega GS, 2000, PERITONEAL SURG, P3
   ELKINS TE, 1984, FERTIL STERIL, V41, P926
   ELKINS TE, 1984, FERTIL STERIL, V41, P929
   FAGER CA, 1980, SPINE, V5, P87, DOI 10.1097/00007632-198001000-00015
   FANDINO J, 1993, ACTA NEUROCHIR, V122, P102, DOI 10.1007/BF01446994
   FINSTERBUSH A, 1989, AM J SPORT MED, V17, P92, DOI 10.1177/036354658901700116
   FREDERICKS CM, 1986, AM J OBSTET GYNECOL, V155, P667, DOI 10.1016/0002-9378(86)90304-2
   GABRIEL EM, 1996, NEUROSURGERY, P3863
   Golander C. G., 1992, POLYETHYLENE GLYCOL, P221, DOI DOI 10.1007/978-1-4899-0703-5_15.
   Gombotz W. R., 1992, POLYETHYLENE GLYCOL, P247
   GOMEL V, 1995, FERTIL STERIL, V64
   HE Y, 1995, SPINE, V20, P557, DOI 10.1097/00007632-199503010-00010
   HERRON L, 1994, J SPINAL DISORD, V7, P161, DOI 10.1097/00002517-199407020-00010
   Hieb LD, 2001, SPINE, V26, P748, DOI 10.1097/00007632-200104010-00009
   Howard FM, 2000, OBSTET GYNECOL, V96, P934, DOI 10.1016/S0029-7844(00)01056-5
   HURME M, 1991, ACTA RADIOL, V32, P286
   Ido K, 2001, SPINAL CORD, V39, P269, DOI 10.1038/sj.sc.3101157
   Johns DB, 2001, FERTIL STERIL, V76, P595, DOI 10.1016/S0015-0282(01)01954-9
   Kim KD, 2003, SPINE, V28, P1080, DOI 10.1097/00007632-200305150-00023
   Kim Kee D, 2004, Neurosurg Focus, V17, pECP1
   KIMM SS, 1992, SPINE, V61, P957
   Le AX, 2001, SPINE, V26, P115, DOI 10.1097/00007632-200101010-00020
   Leach RE, 1998, FERTIL STERIL, V69, P415, DOI 10.1016/S0015-0282(97)00573-6
   LEWIS PJ, 1987, J NEUROSURG, V67, P49, DOI 10.3171/jns.1987.67.1.0049
   Liu LS, 2002, J BIOMED MATER RES, V63, P326, DOI 10.1002/jbm.10211
   Lower AM, 2000, BRIT J OBSTET GYNAEC, V107, P855, DOI 10.1111/j.1471-0528.2000.tb11083.x
   Lundorff P, 2005, HUM REPROD, V20, P514, DOI 10.1093/humrep/deh651
   Lundorff P, 2001, HUM REPROD, V16, P1982, DOI 10.1093/humrep/16.9.1982
   MAGE G, 1986, FERTIL STERIL, V46, P807
   MAGE G, 2000, PERITONEAL SURG, P221
   Marana R, 2000, PERITONEAL SURG, P329
   MARCH CM, 1992, FERTIL STERIL, V57, P921
   MARIANI PP, 1977, ARTHROSCOPY, V13, P313
   MAROON JC, 1999, NEUROL RES, V1, pS43
   MARTINFERRER S, 1989, NEUROSURGERY, V24, P718, DOI 10.1227/00006123-198905000-00010
   MARZO J M, 1992, Arthroscopy, V8, P10, DOI 10.1016/0749-8063(92)90129-Y
   MENZIES D, 1990, ANN ROY COLL SURG, V72, P60
   Mettler L, 2004, FERTIL STERIL, V82, P398, DOI 10.1016/j.fertnstert.2003.12.046
   Mettler L, 2003, J AM ASSOC GYN LAP, V10, P339, DOI 10.1016/S1074-3804(05)60258-7
   MORTAZAVI SA, 1995, INT J PHARM, V116, P223, DOI 10.1016/0378-5173(94)00299-K
   Nagata Y, 1998, HUM REPROD, V13, P2072, DOI 10.1093/humrep/13.8.2072
   NAGATA Y, 1997, J FERTIL IMPLANT TOK, V14, P54
   Nagelschmidt M, 1997, J SURG RES, V67, P113, DOI 10.1006/jsre.1996.4973
   Nisolle M, 1997, FERTIL STERIL, V68, P585, DOI 10.1016/S0015-0282(97)00191-X
   Nykvist F, 1995, Eur Spine J, V4, P335, DOI 10.1007/BF00300292
   OSULLIVAN D, 1991, BRIT J SURG, V78, P427, DOI 10.1002/bjs.1800780414
   Porchet F, 1999, NEUROL RES, V21, pS51, DOI 10.1080/01616412.1999.11741028
   RAY NF, 1993, SURG GYNECOL OBSTET, V176, P271
   Ray NF, 1994, J AM COLL SURGEONS, V186, P1
   ROBERTSON JT, 2001, AM ASS NEUR ANN M TO
   Rodgers Kathleen E, 2003, Spine J, V3, P277, DOI 10.1016/S1529-9430(03)00035-4
   Rodgers KE, 2000, FERTIL STERIL, V73, P831, DOI 10.1016/S0015-0282(99)00642-1
   Ross JS, 1996, NEUROSURGERY, V38, P855, DOI 10.1227/00006123-199604000-00053
   SCHWARTZ H, 2000, Patent No. 6017301
   Shiraishi T, 1995, Eur Spine J, V4, P84, DOI 10.1007/BF00278917
   STOUT AL, 1991, AM J OBSTET GYNECOL, V164, P173
   Tulandi T, 2001, HUM REPROD UPDATE, V7, P545, DOI 10.1093/humupd/7.6.545
   Woertgen C, 1999, SPINE, V24, P807, DOI 10.1097/00007632-199904150-00013
   WURSTER SH, 1995, J SURG RES, V59, P97, DOI 10.1006/jsre.1995.1138
   Young P, 2005, FERTIL STERIL, V84, P1450, DOI 10.1016/j.fertnstert.2005.04.055
NR 88
TC 29
Z9 35
U1 0
U2 8
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2007
VL 81B
IS 1
BP 239
EP 250
DI 10.1002/jbm.b.30659
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 149IN
UT WOS:000245140700029
PM 16969823
DA 2018-10-20
ER

PT J
AU Geelhood, SJ
   Horbett, TA
   Ward, WK
   Wood, MD
   Quinn, MJ
AF Geelhood, Steven J.
   Horbett, Thomas A.
   Ward, W. Kenneth
   Wood, Michael D.
   Quinn, Matthew J.
TI Passivating protein coatings for implantable glucose sensors: Evaluation
   of protein retention
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE foreign-body reaction; biosensor; protein adsorption; biomaterial;
   biocompatibility
ID MOLECULAR-WEIGHT KININOGEN; PLATELET-ADHESION; HUMAN-SERUM;
   POSTADSORPTIVE TRANSITIONS; SEGMENTED POLYURETHANES; ADSORBED
   FIBRINOGEN; ELECTRON-MICROSCOPY; SURFACE-CHEMISTRY; ANTIBODY-BINDING;
   ADSORPTION
AB The long-term function of implantable biosensors is limited by the foreign-body reaction (FBR). Since the acute phase of the FBR involves macrophage attachment mediated by adsorbed fibrinogen, preadsorption, and retention of other proteins might reduce the FBR. The retention of preadsorbed albumin, hemoglobin, von Willebrand's factor, and high-molecular-weight kininogen was therefore measured after exposure to plasma. The retention of preadsorbed proteins after incubation with monocyte cultures and implantation in rats was also measured. Fibrinogen adsorption from plasma to the preadsorbed surfaces was also measured. Hemoglobin adsorption was higher than that for other proteins, and it also had the greatest retention after exposure to blood plasma. When surfaces preadsorbed with hemoglobin were incubated with monocytes, more of the hemoglobin was displaced than that after incubation in plasma, while still more hemoglobin was displaced when the surfaces were implanted in vivo. Protein preadsorption on polystyrene greatly reduced fibrinogen adsorption. However, polyurethane surfaces used for glucose sensors had low fibrinogen adsorption compared with polystyrene, and this low level was not further reduced by preadsorption with other proteins. Preadsorbed proteins on polymers appear to be removed by passive exchange and/or displacement by plasma proteins and by proteases released by monocvtes. (c) 2006 Wiley Periodicals, Inc.
C1 Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA.
   Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
   Legacy Hlth Syst, Diabet Res, Portland, OR 97208 USA.
RP Geelhood, SJ (reprint author), Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA.
EM sgeelhood@bloodcellstorage.com
FU NIBIB NIH HHS [R01 EB00734-01]
CR ANDERSON J, 2004, BIOMATERIALS SCI
   BOHNERT JL, 1986, J COLLOID INTERF SCI, V111, P363, DOI 10.1016/0021-9797(86)90040-8
   Chen KM, 2002, J IMMUNOL, V169, P6530, DOI 10.4049/jimmunol.169.11.6530
   CHINN JA, 1992, J BIOMED MATER RES, V26, P757, DOI 10.1002/jbm.820260606
   HORBETT TA, 1977, J BIOENG, V1, P61
   HORBETT TA, 1984, THROMB HAEMOSTASIS, V51, P174
   Horbett TA, 1998, J BIOMAT SCI-POLYM E, V9, P1071, DOI 10.1163/156856298X00334
   HORBETT TA, 1981, J BIOMED MATER RES, V15, P673, DOI 10.1002/jbm.820150506
   HORBETT TA, 1996, BIOMATERIALS SCI
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Lan MA, 2005, BIOMATERIALS, V26, P4523, DOI 10.1016/j.biomaterials.2004.11.028
   MOHAMMAD SF, 1983, BIOCHIM BIOPHYS ACTA, V749, P47, DOI 10.1016/0167-4838(83)90149-8
   MOHAMMAD SF, 1987, T AM SOC ART INT ORG, V33, P588
   MOHAMMAD SF, 1989, T AM SOC ART INT ORG, V35, P384
   Nelson CM, 2003, LANGMUIR, V19, P1493, DOI 10.1021/la026178b
   RAPOZA R J, 1989, Journal of Biomaterials Science Polymer Edition, V1, P99, DOI 10.1163/156856289X00091
   RAPOZA RJ, 1990, J BIOMED MATER RES, V24, P1263, DOI 10.1002/jbm.820241002
   RAPOZA RJ, 1990, J COLLOID INTERF SCI, V136, P480, DOI 10.1016/0021-9797(90)90395-5
   SEFTON MV, 2004, BIOMATERIALS SCI
   SHARMA NC, 1980, THROMB RES, V17, P683, DOI 10.1016/0049-3848(80)90371-0
   SHARMA NC, 1981, P NATL ACAD SCI-BIOL, V78, P7750, DOI 10.1073/pnas.78.12.7750
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   SLACK SM, 1989, J COLLOID INTERF SCI, V133, P148, DOI 10.1016/0021-9797(89)90288-9
   SLACK SM, 1992, J BIOMED MATER RES, V26, P1633, DOI 10.1002/jbm.820261208
   SLAYTER H, 1985, J BIOL CHEM, V260, P8559
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   WARD, 1998, Patent No. 5756632
   Ward W Kenneth, 2003, Diabetes Technol Ther, V5, P943, DOI 10.1089/152091503322640980
   Ward WK, 1999, ASAIO J, V45, P555, DOI 10.1097/00002480-199911000-00009
   Ward WK, 2003, BIOSENS BIOELECTRON, V19, P155, DOI 10.1016/S0956-5663(03)00180-5
   WEISEL JW, 1994, J BIOL CHEM, V269, P10100
   Wu YG, 2005, J BIOMED MATER RES A, V74A, P722, DOI 10.1002/jbm.a.30381
   Yung LYL, 2000, BIOMATERIALS, V21, P405, DOI 10.1016/S0142-9612(99)00203-3
NR 34
TC 24
Z9 24
U1 1
U2 15
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2007
VL 81B
IS 1
BP 251
EP 260
DI 10.1002/jbm.b.30660
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 149IN
UT WOS:000245140700030
PM 17022059
DA 2018-10-20
ER

PT J
AU Xie, H
   Campbell, CE
   Shaffer, BS
   Gregory, KW
AF Xie, Hua
   Campbell, Carmen E.
   Shaffer, Brian S.
   Gregory, Kenton W.
TI Different outcomes in urethral reconstruction using elastin and collagen
   patches and conduits in rabbits
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE urethra; urethroplasty; repair; biomaterial; animal study
ID MATRIX; URETHROPLASTY; REGENERATION; SUBMUCOSA; GRAFTS; REPAIR
AB Objectives: To study the feasibility of urethral reconstruction with two urethroplasty techniques using an elastin and collagen beterograft in rabbits. Materials and Methods: Fifty-two male rabbits were studied. Two types of injury, (1) a 1.5 x 0.6 cm(2) semicircumferential defect; (2) a 1.5 cm segmental defect of the penile urethra, were created and repaired using size-matched elastin and collagen patches or tubed conduits. Urethral repair by primary closure for the type 1 injury and a tubularized autologous bladder mucosal graft for the type 2 injury served as controls. At 3 months, urethral diameter was measured with retrograde urethrography. The animals were then euthanized for histological examination. Results: The postoperative complication rate was significantly higher in the urethral reconstructions using tubed collagen (83%) and elastin (50%) grafts compared to the patch onlay grafts (p = 0.001 for collagen and p = 0.01 for elastin) and tubularized ABM (10%,p = 0.003 and 0.05, respectively). At the type 2 injury site, a dense circumferential fibrosis developed after all repairs. Only minimal ventral fibrosis presented in the type I injury repair. The intensity of chronic inflammation and fibrosis was greatest when collagen was used for the urethral repair. In the elastin urethral repairs the urethral diameter decreased significantly for the tubed repair compared to the patch onlay (p = 0.02). Conclusion: Urethral injury repair using elastin and collagen biomaterials is feasible in the rabbit model. The results of onlay urethroplasty using the elastin and collagen patches are significantly superior to those using the elastin and collagen tubed conduits. (c) 2006 Wiley Periodicals, Inc.
C1 St Vincent Hosp & Med Ctr, Oregon Med Laser Ctr, Portland, OR 97225 USA.
   St Vincent Hosp & Med Ctr, Dept Urol, Portland, OR 97225 USA.
RP Xie, H (reprint author), St Vincent Hosp & Med Ctr, Oregon Med Laser Ctr, 9205 SW Barnes Rd, Portland, OR 97225 USA.
EM hua.xie@providence.org
CR Andrich DE, 2001, J UROLOGY, V165, P1131, DOI 10.1016/S0022-5347(05)66447-6
   Atala A, 1999, J UROLOGY, V162, P1148, DOI 10.1016/S0022-5347(01)68105-9
   El-Sherbiny MT, 2002, J UROLOGY, V167, P2225, DOI 10.1016/S0022-5347(05)65133-6
   Italiano G, 1998, UROL RES, V26, P281, DOI 10.1007/s002400050058
   JORDAN GH, 2000, CAMPBELLS UROLOGY, P3341
   Kajitani M, 2000, ASAIO J, V46, P409, DOI 10.1097/00002480-200007000-00007
   Kropp BP, 1998, UROLOGY, V52, P138, DOI 10.1016/S0090-4295(98)00114-9
   Mantovani F, 2003, EUR UROL, V44, P600, DOI 10.1016/S0302-2838(03)00212-4
   METRO MJ, 2002, J UROLOGY, V166, P1459
   OLSEN L, 1992, SCAND J UROL NEPHROL, V26, P323, DOI 10.3109/00365599209181220
   Parnigotto PP, 2000, UROL RES, V28, P46, DOI 10.1007/s002400050009
   Xie H, 2000, ASAIO J, V46, P268, DOI 10.1097/00002480-200005000-00005
NR 12
TC 3
Z9 7
U1 0
U2 0
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2007
VL 81B
IS 1
BP 269
EP 273
DI 10.1002/jbm.b.30662
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 149IN
UT WOS:000245140700032
PM 16969825
DA 2018-10-20
ER

PT J
AU Werner, L
AF Werner, Liliana
TI Causes of intraocular lens opacification or discoloration
SO JOURNAL OF CATARACT AND REFRACTIVE SURGERY
LA English
DT Review
ID LATE POSTOPERATIVE OPACIFICATION; PERMANENT BLUE DISCOLORATION;
   HYDROPHILIC ACRYLIC LENS; SILICONE OIL ADHESION; CATARACT-SURGERY;
   CLINICOPATHOLOGICAL CORRELATION; INTERLENTICULAR OPACIFICATION;
   POLYMETHYL METHACRYLATE; SNOWFLAKE DEGENERATION; SURFACE CALCIFICATION
AB Various pathologic processes may lead to clinically significant opacification or discoloration of the optic component of intraocular lenses (IOLs) manufactured from different biomaterials and in different designs. Factors such as the patient's associated conditions, the manufacturing process, the method of IOL storage, the surgical technique and adjuvants, or a combination of these may be involved. The complication may be observed intraoperatively or postoperatively from a few hours after implantation to many years after surgery, depending on the processes involved. Based on a review of the literature as well as our own laboratory analyses, the following types of processes were identified: formation of deposits/precipitates on the IOL surface or within the IOL substance; opacification by excess influx of water in hydrophobic materials; direct discoloration by capsular dyes or medications; coating by substances such as ophthalmic ointment and silicone oil; and a slow, progressive degradation of the IOL biomaterial.
C1 Univ Utah, John A Moran Eye Ctr, Salt Lake City, UT USA.
   Berlin Eye Res Inst, Berlin, Germany.
RP Werner, L (reprint author), 65 Med Dr,N Tower, Salt Lake City, UT 84132 USA.
EM werner.liliana@gmail.com
CR Apple D J, 2001, Trans Am Ophthalmol Soc, V99, P95
   Apple DJ, 1996, OPHTHALMOLOGY, V103, P1555, DOI 10.1016/S0161-6420(96)30463-6
   Apple DJ, 2002, OPHTHALMOLOGY, V109, P1666, DOI 10.1016/S0161-6420(02)01122-3
   Apple DJ, 1997, J CATARACT REFR SURG, V23, P536, DOI 10.1016/S0886-3350(97)80210-6
   Chen KH, 2005, AM J OPHTHALMOL, V139, P743, DOI 10.1016/j.ajo.2004.10.042
   Chew JJL, 2006, J CATARACT REFR SURG, V32, P341, DOI 10.1016/j.jcrs.2005.07.018
   Dahle N, 2006, ARCH OPHTHALMOL-CHIC, V124, P1350, DOI 10.1001/archopht.124.9.1350
   Elgohary M, 2007, J CATARACT REFR SURG, V33, P342, DOI 10.1016/j.jcrs.2006.09.034
   Faschinger CW, 2002, J CATARACT REFR SURG, V28, P8, DOI 10.1016/S0886-3350(01)01301-3
   Foot L, 2004, AM J OPHTHALMOL, V137, P979, DOI 10.1016/j.ajo.2003.12.047
   Frohn A, 2001, OPHTHALMOLOGY, V108, P1999, DOI 10.1016/S0161-6420(01)00778-3
   Gayton JL, 2000, J CATARACT REFR SURG, V26, P330, DOI 10.1016/S0886-3350(99)00433-2
   Hickman MS, 2006, EYE, V20, P1054, DOI 10.1038/sj.eye.6702124
   Hilgert CR, 2004, J CATARACT REFR SURG, V30, P2225, DOI 10.1016/j.jcrs.2004.06.039
   Hunter B, 2005, J CATARACT REFR SURG, V31, P1836, DOI 10.1016/j.jcrs.2005.06.040
   Izak AM, 2003, EYE, V17, P393, DOI 10.1038/sj.eye.6700341
   JENSEN MK, 1994, ARCH OPHTHALMOL-CHIC, V112, P1037, DOI 10.1001/archopht.1994.01090200043019
   Jones DF, 2002, ARCH OPHTHALMOL-CHIC, V120, P1211
   Katai N, 1999, J CATARACT REFR SURG, V25, P451, DOI 10.1016/S0886-3350(99)80099-6
   KERSHNER RM, 1991, ARCH OPHTHALMOL-CHIC, V109, P913, DOI 10.1001/archopht.1991.01080070023007
   Kleinmann G, 2006, J CATARACT REFR SURG, V32, P158, DOI 10.1016/j.jcrs.2005.07.043
   Kleinmann G, 2006, J CATARACT REFR SURG, V32, P1932, DOI 10.1016/j.jcrs.2006.06.035
   KOCH DD, 1992, ARCH OPHTHALMOL-CHIC, V110, P319, DOI 10.1001/archopht.1992.01080150017007
   Macky TA, 2003, OPHTHALMIC SUR LA IM, V34, P197
   McDonnell PJ, 2003, OPHTHALMOLOGY, V110, P2342, DOI 10.1016/S0161-6420(03)00733-4
   Melles GRJ, 1999, J CATARACT REFR SURG, V25, P7, DOI 10.1016/S0886-3350(99)80004-2
   MILAUSKAS AT, 1991, ARCH OPHTHALMOL-CHIC, V109, P913, DOI 10.1001/archopht.1991.01080070023006
   Milauskas AT, 1991, ARCH OPHTHALMOL-CHIC, V109, P1495
   Neuhann IM, 2006, J CATARACT REFR SURG, V32, P879, DOI 10.1016/j.jcrs.2006.01.076
   Neuhann IM, 2004, OPHTHALMOLOGY, V111, P2094, DOI 10.1016/j.ophtha.2004.06.032
   Olson RJ, 1998, AM J OPHTHALMOL, V126, P177, DOI 10.1016/S0002-9394(98)00076-2
   Ozbek Z, 2004, OPHTHALMOLOGICA, V218, P243, DOI 10.1159/000078614
   Pandey SK, 2002, ARCH OPHTHALMOL-CHIC, V120, P391
   Sathyan P, 2006, J CATARACT REFR SURG, V32, P1584, DOI 10.1016/j.jcrs.2006.06.012
   Shingleton BJ, 2001, J CATARACT REFR SURG, V27, P524, DOI 10.1016/S0886-3350(00)00641-6
   Siddique M, 2005, EYE, V19, P1349, DOI 10.1038/sj.eye.6701783
   STARK WJ, 1983, AM J OPHTHALMOL, V96, P304, DOI 10.1016/S0002-9394(14)77819-5
   Stevens S, 2007, OPHTHAL SURG LAS IM, V38, P136
   Tanaka T, 2004, J CATARACT REFR SURG, V30, P250, DOI 10.1016/S0886-3350(03)00501-7
   Tehrani M, 2004, J CATARACT REFR SURG, V30, P115, DOI 10.1016/S0886-3350(03)00461-9
   Tognetto D, 2002, J CATARACT REFR SURG, V28, P1211, DOI 10.1016/S0886-3350(02)01353-6
   Wackernagel W, 2004, J CATARACT REFR SURG, V30, P517, DOI 10.1016/S0886-3350(03)00672-2
   WATT RH, 1991, ARCH OPHTHALMOL-CHIC, V109, P1494, DOI 10.1001/archopht.1991.01080110028013
   Werner L, 2006, AM J OPHTHALMOL, V141, P35, DOI 10.1016/j.ajo.2005.08.045
   Werner L, 2006, J CATARACT REFR SURG, V32, P499, DOI 10.1016/j.jcrs.2005.12.137
   Werner L, 2002, AM J OPHTHALMOL, V133, P320, DOI 10.1016/S0002-9394(01)01405-2
   Werner L, 2000, J CATARACT REFR SURG, V26, P1612, DOI 10.1016/S0886-3350(00)00485-5
   Werner L, 2006, J CATARACT REFR SURG, V32, P227, DOI 10.1016/j.jcrs.2005.12.093
   Werner L, 2006, J CATARACT REFR SURG, V32, P655, DOI 10.1016/j.jcrs.2006.01.022
   Werner L, 2005, OPHTHALMOLOGY, V112, P447, DOI 10.1016/j.ophtha.2004.10.025
   Werner L, 2002, J CATARACT REFR SURG, V28, P1279, DOI 10.1016/S0886-3350(02)01207-5
   Werner L, 2001, J CATARACT REFR SURG, V27, P1485, DOI 10.1016/S0886-3350(01)00841-0
   Werner L, 2000, OPHTHALMOLOGY, V107, P2179, DOI 10.1016/S0161-6420(00)00416-4
   WERNER L, 2001, INT OPHTHALMOL CLIN, V41
   ZIEMBA SL, 1991, ARCH OPHTHALMOL-CHIC, V109, P914, DOI 10.1001/archopht.1991.01080070023008
NR 55
TC 72
Z9 78
U1 1
U2 14
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0886-3350
J9 J CATARACT REFR SURG
JI J. Cataract. Refract. Surg.
PD APR
PY 2007
VL 33
IS 4
BP 713
EP 726
DI 10.1016/j.jcrs.2007.01.015
PG 14
WC Ophthalmology; Surgery
SC Ophthalmology; Surgery
GA 154XB
UT WOS:000245540200032
PM 17397749
DA 2018-10-20
ER

PT J
AU Davis, SC
   Martineau, L
AF Davis, S. C.
   Martineau, L.
TI Controlling methicillin resistant Staphylococcus aureus and Pseudomonas
   aeruginosa wound infections with a novel biomaterial
SO JOURNAL OF INVESTIGATIVE DERMATOLOGY
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the Society-for-Investigative-Dermatology
CY MAY 09-12, 2007
CL Los Angeles, CA
SP Soc Investigat Dermatol
C1 Univ Miami, Miller Sch Med, Miami, FL 33152 USA.
   Def R&D Canada, Operat Med Sect, Toronto, ON, Canada.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA
SN 0022-202X
J9 J INVEST DERMATOL
JI J. Invest. Dermatol.
PD APR
PY 2007
VL 127
SU 1
MA 790
BP S132
EP S132
PG 1
WC Dermatology
SC Dermatology
GA 152UP
UT WOS:000245387800786
DA 2018-10-20
ER

PT J
AU Lin, S
   Lee, C
   Chan, J
   Hsu, C
   Chiu, H
AF Lin, S.
   Lee, C.
   Chan, J.
   Hsu, C.
   Chiu, H.
TI Microtissue culture of dermal papilla cells by use of controlled
   biomaterial surface
SO JOURNAL OF INVESTIGATIVE DERMATOLOGY
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the Society-for-Investigative-Dermatology
CY MAY 09-12, 2007
CL Los Angeles, CA
SP Soc Investigat Dermatol
C1 Natl Taiwan Univ Hosp, Coll Med, Dept Dermatol, Taipei, Taiwan.
   Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan.
   Cathay Gen Hosp, Dept Dermatol, Taipei, Taiwan.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA
SN 0022-202X
J9 J INVEST DERMATOL
JI J. Invest. Dermatol.
PD APR
PY 2007
VL 127
SU 1
MA 620
BP S104
EP S104
PG 1
WC Dermatology
SC Dermatology
GA 152UP
UT WOS:000245387800618
DA 2018-10-20
ER

PT J
AU Tavakkol, Z
   Usui, M
   Marshall, A
   Fleckman, P
   Ratner, B
   Olerud, J
AF Tavakkol, Z.
   Usui, M.
   Marshall, A.
   Fleckman, P.
   Ratner, B.
   Olerud, J.
TI Porous silicone: A promising material for sealing the skin-biomaterial
   interface
SO JOURNAL OF INVESTIGATIVE DERMATOLOGY
LA English
DT Meeting Abstract
CT 68th Annual Meeting of the Society-for-Investigative-Dermatology
CY MAY 09-12, 2007
CL Los Angeles, CA
SP Soc Investigat Dermatol
C1 Univ Washington, Seattle, WA 98195 USA.
NR 0
TC 0
Z9 0
U1 1
U2 2
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA
SN 0022-202X
J9 J INVEST DERMATOL
JI J. Invest. Dermatol.
PD APR
PY 2007
VL 127
SU 1
MA 218
BP S37
EP S37
PG 1
WC Dermatology
SC Dermatology
GA 152UP
UT WOS:000245387800219
DA 2018-10-20
ER

PT J
AU Bellon, JM
   Rodriguez, M
   Garcia-Honduvilla, N
   Pascual, G
   Gomez, V
   Bujan, J
AF Bellon, Juan M.
   Rodriguez, Marta
   Garcia-Honduvilla, Natalio
   Pascual, Gemma
   Gomez, Veronica
   Bujan, Julia
TI Peritoneal effects of prosthetic meshes used to repair abdominal wall
   defects: Monitoring adhesions by sequential laparoscopy
SO JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES
LA English
DT Article
ID POLYPROPYLENE MESH; BIOMATERIAL; PREVENTION; HERNIA
AB Background: The prosthetic materials currently used to repair abdominal wall defects sometimes have to be placed in contact with the visceral peritoneum. This interface is often a site of complications such as intestinal obstruction or fistulas due to adhesions. The aim of this study was to follow the process of adhesion formation in several prosthetic materials by sequential laparoscopy.
   Material and Methods: Defects (7 x 5 cm) were created in the abdominal wall of 30 New Zealand White rabbits and repaired using Surgipro polypropylene mesh (PP), Ultrapro monocryl-prolene mesh (UP), Dual Mesh expanded polytetrafluoroethylene (ePTFE), Composix (PP-ePTFE), Parietex Composite (polyester with collagen-polyethylene glycol-glycerol coating [PO-gl]), or PL-PU99 (PP-polyurethane) patches fixed to the edges of the defect by running polypropylene suture. Adhesions to the implants were laparoscopically determined at 3, 7, and 14 days after surgery.
   Results: Percentage adhesion scores were significantly lower for ePTFE, PP-ePTFE, PO-gl, and PP-PU, compared to PP or UP. No differences were observed in adhesion scores recorded at 3, 7, and 14 days postimplant. Reticular prostheses were infiltrated by disorganized scar tissue with fibers concentric to the mesh filaments. In contrast, ePTFE implants were encapsulated by organized tissue, with fibers running parallel to the surface of biomaterial. All three composites achieved good recipient tissue integration and a homogeneous, organized, and well-vascularized neoperitoneum.
   Conclusion: At 14 days postimplant, laminar prostheses and composites showed similar results in terms of adhesion formation and integration within host tissue. Our findings suggest that both the composite prostheses and the laminar ePTFE performed very well in terms of reduced adhesion formation at the peritoneal interface.
C1 Univ Alcala de Henares, Fac Med, Dept Surg, E-28871 Alcala De Henares, Spain.
   Univ Alcala de Henares, Fac Med, Dept Med Specialit, E-28871 Alcala De Henares, Spain.
RP Bellon, JM (reprint author), Univ Alcala de Henares, Fac Med, Dept Surg, Ctra Madrid-Barcelona,Km 33-600, E-28871 Alcala De Henares, Spain.
EM juanm.bellon@uah.es
OI BELLON, JUAN M./0000-0002-6071-5011; PASCUAL, GEMMA/0000-0002-1623-4384;
   Gomez-Gil, Veronica/0000-0002-6642-5912; Garcia Honduvilla,
   Natalio/0000-0003-0904-6198; bujan, Julia/0000-0003-2419-2476
CR Baptista ML, 2000, J AM COLL SURGEONS, V190, P271, DOI 10.1016/S1072-7515(99)00277-X
   Bellon JM, 2005, J BIOMED MATER RES B, V74B, P718, DOI 10.1002/jbm.b.30248
   Bellon JM, 2003, J MATER SCI-MATER M, V14, P359, DOI 10.1023/A:1022936016618
   Bellon JM, 2002, AM J SURG, V184, P154, DOI 10.1016/S0002-9610(02)00907-8
   Bellon JM, 2000, J MATER SCI-MATER M, V11, P25, DOI 10.1023/A:1008981517743
   Bellon JM, 1996, BIOMATERIALS, V17, P1369, DOI 10.1016/0142-9612(96)87276-0
   Bellon JM, 1997, J BIOMED MATER RES, V38, P197
   Chew DK, 2000, SURGERY, V125, P109
   Chuback JA, 2000, SURGERY, V127, P475, DOI 10.1067/msy.2000.104122
   DEGUZMAN LJ, 1995, ENDOSCOPY, V27, P459, DOI 10.1055/s-2007-1005743
   Felemovicius I, 2004, J AM COLL SURGEONS, V198, P543, DOI 10.1016/j.jamcollsurg.2003.12.004
   Holmdahl Lena, 1999, European Journal of Surgery, V165, P1012
   Law NW, 1988, CLIN MATER, V3, P95
   Losanoff J E, 2002, Hernia, V6, P144
   Matthews BD, 2003, J SURG RES, V114, P126, DOI 10.1016/S0022-4804(03)00158-6
NR 15
TC 33
Z9 37
U1 4
U2 6
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1092-6429
J9 J LAPAROENDOSC ADV S
JI J. Laparoendosc. Adv. Surg. Tech.
PD APR
PY 2007
VL 17
IS 2
BP 160
EP 166
DI 10.1089/lap.2006.0028
PG 7
WC Surgery
SC Surgery
GA 161HI
UT WOS:000246005000003
PM 17484641
DA 2018-10-20
ER

PT J
AU Wiedmann-Al-Ahmad, M
   Gutwald-, R
   Gellrich, NC
   Hubner, U
   Schmelzeisen, R
AF Wiedmann-Al-Ahmad, M.
   Gutwald-, R.
   Gellrich, N. -C.
   Huebner, U.
   Schmelzeisen, R.
TI Growth of human osteoblast-like cells on beta-tricalciumphosphate (TCP)
   membranes with different structures
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CALCIUM-PHOSPHATE CEMENT; BONE-FORMATION; ALKALINE-PHOSPHATASE;
   IN-VITRO; PARTICLES; CERAMICS; IMPLANTATION; DEGRADATION; EXPRESSION;
   BEHAVIOR
AB Bioresorb(R), a bioactive, bioresorbable bone replacement material, consisting of pure beta-tricalciumphosphate (TCP) ceramic, was evaluated in cell culture with human osteoblast-like cells. The aim of our study was to investigate the influence of TCP on the growth behavior of human osteoblast-like cells. Different granule sizes and plate sizes were used in this study: Granule sizes 500-1000 mu m, 1000-2000 mu m and 2000-5000 mu m; plate sizes 1.7 mm, 2.0 mm and 2.2 mm. Under scanning electron microscopic (SEM) observations the cell colonization on the surface of the biomaterial and the tissue compatibility were studied. Thin sections were used to study the growth of human osteoblast-like cells inside the biomaterial. It could be clearly shown that all investigated biomaterials are tissue compatible and that the size and structure (granule or plate) of the biomaterial effects the colonization rate. Bioresorb plates enhance the colonization comparable to granule. The results obtained by SEM and thin sections were confirmed immunhistochemically by the nonradioactive assay EZ4U-EASY FOR YOU. In conclusion, all investigated sizes and structures of Bioresorb(R) are tissue compatible but the cell growth is much better on plates than on granule small in size. The results suggest that the plates may be favourable useful as scaffold for regrowth of bone.
C1 Univ Freiburg, Klin &Poliklin Mund Kiefer & Gesichtschirurg, D-79106 Freiburg, Germany.
   Hannover Med Sch, Klin & Poliklin Mund Kiefer & Gesichtschirurg, Hannover, Germany.
RP Wiedmann-Al-Ahmad, M (reprint author), Univ Freiburg, Klin &Poliklin Mund Kiefer & Gesichtschirurg, Hugstetter Str 55, D-79106 Freiburg, Germany.
EM wiedmannalahmad@t-online.de
OI Schmelzeisen, Rainer/0000-0002-9686-6989
CR ASHTON BA, 1985, BONE, V6, P313, DOI 10.1016/8756-3282(85)90321-7
   Aubin Jane E., 1993, P1
   CARMICHAEL J, 1987, CANCER RES, V47, P943
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   DECKER B, 1995, ANAT REC, V242, P310, DOI 10.1002/ar.1092420304
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   FREDERICKS DC, 2004, ORTHOPEDICS, V27, P167
   Ginebra MP, 2004, BIOMATERIALS, V25, P3453, DOI 10.1016/j.biomaterials.2003.10.049
   Handschel J, 2002, BIOMATERIALS, V23, P1689, DOI 10.1016/S0142-9612(01)00296-4
   HOLLINGER JO, 1986, CLIN ORTHOP RELAT R, P290
   HYLDSTRUP L, 1988, SCAND J CLIN LAB INV, V48, P611, DOI 10.3109/00365518809085780
   Kitsugi T, 1996, J BIOMED MATER RES, V30, P261, DOI 10.1002/(SICI)1097-4636(199602)30:2<261::AID-JBM17>3.0.CO;2-P
   KLEIN CPAT, 1986, BIOMATERIALS, V7, P144
   Knabe C, 2004, J BIOMED MATER RES A, V69A, P145, DOI 10.1002/jbm.a.20131
   KRAJEWSKI A, 1988, J BIOMED MATER RES, V22, P445, DOI 10.1002/jbm.820220602
   Kwon SY, 2000, J ORTHOPAED RES, V18, P203, DOI 10.1002/jor.1100180207
   LANGE TA, 1986, ANN CLIN LAB SCI, V16, P467
   Mailhot JM, 1998, CLIN ORAL IMPLAN RES, V9, P43, DOI 10.1034/j.1600-0501.1998.090106.x
   MANKIN HJ, 1987, ORTHOP CLIN N AM, V18, P275
   Mayr-Wohlfart U, 2001, J BIOMED MATER RES, V57, P132, DOI 10.1002/1097-4636(200110)57:1<132::AID-JBM1152>3.0.CO;2-K
   Merten HA, 2001, J CRANIOFAC SURG, V12, P59, DOI 10.1097/00001665-200101000-00010
   Ninomiya JT, 2001, J ORTHOPAED RES, V19, P621, DOI 10.1016/S0736-0266(00)00061-9
   Pioletti DP, 2000, BIOMATERIALS, V21, P1103, DOI 10.1016/S0142-9612(99)00250-1
   Pioletti DP, 1999, J BIOMED MATER RES, V46, P399, DOI 10.1002/(SICI)1097-4636(19990905)46:3<399::AID-JBM13>3.3.CO;2-2
   Rice JM, 2003, CALCIFIED TISSUE INT, V72, P726, DOI 10.1007/s00223-002-2045-y
   SAFFAR JL, 1990, J PERIODONTOL, V61, P209, DOI 10.1902/jop.1990.61.4.209
   Schliephake H, 2001, J BIOMED MATER RES, V56, P128, DOI 10.1002/1097-4636(200107)56:1<128::AID-JBM1077>3.0.CO;2-L
   STEIN GS, 1990, FASEB J, V4, P3111
   Sun JS, 1997, J BIOMED MATER RES, V37, P324, DOI 10.1002/(SICI)1097-4636(19971205)37:3<324::AID-JBM3>3.0.CO;2-N
   TAYLOR SR, 1983, J BIOMED MATER RES, V17, P205, DOI 10.1002/jbm.820170202
   Wang JX, 1998, BIOMATERIALS, V19, P1387, DOI 10.1016/S0142-9612(98)00014-3
   Wiedmann-Al-Ahmad M, 2002, BIOMATERIALS, V23, P3319, DOI 10.1016/S0142-9612(02)00019-4
   Wiltfang J, 2002, J BIOMED MATER RES, V63, P115, DOI 10.1002/jbm.10084
NR 33
TC 1
Z9 1
U1 0
U2 2
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2007
VL 18
IS 4
BP 551
EP 563
DI 10.1007/s10856-007-2302-8
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 152JA
UT WOS:000245357100003
PM 17546414
DA 2018-10-20
ER

PT J
AU Koo, KT
   Susin, C
   Wikesjo, UME
   Choi, SH
   Kim, CK
AF Koo, Ki-Tae
   Susin, Cristiano
   Wikesjo, Ulf M. E.
   Choi, Seong-Ho
   Kim, Chong-Kwan
TI Transforming growth factor-beta 1 accelerates resorption of a calcium
   carbonate biomaterial in peridontal defects
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE biodegradation; calcium carbonate carrier; periodontal regeneration;
   transforming growth factor-beta1
ID GUIDED TISSUE REGENERATION; GROWTH-FACTOR-BETA; PERIODONTAL REPAIR;
   DOGS; BONE; MODEL
AB Background: In a previous study, recombinant human transforming growth factor-beta 1 (rh TGF-beta(1)) in a calcium carbonate carrier was implanted into critical-size, supraalveolar periodontal defects under conditions, for guided tissue regeneration (GTR) to study whether rhTGF-beta(1) would enhance or accelerate periodontal regeneration. The results showed minimal benefits of rhTGF-beta(1,) and a clear account for this could not be offered. One potential cause may be that the rhTGf-beta(1) formulation was biologically inactive. Several growth of differentiation factors have been suggested to accelerate degradation of biomaterials used as carriers. The objective of this study was to evaluate possible activity of rhTGF-beta(1) on biodegradation of the calcium carbonate carrier.
   Methods: rhTGF-beta(1) in a putty-formulated particulate calcium carbonate carrier was implanted into critical-size, supraalveolar periodontal defects under conditions for GTR in five beagle dogs. Contralateral defects received the calcium carbonate carrier combined with GTR without rhTGF-beta(1) (control). The animals were euthanized at week 4 post-surgery and block biopsies of the defect sites were collected for histologic and histometric analysis. Radiographs were obtained at defect creation and week 2 and 4 after defect creation.
   Results: No statistically significant differences were observed in new bone formation (bone height and area) among the treatments. However, total residual carrier was significantly reduced in sites receiving rhTGF-beta(1) compared to control (P = 0.04). Similarly, carrier density to control; the differences was borderline statistically significant (P = 0.06).
   Conclusions: Within the limitations of the study, it may be concluded that rhTGF-beta(1) accelerates biodegradation of a particulate calcium carbonate biomaterial, indicating a biologic activity of the rhTGF-beta(1) formulation apparently not encompassing enhanced or accelerated periodontal regeneration.
C1 Yonsei Univ, Coll Dent, Res Inst Periodontal Regenerat, Seoul, South Korea.
   Yonsei Univ, Coll Dent, Res Inst Periodontal Regenerat, Dept Periodontol, Seoul, South Korea.
   Med Coll Georgia, Lab Appl Periodontal & Craniofacial Regenerat, Augusta, GA USA.
   Univ Fed Rio Grande do Sul, Dept Periodontol, Porto Alegre, RS, Brazil.
   Med Coll Georgia, Sch Dent, Dept Periodont, Augusta, GA 30912 USA.
   Med Coll Georgia, Sch Dent, Dept Oral Biol & Maxillofacial Pathol, Augusta, GA 30912 USA.
RP Kim, CK (reprint author), Yonsei Univ, Coll Dent, Res Inst Periodontal Regenerat, 134 Shinchon Dong, Seoul, South Korea.
EM ckkim@yumc.yonsei.ac.kr
RI Susin, Cristiano/B-9822-2008; Wikesjo, Ulf/A-4159-2009
OI Susin, Cristiano/0000-0002-4092-908X; Wikesjo, Ulf/0000-0003-1607-0583
CR CENTRELLA M, 1994, ENDOCR REV, V15, P27, DOI 10.1210/er.15.1.27
   CENTRELLA M, 1987, J BIOL CHEM, V262, P2869
   HANEY JM, 1993, J PERIODONTOL, V64, P883, DOI 10.1902/jop.1993.64.9.883
   HAUSCHKA PV, 1986, J BIOL CHEM, V261, P2665
   Hughes FJ, 2006, PERIODONTOL 2000, V41, P48, DOI 10.1111/j.1600-0757.2006.00161.x
   Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001
   Koo KT, 2004, J PERIODONTOL, V75, P1688, DOI 10.1902/jop.2004.75.12.1688
   Koo KT, 2005, J CLIN PERIODONTOL, V32, P104, DOI 10.1111/j.1600-051X.2004.00632.x
   Koo KT, 2004, J CLIN PERIODONTOL, V31, P439, DOI 10.1111/j.1600-051X.2004.00508.x
   Polimeni G, 2006, PERIODONTOL 2000, V41, P30, DOI 10.1111/j.1600-0757.2006.00157.x
   Roberts Anita B., 1995, Wound Repair and Regeneration, V3, P408, DOI 10.1046/j.1524-475X.1995.30405.x
   ROBEY PG, 1987, J CELL BIOL, V105, P457, DOI 10.1083/jcb.105.1.457
   Sigurdsson T J, 1996, Int J Periodontics Restorative Dent, V16, P524
   Tatakis DN, 2000, J CLIN PERIODONTOL, V27, P698, DOI 10.1034/j.1600-051x.2000.027009698.x
   Trombelli L, 1999, J CLIN PERIODONTOL, V26, P381, DOI 10.1034/j.1600-051X.1999.260608.x
   Wikesjo Ulf M E, 2002, Clin Implant Dent Relat Res, V4, P174, DOI 10.1111/j.1708-8208.2002.tb00169.x
   WIKESJO UME, 1994, J PERIODONTOL, V65, P1151, DOI 10.1902/jop.1994.65.12.1151
   Wikesjo UME, 1998, J CLIN PERIODONTOL, V25, P475, DOI 10.1111/j.1600-051X.1998.tb02476.x
NR 18
TC 10
Z9 10
U1 0
U2 2
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA
SN 0022-3492
J9 J PERIODONTOL
JI J. Periodont.
PD APR
PY 2007
VL 78
IS 4
BP 723
EP 729
DI 10.1902/jop.2007.060336
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 157MS
UT WOS:000245724800019
PM 29539140
DA 2018-10-20
ER

PT J
AU Tatara, RA
   Suraparaju, S
   Rosentrater, KA
AF Tatara, R. A.
   Suraparaju, S.
   Rosentrater, K. A.
TI Compression molding of phenolic resin and corn-based DDGS blends
SO JOURNAL OF POLYMERS AND THE ENVIRONMENT
LA English
DT Article
DE biofillers; bioplastics; composites; mechanical properties; tensile
   testing
ID BIOCOMPOSITES; LIQUEFACTION; LIGNIN; POWDER; WOOD
AB With the rapid growth in the ethanol fuel industry in recent years, considerable research is being devoted to optimizing the use of processing coproducts, such as distillers dried grains with solubles (DDGS), in livestock diets. Because these residues contain high fiber levels, they may be amendable to incorporation into bio-based composites. Thus, the goal of this study was to demonstrate the viability of using corn-based DDGS as a biofiller with phenolic resin, in order to produce a novel biomaterial. DDGS was blended with phenolic resin at 0, 10, 25, 50, 75, and 90%, by weight, and then compression molded at 51 MPa (3.7 tons/in(2)) and 174 degrees C (345 degrees F). Molded specimens were then tested for tensile strength. Tensile yield strengths ranged from 32 MPa (4,700 psi) to 7.6 MPa (1,100 psi), while the engineering strain ranged from 0.6% to 1.25%. Results indicate that DDGS concentrations between 25% and 50% retained sufficient mechanical strength and thus represent reasonable inclusion values. Additionally, data were similar to those from other studies that have investigated biofillers. Follow-up studies should quantify the effects of altering molding parameters, including molding pressure, temperature, and time, as well as pretreatment of the DDGS. Additionally, strength of the DDGS composites should be optimized through the use of coupling agents or other additives.
C1 No Illinois Univ, Dept Technol, De Kalb, IL 60115 USA.
   No Illinois Univ, Dept Mech Engn, De Kalb, IL 60115 USA.
   USDA, ARS, No Cent Agr Res Lab, Brookings, SD 57006 USA.
RP Tatara, RA (reprint author), No Illinois Univ, Dept Technol, De Kalb, IL 60115 USA.
EM tatara@ceet.niu.edu; krishna1150@gmail.com; krosentr@ngirl.ars.usda.gov
OI Rosentrater, Kurt/0000-0003-0131-7037
CR *ASTM INT, 2005, ANN BOOK ASTM STAND, V1, P50
   BERINS ML, 1991, SPI PLASTICS ENG HDB, P253
   Hattali S, 2005, J APPL POLYM SCI, V97, P1065, DOI [10.1002/app.21243, 10.1002/APP.21243]
   Kharade AY, 1998, EUR POLYM J, V34, P201
   Lee SH, 2000, J APPL POLYM SCI, V78, P311, DOI 10.1002/1097-4628(20001010)78:2<311::AID-APP110>3.0.CO;2-N
   Leite JL, 2004, BRAZ J CHEM ENG, V21, P253, DOI 10.1590/S0104-66322004000200015
   Maldas D, 1997, J REINF PLAST COMP, V16, P870, DOI 10.1177/073168449701601001
   Maldas D, 1996, POLYM-PLAST TECHNOL, V35, P917, DOI 10.1080/03602559608000607
   Mohanty AK, 2001, COMPOS INTERFACE, V8, P313, DOI 10.1163/156855401753255422
   Mohanty AK, 2000, MACROMOL MATER ENG, V276, P1, DOI 10.1002/(SICI)1439-2054(20000301)276:1<1::AID-MAME1>3.0.CO;2-W
   Xanthos M, 2005, FUNCTIONAL FILLERS FOR PLASTICS, P1, DOI 10.1002/3527605096
NR 11
TC 24
Z9 24
U1 0
U2 8
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1566-2543
J9 J POLYM ENVIRON
JI J. Polym. Environ.
PD APR
PY 2007
VL 15
IS 2
BP 89
EP 95
DI 10.1007/s10924-007-0052-9
PG 7
WC Engineering, Environmental; Polymer Science
SC Engineering; Polymer Science
GA 162TE
UT WOS:000246111600003
DA 2018-10-20
ER

PT J
AU Parhi, P
   Ray, AR
   Ramanan, A
AF Parhi, Purnendu
   Ray, Alok R.
   Ramanan, Arunachalam
TI Metathetic reaction in reverse micelles: Synthesis of nanostructured
   alkaline-earth metal phosphates
SO JOURNAL OF THE AMERICAN CERAMIC SOCIETY
LA English
DT Article
ID CALCIUM-PHOSPHATE; CHEMICAL-SYNTHESIS; HYDROXYAPATITE NANORODS;
   HYDROTHERMAL SYNTHESIS; SURFACTANT; SOL; MICROEMULSIONS; BIOCERAMICS;
   POWDERS; TRANSFORMATION
AB For the past few years, hydroxyapatite (HAp) has been identified as a potential biomaterial due to its excellent biocompatibility and bioactivity. The preparation of nanostructured HAp with controlled powder characteristics is a pre-requisite for processing it into useful biocomposites. Here, the synthesis of nanorods of calcium hydroxyapatite (Ca-HAp), strontium hydroxyapatite (Sr-HAp), and barium hydroxyapatite (Ba-HAp) by exploiting the metathetic reaction taking place in reverse micelles in the presence of cetyltrimethylammonium bromide has been reported. Powder X-ray diffraction analysis and thermogravimetric measurements confirm the formation of monophasic Ca-HAp and Sr-HAp. The growth of nanorods was further confirmed using transmission electron microscopy studies. The average lengths of Ca-HAp and Sr-HAp were similar to 60 and 30 nm, respectively. However, the preparation of Ba-HAp invariably yielded a multiphasic mixture with other competitive phases like BaHPO4 and Ba(H2PO4)(2).
C1 Indian Inst Technol, Dept Chem, Delhi, India.
   Indian Inst Technol, Ctr Biomed Engn, Delhi, India.
RP Ramanan, A (reprint author), Indian Inst Technol, Dept Chem, Delhi, India.
EM aramanan@chemistry.iitd.ac.in
RI Ray, Alok/A-7791-2011
OI Ray, Alok/0000-0002-2223-222X
CR AIZAWA M, 1996, PHOSPHORUS RES B, V6, P217
   BIELLE S, 2005, INORG CHEM, V44, P9895
   Bose S, 2003, CHEM MATER, V15, P4464, DOI 10.1021/cm0303437
   Cao MH, 2004, LANGMUIR, V20, P4784, DOI 10.1021/la0498197
   Cruz FJAL, 2005, J CHEM THERMODYN, V37, P1061, DOI 10.1016/j.jct.2005.01.010
   Curri ML, 2000, J PHYS CHEM B, V104, P8391, DOI 10.1021/jp0007639
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hirai T, 2000, LANGMUIR, V16, P955, DOI 10.1021/la990590i
   Holmberg K, 2004, J COLLOID INTERF SCI, V274, P355, DOI 10.1016/j.jcis.2004.04.006
   Ioku K, 2002, SOLID STATE IONICS, V151, P147, DOI 10.1016/S0167-2738(02)00593-3
   Kim TG, 2005, INORG CHEM, V44, P9895, DOI 10.1021/ic051013m
   Kordas G, 1997, J SOL-GEL SCI TECHN, V9, P17, DOI 10.1023/A:1026452021666
   Layrolle P, 1998, J AM CERAM SOC, V81, P1421
   Li M, 2003, ADV MATER, V15, P2032, DOI 10.1002/adma.200305589
   Li M, 2002, ADV FUNCT MATER, V12, P773, DOI 10.1002/adfm.200290006
   Liu YK, 2004, MATER CHEM PHYS, V86, P69, DOI 10.1016/j.matchemphys.2004.02.009
   Parhi P, 2006, J MATER SCI, V41, P1455, DOI 10.1007/s10853-006-7460-4
   Parhi P, 2006, MATER LETT, V60, P218, DOI 10.1016/j.matlet.2005.08.019
   Parhi P, 2004, MATER LETT, V58, P3610, DOI 10.1016/j.matlet.2004.06.056
   Rao RR, 1997, J MATER SCI-MATER M, V8, P511, DOI 10.1023/A:1018586412270
   Rhee SH, 1998, J AM CERAM SOC, V81, P3029
   Sarda S, 1999, CHEM MATER, V11, P2722, DOI 10.1021/cm991022r
   Song RQ, 2005, J PHYS CHEM B, V109, P22758, DOI 10.1021/jp0533325
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Sugiyama S, 2006, J COLLOID INTERF SCI, V295, P141, DOI 10.1016/j.jcis.2005.08.014
   Tas AC, 2000, J EUR CERAM SOC, V20, P2389, DOI 10.1016/S0955-2219(00)00129-1
   Tas AC, 1997, J MATER SCI-MATER M, V8, P91
   Walsh D, 1996, CHEM MATER, V8, P1944, DOI 10.1021/cm9601345
   WENZ R, 2003, Patent No. 25
   Xiu ZL, 2005, MATER RES BULL, V40, P1617, DOI 10.1016/j.materresbull.2005.04.033
   Yan L, 2001, INT J INORG MATER, V3, P633, DOI 10.1016/S1466-6049(01)00164-7
   Yuan ZY, 2002, LANGMUIR, V18, P2450, DOI 10.1021/la011518z
NR 32
TC 11
Z9 11
U1 0
U2 3
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0002-7820
J9 J AM CERAM SOC
JI J. Am. Ceram. Soc.
PD APR
PY 2007
VL 90
IS 4
BP 1237
EP 1242
DI 10.1111/j.1551-2916.2007.01508.x
PG 6
WC Materials Science, Ceramics
SC Materials Science
GA 156UL
UT WOS:000245675300033
DA 2018-10-20
ER

PT J
AU Nakai, M
   Niinomi, M
   Akahori, T
   Ohtsu, N
   Nishimura, H
   Toda, H
   Fukui, H
   Ogawa, M
AF Nakai, Masaaki
   Niinomi, Mitsuo
   Akahori, Toshikazu
   Ohtsu, Naofumi
   Nishimura, Hideki
   Toda, Hiroyuki
   Fukui, Hisao
   Ogawa, Michiharu
TI Effects of alloying elements on hard ceramic layer formation on surfaces
   of biomedical Ti-29Nb-l3Ta-4.6Zr and Ti-6Al-4V ELI during gas nitriding
SO JOURNAL OF THE JAPAN INSTITUTE OF METALS
LA English
DT Article
DE titanium alloy; biomaterial; gas nitriding; suiface
ID MECHANICAL-PROPERTIES; TITANIUM-ALLOYS; TI-29NB-13TA-4.6ZR; CYTOTOXICITY
AB Formation of the reaction product layer on the surface of biomedical titanium alloys, Ti-29Nb-13Ta-4.6Zr (TNTZ) and Ti6A1-4V ELI (Ti64), during gas nitriding was investigated. These alloys were exposed to nitrogen atmosphere at 1023, 1073, 1123 and 1223 K. After the gas nitriding, a reaction product layer was observed on the surface of both alloys, and was analyzed using an X-ray diffraction (XRD), Auger electron spectroscopy (AES) and X-ray Photoelectron spectroscopy (XPS). The layer was comprised of two phases, which were outer oxide layer (mainly TiO2) and inner nitride layer (mainly TiN or Ti2N). In these layers, the thickness of the oxide layer particularly depended on the kinds of alloys. According to the thermodynamics and point defect theory, the growth rate of oxide layer is expected to be increased by the presence of Al in TiO2. Namely, the dissolution of Al into TiO2 may increase the number of oxygen vacancies, resulting in acceleration of oxygen diffusion inward. On the other hand, the elements that accelerate the growth of the oxide layer are not contained in TNTZ. Thus, the oxide layer formed on Ti64 was thicker than that of TNTZ. In a similar way, the elements that accelerate the growth of the nitride layer are not contained in both TNTZ and Ti64. Thus, the nitride layers with similar thicknesses may be formed on TNTZ and Ti64 during gas nitriding.
C1 Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
   Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 4418580, Japan.
   Aichi Gakuin Univ, Sch Dent, Nagoya, Aichi 4648650, Japan.
   Daido Steel Co Ltd, Nagoya, Aichi 4578545, Japan.
RP Nakai, M (reprint author), Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
RI Niinomi, Mitsuo/B-5965-2011; Nakai, Masaaki/C-1919-2009; Ohtsu,
   Naofumi/L-6021-2018
OI Ohtsu, Naofumi/0000-0001-7935-3949
CR Akahori T, 2002, J JPN I MET, V66, P715, DOI 10.2320/jinstmet1952.66.7_715
   AKAHORI T, 2006, 2006 SPR M JAP I MET, P89
   BARIN I, 1989, THRMOCHEMICAL DATA P
   Kofstad P., 1972, NONSTOICHIOMETRY DIF
   Kuroda D, 2000, TETSU TO HAGANE, V86, P602, DOI 10.2355/tetsutohagane1955.86.9_602
   Kuroda D, 2000, TETSU TO HAGANE, V86, P610, DOI 10.2355/tetsutohagane1955.86.9_610
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   MIZUTA S, 2001, KOTAIDENKIKAGAKU JIK
   MORO T, 2006, J JAPAN SOC BIOMATER, V24, P108
   NAKAYAMA T, 1996, KINZOKU, V66, P986
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Shinozuka K, 1997, DEFECT DIFFUS FORUM, V143, P1237, DOI 10.4028/www.scientific.net/DDF.143-147.1237
NR 12
TC 2
Z9 2
U1 0
U2 7
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 0021-4876
EI 1880-6880
J9 J JPN I MET
JI J. Jpn. Inst. Met.
PD APR
PY 2007
VL 71
IS 4
BP 415
EP 422
DI 10.2320/jinstmet.71.415
PG 8
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 169EQ
UT WOS:000246575900006
OA Bronze
DA 2018-10-20
ER

PT J
AU Yang, JH
   Chen, J
   Felsen, D
   Poppas, DP
AF Yang, Jennifer H.
   Chen, Jie
   Felsen, Diane
   Poppas, Dix P.
TI Biocompatibility assessment and in vivo trial of novel synthetic
   biomaterial for bladder augmentation
SO JOURNAL OF UROLOGY
LA English
DT Meeting Abstract
CT 102nd Annual Meeting of the American-Urological-Association
CY MAY 19-24, 2007
CL Anaheim, CA
SP Amer Urol Assoc
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD APR
PY 2007
VL 177
IS 4
SU S
BP 238
EP 239
PG 2
WC Urology & Nephrology
SC Urology & Nephrology
GA 148VW
UT WOS:000245106501237
DA 2018-10-20
ER

PT J
AU Lee, JS
   Kim, JK
   Park, SR
   Chang, YH
AF Lee, Jung Soo
   Kim, Jae Kyung
   Park, So Ra
   Chang, Yoon Ho
TI Preparation of collagen/poly(L-lactic acid) composite material for wound
   dressing
SO MACROMOLECULAR RESEARCH
LA English
DT Article
DE collagen; PLLA; acrylamide; wound dressing; biomaterial
ID L-LACTIC ACID; DRUG-DELIVERY; POLY(L-LACTIC ACID); COLLAGEN;
   POLYMERIZATION; SYSTEMS
AB Collagen is the major structural protein of connective tissues It can be used as a prosthetic biomaterial applicable to artificial skin, tendon, ligaments, and collagen implants. The objective of this study is to investigate the possibility of realizing wound dressing medical products by the synthesis of composite materials with collagen and a biodegradable polymer, PLLA, via a surface modification process. Type I collagen was obtained from pig skin by a separation process. The structural characteristics of the extracted collagen were confirmed by SIDS-polyacrylamide (PAcr) gel electrophoresis (PAGE) and FTIR. Also, PLLA-g-PAcr was synthesized by the radical polymerization of acrylamide initiated by AIBN in the presence of PLLA. The surface of PLLA was modified by the presence of the acrylamide residues. The structural characteristics of the copolymer were analyzed by FTIR, H-1-NMR and contact angle measurements. The water uptake and WVTR of the collagen/PLLA-g-PAcr composite tended to increase with increasing collagen concentration and with decreasing EDC concentration.
C1 Inha Univ, Dept Chem Engn, Inchon 402751, South Korea.
RP Chang, YH (reprint author), Inha Univ, Dept Chem Engn, Inchon 402751, South Korea.
EM yhchang@inha.ac.kr
CR Auger FA, 1998, MED BIOL ENG COMPUT, V36, P801, DOI 10.1007/BF02518887
   Avella M, 1997, ANGEW MAKROMOL CHEM, V246, P49, DOI 10.1002/apmc.1997.052460104
   BROWDER IW, 1986, AM SURGEON, V52, P492
   BURJANADZE TV, 1979, BIOPOLYMERS, V18, P931, DOI 10.1002/bip.1979.360180413
   Calandrelli L, 2002, J BIOMED MATER RES, V62, P244, DOI 10.1002/jbm.10138
   CAMERON WJ, 1978, OBSTET GYNECOL, V51, P118
   CHVAPIL M, 1993, J BIOMED MATER RES, V27, P313, DOI 10.1002/jbm.820270305
   Fonseca MJ, 1996, BBA-BIOMEMBRANES, V1279, P259
   Jung HJ, 2005, MACROMOL RES, V13, P446, DOI 10.1007/BF03218479
   JUNQUEIRA LC, 1983, BASIC HISTOLOGY, P89
   KAUFMAN HE, 1994, J OCUL PHARMACOL, V10, P17, DOI 10.1089/jop.1994.10.17
   Kemp PD, 2000, METH MOL B, V139, P287
   Khang G, 2002, MACROMOL RES, V10, P158, DOI 10.1007/BF03218266
   Kim KW, 2002, MACROMOL CHEM PHYSIC, V203, P2245, DOI 10.1002/1521-3935(200211)203:15<2245::AID-MACP2245>3.0.CO;2-3
   Ma ZW, 2003, J BIOMAT SCI-POLYM E, V14, P13, DOI 10.1163/15685620360511119
   Maeda M, 1999, J CONTROL RELEASE, V62, P313, DOI 10.1016/S0168-3659(99)00156-X
   MILLER JM, 1964, ARCH SURG-CHICAGO, V88, P167, DOI 10.1001/archsurg.1964.01310200005002
   Nagai T, 1999, J SCI FOOD AGR, V79, P855, DOI 10.1002/(SICI)1097-0010(19990501)79:6<855::AID-JSFA299>3.3.CO;2-E
   Otera J, 1996, CHEM LETT, P225, DOI 10.1246/cl.1996.225
   Rao KP, 1995, J BIOMAT SCI-POLYM E, V7, P623
   ROSSLER B, 1995, J MICROENCAPSUL, V12, P49, DOI 10.3109/02652049509051126
   Shyamroy S, 2005, J POLYM SCI POL CHEM, V43, P2164, DOI 10.1002/pola.20679
   Thacharodi D, 1996, BIOMATERIALS, V17, P1307, DOI 10.1016/0142-9612(96)88676-5
   WONG WS, 1990, FOOD CHEM, V36, P237
NR 24
TC 10
Z9 10
U1 1
U2 11
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1598-5032
EI 2092-7673
J9 MACROMOL RES
JI Macromol. Res.
PD APR
PY 2007
VL 15
IS 3
BP 205
EP 210
DI 10.1007/BF03218776
PG 6
WC Polymer Science
SC Polymer Science
GA 165PB
UT WOS:000246316400003
DA 2018-10-20
ER

PT J
AU Bhowmik, R
   Katti, KS
   Venna, D
   Katti, DR
AF Bhowmik, Rahul
   Katti, Kalpana S.
   Venna, Devendra
   Katti, Dinesh R.
TI Probing molecular interactions in bone biomaterials: Through molecular
   dynamics and Fourier transform infrared spectroscopy
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT Symposium on Next Generation Biomaterals
CY SEP 25-28, 2005
CL Pittsburgh, PA
DE molecular dynamics; biomaterial; FTIR; chelation; nanocomposite
ID SODIUM MONTMORILLONITE INTERLAYER; ALKYL FUNCTIONAL-GROUP; II
   FORCE-FIELDS; MECHANICAL RESPONSE; ALKANE MOLECULES; ENERGY SURFACES;
   BINDING-ENERGY; HYDROXYAPATITE; SIMULATION; INTERFACES
AB Polymer-hydroxyapatite (HAP) composites are widely investigated for their potential use as bone replacement materials. The molecular interactions at mineral polymer interface are known to have significant role of mechanical response of the composite system. Modeling interactions between such dissimilar molecules using molecular dynamics (MD) is an area of current interest. Molecular dynamics studies require potential function or force field parameters. Some force fields are described in literature that represents the structure of hydroxyapatite reasonably well. Yet, the applicability of these force fields for studying the interaction between dissimilar materials (such as mineral and polymer) is limited, as there is no accurate representation of polymer in these force fields. We have obtained the parameters of consistent valence force field (CVFF) for monoclinic hydroxyapatite. Validation of parameters was done by comparing the computationally obtained unit cell parameters, vibrational spectra and atomic distances with XRD and FTIR experiments. Using the obtained parameters of HAP, and available parameters of polymer (polyacrylic acid), interaction study was performed with MD simulations. The MD simulations showed that several hydrogen bonds may form between HAP and polyacrylic acid depending upon the exposed surface of HAP. Also there are some favourable planes of HAP where polyacrylic acid is most likely to attach. We have also simulated the mineralization of HAP using a "synthetic biomineralization". These modeling studies are supported by photoacoustic spectroscopy experiments on both porous and non porous composite samples for potential joint replacement and bone tissue engineering applications. (c) 2006 Elsevier B.V. All rights reserved.
C1 N Dakota State Univ, Dept Civil Engn, Fargo, ND 58105 USA.
RP Katti, KS (reprint author), N Dakota State Univ, Dept Civil Engn, CIE201, Fargo, ND 58105 USA.
EM Kalpana.katti@ndsu.edu
RI Katti, Dinesh/A-5440-2010
OI Katti, Dinesh/0000-0001-9866-2683; Verma, Devendra/0000-0002-7492-1246
CR Bhowmik R, 2005, MATER RES SOC SYMP P, V844, P195
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   DALAS E, 1991, LANGMUIR, V7, P1822, DOI 10.1021/la00056a040
   DAUBEROSGUTHORPE P, 1988, PROTEINS, V4, P31, DOI 10.1002/prot.340040106
   de Leeuw NH, 2004, PHYS CHEM CHEM PHYS, V6, P1860, DOI 10.1039/b313242k
   de Leeuw NH, 2004, J PHYS CHEM B, V108, P1809, DOI 10.1021/jp036784v
   Elliott JC, 1994, STRUCTURE CHEM APATI
   Fermeglia M, 2004, MOL SIMULAT, V30, P289, DOI 10.1080/08927020410001659385
   Fermeglia M, 2003, FLUID PHASE EQUILIBR, V212, P315, DOI 10.1016/S0378-3812(03)00273-5
   Gardebien F, 2004, J PHYS CHEM B, V108, P10678, DOI 10.1021/jp0493069
   Groot K. D., 1980, BIOMATERIALS, V1, P47
   HAGLER AT, 1994, COMPUT PHYS COMMUN, V84, P131, DOI 10.1016/0010-4655(94)90208-9
   HAUPTMANN S, 2003, PHYS CHEM CHEM PHYS, V5, P63
   HEISE U, 1990, INT ORTHOP, V14, P329
   Hochrein O, 2005, CHEM MATER, V17, P1978, DOI 10.1021/cm0401903
   HU H, 1991, MATER LETT, V12, P281, DOI 10.1016/0167-577X(91)90014-W
   HWANG MJ, 1994, J AM CHEM SOC, V116, P2515, DOI 10.1021/ja00085a036
   Itoh S, 2002, BIOMATERIALS, V23, P3919, DOI 10.1016/S0142-9612(02)00126-6
   Kato K, 1997, J MATER SCI, V32, P5533, DOI 10.1023/A:1018616306104
   Katti DR, 2005, BIOMACROMOLECULES, V6, P3276, DOI 10.1021/bm0503219
   Katti DR, 2005, CLAY CLAY MINER, V53, P171, DOI 10.1346/CCMN.2005.0530207
   KATTI KS, 2004, COLLOIDS INTERFACE B, V29, P133
   KOUTSOPOULOS S, 1995, LANGMUIR, V11, P1831, DOI 10.1021/la00005a065
   Lee WT, 2000, J PHYS-CONDENS MAT, V12, P9829, DOI 10.1088/0953-8984/12/48/302
   MANN S, 1993, SCIENCE, V261, P1286, DOI 10.1126/science.261.5126.1286
   MAPLE JR, 1988, P NATL ACAD SCI USA, V85, P5350, DOI 10.1073/pnas.85.15.5350
   MAPLE JR, 1994, J COMPUT CHEM, V15, P162, DOI 10.1002/jcc.540150207
   Minisini B, 2005, COMPOS PART A-APPL S, V36, P531, DOI 10.1016/j.compositesa.2004.10.016
   NAKAMOTO K, 1997, INFRARED RAMAN SPECT
   Qian JJ, 1996, J BIOMED MATER RES, V31, P545, DOI 10.1002/(SICI)1097-4636(199608)31:4<545::AID-JBM15>3.0.CO;2-F
   Ritschl F, 2002, Z ANORG ALLG CHEM, V628, P1385, DOI 10.1002/1521-3749(200206)628:6<1385::AID-ZAAC1385>3.0.CO;2-1
   Schmidt SR, 2005, LANGMUIR, V21, P8069, DOI 10.1021/la050615f
   Shevade AV, 2003, SENSOR ACTUAT B-CHEM, V93, P84, DOI 10.1016/S0925-4005(03)00245-4
   SINGH UC, 1984, J COMPUT CHEM, V5, P129, DOI 10.1002/jcc.540050204
   SKRTIC D, 1992, CALCIFIED TISSUE INT, V50, P55, DOI 10.1007/BF00297298
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Suetsugu Y, 2002, J MATER SCI-MATER M, V13, P767, DOI 10.1023/A:1016170924138
   Thorwarth M, 2005, BIOCHEM BIOPH RES CO, V329, P789, DOI 10.1016/j.bbrc.2005.01.157
   Verma D, 2006, J BIOMED MATER RES A, V77A, P59, DOI 10.1002/jbm.a.30592
   Zahn D, 2005, Z ANORG ALLG CHEM, V631, P1134, DOI 10.1002/zaac.200400529
   Zahn D, 2003, PHYS CHEM CHEM PHYS, V5, P4004, DOI 10.1039/b306358e
NR 41
TC 34
Z9 34
U1 4
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD APR
PY 2007
VL 27
IS 3
SI SI
BP 352
EP 371
DI 10.1016/j.msec.2006.05.048
PG 20
WC Materials Science, Multidisciplinary
SC Materials Science
GA 149EN
UT WOS:000245130000003
DA 2018-10-20
ER

PT J
AU Gil, ES
   Frankowski, DJ
   Hudson, SM
   Spontak, RJ
AF Gil, Eun S.
   Frankowski, David J.
   Hudson, Samuel M.
   Spontak, Richard J.
TI Silk fibroin membranes from solvent-crystallized silk fibroin/gelatin
   blends: Effects of blend and solvent composition
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT Symposium on Next Generation Biomaterals
CY SEP 25-28, 2005
CL Pittsburgh, PA
DE silk fibroin; gelatin; biomacromolecules; membranes; protein blends;
   bioconjugates
ID GELATIN; METHANOL; SCAFFOLDS; ORGANIZATION; DISSOLUTION; NETWORKS;
   BEHAVIOR; CELLS; FILMS
AB Protein membranes have been prepared by mixing gelatin (G) with Bombyx mori silk fibroin (SF) and using aqueous methanol (MeOH) to induce SF crystallization. Amorphous blends of these polymers appear quasi-homogeneous, as discerned from visual observation, electron microscopy and Fourier-transform infrared (FTIR) spectroscopy. Upon subsequent exposure to aqueous MeOH, SF undergoes a conformational change from random-coil to beta-sheet. This transformation occurs in pure SF, as well as in each of the G/SF blends, as discerned from FTIR spectroscopy and thermal calorimetry. The influence of MeOH-induced SF crystallization on structure and property development has been measured as functions of blend and solvent composition. By preserving a support scaffold above the G helix-to-coil transition temperature, the formation of crystalline SF networks in G/SF blends can be used to stabilize G-based hydrogels or generate SF membranes for biomaterial, pharmaceutical and gas-separation purposes. The present study not only examines the properties of G/SF blends before and after SF crystallization, but also establishes the foundation for future research into thermally-responsive G/SF bioconjugates. (c) 2006 Elsevier B.V. All rights reserved.
C1 N Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA.
   N Carolina State Univ, Fiber & Polymer Sci Program, Raleigh, NC 27695 USA.
   N Carolina State Univ, Dept Mat Sci & Engn, Raleigh, NC 27695 USA.
RP Spontak, RJ (reprint author), N Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA.
EM Rich_Spontak@ncsu.edu
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   DIGENIS GA, 1994, J PHARM SCI, V83, P915, DOI 10.1002/jps.2600830702
   Gao QW, 2000, POLYM J, V32, P269, DOI 10.1295/polymj.32.269
   Gil ES, 2006, BIOMACROMOLECULES, V7, P728, DOI 10.1021/bm050622i
   Gil ES, 2005, MACROMOL BIOSCI, V5, P702, DOI 10.1002/mabi.200500076
   Ha SW, 2003, BIOMACROMOLECULES, V4, P488, DOI 10.1021/bm0255948
   Joly-Duhamel C, 2002, LANGMUIR, V18, P7208, DOI 10.1021/la020189n
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kweon HY, 2001, POLYMER, V42, P6651, DOI 10.1016/S0032-3861(01)00104-5
   Laemmel E, 1998, J BIOMED MATER RES, V39, P446, DOI 10.1002/(SICI)1097-4636(19980305)39:3<446::AID-JBM14>3.0.CO;2-8
   Li MZ, 2002, POLYM ADVAN TECHNOL, V13, P605, DOI 10.1002/pat.159
   Li MZ, 2001, MACROMOL MATER ENG, V286, P529
   Liu Y, 2004, POLYMER, V45, P7705, DOI 10.1016/j.polymer.2004.09.005
   Masuda T, 2004, TISSUE ENG, V10, P523, DOI 10.1089/107632704323061889
   Mathur AB, 1997, BIOPOLYMERS, V42, P61, DOI 10.1002/(SICI)1097-0282(199707)42:1<61::AID-BIP6>3.0.CO;2-#
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   Min SJ, 1998, SEN-I GAKKAISHI, V54, P270, DOI 10.2115/fiber.54.5_270
   MINOURA N, 1990, POLYMER, V31, P265, DOI 10.1016/0032-3861(90)90117-H
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P961, DOI 10.1002/polb.1994.090320519
   Ulubayram K, 2001, BIOMATERIALS, V22, P1345, DOI 10.1016/S0142-9612(00)00287-8
   Valluzzi R, 2002, PHILOS T ROY SOC B, V357, P165, DOI 10.1098/rstb.2001.1032
   Viney C, 2000, J TEXT I, V91, P2, DOI 10.1080/00405000008659539
   Yang G, 2000, J MEMBRANE SCI, V177, P153, DOI 10.1016/S0376-7388(00)00467-1
   Yang YH, 2004, BIOMACROMOLECULES, V5, P773, DOI 10.1021/bm0343848
   Yoo MK, 2004, INT J BIOL MACROMOL, V34, P263, DOI 10.1016/j.ijbiomac.2004.06.002
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
NR 27
TC 22
Z9 23
U1 1
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD APR
PY 2007
VL 27
IS 3
SI SI
BP 426
EP 431
DI 10.1016/j.msec.2006.05.017
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 149EN
UT WOS:000245130000012
DA 2018-10-20
ER

PT J
AU Jalota, S
   Bhaduri, SB
   Tas, AC
AF Jalota, Sahil
   Bhaduri, Sarit B.
   Tas, A. Cuneyt
TI Osteoblast proliferation on neat and apatite-like calcium
   phosphate-coated titanium foam scaffolds
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT Symposium on Next Generation Biomaterals
CY SEP 25-28, 2005
CL Pittsburgh, PA
DE biomimetic; synthetic body fluid; coating; titanium
ID SYNTHETIC BODY-FLUIDS; OCTACALCIUM PHOSPHATE; HYDROXYAPATITE POWDERS;
   IN-VITRO; CARBONATE; GROWTH; CERAMICS; SURFACES; BONE; 37-DEGREES-C
AB The biocompatibility and the load-bearing ability of lightweight titanium made it possible to be used as a biomaterial, especially in hip revision and fixation surgery. It was initially shown that sand-blasted or surface-roughened titanium implants had an improved bone-bonding ability over the bioinert metallic surfaces. Plasma-spraying of a phase mixture of loosely-attached calcium phosphates on titanium implants further improved their in vivo bone-bonding ability. However, stoichiometric calcium hydroxyapatite ceramic of high crystallinity is known to have poor in vivo resorbability, and is shy of taking part in bone remodeling and of being resorbed by the osteoclasts. Supersaturated calcium phosphate (CaP). solutions, such as synthetic body fluids (SBF), on the other hand, are able to form "carbonated, hydrophilic and apatite-like" CaP nanoaggregates on titanium surfaces. A Tris-buffered SBF solution with an HCO3- concentration of 27 mM was used in this study. Neat, NaOH-etched, and SBF-coated (biomimetic coating) titanium foams were compared with in vitro cell culture experiments by using rat osteoblasts. SBF-coated foams were found to yield the highest protein concentration at the end of the in vitro culture tests. Such biomimetic coatings were easily formed on flat strips, springs, or 3D foams of titanium, without any geometric constraints. The coated titanium springs and foams were characterized by using XRD, SEM, and FTIR. (c) 2006 Elsevier B.V. All rights reserved.
C1 Mersin Univ, Dept Mat Sci & Engn, TR-33342 Mersin, Turkey.
   Clemson Univ, Sch Mat Sci & Engn, Clemson, SC 29634 USA.
RP Tas, AC (reprint author), Mersin Univ, Dept Mat Sci & Engn, TR-33342 Mersin, Turkey.
EM bhaduri@clemson.edu; actas@mersin.edu.tr
RI Tas, A. Cuneyt/B-1966-2008
CR Astala R, 2005, CHEM MATER, V17, P4125, DOI 10.1021/cm050523b
   Barrere F, 2002, BIOMATERIALS, V23, P1921, DOI 10.1016/S0142-9612(01)00318-0
   Bayraktar D, 1999, J EUR CERAM SOC, V19, P2573, DOI 10.1016/S0955-2219(99)00132-6
   Bigi A, 2000, BIOMACROMOLECULES, V1, P752, DOI 10.1021/bm0055854
   Chou YF, 2004, BIOMATERIALS, V25, P5323, DOI 10.1016/j.biomaterials.2003.12.037
   Chow L.C., 1996, US patent, Patent No. [5525, 148, 5525148, 5,525,148]
   Dorozhkina EI, 2003, J BIOMED MATER RES A, V67A, P578, DOI 10.1002/jbm.a.10127
   DRIESSENS FCM, 1982, MINERAL ASPECTS DENT
   Earle WR, 1943, J NATL CANCER I, V4, P165
   Grassmann O, 2004, BIOMATERIALS, V25, P277, DOI 10.1016/S0142-9612(03)00526-X
   Habibovic P, 2004, J MATER SCI-MATER M, V15, P373, DOI 10.1023/B:JMSM.0000021104.42685.9f
   HANKS JH, 1949, P SOC EXP BIOL MED, V71, P196
   Higgins CL, 2005, ARTERIOSCL THROM VAS, V25, P1567, DOI 10.1161/01.ATV.0000172017.79441.73
   Iijima M, 2001, Monogr Oral Sci, V18, P17
   Iimori Y, 2005, J MATER SCI-MATER M, V16, P73, DOI 10.1007/s10856-005-6449-x
   Kikuchi L, 2005, BIOMATERIALS, V26, P5285, DOI 10.1016/j.biomaterials.2005.01.009
   Kim HM, 2000, J MATER SCI-MATER M, V11, P421, DOI 10.1023/A:1008935924847
   KOKUBO T, 1990, J NON-CRYST SOLIDS, V120, P138, DOI 10.1016/0022-3093(90)90199-V
   Kokubo T, 2004, J MATER SCI-MATER M, V15, P99, DOI 10.1023/B:JMSM.0000011809.36275.0c
   Kokubo T, 1998, ACTA MATER, V46, P2519, DOI 10.1016/S1359-6454(98)80036-0
   Leventouri T, 2001, J MATER RES, V16, P2600, DOI 10.1557/JMR.2001.0357
   Lin SY, 2004, J BIOMED MATER RES B, V70B, P203, DOI 10.1002/jbm.b.30067
   Loong CK, 2000, BONE, V26, P599, DOI 10.1016/S8756-3282(00)00273-8
   Lu X, 2004, BIOMATERIALS, V25, P1779, DOI 10.1016/j.biomaterials.2003.08.028
   Marques PAAP, 2003, BIOMATERIALS, V24, P1541, DOI 10.1016/S0142-9612(02)00539-2
   MOLNAR Z, 1960, CLIN ORTHOP RELAT R, V17, P38
   NEWESELY H, 1961, ARCH ORAL BIOL, V6, P174, DOI 10.1016/0003-9969(61)90032-2
   Onuma K, 1998, CHEM MATER, V10, P3346, DOI 10.1021/cm980062c
   Oyane A, 2003, J BIOMED MATER RES A, V64A, P339, DOI 10.1002/jbm.a.10426
   POSNER AS, 1975, ACCOUNTS CHEM RES, V8, P273, DOI 10.1021/ar50092a003
   Rautaray D, 2004, CHEM MATER, V16, P1356, DOI 10.1021/cm035182l
   Ringer S, 1883, J Physiol, V4, P29
   ROLLAND C, 1991, CAN MINERAL, V29, P337
   Serro AP, 2003, BIOMATERIALS, V24, P4749, DOI 10.1016/S0142-9612(03)00372-7
   Tas AC, 2000, BIOMATERIALS, V21, P1429
   Tas AC, 2004, J MATER RES, V19, P2742, DOI 10.1557/JMR.2004.0349
   TAS AC, 2005, IN PRESS J MAT SCI M
   Yin XL, 2003, J CHEM PHYS, V118, P3717, DOI 10.1063/1.1539093
NR 38
TC 40
Z9 41
U1 2
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD APR
PY 2007
VL 27
IS 3
SI SI
BP 432
EP 440
DI 10.1016/j.msec.2006.05.052
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA 149EN
UT WOS:000245130000013
DA 2018-10-20
ER

PT J
AU Katz, JL
   Misra, A
   Spencer, P
   Wang, Y
   Bumrerraj, S
   Nomura, T
   Eppell, SJ
   Tabib-Azar, M
AF Katz, J. Lawrence
   Misra, Anil
   Spencer, Paulette
   Wang, Yong
   Bumrerraj, Sauwanan
   Nomura, Tsutomu
   Eppell, Steven J.
   Tabib-Azar, Massood
TI Multiscale mechanics of hierarchical structure/property relationships in
   calcified tissues and tissue/material interfaces
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT Symposium on Next Generation Biomaterials
CY SEP 25-28, 2005
CL Pittsburgh, PA
DE nanostructure; microstructure; bone; dentin; hierarchies; interfaces
ID EVANESCENT MICROWAVE PROBES; ATOMIC-FORCE MICROSCOPY; SCANNING
   ELECTRON-MICROSCOPY; DENTIN-ENAMEL JUNCTION; TURKEY LEG TENDONS;
   CONFOCAL RAMAN MICROSPECTROSCOPY; TITANIUM-ALLOY IMPLANTS; ELASTIC
   PROPERTIES; YOUNGS MODULUS; ACOUSTIC MICROSCOPY
AB This paper presents a review plus new data that describes the role hierarchical nanostructural properties play in developing an understanding of the effect of scale on the material properties (chemical, elastic and electrical) of calcified tissues as well as the interfaces that form between such tissues and biomaterials. Both nanostructural and microstructural properties will be considered starting with the size and shape of the apatitic mineralites in both young and mature bovine bone. Microstructural properties for human dentin and cortical and trabecular bone will be considered. These separate sets of data will be combined mathematically to advance the effects of scale on the modeling of these tissues and the tissue/biomaterial interfaces as hierarchical material/structural composites. Interfacial structure and properties to be considered in greatest detail will be that of the dentin/adhesive (d/a),interface, which presents a clear example of examining all three material properties, (chemical, elastic and electrical). In, this case,. finite element modeling (FEA) was based on the actual measured. values of the structure and elastic properties of the materials. comprising the d/a interface; this combination provides insight into factors and mechanisms that contribute to premature failure of dental composite fillings. At present, there are more elastic property data obtained by microstructural measurements, especially high frequency ultrasonic wave propagation (UWP) and scanning acoustic microscopy (SAM) techniques. However, atomic force microscopy (AFM) and nanoindentation (NI)of cortical and trabecular bone. and the dentin-enamel junction (DEJ) among others have become available allowing correlation of the nanostructural level measurements with those made on the microstructural level. (c) 2006 Elsevier B.V. All rights reserved.
C1 Univ Missouri, Sch Comp & Engn, Kansas City, MO USA.
   Univ Missouri, Sch Dent, Kansas City, MO USA.
   Khon Kaen Univ, Sch Med, Khon Kaen 40002, Thailand.
   Niigata Univ, Sch Dent, Niigata, Japan.
   Case Western Reserve Univ, Case Sch Engn, Cleveland, OH 44106 USA.
RP Katz, JL (reprint author), Univ Missouri, Sch Comp & Engn, Kansas City, MO USA.
EM katzjl@umke.edu
OI Eppell, Steven/0000-0002-0302-1910; Bumrerraj,
   Sauwanan/0000-0001-6704-5420; Spencer, Paulette/0000-0003-1447-826X
FU NIDCR NIH HHS [K25 DE015281, R01 DE014392, R01 DE014392-04]
CR Akiva U, 1998, J MATER SCI, V33, P1497, DOI 10.1023/A:1004303926771
   ARSENAULT AL, 1988, CALCIFIED TISSUE INT, V43, P202, DOI 10.1007/BF02555136
   ARSENAULT AL, 1989, BONE MINER, V6, P165, DOI 10.1016/0169-6009(89)90048-2
   ASCENZI A, 1994, J BIOMECH, V27, P875, DOI 10.1016/0021-9290(94)90260-7
   ASH EA, 1972, NATURE, V237, P510, DOI 10.1038/237510a0
   AVERY JK, 2002, ORAL DEV HIST, P74
   BAEZ AV, 1956, J OPT SOC AM, V46, P901, DOI 10.1364/JOSA.46.000901
   BALOOCH M, 1998, J BIOMEDICAL MAT RES, V40
   BERTHETCOLOMINAS C, 1979, J MOL BIOL, V134, P431, DOI 10.1016/0022-2836(79)90362-0
   Bethe HA, 1944, PHYS REV, V66, P163, DOI 10.1103/PhysRev.66.163
   Biro L., 1983, Ultrasonics International 83. Conference Proceedings, P79
   BLAIR JM, 1995, SEMIN ARTHRITIS RHEU, V24, P359, DOI 10.1016/S0049-0172(95)80005-0
   BRIGGS GAD, 1992, ACOUSTIC MICROSCOPY
   BUMRERRAJ S, 2001, ANN BIOMED ENG, V29, P1
   BUMRERRAJ S, 1999, DEP BIOMEDICAL ENG
   BUTLER WT, 1992, OPER DENT, P18
   CHAN MFWY, 1992, J DENT, V20, P287, DOI 10.1016/0300-5712(92)90049-I
   Chang CS, 2002, ENG FRACT MECH, V69, P1907, DOI 10.1016/S0013-7944(02)00068-1
   CHANG CS, 1990, J ENG MECH-ASCE, V116, P1077, DOI 10.1061/(ASCE)0733-9399(1990)116:5(1077)
   CHASE DB, 1991, ANAL RAMAN SPECTROSC, P21
   Ciocan R, 1999, MICROSCALE THERM ENG, V3, P253
   Cowin SC, 2001, BONE MECH
   CRAIG R. G., 1958, JOUR DENTAL RES, V37, P710, DOI 10.1177/00220345580370041801
   Daculsi G, 1997, INT REV CYTOL, V172, P129, DOI 10.1016/S0074-7696(08)62360-8
   DAS P, 1983, ULTR S P, P718
   Dean JC, 1995, J ARTHROPLASTY, V10, P830, DOI 10.1016/S0883-5403(05)80083-X
   Dunne S M, 1997, Int Dent J, V47, P123
   Eick J D, 1992, Proc Finn Dent Soc, V88 Suppl 1, P225
   EICK JD, 1970, J DENT RES, V49, P1359, DOI 10.1177/00220345700490063601
   Eppell SJ, 2001, J ORTHOPAED RES, V19, P1027, DOI 10.1016/S0736-0266(01)00034-1
   FEE M, 1989, OPT COMMUN, V69, P219, DOI 10.1016/0030-4018(89)90103-X
   FEIGHAN JE, 1995, J BONE JOINT SURG AM, V77, P1380, DOI 10.2106/00004623-199509000-00015
   Ferrari M, 1997, ADV DOUBLET MECH
   FRUSHOUR BG, 1975, BIOPOLYMERS, V14, P379, DOI 10.1002/bip.1975.360140211
   Gao C, 1997, APPL PHYS LETT, V71, P1872, DOI 10.1063/1.120444
   Gao HJ, 1998, J MECH PHYS SOLIDS, V46, P187, DOI 10.1016/S0022-5096(97)00047-1
   GILMORE RS, 1970, ARCH ORAL BIOL, V15, P787, DOI 10.1016/0003-9969(70)90042-7
   GILMORE RS, 1982, J MATER SCI, V17, P1131, DOI 10.1007/BF00543533
   GOLDBERG VM, 1995, CLIN ORTHOP RELAT R, P122
   Golosovsky M, 1998, ULTRAMICROSCOPY, V71, P133, DOI 10.1016/S0304-3991(97)00058-2
   Grenoble D E, 1971, J Biomed Mater Res, V5, P503, DOI 10.1002/jbm.820050506
   Grenoble D E, 1971, J Biomed Mater Res, V5, P489, DOI 10.1002/jbm.820050505
   GRENOBLE DE, 1971, J DENT RES, V50, P109, DOI 10.1177/00220345710500010301
   GUTMANN RJ, 1987, IEEE MTT S, P281
   GWINNETT AJ, 1994, DENT MATER, V10, P150
   HALL DR, 1973, J DENT RES, V52, P390, DOI 10.1177/00220345730520023801
   Hashimoto M, 2002, J DENT RES, V81, P74, DOI 10.1177/154405910208100116
   Hodzic A, 2000, POLYMER, V41, P6895, DOI 10.1016/S0032-3861(99)00890-3
   KATZ JL, 1990, J MATER SCI-MATER M, V1, P1, DOI 10.1007/BF00705346
   KATZ JL, 1987, J BIOMECH, V20, P1063, DOI 10.1016/0021-9290(87)90024-8
   Katz JL, 2003, J BIOMED MATER RES A, V66A, P120, DOI 10.1002/jbm.a.10551
   Katz JL, 2002, TISSUE ENGINEERING AND BIODEGRADABLE EQUIVALENTS: SCIENTIFIC AND CLINICAL APPLICATIONS, P775
   KATZ JL, 1980, NATURE, V283, P106, DOI 10.1038/283106a0
   KATZ JL, 1993, J BIOMECH ENG-T ASME, V115, P543, DOI 10.1115/1.2895537
   KATZ JL, 1988, J MATER SCI LETT, V7, P133, DOI 10.1007/BF01730594
   KATZ JL, 1971, J BIOMECH, V4, P221, DOI 10.1016/0021-9290(71)90007-8
   Katz JL, 2001, J BIOMED MATER RES, V58, P366, DOI 10.1002/jbm.1030.abs
   KATZ JL, 1984, CALCIFIED TISSUE INT, V36, pS31
   KATZ JL, 1989, P 1 INT BIOC S TOK, P86
   KATZ JL, 1976, ADV BIOENGINEERING
   KATZ JL, 1985, B SOC CHIM FR, V4, P514
   KATZ JL, 1987, ADV DENT RES, V1, P39
   KATZ JL, 2000, EARLY DETECTION DENT, V2, P443
   Kinney JH, 1999, ARCH ORAL BIOL, V44, P813, DOI 10.1016/S0003-9969(99)00080-1
   Kinney JH, 2001, CALCIFIED TISSUE INT, V69, P31, DOI 10.1007/s00223-001-0006-5
   KINNEY JH, 1996, J BIOMECHANICAL ENG, V118, P9
   LAKES R, 1998, VISCOELASTIC SOLIDS
   LAKES RS, 1974, J BIOMECH, V7, P259, DOI 10.1016/0021-9290(74)90017-7
   LEES S, 1972, J BIOMECH, V15, P557
   LEGEROS RZ, 1991, MONOGRAPHS ORAL SCI, P121
   Leloup G, 2001, J DENT RES, V80, P1605, DOI 10.1177/00220345010800070301
   LEMONS RA, 1974, APPL PHYS LETT, V24, P163, DOI 10.1063/1.1655136
   LEMONS RA, 1979, PHYS ACOUSTICS, V14, P1
   LIN CP, 1994, J DENT RES, V73, P1072, DOI 10.1177/00220345940730050901
   LIN CP, 1993, J HISTOCHEM CYTOCHEM, V41, P381, DOI 10.1177/41.3.8429200
   LISY F, 1994, J APPL POLYM SCI, V52, P329, DOI 10.1002/app.1994.070520217
   LUKOSZ W, 1984, WORKSH UNC IM SEPT, P73
   Maev RG, 2002, ULTRASOUND MED BIOL, V28, P131, DOI 10.1016/S0301-5629(01)00480-X
   Marshall GW, 2001, J BIOMED MATER RES, V54, P87, DOI 10.1002/1097-4636(200101)54:1<87::AID-JBM10>3.0.CO;2-Z
   Marshall GW, 1997, J DENT, V25, P441, DOI 10.1016/S0300-5712(96)00065-6
   MARSHALL GW, 1993, DENT MATER, V9, P265, DOI 10.1016/0109-5641(93)90072-X
   Meiers JC, 1996, OPER DENT, V21, P153
   Meredith N, 1996, ARCH ORAL BIOL, V41, P539, DOI 10.1016/0003-9969(96)00020-9
   MEUNIER A, 1988, J ORTHOPAED RES, V6, P770, DOI 10.1002/jor.1100060521
   MISRA A, 1993, INT J SOLIDS STRUCT, V30, P2547, DOI 10.1016/0020-7683(93)90165-4
   Misra A, 2004, J BIOMED MATER RES B, V70B, P56, DOI 10.1002/jbm.b.30012
   Misra A, 1999, J GEOPHYS RES-SOL EA, V104, P23175, DOI 10.1029/1999JB900210
   MISRA A, 2003, J DENT RES, V82, P1643
   MISRA A, 2004, NUMERICAL MODELS GEO, P5
   Nakabayashi N, 1992, Proc Finn Dent Soc, V88 Suppl 1, P321
   Nakabayashi N, 1996, J DENT RES, V75, P1706, DOI 10.1177/00220345960750091401
   Nordbo H, 1998, QUINTESSENCE INT, V29, P5
   Pashley D H, 1993, Quintessence Int, V24, P618
   Pashley D H, 1992, Proc Finn Dent Soc, V88 Suppl 1, P215
   POHL DW, 1984, APPL PHYS LETT, V44, P651, DOI 10.1063/1.94865
   RASMUSSEN ST, 1984, J DENT RES, V63, P1279, DOI 10.1177/00220345840630110501
   Renugopalakrishnan V, 1998, Z NATURFORSCH C, V53, P383
   Rho JY, 1999, J BIOMED MATER RES, V45, P48, DOI 10.1002/(SICI)1097-4636(199904)45:1<48::AID-JBM7>3.0.CO;2-5
   Rho JY, 1997, BIOMATERIALS, V18, P1325, DOI 10.1016/S0142-9612(97)00073-2
   Rho JY, 1999, BONE, V25, P295, DOI 10.1016/S8756-3282(99)00163-5
   RHO JY, 1999, J MATER SCI-MATER M, V10, P1
   SANO H, 1995, J DENT RES, V74, P1093, DOI 10.1177/00220345950740041001
   Sasaki N, 1996, J BIOMECH, V29, P655, DOI 10.1016/0021-9290(95)00110-7
   Schulze KA, 2002, J DENT RES, V81, pA139
   SINGH S, 1989, J MATER SCI LETT, V8, P165, DOI 10.1007/BF00730713
   SINGH S, 1988, J NON-CRYST SOLIDS, V102, P112, DOI 10.1016/0022-3093(88)90120-2
   SINGH S, 1988, MRS P, P599
   SINGH S, 1989, MAT RES SOC S P BIOM, P599
   SOOHOO RF, 1962, J APPL PHYS, V33, P1276, DOI 10.1063/1.1728690
   Spears IR, 1997, J DENT RES, V76, P1690, DOI 10.1177/00220345970760101101
   Spencer P, 1999, QUINTESSENCE INT, V30, P501
   Spencer P, 2002, J BIOMED MATER RES, V62, P447, DOI 10.1002/jbm.10364
   Spencer P, 2001, J DENT RES, V80, P1802, DOI 10.1177/00220345010800090601
   Spencer P, 2000, J DENT RES, V79, P1458, DOI 10.1177/00220345000790070501
   SPENCER P, 2004, TISSUE ENG NOVEL DEL, P599
   STRANICK SJ, 1994, J PHYS CHEM-US, V98, P1762, DOI 10.1021/j100058a008
   Tabib-Azar M, 1999, BIOMED MICRODEVICES, V2, P73, DOI 10.1023/A:1009911417776
   Tabib-Azar M, 2000, ENG APPL ARTIF INTEL, V13, P549, DOI 10.1016/S0952-1976(00)00035-X
   Tabib-Azar M, 2000, SENSOR ACTUAT B-CHEM, V67, P112, DOI 10.1016/S0925-4005(00)00391-9
   Tabib-Azar M, 1999, REV SCI INSTRUM, V70, P3707, DOI 10.1063/1.1149981
   Tabib-Azar M, 1999, REV SCI INSTRUM, V70, P3387, DOI 10.1063/1.1149924
   Tabib-Azar M, 1999, REV SCI INSTRUM, V70, P3381, DOI 10.1063/1.1149923
   Tabib-Azar M, 1999, REV SCI INSTRUM, V70, P3083, DOI 10.1063/1.1149871
   Tabib-Azar M, 2000, REV SCI INSTRUM, V71, P1460, DOI 10.1063/1.1150480
   Tabib-Azar M, 1999, REV SCI INSTRUM, V70, P2783, DOI 10.1063/1.1149795
   Tabib-Azar M, 1999, REV SCI INSTRUM, V70, P1725, DOI 10.1063/1.1149658
   Tabib-Azar M, 1999, IEEE T INSTRUM MEAS, V48, P1111, DOI 10.1109/19.816123
   TABIBAZAR M, 1993, MEAS SCI TECHNOL, V4, P583, DOI 10.1088/0957-0233/4/5/007
   TABIBAZAR M, 2000, CANADIAN SOC NONDEST
   TABIBAZAR M, 2000, EVANESCENT MICROWAVE
   TABIBAZAR M, 2000, REV PROGR QUANTITA A, V20, P446
   TABIBAZAR M, 2001, MAT EVALUATIONS, P70
   TABIBAZAR M, 2000, REV PROGR QUANTITA A, V20, P400
   TENCATE AR, 1994, ORAL HIST
   Tesch W, 2001, CALCIFIED TISSUE INT, V69, P147, DOI 10.1007/s00223-001-2012-z
   Thanawalla AS, 1998, APPL PHYS LETT, V73, P2491, DOI 10.1063/1.122492
   Thiagarajan G, 2004, INT J SOLIDS STRUCT, V41, P2919, DOI 10.1016/j.ijsolstr.2004.01.013
   Tong W, 2003, CALCIFIED TISSUE INT, V72, P592, DOI 10.1007/s00223-002-1077-7
   Tong WD, 2002, J BIOMED MATER RES, V61, P346, DOI 10.1002/jbm.10165
   Urabe I, 2000, AM J DENT, V13, P129
   van Mier J. G. M., 1997, FRACTURE PROCESSES C
   VANMEERBEEK B, 1993, J DENT RES, V72, P1423, DOI 10.1177/00220345930720101201
   WAHLE JJ, 1993, J PROSTHET DENT, V69, P160, DOI 10.1016/0022-3913(93)90135-B
   WALTERS NE, 1980, MECH PROPERTIES BIOL, P99
   WALTON AG, 1970, CALC TISS RES, V6, P162, DOI 10.1007/BF02196195
   Wang RZ, 1998, CONNECT TISSUE RES, V39, P269, DOI 10.3109/03008209809021502
   Wang Y, 2002, J BIOMED MATER RES, V60, P300, DOI 10.1002/jbm.10108
   Wang Y, 2003, J DENT RES, V82, P141, DOI 10.1177/154405910308200213
   Wang Y, 2002, J BIOMED MATER RES, V59, P46, DOI 10.1002/jbm.1215
   Weiner S, 1999, J STRUCT BIOL, V126, P27, DOI 10.1006/jsbi.1999.4096
   WEISS JA, 1987, IEEE MTT S, P457
   White SN, 2000, J AM CERAM SOC, V83, P238, DOI 10.1111/j.1151-2916.2000.tb01181.x
   WILSON RG, 1984, J APPL PHYS, V55, P3261, DOI 10.1063/1.333384
   Xu HHK, 1998, J DENT RES, V77, P472, DOI 10.1177/00220345980770030601
   YOON HS, 1985, 1984 ULTR S P NEW YO, P786
   Yourtee DM, 2001, J BIOMED MATER RES, V57, P522, DOI 10.1002/1097-4636(20011215)57:4<522::AID-JBM1198>3.0.CO;2-9
   Zhang Y, 1998, DENT MATER, V14, P222, DOI 10.1016/S0109-5641(98)00035-9
   ZIMMERMAN MC, 1990, IEEE T BIO-MED ENG, V37, P433, DOI 10.1109/10.55634
NR 158
TC 35
Z9 35
U1 4
U2 31
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD APR
PY 2007
VL 27
IS 3
SI SI
BP 450
EP 468
DI 10.1016/j.msec.2006.05.055
PG 19
WC Materials Science, Multidisciplinary
SC Materials Science
GA 149EN
UT WOS:000245130000015
PM 18270549
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Koch, CF
   Johnson, S
   Kumar, D
   Jelinek, M
   Chrisey, DB
   Doraiswamy, A
   Jin, C
   Narayan, RJ
   Millailescu, IN
AF Koch, C. F.
   Johnson, S.
   Kumar, D.
   Jelinek, M.
   Chrisey, D. B.
   Doraiswamy, A.
   Jin, C.
   Narayan, R. J.
   Millailescu, I. N.
TI Pulsed laser deposition of hydroxyapatite thin films
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT Symposium on Next Generation Biomaterials
CY SEP 25-28, 2005
CL Pittsburgh, PA
DE hydroxyapatite; pulsed laser deposition; bioactive ceramics
ID DIFFERENT SUBSTRATE TEMPERATURES; TOTAL HIP-ARTHROPLASTY; 355 NM;
   HYDROXYLAPATITE FILMS; MECHANICAL-PROPERTIES; TITANIUM SUBSTRATE;
   APATITE COATINGS; DENTAL IMPLANTS; WEAR PARTICLES; HIGH-ENERGY
AB Hydroxyapatite is a bioactive ceramic material that mimics the mineral composition of natural bone. This material does not possess acceptable mechanical properties for use as a bulk biomaterial; however, it does demonstrate significant potential for use as a coating on metallic orthopaedic and dental prostheses. This paper reviews recent developments involving pulsed laser deposition of hydroxyapatite thin films for medical and dental applications. The structural, mechanical, and biological properties of hydroxyapatite thin films are described. In addition, future directions in pulsed laser deposition of hydroxyapatite thin films are discussed. (c) 2006 Elsevier B.V. All rights reserved.
C1 Univ N Carolina, Joint Dept Biomed Engn, Chapel Hill, NC 27599 USA.
   Natl Inst Lasers Plasma & Radiat Phys, Bucharest, Romania.
   USN, Res Lab, Washington, DC 20375 USA.
   Acad Sci Czech Republ, Inst Phys, Prague, Czech Republic.
   N Carolina Agr & Tech State Univ, Dept Mech & Chem Engn, Greensboro, NC 27411 USA.
   Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.
RP Narayan, RJ (reprint author), Univ N Carolina, Joint Dept Biomed Engn, 152 MacNider Hall,Campus Box 7575, Chapel Hill, NC 27599 USA.
EM roger_narayan@unc.edu
RI Narayan, Roger/J-2789-2013
OI Narayan, Roger/0000-0002-4876-9869; Jelinek,
   Miroslav/0000-0001-9824-1117
CR Antonov EN, 1997, BIOMATERIALS, V18, P1043, DOI 10.1016/S0142-9612(97)00030-6
   Antonov EN, 1996, SPECTROCHIM ACTA A, V52, P123, DOI 10.1016/0584-8539(95)01597-3
   ANTONOV EN, 1995, J ADV MATER, V2, P228
   Antonov EN, 1998, J BIOMED OPT, V3, P423, DOI 10.1117/1.429852
   Arias JL, 2003, APPL SURF SCI, V208, P57, DOI 10.1016/S0169-4332(02)01336-3
   Arias JL, 2003, BIOMATERIALS, V24, P3403, DOI 10.1016/S0142-9612(03)00202-3
   Arias JL, 2002, VACUUM, V67, P653, DOI 10.1016/S0042-207X(02)00257-9
   BAGRATASHVILI VN, 1995, APPL PHYS LETT, V66, P2451, DOI 10.1063/1.113992
   Ball MD, 2001, BIOMATERIALS, V22, P337, DOI 10.1016/S0142-9612(00)00189-7
   Barrack RL, 1999, CLIN ORTHOP RELAT R, P175
   Bi YM, 2001, J BONE MINER RES, V16, P2082, DOI 10.1359/jbmr.2001.16.11.2082
   Buchanan JM, 2002, KEY ENG MAT, V218-2, P487, DOI 10.4028/www.scientific.net/KEM.218-220.487
   COTELL CM, 1992, TISSUE INDUCING MAT, P2
   COTELL CM, 1994, PULSED LASER DEPOSIT, P549
   Craciun V, 1999, J APPL PHYS, V85, P8410, DOI 10.1063/1.370689
   Doorn PF, 1996, CLIN ORTHOP RELAT R, pS206, DOI 10.1097/00003086-199608001-00018
   Dostalova T, 2001, J BIOMED OPT, V6, P239, DOI 10.1117/1.1357191
   DRIESSENS FCM, 1983, BIOCERAMICS CALCIUM, P162
   Dubok VA, 2000, POWDER METALL MET C+, V39, P381, DOI 10.1023/A:1026617607548
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   DULEY WW, 1996, UV LASERS EFFECTS AP
   Dumbleton J, 2004, J BONE JOINT SURG AM, V86A, P2526, DOI 10.2106/00004623-200411000-00028
   Elliott JC, 1994, STRUCTURE CHEM APATI
   Fernandez-Pradas JM, 2000, APPL PHYS A-MATER, V71, P37
   Fernandez-Pradas JM, 1999, J MATER RES, V14, P4715, DOI 10.1557/JMR.1999.0638
   Fernandez-Pradas JM, 1998, THIN SOLID FILMS, V317, P393, DOI 10.1016/S0040-6090(97)00629-9
   Fernandez-Pradas JM, 2002, BIOMATERIALS, V23, P1989, DOI 10.1016/S0142-9612(01)00327-1
   GarciaSanz FJ, 1997, J MATER SCI-MATER M, V8, P861, DOI 10.1023/A:1018549720873
   Hamdi M, 2000, THIN SOLID FILMS, V377, P484, DOI 10.1016/S0040-6090(00)01276-1
   Haynes DR, 2004, BIOMATERIALS, V25, P4877, DOI 10.1016/j.biomaterials.2004.01.003
   HEAD WC, 1995, CLIN ORTHOP RELAT R, V311, P85
   Holand W, 1997, J NON-CRYST SOLIDS, V219, P192, DOI 10.1016/S0022-3093(97)00329-3
   Hontsu S, 1996, JPN J APPL PHYS 2, V35, pL1208
   Hontsu S, 1997, THIN SOLID FILMS, V295, P214, DOI 10.1016/S0040-6090(96)09146-8
   Jelinek M, 1996, P SOC PHOTO-OPT INS, V2887, P120, DOI 10.1117/12.251929
   JELINEK M, 1995, THIN SOLID FILMS, V257, P125, DOI 10.1016/0040-6090(94)06340-0
   Jelinek M, 2002, MOL CRYST LIQ CRYST, V374, P599
   Katto M, 2002, APPL SURF SCI, V197, P768, DOI 10.1016/S0169-4332(02)00411-7
   KIJIMA T, 1979, J AM CERAM SOC, V62, P455, DOI 10.1111/j.1151-2916.1979.tb19104.x
   Liang H, 2004, VACUUM, V73, P317, DOI 10.1016/j.vacuum.2003.12.160
   Lo WJ, 2000, J BIOMED MATER RES, V50, P536, DOI 10.1002/(SICI)1097-4636(20000615)50:4<536::AID-JBM9>3.3.CO;2-L
   Lu YP, 2004, BIOMATERIALS, V25, P4393, DOI [10.1016/j.biomaterials.2003.08.014, 10.1016/j.biomaterials.2003.10.092]
   Masetti E, 1996, P SOC PHOTO-OPT INS, V2965, P128, DOI 10.1117/12.257369
   Mayor B, 1998, THIN SOLID FILMS, V317, P363, DOI 10.1016/S0040-6090(97)00625-1
   Miyazaki T, 2002, BIOMATERIALS, V23, P827, DOI 10.1016/S0142-9612(01)00188-0
   Narayan RJ, 2004, JOM-US, V56, P38, DOI 10.1007/s11837-004-0289-x
   Nelea V, 2003, APPL SURF SCI, V208, P638, DOI 10.1016/S0169-4332(02)01413-7
   Nelea V, 2002, APPL SURF SCI, V186, P483, DOI 10.1016/S0169-4332(01)00754-1
   Nelea V, 2000, APPL SURF SCI, V168, P127, DOI 10.1016/S0169-4332(00)00616-4
   NELEA VD, 1998, SPIE P, V3405, P218
   PARKER TL, 1996, CELL ENG, V1, P91
   Pelletier H, 2004, NUCL INSTRUM METH B, V216, P275, DOI 10.1016/j.nimb.2003.11.046
   Sharkawy AA, 1997, J BIOMED MATER RES, V37, P401
   SINGH RK, 1994, BIOMATERIALS, V15, P522, DOI 10.1016/0142-9612(94)90018-3
   Sun LM, 2001, J BIOMED MATER RES, V58, P570, DOI 10.1002/jbm.1056.abs
   Sun LM, 2002, J BIOMED MATER RES, V62, P228, DOI 10.1002/jbm.10315
   TIGGES S, 1994, AM J ROENTGENOL, V162, P1387, DOI 10.2214/ajr.162.6.8192005
   TORRISI L, 1993, THIN SOLID FILMS, V227, P32, DOI 10.1016/0040-6090(93)90183-P
   TORRISI L, 1994, THIN SOLID FILMS, V237, P12, DOI 10.1016/0040-6090(94)90229-1
   Wang CK, 1997, BIOMATERIALS, V18, P1331, DOI 10.1016/S0142-9612(97)00024-0
   Zeng HT, 2000, J BIOMED MATER RES, V50, P239, DOI 10.1002/(SICI)1097-4636(200005)50:2<239::AID-JBM19>3.0.CO;2-V
NR 61
TC 74
Z9 76
U1 1
U2 30
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD APR
PY 2007
VL 27
IS 3
SI SI
BP 484
EP 494
DI 10.1016/j.msec.2006.05.025
PG 11
WC Materials Science, Multidisciplinary
SC Materials Science
GA 149EN
UT WOS:000245130000018
DA 2018-10-20
ER

PT J
AU Patz, TM
   Doraiswamy, A
   Narayan, RJ
   Menegazzo, N
   Kranz, C
   Mizaikoff, B
   Zhong, Y
   Bellamkonda, R
   Bumgardner, JD
   Elder, SH
   Walboomers, XF
   Modi, R
   Chrisey, DB
AF Patz, T. M.
   Doraiswamy, A.
   Narayan, R. J.
   Menegazzo, N.
   Kranz, C.
   Mizaikoff, B.
   Zhong, Y.
   Bellamkonda, R.
   Bumgardner, J. D.
   Elder, S. H.
   Walboomers, X. F.
   Modi, R.
   Chrisey, D. B.
TI Matrix assisted pulsed laser evaporation of biomaterial thin films
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article
CT Symposium on Next Generation Biomaterials
CY SEP 25-28, 2005
CL Pittsburgh, PA
DE matrix assisted pulsed laser evaporation; poly (D, L) lactic acid;
   chitosan; dexamethasone; thin films
ID IN-VITRO; DEPOSITION; CHITOSAN; POLYMER; DEGRADATION; INJURY; MAPLE;
   VIVO
AB I In this paper, processing of biomaterial thin films using a novel physical vapor deposition process known as matrix assisted pulsed laser evaporation (MAPLE) is reviewed. The matrix assisted pulsed laser evaporation process provides excellent control over several film parameters, including thickness, roughness, homogeneity, and reliability. Deposition of dexamethasone thin films, Poly (1), L) lactic acid/dexamethasone bilayer thin films, and chitosan thin films is reviewed. The results highlight the expanding role of matrix assisted pulsed laser evaporation process in biomaterials, drug delivery, and tissue engineering. (c) 2006 Published by Elsevier B.V.
C1 USN, Res Lab, Washington, DC 20375 USA.
   Univ Nijmegen, Med Ctr, Dept Periodontol & Biomat, Nijmegen, Netherlands.
   Mississippi State Univ, Dept Agr & Biol Engn, Mississippi State, MS 39762 USA.
   Univ Memphis, Dept Biomed Engn, Memphis, TN 38152 USA.
   Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.
   Univ N Carolina, Joint Dept Biomed Engn, Chapel Hill, NC USA.
   Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.
RP Chrisey, DB (reprint author), USN, Res Lab, Washington, DC 20375 USA.
EM douglas.chrisey@ndsu.edu
RI Kranz, Christine/F-3838-2014; Narayan, Roger/J-2789-2013; Mizaikoff,
   Boris/G-9959-2013; Walboomers, X.Frank/B-3692-2013
OI Kranz, Christine/0000-0002-6001-0580; Narayan,
   Roger/0000-0002-4876-9869; Mizaikoff, Boris/0000-0002-5583-7962; 
CR Beamson G., 1992, HIGH RESOLUTION XPS
   Bubb DM, 2002, J APPL PHYS, V91, P2055, DOI 10.1063/1.1427138
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Chrisey DB, 2003, CHEM REV, V103, P553, DOI 10.1021/cr010428w
   Cristescu R, 2004, APPL PHYS A-MATER, V79, P1023, DOI 10.1007/s00339-004-2619-9
   Cui XY, 2003, BIOMATERIALS, V24, P777, DOI 10.1016/S0142-9612(02)00415-5
   Elcin AE, 1998, NEUROL RES, V20, P648
   Elcin YM, 1999, ARTIF ORGANS, V23, P146, DOI 10.1046/j.1525-1594.1999.06222.x
   Golde S, 2003, EUR J NEUROSCI, V18, P2527, DOI 10.1046/j.1460-9568.2003.02917.x
   Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3
   HOROWITZ ST, 1957, J AM CHEM SOC, V79, P5046, DOI 10.1021/ja01575a059
   Illum L, 1998, PHARMACEUT RES, V15, P1326
   Inagaki N, 2003, J APPL POLYM SCI, V89, P96, DOI 10.1002/app.12160
   KATZUNG BG, 1995, EXAMINATION BOARD RE
   Kim JM, 2003, J PHARMACOL SCI, V92, P74, DOI 10.1254/jphs.92.74
   Kister G, 1998, POLYMER, V39, P267, DOI 10.1016/S0032-3861(97)00229-2
   Klokkevold PR, 1996, J PERIODONTOL, V67, P1170, DOI 10.1902/jop.1996.67.11.1170
   LEUCHTNER RE, 1992, SURF COAT TECH, V51, P476, DOI 10.1016/0257-8972(92)90285-I
   Liberto CM, 2004, J NEUROCHEM, V89, P1092, DOI 10.1111/j.1471-4159.2004.02420.x
   Mayumi A, 2003, J FAC AGR KYUSHU U, V48, P97
   McGill RA, 1998, IEEE T ULTRASON FERR, V45, P1370, DOI 10.1109/58.726464
   McGraw J, 2001, J NEUROSCI RES, V63, P109, DOI 10.1002/1097-4547(20010115)63:2<109::AID-JNR1002>3.0.CO;2-J
   MUZZARELLI RAA, 1993, BIOMATERIALS, V14, P925, DOI 10.1016/0142-9612(93)90134-N
   Park JH, 2000, INT J INORG MATER, V2, P153, DOI 10.1016/S1466-6049(99)00071-9
   Pique A, 1998, MATER RES SOC SYMP P, V526, P421, DOI 10.1557/PROC-526-421
   Properzi F, 2003, BIOCHEM SOC T, V31, P335, DOI 10.1042/BST0310335
   Ringeisen BR, 2001, LANGMUIR, V17, P3472, DOI 10.1021/la0016874
   Schwartz AB, 2004, ANNU REV NEUROSCI, V27, P487, DOI 10.1146/annurev.neuro.27.070203.144233
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   Tsang WS, 2003, APPL PHYS A-MATER, V77, P693, DOI 10.1007/s00339-002-1894-6
   Turner JN, 1999, EXP NEUROL, V156, P33, DOI 10.1006/exnr.1998.6983
   WHISTLER RL, 1957, METHODS CARBOHYDRATE
   Wu PK, 2001, THIN SOLID FILMS, V398, P607, DOI 10.1016/S0040-6090(01)01347-5
NR 33
TC 25
Z9 26
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD APR
PY 2007
VL 27
IS 3
BP 514
EP 522
DI 10.1016/j.msec.2006.05.039
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA 149EN
UT WOS:000245130000022
DA 2018-10-20
ER

PT J
AU Thompson, JY
   Stoner, BR
   Piascik, JR
AF Thompson, Jeffrey Y.
   Stoner, Brian R.
   Piascik, Jeffrey R.
TI Ceramics for restorative dentistry: Critical aspects for fracture and
   fatigue resistance
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT Symposium on Next Generation Biomaterals
CY SEP 25-28, 2005
CL Pittsburgh, PA
DE dental ceramics; biomaterial; fracture; toughness; zirconia; thin film
ID ZIRCONIA THIN-FILMS; MECHANICAL-PROPERTIES; TETRAGONAL ZIRCONIA;
   SPUTTERING PROCESS; FLEXURAL STRENGTH; DENTAL CERAMICS; TOUGHNESS;
   COATINGS; ALUMINA; STRESS
AB Development of non-metallic restorative materials is a high priority due to biocompatibility issues and environmental concerns associated with metals waste and disposal. Ceramics are an ideal candidate for replacing metal-based restorative materials. Ceramics provide excellent chemical durability, wear resistance, biocompatibility, environmental friendliness and esthetics. However, widespread all-ceramic restoration use has been hindered by concerns related to marginal fracture resistance and clinical longevity. The recent introduction of higher toughness materials, especially partially stabilized zirconia, has expanded the range of clinically acceptable applications for all-ceramic restorative systems. In addition, advanced fabrication techniques such as CAD/CAM have reduced some of the problems associated with processing-induced flaws that can lead to short-term catastrophic failures in vivo. Some current research is focused on surface modification techniques (thin films, coatings, advanced adhesives) intended to minimize the effects of fabrication-induced defects. (c) 2006 Elsevier B.V. All rights reserved.
C1 Univ Texas, Dept Biomed Engn, San Antonio, TX 78249 USA.
   Univ N Carolina, Curriculum Appl & Mat Sci, Chapel Hill, NC 27599 USA.
   RTI Int, Ctr Mat & Elect Technol, Res Triangle Pk, NC 27709 USA.
RP Thompson, JY (reprint author), Univ Texas, Dept Biomed Engn, San Antonio, TX 78249 USA.
EM jeffrey.thompson@utsa.edu
RI Stoner, Brian/D-9747-2011
CR AMOR SB, 1998, MAT SCI ENG B-SOLID, V57, P28
   Anusavice K J, 1992, Int J Prosthodont, V5, P351
   Arenholt-Bindslev D., 1992, ADV DENT RES, V6, P125
   BAYNE SC, 1996, QUINTESSENCE INT, V27, P137
   DAVIES GB, 1988, SURF COAT TECH, V36, P419, DOI 10.1016/0257-8972(88)90170-3
   DURR D, 1993, J DENT RES, V72, P217
   Guazzato M, 2002, INT J PROSTHODONT, V15, P339
   Guo X, 2004, J AM CERAM SOC, V87, P746, DOI 10.1111/j.1551-2916.2004.00746.x
   Hayden W J, 1997, J Dent Educ, V61, P47
   HIRSCH EH, 1980, J PHYS D APPL PHYS, V13, P2081, DOI 10.1088/0022-3727/13/11/018
   Hoshide T, 1998, JSME INT J A-SOLID M, V41, P25, DOI 10.1299/jsmea.41.25
   Hoshide T, 1996, MATER SCI RES INT, V2, P33
   Kelly J R, 1990, Int J Prosthodont, V3, P430
   KELLY JR, 1989, J PROSTHET DENT, V62, P536, DOI 10.1016/0022-3913(89)90075-9
   Koh YH, 1999, J AM CERAM SOC, V82, P1456
   Lawn BR, 2002, J DENT RES, V81, P433, DOI 10.1177/154405910208100615
   LUDWIG K, 2001, DENT RES, V80, P651
   MECHOLSKY JJ, 1976, J APPL PHYS, V47, P2972, DOI 10.1063/1.323037
   MECHOLSKY JJ, 1992, J APPL PHYS, V71, P4875, DOI 10.1063/1.350632
   MOFFA J P, 1988, Journal of Dental Research, V67, P118
   *NIH NIDR, 1996, ADV DENT RES, V6, P1
   ONG JL, 1994, BIOMATERIALS, V15, P337, DOI 10.1016/0142-9612(94)90245-3
   PETROVIC JJ, 1979, AM SOC TEST MATER, V678, P83
   Piascik JR, 2005, J VAC SCI TECHNOL A, V23, P1419, DOI 10.1116/1.2011403
   PILLIAR RM, 1991, J DENT RES, V70, P1338, DOI 10.1177/00220345910700100501
   Piwowarczyk Andree, 2005, J Prosthodont, V14, P39, DOI 10.1111/j.1532-849X.2005.00003.x
   ROSENSTIEL SF, 1993, DENT MATER, V9, P274, DOI 10.1016/0109-5641(93)90074-Z
   Ruddell DE, 2003, THIN SOLID FILMS, V445, P14, DOI 10.1016/j.tsf.2003.07.009
   Ruddell DE, 2003, J MATER RES, V18, P195, DOI 10.1557/JMR.2003.0027
   Ruddell DE, 2002, J VAC SCI TECHNOL A, V20, P1744, DOI 10.1116/1.1501573
   Ruddell DE, 2000, J BIOMED MATER RES, V51, P316, DOI 10.1002/1097-4636(20000905)51:3<316::AID-JBM4>3.0.CO;2-G
   Seghi R R, 1995, Int J Prosthodont, V8, P239
   SEGHI RR, 1995, J PROSTHET DENT, V74, P145, DOI 10.1016/S0022-3913(05)80177-5
   SEGHI RR, 1990, J DENT RES, V69, P299
   THOMPSON JY, 1994, J DENT RES, V73, P505, DOI 10.1177/00220345940730020401
   Thompson JY, 1996, J PROSTHET DENT, V76, P619, DOI 10.1016/S0022-3913(96)90440-0
   THOMPSON JY, 1994, J DENT RES, V73, P1824, DOI 10.1177/00220345940730120601
   Wagner WC, 1996, J PROSTHET DENT, V76, P140, DOI 10.1016/S0022-3913(96)90297-8
   Yamashita K, 1996, J AM CERAM SOC, V79, P3313, DOI 10.1111/j.1151-2916.1996.tb08111.x
NR 39
TC 23
Z9 29
U1 1
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD APR
PY 2007
VL 27
IS 3
SI SI
BP 565
EP 569
DI 10.1016/j.msec.2006.05.034
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 149EN
UT WOS:000245130000030
DA 2018-10-20
ER

PT J
AU Abidzina, V
   Tereshko, I
   Elkin, I
   Muntele, I
   Muntele, C
   Minamisawa, RA
   Ila, D
AF Abidzina, V.
   Tereshko, I.
   Elkin, I.
   Muntele, I.
   Muntele, C.
   Minamisawa, R. A.
   Ila, D.
TI Investigations of low-energy ion irradiation influence on glassy
   polymeric carbon
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article; Proceedings Paper
CT 15th International Conference on Ion Beam Modification of Materials
CY SEP 18-22, 2006
CL Taormina, ITALY
SP STMicroelect, IMM-CNR, MATIS CNR-INFM, Appl Mat, High Voltage Engn Europe, Axcelis, LPE-ETC, Hitec, Laser Source, 2M Strumenti, Varian, Univ Catania, Fac Sci
DE glassy polymeric carbon; low-energy ion irradiation
AB Glassy polymeric carbon (GPC), which is made from phenolic resins, has a high chemical inertness and is used as high temperature and radiation resistant coatings, as high temperature heat-exchangers, as well as a biomaterial in medicine for the manufacture of heart valves and prosthetic devices [G.M. Jenkins, D. Ila, H. Maleki, Mater. Res. Soc. Symp. Proc. 394 (1995) 181]. GPC is also used for the harsh environment of space, as well as for protective coating against extreme environments such as high temperature, highly ionizing radiation, as well as corrosive environments.
   In this work, we present the results of our investigation of the influence of the low-energy ion irradiation in glow-discharge plasma on GPC.
   Chemical changes in GPC prepared at 1000 degrees C were studied using FTIR, micro-Raman spectroscopy and Rutherford backscattering spectrometry (RBS). Porosity changes were monitored through introducing lithium from a molten LiCl salt into GPC and using the (p, alpha) nuclear reaction analysis (NRA) to measure Li concentration in treated GPC. (c) 2007 Elsevier B.V. All rights reserved.
C1 Belarusian Russian Univ, Mogilyov 212005, Byelarus.
   KAMA VT, Res & Prod Enterprise, Mogilyov 212000, Byelarus.
   Alabama A&M Univ, Ctr Irradiat Mat, Normal, AL 35762 USA.
RP Abidzina, V (reprint author), Belarusian Russian Univ, Prospect Mira 43, Mogilyov 212005, Byelarus.
EM obidina@tut.by
OI Minamisawa, Renato/0000-0002-4187-544X
CR Jenkins G. M., 1976, POLYM CARBONS CARBON
   Jenkins GM, 1995, MATER RES SOC SYMP P, V394, P181, DOI 10.1557/PROC-394-181
   KUTEPOV AM, 2004, VACUUM PLASMA PLASMA
   MALEKI H, 1995, MATER RES SOC SYMP P, V371, P443
   Vallerot JM, 2006, CARBON, V44, P1833, DOI 10.1016/j.carbon.2005.12.029
   Zimmerman RL, 1995, NUCL INSTRUM METH B, V106, P550, DOI 10.1016/0168-583X(95)00768-7
NR 6
TC 5
Z9 5
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
EI 1872-9584
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD APR
PY 2007
VL 257
BP 523
EP 526
DI 10.1016/j.nimb.2007.01.098
PG 4
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA 163NB
UT WOS:000246165500120
DA 2018-10-20
ER

PT J
AU Tummel, S
   Mertens, N
   Wang, JJ
   Viol, W
AF Tuemmel, Stephanie
   Mertens, Nina
   Wang, Jiejun
   Vioel, Wolfgang
TI Low Temperature Plasma Treatment of Living Human Cells
SO PLASMA PROCESSES AND POLYMERS
LA English
DT Article
DE biomaterials; dielectric barrier discharge (DBD); plasma treatment;
   surface temperature; UV-irradiation
ID WOOD SURFACE MODIFICATION; DIELECTRIC BARRIER DISCHARGES;
   ATMOSPHERIC-PRESSURE
AB The purpose of this article is to provide a sustainable dielectric barrier discharge for the treatment of living biological tissue. The investigation aims at the innocuousness of plasma treatment by DBD with biological tissue as counterelectrode on biomaterial. Instead of human tissue, pork and in vitro living epidermal human cells are used for the plasma treatment. Potential detrimental effects like current conduction, temperature, ozone and UV-irradiation are investigated. All the levels are below the danger threshold. After plasma treatment of human cells, no cell damage could be detected. Hence applications on human beings with a DBD plasma source seems to be possible.
C1 [Tuemmel, Stephanie; Mertens, Nina; Wang, Jiejun; Vioel, Wolfgang] HAWK Univ Appl Sci & Arts, Dept Sci & Technol, D-37085 Gottingen, Germany.
RP Viol, W (reprint author), HAWK Univ Appl Sci & Arts, Dept Sci & Technol, Von Ossietzky Str 99, D-37085 Gottingen, Germany.
EM vioel@hawk-hhg.de
CR [Anonymous], 1999, Genium's Handbook of Safety, Health, and Environmental Data for common hazardous Substances, Patent No. 10238931
   [Anonymous], 2001, NATURSCHUTZ REAKTORS, P6
   Bartella P., 1972, THESIS F WILHELMS U
   Bente M, 2004, HOLZ ROH WERKST, V62, P157, DOI 10.1007/s00107-004-0475-0
   BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761
   Brose M., 2001, DGZFP JAHR 2001 BERL
   FREISINGER B, 1989, APPL PHYS B-PHOTO, V49, P121, DOI 10.1007/BF00332271
   Hoelper B., 2005, MODULATION HISTAMINF
   Janzen G., 1992, PLASMATECHNIK GRUNDL
   Kaemling C., 2005, SURF COAT TECH, P668
   Kowarschik J., 1929, ELEKTROTHERAPIE LEHR
   Laroussi M, 2005, PLASMA PROCESS POLYM, V2, P391, DOI 10.1002/ppap.200400078
   Meyer W, 1996, HAUTARZT, V47, P178, DOI 10.1007/s001050050399
   Pearse R.W.B., 1950, IDENTIFICATION MOL S
   Rehn P, 2003, SURF COAT TECH, V174, P515, DOI 10.1016/S0257-8972(03)00372-4
   Rehn P, 2003, HOLZ ROH WERKST, V61, P145, DOI 10.1007/S00107-003-0369-6
   REINAUER S, 1993, BRIT J DERMATOL, V129, P166, DOI 10.1111/j.1365-2133.1993.tb03521.x
   Schade J. P., 2000, LEXIKON MED GESUNDHE
   Senn E., 1990, ELEKTROTHERAPIE GEBR
   Steuernagel O., 1992, SKRIPTEN ELEKTROTHER
   Stoffels E, 2002, PLASMA SOURCES SCI T, V11, P383, DOI 10.1088/0963-0252/11/4/304
   Stoffels E, 2002, HIGH TEMP MATER P-US, V6, P191
   Viebahn-Hansler R., 2001, OZON HDB GRUNDLAGEN
   Viol W., 2006, MOL PROBES
   VIOL W, 1985, P 7 INT S PLASM CHEM, V1, P333
   Viol W, 2003, patent, Patent No. [DE 103 24 926, 10324926]
   Weise E., 2004, ELEKTROSICHERHEIT
   1999, GENIUMS HDB SAFETY H
NR 28
TC 22
Z9 22
U1 0
U2 3
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1612-8850
J9 PLASMA PROCESS POLYM
JI Plasma Process. Polym.
PD APR
PY 2007
VL 4
SI 1
BP S465
EP S469
DI 10.1002/ppap.200731208
PG 5
WC Physics, Applied; Physics, Fluids & Plasmas; Physics, Condensed Matter;
   Polymer Science
SC Physics; Polymer Science
GA V14LF
UT WOS:000207735200090
DA 2018-10-20
ER

PT J
AU Northwood, E
   Fisher, J
   Kowalski, R
AF Northwood, E.
   Fisher, J.
   Kowalski, R.
TI Investigation of the friction and surface degradation of innovative
   chondroplasty materials against articular cartilage
SO PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART H-JOURNAL OF
   ENGINEERING IN MEDICINE
LA English
DT Article
DE articular cartilage; lubrication; friction; degradation; chondroplasty;
   hydrogel
ID SYNOVIAL-FLUID; LUBRICATING ABILITY; HYALURONIC-ACID; HIP JOINTS; WEAR;
   LAYERS; OSTEOARTHRITIS; HYDROGELS; CONTACT; INVITRO
AB Understanding the wear of the biomaterial-cartilage interface is vital for the development of innovative chondroplasty. The aim of this study was to investigate a number of biphasic materials as potential chondroplasty biomaterials. Simple geometry friction and wear studies were conducted using bovine articular cartilage pins loaded against a range of single-phase and biphasic materials. The frictions of each biomaterial was compared within simple and protein-containing lubricants. Longer-term continuous sliding tests within a protein containing lubricant were also conducted at various loading conditions to evaluate the friction and degradation for each surface. All single-phase materials showed a steady rise in friction, which was dependent on the loss of interstitial fluid load support from the opposing cartilage pin. All biphasic materials demonstrated a marked reduction in friction when compared with the single-phase materials. It is postulated that the biphasic nature of each material allowed an element of fluid load support to be maintained by fluid rehydration and expulsion. In the longer-term study, significant differences in the articular cartilage pin (surface damage) between the positive control (stainless steel) and the negative control (articular cartilage) was found. The potential biphasic chondroplasty materials produced a reduction in articular cartilage pin damage when compared with the single-phase materials. The changes in surface topography of the cartilage pin were associated with increased levels of friction achieved during the continuous wear test. The study illustrated the importance of the biphasic properties of potential chondroplasty materials, and future work will focus on the optimization of biphasic properties as well as long-term durability, such that materials will more closely mimic the biotribology of natural articular cartilage.
C1 Univ Leeds, Sch Mech Engn, Inst Med & Biol Engn, Leeds LS2 9JT, W Yorkshire, England.
   DePuy CMW, Blackpool, England.
RP Northwood, E (reprint author), Univ Leeds, Sch Mech Engn, Inst Med & Biol Engn, Leeds LS2 9JT, W Yorkshire, England.
EM men5ejn@leeds.ac.uk
FU Engineering and Physical Sciences Research Council [GR/S76557/01]
CR *AM AC ORTH SURG, 2005, RES PRIOR UN MUSC RE
   Arthritis Research Campaign, 2002, ARTHR BIG PICT
   ATESHIAN GA, 1994, J BIOMECH, V27, P1347, DOI 10.1016/0021-9290(94)90044-2
   ATESHIAN GA, 1995, J BIOMECH, V28, P1341, DOI 10.1016/0021-9290(95)00008-6
   Bell CJ, 2006, P I MECH ENG H, V220, P23, DOI 10.1243/095441105X69060
   Bigsby RJA, 1998, J BIOMECH, V31, P363, DOI 10.1016/S0021-9290(98)00034-7
   BRAY JC, 1973, J BIOMED MATER RES, V7, P431, DOI 10.1002/jbm.820070506
   CARAVIA L, 1993, WEAR, V160, P191, DOI 10.1016/0043-1648(93)90420-Q
   CARAVIA L, 1993, J MATER SCI-MATER M, V4, P515, DOI 10.1007/BF00120132
   Corkhill P H, 1990, Proc Inst Mech Eng H, V204, P147, DOI 10.1243/PIME_PROC_1990_204_249_02
   Covert RJ, 2003, WEAR, V255, P1064, DOI 10.1016/S0043-1648(03)00113-3
   Dowson D, 1969, Biomed Eng, V4, P160
   Dowson D, 1991, Proc Inst Mech Eng H, V205, P59, DOI 10.1243/PIME_PROC_1991_205_269_02
   Dowson D, 1986, Eng Med, V15, P63
   Forster H, 1999, P I MECH ENG H, V213, P329, DOI 10.1243/0954411991535167
   Forster H, 1996, Proc Inst Mech Eng H, V210, P109, DOI 10.1243/PIME_PROC_1996_210_399_02
   FORSTER H, 1996, THESIS U LEEDS
   Freeman ME, 2000, WEAR, V241, P129, DOI 10.1016/S0043-1648(00)00387-2
   Graindorge S, 2005, MED ENG PHYS, V27, P836, DOI 10.1016/j.medengphy.2005.05.001
   Graindorge SL, 2000, WEAR, V241, P143, DOI 10.1016/S0043-1648(00)00386-0
   Hills BA, 2003, J ARTHROPLASTY, V18, P499, DOI 10.1016/S0883-5403(03)00072-X
   Hills BA, 2002, J RHEUMATOL, V29, P200
   Hills BA, 2000, P I MECH ENG H, V214, P83, DOI 10.1243/0954411001535264
   Jay GD, 2001, J ORTHOPAED RES, V19, P677, DOI 10.1016/S0736-0266(00)00040-1
   JAY GD, 1992, CONNECT TISSUE RES, V28, P71, DOI 10.3109/03008209209014228
   Jay GD, 1999, J RHEUMATOL, V26, P2454
   Jin ZM, 2000, BIORHEOLOGY, V37, P57
   Jones ES, 1934, LANCET, V1, P1426
   Koff MF, 2003, J HAND SURG-AM, V28A, P597, DOI 10.1016/S0363-5023(03)00145-X
   Krishnan R, 2005, J BIOMECH, V38, P1665, DOI 10.1016/j.jbiomech.2004.07.025
   Krishnan R, 2004, J ORTHOPAED RES, V22, P565, DOI 10.1016/j.orthres.2003.07.002
   LEWIS PR, 1959, NATURE, V184, P1285, DOI 10.1038/1841285a0
   LIPSHITZ H, 1975, J BONE JOINT SURG AM, VA 57, P527, DOI 10.2106/00004623-197557040-00015
   LIPSHITZ H, 1979, WEAR, V52, P297, DOI 10.1016/0043-1648(79)90070-X
   MABUCHI K, 1994, J BIOMED MATER RES, V28, P865, DOI 10.1002/jbm.820280805
   Mazzucco D, 2002, J ORTHOP RES, V20, P1157, DOI 10.1016/S0736-0266(02)00050-5
   McCutchen C, 1962, WEAR, V5, P1, DOI DOI 10.1016/0043-1648(62)90176-X
   MCCUTCHEN CW, 1969, LUBRICATION WEAR JOI, P117
   MEDLEY JB, 1980, ENG MED, V9, P59
   MOW VC, 1984, J BIOMECH, V17, P377, DOI 10.1016/0021-9290(84)90031-9
   MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73, DOI 10.1115/1.3138202
   MOW VC, 1980, BASIC BIOMECHANICS M, P31
   Murakami T, 2003, JSME INT J C-MECH SY, V46, P594, DOI 10.1299/jsmec.46.594
   OKA M, 1990, Clinical Materials, V6, P361, DOI 10.1016/0267-6605(90)90053-X
   Oka M, 2000, P I MECH ENG H, V214, P59, DOI 10.1243/0954411001535246
   Ozturk HE, 2004, TRIBOL LETT, V16, P283, DOI 10.1023/B:TRIL.0000015204.41674.d3
   Pickard J, 1998, P I MECH ENG H, V212, P177, DOI 10.1243/0954411981533953
   Pickard J, 2000, P I MECH ENG H, V214, P361, DOI 10.1243/0954411001535408
   Pickard JE, 1998, BIOMATERIALS, V19, P1807, DOI 10.1016/S0142-9612(98)00147-1
   ROBERTS BJ, 1982, ANN RHEUM DIS, V41, P217, DOI 10.1136/ard.41.3.217
   SASADA T, 1985, J JPN SOC BIOMATERIA, V3, P151
   STACHOWIAK GW, 1994, WEAR, V171, P135, DOI 10.1016/0043-1648(94)90356-5
   SWANN DA, 1981, ARTHRITIS RHEUM, V24, P22, DOI 10.1002/art.1780240104
   VANDERSLUIJS JA, 1992, J ORTHOPAED RES, V10, P58, DOI 10.1002/jor.1100100107
   WALKER PS, 1971, WEAR, V17, P285, DOI 10.1016/0043-1648(71)90032-9
   WANG A, 1997, LUBRICATION WEAR ULT
   Williams S, 2006, J BIOMECH, V39, P2274, DOI 10.1016/j.jbiomech.2005.07.011
   Yao JQ, 2003, WEAR, V255, P780, DOI 10.1016/s0043-1648(03)00180-7
NR 58
TC 30
Z9 32
U1 3
U2 11
PU PROFESSIONAL ENGINEERING PUBLISHING LTD
PI WESTMINISTER
PA 1 BIRDCAGE WALK, WESTMINISTER SW1H 9JJ, ENGLAND
SN 0954-4119
J9 P I MECH ENG H
JI Proc. Inst. Mech. Eng. Part H-J. Eng. Med.
PD APR
PY 2007
VL 221
IS H3
BP 263
EP 279
DI 10.1243/09544119JEIM178
PG 17
WC Engineering, Biomedical
SC Engineering
GA 171MR
UT WOS:000246740600005
PM 17539582
DA 2018-10-20
ER

PT J
AU Suljovrujic, E
   Ignjatovic, N
   Uskokovic, D
   Mitric, M
   Mitrovic, M
   Tomic, S
AF Suljovrujic, E.
   Ignjatovic, N.
   Uskokovic, D.
   Mitric, M.
   Mitrovic, M.
   Tomic, S.
TI Radiation-induced degradation of hydroxyapatite/poly L-lactide composite
   biomaterial
SO RADIATION PHYSICS AND CHEMISTRY
LA English
DT Article
DE sterilization; composite biomaterial; gamma irradiation; hydroxyapatite;
   poly L-lactide
ID POLY-L-LACTIDE; MECHANICAL-PROPERTIES; POLY(L-LACTIC ACID);
   GAMMA-IRRADIATION; FORGED COMPOSITES; INTERNAL-FIXATION; ETHYLENE-OXIDE;
   CROSS-LINKING; POLYLACTIDE; POLYCARBONATES
AB The effects of gamma irradiation on the structure and properties of hydroxyapatite/poly L-lactide (HAp/PLLA) biomaterial have been investigated. Effects of radiation on microstructure, degradation of polymer part and thermal stability of composite were determined by scanning electronic microscopy (SEM), gel permeation chromatography (GPC) and thermogravimetric analysis (TGA), respectively. Mechanical properties were obtained through mechanical strength and elasticity modulus. Presented results show that properties of HAp/PLLA decay with irradiation dose, but for doses required for sterilization, changes and damaging effects are acceptable. (C) 2006 Elsevier Ltd. All rights reserved.
C1 Vinca Inst Nucl Sci, Belgrade 11001, Serbia.
   Serbian Acad Arts & Sci, Inst Tech Sci, Belgrade, Serbia.
   Fac Phys, Belgrade, Serbia.
   Univ Belgrade, Fac Technol & Met, Belgrade, Serbia.
RP Suljovrujic, E (reprint author), Vinca Inst Nucl Sci, POB 522, Belgrade 11001, Serbia.
EM edin@vin.bg.ac.yu
RI Mitric, Miodrag/D-5056-2011; Ignjatovic, Nenad/C-4489-2008; Uskokovic,
   Dragan/B-4129-2008
OI Ignjatovic, Nenad/0000-0002-5749-094X; Uskokovic,
   Dragan/0000-0002-0421-4968; Mitric, Miodrag/0000-0002-1709-9890; Tomic,
   Simonida/0000-0002-9013-682X; Suljovrujic, Edin/0000-0001-8774-4341
CR BLACK J, 1992, BIOL PERFORMANCE MAT, P21
   Bleach NC, 2002, BIOMATERIALS, V23, P1579, DOI 10.1016/S0142-9612(01)00283-6
   Choi Y, 2001, BIOMATERIALS, V22, P995, DOI 10.1016/S0142-9612(00)00265-9
   Durucan C, 2000, J BIOMED MATER RES, V51, P726, DOI 10.1002/1097-4636(20000915)51:4<726::AID-JBM22>3.3.CO;2-C
   ELGENDY HM, 1993, BIOMATERIALS, V14, P263, DOI 10.1016/0142-9612(93)90116-J
   Furukawa T, 2000, J BIOMED MATER RES, V50, P410, DOI 10.1002/(SICI)1097-4636(20000605)50:3<410::AID-JBM16>3.0.CO;2-Y
   Gogolewski S, 1996, J BIOMED MATER RES, V32, P227
   GUPTA MC, 1983, POLYMER, V24, P827, DOI 10.1016/0032-3861(83)90198-2
   Hooper KA, 1997, J APPL POLYM SCI, V63, P1499, DOI 10.1002/(SICI)1097-4628(19970314)63:11<1499::AID-APP12>3.0.CO;2-Y
   Ignatius AA, 2001, J BIOMED MATER RES, V57, P126, DOI 10.1002/1097-4636(200110)57:1<126::AID-JBM1151>3.0.CO;2-M
   Ignjatovic N, 2004, J BIOMED MATER RES B, V71B, P284, DOI 10.1002/jbm.b.30093
   Ignjatovic N, 2001, KEY ENG MATER, V192-195, P737
   Isama K, 2002, J BIOMAT SCI-POLYM E, V13, P153, DOI 10.1163/156856202317414348
   Jin FZ, 2002, MACROMOL RAPID COMM, V23, P909, DOI 10.1002/1521-3927(20021001)23:15<909::AID-MARC909>3.0.CO;2-8
   Konig C, 1997, J BIOMED MATER RES, V38, P115
   LOO SCJ, 2005, BIOMATERIALS, V26, P1359
   MCNEILL IC, 1985, POLYM DEGRAD STABIL, V11, P309, DOI 10.1016/0141-3910(85)90035-7
   MCNEILL IC, 1985, POLYM DEGRAD STABIL, V11, P267, DOI 10.1016/0141-3910(85)90050-3
   Mitomo H, 2005, POLYMER, V46, P4695, DOI 10.1016/j.polymer.2005.03.088
   Montanari L, 1998, J CONTROL RELEASE, V56, P219, DOI 10.1016/S0168-3659(98)00082-0
   Nijenhuis AJ, 1996, POLYMER, V37, P2783, DOI 10.1016/0032-3861(96)87642-7
   Nijsen JFW, 2002, BIOMATERIALS, V23, P1831, DOI 10.1016/S0142-9612(01)00309-X
   PARK JB, 1992, BIOMATERIALS INTRO, P162
   Shikinami Y, 1999, BIOMATERIALS, V20, P859, DOI 10.1016/S0142-9612(98)00241-5
   Shikinami Y, 2005, BIOMATERIALS, V26, P5542, DOI 10.1016/j.biomaterials.2005.02.016
   SINGH A, 1991, RAD PROCESSING POLYM, P9
   Sintzel MB, 1997, DRUG DEV IND PHARM, V23, P857, DOI 10.3109/03639049709148693
   Suljovrujic E., 2003, RADIAT PHYS CHEM, V67, P375
   Weir NA, 2004, BIOMATERIALS, V25, P3939, DOI 10.1016/j.biomaterials.2003.10.076
NR 29
TC 21
Z9 23
U1 0
U2 12
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0969-806X
J9 RADIAT PHYS CHEM
JI Radiat. Phys. Chem.
PD APR
PY 2007
VL 76
IS 4
BP 722
EP 728
DI 10.1016/j.radphyschem.2006.02.013
PG 7
WC Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic,
   Molecular & Chemical
SC Chemistry; Nuclear Science & Technology; Physics
GA 144AF
UT WOS:000244766800007
DA 2018-10-20
ER

PT J
AU LeBlanc, KA
AF LeBlanc, K. A.
TI Laparoscopic incisional hernia repair: are transfascial sutures
   necessary? A review of the literature
SO SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
LA English
DT Review
DE fixation; hernioplasty; incision; laparoscopy; transfascial sutures
ID VENTRAL HERNIA; PATCH REPAIR; COMPLICATIONS; HERNIOPLASTY; EXPERIENCE;
   MESH; HERNIORRHAPHY; LESSONS; PTFE
AB Background: Laparoscopic repair of incisional and ventral hernias is rapidly becoming more commonplace in the armamentarium of general surgeons. Its utility and low recurrence rates make it a very attractive option. As with all newer procedures, controversies exist with this approach. One significant aspect is the method of fixation for the biomaterial. Most authors add the use of transfascial sutures. Others, in the minority, do not.
   Methods: A literature search using Medline and PubMed was used to evaluate the best practice for fixation in laparoscopic incisional and ventral hernia repair.
   Results: This review of the current literature (including comparative series) seems to show that the recurrence rate is approximately 4% with the use of sutures and 1.8% without their use. However, these data do not show that there is tremendous variation in the method and manner of placing transfascial sutures or that long-term follow-up evaluation is inadequate in most series. No firm conclusions can be drawn about whether it is detrimental to omit the use of transfascial sutures.
   Conclusions: On the basis of this review, a larger overlap of the prosthesis (5 vs 3 cm) is necessary if sutures are not used. If sutures are used, they should be placed no more than 5 cm apart. Prospective randomized trials with and without of transfascial sutures using a consistent biomaterial are necessary to settle this issue.
C1 Minimally Invas Surg Inst, Baton Rouge, LA 70808 USA.
   Louisiana State Univ, Sch Med, New Orleans, LA USA.
RP LeBlanc, KA (reprint author), Minimally Invas Surg Inst, 7777 Hennessy Blvd,Suite 612, Baton Rouge, LA 70808 USA.
CR Aura T, 2002, J LAPAROENDOSC ADV A, V12, P263, DOI 10.1089/109264202760268041
   Bageacu S, 2002, SURG ENDOSC, V16, P345, DOI 10.1007/s00464-001-0018-2
   Ben-Haim M, 2002, SURG ENDOSC, V16, P785, DOI 10.1007/s00464-001-9126-2
   Berger D, 2002, SURG ENDOSC, V16, P1720, DOI 10.1007/s00464-002-9036-y
   Birgisson G, 2001, SURG ENDOSC-ULTRAS, V15, P1419, DOI 10.1007/s004640080077
   Bower CE, 2004, SURG ENDOSC, V18, P672, DOI 10.1007/s00464-003-8506-1
   Carbajo MA, 1999, SURG ENDOSC-ULTRAS, V13, P250, DOI 10.1007/s004649900956
   Carbajo MA, 2003, SURG ENDOSC, V17, P118, DOI 10.1007/s00464-002-9079-0
   Chari R, 2000, SURG ENDOSC-ULTRAS, V14, P117, DOI 10.1007/s004649900079
   Chelala E, 2003, Hernia, V7, P191
   Chowbey PK, 2000, J LAPAROENDOSC ADV A, V10, P79, DOI 10.1089/lap.2000.10.79
   DeMaria EJ, 2000, SURG ENDOSC-ULTRAS, V14, P326, DOI 10.1007/s004640020013
   Eid GM, 2003, SURGERY, V134, P599, DOI 10.1016/S0039-6060(03)00273-6
   EITAN A, 2003, J LAPAROENDO ADV SUR, V12, P309
   Franklin M E Jr, 2004, Hernia, V8, P23, DOI 10.1007/s10029-003-0163-8
   Frantzides CT, 2004, SURG ENDOSC, V18, P1488, DOI 10.1007/s00464-004-8105-9
   Gillian G Kevin, 2002, JSLS, V6, P315
   Gonzalez Rodrigo, 2003, JSLS, V7, P323
   Heniford BT, 2003, ANN SURG, V238, P391, DOI 10.1097/01.sla.0000086662.49499.ab
   Holzman MD, 1997, SURG ENDOSC, V11, P32, DOI 10.1007/s004649900290
   Kyzer S, 1999, SURG ENDOSC-ULTRAS, V13, P928, DOI 10.1007/s004649901137
   LeBlanc K A, 2001, Hernia, V5, P41, DOI 10.1007/BF01576164
   LeBlanc K A, 2003, Hernia, V7, P118, DOI 10.1007/s10029-003-0117-1
   Moreno-Egea A, 2002, SURG LAPARO ENDO PER, V12, P171, DOI 10.1097/01.SLE.0000017670.43677.32
   Moreno-Egea A, 2002, ARCH SURG-CHICAGO, V137, P1266, DOI 10.1001/archsurg.137.11.1266
   Park A, 1998, SURGERY, V124, P816, DOI 10.1067/msy.1998.92102
   Parker HH, 2002, AM SURGEON, V68, P530
   Raftopoulos Ioannis, 2003, JSLS, V7, P227
   Ramshaw BJ, 1999, AM SURGEON, V65, P827
   Robbins SB, 2001, AM SURGEON, V67, P896
   ROTH JS, 1999, HERNIA, V4, P209
   Sanchez L J, 2004, Hernia, V8, P138, DOI 10.1007/s10029-003-0195-0
   Toy FK, 1998, SURG ENDOSC, V12, P955, DOI 10.1007/s004649900755
   Wright BE, 2002, AM SURGEON, V68, P291
   Zanghi A, 2000, Ann Ital Chir, V71, P663
NR 35
TC 72
Z9 73
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0930-2794
J9 SURG ENDOSC
JI Surg. Endosc.
PD APR
PY 2007
VL 21
IS 4
BP 508
EP 513
DI 10.1007/s00464-006-9032-8
PG 6
WC Surgery
SC Surgery
GA 155QO
UT WOS:000245593200003
PM 17287923
DA 2018-10-20
ER

PT J
AU Hall-Bozic, H
AF Hall-Bozic, Heike
TI Biomaterial approaches in peripheral nerve regeneration
SO TISSUE ENGINEERING
LA English
DT Meeting Abstract
CT 2nd International Congress on Regenerative Biology/2nd International
   Congress on Bio-Nano-Interface
CY OCT 09-11, 2006
CL Stuttgart, GERMANY
SP Soc Promot Biotechnol, BioRegioSTERN, BIOPRO Baden Wurttemberg GmbH, Fraunhofer Inst Grenzflachen & Bioverfahrenstechnik
C1 ETH, Dept Mat, Zurich, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD APR
PY 2007
VL 13
IS 4
BP 869
EP 869
PG 1
WC Cell & Tissue Engineering
SC Cell Biology
GA 156WP
UT WOS:000245680900029
DA 2018-10-20
ER

PT J
AU Zhang, S
   Zhang, CH
   Man, HC
   Liu, CS
AF Zhang Song
   Zhang Chun-hua
   Man Hau-chung
   Liu Chang-sheng
TI Laser surface alloying fabricated porous coating on NiTi shape memory
   alloy
SO TRANSACTIONS OF NONFERROUS METALS SOCIETY OF CHINA
LA English
DT Article
DE laser surface alloying; NiTi shape memory alloy; porous coating;
   biomaterial
ID POROSITY
AB Laser surface alloying technique was applied to fabricate a metallic porous coating on a solid NiTi shape memory alloy By laser surface alloying a 40%TiH2-60%NiTi powder mixture on the surface of NiTi alloy using optimized laser process parameters, a porous but crack-free NiTi layer can be fabricated on the NiTi substrate. The porous coating is metallurgically bonded to the substrate NiTi alloy. The pores are uniformly distributed and are interconnected with each other in the coating. An average pore size of less than 10 mu m is achieved. The Ni content of the porous layer is much less than that of the original NiTi surface. The existence of the porous coating on the NiTi alloy causes a 37% reduction of the tensile strength and 55% reduction of the strain as compared with the NiTi alloy. Possible biomedical or other applications for this porous surface with good mechanical strength provided by the substrate are prospective.
C1 Shenyang Univ Technol, Sch Mat Sci & Engn, Shenyang 110023, Peoples R China.
   Northeastern Univ, Sch Met & Mat, Shenyang 110023, Peoples R China.
   Hong Kong Polytech Univ, Dept Ind Syst Engn, Kowloon, Hong Kong, Peoples R China.
RP Zhang, S (reprint author), Shenyang Univ Technol, Sch Mat Sci & Engn, Shenyang 110023, Peoples R China.
EM songzhang_sy@yahoo.com.cn
CR Bobet JL, 2002, INTERMETALLICS, V10, P597, DOI 10.1016/S0966-9795(02)00033-X
   Choi J, 2003, BIOMATERIALS, V24, P3689, DOI 10.1016/S0142-9612(03)00241-2
   Chu CL, 2004, MAT SCI ENG A-STRUCT, V366, P114, DOI 10.1016/j.msea.2003.08.118
   CHU CL, 1999, CHINESE J NONFERROUS, V9, P57
   DUERIG T, 1999, MAT SCI ENG A-STRUCT, V275, P149
   Firetov G. S., 2002, BIOMATERIALS, V23, P4863
   Fu L, 2001, SURF COAT TECH, V140, P263, DOI 10.1016/S0257-8972(01)01168-9
   GIL FJ, 1998, J BIOMECH, V31, P135
   Kujala S, 2003, BIOMATERIALS, V24, P4691, DOI 10.1016/S0142-9612(03)00359-4
   Li BY, 2000, ACTA MATER, V48, P3895, DOI 10.1016/S1359-6454(00)00184-1
   Li YH, 2002, MATER LETT, V57, P448, DOI 10.1016/S0167-577X(02)00809-1
   Lin CM, 2004, J MATER SCI-MATER M, V15, P1237, DOI 10.1007/s10856-004-5678-8
   Ponsonnet L, 2002, MAT SCI ENG C-BIO S, V21, P157, DOI 10.1016/S0928-4931(02)00097-8
   Yang Yong-quiang, 2006, Chinese Journal of Nonferrous Metals, V16, P213
NR 14
TC 2
Z9 2
U1 0
U2 6
PU ALLERTON PRESS INC
PI NEW YORK
PA 18 WEST 27TH ST, NEW YORK, NY 10001 USA
SN 1003-6326
J9 T NONFERR METAL SOC
JI Trans. Nonferrous Met. Soc. China
PD APR
PY 2007
VL 17
IS 2
BP 228
EP 231
DI 10.1016/S1003-6326(07)60076-4
PG 4
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 168FY
UT WOS:000246509900002
DA 2018-10-20
ER

PT J
AU Klemm, DO
   Schumann, DA
   Kramer, F
   Hessbler, N
   Fried, W
AF Klemm, Dieter O.
   Schumann, Dieter A.
   Kramer, Friederike
   Hessbler, Nadine
   Fried, Wolfgang
TI CELL 127-Microbial cellulose as nanostructured biomaterial for medical
   implants
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 [Klemm, Dieter O.; Kramer, Friederike; Hessbler, Nadine] Univ Jena, Inst Organ Chem & Macromol Chem, D-07743 Jena, Germany.
   [Schumann, Dieter A.] Univ Jena, Clin Maxillofacial & Plast Surg, D-07743 Jena, Germany.
   [Fried, Wolfgang] Univ Jena, Inst Mat Sci & Technol, D-07743 Jena, Germany.
EM Dieter.Klemm@uni-jena.de; dieter.schumann@med.uni-jena.de;
   Nadine.Hessler@uni-jena.de; wolfgang.fried@uni-jena.de
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD MAR 25
PY 2007
VL 233
MA 127-CELL
BP 686
EP 686
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA V14GL
UT WOS:000207722800584
DA 2018-10-20
ER

PT J
AU Cejas, MA
   Kinney, WA
   Chen, CL
   Leo, GC
   Brett, T
   Vinter, JG
   Joshi, PP
   Maryanoff, BE
AF Cejas, Mabel A.
   Kinney, William A.
   Chen, Cailin
   Leo, Gregory C.
   Brett, Tounge
   Vinter, Jeremy G.
   Joshi, Pratik P.
   Maryanoff, Bruce E.
TI Collagen-related peptides: Self-assembly of short, single strands into a
   functional biomaterial of micrometer scale
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 [Cejas, Mabel A.; Kinney, William A.; Chen, Cailin; Leo, Gregory C.; Brett, Tounge; Maryanoff, Bruce E.] Johnson & Johnson Pharmaceut Res & Dev, Drug Discovery, Spring House, PA 19477 USA.
   [Joshi, Pratik P.] Univ Miami, Coral Gables, FL 33124 USA.
EM mcejas1@prdus.jnj.com
NR 0
TC 0
Z9 0
U1 0
U2 3
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD MAR 25
PY 2007
VL 233
MA 836-ORGN
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA V14GL
UT WOS:000207722808042
DA 2018-10-20
ER

PT J
AU Jensen, MP
   Gorman-Lewis, D
   Fein, JB
AF Jensen, Mark P.
   Gorman-Lewis, Drew
   Fein, Jeremy B.
TI FUEL 40-Carbon nanotubes: From synthesis to biomaterial applications
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 [Jensen, Mark P.] Argonne Natl Lab, Div Chem, Argonne, IL 60439 USA.
   [Fein, Jeremy B.] Univ Notre Dame, Notre Dame, IN 46556 USA.
EM mjensen@anl.gov; gorman-lewis@anl.gov; fein@nd.edu
RI Fein, Jeremy/C-4733-2012
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD MAR 25
PY 2007
VL 233
MA 58-GEOC
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA V14GL
UT WOS:000207722801838
DA 2018-10-20
ER

PT J
AU Kinloch, IA
   Eder, D
   Prehn, K
   Schulte, K
   Motta, M
   Moisala, A
   Li, YL
   Zhang, SJ
   Roberts, S
   Geng, JF
   Johnson, B
   Singh, C
   Shaffer, M
   White, A
   Emohare, O
   Brooks, R
   Best, S
   Walter, D
   Walker, G
   Scotchford, C
   Brown, D
   Stone, V
   Windle, AH
AF Kinloch, Ian A.
   Eder, Dominik
   Prehn, Kirsten
   Schulte, Karl
   Motta, Marcelo
   Moisala, Anna
   Li, Ya-Li
   Zhang, Shanju
   Roberts, Simon
   Geng, Jungfeng
   Johnson, Brian
   Singh, Charanjeet
   Shaffer, Milo
   White, Ashley
   Emohare, Osa
   Brooks, Roger
   Best, Serena
   Walter, Daniel
   Walker, Gavin
   Scotchford, Colin
   Brown, David
   Stone, Vicki
   Windle, Alan H.
TI Carbon nanotubes: From synthesis to biomaterial applications
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 [Kinloch, Ian A.] Univ Manchester, Sch Mat, Manchester MH1 7HS, Lancs, England.
   [Eder, Dominik; Motta, Marcelo; Moisala, Anna; White, Ashley; Best, Serena; Windle, Alan H.] Univ Cambridge, Dept Mat Sci & Met, Cambridge CB2 3QZ, England.
   [Prehn, Kirsten; Schulte, Karl] Tech Univ Hamburg, Hamburg, Germany.
   [Geng, Jungfeng; Johnson, Brian] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England.
   [Walter, Daniel; Walker, Gavin; Scotchford, Colin] Univ Nottingham, Nottingham NG7 2RD, England.
   [Brown, David; Stone, Vicki] Napier Univ, Sch Life Sci, Ctr Hlth & Environm, Edinburgh EH14 1DJ, Midlothian, Scotland.
EM ian.kinloch@manchester.ac.uk; ahw1@cam.ac.uk
RI Schulte, Karl/C-9550-2013; Zhang, Shanju/E-5119-2011
NR 0
TC 0
Z9 0
U1 0
U2 3
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD MAR 25
PY 2007
VL 233
MA 40-FUEL
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA V14GL
UT WOS:000207722801762
DA 2018-10-20
ER

PT J
AU Ghoroghchian, PP
   Frail, PR
   Li, GZ
   Zupancich, JA
   Bates, FS
   Hammer, DA
   Therien, MJ
AF Ghoroghchian, P. Peter
   Frail, Paul R.
   Li, Guizhi
   Zupancich, John A.
   Bates, Frank S.
   Hammer, Daniel A.
   Therien, Michael J.
TI Controlling bulk optical properties of emissive polymersomes through
   intramembranous polymer-fluorophore interactions
SO CHEMISTRY OF MATERIALS
LA English
DT Article
ID SEMICONDUCTOR QUANTUM DOTS; IN-VIVO; BLOCK-COPOLYMERS; MOLECULAR-WEIGHT;
   CONTRAST AGENTS; VESICLES; ARRAYS; SERIES; STATE; MODULATION
AB Interdisciplinary investigation at the interface of chemistry, engineering, and medicine has enabled the development of self-assembled nanomaterials with novel biochemical and electro-optical properties. We have recently shown that emissive polymersomes, polymer vesicles incorporating porphyrin-based fluorophores, feature large integrated-emission oscillator strengths and narrow emission bands; these nanoscale assemblies can be further engineered to fluoresce at discrete wavelengths throughout the visible and near-infrared (NIR) spectral domains. As such, emissive polymersomes effectively define an organic-based family of soft-matter quantum-dot analogs that possess not only impressive optical properties, but also tunable physical and biomaterial characteristics relative to inorganic fluorescent nanoparticles. Here, we expand upon our initial studies on poly(ethyleneoxide)-block-poly(butadiene)-based vesicles to examine fluorophore membrane-loading in other polymersome systems. Through modulation of fluorophore ancilliary group substituents and choice of polymer chain chemistries, we are able to predictably control intramembranous polymer-fluorophore interactions; these phenomena, in turn, influence the nature of fluorophore solvation, local dielectric environment, and emission quantum yield within emissive polymersome assemblies. By utilizing different classes of vesicle-generating diblock copolymers, including bioresorbable poly(ethyleneoxide)-block-poly(epsilon-caprolactone) (PEO-b-PCL) and poly(ethyleneoxide)-block-poly(gamma-methyl-epsilon-caprolactone) (PEO-b-PMCL), we ascertain general principles important for engineering nanoscale optical vesicles. Further, this work heralds the first generation of fully biodegradable fluorescent nanoparticles suitable for deep-tissue in vivo imaging.
C1 Univ Penn, Sch Engn & Appl Sci, Philadelphia, PA 19104 USA.
   Univ Penn, Inst Med & Engn, Philadelphia, PA 19104 USA.
   Univ Penn, Dept Chem, Philadelphia, PA 19104 USA.
   Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA.
RP Hammer, DA (reprint author), Univ Penn, Sch Engn & Appl Sci, 120 Hayden Hall,3320 Smith Walk, Philadelphia, PA 19104 USA.
EM hammer@seas.upenn.edu; therien@sas.upenn.edu
OI Bates, Frank/0000-0003-3977-1278
FU NCI NIH HHS [R01 CA115229, R01 CA115229-02]; NIBIB NIH HHS [R01
   EB003457]
CR Achilefu S, 2000, INVEST RADIOL, V35, P479, DOI 10.1097/00004424-200008000-00004
   Ahmed F, 2004, J CONTROL RELEASE, V96, P37, DOI 10.1016/j.jconrel.2003.12.021
   Ahmed F, 2003, LANGMUIR, V19, P6505, DOI 10.1021/la034178l
   Angiolillo PJ, 1995, J AM CHEM SOC, V117, P12514, DOI 10.1021/ja00155a015
   Antonietti M, 2003, ADV MATER, V15, P1323, DOI 10.1002/adma.200300010
   Becker A, 2001, NAT BIOTECHNOL, V19, P327, DOI 10.1038/86707
   Bermudez H, 2002, MACROMOLECULES, V35, P8203, DOI 10.1021/ma020669l
   Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016
   Dabbousi BO, 1997, J PHYS CHEM B, V101, P9463, DOI 10.1021/jp971091y
   Discher BM, 1999, SCIENCE, V284, P1143, DOI 10.1126/science.284.5417.1143
   Discher DE, 2002, SCIENCE, V297, P967, DOI 10.1126/science.1074972
   Duncan TV, 2006, J AM CHEM SOC, V128, P9000, DOI 10.1021/ja061897o
   Frangioni JV, 2003, CURR OPIN CHEM BIOL, V7, P626, DOI 10.1016/j.cbpa.2003.08.007
   Gao XH, 2004, NAT BIOTECHNOL, V22, P969, DOI 10.1038/nbt994
   Ghoroghchian PP, 2006, SOFT MATTER, V2, P973, DOI 10.1039/b604212k
   Ghoroghchian PP, 2006, MACROMOLECULES, V39, P1673, DOI 10.1021/ma0519009
   Ghoroghchian PP, 2005, J AM CHEM SOC, V127, P15388, DOI 10.1021/ja055571b
   Ghoroghchian PP, 2005, P NATL ACAD SCI USA, V102, P2922, DOI 10.1073/pnas.0409394102
   Jaiswal JK, 2004, TRENDS CELL BIOL, V14, P497, DOI 10.1016/j.tcb.2004.07.012
   Kim S, 2004, NAT BIOTECHNOL, V22, P93, DOI 10.1038/nbt920
   Larson DR, 2003, SCIENCE, V300, P1434, DOI 10.1126/science.1083780
   Lin VSY, 1995, CHEM-EUR J, V1, P645, DOI 10.1002/chem.19950010913
   LIN VSY, 1994, SCIENCE, V264, P1105, DOI 10.1126/science.8178169
   Photos PJ, 2003, J CONTROL RELEASE, V90, P323, DOI 10.1016/S0168-3659(03)00201-3
   Rubtsov IV, 2003, J AM CHEM SOC, V125, P2687, DOI 10.1021/ja021157p
   Sevick-Muraca EM, 2002, CURR OPIN CHEM BIOL, V6, P642, DOI 10.1016/S1367-5931(02)00356-3
   Susumu K, 2006, J AM CHEM SOC, V128, P8380, DOI 10.1021/ja0614823
   Susumu K, 2002, J AM CHEM SOC, V124, P8550, DOI 10.1021/ja0203925
   Turro N. J., 1991, MODERN MOL PHOTOCHEM
   Voura EB, 2004, NAT MED, V10, P993, DOI 10.1038/nm1096
   Weissleder R, 1999, NAT BIOTECHNOL, V17, P375, DOI 10.1038/7933
   Weissleder R, 2003, NAT MED, V9, P123, DOI 10.1038/nm0103-123
   Won YY, 2002, J PHYS CHEM B, V106, P3354, DOI 10.1021/jp013639d
   Wu SP, 2005, BIOCONJUGATE CHEM, V16, P542, DOI 10.1021/bc0497416
   Wu XY, 2003, NAT BIOTECHNOL, V21, P41, DOI 10.1038/nbt764
   Zupancich JA, 2006, MACROMOLECULES, V39, P4286, DOI 10.1021/ma060642s
NR 36
TC 38
Z9 38
U1 2
U2 29
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0897-4756
J9 CHEM MATER
JI Chem. Mat.
PD MAR 20
PY 2007
VL 19
IS 6
BP 1309
EP 1318
DI 10.1021/cm062427w
PG 10
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 145HC
UT WOS:000244854900018
PM 19079789
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Feng, J
   Wang, XL
   He, F
   Zhuo, RX
AF Feng, Jun
   Wang, Xu-Li
   He, Feng
   Zhuo, Ren-Xi
TI Non-catalyst synthesis of functionalized biodegradable polycarbonate
SO MACROMOLECULAR RAPID COMMUNICATIONS
LA English
DT Article
DE biomaterials; polycarbonates; ring-opening polymerization
ID RING-OPENING POLYMERIZATION; CYCLIC CARBONATES; COPOLYMERS; DELIVERY;
   ACID
AB The thermal ring-opening polymerization of 5-benzyloxy-trimethylene carbonate (BTMC) in bulk in the absence of any catalyst resulted in high molecular weight poly(BTMC) ((M) over bar (n) = 80 300) and subsequent catalytic hydrogenolysis resulted in functional poly(5-hydroxyl-trimethylene carbonate) (PHTMC). Similar spontaneous polymerization of BTMC in the presence of PEG ((M) over bar (n) = 2 000) as a macroinitiator can provide amphiphilic block polymers. The results revealed that the thermal non-catalyst (co)polymerization of BTMC is a highly attractive preparative method because of the lack of usage of toxic initiators or catalysts. Furthermore, an evaluation of the degradation and cytotoxicity of PHTMC demonstrated enhanced degradability compared to poly(trimethylene carbonate) and similar toxicity compared to PLGA, showing PHTMC to be a promising biomaterial.
C1 Wuhan Univ, Dept Chem, Wuhan 430072, Peoples R China.
RP Feng, J (reprint author), Wuhan Univ, Dept Chem, Wuhan 430072, Peoples R China.
EM bmp_lab@hotmail.com
CR Al-Azemi TF, 1999, MACROMOLECULES, V32, P6536, DOI 10.1021/ma990639r
   Chen XH, 1999, MACROMOLECULES, V32, P308, DOI 10.1021/ma980895o
   Chen XH, 1998, J APPL POLYM SCI, V67, P547
   Feng J, 2003, MACROMOL SYMP, V195, P237, DOI 10.1002/masy.200390128
   HAYASHI T, 1994, PROG POLYM SCI, V19, P663, DOI 10.1016/0079-6700(94)90030-2
   KAWAGUCHI T, 1983, CHEM PHARM BULL, V31, P1400
   Liu JB, 2005, J CONTROL RELEASE, V103, P481, DOI 10.1016/j.jconrel.2004.12.013
   Otsuka H, 2003, ADV DRUG DELIVER REV, V55, P403, DOI 10.1016/S0169-409X(02)00226-0
   Putnam D, 1999, MACROMOLECULES, V32, P3658, DOI 10.1021/ma982004i
   Ray WC, 2003, MACROMOLECULES, V36, P3557, DOI 10.1021/ma025872v
   Rokicki G, 2000, PROG POLYM SCI, V25, P259, DOI 10.1016/S0079-6700(00)00006-X
   Sanda F, 2001, MACROMOLECULES, V34, P1564, DOI 10.1021/ma0013307
   Stolnik S, 2001, J DRUG TARGET, V9, P361, DOI 10.3109/10611860108998772
   Ulbrich K, 2000, J CONTROL RELEASE, V64, P63, DOI 10.1016/S0168-3659(99)00141-8
   Wang XL, 2002, J POLYM SCI POL CHEM, V40, P70, DOI 10.1002/pola.10088
   Zeng FQ, 2004, BIOMACROMOLECULES, V5, P1810, DOI 10.1021/bm049836a
   ZHU KJ, 1991, MACROMOLECULES, V24, P1736, DOI 10.1021/ma00008a008
NR 17
TC 31
Z9 33
U1 1
U2 27
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1022-1336
J9 MACROMOL RAPID COMM
JI Macromol. Rapid Commun.
PD MAR 16
PY 2007
VL 28
IS 6
BP 754
EP 758
DI 10.1002/marc.200600774
PG 5
WC Polymer Science
SC Polymer Science
GA 151WA
UT WOS:000245320400011
DA 2018-10-20
ER

PT J
AU de Vos, P
   de Haan, BJ
   Kamps, JAAM
   Faas, MM
   Kitano, T
AF de Vos, Paul
   de Haan, Bart J.
   Kamps, Jan A. A. M.
   Faas, Marijke M.
   Kitano, Toshio
TI Zeta-potentials of alginate-PLL capsules: a predictive measure for
   biocompatibility?
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE transplantation; alginate; microencapsulation; immunoisolation
ID RICH HYALURONAN SOLUTION; RAT PANCREATIC-ISLETS; IMMUNOISOLATED
   TRANSPLANTATION; POLYLYSINE MICROCAPSULES; CELL ENCAPSULATION;
   MICROENCAPSULATION; SURVIVAL; RELEASE; IMMUNOSUPPRESSION; BIOMATERIALS
AB Alginate-poly-L-lysine (PLL) microencapsulation of cells is a promising approach to prevent rejection in the absence of immunosuppression. Clinical application, however, is hampered by insufficient insight in factors influencing biocompatibility of the capsules. By now, it has been accepted that not only the chemical composition of the materials applied but also other factors contribute to bioincompatibility. The zeta-potential serves as a measure for the electrical charge of the surface and has been shown to be a predictive value for the interfacial reactions between the biomaterial and the surrounding tissue in other applications. In the present study, we have assessed the streaming potential of alginate-PLL capsules composed of either low-, intermediate-, or high-guluronic (G) alginate to calculate the zeta-potential. The zeta-potentials of the capsules were compared to the biological response against the capsules at 4 weeks after implantation in the rat. We show that high-G and low-G alginates provoke a more severe response in the rat than capsules prepared of intermediate-G alginate. This correlates with a higher zeta-potential of the high-G and low-G alginates and by a change in zeta-potential at lower pH. These lower pH-levels are common directly after implantation as the consequence of a host-response associated with mandatory surgery. Our results suggest that we should not only consider the capsule properties under physiological circumstances to explain bioincompatibility but also the capsule features during common pathophysiological situations. (c) 2006 Wiley Periodicals, Inc.
C1 Univ Groningen, Univ Med Ctr Groningen, Div Immunoendocrinol, Sect Med Biol,Dept Pathol & Lab Med, NL-9700 RB Groningen, Netherlands.
   Osaka City Univ, Grad Sch Med, Dept Orthopaed Surg, Abeno Ku, Osaka 5458585, Japan.
RP de Vos, P (reprint author), Univ Groningen, Univ Med Ctr Groningen, Div Immunoendocrinol, Sect Med Biol,Dept Pathol & Lab Med, Hanzeplein 1, NL-9700 RB Groningen, Netherlands.
EM p.de.vos@med.ug.nl
RI de Vos, Paul/A-3170-2013
CR AEBISCHER P, 1986, T AM SOC ART INT ORG, V32, P134
   Bunger CM, 2005, BIOMATERIALS, V26, P2353, DOI 10.1016/j.biomaterials.2004.07.017
   CHANG PL, 1993, HUM GENE THER, V4, P433, DOI 10.1089/hum.1993.4.4-433
   de Haan BJ, 2003, CELL TRANSPLANT, V12, P617, DOI 10.3727/000000003108747226
   De Vos P, 1999, DIABETES, V48, P1381, DOI 10.2337/diabetes.48.7.1381
   de Vos P, 2002, J BIOMED MATER RES, V62, P430, DOI 10.1002/jbm.10345
   de Vos P, 2003, DIABETOLOGIA, V46, P666, DOI 10.1007/s00125-003-1087-7
   de Vos P, 2002, J BIOMED MATER RES, V60, P252, DOI 10.1002/jbm.10060
   DeVos P, 1996, TRANSPLANTATION, V62, P888, DOI 10.1097/00007890-199610150-00003
   DeVos P, 1996, TRANSPLANTATION, V62, P893, DOI 10.1097/00007890-199610150-00004
   DeVos P, 1997, DIABETOLOGIA, V40, P262
   DeVos P, 1997, BIOMATERIALS, V18, P273, DOI 10.1016/S0142-9612(96)00135-4
   DEVOS P, 1993, INT J ARTIF ORGANS, V16, P205
   DEVOS P, 1999, CELL ENCAPSULATION T, P63
   FRITSCHY WM, 1991, DIABETES, V40, P37, DOI 10.2337/diabetes.40.1.37
   FRITSCHY WM, 1995, BIOTECH HISTOCHEM, V70, P188, DOI 10.3109/10520299509107311
   FRITSCHY WM, 1994, TRANSPLANT INT, V7, P264, DOI 10.1111/j.1432-2277.1994.tb01572.x
   Hasse C, 1997, LANCET, V350, P1296, DOI 10.1016/S0140-6736(05)62473-7
   Kitano T, 2001, J BIOMECH, V34, P1031, DOI 10.1016/S0021-9290(01)00058-6
   Kitano T, 1998, J BIOMED MATER RES, V42, P453, DOI 10.1002/(SICI)1097-4636(19981205)42:3<453::AID-JBM15>3.0.CO;2-H
   Kitano T, 1996, INT J ARTIF ORGANS, V19, P353
   KLOCK G, 1994, APPL MICROBIOL BIOT, V40, P638
   KOFOED H, 1986, INJURY, V17, P391, DOI 10.1016/0020-1383(86)90078-1
   KOO J, 1993, INT J ARTIF ORGANS, V16, P557
   KOWALCHUK RM, 1995, J BIOMED MATER RES, V29, P47, DOI 10.1002/jbm.820290108
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   LIU HW, 1993, HUM GENE THER, V4, P291, DOI 10.1089/hum.1993.4.3-291
   Ricci M, 2005, J CONTROL RELEASE, V107, P395, DOI 10.1016/j.jconrel.2005.06.023
   SHIONG PS, 1994, LANCET, V343, P950
   SJOHOLM A, 1995, FEBS LETT, V367, P283, DOI 10.1016/0014-5793(95)00470-T
   Sun YL, 1996, J CLIN INVEST, V98, P1417, DOI 10.1172/JCI118929
   Thu B, 1996, BIOMATERIALS, V17, P1031, DOI 10.1016/0142-9612(96)84680-1
   Thu B, 1996, BIOMATERIALS, V17, P1069, DOI 10.1016/0142-9612(96)85907-2
   Uludag H, 2000, ADV DRUG DELIVER REV, V42, P29, DOI 10.1016/S0169-409X(00)00053-3
   van Hoogmoed CG, 2003, J BIOMED MATER RES A, V67A, P172, DOI 10.1002/jbm.a.10086
   VANDENBOSSCHE GMR, 1993, J PHARM PHARMACOL, V45, P115, DOI 10.1111/j.2042-7158.1993.tb03694.x
   WOLTERS GHJ, 1992, J APPL BIOMATER, V3, P281, DOI 10.1002/jab.770030407
   WONG H, 1986, INT J ARTIF ORGANS, V9, P335
   ZEKORN T, 1992, TRANSPLANT P, V24, P937
NR 39
TC 44
Z9 44
U1 1
U2 15
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR 15
PY 2007
VL 80A
IS 4
BP 813
EP 819
DI 10.1002/jbm.a.30979
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 139KB
UT WOS:000244429600005
PM 17058213
DA 2018-10-20
ER

PT J
AU Kondo, SI
   Sasai, Y
   Kuzuya, M
AF Kondo, Shin-ichi
   Sasai, Yasushi
   Kuzuya, Masayuki
TI Development of biomaterial using durable surface wettability fabricated
   by plasma-assisted immobilization of hydrophilic polymer
SO THIN SOLID FILMS
LA English
DT Article; Proceedings Paper
CT 18th Symposium on Plasma Science for Materials
CY JUN   28, 2005-MAY 29, 2006
CL Univ Tokyo, Tokyo, JAPAN
SP Japan Soc Promot Sci, Comm 153, Plasma Mat Sci
HO Univ Tokyo
DE plasma treatment; immobilization; bio-chip; oligo-DNA; hybridization
ID OLIGONUCLEOTIDES
AB As a series of plasma-assisted immobilization of bio-molecule for bio application, 12-mer oligo-DNA was immobilized on the surface of LDPE-VEMAC sheet, which was prepared by plasma-assisted method and possessed a lot of carboxyl groups on the surface. A larger amount of oligo-DNA could be immobilized by the present technique compared with other methods reported. The sheet immobilizing oligo-DNA detected the complementary oligo-DNA and was reusable for several times at least under present experimental condition. This method would be useful for the fabrication of the analytical instrument such as DNA chip, protein chip and affinity chromatography. (c) 2006 Elsevier B.V All rights reserved.
C1 Gifu Pharmaceut Univ, Lab Pharmaceut Phys Chem, Gifu 5028585, Japan.
RP Kuzuya, M (reprint author), Gifu Pharmaceut Univ, Lab Pharmaceut Phys Chem, 5-6-1 Mitahora Higashi, Gifu 5028585, Japan.
EM kuzuya@gifu-pu.ac.jp
OI Sasai, Yasushi/0000-0002-2176-7855
CR Demers LM, 2000, ANAL CHEM, V72, P5535, DOI 10.1021/ac0006627
   FIXE F, 2004, NUCL ACIDS RES, V32
   Halliwell CM, 2001, ANAL CHEM, V73, P2476, DOI 10.1021/ac0010633
   Kondo S, 2003, J PHOTOPOLYM SCI TEC, V16, P71, DOI 10.2494/photopolymer.16.71
   Kuzuya M., 1997, Plasmas and Polymers, V2, P133, DOI 10.1007/BF02766028
   Kuzuya M., 1997, Plasmas and Polymers, V2, P79, DOI 10.1007/BF02766025
   Kuzuya M., 2001, J PHOTOPOLYM SCI TEC, V14, P87
   Kuzuya M., 1995, J PHOTOPOLYM SCI TEC, V8, P381
   Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447
   Nouaimi M, 2001, ENZYME MICROB TECH, V29, P567, DOI 10.1016/S0141-0229(01)00429-X
   Phimister B, 1999, NAT GENET, V21, P1, DOI 10.1038/4423
   Poncin-Epaillard F, 2003, J BIOMAT SCI-POLYM E, V14, P1005, DOI 10.1163/156856203769231538
   Ramsay G, 1998, NAT BIOTECHNOL, V16, P40, DOI 10.1038/nbt0198-40
NR 13
TC 16
Z9 16
U1 0
U2 2
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0040-6090
J9 THIN SOLID FILMS
JI Thin Solid Films
PD MAR 12
PY 2007
VL 515
IS 9
BP 4136
EP 4140
DI 10.1016/j.tsf.2006.02.044
PG 5
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 148HS
UT WOS:000245065900010
DA 2018-10-20
ER

PT J
AU Abraham, LC
   Dice, JF
   Lee, K
   Kaplan, DL
AF Abraham, Leah C.
   Dice, J. Fred
   Lee, Kyongbum
   Kaplan, David L.
TI Phagocytosis and remodeling of collagen matrices
SO EXPERIMENTAL CELL RESEARCH
LA English
DT Article
DE collagen; phagocytosis; remodeling; biodegradation; extracellular
   matrix; denatured
ID HUMAN GINGIVAL FIBROBLASTS; EXTRACELLULAR-MATRIX; IN-VIVO; INTEGRINS
   ALPHA(1)BETA(1); ALPHA-2-BETA-1 INTEGRIN; TROPHOBLAST INVASION;
   GENE-EXPRESSION; BINDING; CELLS; METALLOPROTEINASES
AB The biodegradation of collagen and the deposition of new collagen-based extracellular matrices are of central importance in tissue remodeling and function. Similarly, for collagen-based biomaterials used in tissue engineering, the degradation of collagen scaffolds with accompanying cellular infiltration and generation of new extracellular matrix is critical for the integration of in vitro grown tissues in vivo. In earlier studies we observed significant impact of collagen structure on primary lung fibroblast behavior in vitro in terms of collagen uptake and matrix remodeling. Therefore, in the present work, the response of human fibroblasts (IMR-90) to the structural state of collagen was studied with respect to phagocytosis in the presence and absence of inhibitors. Protein content and transcript levels for collagen I (Col-1), matrix metalloproteinase 1 (MMP-1), matrix metalloproteinase 2 (MMP-2), tissue inhibitor of matrix metalloprotemase I (TIMP-1), tissue inhibitor of matrix metalloproteinase 2 (TIMP-2), and heat shock protein 70 (HSP-70) were characterized as a function of collagen matrix concentration, structure and cell culture time to assess effects on cellular collagen matrix remodeling processes. Phagocytosis of collagen was assessed quantitatively by the uptake of collagen-coated fluorescent beads incorporated into the collagen matrices. Significantly higher levels of collagen phagocytosis were observed for the cells grown on the denatured collagen versus native collagen matrices. Significant reduction in collagen phagocytosis was observed by blocking several phagocytosis pathways when the cells were grown on denatured collagen versus non-denatured collagen. Collagen phagocytosis inhibition effects were significantly greater for PDL57 IMR-90 cells versus PDL48 cells, reflecting a reduced number of collagen processing pathways available to the older cells. Transcript levels related to the deposition of new extracellular matrix proteins varied as a function of the structure of the collagen matrix presented to the cells. A four-fold increase in transcript level of Col-1 and a higher level of collagen matrix incorporation were observed for cells grown on denatured collagen versus cells grown on non-denatured collagen. The data suggest that biomaterial matrices incorporating denatured collagen may promote more active remodeling toward new extracellular matrices in comparison to cells grown on non-denatured collagen. A similar effect of cellular action toward denatured (wound-related) Collagen in the remodeling of tissues in vivo may have significant impact on tissue regeneration as well as the progression of Collagen-related diseases. (c) 2007 Elsevier Inc. All rights reserved.
C1 Tufts Univ, Dept Chem, Bioengn & Biotechnol Ctr, Medford, MA 02155 USA.
   Tufts Univ, Dept Biol Engn, Bioengn & Biotechnol Ctr, Medford, MA 02155 USA.
   Tufts Univ, Dept Biomed Engn, Bioengn & Biotechnol Ctr, Medford, MA 02155 USA.
   Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Boston, MA 02111 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Chem, Bioengn & Biotechnol Ctr, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
RI Lee, Kyongbum/D-9230-2013
FU NIAMS NIH HHS [R01 AR046563-04, R01 AR046563]; NIBIB NIH HHS [P41
   EB002520-05, P41 EB002520, EB002520]
CR Abraham LC, 2004, J BIOMED MATER RES A, V70A, P39, DOI 10.1002/jbm.a.30057
   ABRAHAM LC, UNPUB REV STRUCTURE
   Abraham LC, 2007, BIOMATERIALS, V28, P151, DOI 10.1016/j.biomaterials.2006.07.001
   Arora PD, 2003, EXP CELL RES, V286, P366, DOI 10.1016/S0014-4827(03)00096-X
   Arora PD, 2001, J BIOL CHEM, V276, P14100, DOI 10.1074/jbc.M010298200
   Baciu PC, 2003, EXP CELL RES, V291, P167, DOI 10.1016/S0014-4827(03)00387-2
   Bischof P, 2001, ANN NY ACAD SCI, V943, P157, DOI 10.1111/j.1749-6632.2001.tb03799.x
   Cate A R, 1974, J Anat, V117, P351
   Chen K, 2004, J CARDIOVASC PHARM, V44, P682, DOI 10.1097/00005344-200412000-00010
   CHEN KY, 1986, J CELL PHYSIOL, V128, P27, DOI 10.1002/jcp.1041280106
   Chen M, 1999, EXP CELL RES, V249, P231, DOI 10.1006/excr.1999.4473
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318
   Davis GE, 2000, AM J PATHOL, V156, P1489, DOI 10.1016/S0002-9440(10)65020-1
   DAVIS GE, 1992, BIOCHEM BIOPH RES CO, V182, P1025, DOI 10.1016/0006-291X(92)91834-D
   Demers Laurence M., 2000, Cancer, V88, P2919, DOI 10.1002/1097-0142(20000615)88:12+<2919::AID-CNCR7>3.0.CO;2-Z
   DIEGELMA.RF, 1972, P NATL ACAD SCI USA, V69, P892, DOI 10.1073/pnas.69.4.892
   Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184
   DUNKIN MA, 2001, HANDOUT HLTH SCLEROD
   DURR J, 1993, EXP CELL RES, V207, P235, DOI 10.1006/excr.1993.1189
   EBLE JA, 1993, EMBO J, V12, P4795, DOI 10.1002/j.1460-2075.1993.tb06168.x
   EVERTS V, 1985, COLLAGEN REL RES, V5, P315
   FISHER SJ, 1985, J CELL BIOCHEM, V27, P31, DOI 10.1002/jcb.240270105
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Garfinkel S, 1996, BBA-MOL CELL RES, V1314, P109, DOI 10.1016/S0167-4889(96)00105-X
   Goldsmith EC, 2003, AM J PHYSIOL-HEART C, V284, pH2227, DOI 10.1152/ajpheart.00920.2002
   Gronthos S, 2001, BONE, V28, P174, DOI 10.1016/S8756-3282(00)00424-5
   Hay ED, 1991, CELL BIOL EXTRACELLU
   Hendrix MJC, 2003, ANN NY ACAD SCI, V995, P151, DOI 10.1111/j.1749-6632.2003.tb03218.x
   Huppertz B, 1998, CELL TISSUE RES, V291, P133
   Johnson G, 2000, J BIOMED MATER RES, V51, P612, DOI 10.1002/1097-4636(20000915)51:4<612::AID-JBM9>3.3.CO;2-Q
   KIVIRIKKO KI, 1993, ANN MED, V25, P113, DOI 10.3109/07853899309164153
   Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35
   KNOWLES GC, 1991, J CELL SCI, V98, P551
   Kobayashi T, 2003, ACTA DERM-VENEREOL, V83, P105, DOI 10.1080/00015550310007436
   Laliberte R, 2001, MATRIX BIOL, V19, P743, DOI 10.1016/S0945-053X(00)00120-7
   Lauer-Fields JL, 2002, BIOPOLYMERS, V66, P19, DOI 10.1002/bip.10201
   Lee W, 1997, EXP CELL RES, V237, P383, DOI 10.1006/excr.1997.3802
   Lee W, 1996, J CELL PHYSIOL, V168, P695, DOI 10.1002/(SICI)1097-4652(199609)168:3<695::AID-JCP22>3.0.CO;2-X
   Manyonda IT, 1999, J SOC GYNECOL INVEST, V6, P158, DOI 10.1016/S1071-5576(99)00010-6
   Martin I, 2001, OSTEOARTHR CARTILAGE, V9, P112, DOI 10.1053/joca.2000.0366
   MAUCH C, 1990, RHEUM DIS CLIN N AM, V16, P93
   MAUNEY J, 2004, UNPUB
   McCulloch CA, 2004, CURR OPIN DRUG DISC, V7, P720
   MCCULLOCH CAG, 1993, J CELL PHYSIOL, V155, P461, DOI 10.1002/jcp.1041550305
   MCKEOWN M, 1990, CELL TISSUE RES, V262, P523, DOI 10.1007/BF00305249
   Mook ORF, 2003, J HISTOCHEM CYTOCHEM, V51, P821, DOI 10.1177/002215540305100613
   Paik JW, 2004, J PERIODONTOL, V75, P380, DOI 10.1902/jop.2004.75.3.380
   Petitclerc E, 2000, J BIOL CHEM, V275, P8051, DOI 10.1074/jbc.275.11.8051
   Prockop DJ, 1998, MATRIX BIOL, V16, P519, DOI 10.1016/S0945-053X(98)90064-6
   RIIKONEN T, 1995, J BIOL CHEM, V270, P13548, DOI 10.1074/jbc.270.22.13548
   Rittie L, 1999, BIOCHEM BIOPH RES CO, V264, P488, DOI 10.1006/bbrc.1999.1519
   Severino J, 2000, EXP CELL RES, V257, P162, DOI 10.1006/excr.2000.4875
   Shapiro SD, 1998, CURR OPIN CELL BIOL, V10, P602, DOI 10.1016/S0955-0674(98)80035-5
   Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463
   Stupack DG, 2002, J CELL SCI, V115, P3729, DOI 10.1242/jcs.00071
   Theret N, 2001, HEPATOLOGY, V34, P82, DOI 10.1053/jhep.2001.25758
   Thohan V, 2004, CURR OPIN CARDIOL, V19, P301, DOI 10.1097/01.hco.0000129667.34622.14
   Tian B, 2002, J BIOL CHEM, V277, P24667, DOI 10.1074/jbc.M203565200
   UNDERWOOD PA, 1995, BIOCHEM J, V309, P765, DOI 10.1042/bj3090765
   VANDENBERG P, 1991, J CELL BIOL, V113, P1475, DOI 10.1083/jcb.113.6.1475
   Vogel WF, 2001, EUR J DERMATOL, V11, P506
   Volloch V, 2002, MATRIX BIOL, V21, P533, DOI 10.1016/S0945-053X(02)00038-0
   Wong TTL, 2002, SURV OPHTHALMOL, V47, P239, DOI 10.1016/S0039-6257(02)00287-4
   Xiong JP, 2003, BLOOD, V102, P1155, DOI 10.1182/blood-2003-01-0334
   Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040
   Xu Y, 2000, J BIOL CHEM, V275, P38981, DOI 10.1074/jbc.M007668200
NR 67
TC 36
Z9 39
U1 2
U2 10
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4827
J9 EXP CELL RES
JI Exp. Cell Res.
PD MAR 10
PY 2007
VL 313
IS 5
BP 1045
EP 1055
DI 10.1016/j.yexcr.2006.12.019
PG 11
WC Oncology; Cell Biology
SC Oncology; Cell Biology
GA 141SB
UT WOS:000244597900017
PM 17276428
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Mullett, WM
AF Mullett, Wayne M.
TI Determination of drugs in biological fluids by direct injection of
   samples for liquid-chromatographic analysis
SO JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS
LA English
DT Review
DE direct injection; analysis of biological materials; turbulent flow;
   restricted-access materials (RAM); on-line solid-phase extraction;
   review
ID TANDEM MASS-SPECTROMETRY; TURBULENT-FLOW CHROMATOGRAPHY; SOLID-PHASE
   EXTRACTION; RESTRICTED-ACCESS MATERIAL; MOLECULARLY IMPRINTED POLYMER;
   HUMAN PLASMA SAMPLES; ALKYL-DIOL SILICA; PACKED SYRINGE MEPS; LC-MS-MS;
   ONLINE EXTRACTION
AB The analysis of drugs in various biological fluids is an important criterion for the determination of the physiological performance of a drug. After sampling of the biological fluid, the next step in the analytical process is sample preparation. The complexity of biological fluids adds to the challenge of direct determination of the drug by chromatographic analysis, therefore demanding a sample preparation step that is often time-consuming, tedious, and frequently overlooked. However, direct on-line injection methods offer the advantage of reducing sample preparation steps and enabling effective pre-concentration and clean-up of biological fluids. These procedures can be automated and therefore reduce the requirements for handling potentially infectious biomaterial, improve reproducibility, and minimize sample manipulations and potential contamination.
   The objective of this review is to present an overview of the existing literature with emphasis on advances in automated sample preparation methods for liquid-chromatographic methods. More specifically, this review concentrates on the use of direct injection techniques, such as restricted-access materials, turbulent-flow chromatography and other automated on-line solid-phase extraction (SPE) procedures. It also includes short overviews of emerging automated extraction-phase technologies, such as molecularly imprinted polymers, in-tube solid-phase micro-extraction, and micro-extraction in a packed syringe for a more selective extraction of analytes from complex samples, providing further improvements in the analysis of biological materials. Lastly, the outlook for these methods and potential new applications for these technologies are briefly discussed. (c) 2006 Elsevier B.V. All rights reserved.
C1 Merck Frosst Canada & Co, Quebec City, PQ H9H 3L1, Canada.
RP Mullett, WM (reprint author), Merck Frosst Canada & Co, Quebec City, PQ H9H 3L1, Canada.
EM wayne_mullett@merck.com
CR Abdel-Rehim M, 2005, ANAL CHIM ACTA, V539, P35, DOI 10.1016/j.aca.2005.02.061
   Abdel-Rehim M, 2004, J MASS SPECTROM, V39, P1488, DOI 10.1002/jms.731
   Abdel-Rehim M, 2004, J CHROMATOGR B, V801, P317, DOI 10.1016/j.jchromb.2003.11.042
   Abdel-Rehimi M, 2006, J SEP SCI, V29, P1658, DOI 10.1002/jssc.200600087
   Alnouti Y, 2006, ANAL CHEM, V78, P1331, DOI 10.1021/ac051806q
   Alnouti Y, 2005, J CHROMATOGR A, V1080, P99, DOI 10.1016/j.chroma.2005.04.056
   Altun Z, 2006, J LIQ CHROMATOGR R T, V29, P829, DOI 10.1080/10826070500530526
   Altun Z, 2004, J CHROMATOGR B, V813, P129, DOI 10.1016/j.jchromb.2004.09.020
   ANDERHOEVEN RAM, 1997, J CHROMATOGR A, V762, P193
   Ayrton J, 1998, J CHROMATOGR A, V828, P199, DOI 10.1016/S0021-9673(98)00579-2
   Ayrton J, 1997, RAPID COMMUN MASS SP, V11, P1953, DOI 10.1002/(SICI)1097-0231(199712)11:18<1953::AID-RCM102>3.0.CO;2-Z
   Baeyens WRG, 2000, J CHROMATOGR A, V871, P153, DOI 10.1016/S0021-9673(99)01089-4
   Berna M, 2002, ANAL CHEM, V74, P1197, DOI 10.1021/ac010986a
   BOOS KS, 1995, FRESEN J ANAL CHEM, V352, P684, DOI 10.1007/BF00323048
   Boos KS, 2001, FRESEN J ANAL CHEM, V371, P16, DOI 10.1007/s002160100831
   Cantwell FF, 2002, COMP ANAL C, V37, P297, DOI 10.1016/S0166-526X(02)80048-4
   Cass QB, 2003, J CHROMATOGR B, V798, P275, DOI 10.1016/j.jchromb.2003.09.053
   Cassiano NM, 2006, ANAL BIOANAL CHEM, V384, P1462, DOI 10.1007/s00216-005-0253-9
   Ceglarek U, 2004, CLIN CHIM ACTA, V346, P181, DOI 10.1016/j.ccn.2004.03.017
   Chassaing C, 2005, CHROMATOGRAPHIA, V62, P17, DOI 10.1365/s10337-005-0562-3
   Chiap P, 2002, J PHARMACEUT BIOMED, V27, P447, DOI 10.1016/S0731-7085(01)00647-1
   Cohesive Technologies Inc, 2005, LCGC N AM S, V84
   DESILETS CP, 1991, J CHROMATOGR, V544, P25, DOI 10.1016/S0021-9673(01)83976-5
   Edge T, 2003, HANDB ANALYT SEPARAT, V4, P91
   Esteve-Romero J, 2005, TRAC-TREND ANAL CHEM, V24, P75, DOI 10.1016/j.trac.2004.11.003
   Fan Y, 2005, J CHROMATOGR A, V1074, P9, DOI 10.1016/j.chroma.2005.03.115
   Gage R, 1998, J PHARMACEUT BIOMED, V17, P1449, DOI 10.1016/S0731-7085(98)00004-1
   Georgi K, 2005, LC GC N AM, V23, P396
   Grant RP, 2002, RAPID COMMUN MASS SP, V16, P1785, DOI 10.1002/rcm.784
   HAGESTAM IH, 1986, J CHROMATOGR, V368, P77, DOI 10.1016/S0021-9673(00)91048-3
   Haginaka J, 1999, J CHROMATOGR A, V849, P331, DOI 10.1016/S0021-9673(99)00570-1
   Haginaka J, 2004, ANAL BIOANAL CHEM, V379, P332, DOI 10.1007/s00216-004-2621-2
   Herman JL, 2005, RAPID COMMUN MASS SP, V19, P696, DOI 10.1002/rcm.1843
   Herman JL, 2004, INT J MASS SPECTROM, V238, P107, DOI 10.1016/j.ijms.2003.12.040
   Herman JL, 2002, RAPID COMMUN MASS SP, V16, P421, DOI 10.1002/rcm.593
   HERMANSSON J, 1994, J CHROMATOGR A, V660, P119, DOI 10.1016/0021-9673(94)85105-0
   Hopfgartner G, 2002, THER DRUG MONIT, V24, P134, DOI 10.1097/00007691-200202000-00021
   Hsieh S, 2004, RAPID COMMUN MASS SP, V18, P285, DOI 10.1002/rcm.1327
   Huclova J, 2005, J CHROMATOGR A, V1087, P245, DOI 10.1016/j.chroma.2004.11.055
   Jayewardene AL, 2001, J PHARMACEUT BIOMED, V25, P309, DOI 10.1016/S0731-7085(00)00506-9
   Jhee OH, 2005, J PHARMACEUT BIOMED, V37, P405, DOI 10.1016/j.jpba.2004.11.003
   Kataoka H, 2002, ANAL BIOANAL CHEM, V373, P31, DOI 10.1007/s00216-002-1269-z
   Keski-Hynnila H, 2001, J CHROMATOGR B, V759, P227, DOI 10.1016/S0378-4347(01)00226-2
   KNOX JH, 1963, ANAL CHEM, V35, P449, DOI 10.1021/ac60197a033
   Li KM, 2006, CURR PHARM ANAL, V2, P95, DOI 10.2174/157341206776819346
   Li M, 2005, J CHROMATOGR B, V825, P152, DOI 10.1016/j.jchromb.2005.03.047
   Liesener A, 2005, J SEP SCI, V28, P1658, DOI 10.1002/jssc.200500090
   Lim HK, 2001, ANAL CHEM, V73, P2140, DOI 10.1021/ac001112b
   Ma MH, 1998, ANAL CHEM, V70, P3912, DOI 10.1021/ac980174n
   Machtejevas E, 2004, J CHROMATOGR B, V803, P121, DOI 10.1016/j.jchromb.2003.07.015
   Mahony JO, 2005, ANAL CHIM ACTA, V534, P31, DOI 10.1016/j.aca.2004.07.043
   Mallet CR, 2001, RAPID COMMUN MASS SP, V15, P1075, DOI 10.1002/rcm.346
   Matuszewski BK, 2003, ANAL CHEM, V75, P3019, DOI 10.1021/ac020361s
   Matuszewski BK, 2006, J CHROMATOGR B, V830, P293, DOI 10.1016/j.jchromb.2005.11.009
   Mei H, 2003, RAPID COMMUN MASS SP, V17, P97, DOI 10.1002/rcm.876
   Mullett WM, 2004, J CHROMATOGR B, V801, P297, DOI 10.1016/j.jchromb.2003.11.041
   Mullett WM, 2002, J CHROMATOGR A, V963, P325, DOI 10.1016/S0021-9673(02)00216-9
   Naxing XR, 2006, J PHARM BIOMED ANAL, V40, P728
   Nie J, 2005, J CHROMATOGR B, V828, P62, DOI 10.1016/j.jchromb.2005.09.015
   Niederlander HAG, 2006, J CHROMATOGR B, V834, P98, DOI 10.1016/j.jchromb.2006.02.042
   Ong VS, 2004, INT J MASS SPECTROM, V238, P139, DOI 10.1016/j.ijms.2004.01.021
   Ortelli D, 2002, J SEP SCI, V25, P222, DOI 10.1002/1615-9314(20020301)25:4<222::AID-JSSC222>3.0.CO;2-#
   Papp R, 2004, J PHARMACEUT BIOMED, V36, P457, DOI 10.1016/j.jpba.2004.07.029
   PINTERTON TC, 1985, Patent No. 4455485
   Polson C, 2003, J CHROMATOGR B, V785, P263, DOI 10.1016/S1570-0232(02)00914-5
   PRETORIUS V, 1966, ANAL CHEM, V38, P274, DOI 10.1021/ac60234a030
   Pyrzynska K, 2002, CRIT REV ANAL CHEM, V32, P227, DOI 10.1080/10408340290765533
   QUINN HM, 1997, Patent No. 9716724
   Rbeida O, 2005, J PHARMACEUT BIOMED, V36, P947, DOI 10.1016/j.jpba.2004.08.007
   Rbeida O, 2005, J PHARMACEUT BIOMED, V36, P961, DOI 10.1016/j.jpba.2004.09.017
   RUDOLPHI A, 1997, USE RESTRICTED ACCES, V15, P814
   Sambe H, 2005, ANALYST, V130, P38, DOI 10.1039/b412641f
   Sanbe H, 2003, ANALYST, V128, P593, DOI 10.1039/b301257n
   Santos-Neto AJ, 2006, J CHROMATOGR A, V1105, P71, DOI 10.1016/j.chroma.2005.12.001
   Sauvage FL, 2006, THER DRUG MONIT, V28, P123, DOI 10.1097/01.ftd.0000194026.04483.c3
   Schafer C, 2001, J CHROMATOGR A, V909, P73, DOI 10.1016/S0021-9673(00)01175-4
   Schlauch M, 2002, J CHROMATOGR B, V775, P197, DOI 10.1016/S1570-0232(02)00287-8
   Smalley J, 2006, J CHROMATOGR B, V830, P270, DOI 10.1016/j.jchromb.2005.11.006
   Souverain S, 2004, J CHROMATOGR B, V801, P141, DOI 10.1016/j.jchromb.2003.11.043
   Spegel Peter, 2004, Methods Mol Biol, V243, P217
   Theodoridis G, 2005, ADV CHROMATOGR, V43, P231
   Theodoridis G, 2004, J CHROMATOGR A, V1030, P69, DOI 10.1016/j.chroma.2003.12.036
   Vintiloiu A, 2005, J CHROMATOGR A, V1082, P150, DOI 10.1016/j.chroma.2005.05.081
   Willemsen O, 2004, J CHROMATOGR A, V1025, P209, DOI 10.1016/j.chroma.2003.10.072
   Wu ST, 2004, RAPID COMMUN MASS SP, V18, P2531, DOI 10.1002/rcm.1655
   Xu XH, 2005, J CHROMATOGR B, V814, P29, DOI 10.1016/j.jchromb.2004.09.033
   Yang GL, 2006, J CHROMATOGR A, V1129, P231, DOI 10.1016/j.chroma.2006.07.029
   Ynddal L, 2003, J CHROMATOGR A, V1020, P59, DOI 10.1016/S0021-9673(03)00773-8
   Zeng W, 2004, J CHROMATOGR B, V806, P177, DOI 10.1016/j.jchromb.2004.03.058
   Zhou SL, 2005, RAPID COMMUN MASS SP, V19, P2144, DOI 10.1002/rcm.2037
   2005, LCGC N AM, V18
   2005, LCGC S, V61
NR 92
TC 81
Z9 84
U1 8
U2 40
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-022X
J9 J BIOCHEM BIOPH METH
JI J. Biochem. Biophys. Methods
PD MAR 10
PY 2007
VL 70
IS 2
BP 263
EP 273
DI 10.1016/j.jbbm.2006.10.001
PG 11
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 149OU
UT WOS:000245157100011
PM 17113152
DA 2018-10-20
ER

PT J
AU Webb, AR
   Kumar, VA
   Ameer, GA
AF Webb, Antonio R.
   Kumar, Vivek A.
   Ameer, Guillermo A.
TI Biodegradable poly(diol citrate) nanocomposite elastomers for soft
   tissue engineering
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID IN-VITRO; MECHANICAL-PROPERTIES; POLY(L-LACTIC ACID); COMPOSITE
   SCAFFOLDS; SMOOTH-MUSCLE; BIOMATERIAL; NANOFIBERS; GENERATION;
   NANOTUBES; MATRIX
AB At present, synthetic biodegradable polymers commonly used for scaffolds in tissue engineering have a limited range of mechanical properties. This limitation is a challenge to in vivo tissue engineering, as the cell-scaffold construct is expected to maintain or restore normal tissue biomechanics during new tissue formation. Herein we report the synthesis and characterization of biodegradable elastomeric nanocomposite materials whose mechanical properties can be tailored to meet the requirements of soft tissue engineering applications. The nanocomposite consists of a nanofibrous poly(L-lactic acid) (PLLA) nanophase and an elastomeric poly(diol citrate) macrophase. Incorporation of a PLLA nanophase provides reinforcement to the poly(diol citrate) as demonstrated by an increase in tensile strength, modulus, and elongation at break with minimal permanent deformation. The mechanical properties of the nanocomposite were altered with the concentration of PLLA, choice of poly(diol citrate), and polymerization conditions. More importantly, the tensile mechanical properties compare favorably to those of human cartilage, ligament, and blood vessel. Furthermore, the compressive modulus is very similar to those of human and bovine articular cartilage. These results suggest that poly(diol citrate) nanocomposite elastomers are promising candidate biomaterials for soft tissue engineering.
C1 Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.
RP Ameer, GA (reprint author), Northwestern Univ, Dept Biomed Engn, 2145 Sheridan Rd,Room E310, Evanston, IL 60208 USA.
EM g-ameer@northwestern.edu
RI Ameer, Guillermo/B-6765-2009; Kumar, Vivek/F-3939-2011
OI Kumar, Vivek/0000-0002-3511-4628
CR Andersson H, 2001, J APPL ELECTROCHEM, V31, P1, DOI 10.1023/A:1004105622558
   ATALA A, 2001, METHODS TISSUE ENG
   Blond D, 2006, ADV FUNCT MATER, V16, P1608, DOI 10.1002/adfm.200500855
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Chen VJ, 2006, BIOMATERIALS, V27, P3708, DOI 10.1016/j.biomaterials.2006.02.020
   Finegan IC, 2003, J MATER SCI, V38, P3485, DOI 10.1023/A:1025109103511
   Greenwald SE, 2000, J PATHOL, V190, P292, DOI 10.1002/(SICI)1096-9896(200002)190:3<292::AID-PATH528>3.0.CO;2-S
   Jurvelin J S, 2003, Proc Inst Mech Eng H, V217, P215, DOI 10.1243/095441103765212712
   Kim BS, 2000, J BIOMECH ENG-T ASME, V122, P210, DOI 10.1115/1.429651
   Kim BS, 1999, NAT BIOTECHNOL, V17, P979, DOI 10.1038/13671
   Kim HW, 2006, ADV FUNCT MATER, V16, P1529, DOI 10.1002/adfm.200500750
   Kim HW, 2005, ADV FUNCT MATER, V15, P1988, DOI 10.1002/adfm.200500116
   Korhonen RK, 2002, J BIOMECH, V35, P903, DOI 10.1016/S0021-9290(02)00052-0
   Kweon H, 2003, BIOMATERIALS, V24, P801, DOI 10.1016/S0142-9612(02)00370-8
   Lee SH, 2003, J BIOMED MATER RES A, V66A, P29, DOI 10.1002/jbm.a.10497
   Ma PX, 1999, J BIOMED MATER RES, V46, P60, DOI 10.1002/(SICI)1097-4636(199907)46:1<60::AID-JBM7>3.0.CO;2-H
   MacDonald RA, 2005, J BIOMED MATER RES A, V74A, P489, DOI 10.1002/jbm.a.30386
   Mano JF, 2004, COMPOS SCI TECHNOL, V64, P789, DOI 10.1016/j.compscitech.2003.09.001
   Maquet V, 2004, BIOMATERIALS, V25, P4185, DOI 10.1016/j.biomaterials.2003.10.082
   Mathieu LM, 2006, BIOMATERIALS, V27, P905, DOI 10.1016/j.biomaterials.2005.07.015
   Miyagawa H, 2005, J NANOSCI NANOTECHNO, V5, P1593, DOI 10.1166/jnn.2005.181
   Nerem RM, 2003, BIORHEOLOGY, V40, P281
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   PACHENCE JM, 2000, PRINCIPLES TISSUE EN, P263
   Pego AP, 2003, J CONTROL RELEASE, V87, P69, DOI 10.1016/S0168-3659(02)00351-6
   Ramay HRR, 2004, BIOMATERIALS, V25, P5171, DOI 10.1016/j.biomaterials.2003.12.023
   Safar ME, 2003, CIRCULATION, V107, P2864, DOI 10.1161/01.CIR.0000069826.36125.B4
   Shi ST, 2002, NAT BIOTECHNOL, V20, P587, DOI 10.1038/nbt0602-587
   Waldman SD, 2003, J BONE JOINT SURG AM, V85A, P101, DOI 10.2106/00004623-200300002-00013
   Wang YD, 2003, J BIOMED MATER RES A, V66A, P192, DOI 10.1002/jbm.a.10534
   Webb AR, 2004, EXPERT OPIN BIOL TH, V4, P801, DOI 10.1517/14712598.4.6.801
   Xu LR, 2004, J COMPOS MATER, V38, P1563, DOI 10.1177/0021998304043758
   Yang J, 2004, ADV MATER, V16, P511, DOI 10.1002/adma.200306264
   Yang J, 2002, BIOMATERIALS, V23, P2607, DOI 10.1016/S0142-9612(01)00400-8
   Yang J, 2006, ADV MATER, V18, P1493, DOI 10.1002/adma.200600230
   Yang J, 2006, BIOMATERIALS, V27, P1889, DOI 10.1016/j.biomaterials.2005.05.106
   Yang J, 2002, J BIOMED MATER RES, V62, P438, DOI 10.1002/jbm.10318
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Zhang RY, 2000, J BIOMED MATER RES, V52, P430, DOI 10.1002/1097-4636(200011)52:2<430::AID-JBM25>3.0.CO;2-L
NR 39
TC 21
Z9 21
U1 1
U2 17
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PD MAR 7
PY 2007
VL 17
IS 9
BP 900
EP 906
DI 10.1039/b611353b
PG 7
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 145UW
UT WOS:000244892300010
DA 2018-10-20
ER

PT J
AU Intini, G
   Andreana, S
   Intini, FE
   Buhite, RJ
   Bobek, LA
AF Intini, Giuseppe
   Andreana, Sebastiano
   Intini, Francesco E.
   Buhite, Robert J.
   Bobek, Libuse A.
TI Calcium Sulfate and Platelet-Rich Plasma make a novel osteoinductive
   biomaterial for bone regeneration
SO JOURNAL OF TRANSLATIONAL MEDICINE
LA English
DT Article
ID GROWTH-FACTOR ENHANCEMENT; JOINT DECADE; MORPHOGENETIC PROTEIN-2;
   INTRABONY DEFECTS; GRAFT SUBSTITUTE; AUTOGENOUS BONE; NATIONAL BONE;
   IN-VITRO; REPAIR; PROLIFERATION
AB Background: With the present study we introduce a novel and simple biomaterial able to induce regeneration of bone. We theorized that nourishing a bone defect with calcium and with a large amount of activated platelets may initiate a series of biological processes that culminate in bone regeneration. Thus, we engineered CS-Platelet, a biomaterial based on the combination of Calcium Sulfate and Platelet-Rich Plasma in which Calcium Sulfate also acts as an activator of the platelets, therefore avoiding the need to activate the platelets with an agonist.
   Methods: First, we tested CS-Platelet in heterotopic ( muscle) and orthotopic ( bone) bone regeneration bioassays. We then utilized CS-Platelet in a variety of dental and craniofacial clinical cases, where regeneration of bone was needed.
   Results: The heterotopic bioassay showed formation of bone within the muscular tissue at the site of the implantation of CS-Platelet. Results of a quantitative orthotopic bioassay based on the rat calvaria critical size defect showed that only CS-Platelet and recombinant human BMP2 were able to induce a significant regeneration of bone. A non-human primate orthotopic bioassay also showed that CS-Platelet is completely resorbable. In all human clinical cases where CS-Platelet was used, a complete bone repair was achieved.
   Conclusion: This study showed that CS-Platelet is a novel biomaterial able to induce formation of bone in heterotopic and orthotopic sites, in orthotopic critical size bone defects, and in various clinical situations. The discovery of CS-Platelet may represent a cost-effective breakthrough in bone regenerative therapy and an alternative or an adjuvant to the current treatments.
C1 Univ Buffalo, Dept Oral Biol, Buffalo, NY 14214 USA.
   Univ Buffalo, Dept Periodont & Endodont, Buffalo, NY 14214 USA.
   Univ Buffalo, Dept Restorat Dent, Buffalo, NY 14214 USA.
   Univ Buffalo, Dept Oral & Maxillofacial Surg, Buffalo, NY 14214 USA.
RP Intini, G (reprint author), Univ Buffalo, Dept Oral Biol, 109 Foster Hall,3435 Main St, Buffalo, NY 14214 USA.
EM gintini@buffalo.edu; andrean@buffalo.edu; feintini@gmail.com;
   rjbuhite@buffalo.edu; lbobek@buffalo.edu
FU NIDCR NIH HHS [R01 DE009820, DE009820]
CR Ascencio D, 2004, WOUND REPAIR REGEN, V12, P643, DOI 10.1111/j.1067-1927.2004.12610.x
   Bateman J, 2005, J PERIODONTOL, V76, P1833, DOI 10.1902/jop.2005.76.11.1833
   Bonadio J, 1999, NAT MED, V5, P753, DOI 10.1038/10473
   Bush GW, 2002, J BONE JOINT SURG AM, V84A, P1297, DOI 10.2106/00004623-200208000-00001
   BUSH GW, 2002, J BONE JOINT SURG AM, V84, P1298
   Choi BH, 2005, INT J ORAL MAX SURG, V34, P420, DOI 10.1016/j.ijom.2004.10.018
   CRAIG RG, 2004, DENT MAT PROPERTIES, P201
   DWYER SD, 1986, THROMB RES, V42, P139, DOI 10.1016/0049-3848(86)90290-2
   Ferguson CM, 1998, ANN NY ACAD SCI, V857, P33, DOI 10.1111/j.1749-6632.1998.tb10105.x
   Franceschi RT, 2005, J DENT RES, V84, P1093, DOI 10.1177/154405910508401204
   Frechette JP, 2005, J DENT RES, V84, P434, DOI 10.1177/154405910508400507
   Freymiller EG, 2004, J ORAL MAXIL SURG, V62, P484, DOI 10.1016/j.joms.2003.08.021
   Govender S, 2002, J BONE JOINT SURG AM, V84A, P2123, DOI 10.2106/00004623-200212000-00001
   Graziani F, 2006, CLIN ORAL IMPLAN RES, V17, P212, DOI 10.1111/j.1600-0501.2005.2005.01203.x
   Hanna R, 2004, J PERIODONTOL, V75, P1668, DOI 10.1902/jop.2004.75.12.1668
   HOFFMAN R, 2000, HEMATOLOGY BASIC PRI
   Intini G, 2002, TISSUE ENG, V8, P997, DOI 10.1089/107632702320934092
   Katz SI, 2004, J BONE MINER RES, V19, P1605, DOI 10.1359/JBMR.040810
   Kelly CM, 2001, CLIN ORTHOP RELAT R, P42
   Kelly CM, 2004, ORTHOPEDICS, V27, pS131
   Lacoste E, 2003, J PERIODONTOL, V74, P1498, DOI 10.1902/jop.2003.74.10.1498
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   MARDEN LJ, 1994, J BIOMED MATER RES, V28, P1127, DOI 10.1002/jbm.820281003
   Marx RE, 2004, J ORAL MAXIL SURG, V62, P489, DOI 10.1016/j.joms.2003.12.003
   Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4
   MCKEE MD, 2003, EFFECT HUMAN RECOMBI
   Mitchell R, 2003, BASIC PATHOLOGY, V7, P61
   Nimni ME, 1997, BIOMATERIALS, V18, P1201, DOI 10.1016/S0142-9612(97)00050-1
   OBRIEN WJ, 2002, DENT MAT THEIR SELEC, P37
   Orsini M, 2001, J PERIODONTOL, V72, P296, DOI 10.1902/jop.2001.72.3.296
   Ouyang XY, 2006, CHINESE MED J-PEKING, V119, P1511
   Pecora G, 1997, ORAL SURG ORAL MED O, V84, P424, DOI 10.1016/S1079-2104(97)90043-3
   Pietrzak WS, 2000, J CRANIOFAC SURG, V11, P327, DOI 10.1097/00001665-200011040-00009
   Polimeni G, 2006, PERIODONTOL 2000, V41, P30, DOI 10.1111/j.1600-0757.2006.00157.x
   Ripamonti U, 2004, J CELL MOL MED, V8, P169, DOI 10.1111/j.1582-4934.2004.tb00272.x
   SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299
   Sottosanti J, 1992, Compendium, V13, P226
   Sottosanti J., 1992, COMPENDIUM, V13, P232
   TAKAGI K, 1982, ANN SURG, V196, P100, DOI 10.1097/00000658-198207000-00020
   Termaat MF, 2005, J BONE JOINT SURG AM, V87A, P1367, DOI 10.2106/JBJS.D.02585
   THIEDE MA, 1994, ENDOCRINOLOGY, V135, P929, DOI 10.1210/en.135.3.929
   URIST MR, 1984, P NATL ACAD SCI-BIOL, V81, P371, DOI 10.1073/pnas.81.2.371
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Weibrich G, 2004, BONE, V34, P665, DOI 10.1016/j.bone.2003.12.010
   Weinstein SL, 2000, J BONE JOINT SURG AM, V82A, P1
   Wiltfang J, 2004, CLIN ORAL IMPLAN RES, V15, P187, DOI 10.1111/j.1600-0501.2004.00980.x
NR 46
TC 43
Z9 44
U1 2
U2 7
PU BIOMED CENTRAL LTD
PI LONDON
PA MIDDLESEX HOUSE, 34-42 CLEVELAND ST, LONDON W1T 4LB, ENGLAND
SN 1479-5876
J9 J TRANSL MED
JI J. Transl. Med.
PD MAR 7
PY 2007
VL 5
AR 13
DI 10.1186/1479-5876-5-13
PG 13
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 151ZJ
UT WOS:000245329500001
PM 17343737
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Godara, A
   Raabe, D
   Green, S
AF Godara, A.
   Raabe, D.
   Green, S.
TI The influence of sterilization processes on the micromechanical
   properties of carbon fiber-reinforced PEEK composites for bone implant
   applications
SO ACTA BIOMATERIALIA
LA English
DT Article
DE biomaterial; composite; PEEK; carbon fibers; bone implant
ID MOLECULAR-WEIGHT POLYETHYLENE; COOLING RATE INFLUENCES; ELECTRON-BEAM
   IRRADIATION; MECHANICAL-PROPERTIES; FIBRE/PEEK COMPOSITES;
   NANO-INDENTATION; EPOXY COMPOSITES; ETHER KETONE); GLASS; INTERFACES
AB The effect of sterilization on the structural integrity of the thermoplastic matrix composite polyetheretherketone (PEEK) reinforced with carbon fibers (CF) is investigated by nanoindentation and nanoscratch tests. The use of the material as a medical implant grade requires a detailed understanding of the micromechanical properties which primarily define its in vivo behavior. Sterilization is a mandatory process for such materials used in medical applications like bone implants. The steam and gamma radiation sterilization processes employed in this study are at sufficient levels to affect the micromechanical properties of some polymer materials, particularly in the interphase region between the polymer matrix and the reinforcing fibers. Nanoindentation and nanoscratch tests are used in this work to reveal local gradients in the hardness and the elastic properties of the interphase regions. Both methods help to explore microscopic changes in the hardness, reduced stiffness and scratch resistance in the interphase region and in the bulk polymer matrix due to the different sterilization processes employed. The results reveal that neither steam nor gamma radiation sterilization entails significant changes of the reduced elastic modulus, hardness or coefficient of friction in the bulk polymer matrix. However, minor material changes of the PEEK matrix were observed in the interphase region. Of the two sterilization methods used, the steam treatment has a more significant influence on these small changes in this region and appears to increase slightly the thickness of the interphase zone. (c) 2006 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 Max Planck Inst Eisenforsch GmbH, D-40237 Dusseldorf, Germany.
   Invibio Ltd, Cleveleys FY5 4QD, Lancs, England.
RP Raabe, D (reprint author), Max Planck Inst Eisenforsch GmbH, Max Planck Str 1, D-40237 Dusseldorf, Germany.
EM a.godara@mpie.de; d.raabe@mpie.de; s.green@invibio.com
RI Raabe, Dierk/A-6470-2009
OI Raabe, Dierk/0000-0003-0194-6124
CR Barraza HJ, 2003, J ADHES SCI TECHNOL, V17, P217, DOI 10.1163/156856103762302014
   DESAEGER M, 1993, COMPOS SCI TECHNOL, V48, P215, DOI 10.1016/0266-3538(93)90139-8
   Gao SL, 2002, COMPOS PART A-APPL S, V33, P559, DOI 10.1016/S1359-835X(01)00134-8
   Gao SL, 2002, J APPL POLYM SCI, V84, P1155, DOI 10.1002/app.10406
   Gao SL, 2001, COMPOS PART A-APPL S, V32, P763, DOI 10.1016/S1359-835X(00)00188-3
   Gao SL, 2001, COMPOS PART A-APPL S, V32, P775, DOI 10.1016/S1359-835X(00)00189-5
   Gao SL, 2000, COMPOS PART A-APPL S, V31, P517, DOI 10.1016/S1359-835X(00)00009-9
   Gregory JR, 2005, COMPOS SCI TECHNOL, V65, P595, DOI 10.1016/j.compscitech.2004.09.001
   Hodzic A, 2000, POLYMER, V41, P6895, DOI 10.1016/S0032-3861(99)00890-3
   Hodzic A, 2001, POLYMER, V42, P5701, DOI 10.1016/S0032-3861(01)00029-5
   International Organization for Standardization, 134852003 ISO
   KAELBLE DH, 1976, J ADHESION, V8, P121, DOI 10.1080/00218467608075078
   LEE MC, 1993, J COMPOS MATER, V27, P1146
   Lee SM, 2005, J POLYM SCI POL PHYS, V43, P3019, DOI 10.1002/polb.20578
   LUSTIGER A, 1990, POLYM COMPOSITE, V11, P65, DOI 10.1002/pc.750110109
   Mai K, 1998, COMPOS PART A-APPL S, V29, P1111, DOI 10.1016/S1359-835X(98)00092-X
   MAROM G, 1981, J ADHESION, V2, P153
   MENSITIERI G, 1989, J APPL POLYM SCI, V37, P381, DOI 10.1002/app.1989.070370207
   MIJOVIC J, 1985, J APPL POLYM SCI, V30, P2527, DOI 10.1002/app.1985.070300619
   Nowicki M, 2003, POLYMER, V44, P6599, DOI 10.1016/S0032-3861(03)00729-8
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Premnath V, 1999, POLYMER, V40, P2215, DOI 10.1016/S0032-3861(98)00438-8
   Ray BC, 2006, J COLLOID INTERF SCI, V298, P111, DOI 10.1016/j.jcis.2005.12.023
   SAIELLO S, 1990, J MATER SCI, V25, P3493, DOI 10.1007/BF00575375
   SASUGA T, 1989, J MATER SCI, V24, P1570, DOI 10.1007/BF01105672
   SHINDE A, 1985, J POLYM SCI POL PHYS, V23, P1681, DOI 10.1002/pol.1985.180230819
   Tai NH, 1999, COMPOS PART B-ENG, V30, P849, DOI 10.1016/S1359-8368(99)00048-7
   Vaddadi P, 2003, COMPOS PART A-APPL S, V34, P719, DOI 10.1016/S1359-835X(03)00135-0
   Vanlandingham MR, 1997, J ADHESION, V64, P31, DOI 10.1080/00218469708010531
   VAUGHAN AS, 1995, POLYMER, V36, P1549, DOI 10.1016/0032-3861(95)98998-3
   Vaughan AS, 2001, POLYMER, V42, P8891, DOI 10.1016/S0032-3861(01)00444-X
   WOLF CJ, 2003, J POLYM SCI POL LETT, V33, P331
   Zhang MQ, 1996, POLYMER, V37, P5151, DOI 10.1016/0032-3861(96)00341-2
   ZHENG Q, 1993, J COMPOS MATER, V27, P1465, DOI 10.1177/002199839302701503
NR 34
TC 73
Z9 79
U1 4
U2 68
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR
PY 2007
VL 3
IS 2
BP 209
EP 220
DI 10.1016/j.actbio.2006.11.005
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 144NV
UT WOS:000244804000007
PM 17236831
DA 2018-10-20
ER

PT J
AU Yang, Z
   Peng, XF
   Chu, CP
   Lee, DJ
AF Yang, Z.
   Peng, X. F.
   Chu, C. P.
   Lee, D. J.
TI Image processing and geometric parameters extracted from sliced image of
   porous biomaterial
SO ADVANCED POWDER TECHNOLOGY
LA English
DT Article
DE image thresholding; biomaterials; fractals; flocs
ID ACTIVATED-SLUDGE FLOC; ITERATIVE SELECTION METHOD; DRAG FORCE;
   THRESHOLDING TECHNIQUES; ALUM COAGULATION; INTRAFLOC FLOW; SEGMENTATION;
   ENTROPY; HISTOGRAM; POROSITY
AB To perform comprehensive modeling for intraflow field and transport processes in a biomaterial, a detailed probing technique is needed for profiling its interior. In our 2004 Advanced Powder Technology paper, 10 commonly adopted techniques were compared for their capability to probe the interior structure of sludge floc. However, morphological information extracted from sliced images depends on how the image was thresholded. As a continuation work of our 2004 Advanced Powder Technology paper, this work surveyed several frequently encountered problems when applying the histogram-based and bolb feature-based methods for the bilevel thresholding of the sliced images of flocs. A combined scheme using Otsu's method to obtain the porosity and the maximum convex perimeter method to probe the shapes and spatial distribution of the pores was discussed. Some geometric parameters were adopted to describe the interior structure of flocs. The probable misuse of the Sierpinski fractal dimension, due to the numerous pores and solid grains being simultaneously removed from floc image when its resolution was subsequently reduced, was highlighted.
C1 Natl Taiwan Univ, Dept Chem Engn, Taipei 10617, Taiwan.
   Tsing Hua Univ, Lab Phase Change & Interfacial Transport, Beijing 100084, Peoples R China.
RP Lee, DJ (reprint author), Natl Taiwan Univ, Dept Chem Engn, Taipei 10617, Taiwan.
EM djlee@ccms.ntu.edu.tw
RI Yang, Zhen/E-9135-2011
CR Barbusinski K, 1997, WATER SCI TECHNOL, V36, P107, DOI 10.1016/S0273-1223(97)00700-2
   Baveye P, 1998, WATER RESOUR RES, V34, P2783, DOI 10.1029/98WR01209
   Baveye P, 2002, WATER RES, V36, P805, DOI 10.1016/S0043-1354(01)00415-8
   BRINK AD, 1995, IEE P-VIS IMAGE SIGN, V142, P121
   Cenens C, 2002, WATER SCI TECHNOL, V46, P381
   Chu CP, 2004, J CHIN INST CHEM ENG, V35, P659
   Chu CP, 2004, ADV POWDER TECHNOL, V15, P515, DOI 10.1163/1568552042000246
   Chu CP, 2004, WATER RES, V38, P2125, DOI 10.1016/j.watres.2004.02.003
   Chu CP, 2005, CHEM ENG SCI, V60, P565, DOI 10.1016/j.ces.2004.07.132
   Chu CP, 2004, CHEM ENG SCI, V59, P1875, DOI 10.1016/j.ces.2004.01.040
   Chu CP, 2004, J COLLOID INTERF SCI, V277, P387, DOI 10.1016/j.jcis.2004.04.036
   Chu CP, 2004, J COLLOID INTERF SCI, V273, P483, DOI 10.1016/j.jcis.2004.01.002
   Chu CP, 2004, ENVIRON SCI TECHNOL, V38, P1161, DOI 10.1021/es034732d
   Chu CP, 2003, SEPAR SCI TECHNOL, V38, P967, DOI 10.1081/SS-120017637
   Chung HY, 2005, J CHEM ENG JPN, V38, P81, DOI 10.1252/jcej.38.81
   Chung HY, 2004, J CHIN INST CHEM ENG, V35, P225
   Chung HY, 2003, J COLLOID INTERF SCI, V267, P136, DOI 10.1016/S0021-9797(03)00682-9
   Chung HY, 2003, J COLLOID INTERF SCI, V263, P498, DOI 10.1016/S0021-9797(03)00404-1
   da Motto M, 2002, WATER SCI TECHNOL, V46, P363
   Feder Jens, 1988, FRACTALS
   Gorczyca B, 1999, WATER QUAL RES J CAN, V34, P653
   Gorczyca B, 2001, WATER QUAL RES J CAN, V36, P687
   Grijspeerdt K, 1997, WATER RES, V31, P1126, DOI 10.1016/S0043-1354(96)00350-8
   Hu XM, 1996, SEP SCI TECHNOL, V31, P1877, DOI 10.1080/01496399608001016
   Johannsen G., 1982, Proceedings of the 6th International Conference on Pattern Recognition, P140
   KAPUR JN, 1985, COMPUT VISION GRAPH, V29, P273, DOI 10.1016/0734-189X(85)90125-2
   KITTLER J, 1986, PATTERN RECOGN, V19, P41, DOI 10.1016/0031-3203(86)90030-0
   LEE DJ, 1994, ENVIRON SCI TECHNOL, V28, P1444, DOI 10.1021/es00057a011
   Lee DJ, 1996, WATER RES, V30, P541, DOI 10.1016/0043-1354(95)00229-4
   LEE DJ, 1994, J CHIN INST CHEM ENG, V25, P201
   LEE SU, 1990, COMPUT VISION GRAPH, V52, P171, DOI 10.1016/0734-189X(90)90053-X
   LEVINE MD, 1985, IEEE T PATTERN ANAL, V7, P155, DOI 10.1109/TPAMI.1985.4767640
   LI DH, 1989, ENVIRON SCI TECHNOL, V23, P1385, DOI 10.1021/es00069a009
   LI WP, 1998, THEORY APPL CROSS FL
   Mandelbrot B.B, 1983, FRACTAL GEOMETRY NAT
   MARDIA KV, 1988, IEEE T PATTERN ANAL, V10, P919, DOI 10.1109/34.9113
   OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076
   PAL NR, 1993, PATTERN RECOGN, V26, P1277, DOI 10.1016/0031-3203(93)90135-J
   PAL NR, 1992, INT J SYST SCI, V23, P1903, DOI 10.1080/00207729208949429
   Palmer RJ, 1999, CURR OPIN BIOTECH, V10, P263, DOI 10.1016/S0958-1669(99)80046-9
   PUN T, 1981, COMPUT VISION GRAPH, V16, P210, DOI 10.1016/0146-664X(81)90038-1
   PUN T, 1980, SIGNAL PROCESS, V2, P223, DOI 10.1016/0165-1684(80)90020-1
   RIDLER TW, 1978, IEEE T SYST MAN CYB, V8, P630
   Rosin PL, 2001, PATTERN RECOGN, V34, P2083, DOI 10.1016/S0031-3203(00)00136-9
   Russ JC, 1992, IMAGE PROCESSING HDB
   Saha PK, 2001, IEEE T PATTERN ANAL, V23, P689, DOI 10.1109/34.935844
   Sahoo P, 1997, PATTERN RECOGN, V30, P71, DOI 10.1016/S0031-3203(96)00065-9
   Sahoo PK, 1997, OPT ENG, V36, P1976, DOI 10.1117/1.601404
   SAHOO PK, 1988, COMPUT VISION GRAPH, V41, P233, DOI 10.1016/0734-189X(88)90022-9
   TAMBO N, 1979, WATER RES, V13, P409, DOI 10.1016/0043-1354(79)90033-2
   Tao T, 2005, J CHIN INST CHEM ENG, V36, P511
   Thill A, 1998, J COLLOID INTERF SCI, V204, P357, DOI 10.1006/jcis.1998.5570
   TRUSSELL HJ, 1979, IEEE T SYST MAN CYB, V9, P311, DOI 10.1109/TSMC.1979.4310204
   TSAI WH, 1985, COMPUT VISION GRAPH, V29, P377, DOI 10.1016/0734-189X(85)90133-1
   Wu CC, 1997, COLLOID SURFACE A, V122, P89
   Wu RM, 2003, J CHIN INST CHEM ENG, V34, P275
   Yang XM, 2001, WATER RES, V35, P1149, DOI 10.1016/S0043-1354(00)00361-4
   YEN JC, 1995, IEEE T IMAGE PROCESS, V4, P370, DOI 10.1109/83.366472
   ZAHID WM, 1994, WATER SCI TECHNOL, V29, P271
   Zartarian F, 1997, LANGMUIR, V13, P35, DOI 10.1021/la960566u
   Zhang YJ, 1997, PATTERN RECOGN LETT, V18, P963, DOI 10.1016/S0167-8655(97)00083-4
   Zhang YJ, 1996, PATTERN RECOGN, V29, P1335, DOI 10.1016/0031-3203(95)00169-7
NR 62
TC 8
Z9 9
U1 0
U2 9
PU BRILL ACADEMIC PUBLISHERS
PI LEIDEN
PA PLANTIJNSTRAAT 2, P O BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0921-8831
J9 ADV POWDER TECHNOL
JI Adv. Powder Technol.
PD MAR
PY 2007
VL 18
IS 2
BP 187
EP 213
DI 10.1163/156855207780208655
PG 27
WC Engineering, Chemical
SC Engineering
GA 154EL
UT WOS:000245489500006
DA 2018-10-20
ER

PT J
AU Meade, AD
   Lyng, FM
   Knief, P
   Byrne, HJ
AF Meade, Aidan D.
   Lyng, Fiona M.
   Knief, Peter
   Byrne, Hugh J.
TI Growth substrate induced functional changes elucidated by FTIR and Raman
   spectroscopy in in-vitro cultured human keratinocytes
SO ANALYTICAL AND BIOANALYTICAL CHEMISTRY
LA English
DT Article; Proceedings Paper
CT SPEC 2006
CY MAY 20-24, 2006
CL Heidelberg, GERMANY
DE Raman/FTIR spectroscopy; HaCaT keratinocytes; adhesion effects;
   spectroscopic substrates
ID BIOMATERIAL SURFACE-CHEMISTRY; RADIATION-INDUCED APOPTOSIS;
   MAMMALIAN-CELL CULTURES; LIVING CELLS; INFRARED MICROSPECTROSCOPY;
   INTEGRIN BINDING; EPITHELIAL-CELLS; CYTOTOXICITY; DIFFERENTIATION;
   FIBRONECTIN
AB Non-invasive measurements of cellular function in in vitro cultured cell lines using vibrational spectroscopy require the use of spectroscopic substrates such as quartz, ZnSe and MirrIR etc. These substrates are generally dissimilar to the original in vivo extracellular environment of a given cell line and are often tolerated poorly by cultured cell lines resulting in morphological and functional changes in the cell. The present study demonstrates various correlations between vibrational spectroscopic analyses and biochemical analyses in the evaluation of the interaction of a normal human epithelial keratinocyte cell line (HaCaT) with MirrIR and quartz substrates coated with fibronectin, laminin and gelatin. The findings of this study suggest that there is a correlation between quantitative measurements of cellular proliferative capacity and viability and peak area ratios in FTIR spectra, with replicated differences in similar areas of the observed Raman spectra. Differences in the physiology of cells were observed between the two spectroscopic substrates coated in fibronectin and laminin, but little differences were observed when the cells were attached to gelatin-coated quartz and MirrIR slides. The correlations demonstrate the sensitivity of the spectroscopic techniques to evaluate the physiology of the system. Furthermore the study suggests that gelatin is a suitable coating for use in spectroscopic measurements of cellular function in human keratinocytes, as it provides a material that normalises the effect of substrate attachment on cellular physiology. This effect is likely to be cell-line dependent, and it is recommended that similar evaluations of this effect are performed for those combinations of spectroscopic substrate and cell lines that are to be used in individual experiments.
C1 Dublin Inst Technol, Focas Inst, Radiat & Environm Sci Ctr, Dublin 8, Ireland.
   Dublin Inst Technol, Fac Sci, Sch Phys, Dublin 8, Ireland.
RP Meade, AD (reprint author), Dublin Inst Technol, Focas Inst, Radiat & Environm Sci Ctr, Camden Row, Dublin 8, Ireland.
EM aidan.meade@dit.ie
RI Byrne, Hugh/A-2301-2011; Meade, Aidan/A-5092-2013
OI Byrne, Hugh/0000-0002-1735-8610; Meade, Aidan/0000-0003-0353-9768; Lyng,
   Fiona/0000-0002-9876-963X
CR AHMAD H, 1985, ANAL BIOCHEM, V148, P533, DOI 10.1016/0003-2697(85)90264-7
   Allen LT, 2006, BIOMATERIALS, V27, P3096, DOI 10.1016/j.biomaterials.2006.01.019
   Bill HM, 2004, MOL CELL BIOL, V24, P8586, DOI 10.1128/MCB.24.19.8586-8599.2004
   Borenfreunds E, 1984, J TISSUE CULTURE MET, V9, P7
   Boudreau Nancy J., 1999, Biochemical Journal, V339, P481, DOI 10.1042/0264-6021:3390481
   BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   BRUMFELD V, 1993, ARCH BIOCHEM BIOPHYS, V302, P134, DOI 10.1006/abbi.1993.1191
   Chun J, 1997, J CELL PHYSIOL, V173, P361, DOI 10.1002/(SICI)1097-4652(199712)173:3<361::AID-JCP8>3.0.CO;2-L
   Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R
   Doornaert B, 2003, EXP CELL RES, V287, P199, DOI 10.1016/S0014-4827(03)00114-9
   Edwards HGM, 2000, BIOL APPL RAMAN SPEC, P421
   EVIS Z, 2006, J BIOMED MAT RES A
   Faolain O., 2005, VIB SPECTROSC, V38, P121
   FRUSHOUR BG, 1975, BIOPOLYMERS, V14, P379, DOI 10.1002/bip.1975.360140211
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Gaudenzi S, 2004, SPECTROSC-INT J, V18, P415, DOI 10.1155/2004/483591
   Gaudet C, 2003, BIOPHYS J, V85, P3329, DOI 10.1016/S0006-3495(03)74752-3
   Gault N, 2005, INT J RADIAT BIOL, V81, P767, DOI 10.1080/09553000500515368
   Gault N, 2004, CAN J PHYSIOL PHARM, V82, P38, DOI 10.1139/Y03-126
   Gault N, 2003, RADIAT RES, V160, P238, DOI 10.1667/RR3020.1
   Gazi E, 2005, BIOPOLYMERS, V77, P18, DOI 10.1002/bip.20167
   Holman HN, 2000, BIOPOLYMERS, V57, P329
   Holman HYN, 2002, J BIOMED OPT, V7, P417, DOI 10.1117/1.1485299
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Krishna CM, 2005, BBA-GEN SUBJECTS, V1726, P160, DOI 10.1016/j.bbagen.2005.08.006
   Krishna CM, 2004, APPL SPECTROSC, V58, P1128, DOI 10.1366/0003702041959460
   Liebsch H M, 1995, Methods Mol Biol, V43, P177
   Mammone T, 2000, CELL BIOL TOXICOL, V16, P293, DOI 10.1023/A:1026746330146
   Matthysse S, 2001, CLIN NEUROSCI RES, V1, P8
   Mourant JR, 2003, BIOPHYS J, V85, P1938, DOI 10.1016/S0006-3495(03)74621-9
   Mourant JR, 2000, J BIOMED OPT, V5, P131, DOI 10.1117/1.429979
   Mousia Z, 2001, BIOPOLYMERS, V62, P208, DOI 10.1002/bip.1015
   Ni Shuilleabhain S, 2004, TOXICOL IN VITRO, V18, P365, DOI 10.1016/j.tiv.2003.10.006
   Nijssen A, 2002, J INVEST DERMATOL, V119, P64, DOI 10.1046/j.1523-1747.2002.01807.x
   Notingher I, 2004, BIOSENS BIOELECTRON, V20, P780, DOI 10.1016/j.bios.2004.04.008
   Notingher I, 2004, J CELL BIOCHEM, V92, P1180, DOI 10.1002/jcb.20136
   Notingher I, 2004, ANAL CHEM, V76, P3185, DOI 10.1021/ac0498720
   Notingher I, 2003, BIOPOLYMERS, V72, P230, DOI 10.1002/bip.10378
   Notingher I, 2002, SPECTROSC-INT J, V16, P43, DOI 10.1155/2002/408381
   O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x
   PUPPELS GJ, 1991, EXP CELL RES, V195, P361, DOI 10.1016/0014-4827(91)90385-8
   PUPPELS GJ, 1991, BIOPHYS J, V60, P1046, DOI 10.1016/S0006-3495(91)82142-7
   Putnins EE, 1999, CELL ADHES COMMUN, V7, P211, DOI 10.3109/15419069909010803
   Ramser K, 2003, J BIOMED OPT, V8, P173, DOI 10.1117/1.1559730
   Redey SA, 2000, J BIOMED MATER RES, V50, P353, DOI 10.1002/(SICI)1097-4636(20000605)50:3<353::AID-JBM9>3.0.CO;2-C
   ROUAHI M, 2006, J BIOMED MAT RES A
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   Short KW, 2005, BIOPHYS J, V88, P4274, DOI 10.1529/biophysj.103.038604
   Slaughter MR, 1999, TOXICOL IN VITRO, V13, P567, DOI 10.1016/S0887-2333(99)00037-5
   Sutherland J, 2005, J ANAT, V207, P67, DOI 10.1111/j.1469-7580.2005.00431.x
   Synytsya A, 2004, INT J RADIAT BIOL, V80, P581, DOI [10.1080/09553000412331283315, 10.1080/09553000412331283515]
   Uzunbajakava N, 2003, BIOPHYS J, V84, P3968, DOI 10.1016/S0006-3495(03)75124-8
   Zellmer S, 1998, CHEM PHYS LIPIDS, V94, P97, DOI 10.1016/S0009-3084(98)00046-2
   ZHANG SZ, 1990, CELL BIOL TOXICOL, V6, P219
   ZHU X, 2006, J BIOMED MAT RES A
NR 57
TC 69
Z9 69
U1 2
U2 16
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1618-2642
J9 ANAL BIOANAL CHEM
JI Anal. Bioanal. Chem.
PD MAR
PY 2007
VL 387
IS 5
BP 1717
EP 1728
DI 10.1007/s00216-006-0876-5
PG 12
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 138AO
UT WOS:000244335000017
PM 17102969
DA 2018-10-20
ER

PT J
AU Chen, XC
   Shi, JY
   Chen, YX
   Xu, XJ
   Chen, LT
   Wang, H
   Hu, TD
AF Chen, XinCai
   Shi, JiYan
   Chen, YingXu
   Xu, XiangHua
   Chen, Litao
   Wang, Hui
   Hu, TianDou
TI Determination of copper binding in Pseudomonas putida CZ1 by chemical
   modifications and X-ray absorption spectroscopy
SO APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
LA English
DT Article
DE Pseudomonas putida CZ1; chemical modification; FTIR; XAS; metal binding
ID BACILLUS-SUBTILIS; CELL-WALLS; MODIFIED BIOMASS; METAL-BINDING;
   HEAVY-METALS; BIOSORPTION; IONS; ADSORPTION; MECHANISM; ZINC(II)
AB Previously performed studies have shown that Pseudomonas putida CZ1 biomass can bind an appreciable amount of Cu(II) and Zn(II) ions from aqueous solutions. The mechanisms of Cu- and Zn-binding by P. putida CZ1 were ascertained by chemical modifications of the biomass followed by Fourier transform infrared and X-ray absorption spectroscopic analyses of the living or nonliving cells. A dramatic decrease in Cu(II)- and Zn(II)-binding resulted after acidic methanol esterification of the nonliving cells, indicating that carboxyl functional groups play an important role in the binding of metal to the biomaterial. X-ray absorption spectroscopy was used to determine the speciation of Cu ions bound by living and nonliving cells, as well as to elucidate which functional groups were involved in binding of the Cu ions. The X-ray absorption near-edge structure spectra analysis showed that the majority of the Cu was bound in both samples as Cu(II). The fitting results of Cu K-edge extended X-ray absorption fine structure spectra showed that N/O ligands dominated in living and nonliving cells. Therefore, by combining different techniques, our results indicate that carboxyl functional groups are the major ligands responsible for the metal binding in P. putida CZ1.
C1 Zhejiang Univ, Dept Environm Engn, Hangzhou 310029, Peoples R China.
   Chinese Acad Sci, Inst High Energy Phys, Beijing 100039, Peoples R China.
RP Chen, YX (reprint author), Zhejiang Univ, Dept Environm Engn, Hangzhou 310029, Peoples R China.
EM yxchen@zju.edu.cn
RI Shi, Jiyan/C-2064-2014
CR AKTHAR NM, 1996, BIOMETALS, V9, P21
   Bai RS, 2002, WATER RES, V36, P1224, DOI 10.1016/S0043-1354(01)00330-X
   BEVERIDGE TJ, 1980, J BACTERIOL, V141, P876
   BRADY D, 1994, ENVIRON TECHNOL, V15, P429, DOI 10.1080/09593339409385447
   BUX F, 1994, WATER SA, V20, P73
   Chen XC, 2005, COLLOID SURFACE B, V46, P101, DOI 10.1016/j.colsurfb.2005.10.003
   CONLEY RT, 1972, INFRARED SPECTROSC
   CRIST RH, 1988, ENVIRON SCI TECHNOL, V22, P755, DOI 10.1021/es00172a002
   CRIST RH, 1981, ENVIRON SCI TECHNOL, V15, P1212, DOI 10.1021/es00092a010
   DOYLE RJ, 1980, J BACTERIOL, V143, P471
   Drake LR, 1996, ENVIRON SCI TECHNOL, V30, P110, DOI 10.1021/es950131d
   Figueira MM, 2000, WATER RES, V34, P196, DOI 10.1016/S0043-1354(99)00120-7
   Gadd GM, 1986, IMMOBILISATION IONS, P135
   GARDEATORRESDEY JL, 1990, ENVIRON SCI TECHNOL, V24, P1372, DOI 10.1021/es00079a011
   GardeaTorresdey JL, 1996, J HAZARD MATER, V48, P191, DOI 10.1016/0304-3894(95)00156-5
   GREENE B, 1986, ENVIRON SCI TECHNOL, V20, P627, DOI 10.1021/es00148a014
   GUIBAL E, 1995, ENVIRON SCI TECHNOL, V29, P2496, DOI 10.1021/es00010a007
   HUANG C, 1996, WATER RES, V9, P1985
   Kapoor A, 1997, BIORESOURCE TECHNOL, V61, P221, DOI 10.1016/S0960-8524(97)00055-2
   Kiefer E, 1997, ENVIRON SCI TECHNOL, V31, P759, DOI 10.1021/es960415d
   Kretschmer MC, 2002, MICROCHEM J, V71, P295
   KUYUCAK N, 1989, BIOTECHNOL BIOENG, V33, P823, DOI 10.1002/bit.260330705
   MANTSCH HH, 1995, INFRARED SPECTROSCOP, P120
   MCLEAN RJC, 1994, WORLD J MICROB BIOT, V10, P472, DOI 10.1007/BF00144475
   MEITZNER G, 1992, FRESEN J ANAL CHEM, V342, P61, DOI 10.1007/BF00321692
   MUZZARELLI RAA, 1977, CHITIN
   PAKUNC D, 2004, GEOCHIM COSMOCHIM AC, V68, P969
   PUMPEL T, 1993, FEMS MICROBIOL REV, V11, P159
   Sachs S, 2002, TALANTA, V57, P999, DOI 10.1016/S0039-9140(02)00140-6
   Schiewer S, 1999, ENVIRON SCI TECHNOL, V33, P3821, DOI 10.1021/es981288j
   Sun G, 1998, IND ENG CHEM RES, V37, P1324, DOI 10.1021/ie970468j
   TERNAY AL, 1979, CONT ORGANIC CHEM, P783
   Tiemann KJ, 1999, ENVIRON SCI TECHNOL, V33, P150, DOI 10.1021/es9804722
   TIEMANN KJ, 1998, P 1998 C HAZ WAST RE, P63
   TOBIN JM, 1990, ENZYME MICROB TECH, V12, P591, DOI 10.1016/0141-0229(90)90132-A
   Toner B, 2005, ENVIRON SCI TECHNOL, V39, P8288, DOI 10.1021/es050528+
   Wang JL, 2002, PROCESS BIOCHEM, V37, P847, DOI 10.1016/S0032-9592(01)00284-9
   Wang L, 2003, WATER RES, V37, P561, DOI 10.1016/S0043-1354(02)00350-0
   WIEBER J, 1988, COLLOID SURFACE, V33, P141, DOI 10.1016/0166-6622(88)80056-8
   Yan GY, 2000, WATER SA, V26, P119
   Yee N, 2004, ENVIRON SCI TECHNOL, V38, P775, DOI 10.1021/es0346680
   Yun YS, 2003, ENVIRON SCI TECHNOL, V37, P3601, DOI 10.1021/es011454e
NR 42
TC 19
Z9 20
U1 1
U2 19
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0175-7598
J9 APPL MICROBIOL BIOT
JI Appl. Microbiol. Biotechnol.
PD MAR
PY 2007
VL 74
IS 4
BP 881
EP 889
DI 10.1007/s00253-006-0592-2
PG 9
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 139RV
UT WOS:000244451200020
PM 17021877
DA 2018-10-20
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI An in vitro method for assessing biomaterial-associated platelet
   activation
SO ASAIO JOURNAL
LA English
DT Article
NR 0
TC 6
Z9 6
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1058-2916
J9 ASAIO J
JI Asaio J.
PD MAR-APR
PY 2007
VL 53
IS 2
BP 159
EP 162
DI 10.1097/MAT.0b013e318031121f
PG 4
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 148XT
UT WOS:000245111400009
PM 17413554
OA Bronze
DA 2018-10-20
ER

PT J
AU Mastrogiacomo, M
   Papadimitropoulos, A
   Cedola, A
   Peyrin, F
   Giannoni, P
   Pearce, SG
   Alini, M
   Giannini, C
   Guagliardi, A
   Cancedda, R
AF Mastrogiacomo, M.
   Papadimitropoulos, A.
   Cedola, A.
   Peyrin, F.
   Giannoni, P.
   Pearce, S. G.
   Alini, M.
   Giannini, C.
   Guagliardi, A.
   Cancedda, R.
TI Engineering of bone using bone marrow stromal cells and a
   silicon-stabilized tricalcium phosphate bioceramic: Evidence for a
   coupling between bone formation and scaffold resorption
SO BIOMATERIALS
LA English
DT Article
DE bioceramic; bone tissue engineering; animal model; microCT; X rays
   microdiffraction; synchrotron radiation
ID MESENCHYMAL STEM-CELLS; ILIZAROV METHOD; POROUS HYDROXYAPATITE; CALCIUM
   PHOSPHATES; GRAFT SUBSTITUTES; DEFECTS; CULTURE; REPAIR; CERAMICS;
   INVIVO
AB Resorbable porous ceramic constructs, based on silicon-stabilized tricalcium phosphate, were implanted in critical-size defects of sheep tibias, either alone or after seeding with bone marrow stromal cells (BMSC). Only BMSC-loaded ceramics displayed a progressive scaffold resorption, coincident with new bone deposition. To investigate the coupled mechanisms of bone formation and scaffold resorption, X-ray computed microtomography (mu CT) with synchrotron radiation was performed on BMSC-seeded ceramic cubes. These were analyzed before and after implantation in immunodeficient mice for 2 or 6 months. With increasing implantation time, scaffold thickness significantly decreased while bone thickness increased. The VCT data evidenced that all scaffolds showed a uniform density distribution before implantation. Areas of different segregated densities were instead observed, in the same scaffolds, once seeded with cells and implanted in vivo. A detailed mu X-ray diffraction analysis revealed that only in the contact areas between deposited bone and scaffold, the TCP component of the biomaterial decreased much faster than the HA component. This event did not occur at areas away from the bone surface, highlighting coupling and cell-dependency of the resorption and matrix deposition mechanisms. Moreover, in scaffolds implanted without cells, both the ceramic density and the TCP:HA ratio remained unchanged with respect to the preimplantation analysis. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Genoa, Ist Nazl Ric Canc, I-16132 Genoa, Italy.
   Univ Genoa, Dipartimento Oncol Biol & Genet, I-16132 Genoa, Italy.
   Univ Genoa, Dipartimento Informat Sistemist & Telemat, I-16132 Genoa, Italy.
   INFM, Unita Ancona, Ancona, Italy.
   CNR, Ist Foton & Nanotecnol, Rome, Italy.
   INSERM, U630, CNRS, UMR 551,CREATIS, F-69008 Lyon, France.
   European Synchrotron Radiat Facil, F-38043 Grenoble, France.
   Biorigen Srl, Genoa, Italy.
   AO Fdn, Davos, Switzerland.
   CNR, IC, I-70126 Bari, Italy.
RP Cancedda, R (reprint author), Univ Genoa, Ist Nazl Ric Canc, Largo R Benzi 10, I-16132 Genoa, Italy.
EM ranieri.cancedda@unige.it
RI Cedola, Alessia/F-3865-2012; Guagliardi, Antonietta/K-4471-2015;
   Giannini, Cinzia/B-2409-2012; Peyrin, Francoise/G-2823-2013
OI Guagliardi, Antonietta/0000-0001-6390-2114; Peyrin,
   Francoise/0000-0002-1988-3435; Cedola, Alessia/0000-0002-9256-8853
CR Alekberov C, 2003, CLIN ORTHOP RELAT R, P199, DOI 10.1097/01.blo.0000052937.71325.a2
   Barker KL, 2004, J BONE JOINT SURG BR, V86B, P81, DOI 10.1302/0301-620X.86B1.14347
   BEGLEY CT, 1993, BONE, V14, P661, DOI 10.1016/8756-3282(93)90089-S
   Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007
   Calif Edward, 2004, Acta Orthop Belg, V70, P51
   Cedola A, 2006, PHYS MED BIOL, V51, pN109, DOI 10.1088/0031-9155/51/6/N02
   CHOONG PF, 2003, LIN ORTHOP RELAT R S, V415, pS19
   DACULSI G, 1989, J BIOMED MATER RES, V23, P883, DOI 10.1002/jbm.820230806
   Fink B, 1996, CLIN ORTHOP RELAT R, P261
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   Gilbert M, 2000, J BIOL CHEM, V275, P16213, DOI 10.1074/jbc.M001773200
   GOSHIMA J, 1991, CLIN ORTHOP RELAT R, P298
   Gugenheim JJ, 1998, CLIN PLAST SURG, V25, P567
   Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x
   Kadiyala S, 1997, TISSUE ENG, V3, P173, DOI 10.1089/ten.1997.3.173
   Kon E, 2000, J BIOMED MATER RES, V49, P328
   Lang H, 1991, Dtsch Z Mund Kiefer Gesichtschir, V15, P64
   Langstaff S, 2001, BIOMATERIALS, V22, P135, DOI 10.1016/S0142-9612(00)00139-3
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Martin-Badosa E, 2003, COMPUT MED IMAG GRAP, V27, P447, DOI 10.1016/S0895-6111(03)00031-4
   Mastrogiacomo M, 2006, TISSUE ENG, V12, P1261, DOI 10.1089/ten.2006.12.1261
   Muraglia A, 1998, BONE, V22, p131S, DOI 10.1016/S8756-3282(98)00009-X
   Murray JH, 1996, J AM ACAD ORTHOP SUR, V4, P317
   OHGUSHI H, 1990, J BIOMED MATER RES, V24, P1563, DOI 10.1002/jbm.820241202
   OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076
   PERONA P, 1990, IEEE T PATTERN ANAL, V12, P629, DOI 10.1109/34.56205
   Perry CR, 1999, CLIN ORTHOP RELAT R, P71
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516
   Reid JW, 2005, BIOMATERIALS, V26, P2887, DOI 10.1016/j.biomaterials.2004.09.005
   Salome M, 1999, MED PHYS, V26, P2194, DOI 10.1118/1.598736
   Sayer M, 2003, BIOMATERIALS, V24, P369, DOI 10.1016/S0142-9612(02)00327-7
   VGSTUDIO MAX 1 2 1 U
NR 33
TC 88
Z9 97
U1 2
U2 24
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2007
VL 28
IS 7
BP 1376
EP 1384
DI 10.1016/j.biomaterials.2006.10.001
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 130BE
UT WOS:000243773200006
PM 17134749
DA 2018-10-20
ER

PT J
AU Brody, S
   McMahon, J
   Yao, L
   O'Brien, M
   Dockery, P
   Pandit, A
AF Brody, Sarah
   McMahon, Jillian
   Yao, Li
   O'Brien, Margret
   Dockery, Peter
   Pandit, Abhay
TI The effect of cholecyst-derived extracellular matrix on the phenotypic
   behaviour of valvular endothelial and valvular interstitial cells
SO BIOMATERIALS
LA English
DT Article
DE cardiac tissue engineering; heart valve; biominietic material;
   endothelialisation; scaffold
ID ENGINEERED HEART-VALVES; SMOOTH-MUSCLE-CELLS; IN-VITRO MATURATION;
   AORTIC-VALVE; 3-DIMENSIONAL CULTURE; GROWTH-FACTOR; FIBRIN GEL; TISSUE;
   ADHESION; SCAFFOLD
AB Cholecyst-derived extracellular matrix (CEM) is a novel, proteinaceous biomaterial, derived from the porcine cholecyst, which may have potential applications as a scaffold in the area of heart valve tissue engineering. In this study the potential of CEM to support the proliferation of valvular endothelial cells (VECs) and valvular interstitial cells (VICs), while maintaining, their phenotypic mRNA synthesis, protein expression and morphology was assessed by biochemical assays, electron microscopy, mimunostaining and reversetranscriptase polymerase chain reaction. VICs and VECs were isolated from the porcine aortic valve and techniques were developed for the isolation of CEM for cell culture. VECs and VICs cultured on CEM adhered and proliferated, maintaining their phenotypic morphology. VECs synthesised von Willebrand factor mRNA and endothelial nitric oxide synthase (eNOS) mRNA and expressed eNOS and VICs synthesised alpha-smooth muscle actin (alpha SMA) mRNA and expressed alpha SMA. Cellular area fractior of VICs expressing alpha SMA was 87.7 +/- 6.8% and cellular area fraction of VECs expressing eNOS was 93.8 +/- 9.3%. Findings of this study support the hypothesis that CEM is a potential biomaterial for tissue engineered heart valve scaffold design. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Natl Univ Ireland Univ Coll Galway, Natl Ctr Biomed Engn Sci, Galway, Ireland.
   Natl Univ Ireland Univ Coll Galway, Dept Mech & Biomed Engn, Galway, Ireland.
   Natl Univ Ireland Univ Coll Galway, Dept Anat, Galway, Ireland.
RP Pandit, A (reprint author), Natl Univ Ireland Univ Coll Galway, Natl Ctr Biomed Engn Sci, Galway, Ireland.
EM abhay.pandit@nuigalway.ie
RI Yao, Li/J-1372-2016; Pandit, Abhay/B-6187-2008
OI Pandit, Abhay/0000-0002-6292-4933; Dockery, Peter/0000-0001-5103-6589;
   McMahon, Jill/0000-0003-0787-0749
CR Bader A, 1998, EUR J CARDIO-THORAC, V14, P279, DOI 10.1016/S1010-7940(98)00171-7
   Brody S, 2006, TISSUE ENG, V12, P413, DOI 10.1089/ten.2006.12.413
   Butcher JT, 2004, J HEART VALVE DIS, V13, P478
   Butcher JT, 2004, ARTERIOSCL THROM VAS, V24, P1429, DOI 10.1161/01.ATV.0000130462.50769.5a
   CHAN J, 2006, REG WORLD C TISS ENG
   Cimini M, 2005, J BIOMED MATER RES A, V75A, P895, DOI 10.1002/jbm.a.30493
   COBURN J, 2006, IN PRESS J BIOMED A
   Cuy JL, 2003, J BIOMED MATER RES A, V67A, P538, DOI 10.1002/jbm.a.10095
   DECK JD, 1986, CARDIOVASC RES, V20, P760, DOI 10.1093/cvr/20.10.760
   Dvorin EL, 2003, TISSUE ENG, V9, P487, DOI 10.1089/107632703322066660
   Farivar RS, 2003, EUR J CARDIO-THORAC, V24, P527, DOI 10.1016/S1010-7940(03)00408-1
   Flanagan TC, 2006, CELLS TISSUES ORGANS, V183, P12, DOI 10.1159/000094902
   Flanagan T. C., 2003, International Journal of Artificial Organs, V26, P584
   Flanagan TC, 2006, BIOMATERIALS, V27, P2233, DOI 10.1016/j.biomaterials.2005.10.031
   Gohlke-Barwolf C, 2000, HEART, V84, P567, DOI 10.1136/heart.84.5.567
   Gotlieb AI, 2002, J HEART VALVE DIS, V11, P314
   Gulbins H, 2003, J THORAC CARDIOV SUR, V125, P592, DOI 10.1067/mtc.2003.48
   HILL ADK, 1993, J ANAT, V182, P425
   HOERSTRUP SP, 2000, CIRCULATION, V102, P144
   Jansson K, 2001, J THORAC CARDIOV SUR, V121, P108, DOI 10.1067/mtc.2001.110251
   Jockenhoevel S, 2001, EUR J CARDIO-THORAC, V19, P424, DOI 10.1016/S1010-7940(01)00624-8
   Karuri NW, 2004, J CELL SCI, V117, P3153, DOI 10.1242/jcs.01146
   Lichtenberg A, 2006, BIOMATERIALS, V27, P4221, DOI 10.1016/j.biomaterials.2006.03.047
   Massberg S, 2002, J EXP MED, V196, P887, DOI 10.1084/jem.20012044
   Masters KS, 2005, BIOMATERIALS, V26, P2517, DOI 10.1016/j.biomaterials.2004.07.018
   Masters KS, 2004, J BIOMED MATER RES A, V71A, P172, DOI 10.1002/jbm.a.30149
   MESSIER RH, 1994, J SURG RES, V57, P1, DOI 10.1006/jsre.1994.1102
   Mulholland DL, 1997, CARDIOVASC PATHOL, V6, P167
   MUSTARD JF, 1990, CIRCULATION S, V81, P140
   MUSTARD JF, 1990, CIRCULATION S1, V81, P124
   Neidert MR, 2006, TISSUE ENG, V12, P891, DOI 10.1089/ten.2006.12.891
   Nuttelman CR, 2002, BIOMATERIALS, V23, P3617, DOI 10.1016/S0142-9612(02)00093-5
   Paranya G, 2001, AM J PATHOL, V159, P1335, DOI 10.1016/S0002-9440(10)62520-5
   Rabkin E, 2002, J HEART VALVE DIS, V11, P308
   Ramamurthi A, 2005, BIOMATERIALS, V26, P999, DOI 10.1016/j.biomaterials.2004.04.016
   Rieder E, 2004, J THORAC CARDIOV SUR, V127, P399, DOI 10.1016/j.jtcvs.2003.06.017
   Sodian R, 2000, TISSUE ENG, V6, P183, DOI 10.1089/107632700320793
   Taylor PA, 2003, INT J BIOCHEM CELL B, V35, P113, DOI 10.1016/S1357-2725(02)00100-0
   Taylor PM, 2000, J HEART VALVE DIS, V9, P150
   THOM T, 2006, HEART DIS STROKE STA
   Vesely I, 2004, J HEART VALVE DIS, V13, P485
   Ye Q, 2000, EUR J CARDIO-THORAC, V17, P587, DOI 10.1016/S1010-7940(00)00373-0
   Zanetta L, 2000, INT J CANCER, V85, P281, DOI 10.1002/(SICI)1097-0215(20000115)85:2<281::AID-IJC21>3.0.CO;2-3
   Zeltinger J, 2001, TISSUE ENG, V7, P9, DOI 10.1089/107632701300003250
   Zund G, 1997, EUR J CARDIO-THORAC, V11, P493, DOI 10.1016/S1010-7940(96)01005-6
NR 45
TC 15
Z9 16
U1 2
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2007
VL 28
IS 8
BP 1461
EP 1469
DI 10.1016/j.biomaterials.2006.11.030
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 135BY
UT WOS:000244130000001
PM 17174391
DA 2018-10-20
ER

PT J
AU Lickorish, D
   Guan, L
   Davies, JE
AF Lickorish, D.
   Guan, L.
   Davies, J. E.
TI A three-phase, fully resorbable, polyester/calcium phosphate scaffold
   for bone tissue engineering: Evolution of scaffold design
SO BIOMATERIALS
LA English
DT Article
DE bone tissue engineering; scaffold; calcium phosphate coating; simulated
   body fluid; in vivo test; foreign body response
ID IN-VITRO; COMPOSITE SCAFFOLDS; BIOMIMETIC PROCESS; IMPLANTS; GROWTH;
   VIVO; DEGRADATION; APATITE; RABBIT; CA
AB Bone tissue engineering strategies are fundamentally based upon porous scaffold materials that serve as a support for ingrowth of host cells and/or provide a substrate for exogenously delivered cells. Here we report the application of a surface calcium phosphate (CaP) mineral layer to a macroporous polymeric/CaP composite biomaterial, with a macroporous interconnectivity, and its subsequent in vivo evaluation in a rodent femoral defect. The application of the mineral layer eliminates the fibrous tissue encapsulation and foreign body giant cell response commonly seen at the interface of polymeric materials, yet retains the unique characteristics of the parent material as being macroporous, completely biodegradable and possessing a high degree of interconnectivity. This represents the third generation of this scaffold material, incorporating iterative changes to the scaffold design in response to both materials and biological design criteria to produce a material with enhanced in vitro and in vivo performance. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Toronto, Inst Biomat & Biomed Engn, Bone Interface Grp, Toronto, ON M5S 3G9, Canada.
   Univ Toronto, Fac Dent, Toronto, ON M5S 3G9, Canada.
RP Lickorish, D (reprint author), Univ Toronto, Inst Biomat & Biomed Engn, Bone Interface Grp, Room 407,Rosebrugh Bldg,164 Coll St, Toronto, ON M5S 3G9, Canada.
EM d.lickorish@utoronto.ca
CR Agrawal CM, 1997, J BIOMED MATER RES, V38, P105, DOI 10.1002/(SICI)1097-4636(199722)38:2<105::AID-JBM4>3.0.CO;2-U
   Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   Barrere F, 2002, BIOMATERIALS, V23, P2211, DOI 10.1016/S0142-9612(01)00354-4
   Barrere F, 2003, J BIOMED MATER RES B, V67B, P655, DOI 10.1002/jbm.b.10057
   Causa F, 2006, J BIOMED MATER RES A, V76A, P151, DOI 10.1002/jbm.a.30528
   Devin JE, 1996, J BIOMAT SCI-POLYM E, V7, P661, DOI 10.1163/156856296X00435
   Eppley BL, 2005, J CRANIOFAC SURG, V16, P981, DOI 10.1097/01.scs.0000179662.38172.dd
   Fialkov JA, 2003, J CRANIOFAC SURG, V14, P324, DOI 10.1097/00001665-200305000-00010
   Grayson ACR, 2004, J BIOMAT SCI-POLYM E, V15, P1281, DOI 10.1163/1568562041959991
   Guan LM, 2004, J BIOMED MATER RES A, V71A, P480, DOI 10.1002/jbm.a.30173
   Hedberg EL, 2005, BIOMATERIALS, V26, P4616, DOI 10.1016/j.biomaterials.2004.11.039
   Holy CE, 1999, BIOMATERIALS, V20, P1177, DOI 10.1016/S0142-9612(98)00256-7
   Holy CE, 2003, J BIOMED MATER RES A, V65A, P447, DOI 10.1002/jbm.a.10453
   Hulshoff JEG, 1997, CLIN ORAL IMPLAN RES, V8, P393, DOI 10.1034/j.1600-0501.1997.080506.x
   Kaito T, 2005, BIOMATERIALS, V26, P73, DOI 10.1016/j.biomaterials.2004.02.010
   Karp JM, 2003, J CRANIOFAC SURG, V14, P317, DOI 10.1097/00001665-200305000-00009
   Karp JM, 2003, J BIOMED MATER RES A, V64A, P388, DOI 10.1002/jbm.a.10420
   Khan SN, 2005, J AM ACAD ORTHOP SUR, V13, P77, DOI 10.5435/00124635-200501000-00010
   Kikuchi L, 2005, BIOMATERIALS, V26, P5285, DOI 10.1016/j.biomaterials.2005.01.009
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   Kuroda S, 2004, J BIOMED MATER RES A, V70A, P66, DOI 10.1002/jbm.a.30062
   Leewenburgh S, 2001, J BIOMED MATER RES, V56, P208
   Lickorish D, 2004, J BIOMED MATER RES A, V68A, P19, DOI 10.1002/jbm.a..20031
   Lickorish D, 2004, EUR J CELLS MAT, V13, P12
   Lu HH, 2003, J BIOMED MATER RES A, V64A, P465, DOI 10.1002/jbm.a.10399
   Ma PX, 2001, J BIOMED MATER RES, V54, P284, DOI 10.1002/1097-4636(200102)54:2<284::AID-JBM16>3.0.CO;2-W
   Marra KG, 1999, J BIOMED MATER RES, V47, P324, DOI 10.1002/(SICI)1097-4636(19991205)47:3<324::AID-JBM6>3.0.CO;2-Y
   Mastrogiacomo M, 2005, Orthod Craniofac Res, V8, P277, DOI 10.1111/j.1601-6343.2005.00350.x
   Matsumoto MA, 2005, CLIN ORAL IMPLAN RES, V16, P112, DOI 10.1111/j.1600-0501.2004.01078.x
   MEIKLE MC, 1994, BIOMATERIALS, V15, P513, DOI 10.1016/0142-9612(94)90017-5
   Murphy WL, 2000, J BIOMED MATER RES, V50, P50, DOI 10.1002/(SICI)1097-4636(200004)50:1<50::AID-JBM8>3.0.CO;2-F
   Murphy WL, 2002, J AM CHEM SOC, V124, P1910, DOI 10.1021/ja012433n
   Rzeszutek K, 2003, J CRANIOFAC SURG, V14, P301, DOI 10.1097/00001665-200305000-00007
   Siriphannon P, 2002, J BIOMED MATER RES, V60, P175, DOI 10.1002/jbm.10056
   TANAHASHI M, 1995, J BIOMED MATER RES, V29, P349, DOI 10.1002/jbm.820290310
   Tiainen J, 2004, J BIOMED MATER RES B, V70B, P49, DOI 10.1002/jbm.b.30013
   Yoshikawa Hideki, 2005, J Artif Organs, V8, P131, DOI 10.1007/s10047-005-0292-1
   Zhang RY, 2004, MACROMOL BIOSCI, V4, P100, DOI 10.1002/mabi.200300017
NR 39
TC 79
Z9 83
U1 1
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2007
VL 28
IS 8
BP 1495
EP 1502
DI 10.1016/j.biomaterials.2006.11.025
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 135BY
UT WOS:000244130000005
PM 17166580
DA 2018-10-20
ER

PT J
AU Zhang, YF
   Wang, YN
   Shi, B
   Cheng, XR
AF Zhang, Yufeng
   Wang, Yining
   Shi, Bin
   Cheng, Xiangrong
TI A platelet-derived growth factor releasing chitosan/coral composite
   scaffold for periodontal tissue engineering
SO BIOMATERIALS
LA English
DT Article
DE chitosan; coral; scaffold; platelet-derived growth factor B; gene
   transfer; periodontium
ID BB RHPDGF-BB; INTRABONY DEFECTS; GENE DELIVERY; IN-VITRO; DNA
   NANOPARTICLES; LIGAMENT CELLS; REGENERATION; BONE; THERAPY; OSTEOBLASTS
AB In recent years, functional biomaterial research has been directed towards the development of improved scaffolds and new drug delivery systems. The objective of this Study was to develop growth-factor gene releasing coral composites as a regenerative material for periodontal regeneration. In this study, porous chitosan/coral composites combined with plasmid encoding platelet-derived growth factor B (PDGFB) gene were prepared through a freeze-drying process. These scaffolds were evaluated in vitro by analysis of microscopic structure and cytocompatibility. The expression of PDGFB and type-I collagen were detected with RT-PCR after human periodontal ligament cells (HPLCs) were seeded in this scaffold. Then these scaffolds were implanted subcutaneously into athymic mice. Results indicated that HPLCs showed much better proliferation properties on the gene-activated scaffolds than on the pure coral scaffolds, and the expression of PDGFB and type-I collagen Up-regulated in gene-activated scaffold. After implanted in vivo, HPLCs not only proliferate but also increased the expression of PDGFB. This study demonstrated the potential of coral scaffold combined PDGFB gene as a good substrate candidate in periodontal tissue regeneration. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, Key Lab Oral Biomed Engn, Wuhan 430079, Peoples R China.
RP Cheng, XR (reprint author), Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, Key Lab Oral Biomed Engn, Wuhan 430079, Peoples R China.
EM Xiangrongcheng@hotmail.com
CR Anusaksathien O, 2004, J PERIODONTOL, V75, P429, DOI 10.1902/jop.2004.75.3.429
   Balic A, 2005, Orthod Craniofac Res, V8, P252, DOI 10.1111/j.1601-6343.2005.00347.x
   Bartold PM, 2006, PERIODONTOL 2000, V40, P164, DOI 10.1111/j.1600-0757.2005.00139.x
   Batouli S, 2003, J DENT RES, V82, P976, DOI 10.1177/154405910308201208
   Camelo M, 2003, INT J PERIODONT REST, V23, P213
   DOHERTY MJ, 1994, BIOMATERIALS, V15, P601, DOI 10.1016/0142-9612(94)90210-0
   Ferber D, 2001, SCIENCE, V294, P1638, DOI 10.1126/science.294.5547.1638
   FINN RA, 1980, J MAXILLOFAC SURG, V8, P217, DOI 10.1016/S0301-0503(80)80104-4
   Giannopoulou C, 1996, J DENT RES, V75, P895, DOI 10.1177/00220345960750030601
   Gu DL, 2004, MOL THER, V9, P699, DOI 10.1016/j.ymthe.2004.02.018
   Kim CK, 1996, J PERIODONTOL, V67, P1301, DOI 10.1902/jop.1996.67.12.1301
   Koping-Hoggard M, 2001, GENE THER, V8, P1108, DOI 10.1038/sj.gt.3301492
   Kuru L, 1998, J DENT RES, V77, P555, DOI 10.1177/00220345980770040801
   Lavertu M, 2006, BIOMATERIALS, V27, P4815, DOI 10.1016/j.biomaterials.2006.04.029
   Mao HQ, 2001, J CONTROL RELEASE, V70, P399, DOI 10.1016/S0168-3659(00)00361-8
   Mehrara BJ, 1999, J BONE MINER RES, V14, P1290, DOI 10.1359/jbmr.1999.14.8.1290
   Murphy WL, 1999, J PERIODONTAL RES, V34, P413, DOI 10.1111/j.1600-0765.1999.tb02275.x
   Nakahara T, 2004, TISSUE ENG, V10, P537, DOI 10.1089/107632704323061898
   Needleman I, 2005, PERIODONTOL 2000, V37, P106, DOI 10.1111/j.1600-0757.2004.37101.x
   Nevins M, 2003, J PERIODONTOL, V74, P1282, DOI 10.1902/jop.2003.74.9.1282
   Ojima Y, 2003, ORAL DIS, V9, P144, DOI 10.1034/j.1601-0825.2003.02906.x
   ROMANOS GE, 1992, J PERIODONTAL RES, V27, P101, DOI 10.1111/j.1600-0765.1992.tb01811.x
   Roy K, 1999, NAT MED, V5, P387
   Schroder NWJ, 2005, GENES IMMUN, V6, P448, DOI 10.1038/sj.gene.6364221
   Sculean A, 2001, J CLIN PERIODONTOL, V28, P397, DOI 10.1034/j.1600-051x.2001.028005397.x
   Southwood LL, 2004, VET SURG, V33, P565, DOI 10.1111/j.1532-950X.2004.04080.x
   Taba M Jr, 2005, Orthod Craniofac Res, V8, P292
   Wang HL, 2005, J PERIODONTOL, V76, P1601
   Zhang YF, 2006, BIOCHEM BIOPH RES CO, V344, P362, DOI 10.1016/j.bbrc.2006.03.106
NR 29
TC 61
Z9 72
U1 0
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2007
VL 28
IS 8
BP 1515
EP 1522
DI 10.1016/j.biomaterials.2006.11.040
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 135BY
UT WOS:000244130000007
PM 17169421
DA 2018-10-20
ER

PT J
AU Ahmad, M
   Jones, JR
   Hench, LL
AF Ahmad, Mohammad
   Jones, Julian R.
   Hench, Larry L.
TI Fabricating sol-gel glass monoliths with controlled nanoporosity
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID MICROSTRUCTURE
AB Nanotopography is known to affect cell response, but the mechanisms are unknown. It is therefore important to be able to produce biomaterial surfaces with controllable nanopore sizes and morphologies from materials that can be used to make templates (scaffolds) for tissue regeneration. A rapid method of fabrication of sol-gel monoliths with controlled nanopore size is described in this paper. Pores of 2 nm in diameter were achieved, termed micropores by IUPAC convention. Conventional sol-gel processing yields pores an order of magnitude larger. Gelling time was also reduced from many hours to a few minutes, without using a gelling agent, and large crack-free monoliths were synthesized within 1 week.
C1 Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2AZ, England.
RP Ahmad, M (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Mat, S Kensington Campus, London SW7 2AZ, England.
RI Jones, Julian/B-1007-2012
OI Jones, Julian/0000-0002-2647-8024
CR Ahmad M, 2002, J PHYS D APPL PHYS, V35, P1473, DOI 10.1088/0022-3727/35/13/303
   BRINER CJ, 1990, SOL GEL SCI PHYS CHE
   BRINKER CJ, 1984, J NON-CRYST SOLIDS, V63, P45, DOI 10.1016/0022-3093(84)90385-5
   Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023
   Bryans TR, 2000, J SOL-GEL SCI TECHN, V17, P211, DOI 10.1023/A:1008711921746
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Dalby MJ, 2004, BIOMATERIALS, V25, P5415, DOI 10.1016/j.biomaterials.2003.12.049
   GREGF SJ, 1982, ADSORPTION SURFACE A, P155
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Jones JR, 2006, BIOMATERIALS, V27, P964, DOI 10.1016/j.biomaterials.2005.07.017
   Jones JR, 2006, MATER TODAY, V9, P34, DOI 10.1016/S1369-7021(06)71741-2
   Meixner DL, 1999, J SOL-GEL SCI TECHN, V14, P223, DOI 10.1023/A:1008774827602
   Sepulveda P, 2001, J BIOMED MATER RES, V58, P734, DOI 10.1002/jbm.10026
   SING K, 1995, J POROUS MAT, V2, P508
   SING KSW, 1985, PURE APPL CHEM, V57, P604
   Teixeira AI, 2004, J BIOMED MATER RES A, V71A, P369, DOI 10.1002/jbm.a.30089
   Wagh PB, 1999, MATER CHEM PHYS, V57, P214, DOI 10.1016/S0254-0584(98)00217-X
NR 17
TC 13
Z9 13
U1 1
U2 12
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
J9 BIOMED MATER
JI Biomed. Mater.
PD MAR
PY 2007
VL 2
IS 1
BP 6
EP 10
DI 10.1088/1748-6041/2/1/002
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 212LH
UT WOS:000249597300015
PM 18458427
DA 2018-10-20
ER

PT J
AU Oudadesse, H
   Derrien, AC
   Martin, S
   Lucas-Girot, A
   Cathelineau, G
AF Oudadesse, H.
   Derrien, A. C.
   Martin, S.
   Lucas-Girot, A.
   Cathelineau, G.
TI Comparison of the bony remodelling of two synthetic biomaterials:
   aragonite 55% and aragonite 55% with active substance
SO BIOMEDICAL MATERIALS
LA English
DT Article; Proceedings Paper
CT 3rd International Symposium on Advanced Biomaterials and Biomechanics
CY APR 03-06, 2005
CL Montreal, CANADA
ID STRONTIUM; BIOCERAMICS; GENTAMICIN; KINETICS
AB In this work, the in vivo behaviour of pure aragonite and vectabone, which is an association of aragonite and an active substance such as gentamicin, was studied to highlight the kinetic resorption of these two biomaterials with 55% of porosity destined for the filling or replacement of bony defects. The synthesis conditions and parameters we used permit us to obtain a biomaterial without a sintering stage. These conditions allow introducing of active substances at the first stage of the elaboration. In this work, the gentamycin antibiotic was associated with calcium carbonate (aragonite 55% with gentamycin) to deliver this active substance on the surgical site for local treatment. The tricalcium phosphate biomaterial was used as the control because of its high biocompatibility. The bony remodelling of these three biomaterials was studied by in vivo experiments. This study was ensured with neutron activation analysis (NAA). The resorption kinetic was elaborated and comparisons of the remodelling biomaterials CaCO3 55% and CaCO3 55% with gentamicin (vectabone) and tricalcium phosphate were carried out. The obtained results show that, 6 months after implantation, the mineral composition of vectabone and tricalcium phosphate becomes close to that of young bone. Twelve months after implantation, it becomes similar to that of mature bone.
C1 Univ Rennes 1, UMR CNRS 6226, F-35042 Rennes, France.
   Univ Rennes 1, UMR CNRS 6226, UFR Odontol, F-35042 Rennes, France.
RP Oudadesse, H (reprint author), Univ Rennes 1, UMR CNRS 6226, Campus Beaulieu,263 Av Gen Leclerc, F-35042 Rennes, France.
EM hassane.oudadesse@univ-rennes1.fr
CR Boivin G, 1996, J BONE MINER RES, V11, P1302
   BROUARD S, 1996, CHIRURGIE, V121, P397
   CORRADINO RA, 1971, CALC TISS RES, V7, P81, DOI 10.1007/BF02062596
   Derrien AC, 2004, NUCL INSTRUM METH B, V226, P281, DOI 10.1016/j.nimb.2004.06.014
   ELSOLH N, 1981, HDB STABLE STRONTIUM
   IRIGARAY JL, 1993, J RADIOAN NUCL CH AR, V169, P339, DOI 10.1007/BF02042992
   Langstaff S, 2001, BIOMATERIALS, V22, P135, DOI 10.1016/S0142-9612(00)00139-3
   Lucas-Girot A, 2005, J BIOMED MATER RES B, V73B, P164, DOI 10.1002/jbm.b.30210
   Lucas-Girot A, 2002, BIOMATERIALS, V23, P503, DOI 10.1016/S0142-9612(01)00132-6
   MARTIN S, 2002, THESIS U RENNES
   MOROHASHI T, 1995, JPN J PHARMACOL, V68, P153, DOI 10.1254/jjp.68.153
   Oudadesse H, 2004, J RADIOANAL NUCL CH, V262, P479, DOI 10.1023/B:JRNC.0000046781.15503.eb
   Oudadesse H, 2004, INSTRUM SCI TECHNOL, V32, P545, DOI 10.1081/CI-200029803
   OUDADESSE H, 1989, THESIS U BLAISE PASC
   Pick J, 1997, J PHARMACEUT BIOMED, V16, P131, DOI 10.1016/S0731-7085(96)02044-4
NR 15
TC 2
Z9 2
U1 0
U2 8
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
J9 BIOMED MATER
JI Biomed. Mater.
PD MAR
PY 2007
VL 2
IS 1
BP S65
EP S70
DI 10.1088/1748-6041/2/1/S10
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 212LH
UT WOS:000249597300011
PM 18458422
DA 2018-10-20
ER

PT J
AU Schneider, A
   Richert, L
   Francius, G
   Voegel, JC
   Picart, C
AF Schneider, Aurore
   Richert, Ludovic
   Francius, Gregory
   Voegel, Jean-Claude
   Picart, Catherine
TI Elasticity, biodegradability and cell adhesive properties of
   chitosan/hyaluronan multilayer films
SO BIOMEDICAL MATERIALS
LA English
DT Article; Proceedings Paper
CT 3rd International Symposium on Advanced Biomaterials and Biomechanics
CY APR 03-06, 2005
CL Montreal, CANADA
ID ATOMIC-FORCE MICROSCOPE; CROSS-LINKING; POLYELECTROLYTE MULTILAYERS;
   MOLECULAR-WEIGHT; CHITOSAN; HYALURONATE; TEMPERATURE; VISCOSITY;
   CAPSULES; POLYMERS
AB In the bioengineering field, a recent and promising approach to modifying biomaterial surfaces is the layer-by-layer (LbL) technique used to build thin polyelectrolyte multilayer films. In this work, we focused on polyelectrolyte multilayer films made of two polysaccharides, chitosan (CHI) and hyaluronan ( HA), and on the control of their physico-chemical and cell adhesive properties by chemical cross-linking. CHI/HA films were cross-linked using a water soluble carbodiimide and observed by confocal laser scanning microscopy (CLSM) with a fluorescently labeled CHI. Film thicknesses were similar for native and cross-linked films. The film nanometer roughness was measured by atomic force microscopy and was found to be higher for cross-linked films. Cross-linking the films also leads to a drastic change in film stiffness. The elastic modulus of the films (Young's modulus) as measured by AFM nano-indentation was about tenfold increased for cross-linked films as compared to native ones. From a biological point of view, cross-liked films are more resistant to enzymatic degradation by hyaluronidase. Furthermore, the increase in film stiffness has a favorable effect on the adhesion and spreading of chondrosarcoma cells. Thus, the CHI/HA cross-linked films could be used for various applications due to their adhesive properties and to their mechanical properties (including stability in enzymatic media).
EM catherine.picart@univ-montp2.fr
RI Francius, Gregory/A-4246-2015; Richert, Ludovic/B-5006-2008
OI Francius, Gregory/0000-0001-8533-9449; Richert,
   Ludovic/0000-0003-4479-5418; PICART, Catherine/0000-0002-4854-6366;
   PICART, Catherine/0000-0003-0130-1000
CR Ai H, 2003, CELL BIOCHEM BIOPHYS, V39, P23, DOI 10.1385/CBB:39:1:23
   Collin D, 2003, PHYSICA A, V320, P235, DOI 10.1016/S0378-4371(02)01524-8
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6
   Denuziere A, 1996, CARBOHYD POLYM, V29, P317, DOI 10.1016/S0144-8617(96)00035-5
   Desbrieres J, 2002, BIOMACROMOLECULES, V3, P342, DOI 10.1021/bm010151+
   Dimitriadis EK, 2002, BIOPHYS J, V82, P2798, DOI 10.1016/S0006-3495(02)75620-8
   Dubreuil F, 2003, EUR PHYS J E, V12, P215, DOI 10.1140/epje/i2003-10056-0
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   Etienne O, 2005, BIOMACROMOLECULES, V6, P726, DOI 10.1021/bm049425u
   FOUISSAC E, 1993, MACROMOLECULES, V26, P6945, DOI 10.1021/ma00077a036
   Francius G, 2006, MICROSC RES TECHNIQ, V69, P84, DOI 10.1002/jemt.20275
   Groth T, 1996, BIOMATERIALS, V17, P1227, DOI 10.1016/0142-9612(96)84943-X
   Hemmerle J, 1999, P NATL ACAD SCI USA, V96, P6705, DOI 10.1073/pnas.96.12.6705
   Hermanson G. T., 1996, BIOCONJUGATE TECHNIQ
   Isacke CM, 2002, INT J BIOCHEM CELL B, V34, P718, DOI 10.1016/S1357-2725(01)00166-2
   Lapcik L, 1998, CHEM REV, V98, P2663, DOI 10.1021/cr941199z
   Levy R, 2002, NANOTECHNOLOGY, V13, P33, DOI 10.1088/0957-4484/13/1/307
   Marie E, 2002, BIOMACROMOLECULES, V3, P475, DOI 10.1021/bm015634s
   Mendelsohn JD, 2003, BIOMACROMOLECULES, V4, P96, DOI 10.1021/bm0256101
   Milas M, 1996, J RHEOL, V40, P1155, DOI 10.1122/1.550778
   Nettles DL, 2002, TISSUE ENG, V8, P1009, DOI 10.1089/107632702320934100
   Richert L, 2004, LANGMUIR, V20, P448, DOI 10.1021/la035415n
   Richert L, 2004, BIOMACROMOLECULES, V5, P284, DOI 10.1021/bm0342281
   Richert L, 2006, CELL BIOCHEM BIOPHYS, V44, P273, DOI 10.1385/CBB:44:2:273
   Richert L, 2004, BIOMACROMOLECULES, V5, P1908, DOI 10.1021/bm0498023
   Sabnis S, 2000, INT J BIOL MACROMOL, V27, P181, DOI 10.1016/S0141-8130(00)00118-5
   Serizawa T, 2002, BIOMACROMOLECULES, V3, P724, DOI 10.1021/bm0200027
   Tang ZY, 2003, NAT MATER, V2, P413, DOI 10.1038/nmat906
   Thierry B, 2003, BIOMACROMOLECULES, V4, P1564, DOI 10.1021/bm0341834
   Tomihata K, 1997, J BIOMED MATER RES, V37, P243
   Weisenhorn A. L., 1993, Nanotechnology, V4, P106, DOI 10.1088/0957-4484/4/2/006
NR 32
TC 57
Z9 57
U1 5
U2 53
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
J9 BIOMED MATER
JI Biomed. Mater.
PD MAR
PY 2007
VL 2
IS 1
BP S45
EP S51
DI 10.1088/1748-6041/2/1/S07
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 212LH
UT WOS:000249597300008
PM 18458419
DA 2018-10-20
ER

PT J
AU Sarvestani, AS
   He, XZ
   Jabbari, E
AF Sarvestani, Alireza S.
   He, Xuezhong
   Jabbari, Esmaiel
TI Effect of osteonectin-derived peptide on the viscoelasticity of
   hydrogel/apatite nanocomposite scaffolds
SO BIOPOLYMERS
LA English
DT Article
DE osteonectin-derived peptide; hydroxyapatite; nanocomposite; scaffold;
   viscoelasticity
ID MATRIX INTERACTIONS; BONE; REINFORCEMENT; COMPOSITES; PROTEINS; LINKING;
   GROWTH
AB Hydrogel/apatite nanocomposites are the ideal biomaterial to mimic the physio-chemical and biologic properties of the bone and to fabricate scaffolds for bone regeneration. The objective of this work was to investigate the effect of an osteonectin derived glutamic acid sequence on the viscoelastic properties of poly(lactide-ethylene oxide-fumarate) (PLEOF)/apatite composite, as a model degradable material in bone regeneration. Osteonectin is an extracellular acidic glycoprotein of the bone matrix, which is believed to be involved in linking the collagen network to hydroxyapatite (HA), the mineral phase of the bone. We synthesized a 6-glutamic acid sequence in solid phase with affinity to HA crystals via ionic interactions. One end of the synthesized peptide was functionalized with an acrylate group to covalently attach the peptide (Ac-Glu6) to the aqueous-based biodegradable and in situ crosslinkable PLEOF hydrogel matrix. To determine the effect of energetic interactions between the fillers and hydrogel matrix, HA nanoparticles were also treated with an acrylate functionalized 6-glycine amino acid peptide (Ac-Gly6) that interacts with the filers only by van der Waals and polar interactions (without ionic interactions). Crosslinked PLEOF/apatite scaffolds were prepared using PLEOF as the degradable macromer, HA nanofillers treated with Ac-Glu6 peptide linker, and a neutral redox initiation system. The viscoelastic properties were studied by dynamic time sweep, strain sweep, and small amplitude oscillatory rheometry. Composites without surface treatment, treated with Ac-Gly6, and treated with Ac-Glu6 at different volume fractions and various particle sizes were examined. The results showed that the 6-mer glutamic acid sequence significantly affects the shear modulus of the scaffold because of ionic interactions between the peptide and HA crystals. (c) 2006 Wiley Periodicals, Inc.
C1 Univ S Carolina, Dept Chem Engn, Bioimet Mat & Tissue Engn Labs, Columbia, SC 29208 USA.
RP Jabbari, E (reprint author), Univ S Carolina, Dept Chem Engn, Bioimet Mat & Tissue Engn Labs, Columbia, SC 29208 USA.
EM jabbari@engr.sc.edu
RI Sarvestani, Alireza/G-3181-2012
CR Athanasiou KA, 2000, TISSUE ENG, V6, P361, DOI 10.1089/107632700418083
   Chiou BS, 2001, MACROMOLECULES, V34, P4526, DOI 10.1021/ma010281a
   Fantner GE, 2004, BONE, V35, P1013, DOI 10.1016/j.bone.2004.05.027
   FLORY PJ, 1953, PRINCIPLES POLYM CHE, P470
   Fujisawa R, 1996, BBA-PROTEIN STRUCT M, V1292, P53, DOI 10.1016/0167-4838(95)00190-5
   Glimcher M.J., 1992, DISORDERS BONE MINER, P265
   GUTH E, 1945, J APPL PHYS, V16, P20, DOI 10.1063/1.1707495
   HE X, 2007, IN PRESS BIOMACROMOL
   He XZ, 2006, PROTEIN PEPTIDE LETT, V13, P715, DOI 10.2174/092986606777790610
   Heinrich G, 2002, ADV POLYM SCI, V160, P1
   Huber G, 2002, MACROMOLECULES, V35, P9204, DOI 10.1021/ma0208887
   JABBARI E, 2005, ADV BIONANOTECHNOLOG, P92
   LANE TF, 1994, FASEB J, V8, P163
   MARK JE, 1988, RUBBER ELASTICITY MO, P21
   Osman MA, 2005, POLYMER, V46, P9476, DOI 10.1016/j.polymer.2005.07.030
   Penn RL, 1999, GEOCHIM COSMOCHIM AC, V63, P1549, DOI 10.1016/S0016-7037(99)00037-X
   ROMBERG RW, 1985, J BIOL CHEM, V260, P2728
   Sikavitsas VI, 2001, BIOMATERIALS, V22, P2581, DOI 10.1016/S0142-9612(01)00002-3
   Sousa RA, 2003, J MATER SCI-MATER M, V14, P475, DOI 10.1023/A:1023471011749
   Summitt MC, 2003, J BIOMED MATER RES A, V67A, P742, DOI 10.1002/jbm.a.10123
   Tabata Y, 2003, TISSUE ENG, V9, pS5, DOI 10.1089/10763270360696941
   TERMINE JD, 1981, CELL, V26, P99, DOI 10.1016/0092-8674(81)90037-4
   Young MF, 2003, OSTEOPOROSIS INT, V14, pS35, DOI 10.1007/s00198-002-1342-7
   YOUNG MF, 1992, CLIN ORTHOP RELAT R, P275
NR 24
TC 38
Z9 39
U1 1
U2 17
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0006-3525
J9 BIOPOLYMERS
JI Biopolymers
PD MAR
PY 2007
VL 85
IS 4
BP 370
EP 378
DI 10.1002/bip.20659
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 139MD
UT WOS:000244435000007
PM 17183515
DA 2018-10-20
ER

PT J
AU Bagno, A
   Piovan, A
   Dettin, M
   Chiarion, A
   Brun, P
   Gambaretto, R
   Fontana, G
   Di Bello, C
   Palu, G
   Castagliuolo, I
AF Bagno, Andrea
   Piovan, Alessandro
   Dettin, Monica
   Chiarion, Alessia
   Brun, Paola
   Gambaretto, Roberta
   Fontana, Giovanni
   Di Bello, Carlo
   Palu, Giorgio
   Castagliuolo, Ignazio
TI Human osteoblast-like cell adhesion on titanium substrates covalently
   functionalized with synthetic peptides
SO BONE
LA English
DT Article
DE cell adhesion; adhesion strength; osteoblast-like cells; titanium;
   endosseous devices
ID IN-VITRO; CYTOSKELETAL ORGANIZATION; CHEMICAL-MODIFICATION; IMPLANT
   MATERIALS; BONE-FORMATION; SURFACE; ATTACHMENT; BIOMATERIALS; TI;
   MINERALIZATION
AB Biomaterials to be used for the production of endosseous devices in dental, orthopedic and maxillo-facial applications, might be designed to support, guide and enhance osteoblast adhesion. Cell recruitment onto biomaterial surface is a fundamental step within the complex process responsible for implant osseointegration; this process involves several proteins from the extra cellular matrix (ECM), cytoskeleton and cell membrane.
   A new strategy to improve endosseous implant integration is based on preparing biomimetic surfaces able to present adhesive factors to cells. Osteoblast adhesion takes place by at least two different mechanisms: the most investigated one implies the interaction with RGD sequences via cell-membrane integrin receptors; a further mechanism concerns the interaction between cell-membrane heparan sulfate proteoglycans and heparin-binding sites of ECM proteins.
   In the present study two different biomimetic surfaces were obtained by covalently grafting two adhesive peptides on oxidized titanium substrates after silanization: an RGD-containing peptide and a peptide mapped on human vitronectin. The two sequences are known to act via different adhesive mechanisms. The amount of human osteoblasts adhered onto peptide-enriched or not enriched titanium oxidized surfaces and the strength of cell binding were estimated, thus comparing the capacity of the bioactive substrates in promoting cell adhesion. (c) 2006 Elsevier Inc. All rights reserved.
C1 Univ Padua, Dept Chem Proc Engn, I-35131 Padua, Italy.
   Univ Padua, Dept Histol Microbiol & Med Biotechnol, I-35121 Padua, Italy.
   Univ Padua, Dept Med & Surg Specialties, Dent Clin, I-35121 Padua, Italy.
RP Bagno, A (reprint author), Univ Padua, Dept Chem Proc Engn, Via Marzolo 9, I-35131 Padua, Italy.
EM andrea.bagno@unipd.it
OI Bagno, Andrea/0000-0002-4296-3601; CASTAGLIUOLO,
   IGNAZIO/0000-0001-9888-7030
CR Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Bagno A, 2004, BIOMATERIALS, V25, P2437, DOI 10.1016/j.biomaterials.2003.09.018
   Bagno A, 2004, J MATER SCI-MATER M, V15, P935, DOI 10.1023/B:JMSM.0000042679.28493.7f
   Bigerelle M, 2005, J BIOMED MATER RES A, V72A, P36, DOI 10.1002/jbm.a.30212
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Brunette DM, 1999, J BIOMECH ENG-T ASME, V121, P49, DOI 10.1115/1.2798042
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   DALTON BA, 1995, J CELL SCI, V108, P2083
   Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.3.CO;2-G
   Dettin M, 2002, J BIOMED MATER RES, V60, P466, DOI 10.1002/jbm.10066
   Dettin M, 2005, BIOMATERIALS, V26, P4507, DOI 10.1016/j.biomaterials.2004.11.023
   DETTIN M, 2006, UNPUB COVALENT SURFA
   DETTIN M, 2005, Patent No. 000065
   Ferris DM, 1999, BIOMATERIALS, V20, P2323, DOI 10.1016/S0142-9612(99)00161-1
   Frosch KH, 2002, CELLS TISSUES ORGANS, V170, P214, DOI 10.1159/000047925
   Gawalt ES, 2003, LANGMUIR, V19, P200, DOI 10.1021/la0203436
   Healy KE, 1996, BIOMATERIALS, V17, P195, DOI 10.1016/0142-9612(96)85764-4
   KIM YH, 1990, J BONE JOINT SURG AM, V72, P45
   Koontz CS, 1998, J BIOMED MATER RES, V42, P238, DOI 10.1002/(SICI)1097-4636(199811)42:2<238::AID-JBM8>3.3.CO;2-Y
   Kurachi T, 1997, ARCH ORAL BIOL, V42, P465, DOI 10.1016/S0003-9969(97)00019-8
   LUNA LG, 1968, MANUAL HISTOLOGIC ST, P174
   MacDonald DE, 1998, COLLOID SURFACE B, V11, P131, DOI 10.1016/S0927-7765(98)00030-7
   Nanci A, 1998, J BIOMED MATER RES, V40, P324
   Piattelli A, 1998, INT J ORAL MAX IMPL, V13, P805
   Rezania A, 1999, BIOTECHNOL PROGR, V15, P19, DOI 10.1021/bp980083b
   SCHENK R, 1995, BIOMECHANIK HEFTE UN
   Schwartz J, 2003, MAT SCI ENG C-BIO S, V23, P395, DOI 10.1016/S0928-4931(02)00310-7
   SINHA RK, 1994, CLIN ORTHOP RELAT R, P258
   Xiao Y, 1996, BIOPHYS J, V71, P2869, DOI 10.1016/S0006-3495(96)79484-5
   Yokose S, 1996, ENDOCRINOLOGY, V137, P469, DOI 10.1210/en.137.2.469
NR 30
TC 72
Z9 82
U1 1
U2 26
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 8756-3282
J9 BONE
JI Bone
PD MAR
PY 2007
VL 40
IS 3
BP 693
EP 699
DI 10.1016/j.bone.2006.10.007
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 141CA
UT WOS:000244552800016
PM 17142122
DA 2018-10-20
ER

PT J
AU Martusevich, AK
   Kamakin, NF
AF Martusevich, A. K.
   Kamakin, N. F.
TI Crystallography of biological fluid as a method for evaluating its
   physicochemical characteristics
SO BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Article
DE dehydration; crystallization; biological fluids; facies; factors
AB Using an integral qualitative and quantitative approach to the studies of initiation of the biological material crystallogenesis, we showed in experiments with normal human saliva that the external characteristics of biological fluid (pH, osmolality, and environmental temperature) determine the results of crystallization (tesigraphic facies). The main external (macroenvironment) and inner (microenvironment) factors of biological fluid crystal formation, determining specific features of the tesigraphic facies, were distinguished and classified. The informative value of differential analysis of biomaterial properties by means of modulating the environmental conditions is established.
C1 Kirov State Med Acad, Kirov, Russia.
RP Martusevich, AK (reprint author), Kirov State Med Acad, Kirov, Russia.
EM akmart@mail.ru
RI Martusevich, Andrey/G-1752-2011
OI Martusevich, Andrey/0000-0002-0818-5316
CR Antropova I P, 1997, Klin Lab Diagn, P36
   Barer G M, 1998, Biull Eksp Biol Med, V126, P693
   DENISOV AB, 2004, BYUL EKSPER BIOL, V136, P37
   DERYABINA NI, 2005, VESTN NOV MED TEKHNO, V12, P85
   [Гуляева С.Ф. Gulyaeva S.F.], 2005, [Экология человека, Ekologiya cheloveka], P33
   KAMAKIN NF, 2005, TESIOCRYSTALLOSCOPIC
   KIDALOV VN, 2004, VESTN NOVYKH MED TEK, V11, P23
   Mollaret R, 2004, CHEM ENG RES DES, V82, P471, DOI 10.1205/026387604323050182
   SAVINA LV, 1999, KLIN LAB DIAGNOST, P48
   Shabalin V. N., 2001, MORPHOLOGY HUMAN BIO
NR 10
TC 9
Z9 9
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0007-4888
J9 B EXP BIOL MED+
JI Bull. Exp. Biol. Med.
PD MAR
PY 2007
VL 143
IS 3
BP 385
EP 388
DI 10.1007/s10517-007-0118-7
PG 4
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 221KZ
UT WOS:000250227500031
PM 18225770
DA 2018-10-20
ER

PT J
AU Yuan, ZX
   Jha, G
   McGregor, MA
   King, RS
AF Yuan, Zhi-Xin
   Jha, Gautam
   McGregor, Michael A.
   King, Roberta S.
TI Metabolites of the carcinogen 2-amino-alpha-carboline formed in male
   Sprague-Dawley rats in vivo and in rat hepatocyte and human HepG2 cell
   incubates
SO CHEMICAL RESEARCH IN TOXICOLOGY
LA English
DT Article
ID A-ALPHA-C; HETEROCYCLIC AMINES; INDOXYL SULFATE; GLUTAMIC-ACID; FOOD
   MUTAGEN; MICE; IDENTIFICATION; ACTIVATION; MICROSOMES
AB 2-Amino-alpha-carboline (AaC, 2-amino-9H-pyrido[2,3-b]indole) is a genotoxic carcinogen produced by cooking of protein-containing foods and combustion of biomaterial. Humans are chronically exposed to low levels of AaC through foods (grilled or pan-fried meats), drinking water, and smoke inhalation (cigarette/wood smoke, diesel exhaust). We report herein 17 metabolites of AaC formed in vivo in male Sprague-Dawley rats (from bile, urine, and plasma) and in situ in rat hepatocytes and human HepG2 liver tumor cells. We confirmed several expected sites of AaC metabolism, but also observed novel metabolites. The novel metabolites include extensive N-acetylated AaC conjugates, multiple N-glucuronides, and at least one additional site of aromatic ring hydroxylation. The abundance of N-acetylated metabolites is noteworthy because this metabolic pathway is generally unrecognized for HAAs. Also noteworthy are metabolites that were not detected, i.e., no direct AaC N-sulfonation to form the sulfamate. These results, combined with earlier publications on the reactive (DNA adduct forming) metabolites of AaC, indicate that both bioactivation and detoxification of AaC share the same metabolic pathwaysnamely, oxidation, acetylation, and sulfonation. This may be an important factor attenuating the risk of carcinogenesis from AaC exposure; increased potential for bioactivation could be balanced by increased potential for detoxification.
C1 Univ Rhode Isl, Dept Biomed, Coll Pharm, Kingston, RI 02881 USA.
   Univ Rhode Isl, Dept Pharmaceut Sci, Coll Pharm, Kingston, RI 02881 USA.
   Univ Rhode Isl, Dept Chem, Kingston, RI 02881 USA.
RP King, RS (reprint author), Univ Rhode Isl, Dept Biomed, Coll Pharm, Kingston, RI 02881 USA.
EM rking@uri.edu
RI King, Roberta/A-1749-2010; yang, min/G-3030-2011
OI King, Roberta/0000-0002-3550-4255; 
FU NCRR NIH HHS [P20 RR016457, P20 RR016457-040016, P20 RR16457]
CR AUGUSTSSON K, 2000, FOOD BORNE CARCINOGE, P332
   Banoglu E, 2002, EUR J DRUG METAB PH, V27, P135, DOI 10.1007/BF03190428
   Banoglu E, 2001, EUR J DRUG METAB PH, V26, P235, DOI 10.1007/BF03226377
   Baranczewski P, 2004, BIOMARKERS, V9, P243, DOI 10.1080/13547500400010056
   Frederiksen H, 2004, FOOD CHEM TOXICOL, V42, P879, DOI 10.1016/j.fct.2004.01.011
   Frederiksen H, 2002, PHARMACOL TOXICOL, V90, P127, DOI 10.1034/j.1600-0773.2002.900303.x
   Hasegawa R, 1996, JPN J CANCER RES, V87, P1125, DOI 10.1111/j.1349-7006.1996.tb03122.x
   HEIN DW, 1993, CARCINOGENESIS, V14, P1633, DOI 10.1093/carcin/14.8.1633
   KANAI Y, 1988, MUTAT RES, V207, P63, DOI 10.1016/0165-7992(88)90043-7
   KANAI Y, 1988, CARCINOGENESIS, V9, P2179, DOI 10.1093/carcin/9.12.2179
   Kataoka H, 2000, MUTAT RES-GEN TOX EN, V466, P27, DOI 10.1016/S1383-5718(99)00235-1
   King RS, 1999, CANCER LETT, V143, P167, DOI 10.1016/S0304-3835(99)00119-6
   King RS, 2000, CARCINOGENESIS, V21, P1347, DOI 10.1093/carcin/21.7.1347
   KING RS, 2000, FOOD BORNE CARCINOGE, P90
   LAYTON DW, 1995, CARCINOGENESIS, V16, P39, DOI 10.1093/carcin/16.1.39
   Majer BJ, 2004, J CHROMATOGR B, V802, P167, DOI 10.1016/j.jchromb.2003.10.042
   OHGAKI H, 1984, CARCINOGENESIS, V5, P815, DOI 10.1093/carcin/5.6.815
   Pfau W, 1997, CHEM RES TOXICOL, V10, P1192, DOI 10.1021/tx9701182
   Raza H, 1996, DRUG METAB DISPOS, V24, P395
   Snyderwine EG, 1998, FOOD CHEM TOXICOL, V36, P1033, DOI 10.1016/S0278-6915(98)00088-X
   Steffensen IL, 2002, CARCINOGENESIS, V23, P1373, DOI 10.1093/carcin/23.8.1373
   YAMAZOE Y, 2000, FOOD BORNE CARCINOGE, P74
   Zhang XB, 1996, CARCINOGENESIS, V17, P2259, DOI 10.1093/carcin/17.10.2259
NR 23
TC 6
Z9 6
U1 1
U2 4
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0893-228X
J9 CHEM RES TOXICOL
JI Chem. Res. Toxicol.
PD MAR
PY 2007
VL 20
IS 3
BP 497
EP 503
DI 10.1021/tx600303d
PG 7
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Toxicology
SC Pharmacology & Pharmacy; Chemistry; Toxicology
GA 146TU
UT WOS:000244958400017
PM 17291013
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Comelekoglu, U
   Bagis, S
   Yalin, S
   Ogenler, O
   Yildiz, A
   Sahin, NO
   Oguz, I
   Hatungil, R
AF Comelekoglu, Ulku
   Bagis, Selda
   Yalin, Serap
   Ogenler, Oya
   Yildiz, Altan
   Sahin, N. Ozlen
   Oguz, Izzet
   Hatungil, R.
TI Biomechanical evaluation in osteoporosis: ovariectomized rat model
SO CLINICAL RHEUMATOLOGY
LA English
DT Article
DE biomechanical measurement; DEXA; ovariectomy
ID CORTICAL BONE; MINERAL-CONTENT; COMPACT-BONE; DENSITY; STRENGTH;
   POROSITY; IMMOBILIZATION; COLLAGEN; FEMUR
AB The aim of our study was to investigate the effects of ovariectomy on rat femur biomechanical parameters. Bone mineral density (BMD) and histological investigation were also evaluated. Fourteen female Sprague-Dawley rats (seven ovariectomized, seven control) were used. BMD was measured by dual-energy X-ray absorbsiometry. Bone biomechanical parameters were measured in femoral midshaft with tensile test using a biomaterial testing machine and maximum load, stiffness, energy absorption capacity (structural properties), ultimate stress, ultimate strain, and elastic modulus (material properties) were calculated. Diaphyseal cortical bone thickness was measured by using histological method. The ovariectomized (OVX) rat femur's BMD was 14% lower than control rats (p=0.006). Mean maximum load was 55% less than the control group's (p=0.0001). Stiffness was 72% less in OVX rats (p=0.05). Femurs of rats with OVX had 32% less absorbed energy than controls (p=0.09). From the stress-strain curve ultimate stress, ultimate strain and elastic modulus was calculated. Elastic modulus was 53% less than controls (p=0.05). Ultimate stress decreased 21% in OVX rats (p=0.097). Ultimate strain was 25% less than controls in OVX rats. Cortical thickness was significantly decreased in OVX rats than in controls (p < 0.05). In conclusion, femur biomechanical parameters are decreased in osteoporosis.
C1 Mersin Univ, Eczacilik Fak, Sch Med, Dept Biochem, TR-33169 Mersin, Turkey.
   Mersin Univ, Sch Med, Dept Phys Med & Rehabil, TR-33169 Mersin, Turkey.
   Mersin Univ, Dept Radiol, TR-33169 Mersin, Turkey.
   Mersin Univ, Fac Pharm, TR-33169 Mersin, Turkey.
   Mersin Univ, Sch Med, Dept Histol & Embryol, TR-33169 Mersin, Turkey.
   Mersin Univ, Sch Med, Dept Physiol, Mersin, Turkey.
RP Yalin, S (reprint author), Mersin Univ, Eczacilik Fak, Sch Med, Dept Biochem, TR-33169 Mersin, Turkey.
EM syalin01@hotmail.com
RI yalin, serap/A-3195-2012; sahin, nefise/A-9867-2017; Comelekoglu,
   Ulku/E-2239-2016
OI Comelekoglu, Ulku/0000-0001-8060-6333
CR AERSSENS J, 1993, CALCIFIED TISSUE INT, V53, P269, DOI 10.1007/BF01320913
   BAGI CM, 1993, BONE, V14, P877, DOI 10.1016/8756-3282(93)90318-5
   BURR DB, 2002, J MUSCULOSKEL NEURON, V2, P544
   Chesnut CH, 2001, J BONE MINER RES, V16, P2163, DOI 10.1359/jbmr.2001.16.12.2163
   CURREY JD, 1988, J BIOMECH, V21, P131, DOI 10.1016/0021-9290(88)90006-1
   Dequeker J., 1998, RHEUMATOLOGY, V8- 34, P1
   Faulkner KG, 2000, J BONE MINER RES, V15, P183, DOI 10.1359/jbmr.2000.15.2.183
   Ferretti J. L., 2001, Journal of Musculoskeletal & Neuronal Interactions, V1, P263
   Giavaresi G, 2004, BIOMED PHARMACOTHER, V58, P494, DOI 10.1016/j.biopha.2004.08.017
   Han SM, 1998, CLIN BIOMECH, V13, P480, DOI 10.1016/S0268-0033(98)00019-9
   KALU DN, 1991, BONE MINER, V15, P175, DOI 10.1016/0169-6009(91)90124-I
   Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785
   LAURITZEN DB, 1993, J BONE MINER RES, V8, P871
   LEPOLA V, 1994, BONE, V15, P367, DOI 10.1016/8756-3282(94)90302-6
   MARTIN RB, 1993, J BIOMECH, V26, P1047, DOI 10.1016/S0021-9290(05)80004-1
   NIGG BM, 1999, BIOMECHANICS MUSCULO, P50
   PENG Z, 1994, BONE, V15, P523, DOI 10.1016/8756-3282(94)90276-3
   Reddy G, 2001, DIABETES RES CLIN PR, V54, P1, DOI 10.1016/S0168-8227(01)00273-X
   SCHAFFLER MB, 1988, J BIOMECH, V21, P13, DOI 10.1016/0021-9290(88)90186-8
   Wronski TJ, 1992, CELLS MATER S, V1, P69
NR 20
TC 36
Z9 43
U1 1
U2 13
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0770-3198
J9 CLIN RHEUMATOL
JI Clin. Rheumatol.
PD MAR
PY 2007
VL 26
IS 3
BP 380
EP 384
DI 10.1007/s10067-006-0367-2
PG 5
WC Rheumatology
SC Rheumatology
GA 132VD
UT WOS:000243969700018
PM 16944072
DA 2018-10-20
ER

PT J
AU Pezzotti, G
AF Pezzotti, Giuseppe
TI Stress microscopy and confocal Raman imaging of load-bearing surfaces in
   artificial hip joints
SO EXPERT REVIEW OF MEDICAL DEVICES
LA English
DT Review
DE alumina; artificial hip joints; confocal probe configuration;
   nondestructive evaluation; Raman spectroscopy; reliability; ultra-high
   molecular weight polyethylene; zirconia
ID MOLECULAR-WEIGHT POLYETHYLENE; SPECTROSCOPIC ANALYSIS; RESIDUAL-STRESS;
   CRYSTALLINITY; OXIDATION; ALUMINA; UHMWPE; STERILIZATION; REPLACEMENT;
   RADIATION
AB Confocal Raman microprobe spectroscopy is a technique with considerable potential in biomedical science owing to its ability to nondestructively scan samples in 3D with high spatial resolution and to precisely characterize the chemical, physical and mechanical characteristics of biomaterials at their molecular scale. Beyond the capacity of other conventional assessments of biomaterial oxidation state, crystalline and phase fractions, Raman and luminescence techniques can be used for assessing residual stress fields in artificial hip joints. Provided that the probe response function characterizing the probe/biomaterial interaction is known, 3D residual stress fields can be determined precisely with high axial and lateral resolution.
C1 Kyoto Inst Technol, RIN, Ceram Phys Lab, Sakyo Ku, Kyoto 92354, Japan.
   Kyoto Inst Technol, RIN, Res Inst Nanosci, Sakyo Ku, Kyoto 92354, Japan.
   Loma Linda Univ, Orthopaed Res Ctr, Dept Orthopaed, Loma Linda, CA 92354 USA.
RP Pezzotti, G (reprint author), Kyoto Inst Technol, RIN, Ceram Phys Lab, Sakyo Ku, Kyoto 92354, Japan.
EM pezzotti@kit.ac.jp
CR ADAR F, 2001, HDB RAMAN SPECTROSCO, P11
   ANASTASSAKIS E, 1970, SOLID STATE COMMUN, V8, P133, DOI 10.1016/0038-1098(70)90588-0
   Atkinson A, 1999, J RAMAN SPECTROSC, V30, P885, DOI 10.1002/(SICI)1097-4555(199910)30:10<885::AID-JRS485>3.3.CO;2-X
   Baldwin KJ, 2001, APPL SPECTROSC, V55, P517, DOI 10.1366/0003702011952190
   BHATEJA SK, 1989, POLYM J, V21, P739, DOI 10.1295/polymj.21.739
   Bruneel JL, 2002, J RAMAN SPECTROSC, V33, P815, DOI 10.1002/jrs.915
   Chenery DH, 1997, BIOMATERIALS, V18, P415, DOI 10.1016/S0142-9612(96)00149-4
   CLARKE FJP, 1964, ACTA METALL MATER, V12, P139, DOI 10.1016/0001-6160(64)90181-6
   Clarke IC, 2003, J BONE JOINT SURG AM, V85A, P73, DOI 10.2106/00004623-200300004-00009
   CORDINGLEY R, 2003, J AUST CERAM SOC, V29, P30
   *DORL BIOM KNOWL E, 2001, WORLDW ORTH MARK 200
   FEHER E, 1968, PHYS REV, V172, P172
   GRABNER L, 1978, J APPL PHYS, V49, P580, DOI 10.1063/1.324682
   HE J, 1995, J AM CERAM SOC, V78, P1347, DOI 10.1111/j.1151-2916.1995.tb08493.x
   HEROS RJ, 1998, SEMIN ARTHROPLASTY, V9, P114
   Katagiri G, 1988, ADV CERAM, V24, P537
   Kurtz SM, 2001, BIOMATERIALS, V22, P2875, DOI 10.1016/S0142-9612(01)00033-3
   Kyomoto M, 2007, J BIOMAT SCI-POLYM E, V18, P165, DOI 10.1163/156856207779116685
   Lewis I.R., 2001, HDB RAMAN SPECTROSCO
   LIPKIN DM, 1995, J APPL PHYS, V77, P1855, DOI 10.1063/1.358885
   MA Q, 1994, J AM CERAM SOC, V77, P298, DOI 10.1111/j.1151-2916.1994.tb06996.x
   MAHONEY OM, 1990, J BONE JOINT SURG AM, V72A, P663, DOI 10.2106/00004623-199072050-00004
   Nylor C.C., 1995, MACROMOLECULES, V28, P2969
   O'Leary J F, 1988, J Arthroplasty, V3, P87, DOI 10.1016/S0883-5403(88)80057-3
   Pezzotti G, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2193470
   Pezzotti G, 2005, ANAL BIOANAL CHEM, V381, P577, DOI 10.1007/s00216-004-2780-1
   Pezzotti G, 2004, J BIOMED OPT, V9, P372, DOI 10.1117/1.1647547
   Pezzotti G, 2003, KEY ENG MAT, V240-2, P893, DOI 10.4028/www.scientific.net/KEM.240-242.893
   Premnath V, 1996, BIOMATERIALS, V17, P1741, DOI 10.1016/0142-9612(95)00349-5
   Premnath V, 1999, POLYMER, V40, P2215, DOI 10.1016/S0032-3861(98)00438-8
   Raman CV, 1928, NATURE, V121, P501, DOI 10.1038/121501c0
   RULL F, 1993, J RAMAN SPECTROSC, V24, P545, DOI 10.1002/jrs.1250240813
   SEDEL L, 1990, J BONE JOINT SURG BR, V72, P658
   Shishido T, 2003, J BIOMED MATER RES B, V67B, P638, DOI 10.1002/jbm.b.10048
   Smith E, 2005, MODERN RAMAN SPECTROSCOPY: A PRACTICAL APPROACH, P1
   STROBL GR, 1978, J POLYM SCI POL PHYS, V16, P1181, DOI 10.1002/pol.1978.180160704
   Taddei P, 2002, J MOL STRUCT, V613, P121, DOI 10.1016/S0022-2860(02)00141-2
   TATEIWA T, 2007, J BIOMED MAT RES B
   TVERGAARD V, 1988, J AM CERAM SOC, V71, P157, DOI 10.1111/j.1151-2916.1988.tb05022.x
   WAN KS, 2005, J APPL PHYS, V98
   Willmann G, 1998, ORTHOPEDICS, V21, P173
   WOLFRAM S, 2000, MATHEMATICA 4
   Yeom B, 1998, J POLYM SCI POL CHEM, V36, P329, DOI 10.1002/(SICI)1099-0518(19980130)36:2<329::AID-POLA16>3.0.CO;2-Q
   ZERBI G, 1989, POLYMER, V30, P2324, DOI 10.1016/0032-3861(89)90269-3
NR 44
TC 19
Z9 19
U1 0
U2 13
PU EXPERT REVIEWS
PI LONDON
PA UNITEC HOUSE, 3RD FL, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON N3 1QB,
   ENGLAND
SN 1743-4440
EI 1745-2422
J9 EXPERT REV MED DEVIC
JI Expert Rev. Med. Devices
PD MAR
PY 2007
VL 4
IS 2
BP 165
EP 189
DI 10.1586/17434440.4.2.165
PG 25
WC Engineering, Biomedical
SC Engineering
GA 148IA
UT WOS:000245066800018
PM 17359223
DA 2018-10-20
ER

PT J
AU Ivanchenko, LA
   Pinchuk, ND
   Parkhomei, AR
AF Ivanchenko, L. A.
   Pinchuk, N. D.
   Parkhomei, A. R.
TI Effect of the plasticizer on structure formation in porified
   polydispersed glass ceramic composites
SO GLASS AND CERAMICS
LA English
DT Article
AB A composite material based on synthetic phosphates strengthened with 50 wt.% glass phase has been obtained. The porosity of the material is 48-61%, depending on the plasticizer agent and sintering regime. The experimental samples showed adequate mechanical strength and biochemical solubility, which commends this material for use as a biomaterial.
C1 Natl Acad Sci Ukraine, IN Frantsevich Inst Mat Sci, UA-252143 Kiev, Ukraine.
RP Ivanchenko, LA (reprint author), Natl Acad Sci Ukraine, IN Frantsevich Inst Mat Sci, Zabolotny St 154, UA-252143 Kiev, Ukraine.
CR IVANCHENKO LA, 2003, STEKLO KERAM, P81
   IVANCHENKO LA, 2006, NANOSTRUKT MAT, P50
   Kanazawa T., 1998, INORGANIC PHOSPHATE
   KITAIGORODSKII II, 1963, HDB GLASS MAKING, V1
   PINCHUK ND, 2003, POROSHKOV METALL, P36
   Rayner M., 1965, RHEOLOGY
   SAVICH VV, 2003, MODERN MAT SURG IMPL
   SKOROKHOD VV, 1974, POROSHKOV METALL, P31
   Strelov K. K., 1985, THEORETICAL PRINCIPL
NR 9
TC 3
Z9 4
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0361-7610
J9 GLASS CERAM+
JI Glass Ceram.
PD MAR
PY 2007
VL 64
IS 3-4
BP 136
EP 139
DI 10.1007/s10717-007-0035-2
PG 4
WC Materials Science, Ceramics
SC Materials Science
GA 195PI
UT WOS:000248423700019
DA 2018-10-20
ER

PT J
AU Broekhuizen, CAN
   de Boer, L
   Schipper, K
   Jones, CD
   Quadir, S
   Feldman, RG
   Dankert, J
   Vandenbroucke-Grauls, CMJE
   Weening, JJ
   Zaat, SAJ
AF Broekhuizen, Corine A. N.
   de Boer, Leonie
   Schipper, Kim
   Jones, Christopher D.
   Quadir, Shan
   Feldman, Roger G.
   Dankert, Jacob
   Vandenbroucke-Grauls, Christina M. J. E.
   Weening, Jan J.
   Zaat, Sebastian A. J.
TI Peri-implant tissue is an important niche for Staphylococcus epidermidis
   in experimental biomaterial-associated infection in mice
SO INFECTION AND IMMUNITY
LA English
DT Article
ID FOREIGN-BODY INFECTION; VIRULENT BURKHOLDERIA-PSEUDOMALLEI; SUBCUTANEOUS
   ABSCESS FORMATION; BACTERIAL-COLONIZATION; BIOFILM FORMATION; BINDING
   PROTEIN; C57BL/6 MICE; IN-VITRO; MODEL; STRAINS
AB Biomaterial-associated infections (BAI), which are predominantly caused by Staphylococcus epidermidis, are a significant problem in modern medicine. Biofilm formation is considered the pivotal element in the pathogenesis, but in previous mouse studies we retrieved S. epidermidis from peri-implant tissue. To assess the kinetics and generality of tissue colonization, we investigated BAI using two S. epidermidis strains, two biomaterials, and two mouse strains. With small inocula all implants were culture negative, whereas surrounding tissues were positive. When higher doses were used, tissues were culture positive more often than implants, with higher numbers of CFU. This was true for the different biomaterials tested, for both S. epidermidis strains, at different times, and for both mouse strains. S. epidermidis colocalized with host cells at a distance that was > 10 cell layers from the biomaterial-tissue interface. We concluded that in mouse experimental BAI S. epidermidis peri-implant tissue colonization is more important than biofilm formation.
C1 Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, CINIMA, NL-1105 AZ Amsterdam, Netherlands.
   Emergent Europe, Wokingham RG41 5TU, Berks, England.
   Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands.
   VU Med Ctr, Dept Med Microbiol & Infect Dis, Amsterdam, Netherlands.
RP Zaat, SAJ (reprint author), Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, CINIMA, Meibergdreef 15,L1-116, NL-1105 AZ Amsterdam, Netherlands.
EM s.a.zaat@amc.uva.nl
CR Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   Boelens JJ, 2000, INFECT IMMUN, V68, P1692, DOI 10.1128/IAI.68.3.1692-1695.2000
   Boelens JJ, 2000, J BIOMED MATER RES, V50, P546, DOI 10.1002/(SICI)1097-4636(20000615)50:4<546::AID-JBM10>3.0.CO;2-Y
   Boelens JJ, 2000, J INFECT DIS, V181, P1337, DOI 10.1086/315369
   BROEKHUIZEN CAN, 2006, 106 GEN M AM SOC MIC
   CHRISTENSEN GD, 1983, INFECT IMMUN, V40, P407
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251
   Deighton MA, 1996, EPIDEMIOL INFECT, V117, P267, DOI 10.1017/S0950268800001448
   Francois P, 2003, FEMS IMMUNOL MED MIC, V35, P135, DOI 10.1016/S0928-8244(02)00463-7
   Frebourg NB, 2000, J CLIN MICROBIOL, V38, P877
   Galdbart JO, 2000, J INFECT DIS, V182, P351, DOI 10.1086/315660
   Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x
   Hazlett LD, 2000, INVEST OPHTH VIS SCI, V41, P805
   HEBERT GA, 1985, J CLIN MICROBIOL, V22, P409
   Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x
   Hoppe I, 1999, INFECT IMMUN, V67, P2891
   Hussain M, 1997, INFECT IMMUN, V65, P519
   KAPLAN SS, 1992, J BIOMED MATER RES, V26, P1039, DOI 10.1002/jbm.820260806
   Klug D, 2003, J CLIN MICROBIOL, V41, P3348, DOI 10.1128/JCM.41.7.3348-3350.2003
   Leakey AK, 1998, MICROB PATHOGENESIS, V24, P269, DOI 10.1006/mpat.1997.0179
   MacEwan MR, 2005, J BIOMED MATER RES A, V74A, P285, DOI 10.1002/jbm.a.30316
   Mack D, 2004, INT J MED MICROBIOL, V294, P203, DOI 10.1016/j.ijmm.2004.06.015
   MARRIE TJ, 1984, J CLIN MICROBIOL, V19, P687
   Nilsson M, 1998, INFECT IMMUN, V66, P2666
   O'Gara JP, 2001, J MED MICROBIOL, V50, P582, DOI 10.1099/0022-1317-50-7-582
   OSTERHOLM MT, 2005, DOUGLAS BENNETS PRIN, P161
   Panthel K, 2003, INFECT IMMUN, V71, P794, DOI 10.1128/IAI.71.2.794-800.2003
   PATRICK CC, 1995, PEDIATR RES, V37, P70, DOI 10.1203/00006450-199501000-00014
   Qazi SNA, 2004, J BACTERIOL, V186, P1065, DOI 10.1128/JB.186.4.1065-1077.2004
   Rohde H, 2005, MOL MICROBIOL, V55, P1883, DOI 10.1111/j.1365-2958.04515.x
   Rupp ME, 2001, J INFECT DIS, V183, P1038, DOI 10.1086/319279
   Rupp ME, 1999, INFECT IMMUN, V67, P2627
   SCHUMACHERPERDREAU F, 1994, FEMS MICROBIOL LETT, V117, P71
   SHERERTZ RJ, 1995, J BIOMED MATER RES, V29, P635, DOI 10.1002/jbm.820290511
   Stevens DL, 2006, CLIN INFECT DIS, V42, pS51, DOI 10.1086/491714
   Svensson E, 1997, J ANTIMICROB CHEMOTH, V39, P817, DOI 10.1093/jac/39.6.817
   Ulett GC, 2000, INFECT IMMUN, V68, P2034, DOI 10.1128/IAI.68.4.2034-2042.2000
   Vandecasteele SJ, 2003, J INFECT DIS, V188, P730, DOI 10.1086/377452
   Vandecasteele SJ, 2003, CLIN MICROBIOL INFEC, V9, P114, DOI 10.1046/j.1469-0691.2003.00544.x
   VERBRUGH HA, 1987, ZENTRALBLATT BAK 1 S, V16, P55
   Waldvogel FA, 2000, INFECT ASS INDWELLIN
   Williams RJ, 2002, INFECT IMMUN, V70, P6805, DOI 10.1128/IAI.70.12.6805-6810.2002
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487
NR 47
TC 29
Z9 30
U1 0
U2 6
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0019-9567
J9 INFECT IMMUN
JI Infect. Immun.
PD MAR
PY 2007
VL 75
IS 3
BP 1129
EP 1136
DI 10.1128/IAI.01262-06
PG 8
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 143PD
UT WOS:000244733900006
PM 17158900
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Carson, JS
   Bostrom, MPG
AF Carson, Joshua S.
   Bostrom, Mathias P. G.
TI Synthetic bone scaffolds and fracture repair
SO INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED
LA English
DT Article
DE bone; fracture treatments; biomaterials; scaffolds; bone-graft
   substitutes; ceramics; osteoconduction
ID CALCIUM-PHOSPHATE CEMENT; TIBIAL PLATEAU FRACTURES; GRAFT SUBSTITUTE;
   FIXATION; IMPLANTS; SULFATE
AB Synthetic scaffolding has been used in the treatment of bone defects and fractures for over 100 years. They remain a critical toot in the treatment of large-volume bone defects, and their rote as potential substitues for human bone graft continues to expand. Various materials are used commercially to produce osteoconductive scaffolds including ceramics (both bioactive and bioinert) and select polymers, all of which offer distinct advantages and dissadvantages. While currently used principally as osteoconductive conduits for growth, the role of bone-graft substitues in fracture treatment is likely to change, as biomaterial research moves towards utilizing current and future scaffold materials as delivery systems for biologic fracture treatments.
C1 Hosp Special Surg, Dept Res, Div Res, New York, NY 10021 USA.
RP Carson, JS (reprint author), Hosp Special Surg, Dept Res, Div Res, 535 E 70th St,6th Floor Caspary, New York, NY 10021 USA.
EM carsonj@hss.edu
CR ASSELMEIER MA, 1993, AM J SPORT MED, V21, P170, DOI 10.1177/036354659302100202
   Bohner M, 2000, Injury, V31 Suppl 4, P37
   BUCHOLZ RW, 1987, ORTHOP CLIN N AM, V18, P323
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   Deville S, 2006, SCIENCE, V311, P515, DOI 10.1126/science.1120937
   Dreesman H., 1892, BEITR KLIN CHIR, V9, P804
   FLATLEY TJ, 1983, CLIN ORTHOP RELAT R, P246
   Frayssinet P, 1998, BIOMATERIALS, V19, P971, DOI 10.1016/S0142-9612(97)00163-4
   GLOWACKI J, 1986, J BONE MINER RES, V1, P327
   Hench L., 1992, BONE GRAFTS BONE SUB, P263
   HINZ P, 2002, ORTHOPEDICS, V25, pS97
   Horstmann WG, 2003, INJURY, V34, P141, DOI 10.1016/S0020-1383(02)00105-5
   Kelly CM, 2001, CLIN ORTHOP RELAT R, P42
   Kopylov P, 1999, ACTA ORTHOP SCAND, V70, P1, DOI 10.3109/17453679909000946
   Kuboki Y., 2001, J BONE JOINT SURG AM, V83, P105
   Moed BR, 2003, CLIN ORTHOP RELAT R, P303, DOI 10.1097/01.blo.0000063788.32430.8f
   Partio EK, 1997, ARCH ORTHOP TRAUM SU, V116, P213, DOI 10.1007/BF00393712
   PELTIER L, 1992, BONE GRAFTS BONE SUB, P243
   PELTIER L F, 1961, Clin Orthop, V21, P1
   Pihlajamaki H, 1997, BIOMATERIALS, V18, P1311, DOI 10.1016/S0142-9612(97)00068-9
   Trenholm A, 2005, J ORTHOP TRAUMA, V19, P698, DOI 10.1097/01.bot.0000183455.01491.bb
   Welch RD, 2003, J BONE JOINT SURG AM, V85A, P222, DOI 10.2106/00004623-200302000-00007
   YAMAMURO T, 1994, BONE GRAFTS, DERIVATIVES AND SUBSTITUTES, P245
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
NR 24
TC 66
Z9 68
U1 0
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0020-1383
J9 INJURY
JI Injury-Int. J. Care Inj.
PD MAR
PY 2007
VL 38
SU 1
BP S33
EP S37
DI 10.1016/j.injury.2007.02.008
PG 5
WC Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery
SC General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery
GA 173ZW
UT WOS:000246912000005
PM 17383484
DA 2018-10-20
ER

PT J
AU Stylios, G
   Wan, TY
   Giannoudis, P
AF Stylios, George
   Wan, Taoyu
   Giannoudis, Peter
TI Present status and future potential of enhancing bone heating using
   nanotechnology
SO INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED
LA English
DT Review
DE porosity; bone ingrowth; scaffold; nanocomposites
ID CALCIUM-PHOSPHATE CERAMICS; BIODEGRADABLE POLYMER SCAFFOLDS;
   BETA-TRICALCIUM PHOSPHATE; INDUCED PHASE-SEPARATION; COMPOSITE
   SCAFFOLDS; IN-VITRO; CELL TRANSPLANTATION; OSTEOBLAST ADHESION;
   POLY(L-LACTIC ACID); NANOPHASE CERAMICS
AB An overview of the current state of tissue engineering material systems used in bone heating is presented. A variety of fabrication processes have been developed that have resulted in porous implant substrates that can address unresolved clinical problems. The merits of these biomaterial systems are evaluated in the context of the mechanical properties and biomedical performances most suitable for bone heating. An optimal scaffold for bone tissue engineering applications should be biocompatible and act as a 3D template for in vitro and in vivo bone growth; in addition, its degradation products should be non-toxic and easily excreted by the body. To achieve these features, scaffolds must consist of an interconnected porous network of micro- and nanoscale to allow extensive body fluid transport through the pores, which wilt trigger bone ingrowth, cell migration, tissue ingrowth, and eventually vascularization.
C1 Heriot Watt Univ, Edinburgh, Midlothian, Scotland.
   Univ Leeds, Acad Dept Trauma & Orthopaed Surg, Leeds LS2 9JT, W Yorkshire, England.
RP Stylios, G (reprint author), Heriot Watt Univ, Galashiels TD1 3HF, Scotland.
EM G.Stylios@hw.ac.uk
CR Agrawal CM, 1997, MATER SCI FORUM, V250, P115, DOI 10.4028/www.scientific.net/MSF.250.115
   Almirall A, 2004, BIOMATERIALS, V25, P3671, DOI 10.1016/j.biomaterials.2003.10.066
   ANTONIOS GM, 1994, POLYMER, V35, P1068
   AOKI H, 1991, SCI MED APPL HYDROXY
   *ASM, 1977, INT METALS REV, V22, P119
   Bauer TW, 2000, CLIN ORTHOP RELAT R, P10
   Black J, 1998, HDB BIOMATERIALS PRO
   Bohner M, 1997, J PHARM SCI, V86, P565, DOI 10.1021/js960405a
   Bohner M, 2000, INJURY, V31, pS37
   CESTERO HJ, 1975, J BIOMED MATER RES, V9, P1, DOI 10.1002/jbm.820090403
   Chen GP, 2001, BIOMATERIALS, V22, P2563, DOI 10.1016/S0142-9612(00)00447-6
   Chenje TW, 2004, MATER DESIGN, V25, P11, DOI 10.1016/S0261-3069(03)00168-7
   CHO S, 1997, KEY ENG MATER, V132, P802
   Cypher T J, 1996, J Foot Ankle Surg, V35, P413
   Degirmenbasi N, 2006, COLLOID SURFACE B, V48, P42, DOI 10.1016/j.colsurfb.2006.01.002
   DENHOLLANDER W, 1991, BIOMATERIALS, V12, P569, DOI 10.1016/0142-9612(91)90053-D
   Du C, 1999, J BIOMED MATER RES, V44, P407, DOI 10.1002/(SICI)1097-4636(19990315)44:4<407::AID-JBM6>3.0.CO;2-T
   Du C, 1998, J BIOMED MATER RES, V42, P540, DOI 10.1002/(SICI)1097-4636(19981215)42:4<540::AID-JBM9>3.3.CO;2-U
   DUCHEYNE P, 1981, J BIOMED MATER RES, V15, P441, DOI 10.1002/jbm.820150315
   DUCHEYNE P, 1991, P 4 INT S CER MED, P135
   FAMERY R, 1994, CERAM INT, V20, P327, DOI 10.1016/0272-8842(94)90050-7
   FRAYSSINET P, 1993, BIOMATERIALS, V14, P423, DOI 10.1016/0142-9612(93)90144-Q
   FRIEDLAENDER GE, 1991, ADULT SPINE PRINCIPL, P565
   GALANTE J, 1971, J BONE JOINT SURG AM, VA 53, P101, DOI 10.2106/00004623-197153010-00009
   Ginebra MP, 1997, J DENT RES, V76, P905, DOI 10.1177/00220345970760041201
   Ginebra MP, 1999, J AM CERAM SOC, V82, P2808
   Ginebra MP, 2001, J BIOMED MATER RES, V57, P113, DOI 10.1002/1097-4636(200110)57:1<113::AID-JBM1149>3.0.CO;2-5
   Gross KA, 2004, BIOMATERIALS, V25, P4955, DOI 10.1016/j.biomaterials.2004.01.046
   Guan LM, 2004, J BIOMED MATER RES A, V71A, P480, DOI 10.1002/jbm.a.30173
   HAHN H, 1970, Journal of Biomedical Materials Research, V4, P571, DOI 10.1002/jbm.820040407
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   Helsen J.A., 1998, METALS BIOMATERIALS
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HIRSCHHORN JS, 1971, J BIOMED MATER RES S, V2, P49
   Hollinger JO, 1996, CLIN ORTHOP RELAT R, P55
   HOMSY CA, 1972, CLIN ORTHOP RELAT R, P220
   Hulbert SF, 1993, INTRO BIOCERAMICS, P25
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Kamegai Akihide, 1994, Bio-Medical Materials and Engineering, V4, P291
   KARAGIANES M T, 1973, Biomaterials Medical Devices and Artificial Organs, V1, P171
   Kikuchi M, 1997, J MATER SCI-MATER M, V8, P361, DOI 10.1023/A:1018580816388
   Kim HD, 2004, BIOMATERIALS, V25, P2319, DOI 10.1016/j.biomaterials.2003.09.011
   Kim SS, 2006, BIOMATERIALS, V27, P1399, DOI 10.1016/j.biomaterials.2005.08.016
   KITSUGI T, 1993, BIOMATERIALS, V14, P216, DOI 10.1016/0142-9612(93)90026-X
   Kivrak N, 1998, J AM CERAM SOC, V81, P2245
   Klawitter J J, 1974, Acta Orthop Belg, V40, P755
   KLAWITTER JJ, 1976, J BIOMED MATER RES, V10, P311, DOI 10.1002/jbm.820100212
   Knepper-Nicolai B, 2002, BIOMOL ENG, V19, P227, DOI 10.1016/S1389-0344(02)00036-9
   Li N, 2005, CERAM INT, V31, P641, DOI 10.1016/j.ceramint.2004.05.011
   Li XD, 2001, J BONE JOINT SURG BR, V83B, P1063, DOI 10.1302/0301-620X.83B7.11271
   Lickorish D, 2004, J BIOMED MATER RES A, V68A, P19, DOI 10.1002/jbm.a..20031
   Lin XY, 2004, MATER LETT, V58, P3569, DOI 10.1016/j.matlet.2004.06.044
   MA PX, 1995, J BIOMED MATER RES, V29, P1587, DOI 10.1002/jbm.820291215
   Ma PX, 2001, J BIOMED MATER RES, V56, P469, DOI 10.1002/1097-4636(20010915)56:4<469::AID-JBM1118>3.0.CO;2-H
   Maquet V, 1997, MATER SCI FORUM, V250, P15, DOI 10.4028/www.scientific.net/MSF.250.15
   Marra KG, 1999, MATER RES SOC SYMP P, V550, P155
   Marra KG, 1999, J BIOMED MATER RES, V47, P324, DOI 10.1002/(SICI)1097-4636(19991205)47:3<324::AID-JBM6>3.0.CO;2-Y
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   MOONEY J, 1987, LUMBAR SPINE SURG TE, P471
   Murphy WL, 2000, J BIOMED MATER RES, V50, P50, DOI 10.1002/(SICI)1097-4636(200004)50:1<50::AID-JBM8>3.0.CO;2-F
   Murugan R., 2005, HDB NANOSTRUCTURED B, P141
   Myerson MS, 2005, J BONE JOINT SURG AM, V87A, P113, DOI 10.2106/JBJS.C.01735
   Nam YS, 1999, J BIOMED MATER RES, V47, P8, DOI 10.1002/(SICI)1097-4636(199910)47:1<8::AID-JBM2>3.0.CO;2-L
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   Pachence J. M., 2000, PRINCIPLES TISSUE EN
   Park E, 1999, MATER LETT, V40, P228, DOI 10.1016/S0167-577X(99)00080-4
   Park J.B., 2000, BIOMATERIALS PRINCIP
   PARK JB, 1992, BIOMATERIALS INTRO
   Peter SJ, 1998, J BIOMED MATER RES, V43, P422, DOI 10.1002/(SICI)1097-4636(199824)43:4<422::AID-JBM9>3.3.CO;2-T
   Peter SJ, 2000, BIOMATERIALS, V21, P1207, DOI 10.1016/S0142-9612(99)00254-9
   Piskin E, 1997, MATER SCI FORUM, V250, P1
   PITT CG, 1981, BIOMATERIALS, V2, P215
   POHLER EM, 1980, EVALUATION BIOMATERI
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   Ramay HR, 2003, BIOMATERIALS, V24, P3293, DOI 10.1016/S0142-9612(03)00171-6
   Ramay HRR, 2004, BIOMATERIALS, V25, P5171, DOI 10.1016/j.biomaterials.2003.12.023
   Ravaglioli A., 1992, BIOCERAMICS HUMAN BO
   Rezania A, 1999, BIOTECHNOL PROGR, V15, P19, DOI 10.1021/bp980083b
   Rocha LB, 2002, BIOMATERIALS, V23, P449, DOI 10.1016/S0142-9612(01)00126-0
   Rodriguez-Lorenzo LM, 2004, MATER RES BULL, V39, P83, DOI 10.1016/j.materresbull.2003.09.014
   Roveri N, 2003, MAT SCI ENG C-BIO S, V23, P441, DOI 10.1016/S0928-4931(02)00318-1
   SAUER BW, 1974, J BIOMED MATER RES, V8, P145, DOI 10.1002/jbm.820080315
   SCHLIEPHAKE H, 1994, J ORAL MAXIL SURG, V52, P57, DOI 10.1016/0278-2391(94)90016-7
   SCHMITZ JP, 1990, ACTA ANAT, V138, P185
   Schugens C, 1996, POLYMER, V37, P1027, DOI 10.1016/0032-3861(96)87287-9
   Sepulveda P, 2002, J BIOMED MATER RES, V59, P340, DOI 10.1002/jbm.1250
   SPECTOR M, 1978, J BIOMED MATER RES, V12, P665, DOI 10.1002/jbm.820120508
   Stylios GK, 2005, INJURY, V36, pS6, DOI 10.1016/j.injury.2005.10.011
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Vermes C, 2001, J BONE JOINT SURG AM, V83A, P201, DOI 10.2106/00004623-200102000-00007
   Wake MC, 1996, CELL TRANSPLANT, V5, P465, DOI 10.1016/0963-6897(96)00025-5
   Wan ACA, 2001, BIOMATERIALS, V22, P1147, DOI 10.1016/S0142-9612(00)00355-0
   WEBER JN, 1972, MATER RES BULL, V7, P1005, DOI 10.1016/0025-5408(72)90092-X
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Wei GB, 2004, BIOMATERIALS, V25, P4749, DOI 10.1016/j.biomaterials.2003.12.005
   Welch RD, 2003, J BONE JOINT SURG AM, V85A, P222, DOI 10.2106/00004623-200302000-00007
   Whang K, 2000, BIOMATERIALS, V21, P2545, DOI 10.1016/S0142-9612(00)00122-8
   WHITE EW, 1975, J BIOMED MATER RES, V9, P23, DOI 10.1002/jbm.820090406
   Yang XB, 2001, BONE, V29, P523, DOI 10.1016/S8756-3282(01)00617-2
   Yang XH, 1998, J MATER CHEM, V8, P2233, DOI 10.1039/a802067a
   Yaszemski M. J., 2004, BIOMATERIALS ORTHOPE
   Yoon SY, 2005, MATER CHEM PHYS, V91, P48, DOI 10.1016/j.matchemphys.2004.10.049
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
   Zhang Y, 2001, J BIOMED MATER RES, V55, P304, DOI 10.1002/1097-4636(20010605)55:3<304::AID-JBM1018>3.0.CO;2-J
   Zhao F, 2002, BIOMATERIALS, V23, P3227, DOI 10.1016/S0142-9612(02)00077-7
   Zhong JP, 2000, J BIOMED MATER RES, V53, P694, DOI 10.1002/1097-4636(2000)53:6<694::AID-JBM12>3.0.CO;2-6
NR 109
TC 43
Z9 44
U1 0
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0020-1383
EI 1879-0267
J9 INJURY
JI Injury-Int. J. Care Inj.
PD MAR
PY 2007
VL 38
SU 1
BP S63
EP S74
DI 10.1016/j.injury.2007.02.011
PG 12
WC Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery
SC General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery
GA 173ZW
UT WOS:000246912000008
PM 17383487
DA 2018-10-20
ER

PT J
AU Khandeparker, L
   Anil, AC
AF Khandeparker, Lidita
   Anil, Arga Chandrashekhar
TI Underwater adhesion: The barnacle way
SO INTERNATIONAL JOURNAL OF ADHESION AND ADHESIVES
LA English
DT Article
DE adhesives; phenolic; adhesion by chemical bonding; biological adhesion;
   barnacle
ID BALANUS-AMPHITRITE DARWIN; RELEASE COATINGS; CYPRIS LARVAE; BIOCHEMICAL
   COMPOSITION; MARINE INVERTEBRATE; TEMPORARY ADHESION; CEMENT APPARATUS;
   MEGABALANUS-ROSA; BACTERIAL FILMS; SETTLEMENT
AB Barnacle cement is an underwater adhesive insoluble protein complex. Marine proteins secreted by the invertebrates such as barnacles and mussels have potential application as powerful adhesives as they insolubilize and adhere to variety of substrates in aqueous environment. The adhesive properties of the barnacle adhesive proteins have been utilized for various dental and medical purposes. These polyphenolic proteins are currently in demand as they are non-toxic biomaterial, highly effective glues and it is very difficult to raise antibodies against these proteins and owing to this low immunogenicity is also attractive for human applications. This review provides a brief account of biochemical composition of barnacle adhesive proteins and their applications. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Natl Inst Oceanog, Panaji 403004, Goa, India.
RP Anil, AC (reprint author), Natl Inst Oceanog, Panaji 403004, Goa, India.
EM acanil@nio.org
CR ABBOTT A, 1990, SCI PROG, V74, P131
   Anil AC, 2001, J EXP MAR BIOL ECOL, V263, P125, DOI 10.1016/S0022-0981(01)00280-5
   ARVY L, 1968, CR ACAD SCI D NAT, V267, P1326
   ARVY L, 1968, AM ZOOL, V8, P817
   AVELINMARY SX, 1993, J CHEM ECOL, V19, P2155, DOI 10.1007/BF00979654
   BARNES H, 1976, J EXP MAR BIOL ECOL, V25, P263, DOI 10.1016/0022-0981(76)90128-3
   BERGLIN M, 2003, BIOINTERFACES, V28, P107
   BERNARD FJ, 1962, J MORPHOL, V110, P19, DOI 10.1002/jmor.1051100103
   BROWN CH, 1950, NATURE, V165, P275, DOI 10.1038/165275b0
   Burzio LO, 1997, CURR OPIN BIOTECH, V8, P309, DOI 10.1016/S0958-1669(97)80008-0
   Callow M.E., 2002, BIOLOGIST, V49, P4
   CHEUNG PJ, 1977, MAR BIOL, V43, P157, DOI 10.1007/BF00391263
   Cook M., 1970, ADHESION BIOL SYSTEM, P139
   COSTERTON JW, 1978, SCI AM, V238, P86, DOI 10.1038/scientificamerican0178-86
   CRISP DJ, 1963, PROC R SOC SER B-BIO, V158, P364, DOI 10.1098/rspb.1963.0053
   CRISP DJ, 1962, PROC R SOC SER B-BIO, V156, P500, DOI 10.1098/rspb.1962.0052
   Darwin C., 1851, MONOGRAPH SUBCLASS C
   Darwin C. R., 1854, MONOGRAPH SUBCLASS C
   DATTESH DV, 2002, J EXPT MARINE BIOL E, V280, P117
   Dolez PI, 2002, INT J ADHES ADHES, V22, P297, DOI 10.1016/S0143-7496(02)00007-6
   GURNY RE, 1990, BIOADHESION POSSIBIL
   Holm ER, 2005, BIOFOULING, V21, P121, DOI 10.1080/08927010512331344188
   Holmstrom C, 1996, BIOFOULING, V10, P251, DOI 10.1080/08927019609386284
   HOLMSTROM C, 1994, BIOFOULING, V8, P147, DOI 10.1080/08927019409378269
   HOLMSTROM C, 1992, APPL ENVIRON MICROB, V58, P2111
   KALEEM K, 1987, NATURE, V325, P358
   Kamino K, 2001, BIOCHEM J, V356, P503, DOI 10.1042/0264-6021:3560503
   Kamino K, 1996, BIOL BULL, V190, P403, DOI 10.2307/1543033
   Kavanagh CJ, 2003, BIOFOULING, V19, P381, DOI 10.1080/08927010310001623296
   Keough MJ, 1996, J EXP MAR BIOL ECOL, V207, P59, DOI 10.1016/S0022-0981(96)02632-9
   Khandeparker L, 2003, J EXP MAR BIOL ECOL, V289, P1, DOI 10.1016/S0022-0981(03)00024-8
   Khandeparker L, 2002, J EXP MAR BIOL ECOL, V281, P77, DOI 10.1016/S0022-0981(02)00414-8
   Khandeparker L, 2002, AQUAT MICROB ECOL, V28, P37, DOI 10.3354/ame028037
   Kirchman David, 1981, OCEANS 81, P537, DOI 10.1109/OCEANS.1981.1151475
   KIRCHMAN D, 1982, MAR BIOL LETT, V3, P131
   KIRCHMAN D, 1983, BIODETERIORATION, V5, P281
   KIRCHMAN D, 1982, J EXP MAR BIOL ECOL, V56, P153
   KNIGHTJONES EW, 1953, J EXP BIOL, V30, P584
   KNIGHTJONES EW, 1953, NATURE, V171, P1109, DOI 10.1038/1711109a0
   LARMAN VN, 1982, COMP BIOCHEM PHYS B, V72, P329, DOI 10.1016/0305-0491(82)90209-7
   Lenaerts V., 1990, BIOADHESIVE DRUG DEL
   LINDNER E, 1973, P 3 INT C MAR CORR F, P653
   LINDNER E, 1984, ATTACHMENT MACROFOUL, P183
   Lindner E, 1992, BIOFOULING, V6, P193, DOI 10.1080/08927019209386222
   MAKI JS, 1988, MAR BIOL, V97, P199, DOI 10.1007/BF00391303
   MAKI JS, 1985, B MAR SCI, V37, P675
   MAKI JS, 1990, B MAR SCI, V46, P499
   MAKI JS, 1992, MICROBIAL ECOL, V23, P97, DOI 10.1007/BF00165910
   MAKI JS, 1994, BIOFOULING, V8, P121, DOI 10.1080/08927019409378267
   MAKI JS, 1986, FUNCTION LECTINS INT, P409
   MARSHALL KC, 1971, J GEN MICROBIOL, V68, P337, DOI 10.1099/00221287-68-3-337
   Mitchell R., 1988, P489
   Mitchell R., 1984, P49
   MITCHELL R, 1984, COLONIZATION HIGHER, P189
   NALDRETT MJ, 1993, J MAR BIOL ASSOC UK, V73, P689, DOI 10.1017/S0025315400033221
   Naldrett MJ, 1997, MAR BIOL, V127, P629, DOI 10.1007/s002270050053
   NALDRETT MJ, 1992, THESIS U READING
   NOTT JA, 1969, MAR BIOL, V2, P248, DOI 10.1007/BF00351147
   NOTT JA, 1969, PHILOS T ROY SOC B, V256, P115, DOI 10.1098/rstb.1969.0038
   Okano K, 1996, J EXP BIOL, V199, P2131
   OTNESS JS, 1972, COMP BIOCHEM PHYSIOL, V43, P443, DOI 10.1016/0305-0491(72)90305-7
   Pettitt ME, 2004, BIOFOULING, V20, P299, DOI 10.1080/08927010400027068
   PRYOR MGM, 1962, COMP BIOCH         B, V4, P371
   RITTSCHOF D, 1985, B AM MALAC UNION, V1, P111
   Rodriguez SR, 1995, BIOL BULL, V189, P272, DOI 10.2307/1542144
   SAROYAN JR, 1970, IND ENG CHEM PROD RD, V9, P122, DOI 10.1021/i360034a002
   Stein J, 2003, BIOFOULING, V19, P71, DOI 10.1080/0892701031000089525
   Sun YJ, 2004, BIOFOULING, V20, P279, DOI 10.1080/08927010400026383
   Swain G, 2000, BIOFOULING, V16, P331, DOI 10.1080/08927010009378456
   Tay Franklin R, 2002, J Adhes Dent, V4, P91
   Truby K, 2000, BIOFOULING, V15, P141, DOI 10.1080/08927010009386305
   Visscher J. P., 1928, B US BUR FISH, V43, P193
   WAHL M, 1989, MAR ECOL-PROG SER, V58, P1
   WAITE JH, 1987, INT J ADHES ADHES, V7, P9, DOI 10.1016/0143-7496(87)90048-0
   WAITE JH, 1983, J BIOL CHEM, V258, P2911
   WAITE JH, 1986, Patent No. 4585585
   WALKER G, 1984, J MAR BIOL ASSOC UK, V64, P679, DOI 10.1017/S0025315400030344
   WALKER G, 1972, J MAR BIOL ASSOC UK, V52, P429, DOI 10.1017/S0025315400018786
   WALKER G, 1970, MAR BIOL, V7, P239, DOI 10.1007/BF00367494
   WALKER G, 1971, MAR BIOL, V9, P205, DOI 10.1007/BF00351380
   WALKER G, 1999, CIRRIPEDIA, P249
   WEIGEMANN M, 2005, AQUAT SCI, V67, P166
   Wiegemann M, 2003, J ADHES SCI TECHNOL, V17, P1957, DOI 10.1163/156856103770572070
   Wiegemann M, 2004, BIOFOULING, V20, P147, DOI 10.1080/08927010400001147
   YAMAMOTO H, 1989, MAR CHEM, V26, P331, DOI 10.1016/0304-4203(89)90038-8
   Yan Wenxia, 1981, Oceanologia et Limnologia Sinica, V12, P125
   Yin J, 2005, MAT SCI ENG A-STRUCT, V409, P160, DOI 10.1016/j.msea.2005.05.107
NR 87
TC 43
Z9 45
U1 3
U2 46
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0143-7496
J9 INT J ADHES ADHES
JI Int. J. Adhes. Adhes.
PD MAR
PY 2007
VL 27
IS 2
BP 165
EP 172
DI 10.1016/j.ijadhadh.2006.03.004
PG 8
WC Engineering, Chemical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA 114ZX
UT WOS:000242705300010
DA 2018-10-20
ER

PT J
AU Anderson, BN
   Ding, AM
   Nilsson, LM
   Kusuma, K
   Tchesnokova, V
   Vogel, V
   Sokurenko, EV
   Thomas, WE
AF Anderson, Brett N.
   Ding, Albert M.
   Nilsson, Lina M.
   Kusuma, Kaoru
   Tchesnokova, Veronika
   Vogel, Viola
   Sokurenko, Evgeni V.
   Thomas, Wendy E.
TI Weak rolling adhesion enhances bacterial surface colonization
SO JOURNAL OF BACTERIOLOGY
LA English
DT Article
ID URINARY-TRACT INFECTION; PSEUDOMONAS-AERUGINOSA BIOFILMS;
   STAPHYLOCOCCUS-AUREUS BIOFILMS; BIOMATERIAL-CENTERED INFECTION;
   SECRETORY IMMUNOGLOBULIN-A; ESCHERICHIA-COLI; FIMH-ADHESIN; TISSUE
   INTEGRATION; MICROBIAL ADHESION; TYPE-1 FIMBRIAE
AB Bacterial adhesion to and subsequent colonization of surfaces are the first steps toward forming biofilms, which are a major concern for implanted medical devices and in many diseases. It has generally been assumed that strong irreversible adhesion is a necessary step for biofilm formation. However, some bacteria, such as Escherichia coli when binding to mannosylated surfaces via the adhesive protein FimH, adhere weakly in a mode that allows them to roll across the surface. Since single-point mutations or even increased shear stress can switch this FimH-mediated adhesion to a strong stationary mode, the FimH system offers a unique opportunity to investigate the role of the strength of adhesion independently from the many other factors that may affect surface colonization. Here we compare levels of surface colonization by E. coli strains that differ in the strength of adhesion as a result of flow conditions or point mutations in FimH. We show that the weak rolling mode of surface adhesion can allow a more rapid spreading during growth on a surface in the presence of fluid How. Indeed, an attempt to inhibit the adhesion of strongly adherent bacteria by blocking marmose receptors with a soluble inhibitor actually increased the rate of surface colonization by allowing the bacteria to roll. This work suggests that (i) a physiological advantage to the weak adhesion demonstrated by commensal variants of FimH bacteria may be to allow rapid surface colonization and (ii) antiadhesive therapies intended to prevent biofilm formation can have the unintended effect of enhancing the rate of surface colonization.
C1 Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
   Swiss Fed Inst Technol, Dept Mat, Lab Biol Oriented Mat, Zurich, Switzerland.
   Univ Washington, Dept Microbiol, Seattle, WA USA.
RP Thomas, WE (reprint author), Univ Washington, Dept Bioengn, 1705 NE Pacific St Foege N430P Box 355061, Seattle, WA 98195 USA.
EM wendyt@u.washington.edu
RI Vogel, Viola/O-8025-2015
OI Vogel, Viola/0000-0003-2898-7671; Thomas, Wendy/0000-0001-8602-0819
FU NIAID NIH HHS [R01 AI50940]
CR Bollinger RR, 2003, IMMUNOLOGY, V109, P580
   Brown II, 2001, J BACTERIOL, V183, P3784, DOI 10.1128/JB.183.12.3784-3790.2001
   Chiang P, 2003, J BACTERIOL, V185, P2374, DOI 10.1128/JB.185.7.2374-2378.2003
   Connell I., 1996, P NATL ACAD SCI USA, V93, P9827, DOI DOI 10.1073/PNAS.93.18.9827
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   COSTERTON JW, 1983, PROG FOOD NUTR SCI, V7, P91
   DAVIES PF, 1995, PHYSIOL REV, V75, P519
   DICKINSON RB, 1995, INFECT IMMUN, V63, P3143
   Donlan RM, 2001, CLIN INFECT DIS, V33, P1387, DOI 10.1086/322972
   Donovan WH, 1996, SPINAL CORD, V34, P587, DOI 10.1038/sc.1996.104
   Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010
   Genevaux P, 1999, FEMS MICROBIOL LETT, V173, P403, DOI 10.1016/S0378-1097(99)00110-X
   Gristina A, 2004, CLIN ORTHOP RELAT R, P4, DOI 10.1097/01.blo.0000145156.89115.12
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GUO ZY, 1995, ULTRASOUND MED BIOL, V21, P807, DOI 10.1016/0301-5629(95)00007-E
   HENRICHSEN J, 1972, BACTERIOL REV, V36, P478
   Hoffmann N, 2005, INFECT IMMUN, V73, P2504, DOI 10.1128/IAI.73.4.2504-2514.2005
   Isberg RR, 2002, CELL, V110, P1, DOI 10.1016/S0092-8674(02)00821-8
   IWAHI T, 1983, INFECT IMMUN, V39, P1307
   JARVIS WR, 1992, J ANTIMICROB CHEMOTH, V29, P19, DOI 10.1093/jac/29.suppl_A.19
   Jesaitis AJ, 2003, J IMMUNOL, V171, P4329, DOI 10.4049/jimmunol.171.8.4329
   Johnson JR, 2003, J CLIN MICROBIOL, V41, P337, DOI 10.1128/JCM.41.1.337-345.2003
   Johnson JR, 2001, J INFECT DIS, V184, P1556, DOI 10.1086/323891
   JOHNSON JR, 1991, CLIN MICROBIOL REV, V4, P80
   KEITH BR, 1986, INFECT IMMUN, V53, P693
   Klausen M, 2003, MOL MICROBIOL, V50, P61, DOI 10.1046/j.1365-2958.2003.03677.x
   Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x
   Kolari M, 2002, J BACTERIOL, V184, P2473, DOI 10.1128/JB.184.9.2473.2480.2002
   KUNIN CM, 1992, AM J EPIDEMIOL, V135, P291
   Langermann S, 2000, J INFECT DIS, V181, P774, DOI 10.1086/315258
   Langermann S, 1997, SCIENCE, V276, P607, DOI 10.1126/science.276.5312.607
   Leid JG, 2002, INFECT IMMUN, V70, P6339, DOI 10.1128/IAI.70.11.6339-6345.2002
   Maki DG, 2001, EMERG INFECT DIS, V7, P342, DOI 10.3201/eid0702.010240
   MITTELMAN M, 1995, BACTERIAL ADHESION M, P89
   Moshier A, 1996, CURR MICROBIOL, V33, P200, DOI 10.1007/s002849900100
   Nilsson LM, 2006, J BIOL CHEM, V281, P16656, DOI 10.1074/jbc.M511496200
   Nilsson LM, 2006, APPL ENVIRON MICROB, V72, P3005, DOI 10.1128/AEM.72.4.3005-3010.2006
   O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x
   Ofek I, 2003, FEMS IMMUNOL MED MIC, V38, P181, DOI 10.1016/S0928-8244(03)00228-1
   PLATT R, 1982, NEW ENGL J MED, V307, P637, DOI 10.1056/NEJM198209093071101
   Pouttu R, 1999, MOL MICROBIOL, V31, P1747, DOI 10.1046/j.1365-2958.1999.01311.x
   Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x
   Rupp CJ, 2005, APPL ENVIRON MICROB, V71, P2175, DOI 10.1128/AEM.71.4.2175-2178.2005
   Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002
   Schembri MA, 2001, INFECT IMMUN, V69, P1322, DOI 10.1128/IAI.69.3.1322-1328.2001
   SCHEMBRI MA, 2002, STKE
   Serafini-Cessi F, 2003, AM J KIDNEY DIS, V42, P658, DOI 10.1053/S0272-6386(03)00829-1
   Sokurenko EV, 2004, MOL BIOL EVOL, V21, P1373, DOI 10.1093/molbev/msh136
   Sokurenko EV, 1997, J BIOL CHEM, V272, P17880, DOI 10.1074/jbc.272.28.17880
   Sokurenko EV, 1998, P NATL ACAD SCI USA, V95, P8922, DOI 10.1073/pnas.95.15.8922
   Steinberg D, 1999, ARCH ORAL BIOL, V44, P437, DOI 10.1016/S0003-9969(99)00014-X
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1
   Thomas W, 2006, BIOPHYS J, V90, P753, DOI 10.1529/biophysj.105.066548
   Thomas WE, 2004, MOL MICROBIOL, V53, P1545, DOI 10.1111/j.1365-2958.2004.04226.x
   Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1
   Thormann KM, 2004, J BACTERIOL, V186, P8096, DOI 10.1128/JB.186.23.8096-8104.2004
   Weissman SJ, 2006, MOL MICROBIOL, V59, P975, DOI 10.1111/j.1365-2958.2005.04985.x
   Wood TK, 2006, APPL MICROBIOL BIOT, V72, P361, DOI 10.1007/s00253-005-0263-8
   Zhu C, 2005, BIORHEOLOGY, V42, P443
NR 59
TC 40
Z9 40
U1 1
U2 18
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0021-9193
J9 J BACTERIOL
JI J. Bacteriol.
PD MAR
PY 2007
VL 189
IS 5
BP 1794
EP 1802
DI 10.1128/JB.00899-06
PG 9
WC Microbiology
SC Microbiology
GA 139WH
UT WOS:000244462800034
PM 17189376
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Xu, XH
   Zhang, CH
   Zhou, YM
   Liu, Q
   Cheng, J
   Yao, KD
   Chen, Q
AF Xu, Xinhua
   Zhang, Chunhuai
   Zhou, Yumei
   Liu, Qiang
   Cheng, Juan
   Yao, Kangde
   Chen, Qiang
TI Quartz crystal microbalance study of protein adsorption on chitosan,
   chitosan/poly(vinyl pyrrolidone) blends and chitosan graft-poly(vinyl
   pyrrolidone) surfaces
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE chitosan; protein adsorption; quartz crystal microbalance (QCM); protein
   adsorption/desorption kinetics; poly(vinyl pyrrolidone); Langmuir
   isotherm
ID BIOMATERIAL SURFACES; MEMBRANES
AB Adsorption behaviour of bovine serum albumin (BSA) onto chitosan (CS), chitosan/poly(vinyl pyrrolidone) blends (CS/PVP blends), and chitosan-graft-polyvinyl pyrrolidone) (CS-graft-PVP) surfaces were investigated using quartz crystal microbalance (QCM). The adsorbed quantities of protein on the three surfaces were examined and were found to decrease in the following order: CS > CS/PVP blends > CS-graft-PVP. The kinetics of BSA adsorption in the early stage was analysed. The Langmuir isotherm model was used to describe the BSA adsorption behaviour on CS and its derivates. The attachment, detachment rate constants, and the association constants (K-a) were of the same order of magnitude, whereas the Ka for BSA on CS-graft-PVP surface was the lowest of the three surfaces. The adsorbed protein layer structure was also estimated. For CS-graft-PVP, most of the proteins adsorbed on the surface were of side-on structure, whereas for CS only about 40% of the proteins were of side-on structure.
C1 Tianjin Univ, Sch Mat Sci & Engn, Tianjin 300072, Peoples R China.
   Nankai Univ, Inst Life Sci, Tianjin 300071, Peoples R China.
RP Xu, XH (reprint author), Tianjin Univ, Sch Mat Sci & Engn, Tianjin 300072, Peoples R China.
EM xhxu@tju.edu.cn
CR ATKINS P, 1994, SIMPLE MODELS ADSORP, P987
   Avadi MR, 2005, INT J PHARMACEUT, V293, P83, DOI 10.1016/j.ijpharm.2004.12.016
   CHIELLINI F, 2006, J BIOACT COMP POLYM, V22, P176
   Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   CHRISTOPHER RJ, 2000, J BIOMED MATER RES, V49, P435
   Denkbas EB, 2006, J BIOACT COMPAT POL, V21, P351, DOI 10.1177/0883911506066930
   Doutremepuich F, 1998, THROMB RES, V90, P57
   ERTEL SI, 1994, J BIOMED MATER RES, V28, P667, DOI 10.1002/jbm.820280603
   GUILBAULT GG, 1983, ANAL CHEM, V55, P1682, DOI 10.1021/ac00261a010
   MASARU T, 2002, COLLOID SURF A, V203, P195
   MATTHIASSON E, 1983, J MEMBRANE SCI, V16, P23, DOI 10.1016/S0376-7388(00)81297-1
   NAKAMOTO T, 2003, SENSOR ACTUAT B-CHEM, V84, P98
   NOBORU S, 1998, MAT SCI ENG C-BIO S, V6, P261
   Nud'ga LA, 2002, RUSS J APPL CHEM+, V75, P1678, DOI 10.1023/A:1022244221746
   O'Sullivan CK, 1999, BIOSENS BIOELECTRON, V14, P663, DOI 10.1016/S0956-5663(99)00040-8
   Otto M, 2004, J MATER SCI-MATER M, V15, P35, DOI 10.1023/B:JMSM.0000010095.19693.67
   SGOLDERBREY GZ, 1959, Z PHYS, V155, P206
   Stephanie VV, 2003, BIOTECHNOL BIOENG, V82, P784
   Sun SD, 2003, J MEMBRANE SCI, V222, P3, DOI 10.1016/S0376-7388(03)00313-2
   Zhang M, 2002, BIOMATERIALS, V23, P2641, DOI 10.1016/S0142-9612(01)00403-3
NR 20
TC 9
Z9 9
U1 1
U2 19
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD MAR
PY 2007
VL 22
IS 2
BP 195
EP 206
DI 10.1177/0883911507076454
PG 12
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA 146ZZ
UT WOS:000244974500005
DA 2018-10-20
ER

PT J
AU Zhao, XB
   Courtney, JM
AF Zhao, Xiaobin
   Courtney, James M.
TI Surface modification of polymeric biomaterials: Utilization of
   cyclodextrins for blood compatibility improvement
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE plasticized poly(vinyl chloride); cyclodextrins; blood compatibility;
   protein adsorption; surface modification; polymer blending
ID POLY(VINYL CHLORIDE); POLYVINYL-CHLORIDE; BETA-CYCLODEXTRIN; HEPARIN;
   ADSORPTION; MEMBRANES; SELECTION; COATINGS; BYPASS
AB A novel modified polymeric biomaterial surface using cyclodextrins (CDs) for improved blood compatibility was studied. Plasticized poly(vinyl chloride) (PVC-P) was selected for modification and polyethylene was used as a reference material. The modification was achieved by polymer blending. Fibrinogen and albumin adsorption were utilized as indices for the assessment of the blood compatibility. Surface characterization confirmed that CDs were able to accumulate at the PVC surface and alter the surface properties. The combination of other hydrophilic polymers such as poly(ethylene oxide) (PEO) and PLO /poly (propylene oxide) (PPO) copolymers, such as Pluronic F68 (F68), with CDs were also investigated. These modified materials have a remarkable protein-resistant surface. The combination of B-cycloclextrin (B-CD)/PEO and B-CD/F68 in certain feeding ratio are synergistic in producing enhanced blood compatibility. (c) 2006 Wiley Periodicals, Inc.
C1 Univ Strathclyde, Bioengn Unit, Glasgow G4 0NW, Lanark, Scotland.
RP Zhao, XB (reprint author), NovaThera Ltd, Minerva Bldg,Babraham Res Campus, Cambridge CB2 4AT, England.
EM x.zhao@novathera.com
CR Balakrishnan B, 2005, POLYM INT, V54, P1304, DOI 10.1002/pi.1847
   Bender M.L., 1978, CYCLODEXTRIN CHEM
   BRENNER WI, 1974, AM J SURG, V127, P555, DOI 10.1016/0002-9610(74)90316-X
   Brynda E, 2000, J BIOMED MATER RES, V51, P249, DOI 10.1002/(SICI)1097-4636(200008)51:2<249::AID-JBM14>3.3.CO;2-O
   Cooper A, 1996, J INCLUS PHENOM MOL, V25, P85, DOI 10.1007/BF01041542
   Courtney JM, 1999, PERFUSION-UK, V14, P263, DOI 10.1177/026765919901400405
   DING YS, 1996, MED PLASTIC BIOMATER, P1
   FERRUTI P, 1982, BIOMATERIALS, V3, P33, DOI 10.1016/0142-9612(82)90058-8
   FERRUTI P, 1996, BIOMATERIALS, V17, P2199
   GOLANDER CG, 1988, J COLLOID INTERF SCI, V121, P240, DOI 10.1016/0021-9797(88)90428-6
   Harada A, 1997, CARBOHYD POLYM, V34, P183, DOI 10.1016/S0144-8617(97)00023-4
   IGUCHI S, 1998, Patent No. 5756553
   Lakshmi S, 1998, ARTIF ORGANS, V22, P222, DOI 10.1046/j.1525-1594.1998.06124.x
   LARM O, 1983, BIOMATER ARTIF CELL, V11, P161, DOI 10.3109/10731198309118804
   Lee JH, 1999, J BIOMED MATER RES, V48, P328, DOI 10.1002/(SICI)1097-4636(1999)48:3<328::AID-JBM18>3.3.CO;2-C
   MIYAMA H, 1977, J BIOMED MATER RES, V8, P119
   MUZYKEWICZ KJ, 1975, J BIOMED MATER RES, V9, P487, DOI 10.1002/jbm.820090511
   PAUL JF, 1982, ANGEW MAKROMOL CHEM, V105, P131
   RATNER B D, 1992, Clinical Materials, V11, P25, DOI 10.1016/0267-6605(92)90027-Q
   Riesenfeld J, 1995, Med Device Technol, V6, P24
   Shieh WJ, 1996, J MACROMOL SCI PURE, VA33, P673, DOI 10.1080/10601329608010886
   Sreenivasan K, 1996, J APPL POLYM SCI, V59, P2089
   Szejtli J, 1997, J MATER CHEM, V7, P575, DOI 10.1039/a605235e
   VONSEGESSER LK, 1994, INT J ARTIF ORGANS, V17, P294
   Xie YC, 2002, J APPL POLYM SCI, V85, P1013, DOI 10.1002/app.10483
   Yianni J P, 1995, Med Device Technol, V6, P20
   Zdanowski Z, 1997, J BIOMAT SCI-POLYM E, V8, P825, DOI 10.1163/156856297X00029
   Zhang SF, 1998, BIOMATERIALS, V19, P691, DOI 10.1016/S0142-9612(97)00174-9
   Zhao XB, 1998, ARTIF CELL BLOOD SUB, V26, P341, DOI 10.3109/10731199809117676
   ZHAO XB, 1994, REACT POLYM, V24, P9, DOI 10.1016/0923-1137(94)90130-9
   Zhao XB, 2003, J MATER SCI-MATER M, V14, P905, DOI 10.1023/A:1025690828200
   Zhao XB, 2006, FOCUS ON POLYMERIC MATERIALS RESEARCH, P1
NR 32
TC 13
Z9 13
U1 1
U2 16
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR 1
PY 2007
VL 80A
IS 3
BP 539
EP 553
DI 10.1002/jbm.a.30925
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 135DM
UT WOS:000244134300004
PM 17019727
DA 2018-10-20
ER

PT J
AU Van den Beucken, JJJP
   Walboomers, XF
   Vos, MRJ
   Sommerdijk, NAJM
   Nolte, RJM
   Jansen, JA
AF Van den Beucken, J. J. J. P.
   Walboomers, X. F.
   Vos, M. R. J.
   Sommerdijk, N. A. J. M.
   Nolte, R. J. M.
   Jansen, J. A.
TI Macrophage behavior on multilayered DNA-coatings in vitro
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE macrophage; DNA; polyelectrolyte; coating
ID VEIN ENDOTHELIAL-CELLS; INITIAL ATTACHMENT; CYTOKINE EXPRESSION;
   SURFACE-CHEMISTRY; CPG MOTIFS; RESPONSES; FIBRONECTIN; BONE;
   BIOMATERIALS; FIBROBLASTS
AB A pivotal factor to consider in the development of biomaterials and biomaterial coatings is the inflammatory response to these materials. The insertion of implants is followed by protein adsorption and subsequent interactions with cellular components of the biological surroundings, in which macrophages play a dominant role through the production of a myriad of signaling molecules. In view of this, the aims of the present study were to evaluate (i) gross protein adsorption to, and (ii) in vitro behavior of macrophages on novel biomaterial coatings, composed of poly-D-lysine (PDL) or poly(allylamine hydrochloride) (PAH) and DNA, and to compare these coatings with negative (noncoated glass) and positive controls (noncoated glass + LPS-stimulation). The results demonstrate that multilayered DNA-coatings do not affect gross protein adsorption compared to noncoated controls. Cell culture experiments showed that the attachment to, and viability and morphology of two types of macrophages cultured on multilayered DNA-coatings is comparable to noncoated controls. Still, macrophages repeatedly showed decreased secretion levels of the proinflammatory cytokine TNF-alpha on multilayered DNA-coatings, whereas no differences were observed in the secretion of IL-1 beta, IL-10, and TGF-beta 1. Appropriate animal studies are required to elucidate if these in vitro indications have clinical effects on the inflammatory and wound healing processes around implants. (c) 2006 Wiley Periodicals, Inc.
C1 Radboud Univ Nijmegen Med Ctr, Dept Periodontol & Biomat, NL-6500 HB Nijmegen, Netherlands.
   Eindhoven Univ Technol, Lab Macromol & Organ Chem, NL-5600 MB Eindhoven, Netherlands.
   Radboud Univ Nijmegen, Dept Organ Chem, NL-6500 ED Nijmegen, Netherlands.
RP Jansen, JA (reprint author), Radboud Univ Nijmegen Med Ctr, Dept Periodontol & Biomat, POB 9101, NL-6500 HB Nijmegen, Netherlands.
EM j.jansen@dent.umcn.nl
RI Sommerdijk, Nico/B-7239-2013; Jansen, John/H-8055-2014; Nolte,
   Roeland/C-9930-2013; van den beucken, Jeroen/B-8790-2013; van den
   beucken, jeroen/G-9940-2013; van den beucken, jeroen/N-2910-2013;
   Walboomers, X.Frank/B-3692-2013
OI Sommerdijk, Nico/0000-0002-8956-195X; Nolte,
   Roeland/0000-0002-5612-7815; van den beucken,
   jeroen/0000-0002-0301-1966; 
CR Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Bailey LO, 2005, BIOMATERIALS, V26, P5296, DOI 10.1016/j.biomaterilas.2005.01.055
   Bernatchez SF, 1996, BIOMATERIALS, V17, P2077, DOI 10.1016/0142-9612(96)00014-2
   Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Chomyszyn-Gajewska M, 2002, BIOMATERIALS, V23, P463, DOI 10.1016/S0142-9612(01)00128-4
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   DIPIETRO LA, 1995, SHOCK, V4, P233, DOI 10.1097/00024382-199510000-00001
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Harding KG, 2002, BRIT MED J, V324, P160, DOI 10.1136/bmj.324.7330.160
   HOWLETT CR, 1994, BIOMATERIALS, V15, P213, DOI 10.1016/0142-9612(94)90070-1
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Kao WYJ, 1999, BIOMATERIALS, V20, P2213, DOI 10.1016/S0142-9612(99)00152-0
   KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0
   Krieg AM, 2000, VACCINE, V19, P618, DOI 10.1016/S0264-410X(00)00249-8
   Li YW, 2005, BIOMATERIALS, V26, P1081, DOI 10.1016/j.biomaterials.2004.04.018
   Luo LQ, 2001, BIOPHYS CHEM, V94, P11, DOI 10.1016/S0301-4622(01)00204-6
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Petit A, 2002, J ORTHOP RES, V20, P9, DOI 10.1016/S0736-0266(01)00077-8
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Prabhu A, 1998, J BIOMED MATER RES, V42, P655, DOI 10.1002/(SICI)1097-4636(19981215)42:4<655::AID-JBM23>3.3.CO;2-2
   Refai AK, 2004, J BIOMED MATER RES A, V70A, P194, DOI 10.1002/jbm.a.30075
   Saad B, 1996, J BIOMED MATER RES, V32, P355
   Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006
   STEELE JG, 1995, BIOMATERIALS, V16, P1057, DOI 10.1016/0142-9612(95)98901-P
   STEELE JG, 1994, J BIOMAT SCI-POLYM E, V6, P511, DOI 10.1163/156856294X00473
   Stryer L., 1995, BIOCHEMISTRY
   van den Beucken JJJP, 2006, J CONTROL RELEASE, V113, P63, DOI 10.1016/j.jconrel.2006.03.016
   van den Beucken JJJP, 2006, J BIOMED MATER RES A, V77A, P202, DOI 10.1002/jbm.a.30583
   van den Beucken JJJP, 2006, BIOMATERIALS, V27, P691, DOI 10.1016/j.biomaterials.2005.06.015
   VANDENBEUCKEN JJJ, IN PRESS J BIOMED B
   Webb JCJ, 2000, CURR ORTHOPAED, V14, P457, DOI 10.1054/cuor.2000.0145
   Werner MH, 1996, SCIENCE, V271, P778, DOI 10.1126/science.271.5250.778
   Wimhurst JA, 2001, J BONE JOINT SURG BR, V83B, P278, DOI 10.1302/0301-620X.83B2.10392
   YAMAMOTO S, 1992, MICROBIOL IMMUNOL, V36, P983, DOI 10.1111/j.1348-0421.1992.tb02102.x
NR 35
TC 12
Z9 13
U1 0
U2 6
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR 1
PY 2007
VL 80A
IS 3
BP 612
EP 620
DI 10.1002/jbm.a.30971
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 135DM
UT WOS:000244134300010
PM 17031824
DA 2018-10-20
ER

PT J
AU Prasad, CK
   Muraleedharan, CV
   Krishnan, LK
AF Prasad, C. Krishna
   Muraleedharan, C. V.
   Krishnan, Lissy K.
TI Bio-mimetic composite matrix that promotes endothelial cell growth for
   modification of biomaterial surface
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE vascular tissue engineering; fibrin; endothelial cells;
   dedifferentiation; hemo compatibility
ID HEART-VALVES; PROLIFERATION; IDENTIFICATION; EXPERIENCE; PROTEINS;
   POLYMERS; CULTURE; GRAFTS
AB The incidence of thrombogenesis and occlusion of cardiovascular implants is likely to be reduced by endothelial cell (EC) growth promotion on biornaterials used for device fabrication. However, proper signaling between the matrix proteins deposited on the device surface and the cells grown on it is a prime requirement for growth and function. It was demonstrated earlier that a composition of matrix proteins that include fibrin, fibronectin, gelatin, and growth factors maintain a steady proliferation potential and prolong the survival of endothelial cells in vitro. In this study, assessment of the same matrix to prevent EC from dedifferentiation during in vitro culture and to promote endothelialization of biornaterials used for fabrication of cardiovascular implants is carried out. Up/ down regulation of m-RNA expression for a prothrombotic molecule-plasminogen activator inhibitor (PAI), and two antithrombotic molecules- nitric oxide synthetase (eNOS) and tissue plasminogen activator (t-PA) are chosen as the indicators of cell dedifferentiation during cell culture and passaging. Immunostaining for vinculin and actin demonstrated that composite coating on biomaterials improves focal adhesion and cytoskeletal organization that increases the quality of EC grown on it. EC proliferation, measured by H-3-thymidine uptake, on all bare materials was poor and high incidence of cell apoptosis was noticed within 72 h in culture, whereas once coated with composite all materials showed good proliferation and survival. The results suggest that the designed composition of biomimetic adhesive proteins and growth factors is suitable for EC growth, survival, and functional integrity, thus making it suitable for cardiovascular tissue engineering that requires in vitro EC culture. (c) 2006 Wiley Periodicals, Inc.
C1 Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Thrombosis Res Unit, Trivandrum 695012, Kerala, India.
   Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Div Artificial Internal Organs, Trivandrum 695012, Kerala, India.
RP Krishnan, LK (reprint author), Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Thrombosis Res Unit, Trivandrum 695012, Kerala, India.
EM lissykk@sctimst.ac.in
RI CV, Muraleedharan/B-7060-2009
OI CV, Muraleedharan/0000-0002-8398-0379
CR Aplin AE, 2003, FEBS LETT, V534, P11, DOI 10.1016/S0014-5793(02)03840-1
   Badylak S, 1999, BIOMATERIALS, V20, P2257, DOI 10.1016/S0142-9612(99)00156-8
   Balcells M, 2002, J CELL PHYSIOL, V191, P155, DOI 10.1002/jcp.10087
   Becker BF, 2000, Z KARDIOL, V89, P160, DOI 10.1007/PL00007320
   Deutsch M, 1999, SURGERY, V126, P847, DOI 10.1067/msy.2099.99852
   Endo K, 1995, Dent Mater J, V14, P185
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   HAMMERMEISTER KE, 1993, NEW ENGL J MED, V328, P1289, DOI 10.1056/NEJM199305063281801
   ITO Y, 1992, J BIOMED MATER RES, V26, P1065, DOI 10.1002/jbm.820260808
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   Kasemo B, 1998, CURR OPIN SOLID ST M, V3, P451, DOI 10.1016/S1359-0286(98)80006-5
   Kumar TRS, 2001, BIOMATERIALS, V22, P2769
   Kuntze CEE, 1998, ANN THORAC SURG, V66, P101, DOI 10.1016/S0003-4975(98)00313-0
   Laube HR, 2000, J THORAC CARDIOV SUR, V120, P134, DOI 10.1067/mtc.2000.106327
   MACIAG T, 1979, P NATL ACAD SCI USA, V76, P5674, DOI 10.1073/pnas.76.11.5674
   Prasad C.K., 2005, BIOMATERIALS, V26, P5658, DOI DOI 10.1016/J.BIOMATERIALS.2005.02.024
   Reinhart-King CA, 2005, BIOPHYS J, V89, P676, DOI 10.1529/biophysj.104.054320
   Relou IAM, 1998, TISSUE CELL, V30, P525, DOI 10.1016/S0040-8166(98)80032-3
   SCORCIK V, 2002, J MATER SCI, V37, P1183
   SERRUYS PW, 1991, J AM COLL CARDIOL, V17, P143
   SHIVAKUMAR K, 1992, J MOL CELL CARDIOL, V24, P775, DOI 10.1016/0022-2828(92)93391-V
   Skarja GA, 1997, J BIOMED MATER RES, V34, P439, DOI 10.1002/(SICI)1097-4636(19970315)34:4<439::AID-JBM5>3.0.CO;2-L
   Vongpatanasin W, 1996, NEW ENGL J MED, V335, P407, DOI 10.1056/NEJM199608083350607
   Wang DA, 2002, BIOMACROMOLECULES, V3, P1286, DOI 10.1021/bm0255950
NR 24
TC 18
Z9 20
U1 0
U2 8
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR 1
PY 2007
VL 80A
IS 3
BP 644
EP 654
DI 10.1002/jbm.a.30968
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 135DM
UT WOS:000244134300013
PM 17051537
DA 2018-10-20
ER

PT J
AU Patel, JD
   Ebert, M
   Ward, R
   Anderson, JM
AF Patel, Jasmine D.
   Ebert, Michael
   Ward, Robert
   Anderson, James M.
TI S-epidermidis biofilm formation: Effects of biomaterial surface
   chemistry and serum proteins
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE polyurethanes; biofilm; serum proteins; surface chemistry; infection
ID LEUKOCYTE ADHESION; BACTERIAL ADHESION; INTRAVASCULAR CATHETERS;
   ANTIBIOTIC-RESISTANCE; ANTIMICROBIAL AGENTS; FIBRONECTIN; ADHERENCE;
   POLYETHYLENE; MECHANISMS; FIBRINOGEN
AB Most infections due to implanted cardiovascular biomaterials are initiated by bacterial adhesion of Stapliylococcus epidermidis, followed by colonization and biofilm formation on the surface of the implant. This study examined the role of serum proteins and material surface chemistry in the formation of S. epidermidis biofilm on polyurethanes (Elasthane 80A, hydrophobic) modified with polyethylene oxide (Elasthane 80A-6PEO, hydrophilic) and fluorocarbon (Elasthane 80A-6F, hydrophobic). Initial adhesion, aggregation, biofilm thickness, viability, and slime formation of S. epidermidis strain, RP62A in phosphate buffered saline (PBS), tryptic soy broth (TBS), and 20%) pooled human serum was quantified. In the presence of adsorbed serum proteins, initial bacterial adhesion was suppressed significantly to < 2%, relative to adhesion in TSB or PBS. However, adhesion, aggregation, and proliferation increased dramatically in the 12-24 h period on Elasthane 80A and Elasthane 80A-6F, which resulted in an extensive network of biofilm. A contrasting trend was observed on the hydrophilic Elasthane 80A-6PEO surface, with minimal bacterial adhesion, which decreased steadily over 24 h. In the presence of serum proteins, an increasingly thick (similar to 20 mu m) biofilm formed on the hydrophobic surfaces over 48 h whereas the formation of a mature biofilm on the hydrophilic surface was impeded with few viable bacteria present over 48 h. Furthermore, slime was detected during the initial phase of bacterial adhesion at 2 h and increased over time with the formation of biofilm. These results have shown that while initial S. epidermidis adhesion is suppressed in the presence of adsorbed proteins, inter-bacterial adhesion possibly aided by slime production leads to the formation of a robust mature biofilm. Also, biomaterial surface chemistry affected biofilm formation and, most notably, polyethylene oxide significantly inhibited S. epidermidis biofilm formation over 48 h in vitro. (c) 2006 Wiley Periodicals, Inc.
C1 Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   Medtronic Inc, Minneapolis, MN 55432 USA.
   Polymer Technol Grp, Berkeley, CA 94710 USA.
   Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
RP Anderson, JM (reprint author), Case Western Reserve Univ, Dept Biomed Engn, 309 Wickenden Bldg, Cleveland, OH 44106 USA.
EM jma6@case.edu
FU NHLBI NIH HHS [HL 43700]
CR Baugh L, 2004, J BIOMED MATER RES A, V69A, P525, DOI 10.1002/jbm.a.30026
   Bergkvist M, 2003, J BIOMED MATER RES A, V64A, P349, DOI 10.1002/jbm.a.10423
   Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2
   BRIDGETT MJ, 1992, BIOMATERIALS, V13, P411, DOI 10.1016/0142-9612(92)90159-L
   Chen Z, 2002, J BIOMED MATER RES, V62, P254, DOI 10.1002/jbm.10075
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Cunliffe D, 1999, APPL ENVIRON MICROB, V65, P4995
   DESAI NP, 1992, BIOMATERIALS, V13, P417, DOI 10.1016/0142-9612(92)90160-P
   Dickinson RB, 1997, J BIOMED MATER RES, V36, P152, DOI 10.1002/(SICI)1097-4636(199708)36:2<152::AID-JBM3>3.0.CO;2-J
   Dunne WM, 2002, CLIN MICROBIOL REV, V15, P155, DOI 10.1128/CMR.15.2.155-166.2002
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   GRAY ED, 1984, LANCET, V1, P365
   GRISTINA AG, 1987, BIOMATERIALS, V8, P423, DOI 10.1016/0142-9612(87)90077-9
   Gristina Anthony G., 1994, P131
   Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x
   HERRMANN M, 1988, J INFECT DIS, V158, P693, DOI 10.1093/infdis/158.4.693
   Higashi JM, 1998, J BIOMED MATER RES, V39, P341, DOI 10.1002/(SICI)1097-4636(19980305)39:3<341::AID-JBM1>3.0.CO;2-J
   Higashi JM, 1999, HDB BIOMATERIALS EVA, P493
   Hussain M, 1993, FEMS Microbiol Rev, V10, P191
   JOHNSON GM, 1986, INFECT IMMUN, V54, P13
   KHARDORI N, 1995, J IND MICROBIOL, V15, P148, DOI 10.1007/BF01569818
   Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996
   MacKintosh EE, 2006, J BIOMED MATER RES A, V78A, P836, DOI 10.1002/jbm.a.30905
   Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2
   Patel JD, 2005, J BIOMED MATER RES A, V73A, P359, DOI 10.1002/jbm.a.30302
   Patel JD, 2003, J BIOMAT SCI-POLYM E, V14, P279, DOI 10.1163/156856203763572725
   PULVERER G, 1987, ZBL BAKT-INT J MED M, V264, P1
   SAPATNEKAR S, 1995, J BIOMED MATER RES, V29, P247, DOI 10.1002/jbm.820290216
   SHETH NK, 1985, LANCET, V2, P1266
   Shive MS, 1999, J BIOMED MATER RES, V46, P511, DOI 10.1002/(SICI)1097-4636(19990915)46:4<511::AID-JBM9>3.0.CO;2-M
   Stewart PS, 2002, INT J MED MICROBIOL, V292, P107, DOI 10.1078/1438-4221-00196
   Sugarman B, 1989, Infect Dis Clin North Am, V3, P187
   TOJO M, 1988, J INFECT DIS, V157, P713, DOI 10.1093/infdis/157.4.713
   Vacheethasanee K, 2000, J BIOMED MATER RES, V50, P302, DOI 10.1002/(SICI)1097-4636(20000605)50:3<302::AID-JBM3>3.0.CO;2-1
   Vacheethasanee K, 1998, J BIOMED MATER RES, V42, P425, DOI 10.1002/(SICI)1097-4636(19981205)42:3<425::AID-JBM12>3.0.CO;2-F
   VAUDAUX P, 1993, J INFECT DIS, V167, P633, DOI 10.1093/infdis/167.3.633
   Vuong C, 2004, CELL MICROBIOL, V6, P269, DOI 10.1111/j.1462-5822.2004.00367.x
   WANG IW, 1993, J INFECT DIS, V167, P329, DOI 10.1093/infdis/167.2.329
   WANG IW, 1995, J BIOMED MATER RES, V29, P485, DOI 10.1002/jbm.820290408
NR 40
TC 70
Z9 74
U1 0
U2 17
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR 1
PY 2007
VL 80A
IS 3
BP 742
EP 751
DI 10.1002/jbm.a.31103
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 135DM
UT WOS:000244134300024
PM 17177270
DA 2018-10-20
ER

PT J
AU Gilbert, TW
   Stewart-Akers, AM
   Simmons-Byrd, A
   Badylak, SF
AF Gilbert, Thomas W.
   Stewart-Akers, Ann M.
   Simmons-Byrd, Abby
   Badylak, Stephen F.
TI Degradation and remodeling of small intestinal submucosa in canine
   Achilles tendon repair
SO JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
LA English
DT Article
ID EXTRACELLULAR-MATRIX SCAFFOLDS; ACCELERATOR MASS-SPECTROMETRY;
   MARROW-DERIVED CELLS; DOG-MODEL; AUGMENTATION; BIOMATERIAL; BIOSCAFFOLD;
   STRENGTH; COLLAGEN; RABBIT
AB Background: Extracellular matrix derived from porcine small intestinal submucosa is used for the repair of musculotendinous tissues. Preclinical evaluation and clinical use have suggested that small intestinal submucosa extracellular matrix degrades rapidly after implantation and can be replaced by host tissue that is functionally and histologically similar to the normal tissue.
   Methods: The present study analyzed the temporal degradation of a ten-layer multilaminate device of small intestinal submucosa extracellular matrix used for the repair of canine Achilles tendon and examined the corresponding histological appearance of the remodeled tissue during the course of scaffold degradation. Devices were fabricated from small intestinal submucosa extracellular matrix labeled with C-14. The amount of C-14 remaining in the remodeled graft was measured by liquid scintillation counting at three, seven, fourteen, twenty-eight, sixty, and ninety days after surgery. Blood, urine, feces, and other parenchymal tissues were also harvested to determine the fate of scaffold degradation products. Tissue specimens were prepared for routine histological analysis to examine the morphology of the remodeled graft at each time-point.
   Results: The small intestinal submucosa extracellular matrix graft degraded rapidly, with approximately 60% of the mass lost by one month after surgery, and the graft was completely resorbed by three months after surgery. The graft supported rapid cellular infiltration and host tissue ingrowth. By ninety days after surgery, the remodeled small intestinal submucosa extracellular matrix consisted of a dense collagenous tissue with organization, cellularity, and vascularity similar to that of normal tendon.
   Conclusions: Small intestinal submucosa extracellular matrix is rapidly degraded after implantation for the repair of a musculotendinous tissue in this canine Achilles tendon repair model and is replaced by the deposition and organization of host tissue that is histologically similar to that of normal tissue.
   Clinical Relevance: The present study provides insight into the degradation and remodeling of extracellular matrix derived from porcine small intestinal submucosa, a biologic scaffold that has been used clinically for musculotendinous applications.
C1 Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA.
RP Gilbert, TW (reprint author), Univ Pittsburgh, McGowan Inst Regenerat Med, 100 Technol Dr,Suite 200, Pittsburgh, PA 15219 USA.
EM badylaks@upmc.edu
OI Badylak, Stephen/0000-0003-3555-0689
FU NIBIB NIH HHS [EB000506]
CR Abraham GA, 2000, J BIOMED MATER RES, V51, P442, DOI 10.1002/1097-4636(20000905)51:3<442::AID-JBM19>3.3.CO;2-W
   Badylak S, 2003, HEART SURG FORUM, V6, pE20
   Badylak S, 2001, J SURG RES, V99, P282, DOI 10.1006/jsre.2001.6176
   BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   Badylak SF, 1998, TISSUE ENG, V4, P379, DOI 10.1089/ten.1998.4.379
   Badylak SF, 2001, EXP HEMATOL, V29, P1310, DOI 10.1016/S0301-472X(01)00729-9
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   Buchholz BA, 1999, ANAL BIOCHEM, V269, P348, DOI 10.1006/abio.1999.4041
   Cheng EY, 2000, WORLD J UROL, V18, P26, DOI 10.1007/PL00007071
   Colvert JR, 2002, J UROLOGY, V168, P1872, DOI 10.1097/01.ju.0000027285.05828.e6
   DJARDIN LM, 2001, AM J SPORTS MED, V29, P75
   Freytes DO, 2004, BIOMATERIALS, V25, P2353, DOI 10.1016/j.biomaterials.2003.09.015
   Giddings VL, 2000, MED SCI SPORT EXER, V32, P627, DOI 10.1097/00005768-200003000-00012
   Hodde JP, 1997, TISSUE ENG, V3, P27, DOI 10.1089/ten.1997.3.27
   Holtom PD, 2004, CLIN ORTHOP RELAT R, P18, DOI 10.1097/01.blo.0000143573.03645.b4
   KER RF, 1988, J ZOOL, V216, P309, DOI 10.1111/j.1469-7998.1988.tb02432.x
   KOMI PV, 1992, CLIN SPORT MED, V11, P521
   Kropp BP, 1998, UROLOGY, V52, P138, DOI 10.1016/S0090-4295(98)00114-9
   Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2
   Lappin G, 2004, ANAL BIOANAL CHEM, V378, P356, DOI 10.1007/s00216-003-2348-5
   Ledet Eric H, 2002, Spine J, V2, P188, DOI 10.1016/S1529-9430(02)00182-1
   Lee MS, 2004, ORTHOPEDICS, V27, pS151
   Li F, 2004, ENDOTHELIUM-J ENDOTH, V11, P199, DOI 10.1080/10623320490512390
   McCready RA, 2005, J VASC SURG, V41, P782, DOI 10.1016/j.jvs.2005.02.035
   Metcalf M. H., 2002, OPER TECH ORTHOP, V12, P204, DOI DOI 10.1053/OTOR.2002.36298
   Mostow EN, 2005, J VASC SURG, V41, P837, DOI 10.1016/j.jvs.2005.01.042
   Musahl V, 2004, J ORTHOP RES, V22, P214, DOI 10.1016/S0736-0266(03)00163-3
   Niezgoda Jeffrey A, 2005, Adv Skin Wound Care, V18, P258, DOI 10.1097/00129334-200506000-00012
   Record RD, 2001, BIOMATERIALS, V22, P2653, DOI 10.1016/S0142-9612(01)00007-2
   Sacks MS, 1999, J BIOMED MATER RES, V46, P1, DOI 10.1002/(SICI)1097-4636(199907)46:1<1::AID-JBM1>3.0.CO;2-7
   Sarikaya A, 2002, TISSUE ENG, V8, P63, DOI 10.1089/107632702753503063
   Sclamberg SG, 2004, J SHOULDER ELB SURG, V13, P538, DOI 10.1016/j.jse.2004.03.005
   VANWACHEM PB, 1994, INT J ARTIF ORGANS, V17, P230
   Wren TAL, 2001, CLIN BIOMECH, V16, P245, DOI 10.1016/S0268-0033(00)00089-9
   Zantop T, 2006, J ORTHOP RES, V24, P1299, DOI 10.1002/jor.20071
NR 35
TC 154
Z9 159
U1 1
U2 15
PU JOURNAL BONE JOINT SURGERY
PI NEEDHAM
PA 20 PICKERING ST, NEEDHAM, MA 02492 USA
SN 0021-9355
EI 1535-1386
J9 J BONE JOINT SURG AM
JI J. Bone Joint Surg.-Am. Vol.
PD MAR
PY 2007
VL 89A
IS 3
BP 621
EP 630
DI 10.2106/JBJS.F.00742
PG 10
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 143OG
UT WOS:000244731400020
PM 17332112
OA Bronze
DA 2018-10-20
ER

PT J
AU Bleiziffer, O
   Eriksson, E
   Yao, F
   Horch, RE
   Kneser, U
AF Bleiziffer, Oliver
   Eriksson, Elof
   Yao, Feng
   Horch, Raymund E.
   Kneser, Ulrich
TI Gene transfer strategies in tissue engineering
SO JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
LA English
DT Review
DE gene therapy; tissue engineering; scaffold; gene-activated matrix;
   regeneration growth factor
ID NERVE GROWTH-FACTOR; IN-VIVO; STEM-CELLS; MEDIATED TRANSFECTION;
   PARTICLE BOMBARDMENT; HUMAN KERATINOCYTES; LIVER-REGENERATION;
   PERIPHERAL-NERVES; ARTIFICIAL SKIN; VIRUS VECTORS
AB Aiming for regeneration of severed or lost parts of the body, the combined application of gene therapy and tissue engineering has received much attention by regenerative medicine. Techniques of molecular biology can enhance the regenerative potential of a biomaterial by co-delivery of therapeutic genes, and several different strategies have been used to achieve that goal. Possibilities for application are many-fold and have been investigated to regenerate tissues such as skin, cartilage, bone, nerve, liver, pancreas and blood vessels. This review discusses advantages and problems encountered with the different gene delivery strategies as far as they relate to tissue engineering, analyses the positive aspects of polymeric gene delivery from matrices and discusses advances and future challenges of gene transfer strategies in selected tissues.
C1 Univ Erlangen Nurnberg, Med Ctr, Dept Plast & Hand Surg, D-91054 Erlangen, Germany.
   Harvard Univ, Sch Med, Div Plast Surg, Brigham & Womens Hosp, Boston, MA 02115 USA.
RP Kneser, U (reprint author), Univ Erlangen Nurnberg, Med Ctr, Dept Plast & Hand Surg, Krankenhausstr,12, D-91054 Erlangen, Germany.
EM Ulrich.Kneser@chir.imed.uni-erlangen.de
OI Horch, Raymund E./0000-0002-6561-2353
CR Anderson WF, 1998, NATURE, V392, P25
   ANDREE C, 1994, P NATL ACAD SCI USA, V91, P12188, DOI 10.1073/pnas.91.25.12188
   Andree C, 2001, TISSUE ENG, V7, P757, DOI 10.1089/107632701753337708
   BELL E, 1981, SCIENCE, V211, P1052, DOI 10.1126/science.7008197
   Berry M, 2001, MOL CELL NEUROSCI, V17, P706, DOI 10.1006/mcne.2001.0975
   Bonadio J, 2000, J MOL MED-JMM, V78, P303, DOI 10.1007/s001090000118
   Bonadio J, 1999, NAT MED, V5, P753, DOI 10.1038/10473
   Breitbart AS, 2003, ANN PLAS SURG, V51, P409, DOI 10.1097/01.SAP.0000084461.83554.71
   BURKE JF, 1981, ANN SURG, V194, P413, DOI 10.1097/00000658-198110000-00005
   Byers BA, 2004, TISSUE ENG, V10, P1757, DOI 10.1089/ten.2004.10.1757
   Chandler LA, 2000, MOL THER, V2, P153, DOI 10.1006/mthe.2000.0102
   CHENG L, 1993, P NATL ACAD SCI USA, V90, P4455, DOI 10.1073/pnas.90.10.4455
   Coffin RS, 1996, GENE THER, V3, P560
   CRYSTAL RG, 1995, SCIENCE, V270, P404, DOI 10.1126/science.270.5235.404
   Edwards PC, 2005, GENE THER, V12, P75, DOI 10.1038/sj.gt.3302386
   Eming SA, 1996, J INVEST DERMATOL, V107, P113, DOI 10.1111/1523-1747.ep12298351
   Erdag G, 2004, MOL THER, V10, P76, DOI 10.1016/j.ymthe.2004.04.013
   Eriksson E, 1998, J SURG RES, V78, P85, DOI 10.1006/jsre.1998.5325
   Fansa H, 2001, PLAST RECONSTR SURG, V107, P485, DOI 10.1097/00006534-200102000-00026
   FELGNER PL, 1989, NATURE, V337, P387, DOI 10.1038/337387a0
   Fiegel HC, 2006, J CELL MOL MED, V10, P577, DOI 10.2755/jcmm010.003.09
   Fields RC, 2003, TISSUE ENG, V9, P1281, DOI 10.1089/10763270360728198
   Glorioso J C, 1997, Adv Pharmacol, V40, P103, DOI 10.1016/S1054-3589(08)60139-8
   Goins WF, 2001, J UROLOGY, V165, P1748, DOI 10.1016/S0022-5347(05)66407-5
   Grande DA, 2003, J BONE JOINT SURG AM, V85A, P111, DOI 10.2106/00004623-200300002-00015
   GREEN H, 1991, Scientific American, V265, P96
   Haecker SE, 1996, HUM GENE THER, V7, P1907, DOI 10.1089/hum.1996.7.15-1907
   Heine W, 2004, EXP NEUROL, V189, P231, DOI 10.1016/j.expneurol.2004.06.014
   Horch RE, 2005, J CELL MOL MED, V9, P592, DOI 10.1111/j.1582-4934.2005.tb00491.x
   HUARD J, 1995, GENE THER, V2, P385
   Jang JH, 2004, EXPERT REV MED DEVIC, V1, P127, DOI 10.1586/17434440.1.1.127
   Jeschke M. G., 2001, Current Gene Therapy, V1, P267, DOI 10.2174/1566523013348571
   Jeschke MG, 1999, GENE THER, V6, P1015, DOI 10.1038/sj.gt.3300923
   Kneser U, 2006, J CELL MOL MED, V10, P7, DOI 10.1111/j.1582-4934.2006.tb00287.x
   Knight KR, 2006, FASEB J, V20, P565, DOI 10.1096/fj.05-4879fje
   KOTIN RM, 1992, EMBO J, V11, P5071, DOI 10.1002/j.1460-2075.1992.tb05614.x
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Laschke MW, 2006, TISSUE ENG, V12, P2093, DOI 10.1089/ten.2006.12.2093
   Lee RJ, 2000, CIRCULATION, V102, P898
   Lehrman S, 1999, NATURE, V401, P517, DOI 10.1038/43977
   McConnell MP, 2004, TISSUE ENG, V10, P1492, DOI 10.1089/1076327042500463
   Meinel L, 2006, BIOMATERIALS, V27, P4993, DOI 10.1016/j.biomaterials.2006.05.021
   Mian RW, 2000, TISSUE ENG, V6, P595, DOI 10.1089/10763270050199541
   MITANI K, 1995, P NATL ACAD SCI USA, V92, P3854, DOI 10.1073/pnas.92.9.3854
   Murakami T, 2003, BRAIN RES, V974, P17, DOI 10.1016/S0006-8993(03)02539-3
   Narushima M, 2005, NAT BIOTECHNOL, V23, P1274, DOI 10.1038/nbt1145
   Neumann E, 1999, BIOELECTROCH BIOENER, V48, P3, DOI 10.1016/S0302-4598(99)00008-2
   Oligino T, 1999, GENE THER, V6, P1713, DOI 10.1038/sj.gt.3301014
   Pannier AK, 2004, MOL THER, V10, P19, DOI 10.1016/j.ymthe.2004.03.020
   Pascher A, 2004, GENE THER, V11, P133, DOI 10.1038/sj.gt.3302155
   Patrick CW, 2001, ANN PLAS SURG, V47, P660, DOI 10.1097/00000637-200112000-00014
   Ricordi Camillo, 2004, Nat Rev Immunol, V4, P259, DOI 10.1038/nri1332
   Rizzuto G, 1999, P NATL ACAD SCI USA, V96, P6417, DOI 10.1073/pnas.96.11.6417
   ROCK DL, 1983, NATURE, V302, P523, DOI 10.1038/302523a0
   Roizman B, 1996, P NATL ACAD SCI USA, V93, P11307, DOI 10.1073/pnas.93.21.11307
   Saeki Y, 1997, HUM GENE THER, V8, P2133, DOI 10.1089/hum.1997.8.17-2133
   SELDEN C, 1990, FEBS LETT, V270, P81, DOI 10.1016/0014-5793(90)81239-K
   Shea LD, 1999, NAT BIOTECHNOL, V17, P551
   Siemens DR, 2000, J NATL CANCER I, V92, P403, DOI 10.1093/jnci/92.5.403
   Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006
   STEED DL, 1995, J VASC SURG, V21, P71, DOI 10.1016/S0741-5214(95)70245-8
   Svensjo T, 2002, TRANSPLANTATION, V73, P1033, DOI 10.1097/00007890-200204150-00004
   TAKESHITA S, 1994, J CLIN INVEST, V93, P662, DOI 10.1172/JCI117018
   Tanaka Y, 2000, BRIT J PLAST SURG, V53, P51, DOI 10.1054/bjps.1999.3186
   Tepper OM, 2002, PLAST RECONSTR SURG, V109, P716, DOI 10.1097/00006534-200202000-00047
   Trippel S B, 1997, Instr Course Lect, V46, P473
   Vacanti CA, 2006, J CELL MOL MED, V10, P569, DOI 10.2755/jcmm010.003.20
   WILSON JM, 1989, SCIENCE, V244, P1344, DOI 10.1126/science.2734614
   Wolfe D, 2001, MOL THER, V3, P61, DOI 10.1006/mthe.2000.0225
   WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918
   Xie YB, 2001, TISSUE ENG, V7, P585, DOI 10.1089/107632701753213200
   YANG NS, 1990, P NATL ACAD SCI USA, V87, P9568, DOI 10.1073/pnas.87.24.9568
   Yao F, 2006, MOL THER, V13, P1133, DOI 10.1016/j.ymthe.2006.01.009
   Yao F, 1999, HUM GENE THER, V10, P1811, DOI 10.1089/10430349950017491
   Yao F, 1998, HUM GENE THER, V9, P1939, DOI 10.1089/hum.1998.9.13-1939
NR 76
TC 75
Z9 77
U1 2
U2 20
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 1582-1838
J9 J CELL MOL MED
JI J. Cell. Mol. Med.
PD MAR-APR
PY 2007
VL 11
IS 2
BP 206
EP 223
DI 10.1111/j.1582-4934.2007.00027.x
PG 18
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA 166WX
UT WOS:000246412600002
PM 17488473
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Watanabe, W
   Thomas, M
   Clarke, R
   Klibanov, AM
   Langer, R
   Katstra, J
   Fuller, GG
   Griel, LC
   Fiegel, J
   Edwards, D
AF Watanabe, Wiwik
   Thomas, Matthew
   Clarke, Robert
   Klibanov, Alexander M.
   Langer, Robert
   Katstra, Jeffrey
   Fuller, Gerald G.
   Griel, Lester C.
   Fiegel, Jennifer
   Edwards, David
TI Why inhaling salt water changes what we exhale
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE bioaerosol; airway lining fluid; surface interface; cation; mucin;
   gelation; airborne infectious disease
ID RHEOLOGICAL PROPERTIES; KAPPA-CARRAGEENAN; SIMULATED COUGH; TRACHEAL
   MUCUS; CLEARANCE; GEL; TRANSITIONS
AB We find that inhaling salt water diminishes subsequently exhaled biomaterial in man and animals due to reversible stabilization of the airway lining fluid (ALF)/air interface as a novel potential means for control of the spread of airborne infectious disease. The mechanism of this phenomenon relates to charge shielding of mucin or mucin-like macromolecules that consequently undergo gelation; this gelation alters the physical properties of the ALF surface and reduces its breakup. Cations in the nebulized solution and apparent surface viscoelasticity of the ALF (more than any other ALF intrinsic physical property) appear to be responsible for the reduced tendency of the ALF to disintegrate into very small droplets. We confirm these effects in vivo and show their reversibility through nebulization of saline solutions to anesthetized bull calves. (c) 2006 Elsevier Inc. All rights reserved.
C1 Pulmatrix Inc, Cambridge, MA 02139 USA.
   MIT, Dept Chem, Cambridge, MA 02139 USA.
   MIT, Div Biol Engn, Cambridge, MA 02139 USA.
   MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
   Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.
   Penn State Univ, Dept Vet Sci, University Pk, PA 16802 USA.
   Harvard Univ, Cambridge, MA 02138 USA.
RP Edwards, D (reprint author), Pulmatrix Inc, 12 Emily St, Cambridge, MA 02139 USA.
EM dedwards@deas.harvard.edu
CR Brooks CF, 1999, LANGMUIR, V15, P2450, DOI 10.1021/la980465r
   Chen Y, 2001, AM J RESP CELL MOL, V25, P542, DOI 10.1165/ajrcmb.25.5.4298
   Clark REA, 2005, AM J INFECT CON, V33, pe85
   CROWTHER RS, 1984, J PHARM PHARMACOL, V36, P21, DOI 10.1111/j.2042-7158.1984.tb02980.x
   CROWTHER RS, 1984, BIORHEOLOGY, V21, P253
   Edwards D. A, 1991, SERIES CHEM ENG
   Edwards DA, 2004, P NATL ACAD SCI USA, V101, P17383, DOI 10.1073/pnas.0408159101
   FAIRCHILD CI, 1987, AM IND HYG ASSOC J, V48, P948, DOI 10.1080/15298668791385868
   Kara S, 2003, INT J BIOL MACROMOL, V31, P177, DOI 10.1016/S0141-8130(02)00080-6
   KING M, 1987, BIORHEOLOGY, V24, P589
   KING M, 1985, J APPL PHYSIOL, V58, P1776
   KING M, 1980, FED PROC, V39, P3080
   KING M, 1989, BIORHEOLOGY, V26, P737
   MARRIOTT C, 1978, J PHARM PHARMACOL, V30, pP9, DOI 10.1111/j.2042-7158.1978.tb10716.x
   MARRIOTT C, 1979, BIORHEOLOGY, V16, P331
   Papineni R S, 1997, J Aerosol Med, V10, P105, DOI 10.1089/jam.1997.10.105
   PELLEGRINI M, 2005, RESP MED, P748
   Pelletier E, 2001, BIOMACROMOLECULES, V2, P946, DOI 10.1021/bm010060c
   Sikora M, 2003, INT J FOOD PROP, V6, P215, DOI 10.1081/JFP-120017817
   THOMPSON C, 2005, ARIZONA REPUBLIC
NR 20
TC 7
Z9 7
U1 0
U2 8
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD MAR 1
PY 2007
VL 307
IS 1
BP 71
EP 78
DI 10.1016/j.jcis.2006.11.017
PG 8
WC Chemistry, Physical
SC Chemistry
GA 127FJ
UT WOS:000243570400011
PM 17161415
DA 2018-10-20
ER

PT J
AU da Silva, RV
   Bertran, CA
   Kawachi, EY
   Camilli, JA
AF da Silva, Rosane Vieira
   Bertran, Celso Aparecido
   Kawachi, Elizabete Yoshie
   Camilli, Jose Angelo
TI Repair of cranial bone defects with calcium phosphate ceramic implant or
   autogenous bone graft
SO JOURNAL OF CRANIOFACIAL SURGERY
LA English
DT Article
DE biomaterial; bone regeneration; ceramics; graft
ID LONG-TERM; ORTHOGNATHIC SURGERY; HYDROXYAPATITE; SYSTEM
AB Autogenous bone grafts have frequently been used in the treatment of bone defects; however, this procedure can cause clinical complications after surgery. Besides, the amount of available bone is sometimes insufficient. Therefore, synthetic biomaterials have been researched as an alternative to autogenous bone graft, implants. The objective of this study was to evaluate the repair of bone defects treated with compact autogenous bone graft or porous calcium phosphate ceramics. Three defects 3 mm in diameter were produced in the skull of 21 rats. One the defects was produced in the frontal bone, which remained empty, while the others were produced in the right and left parietal bones, which were filled respectively with ceramics and autogenous bone graft. The animals were sacrificed 1, 2, 4, and 24 weeks after surgery and analyzed by light microscopy and radiography. In the twenty-fourth week, the defects filled with autogenous bone graft and ceramics had similar volumes of newly formed bone tissue. The ceramics offered favorable conditions to bone tissue growth. Thus, we concluded that the calcium phosphate ceramic implant proved to be effective in repairing defects produced in the skull of rats.
C1 Univ Estadual Campinas, Inst Biol, Dept Anat, UNICAMP, BR-13081 Campinas, Brazil.
   Technol Inst Aeronaut, Dept Chem, Sao Jose Dos Campos, Sao Paulo, Brazil.
   Univ Estadual Campinas, Inst Chem, Campinas, Brazil.
RP Camilli, JA (reprint author), Univ Estadual Campinas, Inst Biol, Dept Anat, UNICAMP, Cidade Univ Zeferino Vaz,Caixa Postal 6109, BR-13081 Campinas, Brazil.
EM jcamilli@unicamp.br
RI Kawachi, Elizabete Yoshie/D-1240-2012; Bertran, Celso
   Aparecido/C-1174-2013
OI Kawachi, Elizabete Yoshie/0000-0002-6477-0886; 
CR Andrade JCT, 2002, J BIOMED MATER RES, V62, P30, DOI 10.1002/jbm.10242
   BREITBART AS, 1995, PLAST RECONSTR SURG, V96, P699, DOI 10.1097/00006534-199509000-00024
   CITARDI MJ, 1994, OTOLARYNG CLIN N AM, V27, P891
   Cottrell DA, 1998, J ORAL MAXIL SURG, V56, P935, DOI 10.1016/S0278-2391(98)90654-1
   FORREST C, 1992, BRIT J PLAST SURG, V45, P89, DOI 10.1016/0007-1226(92)90163-R
   Fortunato G, 1997, J CRANIO MAXILL SURG, V25, P124, DOI 10.1016/S1010-5182(97)80003-0
   FREEMAN E, 1973, J PERIODONTAL RES, V8, P229, DOI 10.1111/j.1600-0765.1973.tb00762.x
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hill NM, 1999, AUST NZ J SURG, V69, P726, DOI 10.1046/j.1440-1622.1999.01674.x
   Lacerda CAM, 1999, BRAZ J MORPHOL SCI, V16, P131
   Lekholm U, 1999, INT J ORAL MAX SURG, V28, P181, DOI 10.1016/S0901-5027(99)80134-9
   MULLIKEN JB, 1980, PLAST RECONSTR SURG, V65, P553, DOI 10.1097/00006534-198005000-00001
   Ohbayashi Y, 2000, BIOMATERIALS, V21, P501, DOI 10.1016/S0142-9612(99)00208-2
   Ono I, 2000, BIOMATERIALS, V21, P143, DOI 10.1016/S0142-9612(99)00141-6
   PERRY CR, 1999, CLIN ORTHOP RELAT R, V360, pN71
   ROSEN HM, 1991, ANGLE ORTHOD, V61, P185
   Triplett RG, 1996, J ORAL MAXIL SURG, V54, P486, DOI 10.1016/S0278-2391(96)90126-3
   van den Broecke DG, 1998, PLAST RECONSTR SURG, V102, P1163, DOI 10.1097/00006534-199809040-00038
   Yamashita Y, 1998, INT ORTHOP, V22, P247, DOI 10.1007/s002640050252
NR 19
TC 20
Z9 20
U1 1
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1049-2275
J9 J CRANIOFAC SURG
JI J. Craniofac. Surg.
PD MAR
PY 2007
VL 18
IS 2
BP 281
EP 286
DI 10.1097/scs.0b013e31802d8ac4
PG 6
WC Surgery
SC Surgery
GA 153IA
UT WOS:000245424400010
PM 17414276
DA 2018-10-20
ER

PT J
AU Oswal, D
   Korossis, S
   Mirsadraee, S
   Wilcox, H
   Watterson, K
   Fisher, J
   Ingham, E
AF Oswal, Dilip
   Korossis, Sotirios
   Mirsadraee, Saeed
   Wilcox, Hilox
   Watterson, Kevin
   Fisher, John
   Ingham, Eileen
TI Biomechanical characterization of decellularized and cross-linked bovine
   pericardium
SO JOURNAL OF HEART VALVE DISEASE
LA English
DT Article; Proceedings Paper
CT Annual Meeting of the Tissue-and-Cell-Engineering-Society
CY JUL, 2006
CL Sheffield, ENGLAND
SP Tissue & Cell Engn Soc
ID AORTIC-VALVE-REPLACEMENT; AUTOLOGOUS PERICARDIUM; PERACETIC-ACID;
   CARDIAC-VALVE; HEART-VALVES; MATRIX; EXPERIENCE; RECELLULARIZATION;
   PROSTHESIS; REPAIR
AB Background and aim of the study: Although bovine pericardium has been used extensively in cardiothoracic surgery, its degeneration and calcification are important limiting factors in the continued use of this material. The study aims were to decellularize bovine pericardium and to compare the biomechanical properties of fresh and decellularized bovine pericardia to those treated with different concentrations of glutaraldehyde (GA).
   Methods: An established protocol for decellularization using sodium dodecyl sulfate was used, and histological analysis performed to validate the adequacy of decellularization. Contact cytotoxicity was used to study the in-vitro biocompatibility of variously treated pericardia. Mechanical testing involved uniaxial testing to failure. Mechanical properties of the fresh and decellularized pericardia (untreated and treated with 0.5% and 0.05% GA) were compared.
   Results: Histological analysis of decellularized bovine pericardium did not show any remaining cells or cell fragments. The histoarchitecture of the collagen-elastin matrix appeared well preserved. Untreated decellularized pericardium was biocompatible in contact cytotoxicity tests with smooth muscle and fibroblast cells. The GA-treated tissue was cytotoxic. There were no significant differences in the mechanical properties of fresh and decellularized pericardia, but there was an overall tendency for GA-treated pericardia to be stiffer than their untreated counterparts.
   Conclusion: An acellular matrix, cross-linked with a reduced concentration of GA, can be produced using bovine pericardium. This biomaterial has excellent biomechanical properties and, potentially, may be used in the manufacture of heart valves and pericardial patches for clinical application.
C1 Univ Leeds, Gen Infirm, Radiol Acad, Leeds LS1 3EX, W Yorkshire, England.
   Univ Leeds, Inst Med & Biol Engn, Leeds LS1 3EX, W Yorkshire, England.
RP Oswal, D (reprint author), Univ Leeds, Gen Infirm, Radiol Acad, Leeds LS1 3EX, W Yorkshire, England.
EM diliposwal@hotmail.com
RI Korossis, Sotirios/S-4427-2016
OI Korossis, Sotirios/0000-0002-9893-6338
FU Engineering and Physical Sciences Research Council [EP/D073618/1]
CR Bancroft J, 1996, THEORY PRACTICE HIST
   BENDER HW, 1989, ANN THORAC SURG, V47, P218, DOI 10.1016/0003-4975(89)90272-5
   Booth C, 2002, J HEART VALVE DIS, V11, P457
   Caroli E, 2004, SURG NEUROL, V61, P55, DOI 10.1016/S0090-3019(03)00524-X
   Chang Y, 2004, TISSUE ENG, V10, P881, DOI 10.1089/1076327041348509
   COURTMAN DW, 1994, J BIOMED MATER RES, V28, P655, DOI 10.1002/jbm.820280602
   Dahm M, 1998, J HEART VALVE DIS, V7, P30
   DESAI N, 2003, CARDIAC SURG ADULT, P834
   DURAN CMG, 1995, J THORAC CARDIOV SUR, V110, P511, DOI 10.1016/S0022-5223(95)70248-2
   Gross C, 1999, EUR J CARDIO-THORAC, V16, P533, DOI 10.1016/S1010-7940(99)00309-7
   Hodde J, 2002, BIOTECHNOL BIOENG, V79, P211, DOI 10.1002/bit.10281
   Huang QH, 2004, WOUND REPAIR REGEN, V12, P276, DOI 10.1111/j.1067-1927.2004.012312.x
   IONESCU MI, 1982, ANN THORAC SURG, V34, P265, DOI 10.1016/S0003-4975(10)62496-4
   KOROSSIS S, 2002, THESIS U LEEDS LEEDS, P114
   Lomas RJ, 2003, BURNS, V29, P515, DOI 10.1016/S0305-4179(03)00137-2
   MARTUCCI RC, 2000, BRAZ J UROL, V26, P208
   OKITA Y, 1995, J THORAC CARDIOV SUR, V110, P180, DOI 10.1016/S0022-5223(05)80024-8
   Oswal D, 1997, EUR J CARDIO-THORAC, V11, P1183, DOI 10.1016/S1010-7940(97)01158-5
   Oswal D, 2005, THESIS U LEEDS UK, P9
   Rieder E, 2004, J THORAC CARDIOV SUR, V127, P399, DOI 10.1016/j.jtcvs.2003.06.017
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Schoen FJ, 1999, J BIOMED MATER RES, V47, P439, DOI 10.1002/(SICI)1097-4636(19991215)47:4<439::AID-JBM1>3.0.CO;2-O
   SIMMONS DM, 1993, BIOTECHNOL APPL BIOC, V17, P23
   SOKOL R, 1981, BIOMETRY, P208
   Tuli B., 1998, INDIAN J OTOL, V4, P91
   Vincentelli A, 1998, J HEART VALVE DIS, V7, P24
   Wilcox HE, 2005, J HEART VALVE DIS, V14, P228
   Yankah CA, 2005, J HEART VALVE DIS, V14, P172
NR 28
TC 31
Z9 36
U1 3
U2 16
PU I C R PUBLISHERS
PI NORTHWOOD
PA CRISPIN HOUSE, 12/A SOUTH APPROACH, MOOR PARK, NORTHWOOD HA6 2ET,
   ENGLAND
SN 0966-8519
J9 J HEART VALVE DIS
JI J. Heart Valve Dis.
PD MAR
PY 2007
VL 16
IS 2
BP 165
EP 174
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 155HX
UT WOS:000245569600014
PM 17484467
DA 2018-10-20
ER

PT J
AU Wang, N
   Su, HL
   Dong, Q
   Zhang, D
   Lai, YJ
AF Wang Na
   Su Hui-Lan
   Dong Qun
   Zhang Di
   Lai Yi-Jian
TI Bio-induced fabrication of PbSe nano-semiconductors at room temperature
SO JOURNAL OF INORGANIC MATERIALS
LA English
DT Article
DE lead selenide; nanoclusters; eggshell membrane; single crystal
ID ROUTE; NANOPARTICLES; NANOCLUSTERS; NANOCRYSTALS
AB Lead selenide nanoclusters and nanocubes were successfully in situ prepared through a room-temperature biosubstrate-induced approach employing the Pb(Ac)(2) solution, Na2SeSO3 solution as the reactants, and the eggshell membrane (ESM), which contains many unique and periodically distributed functional groups, as the live biomaterial. Results show that under the complexation and electronic roles of these macromolecules with inorganic precursor ions, PbSe nanocrystallites firstly process oriented-formation, controlled-congregation and periodic-distribution on the mantle of ESM fibers, then they are self-assembled into the uniform nanoclusters with well crystalline, which are orderly distributed on the surface of ESM. The results of UV-Vis and PL analysis also indicate PbSe nanoparticles prepared are with fine, uniform size and nice distribution.
C1 Shanghai Jiao Tong Univ, State Key Lab Met Matrix Composites, Shanghai 200030, Peoples R China.
   Shanghai Jiao Tong Univ, Instrumental Anal Ctr, Shanghai 200030, Peoples R China.
RP Wang, N (reprint author), Shanghai Jiao Tong Univ, State Key Lab Met Matrix Composites, Shanghai 200030, Peoples R China.
EM amilyyu@sjtu.edu.cn; hlsu@sjtu.edu.cn
CR Chen M, 2001, J MATER CHEM, V11, P518, DOI 10.1039/b005891m
   Dong Q, 2005, J PHYS CHEM B, V109, P17429, DOI 10.1021/jp052826z
   Dong Q, 2006, NANOTECHNOLOGY, V17, P3968, DOI 10.1088/0957-4484/17/15/060
   Guha S, 1998, SOLID STATE COMMUN, V105, P695, DOI 10.1016/S0038-1098(97)10217-4
   Huang JG, 2003, J AM CHEM SOC, V125, P11834, DOI 10.1021/ja037419k
   Liu YF, 2003, EUR J INORG CHEM, P644
   Liu ZT, 2005, MICROPOR MESOPOR MAT, V85, P82, DOI 10.1016/j.micromeso.2005.06.021
   Lu WG, 2004, J AM CHEM SOC, V126, P11798, DOI 10.1021/ja0469131
   Mo MS, 2002, J CRYST GROWTH, V244, P364, DOI 10.1016/S0022-0248(02)01683-4
   Su HL, 2006, J MEMBRANE SCI, V283, P7, DOI 10.1016/j.memsci.2006.07.010
   Zhang W, 2006, NANOTECHNOLOGY, V17, P840, DOI 10.1088/0957-4484/17/3/038
   Zhu JJ, 2000, J PHYS CHEM B, V104, P7344, DOI 10.1021/jp001488t
   Zhu JJ, 2002, LANGMUIR, V18, P3306, DOI 10.1021/la010988q
NR 13
TC 3
Z9 4
U1 0
U2 4
PU SCIENCE CHINA PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1000-324X
J9 J INORG MATER
JI J. Inorg. Mater.
PD MAR
PY 2007
VL 22
IS 2
BP 209
EP 212
PG 4
WC Materials Science, Ceramics
SC Materials Science
GA 152FZ
UT WOS:000245348000004
DA 2018-10-20
ER

PT J
AU Takagi, Y
   Ura, K
AF Takagi, Yasuaki
   Ura, Kazuhiro
TI Teleost fish scales: A unique biological model for the fabrication of
   materials for corneal stroma regeneration
SO JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
LA English
DT Article; Proceedings Paper
CT International Symposium on Soft-Nanotechnology
CY 2005
CL Hokkaido Univ, Sapporo, JAPAN
HO Hokkaido Univ
DE fish scale collagen; corneal stroma regeneration; collagen-fibril
   orientation; bioinspired technology; biomaterial
ID COLLAGEN
AB The corneal stroma is composed of multiple lamellae, each containing closely packed collagen fibrils. The orientation of fibrils in a lamella is parallel, but those in different lamellae are orthogonal. As a result, the corneal stroma has a characteristic orthogonal plywood-like structure. Such a highly-regulated three-dimensional arrangement of collagen fibrils gives strength and transparency to the corneal stroma, but it also presents a challenge in the fabrication of materials to replace it. A bioinspired technology is required to process such materials, but the regulatory mechanism of collagen-fibril orientation is still unknown. The low regenerating activity of the corneal stroma seems to be a major factor preventing progress in this field of research. A similarly highly-ordered arrangement of collagen fibrils can be seen in the basal plates of teleost fish scales. Moreover, the scales have high regenerating ability. When a scale is mechanically lost, a new scale is rapidly regenerated. The cells that produce the basal plates are extremely activated; thus, production of the highly-ordered collagen fibrils is very rapid. Therefore, the regenerating scales should be a uniquely helpful biological model for studying the regulatory mechanism of collagen-fibril orientation. Fish-scale collagen has another advantage for use as a biomaterial: the low probability of zoonotic infection. Therefore, scale collagen is a most promising biomaterial for fabricating three-dimensionally arranged collagen fibers to substitute for the corneal stroma. Three tasks that must be clarified for the bioinspired production of a corneal substitute from fish scale collagen are proposed.
C1 Hokkaido Univ, Fac Fisheries Sci, Hakodate, Hokkaido 0418611, Japan.
RP Takagi, Y (reprint author), Hokkaido Univ, Fac Fisheries Sci, Minato Cho 3-1-1, Hakodate, Hokkaido 0418611, Japan.
CR BEREITERHAHN J, 1993, COMP BIOCHEM PHYS A, V105, P625, DOI 10.1016/0300-9629(93)90262-3
   Birk DE, 2001, MICRON, V32, P223, DOI 10.1016/S0968-4328(00)00043-3
   Burjanadze TV, 2000, BIOPOLYMERS, V53, P523, DOI 10.1002/(SICI)1097-0282(200005)53:6<523::AID-BIP8>3.0.CO;2-7
   CARSSON DJ, 2003, CURR OPIN OPHTHALMOL, V14, P192
   Griffith M, 1999, SCIENCE, V286, P2169, DOI 10.1126/science.286.5447.2169
   Ikoma T, 2003, INT J BIOL MACROMOL, V32, P199, DOI 10.1016/S0141-8130(03)00054-0
   Kobayashi T, 2005, ENDOCRINOLOGY, V146, P1012, DOI 10.1210/en.2004-1343
   MAURICE DM, 1957, J PHYSIOL-LONDON, V136, P263, DOI 10.1113/jphysiol.1957.sp005758
   Meek KM, 2001, MICRON, V32, P261, DOI 10.1016/S0968-4328(00)00041-X
   Meunier F.J., 2002, P58
   Michelacci YM, 2003, BRAZ J MED BIOL RES, V36, P1037, DOI 10.1590/S0100-879X2003000800009
   Shimmura S, 2003, CORNEA, V22, P81
   SIRE JY, 1989, TISSUE CELL, V21, P447, DOI 10.1016/0040-8166(89)90058-X
   Yamada J., 1961, Memoirs of the Faculty of Fisheries Hokkaido University, V9, P181
NR 14
TC 8
Z9 9
U1 2
U2 11
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1533-4880
J9 J NANOSCI NANOTECHNO
JI J. Nanosci. Nanotechnol.
PD MAR
PY 2007
VL 7
IS 3
BP 757
EP 762
DI 10.1166/jnn.2007.503
PG 6
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 143NU
UT WOS:000244730100010
PM 17450830
DA 2018-10-20
ER

PT J
AU Igarashi, S
   Tanaka, J
   Kobayashi, H
AF Igarashi, Satoshi
   Tanaka, Junzo
   Kobayashi, Hisatoshi
TI Micro-patterned nanofibrous biomaterials
SO JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
LA English
DT Article; Proceedings Paper
CT International Symposium on Soft-Nanotechnology
CY 2005
CL Hokkaido Univ, Sapporo, JAPAN
HO Hokkaido Univ
DE nanofiber; scaffold; bioabsorbable polymer; poly(glycolide); tissue
   engineering
ID POLY(GLYCOLIC ACID); TISSUE; MATS; SCAFFOLD; MATRIX; FIBERS; BLEND; CELL
AB Nanofibrous materials made from bioabsorbable and biocompatible polymers have promising applications as tissue-engineered scaffolds. Genetic analysis of human umbilical vein endothelial cells (HUVEC) that attached to Poly(glycolide) (PGA) nanoifibrous materials prepared via electrospinning methods demonstrated high expression of Integrin v and VEGF receptor genes, which are known angiogenesis markers. In order to improve the function of the PGA nanofibrous materials for tissue engineering applications, we used a micro-patterned template instead of a flat collector in the electrospinning process. "Micro-patterned nanofibrous material" demonstrated uniformly sized dents with diameters of 200 micrometers and depths of 36 micrometers. The dents were regularly spaced, with a 250 micrometer space between two dents. These sizes are similar to that of the template. We will discuss further applications of this designable micro-patterned nanofibrous biomaterial.
C1 Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan.
RP Kobayashi, H (reprint author), Natl Inst Mat Sci, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.
RI kobayashi, hisatoshi/H-2720-2011
OI kobayashi, hisatoshi/0000-0001-9487-0725
CR BAUMGARTEN PK, 1971, J COLLOID INTERF SCI, V36, P71, DOI 10.1016/0021-9797(71)90241-4
   Boland ED, 2004, J BIOMED MATER RES B, V71B, P144, DOI 10.1002/jbm.b.30105
   Boland ED, 2001, J MACROMOL SCI PURE, V38, P1231, DOI 10.1081/MA-100108380
   Buchko CJ, 1999, POLYMER, V40, P7397, DOI 10.1016/S0032-3861(98)00866-0
   Ding B, 2004, POLYMER, V45, P1895, DOI 10.1016/j.polymer.2004.01.026
   Emig D., 2002, US Patent, Patent No. [6395046, 6,395,046 B1]
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Kenawy ER, 2002, J CONTROL RELEASE, V81, P57, DOI 10.1016/S0168-3659(02)00041-X
   Kidoaki S, 2005, BIOMATERIALS, V26, P37, DOI 10.1016/j.biomaterials.2004.01.063
   Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19
   Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   Mo XM, 2004, BIOMATERIALS, V25, P1883, DOI 10.1016/j.biomaterials.2003.08.042
   MOHMAN MM, 2001, PHYS FLUIDS, V13, P2221
   Ohkawa K, 2004, MACROMOL RAPID COMM, V25, P1600, DOI 10.1002/marc.200400253
   Reneker DH, 2002, POLYMER, V43, P6785, DOI 10.1016/S0032-3861(02)00595-5
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Zong XH, 2002, POLYMER, V43, P4403, DOI 10.1016/S0032-3861(02)00275-6
   Zussman E, 2002, EXP FLUIDS, V33, P315, DOI 10.1007/s00348-002-0435-6
NR 21
TC 18
Z9 18
U1 0
U2 15
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1533-4880
J9 J NANOSCI NANOTECHNO
JI J. Nanosci. Nanotechnol.
PD MAR
PY 2007
VL 7
IS 3
BP 814
EP 817
DI 10.1166/jnn.2007.516
PG 4
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 143NU
UT WOS:000244730100018
PM 17450838
DA 2018-10-20
ER

PT J
AU Turhani, D
   Weissenbock, M
   Stein, E
   Wanschitz, F
AF Turhani, Dritan
   Weissenboeck, Martina
   Stein, Elizabeth
   Wanschitz, Felix
TI Exogenous recombinant human BMP-2 has little initial effects on human
   osteoblastic cells cultured on collagen type I coated/noncoated
   hydroxyapatite ceramic granules
SO JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
LA English
DT Article
ID BONE MORPHOGENETIC PROTEIN-2; DIFFERENTIATION; GROWTH; VITRO;
   BIOMATERIALS; MATRIX; AUGMENTATION; EXPRESSION; SCAFFOLDS; CARTILAGE
AB Purpose: Tissue engineering of bone entails the successful interplay between osteoinductive factors, osteogenic cells, their extracellular environment, and an osteoconductive biomaterial scaffold. Naturally produced ceramics, like hydroxyapatite (HA) calcified from red algae, are the most promising materials for use as scaffolds in this field. We hypothesized that extracellular matrix compartments and osteoinductive factors could further ameliorate the bioactivity of the scaffold.
   Materials and Methods: osteosarcoma cells with proven osteogenic phenotype (SaOS-2) were cultured onto type I collagen coated (Coll I/HA) and noncollagen coated HA granules (NC/RA) gained from red algae (C GRAFT/Algipore). Cells grown on tissue culture polystyrene dishes (TCPS) were used as controls. Second, SaOS-2 cells cuhured on Coll I/HA, NC/HA, and TCPS were treated with recombinant human bone morphogenetic protein-2 (rhBMP-2) in different concentrations (10, 100, and 500 ng/mL). Non rhBMP-2-treated cultures were used as controls. Cultures of both experiments were grown under osteogenic differentiation conditions and after 24, 48, and 72 hours assays for cell viability, apoptosis, alkaline phosphatase activity (ALP), and osteocalcin (OC) secretion were done.
   Results: Coating of HA granules with type I collagen showed higher cell viability in rhBMP-2-treated and nontreated cells. Supplementation of cultured cells with exogenous rhBMP-2 showed a dose-dependent effect only in the TCPS group. No alterations of the apoptotic rate within I investigation group were found. Addition of rhBMP-2 did not significantly alter the specific OC secretion of cells grown on Coll I/HA and TCPS.
   Conclusion: These in vitro findings show that in the initial period of cultivation and up to 72 hours, the coating of HA granules with collagen type I had positive effects on cell viability and osteoblastic characteristics of osteoblastic cells. In contrast, the supplementation with exogenous rbBMP-2 shows no dose-dependent effects. The combination of collagen type I and exogenous rhBMP-2 did not ameliorate the bioactivity of hydroxyapatite calcified from red algae in the initial period of cultivation. (C) 2007 American Association of Oral and Maxillofacial Surgeons.
C1 Med Univ Vienna, Dept Craniomaxillofacial & Oral Surg, A-1090 Vienna, Austria.
RP Turhani, D (reprint author), Med Univ Vienna, Dept Craniomaxillofacial & Oral Surg, AKH Gen Hosp Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
EM dritan.turhani@meduniwien.ac.at
OI Stein, Elisabeth/0000-0002-1240-506X
CR Benoit DSW, 2005, BIOMATERIALS, V26, P5209, DOI 10.1016/j.biomaterials.2005.01.045
   Ber S, 2005, BIOMATERIALS, V26, P1977, DOI 10.1016/j.biomaterials.2004.07.007
   Bucholz RW, 2002, CLIN ORTHOP RELAT R, P44
   DEUEL TF, 1997, PRINCIPLES TISSUE EN, P133
   Ewers R, 2004, CLIN ORAL IMPLAN RES, V15, P96, DOI 10.1111/j.1600-0501.2004.00987.x
   EWERS R, 1994, J CRANIO MAXILLOF S1, V22, P92
   Hanks T, 2004, BIOMATERIALS, V25, P4831, DOI 10.1016/j.biomaterials.2003.12.007
   HAUSCHKA PV, 1986, HAEMOSTASIS, V16, P258
   Hay E, 2004, J BIOL CHEM, V279, P1650, DOI 10.1074/jbc.M300969200
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Ignatius A, 2005, BIOMATERIALS, V26, P311, DOI 10.1016/j.biomaterials.2004.02.045
   Kim KJ, 1997, J BIOMED MATER RES, V35, P279, DOI 10.1002/(SICI)1097-4636(19970605)35:3<279::AID-JBM2>3.3.CO;2-S
   KOUML GT, 2005, BIOMATERIALS, V26, P5187
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   LYNCH MP, 1995, EXP CELL RES, V216, P35, DOI 10.1006/excr.1995.1005
   MASI L, 1992, CALCIFIED TISSUE INT, V51, P202, DOI 10.1007/BF00334548
   Moreira-Gonzalez A, 2003, PLAST RECONSTR SURG, V111, P1808, DOI 10.1097/01.PRS.0000055432.20074.93
   Mori M, 2000, J BIOMED MATER RES, V50, P191, DOI 10.1002/(SICI)1097-4636(200005)50:2<191::AID-JBM14>3.0.CO;2-0
   PARSONSWINGERTER PA, 1993, BIOTECHNOL PROGR, V9, P600, DOI 10.1021/bp00024a006
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Reddi A. Hari, 1997, Cytokine and Growth Factor Reviews, V8, P11, DOI 10.1016/S1359-6101(96)00049-4
   RODRIGUES CVM, 2003, BIOMATERIALS, V27, P4987
   Rosen V, 2002, PRINCIPLES BONE BIOL, P919
   Rosso F, 2005, J CELL PHYSIOL, V203, P465, DOI 10.1002/jcp.20270
   SAKANO S, 1993, CLIN ORTHOP RELAT R, P337
   Schmitt JM, 1999, J ORTHOPAED RES, V17, P269, DOI 10.1002/jor.1100170217
   SCHOPPER C, 2003, CLIN ORAL IMPLAN RES, V6, P743
   SHUPNIK MA, 1982, LIFE SCI, V25, P347
   Sykaras Nikitas, 2004, Clin Oral Investig, V8, P196, DOI 10.1007/s00784-004-0270-7
   TAKUWA Y, 1991, BIOCHEM BIOPH RES CO, V174, P96, DOI 10.1016/0006-291X(91)90490-X
   Turhani D, 2005, CLIN ORAL IMPLAN RES, V16, P417, DOI 10.1111/j.1600-0501.2005.01144.x
   Turhani D, 2005, INT J ORAL MAX SURG, V34, P543, DOI 10.1016/j.ijom.2004.10.023
   Turhani D, 2005, J ORAL MAXIL SURG, V63, P793, DOI 10.1016/j.jams.2005.02.015
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Urist MR, 1997, J BONE MINER RES, V12, P343, DOI 10.1359/jbmr.1997.12.3.343
   Vacanti JP, 1999, LANCET S1, V354, pSi32
   Vehof JWM, 2001, TISSUE ENG, V7, P373, DOI 10.1089/10763270152436436
   Wiesmann HP, 2003, J ORAL MAXIL SURG, V61, P1455, DOI 10.1016/j.joms.2003.05.001
   Wikesjo UME, 2004, CLIN ORAL IMPLAN RES, V15, P194, DOI 10.1111/j.1600-0501.2004.00971.x
   Wiltfang J, 2004, J ORAL MAXIL SURG, V62, P29, DOI 10.1016/j.joms.2003.02.002
   Winn SR, 1998, ADV DRUG DELIVER REV, V31, P303, DOI 10.1016/S0169-409X(97)00126-9
   Wozney J. M., 2002, SPINE S, V27, P2
   YAMAGUCHI A, 1991, J CELL BIOL, V113, P681, DOI 10.1083/jcb.113.3.681
   Yang XB, 2001, BONE, V29, P523, DOI 10.1016/S8756-3282(01)00617-2
   Yudell RM, 2000, J ORAL MAXIL SURG, V58, P761, DOI 10.1053/joms.2000.7261
NR 49
TC 24
Z9 27
U1 0
U2 6
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0278-2391
J9 J ORAL MAXIL SURG
JI J. Oral Maxillofac. Surg.
PD MAR
PY 2007
VL 65
IS 3
BP 485
EP 493
DI 10.1016/j.joms.2005.12.065
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 144XU
UT WOS:000244830600019
PM 17307597
DA 2018-10-20
ER

PT J
AU Crow, BD
   Haltom, JD
   Carson, WL
   Greene, WB
   Cook, JL
AF Crow, Bradley D.
   Haltom, J. Douglas
   Carson, William L.
   Greene, Walter B.
   Cook, James L.
TI Evaluation of a novel biomaterial for intrasubstance muscle laceration
   repair
SO JOURNAL OF ORTHOPAEDIC RESEARCH
LA English
DT Article
DE muscle laceration; muscle healing; SIS
ID SMALL-INTESTINAL SUBMUCOSA; TRAUMATIC CLOSED TRANSECTION; BODY-WALL
   REPAIR; GROWTH-FACTORS; SKELETAL-MUSCLE; BICEPS-BRACHII; STRAIN INJURY;
   DOGS; TISSUE; REGENERATION
AB The authors compare the effects of small intestinal submucosa (SIS) treatment to suture repair with respect to histologic and functional outcomes for complete muscle lacerations in a rabbit model. The authors hypothesized that SIS treatment of full-thickness muscle belly lacerations would significantly improve muscle function, strength, and regeneration compared to the current standard-of-care treatment. Muscle belly lacerations were created in the extensor digitorum longus (EDL) of both hind limbs of each rabbit. After randomization, lacerations were left unrepaired (n = 48) or repaired using a 4-0 Prolene modified Kessler stitch (n = 48). A flap of SIS graft was sutured into half (n = 24 each) of the repaired and unrepaired muscles forming four study groups. Suture repair with SIS augmentation of complete muscle lacerations resulted in healed tissue that most closely resembled normal muscle in terms of morphology and function when compared to current standard-of-care treatments. Active force production in this group reached 79% of uninjured controls 12 weeks after surgery. SIS may have important clinical advantages over suture repair alone and warrants further clinical study. (c) 2006 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.
C1 Univ Missouri, Comparat Orthopaed Lab, Columbia, MO 65211 USA.
   Univ Missouri, Dept Orthopaed Surg, Columbia, MO USA.
   Charlotte Orthopaed Specialists, Charlotte, NC USA.
RP Cook, JL (reprint author), Univ Missouri, Comparat Orthopaed Lab, 379 E Campus Dr, Columbia, MO 65211 USA.
EM cookjl@missouri.edu
OI Cook, James/0000-0002-0862-995X
CR Almekinders L C, 1991, J Orthop Trauma, V5, P173, DOI 10.1097/00005131-199105020-00009
   Badylak S, 2002, J SURG RES, V103, P190, DOI 10.1006/jsre.2001.6349
   Badylak S, 2001, J SURG RES, V99, P282, DOI 10.1006/jsre.2001.6176
   BADYLAK SF, 2001, J BIOMED MATER RES, V69, P977
   BOTTE MJ, 1987, J HAND SURG-AM, V12A, P406, DOI 10.1016/S0363-5023(87)80014-X
   Clarke KM, 1996, J SURG RES, V60, P107, DOI 10.1006/jsre.1996.0018
   Cook JL, 2001, TISSUE ENG, V7, P321, DOI 10.1089/10763270152044189
   Cook JL, 1999, AM J SPORT MED, V27, P658, DOI 10.1177/03635465990270051901
   Dejardin LM, 2001, AM J SPORT MED, V29, P175, DOI 10.1177/03635465010290021001
   GARRETT WE, 1984, J HAND SURG-AM, V9A, P683, DOI 10.1016/S0363-5023(84)80014-3
   HECKMAN JD, 1978, J BONE JOINT SURG AM, V60, P369, DOI 10.2106/00004623-197860030-00019
   Huard J, 2002, J BONE JOINT SURG AM, V84A, P822, DOI 10.2106/00004623-200205000-00022
   Kasemkijwattana C, 2000, CLIN ORTHOP RELAT R, P272
   Kragh JF, 2002, J BONE JOINT SURG AM, V84A, P992, DOI 10.2106/00004623-200206000-00014
   LEHTO M, 1985, J BONE JOINT SURG BR, V67, P820
   Menetrey J, 1999, AM J SPORT MED, V27, P222, DOI 10.1177/03635465990270021801
   Menetrey J, 2000, J BONE JOINT SURG BR, V82B, P131, DOI 10.1302/0301-620X.82B1.8954
   MISHRA DK, 1995, J BONE JOINT SURG AM, V77, P1510, DOI 10.2106/00004623-199510000-00005
   OBREMSKY WT, 1994, AM J SPORT MED, V22, P558, DOI 10.1177/036354659402200420
   *ORTH INC, RESTORE ORTH IMPL
   Stoll MR, 2002, VET SURG, V31, P379, DOI 10.1053/jvet.2002.33596
   United States Bureau of Labor Statistics, INJ ILLN FAT PROGR
   Voytik-Harbin SL, 1998, TISSUE ENG, V4, P157, DOI 10.1089/ten.1998.4.157
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
NR 24
TC 15
Z9 15
U1 0
U2 4
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0736-0266
J9 J ORTHOP RES
JI J. Orthop. Res.
PD MAR
PY 2007
VL 25
IS 3
BP 396
EP 403
DI 10.1002/jor.20232
PG 8
WC Orthopedics
SC Orthopedics
GA 139ZS
UT WOS:000244472300013
PM 17106884
OA Bronze
DA 2018-10-20
ER

PT J
AU Nakamura, T
AF Nakamura, Takashi
TI Biomaterial osteoinduction
SO JOURNAL OF ORTHOPAEDIC SCIENCE
LA English
DT Editorial Material
ID CALCIUM-PHOSPHATE CERAMICS; BONE INDUCTION
C1 Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Sakyo Ku, Kyoto 6068507, Japan.
RP Nakamura, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Sakyo Ku, 54 Shogoin,Kawara Machi, Kyoto 6068507, Japan.
CR Fujibayashi S, 2004, BIOMATERIALS, V25, P443, DOI 10.1016/S0142-9612(03)0051-9
   RIPAMONTI U, 1991, J BONE JOINT SURG AM, V73A, P692, DOI 10.2106/00004623-199173050-00007
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
   Yang ZJ, 1996, BIOMATERIALS, V17, P2131, DOI 10.1016/0142-9612(96)00044-0
   Yuan HP, 2001, J BIOMED MATER RES, V58, P270, DOI 10.1002/1097-4636(2001)58:3<270::AID-JBM1016>3.0.CO;2-2
   Yuan HP, 2001, BIOMATERIALS, V22, P2617, DOI 10.1016/S0142-9612(00)00450-6
NR 7
TC 9
Z9 9
U1 0
U2 0
PU SPRINGER TOKYO
PI TOKYO
PA 3-3-13, HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN
SN 0949-2658
J9 J ORTHOP SCI
JI J. Orthop. Sci.
PD MAR
PY 2007
VL 12
IS 2
BP 111
EP 112
DI 10.1007/s00776-007-1109-2
PG 2
WC Orthopedics
SC Orthopedics
GA 151NA
UT WOS:000245296000002
PM 17393263
OA Other Gold, Green Published
DA 2018-10-20
ER

PT J
AU Adachi, K
   Tsurumoto, T
   Yonekura, A
   Nishimura, S
   Kajiyama, S
   Hirakata, Y
   Shindo, H
AF Adachi, Kouichi
   Tsurumoto, Toshiyuki
   Yonekura, Akihiko
   Nishimura, Seisuke
   Kajiyama, Shiro
   Hirakata, Yoichi
   Shindo, Hiroyuki
TI New quantitative image analysis of staphylococcal biofilms on the
   surfaces of nontranslucent metallic biomaterials
SO JOURNAL OF ORTHOPAEDIC SCIENCE
LA English
DT Article
ID BACTERIAL ADHESION; SUSCEPTIBILITY; AUREUS; INFECTIONS; ADHERENCE;
   TITANIUM; IMPLANTS; RABBITS
AB Background. Implant-related infection after orthopedic surgery is difficult to cure. One of the causes of infection is the bacterial biofilm that forms around biomaterials used during surgery. Therefore, it is necessary to investigate bacterial biofilms extensively to resolve the problems of these postoperative infections. However, no established culture method or quantification system exists for bacterial biofilms grown on the surface of the metallic biomaterials used in orthopedics, which are nonradiolucent. The purpose of this study was to develop a quantitative method to evaluate the difference in resistance of stainless steel versus titanium to staphylococcal biofilms and the efficacy of antibiotics against biofilms.
   Methods. The bacterial strains used in this study were three Staphylococcus aureus stains: strain Seattle 1945 and two clinical strains cultured from postoperative infections. Staphylococcal biofilms were formed on stainless steel washers (SUS304) and titanium washers (pure titanium). They were stained with crystal violet and were examined with a digital microscope to calculate the bacterial coverage rate (BCR) by NIH imaging.
   Results. The BCR of S. aureus biofilms formed on stainless steel and titanium washers increased over time. At 24, 48, and 72 h after cultivation, the amount of biofilm on the surface of the stainless steel washers was significantly greater or tended to be greater than that on the titanium. Cefazolin was applied to the obtained biofilms of two clinically isolated S. aureus strains. Cefazolin did not eradicate the biofilms but significantly reduced the biofilm of one strain.
   Conclusion. The newly developed quantitative method (static microtube culture and measurement system) was useful for assessing the amount of bacterial biofilms on the surface of nontranslucent biomaterial. We found that titanium may be more resistant to bacterial infection than stainless steel. To control implant-related severe infections, the biomaterials should be assessed from the viewpoint of their resistibility to bacterial adhesions and infections.
C1 Nagasaki Univ, Grad Sch Biomed Sci, Dept Orthopaed Surg, Nagasaki 8528501, Japan.
   Nagasaki Univ, Grad Sch Biomed Sci, Dept Internal Med 2, Nagasaki 852, Japan.
RP Adachi, K (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Orthopaed Surg, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.
CR Amorena B, 1999, J ANTIMICROB CHEMOTH, V44, P43, DOI 10.1093/jac/44.1.43
   An YH, 1997, J MICROBIOL METH, V30, P141, DOI 10.1016/S0167-7012(97)00058-4
   Arens S, 1996, J BONE JOINT SURG BR, V78B, P647
   CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Costerton W, 2003, J CLIN INVEST, V112, P1466, DOI 10.1172/JCI20365
   Gracia E, 1997, INT ORTHOP, V21, P46, DOI 10.1007/s002640050116
   KARLOV AV, 2002, B EXP BIOL MED, V3, P277
   Nishimura S, 2006, J ORTHOP SCI, V11, P46, DOI 10.1007/s00776-005-0968-7
   Pitts B, 2003, J MICROBIOL METH, V54, P269, DOI 10.1016/S0167-7012(03)00034-4
   Potera C, 1999, SCIENCE, V283, P1837, DOI 10.1126/science.283.5409.1837
   Ramage G, 2003, BIOMATERIALS, V24, P3221, DOI 10.1016/S0142-9612(03)00173-X
   SANZEN L, 1995, BIOMATERIALS, V16, P1273, DOI 10.1016/0142-9612(95)98136-3
   Sheehan E, 2004, J ORTHOPAED RES, V22, P39, DOI 10.1016/S0736-0266(03)00152-9
   Shive MS, 1999, J BIOMED MATER RES, V46, P511, DOI 10.1002/(SICI)1097-4636(19990915)46:4<511::AID-JBM9>3.0.CO;2-M
   Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1
NR 17
TC 14
Z9 16
U1 0
U2 4
PU SPRINGER TOKYO
PI TOKYO
PA 3-3-13, HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN
SN 0949-2658
J9 J ORTHOP SCI
JI J. Orthop. Sci.
PD MAR
PY 2007
VL 12
IS 2
BP 178
EP 184
DI 10.1007/s00776-006-1102-1
PG 7
WC Orthopedics
SC Orthopedics
GA 151NA
UT WOS:000245296000013
PM 17393274
DA 2018-10-20
ER

PT J
AU Nakamura, M
   Ohashi, N
   Nagai, A
   Sekijima, Y
   Tanaka, Y
   Nakamura, S
   Yamashita, K
AF Nakamura, Miho
   Ohashi, Natalie
   Nagai, Akiko
   Sekijima, Yasutaka
   Tanaka, Yumi
   Nakamura, Satoshi
   Yamashita, Kirnihiro
TI Modulation of osteoblast-like cell behavior cultured on hydroxyapatite
   by thrombin
SO JOURNAL OF THE CERAMIC SOCIETY OF JAPAN
LA English
DT Article
DE osteoblast-like cell; hydroxyapatite; thrombin; alkaline phosphatase;
   mineralization; morphology
ID ACTIVATION; POLYMERS
AB Blood proteins have been shown to be effective for osteoconduction and for biomaterial applications. The blood coagulation system progressed rapidly after biomaterial implantation. The interaction of biomaterials with blood coagulation proteins is considered to play an important role in osteoconduction. The purpose of this study was to evaluate the in vitro interaction of the coagulation factor with hydroxyapatite (HA) and the interaction of the coagulation factor with osteoblast-like cells cultured on HA. After 0.2 U/ml thrombin stimulation, the proliferation, alkaline phosphatase (ALP) activity, adherent morphology, and tyrosine phosphorylation of the osteoblast-like cells cultured on HA samples were investigated. Incubation with 0.2 U/ml thrombin stimulation induced an increase in cell number and inhibition of ALP activity. The thrombin stimulation resulted in changes in the morphology of the adherent osteoblast-like cells and static bands recognized as tyrosine phosphorylated proteins lysed from adherent osteoblast-like cells in blot analysis. These results of this study indicated that the thrombin promoted the proliferation, changes of cell morphology, and inhibition of ALP activity. It was suggested that thrombin could affect the cell morphology and proliferation near the HA.
C1 Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo 1010062, Japan.
RP Nakamura, M (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, 2-3-10,Kanda Surugadai, Tokyo 1010062, Japan.
RI Nakamura, Miho/T-3166-2017
CR Abraham LA, 1999, J BONE MINER RES, V14, P1320, DOI 10.1359/jbmr.1999.14.8.1320
   CHRISTENSON L, 1989, J BIOMED MATER RES, V23, P705, DOI 10.1002/jbm.820230704
   COLMAN RW, 1984, J CLIN INVEST, V73, P1249, DOI 10.1172/JCI111326
   GOBEL RJ, 1987, BIOMATERIALS, V8, P285, DOI 10.1016/0142-9612(87)90116-5
   HOGT AH, 1986, J BIOMED MATER RES, V20, P533, DOI 10.1002/jbm.820200409
   KOSSOVSKY N, 1991, J BIOMED MATER RES, V25, P1287, DOI 10.1002/jbm.820251009
   Nakamura M, 2006, J BIOMED MATER RES A, V79A, P627, DOI 10.1002/jbm.a.30827
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Suzuki A, 1996, J CELL PHYSIOL, V168, P209, DOI 10.1002/(SICI)1097-4652(199607)168:1<209::AID-JCP25>3.0.CO;2-0
   Suzuki A, 2000, J BONE MINER RES, V15, P95, DOI 10.1359/jbmr.2000.15.1.95
   TAKAKIS D, 1989, BIOCHEM BIOPH RES CO, V164, P119
NR 11
TC 2
Z9 2
U1 0
U2 2
PU CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI
PI TOKYO
PA 22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN
SN 1882-0743
EI 1348-6535
J9 J CERAM SOC JPN
JI J. Ceram. Soc. Jpn.
PD MAR
PY 2007
VL 115
IS 1339
BP 205
EP 209
DI 10.2109/jcersj.115.205
PG 5
WC Materials Science, Ceramics
SC Materials Science
GA 156JS
UT WOS:000245644600008
OA Bronze
DA 2018-10-20
ER

PT J
AU Negri, S
   Fila, C
   Farinato, S
   Bellomi, A
   Pagliaro, PP
AF Negri, Stefano
   Fila, Chiara
   Farinato, Sara
   Bellomi, Alberto
   Pagliaro, Pasquale Paolo
TI Tissue engineering: chondrocyte culture on type 1 collagen support.
   Cytohistological and immunohistochemical study
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE tissue engineering; cartilage; collagen I; cytology; histology;
   immunohistochemistry
ID IN-VITRO; ARTICULAR-CARTILAGE; MATRIX PRODUCTION; PHENOTYPE; GROWTH
AB The scope of our study is to evaluate the possibility of cultivating and expanding human chondrocytes and seeding them on pure equine type I collagen support.
   Our results show that human articular cartilaginous cells can multiply and grow on type I collagen substrate with production of extracellular matrix. This type of chondrocyte culture on a support can be used for repairing cartilaginous lesions since they show a correct morphology (evaluated by cytological and histological methods) and a suitable differentiation and phenotype as shown by Alcian PAS staining to indicate the presence of mucopolysaccharides, and immunohistochemical methods to identify collagen II.
   We believe that these chondrocyte cultures on this biomaterial can be used for repairing cartilaginous lesions with improvement of surgical technique; the support allows adhesion of the chondrocytes to the cartilaginous lesion and a mallebility that favours optimum spatial adaptation. Copyright (C) 2007 John Wiley & Sons, Ltd.
C1 [Negri, Stefano; Farinato, Sara; Bellomi, Alberto] C Poma Hosp, Serv Anat Pathol, Mantova, Italy.
   [Fila, Chiara; Pagliaro, Pasquale Paolo] C Poma Hosp, Immunohaematol & Transfus Med Serv, Mantova, Italy.
RP Negri, S (reprint author), C Poma Hosp, Serv Anat Pathol, Mantova, Italy.
EM STENE60@LIBERO.IT
CR Anderer U, 2002, J BONE MINER RES, V17, P1420, DOI 10.1359/jbmr.2002.17.8.1420
   Grigolo B, 2002, Reumatismo, V54, P364
   Grigolo B, 2002, OSTEOARTHR CARTILAGE, V10, P879, DOI 10.1053/joca.2002.0836
   HENDRICKSON DA, 1994, J ORTHOPAED RES, V12, P485, DOI 10.1002/jor.1100120405
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   KIMURA T, 1984, CLIN ORTHOP RELAT R, P231
   MASI L, 1992, CALCIFIED TISSUE INT, V51, P202, DOI 10.1007/BF00334548
   Mizuno S, 2001, J BIOMED MATER RES, V56, P368, DOI 10.1002/1097-4636(20010905)56:3<368::AID-JBM1105>3.0.CO;2-V
   Naumann A, 2004, TISSUE ENG, V10, P1695, DOI 10.1089/ten.2004.10.1695
   Povysil C, 2005, Cesk Patol, V41, P133
   Richardson JB, 1999, J BONE JOINT SURG BR, V81B, P1064, DOI 10.1302/0301-620X.81B6.9343
   Shields KJ, 2004, TISSUE ENG, V10, P1510, DOI 10.1089/1076327042500373
   Wachsmuth L, 2006, HISTOL HISTOPATHOL, V21, P477, DOI 10.14670/HH-21.477
   Zhang ZJ, 2005, J ORTHOP RES, V23, P433, DOI 10.1016/j.orthres.2004.08.028
NR 14
TC 7
Z9 7
U1 0
U2 4
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD MAR-APR
PY 2007
VL 1
IS 2
BP 158
EP 159
DI 10.1002/term.15
PG 2
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 310HN
UT WOS:000256519600009
PM 18038405
DA 2018-10-20
ER

PT J
AU Tan, PS
   Teoh, SH
AF Tan, P. S.
   Teoh, S. H.
TI Effect of stiffness of polycaprolactone (PCL) membrane on cell
   proliferation
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT 3rd International Conference on Materials for Advanced Technologies
   (ICMAT-2005)/9th International Conference on Advanced Materials (ICAM
   2005)
CY JUL 03-08, 2005
CL Singapore, SINGAPORE
SP Int Union Mat Res Soc, Mat Res Soc Singapore, Suntec Int Convent & Exhibit Ctr
DE polycaprolactone; stiffness; membrane; cell proliferation
ID SUBSTRATE FLEXIBILITY; TISSUE; APOPTOSIS; MECHANICS; RELEASE; FILMS
AB Polycaprolactone (PCL) has been fabricated into ultra thin membranes (5 +/- 0.01 mu m to 30 +/- 0.01 mu m) for tissue engineering applications by biaxial stretching. However, the traditional solvent casting method raises concerns pertaining toxicity. Heated roll milling technology was included into the fabrication process to achieve a solvent-free biomaterial. The ideal substrate environment that promotes cellular proliferation has been a persistent area of interest in tissue engineering. Other than being biocompatible, the issue of cell proliferation is also important and is hypothesized as a function of the stiffness of the substrate material. This paper reports on experiments carried out to investigate and verify the effect of stiffness of the PCL membrane on fibroblast cell proliferation. Results indicated that 3T3 fibroblasts, belonging to soft tissues, prefer to proliferate in a lower stiffness (0.05 +/- 0.01 N/mm) environment, which is closer to its native environment. (c) 2006 Elsevier B.V. All rights reserved.
C1 NUSTEP, BIOMAT, Dept Engn Mech, Singapore 117576, Singapore.
RP Teoh, SH (reprint author), NUSTEP, BIOMAT, Dept Engn Mech, 9 Engn Dr 1, Singapore 117576, Singapore.
EM mpetsh@nus.edu.sg
CR Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1
   Banes AJ, 1995, BIOCHEM CELL BIOL, V73, P349, DOI 10.1139/o95-043
   CHEN FL, 2004, 7 WORLD BIOM C, P1633
   DAVIES PF, 1995, PHYSIOL REV, V75, P519
   Genes NG, 2004, ARCH BIOCHEM BIOPHYS, V422, P161, DOI 10.1016/j.abb.2003.11.023
   Grinnell F, 1999, EXP CELL RES, V248, P608, DOI 10.1006/excr.1999.4440
   Khor HL, 2002, MAT SCI ENG C-BIO S, V20, P71, DOI 10.1016/S0928-4931(02)00015-2
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   MOCHITATE K, 1991, EXP CELL RES, V193, P198, DOI 10.1016/0014-4827(91)90556-A
   Ng CS, 2000, POLYMER, V41, P5855, DOI 10.1016/S0032-3861(99)00760-0
   Ng Kee Woei, 2001, Tissue Engineering, V7, P441, DOI 10.1089/10763270152436490
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   RATNER B, 1996, BIOMATERIALS SCI
   Schantz JT, 2002, INT J ORAL MAX IMPL, V17, P161
   Wang HB, 2000, AM J PHYSIOL-CELL PH, V279, pC1345
   Wong JY, 2004, SURF SCI, V570, P119, DOI 10.1016/j.susc.2004.06.186
   Zhu YB, 2002, BIOMATERIALS, V23, P4889, DOI 10.1016/S0142-9612(02)00247-8
NR 17
TC 38
Z9 40
U1 2
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD MAR
PY 2007
VL 27
IS 2
SI SI
BP 304
EP 308
DI 10.1016/j.msec.2006.03.010
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 141SV
UT WOS:000244599900019
DA 2018-10-20
ER

PT J
AU Morita, M
   Hashimoto, T
   Yamauchi, K
   Suto, Y
   Homma, T
   Kimura, Y
AF Morita, Masafumi
   Hashimoto, Tokiko
   Yamauchi, Kiyoshi
   Suto, Yuji
   Homma, Takayuki
   Kimura, Yuji
TI Evaluation of biocompatibility for titanium-nickel shape memory alloy in
   vivo and in vitro environments
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE titanium-nickel shape memory alloy; implant metal; corrosion;
   cytotoxicity; biomaterial; biocompatibility
ID IONS
AB This study was conducted to evaluate the biocompatibility of titanium-nickel shape memory alloy used as a medical implant material. The tests for the alloy and some metal and alloys authors carried out the following electrochemical corrosion test and in vivo and in vitro biological clinically used previously to compare the intensities concerned with the biological reactions, that is, (1) anodic polarization test for the alloy in a quasi-body fluid, (2) cell proliferation tests for pure titanium (cp Ti), pure nickel (cp Ni), SUS316L stainless steel, titanium-6 mass% aluminium-4 mass% vanadium (Ti-6Al-4V), and titanium-55 mass% nickel (Ti-55Ni) by using of L929 fibroblastic cells, (3) Lactate dehydrogenaze (LDH), human interlukin-1 beta (hIL-1 beta), and human tumor necrosis factor-alpha (hTNF-alpha) biochemical assays by using of U937 human macrophages administered the corrosion products of these alloys for the cells, (4) measurement of the mount of excretions of the metallic corrosion products of Ti-55Ni, SUS316L stainless steel, and Ti-6Al-4V with urine and feces injected into the abdomen cavity of Wistar rats, and (5) tissue reaction observations for SUS316L, Ti-55Ni, and cp Ni wires implanted along the femoral bone axis of the rats.
   The following results were obtained. (1) The pitting corrosion potentials of Ti-55Ni alloy was drastically improved by the aging treatment. (2) In the case of Ti-55Ni alloy, the inflammatory cytokines, hIL-6 beta and hTNF-alpha were suppressed to lower levels compared with Ti-6Al-4V alloy. (3) Corrosion products prepared from the titanium alloys were stable in the body. Then it is very hard to eliminate the titanium ions with urine and feces. (4) Ti-55Ni alloy was shown an excellent biocompatibility evaluated by the in vivo implantation test, because of the stable passive film formed on the surface and protected the metal ion release to the surrounding tissue.
C1 Saitama Univ, Grad Sch Sci & Engn, Urawa, Saitama 3388570, Japan.
   Tohoku Univ, Biomed Engn Res Org, Sendai, Miyagi 9808574, Japan.
   Kogakuin Univ, Dept Mat Sci & Technol, Tokyo 1638677, Japan.
RP Morita, M (reprint author), Saitama Univ, Grad Sch Sci & Engn, Urawa, Saitama 3388570, Japan.
CR Allen M, 2001, J BIOMED MATER RES, V58, P319, DOI 10.1002/1097-4636(2001)58:3<319::AID-JBM1024>3.0.CO;2-F
   BRAWN SA, 1988, J BIOMED MATER RES, V22, P321
   DAI K, 2002, MATER SCI FORUM, V394, P17
   Goodman SB, 1998, CLIN ORTHOP RELAT R, P25
   HOMMA T, 2003, T MAT RES SOC JPN, V28, P853
   KATO T, 2005, SEIKEIGEKA, V56, P599
   Kuo P P, 1989, Orthopedics, V12, P111
   Miyazaki S, 1999, MAT SCI ENG A-STRUCT, V273, P658, DOI 10.1016/S0921-5093(99)00344-5
   Niki Y, 2003, BIOMATERIALS, V24, P1447, DOI 10.1016/S0142-9612(02)00531-8
   Shih CC, 2000, J BIOMED MATER RES, V52, P395, DOI 10.1002/1097-4636(200011)52:2<395::AID-JBM21>3.0.CO;2-B
   TENGVALL P, 1989, BIOMATERIALS, V10, P166, DOI 10.1016/0142-9612(89)90019-7
   Wataha JC, 2000, J BIOMED MATER RES, V52, P360, DOI 10.1002/1097-4636(200011)52:2<360::AID-JBM16>3.0.CO;2-B
   ZITTER H, 1987, J BIOMED MATER RES, V21, P881, DOI 10.1002/jbm.820210705
NR 13
TC 2
Z9 2
U1 2
U2 14
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD MAR
PY 2007
VL 48
IS 3
BP 352
EP 360
DI 10.2320/matertrans.48.352
PG 9
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 156PV
UT WOS:000245662400015
OA Bronze
DA 2018-10-20
ER

PT J
AU Zhou, YL
   Niinomi, M
   Akahori, T
   Nakai, M
   Fukui, H
AF Zhou, Ying-Long
   Niinomi, Mitsuo
   Akahori, Toshikazu
   Nakai, Masaaki
   Fukui, Hisao
TI Comparison of various properties between titanium-tantalum alloy and
   pure titanium for biomedical applications
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE elastic modulus; titanium-tantalum alloy; mechanical property; metallic
   biomaterial
ID MECHANICAL-PROPERTIES; YOUNGS MODULUS; CORROSION; TI-29NB-13TA-4.6ZR;
   BIOCOMPATIBILITY; MARTENSITE; ALPHA''; MO
AB The mechanical properties, corrosion resistance and biocompatibility of the titanium-tantalum alloys together with pure titanium are comparatively studied for biomedical applications in this study. The experimental results confirm the previous theoretic investigation that tantalum has a potential to enhance the strength and reduce the elastic modulus of titanium alloys at the same time, and indicate that the titanium-tantalum alloys are more suitable than pure titanium for biomedical applications because of their lower elastic modulus, higher strength and enhanced corrosion resistance than pure titanium used as a standard metallic biomaterial, and the same excellent compatibility to pure titanium.
C1 Foshan Univ, Dept Mechatron Engn, Sch Mechatron & Informat Engn, Foshan 528000, Peoples R China.
   Tohoku Univ, Mat Res Inst, Dept Biomat Sci, Sendai, Miyagi 9808577, Japan.
   Aichi Gakuin Univ, Sch Dent, Nagoya, Aichi 4648650, Japan.
RP Zhou, YL (reprint author), Foshan Univ, Dept Mechatron Engn, Sch Mechatron & Informat Engn, Foshan 528000, Peoples R China.
EM ylzhou_2@yahoo.com
RI Nakai, Masaaki/C-1919-2009; Niinomi, Mitsuo/B-5965-2011
CR *ASM INT HDB COMM, 1987, ASM HDB CORR, V13
   BOYER R, 1994, MAT PROPERTIES HDB T
   Burke GL, 1940, CAN MED ASSOC J, V43, P125
   Collings E. W., 1984, PHYS METALLURGY TITA
   Cui Z., 2000, METALLOGRAPHY HEAT T
   Davis JR, 2000, CORROSION UNDERSTAND
   Dieter G. E., 1976, MECH METALLURGY
   GANESAN P, 1974, J LESS-COMMON MET, V34, P209, DOI 10.1016/0022-5088(74)90161-1
   HABZAKI H, 1997, T I MET FINISH, V75, P18
   Hao YL, 2002, METALL MATER TRANS A, V33, P3137, DOI 10.1007/s11661-002-0299-7
   He G, 2006, MAT SCI ENG C-BIO S, V26, P14, DOI 10.1016/j.msec.2005.03.007
   Helsen J.A., 1998, METALS BIOMATERIALS
   Ho WF, 1999, BIOMATERIALS, V20, P2115, DOI 10.1016/S0142-9612(99)00114-3
   LAQUE FL, 1963, CORROSION RESISTANCE
   Lee CM, 2002, J ORAL REHABIL, V29, P314, DOI 10.1046/j.1365-2842.2002.00825.x
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Murry J. L., 1987, PHASE DIAGRAM BINARY
   Niinomi M., 2003, Science and Technology of Advanced Materials, V4, P445, DOI 10.1016/j.stam.2003.09.002
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Okazaki Y, 1997, MATER T JIM, V38, P344, DOI 10.2320/matertrans1989.38.344
   PLENK H, 1990, CONCISE ENCY MED DEN, P355
   Prigent H, 1998, J BIOMED MATER RES, V39, P200, DOI 10.1002/(SICI)1097-4636(199802)39:2<200::AID-JBM5>3.0.CO;2-T
   Song Y, 1999, MAT SCI ENG A-STRUCT, V260, P269, DOI 10.1016/S0921-5093(98)00886-7
   STERN M, 1959, J ELECTROCHEM SOC, V106, P759, DOI 10.1149/1.2427493
   Trillo EA, 2001, J MATER SCI-MATER M, V12, P283, DOI 10.1023/A:1011210101895
   Wang K, 1996, MAT SCI ENG A-STRUCT, V213, P134, DOI 10.1016/0921-5093(96)10243-4
   Zhou YL, 2004, MAT SCI ENG A-STRUCT, V384, P92, DOI 10.1016/j.msea.2004.05.084
NR 28
TC 19
Z9 20
U1 1
U2 15
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD MAR
PY 2007
VL 48
IS 3
BP 380
EP 384
DI 10.2320/matertrans.48.380
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 156PV
UT WOS:000245662400019
OA Bronze
DA 2018-10-20
ER

PT J
AU Kim, HY
   Oshika, N
   Kim, JI
   Inamura, T
   Hosoda, H
   Miyazaki, S
AF Kim, Hee Young
   Oshika, Naomi
   Kim, Jae Il
   Inamura, Tomonari
   Hosoda, Hideki
   Miyazaki, Shuichi
TI Martensitic transformation and superelasticity of Ti-Nb-Pt alloys
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE shape memory; alloy; superelasticity; biomaterial; smart material;
   titanium base alloy
ID SHAPE-MEMORY BEHAVIOR; MECHANICAL-PROPERTIES; BIOMEDICAL ALLOYS; SN
   CONTENT; TEXTURE
AB Shape memory properties and martensitic transformation of Ti-Nb-Pt alloys were investigated in order to develop Ni-free biomedical superelastic alloys. The effect of Pt addition on the transformation strain was investigated by measuring the lattice constants of the parent and martensite phases of Ti-Nb-Pt alloys. The Ti-Nb-Pt alloys were fabricated by arc melting. The ingots were cold-rolled up to 99% reduction in thickness. The cold-rolled specimens were heat treated at 873 K for 0.6 ks. The shape memory effect and/or superelastic behavior were observed in the Ti-Nb-Pt alloys. The martensitic transformation temperature decreases by about 160 K with a 1 at% increase of Pt in the Ti-Nb-Pt alloys. The addition of Pt as a substitute of Nb was effective to increase the transformation strain when compared with compositions which reveal similar transformation temperatures. An aging treatment at 573 K was effective for increasing the stress for inducing the martensitic transformation and the critical stress for plastic deformation, resulting in good superelasticity.
C1 Univ Tsukuba, Inst Sci Mat, Tsukuba, Ibaraki 3058573, Japan.
   Dong A Univ, Dept Mat Sci, Pusan 604714, South Korea.
   Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 2268503, Japan.
RP Kim, HY (reprint author), Univ Tsukuba, Inst Sci Mat, Tsukuba, Ibaraki 3058573, Japan.
EM heeykim@ims.tsukuba.ac.jp; miyazaki@ims.tsukuba.ac.jp
RI Kim, Hee Young/F-6065-2011; Miyazaki, Shuichi/A-3113-2012; Inamura,
   Tomonari/E-5712-2014
OI Kim, Hee Young/0000-0003-1981-6678; Miyazaki,
   Shuichi/0000-0003-3849-4176; 
CR Duerig T, 1999, MAT SCI ENG A-STRUCT, V273, P149, DOI 10.1016/S0921-5093(99)00294-4
   Grosdidier T, 2000, MAT SCI ENG A-STRUCT, V291, P218, DOI 10.1016/S0921-5093(00)00921-7
   HATT BA, 1968, J PHYS D APPL PHYS, V1, P1145, DOI 10.1088/0022-3727/1/9/307
   Inamura T, 2004, MATER TRANS, V45, P1083, DOI 10.2320/matertrans.45.1083
   Kim HY, 2006, MAT SCI ENG A-STRUCT, V438, P839, DOI 10.1016/j.msea.2006.02.136
   Kim HY, 2006, ACTA MATER, V54, P2419, DOI 10.1016/j.actamat.2006.01.019
   Kim HY, 2006, MAT SCI ENG A-STRUCT, V417, P120, DOI 10.1016/j.msea.2005.10.065
   Kim HY, 2006, ACTA MATER, V54, P423, DOI 10.1016/j.actamat.2005.09.014
   Kim HY, 2004, MATER TRANS, V45, P2443, DOI 10.2320/matertrans.45.2443
   Kim HY, 2004, MATER TRANS, V45, P1090, DOI 10.2320/matertrans.45.1090
   Kim JI, 2005, MAT SCI ENG A-STRUCT, V403, P334, DOI 10.1016/j.msea.2005.05.050
   Kim JI, 2005, MATER TRANS, V46, P852, DOI 10.2320/matertrans.46.852
   Kim Sang-Ha, 2006, Yonsei Med J, V47, P505
   Maeshima T, 2006, MATER TRANS, V47, P513, DOI 10.2320/matertrans.47.513
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Takahashi E, 2002, MATER TRANS, V43, P2978, DOI 10.2320/matertrans.43.2978
   Zhou T, 2004, SCRIPTA MATER, V50, P343, DOI 10.1016/j.scriptamat.2003.10.012
NR 17
TC 33
Z9 34
U1 1
U2 15
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD MAR
PY 2007
VL 48
IS 3
BP 400
EP 406
DI 10.2320/matertrans.48.400
PG 7
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 156PV
UT WOS:000245662400023
OA Bronze
DA 2018-10-20
ER

PT J
AU Chai, C
   Leong, KW
AF Chai, Chou
   Leong, Kam W.
TI Biomaterials approach to expand and direct differentiation of stem cells
SO MOLECULAR THERAPY
LA English
DT Review
ID ENDOTHELIAL PROGENITOR CELLS; MARROW STROMAL CELLS; IN-VITRO
   DIFFERENTIATION; HUMAN ADIPOSE-TISSUE; CALCIUM-PHOSPHATE CERAMICS;
   CORNEAL EPITHELIAL-CELLS; PRIMORDIAL GERM-CELLS; SMOOTH-MUSCLE-CELLS;
   SELF-RENEWAL; CHONDROGENIC DIFFERENTIATION
AB Stem cells play increasingly prominent roles in tissue engineering and regenerative medicine. Pluripotent embryonic stem (ES) cells theoretically allow every cell type in the body to be regenerated. Adult stem cells have also been identified and isolated from every major tissue and organ, some possessing apparent pluripotency comparable to that of ES cells. However, a major limitation in the translation of stem cell technologies to clinical applications is the supply of cells. Advances in biomaterials engineering and scaffold fabrication enable the development of ex vivo cell expansion systems to address this limitation. Progress in biomaterial design has also allowed directed differentiation of stem cells into specific lineages. In addition to delivering biochemical cues, various technologies have been developed to introduce micro- and nano-scale features onto culture surfaces to enable the study of stem cell responses to topographical cues. Knowledge gained from these studies portends the alteration of stem cell fate in the absence of biological factors, which would be valuable in the engineering of complex organs comprising multiple cell types. Biomaterials may also play an immunoprotective role by minimizing host immunoreactivity toward transplanted cells or engineered grafts.
C1 Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA.
   Duke NUS Grad Med Sch, Singapore, Singapore.
RP Leong, KW (reprint author), Duke Univ, Dept Biomed Engn, 136 Hudson Hall,Box 90281, Durham, NC 27708 USA.
EM kam.leong@duke.edu
RI Leong, Kam/A-7270-2009
OI Leong, Kam/0000-0002-8133-4955
FU NIBIB NIH HHS [R01 EB003447, R01 EB003447-01A1, EB003447]
CR Alhadlaq A, 2004, ANN BIOMED ENG, V32, P911, DOI 10.1023/B:ABME.0000032454.53116.ee
   Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221
   Ashjian PH, 2003, PLAST RECONSTR SURG, V111, P1922, DOI 10.1097/01.PRS.0000055043.62589.05
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   Bagley J, 1999, EXP HEMATOL, V27, P496, DOI 10.1016/S0301-472X(98)00053-8
   Banu N, 2001, CYTOKINE, V13, P349, DOI 10.1006/cyto.2001.0836
   Berrios VM, 2001, EXP HEMATOL, V29, P1326, DOI 10.1016/S0301-472X(01)00734-2
   Bielby RC, 2004, TISSUE ENG, V10, P1518, DOI 10.1089/ten.2004.10.1518
   Boland GM, 2004, J CELL BIOCHEM, V93, P1210, DOI 10.1002/jcb.20284
   Bonab MM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-14
   Bussolati B, 2005, AM J PATHOL, V166, P545, DOI 10.1016/S0002-9440(10)62276-6
   Charest JL, 2006, BIOMATERIALS, V27, P2487, DOI 10.1016/j.biomaterials.2005.11.022
   Chastain SR, 2006, J BIOMED MATER RES A, V78A, P73, DOI 10.1002/jbm.a.30686
   Chen X, 2006, STEM CELLS, V24, P2052, DOI 10.1634/stemcells.2005-0591
   Cheng SY, 2006, BIOTECHNOL BIOENG, V93, P1079, DOI 10.1002/bit.20817
   Cherqui S, 2006, STEM CELLS, V24, P44, DOI 10.1634/stemcells.2005-0070
   Cho JH, 2004, BIOMATERIALS, V25, P5743, DOI 10.1016/j.biomaterials.2004.01.051
   Cho SW, 2005, BIOMATERIALS, V26, P3577, DOI 10.1016/j.biomaterials.2004.09.013
   Clark BR, 1995, ANN NY ACAD SCI, V770, P70, DOI 10.1111/j.1749-6632.1995.tb31044.x
   Coles BLK, 2004, P NATL ACAD SCI USA, V101, P15772, DOI 10.1073/pnas.0401596101
   Cooper LF, 2000, J PROSTHET DENT, V84, P522, DOI 10.1067/mpr.2000.111966
   Curran JM, 2006, BIOMATERIALS, V27, P4783, DOI 10.1016/j.biomaterials.2006.05.001
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   CURTIS A, 1999, BIOCH SOC S, V65, P15
   CURTIS ASG, 1964, J NATL CANCER I, V33, P15
   Curtis ASG, 2004, IEEE T NANOBIOSCI, V3, P61, DOI 10.1109/TNB.2004.824276
   DACULSI G, 1989, J BIOMED MATER RES, V23, P883, DOI 10.1002/jbm.820230806
   DACULSI G, 1990, BIOMATERIALS, V11, P86
   Dalby MJ, 2000, J MATER SCI-MATER M, V11, P805, DOI 10.1023/A:1008957630020
   David L, 2005, J CRANIOFAC SURG, V16, P129, DOI 10.1097/00001665-200501000-00026
   Di Silvio L, 2002, BIOMATERIALS, V23, P101, DOI 10.1016/S0142-9612(01)00084-9
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7
   Ehring B, 2003, CYTOTHERAPY, V5, P490, DOI 10.1080/14653240310003585
   Ellinger R F, 1986, Int J Periodontics Restorative Dent, V6, P22
   Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103
   Endres M, 2003, TISSUE ENG, V9, P689, DOI 10.1089/107632703768247386
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Ersek RA, 1998, PLAST RECONSTR SURG, V101, P820, DOI 10.1097/00006534-199803000-00038
   Estes BT, 2004, CURR TOP DEV BIOL, V60, P91
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   Fan HB, 2006, BIOMATERIALS, V27, P4573, DOI 10.1016/j.biomaterials.2006.04.013
   Feng Q, 2006, J BIOMED MATER RES A, V78A, P781, DOI 10.1002/jbm.a.30829
   Geissler M, 2004, ADV MATER, V16, P1249, DOI 10.1002/adma.200400835
   George J, 2006, BIOTECHNOL BIOENG, V95, P404, DOI 10.1002/bit.20938
   Gerecht-Nir S, 2004, BIOTECHNOL BIOENG, V86, P493, DOI 10.1002/bit.20045
   Gerecht-Nir S, 2004, BIOTECHNOL BIOENG, V88, P313, DOI 10.1002/bit.20248
   Green D, 2003, TISSUE ENG, V9, P1159, DOI 10.1089/10763270360728062
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   Guilak F, 2006, J CELL PHYSIOL, V206, P229, DOI 10.1002/jcp.20463
   Guo XM, 2004, TISSUE ENG, V10, P1818, DOI 10.1089/ten.2004.10.1818
   Hall VJ, 2006, STEM CELLS, V24, P1628, DOI 10.1634/stemcells.2005-0592
   Harrison J, 2004, BIOMATERIALS, V25, P4963, DOI 10.1016/j.biomaterials.2004.01.054
   Hasenbein ME, 2002, BIOMATERIALS, V23, P3937, DOI 10.1016/S0142-9612(02)00129-1
   Hattori H, 2004, CELLS TISSUES ORGANS, V178, P2, DOI 10.1159/000081088
   Hattori H, 2006, J BIOMED MATER RES B, V76B, P230, DOI 10.1002/jbm.b.30357
   Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x
   Hayman MW, 2005, J BIOCHEM BIOPH METH, V62, P231, DOI 10.1016/j.jbbm.2004.12.001
   He HB, 2003, J THORAC CARDIOV SUR, V126, P455, DOI 10.1016/S0022-5223(02)73264-9
   He W, 2005, TISSUE ENG, V11, P1574, DOI 10.1089/ten.2005.11.1574
   Hemmrich K, 2005, BIOMATERIALS, V26, P7025, DOI 10.1016/j.biomaterials.2005.04.065
   Hermann A, 2004, J CELL SCI, V117, P4411, DOI 10.1242/jcs.01307
   Herrera MB, 2006, STEM CELLS, V24, P2840, DOI 10.1634/stemcells.2006-0114
   Hicok KC, 2004, TISSUE ENG, V10, P371, DOI 10.1089/107632704323061735
   Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2
   Huang CYC, 2004, ANAT REC PART A, V278A, P428, DOI 10.1002/ar.a.20010
   Huang NF, 2006, NANO LETT, V6, P537, DOI 10.1021/nl060060o
   Humes HD, 2004, TRANSPL IMMUNOL, V12, P219, DOI 10.1016/j.trim.2003.12.015
   Ingram DA, 2005, BLOOD, V105, P2783, DOI 10.1182/blood-2004-08-3057
   Jeffcoat MK, 2003, INT J ORAL MAX IMPL, V18, P406
   Jeong B, 2002, ADV DRUG DELIVER REV, V54, P37, DOI 10.1016/S0169-409X(01)00242-3
   Jiang XS, 2006, BIOMATERIALS, V27, P2723, DOI 10.1016/j.biomaterials.2005.12.001
   Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870
   Kallos MS, 1999, BIOTECHNOL BIOENG, V65, P589, DOI 10.1002/(SICI)1097-0290(19991205)65:5<589::AID-BIT12>3.0.CO;2-S
   Kanemura Y, 2002, J NEUROSCI RES, V69, P869, DOI 10.1002/jnr.10377
   Karuri NW, 2004, J CELL SCI, V117, P3153, DOI 10.1242/jcs.01146
   Kaushal S, 2001, NAT MED, V7, P1035, DOI 10.1038/nm0901-1035
   Kenar H, 2006, BIOMATERIALS, V27, P885, DOI 10.1016/j.biomaterials.2005.07.001
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Khakoo AY, 2005, ANNU REV MED, V56, P79, DOI 10.1146/annurev.med.56.090203.104149
   Kilpadi KL, 2001, J BIOMED MATER RES, V57, P258, DOI 10.1002/1097-4636(200111)57:2<258::AID-JBM1166>3.0.CO;2-R
   Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754
   Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711
   Kotobuki N, 2005, BIOMATERIALS, V26, P779, DOI 10.1016/j.biomaterials.2004.03.020
   Lee JA, 2003, ANN PLAS SURG, V50, P610, DOI 10.1097/01.SAP.0000069069.23266.35
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Lenhert S, 2005, BIOMATERIALS, V26, P563, DOI 10.1016/j.biomaterials.2004.02.068
   Levenberg S, 2005, TISSUE ENG, V11, P506, DOI 10.1089/ten.2005.11.506
   Levenberg S, 2002, P NATL ACAD SCI USA, V99, P4391, DOI 10.1073/pnas.032074999
   Levenberg S, 2003, P NATL ACAD SCI USA, V100, P12741, DOI 10.1073/pnas.1735463100
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Li YL, 2005, J BIOMED MATER RES A, V73A, P171, DOI 10.1002/jbm.a.30286
   Liew A, 2006, BIOESSAYS, V28, P261, DOI 10.1002/bies.20372
   Lindahl Anders, 2003, Novartis Found Symp, V249, P175
   LINDVALL G, 2006, NATURE, V441, P1094
   Lisignoli G, 2006, J BIOMED MATER RES A, V77A, P497, DOI 10.1002/jbm.a.30632
   Lisignoli G, 2006, J CELL PHYSIOL, V207, P364, DOI 10.1002/jcp.20572
   Lisignoli G, 2005, BIOMATERIALS, V26, P5677, DOI 10.1016/j.biomaterials.2005.02.031
   LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074
   Lu J, 2006, P NATL ACAD SCI USA, V103, P5688, DOI 10.1073/pnas.0601383103
   Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177
   Ma W, 2004, EXP NEUROL, V190, P276, DOI 10.1016/j.expneurol.2003.10.016
   Maguire T, 2006, BIOTECHNOL BIOENG, V93, P581, DOI 10.1002/bit.20748
   Malafaya PB, 2005, J MATER SCI-MATER M, V16, P1077, DOI 10.1007/s10856-005-4709-4
   Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Meinel L, 2004, BIOTECHNOL BIOENG, V88, P379, DOI 10.1002/bit.20252
   Mendes SC, 2002, TISSUE ENG, V8, P911, DOI 10.1089/107632702320934010
   Mitalipov SM, 2006, METH MOL B, V348, P151
   Muller FA, 2006, BIOMATERIALS, V27, P3955, DOI 10.1016/j.biomaterials.2006.02.031
   Murohara T, 2000, J CLIN INVEST, V105, P1527, DOI 10.1172/JCI8296
   Murphy WL, 2005, BIOMATERIALS, V26, P303, DOI 10.1016/j.biomaterials.2004.02.034
   Murthy N, 2003, P NATL ACAD SCI USA, V100, P4995, DOI 10.1073/pnas.0930644100
   NIECHAJEV I, 1994, PLAST RECONSTR SURG, V94, P496, DOI 10.1097/00006534-199409000-00012
   Niemeyer P, 2004, CELLS TISSUES ORGANS, V177, P68, DOI 10.1159/000079182
   Nienhuis AW, 2006, MOL THER, V13, P1031, DOI 10.1016/j.ymthe.2006.03.001
   Norgren Robert B Jr, 2004, Reprod Biol Endocrinol, V2, P40, DOI 10.1186/1477-7827-2-40
   Norman J, 2006, ANN BIOMED ENG, V34, P89, DOI 10.1007/s10439-005-9005-4
   Nur-E-Kamal A, 2006, STEM CELLS, V24, P426, DOI 10.1634/stemcells.2005-0170
   OHGUSHI H, 1992, J BIOMED MATER RES, V26, P885, DOI 10.1002/jbm.820260705
   Oliva AA, 2003, NEUROCHEM RES, V28, P1639
   Oswald J, 2006, STEM CELLS, V24, P494, DOI 10.1634/stemcells.2005-0276
   Otero JJ, 2004, DEVELOPMENT, V131, P3545, DOI 10.1242/dev.01218
   Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751
   PASSUTI N, 1989, CLIN ORTHOP RELAT R, P169
   Patrick CW, 1999, TISSUE ENG, V5, P139, DOI 10.1089/ten.1999.5.139
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Planat-Benard V, 2004, CIRCULATION, V109, P656, DOI 10.1161/01.CIR.0000114522.38265.61
   Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702
   Raghavan S, 2004, ADV MATER, V16, P1303, DOI 10.1002/adma.200400594
   Rangappa S, 2003, ANN THORAC SURG, V75, P775, DOI 10.1016/S0003-4975(02)04568-X
   Ratajczak J, 2006, LEUKEMIA, V20, P847, DOI 10.1038/sj.leu.2404132
   Recknor JB, 2006, BIOMATERIALS, V27, P4098, DOI 10.1016/j.biomaterials.2006.03.029
   RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0
   Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134
   Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593
   Richardson SM, 2006, STEM CELLS, V24, P707, DOI 10.1634/stemcells.2005-0205
   Richardson SM, 2006, BIOMATERIALS, V27, P4069, DOI 10.1016/j.biomaterials.2006.03.017
   ROSENBERG MD, 1963, SCIENCE, V139, P411, DOI 10.1126/science.139.3553.411
   Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389
   Santiago LY, 2006, BIOMATERIALS, V27, P2962, DOI 10.1016/j.biomaterials.2006.01.011
   Schmidt D, 2005, EUR J CARDIO-THORAC, V27, P795, DOI 10.1016/j.ejcts.2005.01.064
   Schultz SS, 2006, J NEUROSCI METH, V152, P144, DOI 10.1016/j.jneumeth.2005.08.022
   Sen A, 2002, BIOTECHNOL PROGR, V18, P337, DOI 10.1021/bp010150t
   Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726
   SHELTON BM, 2006, BIOMATERIALS, V27, P2874
   Shepherd BE, 2004, EXP HEMATOL, V32, P1040, DOI 10.1016/j.exphem.2004.07.023
   Shim J, 2003, CURR TOP MED CHEM, V3, P687, DOI 10.2174/1568026033452393
   Shimoboji T, 2002, P NATL ACAD SCI USA, V99, P16592, DOI 10.1073/pnas.262427799
   Shirota T, 2003, TISSUE ENG, V9, P473, DOI 10.1089/107632703322066651
   Shirota T, 2003, BIOMATERIALS, V24, P2295, DOI 10.1016/S0142-9612(03)00042-5
   Shirota T, 2003, TISSUE ENG, V9, P127, DOI 10.1089/107632703762687609
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Snyder BJ, 2005, CURR OPIN NEUROL, V18, P376, DOI 10.1097/01.wco.0000174298.27765.91
   Sreerekha PR, 2006, ARTIF ORGANS, V30, P242, DOI 10.1111/j.1525-1594.2006.00211.x
   Suva D, 2004, J CELL PHYSIOL, V198, P110, DOI 10.1002/jcp.10396
   Svendsen CN, 1999, BRAIN PATHOL, V9, P499, DOI 10.1111/j.1750-3639.1999.tb00538.x
   Takahashi T, 1999, NAT MED, V5, P434
   Tangvoranuntakul P, 2003, P NATL ACAD SCI USA, V100, P12045, DOI 10.1073/pnas.2131556100
   Teixeira AI, 2006, BIOMATERIALS, V27, P3945, DOI 10.1016/j.biomaterials.2006.01.044
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   Todorov I, 2005, TRANSPL P, V37, P3420, DOI 10.1016/j.transproceed.2005.09.088
   van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a
   von Heimburg D., 2003, International Journal of Artificial Organs, V26, P1064
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   WEISS P, 1945, J EXP ZOOL, V100, P353, DOI 10.1002/jez.1401000305
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
   Wislet-Gendebien S, 2005, BRAIN RES BULL, V68, P95, DOI 10.1016/j.brainresbull.2005.08.016
   Wollenweber M, 2006, TISSUE ENG, V12, P345, DOI 10.1089/ten.2006.12.345
   Woodbury D, 2002, J NEUROSCI RES, V69, P908, DOI 10.1002/jnr.10365
   Wu X, 2004, AM J PHYSIOL-HEART C, V287, pH480, DOI 10.1152/ajpheart.01232.2003
   Xiao L, 2006, STEM CELLS, V24, P1476, DOI 10.1634/stemcells.2005-0299
   Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971
   Yamamoto M, 2006, ADV DRUG DELIVER REV, V58, P535, DOI 10.1016/j.addr.2006.03.003
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yao S, 2006, P NATL ACAD SCI USA, V103, P6907, DOI 10.1073/pnas.0602280103
   Yeong WY, 2004, TRENDS BIOTECHNOL, V22, P643, DOI 10.1016/j.tibtech.2004.10.004
   Yim EKF, 2006, ACTA BIOMATER, V2, P365, DOI 10.1016/j.actbio.2006.03.006
   Yim EKF, 2005, J BIOMAT SCI-POLYM E, V16, P1193, DOI 10.1163/156856205774269485
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
   Yoshida R, 2005, BIOMACROMOLECULES, V6, P2923, DOI 10.1021/bm050398x
   Yu H, 2006, AM J PATHOL, V168, P1879, DOI 10.2353/ajpath.2006.051170
   Yu H, 2003, J VASC SURG, V38, P557, DOI 10.1016/S0741-5214(03)00334-3
   Zhang K, 2002, J BIOMED MATER RES, V61, P551, DOI 10.1002/jbm.10227
   Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129
   Zhang YZ, 2005, J MATER SCI-MATER M, V16, P933, DOI 10.1007/s10856-005-4428-x
   Zhao F, 2006, BIOMATERIALS, V27, P1859, DOI 10.1016/j.biomaterials.2005.09.031
   Zhao LR, 2002, EXP NEUROL, V174, P11, DOI 10.1006/exnr.2001.7853
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
NR 193
TC 176
Z9 183
U1 1
U2 55
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA
SN 1525-0016
J9 MOL THER
JI Mol. Ther.
PD MAR
PY 2007
VL 15
IS 3
BP 467
EP 480
DI 10.1038/sj.mt.6300084
PG 14
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine,
   Research & Experimental
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Research &
   Experimental Medicine
GA 139AZ
UT WOS:000244405700010
PM 17264853
OA Other Gold, Green Accepted
DA 2018-10-20
ER

PT J
AU Cowan, CM
   Aghaloo, T
   Chou, YF
   Walder, B
   Zhang, XL
   Soo, C
   Ting, K
   Wu, B
AF Cowan, Catherine M.
   Aghaloo, Tara
   Chou, Yu-Fen
   Walder, Benjamin
   Zhang, Xinli
   Soo, Chia
   Ting, Kang
   Wu, Benjamin
TI MicroCT evaluation of three-dimensional mineralization in response to
   BMP-2 doses in vitro and in critical sized rat calvarial defects
SO TISSUE ENGINEERING
LA English
DT Article
ID BONE MORPHOGENETIC PROTEIN-2; MESENCHYMAL STEM-CELLS; EXPERIMENTAL
   SPINAL-FUSION; PLATELET-RICH PLASMA; OSTEOGENIC DIFFERENTIATION;
   DELIVERY SYSTEMS; AUTOGENOUS BONE; GROWTH-FACTOR; SIALOPROTEIN; VIVO
AB Numerous growth factors, peptides, and small molecules are being developed for bone tissue engineering. The optimal dosing, stability, and bioactivity of these biological molecules are likely influenced by the carrier biomaterial. Efficient evaluation of various formulations will require objective evaluation of in vitro culture systems and in vivo regeneration models. The objective of this paper is to examine the utility of microcomputed tomography (microCT) over conventional techniques in the evaluation of the bone morphogenetic protein-2 (BMP-2) dose response effect in a three-dimensional (3D) in vitro culture system and in an established calvarial defect model. Cultured MC3T3-E1 osteoblasts displayed increased cellular density, extracellular matrix (ECM) production, and mineralization on 3D poly(lactic-co-glycolic acid) (PLGA) scaffolds in a BMP-2 dose dependent manner. MicroCT revealed differences in shape and spatial organization of mineralized areas, which would not have been possible through conventional alizarin red staining alone. Additionally, BMP-2 (doses of 30 to 240 ng/mm(3)) was grafted into 5 mm critical sized rat calvarial defects, where increased bone regeneration was observed in a dose dependent manner, with higher doses of BMP- 2 inducing greater bone area, volume, and density. The data revealed the utility of microCT analysis as a beneficial addition to existing techniques for objective evaluation of bone tissue engineering and regeneration.
C1 Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA.
   Univ Calif Los Angeles, Dent & Craniofacial Res Inst, Los Angeles, CA 90095 USA.
   Univ Calif Los Angeles, Sect Orthodont, Sch Dent, Los Angeles, CA 90095 USA.
   Univ So Calif, Dept Plast & Reconstruct Surg, Los Angeles, CA USA.
   Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90095 USA.
RP Wu, B (reprint author), Univ Calif Los Angeles, Dept Bioengn, 420 Westwood Plaza 7523 Boelter Hall, Los Angeles, CA 90095 USA.
EM benwu@ucla.edu
FU NIDCR NIH HHS [R03 DE014649, R01 DE016107, K23DE00422]
CR Aghaloo T, 2006, AM J PATHOL, V169, P903, DOI 10.2353/ajpath.2006.051210
   Al Ruhaimi KA, 2001, J ORAL MAXIL SURG, V59, P1319, DOI 10.1053/joms.2001.27526
   BARDACH J, 1990, MULTIDISCIPLINARY MA, P134
   Berger F, 2002, EUR J NUCL MED MOL I, V29, P1225, DOI 10.1007/s00259-002-0850-1
   Borah B, 2000, J BONE MINER RES, V15, P1786, DOI 10.1359/jbmr.2000.15.9.1786
   Bosch C, 1998, J CRANIOFAC SURG, V9, P310, DOI 10.1097/00001665-199807000-00004
   Bostrom R, 1997, TISSUE ENG BONE, V1
   Bottaro DP, 2002, ANN NY ACAD SCI, V961, P143, DOI 10.1111/j.1749-6632.2002.tb03068.x
   CANADY JW, 1993, CLEFT PALATE-CRAN J, V30, P579, DOI 10.1597/1545-1569(1993)030<0579:SOTICA>2.3.CO;2
   CHEN JK, 1992, J BONE MINER RES, V7, P987
   Chen Y, 2002, BIOCHEM BIOPH RES CO, V298, P121, DOI 10.1016/S0006-291X(02)02394-X
   Cohen Jr MM, 2000, CRANIOSYNOSTOSIS DIA, P316
   Cowan CM, 2005, CURR TOP DEV BIOL, V66, P239, DOI 10.1016/S0070-2153(05)66008-5
   Cowan CM, 2005, TISSUE ENG, V11, P645, DOI 10.1089/ten.2005.11.645
   Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958
   ENNEKING WF, 1991, J BONE JOINT SURG AM, V73A, P1123, DOI 10.2106/00004623-199173080-00002
   Fong KD, 2003, J CRANIOFAC SURG, V14, P333, DOI 10.1097/00001665-200305000-00011
   Franceschi RT, 2005, J DENT RES, V84, P1093, DOI 10.1177/154405910508401204
   FRAZZA E J, 1971, Journal of Biomedical Materials Research Biomedical Materials Symposium, V1, P43
   FRODEL JL, 1993, ARCH OTOLARYNGOL, V119, P17
   FUJISAWA R, 1992, CALCIFIED TISSUE INT, V51, P438
   Gravel M, 2006, TISSUE ENG, V12, P589, DOI 10.1089/ten.2006.12.589
   GREGORY CF, 1972, CLIN ORTHOP RELAT R, P165
   Han DK, 1997, MACROMOLECULES, V30, P6077, DOI 10.1021/ma970302u
   Hanada K, 1997, J BONE MINER RES, V12, P1606, DOI 10.1359/jbmr.1997.12.10.1606
   Hedberg EL, 2005, J BIOMED MATER RES A, V72A, P343, DOI 10.1002/jbm.a.30265
   Hosseinkhani H, 2006, BIOMATERIALS, V27, P4079, DOI 10.1016/j.biomaterials.2006.03.030
   Huang WB, 2004, EXP CELL RES, V299, P325, DOI 10.1016/j.yexcr.2004.04.051
   Jiang Y., 2000, Journal of Musculoskeletal & Neuronal Interactions, V1, P45
   Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298
   KENLEY R, 1994, J BIOMED MATER RES, V28, P1139, DOI 10.1002/jbm.820281004
   Kha HT, 2004, J BONE MINER RES, V19, P830, DOI 10.1359/JBMR.040115
   Langenfeld EM, 2004, MOL CANCER RES, V2, P141
   Lee JY, 2001, J BONE JOINT SURG AM, V83A, P1032, DOI 10.2106/00004623-200107000-00008
   Link Thomas M, 2002, Semin Musculoskelet Radiol, V6, P253, DOI 10.1055/s-2002-36723
   MARDEN LJ, 1994, J BIOMED MATER RES, V28, P1127, DOI 10.1002/jbm.820281003
   Mehrara BJ, 2002, PLAST RECONSTR SURG, V110, P506, DOI 10.1097/00006534-200208000-00022
   Moreira-Gonzalez A, 2003, J CRANIOFAC SURG, V14, P144, DOI 10.1097/00001665-200303000-00003
   MULLIKEN JB, 1980, PLAST RECONSTR SURG, V65, P553, DOI 10.1097/00006534-198005000-00001
   OLDBERG A, 1988, J BIOL CHEM, V263, P19430
   SAITO A, 2003, J BIOMED MATER RES A, V77, P700
   Sandhu HS, 1996, SPINE, V21, P2115, DOI 10.1097/00007632-199609150-00012
   Sandhu HS, 1997, SPINE, V22, P1171, DOI 10.1097/00007632-199706010-00001
   Schlegel KA, 2004, BIOMATERIALS, V25, P5387, DOI 10.1016/j.biomaterials.2003.12.043
   Schmoekel H, 2004, J ORTHOPAED RES, V22, P376, DOI 10.1016/S0736-0266(03)00188-8
   Thomsen JS, 2005, J MICROSC-OXFORD, V218, P171, DOI 10.1111/j.1365-2818.2005.01469.x
   Uludag H, 2001, J BONE JOINT SURG AM, V83A, pS128
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Varkey M, 2006, CLIN ORTHOP RELAT R, P113, DOI 10.1097/01.blo.0000200236.84189.87
   Wang J, 1998, BONE, V22, P621, DOI 10.1016/S8756-3282(98)00057-X
   Wiltfang J, 2004, CLIN ORAL IMPLAN RES, V15, P187, DOI 10.1111/j.1600-0501.2004.00980.x
   WINTER GD, 1969, NATURE, V223, P88, DOI 10.1038/223088a0
   Yang SY, 2003, J BONE MINER RES, V18, P705, DOI 10.1359/jbmr.2003.18.4.705
   Yang XBB, 2004, TISSUE ENG, V10, P1148, DOI 10.1089/1076327041887871
   Zhang XL, 2002, J CLIN INVEST, V110, P861, DOI 10.1172/JCI200215375
NR 55
TC 98
Z9 106
U1 0
U2 22
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD MAR
PY 2007
VL 13
IS 3
BP 501
EP 512
DI 10.1089/ten.2006.0141
PG 12
WC Cell & Tissue Engineering
SC Cell Biology
GA 153VO
UT WOS:000245464500007
PM 17319794
DA 2018-10-20
ER

PT J
AU Kim, SH
   Akaike, T
AF Kim, Sang-Heon
   Akaike, Toshihiro
TI Epidermal growth factor signaling for matrix-dependent cell
   proliferation and differentiation in primary cultured hepatocytes
SO TISSUE ENGINEERING
LA English
DT Article
ID SYNTHETIC GLYCOPOLYMER MATRIX; RAT HEPATOCYTES; EXTRACELLULAR-MATRIX;
   ASIALOGLYCOPROTEIN RECEPTOR; PARTIAL-HEPATECTOMY; GENE TRANSFECTION;
   ADHESION; LIVER; TRANSDUCTION; EFFICIENCY
AB Understanding hepatocellular signaling occurring in biomaterial systems is important for successful hepatic tissue engineering. Toward this end, we employed synthetic glycopolymers, as artificial matrices, to examine integrin-mediated epidermal growth factor (EGF) signaling in primary hepatocyte cultures. We dispersed hepatocytes on a collagen matrix or on a synthetic glycopolymer matrix and subsequently stimulated them with EGF. Only hepatocytes cultured on collagen proliferated, and we observed significant expression of cyclin B1 in these cells. Pharmacological agents, LY294004 (a phosphatidylinositol [PI] 3-kinase inhibitor) and AG1478 (an EGF kinase receptor inhibitor), blocked hepatocyte proliferation and cyclin B1 expression. In addition, EGF-stimulated hepatocytes formed spheroids, exhibited membrane ruffling, and increased tryptophan 2,3-oxygenase (TO) expression when cultured on glycopolymer matrices. Interestingly, PI 3-kinase inhibition suppressed membrane ruffling, spheroid formation, and TO expression. Taken together, this data suggests PI 3-kinase plays an important role in mediating cross talk between integrin and the EGF signaling pathways in primary hepatocyte cultures.
C1 Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biomol Engn, Midori Ku, Yokohama, Kanagawa 2268501, Japan.
   Korea Inst Sci & Technol, Biomat Res Ctr, Seoul 130650, South Korea.
RP Akaike, T (reprint author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biomol Engn, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268501, Japan.
EM takaike@bio.titech.ac.jp
CR Adams JC, 2002, J CELL SCI, V115, P257
   Ajioka I, 2002, J CELL BIOCHEM, V84, P249, DOI 10.1002/jcb.10012
   ALESSI D, 1996, EMBO J, V23, P6541
   Alisi A, 2003, CELL PHYSIOL BIOCHEM, V13, P239, DOI 10.1159/000072427
   Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7
   Cook AD, 1997, J BIOMED MATER RES, V35, P513
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   GULLBERG D, 1990, EXP CELL RES, V190, P254, DOI 10.1016/0014-4827(90)90194-F
   Hackel PO, 1999, CURR OPIN CELL BIOL, V11, P184, DOI 10.1016/S0955-0674(99)80024-6
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   INOUE C, 1989, J BIOL CHEM, V264, P4747
   Katz BZ, 1997, BIOCHIMIE, V79, P467, DOI 10.1016/S0300-9084(97)82738-1
   KENNEDY S, 1995, HEPATOLOGY, V22, P160, DOI 10.1002/hep.1840220126
   Kim SH, 2004, BIOMATERIALS, V25, P1813, DOI 10.1016/j.biomaterials.2003.08.035
   Kim SH, 2003, J BIOMED MATER RES A, V67A, P1351, DOI 10.1002/jbm.a.10166
   Kim SH, 2003, FEBS LETT, V553, P433, DOI 10.1016/S0014-5793(03)01047-0
   Kim SH, 2001, J BIOL CHEM, V276, P35312, DOI 10.1074/jbc.M009749200
   Kim SH, 2000, BIOTECHNOL LETT, V22, P1049, DOI 10.1023/A:1005641928736
   KOBAYASHI A, 1986, MAKROMOL CHEM-RAPID, V7, P645
   Lee JW, 2004, MOL CELLS, V17, P188
   Moriuchi A, 2001, BIOCHEM BIOPH RES CO, V280, P368, DOI 10.1006/bbrc.2000.4063
   ODA H, 1995, BIOCHEM BIOPH RES CO, V212, P800, DOI 10.1006/bbrc.1995.2039
   Otsu K, 2001, CELL PHYSIOL BIOCHEM, V11, P33, DOI 10.1159/000047790
   Prasmickaite L, 2002, BBA-GEN SUBJECTS, V1570, P210, DOI 10.1016/S0304-4165(02)00202-7
   Pricer W E Jr, 1974, Methods Enzymol, V34, P688
   RANIERI JP, 1995, J BIOMED MATER RES, V29, P779, DOI 10.1002/jbm.820290614
   RHIM JA, 1995, P NATL ACAD SCI USA, V92, P4942, DOI 10.1073/pnas.92.11.4942
   Schwartz MA, 1999, CURR OPIN CELL BIOL, V11, P197, DOI 10.1016/S0955-0674(99)80026-X
   Serandour AL, 2005, HEPATOLOGY, V41, P478, DOI 10.1002/hep.20602
   Sharma GD, 2005, J BIOL CHEM, V280, P7917, DOI 10.1074/jbc.M408852200
   Skarpen E, 2005, J CELL PHYSIOL, V202, P707, DOI 10.1002/jcp.20171
   Smets FN, 2002, MOL GENET METAB, V75, P344, DOI 10.1016/S1096-7192(02)00004-5
   STOCKERT RJ, 1995, PHYSIOL REV, V75, P591
   Takizawa CG, 2000, CURR OPIN CELL BIOL, V12, P658, DOI 10.1016/S0955-0674(00)00149-6
   Watanabe Y, 1998, CYTOTECHNOLOGY, V26, P65, DOI 10.1023/A:1007954721159
   Wong WSF, 2005, CURR OPIN PHARMACOL, V5, P264, DOI 10.1016/j.coph.2005.01.009
NR 37
TC 8
Z9 8
U1 0
U2 5
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD MAR
PY 2007
VL 13
IS 3
BP 601
EP 609
DI 10.1089/ten.2006.0104
PG 9
WC Cell & Tissue Engineering
SC Cell Biology
GA 153VO
UT WOS:000245464500015
PM 17518606
DA 2018-10-20
ER

PT J
AU Wu, YN
   Yu, HR
   Chang, S
   Magalhaes, R
   Kuleshova, LL
AF Wu, Yingnan
   Yu, Hanry
   Chang, Shi
   Magalhaes, Raquel
   Kuleshova, Lilia L.
TI Vitreous cryopreservation of cell-biomaterial constructs involving
   encapsulated hepatocytes
SO TISSUE ENGINEERING
LA English
DT Article; Proceedings Paper
CT Symposium on New Trend in Biomaterials - Tissue Engineering
CY JUL09, 2005
CL Natl Univ Singapore, Singapore, SINGAPORE
HO Natl Univ Singapore
ID VITRIFICATION SOLUTION; RAT HEPATOCYTES; EMBRYO CRYOPRESERVATION;
   METABOLISM CAPACITY; ETHYLENE-GLYCOL; MOUSE EMBRYOS; LOW TOXICITY;
   VIABILITY; TRANSPLANTATION; SURVIVAL
AB We put forward a new strategy for cryopreservation, namely vitrification or ice-free preservation, of cell biomaterial constructs for tissue-engineering applications. In this study, for a period of 6 days, we tested vitrified and control hepatocytes entrapped at 2 different cell densities (1.5 x 10(6) and 5 x 10(6) cells/mL) in 2 types of engineered collagen matrices (M- and G-collagen) as models to evaluate efficacy and universality of the developed vitrification method. The nature of collagens caused differences in capsule sizes (100-200 mu m versus 350-450 mu m). The developed method included rapid step-wise introduction of micro-encapsulated hepatocytes to vitrification solution (40 v/v% ethylene glycol 0.6 M sucrose in medium) and their direct immersion in liquid nitrogen. Vitrification did not affect viability and functions of the micro-encapsulated hepatocytes, which exhibited trends similar to those of untreated controls in the decline of their functions and the rate of cell death during continuous culture, irrespective of physical and chemical properties of the biomaterial and cell density. For control and vitrification, the percentage of live cells varied from 80.3% +/- 0.9% to 82.3% +/- 1.4% in capsules formed by M- collagen, from 82.8% +/- 1.1% to 85.0% +/- 3.3% in capsules formed by G-collagen with cells entrapped at low density, and from 84.4% +/- 1.3% to 86.8% +/- 0.6% in capsules formed by G-collagen with cells entrapped at high density (p > 0.05). Within the same day, the maximum relative change in cell viability and functions between control and vitrification was 4% and 16%, respectively. The developed vitrification approach, which is an alternative to freezing, can be applied to other tissue-engineered constructs with comparable sizes, various cell numbers, and various properties of the biomaterials involved.
C1 Natl Univ Singapore, Low Temp Preservat Unit, Natl Univ Med Inst, Yong Loo Lin Sch Med, Singapore 117597, Singapore.
   Natl Univ Singapore, Dept Physiol, Yong Loo Lin Sch Med, Singapore 117597, Singapore.
   Agcy Sci Technol & Res, Inst Bioengn & Nanotechnol, Singapore, Singapore.
   Cent S Univ, Xiang Ya Hosp, Dept Gen Surg, Changsha, Hunan, Peoples R China.
   Natl Univ Singapore, Yong Loo Lin Sch Med, Tissue Engn Programme, Singapore 117597, Singapore.
RP Kuleshova, LL (reprint author), Natl Univ Singapore, Low Temp Preservat Unit, Natl Univ Med Inst, Yong Loo Lin Sch Med, Block MD11 03-01C,10 Med Dr, Singapore 117597, Singapore.
EM nmikl@nus.edu.sg
RI Yu, Hanry/C-1031-2013
OI Yu, Hanry/0000-0002-0339-3685
CR ALI J, 1993, J REPROD FERTIL, V99, P65
   Aoki T, 2005, CELL TRANSPLANT, V14, P609, DOI 10.3727/000000005783982710
   Chia SM, 2000, TISSUE ENG, V6, P481, DOI 10.1089/107632700750022134
   Dahl SLM, 2006, TISSUE ENG, V12, P291, DOI 10.1089/ten.2006.12.291
   Darr TB, 2001, CRYOBIOLOGY, V42, P11, DOI 10.1006/cryo.2001.2295
   DELOECKER P, 1993, CRYOBIOLOGY, V30, P12, DOI 10.1006/cryo.1993.1002
   DEMETRIOU AA, 1986, P NATL ACAD SCI USA, V83, P7475, DOI 10.1073/pnas.83.19.7475
   DIXIT V, 1993, TRANSPLANTATION, V55, P616, DOI 10.1097/00007890-199303000-00028
   DUNN JCY, 1991, BIOTECHNOL PROGR, V7, P237, DOI 10.1021/bp00009a007
   Ekins S, 1996, CRYO-LETT, V17, P7
   Fahy GM, 2004, CRYOBIOLOGY, V48, P157, DOI 10.1016/j.cryobiol.2004.02.002
   Fahy GM, 2004, CRYOBIOLOGY, V48, P22, DOI 10.1016/j.cryobiol.2003.11.004
   Fautrel A, 1997, TOXICOL APPL PHARM, V147, P110, DOI 10.1006/taap.1997.8253
   Fiegel HC, 2004, TISSUE ENG, V10, P165, DOI 10.1089/107632704322791817
   FOY BD, 1993, BIOTECHNOL BIOENG, V42, P579, DOI 10.1002/bit.260420505
   Fuller BJ, 2004, CRYOLETTERS, V25, P375
   Guillouzo A, 1999, CHEM-BIOL INTERACT, V121, P7, DOI 10.1016/S0009-2797(99)00087-3
   Guyomard C, 1996, TOXICOL APPL PHARM, V141, P349, DOI 10.1006/taap.1996.0299
   Heng BC, 2004, J MICROENCAPSUL, V21, P455, DOI 10.1080/02652040410001729250
   Hubel A, 2001, BIOTECHNOL BIOENG, V71, P173, DOI 10.1002/1097-0290(2000)71:3<173::AID-BIT1007>3.0.CO;2-2
   KASAI M, 1990, J REPROD FERTIL, V89, P91
   Koebe HG, 1996, CRYOBIOLOGY, V33, P127, DOI 10.1006/cryo.1996.0013
   Koebe HG, 1999, CHEM-BIOL INTERACT, V121, P99, DOI 10.1016/S0009-2797(99)00093-9
   Kuleshova L, 1999, HUM REPROD, V14, P3077, DOI 10.1093/humrep/14.12.3077
   Kuleshova LL, 2004, CRYOLETTERS, V25, P241
   Kuleshova LL, 2001, CRYOBIOLOGY, V43, P21, DOI 10.1006/cryo.2001.2335
   Kuleshova LL, 2000, HUM REPROD, V15, P2604, DOI 10.1093/humrep/15.12.2604
   Kuleshova LL, 1999, CRYOBIOLOGY, V38, P119, DOI 10.1006/cryo.1999.2153
   Lanza RP, 1997, SURGERY, V121, P1, DOI 10.1016/S0039-6060(97)90175-6
   Lu HF, 2005, TISSUE ENG, V11, P1667, DOI 10.1089/ten.2005.11.1667
   MAGANTO P, 1990, J SURG RES, V48, P24, DOI 10.1016/0022-4804(90)90140-W
   McKay GC, 2002, TOXICOL IN VITRO, V16, P71, DOI 10.1016/S0887-2333(01)00096-0
   MEDZIHRADSKY F, 1975, BIOCHEM MED METAB B, V13, P164, DOI 10.1016/0006-2944(75)90152-0
   Mukaida T, 1998, HUM REPROD, V13, P2874, DOI 10.1093/humrep/13.10.2874
   Ng S, 2005, BIOMATERIALS, V26, P3153, DOI 10.1016/j.biomaterials.2004.08.017
   Rialland L, 2000, CELL BIOL TOXICOL, V16, P105, DOI 10.1023/A:1007690009927
   ROSENBERG DW, 1990, ANAL BIOCHEM, V191, P354, DOI 10.1016/0003-2697(90)90231-W
   Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5
   Shaw JM, 1997, CRYOBIOLOGY, V35, P219, DOI 10.1006/cryo.1997.2043
   SMITH AU, 1950, NATURE, V166, P668, DOI 10.1038/166668a0
   Song YC, 2000, NAT BIOTECHNOL, V18, P296
   Stevenson DJ, 2004, CRYOBIOLOGY, V49, P97, DOI 10.1016/j.cryobiol.2004.05.006
   VALDEZ CA, 1992, J REPROD FERTIL, V96, P793
   Wu FJ, 1999, CELL TRANSPLANT, V8, P233, DOI 10.1177/096368979900800304
   WU Y, 2005, THESIS NATL U SINGAP
   Yu SH, 1999, BIOTECHNOL TECH, V13, P609, DOI 10.1023/A:1008922607119
NR 46
TC 36
Z9 37
U1 0
U2 5
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2152-4947
J9 TISSUE ENG
JI Tissue Eng.
PD MAR
PY 2007
VL 13
IS 3
BP 649
EP 658
DI 10.1089/ten.2006.0075
PG 10
WC Cell & Tissue Engineering
SC Cell Biology
GA 153VO
UT WOS:000245464500020
PM 17362134
DA 2018-10-20
ER

PT J
AU Vanore, M
   Chahory, S
   Payen, G
   Clerc, B
AF Vanore, Maria
   Chahory, Sabine
   Payen, Guillaume
   Clerc, Bernard
TI Surgical repair of deep melting ulcers with porcine small intestinal
   submucosa (SIS) graft in dogs and cats
SO VETERINARY OPHTHALMOLOGY
LA English
DT Article
DE cat; dog; melting ulcer; small intestinal submucosa; xenograft
ID METALLOPROTEINASE INHIBITOR; ULCERATIVE KERATITIS; CORNEAL ULCERATION;
   ANTERIOR SEGMENT; MATRIX; COLLAGENASE; EXPRESSION; REGENERATION;
   BIOMATERIAL; TGF-BETA-2
AB Purpose To evaluate the efficacy of using a porcine small intestinal submucosa (SIS) graft for the surgical repair of deep melting ulcers in dogs and cats.
   Methods Two cats and five dogs presented with deep and large melting ulcers of the cornea. In each case, the necrotic and collagenolytic tissue of the cornea was removed by keratectomy. A SIS graft, I mm greater than the corneal defect, was rehydrated in sterile saline and sutured to the edges of the ulcer with a simple interrupted pattern of 9/0 polyglactin 910. A nictitating membrane flap was utilized in two cats and four dogs for 2 weeks. All cases were treated postoperatively with topical and systemic antibiotics, a systemic anti-inflammatory drug and topical atropine. All animals were re-evaluated 15 days, 4 weeks, 35-45 days, 2-3 months and 6 months postsurgery.
   Results At 15 days postsurgery, a superficial intense corneal neovascularization surrounded the SIS graft. No ocular discomfort was present and fluorescein staining was negative in all cases. At 4 weeks the SIS graft was thick and opaque in all cases, although in one cat the SIS graft had partially detached. Between 35 and 45 days, SIS graft integration was evident in all eyes, and corneal neovascularization had decreased progressively. All eyes healed without complications and retained corneal transparency. This occurred even in the presence of corneal perforation in two cases: one prior to and one during surgery.
   Conclusion Results of our study suggest the SIS graft may be an effective alternative surgical treatment to the traditional conjunctival grafts commonly used to repair melting ulcers in dogs and cats. The advantages of using a SIS graft include good corneal transparency, preservation of corneal integrity and maintenance of vision.
C1 Natl Vet Coll Alfort, Unit Ophthalmol, F-94700 Maisons Alfort, France.
RP Vanore, M (reprint author), Natl Vet Coll Alfort, Unit Ophthalmol, 7 Ave Gen de Gaulle, F-94700 Maisons Alfort, France.
EM rastamimmi@yahoo.com
CR AIKEN SW, 1994, VET COMP ORTHOPAED, V7, P124
   BADYLAK SF, 1993, TISSUE ENGINEERING, P179
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   Barletta JP, 1996, INVEST OPHTH VIS SCI, V37, P20
   Brooks DE, 2004, VET CLIN N AM-SMALL, V34, P611, DOI 10.1016/j.cvsm.2003.12.005
   Bussieres M, 2004, VET OPHTHALMOL, V7, P352, DOI 10.1111/j.1463-5224.2004.04055.x
   CIONNI RJ, 1986, CURR EYE RES, V5, P549, DOI 10.3109/02713688609015118
   Cobb MA, 1999, SURG NEUROL, V51, P99, DOI 10.1016/S0090-3019(97)00475-8
   Cook JL, 1999, AM J SPORT MED, V27, P658, DOI 10.1177/03635465990270051901
   Dejardin LM, 1999, J BIOMED MATER RES, V46, P203, DOI 10.1002/(SICI)1097-4636(199908)46:2<203::AID-JBM9>3.0.CO;2-4
   EDWARDS DR, 1987, EMBO J, V6, P1899, DOI 10.1002/j.1460-2075.1987.tb02449.x
   Featherstone H, 2000, VET REC, V146, P136, DOI 10.1136/vr.146.5.136
   Featherstone HJ, 2001, VET OPHTHALMOL, V4, P147, DOI 10.1046/j.1463-5224.2001.00192.x
   FINI ME, 1990, INVEST OPHTH VIS SCI, V31, P1779
   Fini ME, 1998, ARCH DERMATOL RES, V290, pS12, DOI 10.1007/PL00007449
   Fini ME, 1992, ACTA OPHTHALMOL    S, P26
   Griguer F, 2001, REV MED VET-TOULOUSE, V152, P597
   Haffner JC, 2003, VET OPHTHALMOL, V6, P67, DOI 10.1046/j.1463-5224.2003.00271.x
   HAKANSON NE, 1987, J AM ANIM HOSP ASSOC, V23, P641
   IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337
   Klenkler B, 2004, EXP EYE RES, V79, P677, DOI 10.1016/j.exer.2004.07.008
   Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2
   Lewin GA, 1999, J SMALL ANIM PRACT, V40, P340, DOI 10.1111/j.1748-5827.1999.tb03094.x
   MATSUMOTO K, 1993, INVEST OPHTH VIS SCI, V34, P1945
   Miyazono K, 2002, CORNEA, V21, pS48, DOI 10.1097/01.ICO.0000028327.06702.D5
   MOORE CP, 1999, VET OPHTHALMOLOGY, P276
   Ollivier FJ, 2004, VET OPHTHALMOL, V7, P397, DOI 10.1111/j.1463-5224.2004.04052.x
   PASQUALE LR, 1993, INVEST OPHTH VIS SCI, V34, P23
   ROBERTS AB, 1990, ANN NY ACAD SCI, V580, P225, DOI 10.1111/j.1749-6632.1990.tb17931.x
   STRISSEL KJ, 1995, INVEST OPHTH VIS SCI, V36, P151
   WHITLEY RD, 1999, VET OPHTHALMOLOGY, P646
NR 31
TC 26
Z9 28
U1 3
U2 12
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 1463-5216
J9 VET OPHTHALMOL
JI Vet. Ophthalmol.
PD MAR-APR
PY 2007
VL 10
IS 2
BP 93
EP 99
DI 10.1111/j.1463-5224.2007.00515.x
PG 7
WC Veterinary Sciences
SC Veterinary Sciences
GA 147OO
UT WOS:000245012500005
PM 17324164
DA 2018-10-20
ER

PT J
AU Cejas, MA
   Kinney, WA
   Chen, C
   Leo, GC
   Tounge, BA
   Vinter, JG
   Joshi, PP
   Maryanoff, BE
AF Cejas, Mabel A.
   Kinney, William A.
   Chen, Cailin
   Leo, Gregory C.
   Tounge, Brett A.
   Vinter, Jeremy G.
   Joshi, Pratik P.
   Maryanoff, Bruce E.
TI Collagen-related peptides: Self-assembly of short, single strands into a
   functional biomaterial of micrometer scale
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID GLY-PRO-HYP; MOLECULAR-STRUCTURE; CRYSTAL-STRUCTURE; TRIPLE; STABILITY;
   ACTIVATION; VI
AB We have designed, synthesized, and characterized a short (32-mer; 8-nm), single-stranded, collagen-related peptide (CRP), 1a, which forms triple-helical building blocks that self-assemble into large, composite fibrils by strictly noncovalent means. Computational analysis suggested that the installation of complementary, aromatic pi-stacking recognition elements at the N- and C-termini of (Gly-Pro-Hyp)(10) would facilitate the head-to-tail assembly of triple-helical subunits. Our CD, (1)H NMR, DLS, and TEM results for 1a support the formation of such triple-helical, supramolecular structures. Consistent with self-assembly into micrometer-size, composite fibrils, 1a induced the aggregation of human platelets with nearly the same potency as native Type I collagen. The aromatic-aromatic recognition motif employed in this study provides a straightforward approach to collagen-mimetics and has important implications for the design of triple-helical building blocks that can spontaneously oligomerize into functional fibrillar structures.
C1 Johnson & Johnson Pharmaceut Res & Dev, Vasc Res Team, Spring House, PA 19477 USA.
   Cresset Biomol Discovery, Letchworth SG6 4ET, Herts, England.
   Univ Miami, Ctr Adv Microscopy, Coral Gables, FL 33146 USA.
RP Kinney, WA (reprint author), Johnson & Johnson Pharmaceut Res & Dev, Vasc Res Team, Spring House, PA 19477 USA.
EM wkinney1@prdus.jnj.com
CR BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699
   Berisio R, 2002, PROTEIN SCI, V11, P262, DOI 10.1110/ps.32602
   Feng YB, 1996, J AM CHEM SOC, V118, P10351, DOI 10.1021/ja961260c
   Fields GB, 1996, BIOPOLYMERS, V40, P345, DOI 10.1002/(SICI)1097-0282(1996)40:4<345::AID-BIP1>3.0.CO;2-W
   Gdaniec M, 2003, ANGEW CHEM INT EDIT, V42, P3903, DOI 10.1002/anie.200351432
   HELSETH DL, 1981, J BIOL CHEM, V256, P7118
   Hoekstra WJ, 1999, J MED CHEM, V42, P5254, DOI 10.1021/jm990418b
   Holmgren SK, 1998, NATURE, V392, P666, DOI 10.1038/33573
   HUNTER CA, 1990, J AM CHEM SOC, V112, P5525, DOI 10.1021/ja00170a016
   Jenkins CL, 2002, NAT PROD REP, V19, P49, DOI 10.1039/a903001h
   Knight CG, 1999, CARDIOVASC RES, V41, P450, DOI 10.1016/S0008-6363(98)00306-X
   Koide T, 2005, BIOORG MED CHEM LETT, V15, P5230, DOI 10.1016/j.bmcl.2005.08.041
   Kotch FW, 2006, P NATL ACAD SCI USA, V103, P3028, DOI 10.1073/pnas.0508783103
   LOZMAN OR, 2001, J CHEM SOC PERK T, V2, P1446
   MORTON LF, 1995, BIOCHEM J, V306, P337, DOI 10.1042/bj3060337
   Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882
   Penz S, 2005, FASEB J, V19, P898, DOI 10.1096/fj.04-2748com
   Prockop DJ, 1998, J BIOL CHEM, V273, P15598, DOI 10.1074/jbc.273.25.15598
   RAO GHR, 1994, J BIOL CHEM, V269, P13899
   RICH A, 1961, J MOL BIOL, V3, P483, DOI 10.1016/S0022-2836(61)80016-8
   Shah NK, 1996, BIOCHEMISTRY-US, V35, P10262, DOI 10.1021/bi960046y
NR 21
TC 76
Z9 78
U1 2
U2 29
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD FEB 28
PY 2007
VL 129
IS 8
BP 2202
EP +
DI 10.1021/ja066986f
PG 3
WC Chemistry, Multidisciplinary
SC Chemistry
GA 137ZC
UT WOS:000244330800002
PM 17269769
DA 2018-10-20
ER

PT J
AU Raman, A
   Gawalt, ES
AF Raman, Aparna
   Gawalt, Ellen S.
TI Self-assembled monolayers of alkanoic acids on the native oxide surface
   of SS316L by solution deposition
SO LANGMUIR
LA English
DT Article
ID 316L STAINLESS-STEEL; ORGANIZED MOLECULAR ASSEMBLIES; CELL-ADHESION;
   GOLD SURFACES; ALKANETHIOLATE MONOLAYERS; INFRARED-SPECTROSCOPY; FILMS;
   SILVER; ALUMINUM; COPPER
AB Stainless steel 316L is a widely used biomaterial substrate whose biocompatibility could be improved by surface modification. As a first step in this process, self-assembled monolayers of octanoic acid, octadecylcarboxylic acid, 16-hydroxyhexadecanoic acid, 12-aminododecanoic acid, and 1,12-dodecane dicarboxylic acid have been formed on the native oxide surface of stainless steel 316L by a simple, one-step solution deposition method. The ordering, close-packing, and coverage of the monolayers formed were characterized by diffuse reflectance infrared spectroscopy, contact angle measurements, and atomic force microscopy. The same procedure was applicable for all long alkyl chain carboxylic acids. This process formed chemically and mechanically stable monolayers. These carboxylic acids formed a bidentate bond with the stainless steel substrate. Robust chemical attachment of the acids to stainless steel through a simple process provides a stepping stone to improving the biocompatibility of stainless steel 316L.
C1 Duquesne Univ, Dept Chem & Biochem, Pittsburgh, PA 15282 USA.
RP Gawalt, ES (reprint author), Duquesne Univ, Dept Chem & Biochem, Pittsburgh, PA 15282 USA.
EM gawalte@duq.edu
CR ALLARA DL, 1985, LANGMUIR, V1, P52, DOI 10.1021/la00061a008
   Altankov G, 1996, J MATER SCI-MATER M, V7, P425, DOI 10.1007/BF00122012
   BAIN CD, 1989, J AM CHEM SOC, V111, P321, DOI 10.1021/ja00183a049
   Barbosa JN, 2004, BIOMATERIALS, V25, P2557, DOI [10.1016/j.biomaterials.2003.09.047, 10.1016/j .biomaterials.2003.09.047]
   Barrena E, 1999, J CHEM PHYS, V111, P9797, DOI 10.1063/1.480316
   Brewer SH, 2004, LANGMUIR, V20, P5512, DOI 10.1021/la035037m
   CHIDSEY CED, 1990, LANGMUIR, V6, P682, DOI 10.1021/la00093a026
   Faucheux N, 2004, BIOMATERIALS, V25, P2721, DOI 10.1016/j.biomaterials.2003.09.069
   Gawalt ES, 2001, LANGMUIR, V17, P5736, DOI 10.1021/la010649x
   Geissler M, 2005, ANGEW CHEM INT EDIT, V44, P3596, DOI 10.1002/anie.200500421
   Godin M, 2004, LANGMUIR, V20, P7090, DOI 10.1021/la030257l
   Hanawa T., 2002, RECENT RES DEV BIOMA
   HU WS, 2000, LNGMUIR, V21, P2260
   Hutt DA, 1997, LANGMUIR, V13, P2740, DOI 10.1021/la970069t
   Jiang YG, 2005, LANGMUIR, V21, P1986, DOI 10.1021/la047491b
   Kingshott P, 2003, LANGMUIR, V19, P6912, DOI 10.1021/la034032m
   LAIBINIS PE, 1995, J PHYS CHEM-US, V99, P7663, DOI 10.1021/j100019a054
   LAIBINIS PE, 1989, SCIENCE, V245, P845, DOI 10.1126/science.245.4920.845
   Lee MH, 2005, BIOMATERIALS, V26, P1721, DOI 10.1016/j.biomaterials.2004.05.026
   Li LY, 2005, J PHYS CHEM B, V109, P2934, DOI 10.1021/jp0473321
   Lin SY, 2002, LANGMUIR, V18, P5473, DOI 10.1021/la0157364
   Liu YL, 2006, APPL SURF SCI, V252, P3818, DOI 10.1016/j.apsusc.2005.05.072
   Mahapatro A, 2006, LANGMUIR, V22, P901, DOI 10.1021/la052817h
   Mrksich M, 2000, CHEM SOC REV, V29, P267, DOI 10.1039/a705397e
   Oberg K, 2001, THIN SOLID FILMS, V397, P102, DOI 10.1016/S0040-6090(01)01422-5
   Park JS, 2005, LANGMUIR, V21, P2902, DOI 10.1021/la0475573
   Park JS, 2004, LANGMUIR, V20, P5829, DOI 10.1021/la036424z
   PORTER MD, 1987, J AM CHEM SOC, V109, P3559, DOI 10.1021/ja00246a011
   Raman A, 2006, LANGMUIR, V22, P6469, DOI 10.1021/la060636p
   Ruan CM, 2002, THIN SOLID FILMS, V419, P95, DOI 10.1016/S0040-6090(02)00730-7
   Schmidt HJ, 2004, GEN RELAT GRAVIT, V36, P1, DOI 10.1023/B:GERG.0000006963.20880.a1
   Shustak G, 2006, LANGMUIR, V22, P5237, DOI 10.1021/1a060460r
   Shustak G, 2004, LANGMUIR, V20, P7499, DOI 10.1021/la036470z
   Sinapi F, 2004, SURF INTERFACE ANAL, V36, P1484, DOI 10.1002/sia.1926
   Tao YT, 1996, J AM CHEM SOC, V118, P6724, DOI 10.1021/ja960672i
   Tao YT, 1997, J PHYS CHEM B, V101, P9732, DOI 10.1021/jp972514z
   TAO YT, 1993, J AM CHEM SOC, V115, P4350, DOI 10.1021/ja00063a062
   ULMAN A, 1989, LANGMUIR, V5, P1147, DOI 10.1021/la00089a003
   ULMAN A, 1991, INTRO ULTRATHIN ORGA, V30
   Van Alsten JG, 1999, LANGMUIR, V15, P7605, DOI 10.1021/la981694g
   Wang XY, 2001, CORROSION, V57, P540, DOI 10.5006/1.3290380
   Woodward JT, 1996, LANGMUIR, V12, P3626, DOI 10.1021/la9510689
   Zhao J, 1997, LANGMUIR, V13, P2359, DOI 10.1021/la960878x
NR 43
TC 69
Z9 76
U1 2
U2 39
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD FEB 27
PY 2007
VL 23
IS 5
BP 2284
EP 2288
DI 10.1021/la063089g
PG 5
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 136UD
UT WOS:000244248700005
PM 17266343
DA 2018-10-20
ER

PT J
AU Schneider, A
   Picart, C
   Senger, B
   Schaaf, P
   Voegel, JC
   Frisch, B
AF Schneider, Aurore
   Picart, Catherine
   Senger, Bernard
   Schaaf, Pierre
   Voegel, Jean-Claude
   Frisch, Benoit
TI Layer-by-layer films from hyaluronan and amine-modified hyaluronan
SO LANGMUIR
LA English
DT Article
ID POLYELECTROLYTE MULTILAYER FILMS; QUARTZ-CRYSTAL MICROBALANCE;
   CELL-ADHESION PROPERTIES; CROSS-LINKING; HYDROGEL FILMS;
   CHEMICAL-MODIFICATION; EXTRACELLULAR-MATRIX; FORCE MICROSCOPY; ACID
   HYDROGELS; IN-VITRO
AB Hyaluronan is a polysaccharide that is increasingly investigated for its role in cellular adhesion and for the preparation of biomimetic matrices for tissue engineering. Hyaluronan gels are prepared for application as space fillers, whereas hyaluronan films are usually obtained by adsorbing or grafting a single hyaluronan layer onto a biomaterial surface. Here, we examine the possibility to employ the layer-by-layer technique to deposit thin films of cationic-modified hyaluronan (HA(+)) and hyaluronan (HA) of controlled thicknesses. The buildup conditions are investigated, and growth is compared to that of other polyelectrolyte multilayer films containing either HA as the polyanion or HA(+) as the polycation. The films could be formed in a low ionic strength medium but are required to be cross-linked prior to contact with a physiological medium. NIH3T3 fibroblasts were perfectly viable on self-assembled hyaluronan films with, however, a preference for hyaluronan ending films. These findings point out the possibility to tune the thickness of thin hyaluronan films at the nanometer scale. Such architectures could be employed for investigating cell/substrate interactions or for functionalizing biomaterial surfaces.
C1 INSERM, U595, F-67085 Strasbourg, France.
   Univ Strasbourg 1, Fac Chirurg Dent, F-67000 Strasbourg, France.
   Univ Strasbourg 1, CNRS, Lab Chim Enzymat & Vectorisat LC01, UMR 7175, F-67400 Illkirch Graffenstaden, France.
   Univ Louis Pasteur Strasbourg 1, CNRS, Inst Charles Sadron, F-67083 Strasbourg, France.
   Univ Montpellier 2, CNRS, UMR 5539, F-34095 Montpellier 5, France.
RP Picart, C (reprint author), INSERM, U595, 11 Rue Humann, F-67085 Strasbourg, France.
EM catherine.picart@univ-montp2.fr
RI SCHAAF, Pierre/J-2751-2016
OI SCHAAF, Pierre/0000-0001-7423-5492; PICART,
   Catherine/0000-0003-0130-1000; Frisch, Benoit/0000-0002-8378-2508;
   PICART, Catherine/0000-0002-4854-6366
FU NIBIB NIH HHS [R21 EB004489, R21 EB004489-02]; PHS HHS [R21 544168 A]
CR Arimura H, 2005, J BIOMAT SCI-POLYM E, V16, P1347, DOI 10.1163/156856205774472353
   Ball V, 2005, LANGMUIR, V21, P8526, DOI 10.1021/la050866o
   Barrat JL, 1996, ADV CHEM PHYS, V94, P1, DOI 10.1002/9780470141533.ch1
   Bulpitt P, 1999, J BIOMED MATER RES, V47, P152
   Burke SE, 2005, BIOMACROMOLECULES, V6, P1419, DOI 10.1021/bm0492834
   Charlot A, 2006, BIOMACROMOLECULES, V7, P907, DOI 10.1021/bm0507094
   Cong RJ, 2006, MACROMOLECULES, V39, P731, DOI 10.1021/ma051171x
   Crescenzi V, 2002, BIOMACROMOLECULES, V3, P1384, DOI 10.1021/bm025657m
   DECHER G, 1992, THIN SOLID FILMS, V210, P831, DOI 10.1016/0040-6090(92)90417-A
   DECHER G, 1994, BIOSENS BIOELECTRON, V9, P677, DOI 10.1016/0956-5663(94)80065-0
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Duarte ML, 2002, INT J BIOL MACROMOL, V31, P1, DOI 10.1016/S0141-8130(02)00039-9
   Dubas ST, 2001, MACROMOLECULES, V34, P3736, DOI 10.1021/ma001720t
   FORSTER S, 1992, J PHYS CHEM-US, V96, P4008
   Fukuda J, 2006, BIOMATERIALS, V27, P1479, DOI 10.1016/j.biomaterials.2005.09.015
   Harris JJ, 1999, J AM CHEM SOC, V121, P1978, DOI 10.1021/ja9833467
   Haxaire K, 2003, BIOPOLYMERS, V72, P10, DOI 10.1002/bip.10245
   Hermanson G. T., 1996, BIOCONJUGATE TECHNIQ, P169
   Hoogeveen NG, 1996, LANGMUIR, V12, P3675, DOI 10.1021/la951574y
   Hook F, 1998, J COLLOID INTERF SCI, V208, P63, DOI 10.1006/jcis.1998.5774
   Johansson JA, 2005, BIOMACROMOLECULES, V6, P1353, DOI 10.1021/bm0493741
   Khademhosseini A, 2004, BIOMATERIALS, V25, P3583, DOI 10.1016/j.biomaterials.2003.10.033
   Kovacevic D, 2002, LANGMUIR, V18, P5607, DOI 10.1021/la025639q
   Kozlovskaya V, 2006, CHEM MATER, V18, P328, DOI 10.1021/cm0517364
   Ladam G, 2000, LANGMUIR, V16, P1249, DOI 10.1021/la990650k
   LAURENT TC, 1998, CHEM BIOL MED APPL H, V72
   Lavalle P, 2002, MACROMOLECULES, V35, P4458, DOI 10.1021/ma0119833
   Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605
   Leporatti S, 2000, LANGMUIR, V16, P4059, DOI 10.1021/la991429a
   Li BY, 2004, BIOMACROMOLECULES, V5, P1667, DOI 10.1021/bm0496155
   Liu YC, 2005, BIOMATERIALS, V26, P4737, DOI 10.1016/j.biomaterials.2005.01.003
   Luo Y, 2002, CURR CANCER DRUG TAR, V2, P209, DOI 10.2174/1568009023333836
   Luo Y, 2000, J CONTROL RELEASE, V69, P169, DOI 10.1016/S0168-3659(00)00300-X
   Luo Y, 2000, BIOMACROMOLECULES, V1, P208, DOI 10.1021/bm000283n
   Luo Y, 2001, BIOCONJUGATE CHEM, V12, P1085, DOI 10.1021/bc015513p
   LVOV YM, 2001, HDB SURFACES INTERFA, V3
   Mason M, 2000, BIOMATERIALS, V21, P31, DOI 10.1016/S0142-9612(99)00129-5
   Miller MD, 2005, CHEM MATER, V17, P5375, DOI 10.1021/cm0512225
   Morra M, 2005, BIOMACROMOLECULES, V6, P1205, DOI 10.1021/bm049346i
   Nettles DL, 2004, ANN BIOMED ENG, V32, P391, DOI 10.1023/B:ABME.0000017552.65260.94
   Peattie RA, 2006, BIOMATERIALS, V27, P1868, DOI 10.1016/j.biomaterials.2005.09.035
   Picart C, 2001, LANGMUIR, V17, P7414, DOI 10.1021/la010848g
   Picart C, 2005, ADV FUNCT MATER, V15, P83, DOI 10.1002/adfm.200400106
   Picart C, 2005, ADV FUNCT MATER, V15, P1771, DOI 10.1002/adfm.200400588
   Prestwich GD, 1998, J CONTROL RELEASE, V53, P93, DOI 10.1016/S0168-3659(97)00242-3
   Richert L, 2004, LANGMUIR, V20, P448, DOI 10.1021/la035415n
   Richert L, 2004, BIOMACROMOLECULES, V5, P284, DOI 10.1021/bm0342281
   Richert L, 2006, CELL BIOCHEM BIOPHYS, V44, P273, DOI 10.1385/CBB:44:2:273
   Richert L, 2004, SURF SCI, V570, P13, DOI 10.1016/j.susc.2004.06.178
   Richert L, 2004, BIOMACROMOLECULES, V5, P1908, DOI 10.1021/bm0498023
   Rmaile HH, 2003, J AM CHEM SOC, V125, P6602, DOI 10.1021/ja035251x
   Rodahl M, 1996, REV SCI INSTRUM, V67, P3238, DOI 10.1063/1.1147494
   Schneider A, 2006, LANGMUIR, V22, P1193, DOI 10.1021/la0521802
   SCHNEIDER A, IN PRESS BIOMACROMOL
   Schoeler B, 2002, MACROMOLECULES, V35, P889, DOI 10.1021/ma011349p
   Schuetz P, 2003, ADV FUNCT MATER, V13, P929, DOI 10.1002/adfm.200304483
   Schuler C, 2001, BIOMACROMOLECULES, V2, P921, DOI 10.1021/bm010052w
   Segura T, 2005, BIOMATERIALS, V26, P359, DOI 10.1016/j.biomaterials.2004.02.067
   Serizawa T, 2003, J BIOMED MATER RES A, V67A, P1060, DOI 10.1002/jbm.a.10150
   Shu XZ, 2004, J BIOMED MATER RES A, V68A, P365, DOI 10.1002/jbm.a.20002
   Shu XZ, 2003, BIOMATERIALS, V24, P3825, DOI 10.1016/S0142-9612(03)00267-9
   Tanchak OM, 2006, LANGMUIR, V22, P5137, DOI 10.1021/la0529613
   Thierry B, 2003, BIOMACROMOLECULES, V4, P1564, DOI 10.1021/bm0341834
   Thierry B, 2005, J AM CHEM SOC, V127, P1626, DOI 10.1021/ja045077s
   Tjipto E, 2005, LANGMUIR, V21, P8785, DOI 10.1021/la051197h
   Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391
   Wang XH, 2003, BIOMATERIALS, V24, P3213, DOI 10.1016/S0142-9612(03)00170-4
   Weindl G, 2004, SKIN PHARMACOL PHYSI, V17, P207, DOI 10.1159/000080213
   Zimmerman E, 2002, BIOPHYS J, V82, P1848, DOI 10.1016/S0006-3495(02)75535-5
NR 69
TC 38
Z9 39
U1 1
U2 37
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD FEB 27
PY 2007
VL 23
IS 5
BP 2655
EP 2662
DI 10.1021/la062163s
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 136UD
UT WOS:000244248700058
PM 17309215
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Park, I
   Cheng, J
   Pisano, AP
   Lee, ES
   Jeong, JH
AF Park, Inkyu
   Cheng, Jim
   Pisano, Albert. P.
   Lee, Eung-Sug
   Jeong, Jun-Ho
TI Low temperature, low pressure nanoimprinting of chitosan as a
   biomaterial for bionanotechnology applications
SO APPLIED PHYSICS LETTERS
LA English
DT Article
ID FILMS
AB Micro- and nanoscale structures of chitosan were fabricated by nanoimprinting lithography and biochemically functionalized for bionanodevice applications. Chitosan solutions were prepared and a nanoimprinting process was developed for it, where chitosan solution is used as a functional resist for nanoimprinting lithography. A low temperature (90 degrees C) and low pressure (5-25 psi) nanoimprinting with polydimethylsiloxane mold could achieve not only microscale structures but also nanoscale features such as nanowire and nanodots down to 150 nm dimensions. The nanoimprinted structures were chemically modified and used for the immobilization of protein molecules. (c) 2007 American Institute of Physics.
C1 Univ Calif Berkeley, Berkeley Sensor & Actuator Ctr, Berkeley, CA 94720 USA.
   Korea Inst Machinery & Mat, Nanomech Syst Res Ctr, Taejon 305343, South Korea.
RP Park, I (reprint author), Univ Calif Berkeley, Berkeley Sensor & Actuator Ctr, Berkeley, CA 94720 USA.
EM inkyu@eecs.berkeley.edu
RI Park, Inkyu/C-1717-2011
CR Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   De Campos AM, 2001, INT J PHARM, V224, P159, DOI 10.1016/S0378-5173(01)00760-8
   HIRANO S, 1980, J BIOMED MATER RES, V14, P477, DOI 10.1002/jbm.820140414
   Ilium L., 1998, PHARM RES, V15, P1326, DOI DOI 10.1023/A:1011929016601
   KAWAMURA Y, 1993, IND ENG CHEM RES, V32, P386, DOI 10.1021/ie00014a015
   Lee CK, 2006, SMART MATER STRUCT, V15, P607, DOI 10.1088/0964-1726/15/2/044
   Lin CC, 2005, BIOMATERIALS, V26, P3655, DOI 10.1016/j.biomaterials.2004.09.051
   Mao JS, 2003, J BIOMED MATER RES A, V64A, P301, DOI 10.1002/jbm.a.10223
   Mark H. F., 1985, ENCY POLYM SCI ENG, V1, P20
   Nishiyama Y, 2000, J CHEM SOC PERK T 1, P1161, DOI 10.1039/a908145c
   No HK, 2002, INT J FOOD MICROBIOL, V74, P65, DOI 10.1016/S0168-1605(01)00717-6
   Park SB, 2001, BIOMATERIALS, V22, P323, DOI 10.1016/S0142-9612(00)00187-3
   Ravi Kumar Majeti N. V., 2000, REACTIVE FUNCTIONAL, V46, P1
   Shacham R, 1999, ADV MATER, V11, P384, DOI 10.1002/(SICI)1521-4095(199903)11:5<384::AID-ADMA384>3.3.CO;2-D
   SHIGE M, 1995, BIOTECHNOL GENET ENG, V13, P83
   Shu XZ, 2001, INT J PHARM, V212, P19, DOI 10.1016/S0378-5173(00)00582-2
   Tan L, 2004, J VAC SCI TECHNOL B, V22, P2486, DOI 10.1116/1.1800353
   TANG XH, 2001, J APPL POLYM SCI, V83, P1886
   Wan ACA, 2004, MACROMOLECULES, V37, P7019, DOI 10.1021/ma0498868
   Wu LQ, 2005, ADV FUNCT MATER, V15, P189, DOI 10.1002/adfm.200400279
   YALPANI M, 1984, MACROMOLECULES, V17, P272, DOI 10.1021/ma00133a003
   Yi HM, 2005, BIOMACROMOLECULES, V6, P2881, DOI 10.1021/bm0504101
NR 22
TC 30
Z9 30
U1 1
U2 8
PU AMER INST PHYSICS
PI MELVILLE
PA CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1,
   MELVILLE, NY 11747-4501 USA
SN 0003-6951
J9 APPL PHYS LETT
JI Appl. Phys. Lett.
PD FEB 26
PY 2007
VL 90
IS 9
AR 093902
DI 10.1063/1.2709914
PG 3
WC Physics, Applied
SC Physics
GA 141PR
UT WOS:000244591700116
DA 2018-10-20
ER

PT J
AU Unger, F
   Westedt, U
   Hanefeld, P
   Wombacher, R
   Zimmermann, S
   Greiner, A
   Ausborn, M
   Kissel, T
AF Unger, F.
   Westedt, U.
   Hanefeld, P.
   Wombacher, R.
   Zimmermann, S.
   Greiner, A.
   Ausborn, M.
   Kissel, T.
TI Poly(ethylene carbonate): A thermoelastic and biodegradable biomaterial
   for drug eluting stent coatings?
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE poly(ethylene carbonate); stent; mechanical properties;
   biocompatibility; surface erosion
ID CORONARY-ARTERIES; DELIVERY; BIOCOMPATIBILITY; SIROLIMUS; RESTENOSIS;
   PACLITAXEL; POLYMERS; INJURY; CYTOTOXICITY; PERSPECTIVES
AB A first feasibility study exploring the utility of poly(ethylene carbonate) (PEC) as coating material for drug eluting stents under in vitro conditions is reported. PEC (Mw 242 kDa, Mw/Mn=1.90) was found to be an amorphous polymer with thermoelastic properties. Tensile testing revealed a stress to strain failure of more than 600%. These properties are thought to be advantageous for expanding coated stents. In vitro cytotoxicity tests showed excellent cytocompatibility of PEC. Based on these findings, a new stenting concept was suggested, pre-coating a bare-metal stent with PPX-N as non-biodegradable basis and applying a secondary PEC coating using an airbrush method. After manual expansion, no delamination or destruction of the coating could be observed using scanning electron microscopy.
   The surface degradation-controlled release mechanism of PEC may provide the basis for "on demand" drug eluting stent coatings, releasing an incorporated drug predominantly at an inflamed implantation site upon direct contact with superoxide-releasing macrophages. As a release model, metal plates of a defined size and area were coated under the same conditions as the stents with PEC containing radiolabelled paclitaxel. An alkaline KO2- solution served as a superoxide source. Within 12 h, 100% of the incorporated paclitaxel was released, while only 20% of the drug was released in non-superoxide releasing control buffer within 3 weeks. (c) 2006 Elsevier B.V. All rights reserved.
C1 Univ Marburg, Dept Pharmaceut & Biopharm, Fac Pharm, D-35032 Marburg, Germany.
   Univ Marburg, Dept Polymer Chem, Fac Chem, D-35032 Marburg, Germany.
   Novartis Pharma AG, CH-4002 Basel, Switzerland.
RP Kissel, T (reprint author), Univ Marburg, Dept Pharmaceut & Biopharm, Fac Pharm, Ketzerbach 63, D-35032 Marburg, Germany.
EM kissel@staff.uni-marburg.de
CR Acemoglu M, 1997, J CONTROL RELEASE, V49, P263, DOI 10.1016/S0168-3659(97)00097-7
   Acemoglu M, 2004, INT J PHARM, V277, P133, DOI 10.1016/j.ijpharm.2003.06.002
   Acharya G, 2006, ADV DRUG DELIVER REV, V58, P387, DOI 10.1016/j.addr.2006.01.016
   Antony P, 2003, POLYM ENG SCI, V43, P243, DOI 10.1002/pen.10021
   Bhatia V, 2004, POSTGRAD MED J, V80, P13, DOI 10.1136/pgmj.2003.009431
   Burke SE, 2006, ADV DRUG DELIVER REV, V58, P437, DOI 10.1016/j.addr.2006.01.021
   Cha Y., 1994, P INT S CONTR REL BI, V21, P126
   Chen MC, 2005, J CONTROL RELEASE, V108, P178, DOI 10.1016/j.jconrel.2005.07.022
   Dadsetan M, 2003, J CONTROL RELEASE, V93, P259, DOI 10.1016/j.jconrel.2003.08.010
   Dani B A, 2001, AAPS PharmSciTech, V2, P22
   DEJAEGERE PPT, 1993, CLIN CARDIOL, V16, P369, DOI 10.1002/clc.4960160503
   Edelman ER, 1998, AM J CARDIOL, V81, P4
   Elbert DL, 1996, ANNU REV MATER SCI, V26, P365, DOI 10.1146/annurev.ms.26.080196.002053
   Elliott DM, 2002, J BIOMECH ENG-T ASME, V124, P223, DOI 10.1115/1.1449905
   Fischer D, 1999, PHARMACEUT RES, V16, P1273, DOI 10.1023/A:1014861900478
   Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3
   Gorham W. F., 1967, U. S. Patent, Patent No. [3,342,754, 3342754, 3,342,754A 670919]
   GREENBERG D, 2003, AM J DRUG DELIVERY, V1, P255
   Greiner A, 1997, ACTA POLYM, V48, P1, DOI 10.1002/actp.1997.010480101
   Greiner A., 1996, POLYM MAT ENCY, V9, P7171
   Gunn J, 1999, EUR HEART J, V20, P1693, DOI 10.1053/euhj.1999.1549
   Haase Jurgen, 2003, J Interv Cardiol, V16, P469, DOI 10.1046/j.1540-8183.2003.01059.x
   HOFMA SH, 2001, CURR INTERV CARDIOL, V3, P28
   *ISO, 1999, 10993 ISO 5, P393
   Kamath KR, 2006, ADV DRUG DELIVER REV, V58, P412, DOI 10.1016/j.addr.2006.01.023
   Klugherz BD, 2002, CORONARY ARTERY DIS, V13, P183, DOI 10.1097/00019501-200205000-00008
   Kornowski R, 1998, J AM COLL CARDIOL, V31, P224, DOI 10.1016/S0735-1097(97)00450-6
   LEE MC, 1992, J BIOMECH, V25, P925, DOI 10.1016/0021-9290(92)90232-P
   Lewis Andrew L, 2002, J Long Term Eff Med Implants, V12, P231
   Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071
   Peng T, 1996, BIOMATERIALS, V17, P685, DOI 10.1016/0142-9612(96)86738-X
   PERIN EC, 2005, REV CARDIOVASC ME S1, V6, P13
   Ranade SV, 2004, J BIOMED MATER RES A, V71A, P625, DOI 10.1002/jbm.a.30188
   Schmidt C, 1998, ACTA POLYM, V49, P232, DOI 10.1002/(SICI)1521-4044(199805)49:5<232::AID-APOL232>3.0.CO;2-L
   Scott NA, 2006, ADV DRUG DELIVER REV, V58, P358, DOI 10.1016/j.addr.2006.01.015
   Smith Elliot J, 2003, J Interv Cardiol, V16, P475, DOI 10.1046/j.1540-8183.2003.01058.x
   Stoll GH, 2001, J CONTROL RELEASE, V76, P209, DOI 10.1016/S0168-3659(01)00417-5
   Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441
   Tanabe K, 2004, CURR PHARM DESIGN, V10, P357, DOI 10.2174/1381612043453289
   Toutouzas K, 2004, EUR HEART J, V25, P1679, DOI 10.1016/j.ehj.2004.06.011
   vanderGiessen WJ, 1996, CIRCULATION, V94, P1690, DOI 10.1161/01.CIR.94.7.1690
   Virmani R, 2004, CIRCULATION, V109, P701, DOI 10.1161/01.CIR.0000116202.41966.D4
   Virmani R, 2003, HEART, V89, P133, DOI 10.1136/heart.89.2.133
   Wang YX, 2004, PHARM RES, V21, P1362, DOI 10.1023/B:PHAM.0000036909.41843.18
   Welt FGP, 2003, VASC MED, V8, P1, DOI 10.1191/1358863x03vm462oa
   Westedt U, 2006, J CONTROL RELEASE, V111, P235, DOI 10.1016/j.jconrel.2005.12.012
   Zange R, 1997, EUR J PHARM BIOPHARM, V44, P149, DOI 10.1016/S0939-6411(97)00082-9
NR 47
TC 40
Z9 45
U1 0
U2 22
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
J9 J CONTROL RELEASE
JI J. Control. Release
PD FEB 26
PY 2007
VL 117
IS 3
BP 312
EP 321
DI 10.1016/j.jconrel.2006.11.003
PG 10
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 146IQ
UT WOS:000244928100003
PM 17207879
DA 2018-10-20
ER

PT J
AU Ho, JPY
   Wu, SL
   Poon, RWY
   Chung, CY
   Tjong, SC
   Chu, PK
   Yeung, KWK
   Lu, WW
   Cheung, KMC
   Luk, KDK
AF Ho, J. P. Y.
   Wu, S. L.
   Poon, R. W. Y.
   Chung, C. Y.
   Tjong, S. C.
   Chu, P. K.
   Yeung, K. W. K.
   Lu, W. W.
   Cheung, K. M. C.
   Luk, K. D. K.
TI Oxygen plasma treatment to restrain nickel out-diffusion from porous
   nickel titanium orthopedic materials
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 5th Asian/European International Conference on Plasma Surface
   Engineering
CY SEP 12-16, 2005
CL Qingdao, PEOPLES R CHINA
SP Tsinghua Univ, Shadong Univ, Qingdao Univ Sci & Technol, European Joint Comm Plasma & Ion Surface Engn
DE porous nickel titanium alloy; plasma immersion ion implantation; Ni
   leaching; simulated body fluid
ID IMMERSION ION-IMPLANTATION; SHAPE-MEMORY ALLOYS; CORROSION BEHAVIOR;
   NITI ALLOY; APPOSITION; INGROWTH
AB Porous nickel-titanium (NiTi) shape memory alloy is a prospective orthopedic biomaterial due to its porous structure that allows bone tissue and blood vessel ingrowth during fixation of implants. Unfortunately, the higher probability of Ni release from the increased surface area of a porous surface compared to conventional dense NiTi shape memory alloys causes more serious health concerns. In order to mitigate leaching of harmful Ni ions, we create a firm barrier layer on the surface by conducting oxygen plasma immersion ion implantation (PIII) into the porous structure. The non-line-of-sight capability of PIII allows more uniform treatment of all exposed areas compared to beam-line ion implantation. Our simulated body fluid immersion test indicates that Ni leaching is significantly reduced after oxygen PIII. X-ray photoelectron spectroscopy profiles illustrate that the thickness of the barrier layer is almost unchanged after immersion in SBF for 4 weeks, demonstrating the excellent durability of the layer in a biological medium. (C) 2006 Elsevier B.V. All rights reserved.
C1 City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China.
   Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China.
RP Chu, PK (reprint author), City Univ Hong Kong, Dept Phys & Mat Sci, Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.
EM paul.chu@cityu.edu.hk
RI Chu, Paul/B-5923-2013; Chung, C.Y./H-1689-2011; WU, Shuilin/F-7897-2010;
   Tjong, S C/C-2924-2013
OI Chu, Paul/0000-0002-5581-4883; Chung, C.Y./0000-0003-3639-5852; Tjong, S
   C/0000-0002-8377-3273
CR Ayers RA, 1999, J BIOMED MATER RES, V45, P42
   Chu PK, 1996, MAT SCI ENG R, V17, P207, DOI 10.1016/S0927-796X(96)00194-5
   Chu PK, 2001, SURF COAT TECH, V136, P151, DOI 10.1016/S0257-8972(00)01046-X
   Cisse O, 2002, J BIOMED MATER RES, V61, P339, DOI 10.1002/jbm.10114
   Green SM, 1997, MAT SCI ENG A-STRUCT, V224, P21, DOI 10.1016/S0921-5093(96)10563-3
   ITIN VI, 1994, MATER CHARACT, V32, P179, DOI 10.1016/1044-5803(94)90087-6
   Kao CT, 2002, J BIOMED MATER RES, V63, P786, DOI 10.1002/jbm.10484
   Kapanen A, 2002, BIOMATERIALS, V23, P645, DOI 10.1016/S0142-9612(01)00143-0
   Poon RWY, 2005, BIOMATERIALS, V26, P2265, DOI 10.1016/j.biomaterials.2004.07.056
   Poon RWY, 2005, MAT SCI ENG A-STRUCT, V390, P444, DOI 10.1016/j.msea.2004.08.061
   Ryhanen J., 1999, BIOCOMPATIBILITY EVA
   Shevchenko N, 2004, APPL SURF SCI, V235, P126, DOI 10.1016/j.apsusc.2004.05.273
   SIMSKE SJ, 1995, J BIOMED MATER RES, V29, P527, DOI 10.1002/jbm.820290413
   Tan L, 2003, BIOMATERIALS, V24, P3931, DOI 10.1016/S0142-9612(03)00271-0
   Trepanier C, 1998, J BIOMED MATER RES, V43, P433, DOI 10.1002/(SICI)1097-4636(199824)43:4<433::AID-JBM11>3.0.CO;2-#
   Wang DY, 2002, SURF COAT TECH, V156, P201, DOI 10.1016/S0257-8972(02)00086-5
   Yeung KWK, 2005, J BIOMED MATER RES A, V72A, P238, DOI 10.1002/jbm.a.30201
   Yuan B, 2004, MAT SCI ENG A-STRUCT, V382, P181, DOI 10.1016/j.msea.2004.04.068
NR 18
TC 15
Z9 19
U1 0
U2 3
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD FEB 26
PY 2007
VL 201
IS 9-11
BP 4893
EP 4896
DI 10.1016/j.surfcoat.2006.07.072
PG 4
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 168FT
UT WOS:000246509400020
DA 2018-10-20
ER

PT J
AU Gautron, J
   Murayama, E
   Vignal, A
   Morisson, M
   McKee, MD
   Rehault, S
   Labas, V
   Belghazi, M
   Vidal, ML
   Nys, Y
   Hincke, MT
AF Gautron, Joel
   Murayama, Emi
   Vignal, Alain
   Morisson, Mireille
   McKee, Marc D.
   Rehault, Sophie
   Labas, Valerie
   Belghazi, Maya
   Vidal, Mary-Laure
   Nys, Yves
   Hincke, Maxwell T.
TI Cloning of ovocalyxin-36, a novel chicken eggshell protein related to
   lipopolysaccharide-binding proteins, bactericidal
   permeability-increasing proteins, and plunc family proteins
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID EGG-LAYING CYCLE; MATRIX PROTEINS; AVIAN EGGSHELL;
   ULTRASTRUCTURAL-LOCALIZATION; PROTEOMIC ANALYSIS; GENE-EXPRESSION; HEN;
   COMPONENT; OVIDUCT; CDNA
AB The avian eggshell is a composite biomaterial composed of noncalcifying eggshell membranes and the overlying calcified shell matrix. The shell is deposited in a uterine fluid where the concentration of different protein species varies at different stages of its formation. The role of avian eggshell proteins during shell formation remains poorly understood, and we have sought to identify and characterize the individual components in order to gain insight into their function during elaboration of the eggshell. In this study, we have used direct sequencing, immunochemistry, expression screening, and EST data base mining to clone and characterize a 1995-bp full-length cDNA sequence corresponding to a novel chicken eggshell protein that we have named Ovocalyxin-36 (OCX-36). Ovocalyxin-36 protein was only detected in the regions of the oviduct where eggshell formation takes place; uterine OCX-36 message was strongly up-regulated during eggshell calcification. OCX-36 localized to the calcified eggshell predominantly in the inner part of the shell, and to the shell membranes. BlastN data base searching indicates that there is no mammalian version of OCX-36; however, the protein sequence is 20-25% homologous to proteins associated with the innate immune response as follows: lipopolysaccharide-binding proteins, bactericidal permeability-increasing proteins, and Plunc family proteins. Moreover, the genomic organization of these proteins and OCX-36 appears to be highly conserved. These observations suggest that OCX-36 is a novel and specific chicken eggshell protein related to the superfamily of lipopolysaccharide-binding proteins/bactericidal permeability-increasing proteins and Plunc proteins. OCX-36 may therefore participate in natural defense mechanisms that keep the egg free of pathogens.
C1 INRA, UR83, Unite Rech Avicoles, F-37380 Nouzilly, France.
   Inst Pasteur, Unite Macrophages & Dev Immun, F-75724 Paris, France.
   INRA, UR 444, Lab Genet Cellulaire, F-31326 Castanet Tolosan, France.
   McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada.
   McGill Univ, Fac Dent, Montreal, PQ H3A 2B2, Canada.
   INRA, UMR85, Serv Spectrometrie Masse & Proteom, F-37380 Nouzilly, France.
   Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada.
RP Gautron, J (reprint author), INRA, UR83, Unite Rech Avicoles, F-37380 Nouzilly, France.
EM gautron@tours.inra.fr
RI Gautron, Joel/A-1753-2017; Vignal, Alain/I-6253-2017
OI Gautron, Joel/0000-0001-7800-0578; Vignal, Alain/0000-0002-6797-2125;
   Rehault-Godbert, Sophie/0000-0003-2800-3417
CR Beamer LJ, 1997, SCIENCE, V276, P1861, DOI 10.1126/science.276.5320.1861
   Bingle CD, 2004, TRENDS IMMUNOL, V25, P53, DOI 10.1016/j.it.2003.11.007
   Boardman PE, 2002, CURR BIOL, V12, P1965, DOI 10.1016/S0960-9822(02)01296-4
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   Cabra V, 2006, BBA-PROTEINS PROTEOM, V1764, P1110, DOI 10.1016/j.bbapap.2006.04.002
   Carre W, 2006, PHYSIOL GENOMICS, V25, P514, DOI 10.1152/physiolgenomics.00207.2005
   Carrino DA, 1997, CONNECT TISSUE RES, V36, P175, DOI 10.3109/03008209709160219
   Fernandez MS, 2003, J STRUCT BIOL, V143, P171, DOI 10.1016/j.jsb.2003.08.007
   Fernandez MS, 2001, MATRIX BIOL, V19, P793
   Gautron J, 2001, CONNECT TISSUE RES, V42, P255, DOI 10.3109/03008200109016840
   Gautron J, 2001, J BIOL CHEM, V276, P39243, DOI 10.1074/jbc.M104543200
   Gautron J, 1997, CONNECT TISSUE RES, V36, P195, DOI 10.3109/03008209709160220
   Gautron J., 2003, P 8 INT S BIOM KAN J, P163
   GRAY PW, 1989, J BIOL CHEM, V264, P9505
   Guerin-Dubiard C, 2006, J AGR FOOD CHEM, V54, P3901, DOI 10.1021/jf0529969
   HARRIS ED, 1980, SCIENCE, V208, P55, DOI 10.1126/science.6102412
   Hincke MT, 2003, CONNECT TISSUE RES, V44, P16, DOI 10.1080/03008200390152025
   HINCKE MT, 1995, CALCIFIED TISSUE INT, V56, P578, DOI 10.1007/BF00298593
   Hincke MT, 1999, J BIOL CHEM, V274, P32915, DOI 10.1074/jbc.274.46.32915
   Hincke MT, 1995, CONNECT TISSUE RES, V31, P227, DOI 10.3109/03008209509010814
   Hincke MT, 2000, MATRIX BIOL, V19, P443, DOI 10.1016/S0945-053X(00)00095-0
   Hincke MT, 2000, CHEM BIOL MINERALIZE, P13
   Hubacek JA, 1997, BIOCHEM BIOPH RES CO, V236, P427, DOI 10.1006/bbrc.1997.6970
   *I NAT RECH AGR, 1989, AL AN MOIN PORC LAP
   Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171
   KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229
   Lavelin I, 2001, AM J PHYSIOL-REG I, V281, pR1169
   Lavelin I, 1998, MATRIX BIOL, V17, P615, DOI 10.1016/S0945-053X(98)90112-3
   LAVELIN J, 2002, AM J PHYSIOL, V283, pR853
   Mann K, 2003, MATRIX BIOL, V22, P397, DOI 10.1016/S0945-053X(03)00072-6
   Mann K, 1999, BIOCHEM MOL BIOL INT, V47, P997
   Mann K, 1999, FEBS LETT, V463, P12, DOI 10.1016/S0014-5793(99)01586-0
   Mann K, 2006, PROTEOMICS, V6, P3801, DOI 10.1002/pmic.200600120
   MCKEE MD, 1995, MICROSC RES TECHNIQ, V31, P44, DOI 10.1002/jemt.1070310105
   Messens W, 2005, WORLD POULTRY SCI J, V61, P71, DOI 10.1079/WPS200443
   Mine Y, 2003, J AGR FOOD CHEM, V51, P249, DOI 10.1021/jf020597x
   Morisson M, 2002, GENET SEL EVOL, V34, P521, DOI 10.1051/gse:2002021
   NAU F, 2002, 11 EUR POULTR C BREM
   Nys Y, 2004, CR PALEVOL, V3, P549, DOI 10.1016/j.crpv.2004.08.002
   Pines M, 1995, MATRIX BIOL, V14, P765, DOI 10.1016/S0945-053X(05)80019-8
   Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h
   THIEDE MA, 1991, ENDOCRINOLOGY, V129, P1958, DOI 10.1210/endo-129-4-1958
NR 42
TC 64
Z9 68
U1 0
U2 12
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD FEB 23
PY 2007
VL 282
IS 8
BP 5273
EP 5286
DI 10.1074/jbc.M610294200
PG 14
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 140CZ
UT WOS:000244482300022
PM 17179153
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Baycin, D
   Altiok, E
   Ulku, S
   Bayraktar, O
AF Baycin, Deniz
   Altiok, Evren
   Ulku, Semra
   Bayraktar, Oguz
TI Adsorption of olive leaf (Olea europaea L.) antioxidants on silk fibroin
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE Olea europaea; silk fibroin; olive leaves; antioxidant; antimicrobial;
   oleuropein; rutin
ID ANTI PROLIFERATIVE ACTIVITIES; SELECTIVE ADSORPTION; OLEUROPEIN;
   EXTRACTS; POLYPHENOLS; COLLAGEN; LEAVES; RUTIN
AB The adsorption isotherms of oleuropein and rutin were evaluated at different temperatures, pH values, and solid/liquid ratios. The experimental data of adsorption isotherms were well fitted to a Langmuir model. The maximum adsorption capacities were determined as 108 mg of oleuropein/g of silk fibroin and 21 mg of rutin/g of silk fibroin. After adsorption of oleuropein and rutin, the antioxidant capacity of silk fibroin increased from 1.93 to 3.61 mmol of TEAC/g. Silk fibroin also gained antimicrobial activity against Staphylococcus aureus and Klebsiella pneumoniae after adsorption of olive leaf antioxidants. In a desorption process, 81% of rutin and 85% of oleuropein were removed from the adsorbent surface in 70% aqueous ethanol solution. Consequently, silk fibroin was found to be a promising biomaterial for the production of functional food or dietary supplements and for the purification of oleuropein and rutin from olive leaf extracts.
C1 Izmir Inst Technol, Dept Chem Engn, BERL, TR-35430 Urla Izmir, Turkey.
RP Bayraktar, O (reprint author), Izmir Inst Technol, Dept Chem Engn, BERL, TR-35430 Urla Izmir, Turkey.
EM oguzbayraktar@iyte.edu.tr
CR Aehle E, 2004, FOOD CHEM, V86, P579, DOI 10.1016/j.foodchem.2003.10.006
   Al-Azzawie HF, 2006, LIFE SCI, V78, P1371, DOI 10.1016/j.lfs.2005.07.029
   ALKHAMIS KA, 2002, AM ASS PHARM SCI, V23, P1
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Bayraktar O, 2005, EUR J PHARM BIOPHARM, V60, P373, DOI 10.1016/j.ejpb.2005.02.002
   BONILLA M, 2006, J CHROMATOGR, V1112, P311
   Chen C, 2000, J AGR FOOD CHEM, V48, P5710, DOI 10.1021/jf000807a
   Chu YF, 2002, J AGR FOOD CHEM, V50, P6910, DOI 10.1021/jf020665f
   COULOMBRE J, 1949, J AM CHEM SOC, V71, P661
   Cowan MM, 1999, CLIN MICROBIOL REV, V12, P564
   GARCIA O.B., 2000, FOOD CHEM, V68, P457, DOI 10.1016/S0308-8146(99)00221-6
   Ghica ME, 2005, ELECTROANAL, V17, P313, DOI 10.1002/elan.200403100
   Kim MR, 2007, J FOOD ENG, V78, P27, DOI 10.1016/j.foodeng.2005.09.004
   Koleva II, 2002, PHYTOCHEM ANALYSIS, V13, P8, DOI 10.1002/pca.611
   Kongkachuichay P, 2002, DYES PIGMENTS, V53, P179, DOI 10.1016/S0143-7208(02)00014-1
   Kurisawa M, 2003, BIOMACROMOLECULES, V4, P1394, DOI 10.1021/bm034136b
   Lee KG, 2004, J APPL POLYM SCI, V93, P2174, DOI 10.1002/app.20714
   Liao XP, 2003, IND ENG CHEM RES, V42, P3397, DOI 10.1021/ie0209475
   Park SJ, 1999, J APPL POLYM SCI, V74, P2571, DOI 10.1002/(SICI)1097-4628(19991209)74:11<2571::AID-APP2>3.0.CO;2-A
   PAULING L, 1945, J AM CHEM SOC, V67, P555, DOI 10.1021/ja01220a017
   Ranalli A, 2006, J AGR FOOD CHEM, V54, P434, DOI 10.1021/jf051647b
   Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3
   Ribeiro MHL, 2002, EUR FOOD RES TECHNOL, V215, P462, DOI 10.1007/s00217-002-0592-0
   Scordino M, 2004, J AGR FOOD CHEM, V52, P1965, DOI [10.1021/jf035220l, 10.1021/jf0352201]
   Sheu JR, 2004, J AGR FOOD CHEM, V52, P4414, DOI 10.1021/jf040059f
   SHI J, 2003, FOOD AGR ENV, V1, P42
   Sun J, 2002, J AGR FOOD CHEM, V50, P7449, DOI 10.1021/jf0207530
   TAKAGAI Y, 2005, ANAL SCI, V2, P183
   Tang HR, 2003, BIOPOLYMERS, V70, P403, DOI 10.1002/bip.10499
   WALTER WM, 1973, APPL MICROBIOL, V26, P773
   Xu MC, 2000, REACT FUNCT POLYM, V43, P297, DOI 10.1016/S1381-5148(99)00062-0
   YAMADA H, 2001, THIN SOLID FILMS, V440, P208
   Yoon SY, 1997, BIOTECHNOL TECH, V11, P553, DOI 10.1023/A:1018434704902
NR 33
TC 38
Z9 41
U1 1
U2 15
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD FEB 21
PY 2007
VL 55
IS 4
BP 1227
EP 1236
DI 10.1021/jf062829o
PG 10
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
SC Agriculture; Chemistry; Food Science & Technology
GA 136EZ
UT WOS:000244206700025
PM 17261014
OA Green Published
DA 2018-10-20
ER

PT J
AU Kaehr, B
   Shear, JB
AF Kaehr, Bryan
   Shear, Jason B.
TI Mask-directed multiphoton lithography
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID MICROFABRICATION; FABRICATION; LASER; PHOTOPOLYMERIZATION; HYDROGELS;
   SCAFFOLDS; BACTERIAL; CELLS
AB We report a strategy to direct the multiphoton photocrosslinking (MPP) of proteins using mask objects or transparency-based masks. This approach enables rapid prototyping and generation of microstructures and functional surface gradients with arbitrary three-dimensional features. We demonstrate use of this strategy to transfer detailed shapes into biomaterial patterns and to fabricate microchambers capable of trapping and incubating a single motile bacterium.
C1 Univ Texas, Dept Chem & Biochem, Austin, TX 78712 USA.
   Univ Texas, Inst Mol & Cellular Biol, Austin, TX 78712 USA.
RP Shear, JB (reprint author), Univ Texas, Dept Chem & Biochem, Austin, TX 78712 USA.
EM jshear@mail.utexas.edu
CR Basu S, 2004, BIOMACROMOLECULES, V5, P2347, DOI 10.1021/bm049707u
   Burdick JA, 2004, LANGMUIR, V20, P5153, DOI 10.1021/la049298n
   Deubel M, 2004, NAT MATER, V3, P444, DOI 10.1038/nmat1155
   El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063
   Groisman A, 2005, NAT METHODS, V2, P685, DOI 10.1038/NMETH784
   Hahn MS, 2005, ADV MATER, V17, P2939, DOI 10.1002/adma.200500184
   Hill RT, 2006, ANAL CHEM, V78, P7022, DOI 10.1021/ac061102w
   Kaehr B, 2006, ANAL CHEM, V78, P3198, DOI 10.1021/ac052267s
   Kaehr B, 2004, P NATL ACAD SCI USA, V101, P16104, DOI 10.1073/pnas.0407204101
   Kawata S, 2001, NATURE, V412, P697, DOI 10.1038/35089130
   Lu Y, 2006, J BIOMED MATER RES A, V77A, P396, DOI 10.1002/jbm.a.30601
   Maruo S, 1997, OPT LETT, V22, P132, DOI 10.1364/OL.22.000132
   Park S, 2003, P NATL ACAD SCI USA, V100, P13910, DOI 10.1073/pnas.1935975100
   Pitts JD, 2000, MACROMOLECULES, V33, P1514, DOI 10.1021/ma9910437
   Sun HB, 2004, ADV POLYM SCI, V170, P169, DOI 10.1007/b94405
NR 15
TC 42
Z9 43
U1 1
U2 23
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD FEB 21
PY 2007
VL 129
IS 7
BP 1904
EP +
DI 10.1021/ja068390y
PG 3
WC Chemistry, Multidisciplinary
SC Chemistry
GA 136EW
UT WOS:000244206400034
PM 17260997
OA Bronze
DA 2018-10-20
ER

PT J
AU Lipski, AM
   Jaquiery, C
   Choi, H
   Eberli, D
   Stevens, M
   Martin, I
   Chen, IW
   Shastri, VP
AF Lipski, Anna Marie
   Jaquiery, Claude
   Choi, Hoon
   Eberli, Daniel
   Stevens, Molly
   Martin, Ivan
   Chen, I. -Wei
   Shastri, Venkatram Prasad
TI Nanoscale engineering of biomaterial surfaces
SO ADVANCED MATERIALS
LA English
DT Article
ID CELL-ADHESION; IN-VITRO; SUBSTRATUM
AB Single-step independent modification of the texture and chemistry of a material surface through the assembly of functionalized silica nanoparticles (NPs) is described. Such NP surface modifications enhance the differentiation of human-marrow-derived mesenchymal cells into an osteogenic lineage and present a new paradigm for nanoscale biomimetic engineering of a biomaterial surface.
C1 Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA.
   Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37232 USA.
   Univ Basel Hosp, Dept Surg, CH-4031 Basel, Switzerland.
   Univ Basel Hosp, Dept Res, CH-4031 Basel, Switzerland.
   Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2AZ, England.
RP Shastri, VP (reprint author), Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA.
EM Prasad.Shastri@vanderbilt.edu
OI Chen, I-Wei/0000-0002-4045-4467
CR Bartlett PN, 2000, CHEM COMMUN, P1671, DOI 10.1039/b004398m
   Blanco A, 2000, NATURE, V405, P437
   Choi H, 2003, J COLLOID INTERF SCI, V258, P435, DOI 10.1016/S0021-9797(02)00130-3
   Cima L. G, 1996, U. S. Patent, Patent No. [5,490,962, 5490962]
   Cima LG, 1996, US Patent, Patent No. 5518680
   DANILOV YN, 1989, EXP CELL RES, V182, P186, DOI 10.1016/0014-4827(89)90290-5
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Frank O, 2002, J CELL BIOCHEM, V85, P737, DOI 10.1002/jcb.10174
   GUAR RK, 1989, ANAL BIOCHEM, V180, P253
   Itala A, 2002, J BIOMED MATER RES, V62, P404, DOI 10.1002/jbm.10273
   Jiang P, 1999, J AM CHEM SOC, V121, P11630, DOI 10.1021/ja9903476
   KUMAR A, 1994, LANGMUIR, V10, P1498, DOI 10.1021/la00017a030
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   Lauer G, 2001, BIOMATERIALS, V22, P2799, DOI 10.1016/S0142-9612(01)00024-2
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   Matsuzawa M, 1996, J NEUROSCI METH, V69, P189, DOI 10.1016/S0165-0270(96)00052-0
   Nitschke M, 2002, J BIOMED MATER RES, V59, P632, DOI 10.1002/jbm.1274.abs
   Park S, 2000, J BIOMED MATER RES, V53, P568, DOI 10.1002/1097-4636(200009)53:5<568::AID-JBM17>3.0.CO;2-8
   Piner RD, 1999, SCIENCE, V283, P661, DOI 10.1126/science.283.5402.661
   SCHMIDT JA, 1978, NATURE, V273, P345
   Tan J, 2001, BIOPHYS J, V81, P2569, DOI 10.1016/S0006-3495(01)75901-2
   VONRECUM AF, 1995, J BIOMAT SCI-POLYM E, V7, P181, DOI 10.1163/156856295X00698
NR 23
TC 54
Z9 55
U1 1
U2 28
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0935-9648
J9 ADV MATER
JI Adv. Mater.
PD FEB 19
PY 2007
VL 19
IS 4
BP 553
EP +
DI 10.1002/adma.200502617
PG 6
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 140ON
UT WOS:000244515200009
DA 2018-10-20
ER

PT J
AU Gomes, ASL
   Falcao, EL
   de Araujo, CB
   Rativa, D
   de Araujo, RE
AF Gomes, A. S. L.
   Falcao Filho, E. L.
   de Araujo, Cid B.
   Rativa, Diego
   de Araujo, R. E.
TI Thermally managed eclipse Z-scan
SO OPTICS EXPRESS
LA English
DT Article
ID HIGH-REPETITION-RATE; RESOLVED Z-SCAN; SINGLE-BEAM; OPTICAL
   NONLINEARITIES; RATE LASERS; ABSORPTION; REFRACTION; PHASE
AB We report a new variation of the conventional Z-scan method to characterize the third-order optical nonlinearity of photonic materials. By exploiting the combination of the eclipse Z-scan with a thermal nonlinearity management technique, we demonstrate an improvement in sensitivity and flexibility of the method to simultaneously characterize the thermal and nonthermal nonlinearity of optical materials. The method is demonstrated by measuring the nonlinear refractive index in CS2, SiO2 and H2O, standard materials, and also in a biomaterial, the amino acid Tryptophan in water solution, using a femtosecond Ti-Sapphire laser operating at 76MHz repetition rate. (c) 2007 Optical Society of America.
C1 Univ Fed Pernambuco, Dept Fis, BR-50670901 Recife, PE, Brazil.
   Univ Fed Pernambuco, Dept Elect & Sist, BR-50740530 Recife, PE, Brazil.
RP Gomes, ASL (reprint author), Univ Fed Pernambuco, Dept Fis, BR-50670901 Recife, PE, Brazil.
EM anderson@df.ufpe.br
RI Falcao-Filho, Edilson/K-6851-2013; de Araujo, Renato/G-8540-2014; de
   Araujo, Cid/A-5565-2009; Rativa, Diego/Q-7011-2016
OI Falcao-Filho, Edilson/0000-0003-0600-4523; de Araujo,
   Renato/0000-0003-2026-070X; de Araujo, Cid/0000-0003-1205-9467; Rativa,
   Diego/0000-0002-5256-5279
CR Boyd R. W., 2002, NONLINEAR OPTICS
   CASTILLO J, 1994, OPT LETT, V19, P171, DOI 10.1364/OL.19.000171
   CHEN LXQ, 1988, J PHYS CHEM-US, V92, P4811, DOI 10.1021/j100327a049
   DESALVO R, 1993, OPT LETT, V18, P194, DOI 10.1364/OL.18.000194
   Falconieri M, 1999, APPL PHYS B-LASERS O, V69, P133, DOI 10.1007/s003400050785
   Falconieri M, 1999, J OPT A-PURE APPL OP, V1, P662, DOI 10.1088/1464-4258/1/6/302
   Gnoli A, 2005, OPT EXPRESS, V13, P7976, DOI 10.1364/OPEX.13.007976
   Levenson M., 1982, INTRO NONLINEAR LASE
   MA H, 1991, APPL PHYS LETT, V59, P2666, DOI 10.1063/1.105933
   OLIVEIRA LC, 1994, APPL PHYS LETT, V65, P2121, DOI 10.1063/1.112809
   PETROV DV, 1994, APPL PHYS LETT, V65, P1067, DOI 10.1063/1.112175
   PETROV DV, 1994, PHYS REV B, V50, P9092, DOI 10.1103/PhysRevB.50.9092
   Rodrigues JJ, 2002, OPT MATER, V20, P153, DOI 10.1016/S0925-3467(02)00062-9
   SHEIKBAHAE M, 1990, IEEE J QUANTUM ELECT, V26, P760, DOI 10.1109/3.53394
   SHEIKBAHAE M, 1992, OPT LETT, V17, P260
   Sutherland R. L., 1996, HDB NONLINEAR OPTICS
   Tai SP, 2006, OPT EXPRESS, V14, P6178, DOI 10.1364/OE.14.006178
   Taylor AJ, 1996, OPT LETT, V21, P1812, DOI 10.1364/OL.21.001812
   WANG J, 1994, J OPT SOC AM B, V11, P1009, DOI 10.1364/JOSAB.11.001009
   XIA T, 1994, OPT LETT, V19, P317, DOI 10.1364/OL.19.000317
NR 20
TC 30
Z9 30
U1 0
U2 12
PU OPTICAL SOC AMER
PI WASHINGTON
PA 2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA
SN 1094-4087
J9 OPT EXPRESS
JI Opt. Express
PD FEB 19
PY 2007
VL 15
IS 4
BP 1712
EP 1717
DI 10.1364/OE.15.001712
PG 6
WC Optics
SC Optics
GA 142WV
UT WOS:000244682500039
PM 19532408
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Wang, DG
   Chen, CZ
   Ma, J
   Lei, TQ
AF Wang, Diangang
   Chen, Chuanzhong
   Ma, Jie
   Lei, Tingquan
TI Microstructure of yttric calcium phosphate bioceramic coatings
   synthesized by laser cladding
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE biomaterial; yttria; microstructure; laser cladding
ID ND-YAG LASER; HYDROXYAPATITE COATINGS; THIN-FILMS; DEPOSITED
   HYDROXYAPATITE; STAINLESS-STEEL
AB The yttric calcium phosphate (CaP) coatings were in situ prepared on pure titanium substrate by laser cladding. The morphologies and phases constitution of CaP coatings were studied by electron probe microanalysis, X-ray diffraction and so on. The bonding state between the coating and the substrate is fine metallurgical combination, and the addition of yttria can fine the structure and increase the tensile strength of the coatings. The X-ray result shows that the coating is composed of the phases of HA, alpha-Ca2P2O7, beta-Ca2P2O7 and CaTiO3. (c) 2006 Elsevier B.V. All rights reserved.
C1 Shandong Univ, Sch Mat Sci & Engn, Jinan 250061, Peoples R China.
   Harbin Inst Technol, Sch Mat Sci & Engn, Harbin 150001, Peoples R China.
RP Chen, CZ (reprint author), Shandong Univ, Sch Mat Sci & Engn, Jinan 250061, Peoples R China.
EM czchen@sdu.edu.cn
OI Chen, Chuanzhong/0000-0003-4044-6915; Wang, Diangang/0000-0003-4980-116X
CR Bezzi G, 2003, MATER CHEM PHYS, V78, P816, DOI 10.1016/S0254-0584(02)00392-9
   CHEN C, 2003, ORTHOP BIOMECH MAT C, V1, P51
   Ding SJ, 2003, SURF COAT TECH, V165, P248, DOI 10.1016/S0257-8972(02)00745-4
   Donazzon B, 1998, ANN CHIM-SCI MAT, V23, P53, DOI 10.1016/S0151-9107(98)80010-X
   Fernandez-Pradas JM, 2002, APPL SURF SCI, V195, P31, DOI 10.1016/S0169-4332(02)00002-8
   Ferro D, 2005, BIOMATERIALS, V26, P805, DOI 10.1016/j.biomaterials.2004.03.027
   Gan L, 2005, BIOMATERIALS, V26, P189, DOI 10.1016/j.biomaterials.2004.02.022
   Gao Jia-cheng, 2003, Chinese Journal of Nonferrous Metals, V13, P675
   Guo GS, 2005, CERAM INT, V31, P869, DOI 10.1016/j.ceramint.2004.10.003
   Hwang K, 2000, SURF COAT TECH, V123, P252, DOI 10.1016/S0257-8972(99)00512-5
   Khor KA, 2004, BIOMATERIALS, V25, P4009, DOI 10.1016/j.biomaterials.2003.10.089
   Liu DM, 2002, BIOMATERIALS, V23, P691, DOI 10.1016/S0142-9612(01)00157-0
   Lu X, 2004, BIOMATERIALS, V25, P1779, DOI 10.1016/j.biomaterials.2003.08.028
   Lusquinos F, 2005, APPL SURF SCI, V247, P486, DOI 10.1016/j.apsusc.2005.01.134
   Meng QW, 2005, MATER LETT, V59, P2774, DOI 10.1016/j.matlet.2005.03.056
   Nistor LC, 2004, MATER RES BULL, V39, P2089, DOI 10.1016/j.materresbull.2004.07.006
   Socol G, 2004, BIOMATERIALS, V25, P2539, DOI 10.1016/j.biomaterials.2003.09.044
   Sridhar TM, 2003, CORROS SCI, V45, P237, DOI 10.1016/S0010-938X(02)00091-4
   Sun LM, 2001, J BIOMED MATER RES, V58, P570, DOI 10.1002/jbm.1056.abs
   Tian YS, 2005, APPL SURF SCI, V242, P177, DOI 10.1016/j.apsusc.2004.08.011
   Wang C, 2002, MATER LETT, V57, P99, DOI 10.1016/S0167-577X(02)00706-1
NR 21
TC 28
Z9 29
U1 2
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD FEB 15
PY 2007
VL 253
IS 8
BP 4016
EP 4020
DI 10.1016/j.apsusc.2006.08.036
PG 5
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 142NL
UT WOS:000244656600047
DA 2018-10-20
ER

PT J
AU Remant, BKC
   Aryal, S
   Bhattarai, SR
   Khil, MS
   Kim, HY
AF Remant, Bahadur K. C.
   Aryal, Santosh
   Bhattarai, Shanta Raj
   Khil, Myung Seob
   Kim, Hak Yong
TI Amphiphilic triblock copolymer based on poly(p-dioxanone) and
   poly(ethylene glycol): Synthesis, characterization, and aqueous
   dispersion
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE block copolymer; biomaterial; coprecipitation; nanoparticles;
   polymerization
ID DRUG-RELEASE BEHAVIORS; PLA-PEG NANOPARTICLES; BLOCK-COPOLYMERS;
   HYDROLYTIC DEGRADATION; EPSILON-CAPROLACTONE; MICELLE FORMATION;
   P-DIOXANONE; 1,4-DIOXAN-2-ONE; MICELLIZATION; DELIVERY
AB Amphiphilic triblock copolymers composed of poly(p-dioxanone) (PPDO) and poly(ethylene glycol) (PEG) were synthesized by ring opening polymerization of PDO initiated through dihydroxyl-terminated PEG in the presence of stannous 2-ethylhexanoate [Sn(oct)(2)] as a catalyst. Polymeric nanoparticles were prepared in an aqueous medium (triple distilled water and phosphate buffer pH 7.4) by cosolvent evaporation technique at room temperature (25 degrees C). Stability of nanoparticles was significantly enough in triple distilled water when compared with the phosphate buffer. Core-shell geometry of polymeric nanoparticles was characterized by H-1-NMR spectroscopy and further confirmed by spectrophotometric analysis using pyrene as a probe. Variation in physicochemical characteristics of polymeric nanoparticles with the fraction of PPDO was investigated through the analysis of microscopic, spectroscopic, and light scattering techniques. Critical micelle concentration of polymer in triple distilled water decreased from 2.3 x 10(-3) to 4.7 x 10(-3). Atomic force microscopic observation revealed that polymeric nanoparticles were spherical and uniform with smooth textured of around 50-68 nm diameter. Dynamic light scattering and electrophoretic light scattering measurements showed a mono-disperse size distribution of around 113-171 nm hydrodynamic diameters and negative zeta zeta-potential (-4.00 to -5.87 mV), respectively. The investigation showed a significant effect of polymeric composition on the physicochemical characteristic of polymeric nanoparticles. (c) 2006 Wiley Periodicals, Inc.
C1 Chonbuk Natl Univ, Dept Text Engn, Jeonju 561756, South Korea.
   Chonbuk Natl Univ, Dept Bionanosyst Engn, Jeonju 561756, South Korea.
   Chonbuk Natl Univ, Ctr Healthcare Technol Dev, Jeonju 561756, South Korea.
RP Kim, HY (reprint author), Chonbuk Natl Univ, Dept Text Engn, Jeonju 561756, South Korea.
EM khy@moak.chonbuk.ac.kr
RI Kim, Hak Yong/G-3826-2013
OI Kim, Hak Yong/0000-0002-4133-124X; KC, Remant/0000-0002-3554-7247
CR Allen C, 1999, COLLOID SURFACE B, V16, P3, DOI 10.1016/S0927-7765(99)00058-2
   Bhattarai N, 2003, EUR POLYM J, V39, P1603, DOI 10.1016/S0014-3057(03)00057-0
   Bhattarai N, 2003, EUR POLYM J, V39, P1365, DOI 10.1016/S0014-3057(02)00389-0
   Bhattarai N, 2004, J POLYM SCI POL PHYS, V42, P2558, DOI 10.1002/polb.20118
   Bhattarai N, 2002, POLYM DEGRAD STABIL, V78, P423, DOI 10.1016/S0141-3910(02)00178-7
   BHATTARAI N, 2003, J POLYM INT, V52, P6
   Brigger I, 2002, ADV DRUG DELIVER REV, V54, P631, DOI 10.1016/S0169-409X(02)00044-3
   CERRAI P, 1989, POLYMER, V30, P338, DOI 10.1016/0032-3861(89)90126-2
   GAO ZS, 1993, MACROMOLECULES, V26, P7353, DOI 10.1021/ma00078a035
   Ge HX, 2002, J PHARM SCI, V91, P1463, DOI 10.1002/jps.10143
   Govender T, 2000, INT J PHARMACEUT, V199, P95, DOI 10.1016/S0378-5173(00)00375-6
   GREF R, 1994, SCIENCE, V263, P1600, DOI 10.1126/science.8128245
   GRISLAIN L, 1983, INT J PHARM, V15, P335, DOI 10.1016/0378-5173(83)90166-7
   HEROLD DA, 1989, BIOCHEM PHARMACOL, V38, P73, DOI 10.1016/0006-2952(89)90151-2
   HUATAN H, 1995, J MICROENCAPSUL, V12, P557, DOI 10.3109/02652049509006786
   Jain NJ, 2000, COLLOID SURFACE A, V173, P85, DOI 10.1016/S0927-7757(99)00514-2
   Kabanov AV, 2002, ADV DRUG DELIVER REV, V54, P759, DOI 10.1016/S0169-409X(02)00047-9
   Kim SY, 1998, J CONTROL RELEASE, V51, P13, DOI 10.1016/S0168-3659(97)00124-7
   KOSSOVSKY N, 1993, BIO-TECHNOL, V11, P1534, DOI 10.1038/nbt1293-1534
   Kricheldorf HR, 1998, MACROMOL CHEM PHYSIC, V199, P1089, DOI 10.1002/macp.1998.021990624
   Luo LB, 2004, MACROMOLECULES, V37, P4008, DOI 10.1021/ma035910q
   Nishida H, 2000, MACROMOLECULES, V33, P6982, DOI 10.1021/ma000457t
   OSTERBERG E, 1995, J BIOMED MATER RES, V29, P741, DOI 10.1002/jbm.820290610
   PETRAK K, 1993, DRUGS PHARM SCI, V61, P275
   Rashkov I, 1996, MACROMOLECULES, V29, P50, DOI 10.1021/ma950530t
   RICHTER AW, 1987, ARCH ALLERGY APPL IM, V38, P73
   Riley T, 1999, COLLOID SURFACE B, V16, P147, DOI 10.1016/S0927-7765(99)00066-1
   Ruel-Gariepy E, 2002, J CONTROL RELEASE, V82, P373, DOI 10.1016/S0168-3659(02)00146-3
   SCHACT EH, 1997, ACS SYM SER, P297
   TUZAR Z, 1976, ADV COLLOID INTERFAC, V6, P201, DOI 10.1016/0001-8686(76)80009-7
   Wang H, 1998, J APPL POLYM SCI, V68, P2121, DOI 10.1002/(SICI)1097-4628(19980627)68:13<2121::AID-APP8>3.0.CO;2-E
   WILLELM M, 1991, MACROMOLECULES, V24, P1033
   ZHAO CL, 1990, LANGMUIR, V6, P514, DOI 10.1021/la00092a038
NR 33
TC 8
Z9 9
U1 1
U2 11
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD FEB 15
PY 2007
VL 103
IS 4
BP 2695
EP 2702
DI 10.1002/app.25429
PG 8
WC Polymer Science
SC Polymer Science
GA 119LN
UT WOS:000243013900082
DA 2018-10-20
ER

PT J
AU Vadiraj, A
   Kamaraj, M
   Gnanamoorthy, R
AF Vadiraj, Aravind
   Kamaraj, M.
   Gnanamoorthy, R.
TI Fretting wear studies on uncoated, plasma nitrided and laser nitrided
   biomedical titanium alloys
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE biomaterial; titanium alloys; plasma nitriding; laser nitriding;
   fretting wear
ID TI-6AL-4V ALLOY; SURFACE MODIFICATION; DISCHARGE; BEHAVIOR
AB Fretting wear resistance of uncoated and surface modified biomedical titanium alloys (Ti-6Al-7Nb) in air and Ringer fluid has been investigated in the present work. Laser nitrided specimen has shown superior performance with minimum surface damage and wear rate (< 0.1 X 10(-6) mm(3)/Nm) despite high friction coefficient in air (0.6) compared to uncoated and plasma nitrided (> 12 x 10(-6) mm(3)/Nm) specimens. This is due to presence of TiN dendrites (60-80%) in the laser nitrided layer. Plasma nitrided surface is relatively softer and hence wear rates and surface damage are comparable with uncoated alloys. Friction coefficient is high for uncoated (0.8) and plasma nitrided alloys (0.6) in air as well as Ringer fluid. Fretting induced electrochemical dissolution is responsible for higher wear rates in uncoated and plasma nitrided specimens. The fretting damage resistance is primarily governed by relative hardness and modified layer thickness of the mating components. (c) 2006 Elsevier B.V. All rights reserved.
C1 Indian Inst Technol, Dept Met & Mat Engn, Madras 600036, Tamil Nadu, India.
   Indian Inst Technol, Dept Mech Engn, Madras 600036, Tamil Nadu, India.
RP Vadiraj, A (reprint author), Indian Inst Technol, Dept Met & Mat Engn, Madras 600036, Tamil Nadu, India.
EM kamaraj@iitm.ac.in
RI R, Gnanamoorthy/M-6186-2017
OI R, Gnanamoorthy/0000-0001-6357-7219; M, Kamaraj/0000-0002-7170-3083
CR Alves C, 2005, SURF COAT TECH, V194, P196, DOI 10.1016/j.surfcoat.2004.10.009
   Carpene E, 2005, APPL SURF SCI, V247, P307, DOI 10.1016/j.apsusc.2005.01.059
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Ettaqi S, 1998, SURF COAT TECH, V100, P428, DOI 10.1016/S0257-8972(97)00664-6
   Galliano F, 2001, SURF COAT TECH, V145, P121, DOI 10.1016/S0257-8972(01)01309-3
   GOKUL LS, 2004, TRIBOL INT, V37, P627
   Hallab NJ, 2003, CORROS REV, V21, P183
   Hu C, 1999, MAT SCI ENG A-STRUCT, V265, P268, DOI 10.1016/S0921-5093(98)01135-6
   LEYENS C, 2004, TITANIUM TITANIUM AL, pCH5
   Liang H, 2004, VACUUM, V73, P317, DOI 10.1016/j.vacuum.2003.12.160
   Ma SL, 2004, SURF COAT TECH, V185, P205, DOI 10.1016/j.surfcoat.02003.11.028
   Man HC, 2005, SURF COAT TECH, V192, P341, DOI 10.1016/j.surfcoat.2004.07.076
   Mishra SC, 2003, J MATER PROCESS TECH, V132, P143, DOI 10.1016/S0924-0136(02)00840-3
   Ramesh R, 2006, MATER DESIGN, V27, P141, DOI 10.1016/j.matdes.2004.09.017
   Selamat MS, 2001, J MATER PROCESS TECH, V113, P509, DOI 10.1016/S0924-0136(01)00595-7
   Sobiecki JR, 2001, VACUUM, V64, P41, DOI 10.1016/S0042-207X(01)00373-6
   Sumita M., 2003, COMPREHENSIVE STRUCT, P131
   Tian YS, 2005, APPL SURF SCI, V242, P177, DOI 10.1016/j.apsusc.2004.08.011
   Wei RH, 2004, SURF COAT TECH, V186, P305, DOI 10.1016/j.surfcoat.2004.02.052
NR 19
TC 23
Z9 28
U1 0
U2 9
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD FEB 15
PY 2007
VL 445
BP 446
EP 453
DI 10.1016/j.msea.2006.09.086
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 137OI
UT WOS:000244301500057
DA 2018-10-20
ER

PT J
AU Lin, JJ
   Wei, JC
   Juang, TY
   Tsai, WC
AF Lin, Jiang-Jen
   Wei, Jiun-Chiou
   Juang, Tzong-Yuan
   Tsai, Wei-Cheng
TI Preparation of protein-silicate hybrids from polyamine intercalation of
   layered montmorillonite
SO LANGMUIR
LA English
DT Article
ID CONFORMATIONAL-CHANGE; ADSORPTION; NANOCOMPOSITES; IMMOBILIZATION;
   NANOPARTICLES; CONFINEMENT; COMPLEXES; MEMBRANES; POLYMERS; FILMS
AB Hybrids of the model BSA protein and layered silicate clay with d spacing of similar to 62 A were prepared from either direct or stepwise intercalation. The pristine montmorilloinite (Na+-MMT) was first modified by poly(oxyalkylene)-amine salts (POP- and POE-amine) of 2000 g/mol M-w to a gallery-expanded silicate (d spacing = 53 and 18 A, respectively), which became accessible for BSA protein embedding. Subsequent BSA substitution allowed the embedding of the protein into the layered clay galleries in an uncompressed conformation. The stepwise process of embedding large molecules into the silicate gallery provides a new method for synthesizing biomaterial/clay hybrids potentially useful in drug delivery or biomedical design.
C1 Natl Taiwan Univ, Inst Polymer Sci & Engn, Taipei 10617, Taiwan.
RP Lin, JJ (reprint author), Natl Taiwan Univ, Inst Polymer Sci & Engn, Taipei 10617, Taiwan.
EM jianglin@ntu.edu.tw
OI LIN, JIANG-JEN/0000-0002-8704-9653
CR Baron MH, 1999, J COLLOID INTERF SCI, V214, P319, DOI 10.1006/jcis.1999.6189
   Cao CX, 2005, ANAL CHEM, V77, P955, DOI 10.1021/ac049470s
   Causserand C, 2001, J MEMBRANE SCI, V186, P165, DOI 10.1016/S0376-7388(01)00332-5
   Chou CC, 2004, MACROMOLECULES, V37, P473, DOI 10.1021/ma0343941
   Chou CC, 2003, MACROMOLECULES, V36, P2187, DOI 10.1021/ma025773h
   Choy J. H., 2000, ANGEW CHEM INT EDIT, V22, P4041
   Choy JH, 1999, J AM CHEM SOC, V121, P1399, DOI 10.1021/ja981823f
   De Cristofaro A, 2001, APPL CLAY SCI, V19, P59, DOI 10.1016/S0169-1317(01)00047-3
   Dumat C, 2000, ENVIRON SCI TECHNOL, V34, P2985, DOI 10.1021/es990657o
   Fu X, 2001, POLYMER, V42, P807, DOI 10.1016/S0032-3861(00)00385-2
   Giannelis EP, 1996, ADV MATER, V8, P29, DOI 10.1002/adma.19960080104
   Gil ES, 2004, PROG POLYM SCI, V29, P1173, DOI 10.1016/j.progpolymsci.2004.08.003
   Kelleher BP, 2003, LANGMUIR, V19, P9411, DOI 10.1021/la034971e
   Lin JJ, 2003, MACROMOL RAPID COMM, V24, P492, DOI 10.1002/marc.200390073
   Lin JJ, 2001, MACROMOLECULES, V34, P8832, DOI 10.1021/ma011169f
   Liu YL, 2005, BIOMACROMOLECULES, V6, P368, DOI 10.1021/bm049531w
   LVOV Y, 1995, J AM CHEM SOC, V117, P6117, DOI 10.1021/ja00127a026
   Mikhaylova M, 2004, CHEM MATER, V16, P2344, DOI 10.1021/cm0348904
   MOHAMMED J, 2003, J AM CHEM SOC, V125, P8015
   Musale DA, 1997, J MEMBRANE SCI, V136, P13, DOI 10.1016/S0376-7388(97)00179-8
   Naidja A, 1997, J MOL CATAL A-CHEM, V115, P305, DOI 10.1016/S1381-1169(96)00335-4
   Ray SS, 2003, PROG POLYM SCI, V28, P1539, DOI 10.1016/j.progpolymsci.2003.08.002
   Shchukin DG, 2005, SMALL, V1, P510, DOI 10.1002/smll.200400120
   Wang QG, 2004, J AM CHEM SOC, V126, P14346, DOI 10.1021/ja047224s
   Zhou YL, 2002, LANGMUIR, V18, P211, DOI 10.1021/la010834a
NR 25
TC 52
Z9 55
U1 0
U2 25
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD FEB 13
PY 2007
VL 23
IS 4
BP 1995
EP 1999
DI 10.1021/la062013h
PG 5
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 133CW
UT WOS:000243990200057
PM 17279686
DA 2018-10-20
ER

PT J
AU Zhang, HZ
   Hayashi, T
   Tsuru, K
   Deguchi, K
   Nagdhara, M
   Hayakawa, S
   Nagai, M
   Kamiya, T
   Osaka, A
   Abe, K
AF Zhang, HanZhe
   Hayashi, Takeshi
   Tsuru, Kanji
   Deguchi, Kentaro
   Nagdhara, Mitsuyuki
   Hayakawa, Satoshi
   Nagai, Makiko
   Kamiya, Tatsushi
   Osaka, Akiyoshi
   Abe, Koji
TI Vascular endothelial growth factor promotes brain tissue regeneration
   with a novel biomaterial polydimethylsiloxane-tetraethoxysilane
SO BRAIN RESEARCH
LA English
DT Article
DE brain; scaffold; tissue regeneration; vascular endothelial growth factor
ID SPINAL-CORD; AXON REGENERATION; BIOMEDICAL APPLICATIONS; FUNCTIONAL
   RECOVERY; CELLS SECRETE; ADULT-RAT; IN-VIVO; ANGIOGENESIS; HYDROGELS;
   TRANSPLANTATION
AB In the brain after infarction or trauma, the tissue eventually becomes pannecrotic and forms a cavity. In such situations, a scaffold is necessary for the implanted or migrated cells to produce new tissue. In this present study, therefore, we attempted to restore brain tissue using a novel biomaterial, polydimethylsiloxane-tetraethoxysilane (PDMS-TEOS) hybrid with or without vascular endothelial growth factor (VEGF), which is crucial for new vessel formation. When PDMS-TEOS scaffold was implanted into the artificial brain defect, it remained at the implanted site and kept the integrity of the brain shape. At 30 days after the implantation, the marginal territory of PDMS-TEOS scaffold became occupied by newly formed tissue. Immunohistochemical analysis revealed that the new tissue was constituted by astrocytes and endothelial cells. Addition of VEGF increased the newly produced tissue volume, and the immunohistochemical analysis showed that the numbers of astrocytes and endothelial cells were increased. Double staining with proliferation maker Ki67 demonstrated that VEGF significantly increased newly formed astrocytes and endothelial cells, indicating that addition of VEGF accelerated tissue restoration and angiogenesis. These findings show that implantation of PDMS-TEOS scaffold with VEGF might be effective for treating old brain infarction or trauma. (c) 2006 Elsevier B.V. All rights reserved.
C1 Okayama Univ, Grad Sch Med, Dept Neurol, Okayama 7008558, Japan.
   Okayama Univ, Grad Sch Nat Sci & Technol, Biomat Lab, Okayama 7008558, Japan.
RP Abe, K (reprint author), Okayama Univ, Grad Sch Med, Dept Neurol, 2-5-1 Shikata Cho, Okayama 7008558, Japan.
EM neurotakeshi@hotmail.com
RI HAYAKAWA, Satoshi/B-2104-2011
OI HAYAKAWA, Satoshi/0000-0002-1097-8614
CR AUBERT I, 1995, CURR OPIN NEUROBIOL, V5, P625, DOI 10.1016/0959-4388(95)80068-9
   AUGUSTIN HG, 1995, AM J PATHOL, V147, P339
   Bani-Yaghoub M, 2005, BIOTECHNOL BIOENG, V92, P336, DOI 10.1002/bit.20618
   BELLAMKONDA R, 1995, J BIOMED MATER RES, V29, P663, DOI 10.1002/jbm.820290514
   Chang JC, 2003, BIOMATERIALS, V24, P2863, DOI 10.1016/S0142-9612(03)00116-9
   DEGUCHI K, 2006, J CEREB BLOOD FLOW M, V1, P1
   FERRARA N, 1989, BIOCHEM BIOPH RES CO, V161, P851, DOI 10.1016/0006-291X(89)92678-8
   FLAMME I, 1995, DEV BIOL, V171, P399, DOI 10.1006/dbio.1995.1291
   Griffith LG, 2002, ANN NY ACAD SCI, V961, P83, DOI 10.1111/j.1749-6632.2002.tb03056.x
   Hou SP, 2005, J NEUROSCI METH, V148, P60, DOI 10.1016/j.jneumeth.2005.04.016
   Huang DW, 1999, NEURON, V24, P639, DOI 10.1016/S0896-6273(00)81118-6
   JAKEMAN LB, 1993, ENDOCRINOLOGY, V133, P848, DOI 10.1210/en.133.2.848
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   Kataoka K, 2005, BIOMATERIALS, V26, P2509, DOI 10.1016/j.biomaterials.2004.07.012
   Kataoka K, 2001, J BIOMED MATER RES, V54, P373, DOI 10.1002/1097-4636(20010305)54:3<373::AID-JBM90>3.0.CO;2-Q
   Krum JM, 2002, NEUROSCIENCE, V110, P589, DOI 10.1016/S0306-4522(01)00615-7
   KRUM JM, 2002, EXP NEUROL, V181, P241
   Lakatos A, 2003, EXP NEUROL, V184, P237, DOI 10.1016/S0014-4886(03)00270-X
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lesny P, 2002, J CHEM NEUROANAT, V23, P243, DOI 10.1016/S0891-0618(02)00011-X
   McKerracher L, 2001, NEUROBIOL DIS, V8, P11, DOI 10.1006/nbdi.2000.0359
   Papadopoulos CM, 2002, ANN NEUROL, V51, P433, DOI 10.1002/ana.10144
   PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0
   PORTER GA, 1990, EUR J CELL BIOL, V51, P85
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Ren L, 2001, J SOL-GEL SCI TECHN, V21, P115, DOI 10.1023/A:1011226104173
   Rosenstein JM, 1998, P NATL ACAD SCI USA, V95, P7086, DOI 10.1073/pnas.95.12.7086
   Scholl M, 2000, J NEUROSCI METH, V104, P65, DOI 10.1016/S0165-0270(00)00325-3
   SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562
   SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0
   SILVER J, 1988, CLIN RES, V36, P196
   Silverman WF, 1999, NEUROSCIENCE, V90, P1529, DOI 10.1016/S0306-4522(98)00540-5
   Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977
   Tian WM, 2005, TISSUE ENG, V11, P513, DOI 10.1089/ten.2005.11.513
   Woerly S, 1999, TISSUE ENG, V5, P467, DOI 10.1089/ten.1999.5.467
   WOERLY S, 1993, BIOMATERIALS, V14, P1056, DOI 10.1016/0142-9612(93)90205-G
   Woerly S, 2001, J NEUROSCI RES, V66, P1187
   Yabuta T, 2003, J SOL-GEL SCI TECHN, V26, P1219, DOI 10.1023/A:1020772521781
NR 38
TC 23
Z9 26
U1 1
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0006-8993
J9 BRAIN RES
JI Brain Res.
PD FEB 9
PY 2007
VL 1132
IS 1
BP 29
EP 35
DI 10.1016/j.brainres.2006.09.117
PG 7
WC Neurosciences
SC Neurosciences & Neurology
GA 135RJ
UT WOS:000244170400004
PM 17189618
DA 2018-10-20
ER

PT J
AU Chen, XY
   Wang, J
   Boughton, AP
   Kristalyn, CB
   Chen, Z
AF Chen, Xiaoyun
   Wang, Jie
   Boughton, Andrew P.
   Kristalyn, Cornelius B.
   Chen, Zhan
TI Multiple orientation of melittin inside a single lipid bilayer
   determined by combined vibrational spectroscopic studies
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID SUM-FREQUENCY GENERATION; BOVINE SERUM-ALBUMIN; INFRARED-SPECTROSCOPY;
   MEMBRANE-PROTEINS; SURFACE; INTERFACE; MONOLAYER; PEPTIDES; FILMS; SFG
AB Despite the availability of several mature structure determination techniques for bulk proteins, determination of structural and orientational information of interfacial proteins, e.g., in cell membranes or on biomaterial surfaces, remains a difficult problem. We combine sum frequency generation (SFG) vibrational spectroscopy with attenuated total reflection-Fourier transform infrared spectroscopy (ATR-FTIR) to investigate the orientation of alpha-helical peptides reconstituted in substrate supported lipid bilayers. Melittin was chosen as a model for alpha-helical peptides, and its orientation when interacting with a supported 1,2-dipalmitoyl-sn-glycero-3-phosphoglycerol (DPPG) bilayer has been examined. Through polarization analysis using amide I signals obtained from both SFG and ATR-FTIR measurements, the orientation distribution of melittin inside a DPPG bilayer was deduced using several trial distribution functions. Melittin was modeled as either an ideal helix or a helix with a bent structure. It was found that a simple distribution function such as a delta-distribution or a Gaussian distribution was not adequate to describe the melittin orientation distribution inside a DPPG bilayer. Instead, two populations of melittin, corresponding to two melittin-bilayer association states, could be used to interpret the experimentally observed result. The method employed in this study demonstrates the feasibility of acquiring a more accurate orientation distribution of peptides/proteins in situ using a combination of vibrational spectroscopic techniques without exogenous labeling.
C1 Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.
RP Chen, Z (reprint author), Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.
EM zhanc@umich.edu
RI Chen, Zhan/G-8312-2016
OI Chen, Zhan/0000-0001-8687-8348; Boughton, Andrew/0000-0002-0318-4912
CR Allende D, 2005, BIOPHYS J, V88, P1828, DOI 10.1529/biophysj.104.049817
   Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815
   Beattie DA, 2006, J PHYS CHEM B, V110, P2278, DOI 10.1021/jp056204p
   CHEN X, UNPUB BIOPHYS J
   Chen XY, 2006, J AM CHEM SOC, V128, P2711, DOI 10.1021/ja057029t
   Chen XY, 2005, LANGMUIR, V21, P2662, DOI 10.1021/la050048w
   Constantinescu I, 2004, BBA-BIOMEMBRANES, V1667, P26, DOI 10.1016/j.bbamem.2004.08.012
   DEMPSEY CE, 1990, BIOCHIM BIOPHYS ACTA, V1031, P143, DOI 10.1016/0304-4157(90)90006-X
   Dreesen L, 2004, CHEMPHYSCHEM, V5, P1719, DOI 10.1002/cphc.200400213
   Dreesen L, 2004, LANGMUIR, V20, P7201, DOI 10.1021/la0488001
   Engel A, 2003, HISTOCHEM CELL BIOL, V120, P93, DOI 10.1007/s00418-003-0560-1
   FREY S, 1991, BIOPHYS J, V60, P922, DOI 10.1016/S0006-3495(91)82126-9
   Goormaghtigh E, 1999, BBA-REV BIOMEMBRANES, V1422, P105, DOI 10.1016/S0304-4157(99)00004-0
   HIROSE C, 1992, J CHEM PHYS, V96, P997, DOI 10.1063/1.462120
   Holman J, 2005, J PHYS CHEM B, V109, P18723, DOI 10.1021/jp051564y
   Hristova K, 2001, BIOPHYS J, V80, P801, DOI 10.1016/S0006-3495(01)76059-6
   Jung SY, 2003, J AM CHEM SOC, V125, P12782, DOI 10.1021/ja037263o
   Kataoka S, 2006, J AM CHEM SOC, V128, P5516, DOI 10.1021/ja060156k
   Kim J, 2003, J AM CHEM SOC, V125, P3150, DOI 10.1021/ja028987n
   Ladokhin AS, 2001, BBA-BIOMEMBRANES, V1514, P253, DOI 10.1016/S0005-2736(01)00382-0
   Lee SH, 1998, J RAMAN SPECTROSC, V29, P73, DOI 10.1002/(SICI)1097-4555(199801)29:1<73::AID-JRS210>3.3.CO;2-F
   Lee SH, 1998, BIOPOLYMERS, V46, P283, DOI 10.1002/(SICI)1097-0282(19981015)46:5<283::AID-BIP2>3.0.CO;2-L
   Liu J, 2005, BIOPHYS J, V89, P2522, DOI 10.1529/biophysj.105.065672
   LUDTKE SJ, 1994, BBA-BIOMEMBRANES, V1190, P181, DOI 10.1016/0005-2736(94)90050-7
   Ma G, 2006, LANGMUIR, V22, P5341, DOI 10.1021/la0535227
   Marsh D, 2000, BIOPHYS J, V78, P2499, DOI 10.1016/S0006-3495(00)76795-6
   MEAD LR, 1984, J MATH PHYS, V25, P2404, DOI 10.1063/1.526446
   Mermut O, 2006, J AM CHEM SOC, V128, P3598, DOI 10.1021/ja056031h
   Moad AJ, 2004, J PHYS CHEM B, V108, P3548, DOI 10.1021/jp035362i
   Mohammad-Djafari A. A, 1992, MAXIMUM ENTROPY BAYE, V50, P221
   Opella SJ, 2004, CHEM REV, V104, P3587, DOI 10.1021/cr0304121
   Rintoul L, 2000, BIOPOLYMERS, V57, P19, DOI 10.1002/(SICI)1097-0282(2000)57:1<19::AID-BIP4>3.0.CO;2-Z
   Shen Y. R., 1984, PRINCIPLES NONLINEAR
   Steinem C, 2000, PHYS CHEM CHEM PHYS, V2, P4580, DOI 10.1039/b003865m
   Tamm LK, 1997, Q REV BIOPHYS, V30, P365, DOI 10.1017/S0033583597003375
   Tatulian SA, 2003, BIOCHEMISTRY-US, V42, P11898, DOI 10.1021/bi034235+
   TERWILLIGER TC, 1982, J BIOL CHEM, V257, P6010
   TERWILLIGER TC, 1982, J BIOL CHEM, V257, P6016
   Toraya S, 2004, BIOPHYS J, V87, P3323, DOI 10.1529/biophysj.104.046102
   Wang J, 2002, J AM CHEM SOC, V124, P7016, DOI 10.1021/ja012387r
   Wang J, 2001, J PHYS CHEM B, V105, P12118, DOI 10.1021/jp013161d
   Wang J, 2003, LANGMUIR, V19, P7862, DOI 10.1021/la0349222
   Wang J, 2003, J AM CHEM SOC, V125, P9914, DOI 10.1021/ja036373s
   Wang J, 2003, ANALYST, V128, P773, DOI 10.1039/b212551j
   WANG J, UNPUB
   Watry MR, 2002, LANGMUIR, V18, P8881, DOI 10.1021/la020463d
   Wei X, 2000, PHYS REV E, V62, P5160, DOI 10.1103/PhysRevE.62.5160
   Wiener MC, 2004, METHODS, V34, P364, DOI 10.1016/j.ymeth.2004.03.025
   Yang L, 2001, BIOPHYS J, V81, P1475, DOI 10.1016/S0006-3495(01)75802-X
   Ye S, 2004, LANGMUIR, V20, P357, DOI 10.1021/la036008e
   Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a
   Zhuang X, 1999, PHYS REV B, V59, P12632, DOI 10.1103/PhysRevB.59.12632
NR 52
TC 121
Z9 123
U1 2
U2 69
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD FEB 7
PY 2007
VL 129
IS 5
BP 1420
EP 1427
DI 10.1021/ja067446I
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA 131AL
UT WOS:000243840100062
PM 17263427
DA 2018-10-20
ER

PT J
AU Georgakoudi, I
   Tsai, I
   Greiner, C
   Wong, C
   DeFelice, J
   Kaplan, D
AF Georgakoudi, Irene
   Tsai, Irene
   Greiner, Cherry
   Wong, Cheryl
   DeFelice, Jordy
   Kaplan, David
TI Intrinsic fluorescence changes associated with the conformational state
   of silk fibroin in biomaterial matrices
SO OPTICS EXPRESS
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; LOG-NORMAL COMPONENTS; IN-VITRO; TRYPTOPHAN
   FLUORESCENCE; 3-D SCAFFOLDS; FILMS; DECOMPOSITION; SPECTRA; DITYROSINE;
   ACTIN
AB Silk fibroin is emerging as an important biomaterial for tissue engineering applications. The ability to monitor non-invasively the structural conformation of silk matrices prior to and following cell seeding could provide important insights with regards to matrix remodeling and cell-matrix interactions that are critical for the functional development of silk-based engineered tissues. Thus, we examined the potential of intrinsic fluorescence as a tool for assessing the structural conformation of silk proteins. Specifically, we characterized the intrinsic fluorescence spectra of silk in solution, gel and scaffold configurations for excitation in the 250 to 335 nm range and emission from 265 to 600 nm. We have identified spectral components that are attributed to tyrosine, tryptophan and crosslinks based on their excitation-emission profiles. We have discovered significant spectral shifts in the emission profiles and relative contributions of these components among the silk solution, gel and scaffold samples that represent enhancements in the levels of crosslinking, hydrophobic and intermolecular interactions that are consistent with an increase in the levels of beta-sheet formation and stacking. This information can be easily utilized for the development of simple, non-invasive, ratiometric methods to assess and monitor the structural conformation of silk in engineered tissues. (c) 2007 Optical Society of America.
C1 Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Georgakoudi, I (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby Str,Rm 153, Medford, MA 02155 USA.
EM Irene.Georgakoudi@tufts.edu
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Altman GH, 2002, J BIOMECH ENG-T ASME, V124, P742, DOI 10.1115/1.1519280
   Burstein EA, 2001, BIOPHYS J, V81, P1699, DOI 10.1016/S0006-3495(01)75823-7
   Cantor C. R., 1980, BIOPHYSICAL CHEM 3
   Doyle TC, 2001, BIOPHYS J, V80, P427, DOI 10.1016/S0006-3495(01)76025-0
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   KAPLAN DL, 1994, SILK POLYM SCI BIOTE, V544
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Karageorgiou V, 2006, J BIOMED MATER RES A, V78A, P324, DOI 10.1002/jbm.a.30728
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Kuznetsova IM, 1999, FEBS LETT, V452, P205, DOI 10.1016/S0014-5793(99)00574-8
   Lakowicz J. R., 1999, PRINCIPLES FLUORESCE
   LOTZ B, 1974, J MOL BIOL, V87, P169, DOI 10.1016/0022-2836(74)90141-7
   Malencik DA, 2003, AMINO ACIDS, V25, P233, DOI 10.1007/s00726-003-0014-z
   Malencik DA, 1996, ANAL BIOCHEM, V242, P202, DOI 10.1006/abio.1996.0454
   MARSH RE, 1955, BIOCHIM BIOPHYS ACTA, V16, P1, DOI 10.1016/0006-3002(55)90178-5
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4
   Meinel L, 2004, BIOTECHNOL BIOENG, V88, P379, DOI 10.1002/bit.20252
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Ratner B.D., 2004, BIOMATERIALS SCI
   Reshetnyak YK, 2001, BIOPHYS J, V81, P1735, DOI 10.1016/S0006-3495(01)75825-0
   Reshetnyak YK, 2001, BIOPHYS J, V81, P1710, DOI 10.1016/S0006-3495(01)75824-9
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   TAULER R, 1994, ANAL CHEM, V66, P3337, DOI 10.1021/ac00092a009
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
NR 35
TC 32
Z9 33
U1 0
U2 32
PU OPTICAL SOC AMER
PI WASHINGTON
PA 2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA
SN 1094-4087
J9 OPT EXPRESS
JI Opt. Express
PD FEB 5
PY 2007
VL 15
IS 3
BP 1043
EP 1053
DI 10.1364/OE.15.001043
PG 11
WC Optics
SC Optics
GA 142WS
UT WOS:000244682200033
PM 19532332
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Dominguez, MM
   Wathier, M
   Grinstaff, MW
   Schaus, SE
AF Dominguez, Melissa M.
   Wathier, Michel
   Grinstaff, Mark W.
   Schaus, Scott E.
TI Immobilized hydrogels for screening of molecular interactions
SO ANALYTICAL CHEMISTRY
LA English
DT Article
ID CELL-ADHESION; PROTEIN IMMOBILIZATION; REACTIVE POLYMER; MICROARRAYS;
   DISCOVERY; ARRAYS; DNA; DENDRIMERS; PATTERNS; SURFACES
AB Spatially arrayed, high-density microarrays enable the rapid assessment of biological recognition events, and this information is of widespread interest for those working in basic research laboratories as well as in the clinic. Today, one can find DNA, protein, or small molecule arrays. Limitations with these systems include covalent modification of the target complement to the array substrate, array- and target-dependent setup conditions, multiple steps, and loss of hydration at the surface. To overcome these limitations, we have designed, prepared, and evaluated immobilized hydrogels as general screening chambers for small molecule-protein, protein-protein, and nucleic acid-nucleic acid interactions. This biomaterial-based approach is facile, rapid, requires only one setup protocol, and physically entraps the target complement within the polymer network and thus offers advantages over the conventional chips.
C1 Boston Univ, Dept Biomed Engn, Metcalf Ctr Sci & Engn, Boston, MA 02215 USA.
   Boston Univ, Dept Chem, Metcalf Ctr Sci & Engn, Boston, MA 02215 USA.
RP Grinstaff, MW (reprint author), Boston Univ, Dept Biomed Engn, Metcalf Ctr Sci & Engn, 590 Commonwealth Ave, Boston, MA 02215 USA.
EM mgrin@bu.edu; seschaus@bu.edu
RI Grinstaff, Mark/U-2829-2017
OI Grinstaff, Mark/0000-0002-5453-3668
CR Abbott A, 1999, NATURE, V402, P715, DOI 10.1038/45350
   Afanassiev V, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e66
   Falsey JR, 2001, BIOCONJUGATE CHEM, V12, P346, DOI 10.1021/bc000141q
   Frechet JMJ, 2003, J POLYM SCI POL CHEM, V41, P3713, DOI 10.1002/pola.10952
   GEROLD D, 1999, TRENDS BIOCHEM SCI, V24, P168
   Gong P, 2004, SURF SCI, V570, P67, DOI 10.1016/j.susc.2004.06.181
   Grinstaff MW, 2002, CHEM-EUR J, V8, P2838, DOI 10.1002/1521-3765(20020703)8:13<2838::AID-CHEM2838>3.0.CO;2-I
   Harris RF, 2000, J AM CHEM SOC, V122, P11270, DOI 10.1021/ja0055763
   Hoever M, 2004, DRUG DISCOV TODAY, V9, P358, DOI 10.1016/S1359-6446(04)03037-5
   Hoff A, 2002, CHEMBIOCHEM, V3, P1183, DOI 10.1002/1439-7633(20021202)3:12<1183::AID-CBIC1183>3.0.CO;2-Q
   Hong YL, 2005, J AM CHEM SOC, V127, P15350, DOI 10.1021/ja055101h
   Ito Y, 2003, BIOMATERIALS, V24, P3021, DOI 10.1016/S0142-9612(03)00134-0
   Kanoh N, 2005, ANGEW CHEM INT EDIT, V44, P3559, DOI 10.1002/anie.200462370
   Kanoh N, 2003, ANGEW CHEM INT EDIT, V42, P5584, DOI 10.1002/anie.200352164
   Kiyonaka S, 2004, NAT MATER, V3, P58, DOI 10.1038/nmat1034
   Ko KS, 2005, J AM CHEM SOC, V127, P13162, DOI 10.1021/ja054811k
   LI LS, 1997, MACROMOLECULES, V30, P2110
   MacBeath G, 2002, NAT GENET, V32, P526, DOI 10.1038/ng1037
   MacBeath G, 1999, J AM CHEM SOC, V121, P7967, DOI 10.1021/ja991083q
   MacBeath G, 2000, SCIENCE, V289, P1760
   Min DH, 2004, CURR OPIN CHEM BIOL, V8, P554, DOI 10.1016/j.cbpa.2004.08.007
   NEWKOME GR, 1996, DENDRITIC MOL CONCEP, V2
   Orner BP, 2004, J AM CHEM SOC, V126, P10808, DOI 10.1021/ja0474291
   Peppas N. A., 1987, HYDROGELS MED PHARM, P1
   Proudnikov D, 1998, ANAL BIOCHEM, V259, P34, DOI 10.1006/abio.1998.2620
   Rondelez Y, 2005, NAT BIOTECHNOL, V23, P361, DOI 10.1038/nbt1072
   Schena M, 1998, TRENDS BIOTECHNOL, V16, P301, DOI 10.1016/S0167-7799(98)01219-0
   SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467
   Silva JM, 2004, P NATL ACAD SCI USA, V101, P6548, DOI 10.1073/pnas.0400165101
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   Sparks AB, 1996, NAT BIOTECHNOL, V14, P741, DOI 10.1038/nbt0696-741
   Tomalia DA, 2002, J POLYM SCI POL CHEM, V40, P2719, DOI 10.1002/pola.10301
   TOMALIA DA, 2002, DENDRIMERS OTHER DEN, P688
   Tomizaki Kin-ya, 2005, Chembiochem, V6, P782, DOI 10.1002/cbic.200400232
   Vaschetto M, 2003, CURR OPIN DRUG DI DE, V6, P377
   Watzke A, 2006, ANGEW CHEM INT EDIT, V45, P1408, DOI 10.1002/anie.200502057
   Yousaf MN, 2001, P NATL ACAD SCI USA, V98, P5992, DOI 10.1073/pnas.101112898
   Zhang KC, 2005, J AM CHEM SOC, V127, P10136, DOI 10.1021/ja051457h
   Zhao ZY, 2005, J AM CHEM SOC, V127, P8930, DOI 10.1021/ja051053p
   Ziauddin J, 2001, NATURE, V411, P107, DOI 10.1038/35075114
NR 40
TC 19
Z9 19
U1 0
U2 8
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0003-2700
J9 ANAL CHEM
JI Anal. Chem.
PD FEB 1
PY 2007
VL 79
IS 3
BP 1064
EP 1066
DI 10.1021/ac061709c
PG 3
WC Chemistry, Analytical
SC Chemistry
GA 131AK
UT WOS:000243839900031
PM 17263336
DA 2018-10-20
ER

PT J
AU Kanayama, Y
   Aoki, C
   Sakai, Y
AF Kanayama, Yoshitaka
   Aoki, Chizuru
   Sakai, Yasuo
TI Development of low endotoxin gelatin for regenerative medicine
SO BIOLOGICAL & PHARMACEUTICAL BULLETIN
LA English
DT Article
DE collagen; gelatin; endotoxin; cell culture; scaffold
AB The basic concept of tissue engineering, an actively applied technology in regenerative medicine, is the coordination between cells, scaffolds, and proliferation factors. Collagen and gelatin are materials that have mostly been used as scaffolds because of their excellent affinity for cells, they are biodegradable, and their ability to form gel. However, very few of the collagen or gelatin preparations used as tissue engineering material have been prepared with low levels of endotoxin, which may trigger fever, shock and a fall in blood pressure even in very minute quantities. Therefore we decided to decrease the content of endotoxin in gelatin so that this biomaterial is not harmful to the body but still maintains its properties, namely, bioaffinity and biodegradation for use in the fields of cell culture and regenerative medicine. In this paper, we describe a method whereby endotoxin could be removed from gelatin solution by using an ultrafiltration membrane with a molecular weight cut-off of 100 kDa and low endotoxin gelatin, endotoxin activity in 0.1% gelatin solution was below 0.03 EU/ml, was obtained as the resulting filtrate solution.
C1 Jellice Co Ltd, Cent Res Inst, Wakabayashi Ku, Sendai, Miyagi 9840826, Japan.
RP Kanayama, Y (reprint author), Jellice Co Ltd, Cent Res Inst, Wakabayashi Ku, 4-1-4 Wakabayashi, Sendai, Miyagi 9840826, Japan.
EM kanayama@jellice.com
CR ABIKO Y, 1997, GLUES GELATINS, P245
   BRNSON KW, 1978, J SUPRAMOL STRUCT, V9, P231
   BROCKUTNE JG, 1989, ANAESTH INTENS CARE, V17, P49
   *COMM METH TEST PH, 1997, PAGI METHOD, P8
   HARLAN JM, 1983, LAB INVEST, V48, P269
   Kirikae T, 1997, INT J IMMUNOPHARMACO, V19, P255, DOI 10.1016/S0192-0561(97)00066-0
   *MIN HLTH LAB WELF, 2006, JAP PHARM, P159
   ONGRADI J, 1984, FOLIA MICROBIOL, V29, P450, DOI 10.1007/BF02873158
   Tabata Y, 1999, BIOMATERIALS, V20, P2169, DOI 10.1016/S0142-9612(99)00121-0
   TABATA Y, 2000, PROTEIN NUCL ACID EN, V45, P2179
   ZIEGLER EJ, 1982, NEW ENGL J MED, V307, P1225, DOI 10.1056/NEJM198211113072001
NR 11
TC 12
Z9 12
U1 0
U2 3
PU PHARMACEUTICAL SOC JAPAN
PI TOKYO
PA 2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN
SN 0918-6158
J9 BIOL PHARM BULL
JI Biol. Pharm. Bull.
PD FEB
PY 2007
VL 30
IS 2
BP 237
EP 241
DI 10.1248/bpb.30.237
PG 5
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 155MX
UT WOS:000245582600006
PM 17268058
OA Bronze
DA 2018-10-20
ER

PT J
AU Dubruel, P
   Unger, R
   Van Vlierberghe, S
   Cnudde, V
   Jacobs, PJS
   Schacht, E
   Kirkpatrick, CJ
AF Dubruel, Peter
   Unger, R.
   Van Vlierberghe, Sandra
   Cnudde, Veerle
   Jacobs, Patric J. S.
   Schacht, Etienne
   Kirkpatrick, C. J.
TI Porous gelatin hydrogels: 2. In vitro cell interaction study
SO BIOMACROMOLECULES
LA English
DT Article
ID TISSUE ENGINEERING APPLICATIONS; BETA-TRICALCIUM PHOSPHATE;
   TRI-COPOLYMER SCAFFOLD; HUMAN NUCLEUS PULPOSUS; ENDOTHELIAL-CELLS;
   CROSS-LINKING; GROWTH-FACTOR; CULTURE; HYDROXYAPATITE; CHONDROCYTES
AB We report on the feasibility of applying porous gelatin hydrogels, prepared by a novel and controlled cryogenic treatment, as cell-interactive scaffolds for tissue engineering applications. Despite the large number of publications on gelatin as a biomaterial, a detailed study of screening a limited number of gelatin scaffolds for their interaction with a panel of human cells has, to the best of our knowledge, not yet been published. In the present work, we have evaluated two types of porous gelatin scaffolds that differ in their pore geometry and pore size. Type I hydrogels contained top-to-bottom transverse channels (i.e. cones) with a decreasing diameter from the top (330 mu m) to the bottom (20-30 mu m). Type II hydrogels contained spherical pores with a diameter of 135 mu m. Both types of scaffolds were evaluated by confocal laser scanning microscopy in terms of adhesion, spreading, and proliferation of human cells (endothelial, epithelial, fibroblast, glial, and osteoblast) by visualizing cells using calcein-acetoxy methyl ester as a vital stain. The results indicated that cells attached, spread, and proliferated on both types of hydrogels. In addition, the scaffolds developed can be used for the long-term culturing of human cells.
C1 Univ Ghent, Polymer Chem & Biomat Res Grp, B-9000 Ghent, Belgium.
   Univ Mainz, Inst Pathol, D-55101 Mainz, Germany.
   Univ Ghent, Dept Soil Sci & Geol, B-9000 Ghent, Belgium.
RP Dubruel, P (reprint author), Univ Ghent, Polymer Chem & Biomat Res Grp, Krijgslaan 281,Bldg S4 Bis, B-9000 Ghent, Belgium.
EM Peter.Dubruel@UGent.be
RI Jacobs, Patric/E-4067-2012; Dubruel, Peter/A-3440-2009; Cnudde,
   Veerle/K-2026-2016
OI Jacobs, Patric/0000-0001-9154-385X; Cnudde, Veerle/0000-0002-3269-5914
CR Alperin C, 2005, BIOMATERIALS, V26, P7377, DOI 10.1016/j.biomaterials.2005.05.064
   Balakrishnan B, 2005, BIOMATERIALS, V26, P3941, DOI 10.1016/j.biomaterials.2004.10.005
   Bloch K, 2005, J BIOMED MATER RES A, V75A, P802, DOI 10.1002/jbm.a.30466
   BORRAS A, 1972, AM J OPHTHALMOL, V73, P390, DOI 10.1016/0002-9394(72)90067-0
   Broderick EP, 2005, J BIOMED MATER RES B, V72B, P37, DOI 10.1002/jbm.b.30119
   Brown RQ, 2005, J BIOMED MATER RES A, V74A, P32, DOI 10.1002/jbm.a.30250
   Cascone MG, 2004, J MATER SCI-MATER M, V15, P1309, DOI 10.1007/s10856-004-5739-z
   Chang CH, 2006, BIOMATERIALS, V27, P1876, DOI 10.1016/j.biomaterials.2005.10.014
   CNUDDE V, 2004, P INT WORKSH XRAY CT, P363
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Gamez E, 2004, CELL TRANSPLANT, V13, P549, DOI 10.3727/000000004783983639
   Guo T, 2006, BIOMATERIALS, V27, P1095, DOI 10.1016/j.biomaterials.2005.08.015
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Holland TA, 2005, J BIOMED MATER RES A, V75A, P156, DOI 10.1002/jbm.a.30379
   Holland TA, 2005, J CONTROL RELEASE, V101, P111, DOI 10.1016/j.jconrel.2004.07.004
   Hong L, 2005, ANN BIOMED ENG, V33, P511, DOI 10.1007/s10439-005-2510-7
   HOUGLUM PA, 2005, THERAPEUTIC MUSCULOS
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   ITO A, 2000, J BIOSCI BIOENG, V95, P196
   Ito Y, 2005, J BIOMED MATER RES A, V74A, P659, DOI 10.1002/jbm.a.30360
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   Kim HW, 2005, BIOMATERIALS, V26, P5221, DOI 10.1016/j.biomaterials.2005.01.047
   Kim HW, 2005, J BIOMED MATER RES A, V72A, P136, DOI 10.1002/jbm.a.30168
   Kim S, 2005, J BIOMED MATER RES B, V75B, P442, DOI 10.1002/jbm.b.30324
   Li MY, 2005, IEEE T NANOBIOSCI, V4, P170, DOI 10.1109/TNB.2005.850477
   Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030
   Liu XH, 2005, J BIOMED MATER RES A, V74A, P84, DOI 10.1002/jbm.a.30367
   Ma PX, 2004, MATER TODAY, V7, P30, DOI 10.1016/S1369-7021(04)00233-0
   Ma ZW, 2005, TISSUE ENG, V11, P1149, DOI 10.1089/ten.2005.11.1149
   Ma ZW, 2005, BIOMATERIALS, V26, P2527, DOI 10.1016/j.biomaterials.2004.07.026
   Mironov V, 2005, BIOMATERIALS, V26, P7628, DOI 10.1016/j.biomaterials.2005.05.061
   Ohya Shoji, 2004, J Artif Organs, V7, P181
   Park H, 2005, BIOMATERIALS, V26, P7095, DOI 10.1016/j.biomaterials.2005.05.083
   Steppe K, 2004, J STRUCT BIOL, V148, P11, DOI 10.1016/j.jsb.2004.05.001
   Takahashi Y, 2005, BIOMATERIALS, V26, P4856, DOI 10.1016/j.biomaterials.2005.01.012
   Takahashi Y, 2005, BIOMATERIALS, V26, P3587, DOI 10.1016/j.biomaterials.2004.09.046
   Unger RE, 2005, BIOMATERIALS, V26, P1877, DOI 10.1016/j.biomaterials.2004.05.032
   Van den Bulcke AI, 2000, BIOMACROMOLECULES, V1, P31, DOI 10.1021/bm990017d
   Van Vlierberghe S, 2007, BIOMACROMOLECULES, V8, P331, DOI 10.1021/bm060684o
   Vestweber D, 2000, J PATHOL, V190, P281
   Wang YW, 2005, BIOMACROMOLECULES, V6, P566, DOI 10.1021/bm049342d
   Williamson MR, 2006, BIOMATERIALS, V27, P1019, DOI 10.1016/j.biomaterials.2005.06.018
   Witte RP, 2005, BIOMATERIALS, V26, P3673, DOI 10.1016/j.biomaterials.2004.09.054
   Yang SH, 2005, ARTIF ORGANS, V29, P806, DOI 10.1111/j.1525-1594.2005.00133.x
   Yang SH, 2005, J BIOMED MATER RES B, V74B, P468, DOI 10.1002/jbm.b.30200
   Yang SH, 2005, J BIOMED MATER RES B, V74B, P488, DOI 10.1002/jbm.b.30221
   Zhang YZ, 2005, J BIOMED MATER RES B, V72B, P156, DOI 10.1002/jbm.b.30128
   Zhao F, 2006, BIOMATERIALS, V27, P1859, DOI 10.1016/j.biomaterials.2005.09.031
   Zhu HG, 2005, J BIOMAT SCI-POLYM E, V16, P761, DOI 10.1163/1568562053992450
NR 49
TC 120
Z9 123
U1 5
U2 50
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD FEB
PY 2007
VL 8
IS 2
BP 338
EP 344
DI 10.1021/bm0606869
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 134YA
UT WOS:000244119200006
PM 17291056
DA 2018-10-20
ER

PT J
AU Serrano, F
   Lopez-G, L
   Jadraque, M
   Koper, M
   Ellis, G
   Cano, P
   Martin, M
   Garrido, L
AF Serrano, Fernando
   Lopez-G, Laura
   Jadraque, Maria
   Koper, Marielle
   Ellis, Gary
   Cano, Pilar
   Martin, Margarita
   Garrido, Leoncio
TI A Nd : YAG laser-microperforated
   poly(3-hydroxybutyrate-co-3-hydroxyvalerate)-basal membrane matrix
   composite film as substrate for keratinocytes
SO BIOMATERIALS
LA English
DT Article
DE PHBHV; basal membrane matrix; epithelium; microperforated biomaterial
ID HYDROXYBUTYRATE-HYDROXYVALERATE COPOLYMERS; BIODEGRADABLE MEDICAL
   DEVICES; HYDROLYTIC DEGRADATION; RECOMBINANT LAMININ-5;
   EXTRACELLULAR-MATRIX; BIOENGINEERED SKIN; CELL-CULTURE; IN-VITRO;
   POLYMERS; INTEGRIN
AB Epithelia cultured for the treatment of ulcers, burns and for gene therapy applications require a flexible biomaterial for growth and transplantation that is adaptable to body contours. We tested several materials and found that a poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBHV) polyester provided support for keratinocytes, although adhesion to this material proved to be suboptimal. Since epithelia adhere to the mesoderm through basal membranes, we engineered a basal membrane surrogate by preparing composites of PHBHV with basal membrane matrix (BMM). To allow cell migration into injuried areas the polyester film was micromachined to insert high-density micropores through a Nd:YAG laser ablation process. These flexible composites provided firm attachment for keratinocytes from the outer root sheath of human hair allowing keratinocyte migration through micropores. Films of microperforated PHBHV-BMM may be of use for the replacement of diseased or injured skin epithelia. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Fdn Hosp Alcorcon, E-28922 Alcorcon, Spain.
   CSIC, Inst Quim Fis Rocasolano, E-28006 Madrid, Spain.
   CSIC, Inst Ciencia & Tecnol Polimeros, E-28006 Madrid, Spain.
RP Serrano, F (reprint author), Fdn Hosp Alcorcon, Avda Villaviciosa 1, E-28922 Alcorcon, Spain.
EM fserrano@fhalcorcon.es
RI Garrido, Leoncio/K-3092-2014; Martin, Margarita/L-7758-2013; Ellis,
   Gary/C-1617-2010
OI Garrido, Leoncio/0000-0002-7587-1260; Ellis, Gary/0000-0003-4851-6092
CR Baker SE, 1996, EXP CELL RES, V228, P262, DOI 10.1006/excr.1996.0325
   Baker SE, 1996, J CELL SCI, V109, P2509
   BELL E, 1981, SCIENCE, V211, P1052, DOI 10.1126/science.7008197
   Boyce ST, 2002, AM J SURG, V183, P445, DOI 10.1016/S0002-9610(02)00813-9
   Chen M, 2002, NAT GENET, V32, P670, DOI 10.1038/ng1041
   Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R
   Daniels JT, 1996, BURNS, V22, P35, DOI 10.1016/0305-4179(95)00085-2
   DeHart GW, 2003, EXP CELL RES, V283, P67, DOI 10.1016/S0014-4827(02)00028-0
   Del Rio M, 2002, HUM GENE THER, V13, P959, DOI 10.1089/10430340252939069
   Eble JA, 1998, BIOCHEMISTRY-US, V37, P10945, DOI 10.1021/bi980175+
   Evans RD, 2003, J CELL BIOL, V160, P589, DOI 10.1083/jcb.200209016
   Falk-Marzillier J, 1998, BIOCHEM BIOPH RES CO, V251, P49, DOI 10.1006/bbrc.1998.9400
   Fleischmajer R, 1998, J CELL SCI, V111, P1929
   GALLICO GG, 1984, NEW ENGL J MED, V311, P448, DOI 10.1056/NEJM198408163110706
   Grose R, 2002, DEVELOPMENT, V129, P2303
   Haase I, 2001, J CLIN INVEST, V108, P527, DOI 10.1172/JCI200112153
   Hansbrough John F., 1997, Journal of Burn Care and Rehabilitation, V18, P43, DOI 10.1097/00004630-199701000-00008
   Higham MC, 2003, TISSUE ENG, V9, P919, DOI 10.1089/107632703322495565
   HOLLAND SJ, 1987, BIOMATERIALS, V8, P289, DOI 10.1016/0142-9612(87)90117-7
   HOLLAND SJ, 1990, BIOMATERIALS, V11, P206, DOI 10.1016/0142-9612(90)90157-L
   HORMIA M, 1995, J INVEST DERMATOL, V105, P557, DOI 10.1111/1523-1747.ep12323451
   Kariya Y, 2002, J BIOCHEM, V132, P607, DOI 10.1093/oxfordjournals.jbchem.a003263
   Kariya Y, 2003, J CELL BIOCHEM, V88, P506, DOI 10.1002/jcb.10350
   Kirsner RS, 1998, TRENDS BIOTECHNOL, V16, P246, DOI 10.1016/S0167-7799(98)01196-2
   Kruger J, 2002, APPL SURF SCI, V197, P800, DOI 10.1016/S0169-4332(02)00418-X
   Lam PK, 1999, J TRAUMA, V47, P918, DOI 10.1097/00005373-199911000-00017
   LANGHOFER M, 1993, J CELL SCI, V105, P753
   Larcher F, 2001, FASEB J, V15, P1529, DOI 10.1096/fj.01-0082com
   Lefebvre VH, 1998, DIABETES, V47, P134, DOI 10.2337/diabetes.47.1.134
   Li A, 1998, P NATL ACAD SCI USA, V95, P3902, DOI 10.1073/pnas.95.7.3902
   LISSITZKY JC, 1992, J CELL BIOCHEM, V48, P141, DOI 10.1002/jcb.240480206
   Michel O, 2000, HNO, V48, P4, DOI 10.1007/s001060050002
   Muhart M, 1997, LANCET, V350, P1142, DOI 10.1016/S0140-6736(05)63788-9
   Papini Sandra, 2003, Stem Cells (Miamisburg), V21, P481, DOI 10.1634/stemcells.21-4-481
   Patarroyo M, 2002, SEMIN CANCER BIOL, V12, P197, DOI 10.1016/S1044-579X(02)00023-8
   PATTHY L, 1992, FEBS LETT, V298, P182, DOI 10.1016/0014-5793(92)80051-H
   Petitclerc E, 2000, J BIOL CHEM, V275, P8051, DOI 10.1074/jbc.275.11.8051
   RIDDELLE KS, 1992, J CELL SCI, V103, P475
   Saffle JR, 1995, J BURN CARE REHABIL, V16, P288
   Serrano F, 2003, HUM GENE THER, V14, P1579, DOI 10.1089/104303403322495089
   Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006
   Tezcaner A, 2003, BIOMATERIALS, V24, P4573, DOI 10.1016/S0142-9612(03)00302-8
   Tunggal P, 2000, MICROSC RES TECHNIQ, V51, P214, DOI 10.1002/1097-0029(20001101)51:3<214::AID-JEMT2>3.0.CO;2-J
   Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399
   YASIN M, 1990, BIOMATERIALS, V11, P451, DOI 10.1016/0142-9612(90)90057-W
   YASIN M, 1989, BIOMATERIALS, V10, P400, DOI 10.1016/0142-9612(89)90132-4
NR 46
TC 12
Z9 12
U1 4
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2007
VL 28
IS 4
BP 650
EP 660
DI 10.1016/j.biomaterials.2006.09.018
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 120CE
UT WOS:000243060400010
PM 17027945
DA 2018-10-20
ER

PT J
AU Rapoport, HS
   Connolly, JM
   Fulmer, J
   Dai, N
   Murti, BH
   Gorman, RC
   Gorman, JH
   Alferiev, I
   Levy, RJ
AF Rapoport, H. Scott
   Connolly, Jeanne M.
   Fulmer, James
   Dai, Ning
   Murti, Brandon H.
   Gorman, Robert C.
   Gorman, Joseph H.
   Alferiev, Ivan
   Levy, Robert J.
TI Mechanisms of the in vivo inhibition of calcification of bioprosthetic
   porcine aortic valve cusps and aortic wall with
   triglycidylamine/mercapto bisphosphonate
SO BIOMATERIALS
LA English
DT Article
DE calcification; biomineralization; bioprostheses; heart valve;
   cross-linking; alkaline phosphate
ID ALKALINE-PHOSPHATASE ACTIVITY; HEART-VALVE; CROSS-LINKING;
   GLUTARALDEHYDE; TISSUE; PREVENTION; STABILIZATION; RATS
AB Heart valve replacements fabricated from glutaraldehyde (Glut)-crosslinked heterograft materials, porcine aortic valves or bovine pericardium, have been widely used in cardiac surgery to treat heart valve disease. However, these bioprosthetic heart valves often fail in long-term clinical implants due to pathologic calcification of the bioprosthetic leaflets, and for stentless porcine aortic valve bioprostheses, bioprosthetic aortic wall calcification also typically occurs. Previous use of the epoxide-based crosslinker, triglycidyl amine (TGA), on cardiac bioprosthetic valve materials demonstrated superior biocompatibility, mechanics, and calcification resistance for porcine aortic valve cusps (but not porcine aortic wall) and bovine pericardium, vs. Glut-prepared controls. However, TGA preparation did not completely prevent long-term calcification of cusps or pericardium. Herein we report further mechanistic investigations of an added therapeutic component to this system, 2-mercaptoethylidene-1,1-bisphosphonic acid (MABP), a custom synthesized thiol bisphosphonate, which has previously been shown in a preliminary report to prevent bioprosthetic heterograft biomaterial calcification when used in combination with initial TGA crosslinking for 7 days. In the present studies, we have further investigated the effectiveness of MABP in experiments that examined: (1) The use of MABP after optimal TGA crosslinking, in order to avoid any competitive interference of MABP-reactions with TGA during crosslinking; (2) Furthermore, recognizing the importance of alkaline phosphatase (ALP) in the formation of dystrophic calcific nodules, we have investigated the hypothesis that the mechanism by which MABP primarily functions is through the reduction of ALP activity. Results from cell-free model systems, cell culture studies, and rat subcutaneous implants, show that materials functionalized with MABP after TGA crosslinking have reduced ALP activity, and in vivo have no significant calcification in long-term implant studies. It is concluded that bioprosthetic heart valves prepared in this fashion are compelling alternatives for Glut-prepared bioprostheses. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Childrens Hosp Philadelphia, Div Cardiol, Abramson Res Ctr, Philadelphia, PA 19104 USA.
   Univ Penn, Sch Med, Harrison Dept Surg Res, Philadelphia, PA 19104 USA.
RP Levy, RJ (reprint author), Childrens Hosp Philadelphia, Div Cardiol, Abramson Res Ctr, Suite 702,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.
EM levyr@email.chop.edu
FU NHLBI NIH HHS [T32-HL7915, P50-HL74731, T32 HL007915, P50 HL074731]
CR Alferiev I, 2001, BIOMATERIALS, V22, P2683, DOI 10.1016/S0142-9612(01)00010-2
   Alferiev IS, 2005, J ORGANOMET CHEM, V690, P2543, DOI 10.1016/j.jorganchem.2004.10.011
   Chang Y, 2005, J BIOTECHNOL, V120, P207, DOI 10.1016/j.jbiotec.2005.06.029
   Connolly JM, 2005, AM J PATHOL, V166, P1, DOI 10.1016/S0002-9440(10)62227-4
   DUMONT CE, 1993, J SURG RES, V54, P61, DOI 10.1006/jsre.1993.1011
   Fishbein I, 2006, P NATL ACAD SCI USA, V103, P159, DOI 10.1073/pnas.0502945102
   HENTHORN PS, 1987, P NATL ACAD SCI USA, V84, P1234, DOI 10.1073/pnas.84.5.1234
   HUANGLEE LLH, 1990, J BIOMED MATER RES, V24, P1185, DOI 10.1002/jbm.820240905
   Imamura E, 1989, J Card Surg, V4, P50, DOI 10.1111/j.1540-8191.1989.tb00256.x
   Jian B, 2003, ANN THORAC SURG, V75, P457, DOI 10.1016/S0003-4975(02)04312-6
   Lerones C, 2004, CLIN MICROBIOL INFEC, V10, P984, DOI 10.1111/j.1469-0691.2004.00967.x
   Maranto A R, 1988, ASAIO Trans, V34, P827
   MARANTO AR, 1988, CIRC RES, V63, P844, DOI 10.1161/01.RES.63.4.844
   Mirzaie M, 2000, SCAND CARDIOVASC J, V34, P589
   Moore MA, 1996, J BIOMED MATER RES, V32, P209, DOI 10.1002/(SICI)1097-4636(199610)32:2<209::AID-JBM9>3.0.CO;2-X
   Reszka Alfred A, 2003, Curr Osteoporos Rep, V1, P45, DOI 10.1007/s11914-003-0008-5
   RUSSELL HK, 1972, ARCH PATHOL, V94, P187
   Schoen FJ, 2005, ANN THORAC SURG, V79, P1072, DOI 10.1016/j.athoracsur.2004.06.033
   SHEN SH, 1994, J APPL BIOMATER, V5, P159, DOI 10.1002/jab.770050209
   SIMMONS DM, 1993, BIOTECHNOL APPL BIOC, V17, P23
   Sung HW, 1993, ASAIO J, V39, P532
   Vaisman DN, 2005, BIOL TRACE ELEM RES, V104, P131, DOI 10.1385/BTER:104:2:131
   Vyavahare N, 2000, AM J PATHOL, V157, P885, DOI 10.1016/S0002-9440(10)64602-0
   Vyavahare N, 1997, CIRCULATION, V95, P479
   WEBB CL, 1988, ANN THORAC SURG, V46, P309, DOI 10.1016/S0003-4975(10)65932-2
   WEBB CL, 1989, EXP MOL PATHOL, V50, P291, DOI 10.1016/0014-4800(89)90039-7
   XI TF, 1992, J BIOMED MATER RES, V26, P1241
NR 27
TC 24
Z9 25
U1 1
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2007
VL 28
IS 4
BP 690
EP 699
DI 10.1016/j.biomaterials.2006.09.029
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 120CE
UT WOS:000243060400014
PM 17027944
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Converse, GL
   Yue, WM
   Roeder, RK
AF Converse, Gabriel L.
   Yue, Weimin
   Roeder, Ryan K.
TI Processing and tensile properties of hydroxyapatite-whisker-reinforced
   polyetheretherketone
SO BIOMATERIALS
LA English
DT Article
DE composite; elasticity; hydroxyapatite; mechanical properties;
   microstructure; polyetheretherketone
ID BEARING ORTHOPEDIC IMPLANTS; MECHANICAL-PROPERTIES; BONE-CEMENT;
   COMPOSITES; BEHAVIOR; FATIGUE; BIOMATERIAL
AB Polyetheretherketone (PEEK) was reinforced with 0-50 vol% hydroxyapatite (HA) whiskers using a novel powder processing and compression molding technique which enabled uniform mixing at high whisker content. Texture analysis showed that viscous flow during compression molding produced a preferred orientation of whiskers along the specimen tensile axis. Consequently, the elastic modulus or ultimate tensile strength of HA-whisker-reinforced PEEK was able to be tailored to mimic human cortical bone. PEEK reinforced with 40 and 50 vol% HA whiskers exhibited elastic moduli of 17 and 23 GPa, respectively. Elastic constants were measured using ultrasonic wave propagation and revealed an orthotropic anisotropy also similar to that measured in human cortical bone. PEEK reinforced with 10 and 20 vol% HA whiskers exhibited an ultimate tensile strength of 90 and 75 MPa, respectively. Tensile specimen fracture surfaces showed evidence of brittle failure in both reinforced and un-reinforced PEEK. Whisker pullout was observed with PEEK adhered to HA whiskers, suggesting a relatively strong interface between the PEEK matrix and HA whisker reinforcements. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Notre Dame, Dept Aerosp & Mech Engn, Notre Dame, IN 46556 USA.
RP Roeder, RK (reprint author), Univ Notre Dame, Dept Aerosp & Mech Engn, Notre Dame, IN 46556 USA.
EM rroeder@nd.edu
RI Roeder, Ryan/A-9398-2008
OI Roeder, Ryan/0000-0003-1576-6570; Converse, Gabriel/0000-0002-7572-026X
CR Abu Bakar MS, 2003, COMPOS SCI TECHNOL, V63, P421, DOI 10.1016/S0266-3538(02)00230-0
   Abu Bakar MS, 2003, BIOMATERIALS, V24, P2245, DOI 10.1016/S0142-9612(03)00028-0
   [Anonymous], 2001, D63801 ASTM
   [Anonymous], 1999, C37388 ASTM
   Arcis RW, 2002, DENT MATER, V18, P49, DOI 10.1016/S0109-5641(01)00019-7
   ASHMAN RB, 1984, J BIOMECH, V17, P349, DOI 10.1016/0021-9290(84)90029-0
   BOBYN JD, 1992, CLIN ORTHOP RELAT R, P79
   Chu KT, 2004, BIO-MED MATER ENG, V14, P87
   COWIN SC, 1987, HCB BIOENGINEERING
   Di Silvio L, 2002, BIOMATERIALS, V23, P101, DOI 10.1016/S0142-9612(01)00084-9
   Evans SL, 1998, BIOMATERIALS, V19, P1329, DOI 10.1016/S0142-9612(97)00217-2
   Fang LM, 2006, BIOMATERIALS, V27, P3701, DOI 10.1016/j.biomaterials.2006.02.023
   Gao SL, 2000, COMPOS PART A-APPL S, V31, P517, DOI 10.1016/S1359-835X(00)00009-9
   GUO XE, 2001, BONE MECH HDB, DOI DOI 10.5-10.14
   Harper EJ, 1995, J MATER SCI-MATER M, V6, P799, DOI 10.1007/BF00134320
   HASEGAWA K, 1994, CALCIFIED TISSUE INT, V55, P381, DOI 10.1007/BF00299319
   HUISKES R, 1992, CLIN ORTHOP RELAT R, P124
   Ignjatovic N, 2004, J BIOMED MATER RES B, V71B, P284, DOI 10.1002/jbm.b.30093
   Kobayashi M, 1999, J BIOMED MATER RES, V46, P447, DOI 10.1002/(SICI)1097-4636(19990915)46:4<447::AID-JBM2>3.3.CO;2-G
   Liu TY, 2004, J BIOMED MATER RES B, V71B, P116, DOI 10.1002/jbm.b.30072
   MARTIN RB, 1998, SKELETAL TISSUE MECH, P32
   Moursi AM, 2002, BIOMATERIALS, V23, P133, DOI 10.1016/S0142-9612(01)00088-6
   ORIAS EAA, 2005, THESIS U NOTRE DAME
   REILLY DT, 1975, J BIOMECH, V8, P305
   Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1
   Roeder RK, 2006, J AM CERAM SOC, V89, P2096, DOI 10.1111/j.1551-2916.2006.01067.x
   Roeder RK, 2003, J BIOMED MATER RES A, V67A, P801, DOI 10.1002/jbm.a.10140
   ROEDER RK, 2002, T ORTHOP RES SOC, V27, P1073
   Rose FRAJ, 2002, BIOCHEM BIOPH RES CO, V292, P1, DOI 10.1006/bbrc.2002.6519
   SAITO M, 1993, BIOCERAMICS, V6, P475
   Shikinami Y, 1999, BIOMATERIALS, V20, P859, DOI 10.1016/S0142-9612(98)00241-5
   TAKAKURA Y, 1996, J FOOT SURG, V11, P9
   Tang SM, 2004, INT J FATIGUE, V26, P49, DOI 10.1016/S0142-1123(03)00080-X
   TANNER KE, 1994, BRIT CERAM T, V93, P104
   THAT TPT, 2003, J BIOMED MATER RES, V51, P453
   Toth JM, 2006, BIOMATERIALS, V27, P324, DOI 10.1016/j.biomaterials.2005.07.011
   VANBUSKIRK WC, 1981, J BIOMECH ENG-T ASME, V103, P67, DOI 10.1115/1.3138262
   *VICTR PIC, 2006, MAT PROP GUID
   Wang M, 1998, BIOMATERIALS, V19, P2357, DOI 10.1016/S0142-9612(98)00154-9
   Wang M, 2000, J MATER SCI, V35, P1023, DOI 10.1023/A:1004731315328
   Wei GB, 2004, BIOMATERIALS, V25, P4749, DOI 10.1016/j.biomaterials.2003.12.005
   Wenk HR, 1999, BONE, V24, P361, DOI 10.1016/S8756-3282(98)00192-6
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
   YUE Q, 2006, THESIS U NOTRE DAME
NR 44
TC 96
Z9 101
U1 2
U2 34
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2007
VL 28
IS 6
BP 927
EP 935
DI 10.1016/j.biomaterials.2006.10.031
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 122II
UT WOS:000243219000004
PM 17113143
DA 2018-10-20
ER

PT J
AU Mygind, T
   Stiehler, M
   Baatrup, A
   Li, H
   Zoua, X
   Flyvbjerg, A
   Kassem, M
   Bunger, C
AF Mygind, Tina
   Stiehler, Maik
   Baatrup, Anette
   Li, Haisheng
   Zoua, Xuenong
   Flyvbjerg, Allan
   Kassem, Moustapha
   Bunger, Cody
TI Mesenchymal stem cell ingrowth and differentiation on coralline
   hydroxyapatite scaffolds
SO BIOMATERIALS
LA English
DT Article
DE stem cell; bioreactor; hydroxyapatite; scaffolds; porosity
ID MARROW STROMAL CELLS; FLOW PERFUSION BIOREACTOR; WALL VESSEL BIOREACTOR;
   OSTEOGENIC DIFFERENTIATION; OSTEOBLASTIC CELLS; MECHANICAL STIMULATION;
   PLGA SCAFFOLDS; BONE-FORMATION; EXPRESSION; CULTURE
AB Culture of osteogenic cells on a porous scaffold could offer a new solution to bone grafting using autologous human mesenchymal stem cells (hMSC) from the patient. We compared coralline hydroxyapatite scaffolds with pore sizes of 200 and 500 mu m for expansion and differentiation of hMSCs. We cultivated the hMSC statically or in spinner flasks for 1, 7, 14 and 21 days and found that the 200-mu m pore scaffolds exhibited a faster rate of osteogenic differentiation than did the 500-mu m pore scaffolds as shown by an alkaline phosphatase activity assay and real-time reverse transcriptase polymerase chain reaction for 10 osteogenic markers. The 500-mu m scaffolds had increased proliferation rates and accommodated a higher number of cells (shown by DNA content, scanning electron microscopy and fluorescence microscopy). Thus the porosity of a 3D microporous biomaterial may be used to steer hMSC in a particular direction. We found that dynamic spinner flask cultivation of hMSC/scaffold constructs resulted in increased proliferation, differentiation and distribution of cells in scaffolds. Therefore, spinner flask cultivation is an easy-to-use inexpensive system for cultivating hMSCs on small to intermediate size 3D scaffolds. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Aarhus Univ Hosp, Inst Clin, Lab Mol Orthoped, Orthoped Res Lab, DK-8000 Aarhus C, Denmark.
   Aarhus Univ Hosp, Inst Clin, Med Res Labs, Med Dept M Diabet & Endocrinol, DK-8000 Aarhus, Denmark.
   Odense Univ Hosp, Dept Endocrinol & Metab, DK-5000 Odense C, Denmark.
RP Mygind, T (reprint author), Aarhus Univ Hosp, Inst Clin, Lab Mol Orthoped, Orthoped Res Lab, Norrebrogade 44,Bldg 1A, DK-8000 Aarhus C, Denmark.
EM tina.mygind@ki.au.dk
RI Kassem, Moustapha/J-7688-2013
OI Kassem, Moustapha/0000-0003-1557-0869
CR Abdallah BM, 2005, BIOCHEM BIOPH RES CO, V326, P527, DOI 10.1016/j.bbrc.2004.11.059
   Botchwey EA, 2001, J BIOMED MATER RES, V55, P242
   Carvalho RS, 1998, J CELL BIOCHEM, V70, P376, DOI 10.1002/(SICI)1097-4644(19980901)70:3<376::AID-JCB11>3.0.CO;2-J
   Chou YF, 2005, J BIOMED MATER RES B, V75B, P81, DOI 10.1002/jbm.b.30261
   Dalby MJ, 2006, BIOMATERIALS, V27, P2980, DOI 10.1016/j.biomaterials.2006.01.010
   Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3
   Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025
   Erben RG, 1997, J HISTOCHEM CYTOCHEM, V45, P307, DOI 10.1177/002215549704500215
   Ferrara James L M, 2005, Clin Adv Hematol Oncol, V3, P415
   Ferrari SL, 2000, J BONE MINER RES, V15, P198, DOI 10.1359/jbmr.2000.15.2.198
   Goldstein AS, 2001, BIOMATERIALS, V22, P1279, DOI 10.1016/S0142-9612(00)00280-5
   Gomes ME, 2006, TISSUE ENG, V12, P801, DOI 10.1089/ten.2006.12.801
   Goulet JA, 1997, CLIN ORTHOP RELAT R, P76
   Hing KA, 2004, PHILOS T R SOC A, V362, P2821, DOI 10.1098/rsta.2004.1466
   Holtorf HL, 2005, ANN BIOMED ENG, V33, P1238, DOI 10.1007/s10439-005-5536-y
   Holtorf HL, 2005, J BIOMED MATER RES A, V72A, P326, DOI 10.1002/jbm.a.30251
   Holtorf HL, 2005, J BIOMED MATER RES A, V74A, P171, DOI 10.1002/jbm.a.30330
   Ishaug-Riley SL, 1998, BIOMATERIALS, V19, P1405, DOI 10.1016/S0142-9612(98)00021-0
   Kern B, 2001, J BIOL CHEM, V276, P7101, DOI 10.1074/jbc.M006215200
   Li Z, 1999, BONE, V25, P661, DOI 10.1016/S8756-3282(99)00227-6
   Lietman SA, 2000, CLIN ORTHOP RELAT R, P214
   Long AB, 2001, EDUC GERONTOL, V27, P3, DOI 10.1080/036012701750069012
   Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5
   Pavalko FM, 1998, AM J PHYSIOL-CELL PH, V275, pC1591, DOI 10.1152/ajpcell.1998.275.6.C1591
   Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47
   Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842
   Rose FR, 2004, BIOMATERIALS, V25, P5507, DOI 10.1016/j.biomaterials.2004.01.012
   ROY DM, 1974, NATURE, V247, P220, DOI 10.1038/247220a0
   Rucci N, 2002, J CELL BIOCHEM, V85, P167, DOI 10.1002/jcb.10120
   Salim A, 2004, J BIOL CHEM, V279, P40007, DOI 10.1074/jbc.M403715200
   Schiller PC, 2001, BONE, V28, P362, DOI 10.1016/S8756-3282(00)00458-0
   Sikavitsas VI, 2003, P NATL ACAD SCI USA, V100, P14683, DOI 10.1073/pnas.2434367100
   Sikavitsas VI, 2002, J BIOMED MATER RES, V62, P136, DOI 10.1002/jbm.10150
   Simonsen JL, 2002, NAT BIOTECHNOL, V20, P592, DOI 10.1038/nbt0602-592
   Sorger JI, 2001, CLIN ORTHOP RELAT R, P66
   Spector JA, 2001, PLAST RECONSTR SURG, V107, P124, DOI 10.1097/00006534-200101000-00018
   Stevens HY, 2003, METH MOLEC MED, V80, P381
   Takahashi Y, 2004, J BIOMAT SCI-POLYM E, V15, P41, DOI 10.1163/156856204322752228
   Utting JC, 2006, EXP CELL RES, V312, P1693, DOI 10.1016/j.yexcr.2006.02.007
   Vance J, 2005, TISSUE ENG, V11, P1832, DOI 10.1089/ten.2005.11.1832
   WEINAND C, 2005, BONE, V38, P555
   WILLIAMS JL, 1994, BIORHEOLOGY, V31, P163
   Wu YC, 2006, BIOMATERIALS, V27, P896, DOI 10.1016/j.biomaterials.2005.07.002
   Young MF, 2003, OSTEOPOROSIS INT, V14, pS35, DOI 10.1007/s00198-002-1342-7
   Zhu JX, 2001, HISTOCHEM J, V33, P25, DOI 10.1023/A:1017587712914
   ZOU X, 2003, APMIS S, V109, P127
NR 46
TC 201
Z9 214
U1 2
U2 50
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2007
VL 28
IS 6
BP 1036
EP 1047
DI 10.1016/j.biomaterials.2006.10.003
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 122II
UT WOS:000243219000015
PM 17081601
DA 2018-10-20
ER

PT J
AU Bolland, F
   Korossis, S
   Wilshaw, SP
   Ingham, E
   Fisher, J
   Kearney, JN
   Southgate, J
AF Bolland, Fiona
   Korossis, Sotiris
   Wilshaw, Stacy-Paul
   Ingham, Eileen
   Fisher, John
   Kearney, John N.
   Southgate, Jennifer
TI Development and characterisation of a full-thickness acellular porcine
   bladder matrix for tissue engineering
SO BIOMATERIALS
LA English
DT Article
DE bladder tissue engineering; mechanical properties; scaffold; smooth
   muscle cells
ID SMALL-INTESTINAL SUBMUCOSA; HUMAN UROTHELIAL CELLS; URINARY-BLADDER;
   SULFATED GLYCOSAMINOGLYCANS; EXTRACELLULAR-MATRIX; IN-VITRO;
   HYDROXYPROLINE; RECONSTRUCTION; AUGMENTATION; MODEL
AB The aim of this study was to produce a natural, acellular matrix from porcine bladder tissue for use as a scaffold in developing a tissue-engineered bladder replacement. Full-thickness, intact porcine bladders were decellularised by distention and immersion in hypotonic buffer containing 0.1% (w/v) SDS and nuclease enzymes. Histological analysis of the resultant matrices showed they were completely acellular; that the major structural proteins had been retained and that there were some residual poorly soluble intracellular proteins. The amount of DNA per mg dry weight of fresh porcine bladder was 2.8 (+/- 0.1) mu g/mg compared to 0.1 (+/- 0.1) mu g/mg in decellularised bladder and biochemical analysis showed proportional differences in the hydroxyproline and glycosaminoglycan content of the tissue before and after decellularisation. Uniaxial tensile testing indicated that decellularisation did not significantly compromise the ultimate tensile strength of the tissue. There was, however, an increase in the collagen and elastin phase slopes indicating decreased extensibility. Cytotoxicity assays using porcine smooth muscle cell cultures excluded the presence of soluble toxins in the biomaterial. In summary, a full-thickness natural acellular matrix retaining the major structural components and strength of the urinary bladder has been successfully developed. The matrix is biocompatible with bladder-derived cells and has potential for use in urological surgery and tissue-engineering applications. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ York, Dept Biol, Jack Birch Unit Mol Carcinogenesis, York YO10 5YW, N Yorkshire, England.
   Univ Leeds, Sch Mech Engn, Biomed Engn Res Ctr, Leeds LS2 9JT, W Yorkshire, England.
   Univ Leeds, Fac Biol Sci, Inst Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England.
   Natl Blood Serv, Tissue Serv, Liverpool L24 8RB, Merseyside, England.
RP Southgate, J (reprint author), Univ York, Dept Biol, Jack Birch Unit Mol Carcinogenesis, York YO10 5YW, N Yorkshire, England.
EM js35@york.ac.uk
RI Korossis, Sotirios/S-4427-2016; Sano, Michael/E-1715-2011
OI Korossis, Sotirios/0000-0002-9893-6338; Wilshaw,
   Stacy-Paul/0000-0002-7599-8165; Southgate, Jennifer/0000-0002-0135-480X
FU Biotechnology and Biological Sciences Research Council [E20352];
   Engineering and Physical Sciences Research Council [EP/D073618/1]
CR Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Badylak S, 2002, J SURG RES, V103, P190, DOI 10.1006/jsre.2001.6349
   Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   Badylak SF, 1998, TISSUE ENG, V4, P379, DOI 10.1089/ten.1998.4.379
   BANCROFT JD, 1990, THEORY PRACTICE HIST
   Bank RA, 1997, MATRIX BIOL, V16, P233, DOI 10.1016/S0945-053X(97)90012-3
   Booth C, 2002, J HEART VALVE DIS, V11, P457
   Brown AL, 2002, BIOMATERIALS, V23, P2179, DOI 10.1016/S0142-9612(01)00350-7
   Brown S, 2001, BIOTECHNIQUES, V30, P38, DOI 10.2144/01301bm06
   CARTWRIGHT PC, 1989, J UROLOGY, V142, P1050, DOI 10.1016/S0022-5347(17)38985-1
   Chen MK, 2001, J SURG RES, V99, P352, DOI 10.1006/jsre.2001.6199
   Comer MT, 1999, ADV EXP MED BIOL, V462, P43
   Cross WR, 2003, BJU INT, V92, P165, DOI 10.1046/j.1464-410X.2003.04280.x
   EDWARDS CA, 1980, CLIN CHIM ACTA, V104, P161, DOI 10.1016/0009-8981(80)90192-8
   Elbahnasy AM, 1998, J UROLOGY, V159, P628, DOI 10.1016/S0022-5347(01)63690-5
   Enobakhare BO, 1996, ANAL BIOCHEM, V243, P189, DOI 10.1006/abio.1996.0502
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   FEIL G, 2006, EUR UROL        0616
   Fraser M, 2004, BJU INT, V93, P609, DOI 10.1111/j.1464-410X.2004.04675.x
   Freytes DO, 2004, BIOMATERIALS, V25, P2353, DOI 10.1016/j.biomaterials.2003.09.015
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Harper C, 2001, HOSP MED, V62, P90, DOI 10.12968/hosp.2001.62.2.2379
   KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5
   Kimuli M, 2004, BJU INT, V94, P859, DOI 10.1111/j.1464-410X.2004.05047.x
   Koenig F, 1999, UROLOGY, V53, P853, DOI 10.1016/S0090-4295(98)00628-1
   Korossis SA, 2002, J HEART VALVE DIS, V11, P463
   Korossis S, 2006, TISSUE ENG, V12, P635, DOI 10.1089/ten.2006.12.635
   Kropp B P, 1995, Urology, V46, P396, DOI 10.1016/S0090-4295(99)80227-1
   Kropp BP, 1998, UROLOGY, V52, P138, DOI 10.1016/S0090-4295(98)00114-9
   Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2
   LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7
   Merguerian PA, 2000, BJU INT, V85, P894, DOI 10.1046/j.1464-410x.2000.00513.x
   Mirsadraee S, 2006, TISSUE ENG, V12, P763, DOI 10.1089/ten.2006.12.763
   MURAKUMO M, 1995, J UROLOGY, V154, P251, DOI 10.1016/S0022-5347(01)67289-6
   Pattison MA, 2005, BIOMATERIALS, V26, P2491, DOI 10.1016/j.biomaterials.2004.07.011
   Piechota HJ, 1999, UROL RES, V27, P206, DOI 10.1007/s002400050111
   Probst M, 1997, BRIT J UROL, V79, P505, DOI 10.1046/j.1464-410X.1997.00103.x
   Scriven SD, 2001, J MATER SCI-MATER M, V12, P991, DOI 10.1023/A:1012869318205
   SOUTHGATE J, 1994, LAB INVEST, V71, P583
   Southgate J, 2003, P I MECH ENG H, V217, P311, DOI 10.1243/095441103322060776
   Southgate J, 2002, CULTURE EPITHELIAL C, P381, DOI DOI 10.1002/0471221201.CH12
   STEGEMAN.H, 1967, CLIN CHIM ACTA, V18, P267, DOI 10.1016/0009-8981(67)90167-2
   U LEEDS U YORK, 2006, Patent No. 06062319
   VANDERREST M, 1991, FASEB J, V5, P2814
   Varley CL, 2004, AM J PATHOL, V164, P1789, DOI 10.1016/S0002-9440(10)63737-6
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
NR 46
TC 107
Z9 126
U1 1
U2 30
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2007
VL 28
IS 6
BP 1061
EP 1070
DI 10.1016/j.biomaterials.2006.10.005
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 122II
UT WOS:000243219000017
PM 17092557
DA 2018-10-20
ER

PT J
AU Nillesen, STM
   Geutjes, PJ
   Wismans, R
   Schalkwijk, J
   Daamen, WF
   van Kuppevelt, TH
AF Nillesen, Suzan T. M.
   Geutjes, Paul J.
   Wismans, Ronnie
   Schalkwijk, Joost
   Daamen, Willeke F.
   van Kuppevelt, Toin H.
TI Increased angiogenesis and blood vessel maturation in acellular
   collagen-heparin scaffolds containing both FGF2 and VEGF
SO BIOMATERIALS
LA English
DT Article
DE angiogenesis; growth factors; collagen; tissue response; biomaterial;
   tissue engineering
ID ENDOTHELIAL GROWTH-FACTOR; SULFATE; TISSUE; FACTOR-2; GENERATION;
   MATRICES; THERAPY; RATS; BFGF
AB An important issue in tissue engineering is the vascularisation of the implanted construct, which often takes several weeks. In vivo, the growth factors VEGF and FGF2 show a combined effect on both angiogenesis and maturation of blood vessels. Therefore, we hypothesise that the addition of these growth factors to an acellular construct increases blood vessel formation and maturation. To systematically evaluate the contribution of each scaffold component with respect to tissue response and in particular to blood vessel formation, five porous scaffolds were prepared and characterised, viz.: collagen, collagen with heparin, and collagen with heparin plus one or two growth factors (rrFGF2 and rrVEGF). Scaffolds were subcutaneously implanted in 3 months old Wistar rats. Of all scaffolds tested, the one with a combination of growth factors displayed the highest density of blood vessels (type IV collagen) and most mature blood vessels (smooth muscle actin). In addition, no hypoxic cells were found in this scaffold at day 7 and 21 (hypoxia inducible factor 1-alpha). These results indicate that the addition of both FGF2 and VEGF to an acellular construct enhances an early mature vasculature. This opens prospects for (acellular) tissue-engineered constructs in conditions as ischaemic heart disease or diabetic ulcers. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Radboud Univ Nijmegen, Med Ctr, NCMLS, Dept Biochem 280, NL-6500 HB Nijmegen, Netherlands.
   Radboud Univ Nijmegen, Med Ctr, NCMLS, Dept Dermatol 370, NL-6500 HB Nijmegen, Netherlands.
RP van Kuppevelt, TH (reprint author), Radboud Univ Nijmegen, Med Ctr, NCMLS, Dept Biochem 280, Pob 9101, NL-6500 HB Nijmegen, Netherlands.
EM a.vankuppevelt@ncmls.ru.nl
RI Daamen, Willeke/D-5854-2015; Schalkwijk, Joost/N-1774-2013; Kuppevelt,
   A.H.M.S.M./L-4463-2015; Geutjes, P.J./L-4320-2015
OI Daamen, Willeke/0000-0003-3155-3030; 
CR Asahara T., 1995, CIRCULATION, V92, P11365
   BANCROFT JD, 1990, THEORY PRACTICE HIST
   Bennett SP, 2003, BRIT J SURG, V90, P133, DOI 10.1002/bjs.4019
   Bicknell R, 2004, ANNU REV PHARMACOL, V44, P219, DOI 10.1146/annurev.pharmtox.44.101802.121650
   Blau HM, 2001, NAT MED, V7, P532, DOI 10.1038/87850
   Bruick RK, 2001, GENE DEV, V15, P2497, DOI 10.1101/gad.931601
   BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5
   CALVANI M, 2005, BLOOD
   Daamen WF, 2005, BIOMATERIALS, V26, P81, DOI 10.1016/j.biomaterials.2004.02.011
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   Fujita M, 2004, BIOMATERIALS, V25, P699, DOI 10.1016/S0142-9612(03)00557-X
   Fukuda S, 2004, MOL CELL BIOCHEM, V264, P143, DOI 10.1023/B:MCBI.0000044383.01785.05
   Giavazzi R, 2003, AM J PATHOL, V162, P1913, DOI 10.1016/S0002-9440(10)64325-8
   GITAYGOREN H, 1992, J BIOL CHEM, V267, P6093
   Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3
   HUANG LE, 1998, P NATL ACAD SCI USA, V95, P987
   Hughes GC, 2004, ANN THORAC SURG, V77, P812, DOI 10.1016/j.athorasur.2003.09.060
   Komori M, 2005, ANESTH ANALG, V100, P830, DOI 10.1213/01.ANE.0000144426.18235.5A
   Laschke MW, 2006, HUM REPROD, V21, P262, DOI 10.1093/humrep/dei308
   Lee KH, 2000, YONSEI MED J, V41, P774, DOI 10.3349/ymj.2000.41.6.774
   Masaki I, 2002, CIRC RES, V90, P966, DOI 10.1161/01.RES.0000019540.41697.60
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   Patel ZS, 2004, J BIOMAT SCI-POLYM E, V15, P701, DOI 10.1163/156856204774196117
   Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3
   Pieper JS, 2002, J BIOMED MATER RES, V62, P185, DOI 10.1002/jbm.10267
   Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004
   Rickert D, 2003, CLIN HEMORHEOL MICRO, V28, P175
   Taylor AP, 2003, INT J CANCER, V105, P158, DOI 10.1002/ijc.11059
   Tonnesen MG, 2000, J INVEST DERM SYMP P, V5, P40, DOI 10.1046/j.1087-0024.2000.00014.x
   Trentin D, 2006, P NATL ACAD SCI USA, V103, P2506, DOI 10.1073/pnas.0505964102
   van Amerongen Machteld J., 2002, Angiogenesis, V5, P173, DOI 10.1023/A:1023822504224
   van Kuppevelt TH, 1998, J BIOL CHEM, V273, P12960, DOI 10.1074/jbc.273.21.12960
   Wissink MJB, 2001, BIOMATERIALS, V22, P151, DOI 10.1016/S0142-9612(00)00164-2
NR 33
TC 259
Z9 274
U1 2
U2 75
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2007
VL 28
IS 6
BP 1123
EP 1131
DI 10.1016/j.biomaterials.2006.10.029
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 122II
UT WOS:000243219000023
PM 17113636
DA 2018-10-20
ER

PT J
AU Lerouge, S
   Major, A
   Girard-Lauriault, PL
   Raymond, MA
   Laplante, P
   Soulez, G
   Mwale, F
   Wertheimer, MR
   Hebert, MJ
AF Lerouge, Sophie
   Major, Annie
   Girard-Lauriault, Pierre-Luc
   Raymond, Marc-Andre
   Laplante, Patrick
   Soulez, Gilles
   Mwale, Fackson
   Wertheimer, Michael R.
   Hebert, Marie-Josee
TI Nitrogen-rich coatings for promoting healing around stent-grafts after
   endovascular aneurysm repair
SO BIOMATERIALS
LA English
DT Article
DE aneurysm; stent-graft; plasma polymerisation; chondroitin sulphate; cell
   adhesion; apoptosis
ID ABDOMINAL AORTIC-ANEURYSMS; CELLS IN-VITRO; GROWTH-FACTOR; PLASMA;
   APOPTOSIS; MIGRATION; EXPRESSION; FIXATION; ANOIKIS; BINDING
AB Complications following endovascular aneurysm repair (EVAR) are related to deficient healing around the stent-graft (SG). New generations of SG with surface properties that foster vascular repair could overcome this limitation. Our goal was to evaluate the potential of a new nitrogen-rich plasma-polymerised biomaterial, designated PPE:N, as an external coating for polyethylene terephtalate (PET)- or polytetrafluoro-ethylene (PTFE)-based SGs, to promote healing around the implant. Thin PPE:N coatings were deposited on PET and PTFE films. Then, adhesion, growth, migration and resistance to apoptosis of vascular smooth muscle cells (VSMCs) and fibroblasts, as well as myofibroblast differentiation, were assessed in vitro. In another experimental group, chondroitin sulphate (CS), a newly described mediator of vascular repair, was added to normal culture medium, to search for possible additional benefit. PPE:N-coatings, especially on PET, increased and accelerated cell adhesion and growth, compared with control PET and with standard polystyrene culture plates (PCP). PPE:N was also found to increase the resistance to apoptosis in VSMC, an important finding as aneurysms are characterised by VMSC depletion caused by a pro-apoptotic phenotype. Addition of CS in solution further increased migration and resistance to apoptosis. In conclusion, PPE:N-coating and/or CS could promote vascular repair around SGs following EVAR. (c) 2006 Elsevier Ltd. All rights reserved.
C1 CHUM, Res Ctr, Montreal, PQ, Canada.
   Univ Montreal, Dept Biol, Inst Genie Biomed, Montreal, PQ H3C 3J7, Canada.
   Ecole Polytech, Dept Engn Phys, Montreal, PQ, Canada.
   McGill Univ, Lady Davis Inst, Montreal, PQ H3A 2T5, Canada.
   McGill Univ, Dept Surg, Montreal, PQ H3A 2T5, Canada.
RP Lerouge, S (reprint author), Hop Notre Dame De Bon Secours, LBeV, JA Seve Bldg,Room Y-1603,1560 Sherbrooke St E, Montreal, PQ H2L 4M1, Canada.
EM sophie.lerouge@umontreal.ca
OI soulez, gilles/0000-0002-5566-3552
CR Bullett NA, 2004, APPL SURF SCI, V235, P395, DOI 10.1016/j.apsusc.2004.02.058
   Cejna M, 2002, J VASC INTERV RADIOL, V13, P823, DOI 10.1016/S1051-0443(07)61992-7
   Christenson EM, 2004, J BIOMED MATER RES A, V69A, P407, DOI 10.1002/jbm.a.30002
   Elkouri S, 2004, J VASC SURG, V39, P497, DOI 10.1016/j.jvs.2003.10.018
   Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9
   Geraghty PJ, 2003, J CARDIOVASC SURG, V44, P543
   Girard-Lauriault PL, 2005, PLASMA PROCESS POLYM, V2, P263, DOI 10.1002/ppap.200400092
   GRASLKRAUPP B, 1995, HEPATOLOGY, V21, P1465, DOI 10.1016/0270-9139(95)90071-3
   Greenhalgh RM, 2004, LANCET, V364, P843, DOI 10.1016/S0140-6736(04)16979-1
   Guimond S, 2002, PLASMAS POLYM, V7, P71, DOI 10.1023/A:1015274118642
   Gupta B, 2002, BIOMATERIALS, V23, P863, DOI 10.1016/S0142-9612(01)00195-8
   Hebert MJ, 1996, J IMMUNOL, V157, P3105
   Jacob T, 2001, J SURG RES, V101, P37, DOI 10.1006/jsre.2001.6193
   KAELBLE DH, 1974, PHYS CHEM ADHESION
   Kalliafas S, 2002, J ENDOVASC THER, V9, P743, DOI 10.1583/1545-1550(2002)009<0743:SGMAER>2.0.CO;2
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Laplante P, 2005, J IMMUNOL, V174, P5740, DOI 10.4049/jimmunol.174.9.5740
   Laplante P, 2006, J BIOL CHEM, V281, P30383, DOI 10.1074/jbc.M606412200
   LEROUGE S, 2001, PLASMAS POLYM, V6, P177
   Major A, 2006, J ENDOVASC THER, V13, P457, DOI 10.1583/06-1812MR.1
   Malina M, 2000, EUR J VASC ENDOVASC, V19, P5, DOI 10.1053/ejvs.1999.0867
   Marty B, 2002, J VASC INTERV RADIOL, V13, P601, DOI 10.1016/S1051-0443(07)61654-6
   McArthur C, 2001, J VASC SURG, V33, P733, DOI 10.1067/mva.2001.113980
   MELTON LJ, 1984, AM J EPIDEMIOL, V120, P379, DOI 10.1093/oxfordjournals.aje.a113902
   Michel JB, 2003, ARTERIOSCL THROM VAS, V23, P2146, DOI 10.1161/01.ATV.0000099882.52647.E4
   Mohan IV, 2002, J ENDOVASC THER, V9, P748, DOI 10.1583/1545-1550(2002)009<0748:FAFISG>2.0.CO;2
   Nelea V, 2005, J BIOMED MATER RES A, V75A, P216, DOI 10.1002/jbm.a.30402
   Prinssen M, 2004, NEW ENGL J MED, V351, P1607, DOI 10.1056/NEJMoa042002
   Pu FR, 2002, BIOMATERIALS, V23, P2411, DOI 10.1016/S0142-9612(01)00377-5
   Raymond MA, 2005, BIOCHEM BIOPH RES CO, V338, P1374, DOI 10.1016/j.bbrc.2005.10.105
   Raymond MA, 2004, FASEB J, V18, P705, DOI 10.1096/fj.03-0573fje
   Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053
   Schurink GWH, 1999, BRIT J SURG, V86, P581
   SCHWARTZ MA, 2002, NAT CELL BIOL, V4, P65
   STEHBENS WE, 2000, DEV ANEURYSMS, P84
   Tang PCY, 2005, CIRCULATION, V112, P1098, DOI 10.1161/CIRCULATIONHA.104.511717
   Thompson RW, 1997, CORONARY ARTERY DIS, V8, P623, DOI 10.1097/00019501-199710000-00005
   Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809
   van der Bas JMA, 2004, J VASC SURG, V39, P850, DOI 10.1016/j.jvs.2003.11.045
   Veith FJ, 2002, J VASC SURG, V35, P1029, DOI 10.1067/mva.2002.123095
   Xie YB, 2002, J BIOMED MATER RES, V61, P234, DOI 10.1002/jbm.10141
NR 41
TC 35
Z9 36
U1 1
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2007
VL 28
IS 6
BP 1209
EP 1217
DI 10.1016/j.biomaterials.2006.10.033
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 122II
UT WOS:000243219000032
PM 17129601
DA 2018-10-20
ER

PT J
AU Liu, XD
   Howard, KA
   Dong, MD
   Andersen, MO
   Rahbek, UL
   Johnsen, MG
   Hansen, OC
   Besenbacher, F
   Kjems, J
AF Liu, Xiudong
   Howard, Kenneth A.
   dong, Ming Dong
   Andersen, Morten O.
   Rahbek, Ulrik L.
   Johnsen, Mads G.
   Hansen, Ole C.
   Besenbacher, Flemming
   Kjems, Jorgen
TI The influence of polymeric properties on chitosan/siRNA nanoparticle
   formulation and gene silencing
SO BIOMATERIALS
LA English
DT Article
DE RNA interference; chitosan; siRNA; nanoparticle; delivery; gene
   silencing
ID RNA INTERFERENCE; TRANSFECTION EFFICIENCY; DNA NANOPARTICLES; IN-VITRO;
   MAMMALIAN-CELLS; DELIVERY-SYSTEM; MOLECULAR-MASS; DEACETYLATION;
   VECTORS; THERAPY
AB We have previously introduced the use of the biomaterial chitosan to form chitosan/siRNA nanoparticles for gene silencing protocols. This present study shows that the physicochemical properties (size, zeta potential, morphology and complex stability) and in vitro gene silencing of chitosan/siRNA nanoparticles are strongly dependent on chitosan molecular weight (M,,) and degree of deacetylation (1313). High M-w and DD chitosan resulted in the formation of discrete stable nanoparticles similar to 200 nm in size. Chitosan/siRNA formulations (N:P 50) prepared with low M-w (similar to 10 kDa) showed almost no knockdown of endogenous enhanced green fluorescent protein (EGFP) in H1299 human lung carcinoma cells, whereas those prepared from higher M-w (64.8-170kDa) and DD (similar to 80%) showed greater gene silencing ranging between 45% and 65%. The highest gene silencing efficiency (80%) was achieved using chitosan/siRNA nanoparticles at N:P 150 using higher M,, (114 and 170 kDa) and DD (84%) that correlated with formation of stable nanoparticles of similar to 200 nm. In conclusion, this work confirms the application of chitosan as a non-viral carrier for siRNA and the importance of polymeric properties for the optimisation of gene silencing using chitosan/siRNA nanoparticles. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Aarhus, Dept Mol Biol, iNANO, DK-8200 Aarhus, Denmark.
   Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus, Denmark.
RP Howard, KA (reprint author), Univ Aarhus, Dept Mol Biol, iNANO, Bldg 1130, DK-8200 Aarhus, Denmark.
EM kenh@inano.dk
RI Andersen, Morten/D-5214-2013; Dong, Mingdong/B-3341-2010; Besenbacher,
   Flemming/A-9623-2010
OI Andersen, Morten/0000-0003-4977-3031; Dong,
   Mingdong/0000-0002-2025-2171; Kjems, Jorgen/0000-0003-4128-9317
FU Villum Fonden [7194]
CR Barton GM, 2002, P NATL ACAD SCI USA, V99, P14943, DOI 10.1073/pnas.242594499
   Bitko V, 2005, NAT MED, V11, P50, DOI 10.1038/nm1164
   Borchard G, 2001, ADV DRUG DELIVER REV, V52, P145, DOI 10.1016/S0169-409X(01)00198-3
   CarrenoGomez B, 1997, INT J PHARM, V148, P231, DOI 10.1016/S0378-5173(96)04847-8
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Corsi K, 2003, BIOMATERIALS, V24, P1255, DOI 10.1016/S0142-9612(02)00507-0
   Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703
   Dorsett Y, 2004, NAT REV DRUG DISCOV, V3, P318, DOI 10.1038/nrd1345
   Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107
   Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888
   Hannon GJ, 2004, NATURE, V431, P371, DOI 10.1038/nature02870
   HIRANO S, 1976, CARBOHYD RES, V47, P315, DOI 10.1016/S0008-6215(00)84198-1
   Howard KA, 2006, MOL THER, V14, P476, DOI 10.1016/j.ymthe.2006.04.010
   Huang M, 2005, J CONTROL RELEASE, V106, P391, DOI 10.1016/j.cornel.2005.05.004
   Ichim TE, 2004, AM J TRANSPLANT, V4, P1227, DOI 10.1111/j.1600-6143.2004.00530.x
   ILLUM L, 1994, PHARMACEUT RES, V11, P1186, DOI 10.1023/A:1018901302450
   Ishii T, 2001, BBA-BIOMEMBRANES, V1514, P51, DOI 10.1016/S0005-2736(01)00362-5
   Khan TA, 2002, J PHARM PHARM SCI, V5, P205
   Kiang T, 2004, BIOMATERIALS, V25, P5293, DOI 10.1016/j.biomaterials.2003.12.036
   Koping-Hoggard M, 2004, GENE THER, V11, P1441, DOI 10.1038/sj.gt.3302312
   Li XW, 2003, BBA-GENE STRUCT EXPR, V1630, P7, DOI 10.1016/j.bbaexp.2003.08.011
   Liu WG, 2005, BIOMATERIALS, V26, P2705, DOI 10.1016/j.biomaterials.2004.07.038
   Liu WG, 2002, J CONTROL RELEASE, V83, P1
   Lundstrom K, 2003, TRENDS BIOTECHNOL, V21, P117, DOI 10.1016/S0167-7799(02)00042-2
   Mansouri S, 2004, EUR J PHARM BIOPHARM, V57, P1, DOI 10.1016/s0939-641(03)00155-3
   Mao HQ, 2001, J CONTROL RELEASE, V70, P399, DOI 10.1016/S0168-3659(00)00361-8
   MCLAUGHLIN FC, 1998, J CONTROL RELEASE, V56, P259
   Milhavet O, 2003, PHARMACOL REV, V55, P629, DOI 10.1124/pr.55.4.1
   MUZZARELLI RAA, 1985, CARBOHYD POLYM, V5, P461, DOI 10.1016/0144-8617(85)90005-0
   Ottoy MH, 1996, CARBOHYD POLYM, V31, P253, DOI 10.1016/S0144-8617(96)00096-3
   Plasterk RHA, 2002, SCIENCE, V296, P1263, DOI 10.1126/science.1072148
   Pouton CW, 2001, ADV DRUG DELIVER REV, V46, P187, DOI 10.1016/S0169-409X(00)00133-2
   Richardson SCW, 1999, INT J PHARMACEUT, V178, P231, DOI 10.1016/S0378-5173(98)00378-0
   Sato T, 2001, BIOMATERIALS, V22, P2075, DOI 10.1016/S0142-9612(00)00385-9
   Schiffelers RM, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh140
   Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121
   VARUM KM, 1994, CARBOHYD POLYM, V25, P65, DOI 10.1016/0144-8617(94)90140-6
   VERHOEF JC, 2001, ADV DRUG DELIVER REV, V50, pS91
   Xia HB, 2002, NAT BIOTECHNOL, V20, P1006, DOI 10.1038/nbt739
NR 39
TC 264
Z9 271
U1 1
U2 86
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2007
VL 28
IS 6
BP 1280
EP 1288
DI 10.1016/j.biomaterials.2006.11.004
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 122II
UT WOS:000243219000039
PM 17126901
DA 2018-10-20
ER

PT J
AU De Bartolo, L
   Morelli, S
   Piscioneri, A
   Lopez, LC
   Favia, P
   d'Agostino, R
   Drioli, E
AF De Bartolo, Loredana
   Morelli, Sabrina
   Piscioneri, Antonella
   Lopez, Linda C.
   Favia, Pietro
   d'Agostino, Riccardo
   Drioli, Enrico
TI Novel membranes and surface modification able to activate specific
   cellular responses
SO BIOMOLECULAR ENGINEERING
LA English
DT Article; Proceedings Paper
CT Symposium on Nano-Structured and Intelligent Bioactive Materials held at
   the EMRS 2005 Spring Meeting
CY MAY 29-JUN 02, 2005
CL Strasbourg, FRANCE
DE membrane; human hepatocyte; liver specific functions; biotransformation;
   surface modification
ID MODIFIED POLYMERS; HUMAN HEPATOCYTES; PLASMA; ATTACHMENT; FIBRONECTIN;
   VIABILITY; ADHESION; CULTURE; CELLS
AB The design of new polymeric biomaterials together with new strategies to modify membrane surface are crucial to optimise cell-biomaterial interactions in vivo and in vitro biohybrid systems.
   In this study we report on the novel semipermeable membranes synthesised from a polymeric blend of modified polyetheretherketone and polyurethane able to support the long-term maintenance and differentiation of human liver cells and on the surface modification of polyethersulfone membranes by plasma polymerisation of acrylic acid monomers and by immobilization of arginine-glycine-aspartic acid (RGD) peptide through a hydrophilic "spacer arm" molecule.
   The performance of the modified and unmodified membranes was tested by evaluation of the liver function expression of primary human hepatocytes in terms of albumin production, protein secretion and drug biotransformation. (c) 2006 Elsevier B.V. All rights reserved.
C1 Univ Calabria, Inst Membrane Technol, Natl Res Council Italy, I-87030 Arcavacata Di Rende, CS, Italy.
   Univ Bari, Dept Chem, Bari, Italy.
RP De Bartolo, L (reprint author), Univ Calabria, Inst Membrane Technol, Natl Res Council Italy, Via P Bucci,Cubo 17-C, I-87030 Arcavacata Di Rende, CS, Italy.
EM l.debartolo@itm.cnr.it
RI Piscioneri, Antonella/N-6910-2018; De Bartolo, Loredana/E-5074-2015
OI Piscioneri, Antonella/0000-0002-1052-1550; De Bartolo,
   Loredana/0000-0003-3774-9114; Favia, Pietro/0000-0002-5896-895X; Drioli,
   Enrico/0000-0003-1092-5368; MORELLI, SABRINA/0000-0001-7551-8427
CR Altankov G, 2000, J BIOMED MATER RES, V52, P219, DOI 10.1002/1097-4636(200010)52:1<219::AID-JBM28>3.0.CO;2-F
   Daw R, 1998, BIOMATERIALS, V19, P1717, DOI 10.1016/S0142-9612(98)00080-5
   De Bartolo L, 2005, BIOMATERIALS, V26, P6625, DOI 10.1016/j.biomaterials.2005.04.021
   De Bartolo L, 2005, BIOMATERIALS, V26, P4432, DOI 10.1016/j.biomaterials.2004.11.009
   De Bartolo L, 2000, BIOTECHNOL PROGR, V16, P102, DOI 10.1021/bp990128o
   De Bartolo L, 2002, BIOMATERIALS, V23, P2485, DOI 10.1016/S0142-9612(01)00383-0
   De Bartolo L, 2006, J NANOSCI NANOTECHNO, V6, P2344, DOI 10.1166/jnn.2006.514
   Detomaso L, 2005, BIOMATERIALS, V26, P3831, DOI 10.1016/j.biomaterials.2004.10.011
   Gancarz I, 2003, EUR POLYM J, V39, P1615, DOI 10.1016/S0014-3057(03)00055-7
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   KIMMERLE K, 1990, DESALINATION, V79, P283, DOI 10.1016/0011-9164(90)85012-Y
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Quirk RA, 2003, BIOTECHNOL BIOENG, V81, P625, DOI 10.1002/bit.10502
   Unger RE, 2005, BIOMATERIALS, V26, P1877, DOI 10.1016/j.biomaterials.2004.05.032
   Yin C, 2003, J BIOMED MATER RES A, V67A, P1093, DOI 10.1002/jbm.a.10033
NR 15
TC 32
Z9 33
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1389-0344
J9 BIOMOL ENG
JI Biomol. Eng.
PD FEB
PY 2007
VL 24
IS 1
SI SI
BP 23
EP 26
DI 10.1016/j.bioeng.2006.07.001
PG 4
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Genetics & Heredity
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
GA 147LQ
UT WOS:000245004900004
PM 16914370
DA 2018-10-20
ER

PT J
AU Eisenbarth, E
   Velten, D
   Breme, J
AF Eisenbarth, E.
   Velten, D.
   Breme, J.
TI Biomimetic implant coatings
SO BIOMOLECULAR ENGINEERING
LA English
DT Article; Proceedings Paper
CT Symposium on Nano-Structured and Intelligent Bioactive Materials held at
   the EMRS 2005 Spring Meeting
CY MAY 29-JUN 02, 2005
CL Strasbourg, FRANCE
DE nanostructure; nanosized topography; osteoblast; biomaterial
   interaction; surface modification
ID TITANIUM SURFACES; GROUND TITANIUM; CELL-ADHESION
AB Biomaterials and tissue engineering technologies are becoming increasingly important in biomedical practice, particularly as the population ages. Cellular responses depend on topographical properties of the biomaterial at the nanometer scale. Structures on biomaterial surfaces are used as powerful tools to influence or even control interactions between implants and the biological system [Kawahara, H., Soeda, Y., Niwa, K., Takahashi, M., Kawahara, D., Araki, N., 2004. J. Mater. Sci. Mater. Med. 15 (12), 1297-1307; Winkelmann, M., Gold, J., Hauert, R., Kasemo, B., Spencer, N.D., Brunette, D.M., Textor, M., 2003. Biomaterials 24 (7), 1133-1145]. The influence of nanometer sized surface structures on osteoblastlike cell interactions was tested with niobium oxide coatings on polished titanium slices (cp-Ti grade 2). The aim of the study was to investigate the influence of nanoscopic surface structures on osteoblast interactions in order to support collagen I production and cell adhesion. The coatings were done by means of the sol-gel process. The surface structure was adjusted by annealing of the metaloxide ceramic coatings due to temperature depended crystal growth. The applied annealing temperatures were 450, 550 and 700 degrees C for 1h, corresponding to Ra-numbers of 7, 15 and 40 nm. The surfaces were characterized by means of AFM, DTA/TG, diffractometry and white light interferometry. The cell reactions were investigated concerning adhesion kinetics, migration, spreading, cell adhesion, and collagen I synthesis. The smooth surface (Ra = 7 nm) resulted in the fastest cell anchorage and cell migration. The closest cell adhesion was reached with the surface structure of Ra = 15 nm. The roughest surface (Ra = 40 nm) impedes the cell migration as well as a proper spreading of the cells. The best results concerning cell adhesion and spreading was reached with an intermediate surface roughness of Ra = 15 nm of the niobium oxide coating on cp-titanium slices. (c) 2006 Elsevier B.V. All rights reserved.
C1 Hamburg Univ Technol, Dept Biomech, Hamburg, Germany.
   Univ Saarland, Dept Met Mat, D-6600 Saarbrucken, Germany.
RP Eisenbarth, E (reprint author), Hamburg Univ Technol, Dept Biomech, Hamburg, Germany.
EM eva.eisenbarth@tuhh.de
CR Catledge SA, 2004, J NANOSCI NANOTECHNO, V4, P986, DOI 10.1166/jnn.2004.137
   Eisenbarth E, 2004, BIOMATERIALS, V25, P5705, DOI 10.1016/j.biomaterials.2004.01.021
   Eisenbarth E, 2002, BIOMOL ENG, V19, P233, DOI 10.1016/S1389-0344(02)00028-X
   Huang HH, 2004, BIOMOL ENG, V21, P93, DOI 10.1016/j.bioeng.2004.05.001
   Kawahara H, 2004, J MATER SCI-MATER M, V15, P1297, DOI 10.1007/s10856-004-5738-0
   Landi E, 2005, BIOMATERIALS, V26, P2835, DOI 10.1016/j.biomaterials.2004.08.010
   Velten D, 2004, J MATER SCI-MATER M, V15, P457, DOI 10.1023/B:JMSM.0000021120.86985.f7
   Winkelmann M, 2003, BIOMATERIALS, V24, P1133, DOI 10.1016/S0142-9612(02)00449-0
   Zhu XL, 2004, CELLS TISSUES ORGANS, V178, P13, DOI 10.1159/000081089
NR 9
TC 61
Z9 65
U1 0
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1389-0344
J9 BIOMOL ENG
JI Biomol. Eng.
PD FEB
PY 2007
VL 24
IS 1
SI SI
BP 27
EP 32
DI 10.1016/j.bioeng.2006.05.016
PG 6
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Genetics & Heredity
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
GA 147LQ
UT WOS:000245004900005
PM 16828342
DA 2018-10-20
ER

PT J
AU Leguen, E
   Chassepot, A
   Decher, G
   Schaaf, P
   Voegel, JC
   Jessel, N
AF Leguen, Erell
   Chassepot, Armelle
   Decher, Gero
   Schaaf, Pierre
   Voegel, Jean-Claude
   Jessel, Nadia
TI Bioactive coatings based on polyelectrolyte multilayer architectures
   functionalized by embedded proteins, peptides or drugs
SO BIOMOLECULAR ENGINEERING
LA English
DT Article; Proceedings Paper
CT Symposium on Nano-Structured and Intelligent Bioactive Materials held at
   the EMRS 2005 Spring Meeting
CY MAY 29-JUN 02, 2005
CL Strasbourg, FRANCE
DE PEM films; functionalized biomaterial coating; structured materials
ID ATOMIC-FORCE MICROSCOPE; STAPHYLOCOCCUS-AUREUS; BETA-CYCLODEXTRIN;
   GROWTH-FACTOR; FILMS; ADSORPTION; DELIVERY; POLYMER; SURFACE; CELLS
AB DIn recent years, considerable effort has been devoted to the design and controlled fabrication of structured materials with functional properties. The layer by layer buildup of polyelectrolyte multilayer films (PEM films) from oppositely charged polyelectrolytes offers new opportunities for the preparation of functionalized biomaterial coatings. This technique allows the preparation of supramolecular nano-architectures exhibiting specific properties in terms of control of cell activation and may also play a role in the development of local drug delivery systems. Peptides, proteins, chemically bound to polyelectrolytes, adsorbed or embedded in PEM films, have been shown to retain their biological activities. (c) 2006 Elsevier B.V. All rights reserved.
C1 Univ Strasbourg 1, INSERM Unite 595, F-67085 Strasbourg, France.
   ULP, CNRS, Inst Charles Sadron, F-67083 Strasbourg, France.
RP Jessel, N (reprint author), Univ Strasbourg 1, INSERM Unite 595, 11 Rue Humann, F-67085 Strasbourg, France.
EM nadia.jessel@medecine.u-strasbg.fr
RI SCHAAF, Pierre/J-2751-2016; Decher, Gero/E-7665-2011
OI SCHAAF, Pierre/0000-0001-7423-5492; Decher, Gero/0000-0002-7976-8818;
   Benkirane-Jessel, Nadia/0000-0003-3059-3559
CR Arcos D, 2001, BIOMATERIALS, V22, P701, DOI 10.1016/S0142-9612(00)00233-7
   Braet F, 2001, ULTRAMICROSCOPY, V89, P265, DOI 10.1016/S0304-3991(01)00092-4
   Braet F, 1998, J MICROSC-OXFORD, V190, P328
   Cannizzaro SM, 1998, BIOTECHNOL BIOENG, V58, P529, DOI 10.1002/(SICI)1097-0290(19980605)58:5<529::AID-BIT9>3.3.CO;2-U
   Caruso F, 1997, LANGMUIR, V13, P3427, DOI 10.1021/la9608223
   Caruso F, 1998, SCIENCE, V282, P1111, DOI 10.1126/science.282.5391.1111
   Chluba J, 2001, BIOMACROMOLECULES, V2, P800, DOI 10.1021/bm015529i
   DECHER G, 1992, THIN SOLID FILMS, V210, P831, DOI 10.1016/0040-6090(92)90417-A
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   DECHER G, 2003, MULTILAYER THIN FILM
   Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.3.CO;2-G
   Doliwa A, 2001, SKIN PHARMACOL APPL, V14, P97, DOI 10.1159/000056339
   FRANKENBERGER M, 1995, J INFLAMM, V45, P56
   Frolich JC, 1997, TRENDS PHARMACOL SCI, V18, P30, DOI 10.1016/S0165-6147(96)01017-6
   Getting SJ, 2002, TRENDS PHARMACOL SCI, V23, P447, DOI 10.1016/S0165-6147(02)02103-X
   Ghose AC, 1999, IMMUNOL LETT, V65, P175, DOI 10.1016/S0165-2478(98)00102-3
   Grayson ACR, 2003, NAT MATER, V2, P767, DOI 10.1038/nmat998
   Hiller J, 2002, NAT MATER, V1, P59, DOI 10.1038/nmat719
   Ho PKH, 2000, NATURE, V404, P481, DOI 10.1038/35006610
   Hook F, 2001, ANAL CHEM, V73, P5796, DOI 10.1021/ac0106501
   Ito Y, 1996, P NATL ACAD SCI USA, V93, P3598, DOI 10.1073/pnas.93.8.3598
   Ito Y, 1998, BIOCONJUGATE CHEM, V9, P277, DOI 10.1021/bc970190b
   Jessel N, 2003, ADV MATER, V15, P692, DOI 10.1002/adma.200304634
   JESSEL N, 2004, ADV MATER, V16, P1507
   Jessel N., 2004, ADV FUNCT MATER, V14, P174
   Jessel NB, 2004, ADV FUNCT MATER, V14, P963, DOI 10.1002/adfm.200305089
   KLEINFELD ER, 1994, SCIENCE, V265, P370, DOI 10.1126/science.265.5170.370
   KONG W, 1994, J CHEM SOC CHEM COMM, P1297, DOI 10.1039/c39940001297
   KUMAR S, 1992, CANCER LETT, V61, P105, DOI 10.1016/0304-3835(92)90167-T
   Ladam G, 2001, LANGMUIR, V17, P878, DOI 10.1021/la0013087
   Laurencin CT, 2001, BIOMATERIALS, V22, P1271, DOI 10.1016/S0142-9612(00)00279-9
   Lavalle P, 2002, MACROMOLECULES, V35, P4458, DOI 10.1021/ma0119833
   LVOV Y, 1995, J AM CHEM SOC, V117, P6117, DOI 10.1021/ja00127a026
   LVOV Y, 1994, LANGMUIR, V10, P4232, DOI 10.1021/la00023a052
   McEwen J, 2000, CLIN DRUG INVEST, V19, P27, DOI 10.2165/00044011-200019002-00004
   MEMDELSOHN JD, 2003, BIOMACROMOLECULES, V4, P96
   Miyata T, 1999, NATURE, V399, P766, DOI 10.1038/21619
   Murphy WL, 2000, BIOMATERIALS, V21, P2521, DOI 10.1016/S0142-9612(00)00120-4
   Neff JA, 1998, J BIOMED MATER RES, V40, P511, DOI 10.1002/(SICI)1097-4636(19980615)40:4<511::AID-JBM1>3.3.CO;2-M
   Picart C, 2001, J CHEM PHYS, V115, P1086, DOI 10.1063/1.1375156
   RAY PK, 1982, CANCER RES, V42, P4970
   Schwinte P, 2001, J PHYS CHEM B, V105, P11906, DOI 10.1021/jp0123031
   Srivastava AK, 1997, MYCOPATHOLOGIA, V138, P21, DOI 10.1023/A:1006830620523
   Strand BL, 2001, CELL TRANSPLANT, V10, P263, DOI 10.3727/000000001783986800
   SUBBULAKSHMI V, 1998, BIOCH BIOPHYS RES CO, V250
   Szente L, 1999, ADV DRUG DELIVER REV, V36, P17, DOI 10.1016/S0169-409X(98)00092-1
   Tang ZY, 2003, NAT MATER, V2, P413, DOI 10.1038/nmat906
   Verma AS, 1999, IMMUNOPHARM IMMUNOT, V21, P89, DOI 10.3109/08923979909016396
   Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391
NR 49
TC 51
Z9 52
U1 0
U2 24
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1389-0344
J9 BIOMOL ENG
JI Biomol. Eng.
PD FEB
PY 2007
VL 24
IS 1
SI SI
BP 33
EP 41
DI 10.1016/j.bioeng.2006.05.023
PG 9
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Genetics & Heredity
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
GA 147LQ
UT WOS:000245004900006
PM 16860599
DA 2018-10-20
ER

PT J
AU Garreta, E
   Gasset, D
   Semino, C
   Borros, S
AF Garreta, E.
   Gasset, D.
   Semino, C.
   Borros, S.
TI Fabrication of a three-dimensional nanostructured biomaterial for tissue
   engineering of bone
SO BIOMOLECULAR ENGINEERING
LA English
DT Article; Proceedings Paper
CT Symposium on Nano-Structured and Intelligent Bioactive Materials held at
   the EMRS 2005 Spring Meeting
CY MAY 29-JUN 02, 2005
CL Strasbourg, FRANCE
DE cartilage; hydroxyapatite; bone tissue engineering; nanostructured
   composite
ID PEPTIDE SCAFFOLDS; ACRYLIC-ACID; PLASMA; SURFACES; CELLS
AB A plasma process for the surface modification of HA powders has been developed. Acrylic acid and acrylic acid/octadiene plasma deposited films onto HA particles have demonstrated to interact with SBF allowing the calcium dissolution-precipitation mechanism. Therefore, a nanostructured composite between HA and a self-assembling peptide scaffold (RAD16-I) has been developed. The differentiation of mESC in this scaffold has been studied, in order to test the osteogenic capacity of the new composite material. We have observed that the mESC can be iduced to produce Ca salts (mineralization) in a 3D-microenvironment and moreover, this activity can be enhanced by the presence of HA particules into the nanofiber scaffold. (c) 2006 Elsevier B.V. All rights reserved.
C1 Univ Ramon Llull, Inst Quim Sarria, Barcelona Bioengn Ctr, Barcelona 08017, Spain.
   MIT, Ctr Biomed Engn, Cambridge, MA 02139 USA.
RP Borros, S (reprint author), Univ Ramon Llull, Inst Quim Sarria, Barcelona Bioengn Ctr, Via Augusta 390, Barcelona 08017, Spain.
EM semino@mit.edu; s.borros@iqs.url.edu
RI Borros, Salvador/A-3950-2016
OI Borros, Salvador/0000-0002-4003-0381; Garreta Bahima,
   Elena/0000-0002-1071-9794
CR BOSKEY AL, 1992, CELL MATER, V2, P209
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Detomaso L, 2005, BIOMATERIALS, V26, P3831, DOI 10.1016/j.biomaterials.2004.10.011
   FERNANDEZ T, 2003, THESIS I QUIMIC SARR
   Fraser S, 2002, J PHYS CHEM B, V106, P5596, DOI 10.1021/jp012406j
   Genove E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012
   Hench L. L., 1993, INTRO BIOCERAMICS, V1
   JARCHO M, 1986, DENT CLIN N AM, V30, P25
   LANDIS W, 1995, J BONE MINER RES, V10, pS506
   Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1
   Semino CE, 2004, TISSUE ENG, V10, P643, DOI 10.1089/107632704323061997
   Semino CE, 2003, DIFFERENTIATION, V71, P262, DOI 10.1046/j.1432-0436.2003.7104503.x
   Ward LJ, 2003, CHEM MATER, V15, P1466, DOI 10.1021/cm020289e
   Whittle JD, 2002, J MATER CHEM, V12, P2726, DOI 10.1039/b201471h
   Zizak I, 2003, J STRUCT BIOL, V141, P208, DOI 10.1016/S1047-8477(02)00635-4
NR 15
TC 36
Z9 39
U1 2
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1389-0344
J9 BIOMOL ENG
JI Biomol. Eng.
PD FEB
PY 2007
VL 24
IS 1
SI SI
BP 75
EP 80
DI 10.1016/j.bioeng.2006.05.017
PG 6
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Genetics & Heredity
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
GA 147LQ
UT WOS:000245004900012
PM 16846750
DA 2018-10-20
ER

PT J
AU Welle, A
   Chiumiento, A
   Barbucci, R
AF Welle, Alexander
   Chiumiento, Antonio
   Barbucci, Rolando
TI Competitive protein adsorption on micro patterned polymeric
   biomaterials, and viscoelastic properties of tailor made extracellular
   matrices
SO BIOMOLECULAR ENGINEERING
LA English
DT Article; Proceedings Paper
CT Symposium on Nano-Structured and Intelligent Bioactive Materials held at
   the EMRS 2005 Spring Meeting
CY MAY 29-JUN 02, 2005
CL Strasbourg, FRANCE
DE quartz crystal microgravimetry; QCM-D; serum protein adsorption;
   hyaluronic acid; viscoelasticity
ID QUARTZ-CRYSTAL MICROBALANCE; CELL BEHAVIOR; SUBSTRATE; ADHESION;
   SURFACES; FILMS
AB Cell adhesion on biomaterial surfaces and the vitality of anchorage dependent cells is affected by several parameters of an adsorbate layer which is intentionally or spontaneously formed. Surface pre-treatments and several conditioning steps prior and during to the cell/biomaterial contact affect the composition, orientation, quantity and viscoelasticity of the interfacing layer between cells and biomaterial. This work was performed to elucidate the response of cells on two modified biomaterial surfaces based on protein or carbohydrate adsorbates:
   (a) Masked UV irradiations opened a simple route to obtain chemically patterned substrates controlling serum protein adsorption and cell adhesion. It is possible to achieve structures of subcellular size and to produce immobilized gradients. In order to examine the protein matrix deposited on these substrates we applied a quartz microbalance technique (QCM-D) capable to extract viscoelastic data in addition to the mass uptake during plasma protein deposition. It was found that the quantity and viscosity of surface bound albumin is lowered when the surface is modified (patterned) by UV exposure. Hence, the UV modification promotes the competitive adsorption of cell adhesion proteins from the media or upon secretion by the cells and yields to the observed cell patterns.
   (b) Another tissue engineering technique, using immobilized, modified and/or cross linked hyaluronic acid (HA), an important extra cellular matrix component in vivo, is also examined by QCM-D. Our data demonstrate that HA can be modified by an activation with a carbodiimide, followed by the application of an alpha,omega-bisamino polyethyleneglycol. The QCM-D data can be interpreted as a stiffening of the HA layer combined with the release of hydration water. Further, the hydration state and the viscoclastic behaviour of surface bound ultrathin HA hydrogels was examined.
   Quantification of viscoelastic parameters of thin films of ECM by QCM-D is valuable for the interpretation of durotaxis, describing effects of mechanical substrate parameters on the adhesion and motility of cells. (c) 2006 Published by Elsevier B.V.
C1 Forschungszentrum Karlsruhe, Inst Biol Interfaces, D-76021 Karlsruhe, Germany.
   Univ Siena, CRISMA, Dept Chem & Biosyst Sci & Technol, I-53100 Siena, Italy.
RP Welle, A (reprint author), Forschungszentrum Karlsruhe, Inst Biol Interfaces, POB 3640, D-76021 Karlsruhe, Germany.
EM Alexander.Welle@ibg.fzk.de
RI Welle, Alexander/H-2201-2013
OI Welle, Alexander/0000-0002-3454-6509
CR Barbucci R, 2003, BIOMATERIALS, V24, P915, DOI 10.1016/S0142-9612(02)00425-8
   Cans AS, 2001, ANAL CHEM, V73, P5805, DOI 10.1021/ac010777q
   Curtis A, 2001, PHYS MED BIOL, V46, pR47, DOI 10.1088/0031-9155/46/4/201
   Fredriksson C, 1998, LANGMUIR, V14, P248, DOI 10.1021/la971005l
   Hook F, 1998, LANGMUIR, V14, P729, DOI 10.1021/la970815u
   Hook F, 2001, ANAL CHEM, V73, P5796, DOI 10.1021/ac0106501
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Magnani A, 2003, MAT SCI ENG C-BIO S, V23, P315, DOI 10.1016/S0928-4931(02)00284-9
   Mendelsohn JD, 2003, BIOMACROMOLECULES, V4, P96, DOI 10.1021/bm0256101
   Richert L, 2002, BIOMACROMOLECULES, V3, P1170, DOI 10.1021/bm.0255490
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   Welle A, 2005, J NEUROSCI METH, V142, P243, DOI 10.1016/j.jneumeth.2004.08.011
   Welle A, 2002, BIOMED MICRODEVICES, V4, P33, DOI 10.1023/A:1014267712144
   Zhou T, 2000, BIOTECHNOL PROGR, V16, P268, DOI 10.1021/bp000003f
NR 14
TC 10
Z9 11
U1 1
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1389-0344
J9 BIOMOL ENG
JI Biomol. Eng.
PD FEB
PY 2007
VL 24
IS 1
SI SI
BP 87
EP 91
DI 10.1016/j.bioeng.2006.05.027
PG 5
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Genetics & Heredity
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
GA 147LQ
UT WOS:000245004900014
PM 16861035
DA 2018-10-20
ER

PT J
AU Bartsch, GC
   Malinova, V
   Volkmer, BE
   Hautmann, RE
   Rieger, B
AF Bartsch, Georg C., Jr.
   Malinova, Violeta
   Volkmer, Bjoern E.
   Hautmann, Richard E.
   Rieger, Bernhard
TI CO-alkene polymers are biocompatible scaffolds for primary urothelial
   cells in vitro and in vivo
SO BJU INTERNATIONAL
LA English
DT Article
DE biocompatibility; biomaterials; CO-alkene polymers; urology; urothelial
   cells
ID SMALL-INTESTINAL SUBMUCOSA; URETERAL REPLACEMENT; CARBON-MONOXIDE;
   URINARY-INCONTINENCE; TUBE GRAFTS; BLADDER; RECONSTRUCTION; PROPENE
AB To investigate CO-alkene polymers, novel synthetic nonbiodegradable polymers, as a potential biomaterial for urological applications.
   Porcine urothelial cells were seeded on cover glasses (96 wells; 10 000 cells/well) coated with CO-alkene polymers [propylene/N-Acetyl-O'-(hex-5-enyl)-L-tyrosine ethyl ester/CO (PTCO) and hexene-CO (HxCO)]. The following conditions were investigated: cells seeded; (i) on PTCO, (ii) on HxCO, (iii) in PTCO-conditioned medium, (iv) in HxCO-conditioned medium, (v) on glass without polymers, (vi) on polystyrene, and (vii) on polystyrene treated with 1.25% NaCl (toxic control). Cell counts, cell death detection assay, and a cell activity assay (XTT, a tetrazolium-based colorimetric assay) were performed after 3, 6 and 9 days. Urothelial-cell seeded-PTCO films (0.5 x 10(6) cells/cm(2)) were implanted into the subcutaneous space of athymic mice for up to 12 weeks and unseeded PTCO polymers were implanted as a negative control.
   The urothelial cell adherence rates on the polymers were similar to those for glass and polystyrene. The cell activity (XTT assay) was higher in cells seeded on the polymers than in cells seeded on polystyrene and glass after 3 and 6 days. There were no significant differences between the apoptosis rates of all groups at the given sample times, except for the high levels in the toxic control. In vivo the urothelial cells survived on the polymers for 12 weeks with no adverse reactions in any of the mice.
   CO-alkene polymers are biocompatible materials for urothelial cells in vitro and in vivo, and thus are potential biomaterials for the urogenital tract.
C1 Univ Ulm, Fac Med, Dept Urol, D-89075 Ulm, Germany.
RP Bartsch, GC (reprint author), Univ Ulm, Fac Med, Dept Urol, Prittwitzstr 43, D-89075 Ulm, Germany.
EM georg.bartsch@uniklinik-ulm.de
RI Rieger, Bernhard/C-1183-2010
OI Rieger, Bernhard/0000-0002-0023-884X
CR AbuSurrah AS, 1997, MACROMOL CHEM PHYSIC, V198, P1197, DOI 10.1002/macp.1997.021980421
   [Anonymous], 1992, ISO109935
   Atala A, 2000, J ENDOUROL, V14, P49, DOI 10.1089/end.2000.14.49
   Ateh DD, 2006, TISSUE ENG, V12, P645, DOI 10.1089/ten.2006.12.645
   Baltaci S, 1998, UROLOGY, V51, P400, DOI 10.1016/S0090-4295(97)00632-8
   Beckstead BL, 2005, BIOMATERIALS, V26, P6217, DOI 10.1016/j.biomaterials.2005.04.010
   Foullerat DP, 2004, MACROMOL CHEM PHYS, V205, P374
   Jones JS, 2005, BJU INT, V96, P103, DOI 10.1111/j.1464-410X.2005.05576.x
   Kassardjian ZG, 2004, BJU INT, V93, P665, DOI 10.1111/j.1464-410X.2004.04691.x
   Kim T., 2000, ADV STUD CONT MATH, V2, P9
   Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2
   Liatsikos EN, 2001, J UROLOGY, V165, P1719, DOI 10.1016/S0022-5347(05)66401-4
   Malinova V, 2005, MACROMOL RAPID COMM, V26, P945, DOI 10.1002/marc.200500150
   Moncada I, 2004, CURR OPIN UROL, V14, P375, DOI 10.1097/00042307-200411000-00014
   Muller G, 2002, PROG POLYM SCI, V27, P815, DOI 10.1016/S0079-6700(01)00030-2
   Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149
   Pariente JL, 2002, J UROLOGY, V167, P1867, DOI 10.1016/S0022-5347(05)65251-2
   Pariente JL, 2001, J BIOMED MATER RES, V55, P33, DOI 10.1002/1097-4636(200104)55:1<33::AID-JBM50>3.3.CO;2-Z
   Pariente JL, 1998, J BIOMED MATER RES, V40, P31, DOI 10.1002/(SICI)1097-4636(199804)40:1<31::AID-JBM4>3.0.CO;2-S
   Reuter P, 2003, MACROMOL BIOSCI, V3, P123, DOI 10.1002/mabi.200390012
   ROEHLKE W, 2003, MACROMOL BIOSCI, V3, P131
   ROEHM NW, 1991, J IMMUNOL METHODS, V142, P257, DOI 10.1016/0022-1759(91)90114-U
   Rutman M, 2006, J UROLOGY, V175, P610, DOI 10.1016/S0022-5347(05)00237-5
   Sabanegh ES, 1996, UROLOGY, V48, P312, DOI 10.1016/S0090-4295(96)00185-9
   SCOTT FB, 1989, UROL CLIN N AM, V16, P105
   SEN A, 1989, MACROMOLECULES, V22, P2012, DOI 10.1021/ma00194a084
   Sievert KD, 2000, J UROLOGY, V163, P1958, DOI 10.1016/S0022-5347(05)67610-0
   Sun T, 2005, TISSUE ENG, V11, P1023, DOI 10.1089/ten.2005.11.1023
   TACHIBANA M, 1985, J UROLOGY, V133, P866, DOI 10.1016/S0022-5347(17)49268-8
   XU FY, 1993, MAKROMOL CHEM, V194, P2579
   Yoo JJ, 1998, UROLOGY, V51, P221, DOI 10.1016/S0090-4295(97)00644-4
NR 31
TC 4
Z9 4
U1 0
U2 4
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 1464-4096
J9 BJU INT
JI BJU Int.
PD FEB
PY 2007
VL 99
IS 2
BP 447
EP 453
DI 10.1111/j.1464-410X.2006.06576.x
PG 7
WC Urology & Nephrology
SC Urology & Nephrology
GA 124ZQ
UT WOS:000243411700040
PM 17092287
OA Bronze
DA 2018-10-20
ER

PT J
AU Lee, WC
   Cho, YH
AF Lee, Won Chul
   Cho, Young-Ho
TI Bio-inspired digital nanoactuators for photon and biomaterial
   manipulation
SO CURRENT APPLIED PHYSICS
LA English
DT Article
DE bio-inspired devices; digital actuators; nanoactuators; mechanical
   modulation; high-precision positioning
AB This paper presents a bio-inspired digital nanoactuation device (DND) for applications to nano-precision digital manipulation of photons and biomolecules. The structures and principles of DND device have been inspired from those of the biological muscle actuator. The bio-inspired DND, composed of a digital actuator and a nonlinear mechanical modulator, purifies the stroke of the digital actuator in order to generate the high-precision motion required for nano-positioning of photonic or bio-molecule devices. We design and fabricate two kind of DNDs: one with a linear modulator (1-DND) and the other with nonlinear modulator (n-DND), both having an identical input and output strokes of 15.2 mu m and 5.4 mu m, respectively. In experimental study, n-DND shows the repeatability of 12.3 +/- 2.9 nm, superior to that of 27.8 +/- 2.9 nm achieved by 1-DND. We experimentally verify that the displacement purifying capability of the bio-inspired n-DND achieves nano-precision motion repeatability, applicable to photon and bio-molecule manipulation. (c) 2006 Elsevier B.V. All rights reserved.
C1 Korea Adv Inst Sci & Technol, Digital Nanolocomot Ctr, Dept Biosyst, Taejon 305701, South Korea.
RP Cho, YH (reprint author), Korea Adv Inst Sci & Technol, Digital Nanolocomot Ctr, Dept Biosyst, 373-1 Guseong Dong, Taejon 305701, South Korea.
EM nanosys@kaist.ac.kr
RI Cho, Young-Ho/C-1529-2011
CR Akiyama T., 1993, Journal of Microelectromechanical Systems, V2, P106, DOI 10.1109/84.260254
   CHO YH, 1999, P 5 WORLD MICR SUMM
   CHO YH, 2000, REALIZATION BIOANALO
   FAN LS, 1987, P TRANSD 87 TOK, P849
   HERZIG HP, 1999, P 3 INT C MICR OPT E, P157
   Hosaka S., 1996, IEEE Transactions on Magnetics, V32, P1873, DOI 10.1109/20.492880
   KOVACS GTA, 1998, MICROMACHINES TRANSD, pCH3
   PISANO AP, 1989, P 5 INT C SOL STAT S
   TOSHIYOSHI H, 1999, P 10 INT C SOL STAT, P994
   VIKTOROVITCH P, 1999, P 3 INT C MICR OPT E, P35
NR 10
TC 6
Z9 6
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1739
J9 CURR APPL PHYS
JI Curr. Appl. Phys.
PD FEB
PY 2007
VL 7
IS 2
BP 139
EP 146
DI 10.1016/j.cap.2006.03.001
PG 8
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 116RA
UT WOS:000242818800005
DA 2018-10-20
ER

PT J
AU Colmati, F
   Yoshioka, SA
   Silva, VLVB
   Varela, H
   Gonzalez, ER
AF Colmati, Flavio
   Yoshioka, Sergio A.
   Silva, Victor L. V. B.
   Varela, Hamilton
   Gonzalez, Ernesto R.
TI Enzymatic based biocathode in a polymer electrolyte membrane fuel cell
SO INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE
LA English
DT Article
DE biochemical fuel cell; enzymes; biocatalysts; oxygen reduction reaction
ID BIOFUEL CELL; DIRECT ELECTROCHEMISTRY; LACTATE-DEHYDROGENASE; CARBON;
   ELECTROCATALYSIS; IMMOBILIZATION; PEROXIDASE; REDUCTION; OPERATION;
   CATALYSIS
AB In this communication results of a fuel cell operating with a conventional platinum anode and a peroxidase based biochatode are presented. The biocathode was prepared with peroxidase extracted from vegetal tissue of brazilian zucchini, Cucurbirta pepo, via four different methods. The biomaterial was used either immobilized or adsorbed on carbon cloth and on carbon powder. The tests were carried out at 25 degrees C in a proton exchange membrane fuel cell, in which cathode and anode were fed with oxygen and hydrogen, respectively. The crude extract from brazilian zucchini ( Cucurbirta pepo) was used as peroxidase source in the cathode of the biochemical fuel cell. In spite of the poor stability, evidence of the cathode activity towards oxygen reduction is presented and a maximum power density in the range of 80 to 120 mu W cm(-2) was observed.
C1 [Colmati, Flavio; Yoshioka, Sergio A.; Silva, Victor L. V. B.; Varela, Hamilton; Gonzalez, Ernesto R.] Univ Sao Paulo, Inst Quim Sao Carlos, BR-13560970 Sao Carlos, SP, Brazil.
RP Varela, H (reprint author), Univ Sao Paulo, Inst Quim Sao Carlos, Av Trabalhador Sao Carlense 400,CP-780, BR-13560970 Sao Carlos, SP, Brazil.
EM varela@iqsc.usp.br; ernesto@iqsc.usp.br
RI Gonzalez, Ernesto/C-9422-2012; Varela, Hamilton/C-3901-2012
OI Varela, Hamilton/0000-0002-6237-6068
CR Barton SC, 2004, CHEM REV, V104, P4867, DOI 10.1021/cr020719k
   BRETT AMO, 1696, ELECTROCHEMISTRY PRI
   Chen HJ, 2007, ELECTROCHEM COMMUN, V9, P469, DOI 10.1016/j.elecom.2006.10.019
   Colmati F, 2005, ELECTROCHIM ACTA, V50, P5496, DOI 10.1016/j.electacta.2005.03.030
   Dalla-Vecchia R, 2004, QUIM NOVA, V27, P623, DOI 10.1590/S0100-40422004000400017
   EVERSE J, 1991, PEROXIDASES CHEM BIO, V2, pCH1
   Fatibello O, 2002, QUIM NOVA, V25, P455, DOI 10.1590/S0100-40422002000300019
   Gonzalez ER, 2000, QUIM NOVA, V23, P262, DOI 10.1590/S0100-40422000000200019
   Grzebyk M, 2005, SEP PURIF TECHNOL, V41, P321, DOI 10.1016/j.seppur.2004.04.009
   Halliwell CM, 2002, BIOELECTROCHEMISTRY, V55, P21, DOI 10.1016/S1567-5394(01)00172-4
   Halliwell CM, 2002, ANAL CHIM ACTA, V453, P191, DOI 10.1016/S0003-2670(01)01408-8
   Ikeda T, 2003, BBA-PROTEINS PROTEOM, V1647, P121, DOI 10.1016/S1570-9639(03)00075-X
   Jang JK, 2004, PROCESS BIOCHEM, V39, P1007, DOI 10.1016/S0032-9592(03)00203-6
   KATZ E, 1999, NEW J CHEM, V23, P487
   KATZ E, 2003, HDB FUEL CELL FUNDAM, V1
   Lai ME, 2000, J ELECTROANAL CHEM, V494, P30, DOI 10.1016/S0022-0728(00)00307-7
   Mano N, 2003, J AM CHEM SOC, V125, P6588, DOI 10.1021/ja0346328
   Paganin VA, 1998, ELECTROCHIM ACTA, V43, P3761, DOI 10.1016/S0013-4686(98)00135-2
   Pizzariello A, 2002, BIOELECTROCHEMISTRY, V56, P99, DOI 10.1016/S1567-5394(02)00026-9
   Simon E, 2002, J ELECTROANAL CHEM, V538, P253, DOI 10.1016/S0022-0728(02)00833-1
   Soares CMF, 1999, APPL BIOCHEM BIOTECH, V77-9, P745
   Tarasevich MR, 2003, ELECTROCHEM COMMUN, V5, P491, DOI 10.1016/S1388-2481(03)00104-8
   Wang MK, 2005, J ELECTROANAL CHEM, V578, P121, DOI 10.1016/j.jelechem.2004.12.030
   ZAKS A, 1988, J BIOL CHEM, V263, P3194
   Zhao F, 2004, ANAL CHEM, V76, P4960, DOI 10.1021/ac0494026
NR 25
TC 5
Z9 5
U1 0
U2 8
PU ELECTROCHEMICAL SCIENCE GROUP
PI BELGRADE
PA A SPOMENICE 7/12 , 19210 BOR, BELGRADE, VJ 12, SERBIA
SN 1452-3981
J9 INT J ELECTROCHEM SC
JI Int. J. Electrochem. Sci.
PD FEB
PY 2007
VL 2
IS 2
BP 195
EP 202
PG 8
WC Electrochemistry
SC Electrochemistry
GA 306TM
UT WOS:000256270700007
DA 2018-10-20
ER

PT J
AU Patel, JD
   Krupka, T
   Anderson, JM
AF Patel, Jasmine D.
   Krupka, Tianyi
   Anderson, James M.
TI iNOS-mediated generation of reactive oxygen and nitrogen species by
   biomaterial-adherent neutrophils
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE nitric oxide; superoxide anion; neutrophil; infection; polyurethanes
ID NITRIC-OXIDE SYNTHASE; RABBIT ALVEOLAR MACROPHAGES;
   STAPHYLOCOCCUS-EPIDERMIDIS; POLYMORPHONUCLEAR LEUKOCYTES;
   SUPEROXIDE-DISMUTASE; PEROXYNITRITE; INHIBITION; NITROTYROSINE;
   EXPRESSION; NITRATION
AB Infection due to implanted cardiovascular biomaterials is a serious complication initiated by bacterial adhesion to the surface of the implant. The release of reactive oxygen species by neutrophils, particularly superoxide anion, is a well-known bactericidal mechanism. Additionally, nitric oxide (NO) has also been identified as an important cytotoxic mediator in acute and chronic inflammatory responses with enhanced NO production by upregulation of inducible nitric oxide synthase (iNOS). The interaction of NO and superoxide anion will result in the formation of peroxynitrite (OONO-), a potent cytotoxic oxidant. In this study, we have shown that biomaterial-induced neutrophil activation does not cause upregulation of iNOS and activation of iNOS-mediated pathways. However, NO and O-2(-) production does occur over time upon adhesion to a biomaterial and is modulated by biomaterial surface chemistry. With no stimulus, the polyethylene oxide-modified polyurethane induced greater neutrophil activation than did the control as indicated by the increased production of NO and O-2(-) over time. Adherent-stimulated neutrophils generally produced lower amounts of NO over time in comparison with unstimulated cells. Furthermore, there is no evidence of peroxynitrite activity in unstimulated neutrophils adherent to the Elasthane 80A. However, upon stimulation with adherent Staphylococcus epidermidis, peroxynitrite formation did occur. Our results suggest that bactericidal mechanisms in neutrophils involving NO generation (NOS pathway) are further compromised than O-2(-) producing pathways (NADPH oxidase) upon exposure to biomaterials, resulting in a diminished microbial killing capacity, which can increase the probability of device-centered infections. (c) 2006 Wiley Periodicals, Inc. J Biomed Mater Res 80A: 381-390, 2007.
C1 Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
RP Anderson, JM (reprint author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
EM jma6@po.cwru.edu
FU NIBIB NIH HHS [EB-00279]
CR Anstey NM, 1996, J EXP MED, V184, P557, DOI 10.1084/jem.184.2.557
   Babior BM, 2002, ARCH BIOCHEM BIOPHYS, V397, P342, DOI 10.1006/abbi.2001.2642
   BECKMAN JS, 1992, ARCH BIOCHEM BIOPHYS, V298, P438, DOI 10.1016/0003-9861(92)90432-V
   Denicola A, 1998, P NATL ACAD SCI USA, V95, P3566, DOI 10.1073/pnas.95.7.3566
   EVANS TG, 1993, J IMMUNOL, V151, P907
   Evans TJ, 1996, P NATL ACAD SCI USA, V93, P9553, DOI 10.1073/pnas.93.18.9553
   GIRIDHAR G, 1995, J BIOMED MATER RES, V29, P1179, DOI 10.1002/jbm.820291004
   GIRIDHAR G, 1993, BIOMATERIALS, V14, P609, DOI 10.1016/0142-9612(93)90180-A
   GRAY ED, 1984, LANCET, V1, P365
   GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423
   GRISTINA AG, 1987, BIOMATERIALS, V8, P423, DOI 10.1016/0142-9612(87)90077-9
   Higashi JM, 1999, HDB BIOMATERIALS EVA, P493
   HOFFSTEIN ST, 1985, LAB INVEST, V52, P515
   ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P431, DOI 10.1016/0003-9861(92)90431-U
   Itoh Y, 2000, ANAL BIOCHEM, V287, P203, DOI 10.1006/abio.2000.4859
   KAPLAN SS, 1992, J BIOMED MATER RES, V26, P1039, DOI 10.1002/jbm.820260806
   KLEINSTREUER C, 1997, ENG FLUID DYNAMICS
   KLOCK JC, 1976, BLOOD, V48, P149
   Kojima H, 1999, ANGEW CHEM INT EDIT, V38, P3209, DOI 10.1002/(SICI)1521-3773(19991102)38:21<3209::AID-ANIE3209>3.0.CO;2-6
   LANGREHR JM, 1992, J CLIN INVEST, V90, P679, DOI 10.1172/JCI115911
   Larfars G, 1998, J LAB CLIN MED, V132, P54, DOI 10.1016/S0022-2143(98)90025-7
   LEVICH VG, 1962, PHYSICOCHEMICAL HYDR
   MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323
   MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243
   Nagano T, 1999, LUMINESCENCE, V14, P283, DOI 10.1002/(SICI)1522-7243(199911/12)14:6<283::AID-BIO572>3.0.CO;2-G
   OCHOA JB, 1991, ANN SURG, V214, P621, DOI 10.1097/00000658-199111000-00013
   Ou JH, 1997, NITRIC OXIDE-BIOL CH, V1, P404, DOI 10.1006/niox.1997.0136
   Patel JD, 2003, J BIOMAT SCI-POLYM E, V14, P279, DOI 10.1163/156856203763572725
   PRYOR WA, 1993, ANN NY ACAD SCI, V686, P12, DOI 10.1111/j.1749-6632.1993.tb39148.x
   Rees D. D., 1999, NITRIC OXIDE INFECT, P151
   REILING N, 1994, EUR J IMMUNOL, V24, P1941, DOI 10.1002/eji.1830240836
   Sethi S, 2000, THROMB RES, V100, P223, DOI 10.1016/S0049-3848(00)00320-0
   Shive MS, 1999, J BIOMED MATER RES, V46, P511, DOI 10.1002/(SICI)1097-4636(19990915)46:4<511::AID-JBM9>3.0.CO;2-M
   Shive MS, 2000, P NATL ACAD SCI USA, V97, P6710, DOI 10.1073/pnas.110463197
   Stenger S, 1996, J EXP MED, V183, P1501, DOI 10.1084/jem.183.4.1501
   STOSSEL TP, 1971, J CLIN INVEST, V50, P1745, DOI 10.1172/JCI106664
   Stuehr DJ, 1999, BBA-BIOENERGETICS, V1411, P217, DOI 10.1016/S0005-2728(99)00016-X
   Sugarman B, 1989, Infect Dis Clin North Am, V3, P187
   TOJO M, 1988, J INFECT DIS, V157, P713, DOI 10.1093/infdis/157.4.713
   vanderVliet A, 1996, METHOD ENZYMOL, V269, P175
   Viera L, 1999, METHOD ENZYMOL, V301, P373
   Wootton DM, 1999, ANNU REV BIOMED ENG, V1, P299, DOI 10.1146/annurev.bioeng.1.1.299
   Xia Y, 1997, P NATL ACAD SCI USA, V94, P6954, DOI 10.1073/pnas.94.13.6954
   Ye YZ, 1996, METHOD ENZYMOL, V269, P201
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487
NR 45
TC 21
Z9 22
U1 1
U2 9
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2007
VL 80A
IS 2
BP 381
EP 390
DI 10.1002/jbm.a.30907
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 125PW
UT WOS:000243455300013
PM 17001645
DA 2018-10-20
ER

PT J
AU Chang, CF
   Lee, MW
   Kuo, PY
   Wang, YJ
   Tu, YH
   Hung, SC
AF Chang, Ching-Fang
   Lee, Ming-Wei
   Kuo, Pei-Yin
   Wang, Yng-Jiin
   Tu, Yi-Hsien
   Hung, Shih-Chieh
TI Three-dimensional collagen fiber remodeling by mesenchymal stem cells
   requires the integrin-matrix interaction
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE remodeling; mesenchymal stem cells; biomaterials; type II collagen;
   chondrogenesis; integrin; matrix
ID VITRO CARTILAGE FORMATION; BONE-MARROW; IN-VITRO; TISSUE; SCAFFOLDS;
   DIFFERENTIATION; CHONDROGENESIS; REGENERATION; ALGINATE; POROSITY
AB Tissue engineering aiming to repair or regenerate damaged tissues necessitates fabricating three-dimensional biomaterial scaffolds with controlled porosity for delivering cells. To facilitate cell distribution, a strategy using stem cell-based fabrication of biomaterials was tested in type II collagen fibers. Human mesenchymal stem cells when delivered in type II collagen assembled and reorganized these matrices and differentiated into spherical chondrocytes with the synthesis of cartilage proteins. The cell-mediated assembly and reorganization of collagen fibers was not limitless and only restricted to an appropriate ratio of cell number and collagen amount. The blocking of alpha 2 or beta 1-integrin function with specific antibodies significantly impeded the collagen-assembly effects. In vitro chondrogenesis or in vivo cartilage formation of human mesenchymal stem cells was also dependent on the interactions between cells and surrounding matrices. This method for three-dimensional fabricating collagen fibers may generally be applied to other biomaterials, when combined with surface modification or ligand addition for cell adhesion. (c) 2006 Wiley Periodicals, Inc.
C1 Vet Gen Hosp, Stem Cell Lab, Taipei 112, Taiwan.
   Natl Yang Ming Univ, Inst Anat & Cell Biol, Taipei 112, Taiwan.
   Natl Yang Ming Univ, Inst Biomed Engn, Taipei 112, Taiwan.
   Vet Gen Hosp, Dept Orthopaed & Traumatol, Taipei 112, Taiwan.
   Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan.
RP Hung, SC (reprint author), Vet Gen Hosp, Stem Cell Lab, 201,Sec 2,Shih Pai Rd, Taipei 112, Taiwan.
EM hungsc@vghtpe.gov.tw
CR Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   De Bari C, 2004, ARTHRITIS RHEUM-US, V50, P142, DOI 10.1002/art.11450
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Hu YH, 2003, J BIOMED MATER RES A, V64A, P583, DOI 10.1002/jbm.a.10438
   Hung SC, 2002, STEM CELLS, V20, P249, DOI 10.1634/stemcells.20-3-249
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Ichinose S, 2005, CELL TISSUE RES, V322, P217, DOI 10.1007/s00441-005-1140-6
   Katoh K, 2004, BIOMATERIALS, V25, P4255, DOI 10.1016/j.biomaterials.2003.11.018
   Li SH, 2003, TISSUE ENG, V9, P535, DOI 10.1089/107632703322066714
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Luo Y, 2004, NAT MATER, V3, P249, DOI 10.1038/nmat1092
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Ma HL, 2005, J BIOMED MATER RES A, V74A, P439, DOI 10.1002/jbm.a.30314
   Ma HL, 2003, J BIOMED MATER RES A, V64A, P273, DOI 10.1002/jbm.a.10370
   Meshel AS, 2005, NAT CELL BIOL, V7, P157, DOI 10.1038/ncb1216
   Mizuno M, 2000, J CELL PHYSIOL, V184, P207, DOI 10.1002/1097-4652(200008)184:2<207::AID-JCP8>3.3.CO;2-L
   Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149
   Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751
   Phillips JA, 2005, EXP CELL RES, V310, P79, DOI 10.1016/j.yexcr.2005.03.039
   Pieper JS, 2002, BIOMATERIALS, V23, P3183, DOI 10.1016/S0142-9612(02)00067-4
   Shi ST, 2002, NAT BIOTECHNOL, V20, P587, DOI 10.1038/nbt0602-587
   Tadic D, 2004, BIOMATERIALS, V25, P3335, DOI 10.1016/j.biomaterials.2003.10.007
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   THOROGOOD PV, 1975, J EMBRYOL EXP MORPH, V33, P581
   Yokoyama A, 2005, CELL TISSUE RES, V322, P289, DOI 10.1007/s00441-005-0010-6
   Zimmermann WH, 2004, BIOMATERIALS, V25, P1639, DOI 10.1016/S0142-9612(03)00521-0
NR 26
TC 31
Z9 31
U1 0
U2 5
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2007
VL 80A
IS 2
BP 466
EP 474
DI 10.1002/jbm.a.30963
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 125PW
UT WOS:000243455300022
PM 17013867
DA 2018-10-20
ER

PT J
AU Develioglu, H
   Saraydin, SU
   Dupoirieux, L
   Sahin, ZD
AF Develioglu, Hakan
   Unver Saraydin, Serpil
   Dupoirieux, Laurent
   Deniz Sahin, Zeynep
TI Histological findings of long-term healing of the experimental defects
   by application of a synthetic biphasic ceramic in rats
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE synthetic materials; critical-sized defect; bone formation; rat
ID CALCIUM-PHOSPHATE CERAMICS; MULTINUCLEATED GIANT-CELLS; BONE;
   HYDROXYAPATITE; BIOMATERIALS; PARTICLES; SKELETON; FORMS; MODEL
AB Calcium phosphate ceramics are generally biocompatible and can develop interactions with human recipient bone. Therefore, they can be widely used in the field of periodontology and dentistry. The purpose of this investigation was to assess the long-term histological bone healing results of experimentally created critical size parietal bone defects in rats. Twelve Wistar rats were used in this investigation. Two 6-mm wide, symmetrical, and circular critical size defects were created in each parietal bone of the animals. While the right defects filled with granular implant (Ceraform (R)), the symmetrical defects were taken as controls. Eighteen months after implantation, rats were killed and defects including the biomaterial with surrounding bone was taken for histological examination. Serial histological sections were cut across the defects and stained for the histological analysis. Both control and Ceraform implanted regions contained dense collagenous tissue. In the implantation site, multinuclear giant cells were observed around the material. On the other hand, there were no necrosis, tumour, and infection in the implantation region. There was no statistical difference between the control and ceraform implanted groups when the bone formation results were compared (p > 0.05). In conclusion, the results revealed that this material is biocompatible and does enhance the new bone building despite the long-term observation period. Although this biphasic ceramic shows within the limits of the study as a less resorptive and not osteoconductive properties, it can be considered as a biocompatible bone defect filling material having a limited application alternative in dentistry and medicine. (c) 2006 Wiley Periodicals, Inc.
C1 Cumhuriyet Univ, Fac Med, Dept Histol & Embryol, Sivas, Turkey.
   Cumhuriyet Univ, Fac Dent, Dept Periodontol, Sivas, Turkey.
   Polyclin Marmandais, Marmande, France.
RP Saraydin, SU (reprint author), Cumhuriyet Univ, Fac Med, Dept Histol & Embryol, Sivas, Turkey.
EM usaraydin@cumhuriyet.edu.tr
CR Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008
   BASLE MF, 1993, CALCIFIED TISSUE INT, V53, P348, DOI 10.1007/BF01351842
   BELL DH, 1986, J PROSTHET DENT, V56, P322, DOI 10.1016/0022-3913(86)90013-2
   BLOCK MS, 1986, J ORAL MAXIL SURG, V44, P89, DOI 10.1016/0278-2391(86)90187-4
   BOSCH C, 1995, CLEFT PALATE-CRAN J, V269, P284
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   DACULSI G, 1990, CALCIFIED TISSUE INT, V46, P20, DOI 10.1007/BF02555820
   DACULSI G, 1989, J BIOMED MATER RES, V23, P883, DOI 10.1002/jbm.820230806
   DACULSI G, 1990, BIOMATERIALS, V11, P86
   Daculsi G, 2003, J MATER SCI-MATER M, V14, P195, DOI 10.1023/A:1022842404495
   DERSOT JM, 1993, CELL MATER, V3, P395
   Develioglu H, 2006, J BIOMED MATER RES A, V77A, P627, DOI 10.1002/jbm.a.30692
   Develioglu Hakan, 2005, J Oral Implantol, V31, P309, DOI 10.1563/1548-1336(2005)31[309:TEOABC]2.0.CO;2
   FRAYSSINET P, 1993, CELL MATER, V3, P383
   Le Guehennec L, 2005, J BIOMED MATER RES B, V72B, P69, DOI 10.1002/jbm.b.30118
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Matheson LA, 2004, J CELL PHYSIOL, V199, P8, DOI 10.1002/jcp.10412
   Merkx MAW, 1999, BIOMATERIALS, V20, P2029, DOI 10.1016/S0142-9612(99)00105-2
   Naaman NBA, 1998, INT J ORAL MAX IMPL, V13, P115
   NAJJAR TA, 1977, J ORAL SURG, V35, P375
   NERY EB, 1992, J PERIODONTOL, V63, P629
   Piattelli A, 1996, BIOMATERIALS, V17, P1767, DOI 10.1016/0142-9612(95)00342-8
   REY C, 1990, Biomaterials, V11, P13
   SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299
   WINTER M, 1981, BIOMATERIALS, V2, P159, DOI 10.1016/0142-9612(81)90043-0
   Yuan HP, 2002, J MATER SCI-MATER M, V13, P1271, DOI 10.1023/A:1021191432366
NR 26
TC 11
Z9 11
U1 0
U2 1
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2007
VL 80A
IS 2
BP 505
EP 508
DI 10.1002/jbm.a.31121
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 125PW
UT WOS:000243455300027
PM 17120224
DA 2018-10-20
ER

PT J
AU Jalota, S
   Bhaduri, SB
   Tas, AC
AF Jalota, Sahil
   Bhaduri, Sarit B.
   Tas, A. Cuneyt
TI A new rhenanite (beta-NaCaPO4) and hydroxyapatite biophasic biomaterial
   for skeletal repair
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Review
DE bioresorbable; rhenanite; hydroxylapatite; calcium phosphate(s); bone
   graft
ID CALCIUM-PHOSPHATE CERAMICS; POORLY CRYSTALLINE APATITE; SYNTHETIC
   BODY-FLUIDS; X-RAY-DIFFRACTION; TRICALCIUM PHOSPHATE; HUMAN BONE;
   IN-VIVO; OCTACALCIUM PHOSPHATE; CHEMICAL PREPARATION; BIOCERAMIC POWDERS
AB Biphasic beta-rhenanite (beta-NaCaPO4)-hydroxyapatite (Ca-10(PO4)(6)(OH)(2)) biomaterials were prepared by using a one-pot, solution-based synthesis procedure at the physiological pH of 7.4, followed by low-temperature (300-600 degrees C) calcination in air for 6 h. Calcination was for the sole purpose of crystallization. An aqueous solution of Ca(NO3)(2)(.) 4H(2)O was rapidly added to a solution of Na2HPO4 and NaHCO3, followed by immediate removal of gel-like, poorly-crystallized precursor precipitates from the mother liquors of pH 7.4. Freeze-dried precursors were found to be nanosize with an average particle size of 45 nm and a surface area of 128 m(2)/g. Upon calcination in air, precursor powders crystallized into biphasic (60% HA-40% rhenanite) biomaterials, while retaining their submicron particle sizes and high surface areas. beta-rhenanite is a high solubility sodium calcium phosphate phase. Samples were characterized by XRD, FTIR, SEM, TEM, ICP-AES, TG, DTA, DSC, and surface area measurements. (c) 2006 Wiley Periodicals, Inc.
C1 Clemson Univ, Sch Mat Sci & Engn, Clemson, SC 29634 USA.
RP Tas, AC (reprint author), Mersin Univ, Dept Mat Engn, TR-33342 Mersin, Turkey.
EM actas@mersin.edu.tr
RI Tas, A. Cuneyt/B-1966-2008
CR APEL E, Patent No. 20040167006
   Bayraktar D, 1999, J EUR CERAM SOC, V19, P2573, DOI 10.1016/S0955-2219(99)00132-6
   Benaziz L, 2001, J COLLOID INTERF SCI, V238, P48, DOI 10.1006/jcis.2001.7450
   BERMUDEZ O, 1994, BIOMATERIALS, V15, P1019, DOI 10.1016/0142-9612(94)90084-1
   BETTS F, 1975, P NATL ACAD SCI USA, V72, P2088, DOI 10.1073/pnas.72.6.2088
   *BIOM INC, 2006, CALC NAP BON VOID FI
   Bloemers FW, 2003, J BIOMED MATER RES B, V66B, P526, DOI 10.1002/jbm.b.10045
   BLUMENTH.NC, 1972, MATER RES BULL, V7, P1181, DOI 10.1016/0025-5408(72)90097-9
   BLUMENTHAL NC, 1975, CALC TISS RES, V18, P81, DOI 10.1007/BF02546228
   BOSKEY AL, 1974, MATER RES BULL, V9, P907, DOI 10.1016/0025-5408(74)90169-X
   Cazalbou S, 2004, J BONE MINER METAB, V22, P310, DOI 10.1007/s00774-004-0488-0
   DOI Y, 1993, J DENT RES, V72, P1279, DOI 10.1177/00220345930720090401
   Doi Y, 2001, BIOMATERIALS, V22, P847, DOI 10.1016/S0142-9612(00)00248-9
   DRIESSENS FCM, 1992, J MATER SCI-MATER M, V3, P413, DOI 10.1007/BF00701237
   EANES E. D., 1967, CLIN ORTHOP RELATED RESIN COMPLICATIONS OF ORTHOPAEDIC SURGERY, V53, P223
   EANES ED, 1976, CALC TISS RES, V20, P75, DOI 10.1007/BF02546399
   EANES ED, 1977, CALC TISS RES, V23, P259, DOI 10.1007/BF02012795
   EANES ED, 1973, CALC TISS RES, V12, P143, DOI 10.1007/BF02013730
   *EBI LP, 2006, OST RES BON GRAFT SU
   EBRAHIMPOUR A, 1993, J COLLOID INTERF SCI, V159, P158, DOI 10.1006/jcis.1993.1307
   El-Ghannam AR, 2004, J BIOMED MATER RES A, V69A, P490, DOI 10.1002/jbm.a.30022
   Elliott JC, 1994, STRUCTURE CHEM APATI
   Eppley BL, 2002, J CRANIOFAC SURG, V13, P681, DOI 10.1097/01.SCS.0000026423.83739.44
   GLASSER FP, 1982, Patent No. 4363650
   Gong WL, 2001, J BIOMED MATER RES, V54, P320, DOI 10.1002/1097-4636(20010305)54:3<320::AID-JBM20>3.0.CO;2-E
   Goyenvalle E, 2003, J MATER SCI-MATER M, V14, P219, DOI 10.1023/A:1022876522242
   GREENFIELD DJ, 1974, CALC TISS RES, V14, P131, DOI 10.1007/BF02060289
   GREENFIELD DJ, 1972, CALC TISS RES, V9, P152, DOI 10.1007/BF02061953
   HATA K, 1995, J AM CERAM SOC, V78, P1049, DOI 10.1111/j.1151-2916.1995.tb08435.x
   Hiller JC, 2003, BIOMATERIALS, V24, P5091, DOI 10.1016/S0142-9612(03)00427-7
   Hing KA, 2004, J BIOMED MATER RES A, V68A, P187, DOI 10.1002/jbm.a.10050
   Hoshikawa A, 2003, BIOMATERIALS, V24, P4967, DOI 10.1016/S0142-9612(03)00422-8
   *ICDD PDF, 291193 ICDD PDF
   INSKEEP WP, 1988, GEOCHIM COSMOCHIM AC, V52, P1883, DOI 10.1016/0016-7037(88)90012-9
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   JOHANSEN E, 1960, J BIOPHYS BIOCHEM CY, V7, P743, DOI 10.1083/jcb.7.4.743
   Joschek S, 2000, BIOMATERIALS, V21, P1645, DOI 10.1016/S0142-9612(00)00036-3
   Kamakura S, 2002, J BIOMED MATER RES, V59, P29, DOI 10.1002/jbm.1213.abs
   KANGASNIEMI IMO, 1992, J BIOMED MATER RES, V26, P663, DOI 10.1002/jbm.820260508
   KANGASNIEMI IMO, 1993, J BIOMED MATER RES, V27, P1225, DOI 10.1002/jbm.820271003
   KILIAN O, 2002, BIOMATERIALIEN, V3, P126
   Kim HM, 2001, J BIOMED MATER RES, V56, P250, DOI 10.1002/1097-4636(200108)56:2<250::AID-JBM1092>3.0.CO;2-S
   Kivrak N, 1998, J AM CERAM SOC, V81, P2245
   Knaack D, 1998, J BIOMED MATER RES, V43, P399, DOI 10.1002/(SICI)1097-4636(199824)43:4<399::AID-JBM7>3.0.CO;2-J
   Knabe C, 2004, BIOMATERIALS, V25, P335, DOI 10.1016/S0142-9612(03)00525-8
   Knabe C, 1997, BIOMATERIALS, V18, P1339, DOI 10.1016/S0142-9612(97)00078-1
   Kurashina K, 2002, BIOMATERIALS, V23, P407, DOI 10.1016/S0142-9612(01)00119-3
   Kwon SH, 2003, J EUR CERAM SOC, V23, P1039, DOI 10.1016/S0955-2219(02)00263-7
   Le Nihouannen D, 2005, BONE, V36, P1086, DOI 10.1016/j.bone.2005.02.017
   LEE DD, 2001, Patent No. 6331312
   LEGEROS RZ, 1993, INTRO BIOCERAMICS, P144
   Lin SY, 2004, J BIOMED MATER RES B, V70B, P203, DOI 10.1002/jbm.b.30067
   Loong CK, 2000, BONE, V26, P599, DOI 10.1016/S8756-3282(00)00273-8
   MADSEN HEL, 1984, J CRYST GROWTH, V66, P369
   METSGER DS, 1982, J AM DENT ASSOC, V105, P1035, DOI 10.14219/jada.archive.1982.0408
   MOLNAR Z, 1959, J ULTRA MOL STRUCT R, V3, P39, DOI 10.1016/S0022-5320(59)80012-5
   MOLNAR Z, 1960, CLIN ORTHOP RELAT R, V17, P38
   MULLERMAI CM, 1995, J BIOMED MATER RES, V29, P9, DOI 10.1002/jbm.820290103
   Nakahira A, 2003, J APPL PHYS, V93, P8513, DOI 10.1063/1.1557832
   NEUMAN WF, 1958, CHEM DYNAMICS BONE M
   NICHOLAS RW, 1994, CLIN ORTHOP RELAT R, V306, P197
   Nunes CR, 1997, J BIOMED MATER RES, V36, P560
   NYLEN MU, 1972, CALC TISS RES, V9, P95, DOI 10.1007/BF02061948
   PLESHKO N, 1991, BIOPHYS J, V60, P786, DOI 10.1016/S0006-3495(91)82113-0
   POSNER AS, 1963, ARCH ORAL BIOL, V8, P549, DOI 10.1016/0003-9969(63)90071-2
   POSNER AS, 1952, J DENT RES, V31, P371, DOI 10.1177/00220345520310031501
   POSNER AS, 1969, PHYSIOL REV, V49, P760
   Quizat S, 1999, MATER RES BULL, V34, P2279
   RAMSELAAR MMA, 1993, J MATER SCI-MATER M, V4, P311, DOI 10.1007/BF00122287
   RAMSELAAR MMA, 1991, J MATER SCI-MATER M, V2, P63, DOI 10.1007/BF00703460
   REY C, 1991, CALCIFIED TISSUE INT, V49, P383, DOI 10.1007/BF02555847
   REY C, 1991, J BONE MINER RES, V6, P515
   Rey C, 1995, CELL MATER, V5, P345
   ROBINSON RA, 1955, ANN NY ACAD SCI, V60, P596, DOI 10.1111/j.1749-6632.1955.tb40054.x
   ROBINSON RA, 1952, ANAT REC, V114, P383, DOI 10.1002/ar.1091140302
   Rogers KD, 2002, BIOMATERIALS, V23, P2577, DOI 10.1016/S0142-9612(01)00395-7
   Schmitz JP, 1999, J ORAL MAXIL SURG, V57, P1122, DOI 10.1016/S0278-2391(99)90338-5
   SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, V205, P299
   Skrtic D, 2004, BIOMATERIALS, V25, P1141, DOI 10.1016/j.biomaterials.2003.08.001
   Somrani S, 2003, J MATER CHEM, V13, P888, DOI 10.1039/b210900j
   SPECTOR M, 1994, CLIN PLAST SURG, V21, P437
   Spoerke ED, 2005, BIOMATERIALS, V26, P5120, DOI 10.1016/j.biomaterials.2005.01.039
   STUTMAN JM, 1962, NATURE, V193, P368, DOI 10.1038/193368a0
   Suchanek W, 1998, J EUR CERAM SOC, V18, P1923, DOI 10.1016/S0955-2219(98)00131-9
   Szpalski M, 2002, ORTHOPEDICS, V25, pS601
   Tang RK, 2003, J COLLOID INTERF SCI, V260, P379, DOI 10.1016/S0021-9797(03)00048-12
   Tas AC, 2000, J AM CERAM SOC, V83, P2954, DOI 10.1111/j.1151-2916.2000.tb01666.x
   Tas AC, 2000, BIOMATERIALS, V21, P1429
   Tas AC, 2000, J EUR CERAM SOC, V20, P2389, DOI 10.1016/S0955-2219(00)00129-1
   Tas AC, 2004, J AM CERAM SOC, V87, P2195, DOI 10.1111/j.1151-2916.2004.tb07490.x
   Tas AC, 2004, KEY ENG MAT, V264-268, P1969, DOI 10.4028/www.scientific.net/KEM.264-268.1969
   Tas AC, 2004, J MATER RES, V19, P2742, DOI 10.1557/JMR.2004.0349
   TERMINE J. D., 1967, CALCIFIED TISSUE RES, V1, P8, DOI 10.1007/BF02008070
   TERMINE JD, 1972, CALC TISS RES, V10, P171, DOI 10.1007/BF02012548
   Tofighi A, 2000, KEY ENG MAT, V192-1, P769
   Wenisch S, 2003, J BIOMED MATER RES A, V67A, P713, DOI 10.1002/jbm.a.10091
   WU YT, 1994, J MOL BIOL, V244, P423, DOI 10.1006/jmbi.1994.1740
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
   Yuan HP, 2002, J MATER SCI-MATER M, V13, P1271, DOI 10.1023/A:1021191432366
   Yuan HP, 1998, J MATER SCI-MATER M, V9, P723, DOI 10.1023/A:1008950902047
   ZHOU JM, 1993, J MATER SCI-MATER M, V4, P83, DOI 10.1007/BF00122983
NR 101
TC 22
Z9 24
U1 1
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD FEB
PY 2007
VL 80B
IS 2
BP 304
EP 316
DI 10.1002/jbm.b.30598
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 131KA
UT WOS:000243866500004
PM 16767721
DA 2018-10-20
ER

PT J
AU Dallan, PRM
   Moreira, PD
   Petinari, L
   Malmonge, SM
   Beppu, MM
   Genari, SC
   Moraes, AM
AF Marreco Dallan, Paula Rulf
   da Luz Moreira, Patricia
   Petinari, Leandro
   Malmonge, Sonia Maria
   Beppu, Marisa Masumi
   Genari, Selma Candelaria
   Moraes, Angela Maria
TI Effects of chitosan solution concentration and incorporation of chitin
   and glycerol on dense chitosan membrane properties
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE chitin; chitosan; glycerol; membrane; burn dressing
ID IN-VITRO; MECHANICAL-PROPERTIES; PHYSICAL-PROPERTIES; SKIN SUBSTITUTES;
   FILMS; SCAFFOLDS; FIBROBLASTS; DEGRADATION; DERIVATIVES; FABRICATION
AB The aim of this work was to perform a systematic study about the effects induced by chitosan solution concentration and by chitin or glycerol incorporation on dense chitosan membranes with potential use as burn dressings. The membrane properties analyzed were total raw material cost, thickness, morphology, swelling ratio, tensile strength, percentage of strain at break, crystallinity, in vitro enzymatic degradation with lysozyme, and in vitro Vero cells adhesion. While the use of the most concentrated chitosan solution (2.5% w/w) increased membrane cost, it also improved the biomaterial mechanical resistance and ductility, as well as reduced membrane degradation when exposed for 2 months to llysozyme. The remaining evaluated properties were not affected by initial chitosan solution concentration. Chitin incorporation, on the other hand, reduced the membranes cost, swelling ratio, mechanical properties, and crystallinity, resulting in thicker biomaterials with irregular surface more easily degradable when exposed to lysozyme. Glycerol incorporation also reduced the membranes cost and crystallinity and increased membranes degradability after exposure to lysozyme. Strong Vero cells adhesion was not observed in any of the tested membrane formulations. The overall results indicate that the majority of the prepared membranes meet the performance requirements of temporary nonbiodegradable burn dressings (e.g. adequate values of mechanical resistance and ductility, low values of in vitro cellular adhesion on their surfaces, low extent of degradation when exposed to lysozyme solution, and high stability in aqueous solutions). (c) 2006 Wiley Periodicals, Inc.
C1 Univ Estadual Campinas, Sch Chem Engn, Dept Biotechnol Proc, BR-13081970 Campinas, SP, Brazil.
   Univ Estadual Campinas, Inst Biol, Dept Cellular Biol, BR-13094970 Campinas, SP, Brazil.
   Univ Estadual Campinas, Sch Chem Engn, Dept Thermofluiddynam, BR-13081970 Campinas, SP, Brazil.
   UNIMEP, Sch Engn Architecture & Urbanism, BR-13450000 Santa Barbara Doeste, SP, Brazil.
RP Moraes, AM (reprint author), Univ Estadual Campinas, Sch Chem Engn, Dept Biotechnol Proc, POB 6066, BR-13081970 Campinas, SP, Brazil.
EM ammoraes@feq.unicamp.br
RI Malmonge, Sonia/I-4610-2012; BEPPU, MARISA/E-1057-2012; Moraes,
   Angela/K-5181-2012
OI Moraes, Angela/0000-0002-5813-332X
CR Averbach BL, 1978, P 1 INT C CHIT CHIT, P199
   Azad AK, 2004, J BIOMED MATER RES B, V69B, P216, DOI 10.1002/jbm.b.30000
   Balasubramani M, 2001, BURNS, V27, P534, DOI 10.1016/S0305-4179(01)00018-3
   Brown CD, 2001, J CONTROL RELEASE, V72, P35, DOI 10.1016/S0168-3659(01)00260-7
   Cervera MF, 2004, EUR J PHARM BIOPHARM, V58, P69, DOI 10.1016/j.ejpb.2004.03.015
   CERVERA MF, 2004, AAPS PHARM SCI TECH, V5
   Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   Cheng MY, 2003, BIOMATERIALS, V24, P2871, DOI 10.1016/S0142-9612(03)00117-0
   Chupa JM, 2000, BIOMATERIALS, V21, P2315, DOI 10.1016/S0142-9612(00)00158-7
   Dewez JL, 1998, BIOMATERIALS, V19, P1441, DOI 10.1016/S0142-9612(98)00055-6
   Hansen B, 2002, ARCH DERMATOL, V138, P909, DOI 10.1001/archderm.138.7.909
   HUBELL JA, 1995, BIOTECHNOLOGY, V13, P565
   Khan TA, 2000, J PHARM PHARM SCI, V3, P303
   Kweon H, 2001, J APPL POLYM SCI, V80, P928, DOI 10.1002/app.1172
   LEVENSON SM, 1965, ANN SURG, V161, P293, DOI 10.1097/00000658-196502000-00019
   LIM LY, 2001, DEV CHITIN CHITOSAN
   LYNDON MJ, 1985, BIOMAT, V6, P396
   Ma JB, 2001, BIOMATERIALS, V22, P331, DOI 10.1016/S0142-9612(00)00188-5
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Mao JS, 2003, BIOMATERIALS, V24, P1621, DOI 10.1016/S0142-9612(02)00549-5
   Marreco PR, 2004, J BIOMED MATER RES B, V71B, P268, DOI 10.1002/jbm.b.30081
   Mi FL, 2001, BIOMATERIALS, V22, P165, DOI 10.1016/S0142-9612(00)00167-8
   Mi FL, 2003, J MEMBRANE SCI, V212, P237, DOI 10.1016/S0376-7388(02)00505-7
   MU Y, 1999, TSINGHUA SCI TECHNOL, V4, P1578
   MUZZARELLI R, 1988, BIOMATERIALS, V9, P247, DOI 10.1016/0142-9612(88)90092-0
   Paul W., 2004, TRENDS BIOMATERIALS, V18, P18
   Qu X, 2000, POLYMER, V41, P4841, DOI 10.1016/S0032-3861(99)00704-1
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   Risbud M, 2000, J BIOSCIENCES, V25, P25, DOI 10.1007/BF02985178
   Santos AR, 2001, ARTIF ORGANS, V25, P7, DOI 10.1046/j.1525-1594.2001.025001007.x
   Senel S, 2004, ADV DRUG DELIVER REV, V56, P1467, DOI 10.1016/j.addr.2004.02.007
   Sheridan RL, 1999, BURNS, V25, P97, DOI 10.1016/S0305-4179(98)00176-4
   Silver F.H., 1994, BIOMATERIALS MED DEV, P46
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   *US C OFF TECHN AS, 1993, OTABPE102 US C, P39
   Wang LH, 2002, J BIOMED MATER RES, V63, P610, DOI 10.1002/jbm.10382
   WISNIEWSKAWRONA M, 2002, FIBRES TEXT EAST EUR, V38, P82
   Wu YB, 2004, CARBOHYD POLYM, V57, P435, DOI 10.1016/j.carbpol.2004.05.013
   Xia WY, 2004, J BIOMED MATER RES B, V71B, P373, DOI 10.1002/jbm.b.30087
   Yang JM, 2004, J MEMBRANE SCI, V236, P39, DOI 10.1016/j.memsci.2004.02.005
   Yang JM, 2004, J MEMBRANE SCI, V243, P1, DOI 10.1016/j.memsci.2004.03.019
   YOSOF NLB, 2001, J BIOMED MATER RES, V54, P59
   Zhang M, 2002, BIOMATERIALS, V23, P2641, DOI 10.1016/S0142-9612(01)00403-3
NR 44
TC 18
Z9 18
U1 1
U2 13
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD FEB
PY 2007
VL 80B
IS 2
BP 394
EP 405
DI 10.1002/jbm.b.30610
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 131KA
UT WOS:000243866500015
PM 16850463
DA 2018-10-20
ER

PT J
AU Le Nihouannen, D
   Saffarzadeh, A
   Aguado, E
   Goyenvalle, E
   Gauthier, O
   Moreau, F
   Pilet, P
   Spaethe, R
   Daculsi, G
   Layrolle, P
AF Le Nihouannen, Damien
   Saffarzadeh, Afchine
   Aguado, Eric
   Goyenvalle, Eric
   Gauthier, Olivier
   Moreau, Francoise
   Pilet, Paul
   Spaethe, Reiner
   Daculsi, Guy
   Layrolle, Pierre
TI Osteogenic properties of calcium phosphate ceramics and fibrin glue
   based composites
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 20th Conference of the European-Society-for-Biomaterials
CY SEP 27-OCT 01, 2006
CL Nantes, FRANCE
SP European Soc Biomat
ID STEM-CELL TRANSPLANTATION; BONE-FORMATION; BIOLOGICAL PERFORMANCE;
   IN-VIVO; GRANULES; PARTICLES; SEALANT; OSTEOINDUCTION; BIOMATERIALS;
   REGENERATION
AB Calcium phosphate (Ca-P) ceramics are currently used in various types of orthopaedic and maxillofacial applications because of their osteoconductive properties. Fibrin glue is also used in surgery due to its haemostatic, chemotactic and mitogenic properties and also as scaffolds for cell culture and transplantation. In order to adapt to surgical sites, bioceramics are shaped in blocks or granules and preferably in porous forms. Combining these bioceramics with fibrin glue provides a mouldable and self-hardening composite biomaterial. The aim of this work is to study the osteogenic properties of this composite material using two different animal models. The formation of newly formed bone (osteoinduction) and bone healing capacity (osteconduction) have been study in the paravertebral muscles of sheep and in critical sized defects in the femoral condyle of rabbits, respectively. The different implantations sites were filled with composite material associating Ca-P granules and fibrin glue. Ca-P granules of 1-2 mm were composed with 60% of hydroxyapatite and 40% of beta tricalcium phosphate in weight. The fibrin glue was composed of fibrinogen, thrombin and other biological factors. After both intramuscular or intraosseous implantations for 24 weeks and 3, 6, 12 and 24 weeks, samples were analyzed using histology and histomorphometry and mechanical test. In all cases, the newly formed bone was observed in close contact and around the ceramic granules. Depending on method of quantification, 6.7% (with BSEM) or 17% (with mu CT) of bone had formed in the sheep muscles and around 40% in the critical sized bone rabbit defect after 24 weeks. The Ca-P/fibrin material could be used for filling bone cavities in various clinical indications.
C1 INSERM, U791, Nantes, France.
   Univ Nantes, Fac Chirurg Dent, Lab Ingn Osteoarticulaire & Dent, F-44042 Nantes, France.
   Ecole Natl Vet, Serv Chirurg, F-44307 Nantes, France.
   INSERM, RIO IFR, F-44042 Nantes, France.
   Baxter BioSci BioSurg, Vienna, Austria.
RP Le Nihouannen, D (reprint author), INSERM, U791, Nantes, France.
EM damien.lenihouannen@mcgill.ca
RI Daculsi, Guy/P-1320-2014; Paul, Pilet/A-3755-2015; Gauthier,
   Olivier/A-4639-2015; Layrolle, Pierre/K-9257-2015
OI Daculsi, Guy/0000-0003-1030-3446; Layrolle, Pierre/0000-0001-9800-5210
CR Abiraman S, 2002, BIOMATERIALS, V23, P3023, DOI 10.1016/S0142-9612(02)00064-9
   Albala DM, 2003, CARDIOVASC SURG, V11, P5, DOI 10.1016/S0967-2109(03)00065-6
   Barrere F, 2003, J BIOMED MATER RES A, V66A, P779, DOI 10.1002/jbm.a.10454
   Bensaid W, 2003, BIOMATERIALS, V24, P2497, DOI 10.1016/S0142-9612(02)00618-X
   BIEBER EJ, 1986, CLIN PLAST SURG, V13, P645
   Bluteau G, 2006, BIOMATERIALS, V27, P2934, DOI 10.1016/j.biomaterials.2006.01.004
   BURCHARDT H, 1987, ORTHOP CLIN N AM, V18, P187
   Burstein FD, 2000, PLAST RECONSTR SURG, V105, P34, DOI 10.1097/00006534-200001000-00006
   Daculsi G, 2003, J MATER SCI-MATER M, V14, P195, DOI 10.1023/A:1022842404495
   DACULSI G, 1992, ANN OTO RHINOL LARYN, V101, P669, DOI 10.1177/000348949210100808
   Delloye C, 2003, Chir Organi Mov, V88, P335
   FRAYSSINET P, 1993, BIOMATERIALS, V14, P423, DOI 10.1016/0142-9612(93)90144-Q
   FROST HM, 1969, CALC TISS RES, V3, P211, DOI 10.1007/BF02058664
   Geer DJ, 2002, TISSUE ENG, V8, P787, DOI 10.1089/10763270260424141
   Habibovic P, 2005, BIOMATERIALS, V26, P3565, DOI 10.1016/j.biomaterials.2004.09.056
   Habibovic P, 2005, BIOMATERIALS, V26, P23, DOI 10.1016/j.biomaterials.2004.02.026
   Harasen G, 2002, CAN VET J, V43, P299
   Jegoux F, 2005, ARCH ORTHOP TRAUM SU, V125, P153, DOI 10.1007/s00402-004-0748-4
   Karp JM, 2004, J BIOMED MATER RES A, V71A, P162, DOI 10.1002/jbm.a.30147
   Kumar TRS, 2001, BIOMATERIALS, V22, P2769
   KURZ LT, 1989, SPINE, V14, P1324, DOI 10.1097/00007632-198912000-00009
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Le Guehennec L, 2004, Eur Cell Mater, V8, P1
   Le Guehennec L, 2005, J MATER SCI-MATER M, V16, P29, DOI 10.1007/s10856-005-6443-3
   Le Guehennec L, 2005, J BIOMED MATER RES B, V72B, P69, DOI 10.1002/jbm.b.30118
   Le Nihouannen D, 2006, BIOMATERIALS, V27, P2716, DOI 10.1016/j.biomaterials.2005.11.038
   Le Nihouannen D, 2005, BONE, V36, P1086, DOI 10.1016/j.bone.2005.02.017
   Li G, 2005, J ORTHOP RES, V23, P196, DOI 10.1016/j.prthres.2004.05.006
   Lu JX, 2004, J MATER SCI-MATER M, V15, P361, DOI 10.1023/B:JMSM.0000021102.68509.65
   MATRAS H, 1985, J ORAL MAXIL SURG, V43, P605, DOI 10.1016/0278-2391(85)90129-6
   PEARSON OM, 2004, AM J PHYS ANTHR S, V39, P63
   Pfister RR, 2005, CORNEA, V24, P593, DOI 10.1097/01.ico.0000157402.89032.ad
   RAMRAKHIANI M, 1979, ACTA ANAT, V103, P358
   Ripamonti U, 1999, S AFR J SCI, V95, P335
   Schwarz N, 1993, Ann Chir Gynaecol Suppl, V207, P63
   Spitzer RS, 2002, J BIOMED MATER RES, V59, P690, DOI 10.1002/jbm.1277
   WITTKAMPF ARM, 1989, J CRANIO MAXILL SURG, V17, P179, DOI 10.1016/S1010-5182(89)80019-8
   Yamada Y, 2003, J CRANIO MAXILL SURG, V31, P27, DOI 10.1016/S1010-5182
   YAMASAKI H, 1992, BIOMATERIALS, V13, P308, DOI 10.1016/0142-9612(92)90054-R
   Yuan HP, 2002, J MATER SCI-MATER M, V13, P1271, DOI 10.1023/A:1021191432366
   Yuan HP, 1998, J MATER SCI-MATER M, V9, P717, DOI 10.1023/A:1008998817977
   Yuan HP, 1998, J MATER SCI-MATER M, V9, P723, DOI 10.1023/A:1008950902047
NR 42
TC 36
Z9 36
U1 1
U2 10
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2007
VL 18
IS 2
BP 225
EP 235
DI 10.1007/s10856-006-0684-7
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 140LV
UT WOS:000244507600006
PM 17323153
DA 2018-10-20
ER

PT J
AU Andersson, M
   Hedlund, J
   Berglin, M
   Elwing, H
   Tang, L
AF Andersson, M.
   Hedlund, J.
   Berglin, M.
   Elwing, H.
   Tang, L.
TI Molecular mobility of polymeric implants and acute inflammatory
   response: An experimental study in mice
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 20th Conference of the European-Society-for-Biomaterials
CY SEP 27-OCT 01, 2006
CL Nantes, FRANCE
SP European Soc Biomat
ID IMMUNE COMPLEMENT ACTIVATION; BIOMATERIALS; COAGULATION; SURFACES
AB An overlooked factor in biomaterial research is the surface molecular flexibility for polymer based implants. The mobility of the polymer chains provides a way for the surface to adapt itself to the environment. This is relevant when the implant comes in contact with a biological fluid and its constituents. By changing the length of the alkyl side chain of poly(alkyl methacrylates) (PAMAs) an interesting opportunity is provided where it is possible to study the surface molecular mobility without changing the surface hydrophobicity, nor does it introduce any additives or any changes in the degree of polymer cross-linking. Four variants of PAMAs were implanted in the peritoneum of Balb/c mice using a well described setup. End points were taken after 18 h and estimations of inflammatory cell recruitment and implant-associated cells were studied. Relationship between surface molecular mobility and inflammatory cell recruitment as well as surface-associated cells was noted.
C1 Gothenburg Univ, Lundberg Lab, Dept Cell & Mol Biol Interface Biophys, SE-40530 Gothenburg, Sweden.
   Univ Texas, Dept Bioengn, Arlington, TX 76019 USA.
RP Andersson, M (reprint author), Gothenburg Univ, Lundberg Lab, Dept Cell & Mol Biol Interface Biophys, Box 462, SE-40530 Gothenburg, Sweden.
EM Marcus.Andersson@gmm.gu.se
CR ALTIERI DC, 1993, J BIOL CHEM, V268, P1847
   Andersson M, 2005, BIOSENS BIOELECTRON, V21, P79, DOI 10.1016/j.bios.2004.09.026
   BAIN JA, 1949, P SOC EXP BIOL MED, V72, P9
   Berglin M, 2004, BIOMATERIALS, V25, P4581, DOI 10.1016/j.biomaterials.2003.11.050
   Busuttil SJ, 2004, J THROMB HAEMOST, V2, P1798, DOI 10.1111/j.1538-7836.2004.00916.x
   DAHLGREN C, 1981, J IMMUNOL METHODS, V40, P171, DOI 10.1016/0022-1759(81)90064-8
   Garbassi F., 1994, POLYM SURFACE PHYS T
   HIMMELHOCH SR, 1969, BIOCHEMISTRY-US, V8, P914, DOI 10.1021/bi00831a022
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Mollnes TE, 1998, VOX SANG, V74, P303, DOI 10.1111/j.1423-0410.1998.tb05435.x
   Sellborn A, 2003, COLLOID SURFACE B, V27, P295, DOI 10.1016/S0927-7765(02)00066-8
   TANG LP, 1993, J LAB CLIN MED, V122, P292
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   TORRES JL, 1988, ARCH BIOCHEM BIOPHYS, V267, P271, DOI 10.1016/0003-9861(88)90032-X
   YAM LT, 1971, AM J CLIN PATHOL, V55, P283
NR 15
TC 5
Z9 5
U1 0
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2007
VL 18
IS 2
BP 283
EP 286
DI 10.1007/s10856-006-0690-9
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 140LV
UT WOS:000244507600012
PM 17323159
DA 2018-10-20
ER

PT J
AU Thebaud, NB
   Pierron, D
   Bareille, R
   Le Visage, C
   Letourneur, D
   Bordenave, L
AF Thebaud, Noelie-Brunehilde
   Pierron, Dorothee
   Bareille, Reine
   Le Visage, Catherine
   Letourneur, Didier
   Bordenave, Laurence
TI Human endothelial progenitor cell attachment to polysaccharide-based
   hydrogels: A pre-requisite for vascular tissue engineering
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 20th Conference of the European-Society-for-Biomaterials
CY SEP 27-OCT 01, 2006
CL Nantes, FRANCE
SP European Soc Biomat
ID STEM-CELLS; IN-VITRO; BONE-MARROW; PRECURSOR CELLS; CORD BLOOD;
   NEOVASCULARIZATION; DIFFERENTIATION; PROLIFERATION; EXPRESSION;
   MIGRATION
AB A hydrogel was prepared from polysaccharides (pullulan/dextran/fucoidan) and evaluated as a novel biomaterial for Endothelial Progenitor Cell (EPC) culture. Using a cross-linking process with sodium trimetaphosphate in aqueous solution, homogeneous, transparent and easy to handle gels were obtained with a water content higher than 90%. Circular scaffolds (6 mm diameter and 2 mm thickness discs) were used for cell culture. Different types of EPCs were used: CD34+ derived ECs from cord blood and two sorts of CD133+ derived ECs from human bone marrow, old (30 days) and young (4 days) cells. EPCs were characterised as endothelial cells by immunofluorescent stainings for CD31 and Dil-Ac-LDL. CD133+ derived ECs from bone marrow were characterized by RT-PCR for CD31, VE-cadherin and KDR. HSVECs (Human Saphenous Vein Endothelial Cells) were used as control cells. We evaluated whether different kinds of EPCs could adhere on this novel hydrogel 4 h and 24 h after seeding, by a colorimetric quantitative test. EPCs adhered to hydrogels in serum- free conditions with values being over than 80% for young CD133+ cells at 4 h and 24 h. This pullulan-based hydrogel could constitute a suitable support for vascular cell adhesion as a pre-requisite for vascular tissue engineering.
C1 INSERM, U577, F-33076 Bordeaux, France.
   Univ Victor Segalen Bordeaux 2, F-33076 Bordeaux, France.
   CHU Xavier Bichat, INSERM, U698, F-75877 Paris, France.
RP Thebaud, NB (reprint author), INSERM, U577, F-33076 Bordeaux, France.
EM noelie.thebaud@bordeaux.inserm.fr
RI Didier, letourneur/H-5268-2012; Le Visage, Catherine/E-5460-2011
OI Didier, letourneur/0000-0003-2197-9468; Le Visage,
   Catherine/0000-0003-1816-1649
CR Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221
   AUTISSIER A, IN PRESS J BIOMED MA
   Bagley RG, 2003, CANCER RES, V63, P5866
   Bompais H, 2004, BLOOD, V103, P2577, DOI 10.1182/blood-2003-08-2770
   Bordenave L, 2005, CLIN HEMORHEOL MICRO, V33, P227
   Chaouat M, 2006, BIOMATERIALS, V27, P5546, DOI 10.1016/j.biomaterials.2006.06.032
   Eggermann J, 2003, CARDIOVASC RES, V58, P478, DOI 10.1016/S0008-6363(03)00252-9
   FERNANDEZ P, 2006, TISSUE ENG
   Kaushal S, 2001, NAT MED, V7, P1035, DOI 10.1038/nm0901-1035
   Lake AC, 2006, J BIOL CHEM, V281, P37844, DOI 10.1074/jbc.M600686200
   Leathers TD, 2003, APPL MICROBIOL BIOT, V62, P468, DOI 10.1007/s00253-003-1386-4
   Letourneur D, 2002, J BIOMED MATER RES, V60, P94, DOI 10.1002/jbm.10072
   Levenberg S, 2005, CURR OPIN BIOTECH, V16, P516, DOI 10.1016/j.copbio.2005.08.007
   Liew A, 2006, BIOESSAYS, V28, P261, DOI 10.1002/bies.20372
   Luyt CE, 2003, J PHARMACOL EXP THER, V305, P24, DOI 10.1124/jpet.102.046144
   Maire M, 2005, BIOMATERIALS, V26, P1771, DOI 10.1016/j.biomaterials.2004.06.003
   Mann BK, 2002, J BIOMED MATER RES, V60, P86, DOI 10.1002/jbm.10042
   Murohara T, 2000, J CLIN INVEST, V105, P1527, DOI 10.1172/JCI8296
   Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377
   Peichev M, 2000, BLOOD, V95, P952
   Quirici N, 2001, BRIT J HAEMATOL, V115, P186, DOI 10.1046/j.1365-2141.2001.03077.x
   Reyes M, 2002, J CLIN INVEST, V109, P337, DOI 10.1172/JCI200214327
   Riha GM, 2005, TISSUE ENG, V11, P1535, DOI 10.1089/ten.2005.11.1535
   Shingel KI, 2004, CARBOHYD RES, V339, P447, DOI 10.1016/j.carres.2003.10.034
   Trudel J, 2002, BIOMATERIALS, V23, P3299, DOI 10.1016/S0142-9612(02)00009-1
   Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78
   Vats A, 2005, LANCET, V366, P592, DOI 10.1016/S0140-6736(05)66879-1
   Verrier S, 1996, J MATER SCI-MATER M, V7, P46, DOI 10.1007/BF00121189
   Yang Z, 2006, BIOCHEM BIOPH RES CO, V342, P577, DOI 10.1016/j.bbrc.2006.01.072
   Yow KH, 2006, BRIT J SURG, V93, P652, DOI 10.1002/bjs.5343
NR 31
TC 49
Z9 54
U1 0
U2 16
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2007
VL 18
IS 2
BP 339
EP 345
DI 10.1007/s10856-006-0698-1
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 140LV
UT WOS:000244507600020
PM 17323167
DA 2018-10-20
ER

PT J
AU Biggs, MJP
   Richards, RG
   Gadegaard, N
   Wilkinson, CDW
   Dalby, MJ
AF Biggs, M. J. P.
   Richards, R. G.
   Gadegaard, N.
   Wilkinson, C. D. W.
   Dalby, M. J.
TI The effects of nanoscale pits on primary human osteoblast adhesion
   formation and cellular spreading
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 20th Conference of the European-Society-for-Biomaterials
CY SEP 27-OCT 01, 2006
CL Nantes, FRANCE
SP European Soc Biomat
ID FIBROBLAST RESPONSE; REMOVAL; NANOTOPOGRAPHY; COMPLICATIONS; TOPOGRAPHY;
   FRACTURES; FILOPODIA; METALWORK; SURFACES; CELLS
AB Current understanding of the mechanisms involved in ossesoinegration following implantation of a biomaterial has led to an emphasis being placed on the modification of material topography to control interface reactions. Recent studies have inferred nanoscale topography as an important mediator of cell adhesion and differentiation. Biomimetic strategies in orthopaedic research aim to exploit these influences to regulate cellular adhesion and subsequent bony tissue formation. Here experimental topographies of nanoscale pits demonstrating varying order have been fabricated by electron-beam lithography in (poly)carbonate. Osteoblast adhesion to these nanotopographies was ascertained by quantification of the relation between adhesion complex formation and total cell area. This study is specifically concerned with the effects these nanotopographies have on adhesion formation in S-phase osteoblasts as identified by BrdU incorporation. Nanopits were found to reduce cellular spreading and adhesion formation.
C1 Univ Glasgow, Inst Biomed & Life Sci, Ctr Cell Engn, Glasgow G12 8QQ, Lanark, Scotland.
   AO Fdn, AO Res Inst, Davos, Switzerland.
RP Biggs, MJP (reprint author), Univ Glasgow, Inst Biomed & Life Sci, Ctr Cell Engn, Joseph Black Bldg, Glasgow G12 8QQ, Lanark, Scotland.
EM m.biggs.1@research.gla.ac.uk
RI Gadegaard, Nikolaj/E-9243-2010; Richards, Robert/I-8235-2015; Biggs,
   Manus/N-8542-2013; Dalby, Matthew/G-2426-2012
OI Gadegaard, Nikolaj/0000-0002-3396-846X; Richards,
   Robert/0000-0002-7778-2480; Biggs, Manus/0000-0003-4699-1025; Dalby,
   Matthew/0000-0002-0528-3359
CR BAUMS MH, 2006, KNEE SURG SPORTS TRA
   Bershadsky AD, 2006, EUR J CELL BIOL, V85, P165, DOI 10.1016/j.ejcb.2005.11.001
   Brown OL, 2001, J ORTHOP TRAUMA, V15, P271, DOI 10.1097/00005131-200105000-00006
   Cordioli G, 2000, INT J ORAL MAX IMPL, V15, P668
   CROSS SJ, 1987, CYTOBIOS, V50, P41
   Dalby MJ, 2002, EXP CELL RES, V276, P1, DOI 10.1006/EXCR.2002.5498
   Dalby MJ, 2004, INT J BIOCHEM CELL B, V36, P2005, DOI 10.1016/j.biocel.2004.03.001
   Dalby MJ, 2004, CELL BIOL INT, V28, P229, DOI 10.1016/j.cellbi.2003.12.004
   Dalby MJ, 2003, J BIOMED MATER RES A, V67A, P1025, DOI 10.1002/jbm.a.10139
   Dalby MJ, 2003, BIOMATERIALS, V24, P927, DOI 10.1016/S0142-9612(02)00427-1
   DIEHL KA, 2005, J BIOMED MAT RES A
   Gadegaard N, 2003, MACROMOL MATER ENG, V288, P76, DOI 10.1002/mame.200290037
   GADEGAARD N, 2003, MICROELECTRON ENG, V67, P126
   Gallagher JO, 2002, IEEE T NANOBIOSCI, V1, P24, DOI 10.1109/TNB.2002.806918
   Girish V, 2004, Indian J Cancer, V41, P47
   Heyderman LJ, 2000, MICROELECTRON ENG, V54, P229, DOI 10.1016/S0167-9317(00)00414-7
   Islamoglu K, 2002, ANN PLAS SURG, V48, P265, DOI 10.1097/00000637-200203000-00006
   Jago RD, 1998, INJURY, V29, P439, DOI 10.1016/S0020-1383(98)00080-1
   Liao HH, 2003, BIOMATERIALS, V24, P649, DOI 10.1016/S0142-9612(02)00379-4
   Marchisio M, 2005, J BIOMED MATER RES B, V75B, P251, DOI 10.1002/jbm.b.30287
   MCBEATH R, 2004, DEV CELL, V4, P483
   Meredith DO, 2004, EXP CELL RES, V293, P58, DOI 10.1016/j.yexcr.2003.10.005
   Oleschuk RD, 2000, BIOMATERIALS, V21, P1701, DOI 10.1016/S0142-9612(00)00054-5
   Prather R S, 1999, Cloning, V1, P17, DOI 10.1089/15204559950020067
   SANDERSON PL, 1992, INJURY, V23, P29, DOI 10.1016/0020-1383(92)90121-8
   Santiago A. S., 2005, PESQUI ODONTOL BRAS, V19, P203
   Sundfeldt M, 2006, ACTA ORTHOP, V77, P177, DOI 10.1080/17453670610045902
   Zamir E, 2001, J CELL SCI, V114, P3583
   Zhu BS, 2004, BIOMATERIALS, V25, P4215, DOI 10.1016/j.biomaterials.2003.11.020
   Zimerman B, 2004, CELL MOTIL CYTOSKEL, V58, P143, DOI 10.1002/cm.20005
NR 30
TC 106
Z9 106
U1 0
U2 22
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2007
VL 18
IS 2
BP 399
EP 404
DI 10.1007/s10856-006-0705-6
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 140LV
UT WOS:000244507600027
PM 17323174
DA 2018-10-20
ER

PT J
AU Tamura, K
   Sato, S
   Kishida, M
   Asano, S
   Murai, M
   Ito, K
AF Tamura, Kazuaki
   Sato, Shuichi
   Kishida, Mamoru
   Asano, Shoichi
   Murai, Masakazu
   Ito, Koichi
TI The use of porous beta-tricalcium phosphate blocks with platelet-rich
   plasma as an onlay bone graft biomaterial
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE beta-tricalcium phosphate; bone graft; platelet-rich plasma
ID FREEZE-DRIED BONE; MANDIBULAR DEFECTS; RABBIT CALVARIUM; AUTOLOGOUS
   BONE; TITANIUM CAP; REGENERATION; IMPLANTS; COMBINATION; RATS;
   AUGMENTATION
AB Background: An experimental study of rabbit calvaria evaluated the suitability of porous beta-tricalcium phosphate (beta-TCP) block as a biomaterial for onlay bone grafting and determined whether the addition of platelet-rich plasma (PRP) can accelerate bone formation inside the pores of the beta-TCP block.
   Methods: In eight rabbits, the calvarium was exposed, and the marrow was penetrated. The beta-TCP blocks were made of Ca-3(CO4)(3) (porosity, 75%; diameter, 8 mm; thickness, 5 mm). For the experimental group, the blocks were treated with PRP; for the control group, the blocks were treated with venous blood only. Each block was placed in the bone, attached with a titanium screw, and covered with a cutaneous flap. The animals were sacrificed after 3 months, and the tissue ingrowth into the blocks was euthanized.
   Results: Histologic and histomorphometric measurements demonstrated that there was no inflammatory infiltration around the blocks in either group. New bone formation inside the blocks originated from the parent bone in both groups. The mineralized bone generated tended to climb along the inner walls of the block. In addition, mineralized bone formation was noted around the titanium screw. Furthermore, there was no significant difference between the experimental and control groups in the relative amounts of newly generated tissue and mineralized bone generated in the blocks.
   Conclusion: Porous beta-TCP block is a promising biomaterial for clinical situations requiring bone augmentation; however, the addition of PRP did not induce significantly more new bone formation.
C1 Nihon Univ, Sch Dent, Dept Periodontol, Duv Adv Dent Treatment,Dent Res Ctr,Chiyoda Ku, Tokyo 1018310, Japan.
RP Sato, S (reprint author), Nihon Univ, Sch Dent, Dept Periodontol, Duv Adv Dent Treatment,Dent Res Ctr,Chiyoda Ku, 1-8-13 Kanda Surugadai, Tokyo 1018310, Japan.
EM sato-su@dent.nihon-u.ac.jp
CR Aghaloo TL, 2005, CLIN ORAL IMPLAN RES, V16, P250, DOI 10.1111/j.1600-0501.2004.01075.x
   Araujo MG, 2002, J CLIN PERIODONTOL, V29, P1122, DOI 10.1034/j.1600-051X.2002.291213.x
   BOWERS GM, 1986, J PERIODONTOL, V57, P286, DOI 10.1902/jop.1986.57.5.286
   BOYNE PJ, 1969, J AM DENT ASSOC, V78, P767, DOI 10.1016/S0002-8177(69)84023-7
   BREITBART AS, 1995, PLAST RECONSTR SURG, V96, P699, DOI 10.1097/00006534-199509000-00024
   BURCHARDT H, 1983, CLIN ORTHOP RELAT R, P28
   Buser D, 1990, CLIN ORAL IMPLAN RES, V1, P22, DOI 10.1034/j.1600-0501.1990.010104.x
   Choi BH, 2005, INT J ORAL MAX SURG, V34, P420, DOI 10.1016/j.ijom.2004.10.018
   DAHLIN C, 1988, PLAST RECONSTR SURG, V81, P672, DOI 10.1097/00006534-198805000-00004
   Gerard D, 2006, J ORAL MAXIL SURG, V64, P443, DOI 10.1016/j.joms.2005.11.016
   Hokugo A, 2005, TISSUE ENG, V11, P1224, DOI 10.1089/ten.2005.11.1224
   Huse RO, 2004, CLIN ORAL IMPLAN RES, V15, P741, DOI 10.1111/j.1600-0501.2004.01068.x
   Kim SG, 2002, INT J ORAL MAX IMPL, V17, P86
   Kim SG, 2002, J ORAL MAXIL SURG, V60, P1018, DOI 10.1053/joms.2002.34413
   KOSTOPOULOS L, 1994, CLIN ORAL IMPLAN RES, V5, P66, DOI 10.1034/j.1600-0501.1994.050202.x
   LINDE A, 1993, J ORAL MAXIL SURG, V51, P892, DOI 10.1016/S0278-2391(10)80111-9
   Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4
   Murai M, 2006, DENT MATER J, V25, P87, DOI 10.4012/dmj.25.87
   NYSTROM E, 1995, INT J ORAL MAX SURG, V24, P20, DOI 10.1016/S0901-5027(05)80851-3
   PHILLIPS JH, 1988, PLAST RECONSTR SURG, V82, P872, DOI 10.1097/00006534-198811000-00023
   Rasmusson L, 1999, CLIN ORAL IMPLAN RES, V10, P267, DOI 10.1034/j.1600-0501.1999.100403.x
   Roldan JC, 2004, BONE, V34, P80, DOI 10.1016/j.bone.2003.09.011
   Sanchez AR, 2003, INT J ORAL MAX IMPL, V18, P93
   Schmid J, 1991, CLIN ORAL IMPLAN RES, V2, P199, DOI 10.1034/j.1600-0501.1991.020407.x
   Schmid J, 1997, CLIN ORAL IMPLAN RES, V8, P75, DOI 10.1034/j.1600-0501.1997.080201.x
   Tamura T, 2005, J PERIODONTAL RES, V40, P269, DOI 10.1111/j.1600-0765.2005.00802.x
   Thorwarth M, 2006, BONE, V38, P30, DOI 10.1016/j.bone.2005.06.020
   TURGEON ML, 1993, CLIN HEMATOLOGY THEO, P352
   URIST MR, 1968, CLIN ORTHOP RELAT R, P59
   WADA T, 1989, J PERIODONTAL RES, V24, P391, DOI 10.1111/j.1600-0765.1989.tb00888.x
   Wiltfang J, 2004, CLIN ORAL IMPLAN RES, V15, P187, DOI 10.1111/j.1600-0501.2004.00980.x
   Yamada Y, 2003, CLIN ORAL IMPLAN RES, V14, P455, DOI 10.1034/j.1600-0501.2003.00832.x
NR 32
TC 16
Z9 18
U1 0
U2 2
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA
SN 0022-3492
J9 J PERIODONTOL
JI J. Periodont.
PD FEB
PY 2007
VL 78
IS 2
BP 315
EP 321
DI 10.1902/jop.2007.060228
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 137BO
UT WOS:000244268000017
PM 17274721
DA 2018-10-20
ER

PT J
AU Hou, LT
   Liu, CM
   Liu, BY
   Chang, PC
   Chen, MH
   Ho, MH
   Jehng, SM
   Liu, HC
AF Hou, Lein-Tuan
   Liu, Cheng-Meei
   Liu, Bu-Yuan
   Chang, Po-Chun
   Chen, Min-Huei
   Ho, Ming-Hua
   Jehng, Su-Min
   Liu, Hwa-Chang
TI Tissue engineering bone formation in novel recombinant human bone
   morphogenic protein 2-atelocollagen composite scaffolds
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE bone morphogenic protein; bone sialoprotein; osteopontin; tissue
   engineering
ID COLLAGEN SCAFFOLDS; I ATELOCOLLAGEN; ECTOPIC OSTEOINDUCTION; ALVEOLAR
   BONE; RHBMP-2; REGENERATION; BIOMATERIAL; IMPLANT; CARRIER; MATRIX
AB Background: Bone morphogenic proteins (BMPs) are important bone-induction factors, and the development of a suitable carrier for BMPs is a critical step to achieve osteoinductive function. The aims of the present study were to evaluate, at the cellular and molecular levels, the feasibility of recombinant human BMP-2 (rhBMP-2)-collagen composite scaffold and its efficiency for carrying BMP-2 in ectopic bone formation in rats.
   Methods: Scaffolds with (test) or without rhBMP-2 (control) were made and implanted into the calf muscle of 16 5-weekold rats. The tissue responses to the scaffolds were examined by histology. Masson's trichrome and von Kossa stainings were performed to examine collagen matrix deposition and calcification at 3, 7, 10, and 14 days. Expressions of bone phenotypic markers, alkaline phosphatase, osteocalcin, osteopontin, and bone sialoprotein were detected by reverse transcription-polymerase chain reaction and immunohistochemistry.
   Results: No detectable adverse responses were noted around the implanted scaffolds, and the area of the resorbed scaffold had been replaced by young connective tissue by 3 to 7 days in both groups. In the rhBMP-2 composite scaffold, collagen matrix deposition was found in the implanted site on day 7 and initial signs of endochondral differentiation also appeared. Mineralization and the expressions of key bone proteins were demonstrated in chondroblasts and osteoblasts at 7 to 14 days. Molecular cascades of bone induction were not shown in control specimens.
   Conclusion: The rhBMP-2-atelocollagen scaffold showed excellent biocompatibility and possessed a bone-inducing capacity in rat within 2 weeks, and, thus, may provide a potential application in tissue engineering of bone tissue.
C1 Natl Taiwan Univ Hosp, Coll Med, Grad Inst Clin Dent, Taipei 100, Taiwan.
   Natl Taiwan Univ Hosp, Coll Med, Dept Orthoped, Taipei 100, Taiwan.
   Natl Taiwan Univ Hosp, Dept Periodontol, Taipei 100, Taiwan.
   Natl Taiwan Univ, Coll Engn, Grad Inst Chem Engn, Taipei 100, Taiwan.
RP Hou, LT (reprint author), Natl Taiwan Univ, Sch Dent, Dept Periodontol, 1 Chang Te St, Taipei 100, Taiwan.
EM lthou@ha.mc.ntu.edu.tw
OI CHANG, PO-CHUN/0000-0002-4493-6922
CR An YH, 2000, BIOMATERIALS, V21, P2635, DOI 10.1016/S0142-9612(00)00132-0
   Aubin JE, 1995, BONE, V17, P77
   Bessho K, 1999, BRIT J ORAL MAX SURG, V37, P2, DOI 10.1054/bjom.1998.0379
   BIANCO P, 1991, CALCIFIED TISSUE INT, V49, P421, DOI 10.1007/BF02555854
   Bonassar LJ, 1998, J CELL BIOCHEM, P297, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<297::AID-JCB36>3.0.CO;2-6
   BOSS JH, 2000, BIOMATERIALS BIOENGI, P46
   Boyan BD, 1999, J BIOMED MATER RES, V46, P51, DOI 10.1002/(SICI)1097-4636(199907)46:1<51::AID-JBM6>3.3.CO;2-9
   Bunyaratavej P, 2000, EXP CELL RES, V260, P324, DOI 10.1006/excr.2000.5019
   Chakkalakal DA, 2001, TISSUE ENG, V7, P161, DOI 10.1089/107632701300062778
   CHARRIERE G, 1989, J AM ACAD DERMATOL, V21, P1203, DOI 10.1016/S0190-9622(89)70330-3
   Cochran DI, 2000, J PERIODONTOL, V71, P1241, DOI 10.1902/jop.2000.71.8.1241
   DELUSTRO F, 1986, J BIOMED MATER RES, V20, P109, DOI 10.1002/jbm.820200110
   Fiorellini JP, 2005, J PERIODONTOL, V76, P605, DOI 10.1902/jop.2005.76.4.605
   FUJIMURA K, 1995, BIOCHEM BIOPH RES CO, V208, P316, DOI 10.1006/bbrc.1995.1340
   Fujioka K, 1998, ADV DRUG DELIVER REV, V31, P247, DOI 10.1016/S0169-409X(97)00119-1
   Furthmayr H, 1976, Int Rev Connect Tissue Res, V7, P61
   Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010
   Gersbach CA, 2004, BIOTECHNOL BIOENG, V88, P369, DOI 10.1002/bit.20251
   GRUBER HE, 1992, BIOTECH HISTOCHEM, V67, P30, DOI 10.3109/10520299209110002
   Hanai K, 2004, HUM GENE THER, V15, P263, DOI 10.1089/104303404322886110
   Ho MH, 2005, BIOMATERIALS, V26, P3197, DOI 10.1016/j.biomaterials.2004.08.032
   HUGGINS C, 1970, J EXP MED, V132, P1250, DOI 10.1084/jem.132.6.1250
   Itoh H, 2001, ARTIF ORGANS, V25, P213, DOI 10.1046/j.1525-1594.2001.025003213.x
   Juncosa-Melvin N, 2005, TISSUE ENG, V11, P448, DOI 10.1089/ten.2005.11.448
   Jung RE, 2003, CLIN ORAL IMPLAN RES, V14, P556, DOI 10.1034/j.1600-0501.2003.00921.x
   King GN, 2002, J PERIODONTOL, V73, P925, DOI 10.1902/jop.2002.73.8.925
   Kodama T, 1990, Nihon Shishubyo Gakkai Kaishi, V32, P1
   Kusumoto K, 1996, J CRANIO MAXILL SURG, V24, P360, DOI 10.1016/S1010-5182(96)80037-0
   LAM KH, 1993, J BIOMED MATER RES, V27, P1569, DOI 10.1002/jbm.820271214
   LIAN JB, 1993, J CELL BIOCHEM, V52, P206, DOI 10.1002/jcb.240520212
   Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096
   Masuoka K, 2005, J BIOMED MATER RES B, V75B, P177, DOI 10.1002/jbm.b.30284
   MIYAMOTO S, 1992, CLIN ORTHOP RELAT R, P274
   MIYATA T, 1992, Clinical Materials, V9, P139, DOI 10.1016/0267-6605(92)90093-9
   NUMABE Y, 1993, J PERIODONTOL, V64, P706, DOI 10.1902/jop.1993.64.8.706
   Ochiya Takahiro, 2001, Current Gene Therapy, V1, P31, DOI 10.2174/1566523013348887
   Okubo Y, 2000, INT J ORAL MAX SURG, V29, P62, DOI 10.1016/S0901-5027(00)80127-7
   PIATTELLI A, 1994, BIOMATERIALS, V15, P194, DOI 10.1016/0142-9612(94)90067-1
   PONTZ B, 1970, EUR J BIOCHEM, V16, P50, DOI 10.1111/j.1432-1033.1970.tb01051.x
   REDDI AH, 1987, ORTHOP CLIN N AM, V18, P207
   Ripamonti U, 2001, EUR J ORAL SCI, V109, P241, DOI 10.1034/j.1600-0722.2001.00041.x
   Rousseau CF, 2002, BIOMATERIALS, V23, P1503, DOI 10.1016/S0142-9612(01)00276-9
   Sachlos E, 2003, BIOMATERIALS, V24, P1487, DOI 10.1016/S0142-9612(02)00528-8
   Shukunami C, 1998, EXP CELL RES, V241, P1, DOI 10.1006/excr.1998.4045
   Sigurdsson T J, 1996, Int J Periodontics Restorative Dent, V16, P524
   Snyder A, 2004, J CELL BIOCHEM, V93, P224, DOI 10.1002/jcb.20191
   Song E, 2006, BIOMATERIALS, V27, P2951, DOI 10.1016/j.biomaterials.2006.01.015
   STENZEL KH, 1974, ANNU REV BIOPHYS BIO, V3, P231, DOI 10.1146/annurev.bb.03.060174.001311
   Suh H, 2001, BIOMATERIALS, V22, P219, DOI 10.1016/S0142-9612(00)00177-0
   Tsujigiwa H, 2005, J BIOMED MATER RES A, V75A, P210, DOI 10.1002/jbm.a.30416
   Uchio Y, 2000, J BIOMED MATER RES, V50, P138, DOI 10.1002/(SICI)1097-4636(200005)50:2<138::AID-JBM7>3.0.CO;2-K
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   van den Bergh JPA, 2000, J CLIN PERIODONTOL, V27, P627, DOI 10.1034/j.1600-051x.2000.027009627.x
   VIZAROVA K, 1995, BIOMATERIALS, V16, P1217, DOI 10.1016/0142-9612(95)98127-Z
   WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220
   Wikesjo UME, 2001, J BONE JOINT SURG AM, V83A, pS136
   Winn SR, 1999, J BIOMED MATER RES, V45, P414, DOI 10.1002/(SICI)1097-4636(19990615)45:4<414::AID-JBM17>3.0.CO;2-Z
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
   Xiao Y, 2003, TISSUE ENG, V9, P1167, DOI 10.1089/10763270360728071
   Yang CL, 2004, BIODRUGS, V18, P103, DOI 10.2165/00063030-200418020-00004
NR 61
TC 25
Z9 29
U1 0
U2 2
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA
SN 0022-3492
J9 J PERIODONTOL
JI J. Periodont.
PD FEB
PY 2007
VL 78
IS 2
BP 335
EP 343
DI 10.1902/jop.2007.060106
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 137BO
UT WOS:000244268000020
PM 17274724
DA 2018-10-20
ER

PT J
AU Zhu, SL
   Wang, XM
   Qin, FX
   Inoue, A
AF Zhu, Shengli
   Wang, Xinmin
   Qin, Fengxiang
   Inoue, Akihisa
TI Glass-forming ability and thermal stability of Ti-Zr-Cu-Pd-Si bulk
   glassy alloys for biomedical applications
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE titanium alloy; bulk glassy alloy; biomaterial; glass-forming ability
ID SUPERCOOLED LIQUID REGION; AMORPHOUS-ALLOYS; METALLIC GLASSES;
   MECHANICAL-PROPERTIES; NI-CU; CRYSTALLIZATION; CRITERION; CO
AB The thermal properties, glass forming ability (GFA) and mechanical properties of a series of Ti40Zr10Cu40-xPd10Six (x= 0, 1, 2) bulk glassy alloys were examined by differential scanning calorimetry (DSC), differential thermal analysis (I)TA), X-ray diffractometry (XRD) and compression test. The bulk glassy alloys are expected to be used as biomedical materials because of the absence of toxic elements such as Ni, Al and Be. The glass-forming ability and thermal stability of the Ti-Zr-CU-Pd alloy can be unproved by a small amount of Si addition. The critical diameters for glass formation are 5 nun for both Ti40Zr10Cu39Pd10Si1 and Ti40Zr10Cu38Pd10Si2 alloys. A large Supercooled liquid region of 65 K was obtained for the Ti40Zr10Cu38Pd10Si2 bulk glassy alloy. The bulk glassy alloys have higher compressive strength of over 1900 MPa and lower Young's modulus below 85 GPa as compared with conventional biomedical Ti alloys.
C1 Tohoku Univ, Mat Res Inst, Sendai, Miyagi 9808577, Japan.
RP Zhu, SL (reprint author), Tohoku Univ, Mat Res Inst, Sendai, Miyagi 9808577, Japan.
RI Inoue, Akihisa/E-5271-2015; Zhu, Shengli/D-5281-2009; BAI,
   JIE/D-7448-2016; Qin, Fengxiang/A-8359-2011; zhu, shengli/A-8818-2011
OI Zhu, Shengli/0000-0002-0190-2626; 
CR Chen QJ, 2005, CHINESE PHYS LETT, V22, P1736, DOI 10.1088/0256-307X/22/7/048
   Choi-Yim H, 1998, J APPL PHYS, V83, P7993, DOI 10.1063/1.367981
   Hasegawa M, 2004, ACTA MATER, V52, P1799, DOI 10.1016/j.actamat.2003.12.019
   INOUE A, 1994, MATER LETT, V19, P131, DOI 10.1016/0167-577X(94)90057-4
   Inoue A, 2000, ACTA MATER, V48, P279, DOI 10.1016/S1359-6454(99)00300-6
   INOUE A, 1995, MATER T JIM, V36, P866, DOI 10.2320/matertrans1989.36.866
   INOUE A, 1990, MATER T JIM, V31, P177, DOI 10.2320/matertrans1989.31.177
   Kakiuchi H, 2001, MATER TRANS, V42, P678, DOI 10.2320/matertrans.42.678
   Kim YC, 2004, MAT SCI ENG A-STRUCT, V375, P127, DOI 10.1016/j.msea.2003.10.115
   Liang WZ, 2006, J ALLOY COMPD, V420, P94, DOI 10.1016/j.jallcom.2005.10.018
   Liu CT, 2005, INTERMETALLICS, V13, P415, DOI 10.1016/j.intermet.2004.07.034
   Lu ZP, 2002, ACTA MATER, V50, P3501, DOI 10.1016/S1359-6454(02)00166-0
   Lu ZP, 2001, MAT SCI ENG A-STRUCT, V304, P679, DOI 10.1016/S0921-5093(00)01563-X
   Ma C, 2004, MATER TRANS, V45, P3223, DOI 10.2320/matertrans.45.3223
   MEN H, 2005, MAT T, V10, P2218
   Qin FX, 2004, J ALLOY COMPD, V375, P318, DOI 10.1016/j.jallcom.2003.12.004
   Xia MX, 2005, MAT SCI ENG A-STRUCT, V390, P372, DOI 10.1016/j.msea.2004.08.019
   ZHANG T, 1994, MAT SCI ENG A-STRUCT, V181, P1423, DOI 10.1016/0921-5093(94)90877-X
   Zhang T, 1998, MATER T JIM, V39, P1001, DOI 10.2320/matertrans1989.39.1001
   Zhang T, 2001, MAT SCI ENG A-STRUCT, V304, P771, DOI 10.1016/S0921-5093(00)01592-6
   ZHANG T, 1991, MATER T JIM, V32, P1005, DOI 10.2320/matertrans1989.32.1005
   Zhu S., IN PRESS
NR 22
TC 21
Z9 21
U1 1
U2 20
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD FEB
PY 2007
VL 48
IS 2
BP 163
EP 166
DI 10.2320/matertrans.48.163
PG 4
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 147PG
UT WOS:000245014300015
OA Bronze
DA 2018-10-20
ER

PT J
AU Moutos, FT
   Freed, LE
   Guilak, F
AF Moutos, Franklin T.
   Freed, Lisa E.
   Guilak, Farshid
TI A biomimetic three-dimensional woven composite scaffold for functional
   tissue engineering of cartilage
SO NATURE MATERIALS
LA English
DT Article
ID TENSION-COMPRESSION NONLINEARITY; INTRINSIC MECHANICAL-PROPERTIES;
   ANTERIOR CRUCIATE LIGAMENT; HUMAN ARTICULAR-CARTILAGE; AGAROSE GELS;
   EXPERIMENTAL-VERIFICATION; EXTRACELLULAR-MATRIX; CONFINED COMPRESSION;
   SHEAR PROPERTIES; POISSONS RATIO
AB Tissue engineering seeks to repair or regenerate tissues through combinations of implanted cells, biomaterial scaffolds and biologically active molecules. The rapid restoration of tissue biomechanical function remains an important challenge, emphasizing the need to replicate structural and mechanical properties using novel scaffold designs. Here we present a microscale 3D weaving technique to generate anisotropic 3D woven structures as the basis for novel composite scaffolds that are consolidated with a chondrocyte-hydrogel mixture into cartilage tissue constructs. Composite scaffolds show mechanical properties of the same order of magnitude as values for native articular cartilage, as measured by compressive, tensile and shear testing. Moreover, our findings showed that porous composite scaffolds could be engineered with initial properties that reproduce the anisotropy, viscoelasticity and tension-compression nonlinearity of native articular cartilage. Such scaffolds uniquely combine the potential for load-bearing immediately after implantation in vivo with biological support for cell-based tissue regeneration without requiring cultivation in vitro.
C1 Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA.
   Duke Univ, Med Ctr, Dept Biomed Engn, Durham, NC 27710 USA.
   Harvard Univ, MIT, Div Hlth Sci & Technol, MIT, Cambridge, MA 02139 USA.
   Duke Univ, Med Ctr, Dept Mech Engn & Mat Sci, Durham, NC 27710 USA.
RP Moutos, FT (reprint author), Duke Univ, Med Ctr, Dept Surg, 375 MSRB,Box 3093, Durham, NC 27710 USA.
EM guilak@duke.edu
RI Zhou, Gina/D-2837-2009
OI Freed, Lisa/0000-0002-0720-8432; Guilak, Farshid/0000-0001-7380-0330
FU NIA NIH HHS [AG15768]; NIAMS NIH HHS [AR50245, AR49294, AR48182]
CR AKIZUKI S, 1986, J ORTHOPAED RES, V4, P379, DOI 10.1002/jor.1100040401
   Ameer GA, 2002, J ORTHOPAED RES, V20, P16, DOI 10.1016/S0736-0266(01)00074-2
   ATALA A, 1993, J UROLOGY, V150, P745, DOI 10.1016/S0022-5347(17)35603-3
   Ateshian GA, 1997, J BIOMECH ENG-T ASME, V119, P81, DOI 10.1115/1.2796069
   ATHANASIOU KA, 1994, J ORTHOPAED RES, V12, P340, DOI 10.1002/jor.1100120306
   ATHANASIOU KA, 1991, J ORTHOP RES, V9, P330, DOI 10.1002/jor.1100090304
   Aufderheide AC, 2005, TISSUE ENG, V11, P1095, DOI 10.1089/ten.2005.11.1095
   BADER DL, 1981, BIOCHIM BIOPHYS ACTA, V677, P103, DOI 10.1016/0304-4165(81)90150-1
   Below S, 2002, ARTHROSCOPY, V18, P613, DOI 10.1053/jars.2002.29877
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   BUSCHMANN MD, 1992, J ORTHOPAED RES, V10, P745, DOI 10.1002/jor.1100100602
   Caterson EJ, 2002, ANN NY ACAD SCI, V961, P134, DOI 10.1111/j.1749-6632.2002.tb03066.x
   Cohen B, 1998, J BIOMECH ENG-T ASME, V120, P491, DOI 10.1115/1.2798019
   Elliott DM, 1999, J ORTHOP RES, V17, P503, DOI 10.1002/jor.1100170407
   Elliott DM, 2002, J BIOMECH ENG-T ASME, V124, P223, DOI 10.1115/1.1449905
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Freed LE, 1997, P NATL ACAD SCI USA, V94, P13885, DOI 10.1073/pnas.94.25.13885
   Gao Jizong, 2002, Tissue Engineering, V8, P827, DOI 10.1089/10763270260424187
   Gu WY, 2003, J BIOMECH, V36, P593, DOI 10.1016/S0021-9290(02)00437-2
   GUILAK F, 1994, J ORTHOPAED RES, V12, P474, DOI 10.1002/jor.1100120404
   Guilak F, 2001, CLIN ORTHOP RELAT R, pS295
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Huang CY, 2005, J BIOMECH, V38, P799, DOI 10.1016/j.jbiomech.2004.05.006
   Huang CY, 2003, J BIOMECH ENG-T ASME, V125, P84, DOI 10.1115/1.1531656
   Huang CY, 2001, J BIOMECH ENG-T ASME, V123, P410, DOI 10.1115/1.1392316
   Jurvelin JS, 1997, J BIOMECH, V30, P235, DOI 10.1016/S0021-9290(96)00133-9
   KEMPSON GE, 1976, BIOCHIM BIOPHYS ACTA, V428, P741, DOI 10.1016/0304-4165(76)90205-1
   Lee DA, 1997, J ORTHOP RES, V15, P181, DOI 10.1002/jor.1100150205
   LeRoux MA, 1999, J BIOMED MATER RES, V47, P46, DOI 10.1002/(SICI)1097-4636(199910)47:1<46::AID-JBM6>3.0.CO;2-N
   LeRoux MA, 2000, J ORTHOP RES, V18, P383, DOI 10.1002/jor.1100180309
   Li WJ, 2006, TISSUE ENG, V12, P1775, DOI 10.1089/ten.2006.12.1775
   Marijnissen WJCM, 2002, BIOMATERIALS, V23, P1511, DOI 10.1016/S0142-9612(01)00281-2
   Mauck RL, 2000, J BIOMECH ENG-T ASME, V122, P252, DOI 10.1115/1.429656
   Mohamed MH, 2001, SAMPE J, V37, P8
   Mow V, 2002, ANNU REV BIOMED ENG, V4, P175, DOI 10.1146/annurev.bioeng.4.110701.120309
   MOW VC, 1992, BIOMATERIALS, V13, P67, DOI 10.1016/0142-9612(92)90001-5
   MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73, DOI 10.1115/1.3138202
   Paige KT, 1996, PLAST RECONSTR SURG, V97, P168, DOI 10.1097/00006534-199601000-00027
   Pei M, 2002, FASEB J, V16, P1691, DOI 10.1096/fj.02-0083fje
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   SETTON LA, 1995, J ORTHOPAED RES, V13, P473, DOI 10.1002/jor.1100130402
   SETTON LA, 1994, J ORTHOPAED RES, V12, P451, DOI 10.1002/jor.1100120402
   SETTON LA, 1993, J BIOMECH, V26, P581, DOI 10.1016/0021-9290(93)90019-B
   Soltz MA, 1998, J BIOMECH, V31, P927, DOI 10.1016/S0021-9290(98)00105-5
   Soltz MA, 2000, J BIOMECH ENG-T ASME, V122, P576, DOI 10.1115/1.1324669
   Tognana E, 2005, OSTEOARTHR CARTILAGE, V13, P129, DOI 10.1016/j.joca.2004.10.015
   Vunjak-Novakovic G, 1999, J ORTHOPAED RES, V17, P130, DOI 10.1002/jor.1100170119
   WOO SLY, 1979, J BIOMECH, V12, P437, DOI 10.1016/0021-9290(79)90028-9
   ZHU WB, 1993, J ORTHOPAED RES, V11, P771, DOI 10.1002/jor.1100110602
NR 49
TC 394
Z9 409
U1 20
U2 307
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1476-1122
J9 NAT MATER
JI Nat. Mater.
PD FEB
PY 2007
VL 6
IS 2
BP 162
EP 167
DI 10.1038/nmat1822
PG 6
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 132KN
UT WOS:000243941800024
PM 17237789
DA 2018-10-20
ER

PT J
AU Gentleman, E
   Dee, KC
   Livesay, GA
   Nauman, EA
AF Gentleman, Eileen
   Dee, Kay C.
   Livesay, Glen A.
   Nauman, Eric A.
TI Operating curves to characterize the contraction of fibroblast-seeded
   collagen gel/collagen fiber composite biomaterials: Effect of fiber mass
SO PLASTIC AND RECONSTRUCTIVE SURGERY
LA English
DT Article; Proceedings Paper
CT Annual Fall Meeting of the Biomedical-Engineering-Society
CY OCT 13-16, 2004
CL Philadelphia, PA
SP IEEE Engn Med & Biol, Biomed Engn Soc
ID IN-VITRO; LIGAMENT RECONSTRUCTION; CELL LOCOMOTION; TISSUE; GELS;
   IMPLANTS; PROSTHESIS; SCAFFOLDS; MATRICES; DENSITY
AB Background: Collagen is a well-established and important biomaterial that could be used to help meet significant medical needs for various soft-tissue replacements. Many efforts to create engineered soft-tissue constructs by seeding cells within collagen gels have been hampered because constituent cells contract collagen gels over time, resulting in a construct that is only a fraction of the original size and that contains a cell population that has suffered a large degree of cell death. However, the presence of embedded short collagen fibers has been shown to significantly limit contraction and dramatically enhance permeability in fibroblast-seeded collagen gels.
   Methods: Five volume fractions of short collagen fibers were embedded in fibroblast-seeded collagen gels. Collagen gel contraction (n >= 4 for all groups) and cell viability (n >= 3 for all groups) were examined after up to 2 weeks in culture.
   Results: The present study demonstrated that increasing the volume fraction of short collagen fibers in fibroblast-seeded collagen gels correspondingly reduced the amount of gel contraction without negatively impacting cell viability after 2 weeks of culture. Furthermore, operating curves that describe the quantitative relationships between the contraction of fibroblast-seeded collagen gel/collagen fiber composite biomaterials, time in culture, and volume fraction of embedded fibers were obtained.
   Conclusion: The resulting operating curves enable investigators to tailor initial fabrication procedures to ultimately yield cell-seeded collagen composites of specifically desired sizes-a critical step toward developing clinically useful engineered soft-tissue constructs.
C1 Purdue Univ, Sch Mech Engn, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.
   Tulane Univ, Dept Biomed Engn, New Orleans, LA 70118 USA.
   Rose Hulman Inst Technol, Dept Appl Biol & Biomed Engn, Terre Haute, IN 47803 USA.
RP Nauman, EA (reprint author), Purdue Univ, Sch Mech Engn, Weldon Sch Biomed Engn, 585 Purdue Mall, W Lafayette, IN 47907 USA.
EM enauman@purdue.edu
OI Gentleman, Eileen/0000-0003-0447-5137; Dee, Kay C/0000-0002-9069-4880
CR Allen Matthew, 1994, Clinical Materials, V16, P189, DOI 10.1016/0267-6605(94)90116-3
   *AM SOC PLAST SURG, 2004, 2003 REC SURG PROC
   ANDUJAR MB, 1992, J SUBMICR CYTOL PATH, V24, P145
   BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274
   Bellincampi LD, 1998, J ORTHOP RES, V16, P414, DOI 10.1002/jor.1100160404
   Cretel E, 2001, RHEUMATOL INT, V20, P129, DOI 10.1007/s002960000088
   CUKIER J, 1993, ANN INTERN MED, V118, P920, DOI 10.7326/0003-4819-118-12-199306150-00002
   De Filippo RE, 2002, J UROLOGY, V168, P1789, DOI 10.1097/01.ju.0000027662.69103.72
   DUNN MG, 1992, AM J SPORT MED, V20, P507, DOI 10.1177/036354659202000504
   DUNN MG, 1994, J ORTHOPAED RES, V12, P128, DOI 10.1002/jor.1100120116
   EHRLICH HP, 1990, TISSUE CELL, V22, P407, DOI 10.1016/0040-8166(90)90070-P
   Gentleman E, 2004, TISSUE ENG, V10, P421, DOI 10.1089/107632704323061780
   Gentleman E, 2003, BIOMATERIALS, V24, P3805, DOI 10.1016/S0142-9612(03)00206-0
   Hafemann B, 2001, J MATER SCI-MATER M, V12, P437, DOI 10.1023/A:1011205221972
   HARRIS AK, 1981, NATURE, V290, P249, DOI 10.1038/290249a0
   HARRIS AK, 1980, SCIENCE, V208, P177, DOI 10.1126/science.6987736
   HOUCK J, 1971, P SOC EXP BIOL MED, V138, P69
   Hunter CJ, 2002, BIOMATERIALS, V23, P1249, DOI 10.1016/S0142-9612(01)00245-9
   Jones R.M., 1975, MECH COMPOSITE MAT, P355
   Katz AJ, 1999, CLIN PLAST SURG, V26, P587
   Liu XD, 1998, AM J PHYSIOL-LUNG C, V274, pL58, DOI 10.1152/ajplung.1998.274.1.L58
   Masur SK, 1996, P NATL ACAD SCI USA, V93, P4219, DOI 10.1073/pnas.93.9.4219
   PACHENCE JM, 2000, PRINCIPLES TISSUE EN, P263
   Patrick CW, 2004, ANNU REV BIOMED ENG, V6, P109, DOI 10.1146/annurev.bioeng.6.040803.140032
   POSTLETHWAITE AE, 1978, P NATL ACAD SCI USA, V75, P871, DOI 10.1073/pnas.75.2.871
   Sittinger M, 1996, BIOMATERIALS, V17, P237, DOI 10.1016/0142-9612(96)85561-X
   SOO C, 1993, J DERMATOL SURG ONC, V19, P431, DOI 10.1111/j.1524-4725.1993.tb00370.x
   Taira M, 2003, J ORAL REHABIL, V30, P106, DOI 10.1046/j.1365-2842.2003.01001.x
   van Wachem PB, 2001, J BIOMED MATER RES, V55, P368, DOI 10.1002/1097-4636(20010605)55:3<368::AID-JBM1025>3.0.CO;2-5
   Vernon RB, 1996, J CELL BIOCHEM, V60, P185, DOI 10.1002/(SICI)1097-4644(19960201)60:2<185::AID-JCB3>3.0.CO;2-T
   von Heimburg D, 2001, BIOMATERIALS, V22, P429, DOI 10.1016/S0142-9612(00)00186-1
   Zhu YK, 2001, IN VITRO CELL DEV-AN, V37, P10
NR 32
TC 1
Z9 1
U1 0
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0032-1052
J9 PLAST RECONSTR SURG
JI Plast. Reconstr. Surg.
PD FEB
PY 2007
VL 119
IS 2
BP 508
EP 516
DI 10.1097/01.prs.0000246316.87802.b4
PG 9
WC Surgery
SC Surgery
GA 127KI
UT WOS:000243584300008
PM 17230083
DA 2018-10-20
ER

PT J
AU Martina, M
   Hutmacher, DW
AF Martina, Monique
   Hutmacher, Dietmar W.
TI Biodegradable polymers applied in tissue engineering research: a review
SO POLYMER INTERNATIONAL
LA English
DT Review
DE scaffolds; biodegradable polymers; tissue engineering; matrices
ID SHAPE-MEMORY POLYMERS; EPSILON-CAPROLACTONE; IN-VIVO; 1,3-TRIMETHYLENE
   CARBONATE; BIOMEDICAL APPLICATIONS; POLY(ETHYLENE GLYCOL); MULTIBLOCK
   COPOLYMERS; TRIBLOCK COPOLYMERS; NERVE GUIDE; SCAFFOLDS
AB Typical applications and research areas of polymeric biomaterials include tissue replacement, tissue augmentation, tissue support, and drug delivery. In many cases the body needs only the temporary presence of a device/biomaterial, in which instance biodegradable and certain partially biodegradable polymeric materials are better alternatives than biostable ones. Recent treatment concepts based on scaffold-based tissue engineering principles differ from standard tissue replacement and drug therapies as the engineered tissue aims not only to repair but also regenerate the target tissue. Cells have been cultured outside the body for many years; however, it has only recently become possible for scientists and engineers to grow complex three-dimensional tissue grafts to meet clinical needs. New generations of scaffolds based on synthetic and natural polymers are being developed and evaluated at a rapid pace, aimed at mimicking the structural characteristics of natural extracellular matrix. This review focuses on scaffolds made of more recently developed synthetic polymers for tissue engineering applications. Currently, the design and fabrication of biodegradable synthetic scaffolds is driven by four material categories: (i) common clinically established polymers, including polyglycolide, polylactides, polycaprolactone; (ii) novel di- and tri-block polymers; (iii) newly synthesized or studied polymeric biomaterials, such as polyorthoester, polyanhydrides, polyhydroxyalkanoate, polypyrroles, poly(ether ester amide)s, elastic shape-memory polymers; and (iv) biomimetic materials, supramolecular polymers formed by self-assembly, and matrices presenting distinctive or a variety of biochemical cues. This paper aims to review the latest developments from a scaffold material perspective, mainly pertaining to categories (ii) and (iii) listed above. (c) 2006 Society of Chemical Industry.
C1 Natl Univ Singapore, Yong Loo Lin Sch Med, Fac Engn, Div Bioengn,Dept Orthopaed Surg, Singapore 119260, Singapore.
RP Hutmacher, DW (reprint author), Natl Univ Singapore, Yong Loo Lin Sch Med, Fac Engn, Div Bioengn,Dept Orthopaed Surg, 10 Kent Ridge Crescent, Singapore 119260, Singapore.
EM biedwh@nus.edu.sg
OI Hutmacher, Dietmar Werner/0000-0001-5678-2134
CR AMBROSIO AM, 2003, IEEE ENG MED BIO SEP, P18
   Ambrosio AMA, 2002, BIOMATERIALS, V23, P1667, DOI 10.1016/S0142-9612(01)00293-9
   Barbato F, 2001, BIOMATERIALS, V22, P1371, DOI 10.1016/S0142-9612(00)00291-X
   Bezemer JM, 2000, J BIOMED MATER RES, V52, P8, DOI 10.1002/1097-4636(200010)52:1<8::AID-JBM2>3.0.CO;2-3
   BOURKE SL, 2003, TISSUE ENG, V10, P43
   Cohn D, 2002, J BIOMED MATER RES, V59, P273, DOI 10.1002/jbm.1242
   Cui XY, 2001, J BIOMED MATER RES, V56, P261, DOI 10.1002/1097-4636(200108)56:2<261::AID-JBM1094>3.0.CO;2-I
   Cui XY, 2003, BIOMATERIALS, V24, P777, DOI 10.1016/S0142-9612(02)00415-5
   Deng JS, 2003, PHARM DEV TECHNOL, V8, P31, DOI 10.1081/PDT-120017521
   Deschamps AA, 2003, BIOMATERIALS, V24, P2643, DOI 10.1016/S0142-9612(03)00054-1
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Fabre T, 2001, BIOMATERIALS, V22, P2951, DOI 10.1016/S0142-9612(01)00012-6
   Ferruti P, 2005, BIOMACROMOLECULES, V6, P2229, DOI 10.1021/bm050210+
   Ferruti P, 2005, MACROMOL BIOSCI, V5, P613, DOI 10.1002/mabi.200500020
   Fidkowski C, 2005, TISSUE ENG, V11, P302, DOI 10.1089/ten.2005.11.302
   George PM, 2005, BIOMATERIALS, V26, P3511, DOI 10.1016/j.biomaterials.2004.09.037
   Greish YE, 2005, BIOMATERIALS, V26, P1, DOI 10.1016/j.biomaterials.2004.02.016
   Grijpma DW, 2005, BIOMATERIALS, V26, P2795, DOI 10.1016/j.biomaterials.2004.08.002
   Guan HL, 2005, BIOMACROMOLECULES, V6, P1954, DOI 10.1021/bm0492069
   Guan JJ, 2005, BIOMATERIALS, V26, P3961, DOI 10.1016/j.biomaterials.2004.10.018
   Horch RA, 2004, BIOMACROMOLECULES, V5, P1990, DOI 10.1021/bm049768s
   Huang MH, 2004, J BIOMED MATER RES A, V69A, P417, DOI 10.1002/jbm.a.30008
   Hutmacher DW, 2001, ANN ACAD MED SINGAP, V30, P183
   Hwang MJ, 2005, BIOMACROMOLECULES, V6, P885, DOI 10.1021/bm049347a
   Jabbari E, 2005, BIOMACROMOLECULES, V6, P2503, DOI 10.1021/bm050206y
   Lee SH, 2003, J BIOMED MATER RES A, V66A, P29, DOI 10.1002/jbm.a.10497
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lendlein A, 2001, P NATL ACAD SCI USA, V98, P842, DOI 10.1073/pnas.031571398
   Lendlein A, 2005, NATURE, V434, P879, DOI 10.1038/nature03496
   Li SM, 2002, J MATER SCI-MATER M, V13, P81, DOI 10.1023/A:1013651022431
   Lietz M, 2006, BIOTECHNOL BIOENG, V93, P99, DOI 10.1002/bit.20688
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   NAIR SL, 2004, BIOMACROMOLECULES, V5, P2215
   Payne RG, 2002, BIOMATERIALS, V23, P4381, DOI 10.1016/S0142-9612(02)00186-2
   Pego AP, 2003, J BIOMED MATER RES A, V67A, P1044, DOI 10.1002/jbm.a.10121
   Pego AP, 2003, TISSUE ENG, V9, P981, DOI 10.1089/107632703322495628
   Porter BD, 2000, J BIOMECH ENG-T ASME, V122, P286, DOI 10.1115/1.429659
   Schachter DM, 2002, J CONTROL RELEASE, V78, P143, DOI 10.1016/S0168-3659(01)00487-4
   Sharma RI, 2004, J BIOMED MATER RES A, V69A, P114, DOI 10.1002/jbm.a.20125
   Shin H, 2003, BIOMATERIALS, V24, P3201, DOI 10.1016/S0142-9612(03)00168-6
   Stankus JJ, 2004, J BIOMED MATER RES A, V70A, P603, DOI 10.1002/jbm.a.30122
   Sundback CA, 2005, BIOMATERIALS, V26, P5454, DOI 10.1016/j.biomaterials.2005.02.004
   Wang C, 2004, NAT MATER, V3, P190, DOI 10.1038/nmat1075
   Wang SF, 2006, BIOMATERIALS, V27, P832, DOI 10.1016/j.biomaterials.2005.07.013
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Zhang JY, 2003, TISSUE ENG, V9, P1143, DOI 10.1089/10763270360728053
   Zhang JY, 2002, TISSUE ENG, V8, P771, DOI 10.1089/10763270260424132
NR 47
TC 248
Z9 260
U1 16
U2 236
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 0959-8103
J9 POLYM INT
JI Polym. Int.
PD FEB
PY 2007
VL 56
IS 2
BP 145
EP 157
DI 10.1002/pi.2108
PG 13
WC Polymer Science
SC Polymer Science
GA 128ZZ
UT WOS:000243699500001
DA 2018-10-20
ER

PT J
AU Lai, JCK
   Schoen, MP
   Gracia, AP
   Naidu, DS
   Leung, SW
AF Lai, J. C. K.
   Schoen, M. P.
   Gracia, A. Perez
   Naidu, D. S.
   Leung, S. W.
TI Prosthetic devices: challenges and implications of robotic implants and
   biological interfaces
SO PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART H-JOURNAL OF
   ENGINEERING IN MEDICINE
LA English
DT Article
DE prosthetics; robotic implants; functional prosthetic; robotic hand;
   artificial hand; electromyography signals and control; biocompatibility;
   inflammatory responses of cells to implanted material; interference of
   cells and tissues with implanted sensors; toxicity; nanomaterials
ID CARBON NANOTUBES; DESIGN; HANDS; SIGNALS; MUSCLE
AB Although among designs of prosthetics there have been some successes in the design of functional robotic implants, there remain many issues and challenges concerned with the failure to meet the 'ideal' requirements of a satisfactory prosthetic. These 'ideals' require the device to be easy to control, comfortable to wear, and cosmetically pleasing. Because the literature on prosthetics and robotic implants are voluminous, this review focuses on four topics to determine key challenges and opportunities underlying these interdisciplinary research areas: firstly, an artificial hand as a biomimetic; secondly, prosthetic implants (electromyography signals and control); thirdly, prosthetic implants and tissue reactions to the material(s) of implants; fourthly, how inflammatory responses of cells and tissues surrounding implanted sensors interfere with the signal transmission of such sensors. This review also notes the importance of the biological interfaces that robotic implants and other prosthetic devices are in contact with and how an improved knowledge of pathophysiological changes at such biological interfaces will lead to improved and more biocompatible designs of prosthetics. This review concludes with the vision that, to develop a design that satisfies the above 'ideals', an interdisciplinary team of biomedical and tissue engineers, and biomaterial and biomedical scientists is needed to work together holistically and synergistically.
C1 Idaho State Univ, Coll Pharm, Dept Pharmaceut Sci, Pocatello, ID 83209 USA.
   Idaho State Univ, Coll Engn, Pocatello, ID 83209 USA.
   Idaho State Univ, Measurement & Control Engn Res Ctr, Pocatello, ID 83209 USA.
   Idaho State Univ, Biomed Res Inst, Pocatello, ID 83209 USA.
RP Lai, JCK (reprint author), Idaho State Univ, Coll Pharm, Dept Pharmaceut Sci, 921 S 8th Ave,Stop 8288, Pocatello, ID 83209 USA.
EM lai@otc.isu.edu
RI Perez Gracia, Alba/L-6677-2017
OI Perez Gracia, Alba/0000-0002-6023-7857
FU NCRR NIH HHS [P20 RR16454]
CR Balasubramanian K, 2006, ANAL BIOANAL CHEM, V385, P452, DOI 10.1007/s00216-006-0314-8
   Bento R F, 1995, Ear Nose Throat J, V74, P640
   BICCHI A, 2000, P IEEE INT C ROB AUT, V1, P348
   BINGHAM JT, 2004, P 2004 ASME INT MECH
   Caffaz A, 1998, IEEE INT CONF ROBOT, P2075, DOI 10.1109/ROBOT.1998.680623
   Chan FHY, 2000, IEEE T REHABIL ENG, V8, P305, DOI 10.1109/86.867872
   Cheron G, 1996, IEEE T BIO-MED ENG, V43, P552, DOI 10.1109/10.488803
   CHO KJ, 2006, P IEEE INT C ROB AUT, P706
   Cram J, 1988, INTRO SURFACE ELECTR
   CUTKOSKY MR, 1989, IEEE T ROBOTIC AUTOM, V5, P269, DOI 10.1109/70.34763
   De Laurentis Kathryn J, 2002, Technol Health Care, V10, P91
   DOLLAR AM, 2006, P ASME 2006 INT ENG, P1
   ENGLEHART K, 1999, P 21 ANN INT C IEEE, V1, P569
   FERNANDEZ JJ, 1996, P GEN PROGR C, P63
   Fiorito S, 2006, J NANOSCI NANOTECHNO, V6, P591, DOI 10.1166/jnn.2006.125
   Furukawa N, 2006, IEEE INT CONF ROBOT, P181, DOI 10.1109/ROBOT.2006.1641181
   GIALIAS N, 2004, P IEEE INT C ROB AUT, V4, P3380
   GRACIA AP, 2006, LIT REV HAND RES
   Haynes DR, 1998, CLIN ORTHOP RELAT R, P223
   Huang H P, 1999, P IEEE INT C ROB AUT, V3, P2392
   Kargov A, 2004, DISABIL REHABIL, V26, P705, DOI 10.1080/09638280410001704278
   Karlsson S, 2000, IEEE T BIO-MED ENG, V47, P228, DOI 10.1109/10.821766
   Kim G, 2005, P ANN INT IEEE EMBS, P6908, DOI 10.1109/IEMBS.2005.1616094
   Kyberd P. J., 2003, P 2003 IEEE INT C RO, V3, P3231
   Kyberd PJ, 2001, ROBOTICA, V19, P593
   Lai J. C. K., 2005, ENCY BIOMATERIALS BI, P1
   Lee M. -J., 2006, P 1 IEEE RAS EMBS IN, p1172 1177
   Lee YK, 2002, PROC IEEE MICR ELECT, P702, DOI 10.1109/MEMSYS.2002.984367
   LEUNG SW, 2006, ENCY BIOMATERIALS BI, P1
   LI J, 1999, P IEEE C SYST MAN CY, V6, P792
   Loh CS, 2005, P ANN INT IEEE EMBS, P6900
   LOTTI F, 2005, P 2005 IEEE INT C R
   Luo ZW, 2006, BIOMIMETICS: BIOLOGICALLY INSPIRED TECHNOLOGIES, P399
   MCGREERY D, 2004, NEUROPROSTHETICS THE, P592
   Munichor M, 2003, ACTA CYTOL, V47, P270, DOI 10.1159/000326515
   Murray R.M., 1994, MATH INTRO ROBOTIC M
   Naidu DS, 2003, OPTIMAL CONTROL SYST
   NELSON JR, 2004, NEUROPROSTHETICS THE, P1219
   Northrop R, 2004, ANAL APPL ANALOG ELE, P6
   Okamura A., 2000, P IEEE INT C ROB AUT, VI, P255
   OSTOVSKII AI, 1995, VESTN OTORINOLARYNG, V3, P47
   Ovaska SJ, 2002, IEEE T SYST MAN CY C, V32, P72, DOI 10.1109/TSMCC.2002.801354
   Pennekamp PH, 2006, J ORTHOP RES, V24, P531, DOI 10.1002/jor.20066
   PRINCE MR, 1988, INVEST RADIOL, V23, P294, DOI 10.1097/00004424-198804000-00009
   RODRIGUEZCHEU LE, 2005, P IEEE RSJ INT C INT, P541
   Sebastiani F, 2003, P 2003 IEEE ASME INT, V1, P64
   Shahid S, 2005, IEEE T BIO-MED ENG, V52, P1195, DOI 10.1109/TBME.2005.847525
   Sinha N, 2006, J NANOSCI NANOTECHNO, V6, P573, DOI 10.1166/jnn.2006.121
   Supan TJ, 2003, HAND CLIN, V19, P185, DOI 10.1016/S0749-0712(02)00139-7
   Tian FR, 2006, TOXICOL IN VITRO, V20, P1202, DOI 10.1016/j.tiv.2006.03.008
   Trocciola SA, 2006, J VASC SURG, V43, P109, DOI 10.1016/j.jvs.2005.09.023
   Wang W, 2005, DENT MATER J, V24, P478, DOI 10.4012/dmj.24.478
   Weir RF, 2001, J REHABIL RES DEV, V38, P357
   YANG J, 2004, DES ENG TECHN C COMP
   Zecca M, 2002, Crit Rev Biomed Eng, V30, P459, DOI 10.1615/CritRevBiomedEng.v30.i456.80
   ZHAO J, 2006, P 1 IEEE RAS INT C B
   ZOLLO L, 2006, P 1 IEEE RAS INT C B
NR 57
TC 30
Z9 31
U1 2
U2 24
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0954-4119
EI 2041-3033
J9 P I MECH ENG H
JI Proc. Inst. Mech. Eng. Part H-J. Eng. Med.
PD FEB
PY 2007
VL 221
IS H2
BP 173
EP 183
DI 10.1243/09544119JEIM210
PG 11
WC Engineering, Biomedical
SC Engineering
GA 147FI
UT WOS:000244988400008
PM 17385571
DA 2018-10-20
ER

PT J
AU Narayanan, R
   Seshadri, SK
   Kwon, TY
   Kim, KH
AF Narayanan, R.
   Seshadri, S. K.
   Kwon, T. Y.
   Kim, K. H.
TI Electrochemical nano-grained calcium phosphate coatings on Ti-6Al-4V for
   biomaterial applications
SO SCRIPTA MATERIALIA
LA English
DT Article
DE titanium alloy; ultrasonics; coating; nano; calcium phosphate
ID SIMULATED BODY-FLUID; SPRAYED HYDROXYAPATITE COATINGS; APATITE COATINGS;
   TITANIUM SUBSTRATE; DEPOSITION; MICROSTRUCTURE; TEMPERATURE; MORPHOLOGY;
   BEHAVIOR; ALLOYS
AB Electrochemically deposited nano-grained calcium phosphate coatings were produced on titanium alloy substrates using aqueous electrolyte maintained at acidic pH. Different coatings were produced by using different cathodic current densities and/or ultrasonic agitation of the electrolytic bath. The structure of the coatings was characterized by X-ray diffraction, scanning electron microscopy and transmission electron microscopy. Ultrasonated bath produced coatings containing dicalcium phosphate dehydrate and the grain sizes were in the range of 50-100 nm. (c) 2006 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 Indian Inst Technol, Dept Met & Mat Engn, Madras 600036, Tamil Nadu, India.
   Kyungpook Natl Univ, Coll Dent, Dept Dent Biomat, Taegu 702701, South Korea.
RP Narayanan, R (reprint author), Indian Inst Technol, Dept Met & Mat Engn, Madras 600036, Tamil Nadu, India.
EM rnarayan69@hotmail.com
CR Arenas MA, 2000, BRIT CORROS J, V35, P232, DOI 10.1179/000705900101501308
   Balasundaram G, 2006, BIOMATERIALS, V27, P2798, DOI 10.1016/j.biomaterials.2005.12.008
   Ban S, 1998, BIOMATERIALS, V19, P1245, DOI 10.1016/S0142-9612(98)00032-5
   BAN SJ, 1995, BIOMATERIALS, V16, P977, DOI 10.1016/0142-9612(95)94904-Y
   de Sena LA, 2002, J BIOMED MATER RES, V60, P1
   DUCHEYNE P, 1986, BIOMATERIALS, V7, P97, DOI 10.1016/0142-9612(86)90063-3
   Gledhill HC, 2001, BIOMATERIALS, V22, P695, DOI 10.1016/S0142-9612(00)00232-5
   Grassmann O, 2000, J BIOMED MATER RES, V53, P685, DOI 10.1002/1097-4636(2000)53:6<685::AID-JBM11>3.3.CO;2-2
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   ISHIZAWA H, 1995, J BIOMED MATER RES, V29, P65, DOI 10.1002/jbm.820290110
   Jonasova L, 2002, BIOMATERIALS, V23, P3095, DOI 10.1016/S0142-9612(02)00043-1
   Kasuga T, 2002, J CRYST GROWTH, V235, P235, DOI 10.1016/S0022-0248(01)01782-1
   Khor KA, 2000, MAT SCI ENG A-STRUCT, V281, P221, DOI 10.1016/S0921-5093(99)00717-0
   Kim HW, 2004, BIOMATERIALS, V25, P2533, DOI 10.1016/j.biomaterials.2003.09.041
   Kumta PN, 2005, ACTA BIOMATER, V1, P65, DOI 10.1016/j.actbio.2004.09.008
   Kuo MC, 2002, MAT SCI ENG C-BIO S, V20, P153, DOI 10.1016/S0928-4931(02)00026-7
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Meng XW, 2006, KEY ENG MAT, V309-311, P639, DOI 10.4028/www.scientific.net/KEM.309-311.639
   Montenero A, 2000, J MATER SCI, V35, P2791, DOI 10.1023/A:1004738900778
   Narayanan R, 2006, SURF COAT TECH, V200, P4720, DOI 10.1016/j.surfcoat.2005.04.040
   Peng P, 2006, J BIOMED MATER RES A, V76A, P347, DOI 10.1002/jbm.a.30514
   SHIRKHANZADEH M, 1992, J MATER SCI-MATER M, V3, P322, DOI 10.1007/BF00705362
   Shirkhanzadeh M., 1994, Nanostructured Materials, V4, P677, DOI 10.1016/0965-9773(94)90020-5
   Shirkhanzadeh M, 1998, J MATER SCI-MATER M, V9, P67, DOI 10.1023/A:1008838813120
   Song WH, 2004, BIOMATERIALS, V25, P3341, DOI 10.1016/j.biomaterials.2003.09.103
   WARD BC, 2006, MAT SCI ENG C
   WEBSTER T, 2005, NANOMED-NANOTECHNOL, V1, P251
   Yen S. K., 2002, MATER CHEM PHYS, V77, P70
NR 28
TC 60
Z9 61
U1 0
U2 13
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1359-6462
J9 SCRIPTA MATER
JI Scr. Mater.
PD FEB
PY 2007
VL 56
IS 3
BP 229
EP 232
DI 10.1016/j.scriptamat.2006.10.004
PG 4
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 115HX
UT WOS:000242726500013
DA 2018-10-20
ER

PT J
AU Takahashi, Y
   Yamamoto, M
   Yamada, K
   Kawakami, O
   Tabata, Y
AF Takahashi, Yoshitake
   Yamamoto, Masaya
   Yamada, Keisuke
   Kawakami, Osamu
   Tabata, Yasuhiko
TI Skull bone regeneration in nonhuman primates by controlled release of
   bone morphogenetic protein-2 from a biodegradable hydrogel
SO TISSUE ENGINEERING
LA English
DT Article
ID FIBROBLAST-GROWTH-FACTOR; RAT ECTOPIC MODEL; CLINICAL-APPLICATIONS;
   BIOMATERIAL CARRIERS; COLLAGEN SPONGES; RHBMP-2; PHARMACOKINETICS;
   OSTEOINDUCTION; IMPLANTATION; DELIVERY
AB The objective of this study was to investigate the feasibility of biodegradable gelatin hydrogels as the controlled-release carrier of bone morphogenetic protein-2 (BMP-2) to enhance bone regeneration at a skull defect of nonhuman primates. Hydrogels with 3 different water contents were prepared through glutaraldehyde crosslinking of gelatin with an isoelectric point of 9.0 under varied reaction conditions. A critical-sized defect (6 mm in diameter) was prepared at the skull bone of skeletally mature cynomolgus monkeys, and gelatin hydrogels incorporating various doses of BMP-2 were applied to the defects. When the bone regeneration was evaluated by soft radiography and bone mineral density (BMD) examinations, the gelatin hydrogel incorporating BMP-2 exhibited significantly higher osteoinduction activity than did an insoluble bone matrix that incorporated BMP-2 (one of the best osteoinduction systems), although the activity depended on the water content of hydrogels. BMD enhancement was highest for the gelatin hydrogel that had a water content of 97.8 wt% among all types of hydrogels. Moreover, the gelatin hydrogel enabled BMP-2 to induce the bone regeneration in nonhuman primates even at low doses. We conclude that the controlled release of BMP-2 for a certain time period was essential to inducing the osteoinductive potential of BMP-2.
C1 Kyoto Univ, Inst Frontier Med Sci, Dept Biomat, Field Tissue Engn,Sakyo Ku, Kyoto 6068507, Japan.
   Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto 6068507, Japan.
RP Tabata, Y (reprint author), Kyoto Univ, Inst Frontier Med Sci, Dept Biomat, Field Tissue Engn,Sakyo Ku, 53 Kawahara Cho, Kyoto 6068507, Japan.
EM yasuhiko@frontier.kyoto-u.ac.jp
CR Boden SD, 2000, SPINE, V25, P376, DOI 10.1097/00007632-200002010-00020
   Boyne P J, 1997, Int J Periodontics Restorative Dent, V17, P11
   COOK SD, 1994, J BONE JOINT SURG AM, V76A, P827, DOI 10.2106/00004623-199406000-00006
   Einhorn TA, 2003, J BONE JOINT SURG AM, V85A, P82, DOI 10.2106/00004623-200300003-00014
   Friedlaender GE, 2001, J BONE JOINT SURG S1, V83, P151
   Friess W, 1999, INT J PHARM, V187, P91, DOI 10.1016/S0378-5173(99)00174-X
   Geesink RGT, 1999, J BONE JOINT SURG BR, V81B, P710, DOI 10.1302/0301-620X.81B4.9311
   Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010
   Gittens SA, 2001, J DRUG TARGET, V9, P407, DOI 10.3109/10611860108998776
   Groeneveld EHJ, 1999, CLIN ORAL IMPLAN RES, V10, P499, DOI 10.1034/j.1600-0501.1999.100608.x
   Hollinger JO, 1998, J BIOMED MATER RES, V43, P356, DOI 10.1002/(SICI)1097-4636(199824)43:4<356::AID-JBM3>3.0.CO;2-7
   Hollinger JO, 1998, ADV DRUG DELIV REV, V31, P303
   Lieberman JR, 2002, J BONE JOINT SURG AM, V84A, P1032, DOI 10.2106/00004623-200206000-00022
   Mont MA, 2004, J BONE JOINT SURG AM, V86A, P41, DOI 10.2106/00004623-200412002-00008
   SEEHERMAN H, 2003, J BONE JOINT SURG S, V3, P96
   Tabata Y, 1999, J NEUROSURG, V91, P851, DOI 10.3171/jns.1999.91.5.0851
   Takita H, 2004, J BIOMED MATER RES A, V71A, P181, DOI 10.1002/jbm.a.30152
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   URIST MR, 1984, CLIN ORTHOP RELAT R, P277
   Valentin-Opran A, 2002, CLIN ORTHOP RELAT R, P110
   VEHOF JW, 2004, J BIOMED MATER RES, V71, P181
   Wheeler DI, 1998, J BIOMED MATER RES, V43, P365, DOI 10.1002/(SICI)1097-4636(199824)43:4<365::AID-JBM4>3.0.CO;2-6
   Wozney JM, 1998, CLIN ORTHOP RELAT R, P26
   Yamada K, 1997, J NEUROSURG, V86, P871, DOI 10.3171/jns.1997.86.5.0871
   Yamamoto M, 2003, BIOMATERIALS, V24, P4375, DOI 10.1016/S0142-9612(03)00337-5
   Yamamoto M, 2006, TISSUE ENG, V12, P1305, DOI 10.1089/ten.2006.12.1305
   Yoon ST, 2002, CLIN ORTHOP RELAT R, P33
   Zegzula HD, 1997, J BONE JOINT SURG AM, V79A, P1778, DOI 10.2106/00004623-199712000-00003
NR 29
TC 56
Z9 60
U1 0
U2 3
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD FEB
PY 2007
VL 13
IS 2
BP 293
EP 300
DI 10.1089/ten.2006.0088
PG 8
WC Cell & Tissue Engineering
SC Cell Biology
GA 136UW
UT WOS:000244250600008
PM 17504062
DA 2018-10-20
ER

PT J
AU Gupta, MK
   Khokhar, SK
   Phillips, DM
   Sowards, LA
   Drummy, LF
   Kadakia, MP
   Naik, RR
AF Gupta, Maneesh K.
   Khokhar, Shama K.
   Phillips, David M.
   Sowards, Laura A.
   Drummy, Lawrence F.
   Kadakia, Madhavi P.
   Naik, Rajesh R.
TI Patterned silk films cast from ionic liquid solubilized fibroin as
   scaffolds for cell growth
SO LANGMUIR
LA English
DT Article
ID FIBROBLASTS; DISSOLUTION; SPECTROSCOPY; SUBSTRATUM; ALIGNMENT; SOLVENTS;
   FIBERS
AB Silk is an attractive biomaterial for use in tissue engineering applications because of its slow degradation, excellent mechanical properties, and biocompatibility. In this report, we demonstrate a simple method to cast patterned films directly from silk fibroin dissolved in an ionic liquid. The films cast from the silk ionic liquid solution were found to support normal cell proliferation and differentiation. The versatility of the silk ionic liquid solutions and the ability to process large amounts of silk into materials with controlled surface topography directly from the dissolved silk ionic liquid solution could enhance the desirability of biomaterials such as silk for a variety of applications.
C1 Wright State Univ, Dept Biochem & Mol Biol, Dayton, OH 45432 USA.
   Air Force Res Lab, Mat & Mfg Directorate, Dayton, OH 45433 USA.
RP Kadakia, MP (reprint author), Wright State Univ, Dept Biochem & Mol Biol, Dayton, OH 45432 USA.
EM madhavi.kadakia@wright.edu; rajesh.naik@wpafb.af.mil
RI Gupta, Maneesh/E-7492-2010
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Asakura T, 2002, J AM CHEM SOC, V124, P8794, DOI 10.1021/ja020244e
   CANETTI M, 1989, BIOPOLYMERS, V28, P1613, DOI 10.1002/bip.360280910
   Chen X, 2001, BIOPHYS CHEM, V89, P25, DOI 10.1016/S0301-4622(00)00213-1
   CHOU LS, 1995, J CELL SCI, V108, P1563
   CURTIS ASG, 1990, CRIT REV BIOCOMPAT, V5, P343
   DENBRABER ET, 1995, J BIOMED MATER RES, V29, P511, DOI 10.1002/jbm.820290411
   Docherty KM, 2005, GREEN CHEM, V7, P185, DOI 10.1039/b419172b
   DUNN GA, 1986, J CELL SCI, V83, P313
   Grinnell F, 2003, TRENDS CELL BIOL, V13, P264, DOI 10.1016/S0962-8924(03)00057-6
   Inouye K, 1998, J BIOCHEM BIOPH METH, V37, P159, DOI 10.1016/S0165-022X(98)00024-4
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   Lam MT, 2006, BIOMATERIALS, V27, P4340, DOI 10.1016/j.biomaterials.2006.04.012
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Lu JF, 2005, J INVEST DERMATOL, V124, P778, DOI 10.1111/j.0022-202X.2005.23641.x
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V92, P2002, DOI DOI 10.1093/NAR/29.9.E45
   Phillips DM, 2005, J MATER CHEM, V15, P4206, DOI 10.1039/b510069k
   Phillips DM, 2004, J AM CHEM SOC, V126, P14350, DOI 10.1021/ja046079f
   Rogers RD, 2003, SCIENCE, V302, P792, DOI 10.1126/science.1090313
   Rosso F, 2005, J CELL PHYSIOL, V203, P465, DOI 10.1002/jcp.20270
   Servoli E, 2005, MACROMOL BIOSCI, V5, P1175, DOI 10.1002/mabi.200500137
   Stepnowski P, 2004, HUM EXP TOXICOL, V23, P513, DOI 10.1191/0960327104ht480oa
   Swatloski RP, 2002, J AM CHEM SOC, V124, P4974, DOI 10.1021/ja025790m
   SWATLOSKI RP, 2005, CHEM COMMUN, V1, P668
   Turner MB, 2004, BIOMACROMOLECULES, V5, P1379, DOI 10.1021/bm049748q
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   WENTA S, MICRON
   Xie HB, 2005, GREEN CHEM, V7, P606, DOI 10.1039/b502547h
   Yamada H, 2001, MAT SCI ENG C-BIO S, V14, P41, DOI 10.1016/S0928-4931(01)00207-7
   Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078
   Zhou ZH, 2006, IND ENG CHEM RES, V45, P525, DOI 10.1021/ie050947f
NR 31
TC 78
Z9 83
U1 6
U2 50
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD JAN 30
PY 2007
VL 23
IS 3
BP 1315
EP 1319
DI 10.1021/la062047p
PG 5
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 128UK
UT WOS:000243684100058
PM 17241052
DA 2018-10-20
ER

PT J
AU Hwang, DS
   Gim, Y
   Kang, DG
   Kim, YK
   Cha, HJ
AF Hwang, Dong Soo
   Gim, Youngsoo
   Kang, Dong Gyun
   Kim, Yeon Kyu
   Cha, Hyung Joon
TI Recombinant mussel adhesive protein Mgfp-5 as cell adhesion biomaterial
SO JOURNAL OF BIOTECHNOLOGY
LA English
DT Article
DE mussel adhesive protein; recombinant adhesive; Mgfp-5; cell adhesion;
   cytochemistry
ID TYROSINE-CONTAINING PEPTIDES; DROSOPHILA S2 CELLS; MYTILUS-EDULIS-L;
   ESCHERICHIA-COLI; EXPRESSION; GENE; MICROCAPSULES; OPTIMIZATION;
   POLYLYSINE; INDUCTION
AB Mytilus galloprovincialis foot protein type-5 (Mgfp-5) is one of the mussel adhesive proteins that participate in adhesion with the substratum. We previously reported the production of recombinant Mgfp-5 in Escherichia coli and showed that the recombinant protein had superior adhesion abilities versus those of Cell-Tak, a commercially available mussel adhesive protein mixture. In the present work, we investigated the feasibility of using recombinant Mgfp-5 as a cell adhesion agent. Purified and tyrosinase-modified recombinant Mgfp-5 was used to adhere living anchorage-independent cells such as insect Drosophila S2 cells and human MOLT-4 cells onto glass slides. Our results revealed that these cell lines efficiently attached to recombinant Mgfp-5-coated glass surfaces, and that surface-immobilized S2 cells were viable and able to undergo cell division for up to 1 week. Cytochemical studies with 4',6-diamidino-2-phenylindole (DAPI) staining of nuclei and immunofluorescence for secreted foreign human erythropoietin (hEPO) from recombinant S2 cells and quantitative comparative analyses of S2 cell binding ability with Cell-Tak and poly-L-lysine, the main cell adhesion agent, were performed to demonstrate successful usage of recombinant Mgfp-5 for cell biological applications. Collectively, these results indicate that recombinant Mgfp-5 may be a useful new cell adhesion biomaterial for anchorage-independent cells. (c) 2006 Elsevier B.V. All rights reserved.
C1 Pohang Univ Sci & Technol, Dept Chem Engn, Pohang 790784, South Korea.
   Pohang Univ Sci & Technol, Inst Environm & Energy Technol, Pohang 790784, South Korea.
RP Cha, HJ (reprint author), Pohang Univ Sci & Technol, Dept Chem Engn, Pohang 790784, South Korea.
EM hjcha@postech.ac.kr
RI Hwang, Dong Soo/C-7291-2011
OI Hwang, Dong Soo/0000-0002-2487-2255
CR BENEDICT CV, 1989, ACS SYM SER, V385, P465, DOI 10.1021/bk-1989-0385.ch033
   Benthien JP, 2004, ANN ANAT, V186, P561, DOI 10.1016/S0940-9602(04)80108-0
   CURIEL DT, 1991, P NATL ACAD SCI USA, V88, P8850, DOI 10.1073/pnas.88.19.8850
   Deming TJ, 1999, CURR OPIN CHEM BIOL, V3, P100, DOI 10.1016/S1367-5931(99)80018-0
   DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680
   DOVE J, 1986, J AM DENT ASSOC, V112, P879
   FILPULA DR, 1990, BIOTECHNOL PROGR, V6, P171, DOI 10.1021/bp00003a001
   GRANDE DA, 1988, B HOSP JOINT DIS ORT, V48, P140
   Hill RM, 2001, PROTEIN EXPRES PURIF, V22, P406, DOI 10.1006/prep.2001.1463
   Hwang DS, 2005, BIOTECHNOL PROGR, V21, P965, DOI 10.1021/bp050014e
   Hwang DS, 2004, APPL ENVIRON MICROB, V70, P3352, DOI 10.1128/AEM.70.6.3352-3359.2004
   INOUE K, 1995, J BIOL CHEM, V270, P6698, DOI 10.1074/jbc.270.12.6698
   ISHIYAMA M, 1995, ANALYST, V120, P113, DOI 10.1039/an9952000113
   Jee JG, 2000, RAPID COMMUN MASS SP, V14, P1563, DOI 10.1002/1097-0231(20000830)14:16<1563::AID-RCM45>3.0.CO;2-4
   Kamino K, 2000, J BIOL CHEM, V275, P27360
   King A, 2003, J BIOMED MATER RES A, V64A, P533, DOI 10.1002/jbm.a.10276
   Kitamura M, 1999, J POLYM SCI POL CHEM, V37, P729, DOI 10.1002/(SICI)1099-0518(19990315)37:6<729::AID-POLA8>3.3.CO;2-V
   MARUMO K, 1986, BIOCHIM BIOPHYS ACTA, V872, P98, DOI 10.1016/0167-4838(86)90152-4
   MAZIA D, 1975, J CELL BIOL, V66, P198, DOI 10.1083/jcb.66.1.198
   MINOWADA J, 1972, J NATL CANCER I, V49, P891
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   PAPOV VV, 1995, J BIOL CHEM, V270, P20183, DOI 10.1074/jbc.270.34.20183
   RZEPECKI LM, 1992, BIOL BULL, V183, P123, DOI 10.2307/1542413
   SALERNO AJ, 1993, APPL MICROBIOL BIOT, V39, P221
   SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353
   Shin HS, 2002, BIOTECHNOL PROGR, V18, P1187, DOI 10.1021/bp025533l
   Strand BL, 2001, CELL TRANSPLANT, V10, P263, DOI 10.3727/000000001783986800
   Waite JH, 2005, J ADHESION, V81, P297, DOI 10.1080/00218460590944602
   Waite JH, 2002, INTEGR COMP BIOL, V42, P1172, DOI 10.1093/icb/42.6.1172
   WAITE JH, 1983, J BIOL CHEM, V258, P2911
   Waite JH, 2001, BIOCHEMISTRY-US, V40, P2887, DOI 10.1021/bi002718x
   WAITE JH, 1983, BIOL REV, V58, P209, DOI 10.1111/j.1469-185X.1983.tb00387.x
   WAITE JH, 1984, ANAL CHEM, V56, P1935, DOI 10.1021/ac00275a040
   Yu ME, 1998, MACROMOLECULES, V31, P4739, DOI 10.1021/ma980268z
   Yu ME, 1999, J AM CHEM SOC, V121, P5825, DOI 10.1021/ja990469y
   Yuan J, 2004, ALTEX-ALTERN TIEREXP, V21, P3
NR 36
TC 25
Z9 31
U1 3
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1656
J9 J BIOTECHNOL
JI J. Biotechnol.
PD JAN 20
PY 2007
VL 127
IS 4
BP 727
EP 735
DI 10.1016/j.jbiotec.2006.08.005
PG 9
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 129BY
UT WOS:000243704600017
PM 16979252
DA 2018-10-20
ER

PT J
AU Xue, WC
   Hosick, HL
   Bandyopadhyay, A
   Bose, S
   Ding, CX
   Luk, KDK
   Cheung, KMC
   Lu, WW
AF Xue, Weichang
   Hosick, Howard L.
   Bandyopadhyay, Arnit
   Bose, Susmita
   Ding, Chuanxian
   Luk, K. D. K.
   Cheung, K. M. C.
   Lu, W. W.
TI Preparation and cell-materials interactions of plasma sprayed
   strontium-containing hydroxyapatite coating
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE strontium; hydroxyapatite coating; plasma spraying; bioactivity;
   ostcoblast
ID BONE-FORMATION; IN-VITRO; POSTMENOPAUSAL OSTEOPOROSIS; RANELATE;
   RESORPTION; WOMEN; RATS; CEMENT; GROWTH; MODE
AB The use of strontium-containing hydroxyapatite (Sr-HA) as a biomaterial has been reported recently. In vitro and in vivo studies have shown that Sr-RA promotes osteoblast response and stimulates new bone formation. In order to extend its usage to major load-bearing applications, such as artificial hip replacement, it has been proposed that the material could be used in the form of a coating on implant surfaces. This paper reports a preliminary study of biocompatibility of plasma sprayed Sr-HA coatings on a metallic substrate. Coatings of Sr-HA containing 10 mol% Sr2+ was produced on titanium alloy substrates. The coating exhibited good bonding with the substrate. The bioactivity of Sr-HA coating was evaluated in vitro by immersion in simulated body fluid (SBF). After immersion in SBF, Sr-HA coating exhibited great ability to induce apatite precipitation on its surface. The possible effects of cell-materials interactions of Sr-HA coating were examined by culturing osteoprecursor cells (OPC1) on coating surfaces. The effect of Sr-HA was also compared to a hydroxyapatite (HA) coating, which is widely used in orthopedics and dentistry. The results indicated that Sr-HA coating had good biocompatibility with human osteoblasts. OPC1 cells survived and proliferated well on the surface of coating. Sr-HA coating promoted OPC1 cells attachment, and more local contacts were produced on the surface. The presence of Sr stimulated OPC1 cell differentiation and ALP expression. No deleterious effect on ECM formation and mineralization was found with Sr-HA coating. The results indicated that Sr-HA coating had good mechanical properties and bioactivity in vitro. (c) 2006 Elsevier B.V. All rights reserved.
C1 Washington State Univ, Sch Mech & Mat Engn, Pullman, WA 99164 USA.
   Washington State Univ, WM Keck Biomed Mat Res Lab, Pullman, WA 99164 USA.
   Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA.
   Chinese Acad Sci, Shanghai Inst Ceram, Shanghai 200050, Peoples R China.
   Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China.
RP Bose, S (reprint author), Washington State Univ, Sch Mech & Mat Engn, Pullman, WA 99164 USA.
EM sbose@wsu.edu
RI Bandyopadhyay, Amit/A-7780-2012
OI Bandyopadhyay, Amit/0000-0003-0992-5387
CR Ammann P, 2004, J BONE MINER RES, V19, P2012, DOI 10.1359/JBMR.040906
   Ammann P, 2005, OSTEOPOROSIS INT, V16, pS11, DOI 10.1007/s00198-004-1809-9
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Aubin Jane E., 1996, P51
   Barbara A, 2004, METABOLISM, V53, P532, DOI 10.1016/j.metabol.2003.10.022
   BERESFORD JN, 1993, AM J MED GENET, V45, P163, DOI 10.1002/ajmg.1320450205
   Canalis E, 1996, BONE, V18, P517, DOI 10.1016/8756-3282(96)00080-4
   Christoffersen J, 1997, BONE, V20, P47, DOI 10.1016/S8756-3282(96)00316-X
   Delmas PD, 2005, OSTEOPOROSIS INT, V16, pS16, DOI 10.1007/s00198-004-1767-2
   Fu Y.F., 2001, CHIN J STOMA MAT APP, V19, P178
   Grynpas MD, 1996, BONE, V18, P253, DOI 10.1016/8756-3282(95)00484-X
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Kim HW, 2004, J MATER SCI-MATER M, V15, P1129, DOI 10.1023/B:JMSM.0000046395.76435.60
   Lacefield WR, 1993, INTRO BIOCERAMICS
   Leroux L, 2001, J MATER RES, V16, P171, DOI 10.1557/JMR.2001.0028
   Li YW, 2000, J BIOMED MATER RES, V52, P164, DOI 10.1002/1097-4636(200010)52:1<164::AID-JBM21>3.3.CO;2-I
   MALAVAL L, 1994, J CELL PHYSIOL, V158, P555, DOI 10.1002/jcp.1041580322
   MARIE PJ, 1993, J BONE MINER RES, V8, P607
   Marie PJ, 2005, OSTEOPOROSIS INT, V16, pS7, DOI 10.1007/s00198-004-1753.8
   Meunier PJ, 2004, NEW ENGL J MED, V350, P459, DOI 10.1056/NEJMoa022436
   Qiu K, 2006, BIOMATERIALS, V27, P1277, DOI 10.1016/j.biomaterials.2005.08.006
   Reginster JY, 2005, J CLIN ENDOCR METAB, V90, P2816, DOI 10.1210/jc.2004-1774
   Rokusek D, 2005, J BIOMED MATER RES A, V75A, P588, DOI 10.1002/jbm.a.30459
   Stein GS, 1993, CELLULAR MOL BIOL BO, P48
   Storrie H, 2005, BIOMATERIALS, V26, P5492, DOI 10.1016/j.biomaterials.2005.01.043
   Takahashi N, 2003, J BONE MINER RES, V18, P1082, DOI 10.1359/jbmr.2003.18.6.1082
   Winn SR, 1999, J BONE MINER RES, V14, P1721, DOI 10.1359/jbmr.1999.14.10.1721
   Wong CT, 2004, J BIOMED MATER RES A, V68A, P513, DOI 10.1002/jbm.a.20089
   XUE WC, IN PRESS J BIOMED A
   Zamir E, 2001, J CELL SCI, V114, P3583
NR 30
TC 94
Z9 97
U1 3
U2 48
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD JAN 15
PY 2007
VL 201
IS 8
BP 4685
EP 4693
DI 10.1016/j.surfcoat.2006.10.012
PG 9
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 128KF
UT WOS:000243655900026
DA 2018-10-20
ER

PT J
AU Hanif, MA
   Nadeem, R
   Bhatti, HN
   Ahmad, NR
   Ansari, TM
AF Hanif, Muhammad Asif
   Nadeem, Raziya
   Bhatti, Haq Nawaz
   Ahmad, Najum Rashid
   Ansari, Tariq Mehmood
TI Ni(II) biosorption by Cassia fistula (Golden Shower) biomass
SO JOURNAL OF HAZARDOUS MATERIALS
LA English
DT Article
DE sorption; Ni(II); equilibrium; kinetics; Cassia fistula
ID HEAVY-METALS; AQUEOUS-SOLUTIONS; ARTHROBACTER-SP; TOXIC METALS; BASIC
   DYE; REMOVAL; EQUILIBRIUM; COPPER; IONS; BIOSORBENT
AB Cassia fistula is a fast-growing, medium-sized, deciduous tree which is now widely cultivated worldwide as an ornamental tree for its beautiful showy yellow flowers. Methods are required to reuse fallen leaves, branches, stem bark and pods when they start getting all over lawn. This investigation studies the use of these non-useful parts of C fistula as naturally occurring biosorbent for the batch removal of Ni(II) in a well stirred system under different experimental conditions. The data showed that the maximum pH (pH(max)) for efficient sorption of Ni(II) was 6 at which evaluated biosorbent dosage, biosorbent particle size, initial concentrations of Ni(II) and sorption time were 0.1 g/100 mL, < 0.255 mm, up to 200 mg/L and 720 min, respectively. The experimental results were analyzed in terms of Langmuir and Freundlich isotherms. The Langnmir isotherm model fitted well to data of Ni(II) biosorption by C. fistula biomass as compared to the model of Freundlich. The kinetic studies showed that the sorption rates could be described better by a second order expression than by a more commonly applied Lagergren equation. The magnitude of the Gibbs free energy values indicates spontaneous nature of the sorption process. The sorption ability of C. fistula biomass for Ni(II) removal tends to be in the order: leaves < stem bark < pods bark. One hundred percent Ni(II) removal was achieved when the initial Ni(II) concentration was 25 mg/L. Due to its outstanding Ni(II) uptake capacity, C. fistula biomass proved to be an excellent biomaterial for accumulating Ni(II) from aqueous solutions. (c) 2006 Elsevier B.V. All rights reserved.
C1 Univ Agr Faisalabad, Dept Chem, Faisalabad 38040, Pakistan.
   Baha U Din Zakariya Univ, Dept Chem, Multan 60800, Pakistan.
RP Bhatti, HN (reprint author), Univ Agr Faisalabad, Dept Chem, Faisalabad 38040, Pakistan.
EM hnbhatti2005@yahoo.com
RI Bhatti, Haq Nawaz/I-2069-2015; Hanif, Muhammad Asif/G-7242-2015; Ansari,
   Tariq Mahmood/J-2845-2015
OI Bhatti, Haq Nawaz/0000-0002-5445-8338; Ansari, Prof Dr Tariq
   Mahmood/0000-0002-8074-3941
CR Ahalya N, 2005, ELECTRON J BIOTECHN, V8, DOI 10.2225/vol8-issue3-fulltext-10
   Benguella B, 2002, WATER RES, V36, P2463, DOI 10.1016/S0043-1354(01)00459-6
   CHEUNG CW, 1997, PURIF TECHNOL, V19, P55
   Chubar N, 2003, COLLOID SURFACE A, V230, P57, DOI 10.1016/j.colsurfa.2003.09.014
   Cordero B, 2004, ENVIRON CHEM, V1, P180, DOI 10.1071/EN04039
   CRIST RH, 1981, ENVIRON SCI TECHNOL, V15, P1212, DOI 10.1021/es00092a010
   Davis TA, 2000, WATER RES, V34, P4270, DOI 10.1016/S0043-1354(00)00177-9
   Dilek FB, 2002, PROCESS BIOCHEM, V37, P723, DOI 10.1016/S0032-9592(01)00261-8
   Farajzadeh MA, 2003, J CHIN CHEM SOC-TAIP, V50, P245, DOI 10.1002/jccs.200300036
   Gomes NCM, 1996, REV MICROBIOL, V27, P218
   Ho YS, 1996, ENVIRON TECHNOL, V17, P71, DOI 10.1080/09593331708616362
   Loukidou MX, 2004, COLLOID SURFACE A, V242, P93, DOI 10.1016/j.colsurfa.2004.03.030
   Matheickal JT, 1999, BIORESOURCE TECHNOL, V69, P223, DOI 10.1016/S0960-8524(98)00196-5
   MCKAY G, 1980, WATER RES, V14, P15, DOI 10.1016/0043-1354(80)90037-8
   Padmavathy V, 2003, PROCESS BIOCHEM, V38, P1389, DOI 10.1016/S0032-9592(02)00168-1
   Pagnanelli F, 2000, ENVIRON SCI TECHNOL, V34, P2773, DOI 10.1021/es99127g
   POOTS VJP, 1978, J WATER POLLUT CON F, V50, P926
   Prasad MNV, 2000, ENVIRON POLLUT, V110, P277, DOI 10.1016/S0269-7491(99)00306-1
   Quek SY, 1998, PROCESS SAF ENVIRON, V76, P50, DOI 10.1205/095758298529254
   Quek SY, 1998, WATER SA, V24, P251
   Rudresh H. B., 1977, J ENV SCI TECHNOL, V122, P251
   Sag Y, 1998, HYDROMETALLURGY, V50, P297, DOI 10.1016/S0304-386X(98)00065-6
   SAG Y, 1995, PROCESS BIOCHEM, V30, P169, DOI 10.1016/0032-9592(95)95716-V
   SCHIEWER S, 1995, ENVIRON SCI TECHNOL, V29, P3049, DOI 10.1021/es00012a024
   Sheng PX, 2004, J COLLOID INTERF SCI, V275, P131, DOI 10.1016/j.jcis.2004.01.036
   STMIHOVA T, 2001, BIOSORPTION HEAVY ME
   Tarley CRT, 2004, CHEMOSPHERE, V54, P987, DOI 10.1016/j.chemosphere.2003.09.001
   Veglio F, 1997, PROCESS BIOCHEM, V32, P99, DOI 10.1016/S0032-9592(96)00047-7
   Veglio F, 2003, PROCESS BIOCHEM, V38, P953, DOI 10.1016/S0032-9592(02)00235-2
   VOLESKY B, 1995, BIOTECHNOL PROGR, V11, P235, DOI 10.1021/bp00033a001
   Volesky B., 1990, BIOSORPTION HEAVY ME, P3
   Waranusantigul P, 2003, ENVIRON POLLUT, V125, P385, DOI 10.1016/S0269-7491(03)00107-6
   Zhou JL, 1998, ENVIRON POLLUT, V101, P67, DOI 10.1016/S0269-7491(98)00034-7
   2004, AFR J BIOTECHNOL, V4, P191
   2004, EUR J BIOTECHNOL, V7, P313
NR 35
TC 170
Z9 185
U1 1
U2 19
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-3894
J9 J HAZARD MATER
JI J. Hazard. Mater.
PD JAN 10
PY 2007
VL 139
IS 2
BP 345
EP 355
DI 10.1016/j.jhazmat.2006.06.040
PG 11
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 130TP
UT WOS:000243822200023
PM 16860463
DA 2018-10-20
ER

PT J
AU Shi, R
   Liu, QY
   Ding, T
   Han, YM
   Zhang, LQ
   Chen, DF
   Tian, W
AF Shi, Rui
   Liu, Quanyong
   Ding, Tao
   Han, Yanming
   Zhang, Liqun
   Chen, Dafu
   Tian, Wei
TI Ageing of soft thermoplastic starch with high glycerol content
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE thermoplastics; ageing; crystal structures; glass transition; FUR
ID B-TYPE CRYSTALLINITY; POTATO STARCH; MAIZE STARCH;
   MECHANICAL-PROPERTIES; GLASS-TRANSITION; MATRIX IMPLANTS; PLASTIC
   SHEETS; WATER-CONTENT; AMYLOSE; SPECTROSCOPY
AB In this study, a soft and thermoplastic starch with an improved ageing-resistant property was prepared by melt blending method for a biodegradable biomaterial. The glycerol content varies from 30 to 60 wt %. The aging temperature and humidity of the glycerol-plasticized thermoplastic starch (GTPS) was 37 degrees C and 50 +/- 5 RH %, respectively. The retrogradation was characterized by X-ray diffraction (XRD), dynamic mechanical thermal analysis (DMTA), Fourier transform infrared (FTIR), and the stress-strain mechanical properties. The XRD results suggest that high content of glycerol promotes the formation of single helix structure of V-type, but inhibits double helix structure of B-type. Changing of the tan delta, storage modules (P), and the glass transition temperatures as a function of glycerol content and ageing time was detected by DMTA. FUR result shows that the shifting speed of the peak of hydroxyl group stretching fell as the glycerol content increased. The glycerol content has no obvious effect on the mechanical properties when it is high enough. Results from all characterizations demonstrate that the ageing speed is closely relative to the plasticizers content. The higher content of glycerol possesses an obviously inhibitory effect on the ageing. (c) 2006 Wiley Periodicals, Inc. J Appl Polym Sci 103: 574-586, 2007
C1 Beijing Univ Chem Technol, Key Lab Beijing City Preparat & Proc Novel Polyme, Beijing 100029, Peoples R China.
   Beijing Res Inst Traumatol & Orthopaed, Lab Bone Tissue Engn, Beijing 100035, Peoples R China.
   Peking Univ, Clin Med Coll 4, Dept Spine Surg, Beijing JiShuiTan Hosp, Beijing 100035, Peoples R China.
RP Zhang, LQ (reprint author), Beijing Univ Chem Technol, Key Lab Beijing City Preparat & Proc Novel Polyme, Beijing 100029, Peoples R China.
EM zhanglq@mail.buct.edu; chendafugo@yahoo.com.cn
RI Santos, Jonnatan/K-1862-2013; zhang, liqun/S-7337-2016
OI Santos, Jonnatan/0000-0003-3789-6229; zhang, liqun/0000-0003-0291-4351
CR Bogracheva TY, 2001, BIOPOLYMERS, V58, P247, DOI 10.1002/1097-0282(200103)58:3<247::AID-BIP1002>3.0.CO;2-L
   CAEL JJ, 1973, CARBOHYD RES, V29, P123
   CAEL JJ, 1975, J CARBOHYDR RES, V14, P1185
   Cheetham NWH, 1998, CARBOHYD POLYM, V36, P277, DOI 10.1016/S0144-8617(98)00007-1
   Chung HJ, 2004, CARBOHYD POLYM, V57, P15, DOI 10.1016/j.carbpol.2004.01.010
   Desevaux C, 2002, J CONTROL RELEASE, V82, P83, DOI 10.1016/S0168-3659(02)00133-5
   Desevaux C, 2002, J CONTROL RELEASE, V82, P95, DOI 10.1016/S0168-3659(02)00132-3
   EISENHABER F, 1992, BIOPOLYMERS, V32, P1643, DOI 10.1002/bip.360321207
   Forssell PM, 1999, CARBOHYD POLYM, V39, P43, DOI 10.1016/S0144-8617(98)00128-3
   Forssell PM, 1997, CARBOHYD POLYM, V34, P275, DOI 10.1016/S0144-8617(97)00133-1
   Gomes ME, 2003, J BIOMED MATER RES A, V67A, P87, DOI 10.1002/jbm.a.10075
   Gomes ME, 2001, BIOMATERIALS, V22, P883, DOI 10.1016/S0142-9612(00)00211-8
   Graaf R. A. de, 2003, Starch/Staerke, V55, P80, DOI 10.1002/star.200390020
   Hulleman SHD, 1999, CARBOHYD POLYM, V39, P351, DOI 10.1016/S0144-8617(99)00024-7
   IMBERTY A, 1988, BIOPOLYMERS, V27, P1205, DOI 10.1002/bip.360270803
   KALICHEVSKY MT, 1993, POLYMER, V34, P346, DOI 10.1016/0032-3861(93)90088-R
   Le Bail P, 1999, BIOPOLYMERS, V50, P99, DOI 10.1002/(SICI)1097-0282(199907)50:1<99::AID-BIP9>3.3.CO;2-1
   LIU ZH, 2002, THESIS TIANJIN U TIA, P102
   Lourdin D, 1997, J APPL POLYM SCI, V63, P1047, DOI 10.1002/(SICI)1097-4628(19970222)63:8<1047::AID-APP11>3.0.CO;2-3
   Lourdin D, 1998, CARBOHYD RES, V306, P551, DOI 10.1016/S0008-6215(98)00007-X
   Lu TJ, 1997, CARBOHYD POLYM, V33, P19, DOI 10.1016/S0144-8617(97)00038-6
   MULLARINEN P, 2002, CARBOHYD POLYM, V50, P361
   Otani Y, 1998, BIOMATERIALS, V19, P2167, DOI 10.1016/S0142-9612(98)00123-9
   Salgado AJ, 2004, TISSUE ENG, V10, P465, DOI 10.1089/107632704323061825
   Smits ALM, 1998, STARCH-STARKE, V50, P478, DOI 10.1002/1521-379X(199812)50:11/12<478::AID-STAR478>3.3.CO;2-G
   Tang HR, 2001, CARBOHYD POLYM, V46, P7, DOI 10.1016/S0144-8617(00)00265-4
   vanSoest JJG, 1995, CARBOHYD RES, V279, P201, DOI 10.1016/0008-6215(95)00270-7
   vanSoest JJG, 1997, TRENDS BIOTECHNOL, V15, P208, DOI 10.1016/S0167-7799(97)01021-4
   VanSoest JJG, 1996, J APPL POLYM SCI, V61, P1927
   VanSoest JJG, 1997, J APPL POLYM SCI, V64, P1411, DOI 10.1002/(SICI)1097-4628(19970516)64:7<1411::AID-APP21>3.0.CO;2-Y
   vanSoest JJG, 1997, J MACROMOL SCI PURE, VA34, P1665, DOI 10.1080/10601329708010034
   vanSoest JJG, 1996, CARBOHYD POLYM, V29, P225, DOI 10.1016/0144-8617(96)00011-2
   WU HCH, 1978, CARBOHYD RES, V61, P7
   ZOBEL HF, 1988, STARCH-STARKE, V40, P44, DOI 10.1002/star.19880400203
NR 34
TC 45
Z9 46
U1 5
U2 32
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD JAN 5
PY 2007
VL 103
IS 1
BP 574
EP 586
DI 10.1002/app.25193
PG 13
WC Polymer Science
SC Polymer Science
GA 105VQ
UT WOS:000242060800075
DA 2018-10-20
ER

PT J
AU Li, DH
   Liu, LM
   Tian, KL
   Liu, JC
   Fan, XQ
AF Li, Dong-Hong
   Liu, Liang-Ming
   Tian, Kun-Lun
   Liu, Jian-Chang
   Fan, Xiao-Qing
TI Synthesis, biodegradability and cytotoxicity of water-soluble
   isobutylchitosan
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE isobutylchitosan; water solubility; biodegradability; cytotoxicity
ID IN-VITRO; CHITOSAN; CHITIN; DERIVATIVES; PROLIFERATION; ACID
AB The objective of the present study was to improve the solubility of chitosan at neutral aqueous solution without altering its bioactivity. Through an alkylation reaction under mild conditions, isobutyl was introduced to chitosan to form isobutylchitosan, which showed a good solubility in neutral aqueous media resulting from the reduced crystallinity of the product. The structure of isobutylchitosan was characterized by IR, H-1 NMR spectroscopy, and X-ray diffraction. The degradation of the product was evaluated in vivo using a mouse model, and the cytotoxicity of the product in L929 mouse fibroblasts was monitored using the MTT assay and the release of the cytosolic enzyme lactate dehydrogenase (LDH). It was found that the product exhibited the properties of improved biodegradability, increased MTT values and decreased LDH release. The results suggested that isobutylchitosan might be one of promising and safe biomaterial with potential applications. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Mil Med Univ, State Key Lab Trauma Burn & Combined Injury, Dept Res 2, Inst Surg, Chongqing 400042, Peoples R China.
RP Li, DH (reprint author), Mil Med Univ, State Key Lab Trauma Burn & Combined Injury, Dept Res 2, Inst Surg, Chongqing 400042, Peoples R China.
EM lqs_cq@yahoo.com.cn
CR Chung YC, 2003, BIORESOURCE TECHNOL, V88, P179, DOI 10.1016/S0960-8524(03)00002-6
   Chung YC, 2005, BIORESOURCE TECHNOL, V96, P1473, DOI 10.1016/j.biortech.2004.12.001
   DUNG P, 1994, CARBOHYD POLYM, V24, P209
   Graeme I., 2001, BIOMATERIALS, V22, P2959
   HIRANO S, 1985, CARBOHYD RES, V144, P338, DOI 10.1016/S0008-6215(00)90682-7
   Hirano S, 2002, CARBOHYD POLYM, V48, P203, DOI 10.1016/S0144-8617(01)00243-0
   IKEDA I, 1993, J AGR FOOD CHEM, V41, P431, DOI 10.1021/jf00027a016
   Jang MK, 2004, J POLYM SCI POL CHEM, V42, P3423, DOI 10.1002/pola.20179
   KENJI T, 1997, BIOMATERIALS, V18, P567
   KIM JH, 1993, POLYMER, V34, P1952, DOI 10.1016/0032-3861(93)90441-C
   Kurita K, 2002, BIOMACROMOLECULES, V3, P1, DOI 10.1021/bm0101163
   Kurita K, 1998, POLYM DEGRAD STABIL, V59, P117, DOI 10.1016/S0141-3910(97)00160-2
   Lee MY, 2005, INT J BIOL MACROMOL, V36, P152, DOI 10.1016/j.ijbiomac.2005.05.004
   Liu XF, 2001, J APPL POLYM SCI, V79, P1324
   Mao SR, 2005, BIOMATERIALS, V26, P6343, DOI 10.1016/j.biomaterials.2005.03.036
   MOCHIZUKI A, 1989, J APPL POLYM SCI, V37, P3375, DOI 10.1002/app.1989.070371209
   Mori T, 1997, BIOMATERIALS, V18, P947, DOI 10.1016/S0142-9612(97)00017-3
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   MUZZARELLI RAA, 1985, CARBOHYD POLYM, V5, P461, DOI 10.1016/0144-8617(85)90005-0
   NISHIMURA SI, 1986, CARBOHYD RES, V146, P251, DOI 10.1016/0008-6215(86)85044-3
   Nordtveit RJ, 1996, CARBOHYD POLYM, V29, P163, DOI 10.1016/0144-8617(96)00003-3
   Prasitsilp M, 2000, J MATER SCI-MATER M, V11, P773, DOI 10.1023/A:1008997311364
   Terbojevich M, 1996, CARBOHYD POLYM, V29, P63, DOI 10.1016/0144-8617(95)00147-6
   WATANABE K, 1992, CARBOHYD POLYM, V17, P29, DOI 10.1016/0144-8617(92)90020-Q
NR 24
TC 31
Z9 37
U1 1
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JAN 2
PY 2007
VL 67
IS 1
BP 40
EP 45
DI 10.1016/j.carbpol.2006.04.022
PG 6
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 118SD
UT WOS:000242961100005
DA 2018-10-20
ER

PT J
AU Arul, V
   Kartha, R
   Jayakumar, R
AF Arul, Vadivel
   Kartha, Reena
   Jayakumar, Rajadas
TI A therapeutic approach for diabetic wound healing using biotinylated GHK
   incorporated collagen matrices
SO LIFE SCIENCES
LA English
DT Article
DE collagen; wound healing; GHK; fibroblast; antioxidant enzymes
ID GROWTH-FACTOR; HUMAN-SKIN; CELLS; FIBROBLASTS; TRIPEPTIDE; RAT;
   STIMULATION; EXPRESSION; MICE; GLUTATHIONE
AB Chronically elevated blood glucose levels result in reduced leukocyte function and cell malnutrition, which contribute to a high rate of wound infection and associated healing problems in diabetic patients. In the present study, the role of biotinylated GHK peptide (BioGHK) incorporated collagen biomaterial was tested for wound healing in diabetic rats. The rate of wound contraction and the levels of collagen, uronic acid, protein and DNA in the granulation tissue were determined. Further, the concentration of nitric oxide and other skin antioxidants was also monitored during the study. In diabetic rats treated with BioGHK incorporated collagen (Peptide Incorporated Collagen - PIC), the healing process was hastened with an increased rate of wound contraction. Glutathione (GSH) and ascorbic acid levels in the skin of streptozotocin-induced diabetic rats were higher in the PIC group as compared to control (Untreated) and collagen (Collagen Film - CF) treated groups. Superoxide dismutase (SOD) and catalase (CAT) activity was altered in all the groups. In vitro fibroblast cell culture studies suggest that PIC promotes fibroblast growth. Histological evaluation by haematoxylin-eosin and Masson's trichrome method revealed epithelialization, increased synthesis of collagen and activation of fibroblasts and mast cells in the PIC group. This study provides a rationale for the topical application of BioGHK incorporated collagen as a feasible and productive approach to support diabetic wound healing. (c) 2006 Elsevier Inc. All rights reserved.
C1 Cent Leather Res Inst, Bioorgan & Neurochem Lab, Madras 600020, Tamil Nadu, India.
   Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.
RP Jayakumar, R (reprint author), Cent Leather Res Inst, Bioorgan & Neurochem Lab, Madras 600020, Tamil Nadu, India.
EM karkuvi77@yahoo.co.uk
OI Kartha, Reena/0000-0002-1692-1539
CR ALBERTSON S, 1993, SURGERY, V114, P368
   Albuquerque MLC, 2002, EXP BIOL MED, V227, P1006
   Arora PD, 1999, AM J PATHOL, V154, P871, DOI 10.1016/S0002-9440(10)65334-5
   Arul V, 2005, J BIOMED MATER RES B, V73B, P383, DOI 10.1002/jbm.b.30246
   Bab Itai A., 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P31
   Bae GU, 1999, J BIOL CHEM, V274, P32596, DOI 10.1074/jbc.274.46.32596
   BERGMEYER HU, 1974, METHOD ENZYMAT AN, V1, P438
   BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7
   BODANSKY A, 1984, PRACTICE PEPTIDE SYN, V21
   Chen MM, 2000, J MOL CELL CARDIOL, V32, P1805, DOI 10.1006/jmcc.2000.1215
   CHENG K, 1999, ANIMAL COGNITION, V2, P79
   COLLINS T, 1995, FASEB J, V9, P899
   Deyl ZAM, 1976, METHODOLOGY CONNECTI, P1
   Draye JP, 1998, BIOMATERIALS, V19, P1677, DOI 10.1016/S0142-9612(98)00049-0
   Etscheid M, 2004, EUR J CELL BIOL, V82, P597, DOI 10.1078/0171-9335-00349
   Galiano RD, 2004, AM J PATHOL, V164, P1935, DOI 10.1016/S0002-9440(10)63754-6
   Gopinath D, 2005, J BIOMED MATER RES A, V73A, P320, DOI 10.1002/jbm.a.30303
   Gopinath D, 2004, BIOMATERIALS, V25, P1911, DOI 10.1016/S0142-9612(03)00625-2
   JOHNSON LJ, 1993, SEMINARS PERIOPERATI, V2, P438
   Kamoun A, 1995, CELL ADHES COMMUN, V3, P273, DOI 10.3109/15419069509081013
   Kane J. B., 1996, BIOMATERIALS SCI INT, P360
   Kobuchi H, 1999, AM J PHYSIOL-CELL PH, V277, pC403, DOI 10.1152/ajpcell.1999.277.3.C403
   Komesu Marilena Chinali, 2004, Pathophysiology, V11, P63, DOI 10.1016/j.pathophys.2004.02.002
   LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7
   Lockhart LK, 2001, THROMB HAEMOSTASIS, V85, P882
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Madlener M, 1998, EXP CELL RES, V242, P201, DOI 10.1006/excr.1998.4049
   MAQUART FX, 1988, FEBS LETT, V238, P343, DOI 10.1016/0014-5793(88)80509-X
   MAQUART FX, 1993, J CLIN INVEST, V92, P2368, DOI 10.1172/JCI116842
   MEISTER A, 1983, BIOCHEM SOC T, V11, P793, DOI 10.1042/bst0110793
   MISRA HP, 1972, J BIOL CHEM, V247, P3170
   MORON MS, 1979, BIOCHIM BIOPHYS ACTA, V582, P67, DOI 10.1016/0304-4165(79)90289-7
   Moulin V, 2000, BURNS, V26, P3, DOI 10.1016/S0305-4179(99)00091-1
   Neely Alice N., 1997, Wound Repair and Regeneration, V5, P302
   NEUMAN RE, 1950, J BIOL CHEM, V184, P299
   Nwomeh BC, 1999, J SURG RES, V81, P189, DOI 10.1006/jsre.1998.5495
   Phan TT, 2001, BIOL PHARM BULL, V24, P1373, DOI 10.1248/bpb.24.1373
   PICKART L, 1973, NATURE-NEW BIOL, V243, P85
   Pollard JD, 2005, ARCH FACIAL PLAST S, V7, P27, DOI 10.1001/archfaci.7.1.27
   Rasik AM, 2000, INT J EXP PATHOL, V81, P257, DOI 10.1046/j.1365-2613.2000.00158.x
   REED JA, 1995, LAB INVEST, V72, P215
   SCHNEIDER WC, 1957, J NATL CANCER I, V18, P569
   SCHNIDER SL, 1981, J CLIN INVEST, V67, P1630, DOI 10.1172/JCI110198
   Sidhu GS, 1999, WOUND REPAIR REGEN, V7, P362, DOI 10.1046/j.1524-475X.1999.00362.x
   SPANHEIMER RG, 1988, DIABETES, V37, P371, DOI 10.2337/diabetes.37.4.371
   STOMPRO BE, 1989, J SURG RES, V46, P413, DOI 10.1016/0022-4804(89)90153-4
   TOLSTYKH PI, 1988, KHIRURGIYA, P3
   Vaalamo M, 1999, HUM PATHOL, V30, P795, DOI 10.1016/S0046-8177(99)90140-5
   Wakatsuki T, 2003, BIOPHYS CHEM, V100, P593, DOI 10.1016/S0301-4622(02)00308-3
   Weller R, 1996, J INVEST DERMATOL, V107, P327, DOI 10.1111/1523-1747.ep12363167
   Wilkinson-Berka JL, 2004, CURR PHARM DESIGN, V10, P3313, DOI 10.2174/1381612043383179
   Williams JZ, 2002, ANN SURG, V236, P369, DOI 10.1097/01.SLA.0000027527.01984.00
   Yamasaki K, 1998, J CLIN INVEST, V101, P967, DOI 10.1172/JCI2067
NR 53
TC 35
Z9 35
U1 2
U2 7
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0024-3205
EI 1879-0631
J9 LIFE SCI
JI Life Sci.
PD JAN 2
PY 2007
VL 80
IS 4
BP 275
EP 284
DI 10.1016/j.lfs.2006.09.018
PG 10
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA 127HP
UT WOS:000243576500002
PM 17049946
DA 2018-10-20
ER

PT S
AU Duygulu, O
   Kaya, AA
   Oktay, G
   Sahin, FC
AF Duygulu, Ozgur
   Kaya, Ali Arslan
   Oktay, Gizem
   Sahin, Filiz Cinar
BE Long, S
   Pan, FH
   Kainer, KU
   Han, YF
   Ke, W
   Liu, B
   Zhang, XM
   Peng, CQ
   Zhao, XQ
   Feng, Q
   Lu, YF
   Zhang, PX
   Jiang, CB
TI Diffusion bonding of magnesium, zirconium and titanium as implant
   material
SO 2006 BIMW: 2006 BEIJING INTERNATIONAL MATERIALS WEEK, PTS 1-4: MAGNESIUM
SE Materials Science Forum
LA English
DT Proceedings Paper
CT Beijing International Materials Week
CY JUN 25-30, 2006
CL Beijing, PEOPLES R CHINA
SP Chinese Mat Res Soc, European Mat Res Soc, Gen Res Inst Nonferrous Metals, Pulead Technol Ind Co Ltd, Shanshan Technol Grp, Chongqing Univ, China Magnesium Ctr, Minist Sci & Technol China, Natl Dev & Reform Commiss China, Minist Educ China, Minist Informat Ind China, Natl Nat Sci Fdn China, Chinese Acad Engn, China Assoc Sci & Technol, Int Union Mat Res Soc
DE magnesium; AZ31; biomaterial; titanium; zirconium; diffusion bond
ID IN-VIVO CORROSION; ALLOYS
AB Titanium, zirconium and magnesium alloys are considered to be biocompatible, and can be used as implants such as hip ball and sockets and to make medical equipments. Biomaterials with hybrid structures in some applications utilizing the beneficial properties of different metals together are considered potential implant materials. Therefore, in this study, experimental trials were attempted to bond pure magnesium, AM60 (6 wt% Al-0.27 wt% Mn), and AZ31 (3 wt% Al-1 wt% Zn) alloys to pure zirconium and Ti6Al4V (6 wt% Al-4 wt% V) alloy to experimentally evaluate the forming bimetallic structures by diffusion bonding technique by vacuum hot pressing. SEM analysis showed the presence of a significant diffusion zone and a presence of diffusion bonding in some metallic couples. It may be suggested that novel hybrid implant materials, composed of diffusion couples of magnesium, zirconium and titanium alloys may emerge in the future.
C1 [Duygulu, Ozgur; Kaya, Ali Arslan; Oktay, Gizem] TUBITAK MRC, Mat Inst, POB 21, TR-41470 Gebze, Turkey.
   [Sahin, Filiz Cinar] Istanbul Tech Univ, Dept Met & Mat Engn, TR-34469 Istanbul, Turkey.
RP Duygulu, O (reprint author), TUBITAK MRC, Mat Inst, POB 21, TR-41470 Gebze, Turkey.
EM ozgur.duygulu@mam.gov.tr; aliarslan.kaya@mam.gov.tr;
   gizem.oktay@mam.gov.tr; cinar@itu.edu.tr
RI Duygulu, Ozgur/A-9076-2015
OI Duygulu, Ozgur/0000-0001-8646-0363
CR BHANUMURTHY K, 1994, J NUCL MATER, V217, P67, DOI 10.1016/0022-3115(94)90305-0
   Cordingley R., 2003, Journal of the Australasian Ceramic Society, V39, P20
   DENKENA B, 2005, P 5 EUSP INT C
   Heublein B, 2003, HEART, V89, P651, DOI 10.1136/heart.89.6.651
   Kale GB, 1998, J NUCL MATER, V257, P44, DOI 10.1016/S0022-3115(98)00179-2
   Leyens C, 2003, TITANIUM TITANIUM AL
   Peng L, 2005, MATER LETT, V59, P2001, DOI DOI 10.1016/J.MATLET.2005.02.038
   Somekawa H, 2003, SCRIPTA MATER, V48, P1249, DOI 10.1016/S1359-6462(03)00054-X
   Somekawa H, 2003, MAT SCI ENG A-STRUCT, V339, P328, DOI 10.1016/S0921-5093(02)00127-2
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   YANDONG Y, 2005, MATER SCI FORUM, V488, P227
   Zartner P, 2005, CATHETER CARDIO INTE, V66, P590, DOI 10.1002/ccd.20520
NR 14
TC 6
Z9 6
U1 1
U2 6
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
BN 978-0-87849-432-3
J9 MATER SCI FORUM
PY 2007
VL 546-549
BP 417
EP +
DI 10.4028/www.scientific.net/MSF.546-549.417
PN 1-4
PG 2
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BGD24
UT WOS:000246145500088
DA 2018-10-20
ER

PT S
AU Duygulu, O
   Kaya, RA
   Oktay, G
   Kaya, AA
AF Duygulu, Ozgur
   Kaya, R. Alper
   Oktay, Gizern
   Kaya, A. Arslan
BE Long, S
   Pan, FH
   Kainer, KU
   Han, YF
   Ke, W
   Liu, B
   Zhang, XM
   Peng, CQ
   Zhao, XQ
   Feng, Q
   Lu, YF
   Zhang, PX
   Jiang, CB
TI Investigation on the potential of magnesium alloy AZ31 as a bone implant
SO 2006 BIMW: 2006 BEIJING INTERNATIONAL MATERIALS WEEK, PTS 1-4: MAGNESIUM
SE Materials Science Forum
LA English
DT Proceedings Paper
CT Beijing International Materials Week
CY JUN 25-30, 2006
CL Beijing, PEOPLES R CHINA
SP Chinese Mat Res Soc, European Mat Res Soc, Gen Res Inst Nonferrous Metals, Pulead Technol Ind Co Ltd, Shanshan Technol Grp, Chongqing Univ, China Magnesium Ctr, Minist Sci & Technol China, Natl Dev & Reform Commiss China, Minist Educ China, Minist Informat Ind China, Natl Nat Sci Fdn China, Chinese Acad Engn, China Assoc Sci & Technol, Int Union Mat Res Soc
DE magnesium; AZ31; biomaterial; bone
ID IN-VIVO CORROSION
AB Degradable implants have been in use for bone surgery for decades. However, degradable metal implants are one of the new research areas of biomaterials science. There is a potential for application of degradable metal implants as screws and plates in bones. Magnesium alloys are one of the new candidate materials for degradable implants. Magnesium has good biocompatibility due to its low toxicity, and it is a corroding, i.e. dissolvable, metal. Furthermore, magnesium is needed in human body, and naturally found in bone tissue. Mechanical properties of magnesium alloys are dimensionally comparable to the cortical bone substance. In this study, corrosion behavior of magnesium metal at the bone interface and the possibility of new bone cell formation have been investigated. Cortical bone screws were machined from magnesium alloy AZ31 extruded rod and implanted to hip-bones of sheep via surgery. Three months after surgery, the bone segments carrying these screws were removed from the sacrificed animals. Samples were sectioned to reveal Mg/bone interfaces and investigated using optical microscope, SEM-EDS and radiography. Optical and SEM images showed that there was a significant amount of corrosion on the magnesium screw. The elemental mapping results indicate, due to the presence of calcium and phosphorus elements, that there exists new bone formation at the interface. From the results of this study, it may be stated that the potential for using magnesium alloys as a bone implant material is expected to be significant.
C1 TUBITAK MRC, Mat Inst, POB 21, TR-41470 Gebze, Turkey.
   [Kaya, R. Alper] Sisli Etfal State Hosp, Clin Neurosurg Dept, TR-34377 Istanbul, Turkey.
RP Duygulu, O (reprint author), TUBITAK MRC, Mat Inst, POB 21, TR-41470 Gebze, Turkey.
EM ozgur.duygulu@mam.gov.tr; alpkaya67@yahoo.com; gizem.oktay@mam.gov.tr;
   aliarslan.kaya@mam.gov.tr
RI Duygulu, Ozgur/A-9076-2015
OI Duygulu, Ozgur/0000-0001-8646-0363
CR *ASTM, 2002, ASTMF54302
   DENKENA B, 2005, P 5 EUSP INT C
   Heublein B, 2003, HEART, V89, P651, DOI 10.1136/heart.89.6.651
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Zartner P, 2005, CATHETER CARDIO INTE, V66, P590, DOI 10.1002/ccd.20520
NR 7
TC 30
Z9 37
U1 0
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
BN 978-0-87849-432-3
J9 MATER SCI FORUM
PY 2007
VL 546-549
BP 421
EP +
DI 10.4028/www.scientific.net/MSF.546-549.421
PN 1-4
PG 2
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BGD24
UT WOS:000246145500089
DA 2018-10-20
ER

PT S
AU Oktay, G
   Duygulu, O
   Kaya, AA
AF Oktay, Gizem
   Duygulu, Ozgur
   Kaya, Ali Arslan
BE Long, S
   Pan, FH
   Kainer, KU
   Han, YF
   Ke, W
   Liu, B
   Zhang, XM
   Peng, CQ
   Zhao, XQ
   Feng, Q
   Lu, YF
   Zhang, PX
   Jiang, CB
TI Magnesium films deposited on different substrates via arc PVD method
SO 2006 BIMW: 2006 BEIJING INTERNATIONAL MATERIALS WEEK, PTS 1-4: MAGNESIUM
SE Materials Science Forum
LA English
DT Proceedings Paper
CT Beijing International Materials Week
CY JUN 25-30, 2006
CL Beijing, PEOPLES R CHINA
SP Chinese Mat Res Soc, European Mat Res Soc, Gen Res Inst Nonferrous Metals, Pulead Technol Ind Co Ltd, Shanshan Technol Grp, Chongqing Univ, China Magnesium Ctr, Minist Sci & Technol China, Natl Dev & Reform Commiss China, Minist Educ China, Minist Informat Ind China, Natl Nat Sci Fdn China, Chinese Acad Engn, China Assoc Sci & Technol, Int Union Mat Res Soc
DE magnesium; film; biomaterial; PVD
ID CORROSION-RESISTANCE; ALLOYS
AB A hybrid biomaterial was produced by dressing titanium with magnesium in order to utilize the most advantageous properties of both materials. Titanium was coated with magnesium via arc physical vapor deposition (PVD) method, and a third agent between titanium and magnesium, as a bonding medium was also used. The microstructures and chemical compositions of magnesium arc-PVD coated Ti-6Al-4V alloy and silicon wafer were investigated. The experimental results showed that Mg can be deposited onto Ti-6Al-4V alloy and on silicon wafer by using arc-PVD method.
C1 [Oktay, Gizem; Duygulu, Ozgur; Kaya, Ali Arslan] TUBITAK MRC, Mat Inst, POB 21, Kocaeli 41470, Turkey.
RP Oktay, G (reprint author), TUBITAK MRC, Mat Inst, POB 21, Kocaeli 41470, Turkey.
EM gizem.oktay@mam.gov.tr; ozgur.duygulu@mam.gov.tr;
   aliarslan.kaya@mam.gov.tr
RI Duygulu, Ozgur/A-9076-2015
OI Duygulu, Ozgur/0000-0001-8646-0363
CR DENKENA B, 2005, P 5 EUSP INT C
   Gray JE, 2002, J ALLOY COMPD, V336, P88, DOI 10.1016/S0925-8388(01)01899-0
   Lee MH, 2003, SURF COAT TECH, V169, P670, DOI 10.1016/S0257-8972(03)00054-9
   Leyens C, 2003, TITANIUM TITANIUM AL
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Yamamoto A, 2001, SCRIPTA MATER, V44, P1039, DOI 10.1016/S1359-6462(01)00662-5
NR 6
TC 1
Z9 1
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
BN 978-0-87849-432-3
J9 MATER SCI FORUM
PY 2007
VL 546-549
BP 519
EP +
DI 10.4028/www.scientific.net/MSF.546-549.519
PN 1-4
PG 2
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BGD24
UT WOS:000246145500111
DA 2018-10-20
ER

PT S
AU Gao, JC
   Xue, Y
   Qiao, LY
   Wang, Y
   Zhang, Y
AF Gao, Jiacheng
   Xue, Yan
   Qiao, Liying
   Wang, Yong
   Zhang, Yan
BE Long, S
   Pan, FH
   Kainer, KU
   Han, YF
   Ke, W
   Liu, B
   Zhang, XM
   Peng, CQ
   Zhao, XQ
   Feng, Q
   Lu, YF
   Zhang, PX
   Jiang, CB
TI Surface modification of magnesium with rare earth conversion films for
   biomedical protection
SO 2006 BIMW: 2006 BEIJING INTERNATIONAL MATERIALS WEEK, PTS 1-4: MAGNESIUM
SE Materials Science Forum
LA English
DT Proceedings Paper
CT Beijing International Materials Week
CY JUN 25-30, 2006
CL Beijing, PEOPLES R CHINA
SP Chinese Mat Res Soc, European Mat Res Soc, Gen Res Inst Nonferrous Metals, Pulead Technol Ind Co Ltd, Shanshan Technol Grp, Chongqing Univ, China Magnesium Ctr, Minist Sci & Technol China, Natl Dev & Reform Commiss China, Minist Educ China, Minist Informat Ind China, Natl Nat Sci Fdn China, Chinese Acad Engn, China Assoc Sci & Technol, Int Union Mat Res Soc
DE rare-earths; conversion film; corrosion; biomaterial; simulated body
   fluid (SBF)
AB The specific gravity and elastic modulus of magnesium alloys are similar to that of human bone. Magnesium is one of the most important elements in the human body and plays a key role in the metabolic process. But the application of magnesium is seriously limited as a biomaterial since it corrodes easily in the physiological environment of the body. In order to reduce the corrosion, we developed protective films using rare earth (RE) conversion processing. The surface of magnesium samples was modified by contact with different rare-earth salt solutions; then the samples were dipped in SBF to test their corrosion resistance. The change of mass and the pH of the solutions were measured continuously using an electronic scale and a pH micrometer. The surface microstructure of the samples was observed by XRD and metallomicroscope. Corrosion rates of the samples in SBF were determined using Taffier curve. The preliminary results show that the conversion treatment with CeCl3 or Y(NO3)(3) can improve the corrosion resistance of magnesium in SBF. The relationship of the RE salts concentration and the corrosion properties were studied,the best combination of parameters was determined, and the formation mechanism of rare-earth conversion film has been also elaborated.
C1 [Gao, Jiacheng; Qiao, Liying] Chongqing Univ, Chongqing Engn Res Ctr Magnesium Alloy, Chongqing 400044, Peoples R China.
   [Xue, Yan; Qiao, Liying; Wang, Yong; Zhang, Yan] Chongqing Univ, Coll Mat Sci & Engn, Chongqing 400044, Peoples R China.
RP Gao, JC (reprint author), Chongqing Univ, Chongqing Engn Res Ctr Magnesium Alloy, Chongqing 400044, Peoples R China.
EM gaojch@cqu.edu.cn
FU Chongqing Science Committee [2004AA40003]
FX This project was sponsored by the Chongqing Science Committee under
   Grant 2004AA40003
CR Gao Jia-cheng, 2004, Chinese Journal of Nonferrous Metals, V14, P1508
   Gray JE, 2002, J ALLOY COMPD, V336, P88, DOI 10.1016/S0925-8388(01)01899-0
   Kim SR, 2003, BIOMATERIALS, V24, P1389, DOI 10.1016/S0142-9612(02)00523-9
   LIU ZD, 2002, CHINESE WOUND BONE, V4, P62
   URRAPPA I, 2001, CORROSION PREVENTION, V48, P23
   YOUSEF AA, 2001, MAT T, V42, P1777
   ZHANG M, 2005, THESIS CHONGQING U C
NR 7
TC 2
Z9 8
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
BN 978-0-87849-432-3
J9 MATER SCI FORUM
PY 2007
VL 546-549
BP 601
EP +
DI 10.4028/www.scientific.net/MSF.546-549.601
PN 1-4
PG 2
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BGD24
UT WOS:000246145500130
DA 2018-10-20
ER

PT S
AU Jiang, HC
   Rong, LJ
AF Jiang, H. C.
   Rong, L. J.
BE Long, S
   Pan, FH
   Kainer, KU
   Han, YF
   Ke, W
   Liu, B
   Zhang, XM
   Peng, CQ
   Zhao, XQ
   Feng, Q
   Lu, YF
   Zhang, PX
   Jiang, CB
TI Microstructures and mechanical properties of porous Ti51Ni(49-X)MoX
   shape memory alloys
SO 2006 BIMW: 2006 BEIJING INTERNATIONAL MATERIALS WEEK, PTS 1-4: MAGNESIUM
SE Materials Science Forum
LA English
DT Proceedings Paper
CT Beijing International Materials Week
CY JUN 25-30, 2006
CL Beijing, PEOPLES R CHINA
SP Chinese Mat Res Soc, European Mat Res Soc, Gen Res Inst Nonferrous Metals, Pulead Technol Ind Co Ltd, Shanshan Technol Grp, Chongqing Univ, China Magnesium Ctr, Minist Sci & Technol China, Natl Dev & Reform Commiss China, Minist Educ China, Minist Informat Ind China, Natl Nat Sci Fdn China, Chinese Acad Engn, China Assoc Sci & Technol, Int Union Mat Res Soc
DE porous TiNi shape memory alloy; TiNiMo alloy; compressive properties
ID PHASE-TRANSFORMATION BEHAVIORS; HIGH-TEMPERATURE SYNTHESIS;
   NICKEL-TITANIUM; NITI
AB Porous Ti51Ni(49-x)Mox (x=0, 0.7, 1.0, 1.2) shape memory alloys were successfully fabricated by the self-propagating high-temperature synthesis (SHS) method. The effect of Mo content on micro structures, transformation characteristics and compressive properties of porous TiNiMo alloys was investigated systemically. It has been found that Mo doping into porous TiNi alloys will induce R phase transformation. A small amount of Mo addition (0.7at.%) improves compressive properties of porous TiNiMo alloy due to Mo solution strengthening and the obvious ductile fracture is observed on the fracture photography. However, the compressive strength and compressive strain of porous TiNiMo alloys with excessive Mo content decrease sharply and the failure manner turned into brittle fracture mode, which results from a large amount of Ti2Ni and Ti4Ni2O phases precipitated at grain boundary. Porous Ti51Ni48.3Mo0.7 alloy with suitable transformation temperature and high compressive strength is very promising for use as biomaterial and damping material.
C1 [Jiang, H. C.; Rong, L. J.] Chinese Acad Sci, Inst Met Res, Shenyang 110016, Peoples R China.
RP Jiang, HC (reprint author), Chinese Acad Sci, Inst Met Res, Shenyang 110016, Peoples R China.
EM hcjiang@imr.ac.cn; ljrong@imr.ac.cn
CR Chu CL, 2006, T NONFERR METAL SOC, V16, P49, DOI 10.1016/S1003-6326(06)60009-5
   GYUNTER VE, 1998, MED MAT IMPLANTS SHA
   ITIN VI, 1994, MATER CHARACT, V32, P179, DOI 10.1016/1044-5803(94)90087-6
   Jarfors AEW, 2003, MATER SCI FORUM, V437-4, P475, DOI 10.4028/www.scientific.net/MSF.437-438.475
   JIANG HC, IN PRESS MAT SIC E A
   Li BY, 2000, ACTA MATER, V48, P3895, DOI 10.1016/S1359-6454(00)00184-1
   Li YH, 2002, J MATER SCI TECHNOL, V18, P248
   Liu FS, 2005, INTERMETALLICS, V13, P357, DOI [10.1016/j.intermet.2004.07.024, 10.1016/j.intermet.2005.07.024]
   Nam TH, 2002, MATER LETT, V52, P234, DOI 10.1016/S0167-577X(01)00424-4
   Nam TH, 2001, J MATER SCI, V36, P4181, DOI 10.1023/A:1017964806065
   Rhalmi S, 1999, BIO-MED MATER ENG, V9, P151
   SABURI T, 1979, J IRON STEEL I JPN, V72, P62
   SIMSKE SJ, 1999, J BIOMED MATER RES, V29, P527
NR 13
TC 2
Z9 2
U1 1
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
BN 978-0-87849-432-3
J9 MATER SCI FORUM
PY 2007
VL 546-549
BP 2127
EP +
DI 10.4028/www.scientific.net/MSF.546-549.2127
PN 1-4
PG 2
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BGD24
UT WOS:000246145503061
DA 2018-10-20
ER

PT S
AU Frischholz, M
   Sarmento, L
   Wenzel, M
   Aquilina, K
   Edwards, R
   Coakham, HB
AF Frischholz, M.
   Sarmento, L.
   Wenzel, M.
   Aquilina, K.
   Edwards, R.
   Coakham, H. B.
GP IEEE
TI Telemetric Implantable pressure sensor for short- and long-term
   monitoring of intracranial pressure
SO 2007 ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE
   AND BIOLOGY SOCIETY, VOLS 1-16
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 29th Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY AUG 22-26, 2007
CL Lyon, FRANCE
SP IEEE Engn Med & Biol Soc
AB Patients with hydrocephalus, idiopathic intracranial hypertension and head injury frequently require monitoring of intracranial pressure (ICP) and may need repeated episodes of monitoring months or years apart. The gold standard for measurement of ICP remains the external ventricular catheter. This is a fluid-filled. catheter transducer system that allows regular recalibration and correction of zero drift by its position relative to a fixed anatomical reference. It also allows drainage of cerebrospinal fluid (CSF), providing a means of lowering the ICP. Several catheter tip transducer systems are currently in clinical use, including using strain gauges or fiber-optical pressure sensing techniques. In these devices zero drift and calibration cannot be checked in vivo.
   All the ICP monitoring devices in current clinical use require a physical connection between the brain and the external environment. This is a source of infection and limits the duration of monitoring. A number of telemetric monitoring devices, in which data is in some way transmitted transcutaneously, have been developed over the last twenty years, but significant technical problems have precluded their use in routine clinical practice.
   All current ICP monitors are temporary percutaneous implanted devices. Placement of these devices carries significant morbidity, particularly infection. Patients undergoing repeated monitoring require multiple surgical procedures.
   Apart from decreasing the risk of infection in patients with severe head injury, the clinical value of an accurate telemetric ICP monitoring system which maintains its reliability over a long period of implantation is high. Several neurosurgical conditions require close control of ICP over several years to ensure a satisfactory outcome, such as hydrocephalus treated by a VP shunt or endoscopic third ventriculostomy as well as idiopathic intracranial hypertension. Currently, in these situations, ICP is measured by tapping a ventricular access device or by lumbar puncture; these invasive procedures, often necessary in children, carry a risk of infection. Current ICP monitors show a significant zero drift of the sensor over time which excludes them from being used in long-term implants where recalibration of the sensor is not possible.
   An implantable telemetric device would overcome many of the problems currently associated with ICP monitoring. Telemetry would allow the ICP to be measured non-invasively at home; symptoms could then be easily evaluated and the necessary adjustments to a programmable shunt, when present, could be performed and confirmed.
   Utilizing micro- and nanotechnologies as well as advanced packaging technologies, we have developed a fully implantable ICP sensor for long-term use. The sensor implant comprises an absolute capacitive pressure sensor and readout integrated circuit with ultra low power consumption and hence does not require an implanted battery as a power supply, which would otherwise limit the implant's lifetime. The sensor transmits pressure data via inductive coupling to an external device transcutaneously while being powered from outside via radio frequency. The external reader device compensates the absolute pressure data by measuring and subtracting the barometric pressure and displays data representative of intracranial fluid pressure.
   The implant is encapsulated by several functional layers, ensuring a hermetical sealing while at the same time providing high flexibility. A final biomaterial nano-layer to reduce cell growth and impairment of the mechanical functionality of the sensor is in development The use of capacitive sensors and the encapsulation scheme guarantees a drift-free performance over time.
   The implant is designed in a manner so that it can be inserted according to the proven minimally invasive procedures known from current ICP monitors. The measurement tip can be placed either in the ventricle or brain parenchyma while the telemetry unit is located outside the cranial bone directly under the skin for optimal linking to the external unit. Pressure readings can be taken continuously at any time either at home or in hospital. The external read-out device communicates to the clinical periphery or home base station via radio-frequency link. Our device prototypes have successfully passed extensive laboratory tests and are currently tested in vivo in animal trials.
C1 [Frischholz, M.; Sarmento, L.; Wenzel, M.] Campus Micro Technol GmbH, Univ Allee 29, D-28359 Bremen, Germany.
   [Aquilina, K.; Edwards, R.; Coakham, H. B.] Frenchay Hosp, Dept Neurosurg, Bristol BS16 1LE, Avon, England.
RP Frischholz, M (reprint author), Campus Micro Technol GmbH, Univ Allee 29, D-28359 Bremen, Germany.
EM manfred.frischholz@campus-micro-technologies.de
FU European Commission [IST-2002-1-001837]
FX The authors acknowledge financial support from the European Commission
   in the 6th Framework Programme as part of the HEALTHY AIMS Integrated
   Project (Contract No. IST-2002-1-001837).
CR MERCANZINI A, 2007, P 20 IEEE INT C MICR
   Szmigiel D, 2006, MICROELECTRON ENG, V83, P1178, DOI 10.1016/j.mee.2006.01.070
   VANDENBULCKE M, 2006, P 28 IEEE ANN INT C, P2811
NR 3
TC 13
Z9 13
U1 1
U2 15
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 978-1-4244-0787-3
J9 P ANN INT IEEE EMBS
PY 2007
BP 514
EP +
DI 10.1109/IEMBS.2007.4352337
PG 2
WC Engineering, Biomedical; Imaging Science & Photographic Technology;
   Radiology, Nuclear Medicine & Medical Imaging
SC Engineering; Imaging Science & Photographic Technology; Radiology,
   Nuclear Medicine & Medical Imaging
GA BHI92
UT WOS:000253467000130
PM 18002003
DA 2018-10-20
ER

PT S
AU Forget, G
   Latxague, L
   Heroguez, V
   Labruegre, C
   Durrieu, MC
AF Forget, G.
   Latxague, L.
   Heroguez, V.
   Labruegre, C.
   Durrieu, M. C.
GP IEEE
TI RGD nanodomains grafting onto titanium surface
SO 2007 ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE
   AND BIOLOGY SOCIETY, VOLS 1-16
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 29th Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY AUG 22-26, 2007
CL Lyon, FRANCE
SP IEEE Engn Med & Biol Soc
ID CELL-ADHESION; POLYMERS
AB Titanium alloys exhibit excellent biocompatibility and corrosion resistance in the body fluid and possess mechanical properties similar of the bones' properties. When the loss of osseous is important in osseous surgery, large biomaterials are implanted and should be accepted by the organism. For increasing the biomaterials biocompatibility, biological compounds can be linked or deposited on the material surface making them biologically active.
   In order to study the tissue-implant interaction and to favor osteoblast-adhesion onto titanium, our work deals with the grafting of cell-binding peptides containing the Arginine-Glycine-Aspartic acid (RGD) sequence.
   In the present study, we focus on the elaboration of patterned biomaterial surfaces with highly functionalized nanodomains. The strategy of RGD peptide immobilization involves first the grafting if an amino-functional organosilane (APTES). Then, each of the free amino moieties were used as an initiator core for a dendrimer-like synthesis to multiply the number of free groups available for RGD immobilization on the material surface.
C1 [Forget, G.; Latxague, L.; Durrieu, M. C.] Univ Bordeaux 1, INSERM, U577 Lab, Bordeaux, France.
RP Forget, G (reprint author), Univ Bordeaux 1, INSERM, U577 Lab, Bordeaux, France.
EM guillaume.forget@bordeaux.inserm.fr
RI DURRIEU, Marie-Christine/I-4358-2016
OI DURRIEU, Marie-Christine/0000-0003-0583-9289; Latxague,
   Laurent/0000-0002-6115-7437
CR Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   OHKURA Y, 1979, ANAL CHIM ACTA, V106, P89, DOI 10.1016/S0003-2670(01)83708-9
   PLUDMAN EP, 1991, SILANE COUPLING AGEN
   PORTEDURRIEU MC, 2004, J MATER SCI, V15, P779
   Quemener D, 2005, POLYMER, V46, P1067, DOI 10.1016/j.polymer.2004.11.096
   TOMALIA DA, 1985, POLYM J, V17, P117, DOI 10.1295/polymj.17.117
   WHITMORE PM, 1982, J CHEM PHYS, V77, P1560, DOI 10.1063/1.443938
NR 9
TC 1
Z9 2
U1 0
U2 3
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 978-1-4244-0787-3
J9 P ANN INT IEEE EMBS
PY 2007
BP 5107
EP 5110
DI 10.1109/IEMBS.2007.4353489
PG 4
WC Engineering, Biomedical; Imaging Science & Photographic Technology;
   Radiology, Nuclear Medicine & Medical Imaging
SC Engineering; Imaging Science & Photographic Technology; Radiology,
   Nuclear Medicine & Medical Imaging
GA BHI92
UT WOS:000253467004011
PM 18003155
DA 2018-10-20
ER

PT S
AU Fassina, L
   Saino, E
   Visai, L
   de Angelis, MGC
   Benazzo, F
   Magenes, G
AF Fassina, Lorenzo
   Saino, Enrica
   Visai, Livia
   de Angelis, Maria G. Cusella
   Benazzo, Francesco
   Magenes, Giovanni
GP IEEE
TI Enhanced in vitro culture of human SAOS-2 osteoblasts on a sand-blasted
   titanium surface modified with plastic deformation
SO 2007 ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE
   AND BIOLOGY SOCIETY, VOLS 1-16
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 29th Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY AUG 22-26, 2007
CL Lyon, FRANCE
SP IEEE Engn Med & Biol Soc
ID POLYURETHANE POROUS SCAFFOLD; CALCIFIED MATRIX PRODUCTION; ACID-ETCHED
   SURFACE; BONE-FORMATION; FIBER MESH; SMALL PROTEOGLYCAN; MINIATURE PIGS;
   CELLS; IMPLANTS; COLLAGEN
AB The titanium surfaces with micro-roughness have been studied to substitute machined titanium, with the focus on enhancing the bone apposition onto the implant. In this study we have followed a biomimetic strategy where human SAOS-2 osteoblasts proliferated and built their extracellutar matrix on a sandblasted titanium surface modified with plastic deformation. In comparison with sandblasted titanium surface, the plastic deformation increased the cell proliferation and the surface coating with bone matrix. The superficially modified biomaterial could be used, in clinical applications, as an implant for bone repair.
C1 [Fassina, Lorenzo; Magenes, Giovanni] Univ Pavia, Dipartimento Informat & Sistemist, CIT, Via Ferrata 1, I-27100 Pavia, Italy.
   [Saino, Enrica; Visai, Livia] Univ Pavia, Dipartimento Biochim, CIT, I-27100 Pavia, Italy.
   [de Angelis, Maria G. Cusella] Univ Pavia, Dipartimento Med Sperimentale, CIT, I-27100 Pavia, Italy.
   [Benazzo, Francesco] Univ Pavia, IRCCS San Matteo, Dipartimento SMEC, CIT, I-27100 Pavia, Italy.
RP Fassina, L (reprint author), Univ Pavia, Dipartimento Informat & Sistemist, CIT, Via Ferrata 1, I-27100 Pavia, Italy.
EM lorenzo.fassina@unipv.it; enrica.saino@unipv.it; livia.visai@unipv.it;
   cusella@unipv.it; francesco.benazzo@unipv.it; giovanni.magenes@unipv.it
RI Fassina, Lorenzo/K-9283-2015; Magenes, Giovanni/C-4202-2012
OI Fassina, Lorenzo/0000-0002-5587-4632; Magenes,
   Giovanni/0000-0002-7558-1490
FU Fondazione Cariplo; PRIN from Italian Ministry MUR; FIRB from Italian
   Ministry MUR [RBIP06FH7J]
FX Manuscript received April 15, 2007. This work was supported by
   Fondazione Cariplo Grant (2004) to F. B., by PRIN Grant (2004) from
   Italian Ministry MUR to L. V., and by FIRB Grant (CINECA no. RBIP06FH7J)
   from Italian Ministry MUR.
CR BIANCO P, 1990, J HISTOCHEM CYTOCHEM, V38, P1549, DOI 10.1177/38.11.2212616
   Buser D, 1999, J BIOMED MATER RES, V45, P75, DOI 10.1002/(SICI)1097-4636(199905)45:2<75::AID-JBM1>3.0.CO;2-P
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   BUTLER WT, 1995, ANN NY ACAD SCI, V760, P6, DOI 10.1111/j.1749-6632.1995.tb44615.x
   BUTLER WT, 1989, CONNECT TISSUE RES, V23, P123, DOI 10.3109/03008208909002412
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Cochran DL, 1998, J BIOMED MATER RES, V40, P1, DOI 10.1002/(SICI)1097-4636(199804)40:1<1::AID-JBM1>3.0.CO;2-Q
   Fassina L, 2007, Technol Health Care, V15, P33
   Fassina L, 2005, TISSUE ENG, V11, P685, DOI 10.1089/ten.2005.11.685
   Fassina L, 2006, TISSUE ENG, V12, P1985, DOI 10.1089/ten.2006.12.1985
   Ferguson SJ, 2006, J BIOMED MATER RES A, V78A, P291, DOI 10.1002/jbm.a.30678
   FISHER LW, 1989, J BIOL CHEM, V264, P4571
   Fisher LW, 1995, ACTA ORTHOP SCAND, V66, P61
   FITZSIMMONS RJ, 1994, CALCIFIED TISSUE INT, V55, P376, DOI 10.1007/BF00299318
   GERICKE A, 2005, CALCIF TISSUE INT
   KASUGAI S, 1992, J CELL PHYSIOL, V152, P467, DOI 10.1002/jcp.1041520305
   Li DH, 2002, J BIOMED MATER RES, V60, P325, DOI 10.1002/jbm.10063
   Li JKJ, 2006, ULTRASOUND MED BIOL, V32, P769, DOI 10.1016/j.ultrasmedbio.2006.01.017
   Luan YJ, 2000, COMP BIOCHEM PHYS A, V126, P213, DOI 10.1016/S1095-6433(00)00200-2
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Pavalko FM, 2003, J CELL BIOCHEM, V88, P104, DOI 10.1002/jcb.10284
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Rossi A, 1996, BIOCHEMISTRY-US, V35, P6048, DOI 10.1021/bi9518151
   Sanchez C, 2005, NAT MATER, V4, P277, DOI 10.1038/nmat1339
   Sini P, 1997, GLYCOCONJUGATE J, V14, P871, DOI 10.1023/A:1018550307649
   van den Dolder J, 2003, TISSUE ENG, V9, P505, DOI 10.1089/107632703322066688
   Vehof JWM, 2003, J BIOMED MATER RES A, V64A, P417, DOI 10.1002/jbm.a.10288
   Vehof JWM, 2002, CLIN ORAL IMPLAN RES, V13, P94, DOI 10.1034/j.1600-0501.2002.130112.x
   VOGEL KG, 1984, BIOCHEM J, V223, P587, DOI 10.1042/bj2230587
   VOGEL KG, 1987, J BIOL CHEM, V262, P13607
NR 30
TC 1
Z9 1
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 978-1-4244-0787-3
J9 P ANN INT IEEE EMBS
PY 2007
BP 6411
EP +
PG 2
WC Engineering, Biomedical; Imaging Science & Photographic Technology;
   Radiology, Nuclear Medicine & Medical Imaging
SC Engineering; Imaging Science & Photographic Technology; Radiology,
   Nuclear Medicine & Medical Imaging
GA BHI92
UT WOS:000253467005131
PM 18003489
DA 2018-10-20
ER

PT S
AU Fassina, L
   Saino, E
   Visai, L
   Magenes, G
AF Fassina, Lorenzo
   Saino, Enrica
   Visai, Livia
   Magenes, Giovanni
GP IEEE
TI Physically enhanced coating of a titanium plasma-spray surface with
   human SAOS-2 osteoblasts and extracellular matrix
SO 2007 ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE
   AND BIOLOGY SOCIETY, VOLS 1-16
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 29th Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY AUG 22-26, 2007
CL Lyon, FRANCE
SP IEEE Engn Med & Biol Soc
ID FIBER MESH; BONE-FORMATION; CELLS; ULTRASOUND; IMPLANTS; GROWTH
AB Several studies suggest that the modification of a titanium surface could play an important role in bone tissue engineering. In this study we have followed a biomimetic strategy where ultrasonically or electromagnetically stimulated human SAOS-2 osteoblasts proliferated and built their extracellular matrix on a titanium plasma-spray surface. In comparison with control conditions, the ultrasonic stimulus (power, 149 mW; frequency, 1.5 MHz) and the electromagnetic stimulus (magnetic field, 2 mT; frequency, 75 Hz) increased the cell proliferation and the surface coating with type-I collagen. The physical stimuli aimed at obtaining a better modification of the rough titanium plasma-spray surface in terms of cell colonization and coating with bone matrix. The superficially modified biomaterial could be used, in clinical applications, as an implant for bone repair.
C1 [Fassina, Lorenzo; Magenes, Giovanni] Univ Pavia, Dipartimento Informat & Sistemist, CIT, Via Ferrata 1, I-27100 Pavia, Italy.
   [Saino, Enrica; Visai, Livia] Univ Pavia, Dipartimento Biochim, CIT, I-27100 Pavia, Italy.
RP Fassina, L (reprint author), Univ Pavia, Dipartimento Informat & Sistemist, CIT, Via Ferrata 1, I-27100 Pavia, Italy.
EM lorenzo.fassina@unipv.it; enrica.saino@unipv.it; livia.visai@unipv.it;
   giovanni.magenes@unipv.it
RI Magenes, Giovanni/C-4202-2012; Fassina, Lorenzo/K-9283-2015
OI Magenes, Giovanni/0000-0002-7558-1490; Fassina,
   Lorenzo/0000-0002-5587-4632
FU Fondazione Cariplo; PRIN from Italian Ministry MUR; FIRB from Italian
   Ministry MUR [RBIP06FH7J]
FX This work was supported by Fondazione Cariplo Grant (2004) to F. B., by
   PRIN Grant (2004) from Italian Ministry MUR to L. V., and by FIRB Grant
   (CINECA no. RBIP06FH7J) from Italian Ministry MUR.
CR BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Fassina L, 2007, Technol Health Care, V15, P33
   Fassina L, 2006, TISSUE ENG, V12, P1985, DOI 10.1089/ten.2006.12.1985
   HECKMAN JD, 1994, J BONE JOINT SURG AM, V76A, P26, DOI 10.2106/00004623-199401000-00004
   Li JKJ, 2006, ULTRASOUND MED BIOL, V32, P769, DOI 10.1016/j.ultrasmedbio.2006.01.017
   Pavalko FM, 2003, J CELL BIOCHEM, V88, P104, DOI 10.1002/jcb.10284
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Rossi A, 1996, BIOCHEMISTRY-US, V35, P6048, DOI 10.1021/bi9518151
   Sanchez C, 2005, NAT MATER, V4, P277, DOI 10.1038/nmat1339
   van den Dolder J, 2003, TISSUE ENG, V9, P505, DOI 10.1089/107632703322066688
   van den Dolder J, 2003, BIOMATERIALS, V24, P1745, DOI 10.1016/S0142-9612(02)00537-9
   Vehof JWM, 2003, J BIOMED MATER RES A, V64A, P417, DOI 10.1002/jbm.a.10288
   Vehof JWM, 2002, CLIN ORAL IMPLAN RES, V13, P94, DOI 10.1034/j.1600-0501.2002.130112.x
NR 14
TC 4
Z9 4
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 978-1-4244-0787-3
J9 P ANN INT IEEE EMBS
PY 2007
BP 6415
EP +
PG 2
WC Engineering, Biomedical; Imaging Science & Photographic Technology;
   Radiology, Nuclear Medicine & Medical Imaging
SC Engineering; Imaging Science & Photographic Technology; Radiology,
   Nuclear Medicine & Medical Imaging
GA BHI92
UT WOS:000253467005132
PM 18003490
DA 2018-10-20
ER

PT S
AU Liu, Y
   Ghosh, K
   Sokolov, J
   Rafailovich, M
AF Liu, Ying
   Ghosh, Kaustabh
   Sokolov, Jon
   Rafailovich, Miriam
GP IEEE
TI The effects of the fiber alignment on the behavior of rat osteosarcoma
   and mouse osteoblast cells
SO 2007 IEEE 33RD ANNUAL NORTHEAST BIOENGINEERING CONFERENCE
SE Annual IEEE Northeast Bioengineering Conference
LA English
DT Proceedings Paper
CT IEEE 33rd Annual Northeast Bioengineering Conference
CY MAR 10-11, 2007
CL Long Isl, NY
SP IEEE, EMB, AIChE
AB Electrospinning is a promising method to construct biomaterial scaffolds for tissue engineering applications, but the efficacy depends on how the substrate topography affects cell function! In order to test whether the response of normal and cancerous cells differs, we tested the response of mouse osteoblasts (MC3T3-E1) and rat osteosarcoma (ROS). Poly (methyl methacrylate) fibers were electrospun into rectangular meshes with fiber diameters of 8.64 mu on a rigid support. Examination of cell morphology revealed that both types of cells can adhere to the scaffolds. In both cases the cells on the fibers were far more oriented than those on the planar surface. The aspect ration of the MC3T3 cells though was significantly larger than that of the ROS cells, indicating that cancer cells may not be able to adapt to the underlying morphology as easily as normal cells.
C1 [Liu, Ying; Sokolov, Jon; Rafailovich, Miriam] SUNY Stony Brook, Dept Mat Sci & Engn, Stony Brook, NY 11790 USA.
   [Ghosh, Kaustabh] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA.
RP Liu, Y (reprint author), SUNY Stony Brook, Dept Mat Sci & Engn, Stony Brook, NY 11790 USA.
FU NSF-MRSEC
FX This study was supported by the (NSF-MRSEC).
CR Baker SC, 2006, BIOMATERIALS, V27, P3136, DOI 10.1016/j.biomaterials.2006.01.026
   BASAMI AS, 2006, BIOMATERIALS, V27, P596
   Sundaray B, 2004, APPL PHYS LETT, V84, P1222, DOI 10.1063/1.1647685
NR 3
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0277-1063
BN 978-1-4244-1032-3
J9 NORTHEAST BIOENGIN C
PY 2007
BP 213
EP +
DI 10.1109/ISITAE.2007.4409273
PG 2
WC Engineering, Biomedical; Engineering, Electrical & Electronic; Materials
   Science, Biomaterials; Radiology, Nuclear Medicine & Medical Imaging
SC Engineering; Materials Science; Radiology, Nuclear Medicine & Medical
   Imaging
GA BHP13
UT WOS:000255100600105
DA 2018-10-20
ER

PT S
AU Pan, H
   Jiang, H
   Chen, W
AF Pan, Hui
   Jiang, Hongliang
   Chen, Weiliam
GP IEEE
TI A fibroblast/macrophage co-culture model for in vitro evaluation of
   material biocompatibility and biodegradability
SO 2007 IEEE 33RD ANNUAL NORTHEAST BIOENGINEERING CONFERENCE
SE Annual IEEE Northeast Bioengineering Conference
LA English
DT Proceedings Paper
CT IEEE 33rd Annual Northeast Bioengineering Conference
CY MAR 10-11, 2007
CL Long Isl, NY
SP IEEE, EMB, AIChE
ID SCAFFOLDS; DEXTRAN
AB Fibroblast and macrophage are two major cell types respond cooperatively to implanted biomaterials. They play crucial roles in material degradation, inflammatory response and tissue remodeling(1). However, the interactions of these two cell types with biomaterials have not been fully elucidated. In this study, an in vitro fibroblast/macrophage co-culture system was explored to investigate the biodegradability and biocompatibility of an electrospun PLGA/Dextran scaffold(2-3) as a model biomaterial. Both cell types were capable of degrading the scaffold individually or cooperatively. Lysozyme and nonspecific esterase were involved in scaffold degradation. The scaffold activated macrophages but did not induce server and chronic inflammatory response.
C1 [Pan, Hui; Chen, Weiliam] SUNY Stony Brook, Stony Brook, NY 11794 USA.
   [Jiang, Hongliang] Zhejiang Univ, Hangzhou, Zhejiang, Peoples R China.
RP Pan, H (reprint author), SUNY Stony Brook, Stony Brook, NY 11794 USA.
FU NIH [DK068401]
FX This study was supported by the NIH (DK068401, WC). We would also thank
   Dr. James Quinn on the SEM study, and Dr. Michael Hadjiargyrou and Dr.
   Howard Fleit for their insights.
CR Balakrishnan B, 2005, BIOMATERIALS, V26, P3941, DOI 10.1016/j.biomaterials.2004.10.005
   Hornebeck W, 2003, PATHOL BIOL, V51, P569, DOI 10.1016/j.patbio.2003.09.003
   Jiang HL, 2004, BIOMACROMOLECULES, V5, P326, DOI 10.1021/bm034345w
   Pan H, 2006, BIOMATERIALS, V27, P3209, DOI 10.1016/j.biomaterials.2006.01.032
   Ratner B. D., 2004, BIOMATERIALS SCI INT
NR 5
TC 1
Z9 1
U1 0
U2 3
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0277-1063
BN 978-1-4244-1032-3
J9 NORTHEAST BIOENGIN C
PY 2007
BP 215
EP +
DI 10.1109/NEBC.2007.4413355
PG 2
WC Engineering, Biomedical; Engineering, Electrical & Electronic; Materials
   Science, Biomaterials; Radiology, Nuclear Medicine & Medical Imaging
SC Engineering; Materials Science; Radiology, Nuclear Medicine & Medical
   Imaging
GA BHP13
UT WOS:000255100600106
DA 2018-10-20
ER

PT S
AU Ranjan, A
   Webster, TJ
AF Ranjan, Ashwini
   Webster, Thomas J.
GP IEEE
TI Nanotechnology-derived hydrogels for cardiac tissue replacement
SO 2007 IEEE 33RD ANNUAL NORTHEAST BIOENGINEERING CONFERENCE
SE Annual IEEE Northeast Bioengineering Conference
LA English
DT Proceedings Paper
CT IEEE 33rd Annual Northeast Bioengineering Conference
CY MAR 10-11, 2007
CL Long Isl, NY
SP IEEE, EMB, AIChE
AB The national organ transplant waiting list is growing five times faster than the rate of organ donation, indicating a need to provide a more plentiful source of tissue replacements. Furthermore, the national number one cause for human death is heart disease. Because of the high percentage of heart failure and a low number of successful organ donations, studies are now focusing on the design of new generation biomaterials and functional tissue constructs for specialized tissue repair and replacement. Developing such biomaterials requires the fabrication of scaffolds that mimic in vivo extracellular matrices (ECM). The objective of this study was to design a 'smart' biomaterial that mimics conditions in vivo, creating a micro- and nano-environment suitable for healthy cardiac tissue growth and function.
C1 [Ranjan, Ashwini; Webster, Thomas J.] Brown Univ, Div Engn, Providence, RI 02912 USA.
RP Ranjan, A (reprint author), Brown Univ, Div Engn, Providence, RI 02912 USA.
CR Cadotte AJ, 2005, J NEURAL ENG, V2, P114, DOI 10.1088/1741-2560/2/4/007
   Davis ME, 2005, CIRC RES, V97, P8, DOI 10.1161/01.RES.0000173376.39447.01
   DEUTSCH J, 1999, ASAIO C P JUN
   He JQ, 2003, CIRC RES, V93, P32, DOI 10.1161/01.RES.0000080317.92718.99
   Miller DC, 2005, J BIOMED MATER RES A, V73A, P476, DOI 10.1002/jbm.a.30318
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   ZHAO Y, 2005, 9 INT C MIN SYST CHE
NR 7
TC 0
Z9 0
U1 0
U2 3
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0277-1063
BN 978-1-4244-1032-3
J9 NORTHEAST BIOENGIN C
PY 2007
BP 230
EP 231
DI 10.1109/NEBC.2007.4413362
PG 2
WC Engineering, Biomedical; Engineering, Electrical & Electronic; Materials
   Science, Biomaterials; Radiology, Nuclear Medicine & Medical Imaging
SC Engineering; Materials Science; Radiology, Nuclear Medicine & Medical
   Imaging
GA BHP13
UT WOS:000255100600113
DA 2018-10-20
ER

PT S
AU Sirivisoot, S
   Yao, C
   Xiao, XC
   Sheldon, BW
   Webster, TJ
AF Sirivisoot, Sirinrath
   Yao, Chang
   Xiao, Xingcheng
   Sheldon, Brian W.
   Webster, Thomas J.
GP IEEE
TI Carbon nanotubes-titanium electrode for detecting calcium deposition by
   osteoblasts
SO 2007 IEEE 33RD ANNUAL NORTHEAST BIOENGINEERING CONFERENCE
SE Annual IEEE Northeast Bioengineering Conference
LA English
DT Proceedings Paper
CT IEEE 33rd Annual Northeast Bioengineering Conference
CY MAR 10-11, 2007
CL Long Isl, NY
SP IEEE, EMB, AIChE
AB The objective of this in vitro present study was to develop an electrode which can detect calcium deposition by osteoblasts. The primary biomaterial for this electrode is anodized Ti, developed by chemical etching and passivation treatments. Carbon nanotubes (CNTs), because of their enhancement in electron transfer reaction [1], are essential to consider when designing the electrodes. For this, parallel multiwall CNTs were grown from the pores of the anodized Ti by a chemical vapor deposition process. Preliminary in vitro results suggest that osteoblast functions (specifically alkaline phosphatase activity and calcium deposition) on CNTs grown on anodized Ti are significantly enhanced when compared to anodized Ti and currently-used Ti; thus, it is anticipated that bone growth could be enhanced on these biomaterial electrodes.
C1 [Sirivisoot, Sirinrath; Yao, Chang; Xiao, Xingcheng; Sheldon, Brian W.; Webster, Thomas J.] Brown Univ, Div Engn, Providence, RI 02912 USA.
RP Sirivisoot, S (reprint author), Brown Univ, Div Engn, Providence, RI 02912 USA.
CR Padigi SK, 2007, BIOSENS BIOELECTRON, V22, P829, DOI 10.1016/j.bios.2006.02.023
   Roy S, 2006, NANOTECHNOLOGY, V17, pS14, DOI 10.1088/0957-4484/17/4/003
   Tang H, 2004, CARBON, V42, P191, DOI [10.1016/j.carbon.2003.10.023, 10.1016/j.carbon.2003.09.023]
   Yao C, 2005, J BIOMED NANOTECHNOL, V1, P68, DOI 10.1166/jbn.2005.008
   Zanello LP, 2006, NANO LETT, V6, P562, DOI 10.1021/nl051861e
NR 5
TC 0
Z9 0
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0277-1063
BN 978-1-4244-1032-3
J9 NORTHEAST BIOENGIN C
PY 2007
BP 238
EP 240
DI 10.1109/NEBC.2007.4413366
PG 3
WC Engineering, Biomedical; Engineering, Electrical & Electronic; Materials
   Science, Biomaterials; Radiology, Nuclear Medicine & Medical Imaging
SC Engineering; Materials Science; Radiology, Nuclear Medicine & Medical
   Imaging
GA BHP13
UT WOS:000255100600117
DA 2018-10-20
ER

PT S
AU Xue, JX
   Gao, J
   Tang, LP
AF Xue, Jiaxing
   Gao, Jean
   Tang, Liping
BE Hu, X
   Mandoiu, I
   Obradovic, Z
   Xia, J
TI Mathematical modeling of phagocyte chemotaxis toward and adherence to
   biomaterial implants
SO 2007 IEEE INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICINE,
   PROCEEDINGS
SE IEEE International Conference on Bioinformatics and Biomedicine-BIBM
LA English
DT Proceedings Paper
CT IEEE International Conference on Bioinformatics and Biomedicine
CY NOV 02-04, 2007
CL Fremont, CA
SP IEEE Comp Soc Local Chapter, Addison Wesley, AT&T Res, Bell Labs, Brio, Course Technol, Crystal Decis, Dell, Elsevier, Google, HP Res, Hyperion, IBM Silicon Valley, IBM, Intel Corp, Microsoft, NASA, Nokia, Oak Ridge Natl Labs, Oracle, Pfizer, Sony, Verizon, Yahoo
ID ACTIVATION; SYSTEMS; ALPHA
AB Medical implanted devices usually prompt foreign body reactions that lead to the formation of fibrotic capsule surrounding the implanted devices. Cascade phagocyte responses, such as phagocyte chemotaxis and phagocyte adherence, are believed important in pathogenesis of fibrotic responses. Therefore, in-depth understanding of phagocyte chemotaxis and adherence processes is important to successfully reduce the fibrotic responses to improve the stability and functionality of implanted medical devices. This paper hypothesizes the molecular mechanisms governing phagocyte chemotaxis and adherence. To support our hypotheses and to provide the prediction of un-measured dynamic features in phagocyte chemotaxis and adherence processes, mathematical models based on system and control theory are built. To maximize the prediction ability and to guide future experimental design, external controls are provided by the mathematical model. The effectiveness of the mathematical model is demonstrated by computer simulation.
C1 [Xue, Jiaxing; Gao, Jean] Univ Texas Arlington, Dept Comp Sci, Arlington, TX 76019 USA.
   [Tang, Liping] Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA.
RP Xue, JX (reprint author), Univ Texas Arlington, Dept Comp Sci, Arlington, TX 76019 USA.
EM joshjx@yahoo.com; gao@uta.edu; ltang@uta.edu
CR ACERENZA L, 1989, J THEOR BIOL, V137, P423, DOI 10.1016/S0022-5193(89)80038-4
   Bailey JE, 1998, BIOTECHNOL PROGR, V14, P8, DOI 10.1021/bp9701269
   Carro LP, 1999, ARTHROSCOPY, V15, P103, DOI 10.1053/ar.1999.v15.015010
   Cutroneo KR, 2006, J CELL BIOCHEM, V97, P1161, DOI 10.1002/jcb.20750
   FINKELSTEIN L, 1979, MATH MODELING DYNAMI
   Garcia-Ramallo E, 2002, J IMMUNOL, V169, P6467, DOI 10.4049/jimmunol.169.11.6467
   Hannon B, 1997, MODELING DYNAMIC BIO
   HIGGINS J, 1964, DYNAMICS CONTROL CEL
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492
   Lebiedz D., 2004, IEE Systems Biology, V1, P222, DOI 10.1049/sb:20045022
   Nichols M F, 1979, Biomed Sci Instrum, V15, P1
   ROXIN EO, 1979, CONTROL THEORY APPL
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   WEINER N, 1948, CYBERNETICS CONTROL
   WITTHAUT R, 1994, J LEUKOCYTE BIOL, V55, P105
   Wolkenhauer O, 2004, IEEE T NANOBIOSCI, V3, P200, DOI 10.1109/TNB.2004.833694
   XUE JX, 2007, IN PRESS BIBE
   Yan SR, 2004, IMMUNOL CELL BIOL, V82, P435, DOI 10.1111/j.1440-1711.2004.01268.x
NR 19
TC 2
Z9 2
U1 0
U2 0
PU IEEE COMPUTER SOC
PI LOS ALAMITOS
PA 10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1264 USA
SN 2156-1125
EI 2156-1133
BN 978-0-7695-3031-4
J9 IEEE INT C BIOINFORM
PY 2007
BP 302
EP +
DI 10.1109/BIBM.2007.38
PG 2
WC Computer Science, Information Systems; Computer Science,
   Interdisciplinary Applications; Computer Science, Theory & Methods;
   Engineering, Electrical & Electronic
SC Computer Science; Engineering
GA BHD92
UT WOS:000252387400041
DA 2018-10-20
ER

PT B
AU Wang, BQ
   Li, YD
   Deng, CJ
   Wu, MF
AF Wang, Baoqiang
   Li, Yiding
   Deng, Changjian
   Wu, Maofang
BE Ming, A
   Guo, S
   Liu, S
TI Researches on nonlinearity of acoustic parameters in biomaterial
   extraction with ultrasound
SO 2007 IEEE INTERNATIONAL CONFERENCE ON MECHATRONICS AND AUTOMATION, VOLS
   I-V, CONFERENCE PROCEEDINGS
LA English
DT Proceedings Paper
CT IEEE International Conference on Mechatronics and Automation
CY AUG 05-08, 2007
CL Harbin, PEOPLES R CHINA
SP IEEE Robot & Automat Soc, Harbin Engn Univ, Kagawa Univ, Natl Nat Sci Fdn China, Minist Educ China, Chinese Assoc Automat, Chinese Assoc Artificial Intelligence, Robot Soc Japan, Japan Soc Mech Engineers, Japan Soc Precis Engn, Univ Electro Commun, Univ Elect Sci & Technol China, Changchun Univ Sci & Technol, Beijing Univ Technol, IEEE, Hong Kong Sect, Joint RACS Chapter
DE ultrasonics; nonlinearity; biomaterial processing; acoustic parameter
   detection
ID CAVITATION; SENSOR; PROPAGATION
AB Sonication is one of effective and economical techniques for biomaterial processing in a lot of fields. Chinese traditional medicine extraction assisted with power ultrasound is one of the innovative techniques nowadays in point of fact. An important need is that the ultrasonic intensity must be strong and symmetrical in all over the acoustic field within the large-scale ultrasonic kettles for engineering practice. However the nonlinearity of the acoustic characteristics makes the distribution of ultrasonic energy in the ultrasonic processor asymmetrical-in 4 dimensions D (x, y, z, t). So, the nonlinearity of the spatial and temporal vicissitude of acoustic characters in the bulky ultrasonic kettle must be realized and dealt with seriously. In the paper, the topics involve: (1) To analyse some description methods of nonlinearity; (2) To research on some nonlinear rules about the acoustic parameters of ultrasonic propagation in the mixture of biomaterials and mediums; (3) To make experiments on nonlinearity of acoustic cavitation and sonication yield in fluids. There are 3 aspects introduced in the paper: (1) Besides the rules of wave propagation, some nonlinear relations of momentum for the motion of fluids are discussed, and the second order acoustic nonlinearity parameter B/A of fluids is introduced too; (2) A new free from paraxial approximation and computationally efficient numerical algorithm capable of predicting 4D acoustic fields in lossy and nonlinear media from arbitrary shaped sources is described. (3) The nonlinearity of the spatial distribution of cavitation activity generated within an ultrasonic processing vessel is studied. Based on the researches above, an applied biomaterial extraction vessel has been set up for Chinese traditional medicine extraction manufacture. It was proved that the researches in the paper are rational, effective and useful for biomaterial extraction with ultrasound.
C1 [Wang, Baoqiang; Li, Yiding] Chengdu Univ Informat Technol, Inst Bio Mat Engn, Chengdu 610225, Sichuan, Peoples R China.
   [Deng, Changjian; Wu, Maofang] Chengdu Univ Informat Technol, Dept Control Engn, Chengdu 610225, Peoples R China.
RP Wang, BQ (reprint author), Chengdu Univ Informat Technol, Inst Bio Mat Engn, Chengdu 610225, Sichuan, Peoples R China.
EM bqwang@cuit.edu.cn; jywmfang@126.com
FU NSFC Research Project [30470420]; Sichuan Province Applied Base Research
   Subject
FX The work is supported by the NSFC Research Project (30470420) and
   Sichuan Province Applied Base Research Subject.
CR Bjorno L, 2002, ULTRASONICS, V40, P11, DOI 10.1016/S0041-624X(02)00084-7
   Bloomfield PE, 2005, ULTRASONICS, V43, P421, DOI 10.1016/j.ultras.2004.11.002
   Feng R, 2002, ULTRASON SONOCHEM, V9, P231, DOI 10.1016/S1350-4177(02)00083-4
   Hodnett M, 2004, ULTRASON SONOCHEM, V11, P441, DOI 10.1016/j.ultsonch.2003.09.002
   JCIK JW, 2003, EFFECTIVE ALGORITHM, P246
   Radulescu EG, 2004, ULTRASONICS, V42, P367, DOI 10.1016/j.ultras.2003.11.019
   Wang BQ, 2006, IEEE ICMA 2006: PROCEEDING OF THE 2006 IEEE INTERNATIONAL CONFERENCE ON MECHATRONICS AND AUTOMATION, VOLS 1-3, PROCEEDINGS, P463
   WANG BQ, 2003, J CHENGDU U INFORM T, V18, P25
   WANG BQ, 2005, IEEE P ICIMA, P763
   Wang J, 2004, ADV ATMOS SCI, V21, P662, DOI 10.1007/BF02915733
   WO J, ANN J, P1642
   Wojcik J, 2006, ULTRASONICS, V44, P310, DOI [10.1016/j.ultras.2006.04.001, 10.1016/j.ultras.2006.01.001]
   WOJCIK J, 2002, ULTRASONICS, V40, P11
   Yang XM, 2005, J ACOUST SOC AM, V117, P113, DOI 10.1121/1.1828671
   Zemp RJ, 2003, J ACOUST SOC AM, V113, P139, DOI 10.1121/1.1528926
   Zeqiri B, 2003, IEEE T ULTRASON FERR, V50, P1342, DOI 10.1109/TUFFC.2003.1244751
   Zeqiri B, 2003, IEEE T ULTRASON FERR, V50, P1351, DOI 10.1109/TUFFC.2003.1244752
NR 17
TC 0
Z9 0
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4244-0827-6
PY 2007
BP 2258
EP +
DI 10.1109/ICMA.2007.4303904
PG 2
WC Automation & Control Systems; Engineering, Electrical & Electronic;
   Robotics
SC Automation & Control Systems; Engineering; Robotics
GA BGX87
UT WOS:000251178102118
DA 2018-10-20
ER

PT S
AU Martynenko, AI
   Yang, SX
AF Martynenko, Alex I.
   Yang, Simon X.
GP IEEE
TI An intelligent control system for thermal processing of biomaterials
SO 2007 IEEE INTERNATIONAL CONFERENCE ON NETWORKING, SENSING, AND CONTROL,
   VOLS 1 AND 2
SE IEEE International Conference on Networking, Sensing and Control
LA English
DT Proceedings Paper
CT IEEE International Conference on Networking, Sensing and Control
CY APR 15-17, 2007
CL London, ENGLAND
SP IEEE Syst Man & Cybernet Soc
ID MACHINE VISION; NEURAL-NETWORKS; TEXTURE MODELS; GRAIN DRYERS; QUALITY;
   CLASSIFICATION; COLOR; PREDICTION; MORPHOLOGY; POTATOES
AB An intelligent control system for thermal processing of natural biomaterials, based on machine vision, sensor fusion and neural network was developed. Experiments with ginseng drying showed advantages of machine vision for real-time imaging of morphological, colour and texture attributes, providing sufficient discriminatory information about biomaterial moisture and quality in the range of 3.2-0.1 g/g and temperatures from 30 to 50 degrees C. Both moisture and quality was estimated by using neural network models: moisture with 6-8% error and quality. with 10-16% error. Online estimates of moisture and quality were used for temperature control in pilot batch dryer. Testing of the intelligent control system with embedded machine-vision observer (IMAQ (TM) Vision Builder) and controller (Lab View 7.0) showed stability and robustness, combined with high accuracy of temperature control. Multi-stage optimization of temperature with respect to quality allowed decrease of drying time from 240 to 90-110 hours with appropriate final quality.
C1 [Martynenko, Alex I.; Yang, Simon X.] Univ Guelph, Sch Engn, Guelph, ON N1G 2W1, Canada.
RP Martynenko, AI (reprint author), Univ Guelph, Sch Engn, Guelph, ON N1G 2W1, Canada.
EM syang@uoguelph.ca
RI Yang, Simon X./A-4399-2008
OI Yang, Simon X./0000-0002-6888-7993
CR Chiang Alpha C., 1992, ELEMENTS DYNAMIC OPT
   Davidson VJ, 1999, J FOOD ENG, V41, P141, DOI 10.1016/S0260-8774(99)00081-3
   Davidson VJ, 2004, J FOOD ENG, V63, P361, DOI 10.1016/j.jfoodeng.2003.08.014
   Davies E., 2000, IMAGE PROCESSING FOO
   DOUGLAS PL, 1994, T I CHEME, V72, P341
   Du CJ, 2006, J FOOD ENG, V72, P39, DOI 10.1016/j.jfoodeng.2004.11.017
   Fernandez L, 2005, J FOOD ENG, V67, P185, DOI 10.1016/j.jfoodeng.2004.05.070
   Gunasekaran S., 2000, NONDESTRUCTIVE FOOD
   Harris C., 1993, INTELLIGENT CONTROL
   Hussain MA, 2002, J FOOD ENG, V51, P239, DOI 10.1016/S0260-8774(01)00063-2
   Kudra T., 1998, THERMAL PROCESSING B
   Kulkarni A. D., 2001, COMPUTER VISION FUZZ
   LI X, 2002, THESIS U GUELPH CANA
   LI YF, 1987, T ASAE, V30, P842
   Majumdar S, 2000, T ASAE, V43, P1669
   Majumdar S, 2000, T ASAE, V43, P1689
   Majumdar S, 2000, T ASAE, V43, P1677
   Majumdar S, 2000, T ASAE, V43, P1681
   Mao ZH, 1999, DRY TECHNOL, V17, P1767, DOI 10.1080/07373939908917651
   MARTYNENKO AI, UNPUB RISK QUALITY D
   MARTYNENKO AI, 2005, THESIS U GUELPH CANA
   Mittal G. S., 1996, COMPUTERIZED CONTROL
   MULET A, 1994, J FOOD ENG, V22, P329, DOI 10.1016/0260-8774(94)90038-8
   Oliveira F.A.R., 1999, PROCESSING FOODS QUA
   Olmos A, 2002, DRY TECHNOL, V20, P1319, DOI 10.1081/DRT-120005855
   Perrot N, 2000, J FOOD PROCESS ENG, V23, P249, DOI 10.1111/j.1745-4530.2000.tb00515.x
   Qiao J, 2007, J FOOD ENG, V79, P1065, DOI 10.1016/j.jfoodeng.2006.03.026
   TAO Y, 1995, T ASAE, V38, P1555
   Trelea IC, 1997, DRY TECHNOL, V15, P1095, DOI 10.1080/07373939708917280
   Trelea IC, 1997, J FOOD ENG, V31, P403, DOI 10.1016/S0260-8774(96)00096-9
   Vasconcelos LGS, 1998, DRY TECHNOL, V16, P2017, DOI 10.1080/07373939808917509
   Yang W, 2005, BIOSYST ENG, V91, P1, DOI 10.1016/j.biosystemseng.2005.02.002
   Zhang Q., 1993, J FOOD PROCESS ENG, V16, P59
   Zhang QH, 2002, BIOSYST ENG, V83, P281, DOI [10.1006/bioe.2002.0123, 10.1016/S1537-S110(02)00190-3]
   1998, GRADE QUALITY STANDA
NR 35
TC 1
Z9 1
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1810-7869
BN 978-1-4244-1075-0
J9 IEEE INT C NETW SENS
PY 2007
BP 93
EP 98
DI 10.1109/ICNSC.2007.372939
PG 6
WC Automation & Control Systems; Computer Science, Theory & Methods;
   Engineering, Electrical & Electronic
SC Automation & Control Systems; Computer Science; Engineering
GA BHB32
UT WOS:000252065800017
DA 2018-10-20
ER

PT S
AU Nakamura, N
   Mukaiyama, T
   Kawakami, S
   Matsuyama, T
   Wada, K
   Matsunaka, T
   Kono, K
   Horinaka, H
AF Nakamura, N.
   Mukaiyama, T.
   Kawakami, S.
   Matsuyama, T.
   Wada, K.
   Matsunaka, T.
   Kono, K.
   Horinaka, H.
GP IEEE
TI Monitoring device of Au nano-particle distribution in living body using
   ultrasonic velocity change image
SO 2007 IEEE ULTRASONICS SYMPOSIUM PROCEEDINGS, VOLS 1-6
SE ULTRASONICS SYMPOSIUM
LA English
DT Proceedings Paper
CT IEEE Ultrasonics Symposium
CY OCT 28-31, 2007
CL New York, NY
SP IEEE
DE ultrasonic velocity change; Au nano-particles; drug delivery system
   (DDS); optical tomography
ID GOLD NANORODS; SENSITIVITY
AB We could obtain ultrasonic velocity change Images of Au nano-particles In the two phantoms which ware made of highly optical scattering ager and the chicken breast meet by using the remodeled diagnostic ultrasound equipment. All experimental results suggested that our Imaging method could be applied to a practical monitor for the thermal therapy and the drug delivery system (DDS), and could be applied to biomaterial identification.
C1 [Nakamura, N.; Mukaiyama, T.; Kawakami, S.; Matsuyama, T.; Wada, K.; Matsunaka, T.; Kono, K.; Horinaka, H.] Osaka Prefecture Univ, Dept Engn, Naka Ku, Osaka 5998531, Japan.
RP Nakamura, N (reprint author), Osaka Prefecture Univ, Dept Engn, Naka Ku, 1-1 Gakuen Cho, Osaka 5998531, Japan.
EM na-namura@pe.osakafu-u.ac.jp
CR Eghtedari M, 2007, NANO LETT, V7, P1914, DOI 10.1021/nl070557d
   HORINAKA H, 2006, P 2006 IEEE ULTR S V, P2060
   Kono K, 2002, J CONTROL RELEASE, V80, P321, DOI 10.1016/S0168-3659(02)00018-4
   Link S, 1999, J PHYS CHEM B, V103, P3073, DOI 10.1021/jp990183f
   Niidome T, 2006, J CONTROL RELEASE, V114, P343, DOI 10.1016/j.jconrel.2006.06.017
   Petrova H, 2006, PHYS CHEM CHEM PHYS, V8, P814, DOI 10.1039/b514644e
   THERESA MA, 2004, SCIENCE, V303, P1818
NR 7
TC 1
Z9 1
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1051-0117
BN 978-1-4244-1383-6
J9 ULTRASON
PY 2007
BP 2227
EP 2230
DI 10.1109/ULTSYM.2007.560
PG 4
WC Acoustics; Biophysics; Engineering, Electrical & Electronic; Physics,
   Applied; Imaging Science & Photographic Technology
SC Acoustics; Biophysics; Engineering; Physics; Imaging Science &
   Photographic Technology
GA BHM55
UT WOS:000254281802057
DA 2018-10-20
ER

PT B
AU Chen, ZG
   Mo, XM
AF Chen Zong-Gang
   Mo Xiu-Mei
GP Donghua University
TI Preparation and properties of electrospun collagen-chitosan nanofibers
SO 2007 INTERNATIONAL FORUM ON BIOMEDICAL TEXTILE MATERIALS, PROCEEDINGS
LA English
DT Proceedings Paper
CT International Forum on Biomedical Textile Materials
CY MAY 30-JUN 02, 2007
CL Donghua Univ, Songjiang Campus, Shanghai, PEOPLES R CHINA
SP Shanghai Soc Biomed Engn, Key Lab Textile Sci & Technol, Minist Educ, Engn Res Ctr Tech Textiles, Minist Educ, Donghua Univ, Coll Textiles, Donghua Univ, Inst Biol Sci & Biotechnol, State Key Lab Modificat Chem Fiber & Polymer Mat
HO Donghua Univ, Songjiang Campus
DE collagen; chitosan; electronspinning; FTIR; XRD
ID BENDING INSTABILITY; SCAFFOLDS; POLYMER; MATRICES; GELATIN
AB The collagen-chitosan nanofibers have been prepared by electrospinning from a mixed HFP/TFA(the volume ratio of 90/10) solution. The intermolecular interactions in collagen-chitosan nanofibers were characterized by Fourier transform infrared spectroscopy (FTIR). XRD patterns show that the collagen-chitosan nanofibers have become amorphous phases after electrospinning. Mechanical characterization indicates that the ratio of collagen to chitosan will affect the mechanical properties of electrospun collagen-chitosan fibers. Both the ultimate tensile elongation and the ultimate tensile strength of fibrous. membrane decrease with the increase of chitosan content. All these would be useful to a biomaterial design by electrospinning method.
C1 [Chen Zong-Gang; Mo Xiu-Mei] Donghua Univ, Inst Biol Sci Biotechnol, Shanghai 201620, Peoples R China.
RP Mo, XM (reprint author), Donghua Univ, Inst Biol Sci Biotechnol, Shanghai 201620, Peoples R China.
RI mo, xiumei/C-9340-2013
CR Adekogbe I, 2005, BIOMATERIALS, V26, P7241, DOI 10.1016/j.biomaterials.2005.05.043
   ALBERTS B, 1994, MOL BIOL CELL
   Chen RN, 2006, BIOMACROMOLECULES, V7, P1058, DOI 10.1021/bm050754b
   Chen ZG, 2006, TISSUE ENG, V12, P1074
   CHEN ZG, 2006, MAT LETTERS
   Gomathi K, 2003, BIOMATERIALS, V24, P2767, DOI 10.1016/S0142-9612(03)00059-0
   HASEGAWA M, 1992, J APPL POLYM SCI, V45, P1857, DOI 10.1002/app.1992.070451020
   Hirano S, 2000, BIOMATERIALS, V21, P997, DOI 10.1016/S0142-9612(99)00258-6
   Huang ZL, 2006, TISSUE ENG, V12, P1070
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Huang ZM, 2004, POLYMER, V45, P5361, DOI 10.1016/j.polymer.2004.04.005
   Kim SH, 2003, POLYM J, V35, P185, DOI 10.1295/polymj.35.185
   Lee SB, 2004, BIOMATERIALS, V25, P2309, DOI 10.1016/j.biomaterials.2003.09.016
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   MAROIS Y, 1995, BIOMATERIALS, V16, P1131, DOI 10.1016/0142-9612(95)93576-Y
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   Mo X. M., 1997, ACTA POLYM SIN, V46, P222
   Prabu P, 2006, J BIOMED MATER RES A, V79A, P153, DOI 10.1002/jbm.a.30715
   Reneker DH, 2000, J APPL PHYS, V87, P4531, DOI 10.1063/1.373532
   Silver F. H., 1999, BIOMATERIALS SCI BIO
   Sionkowska A, 2004, BIOMATERIALS, V25, P795, DOI 10.1016/S0142-9612(03)00595-7
   Verreck G, 2003, J CONTROL RELEASE, V92, P349, DOI 10.1016/S0168-3659(03)00342-0
   Wang XH, 2003, BIOMATERIALS, V24, P3213, DOI 10.1016/S0142-9612(03)00170-4
   Webster TJ, 2004, NANOTECHNOLOGY, V15, P48, DOI 10.1088/0957-4484/15/1/009
   Yarin AL, 2001, J APPL PHYS, V89, P3018, DOI 10.1063/1.1333035
   Zong XH, 2003, POLYMER, V44, P4959, DOI 10.1016/S0032-3861(03)00464-6
NR 26
TC 1
Z9 1
U1 0
U2 9
PU DONGHUA UNIV PRESS
PI SHANGHAI
PA 1882 YAN AN WEST RD, SHANGHAI, 00000, PEOPLES R CHINA
BN 978-7-81111-065-4
PY 2007
BP 151
EP 155
PG 5
WC Biotechnology & Applied Microbiology; Engineering, Biomedical;
   Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Engineering; Science & Technology
   - Other Topics
GA BHH67
UT WOS:000253308000029
DA 2018-10-20
ER

PT B
AU Anderson, JM
   Jones, JA
AF Anderson, James M.
   Jones, Jacqueline A.
GP Donghua University
TI Inflammatory cell interations with surface-modified biomaterials
SO 2007 INTERNATIONAL FORUM ON BIOMEDICAL TEXTILE MATERIALS, PROCEEDINGS
LA English
DT Proceedings Paper
CT International Forum on Biomedical Textile Materials
CY MAY 30-JUN 02, 2007
CL Donghua Univ, Songjiang Campus, Shanghai, PEOPLES R CHINA
SP Shanghai Soc Biomed Engn, Key Lab Textile Sci & Technol, Minist Educ, Engn Res Ctr Tech Textiles, Minist Educ, Donghua Univ, Coll Textiles, Donghua Univ, Inst Biol Sci & Biotechnol, State Key Lab Modificat Chem Fiber & Polymer Mat
HO Donghua Univ, Songjiang Campus
DE biomaterials; inflammatory cells; foreign body reaction; macrophages;
   cell culture
ID IN-VIVO; CHEMISTRY; APOPTOSIS; MACROPHAGES; ADHESION
AB Implantation of biomedical polymers, devices, and prostheses results in the normal sequence of inflammatory and wound healing events, ultimately resulting in the foreign body reaction at the tissue/material interface. The normal foreign body reaction consists of adherent macrophages and foreign body giant cells at the tissue/material interface. Our studies have focused on developing a mechanistic understanding of the effect of biomaterial surface chemistry on the formation and activity of monocytes, macrophages, lymphocytes, and foreign body giant cells in the foreign body reaction. Studies utilizing materials with a broad range of surface chemistries have been used to investigate the capability of surfaces to enhance or reduce macrophage and foreign body giant cell adhesion, fusion, activation, and apoptosis. Correlative in vitro and in vivo studies will be presented that identify certain surface chemistries that facilitate a reduction in the foreign body reaction while others enhance the foreign body reaction at material/tissue interfaces. Our ultimate goal is to identify biological design criteria that will prove useful in the development of new biomaterials and tissue engineering constructs.
C1 Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
RP Anderson, JM (reprint author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
CR Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Brodbeck WG, 2002, J LAB CLIN MED, V139, P90, DOI 10.1067/mlc.2002.121260
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   Dadsetan M, 2004, J BIOMED MATER RES A, V71A, P439, DOI 10.1002/jbm.a.30165
   DeFife KM, 1999, J BIOMED MATER RES, V45, P148, DOI 10.1002/(SICI)1097-4636(199905)45:2<148::AID-JBM10>3.0.CO;2-U
   JONES AJ, 2007, IN PRESS J BIOMED MA, pA81
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   Nakayama Y, 1996, MACROMOLECULES, V29, P8622, DOI 10.1021/ma9606014
NR 10
TC 0
Z9 0
U1 0
U2 0
PU DONGHUA UNIV PRESS
PI SHANGHAI
PA 1882 YAN AN WEST RD, SHANGHAI, 00000, PEOPLES R CHINA
BN 978-7-81111-065-4
PY 2007
BP 197
EP 200
PG 4
WC Biotechnology & Applied Microbiology; Engineering, Biomedical;
   Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Engineering; Science & Technology
   - Other Topics
GA BHH67
UT WOS:000253308000037
DA 2018-10-20
ER

PT B
AU Gang, X
   Du-Yu, N
   Wen-Zu, W
   Pei-Hua, Z
   Jie, S
   Beng-Ti, A
   Guo-Hua, L
   Xue-Gang, L
   Nan-Liang, C
   Zhi-Cheng, X
AF Gang, Xu
   Du-yu, Nie
   Wen-zu, Wang
   Pei-hua, Zhang
   Jie, Shen
   Beng-ti, Ang
   Guo-hua, Liu
   Xue-gang, Luo
   Nan-liang, Chen
   Zhi-cheng, Xiao
GP Donghua University
TI Evaluation of optic nerve regeneration by using polyglycolic
   acid-chitosan conduits coated with recombinant L1-Fc
SO 2007 INTERNATIONAL FORUM ON BIOMEDICAL TEXTILE MATERIALS, PROCEEDINGS
LA English
DT Proceedings Paper
CT International Forum on Biomedical Textile Materials
CY MAY 30-JUN 02, 2007
CL Donghua Univ, Songjiang Campus, Shanghai, PEOPLES R CHINA
SP Shanghai Soc Biomed Engn, Key Lab Textile Sci & Technol, Minist Educ, Engn Res Ctr Tech Textiles, Minist Educ, Donghua Univ, Coll Textiles, Donghua Univ, Inst Biol Sci & Biotechnol, State Key Lab Modificat Chem Fiber & Polymer Mat
HO Donghua Univ, Songjiang Campus
DE optic nerve; regeneration; L1; PGA; chitosan
ID CELL-DEATH; REPAIR; RATS; L1
AB Autografts have been extensively studied to facilitate optic nerve(ON) regeneration in animal experiments, but same approach for clinical application to aid in autoregeneration has not yet been attempted due to its obvious shortcomings. This study aims to explore the guided regeneration by an artificial polyglycolic acid-chitosan conduit coated with recombinant L1-Fc. Consisting with previous studies, in vitro assay showed that both chitosan, a natural biomaterial, and the neural cell adhesion molecule L1-Fc enhanced the neurite outgrowth. Rat optic nerve transection was used as an in vivo model. The implanted PGA-chitosan conduit was progressively degraded and absorbed, accompanied by significant axonal regeneration as revealed by GAP-43 immunohistochemistry and Fluorogold retrograde tracing.. Moreover, the polyglycolic acid-chitosan conduit coated with L1-Fc showed more effective to promote axonal regeneration and remyelination. Taken together, our observations demonstrated that the L1-Fc coated PGA-chitosan conduits provided a compatible and supportive canal to guild the injured nerve regeneration and remyelination.
C1 [Gang, Xu; Du-yu, Nie; Jie, Shen; Beng-ti, Ang; Zhi-cheng, Xiao] Singapore Gen Hosp, Dept Clin Res, Singapore 0316, Singapore.
RP Gang, X (reprint author), Singapore Gen Hosp, Dept Clin Res, Singapore 0316, Singapore.
CR Asher R A, 2001, Prog Brain Res, V132, P611
   BARTSCH U, 2003, FRONT BIOSCI, V8, P477
   Chen S, 1999, J NEUROBIOL, V38, P428, DOI 10.1002/(SICI)1097-4695(19990215)38:3<428::AID-NEU10>3.0.CO;2-6
   DOHERTY P, 1995, NEURON, V14, P57, DOI 10.1016/0896-6273(95)90240-6
   Ellezam B, 2003, NEUROBIOL DIS, V12, P1, DOI 10.1016/S0969-9961(02)00013-X
   EVANS GR, 1995, BIOMATERIALS, V20, P1109
   Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195
   Haipeng G, 2000, J Biomed Mater Res, V52, P285, DOI 10.1002/1097-4636(200011)52:2<285::AID-JBM7>3.3.CO;2-7
   LANGER R, 1995, ANN BIOMED ENG, V23, P101, DOI 10.1007/BF02368317
   LEMMON V, 1992, J NEUROSCI, V12, P818
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Matsumoto K, 2000, BRAIN RES, V868, P315, DOI 10.1016/S0006-8993(00)02207-1
   Roonprapunt C, 2003, J NEUROTRAUM, V20, P871, DOI 10.1089/089771503322385809
   Sauve Y, 2001, J NEUROSCI, V21, P951
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   SellesNavarro I, 1996, INVEST OPHTH VIS SCI, V37, P2002
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Vasconcelos BCE, 2000, J ORAL MAXIL SURG, V58, P1257, DOI 10.1053/joms.2000.16626
   Whiteley SJO, 1998, EXP NEUROL, V154, P560, DOI 10.1006/exnr.1998.6959
   Xiao ZC, 1996, EUR J NEUROSCI, V8, P766, DOI 10.1111/j.1460-9568.1996.tb01262.x
   Zhang SL, 1995, CHEM J CHINESE U, V16, P193
NR 21
TC 0
Z9 0
U1 0
U2 3
PU DONGHUA UNIV PRESS
PI SHANGHAI
PA 1882 YAN AN WEST RD, SHANGHAI, 00000, PEOPLES R CHINA
BN 978-7-81111-065-4
PY 2007
BP 275
EP 282
PG 8
WC Biotechnology & Applied Microbiology; Engineering, Biomedical;
   Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Engineering; Science & Technology
   - Other Topics
GA BHH67
UT WOS:000253308000052
DA 2018-10-20
ER

PT B
AU Ling, W
   Xin, D
AF Ling, Wang
   Xin, Ding
GP Donghua University
TI Research progressing on the porosity of blood vessels with respect to
   the seeding of endothelial cells
SO 2007 INTERNATIONAL FORUM ON BIOMEDICAL TEXTILE MATERIALS, PROCEEDINGS
LA English
DT Proceedings Paper
CT International Forum on Biomedical Textile Materials
CY MAY 30-JUN 02, 2007
CL Donghua Univ, Songjiang Campus, Shanghai, PEOPLES R CHINA
SP Shanghai Soc Biomed Engn, Key Lab Textile Sci & Technol, Minist Educ, Engn Res Ctr Tech Textiles, Minist Educ, Donghua Univ, Coll Textiles, Donghua Univ, Inst Biol Sci & Biotechnol, State Key Lab Modificat Chem Fiber & Polymer Mat
HO Donghua Univ, Songjiang Campus
DE porosity; blood Vessel; endothelial; cell seeding
ID BONE-MARROW-CELLS; PLATELET-ADHESION; VASCULAR GRAFTS;
   TRANSPORT-PROPERTIES; PROTEIN ADSORPTION; BYPASS GRAFTS; IN-VITRO;
   DIAMETER; SURFACE; POLYMER
AB Biocompatibility is one of the key issues of artificial blood vessels application. The common method to improve the compatibility of the artificial blood vessels is to modify the surface of the biomaterial. Endothelial cell seeding on the surface of blood vessels material has made great progress, and improves the biocompatibility of biomaterial greatly. The application and the performance of textile artificial blood vessels when seeding of endothelial cells on the surface are briefly presented. In addition, it discusses research progressing on the porosity of blood vessels with respect to the seeding of endothelial cells. At last, an effective method using electrospinning is given which makes the surface of textile artificial blood vessels suits for seeding of endothelial cells.
C1 [Ling, Wang; Xin, Ding] Donghua Univ, Coll Text, Shanghai 201620, Peoples R China.
RP Xin, D (reprint author), Donghua Univ, Coll Text, Shanghai 201620, Peoples R China.
CR Bhattacharya V, 2000, BLOOD, V95, P581
   BRINKMAN E, 1990, BIOMATERIALS, V11, P200, DOI 10.1016/0142-9612(90)90156-K
   Chen YM, 2007, BIOMATERIALS, V28, P1752, DOI 10.1016/j.biomaterials.2006.12.005
   FOLEY DP, 1994, CIRCULATION, V90, P1239, DOI 10.1161/01.CIR.90.3.1239
   FUJIMOTO K, 1993, BIOMATERIALS, V14, P442, DOI 10.1016/0142-9612(93)90147-T
   GAYLORD NG, 1975, ADV CHEM SER, V142, P76
   Gibson P, 2001, COLLOID SURFACE A, V187, P469, DOI 10.1016/S0927-7757(01)00616-1
   Gibson PW, 1999, AICHE J, V45, P190, DOI 10.1002/aic.690450116
   Griese DP, 2003, CIRCULATION, V108, P2710, DOI 10.1161/01.CIR.0000096490.16596.A6
   Haimovich B, 1997, J APPL POLYM SCI, V63, P1393
   HARRIS JM, 1992, POLY ETHYLENE GLYCOL
   He HB, 2003, J THORAC CARDIOV SUR, V126, P455, DOI 10.1016/S0022-5223(02)73264-9
   He W, 2005, BIOMATERIALS, V26, P7606, DOI 10.1016/j.biomaterials.2005.05.049
   HERRING M, 1978, SURGERY, V84, P498
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Kaushal S, 2001, NAT MED, V7, P1035, DOI 10.1038/nm0901-1035
   KWON K, 2005, BIOMATERIALS, V26, P3929
   Laube HR, 2000, J THORAC CARDIOV SUR, V120, P134, DOI 10.1067/mtc.2000.106327
   LEE JH, 2003, J BIOL MACROMOLECULE, V32, P17
   Leon CALY, 1998, ADV COLLOID INTERFAC, V76, P341, DOI 10.1016/S0001-8686(98)00052-9
   Li DP, 2006, J MEMBRANE SCI, V286, P104, DOI 10.1016/j.memsci.2006.09.020
   Losi P, 2004, BIOMATERIALS, V25, P4447, DOI 10.1016/j.biomaterials.2003.11.025
   LUCH R, 2006, COMPOS SCI TECHNOL, V66, P2436
   Matsumura G, 2003, CIRCULATION, V108, P1729, DOI 10.1161/01.CIR.0000092165.32213.61
   MCENANEY B, 1995, POROSITY CARBONS CHA, P93
   Meinhart J, 1997, ASAIO J, V43, P515
   MORI Y, 1982, T AM SOC ART INT ORG, V28, P459
   Moroni L, 2006, BIOMATERIALS, V27, P4911, DOI 10.1016/j.biomaterials.2006.05.027
   Njatawidjaja E, 2006, SURF COAT TECH, V201, P699, DOI 10.1016/j.surfcoat.2005.12.017
   NOISHIKI Y, 1992, J THORAC CARDIOV SUR, V104, P770
   OKANO T, 1981, J BIOMED MATER RES, V15, P393, DOI 10.1002/jbm.820150310
   Park JH, 1999, BIOMATERIALS, V20, P943, DOI 10.1016/S0142-9612(98)00250-6
   RUY YJ, 2003, EUR POLYM J, V39, P1883
   Ryu YJ, 2003, EUR POLYM J, V39, P1883, DOI 10.1016/S0014-3057(03)00096-X
   SAPSFORD RN, 1981, J THORAC CARDIOV SUR, V81, P860
   SCATTERFIELD CN, 1991, HETEROGENEOUS CATALY, P131
   Schindler M, 2005, BIOMATERIALS, V26, P5624, DOI 10.1016/j.biomaterials.2005.02.014
   Severian D., 2002, POLYM BIOMATERIALS
   Shirota T, 2003, TISSUE ENG, V9, P127, DOI 10.1089/107632703762687609
   SHIROTA T, 2003, FABRICATION ENDOTHEL, V13, P2295
   Steinthorsson G, 1999, ACTA CHIR BELG, V99, P282
   Tanaka M, 2000, BIOMATERIALS, V21, P1471, DOI 10.1016/S0142-9612(00)00031-4
   Tanaka M., 2000, Japanese Journal of Artificial Organs, V29, P209
   Teebken OE, 2002, EUR J VASC ENDOVASC, V23, P475, DOI 10.1006/ejvs.2002.1654
   Tsuruta T, 1996, ADV POLYM SCI, V126, P1
   VEITH FJ, 1986, J VASC SURG, V3, P104
   Wu HC, 2007, BIOMATERIALS, V28, P1385, DOI 10.1016/j.biomaterials.2006.11.012
   Zhang J, 2003, BIOMATERIALS, V24, P4223, DOI 10.1016/S0142-9612(03)00365-X
   ZILLA P, 1994, J VASC SURG, V19, P540, DOI 10.1016/S0741-5214(94)70083-4
NR 49
TC 0
Z9 0
U1 0
U2 3
PU DONGHUA UNIV PRESS
PI SHANGHAI
PA 1882 YAN AN WEST RD, SHANGHAI, 00000, PEOPLES R CHINA
BN 978-7-81111-065-4
PY 2007
BP 301
EP 305
PG 5
WC Biotechnology & Applied Microbiology; Engineering, Biomedical;
   Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Engineering; Science & Technology
   - Other Topics
GA BHH67
UT WOS:000253308000056
DA 2018-10-20
ER

PT B
AU Ji, HY
   Rao, ZH
AF Ji, Haiyan
   Rao, Zhenhong
GP IEEE
TI Quantitative Analysis the Protein of Millet by Artificial Neural Network
   and Fourier Coefficients of Near Infrared Diffuse Reflectance
   Spectroscopy
SO 2007 SECOND INTERNATIONAL CONFERENCE ON BIO-INSPIRED COMPUTING: THEORIES
   AND APPLICATIONS
LA English
DT Proceedings Paper
CT 2nd International Conference on Bio-Inspired Computing
CY SEP 14-17, 2007
CL Zhengzhou, PEOPLES R CHINA
AB For biomaterial, the signal energy is concentrated at low frequencies, and then the first few Fourier coefficients can represent the whole spectrum. Fourier coefficients are useful wavelength reducing method. The first few Fourier coefficients of millet's near infrared diffuse reflectance spectroscopy were used as the input nodes of artificial neural network, to build the quantitative analysis calibration model of protein in millet. The advantages of this method are that Fourier coefficient can reduce spectrum, filter the high frequency noise with an ideal filter of unity gain and zero phase shift. Better results were obtained from artificial neural network quantitative analysis model, the correlation coefficient and relative standard deviation of protein is 0.971 and 2.40% in calibration set, 0.955 and 2.96% in prediction set respectively. These results were satisfactory.
C1 [Ji, Haiyan] China Agr Univ, Coll Elect & Informat Engn, Beijing 100083, Peoples R China.
   [Rao, Zhenhong] China Agr Univ, Coll Sci, Beijing 100094, Peoples R China.
RP Ji, HY (reprint author), China Agr Univ, Coll Elect & Informat Engn, Beijing 100083, Peoples R China.
EM yuntian@cau.edu.cn
CR Burns D. A., 1992, HDB NEAR INFRARED AN
   JERORE J, 1999, APPL SPECTROSCOPY RE, V34, P1
   JI HY, 1993, CHEM J CHINESE U, V14, P618
   LONG JR, 1990, ANAL CHEM, V62, P1791, DOI 10.1021/ac00216a013
   MARTIN KA, 1992, APPL SPECTROSC REV, V27, P325, DOI 10.1080/05704929208018109
   MCCLURE WF, 1994, ANAL CHEM, V66, pA43, DOI 10.1021/ac00073a002
   MCCLURE WF, 1984, APPL SPECTROSC, V38, P322, DOI 10.1366/0003702844555449
NR 7
TC 0
Z9 0
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4244-4105-1
PY 2007
BP 74
EP +
DI 10.1109/BICTA.2007.4806422
PG 2
WC Computer Science, Artificial Intelligence; Engineering, Electrical &
   Electronic
SC Computer Science; Engineering
GA BKH11
UT WOS:000268062100017
DA 2018-10-20
ER

PT S
AU Joyce, TJ
AF Joyce, T. J.
BE Ibrahim, F
   Osman, NAA
   Usman, J
   Kadri, NA
TI Theoretical determination of lubrication regimes in two-piece first
   metatarsophalangeal prostheses
SO 3RD KUALA LUMPUR INTERNATIONAL CONFERENCE ON BIOMEDICAL ENGINEERING 2006
SE IFMBE Proceedings
LA English
DT Proceedings Paper
CT 3rd Kuala Lumpur International Conference on Biomedical Engineering 2006
   (BioMed 2006)
CY DEC 11-14, 2006
CL Kuala Lumpur, MALAYSIA
SP Int Federat Med & Biol Engn
DE metatarsophalangeal; lubrication regimes; metalon-metal;
   ceramic-on-ceramic; metal-on-polymer
ID 1ST METATARSOPHALANGEAL JOINT; METAL RESURFACING ARTHROPLASTY;
   LOW-FRICTION ARTHROPLASTY; TOTAL HIP PROSTHESES; FOLLOW-UP;
   ELASTOHYDRODYNAMIC LUBRICATION; REPLACEMENT ARTHROPLASTY; FORCES; GAIT;
   PREDICTION
AB The key joint of the forefoot during gait is the first metatarsophalangeal joint. It is subject to high loads and plays an important role in propelling the human form. Unfortunately the first metatarsophalangeal joint can be subject to a number of diseases, such as rheumatoid arthritis, hallux rigidus and hallux valgus, all of which can lead to replacement of the natural joint with a prosthesis. Most commonly, a silicone spacer might be implanted but other designs are available which more closely try to match the natural joint by employing a two-piece ball and socket arrangement. Such designs are available with a range of biomaterial couples including ceramic-on-ceramic, metal-on-metal and metal-on-polymer. Calculation of predicted lubrication regimes applicable to these implant designs was undertaken. Modeling the ball and socket implant as an equivalent ball-on-plane model and employing elastohydrodynamic theory allowed the minimum film thickness to be calculated and in turn the lambda ratio to indicate the lubrication regime. Boundary lubrication is indicated for lambda less than 1, mixed lubrication for lambda between I and 3, and fluid film lubrication for lambda greater than 3. The calculations were undertaken for a 10 to 1500N range of loading values, a 0 to 30mm/s range of entraining velocities, and a 3 to 15mm radius ranger of sizes. Calculations showed that, for the range of loads, sizes and entraining velocities considered, the ceramic-on-ceramic and metal-on-metal implants could operate under fluid film lubrication, whereas the metal-on-polymer combination operated in the boundary lubrication regime. It was also recognized that manufacturing capabilities are critical to the radial clearances and values of surface roughness that can be achieved, and thus the predicted lubrication regime. Inevitably, a range of factors need to be considered when designing or choosing an implant for the first metatarsophalangeal joint.
C1 Univ Newcastle, Sch Mech & Syst Engn, Ctr Rehab Engn Studies, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
RP Joyce, TJ (reprint author), Univ Newcastle, Sch Mech & Syst Engn, Ctr Rehab Engn Studies, Claremont Rd, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
EM tj.joyce@ncl.ac.uk
RI Joyce, Thomas/G-3689-2013
OI Joyce, Thomas/0000-0002-8497-5790
CR Back DL, 2005, J BONE JOINT SURG BR, V87B, P324, DOI 10.1302/0301-620X.87B3.15556
   BOMMIREDDY R, 2003, FOOT, V13, P151
   GRANBERRY WM, 1991, J BONE JOINT SURG AM, V73A, P1453, DOI 10.2106/00004623-199173100-00002
   HAMROCK BJ, 1978, J LUBRIC TECH-T ASME, V100, P236, DOI 10.1115/1.3453152
   Hanyu T, 2001, J Orthop Sci, V6, P141, DOI 10.1007/s007760100062
   HARRIS WH, 1995, CLIN ORTHOP RELAT R, P46
   HASSAN K, 2006, FOOT, V16, P142
   Hungerford DS, 2005, J ARTHROPLASTY, V20, P68, DOI 10.1016/j.arth.2005.03.023
   Jacob HAC, 2001, CLIN BIOMECH, V16, P783, DOI 10.1016/S0268-0033(01)00070-5
   Jalali-Vahid D, 2001, J BIOMECH, V34, P261, DOI 10.1016/S0021-9290(00)00181-0
   JOHNSON KL, 1972, WEAR, V19, P91, DOI 10.1016/0043-1648(72)90445-0
   Joyce TJ, 2005, EXPERT REV MED DEVIC, V2, P453, DOI 10.1586/17434440.2.4.453
   JOYCE TJ, 2006, J BIOMECH, V39, pS525
   MCBRIDE ID, 1991, FOOT ANKLE, V11, P282, DOI 10.1177/107110079101100505
   MINAMIKAWA Y, 1994, J HAND SURG-AM, V19A, P567, DOI 10.1016/0363-5023(94)90258-5
   Nawoczenski DA, 1999, J BONE JOINT SURG AM, V81A, P370, DOI 10.2106/00004623-199903000-00009
   Nercessian OA, 2005, J ARTHROPLASTY, V20, P162, DOI 10.1016/j.arth.2004.07.006
   Older J, 2002, J ARTHROPLASTY, V17, P675, DOI 10.1054/arth.2002.31973
   Olms K, 1999, INT ORTHOP, V23, P240, DOI 10.1007/s002640050360
   PAVIER J, 2005, FOOT, V15, P47
   PEIMER CA, 1991, J HAND SURG-AM, V16A, P835, DOI 10.1016/S0363-5023(10)80146-7
   Pylios T, 2004, J BIOMECH, V37, P405, DOI 10.1016/S0021-9290(03)00265-3
   Saikko V, 2001, BIOMATERIALS, V22, P1507, DOI 10.1016/S0142-9612(00)00306-9
   Schmalzried TP, 2005, J ARTHROPLASTY, V20, P70, DOI 10.1016/j.arth.2005.03.007
   Scholes SC, 2000, PHYS MED BIOL, V45, P3721, DOI 10.1088/0031-9155/45/12/315
   Scholes SC, 2000, WEAR, V241, P209, DOI 10.1016/S0043-1648(00)00377-X
   Scholes SC, 2000, P I MECH ENG H, V214, P49, DOI 10.1243/0954411001535237
   Smith SL, 2001, P I MECH ENG J-J ENG, V215, P483, DOI 10.1243/1350650011543718
   STOKES IAF, 1979, J ANAT, V129, P579
   Treacy RBC, 2005, J BONE JOINT SURG BR, V87B, P167, DOI 10.1302/0301-620X.87B2.15030
   Udofia IJ, 2003, J BIOMECH, V36, P537, DOI 10.1016/S0021-9290(02)00422-0
   Villar R, 2004, J BONE JOINT SURG BR, V86B, P157, DOI 10.1302/0301-620X.86B2.15231
   Wroblewski BM, 2002, J BONE JOINT SURG BR, V84B, P540, DOI 10.1302/0301-620X.84B4.10293
NR 33
TC 0
Z9 0
U1 0
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 1680-0737
BN 978-3-540-68016-1
J9 IFMBE PROC
PY 2007
VL 15
BP 651
EP 655
PG 5
WC Computer Science, Artificial Intelligence; Computer Science,
   Interdisciplinary Applications; Engineering, Biomedical
SC Computer Science; Engineering
GA BGF91
UT WOS:000246513200164
DA 2018-10-20
ER

PT J
AU Shapira-Schweitzer, K
   Seliktar, D
AF Shapira-Schweitzer, Keren
   Seliktar, Dror
TI Matrix stiffness affects spontaneous contraction of cardiomyocytes
   cultured within a PEGylated fibrinogen biomaterial
SO ACTA BIOMATERIALIA
LA English
DT Article
DE cardiac cell therapy; mechanical properties; fibrin; polyethylene
   glycol; image analysis; hydrogel
ID HYDROGEL SCAFFOLDS; TISSUE; MYOCARDIUM; MICROENVIRONMENTS; STIMULATION;
   SURVIVAL; MYOCYTES; THERAPY; CELLS
AB Successful implementation of cardiac cell transplantation for treating damaged myocardium relies on the development of improved injectable biomaterials. A novel biomaterial technology using PEGylated fibrinogen has been developed with controllable physicochemical properties based on the poly(ethylene glycol) (PEG) constituent. In addition, the fibrinogen backbone of the material confers inherent bioactivity to cells. The purpose of this investigation was to explore by in vitro techniques the use of this biomaterial as a scaffold for cardiac tissue regeneration. To this end neonatal rat cardiomyocytes were cultivated in PEGylated fibrinogen constructs. The cell-seeding density and biomaterial composition were optimized to obtain maximum spontaneous contraction of the constructs. Quantitative characterization of the contraction pattern was accomplished by video image analysis. It was possible to demonstrate an inverse correlation between the material stiffness and the amplitude of contraction of the tissue constructs by changing the modulus of the matrix using different compositions of PEG and fibrinogen. The relationship between matrix stiffness, cell density and tissue contraction also provided some insight into the mechanism of cellular remodeling that ultimately leads to synchronized contraction of the constructs. These findings indicate that PEGylated fibrinogen hydrogels can be used as a scaffold for cardiomyocytes, and offer the possibility of controlling cellular remodeling via simple compositional modifications to the matrix. (C) 2006 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 Technion Israel Inst Technol, Fac Biomed Engn, IL-32000 Haifa, Israel.
RP Seliktar, D (reprint author), Technion Israel Inst Technol, Fac Biomed Engn, IL-32000 Haifa, Israel.
EM dror@bm.technion.ac.il
OI Seliktar, Dror/0000-0001-6964-8567
CR Almany L, 2005, BIOMATERIALS, V26, P2467, DOI 10.1016/j.biomaterials.2004.06.047
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Davis ME, 2005, CIRC RES, V97, P8, DOI 10.1161/01.RES.0000173376.39447.01
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Dikovsky D, 2006, BIOMATERIALS, V27, P1496, DOI 10.1016/j.biomaterials.2005.09.038
   Eschenhagen T., 2006, CULTURE CELLS TISSUE, P259
   Fazel S, 2005, ANN THORAC SURG, V79, pS2238, DOI 10.1016/j.athoracsur.2005-02-085
   Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI200112131
   Kofidis T, 2003, TISSUE ENG, V9, P517, DOI 10.1089/107632703322066697
   Kofidis T., 2005, CIRCULATION, V112, pI173
   Leor Jonathan, 2006, Expert Rev Cardiovasc Ther, V4, P239, DOI 10.1586/14779072.4.2.239
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   McDevitt TC, 2003, J BIOMED MATER RES A, V66A, P586, DOI 10.1002/jbm.a.10504
   Muller-Ehmsen J, 2002, J MOL CELL CARDIOL, V34, P107, DOI 10.1006/jmcc.2001.1491
   Murry CE, 2002, J CARD FAIL, V8, pS532, DOI 10.1054/jcaf.2002.129268
   PELED E, 2006, IN PRESS J BIOMED MA
   Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101
   SCHMIDT O, 2006, IN PRESS BIOTECHNOL
   Seliktar D, 2005, ANN NY ACAD SCI, V1047, P386, DOI 10.1196/annals.1341.034
   Shin M, 2004, BIOMATERIALS, V25, P3717, DOI 10.1016/j.biomaterials.2003.10.055
   Sun Y, 2000, CARDIOVASC RES, V46, P250, DOI 10.1016/S0008-6363(00)00032-8
   Tekalp AM, 1995, DIGITAL VIDEO PROCES
   Williams CG, 2005, BIOMATERIALS, V26, P1211, DOI 10.1016/j.biomaterials.2004.04.024
   Zimmermann WH, 2002, CIRC RES, V90, P223, DOI 10.1161/hh0202.103644
   Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394
   Zimmermann WH, 2003, HEART FAIL REV, V8, P259, DOI 10.1023/A:1024725818835
   Zimmermann WH, 2006, CARDIOVASC RES, V71, P419, DOI 10.1016/j.cardiores.2006.03.023
NR 27
TC 105
Z9 107
U1 0
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN
PY 2007
VL 3
IS 1
BP 33
EP 41
DI 10.1016/j.actbio.2006.09.003
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 121SX
UT WOS:000243178400004
PM 17098488
DA 2018-10-20
ER

PT J
AU Rowe, SL
   Lee, S
   Stegemann, JP
AF Rowe, Shaneen L.
   Lee, SungYun
   Stegemann, Jan P.
TI Influence of thrombin concentration on the mechanical and morphological
   properties of cell-seeded fibrin hydrogels
SO ACTA BIOMATERIALIA
LA English
DT Article
DE fibrin; thrombin; smooth muscle cells; tissue engineering
ID SMOOTH-MUSCLE-CELLS; MEDIA EQUIVALENT; BLOOD-VESSELS; GEL STRUCTURE;
   BEHAVIOR; TURBIDITY; CLOTS
AB Fibrin is a biopolymer that has been used in a variety of biomaterial, cell delivery and tissue engineering applications. The enzyme thrombin catalyzes the formation of fibrin microfibrils, which form a three-dimensional mesh in which cells can be directly embedded at the time of gel formation. In this study, fibrin hydrogels containing vascular smooth muscle cells were created using varying concentrations of thrombin. Over 7 days in culture, all gels decreased in volume as the fibrin matrix compacted, and the degree of gel compaction increased as thrombin concentration decreased. The material modulus and ultimate tensile stress of the gels also increased with decreasing thrombin concentration. Addition of thrombin to similar constructs made using collagen Type I did not show an effect on gel compaction or mechanical properties, suggesting that these effects were a result of thrombin's action on fibrin polymerization, and not cellular functions. Cell proliferation in fibrin hydrogels was not significantly affected by thrombin addition. Matrix examination using scanning electron microscopy showed increasing fibrin fiber diameters as thrombin concentration decreased. Confocal microscopic imaging of the actin cytoskeleton showed that cell morphology on two-dimensional substrates of fibrin showed marked changes, with higher thrombin concentrations producing cells with longer cellular projections. However, these morphological changes were not as apparent in cells embedded in three-dimensional (3-D) matrices, in which cells exhibited a similar morphology independent of thrombin concentration. These results relate features of the matrix and cellular components of 3-D fibrin constructs to mechanical properties, and contribute to the understanding of structure-function relationships in cell-seeded, 3-D protein hydrogels. (C) 2006 Acta Materialia, Inc. Published by Elsevier Ltd. All rights reserved.
C1 Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA.
RP Stegemann, JP (reprint author), Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA.
EM stegemann@rpi.edu
FU NIBIB NIH HHS [R21 EB003978, R21-EB003978]
CR Barocas VH, 1998, J BIOMECH ENG-T ASME, V120, P660, DOI 10.1115/1.2834759
   BLOMBACK B, 1982, THROMB RES, V25, P51, DOI 10.1016/0049-3848(82)90214-6
   Blomback B, 2004, BIOPHYS CHEM, V112, P147, DOI 10.1016/j.bpc.2004.07.013
   BLOMBACK B, 1989, BIOCHIM BIOPHYS ACTA, V997, P96, DOI 10.1016/0167-4838(89)90140-4
   Cox S, 2004, TISSUE ENG, V10, P942, DOI 10.1089/1076327041348392
   CUMMINGS CL, 2004, BIOMATERIALS, V17, P3699
   DHALL TZ, 1976, THROMB HAEMOSTASIS, V35, P737, DOI 10.1055/s-0038-1647971
   DIKOVSKY D, 2005, BIOMATERIALS, V19, P1496
   FERRY JD, 1947, J AM CHEM SOC, V69, P388, DOI 10.1021/ja01194a066
   GLOVER CJ, 1975, J LAB CLIN MED, V86, P644
   Grassl ED, 2003, J BIOMED MATER RES A, V66A, P550, DOI 10.1002/jbm.a.10589
   Grassl ED, 2002, J BIOMED MATER RES, V60, P607, DOI 10.1002/jbm.10107
   Herbert CB, 1998, J BIOMED MATER RES, V40, P551, DOI 10.1002/(SICI)1097-4636(19980615)40:4<551::AID-JBM6>3.0.CO;2-E
   Karp JM, 2004, J BIOMED MATER RES A, V71A, P162, DOI 10.1002/jbm.a.30147
   Krishnan LK, 2003, BIOMATERIALS, V24, P321, DOI 10.1016/S0142-9612(02)00322-8
   KUBOTA K, 2004, COLLOID SURFACE B, V38, P104
   MCNAMARA CA, 1993, J CLIN INVEST, V91, P94, DOI 10.1172/JCI116206
   Neidert MR, 2002, BIOMATERIALS, V23, P3717, DOI 10.1016/S0142-9612(02)00106-0
   Pizzo AM, 2005, J APPL PHYSIOL, V98, P1909, DOI 10.1152/japplphysiol.01137.2004
   ROSS JJ, 2003, MATRIX BIOL, P477
   ROWE SL, 2006, IN PRESS BIOMACROMOL, V7
   Schauwienold D, 2003, HYPERTENSION, V41, P546, DOI 10.1161/01.HYP.0000054213.37471.84
   Schmoekel HG, 2005, BIOTECHNOL BIOENG, V89, P253, DOI 10.1002/bit.20168
   Swartz DD, 2005, AM J PHYSIOL-HEART C, V288, pH1451, DOI 10.1152/ajpheart.00479.2004
   Trentin D, 2006, P NATL ACAD SCI USA, V103, P2506, DOI 10.1073/pnas.0505964102
   WEISEL JW, 1992, BIOPHYS J, V63, P111, DOI 10.1016/S0006-3495(92)81594-1
   WESLEY WW, 1974, BIOPHYS CHEM, V1, P152
   Yao L, 2005, TISSUE ENG, V11, P991, DOI 10.1089/ten.2005.11.991
NR 28
TC 109
Z9 117
U1 3
U2 32
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN
PY 2007
VL 3
IS 1
BP 59
EP 67
DI 10.1016/j.actbio.2006.08.006
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 121SX
UT WOS:000243178400007
PM 17085089
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Hamdaoui, O
   Chiha, M
AF Hamdaoui, Oualid
   Chiha, Mahdi
TI Removal of methylene blue from aqueous solutions by wheat bran
SO ACTA CHIMICA SLOVENICA
LA English
DT Article
DE removal; methylene blue; wheat bran; sorption; kinetics
ID WASTE-WATER; AGRICULTURAL RESIDUES; ACTIVATED CARBON; ORANGE PEEL;
   AZO-DYE; ADSORPTION; SORPTION; EQUILIBRIUM; KINETICS; ADSORBENT
AB In this work, a fundamental investigation on the removal of methylene blue from aqueous solutions by wheat bran is conducted in batch conditions. Removal kinetic data are determined, and the effects of different experimental parameters, such as wheat bran mass, initial concentration of methylene blue, agitation speed, solution pH, particle size, temperature, and ionic strength on the kinetics of methylene blue removal are investigated. The cationic dye recovery increases with an increase of sorbent mass, solution pH, and temperature. Methylene blue removal decreases with an increase of initial concentration, particle size, and ionic strength. The agitation speed showed a limited influence on the removal kinetics. Modeling of kinetic results shows that sorption process is best described by the pseudo- second order model, with determination coefficients higher than 0.996 under all experimental conditions. The applicability of both internal and external diffusion models shows that liquid-film and particle diffusion are effective sorption mechanisms. The activation energy of sorption calculated using the pseudo- second order rate constants is found to be 13.41 kJ mol(-1) from an Arrhenius plot. The low value of the activation energy indicates that sorption is an activated and physical process. Thus, wheat bran, a low cost and easily available biomaterial, can be efficiently used as an excellent sorbent for the removal of dyes from wastewater. It can be safely concluded that wheat bran is much economical, effectual, viable, and can be an alternative to more costly adsorbents.
C1 Univ Annaba, Fac Engn, Dept Proc Engn, Annaba 23000, Algeria.
RP Hamdaoui, O (reprint author), Univ Annaba, Fac Engn, Dept Proc Engn, PO Box 12, Annaba 23000, Algeria.
EM ohamdaoui@yahoo.fr
RI Hamdaoui, Oualid/F-8734-2012
OI Hamdaoui, Oualid/0000-0002-5135-0524
CR Adachi A, 2005, CHEMOSPHERE, V58, P817, DOI 10.1016/j.chemosphere.2004.09.077
   Allen SJ, 1997, J CHEM TECHNOL BIOT, V68, P442, DOI 10.1002/(SICI)1097-4660(199704)68:4<442::AID-JCTB643>3.3.CO;2-U
   Arami M, 2005, J COLLOID INTERF SCI, V288, P371, DOI 10.1016/j.jcis.2005.03.020
   Chandran CB, 2002, APPL BIOCHEM BIOTECH, V102, P207, DOI 10.1385/ABAB:102-103:1-6:207
   Chen KC, 2003, J BIOTECHNOL, V101, P241, DOI 10.1016/S0168-1656(02)00362-0
   Farajzadeh MA, 2004, SEP PURIF TECHNOL, V38, P197, DOI 10.1016/j.seppur.2003.11.005
   Ghosh D, 2002, APPL CLAY SCI, V20, P295, DOI 10.1016/S0169-1317(01)00081-3
   Ho YS, 1998, CHEM ENG J, V70, P115, DOI 10.1016/S0923-0467(98)00076-1
   Ho YS, 2000, WATER RES, V34, P735, DOI 10.1016/S0043-1354(99)00232-8
   Ho YS, 2005, PROCESS BIOCHEM, V40, P119, DOI 10.1016/j.procbio.2003.11.035
   Ho YS, 2000, SEPAR PURIF METHOD, V29, P189, DOI 10.1081/SPM-100100009
   HO YS, 1995, THESIS U BIRMINGHAM
   KNOCKE WR, 1981, WATER RES, V15, P275, DOI 10.1016/0043-1354(81)90121-4
   Kumar KV, 2005, J COLLOID INTERF SCI, V284, P14, DOI 10.1016/j.jcis.2004.09.063
   Lagergren S, 1898, KUNGLIGA SVENSKA VET, V24, P1, DOI DOI 10.1007/BF01501332
   MCKAY G, 1982, J CHEM TECHNOL BIOT, V32, P759
   Mohan SV, 2002, J HAZARD MATER, V90, P189
   Nigam P, 2000, BIORESOURCE TECHNOL, V72, P219, DOI 10.1016/S0960-8524(99)00123-6
   Ozer A, 2004, PROCESS BIOCHEM, V39, P2183, DOI 10.1016/j.procbio.2003.11.008
   Ravat C, 2000, WATER RES, V34, P1327, DOI 10.1016/S0043-1354(99)00255-9
   Reid R, 1996, J SOC DYERS COLOUR, V112, P103
   Robinson T, 2002, ENVIRON INT, V28, P29, DOI 10.1016/S0160-4120(01)00131-3
   Senthilkumaar S, 2005, J COLLOID INTERF SCI, V284, P78, DOI 10.1016/j.jcis.2004.09.027
   SESHADRI S, 1994, WASTE MANAGE, V14, P127, DOI 10.1016/0956-053X(94)90005-1
   Shen JC, 2005, SEP PURIF TECHNOL, V44, P69, DOI 10.1016/j.seppur.2004.12.011
   Sivaraj R, 2001, WASTE MANAGE, V21, P105, DOI 10.1016/S0956-053X(00)00076-3
   SPAHN H, 1975, CHEM ENG SCI, V30, P529, DOI 10.1016/0009-2509(75)80023-6
   WEBER EJ, 1987, ENVIRON TOXICOL CHEM, V6, P911, DOI 10.1897/1552-8618(1987)6[911:KSOTRO]2.0.CO;2
   Weber WJ, 1963, J SANITARY ENGINEERI, V89, P31, DOI DOI 10.1016/J.DESAL.2010.08.036
   WEBER WJ, 1967, PRINCIPLES APPL WATE
   YOUSSEF BM, 1993, AM DYEST REP, V82, P36
NR 31
TC 59
Z9 59
U1 1
U2 14
PU SLOVENSKO KEMIJSKO DRUSTVO
PI LJUBLJANA
PA HAJDRIHOVA 19, LJUBLJANA 1000, SLOVENIA
SN 1318-0207
J9 ACTA CHIM SLOV
JI Acta Chim. Slov.
PY 2007
VL 54
IS 2
BP 407
EP 418
PG 12
WC Chemistry, Multidisciplinary
SC Chemistry
GA 180XL
UT WOS:000247401200026
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Neut, D
   van der Mei, HC
   Bulstra, SK
   Busscher, HJ
AF Neut, Danielle
   van der Mei, Henny C.
   Bulstra, Sjoerd K.
   Busscher, Henk J.
TI The role of small-colony variants in failure to diagnose and treat
   biofilm infections in orthopedics
SO ACTA ORTHOPAEDICA
LA English
DT Review
ID TOTAL HIP-ARTHROPLASTY; C-REACTIVE PROTEIN; COAGULASE-NEGATIVE
   STAPHYLOCOCCI; PROSTHETIC JOINT INFECTION; PSEUDOMONAS-AERUGINOSA;
   ANTIBIOTIC-RESISTANCE; BACTERIAL BIOFILMS; ESCHERICHIA-COLI; PERSISTER
   CELLS; CYSTIC-FIBROSIS
AB Biomaterial-related infection of joint replacements is the second most common cause of implant failure, with serious consequences. Chronically infected replacements cannot be treated without removal of the implant, as the bio film mode of growth protects the bacteria against antibiotics. This review discusses bio film formation on joint replacements and the important clinical phenomenon of small-colony variants (SCVs). These slow-growing phenotypic variants often remain undetected or are misdiagnosed using hospital microbiological analyses due to their unusual morphological appearance and biochemical reactions. In addition, SCVs make the infection difficult to eradicate. They often lead to recurrence since they respond poorly to standard antibiotic treatment and can sometimes survive intracellularly.
C1 Univ Groningen, Med Ctr, Dept Biomed Engn, Groningen, Netherlands.
   Univ Groningen, Med Ctr, Dept Orthopaed Surg, Groningen, Netherlands.
RP Neut, D (reprint author), Univ Groningen, Med Ctr, Dept Biomed Engn, Groningen, Netherlands.
EM d.neut@med.umcg.nl
CR Arciola CR, 2005, BIOMATERIALS, V26, P6530, DOI 10.1016/j.biomaterials.2005.04.031
   ASHBY MJ, 1994, J ANTIMICROB CHEMOTH, V33, P443, DOI 10.1093/jac/33.3.443
   Atkins BL, 1998, J HOSP INFECT, V40, P263, DOI 10.1016/S0195-6701(98)90302-4
   BALWIT JM, 1994, J INFECT DIS, V170, P1033, DOI 10.1093/infdis/170.4.1033
   BARRACK RL, 1997, CLIN ORTHOP RELAT R, V345, P8
   Baumert N, 2002, MICROB DRUG RESIST, V8, P253, DOI 10.1089/10766290260469507
   BAYER AS, 1987, ANTIMICROB AGENTS CH, V31, P70, DOI 10.1128/AAC.31.1.70
   BAYSTON R, 2000, COMMUNITY STRUCTURE, P295
   Bergogne-Berezin E, 2000, PRESSE MED, V29, P2018
   Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2
   Cochran WL, 2000, J APPL MICROBIOL, V88, P546, DOI 10.1046/j.1365-2672.2000.00995.x
   Cogan NG, 2006, J THEOR BIOL, V238, P694, DOI 10.1016/j.jtbi.2005.06.017
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251
   DAROUICHE RO, 1994, J INFECT DIS, V170, P720, DOI 10.1093/infdis/170.3.720
   DAVENPORT DS, 1986, J INFECT DIS, V153, P332, DOI 10.1093/infdis/153.2.332
   Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a
   Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010
   Gracia E, 1997, INT ORTHOP, V21, P46, DOI 10.1007/s002640050116
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GRISTINA AG, 1985, J BONE JOINT SURG AM, V67A, P264, DOI 10.2106/00004623-198567020-00014
   Haussler S, 1999, CLIN INFECT DIS, V29, P621
   Hudson MC, 1995, MICROB PATHOGENESIS, V19, P409, DOI 10.1006/mpat.1995.0075
   Jefferson KK, 2005, ANTIMICROB AGENTS CH, V49, P2467, DOI 10.1118/AAC.49.6.2467-2473.2005
   JOSEFSSON G, 1993, CLIN ORTHOP RELAT R, P210
   Kahl B, 1998, J INFECT DIS, V177, P1023, DOI 10.1086/515238
   Kahl BC, 2003, J CLIN MICROBIOL, V41, P410, DOI 10.1128/JCM.41.1.410-413.2003
   Kahl BC, 2003, J CLIN MICROBIOL, V41, P4424, DOI 10.1128/JCM.41.9.4424-4427.2003
   Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5
   Kirisits MJ, 2005, APPL ENVIRON MICROB, V71, P4809, DOI 10.1128/AEM.71.8.4809-4821.2005
   KRAGSBJERG P, 1995, EUR J SURG, V161, P17
   Kurtz S, 2005, J BONE JOINT SURG AM, V87A, P1487, DOI 10.2106/JBJS.D.02441
   LANGFORD PR, 1989, FEMS MICROBIOL LETT, V61, P33
   Lewis K, 2005, BIOCHEMISTRY-MOSCOW+, V70, P267, DOI 10.1007/s10541-005-0111-6
   LEWIS LA, 1991, MICROBIOL IMMUNOL, V35, P289, DOI 10.1111/j.1348-0421.1991.tb01558.x
   LIDWELL OM, 1983, J HOSP INFECT, V4, P111, DOI 10.1016/0195-6701(83)90041-5
   Looney WJ, 2000, BRIT J BIOMED SCI, V57, P317
   Mah TF, 2003, NATURE, V426, P306, DOI 10.1038/nature02122
   MCDONALD DJ, 1989, J BONE JOINT SURG AM, V71A, P828, DOI 10.2106/00004623-198971060-00005
   Muli FW, 1998, J MED MICROBIOL, V47, P401, DOI 10.1099/00222615-47-5-401
   MUSHER DM, 1977, J INFECT DIS, V136, P360, DOI 10.1093/infdis/136.3.360
   Neut D, 2003, CLIN ORTHOP RELAT R, P261, DOI 10.1097/01.blo.0000073345.50837.84
   Neut D, 2001, J ANTIMICROB CHEMOTH, V47, P885, DOI 10.1093/jac/47.6.885
   Ng T, 1998, BR J HOSP MED, V58, P521
   Phillips S. E., 1988, ED MEASUREMENT ISSUE, V7, P8
   PHILLIPS WC, 1983, CLIN ORTHOP RELAT R, P141
   PITTET D, 1994, INFECT CONT HOSP EP, V15, P456
   PROCTOR RA, 1995, CLIN INFECT DIS, V20, P95, DOI 10.1093/clinids/20.1.95
   Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384
   Proctor RA, 1998, CLIN INFECT DIS, V27, pS68, DOI 10.1086/514906
   Proctor RA, 1998, CLIN INFECT DIS, V27, P419, DOI 10.1086/514706
   Proctor Richard A., 1994, P79
   Roberts ME, 2005, MICROBIOL-SGM, V151, P75, DOI 10.1099/mic.0.27385-0
   Roggenkamp A, 1998, J CLIN MICROBIOL, V36, P2530
   RUSTHOVEN JJ, 1979, AM J MED, V67, P702, DOI 10.1016/0002-9343(79)90269-9
   SANZEN L, 1989, J BONE JOINT SURG BR, V71, P638
   Seifert H, 1999, EMERG INFECT DIS, V5, P450, DOI 10.3201/eid0503.990319
   Seifert H, 2003, EMERG INFECT DIS, V9, P1316
   Sendi P, 2006, CLIN INFECT DIS, V43, P961, DOI 10.1086/507633
   Sheldon Albert T Jr, 2005, Clin Lab Sci, V18, P170
   SHIH LY, 1987, CLIN ORTHOP RELAT R, V225, P238
   Spanu T, 2005, CLIN INFECT DIS, V41, pE48, DOI 10.1086/432577
   Stewart PS, 2002, INT J MED MICROBIOL, V292, P107, DOI 10.1078/1438-4221-00196
   Tattevin P, 1999, CLIN INFECT DIS, V29, P292, DOI 10.1086/520202
   Tunney MM, 1998, J BONE JOINT SURG BR, V80B, P568, DOI 10.1302/0301-620X.80B4.8473
   Vaudaux P, 2002, INFECT IMMUN, V70, P5428, DOI 10.1128/IAI.70.10.5428-5437.2002
   Vaudaux P, 2006, CLIN INFECT DIS, V43, P968, DOI 10.1086/507643
   von Eiff C, 1999, CLIN INFECT DIS, V29, P932, DOI 10.1086/520462
   von Eiff C, 2001, CLIN INFECT DIS, V32, P1643, DOI 10.1086/320519
   vonEiff C, 1997, CLIN INFECT DIS, V25, P1250, DOI 10.1086/516962
   VONEIFF C, 2000, INT J CLIN PRACT, V115, pS44
   Walenkamp GHIM, 1997, ACTA ORTHOP SCAND, V68, P497, DOI 10.3109/17453679708996270
   WIDMER AF, 1990, J INFECT DIS, V162, P96, DOI 10.1093/infdis/162.1.96
   Widmer AF, 2001, CLIN INFECT DIS, V33, pS94, DOI 10.1086/321863
   WISE RI, 1956, ANN NY ACAD SCI, V65, P169, DOI 10.1111/j.1749-6632.1956.tb36636.x
   Zheng ZL, 2002, ANTIMICROB AGENTS CH, V46, P900, DOI 10.1128/AAC.46.3.900-903.2002
NR 76
TC 64
Z9 68
U1 0
U2 6
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1745-3674
EI 1745-3682
J9 ACTA ORTHOP
JI Acta Orthop.
PY 2007
VL 78
IS 3
BP 299
EP 308
DI 10.1080/17453670710013843
PG 10
WC Orthopedics
SC Orthopedics
GA 200IZ
UT WOS:000248758400001
PM 17611841
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Nilsdotter-Augustinsson, A
   Briheim, G
   Herder, A
   Ljunghusen, O
   Wahlstrom, O
   Ohman, L
AF Nilsdotter-Augustinsson, Asa
   Briheim, Gunnar
   Herder, Anders
   Ljunghusen, Olof
   Wahlstrom, Ola
   Ohman, Lena
TI Inflammatory response in 85 patients with loosened hip prostheses - A
   prospective study comparing inflammatory markers in patients with
   aseptic and septic prosthetic loosening
SO ACTA ORTHOPAEDICA
LA English
DT Article
ID BIOMATERIAL-CENTERED INFECTION; TOTAL KNEE ARTHROPLASTY; JOINT
   INFECTION; REVISION ARTHROPLASTY; SYNOVIAL-FLUID; CYTOKINE PRODUCTION;
   TISSUE INTEGRATION; MICROBIAL ADHESION; DIAGNOSIS; REPLACEMENTS
AB Background The most common complications of prosthetic hip joints are aseptic mechanical failure and infection. Delayed low-grade infections are seen most often, and they are also most difficult to distinguish from aseptic mechanical failures.
   Methods We conducted a prospective study to compare in. ammatory markers in patients diagnosed with aseptic or septic prosthetic loosening. The diagnostic criteria were based on the decisions of experienced orthopedic surgeons and microbiological analysis of periprosthetic tissue samples taken perioperatively.
   Results Coagulase-negative staphylococci were the commonest pathogens in the infected patients. Pre- or perioperative elevation of C-reactive protein and erythrocyte sedimentation rate were significantly greater in the infection group, as were white blood cell count and levels of cytokines in synovial fluid. The patterns of infiltration of inflammatory cells in periprosthetic tissue were also significantly different between the groups.
   Interpretation A combination of clinical judgment and multiple tissue samples constitutes a good platform for distinguishing between septic and aseptic loosening of prostheses. Moreover, the combined use of several laboratory and histopathological markers of inflammation, especially infiltration of polymorphonuclear cells, further helps the diagnosis.
C1 Linkoping Univ, Div Infect Dis, Linkoping, Sweden.
   Linkoping Univ, Div Med Microbiol, Dept Mol Med & Clin Med, Linkoping, Sweden.
   Linkoping Univ, Dept Mol Med & Clin Med, Div Morphol Clin Pathol & Clin Cytol, Linkoping, Sweden.
   Linkoping Univ, Div Orthopaed, Dept Neurosci & Locomot, Linkoping, Sweden.
RP Nilsdotter-Augustinsson, A (reprint author), Linkoping Univ, Div Infect Dis, Linkoping, Sweden.
EM asa.nilsdotter@lio.se
CR ALSAFFAR N, 1994, BRIT J RHEUMATOL, V33, P309
   Atkins BL, 1998, J CLIN MICROBIOL, V36, P2932
   Augustinsson A, 2001, SCAND J INFECT DIS, V33, P408, DOI 10.1080/00365540152029855
   Bernard L, 2004, SCAND J INFECT DIS, V36, P410, DOI 10.1080/00365540410015240
   CHIBA J, 1994, CLIN ORTHOP RELAT R, P114
   COVENTRY MB, 1975, ORTHOP CLIN N AM, V6, P991
   Crowe JF, 2003, CLIN ORTHOP RELAT R, P175, DOI 10.1097/01.blo.0000072469.32680.b6
   El Esper I, 2004, NUCL MED COMMUN, V25, P171, DOI 10.1097/01.mnm.0000109830.10116.61
   Gallo Jiri, 2003, Biomedical Papers (Olomouc), V147, P27
   GLANT TT, 1993, J BONE MINER RES, V8, P1071
   Goodman SB, 1998, J BONE JOINT SURG BR, V80B, P531, DOI 10.1302/0301-620X.80B3.8158
   Gristina A, 2004, CLIN ORTHOP RELAT R, P4, DOI 10.1097/01.blo.0000145156.89115.12
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Hirakawa K, 2004, CLIN ORTHOP RELAT R, P10
   Horowitz SM, 1996, CALCIFIED TISSUE INT, V59, P392, DOI 10.1007/s002239900145
   Lentino Joseph R, 2004, Curr Infect Dis Rep, V6, P388, DOI 10.1007/s11908-004-0038-x
   Li SF, 2004, ACAD EMERG MED, V11, P276, DOI 10.1197/j.aem.2003.09.018
   McEvoy A, 2002, BONE, V30, P171
   Messieh M, 1996, J ARTHROPLASTY, V11, P484, DOI 10.1016/S0883-5403(96)80042-8
   Mirra J M, 1976, Clin Orthop Relat Res, P221
   Musso AD, 2003, POSTGRAD MED J, V79, P590, DOI 10.1136/pmj.79.936.590
   Neut D, 2003, CLIN ORTHOP RELAT R, P261, DOI 10.1097/01.blo.0000073345.50837.84
   Nguyen LL, 2002, CLIN ORTHOP RELAT R, P29, DOI 10.1097/01.blo.0000030073.92399.96
   Nivbrant B, 1999, J BONE JOINT SURG BR, V81B, P163, DOI 10.1302/0301-620X.81B1.8664
   Pandey R, 1999, J CLIN PATHOL, V52, P118, DOI 10.1136/jcp.52.2.118
   Patel R, 2005, CLIN ORTHOP RELAT R, P41, DOI 10.1097/01.blo.0000175714.68624.74
   Sanzen L, 1997, ACTA ORTHOP SCAND, V68, P461, DOI 10.3109/17453679708996263
   Spangehl MJ, 1999, J BONE JOINT SURG AM, V81A, P672, DOI 10.2106/00004623-199905000-00008
   Sundfeldt M, 2006, ACTA ORTHOP, V77, P177, DOI 10.1080/17453670610045902
   Trampuz A, 2004, AM J MED, V117, P556, DOI 10.1016/j.amjmed.2004.06.022
   Trampuz A, 2003, CLIN ORTHOP RELAT R, P69, DOI 10.1097/01.blo.0000087324.60612.93
   Tunney MM, 1998, J BONE JOINT SURG BR, V80B, P568, DOI 10.1302/0301-620X.80B4.8473
   Wang ML, 2004, J ARTHROPLASTY, V19, P1028, DOI 10.1016/j.arth.2004.03.024
   WYMENGA AB, 1992, ACTA ORTHOP SCAND, V63, P665, DOI 10.1080/17453679209169732
   Zheng LM, 2004, J IMMUNOL, V173, P6319, DOI 10.4049/jimmunol.173.10.6319
   Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181
NR 36
TC 38
Z9 39
U1 0
U2 8
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1745-3674
EI 1745-3682
J9 ACTA ORTHOP
JI Acta Orthop.
PY 2007
VL 78
IS 5
BP 629
EP 639
DI 10.1080/17453670710014329
PG 11
WC Orthopedics
SC Orthopedics
GA 225KM
UT WOS:000250516800010
PM 17966022
OA DOAJ Gold
DA 2018-10-20
ER

PT B
AU Koller, B
   Laib, A
AF Koller, Bruno
   Laib, Andres
BE Qin, L
   Griffith, JF
   Leung, KS
TI Calibration of micro-CT data for quantifying bone mineral and
   biomaterial density and microarchitecture
SO ADVANCED BIOIMAGING TECHNOLOGIES IN ASSESSMENT OF THE QUALITY OF BONE
   AND SCAFFOLD MATERIALS: TECHNIQUES AND APPLICATIONS
LA English
DT Proceedings Paper
CT International Symposium on Advanced Biotechnologies for Assessing
   Quality of Bone and Scaffold Biomaterials
CY OCT 17-19, 2005
CL Hong Kong, PEOPLES R CHINA
ID CANCELLOUS BONE; IMAGES
AB With the awareness of the importance of the bone architecture to the overall stability of bone, micro-CT has become the gold standard for 3D static histomorphometry in bone research over the past 10 years. Nevertheless, bone densitometry is still the method of choice in the clinical environment. It is, however, anticipated that only a combination of the two methods, densitometry and morphometry, will improve the diagnosis and treatment of patients. This chapter introduces the calibration of micro-CT for quantification of bone mineral and material density at both organ and tissue levels and its impact in bone and mineral research based on bone biopsy. This approach may also be widely applied to measure the density of other appreciated materials.
C1 [Koller, Bruno; Laib, Andres] Scanco Med AG, Bassersdorf, Switzerland.
RP Koller, B (reprint author), Scanco Med AG, Bassersdorf, Switzerland.
EM bkoller@scanco.ch
CR Gong H, 2005, J BONE MINER METAB, V23, P174, DOI 10.1007/s00774-004-0557-4
   Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x
   Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167
   Hildebrand T, 1997, COMPUTER METH BIOMEC, V1, P15, DOI DOI 10.1080/01495739708936692
   Lai YM, 2005, BONE, V37, P274, DOI 10.1016/j.bone.2005.04.025
   Lai YM, 2005, BONE, V36, P465, DOI 10.1016/j.bone.2004.11.005
   Laib A, 2002, OSTEOPOROSIS INT, V13, P130, DOI 10.1007/s001980200004
   LORENSEN WE, 1987, COMPUT GRAPH, V21, P163, DOI DOI 10.1145/37402.37422
   ODGAARD A, 1993, BONE, V14, P173, DOI 10.1016/8756-3282(93)90245-6
NR 9
TC 2
Z9 2
U1 0
U2 1
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
BN 978-3-540-45454-0
PY 2007
BP 79
EP +
DI 10.1007/978-3-540-45456-4_5
PG 2
WC Biochemical Research Methods; Endocrinology & Metabolism; Radiology,
   Nuclear Medicine & Medical Imaging
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism; Radiology,
   Nuclear Medicine & Medical Imaging
GA BGU36
UT WOS:000250578800005
DA 2018-10-20
ER

PT B
AU Chan, CW
   Cheng, JCY
   Yeung, HY
   Qin, L
AF Chan, Chun Wai
   Cheng, Jack Chun-Yiu
   Yeung, Hiu-Yan
   Qin, Ling
BE Qin, L
   Griffith, JF
   Leung, KS
TI Bio-imaging technologies in studying bone-biomaterial interface:
   Applications in experimental spinal fusion model
SO ADVANCED BIOIMAGING TECHNOLOGIES IN ASSESSMENT OF THE QUALITY OF BONE
   AND SCAFFOLD MATERIALS: TECHNIQUES AND APPLICATIONS
LA English
DT Proceedings Paper
CT International Symposium on Advanced Biotechnologies for Assessing
   Quality of Bone and Scaffold Biomaterials
CY OCT 17-19, 2005
CL Hong Kong, PEOPLES R CHINA
ID QUANTITATIVE COMPUTED-TOMOGRAPHY; INTERTRANSVERSE PROCESS FUSION;
   MICROCOMPUTED TOMOGRAPHY; MORPHOGENETIC PROTEIN-2; PARTIAL PATELLECTOMY;
   ELASTIC PROPERTIES; GRAFT SUBSTITUTES; CALCIUM-PHOSPHATE; NONHUMAN
   PRIMATE; MU-CT
AB Spinal fusion in orthopedic surgery is commonly used to treat spinal deformity and degenerative diseases such as scoliosis and degenerative disc disease. To advance surgical and outcome efficacy and study the biological regulations, different animal models of spinal fusion have been established, including rats, rabbits, dogs, sheep, goats, and even non-human primates. With novel biological factors, biomaterials, biophysical devices and gene therapy, and stem-cell-based-therapy being developed, many medical imaging assessment techniques are being adopted further to evaluate their potential in facilitating spinal fusion experimentally before clinical application. Many bio-imaging evaluation technologies have been developed and their potential has been explored in evaluation of bone and biomaterial interface integration both preclinically and clinically. This chapter reviews some of the conventional and advanced techniques being applied for evaluation of rate and quality of spinal fusion, especially the experimental spinal fusion models based on our own studies. These techniques are summarized in the following categories in studying fusion complex or materials properties: (a) low resolution X-ray; quantitative CT, MRI, and clinical densitometry; (b) high-resolution micro-CT, 2D and 3D histomorphometry with both static and dynamic indices; and (c) macro- and microbiomechanical tests. The general advantages and limitations of the technologies are also briefly summarized. This overview might serve as a reference for future studies concerning study design and selection of technologies for qualitative and quantitative evaluation of spinal fusion based on availability of these methods and potential local and international collaborations.
C1 [Chan, Chun Wai; Cheng, Jack Chun-Yiu; Yeung, Hiu-Yan; Qin, Ling] Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Musculoskeletal Res Lab, Hong Kong, Hong Kong, Peoples R China.
RP Chan, CW (reprint author), Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Musculoskeletal Res Lab, Hong Kong, Hong Kong, Peoples R China.
EM chanwai@cuhk.edu.hk
RI Chan, Chun Wai/B-5889-2015; Qin, Ling/J-9047-2018; Cheng,
   Jack/J-3878-2018
OI Qin, Ling/0000-0001-6173-6167; Cheng, Jack/0000-0001-8153-364X
CR Boden SD, 1995, SPINE, V20, pS113, DOI 10.1097/00007632-199512151-00007
   Boden SD, 1999, SPINE, V24, P1179, DOI 10.1097/00007632-199906150-00002
   Boden SD, 2002, SPINE, V27, pS26, DOI 10.1097/01.BRS.0000020731.64266.B2
   BODEN SD, 1995, SPINE, V20, P412, DOI 10.1097/00007632-199502001-00003
   Boden SD, 1999, SPINE, V24, P320, DOI 10.1097/00007632-199902150-00003
   BODEN SD, 1998, CLIN ORTHOP S, V355, pS336
   Chan CW, 2005, KEY ENG MAT, V288-289, P491, DOI 10.4028/www.scientific.net/KEM.288-289.491
   CHAN CW, 2004, HONG KONG J ORTHOP S, V8, pS12
   CHAN CW, 2003, HONG KONG J ORTHOP S, V7, pS112
   CHAN CW, 2005, HONG KONG J ORTHOP S, V9, pS28
   Chen WJ, 2002, J TRAUMA, V52, P333, DOI 10.1097/00005373-200202000-00020
   Cheng JCY, 2002, SPINE, V27, P467, DOI 10.1097/00007632-200203010-00006
   CHENG JCY, 2002, P 12 INT RES C BIOM, P70
   COLLIER JH, 2002, J BIOMED MATER RES, V50, P574
   Cook S D, 2001, Spine J, V1, P246, DOI 10.1016/S1529-9430(01)00086-9
   DICKSON GR, 1984, METHODS CALCIFIED PR
   Glazer P A, 2001, Spine J, V1, P395, DOI 10.1016/S1529-9430(01)00108-5
   Greenwald AS, 2001, J BONE JOINT SURG AM, V83A, P98, DOI 10.2106/00004623-200100022-00007
   Guo LH, 2001, J BIOMED MATER RES, V54, P554, DOI 10.1002/1097-4636(20010315)54:4<554::AID-JBM120>3.3.CO;2-0
   Guo X, 2002, J ORTHOPAED RES, V20, P740, DOI 10.1016/S0736-0266(01)00167-X
   Hasharoni A, 2005, J NEUROSURG-SPINE, V3, P47, DOI 10.3171/spi.2005.3.1.0047
   Hodges Scott D, 2003, J Am Acad Orthop Surg, V11, P81
   Iyama S, 1997, J PERIODONTOL, V68, P1169, DOI 10.1902/jop.1997.68.12.1169
   Jaecques SVN, 2004, BIOMATERIALS, V25, P1683, DOI 10.1016/S0142-9612(03)00516-7
   Jung H, 2003, INT J ORAL MAX IMPL, V18, P121
   Kandziora F, 2003, EUR SPINE J, V12, P464, DOI 10.1007/s00586-002-0483-x
   Katz JL, 1997, ST HEAL T, V40, P123
   Linovitz RJ, 2002, SPINE, V27, P1383, DOI 10.1097/00007632-200207010-00002
   Linovitz RJ, 2002, ORTHOPEDICS, V25, pS585
   Ludwig SC, 1999, ORTHOP CLIN N AM, V30, P635, DOI 10.1016/S0030-5898(05)70116-4
   Magin MN, 2001, SPINE, V26, P469, DOI 10.1097/00007632-200103010-00009
   MEDING JB, 1993, J SPINAL DISORD, V6, P166
   Moazzaz P, 2005, SPINE, V30, P1706, DOI 10.1097/01.brs.0000172230.01655.55
   Ortiz MC, 2000, KIDNEY INT, V58, P1632, DOI 10.1111/j.1523-1755.2000.00324.x
   PARFITT AM, 1983, BONE HISTOMORPHOMETR, P143
   Qin L, 2006, CLIN BIOMECH, V21, P387, DOI 10.1016/j.clinbiomech.2005.11.008
   Qin L, 2004, J BONE MINER METAB, V22, P86, DOI 10.1007/s00774-003-0454-2
   Qin L, 2001, J BONE MINER METAB, V19, P359, DOI 10.1007/s007740170005
   Qin L, 1999, MED SCI SPORT EXER, V31, P502, DOI 10.1097/00005768-199904000-00002
   Salamon ML, 2003, J SPINAL DISORD TECH, V16, P90, DOI 10.1097/00024720-200302000-00014
   Sandhu HS, 1997, SPINE, V22, P1171, DOI 10.1097/00007632-199706010-00001
   Sandhu HS, 2001, EUR SPINE J, V10, pS122, DOI 10.1007/s005860100303
   Schmidt C, 2003, J BONE MINER RES, V18, P1486, DOI 10.1359/jbmr.2003.18.8.1486
   Siu WS, 2004, BONE, V35, P21, DOI 10.1016/j.bone.2004.03.014
   Suh DY, 2002, SPINE, V27, P353, DOI 10.1097/00007632-200202150-00006
   Takagi M, 2001, J BONE MINER RES, V16, P79, DOI 10.1359/jbmr.2001.16.1.79
   Toribatake Y, 1998, SPINE, V23, P1149, DOI 10.1097/00007632-199805150-00015
   Turner CH, 1999, J BIOMECH, V32, P437, DOI 10.1016/S0021-9290(98)00177-8
   Vaccaro AR, 2001, ORTHOPEDICS, V24, P191
   vonRecum AF, 1999, HDB BIOMATERIALS EVA
   Wang RR, 1998, J BIOMED MATER RES, V42, P508, DOI 10.1002/(SICI)1097-4636(19981215)42:4<508::AID-JBM5>3.0.CO;2-V
   Yeung HY, 2005, J BIOMED MATER RES B, V75B, P234
   Yeung HY, 2003, J BONE MINER RES, V18, pS301
   ZERWEKH JE, 1992, J ORTHOPAED RES, V10, P562, DOI 10.1002/jor.1100100411
   ZETTERQVIST L, 1995, CLIN ORAL IMPLAN RES, V6, P104, DOI 10.1034/j.1600-0501.1995.060206.x
NR 55
TC 0
Z9 0
U1 0
U2 4
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
BN 978-3-540-45454-0
PY 2007
BP 333
EP +
DI 10.1007/978-3-540-45456-4_20
PG 5
WC Biochemical Research Methods; Endocrinology & Metabolism; Radiology,
   Nuclear Medicine & Medical Imaging
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism; Radiology,
   Nuclear Medicine & Medical Imaging
GA BGU36
UT WOS:000250578800020
DA 2018-10-20
ER

PT B
AU Cheung, WH
   Qin, L
   Tam, KF
   Siu, WS
   Leung, KS
AF Cheung, Wing-Hoi
   Qin, Ling
   Tam, Kam-Fai
   Siu, Wing-Sum
   Leung, Kwok-Sui
BE Qin, L
   Griffith, JF
   Leung, KS
TI Enhancement of osteoporotic bone using injectable hydroxyapatite in OVX
   goats evaluated by multi-imaging modalities
SO ADVANCED BIOIMAGING TECHNOLOGIES IN ASSESSMENT OF THE QUALITY OF BONE
   AND SCAFFOLD MATERIALS: TECHNIQUES AND APPLICATIONS
LA English
DT Proceedings Paper
CT International Symposium on Advanced Biotechnologies for Assessing
   Quality of Bone and Scaffold Biomaterials
CY OCT 17-19, 2005
CL Hong Kong, PEOPLES R CHINA
ID CALCIUM-PHOSPHATE CEMENT; QUANTITATIVE COMPUTED-TOMOGRAPHY; MINERAL
   DENSITY; FRACTURE TREATMENT; CORTICAL BONE; FIXATION; INTENSITY; WOMEN;
   MODEL; PQCT
AB Osteoporotic fracture is very common in aged population, with an average of 1-3% increase per year in most areas of the world because of increase in aging population. Fixation of osteoporotic fracture is difficult, often with implant loosening or backout. Fixation enhancement with various biomaterials and implants is investigated before clinical application. This chapter describes a study investigating the effect of an optimized injectable hydroxyapatite (HA) on enhancing screw fixation in osteoporotic bones. By using radiography, pQCT and micro-CT, the development of osteoporosis in ovariectomized Chinese goats was confirmed. There was an averaged 25% decrease of bone mineral density in the goats after 6-month ovariectomy as well as a significant reduction of trabecular thickness and connectivity. The established osteoporotic goat model was then used for evaluating the efficacy of an optimized injectable HA in screw fixation. With the application of micro-CT and histomorphometry, it was confirmed that the injectable HA was distributed evenly along the screw threads and new bone formation was detected on HA surface without fibrous tissues. The HA increased the contact area between implants and trabecular bones, and hence the holding power to screws. Mechanical test further confirmed the significant increase of screw pull-out force by HA. This study demonstrated the application of multiple non-invasive bioimaging technologies in biomaterial research.
C1 [Cheung, Wing-Hoi; Qin, Ling; Tam, Kam-Fai; Siu, Wing-Sum; Leung, Kwok-Sui] Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Shatin, Hong Kong, Peoples R China.
RP Cheung, WH (reprint author), Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Shatin, Hong Kong, Peoples R China.
EM louis@ort.cuhk.edu.hk
RI Qin, Ling/J-9047-2018; Cheung, Wing Hoi/J-2150-2018
OI Qin, Ling/0000-0001-6173-6167; Cheung, Wing Hoi/0000-0003-3247-8255
CR Blattert TR, 2002, SPINE, V27, P2697, DOI 10.1097/00007632-200212010-00009
   Breusch SJ, 2003, ORTHOPADE, V32, P41, DOI 10.1007/s00132-002-0411-0
   Chan KM, 2004, ARCH PHYS MED REHAB, V85, P717, DOI 10.1016/j.apmr.2003.08.091
   Cheng J. C. Y., 2001, Hong Kong Medical Journal, V7, P241
   Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9
   Dambacher M, 2005, BONE, V36, pS324
   DAMBACHER MA, 2004, J BONE MINER METAB, V3, P2
   Elder S, 2000, J ORTHOP TRAUMA, V14, P386, DOI 10.1097/00005131-200008000-00002
   Goodman SB, 1998, CLIN ORTHOP RELAT R, P42
   [贺颖 He Ying], 2003, [中华妇产科杂志, Chinese Journal of Obstetrics and Gynecology], V38, P405
   Ho KS, 2003, PUBLIC HLTH EPIDEMIO, V12, P13
   ITO M, 1995, RADIOLOGY, V194, P55, DOI 10.1148/radiology.194.1.7997582
   Lai YM, 2005, BONE, V36, P465, DOI 10.1016/j.bone.2004.11.005
   Larsson S, 2002, CLIN ORTHOP RELAT R, P23
   Leung KS, 2006, J BIOMED MATER RES B, V78B, P153, DOI 10.1002/jbm.b.30467
   Leung KS, 2001, J BONE MINER RES, V16, P2348, DOI 10.1359/jbmr.2001.16.12.2348
   Lill CA, 2000, J ORTHOP TRAUMA, V14, P559, DOI 10.1097/00005131-200011000-00007
   Muller R, 1996, BONE, V18, P215, DOI 10.1016/8756-3282(95)00489-0
   NEFF M, 2004, OSTEOLOGY, V13, pS98
   PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617
   PECK WA, 1993, AM J MED, V94, P646
   Qin L, 2006, CLIN BIOMECH, V21, P387, DOI 10.1016/j.clinbiomech.2005.11.008
   Qin L, 2002, OSTEOPOROSIS INT, V13, P962, DOI 10.1007/s001980200134
   Qin L, 2001, J BONE MINER METAB, V19, P359, DOI 10.1007/s007740170005
   Qin L, 1999, ANAT RECORD, V255, P380
   QIN L, 2003, MENOPAUSE STATE ART, P1124
   QIN L, 1998, LAUREATE DRAGON, V2
   Rauch F, 2001, J BONE MINER RES, V16, P597, DOI 10.1359/jbmr.2001.16.4.597
   RUEGSEGGER P, 1976, RADIOLOGY, V121, P93
   SHELDON RS, 1994, ORTHOPAEDIC BASIC SC, P129
   Siu WS, 2004, BONE, V35, P21, DOI 10.1016/j.bone.2004.03.014
   Siu WS, 2003, J BONE MINER METAB, V21, P316, DOI 10.1007/s00774-003-0427-5
   Wilke HJ, 1998, ANAT REC, V251, P15, DOI 10.1002/(SICI)1097-0185(199805)251:1<15::AID-AR4>3.0.CO;2-D
   World Health Organizations, 1994, WHO TECH REP SER, V843
NR 34
TC 0
Z9 0
U1 0
U2 2
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
BN 978-3-540-45454-0
PY 2007
BP 517
EP +
DI 10.1007/978-3-540-45456-4_32
PG 4
WC Biochemical Research Methods; Endocrinology & Metabolism; Radiology,
   Nuclear Medicine & Medical Imaging
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism; Radiology,
   Nuclear Medicine & Medical Imaging
GA BGU36
UT WOS:000250578800032
DA 2018-10-20
ER

PT S
AU Kurosu, S
   Nomura, N
   Chiba, A
AF Kurosu, Shingo
   Nomura, Naoyuki
   Chiba, Akihiko
BE Chang, YW
   Kim, NJ
   Lee, CS
TI Effect of Sigma Phase in Co-29Cr-6Mo Alloy on Corrosion and Mechanical
   Properties
SO ADVANCED MATERIALS AND PROCESSING
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 6th Pacific Rim International Conference on Advanced Materials and
   Processing
CY NOV 05-09, 2007
CL Cheju Isl, SOUTH KOREA
SP Korean Inst Met & Mat, Chinese Soc Met, Japan Inst Met, Minerals, Met & Mat Soc, Inst Mat Engn Australia
DE cobalt-chromium-molybdenum alloy; biomaterial; corrosion; mechanical
   properties; sigma phase (sigma); aging treatment
AB Effect of the sigma (sigma) phase in Co-29Cr-6Mo alloy on corrosion and mechanical behavior has been investigated. The area fraction of the s phase varies depending on the aging time at 1023 K. The area fraction of the sigma phase increases with increasing aging time and reaches 0.6 % after aging at 1023 K for 21.6 ks. Inductively coupled plasma atomic emission spectrometer (ICP-AES) analysis revealed the quantity of released Co ion shows almost the same values regardless of different area fraction of the s phase. In addition, plastic elongation and 0.2% proof strength exhibit almost the same values, although the alloys have different area fraction of the s phase. These results suggest that a small amount of the s phase (<0.6%) hardly affect the corrosion and mechanical properties in the Co-29Cr-6Mo alloy.
C1 [Kurosu, Shingo] Iwate Univ, Grad Sch Engn, Dept Mat Sci, Morioka, Iwate 0208551, Japan.
   [Nomura, Naoyuki] Iwate Univ, Fac Engn, Dept Welf Engn, Morioka, Iwate 0208551, Japan.
   [Chiba, Akihiko] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
RP Kurosu, S (reprint author), Iwate Univ, Grad Sch Engn, Dept Mat Sci, Morioka, Iwate 0208551, Japan.
EM t5105001@iwate-u.ac.jp; nnomura@iwate-u.ac.jp; a.chiba@imr.tohoku.ac.jp
RI NOMURA, Naoyuki/L-7149-2017
FU Cooperation of Innovative Technology; Cooperation of Innovative
   Technology and Advanced Research in Evolutional Area from Ministry of
   Education, Culture, Sports, Science and Technology of Japan
FX The authors would like to thank to Prof. K. Yamaguchi at Department of
   Materials Science and Engineering, Faculty of engineering, Iwate
   University for the measurement with ICP-AES and technical supports. This
   research was supported by a Cooperation of Innovative Technology and
   Advanced Research in Evolutional Area from Ministry of Education,
   Culture, Sports, Science and Technology of Japan.
CR AGELINI E, 2004, CORROS SCI, V46, P1351
   Hiromoto S, 2005, BIOMATERIALS, V26, P4912, DOI 10.1016/j.biomaterials.2005.01.028
   HOLLEK H, 1995, HDB TERNARY ALLOY PH, V6
   PARK CJ, 2006, MAT SCI ENG A-STRUCT, V418, P1961
   SILVERMAN R, 1957, AM SOC MET, V49, P805
NR 5
TC 0
Z9 0
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-0-87849-463-7
J9 ADV MATER RES-SWITZ
PY 2007
VL 26-28
BP 777
EP +
DI 10.4028/www.scientific.net/AMR.26-28.777
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA BOP79
UT WOS:000277260000184
DA 2018-10-20
ER

PT S
AU Oh, MY
   Choe, HC
   Ko, YM
AF Oh, Mi Young
   Choe, Han Cheol
   Ko, Yeong Mu
BE Chang, YW
   Kim, NJ
   Lee, CS
TI AC IMPEDANCE BEHAVIORS OF Ti-Zr BINARY ALLOYS FOR BIOMATERIALS
SO ADVANCED MATERIALS AND PROCESSING
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 6th Pacific Rim International Conference on Advanced Materials and
   Processing
CY NOV 05-09, 2007
CL Cheju Isl, SOUTH KOREA
SP Korean Inst Met & Mat, Chinese Soc Met, Japan Inst Met, Minerals, Met & Mat Soc, Inst Mat Engn Australia
DE Ti-Zr alloy; biomaterial; AC impedance
AB In this study, AC impedance behaviors of Ti-Zr binary alloys for biomaterials have been investigated using by electrochemical impedance spectroscopy. Ti-10wt%, 20wt%, 30wt%, and 40wt% Zr alloys were prepared by arc melting and homogenized for 24 hr at 1000 C in argon atmosphere. Phase constitutions and microstructure of the specimens were conducted by using XRD, OM and SEM. The corrosion properties of the specimens were examined through potentiodynamic test (potential range of -1500 similar to 2000 mV), AC impedance spectroscopy(100kHz similar to 10mHz) in artificial saliva solution by potentiostat (EG&G Co, PARSTAT 2273. USA). In as-cast and homogenized Ti-xZr alloys, alpha-phase was identified by XRD. Microstructures were changed from lamellar structure to needle-like structure as Zr content increased. From the results of polarization behavior in the Ti-xZr alloys, it was found that the corrosion resistance was increased with increasing Zr content. From results of AC impedance spectroscopy, passive film resistance value of homogenized Ti-40Zr specimen(1.60x10(6) Omega cm(2)) showed higher than that of as-cast specimen.
C1 [Oh, Mi Young; Choe, Han Cheol; Ko, Yeong Mu] Chosun Univ, Stage Brain Korea Coll Dent 2 21, Kwangju, South Korea.
RP Oh, MY (reprint author), Chosun Univ, Stage Brain Korea Coll Dent 2 21, Kwangju, South Korea.
EM my4130@nate.com; hcchoe@chosun.ac.kr; ymgo@chosun.ac.kr
CR Aziz-Kerrzo M, 2001, BIOMATERIALS, V22, P1531, DOI 10.1016/S0142-9612(00)00309-4
   JIANG XP, MAT SCI ENG A, V429, P30
   KOBAYASHI E, MAT SCI, V9
   KURODA D, 1998, MATER SCI ENG, V243, P224
   LUCKEY HA, 1998, ASTM PUBLICATION STP, V1, P796
   Park JJ, 2007, MATER SCI FORUM, V539-543, P1270, DOI 10.4028/www.scientific.net/MSF.539-543.1270
   Rao S, 1996, BIO-MED MATER ENG, V6, P79
   WALKER PR, 1989, BIOCHEMISTRY-US, V28, P3911, DOI 10.1021/bi00435a043
   Zhou YL, 2004, MAT SCI ENG A-STRUCT, V384, P92, DOI 10.1016/j.msea.2004.05.084
NR 9
TC 3
Z9 3
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-0-87849-463-7
J9 ADV MATER RES-SWITZ
PY 2007
VL 26-28
BP 817
EP +
DI 10.4028/www.scientific.net/AMR.26-28.817
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA BOP79
UT WOS:000277260000194
DA 2018-10-20
ER

PT S
AU Ye, JJ
   Sun, DH
AF Ye Junjun
   Sun Daoheng
BE Yang, L
   Chen, Y
   Kley, YB
   Li, R
TI Fabrication of electrospun nanofibers bundles - art. no. 6722F
SO ADVANCED OPTICAL MANUFACTURING TECHNOLOGIES, PTS 1 AND 2
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT 3rd International Symposium on Advanced Optical Manufacturing and
   Testing Technologies
CY JUL 08-12, 2007
CL Chengdu, PEOPLES R CHINA
SP China Opt Soc, CAS, Inst Opt & Elect, SPIE, State Key Lab Opt Technol Microfabricat, Sichuan Opt Soc
DE electrospinning; nanofibers bundles; density; non-uniform
   electricalfield
ID POLYMER NANOFIBERS; NANOLITHOGRAPHY; DIAMETER; FIBERS
AB Aligned nanofibers, filament bundle composed of large number of nanofibers have potential applications such as biomaterial, composite material etc. A series of electrospinning experiments have been conducted to investigate the electrospinning process,in which some parameters such as polymer solution concentration, bias voltage, distance between spinneret and collector, solution flow rate etc have been setup to do the experiment of nanofibers bundles construction. This work firstly reports electrospun nanofiber bundle through non-uniform electrical field, and nanofibers distributed in different density on electrodes from that between them. Thinner nanofibers bundle with a few numbers of nanofiber is collected for 3 seconds; therefore it's also possible that the addressable single nanofiber could be collected to bridge two electrodes.
C1 [Ye Junjun; Sun Daoheng] Xiamen Univ, Dept Mech & Elect Engn, Xiamen 361005, Peoples R China.
RP Ye, JJ (reprint author), Xiamen Univ, Dept Mech & Elect Engn, Xiamen 361005, Peoples R China.
CR Dersch R, 2003, J POLYM SCI POL CHEM, V41, P545, DOI 10.1002/pola.10609
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Kameoka J, 2003, NANOTECHNOLOGY, V14, P1124, DOI 10.1088/0957-4484/14/10/310
   Li D, 2004, ADV MATER, V16, P1151, DOI 10.1002/adma.200400719
   Li D, 2005, NANO LETT, V5, P913, DOI 10.1021/nl0504235
   Liu HQ, 2004, NANO LETT, V4, P671, DOI 10.1021/nl049826f
   LODISH HB, 2000, MOL CELL BIOL
   Lyuksyutov SF, 2003, APPL PHYS LETT, V83, P4405, DOI 10.1063/1.1629787
   Piner RD, 1999, SCIENCE, V283, P661, DOI 10.1126/science.283.5402.661
   Pinto NJ, 2003, APPL PHYS LETT, V83, P4244, DOI 10.1063/1.1627484
   Reneker DH, 2000, J APPL PHYS, V87, P4531, DOI 10.1063/1.373532
   Reneker DH, 1996, NANOTECHNOLOGY, V7, P216, DOI 10.1088/0957-4484/7/3/009
   Sarazin P, 2004, BIOMATERIALS, V25, P5965, DOI 10.1016/j.biomaterials.2004.01.065
   Son WK, 2004, POLYMER, V45, P2959, DOI 10.1016/j.polymer.2004.02.006
   Sun ZC, 2003, ADV MATER, V15, P1929, DOI 10.1002/adma.200305136
   Wang XY, 2002, NANO LETT, V2, P1273, DOI 10.1021/nl020216u
   Zhou YX, 2003, APPL PHYS LETT, V83, P3800, DOI 10.1063/1.1622108
NR 17
TC 0
Z9 0
U1 1
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-0-8194-6879-6
J9 P SOC PHOTO-OPT INS
PY 2007
VL 6722
BP F6722
EP F6722
PN 1-2
PG 5
WC Engineering, Manufacturing; Optics
SC Engineering; Optics
GA BHF71
UT WOS:000252739500050
DA 2018-10-20
ER

PT S
AU Hermansson, L
   Engqvist, H
AF Hermansson, L.
   Engqvist, H.
BE Mizuno, M
TI CHEMICALLY BONDED CERAMICS BASED ON CA-ALUMINATES AS BIOMATERIALS
SO ADVANCES IN BIOCERAMICS AND BIOCOMPOSITES II
SE Ceramic Engineering and Science Proceedings
LA English
DT Proceedings Paper
CT 30th International Conference and Exposition on Advanced Ceramics and
   Composites
CY JAN 22-27, 2006
CL Cocoa Beach, FL
SP Amer Ceram Soc,Engn Ceram Div
ID CEMENT
AB This presentation aims at giving an overview picture of the potential of Ca-aluminate as biomaterial Identified possible applications for Ca-aluminate based materials are within vertebroplasty and odontology An additional field of interest is as an implant coating material Ca-aluminate with oxide particles as well as Ca aluminate with glass particles were examined concerning handling and mechanical properties, biocompatibility and bioactivity For both orthopaedic and dental injectable CA-pastes the working time of 4 minutes and the setting time about 10 minutes are achievable The fracture toughness was determined to be in the range 0 5-1 0 MPam(1/2) and the compressive strength in the interval 150-250 MPa depending on selected w/c ratio, and the flexural strength above 50 MPa The hardness is about 100 HV, and Young s modulus 10-15 GPa The hydrates formed are in the size range of 20 50 nm In lard tissue the Ca-aluminate based materials form a chemical interface totally closing the gap between the biomaterial and the surrounding tissue Two features contribute to this sealing of interfaces, first the general dissolution of Ca-aluminate and precipitation of nanosize hydrates m micro-voids between particles and tissue, and on all possible walls including tissue surfaces, and second the zone formation including possible apatite formation upon which bioactive-induced formation of new tissue including apatite formation Thus both a pure chemical integration and a biologically induced integration contribute to sealing of biomaterial-tissue interfaces
OI Engqvist, Hakan/0000-0001-9529-650X
CR Axen N, 2004, KEY ENG MAT, V254-2, P265, DOI 10.4028/www.scientific.net/KEM.254-256.265
   AXEN N, KEY ENG MAT, V284, P831
   AXEN N, 2005, ADV CER COM IN PRESS
   AXEN N, 2004, CELLS T IN PRESS SEP
   Engqvist H, 2004, BIOMATERIALS, V25, P2781, DOI 10.1016/j.biomaterials.2003.09.053
   ENGQVIST H, 2005, ADV CER COM IN PRESS
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   Hermansson L, 2003, KEY ENG MAT, V247, P437, DOI 10.4028/www.scientific.net/KEM.247.437
   KRAFT L, 2002, THESIS UPPSALA U SWE
   LIU Y, 2001, IADR CHIB C JAP JUN
   Loof J, 2005, KEY ENG MAT, V284-286, P741
   Loof J, 2004, KEY ENG MAT, V254-2, P51
   NILSSON M, 2003, THESIS LUND
   PATTERSON RJ, MICROSCOPY MIC UNPUB
   Powers T., 1946, J AM CONCRETE I, V43, P492
   Roemhildt ML, 2003, J MATER SCI-MATER M, V14, P137, DOI 10.1023/A:1022067729008
   SPENGLER H, 16 INT RES C B UNPUB
NR 17
TC 0
Z9 0
U1 0
U2 2
PU AMER CERAMIC SOC
PI WESTERVILLE
PA 735 CERAMIC PLACE, WESTERVILLE, OH 43081-8720 USA
SN 0196-6219
BN 978-0-470-08056-6
J9 CERAM ENG SCI PROC
PY 2007
VL 27
IS 6
BP 71
EP 86
PG 16
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BSL63
UT WOS:000284867100007
DA 2018-10-20
ER

PT S
AU Chen, B
   Peng, XH
   Wu, XY
AF Chen, Bin
   Peng, Xianghe
   Wu, Xinyan
BE Kim, JK
   Wo, DZ
   Zhou, LM
   Huang, HT
   Lau, KT
   Wang, M
TI Sheet-layer microstructure and toughness mechanism of shinbone
SO ADVANCES IN COMPOSITE MATERIALS AND STRUCTURES, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 5th Asian/Australasian Conference on Composite Materials (ACCM-5)
CY NOV 27-30, 2006
CL Hong Kong, PEOPLES R CHINA
SP Hong Kong Univ Sci & Technol, Nanjing Univ Aeronaut & Astronaut, Hong Kong Polytech Univ, Univ Hong Kong
DE shinbone; ceramic composite; hydroxyapatite sheet; fracture toughness
ID BONE
AB Most structural materials existing in nature take the form of composite. After centuries' evolution, these materials gain highly optimized microstructures and performances. In this work, a kind of natural biomaterial, shinbone, is observed with a scanning electron microscope (SEM). The observation result shows that the bone is a bioceramic composite consisting of hydroxyapatite layers and collagen matrix. The observation also shows that the hydroxyapatite layers are composed of hydroxyapatite sheets. The hydroxyapatite sheets are of thin and long shape and parallel distribution along the orientation of the maximum main stress of the bone. The shape and distribution of the hydroxyapatite sheets may endow the bone with favorable fracture toughness, which is analyzed and illuminated based a representational model of the hydroxyapatite sheets and the idea of maximum pullout force.
C1 [Chen, Bin] Chongqing Univ, Coll Resources & Environm Sci, Dept Mech Engn, Chongqing 400044, Peoples R China.
RP Chen, B (reprint author), Chongqing Univ, Coll Resources & Environm Sci, Dept Mech Engn, Chongqing 400044, Peoples R China.
EM bchen@cqu.edu.cn; xhpeng@cqu.edu.cn; cdxywu@163.com
FU Natural Science Foundations of China [10572157, 10272120]
FX The authors gratefully acknowledge the financial supports to this work
   from the Natural Science Foundations of China (Grant no. 10572157 and
   10272120).
CR CHONG KP, 1999, MECH AAM, V28, P1
   Currey JD, 2003, J BIOMECH, V36, P1487, DOI 10.1016/S0021-9290(03)00124-6
   HOGAN HA, 1992, P AM SOC COM, P196
   Katti DR, 2001, COMPUT THEOR POLYM S, V11, P397, DOI 10.1016/S1089-3156(01)00012-5
   SARIKAYA M, 1989, P AM COMP, P176
   Zioupos P, 1998, BONE, V22, P57, DOI 10.1016/S8756-3282(97)00228-7
NR 6
TC 3
Z9 3
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
BN 978-0-87849-427-9
J9 KEY ENG MATER
PY 2007
VL 334-335
BP 1129
EP +
DI 10.4028/www.scientific.net/KEM.334-335.1129
PN 1-2
PG 2
WC Materials Science, Ceramics; Materials Science, Characterization &
   Testing; Materials Science, Composites
SC Materials Science
GA BFV92
UT WOS:000245033100283
DA 2018-10-20
ER

PT S
AU Yeung, HY
   Qin, L
   Lee, KM
   Leung, KS
   Cheng, JCY
AF Yeung, H. Y.
   Qin, L.
   Lee, K. M.
   Leung, K. S.
   Cheng, J. C. Y.
BE Kim, JK
   Wo, DZ
   Zhou, LM
   Huang, HT
   Lau, KT
   Wang, M
TI Objective quantification of porous structure in orthopaedic biomaterial
   implants using micro computed tomography
SO ADVANCES IN COMPOSITE MATERIALS AND STRUCTURES, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 5th Asian/Australasian Conference on Composite Materials (ACCM-5)
CY NOV 27-30, 2006
CL Hong Kong, PEOPLES R CHINA
SP Hong Kong Univ Sci & Technol, Nanjing Univ Aeronaut & Astronaut, Hong Kong Polytech Univ, Univ Hong Kong
DE bioceramics; micro-computed tomography; porosity; porous structure
   quantification
ID BMP-INDUCED OSTEOGENESIS; PORE-SIZE; HYDROXYAPATITE; BONE
AB Porous calcium phosphate ceramics have been widely investigated in orthopaedic surgery as bone extensor. Attention has been given to manufacturing of a porous bioceramic that mimics the trabecular bone structure for proper bone regeneration and integration. Although different methods have been applied to manufacture the porous structure, it was unable to visualize the pores and their interconnections within the ceramic and had objective measurement of the calcium phosphate ceramics. With the advance of biomedical imaging through micro-computed tomography (microCT), the study attempted to quantify the pore structure of different calcium phosphate ceramics. Three kinds of bioceramic blocks, namely BSC, ChronOS, and THA, were synthesized by three methods and tested in the study. Six blocks of each bioceramic were evaluated by conventional water immersion method and microCT. The pore size and connectivity of the pores were evaluated with standardized protocols. The three-dimensional analysis of the pores and their distribution by microCT was presented. The ChronOS had more functional pores (200-400wm in diameter) than the BSC and THA did (p < 0.05). Providing objective information on the functional pores, the microCT evaluation serves as a good standard for specification of the bioceramic-related implants.
C1 [Yeung, H. Y.; Qin, L.; Leung, K. S.; Cheng, J. C. Y.] Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China.
   [Lee, K. M.] Chinese Univ Hong Kong, Lee Hysan Clin Res Lab, Hong Kong, Hong Kong, Peoples R China.
RP Yeung, HY (reprint author), Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China.
EM byeung@cuhk.edu.hk; lingqin@cuhk.edu.hk; simonlee@cuhk.edu.hk;
   ksleung@cuhk.edu.hk; jackcheng@cuhk.edu.hk
RI Qin, Ling/J-9047-2018; Cheng, Jack/J-3878-2018
OI Qin, Ling/0000-0001-6173-6167; Cheng, Jack/0000-0001-8153-364X
FU Hong Kong Jockey Club Osteoporosis Center for Care and Control (JOCOC);
   AO Research Fund of the AO Foundation [AO/ASIF 03-C46]
FX We would like to thank the Hong Kong Jockey Club Osteoporosis Center for
   Care and Control (JOCOC) for providing the funding for the microCT
   machine used for this study. This project (Ref. AO/ASIF 03-C46) was
   supported by the AO Research Fund of the AO Foundation.
CR ANGEL M F, 1985, Microsurgery, V6, P175, DOI 10.1002/micr.1920060309
   GRENGA TE, 1989, PLAST RECONSTR SURG, V84, P245, DOI 10.1097/00006534-198908000-00009
   GUO X, 1993, THESIS U ESSEN GERMA
   Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   KLAWITTER JJ, 1979, THESIS CLEMSON U
   Kuboki Y, 2001, J BONE JOINT SURG AM, V83A, pS105
   Kurioka Kazuhito, 1999, Kobe Journal of Medical Sciences, V45, P149
   ODGAARD A, 1993, BONE, V14, P173, DOI 10.1016/8756-3282(93)90245-6
   Oya M, 2002, AM CERAM SOC BULL, V81, P52
   Shors EC, 1999, ORTHOP CLIN N AM, V30, P599, DOI 10.1016/S0030-5898(05)70113-9
   Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317
   VANBLITTERSWIJK CA, 1986, BIOMATERIALS, V7, P137, DOI 10.1016/0142-9612(86)90071-2
NR 13
TC 0
Z9 0
U1 1
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
BN 978-0-87849-427-9
J9 KEY ENG MATER
PY 2007
VL 334-335
BP 1205
EP +
DI 10.4028/www.scientific.net/KEM.334-335.1205
PN 1-2
PG 2
WC Materials Science, Ceramics; Materials Science, Characterization &
   Testing; Materials Science, Composites
SC Materials Science
GA BFV92
UT WOS:000245033100302
DA 2018-10-20
ER

PT J
AU Richards, RG
   Simpson, AE
   Jaehn, K
   Furlong, PI
   Stoddart, MJ
AF Richards, R. Geoff
   Simpson, Angharad E.
   Jaehn, Katharina
   Furlong, Pamela I.
   Stoddart, Martin J.
TI Establishing a 3D Ex vivo culture system for investigations of bone
   metabolism and biomaterial interactions
SO ALTEX-ALTERNATIVEN ZU TIEREXPERIMENTEN
LA English
DT Article
DE human; bone; osteocytes; osteoblasts; loading culture chamber;
   reduction; replacement; toxicity testing; biomaterials implants;
   validation
AB A 3D load-providing culture system is presented, which enables human cancellous bone explants to be studied ex vivo. Bone integrity and activity was demonstrated during 2 to 3 weeks of culture. Viable osteocytes and bone specific markers could be identified. Culture conditions were improved using a serum free medium containing TGF-beta 3. Therefore this system gives the opportunity to study bone biology, hormonal effects as well as biomaterial interactions ex vivo prior to animal studies.
C1 AO Res Inst, CH-7270 Davos, Switzerland.
RP Richards, RG (reprint author), AO Res Inst, Clavadelerstr 8, CH-7270 Davos, Switzerland.
EM geoff.richards@aofoundation.org
RI Richards, Robert/I-8235-2015; Stoddart, Martin/E-3240-2013
OI Richards, Robert/0000-0002-7778-2480; Stoddart,
   Martin/0000-0002-9538-1517
CR Davies CM, 2006, EUR CELLS MATER, V11, P57, DOI 10.22203/eCM.v011a07
   Jones D. B., 2003, European Cells & Materials, V5, P48
   Stoddart MJ, 2006, EUR CELLS MATER, V12, P16, DOI 10.22203/eCM.v012a02
   TENDIJKE P, 1990, MOL CELL BIOL, V10, P4473, DOI 10.1128/MCB.10.9.4473
   Yang R, 2003, Eur Cell Mater, V6, P57
NR 5
TC 6
Z9 6
U1 0
U2 4
PU SPEKTRUM AKAD VERLAG
PI HEIDELBERG
PA VANGEROWSTR 20, D-69115 HEIDELBERG, GERMANY
SN 0946-7785
J9 ALTEX-ALTERN TIEREXP
JI Altex Altern. Tierexp.
PY 2007
VL 24
SI SI
BP 56
EP 59
PG 4
WC Integrative & Complementary Medicine
SC Integrative & Complementary Medicine
GA 211PG
UT WOS:000249535100019
PM 19835059
DA 2018-10-20
ER

PT J
AU Guzzo, JL
   Bochicchio, GV
   Henry, S
   Keller, E
   Scalea, TM
AF Guzzo, James L.
   Bochicchio, Grant V.
   Henry, Sharon
   Keller, Elena
   Scalea, Thomas M.
TI Incarcerated inguinal hernia in the presence of Fournier's gangrene: A
   novel approach to a complex problem
SO AMERICAN SURGEON
LA English
DT Article
ID INTESTINAL SUBMUCOSA; LAPAROSCOPIC MESH; GROIN HERNIA; DOG-MODEL;
   REPAIR; DEFECTS
AB Fournier's gangrene is an aggressive, polymicrobial soft tissue infection that specifically affects the genital and perineal region. Treatment requires early recognition, broad-spectrum intravenous antibiotics, and radical surgical debridement of all infected tissues. Optimal therapy may necessitate multiple debridements that leave the patient with large tissue defects that require skin grafting for scrotal and perineal reconstruction. The presence of other surgical emergencies, such as an incarcerated inguinal hernia, in the face of Fournier's gangrene presents a rare and challenging dilemma to the general surgeon. With the widespread acceptance of tension-free repair utilizing prosthetic mesh in uncomplicated hernia surgery, outcomes have been improved. However, surgical options for hernia repair may become limited in the face of a regional necrotizing soft tissue infection, for which mesh use in an open repair after debridement of infected tissues is generally contraindicated. In this report, the authors describe three consecutive cases of incarcerated inguinal hernia in the presence of concomitant Fournier's gangrene using a laparoscopic approach and natural biomaterial mesh for abdominal wall reinforcement.
C1 R Adams Cowley Shock Trauma Ctr, Baltimore, MD 21201 USA.
   Univ Maryland, Sch Med, Baltimore, MD 21201 USA.
RP Bochicchio, GV (reprint author), R Adams Cowley Shock Trauma Ctr, 22 S Greene St, Baltimore, MD 21201 USA.
CR Badylak S, 2001, J SURG RES, V99, P282, DOI 10.1006/jsre.2001.6176
   BADYLAK SF, 1994, J VASC SURG, V19, P465, DOI 10.1016/S0741-5214(94)70073-7
   Birolini C, 2000, J AM COLL SURGEONS, V191, P366, DOI 10.1016/S1072-7515(00)00703-1
   CARKE KM, 1996, J SURG RES, V60, P107
   DAYTON MT, 1986, ARCH SURG-CHICAGO, V121, P954
   Dejardin LM, 1999, J BIOMED MATER RES, V46, P203, DOI 10.1002/(SICI)1097-4636(199908)46:2<203::AID-JBM9>3.0.CO;2-4
   Eke N, 2000, BRIT J SURG, V87, P718, DOI 10.1046/j.1365-2168.2000.01497.x
   FELIX EL, 1995, SURG ENDOSC-ULTRAS, V9, P984
   Ferzli G, 2004, SURG ENDOSC, V18, P228, DOI 10.1007/s00464-003-8185-y
   Ferzli G, 1998, SURG ENDOSC-ULTRAS, V12, P1311, DOI 10.1007/s004649900847
   Franklin M E Jr, 2004, Hernia, V8, P186
   Franklin M E Jr, 2002, Hernia, V6, P171
   GALLEGOS NC, 1991, BRIT J SURG, V78, P1171, DOI 10.1002/bjs.1800781007
   GILBERT AI, 1989, AM J SURG, V157, P331, DOI 10.1016/0002-9610(89)90564-3
   Helton WS, 2005, ARCH SURG-CHICAGO, V140, P549, DOI 10.1001/archsurg.140.6.549
   Ishihara T, 1996, SURG ENDOSC-ULTRAS, V10, P1111, DOI 10.1007/s004649900254
   Jacobs DO, 2004, NEW ENGL J MED, V350, P1895, DOI 10.1056/NEJMe048062
   Johansson B, 1999, ANN SURG, V230, P225, DOI 10.1097/00000658-199908000-00013
   KELLEY ME, 2002, AM SURGEON, V6, P524
   Lantz G C, 1993, J Invest Surg, V6, P297, DOI 10.3109/08941939309141619
   Lavonius MI, 2000, SURG ENDOSC-ULTRAS, V14, P488, DOI 10.1007/s004640000018
   LEIBL BJ, 2000, SURG ENDOSC, V15, P1179
   LICHTENSTEIN IL, 1993, SURG CLIN N AM, V73, P529
   MCKERNAN JB, 1993, SURG ENDOSC-ULTRAS, V7, P26, DOI 10.1007/BF00591232
   Neumayer L, 2004, NEW ENGL J MED, V350, P1819, DOI 10.1056/NEJMoa040093
   Sarikaya A, 2002, TISSUE ENG, V8, P63, DOI 10.1089/107632702753503063
   UNEO T, 2004, J GASTROINTEST SURG, V8, P109
   WATSON SD, SURG LAPAROSC ENDOSC, V3, P106
NR 28
TC 6
Z9 7
U1 0
U2 1
PU SOUTHEASTERN SURGICAL CONGRESS
PI ATLANTA
PA 141 WEST WIEUCA RD, STE B100, ATLANTA, GA 30342 USA
SN 0003-1348
J9 AM SURGEON
JI Am. Surg.
PD JAN
PY 2007
VL 73
IS 1
BP 93
EP 95
PG 3
WC Surgery
SC Surgery
GA 123QR
UT WOS:000243310900022
PM 17249467
DA 2018-10-20
ER

PT J
AU Mack, D
   Davies, AP
   Harris, LG
   Rohde, H
   Horstkotte, MA
   Knobloch, JKM
AF Mack, Dietrich
   Davies, Angharad P.
   Harris, Llinos G.
   Rohde, Holger
   Horstkotte, Matthias A.
   Knobloch, Johannes K-M.
TI Microbial interactions in Staphylococcus epidermidis biofilms
SO ANALYTICAL AND BIOANALYTICAL CHEMISTRY
LA English
DT Review
DE Staphylococcus epidermidis; quorum sensing; polysaccharide intercellular
   adhesin; biomaterial-related infection; biofilms
ID POLYSACCHARIDE INTERCELLULAR ADHESIN; QUORUM-SENSING SYSTEM; GENE
   REGULATOR AGR; COAGULASE-NEGATIVE STAPHYLOCOCCI; ACCUMULATION-ASSOCIATED
   PROTEIN; CATHETER-ASSOCIATED INFECTION; SEQUENCE ELEMENT IS256;
   SIGMA-FACTOR SIGMA(B); ICA LOCUS; IN-VIVO
AB Medical device-associated infections, most frequently caused by coagulase-negative staphylococci, especially Staphylococcus epidermidis, are of increasing importance in modern medicine. The formation of adherent, multilayered bacterial biofilms is the most important factor in the pathogenesis of these infections, which regularly fail to respond to appropriate antimicrobial therapy. Progress in elucidating the factors functional in elaboration of S. epidermidis biofilms and the regulation of their expression with a special emphasis on the role of quorum sensing are reviewed. Significant progress has been made in recent years, which provides the rationale for developing better preventive, therapeutic and diagnostic measures.
C1 Swansea Univ, Sch Med, Swansea SA2 8PP, W Glam, Wales.
   Univ Klinikum Hamburg Eppendorf, Inst Med Mikrobiol Virol & Hyg, Zentrum Klin Pathol, D-20246 Hamburg, Germany.
   Inst Med Diagnost, Reg Labor Moers, D-47441 Moers, Germany.
   Univ Lubeck, Inst Med Mikrobiol & Hyg, D-23538 Lubeck, Germany.
RP Mack, D (reprint author), Swansea Univ, Sch Med, Grove Bldg,Singleton Pk, Swansea SA2 8PP, W Glam, Wales.
EM D.Mack@swansea.ac.uk
RI Knobloch, Johannes/D-6456-2011
OI Knobloch, Johannes/0000-0002-2591-6387; Davies,
   Angharad/0000-0003-4190-8894; Harris, Llinos/0000-0002-0295-3038
CR ABDELNOUR A, 1993, INFECT IMMUN, V61, P3879
   Allignet J, 2001, INFECT IMMUN, V69, P712, DOI 10.1128/IAI.69.2.712-718.2001
   Arciola CR, 2004, BIOMATERIALS, V25, P4117, DOI 10.1016/j.biomaterials.2003.11.027
   Balaban N, 2005, CLIN ORTHOP RELAT R, P48, DOI 10.1097/01.blo.0000175889.82865.67
   Balaban N, 2003, J INFECT DIS, V187, P625, DOI 10.1086/345879
   Balaban N, 1998, SCIENCE, V280, P438, DOI 10.1126/science.280.5362.438
   Bateman A, 2005, BIOINFORMATICS, V21, P1301, DOI 10.1093/bioinformatics/bti206
   Batzilla CF, 2006, PROTEOMICS, V6, P3602, DOI 10.1002/pmic.200500732
   Baveja JK, 2004, BIOMATERIALS, V25, P5003, DOI 10.1016/j.biomaterials.2004.02.051
   Blevins JS, 2003, INFECT IMMUN, V71, P516, DOI 10.1128/IAI.71.1.516-523.2003
   Bowden MG, 2005, MICROBIOL-SGM, V151, P1453, DOI 10.1099/mic.0.27534-0
   Bowden MG, 2002, J BIOL CHEM, V277, P43017, DOI 10.1074/jbc.M207921200
   Carmody AB, 2004, ARCH MICROBIOL, V181, P250, DOI 10.1007/s00203-003-0644-2
   Chen H, 2004, P NATL ACAD SCI USA, V101, P5048, DOI 10.1073/pnas.0401416101
   Chokr A, 2006, INT J MED MICROBIOL, V296, P381, DOI 10.1016/j.ijmm.2006.02.018
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   Cole SP, 2004, J BACTERIOL, V186, P3124, DOI 10.1128/JB.186.10.3124-3132.2004
   Conlon KM, 2004, J BACTERIOL, V186, P6208, DOI 10.1128/JB.186.18.6208-6219.2004
   Conlon KM, 2002, J BACTERIOL, V184, P4400, DOI 10.1128/JB.184.16.4400-4408.2002
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Cramton SE, 1999, INFECT IMMUN, V67, P5427
   Cramton SE, 2001, INFECT IMMUN, V69, P4079, DOI 10.1128/IAI.69.6.4079-4085.2001
   Cucarella C, 2001, J BACTERIOL, V183, P2888, DOI 10.1128/JB.183.9.2888-2896.2001
   Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295
   DEIGHTON M, 1993, INFECT IMMUN, V61, P4473
   Dobinsky S, 2003, J BACTERIOL, V185, P2879, DOI 10.1128/JB.185.9.2879-2886.2003
   DOBINSKY S, 2004, BIOFILMS, V1, P101
   Doherty N, 2006, J BACTERIOL, V188, P2885, DOI 10.1128/JB.188.8.2885-2897.2006
   Dufour P, 2002, J BACTERIOL, V184, P1180, DOI 10.1128/jb.184.4.1180-1186.2002
   DUNNE WM, 1993, ANTIMICROB AGENTS CH, V37, P2522, DOI 10.1128/AAC.37.12.2522
   Fey PD, 1999, J INFECT DIS, V179, P1561, DOI 10.1086/314762
   Fitzpatrick F, 2002, J HOSP INFECT, V52, P212, DOI 10.1053/jhin.2002.1309
   Frank KL, 2004, J CLIN MICROBIOL, V42, P4846, DOI 10.1128/JCM.42.10.4846-4849.2004
   Galdbart JO, 1999, J CLIN MICROBIOL, V37, P1306
   Galdbart JO, 2000, J INFECT DIS, V182, P351, DOI 10.1086/315660
   Gerke C, 1998, J BIOL CHEM, V273, P18586, DOI 10.1074/jbc.273.29.18586
   Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005
   GILLASPY AF, 1995, INFECT IMMUN, V63, P3373
   Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x
   Gotz F, 2000, INFECT ASS INDWELLIN, P55
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   Handke LD, 2004, J MED MICROBIOL, V53, P367, DOI 10.1099/jmm.0.05372-0
   Harris LG, 2004, J MATER SCI-MATER M, V15, P311, DOI 10.1023/B:JMSM.0000021093.84680.bb
   Hartford O, 2001, MICROBIOL-SGM, V147, P2545, DOI 10.1099/00221287-147-9-2545
   Heilmann C, 2003, MICROBIOL-SGM, V149, P2769, DOI 10.1099/mic.0.26527-0
   Heilmann C, 1996, INFECT IMMUN, V64, P277
   Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x
   Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x
   Hentzer M, 2003, EMBO J, V22, P3803, DOI 10.1093/emboj/cdg366
   Hentzer M, 2002, MICROBIOL-SGM, V148, P87, DOI 10.1099/00221287-148-1-87
   Huber B, 2001, MICROBIOL-SGM, V147, P2517, DOI 10.1099/00221287-147-9-2517
   Hume EBH, 2004, BIOMATERIALS, V25, P5023, DOI 10.1016/j.biomaterials.2004.01.048
   HUSSAIN M, 1992, J HOSP INFECT, V20, P173, DOI 10.1016/0195-6701(92)90085-Z
   Hussain M, 1997, INFECT IMMUN, V65, P519
   Jabra-Rizk MA, 2006, ANTIMICROB AGENTS CH, V50, P1463, DOI 10.1128/AAC.50.4.1463-1469.2006
   Jager S, 2005, APPL ENVIRON MICROB, V71, P5577, DOI 10.1128/AEM.71.9.5577-5581.2005
   Jefferson KK, 2003, MOL MICROBIOL, V48, P889, DOI 10.1046/j.1365-2958.2003.03482.x
   Ji GY, 1997, SCIENCE, V276, P2027, DOI 10.1126/science.276.5321.2027
   Joyce JG, 2003, CARBOHYD RES, V338, P903, DOI 10.1016/S0008-6215(03)00045-4
   Kaufmann GF, 2005, P NATL ACAD SCI USA, V102, P309, DOI 10.1073/pnas.0408639102
   Kilstrup M, 1998, J BACTERIOL, V180, P3907
   Knobloch JKM, 2005, ANTIMICROB AGENTS CH, V49, P1216, DOI 10.1128/AAC.49.3.1216-1219.2005
   Knobloch JKM, 2004, INFECT IMMUN, V72, P3838, DOI 10.1128/IAI.72.7.3838-3848.2004
   Knobloch JKM, 2003, APPL ENVIRON MICROB, V69, P5812, DOI 10.1128/AEM.69.10.5812-5818.2003
   Knobloch JKM, 2002, MED MICROBIOL IMMUN, V191, P101, DOI 10.1007/s00430-002-0124-3
   Knobloch JKM, 2002, MED MICROBIOL IMMUN, V191, P107, DOI 10.1007/s00430-002-0125-2
   Knobloch JKM, 2002, J ANTIMICROB CHEMOTH, V49, P683, DOI 10.1093/jac/49.4.683
   Knobloch JKM, 2001, J BACTERIOL, V183, P2624, DOI 10.1128/JB.183.8.2624-2633.2001
   Kogan G, 2006, FEMS MICROBIOL LETT, V255, P11, DOI 10.1111/j.1574-6968.2005.00043.x
   Kong KF, 2006, INT J MED MICROBIOL, V296, P133, DOI 10.1016/j.ijmm.2006.01.042
   Kozitskaya S, 2004, INFECT IMMUN, V72, P1210, DOI 10.1128/IAI.72.2.1210-1215.2004
   Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001
   Li HL, 2005, INFECT IMMUN, V73, P3188, DOI 10.1128/IAI.73.5.3188-3191.2005
   Mack D, 1996, J INFECT DIS, V174, P881, DOI 10.1093/infdis/174.4.881
   Mack D, 2006, INT J ARTIF ORGANS, V29, P343
   Mack D, 2002, ANTIMICROB AGENTS CH, V46, P178, DOI 10.1128/AAC.46.1.178-183.2002
   MACK D, 1994, INFECT IMMUN, V62, P3244
   Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996
   Mack D, 1999, INFECT IMMUN, V67, P1004
   MACK D, 1992, INFECT IMMUN, V60, P2048
   Mack D, 2000, INFECT IMMUN, V68, P3799, DOI 10.1128/IAI.68.7.3799-3807.2000
   Mack D., 2006, BIOFILMS INFECT ANTI, P109
   Mayville P, 1999, P NATL ACAD SCI USA, V96, P1218, DOI 10.1073/pnas.96.4.1218
   McKenney D, 1999, SCIENCE, V284, P1523, DOI 10.1126/science.284.5419.1523
   Mehlin C, 1999, J EXP MED, V189, P907, DOI 10.1084/jem.189.6.907
   Merritt J, 2003, INFECT IMMUN, V71, P1972, DOI 10.1128/IAI.71.4.1972-1979.2003
   Moretro T, 2003, APPL ENVIRON MICROB, V69, P5648, DOI 10.1128/AEM.69.9.5648-5655.2003
   Nilsson M, 1998, INFECT IMMUN, V66, P2666
   Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x
   NOVICK RP, 2000, SCIENCE, V287, pA391
   Otto M, 2004, FEMS MICROBIOL LETT, V241, P135, DOI 10.1016/j.femsle.2004.11.016
   Otto M, 2004, J INFECT DIS, V190, P748, DOI 10.1086/422157
   Otto M, 1999, FEBS LETT, V450, P257, DOI 10.1016/S0014-5793(99)00514-1
   Otto M, 1998, FEBS LETT, V424, P89, DOI 10.1016/S0014-5793(98)00145-8
   Otto M, 2001, PEPTIDES, V22, P1603, DOI 10.1016/S0196-9781(01)00495-8
   Otto M, 2001, INFECT IMMUN, V69, P1957, DOI 10.1128/IAI.69.3.1957-1960.2001
   PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101
   PENG HL, 1988, J BACTERIOL, V170, P4365, DOI 10.1128/jb.170.9.4365-4372.1988
   Qazi S, 2006, INFECT IMMUN, V74, P910, DOI 10.1128/IAI.74.2.910-919.2006
   Rachid S, 2000, J BACTERIOL, V182, P6824, DOI 10.1128/JB.182.23.6824-6826.2000
   Rachid S, 2000, ANTIMICROB AGENTS CH, V44, P3357, DOI 10.1128/AAC.44.12.3357-3363.2000
   Rani SA, 2005, ANTIMICROB AGENTS CH, V49, P728, DOI 10.1128/AAC.49.2.728-732.2005
   Rickard AH, 2006, MOL MICROBIOL, V60, P1446, DOI 10.1111/j.1365-2958.2006.05202.x
   Rohde H, 2004, J CLIN MICROBIOL, V42, P5614, DOI 10.1128/JCM.42.12.5614-5619.2004
   Rohde H, 2001, MED MICROBIOL IMMUN, V190, P105, DOI 10.1007/s00430-001-0099-5
   Rohde H, 2005, MOL MICROBIOL, V55, P1883, DOI 10.1111/j.1365-2958.04515.x
   Rupp ME, 2001, J INFECT DIS, V183, P1038, DOI 10.1086/319279
   Rupp ME, 1999, INFECT IMMUN, V67, P2656
   Rupp ME, 1999, INFECT IMMUN, V67, P2627
   RUPP ME, 1994, CLIN INFECT DIS, V19, P231, DOI 10.1093/clinids/19.2.231
   Sadovskaya I, 2005, INFECT IMMUN, V73, P3007, DOI 10.1128/IAI.73.5.3007-3017.2005
   Schauder S, 2001, GENE DEV, V15, P1468, DOI 10.1101/gad.899601
   SCHUMACHERPERDREAU F, 1994, FEMS MICROBIOL LETT, V117, P71
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1
   Sun DQ, 2005, CLIN DIAGN LAB IMMUN, V12, P93, DOI 10.1128/CDLI.12.1.93-100.2005
   Surette MG, 1999, P NATL ACAD SCI USA, V96, P1639, DOI 10.1073/pnas.96.4.1639
   TIMMERMAN CP, 1991, INFECT IMMUN, V59, P4187
   TOJO M, 1988, J INFECT DIS, V157, P713, DOI 10.1093/infdis/157.4.713
   Tormo MA, 2005, J BACTERIOL, V187, P2348, DOI 10.1128/JB.187.7.2348-2356.2005
   Tormo MA, 2005, MICROBIOL-SGM, V151, P2465, DOI 10.1099/mic.0.27865-0
   Valle J, 2003, MOL MICROBIOL, V48, P1075, DOI 10.1046/j.1365-2958.2003.03493.x
   Veenstra GJC, 1996, J BACTERIOL, V178, P537, DOI 10.1128/jb.178.2.537-541.1996
   Vuong C, 2005, J BACTERIOL, V187, P2967, DOI 10.1128/JB.187.9.2967-2973.2005
   Vuong C, 2004, J BIOL CHEM, V279, P54881, DOI 10.1074/jbc.M411374200
   Vuong C, 2004, CELL MICROBIOL, V6, P753, DOI 10.1111/j.1462-5822.2004.00401.x
   Vuong C, 2004, CELL MICROBIOL, V6, P269, DOI 10.1111/j.1462-5822.2004.00367.x
   Vuong C, 2000, INFECT IMMUN, V68, P1048, DOI 10.1128/IAI.68.3.1048-1053.2000
   Vuong C, 2000, J INFECT DIS, V182, P1688, DOI 10.1086/317606
   Vuong C, 2004, J INFECT DIS, V190, P1498, DOI 10.1086/424487
   Vuong C, 2003, J INFECT DIS, V188, P706, DOI 10.1086/377239
   Weng ML, 2000, CURR MICROBIOL, V41, P56, DOI 10.1007/s002840010091
   WENG ML, 1995, P NATL ACAD SCI USA, V92, P7455, DOI 10.1073/pnas.92.16.7455
   Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4
   Williams RJ, 2002, INFECT IMMUN, V70, P6805, DOI 10.1128/IAI.70.12.6805-6810.2002
   Winans SC, 2002, J BACTERIOL, V184, P873, DOI 10.1128/jb.184.4.873-883.2002
   Wright JS, 2005, P NATL ACAD SCI USA, V102, P1691, DOI 10.1073/pnas.0407661102
   Xu L, 2006, INFECT IMMUN, V74, P488, DOI 10.1128/IAI.74.1.488-496.2006
   Yao YF, 2006, J INFECT DIS, V193, P841, DOI 10.1086/500246
   Zhang YQ, 2003, MOL MICROBIOL, V49, P1577, DOI 10.1046/j.1365-2958.2003.03671.x
   Zheng ZL, 2002, ANTIMICROB AGENTS CH, V46, P900, DOI 10.1128/AAC.46.3.900-903.2002
   Ziebuhr W, 1999, MOL MICROBIOL, V32, P345, DOI 10.1046/j.1365-2958.1999.01353.x
   Ziebuhr W, 1997, INFECT IMMUN, V65, P890
NR 142
TC 87
Z9 92
U1 2
U2 13
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1618-2642
EI 1618-2650
J9 ANAL BIOANAL CHEM
JI Anal. Bioanal. Chem.
PD JAN
PY 2007
VL 387
IS 2
BP 399
EP 408
DI 10.1007/s00216-006-0745-2
PG 10
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 124FX
UT WOS:000243354400005
PM 16955256
DA 2018-10-20
ER

PT J
AU Chaieb, K
   Chehab, O
   Zmantar, T
   Rouabhia, M
   Mahdouani, K
   Bakhrouf, A
AF Chaieb, Kamel
   Chehab, Olfa
   Zmantar, Tarek
   Rouabhia, Mahmoud
   Mahdouani, Kacem
   Bakhrouf, Amina
TI In vitro effect of pH and ethanol on biofilm formation by clinical
   ica-positive Staphylococcus epidermidis strains
SO ANNALS OF MICROBIOLOGY
LA English
DT Article
DE Staphylococcus epidermidis; biofilm; ica gene; Congo Red agar; pH;
   ethanol
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; POLYSACCHARIDE INTERCELLULAR ADHESIN;
   ENVIRONMENTAL-REGULATION; SLIME PRODUCTION; INFECTIONS; AUREUS;
   EXPRESSION; PREVENTION; CATHETERS; ADHERENCE
AB Biofilm production is an important step in the pathogenesis of Staphylococcus epidermidis associated biomaterial infections. Staphylococcus epidermidis strains isolated from dialysis fluid (n = 9) and needle cultures (n = 14) were phenotyped and genotyped for extracellular polysaccharide production and were examined for their ability to produce slime in a medium at various pH levels (3, 5, 7, 9 and 12) and with ethanol supplementation (0, 2, 5, 10 and 15%) using a semi-quantitative adherence assay. A total of 23 clinical icaADBC positive S. epidermidis, one reference strain (S. epidermidis CIP 106510) used as positive control, and one icaADBC negative strain (E21) were investigated. Qualitative biofilm production analysis revealed that 15 of the 23 icaADBC positive strains (65.21%) produced slime on Congo Red agar plates. Quantitative biofilm was determined by measuring the optical density at 570 nm (OD(570)). The results show that the slime production depended on the pH value of the medium and the ethanol concentration. At highly acidic (pH 3) and alkaline (pH 12) levels, the OD(570) was lower, while at pH 7 the adhesion was moderate, In addition the cells adhered strongly with 2% ethanol than with the other concentrations. Our results suggest that pH and ethanol were stress factors that led to S. epidermidis biofilm formation and also play a possible role in the pathogenesis of biomaterial-related infections.
C1 Fac Pharm, Lab Anal Traitement & Valorisat Polluants Environ, Monastir, Tunisia.
   Univ Laval, Grp Rech Ecol Buccale, Fac Med Dentaire, Quebec City, PQ, Canada.
RP Chaieb, K (reprint author), Fac Pharm, Lab Anal Traitement & Valorisat Polluants Environ, Monastir, Tunisia.
EM chaieb_mo@yahoo.fr
CR Arciola CR, 2002, BIOMATERIALS, V23, P4233, DOI 10.1016/S0142-9612(02)00171-0
   BAYER ME, 1990, J GEN MICROBIOL, V136, P867, DOI 10.1099/00221287-136-5-867
   Cerca N, 2005, RES MICROBIOL, V156, P506, DOI 10.1016/j.resmic.2005.01.007
   CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996
   Conlon KM, 2002, J BACTERIOL, V184, P4400, DOI 10.1128/JB.184.16.4400-4408.2002
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   DOYLE R, 2000, MICROB INFECT, V2, P39
   ELLIOTT TSJ, 1994, J HOSP INFECT, V28, P163, DOI 10.1016/0195-6701(94)90100-7
   Fitzpatrick F, 2002, J HOSP INFECT, V52, P212, DOI 10.1053/jhin.2002.1309
   FREEMAN DJ, 1989, J CLIN PATHOL, V42, P872, DOI 10.1136/jcp.42.8.872
   Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x
   Knobloch JKM, 2001, J BACTERIOL, V183, P2624, DOI 10.1128/JB.183.8.2624-2633.2001
   Lawrence EL, 2005, MED ENG PHYS, V27, P443, DOI 10.1016/j.medengphy.2004.12.013
   Mack D, 2001, METHOD ENZYMOL, V336, P215, DOI 10.1016/S0076-6879(01)36592-8
   Mack D, 2000, INFECT IMMUN, V68, P3799, DOI 10.1128/IAI.68.7.3799-3807.2000
   McKenney D, 1999, SCIENCE, V284, P1523, DOI 10.1126/science.284.5419.1523
   MEINDERS JM, 1994, J COLLOID INTERF SCI, V164, P355, DOI 10.1006/jcis.1994.1177
   Mempel M, 1998, J INVEST DERMATOL, V111, P452, DOI 10.1046/j.1523-1747.1998.00293.x
   Mermel LA, 2000, ANN INTERN MED, V132, P391, DOI 10.7326/0003-4819-132-5-200003070-00009
   PATRICK CC, 1992, INFECT IMMUN, V60, P1363
   Pearson ML, 1996, INFECT CONT HOSP EP, V17, P438
   PETERS G, 1982, J INFECT DIS, V146, P479, DOI 10.1093/infdis/146.4.479
   Rachid S, 2000, ADV EXP MED BIOL, V485, P159
   Rachid S, 2000, ANTIMICROB AGENTS CH, V44, P3357, DOI 10.1128/AAC.44.12.3357-3363.2000
   RUPP ME, 1994, CLIN INFECT DIS, V19, P231, DOI 10.1093/clinids/19.2.231
   Shapiro JA, 1998, ANNU REV MICROBIOL, V52, P81, DOI 10.1146/annurev.micro.52.1.81
   Vasudevan P, 2003, VET MICROBIOL, V92, P179, DOI 10.1016/S0378-1135(02)00360-7
   von Eiff C, 1999, EUR J CLIN MICROBIOL, V18, P843, DOI 10.1007/s100960050417
   White A., 1978, PRINCIPLES BIOCH, P196
   Zmantar T, 2006, ANN MICROBIOL, V56, P349, DOI 10.1007/BF03175030
NR 30
TC 20
Z9 21
U1 1
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1590-4261
J9 ANN MICROBIOL
JI Ann. Microbiol.
PY 2007
VL 57
IS 3
BP 431
EP 437
DI 10.1007/BF03175085
PG 7
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA 222TK
UT WOS:000250319900022
DA 2018-10-20
ER

PT J
AU Donzelli, E
   Salvade, A
   Mimo, P
   Vigano, M
   Morrone, M
   Papagna, R
   Carini, F
   Zaopo, A
   Miloso, M
   Baldoni, M
   Tredici, G
AF Donzelli, E.
   Salvade, A.
   Mimo, P.
   Vigano, M.
   Morrone, M.
   Papagna, R.
   Carini, F.
   Zaopo, A.
   Miloso, M.
   Baldoni, M.
   Tredici, G.
TI Mesenchymal stem cells cultured on a collagen scaffold: In vitro
   osteogenic differentiation
SO ARCHIVES OF ORAL BIOLOGY
LA English
DT Article
DE mesenchymal stem cells; osteogenic differentiation; collagen scaffold;
   periodontal disease
ID BONE-MARROW; STROMAL CELLS; TISSUE REGENERATION; INVITRO; BIOLOGY;
   MINERALIZATION; CARTILAGE; REPAIR; GRAFT
AB Objective: Management of periodontal defects has always been a challenge in clinical periodontics. Recently mesenchymal stem cells (MSC) have been proposed for tissue regeneration in periodontal disease and repair of large bone defects. Bone regeneration has to be supported by a scaffold which has to be biocompatible, biodegradable, and able to support cell growth and differentiation. The aim of this study was to evaluate osteogenic differentiation of MSC seeded on a Collagen scaffold.
   Design: MSC were obtained from adult rat bone marrow, expanded and cultured in plastic dishes or seeded in a collagen scaffold (Gingistat (R)). MSC were induced towards osteogenic differentiation using osteogenic supplements. Cell differentiation and calcium deposits were evaluated by immunoblotting, immunohistochemistry, histochemical techniques, enzymatic activity assay, and SEM-EDX analysis. Biomaterial in vitro degradation was evaluated by measuring mass reduction after incubation in culture medium.
   Results: Rat MSC osteogenic differentiation was demonstrated by osteopontin and osteocalcin expression and an increase in alkaline phosphatase activity. MSC were distributed homogeneously in the Collagen scaffold. Nodular aggregates and alizarin red stained calcium deposits were observed in MSC induced towards osteogenic differentiation cultured in dishes or seeded in the collagen scaffold. SEM-EDX analysis demonstrated that calcium co-localized with phosphorous. The biomaterial in vitro degraded in 4-5 weeks.
   Conclusions: MSC from bone marrow differentiate towards osteogenic lineage, representing a suitable cell source for bone formation in periodontal regeneration. Gingistat (R) collagen scaffold supports MSC distribution and differentiation, but its short degradation time may be a limitation for a future application in bone tissue regeneration. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Milan, Dipartimento Neurosci & Tecnol Biomed, I-20052 Monza, MI, Italy.
   CORIMAV, I-20126 Milan, Italy.
   Pirelli Labs SpA, I-20126 Milan, Italy.
   Osped San Gerardo, Clin Odontoiatr, Monza, Italy.
RP Donzelli, E (reprint author), Univ Milan, Dipartimento Neurosci & Tecnol Biomed, Via Cadore 48, I-20052 Monza, MI, Italy.
EM elisabetta.donzelli@unimib.it
RI Donzelli, Elisabetta/J-6837-2015
CR AUBIN JE, 1995, BONE, V17, pS77, DOI 10.1016/8756-3282(95)00183-E
   Bartold PM, 2000, PERIODONTOL 2000, V24, P253, DOI 10.1034/j.1600-0757.2000.2240113.x
   BERESFORD JN, 1992, J CELL SCI, V102, P341
   Betz RR, 2002, ORTHOPEDICS, V25, P561
   Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180
   Brekke JH, 1998, J BIOMED MATER RES, V43, P380, DOI 10.1002/(SICI)1097-4636(199824)43:4<380::AID-JBM6>3.0.CO;2-D
   BUTLER WT, 1989, CONNECT TISSUE RES, V23, P123, DOI 10.3109/03008208909002412
   Donzelli E, 2004, J NEURO-ONCOL, V67, P65, DOI 10.1023/B:NEON.0000021787.70029.ce
   DRAGOO MR, 1973, J PERIODONTOL, V44, P599, DOI 10.1902/jop.1973.44.10.599
   ELAMIN SF, 2003, BIOMATERIALS, V4, P1213
   Fibbe WE, 2002, ANN RHEUM DIS, V61, P29
   FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001
   Garrett S, 1996, Ann Periodontol, V1, P621, DOI 10.1902/annals.1996.1.1.621
   Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Kawaguchi H, 2004, J PERIODONTOL, V75, P1281, DOI 10.1902/jop.2004.75.9.1281
   KENLEY RA, 1993, PHARMACEUT RES, V10, P1393, DOI 10.1023/A:1018902720816
   Khan SN, 2005, J AM ACAD ORTHOP SUR, V13, P77, DOI 10.5435/00124635-200501000-00010
   Kim H, 2003, BIOMATERIALS, V24, P4671, DOI 10.1016/S0142-9612(03)00358-2
   Kotobuki N, 2004, ARTIF ORGANS, V28, P33, DOI 10.1111/j.1525-1594.2004.07320.x
   Laurell L, 1998, J PERIODONTOL, V69, P303, DOI 10.1902/jop.1998.69.3.303
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Long MW, 2001, BLOOD CELL MOL DIS, V27, P677, DOI 10.1006/bcmd.2001.0431
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   Marie P, 2000, JOINT BONE SPINE, V67, P150
   Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4
   Minguell JJ, 2001, EXP BIOL MED, V226, P507
   Mizutani K, 1998, BIOCHEM BIOPH RES CO, V253, P859, DOI 10.1006/bbrc.1998.9870
   MOSKOW BS, 1979, J PERIODONTOL, V50, P291, DOI 10.1902/jop.1979.50.6.291
   Otto WR, 2004, CELL PROLIFERAT, V37, P97, DOI 10.1111/j.1365-2184.2004.00303.x
   OWEN ME, 1987, J CELL SCI, V87, P731
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71
   Radice M, 2000, J BIOMED MATER RES, V50, P101, DOI 10.1002/(SICI)1097-4636(200005)50:2<101::AID-JBM2>3.0.CO;2-M
   Reynolds Mark A, 2003, Ann Periodontol, V8, P227, DOI 10.1902/annals.2003.8.1.227
   SCHALLHORN RG, 1972, J PERIODONTOL, V43, P3, DOI 10.1902/jop.1972.43.1.03
   Seiler J G 3rd, 2000, J South Orthop Assoc, V9, P91
   Sugawara Y, 2002, JPN J PHARMACOL, V88, P262, DOI 10.1254/jjp.88.262
   Yamada Y, 2003, J CRANIO MAXILL SURG, V31, P27, DOI 10.1016/S1010-5182
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
NR 42
TC 113
Z9 124
U1 2
U2 21
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0003-9969
J9 ARCH ORAL BIOL
JI Arch. Oral Biol.
PD JAN
PY 2007
VL 52
IS 1
BP 64
EP 73
DI 10.1016/j.archoralbio.2006.07.007
PG 10
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 125RT
UT WOS:000243460800010
PM 17049335
DA 2018-10-20
ER

PT S
AU Miao, JC
   Sheng, WH
   Li, MZ
   Xie, YF
   Gong, AH
   Yang, JC
AF Miao, Jing-cheng
   Sheng, Wei-hua
   Li, Ming-zhong
   Xie, Yu-feng
   Gong, Ai-hua
   Yang, Ji-cheng
BE Kim, YH
   Cho, CS
   Kang, IK
   Kim, SY
   Kwon, OH
TI Genotoxic potential of regenerated silk fibroin films by different
   cross-linking mode
SO ASBM7: ADVANCED BIOMATERIALS VII
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 7th Asian Symposium on Biomedical Materials (ASBM7)
CY AUG 20-23, 2006
CL Cheju Isl, SOUTH KOREA
DE regenerated silk fibroin films (RSFFs); Micronucleus; Comet assay
ID CELLS; ASSAY
AB Emerging studies have showed that silk fibroin might be as a naturally occurring degradable biomaterial for tissue engineering with unique mechanical properties, biocompatib ility and processability. To optimize the formation of the regenerated silk fibroin film, in thi s study. we examined the genotoxic potential of the regenerated silk fibroin films by differe nt cross-linking mode with micronucleus and the single cell gel electrophoresis (comet) assay. The data showed that MNF in group PC and group SD showed significantly no difference with blank group (P > 0.05), and no evident comet tails were observed. However, the result of EC group was significantly different frorn the control group(P < 0.01). Taken together, R SFFs in group PC and group SD have no evident genotoxicity, which is better than group EC.
C1 [Miao, Jing-cheng; Sheng, Wei-hua; Li, Ming-zhong; Xie, Yu-feng; Yang, Ji-cheng] Suzhou Univ, Suzhou 215006, Peoples R China.
   [Gong, Ai-hua] Jiangsu Univ, Zhenjiang, Peoples R China.
RP Yang, JC (reprint author), Suzhou Univ, Suzhou 215006, Peoples R China.
EM mjc@suda.edu.cn; shengweihua@163.com; mzli@suda.edu.cn;
   jcyang@suda.edu.cn
CR Chen X, 1997, J APPL POLYM SCI, V65, P2257, DOI 10.1002/(SICI)1097-4628(19970912)65:11<2257::AID-APP23>3.0.CO;2-Z
   COSTA LG, 1995, TOXICOLOGY, V98, P151, DOI 10.1016/0300-483X(94)02986-5
   FREDDI G, 1995, J APPL POLYM SCI, V56, P1537, DOI 10.1002/app.1995.070561203
   Gregory H., 2003, BIOMATERIALS, V24, P401
   Li MZ, 2003, INT J BIOL MACROMOL, V32, P159, DOI 10.1016/S0141-8130(03)00049-7
   Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   WANG YZ, 2006, BIOMATERIALS, V4, P1
   Wolz L, 2002, ATLA-ALTERN LAB ANIM, V30, P331
NR 9
TC 7
Z9 8
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
BN 978-0-87849-436-1
J9 KEY ENG MATER
PY 2007
VL 342-343
BP 257
EP +
DI 10.4028/www.scientific.net/KEM.342-343.257
PG 2
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BGG39
UT WOS:000246657900065
DA 2018-10-20
ER

PT S
AU Kikuchi, M
   Tanaka, J
AF Kikuchi, Masanori
   Tanaka, Junzo
BE Kim, YH
   Cho, CS
   Kang, IK
   Kim, SY
   Kwon, OH
TI Bone regeneration materials
SO ASBM7: ADVANCED BIOMATERIALS VII
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 7th Asian Symposium on Biomedical Materials (ASBM7)
CY AUG 20-23, 2006
CL Cheju Isl, SOUTH KOREA
DE tricalcium phosphate; biodegradable polymer; guided bone regeneration;
   hydroxyapatite; collagen; nanocomposite; bone remodeling process
ID L-LACTIDE COMPOSITES; SELF-ORGANIZATION MECHANISM;
   HYDROXYAPATITE/COLLAGEN COMPOSITE; IN-VITRO; NANOCOMPOSITES;
   BIOMATERIAL; PHOSPHATE
AB Biomaterials Center is composed of five groups and collaborate each other to examine interdisciplinary fields of biomaterials. In the ceramics-based biomaterials research, we have been developing three novel bone regeneration materials, i.e., high-porosity hydroxyapatite (HAp) ceramics with high-strength, guided bone regeneration (GBR) membranes and bone-like nanocomposite composed of HAp and collagen. The GBR membrane composed of beta-tricalcium phosphate and biodegradable copolymer of lactide, glycolide and epsilon-caprolactone has thermoplastic, pH auto-adjustment and enough mechanical property to protect an invasion of surrounding tissues. With the membrane, bone defect up to 20 x 10 x 10 mm(3) in length in mandibles and segmental bone defect Lip to 20 mm in length in tibiae of beagles are regenerated without any additional bone fillers or cell transplantations. The bone-like nanocomposite is synthesized by a co-precipitation of HAp and collagen via their self-organization. The dense composite has a half to quarter mechanical strength (40 MPa) to cortical bone and the porous one demonstrates sponge-like viscoelasticity. The composites implanted into bone are incorporated into bone remode ing metabolism like as autogenous bone graft, i.e., they are resorbed by osteolasts followed by osteogenesis by osteoblasts.
C1 [Kikuchi, Masanori] Natl Inst Mat Sci, Ctr Biomat, Tsukuba, Ibaraki 305004, Japan.
   [Tanaka, Junzo] Tokyo Inst Technol, Dept Met & Ceram Sci, Meguro Ku, Tokyo 152, Japan.
RP Kikuchi, M (reprint author), Natl Inst Mat Sci, Ctr Biomat, Tsukuba, Ibaraki 305004, Japan.
EM KIKUCHI.Masanori@nims.go.jp; Junzo.Tanaka@ceram.titech.ac.jp
RI Kikuchi, Masanori/B-5993-2008
OI Kikuchi, Masanori/0000-0002-9451-8147
FU Research Promotion Bureau; Ministry of Education, Culture, Sports,
   Science and Technology, Japan [17-83]
FX The authors are very grateful to Prof Kenichi Shinomiya, Assoc. Prof.
   Soichiro Itoh, Drs. Yoshinori Asou and Shinichi Sotome of Department of
   Orthopedic Surgery and Prof. Kazuo Takakuda, Drs. Yoshihisa Koyama and
   Hiroko N. Matsumoto of Institute of Biomaterials and Bioengineering,
   Tokyo Medical and Dental University, and Prof. Shigeo Tanaka, Drs.
   Katsuyoshi Nagaoka and Takeki Yamada of College of Bioresource Sciences,
   Nihon University for valuable suggestion and help for biological and
   clinical evaluations. The study is supported in part by Research
   Promotion Bureau, Ministry of Education, Culture, Sports, Science and
   Technology, Japan under the contract No.17-83.
CR Itoh S, 2001, J BIOMED MATER RES, V54, P445, DOI 10.1002/1097-4636(20010305)54:3<445::AID-JBM190>3.0.CO;2-9
   Itoh S, 2004, CELL TRANSPLANT, V13, P451, DOI 10.3727/000000004783983774
   Itoh S, 2002, J BIOMED MATER RES, V63, P507, DOI 10.1002/jbm.10305
   Itoh S, 2002, BIOMATERIALS, V23, P3919, DOI 10.1016/S0142-9612(02)00126-6
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   Kikuchi M, 1999, J BIOMED MATER RES, V48, P108, DOI 10.1002/(SICI)1097-4636(1999)48:2<108::AID-JBM2>3.3.CO;2-6
   Kikuchi M, 2000, J CERAM SOC JPN, V108, P642, DOI 10.2109/jcersj.108.1259_642
   Kikuchi M, 2004, BIOMATERIALS, V25, P5979, DOI 10.1016/j.biomaterials.2004.02.001
   Kikuchi M, 2004, COMPOS SCI TECHNOL, V64, P819, DOI 10.1016/j.compscitech.2003.09.002
   Kikuchi M, 2003, KEY ENG MAT, V240-2, P567, DOI 10.4028/www.scientific.net/KEM.240-242.567
   Kikuchi M, 2004, BIOMATERIALS, V25, P63, DOI 10.1016/S0142-9612(03)00472-1
   Kikuchi M, 2002, J BIOMED MATER RES, V62, P265, DOI 10.1002/jbm.10248
   Kikuchi M, 1997, J MATER SCI-MATER M, V8, P361, DOI 10.1023/A:1018580816388
   Kikuchi M, 2004, KEY ENG MAT, V254-2, P561, DOI 10.4028/www.scientific.net/KEM.254-256.561
   Koyama Y, 2003, JSME INT J C-MECH SY, V46, P1409, DOI 10.1299/jsmec.46.1409
NR 15
TC 2
Z9 2
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
BN 978-0-87849-436-1
J9 KEY ENG MATER
PY 2007
VL 342-343
BP 277
EP +
DI 10.4028/www.scientific.net/KEM.342-343.277
PG 2
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BGG39
UT WOS:000246657900070
DA 2018-10-20
ER

PT S
AU Cho, WJ
   Kim, JH
   Oh, SH
   Lee, JH
AF Cho, Wan Jin
   Kim, Jun Ho
   Oh, Se Heang
   Lee, Jin Ho
BE Kim, YH
   Cho, CS
   Kang, IK
   Kim, SY
   Kwon, OH
TI Characterization of hydrophilized PCL electrospun sheet as an effective
   guided bone regeneration membrane
SO ASBM7: ADVANCED BIOMATERIALS VII
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 7th Asian Symposium on Biomedical Materials (ASBM7)
CY AUG 20-23, 2006
CL Cheju Isl, SOUTH KOREA
DE guide bone regeneration membrane; nano-fiber; electrospun;
   polycaprolactone; tween 80; selective permeability
AB Electrospinning is a fabrication process that can produce highly porous nano-scale fiber-based matrices using an electrostatically driven jet of polymer solution. This method represents an attractive approach for polymeric biomaterial processing which provides the membrane structure that may retain mechanical strengths, flexibility, and high surface area. In this study, we prepared a guided bone regeneration (GBR) membrane with selective permeability, hydrophilicity, good mechanical strength and adhesiveness with bone using polycaprolactone (PCL) and Tween 80 by the electrospinning method. The prepared PCL and PCL/Tween 80 electrospun sheets were characterized via morphology observation, mechanical property, water absorbability, and model nutrient permeability. It was observed that the PCL/Tween 80 (3 wt%) electrospun sheet have an effective permeation of nutrients as well as the good mechanical strength to maintain a secluded space for the bone regeneration. From the results, the hydrophilized PCL/Tween 80 (3 wt%) electrospun sheet seem to be a good candidate as a GBR membrane.
C1 [Cho, Wan Jin; Kim, Jun Ho; Oh, Se Heang; Lee, Jin Ho] Hannam Univ, Dept Adv Mat, Taejon 306791, South Korea.
RP Cho, WJ (reprint author), Hannam Univ, Dept Adv Mat, Taejon 306791, South Korea.
EM wjcho@hannam.ac.kr; junho1012@hanmail.net; shoh@hanam.ac.kr;
   jhlee@hannam.ac.kr
FU Korea Research Foundation [KRF-2004-202-D00768]
FX This work was supported by a grant from the Korea Research Foundation
   (Grant No. KRF-2004-202-D00768).
CR Anton F., 1934, U.S. Patent, Patent No. [1,975,504, 1975504]
   ASTM - American Society for Testing and Materials, 1996, ANN BOOK ASTM STAND
   BAUMGARTEN PK, 1971, J COLLOID INTERF SCI, V36, P71, DOI 10.1016/0021-9797(71)90241-4
   Fujihara K, 2005, BIOMATERIALS, V26, P4139, DOI 10.1016/j.biomaterials.2004.09.014
   Hillmann G, 2002, BIOMATERIALS, V23, P1461, DOI 10.1016/S0142-9612(01)00270-8
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Imbronito AV, 2002, BIOMATERIALS, V23, P4079, DOI 10.1016/S0142-9612(02)00145-X
   LARRONDO L, 1981, J POLYM SCI POL PHYS, V19, P909, DOI 10.1002/pol.1981.180190601
   Maeda H, 2006, BIOMATERIALS, V27, P1216, DOI 10.1016/j.biomaterials.2005.08.010
   Piattelli A, 1996, BIOMATERIALS, V17, P1725, DOI 10.1016/0142-9612(96)87653-8
   Tan SH, 2005, POLYMER, V46, P6128, DOI 10.1016/j.polymer.2005.05.068
NR 11
TC 5
Z9 5
U1 0
U2 7
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
BN 978-0-87849-436-1
J9 KEY ENG MATER
PY 2007
VL 342-343
BP 293
EP +
DI 10.4028/www.scientific.net/KEM.342-343.293
PG 2
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BGG39
UT WOS:000246657900074
DA 2018-10-20
ER

PT S
AU Lee, HJ
   Park, KH
   Park, SR
   Min, BH
AF Lee, Hyun Jung
   Park, Keun-Hong
   Park, So Ra
   Min, Byoung-Hyun
BE Kim, YH
   Cho, CS
   Kang, IK
   Kim, SY
   Kwon, OH
TI Chitosan/Heparin polyelectrolyte complex nanoparticles (100 similar to
   200nm) covalently bonded with PEI for enhancement of chondrogenic
   phenotype
SO ASBM7: ADVANCED BIOMATERIALS VII
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 7th Asian Symposium on Biomedical Materials (ASBM7)
CY AUG 20-23, 2006
CL Cheju Isl, SOUTH KOREA
DE polyethyleni mine (PEI); chitosan; heparin; nanoparticle culture system
ID HEPARIN
AB Acknowledging the supportive influence of matrix molecules on the chondrocytic phenotype, we combined heparin and chitosan to develop a novel biomaterial, supporting chondrogenesis. Chitosan had been shown as a promising structural material for a number of tissue engineering applications. Similar to heparin, one of the glycosamino-glycans (GAGs) had been known to exert various influences on the biological activities. In this study we evaluated the potential of heparin/chitosan polyelectrolyle complex materials for controlling the proliferation and differentiation of chondrocytes. The heparin/chitosan polyelectrolyte complex was coated over the polyethyleneimine (PEI) layer precoated on the commercial polystyrene dish. When examined by using human chondrocyte cell line (C28/12), the heparin/chitosan surfaces supported well not only the cell proliferation but also the chondrocytic functions, such as expression of collagen type II. These results indicated that the heparin/chitosan complex could be used to modulate the activity of chondrocytes in vitro.
C1 [Lee, Hyun Jung; Min, Byoung-Hyun] Ajou Univ, Dept Mol Sci & Technol, San 5, Wonchon 442749, South Korea.
   [Park, Keun-Hong] Pochon CHA Univ, Coll Med, Cell & Gene Therapy Res Inst, Seoul 135081, South Korea.
   [Park, So Ra] Inha Univ, Coll Med, Dept Physiol, Incheon 440712, South Korea.
   [Min, Byoung-Hyun] Ajou Univ, Dept Orthopaed, Suwon 442749, South Korea.
RP Lee, HJ (reprint author), Ajou Univ, Dept Mol Sci & Technol, San 5, Wonchon 442749, South Korea.
EM queenjung@ajou.ac.kr; phd0410@hanmail.net; srpark@inha.ac.kr;
   bhmin@ajou.ac.kr
FU Ministry of Health & Welfare, Republic of Korea [02-PJ10-PG8-EC01-0022]
FX This work was supported by a grant of the Korea Health 21 R&D Project,
   Ministry of Health & Welfare, Republic of Korea (02-PJ10-PG8-EC01-0022).
CR Lin WC, 2004, BIOMATERIALS, V25, P1947, DOI 10.1016/j.biomaterials.2003.08.027
   ROSA MD, 2004, J CELL PHYSL, V198, P133
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Wang XH, 2003, INT J BIOL MACROMOL, V33, P95, DOI 10.1016/S0141-8130(03)00072-2
NR 4
TC 3
Z9 3
U1 1
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
BN 978-0-87849-436-1
J9 KEY ENG MATER
PY 2007
VL 342-343
BP 329
EP +
DI 10.4028/www.scientific.net/KEM.342-343.329
PG 2
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BGG39
UT WOS:000246657900083
DA 2018-10-20
ER

PT S
AU Kim, SH
   Choi, B
   Ko, YK
   Ha, HJ
   Yoon, SJ
   Rhee, JM
   Kim, MS
   Lee, HB
   Khang, G
AF Kim, Soon Hee
   Choi, BangSil
   Ko, Youn Kyung
   Ha, Hyun Jung
   Yoon, Sun Jung
   Rhee, John M.
   Kim, Moon Suk
   Lee, Hai Bang
   Khang, Gilson
BE Kim, YH
   Cho, CS
   Kang, IK
   Kim, SY
   Kwon, OH
TI The characterization of PLGA/small intestinal submucosa composites as
   scaffolds for intervertebral disc
SO ASBM7: ADVANCED BIOMATERIALS VII
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 7th Asian Symposium on Biomedical Materials (ASBM7)
CY AUG 20-23, 2006
CL Cheju Isl, SOUTH KOREA
DE PLGA; small intestinal submucosa; pore size; MTT assay; FTIR
ID STEM-CELL; SPONGE; RAT
AB In order to application for the tissue engineered intervertebral disc (IVD), we designed the synthetic/natural hybrid scaffolds with poly(lactide-co-glycolide) (PLGA) and small intestine submucosa (SIS). SIS has been widely used as a biomaterial because :;IS consists of various collagens and cytokines. SIS, however, possesses disadvantages such as their weak mechanical properties and uncontrolled degradation. Novel composite scaffolds of PLGA/SIS were manufactured by simple immersion method of PLGA scaffolds in SIS solution under vacuum. Then SIS was crosslinked. Also, PLGA scaffolds and SIS sponges were minufactured by solvent casting/salt leaching and freeze-dried methods, respectively. We evaluated pore structure, porosity, water absorption ability and cell viability of three types of scaffolds for the application of IVD.
C1 Chonnam Natl Univ, BK 21 Polymer BIN Fus Res Team, Jeonju 561756, South Korea.
   [Kim, Moon Suk; Lee, Hai Bang] Korea Res Inst Chem Technol, Nanobiomat Lab, Taejon 305606, South Korea.
RP Kim, SH (reprint author), Chonnam Natl Univ, BK 21 Polymer BIN Fus Res Team, Jeonju 561756, South Korea.
EM aofurwjr@hanmail.net; apriltime@hanmail.net; youn2129@nate.com;
   greenmail77@hanmail.net; timmons@hanmail.net; limrhee@chonbuk.ac.kr;
   gmskim@krict.re.kr; hblee@krict.re.kr; gskhang@chonbuk.ac.kr
OI Yoon, Sun-Jung/0000-0003-3487-6863
FU KMOHW [0405-BO01-0204-0006]; SCRC [SC3100]
FX This work was supported by KMOHW (0405-BO01-0204-0006) and SCRC
   (SC3100).
CR Chen GP, 2006, MAT SCI ENG C-BIO S, V26, P118, DOI 10.1016/j.msec.2005.07.024
   Crevensten G, 2004, ANN BIOMED ENG, V32, P430, DOI 10.1023/B:ABME.0000017545.84833.7c
   KHANG G, 2004, TISSUE ENG REGEN MED, V1, P9
   Kim MS, 2005, INT J BIOL MACROMOL, V36, P54, DOI 10.1016/j/ijbiomac.2005.03.013
   Kim SH, 2006, POLYM-KOREA, V30, P14
   KIM SH, 2006, IN PRESS ADV EXP BIO
   Shin HW, 2004, POLYM-KOREA, V28, P194
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
NR 8
TC 7
Z9 7
U1 1
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
BN 978-0-87849-436-1
J9 KEY ENG MATER
PY 2007
VL 342-343
BP 389
EP +
DI 10.4028/www.scientific.net/KEM.342-343.389
PG 2
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BGG39
UT WOS:000246657900098
DA 2018-10-20
ER

PT S
AU Kim, SK
   Lee, JS
   Chae, GJ
   Jung, UW
   Lee, YK
   Kim, CK
   Choi, SH
AF Kim, Sung-Koo
   Lee, Jung-Seok
   Chae, Gyung-Joon
   Jung, Ui-Won
   Lee, Yong-Keun
   Kim, Chong-Kwan
   Choi, Seong-Ho
BE Kim, YH
   Cho, CS
   Kang, IK
   Kim, SY
   Kwon, OH
TI The effects of calcium phosphate-chitosan block bone graft on the
   periodontal regeneration in one wall intrabony defects in beagle dogs
SO ASBM7: ADVANCED BIOMATERIALS VII
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 7th Asian Symposium on Biomedical Materials (ASBM7)
CY AUG 20-23, 2006
CL Cheju Isl, SOUTH KOREA
DE periodontal regeneration; bone graft material; chitosan; intrabony
   defect
AB This study evaluated periodontal repair and biomaterial reaction following implantation of a newly fabricated calcium phosphate chitosan block bone and chitosan membrane on the regeneration of 1- wall intrabony defects in the beagle dogs. The surgical control group received a flap operation only, while experimental group was treated with calcium phosphate chitosan block bone and/or chitosan membrane. All dogs were uneventful healing without any complication. The subjects were sacrificed 8 weeks after the experimental Surgery, and a comparative histological and histometric examination was done. Chitosan membrane group significantly enhanced bone regeneration compared to control, CaP-chitosan block bone and combination group. Chitosan membrane remnants were observed in chitosan and combination group, while CaP-chitosan bone materials were resorbed completely. These results suggest that Chitosan membrane significantly enhanced bone and cementum formation in advanced periodontal defects.
C1 [Kim, Sung-Koo; Lee, Jung-Seok; Chae, Gyung-Joon; Jung, Ui-Won; Kim, Chong-Kwan; Choi, Seong-Ho] Yonsei Univ, Coll Dent, Res Inst Periodontal Regenerat, Dept Periodontol, Seoul 120749, South Korea.
   [Lee, Yong-Keun] Yonsei Univ, Dent Biomat & Bioengn, Dept & Res Inst, Seoul, South Korea.
RP Kim, SK (reprint author), Yonsei Univ, Coll Dent, Res Inst Periodontal Regenerat, Dept Periodontol, Seoul 120749, South Korea.
EM akskdent@hanmail.net; shchoi726@yumc.yonsei.ac.kr
OI Jung, Ui-Won/0000-0001-6371-4172; Lee, Jung-Seok/0000-0003-1276-5978
FU Ministry of Health & Welfare, Republic of Korea [03-PJI-PG1-CH08-001]
FX This study was supported by a grant from the Korean Health 21 R&D
   Project, Ministry of Health & Welfare, Republic of Korea
   (03-PJI-PG1-CH08-001)
CR MUZZARELLI R, 1988, BIOMATERIALS, V14, P39
   Park JS, 2003, J CLIN PERIODONTOL, V30, P443, DOI 10.1034/j.1600-051X.2003.10283.x
   Shin SY, 2005, J PERIODONTOL, V76, P1778, DOI 10.1902/jop.2005.76.10.1778
   ULF ME, 1991, J CLIN PERIODONTOL, V18, P49
   YEO YJ, 1997, J BIOMED MATER RES B, V72, P86
NR 5
TC 0
Z9 0
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
BN 978-0-87849-436-1
J9 KEY ENG MATER
PY 2007
VL 342-343
BP 393
EP +
DI 10.4028/www.scientific.net/KEM.342-343.393
PG 2
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BGG39
UT WOS:000246657900099
DA 2018-10-20
ER

PT S
AU Yu, QF
   Li, ZS
   Yang, BC
   Huang, Y
   Gan, L
   Qu, Y
   Zhang, XD
AF Yu, Q. F.
   Li, Z. S.
   Yang, B. C.
   Huang, Y.
   Gan, L.
   Qu, Y.
   Zhang, X. D.
BE Kim, YH
   Cho, CS
   Kang, IK
   Kim, SY
   Kwon, OH
TI A study on the effect of grain size on the bioactivity of nano-titania
   ceramics
SO ASBM7: ADVANCED BIOMATERIALS VII
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 7th Asian Symposium on Biomedical Materials (ASBM7)
CY AUG 20-23, 2006
CL Cheju Isl, SOUTH KOREA
DE nano-titania; bioactivity; hydroxyapatite; grain growth inhibitor; grain
   size
ID NANOPHASE CERAMICS
AB Nano-titania cerarnics is a potential biomaterial for orthopaedic application. In our previous studies, a bioactive nano-titania ceramics was prepared by using alkali-heat treatment. In this paper, hydroxyapatite was used as a grain growth inhibitor additive to get nano-titania ceramics with different grain size, and the effect of grain size on the bioactivity was studied in vitro.
C1 [Yu, Q. F.; Li, Z. S.; Yang, B. C.; Huang, Y.; Gan, L.; Qu, Y.; Zhang, X. D.] Sichuan Univ, Engn Res Ctr Biomat, Chengdu 610064, Peoples R China.
RP Yang, BC (reprint author), Sichuan Univ, Engn Res Ctr Biomat, Chengdu 610064, Peoples R China.
EM qfyu@microportmedical.com; li.zhensheng@163.com; yangbchengc@126.com;
   huangyi516@yahoo.com; lala1982@sohu.com; quyang1072002@163.com;
   zhangxd@scu.edu.cn
RI Huang, Yi/F-9592-2011
FU Sichuan University, P. R. China.
FX The SEM photographs are supported by Analytical & Testing Center,
   Sichuan University, P. R. China.
CR BRUNSKI JB, 1991, BONE-BIOMATERIAL INTERFACE, P391
   Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.3.CO;2-G
   HOLLINGER JO, 1996, CLIN ORTHOP RELAT R, V324, P55
   NAKAMURA T, 1991, KEY ENG MATER, V9, P31
   NEGAMI S, 1988, Journal of the Japanese Orthopaedic Association, V62, P85
   Nonami T, 1998, MATER RES BULL, V33, P125, DOI 10.1016/S0025-5408(97)00197-9
   PIECUCH JF, 1982, J DENT RES, V61, P1458, DOI 10.1177/00220345820610121801
   UEYAMA Y, 1998, KEY ENG MATER, V11, P567
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Yang BC, 2006, KEY ENG MAT, V309-311, P411, DOI 10.4028/www.scientific.net/KEM.309-311.411
NR 11
TC 0
Z9 0
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
BN 978-0-87849-436-1
J9 KEY ENG MATER
PY 2007
VL 342-343
BP 565
EP +
DI 10.4028/www.scientific.net/KEM.342-343.565
PG 2
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BGG39
UT WOS:000246657900142
DA 2018-10-20
ER

PT S
AU Ren, YB
   Wang, H
   Huang, JJ
   Zhang, BC
   Yang, K
AF Ren, Yibin
   Wang, Hao
   Huang, Jingjing
   Zhang, Bingchun
   Yang, Ke
BE Kim, YH
   Cho, CS
   Kang, IK
   Kim, SY
   Kwon, OH
TI Study of biodegradation of pure magnesium
SO ASBM7: ADVANCED BIOMATERIALS VII
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 7th Asian Symposium on Biomedical Materials (ASBM7)
CY AUG 20-23, 2006
CL Cheju Isl, SOUTH KOREA
DE magnesium; corrosion; biodegradation; biomaterial; biocompatibility
ID ALLOYS
AB Magnesium and its alloys are possible to develop new type of biodegradable medical magnesium alloys by using their active corrosion potential. The bio-corrosion properties of the high pure magnesium in the Hank's solution were investigated in this paper, the results showed that high pure magnesium had a low corrosion rate and hydrogen release in Hank's solution, when the pH value of Solution was controlled at 7.5, the corrosion rate was under 0.2mm/year, the production of hydrogen was about 0.1 5ml/cm(2) and if the solution wasn't controlled on pH value, the corrosion rate was about 0.02 mm/year, production of hydrogen was about 0.1 ml/cm(2). Result of in vitro Kinetic clotting time test and animal implant prep-test showed that High pure magnesium had good thromboresistant property and tissue compatibility p, pure magnesium can biodegrade lowly in animal body and formed surface apatite, which proportion of Ca/P was similar with bone tissue.
C1 [Ren, Yibin; Huang, Jingjing; Zhang, Bingchun; Yang, Ke] Chinese Acad Sci, Inst Met Res, Shenyang 110016, Peoples R China.
   [Wang, Hao] Univ So Queensland, Toowoomba, Qld A-4350, Australia.
RP Ren, YB (reprint author), Chinese Acad Sci, Inst Met Res, Shenyang 110016, Peoples R China.
EM ybren@imr.ac.cn
RI ren, yibin/M-5508-2014
OI ren, yibin/0000-0002-5422-761X
CR Di Mario Carlo, 2004, J Interv Cardiol, V17, P391, DOI 10.1111/j.1540-8183.2004.04081.x
   Heublein B, 2003, HEART, V89, P651, DOI 10.1136/heart.89.6.651
   Kuwahara H, 2001, MATER TRANS, V42, P1317, DOI 10.2320/matertrans.42.1317
   McBride ED, 1938, J AMER MED ASSOC, V111, P2464, DOI 10.1001/jama.1938.02790530018007
   Stroganov G. B., 1972, [No title captured], Patent No. [3687135, 3, 687, 135]
   [王德永 Wang Deyong], 2002, [生物医学工程学杂志, Journal of Biomedical Engineering], V19, P17
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   YB R, 2005, ACTA METALLURGICA SI, V41, P1228
   YU YT, 2000, BIOMEDICAL MAT
NR 9
TC 8
Z9 10
U1 0
U2 9
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
BN 978-0-87849-436-1
J9 KEY ENG MATER
PY 2007
VL 342-343
BP 601
EP +
DI 10.4028/www.scientific.net/KEM.342-343.601
PG 2
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BGG39
UT WOS:000246657900151
OA Green Published
DA 2018-10-20
ER

PT S
AU He, J
   Lu, XY
   Hong, QY
   Lu, ZH
   Huang, Y
   Sun, PZ
AF He Jian
   Lue Xiaoying
   Hong Qingyue
   Lu Zuhong
   Huang Yan
   Sun Paizheng
BE Kim, YH
   Cho, CS
   Kang, IK
   Kim, SY
   Kwon, OH
TI Study of protein adsorption on biomaterial surfaces by SPR
SO ASBM7: ADVANCED BIOMATERIALS VII
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 7th Asian Symposium on Biomedical Materials (ASBM7)
CY AUG 20-23, 2006
CL Cheju Isl, SOUTH KOREA
DE surface plasmon resonance; biosensor; protein adsorption;
   biocompatibility
ID PLASMON RESONANCE
AB Object. The aim of this study was to Set Lip a SPR sensor and to investigate protein adsorption onto biomaterial surface using it. Methods. The adsorption of human albumin (Alb), fibrinogen (Fib) and immunoglobulin G (IgG) onto polyurethane (PU) H50-50 and ALL surface were measured using this SPR sensor. Results: The results of protein adsorption showed that the amount of Alb, Fib and IgG adsorbed on PU (H50-50) are smaller than Au, and on these two material surfaces. the amount sequence of adsorbed protein is: IgG > Fib > Alb. Both the Alb/Fib ratio and Alb/IgG ratio on PU (H50-50) surface are higher than Au. Conclusion: The antithrombogenicity of PU (H50-50) is better than Au.
C1 [He Jian; Lue Xiaoying; Hong Qingyue; Lu Zuhong; Huang Yan; Sun Paizheng] Southeast Univ, Dept Biomed Engn, State Key Lab Bioelectron, Nanjing 210096, Peoples R China.
RP He, J (reprint author), Southeast Univ, Dept Biomed Engn, State Key Lab Bioelectron, Nanjing 210096, Peoples R China.
EM luxy@seu.edu.cn
FU NSFC [30270391]; 863 plan [2002AA326064, 2002AA312230]
FX This study is supported by NSFC with Project 30270391 and 863 plan
   2002AA326064 and 2002AA312230.
CR Green RJ, 1999, BIOMATERIALS, V20, P385, DOI 10.1016/S0142-9612(98)00201-4
   Green RJ, 1997, BIOMATERIALS, V18, P405, DOI 10.1016/S0142-9612(96)00141-X
   Hansson KM, 1999, BIOSENS BIOELECTRON, V14, P671, DOI 10.1016/S0956-5663(99)00050-0
   [吕晓迎 Lu Xiaoying], 2003, [中国生物医学工程学报, Chinese Journal of Biomedical Engineering], V22, P165
   STENBERG E, 1991, J COLLOID INTERF SCI, V143, P513, DOI 10.1016/0021-9797(91)90284-F
   Wang L, 1996, PROG BIOCHEM BIOPHYS, V23, P483
   XIAO CD, 2000, CHINESE J BIOMEDICAL, V19, P60
NR 7
TC 0
Z9 0
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
BN 978-0-87849-436-1
J9 KEY ENG MATER
PY 2007
VL 342-343
BP 825
EP +
DI 10.4028/www.scientific.net/KEM.342-343.825
PG 2
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BGG39
UT WOS:000246657900207
DA 2018-10-20
ER

PT S
AU Shao, ZY
   Zhao, AS
   Yang, P
   Zhou, HF
   Huang, N
AF Shao Zhenyi
   Zhao Ansha
   Yang Ping
   Zhou Hongfang
   Huang Nan
BE Kim, YH
   Cho, CS
   Kang, IK
   Kim, SY
   Kwon, OH
TI In situ investigation of biomaterial surfaces using LDH and ELISA
SO ASBM7: ADVANCED BIOMATERIALS VII
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 7th Asian Symposium on Biomedical Materials (ASBM7)
CY AUG 20-23, 2006
CL Cheju Isl, SOUTH KOREA
DE blood compatibility; platelet adhesion & activation; LDH; ELISA
ID LACTATE-DEHYDROGENASE; ACTIVATION; HEMOCOMPATIBILITY; EXPRESSION;
   ENZYME; FILMS; CD62P
AB Lactate dehydrogenase (LDH) and enzyme-linked immunosorbent assay (ELISA) have attracted much attention recently for the evaluation of blood compatibility of biomaterials due to their convenience and quantifiability. In this paper, the use of LDH and ELISA is described for in suit investigation of platelet behavior on biomaterial surfaces, including quantification of platelet adhesion and platelet activation, after suitable testing conditions have been established. The material samples investigated in these tests included low temperature isotropic carbon (LTIC), Ti-O films, and phosphorus- and aluminum-doped TiO2 films. The evaluation results show that the lowest platelet adhesion and activation are observed on phosphorus-doped TiO2 films while the highest platelet adhesion and activation are observed on LTIC. In addition, conventional platelet adhesion experiments were performed for comparison, and yielding similar evaluation results as LDH and ELISA. It is suggested that LDH and ELISA tests can be successfully applied to evaluate the blood compatibility of biomaterials and can show many advantages, such as quantification, reliability and objectivity, compared with conventional platelet adhesion test.
C1 [Shao Zhenyi; Zhao Ansha; Yang Ping; Zhou Hongfang; Huang Nan] Southwest Jiao Tong Univ, Minist Educ, Key Lab Adv Mat Technol, Key Lab Artific Organ Surface Engn Sichuan, Chengdu 610031, Peoples R China.
RP Yang, P (reprint author), Southwest Jiao Tong Univ, Minist Educ, Key Lab Adv Mat Technol, Key Lab Artific Organ Surface Engn Sichuan, Chengdu 610031, Peoples R China.
EM yangping@home.swjtu.edu.cn; nhuang@263.net
FU G2005CB623904;  [NSFC30318006];  [NSFC30300087];  [NSFC30570502]
FX This work was jointly supported by Key basic research G2005CB623904,
   NSFC30318006, NSFC30300087 and NSFC30570502 Authors would like to thank
   Dr. Ian Brown and Dr. M.Maitz's help.
CR Chen JY, 2002, BIOMATERIALS, V23, P2545, DOI 10.1016/S0142-9612(01)00389-1
   Diamantino TC, 2001, CHEMOSPHERE, V45, P553, DOI 10.1016/S0045-6535(01)00029-7
   Downer J, 2006, J THEOR BIOL, V240, P464, DOI 10.1016/j.jtbi.2005.10.007
   Eriksson Andreas C., 2005, Journal of Pharmacological and Toxicological Methods, V52, P356, DOI 10.1016/j.vascn.2005.06.002
   Fiore MM, 2003, BIOCHEM BIOPH RES CO, V311, P71, DOI 10.1016/j.bbrc.2003.09.171
   GROTH T, 1995, BIOMATERIALS, V16, P1009, DOI 10.1016/0142-9612(95)94909-5
   GROTH T, 1994, COLLOID SURFACE B, V3, P24
   GROTH T, 1994, COLLOID SURFACE B, V3, P241
   Gutensohn K, 1996, TRANSFUS SCI, V17, P489
   Huang N, 1998, BIOMATERIALS, V19, P771, DOI 10.1016/S0142-9612(98)00212-9
   Lalko CC, 2003, VET IMMUNOL IMMUNOP, V91, P119, DOI 10.1016/S0165-2427(02)00287-8
   Lobner D, 2000, J NEUROSCI METH, V96, P147, DOI 10.1016/S0165-0270(99)00193-4
   MARIC DM, 1992, BIOMATERIALS, V50, P119
   RADZIWON P, 2000, THROMB RES, V100, P19
   RADZIWON P, 2000, THROMB RES, V100, P4
   WATANABE W, 1995, J VIROL METHODS, V51, P185, DOI 10.1016/0166-0934(94)00103-N
   Yang P, 2003, BIOMATERIALS, V24, P2821, DOI 10.1016/S0142-9612(03)00091-7
NR 17
TC 5
Z9 5
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
BN 978-0-87849-436-1
J9 KEY ENG MATER
PY 2007
VL 342-343
BP 841
EP +
DI 10.4028/www.scientific.net/KEM.342-343.841
PG 2
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BGG39
UT WOS:000246657900211
DA 2018-10-20
ER

PT S
AU Wei, QR
   Yang, XD
   Lu, J
   Zhang, B
   Jiang, B
   Fan, HS
   Chen, JY
   Gu, ZW
   Zhang, XD
AF Wei, Qingrong
   Yang, Xiudong
   Lu, Jian
   Zhang, Bo
   Jiang, Bo
   Fan, Hongsong
   Chen, Jiyong
   Gu, Zhongwei
   Zhang, Xingdong
BE Kim, YH
   Cho, CS
   Kang, IK
   Kim, SY
   Kwon, OH
TI Effect of inorganic ions on morphology and crystallinity of collagen
   fibrils
SO ASBM7: ADVANCED BIOMATERIALS VII
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 7th Asian Symposium on Biomedical Materials (ASBM7)
CY AUG 20-23, 2006
CL Cheju Isl, SOUTH KOREA
DE collagen fibril; inorganic ion; morphology; crystallinity
ID INVITRO
AB As a natural biomaterial, collagen especially pepsin-solubilized collagen (type 1) has been used widely in biomedical fields due to its excellent biocompatibility. In this preliminary study, we investigate the effect of some inorganic ions which are frequently utilized in the preparation of collagen on the morphology and crystallinity of fibrils. The scanning electron microscope and x-ray diffraction were applied to analyze the morphology and the crystallization of the reconstituted collagen fibrils, respectively. Although further studies are needed, these initial results indicate that by controlling the self-assembly conditions of collagen molecules, we may achieve the desired properties of fibrillar collagen products.
C1 [Wei, Qingrong; Yang, Xiudong; Lu, Jian; Zhang, Bo; Jiang, Bo; Fan, Hongsong; Chen, Jiyong; Gu, Zhongwei; Zhang, Xingdong] Sichuan Univ, Engn Res Ctr Biomat, Chengdu 610064, Peoples R China.
RP Chen, JY (reprint author), Sichuan Univ, Engn Res Ctr Biomat, Chengdu 610064, Peoples R China.
EM qingrongwei@gmail.com
RI wei, qingrong/G-5860-2010
CR CLARKE KI, 1993, J MATER SCI-MATER M, V4, P107, DOI 10.1007/BF00120378
   COLLINS KD, 1985, Q REV BIOPHYS, V18, P323, DOI 10.1017/S0033583500005369
   KomsaPenkova R, 1996, BBA-PROTEIN STRUCT M, V1297, P171, DOI 10.1016/S0167-4838(96)00092-1
   MCPHERSON JM, 1985, COLLAGEN REL RES, V5, P119
   MILLER EJ, 1972, BIOCHEMISTRY-US, V11, P119
   NA GC, 1989, BIOCHEMISTRY-US, V28, P7153, DOI 10.1021/bi00444a004
   OUYANG PK, 2004, PRINCIPLE TECHNOLOGY
   Prockop DJ, 1998, J STRUCT BIOL, V122, P111, DOI 10.1006/jsbi.1998.3976
   STENZEL KH, 1974, ANNU REV BIOPHYS BIO, V3, P231, DOI 10.1146/annurev.bb.03.060174.001311
   WILLIAMS BR, 1978, J BIOL CHEM, V253, P6578
NR 10
TC 0
Z9 0
U1 1
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
BN 978-0-87849-436-1
J9 KEY ENG MATER
PY 2007
VL 342-343
BP 929
EP +
DI 10.4028/www.scientific.net/KEM.342-343.929
PG 2
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BGG39
UT WOS:000246657900233
DA 2018-10-20
ER

PT J
AU Gras, SL
AF Gras, Sally L.
TI Amyloid fibrils: From disease to design. New biomaterial applications
   for self-assembling cross-beta fibrils
SO AUSTRALIAN JOURNAL OF CHEMISTRY
LA English
DT Review
ID PEPTIDE-AMPHIPHILE NANOFIBERS; PROTEIN AGGREGATION RATES;
   EXTRACELLULAR-MATRIX; IN-VITRO; NANOTECHNOLOGICAL APPLICATIONS; FUNGAL
   HYDROPHOBINS; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE;
   POLYPEPTIDE-CHAINS; PROGENITOR CELLS
AB Amyloid fibrils are self-assembling protein aggregates. They are essentially insoluble and resilient nanofibres that offer great potential as materials for nanotechnology and bionanotechnology. Fibrils are associated with several debilitating diseases, for example Alzheimer's disease, but recent advances suggest they also have positive functions in nature and can be formed in vitro from generic proteins. This article explores how the unique nanotopography and advantageous properties of fibrils may be used to develop tools for probing cell behaviour, protein-based biomimetic materials for supporting cells, or platforms for biosensors and enzyme immobilization.
C1 Univ Melbourne, Dept Chem & Biomol Engn, Parkville, Vic 3010, Australia.
   Univ Melbourne, Bio21 Mol Sci & Biotechnol Inst, Parkville, Vic 3010, Australia.
RP Gras, SL (reprint author), Univ Melbourne, Dept Chem & Biomol Engn, Parkville, Vic 3010, Australia.
EM sgras@unimelb.edu.au
RI Gras, Sally/G-2025-2014
OI Gras, Sally/0000-0002-4660-1245
CR Adler-Abramovich L, 2006, LANGMUIR, V22, P1313, DOI 10.1021/la052409d
   Aggeli A, 1997, NATURE, V386, P259, DOI 10.1038/386259a0
   Aggeli A, 2001, P NATL ACAD SCI USA, V98, P11857, DOI 10.1073/pnas.191250198
   Aggeli A, 2003, ANGEW CHEM INT EDIT, V42, P5603, DOI 10.1002/anie.200352207
   Aggeli A, 2003, J AM CHEM SOC, V125, P9619, DOI 10.1021/ja021047i
   Alexandrescu AT, 2005, PROTEIN SCI, V14, P1
   Bader R, 2006, J MOL BIOL, V356, P189, DOI 10.1016/j.jmb.2005.11.034
   Baglioni S, 2006, J NEUROSCI, V26, P8160, DOI 10.1523/JNEUROSCI.4809-05.2006
   Baldwin AJ, 2006, J AM CHEM SOC, V128, P2162, DOI 10.1021/ja0565673
   Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106
   Baxa U, 2003, J BIOL CHEM, V278, P43717, DOI 10.1074/jbc.M306004200
   Baxa U, 2002, P NATL ACAD SCI USA, V99, P5253, DOI 10.1073/pnas.082097899
   Bell CJ, 2006, J BIOMED MATER RES A, V78A, P236, DOI 10.1002/jbm.a.30672
   Berry CC, 2005, BIOMATERIALS, V26, P4985, DOI 10.1016/j.biomaterials.2005.01.046
   Berson JF, 2003, J CELL BIOL, V161, P521, DOI 10.1083/jcb.200302072
   Biere AL, 2000, J BIOL CHEM, V275, P34574, DOI 10.1074/jbc.M005514200
   Bieschke J, 2006, ACCOUNTS CHEM RES, V39, P611, DOI 10.1021/ar0500766
   Caflisch A, 2006, CURR OPIN CHEM BIOL, V10, P437, DOI 10.1016/j.cbpa.2006.07.009
   Calamai M, 2005, BIOPHYS J, V89, P4201, DOI 10.1529/biophysj.105.068726
   Chai C, 2007, MOL THER, V15, P467, DOI 10.1038/sj.mt.6300084
   Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484
   Cherny I, 2005, J MOL BIOL, V352, P245, DOI 10.1016/j.jmb.2005.07.028
   Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891
   Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901
   Claessen D, 2003, GENE DEV, V17, P1714, DOI 10.1101/gad.264303
   COLLINS SR, 2004, PLOS BIOL, V2, pE321
   Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571
   Dalby MJ, 2004, BIOMATERIALS, V25, P5415, DOI 10.1016/j.biomaterials.2003.12.049
   Dallas SL, 2006, CURR TOP DEV BIOL, V75, P1, DOI 10.1016/S0070-2153(06)75001-3
   de la Paz ML, 2004, P NATL ACAD SCI USA, V101, P87, DOI 10.1073/pnas.2634884100
   de la Paz ML, 2002, P NATL ACAD SCI USA, V99, P16052, DOI 10.1073/pnas.252340199
   Devlin GL, 2006, J MOL BIOL, V360, P497, DOI 10.1016/j.jmb.2006.05.007
   Ding TT, 2002, BIOCHEMISTRY-US, V41, P10209, DOI 10.1021/bi020139h
   Dirix C, 2005, J MOL BIOL, V347, P903, DOI 10.1016/j.jmb.2005.01.073
   Dobson CM, 2006, PROTEIN PEPTIDE LETT, V13, P219, DOI 10.2174/092986606775338362
   Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0
   DOBSON CM, 2000, Patent No. 017328
   Dos Santos S, 2005, J AM CHEM SOC, V127, P11888, DOI 10.1021/ja052083v
   Duan XD, 2007, BIOMATERIALS, V28, P78, DOI 10.1016/j.biomaterials.2006.08.034
   Dubay KF, 2004, J MOL BIOL, V341, P1317, DOI 10.1016/j.jmb.2004.06.043
   Dumoulin M, 2006, PROTEIN PEPTIDE LETT, V13, P213, DOI 10.2174/092986606775338434
   Eisert R, 2006, ANAL BIOCHEM, V353, P144, DOI 10.1016/j.ab.2006.03.015
   Esteras-Chopo A, 2005, P NATL ACAD SCI USA, V102, P16672, DOI 10.1073/pnas.0505905102
   Esteras-Chopo Alexandra, 2006, V340, P253
   Fandrich M, 2003, P NATL ACAD SCI USA, V100, P15463, DOI 10.1073/pnas.0303758100
   Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514
   Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012
   Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006
   Fukuma T, 2006, TRIBOL LETT, V22, P233, DOI 10.1007/s11249-006-9086-8
   Gast K, 2003, EUR BIOPHYS J BIOPHY, V32, P710, DOI 10.1007/s00249-003-0336-5
   Gazit E, 2005, FEBS J, V272, P5971, DOI 10.1111/j.1742-4658.2005.05022.x
   Genove E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012
   Gillmore JD, 2006, NAT CLIN PRACT NEPHR, V2, P263, DOI 10.1038/ncpneph0169
   Gosal WS, 2006, PROTEIN PEPTIDE LETT, V13, P261, DOI 10.2174/092986606775338498
   GRAS SL, UNPUB
   Griffith LG, 2002, ANN NY ACAD SCI, V961, P83, DOI 10.1111/j.1749-6632.2002.tb03056.x
   Guijarro JI, 1998, P NATL ACAD SCI USA, V95, P4224, DOI 10.1073/pnas.95.8.4224
   GUIRADOLOPEZ RA, 2006, J CHEM PHYS, V125, DOI DOI 10.1063/1.2357955
   Guler MO, 2005, NANO LETT, V5, P249, DOI 10.1021/nl048238z
   GUSTAVSSON A, 1991, BIOCHEM BIOPH RES CO, V175, P1159, DOI 10.1016/0006-291X(91)91687-8
   Ha C, 2005, BIOTECHNOL BIOENG, V90, P848, DOI 10.1002/bit.20486
   HALTRICH D, 2006, APPL BIOCHEM BIOTECH, V129, P215, DOI DOI 10.1385/ABAB:129:1:215
   HAMADA D, 2004, TRENDS BIOTECHNOL, P22
   Hartgerink JD, 2004, CURR OPIN CHEM BIOL, V8, P604, DOI 10.1016/j.cbpa.2004.10.001
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   Hatters DM, 2003, BIOPHYS J, V85, P3979, DOI 10.1016/S0006-3495(03)74812-7
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Inoue Y, 2001, J BIOL CHEM, V276, P35227, DOI 10.1074/jbc.C100304200
   Janssen MI, 2004, BIOMATERIALS, V25, P2731, DOI 10.1016/j.biomaterials.2003.09.060
   Janssen MI, 2002, BIOMATERIALS, V23, P4847, DOI 10.1016/S0142-9612(02)00240-5
   Jaroniec CP, 2004, P NATL ACAD SCI USA, V101, P711, DOI 10.1073/pnas.0304849101
   Jaroniec CP, 2002, P NATL ACAD SCI USA, V99, P16748, DOI 10.1073/pnas.252625999
   JIN LW, 1994, J NEUROSCI, V14, P5461
   Johan K, 1998, P NATL ACAD SCI USA, V95, P2558, DOI 10.1073/pnas.95.5.2558
   Kammerer RA, 2004, P NATL ACAD SCI USA, V101, P4435, DOI 10.1073/pnas.0306786101
   Kasai S, 2004, BIOPOLYMERS, V76, P27, DOI 10.1002/bip.10565
   Katz Eugenii, 2004, Chemphyschem, V5, P1084, DOI 10.1002/cphc.200400193
   Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469
   Kayed R, 2006, METHOD ENZYMOL, V413, P326, DOI 10.1016/S0076-6879(06)13017-7
   KIBBEY MC, 1993, P NATL ACAD SCI USA, V90, P10150, DOI 10.1073/pnas.90.21.10150
   Kishimoto A, 2004, BIOCHEM BIOPH RES CO, V315, P739, DOI 10.1016/j.bbrc.2004.01.117
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Knowles TPJ, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.238301
   KODAMA HM, 2004, CHEMCOMM, V24, P2876
   Koga T, 2005, J AM CHEM SOC, V127, P17596, DOI 10.1021/ja0558387
   Kowalewski T, 1999, P NATL ACAD SCI USA, V96, P3688, DOI 10.1073/pnas.96.7.3688
   Krebs MRH, 2005, J STRUCT BIOL, V149, P30, DOI 10.1016/j.jsb.2004.08.002
   Krebs MRH, 2004, P NATL ACAD SCI USA, V101, P14420, DOI 10.1073/pnas.0405933101
   Krebs MRH, 2004, PROTEIN SCI, V13, P1933, DOI 10.1110/ps.04707004
   Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679
   Kwan AHY, 2006, P NATL ACAD SCI USA, V103, P3621, DOI 10.1073/pnas.0505704103
   LARSEN NG, 2005, Patent No. 033131
   Lazo ND, 1998, BIOCHEMISTRY-US, V37, P1731, DOI 10.1021/bi971016d
   Lee CH, 2005, BIOMATERIALS, V26, P1261, DOI 10.1016/j.biomaterials.2004.04.037
   Linder MB, 2004, BIOCHEMISTRY-US, V43, P11873, DOI 10.1021/bi0488202
   Litvinovich SV, 1998, J MOL BIOL, V280, P245, DOI 10.1006/jmbi.1998.1863
   Lundmark K, 2005, P NATL ACAD SCI USA, V102, P6098, DOI 10.1073/pnas.0501814102
   MacPhee CE, 2004, CURR OPIN SOLID ST M, V8, P141, DOI 10.1016/j.cossms.2004.01.010
   MacPhee CE, 2000, J AM CHEM SOC, V122, P12707, DOI 10.1021/ja0029580
   Makin OS, 2005, FEBS J, V272, P5950, DOI 10.1111/j.1742-4658.2005.05025.x
   Mesquida P, 2005, ADV MATER, V17, P893, DOI 10.1002/adma.200401229
   Mesquida P, 2006, LANGMUIR, V22, P9089, DOI 10.1021/la061485t
   Mineur P, 2005, BBA-MOL CELL RES, V1746, P28, DOI 10.1016/j.bbamcr.2005.07.004
   MOK S, 2005, J NEUROCHEM, V96, P53
   Moreira D, 2002, TRENDS MICROBIOL, V10, P31, DOI 10.1016/S0966-842X(01)02257-0
   Morgan C, 2004, PROG NEUROBIOL, V74, P323, DOI 10.1016/j.pneurobio.2004.10.004
   MOSTAERT AS, 2007, NANOTECHNOLOGY, V18, DOI DOI 10.1088/0957-4484/18/4/0044010
   Nelson R, 2006, CURR OPIN STRUC BIOL, V16, P260, DOI 10.1016/j.sbi.2006.03.007
   Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012
   Pastor MT, 2005, CURR OPIN STRUC BIOL, V15, P57, DOI 10.1016/j.sbi.2005.01.004
   PAULING L, 1951, P NATL ACAD SCI USA, V37, P251, DOI 10.1073/pnas.37.5.251
   Pawar AP, 2005, J MOL BIOL, V350, P379, DOI 10.1016/j.jmb.2005.04.016
   Pearce FG, 2007, J AGR FOOD CHEM, V55, P318, DOI 10.1021/jf062154p
   Pepys MB, 2006, ANNU REV MED, V57, P223, DOI 10.1146/annurev.med.57.121304.131243
   Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5591, DOI 10.1073/pnas.042681399
   Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   PIERSCHBACHER MD, 1984, P NATL ACAD SCI-BIOL, V81, P5985, DOI 10.1073/pnas.81.19.5985
   Prestwich GD, 2002, ANN NY ACAD SCI, V961, P106, DOI 10.1111/j.1749-6632.2002.tb03058.x
   Reches M, 2006, PHYS BIOL, V3, pS10, DOI 10.1088/1478-3975/3/1/S02
   Royal Society/ Royal Academy of Engineering, 2004, NAN NAN OPP UNC
   Scheibel T, 2003, P NATL ACAD SCI USA, V100, P4527, DOI 10.1073/pnas.0431081100
   Scholtmeijer K, 2002, APPL ENVIRON MICROB, V68, P1367, DOI 10.1128/AEM.68.3.1367-1373.2002
   Scholtmeijer K, 2001, APPL MICROBIOL BIOT, V56, P1, DOI 10.1007/s002530100632
   Sedman VL, 2006, J AM CHEM SOC, V128, P6903, DOI 10.1021/ja060358g
   Semino CE, 2004, TISSUE ENG, V10, P643, DOI 10.1089/107632704323061997
   Semino CE, 2003, DIFFERENTIATION, V71, P262, DOI 10.1046/j.1432-0436.2003.7104503.x
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Smith DP, 2003, J MOL BIOL, V330, P943, DOI 10.1016/S0022-2836(03)00687-9
   Smith JF, 2006, P NATL ACAD SCI USA, V103, P15806, DOI 10.1073/pnas.0604035103
   Sohma Y, 2006, CHEMBIOCHEM, V7, P1549, DOI 10.1002/cbic.200600112
   Squires AM, 2006, J AM CHEM SOC, V128, P11738, DOI 10.1021/ja063751v
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348
   Takahashi Y, 2004, BIOORGAN MED CHEM, V12, P693, DOI 10.1016/j.bmc.2003.11.022
   Talbot NJ, 2003, CURR BIOL, V13, pR696, DOI 10.1016/S0960-9822(03)00643-2
   Tartaglia GG, 2005, PROTEIN SCI, V14, P2723, DOI 10.1110/ps.051471205
   Tartaglia GG, 2004, PROTEIN SCI, V13, P1939, DOI 10.1110/ps.04663504
   Teixeira AI, 2006, BIOMATERIALS, V27, P3945, DOI 10.1016/j.biomaterials.2006.01.044
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   Tjernberg L, 2002, J BIOL CHEM, V277, P43243, DOI 10.1074/jbc.M205570200
   Tycko R, 2000, CURR OPIN CHEM BIOL, V4, P500, DOI 10.1016/S1367-5931(00)00123-X
   Waterhouse SH, 2004, AUST J CHEM, V57, P519, DOI 10.1071/CH04070
   West MW, 1999, P NATL ACAD SCI USA, V96, P11211, DOI 10.1073/pnas.96.20.11211
   Westermark P, 2005, AMYLOID, V12, P1, DOI 10.1080/13506120500032196
   Westermark P, 2005, FEBS J, V272, P5942, DOI 10.1111/j.1742-4658.2005.05024.x
   Wille H, 2002, P NATL ACAD SCI USA, V99, P3563, DOI 10.1073/pnas.052703499
   Wright CF, 2005, NATURE, V438, P878, DOI 10.1038/nature04195
   Xu CY, 2004, TISSUE ENG, V10, P1160, DOI 10.1089/ten.2004.10.1160
   Yamada M, 2002, FEBS LETT, V530, P48, DOI 10.1016/S0014-5793(02)03393-8
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
   Yim EKF, 2005, NANOMED-NANOTECHNOL, V1, P10, DOI 10.1016/j.nano.2004.11.008
   Yip C, 2002, ANN NY ACAD SCI, V961, P109, DOI 10.1111/j.1749-6632.2002.tb03059.x
   Zhang SG, 2002, CURR OPIN CHEM BIOL, V6, P865, DOI 10.1016/S1367-5931(02)00391-5
   Zhu M, 2002, J BIOL CHEM, V277, P50914, DOI 10.1074/jbc.M207225200
   Zurdo J, 2001, J AM CHEM SOC, V123, P8141, DOI 10.1021/ja016229b
   ZURDO J, 2003, Patent No. 003019
NR 159
TC 42
Z9 42
U1 0
U2 34
PU CSIRO PUBLISHING
PI COLLINGWOOD
PA 150 OXFORD ST, PO BOX 1139, COLLINGWOOD, VICTORIA 3066, AUSTRALIA
SN 0004-9425
J9 AUST J CHEM
JI Aust. J. Chem.
PY 2007
VL 60
IS 5
BP 333
EP 342
DI 10.1071/CH06485
PG 10
WC Chemistry, Multidisciplinary
SC Chemistry
GA 171ZV
UT WOS:000246774800003
DA 2018-10-20
ER

PT J
AU Luis, AL
   Rodrigues, JM
   Lobato, JV
   Lopes, MA
   Amado, S
   Veloso, AP
   Armada-da-Silva, PAS
   Raimondo, S
   Geuna, S
   Ferreira, AJ
   Varejao, ASP
   Santos, JD
   Mauricio, AC
AF Luis, Ana L.
   Rodrigues, Jorge M.
   Lobato, Jose V.
   Lopes, Maria A.
   Amado, Sandra
   Veloso, Antonio P.
   Armada-da-Silva, Paulo A. S.
   Raimondo, Stefania
   Geuna, Stefano
   Ferreira, Antonio J.
   Varejao, Artur S. P.
   Santos, Jose D.
   Mauricio, Ana C.
TI Evaluation of two biodegradable nerve guides for the reconstruction of
   the rat sciatic nerve
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE nerve entubulation; PLGA; caprolactone; sciatic nerve; rat
ID FRESH SKELETAL-MUSCLE; LONG-TERM EVALUATION; FUNCTIONAL ASSESSMENT;
   NEUROLOGIC EVALUATION; REPAIR; REGENERATION; RECOVERY;
   POLY(DL-LACTIDE-EPSILON-CAPROLACTONE); CONDUITS; DEGRADATION
AB The purpose of this study was to test in vivo two different nerve guides, one of PLGA made of a novel proportion (90:10) of the two polymers, Poly(L-lactide):Poly(glycolide), with (DL-lactide-epsilon-caprolactone) copolyester (Neurolac((R))) tube, in promoting nerve regeneration across a 10 mm-gap of the rat sciatic nerve. Finally, end-to-end coaptation was performed. Motor and sensory functional recovery was assessed throughout the healing period of 20 weeks and the repaired nerves were processed for morphological analysis. Both motor and sensory functions improved significantly in all experimental nerve repair groups, although the rate and extent of recovery was significantly higher in the end-to-end group. No significant differences were detected in the comparison between the two types of tubes. Compatible with results of functional tests, morphological analysis showed that axon regeneration occurred in both PLGA and Neurolac((R)) experimental groups but disclosed a different pattern of degradation of the two types of tubes with larger biodegradation of PLGA material by the end of 20 weeks. These results suggest that both types of biomaterial are a good substrate for preparing tubular nerve guides and the different pattern of degradation does not seem to influence the degree of nerve regeneration.
C1 Univ Porto, CECA, ICETA, P-4485661 Vairao, Portugal.
   Univ Porto, Dept Clin Vet, ICBAS, P-4099003 Oporto, Portugal.
   Univ Tecn Lisboa, FMH, P-1495688 Cruz Quebrada, Dafundo, Portugal.
   Univ Porto, Fac Engn, P-4200465 Oporto, Portugal.
   Univ Turin, Dipartimento Sci Clin & Biol, Osped San Luigi, I-10043 Turin, Italy.
   Univ Tecn Lisboa, FMV, P-1300477 Lisbon, Portugal.
   CHVNG, Dept Estomatol, P-4434502 Vila Nova De Gaia, Portugal.
   Univ Tras Os Montes & Alto Douro, CETAV, Dept Ciencias Vet, P-5001911 Vila Real, Portugal.
RP Mauricio, AC (reprint author), Campus Agrario de Vairao,Rua Padre Armando Quinta, P-4485661 Vairao, Portugal.
EM ana.colette@mail.icav.up.pt
RI Lopes, Cristina/A-4241-2010; Raimondo, Stefania/R-5856-2016;
   Armada-da-Silva, Paulo/L-5675-2013; Amado, Sandra/O-6988-2016; Lopes,
   Maria A./P-4442-2014; Veloso, Antonio/F-5064-2013
OI Raimondo, Stefania/0000-0002-8907-473X; Armada-da-Silva,
   Paulo/0000-0002-3814-6879; Amado, Sandra/0000-0001-8356-4810; Lopes,
   Maria A./0000-0003-4105-8148; Veloso, Antonio/0000-0003-1068-1113;
   Varejao, Artur/0000-0002-0736-3635; Mauricio, Ana
   Colette/0000-0002-0018-9363; Santos, Jose Domingos/0000-0002-6871-9850;
   Ferreira, Antonio/0000-0002-0142-6578; Rodrigues, Jorge
   Manuel/0000-0003-1889-4914; Geuna, Stefano/0000-0002-6962-831X
CR Battiston B, 2005, MICROSURG, V25, P258, DOI 10.1002/micr.20127
   Bertleff MJOE, 2005, J HAND SURG-AM, V30A, P513, DOI 10.1016/j.jhsa.2004.12.009
   Campbell JN, 2001, MUSCLE NERVE, V24, P1261, DOI 10.1002/mus.1143
   DenDunnen WFA, 1996, MICROSURG, V17, P348, DOI 10.1002/(SICI)1098-2752(1996)17:7<348::AID-MICR2>3.0.CO;2-C
   denDunnen WFA, 1997, J BIOMED MATER RES, V36, P337, DOI 10.1002/(SICI)1097-4636(19970905)36:3<337::AID-JBM9>3.3.CO;2-8
   Doolabh VB, 1996, REV NEUROSCIENCE, V7, P47
   Dubey N, 1999, EXP NEUROL, V158, P338, DOI 10.1006/exnr.1999.7095
   FIELDS RD, 1989, PROG NEUROBIOL, V33, P87, DOI 10.1016/0301-0082(89)90036-1
   Hu D, 1997, ANESTHESIOLOGY, V86, P957, DOI 10.1097/00000542-199704000-00026
   Jensen JN, 2004, MICROSURG, V24, P309, DOI 10.1002/micr.20028
   Kannan RY, 2005, BIOTECHNOL APPL BIOC, V41, P193, DOI 10.1042/BA20040137
   Kline DG, 2000, J NEUROSURG, V93, P336
   Koka R, 2001, EXP NEUROL, V168, P192, DOI 10.1006/exnr.2000.7600
   Lundborg G, 2004, Handchir Mikrochir Plast Chir, V36, P1
   Lundborg G, 2002, J PERIPHER NERV SYST, V7, P139, DOI 10.1046/j.1529-8027.2002.02019.x
   Lundborg G., 2003, SEVERE TRAUMATIC DEF, P153
   MACKINNON SE, 1985, PLAST RECONSTR SURG, V75, P384, DOI 10.1097/00006534-198503000-00014
   Madison R.D., 1992, WOUND HEALING BIOCH, P450
   Madorsky SJ, 1998, PLAST RECONSTR SURG, V102, P430, DOI 10.1097/00006534-199808000-00021
   MASTERS DB, 1993, ANESTHESIOLOGY, V79, P340, DOI 10.1097/00000542-199308000-00020
   Matsuyama T, 2000, NEUROL MED-CHIR, V40, P187, DOI 10.2176/nmc.40.187
   MAY M, 1983, OTOLARYNG CLIN N AM, V16, P661
   Meek MF, 1999, MICROSURG, V19, P247, DOI 10.1002/(SICI)1098-2752(1999)19:5<247::AID-MICR7>3.0.CO;2-E
   Meek MF, 2004, J BIOMED MATER RES A, V68A, P43, DOI 10.1002/jbm.a.10157
   Meek MF, 2004, TISSUE ENG, V10, P1027, DOI 10.1089/ten.2004.10.1027
   MILLESI H, 1990, WORLD J SURG, V14, P733, DOI 10.1007/BF01670520
   OLIVER JE, 1987, VET NEUROLOGY, P7
   RODRIGUEZ FJ, 2004, DRUG DISCOV TODAY DI, V1, P177, DOI DOI 10.1016/J.DDMOD.2004.09.008
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Shir Y, 2001, PAIN, V90, P75, DOI 10.1016/S0304-3959(00)00388-2
   THALHAMMER JG, 1995, ANESTHESIOLOGY, V82, P1013, DOI 10.1097/00000542-199504000-00026
   Tos P, 2004, MICROSURG, V24, P459, DOI 10.1002/micr.20064
   Varejao ASP, 2004, NEUROL RES, V26, P186, DOI 10.1179/016164104225013833
   Varejao ASP, 2003, MICROSURG, V23, P346, DOI 10.1002/micr.10148
   Varejao ASP, 2003, MICROSURG, V23, P338, DOI 10.1002/micr.10147
   Varejao ASP, 2003, MUSCLE NERVE, V27, P706, DOI 10.1002/mus.10374
   YOSHII S, 1988, BRAIN RES, V201, P158
NR 37
TC 24
Z9 24
U1 1
U2 14
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2007
VL 17
IS 1
BP 39
EP 52
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 131SN
UT WOS:000243890300005
PM 17264386
DA 2018-10-20
ER

PT J
AU Santoni, BG
   Pluhar, GE
   Motta, T
   Wheeler, DL
AF Santoni, Brandon G.
   Pluhar, G. Elizabeth
   Motta, Tatiana
   Wheeler, Donna L.
TI Hollow calcium phosphate microcarriers for bone regeneration: In vitro
   osteoproduction and ex vivo mechanical assessment
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE biomaterials; biomechanics; drug delivery; bone regeneration; bone
   morphogenic protein; mesenchymal stem cell
ID OSTEOGENIC PROTEIN-1 BMP-7; MESENCHYMAL STEM-CELLS; MORPHOGENETIC
   PROTEIN; TRICALCIUM PHOSPHATE; BIOMATERIAL CARRIERS; HYDROXYAPATITE;
   ALLOGRAFTS; MARROW; DIFFERENTIATION; PROLIFERATION
AB Synthetic grafting materials, such as calcium phosphates (hydroxyapatite, HA; tricalcium phosphate, TCP), polymers, or composites thereof, can be used as osteoconductive scaffolds and delivery vehicles for osteoinductive growth factors. Carrier materials must be engineered to deliver these factors in a controlled fashion at a rate and dose consistent with the biological need and responsiveness of the system to optimize bone formation and ingrowth. They should also simultaneously provide mechanical support and slowly resorb as new bone is formed.
   This investigation assessed the elution characteristics of BMP-7 (OP-1) from hollow calcium phosphate spheres of varying chemical composition (HA/beta-TCP) and porosity (dense/porous). The pharmacokinetics indicated a bimodal trend of protein release with protein elution peaking between fifteen and thirty minutes in solution (bolus release) and continuing through the eight-week time point (sustained release). Eluted OP-1 bioactivity was characterized over a three-week period using mesenchymal stem cell (MSC) cultures and included assessment of the protein's differential, proliferative, and calcified nodule forming abilities. Alkaline phosphatase enzyme (ALP) activity in MSCs peaked between 12 and 16 days post-OP-1 exposure. Elutant from the HA dense treatment group induced the highest degree of ALP expression while elutant from the beta-TCP treatment groups induced the formation of significantly higher numbers of calcified nodules in culture. The aggregate modulus of a clinically relevant 2 cc dose of carriers was quantified using custom designed testing fixtures to investigate the effects of carrier size, porosity, chemical composition, and the presence of a central hole on mechanical integrity. Significant increases in moduli were noted for carrier size and chemical composition (HA >beta-TCP). These preliminary in vitro and ex vivo results indicate the clinical potential of the hollow calcium phosphate carriers as successful load-bearing delivery vehicles for OP-1.
C1 Colorado State Univ, Dept Mech Engn, Orthopaed Bioengn Res Lab, Ft Collins, CO 80523 USA.
   Univ Minnesota, Dept Vet Clin Sci, St Paul, MN 55108 USA.
   Biosolut Consulting LLC, Webster, NY 14580 USA.
RP Santoni, BG (reprint author), Colorado State Univ, Anim Canc Ctr, Dept Clin Sci, 300 W Drake Rd,Campus Delivery Code 1620, Ft Collins, CO 80523 USA.
EM bgsant@holly.colostate.edu
CR Alam MI, 2001, BIOMATERIALS, V22, P1643
   Asahina I, 1996, EXP CELL RES, V222, P38, DOI 10.1006/excr.1996.0005
   Blokhuis TJ, 2001, BIOMATERIALS, V22, P725, DOI 10.1016/S0142-9612(00)00238-6
   BROOKES M, 1971, BLOOD SUPPLY BONE SC
   Cassiede P, 1996, J BONE MINER RES, V11, P1264
   Chu TMG, 2002, BIOMATERIALS, V23, P1283, DOI 10.1016/S0142-9612(01)00243-5
   Cook SD, 1996, CLIN ORTHOP RELAT R, P29
   Cowin S., 2001, BONE MECH HDB
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   DELLOYE C, 1992, CLIN ORTHOP RELAT R, P273
   Dennis J E, 1992, Cell Transplant, V1, P23
   Dimitriou R, 2005, INJURY, V36, pS51, DOI 10.1016/j.injury.2005.10.010
   Enneking WE, 2001, J BONE JOINT SURG AM, V83A, P971, DOI 10.2106/00004623-200107000-00001
   Friedlaender Gary E, 2004, Surg Technol Int, V13, P249
   GOLDBERG VM, 1987, CLIN ORTHOP RELAT R, P7
   Habibovic P, 2006, J ORTHOP RES, V24, P867, DOI 10.1002/jor.20115
   Hanada K, 1997, J BONE MINER RES, V12, P1606, DOI 10.1359/jbmr.1997.12.10.1606
   HEIPLE KG, 1963, J BONE JOINT SURG AM, V45, P1593, DOI 10.2106/00004623-196345080-00003
   Itokazu M, 1998, J BIOMED MATER RES, V39, P536, DOI 10.1002/(SICI)1097-4636(19980315)39:4<536::AID-JBM5>3.0.CO;2-K
   Kanayama M, 2006, SPINE, V31, P1067, DOI 10.1097/01.brs.0000216444.01888.21
   Korhonen RK, 2002, J BIOMECH, V35, P903, DOI 10.1016/S0021-9290(02)00052-0
   Kurashina K, 2002, BIOMATERIALS, V23, P407, DOI 10.1016/S0142-9612(01)00119-3
   LENNON DP, 1995, EXP CELL RES, V219, P211, DOI 10.1006/excr.1995.1221
   Li RH, 2001, TRENDS BIOTECHNOL, V19, P255, DOI 10.1016/S0167-7799(01)01665-1
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   Manjubala I, 2002, J BIOMED MATER RES, V63, P200, DOI 10.1002/jbm.10128
   Pecina M, 2001, INT ORTHOP, V25, P203, DOI 10.1007/s002640100262
   PELKER RR, 1983, CLIN ORTHOP RELAT R, P54
   Pluhar GE, 2006, J BONE JOINT SURG BR, V88B, P960, DOI 10.1302/0301-620X.88B7.17056
   Salkeld SL, 2001, J BONE JOINT SURG AM, V83A, P803, DOI 10.2106/00004623-200106000-00001
   SAMPATH TK, 1992, J BIOL CHEM, V267, P20352
   SCHOUTENS AJ, 1993, BONE CIRCULATION VAS, P121
   SUMMERS BN, 1989, J BONE JOINT SURG BR, V71, P677
   Taichman RS, 1996, EXP HEMATOL, V24, P509
   TAKAOKA K, 1988, CLIN ORTHOP RELAT R, P250
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   URIST MR, 1984, P NATL ACAD SCI-BIOL, V81, P371, DOI 10.1073/pnas.81.2.371
   URIST MR, 1984, CLIN ORTHOP RELAT R, P277
   Verdonschot N, 2001, J BIOMED MATER RES, V58, P599, DOI 10.1002/jbm.1058
   WESTERGRENTHORSSON G, 1991, J CELL PHYSIOL, V147, P523, DOI 10.1002/jcp.1041470319
   Wozney J M, 1989, Prog Growth Factor Res, V1, P267, DOI 10.1016/0955-2235(89)90015-X
   Zhang Y, 2002, J BIOMED MATER RES, V61, P1, DOI 10.1002/jbm.10176
   Zysset PK, 1999, J BIOMECH, V32, P1005, DOI 10.1016/S0021-9290(99)00111-6
NR 43
TC 27
Z9 34
U1 0
U2 15
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2007
VL 17
IS 5
BP 277
EP 289
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 207LC
UT WOS:000249251600003
PM 17851170
DA 2018-10-20
ER

PT J
AU Padois, K
   Rodriguez, F
AF Padois, K.
   Rodriguez, F.
TI Effects of chitosan addition to self-setting bone cement
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE bone cement; biomaterial; chitosan; mechanical properties;
   gamma-sterilization
ID CALCIUM-PHOSPHATE CEMENT; COMPOSITE SCAFFOLDS; ACID
AB The Cementek((R)) is a self-setting bone cement composed of a solid phase and a liquid phase. After mixing these two phases, it sets in situ to form an hydroxyapatite (HAp) as the only end product. It is difficult to introduce a new component into this cement without modifying the final product and its mechanical properties. In order to improve the mechanical properties of the Cementek((R)), a natural polymer (chitosan) was added in the initial formulation. Two types of chitosan were added into the Cementek((R)), at various concentration, in either the liquid or the solid phase. The effects of chitosan addition on the properties of the self-setting bone cement are examined. The different composites were characterized by the determination of the setting time, the chemical transformation by X-ray diffraction and mechanical tests. The chemical transformations were not affected by the addition of chitosan neither in the liquid nor in the solid phase. The maturation towards HAp appeared to be complete for all the composites. The setting time was decreased by the addition of chitosan in the solid phase. However the setting time value of each composite remained compatible with a practical use in situ. This study shows that the maturation mode of the samples directly affects the mechanical properties of the obtained composites. The sterilization of the cement with chitosan has been studied.
C1 Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA.
   Univ Toulouse 3, Fac Pharmaceut Sci, Pharm Galen Lab, F-31062 Toulouse 09, France.
RP Padois, K (reprint author), Stanford Univ, Dept Mat Sci & Engn, 416 Escondido Mall,Bldg 550,Room 555K, Stanford, CA 94305 USA.
EM kpadois@stanford.edu
CR Chappuis J, 1999, COLLOID SURFACE A, V156, P223, DOI 10.1016/S0927-7757(99)00075-8
   DRIESSENS FCM, 1993, J MATER SCI-MATER M, V4, P503, DOI 10.1007/BF00120130
   Fernandez E, 1998, J BIOMED MATER RES, V42, P403, DOI 10.1002/(SICI)1097-4636(19981205)42:3<403::AID-JBM8>3.0.CO;2-N
   Furlan L, 1996, POLYMER, V37, P843, DOI 10.1016/0032-3861(96)87263-6
   GONCALVES S, 2000, P 13 INT S CER MED B
   *GROUP FRANC ETUD, 1989, MAT COMP BAS POLYM
   HATIM Z, 1997, ACTUALITES BIOMATERI, V4, P209
   HATIM Z, 1998, THESIS U CHOUAIB JAD
   Lim LY, 1998, J BIOMED MATER RES, V43, P282
   Ratier A, 2001, BIOMATERIALS, V22, P897, DOI 10.1016/S0142-9612(00)00252-0
   Ren DW, 2005, CARBOHYD RES, V340, P2403, DOI 10.1016/j.carres.2005.07.022
   VIALA S, 1996, THESIS I NATL POLYTE
   Wan ACA, 1998, BIOMATERIALS, V19, P1309
   Xu HHK, 2002, BIOMATERIALS, V23, P193, DOI 10.1016/S0142-9612(01)00095-3
   Yokoyama A, 2002, BIOMATERIALS, V23, P1091, DOI 10.1016/S0142-9612(01)00221-6
   Zahraoui C, 1999, BONE, V25, p63S, DOI 10.1016/S8756-3282(99)00136-2
   Zhang Y, 2001, J BIOMED MATER RES, V55, P304, DOI 10.1002/1097-4636(20010605)55:3<304::AID-JBM1018>3.0.CO;2-J
   Zhao F, 2002, BIOMATERIALS, V23, P3227, DOI 10.1016/S0142-9612(02)00077-7
NR 18
TC 5
Z9 6
U1 0
U2 4
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2007
VL 17
IS 5
BP 309
EP 320
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 207LC
UT WOS:000249251600006
PM 17851173
DA 2018-10-20
ER

PT J
AU Zhou, GS
   Su, ZY
   Cai, YR
   Liu, YK
   Dai, LC
   Tang, RK
   Zhang, M
AF Zhou, Guo Shun
   Su, Zhong Yuan
   Cai, Yu Rong
   Liu, Yu Kan
   Dai, Li Cheng
   Tang, Rui Kang
   Zhang, Ming
TI Different effects of nanophase and conventional hydroxyapatite thin
   films on attachment, proliferation and osteogenic differentiation of
   bone marrow derived mesenchymal stem cells
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE hydroxyapatite; nanophase; mesenchymal stem cells
ID OSTEOBLASTS; RECONSTRUCTION; REGENERATION; INTERFACE; COMPOSITE;
   SCAFFOLDS; RESPONSES; CERAMICS; IMPLANTS; COATINGS
AB It is suggested that nanophase hydroxyapatite (nHAP) might have advantages over conventional hydroxyapatite (cHAP) as a biomaterial for bone regeneration. To be a satisfactory candidate for bone tissue engineering, it is important to support the growth and differentiation of bone marrow-derived mesenchymal stem cells (BMSCs). The purpose of this study is to determine whether nHAP as cell growth substrata could give better support for attachment, proliferation and osteogenic differentiation of BMSCs than cHAP. Materials and Methods: nHAP and cHAP films were prepared as the substrata for the cell growth. BMSCs obtained from rabbit were seeded on the films. Attachment, proliferation and osteogenic differentiation of BMSCs on the two kinds of films were evaluated. Results: Cell attachment ratio on nHAP films was significantly higher than that on cHAP films. Doubling time on nHAP films was significantly shorter than that on cHAP films. Amount of total proteins detected from cells cultured on nHAP films was significantly higher than that on cHAP films. However, alkaline phosphatase activity and osteocalcin content of the two groups showed no significant difference. Conclusions: nHAP films favored cell attachment and proliferation but not osteogenic differentiation of BMSCs compared with cHAP films.
C1 [Su, Zhong Yuan; Liu, Yu Kan; Zhang, Ming] Zhejiang Univ, Coll Life Sci, Dept Biotechnol, Hangzhou 310058, Peoples R China.
   [Zhou, Guo Shun; Dai, Li Cheng] Huzhou Cent Hosp, Huzhou Key Lab Mol Med, Huzhou, Zhejiang, Peoples R China.
   [Cai, Yu Rong; Tang, Rui Kang] Zhejiang Univ, Coll Sci, Dept Chem, Hangzhou, Peoples R China.
RP Zhang, M (reprint author), Zhejiang Univ, Coll Life Sci, Dept Biotechnol, 325 Room,Zi Jin Gang Campus, Hangzhou 310058, Peoples R China.
EM gfz@mail.huptt.zj.cn; Lyk_cn@yahoo.com.cn
CR Baharloo B, 2005, J BIOMED MATER RES A, V74A, P12, DOI 10.1002/jbm.a.30321
   Brett PM, 2004, BONE, V35, P124, DOI 10.1016/j.bone.2004.03.009
   CAI YR, 2007, J MATER CHEM, V17, P1
   Chistolini P, 1999, J MATER SCI-MATER M, V10, P739, DOI 10.1023/A:1008939524807
   Ito Y, 2004, J BIOMED MATER RES A, V69A, P454, DOI 10.1002/jbm.a.30014
   Jha LJ, 1997, J MATER SCI-MATER M, V8, P185, DOI 10.1023/A:1018531505484
   Kim HW, 2005, BIOMATERIALS, V26, P5221, DOI 10.1016/j.biomaterials.2005.01.047
   Kim HW, 2004, J BIOMED MATER RES B, V70B, P270, DOI 10.1002/jbm.b.30032
   Kim HW, 2004, J BIOMED MATER RES A, V68A, P522, DOI 10.1002/jbm.a..20094
   Liu Q, 1996, J MATER SCI-MATER M, V7, P551, DOI 10.1007/BF00122178
   Livingston TL, 2003, J MATER SCI-MATER M, V14, P211, DOI 10.1023/A:1022824505404
   MEHLISCH DR, 1990, ORAL SURG ORAL MED O, V70, P685, DOI 10.1016/0030-4220(90)90001-9
   Montanaro L, 2002, BIOMATERIALS, V23, P3651, DOI 10.1016/S0142-9612(02)00098-4
   NANCOLLAS GH, 1970, ARCH ORAL BIOL, V15, P731, DOI 10.1016/0003-9969(70)90037-3
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1
   Rosa Adalberto Luiz, 2003, Braz. Dent. J., V14, P16, DOI 10.1590/S0103-64402003000100003
   Sakai D, 2005, SPINE, V30, P2379, DOI 10.1097/01.brs.0000184365.28481.e3
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   SHELTON RM, 1988, BIOMATERIALS, V9, P24, DOI 10.1016/0142-9612(88)90065-8
   STEPHEN M, 2004, J CRANIOFAC SURG, V15, P34
   van den Dolder J, 2003, BIOMATERIALS, V24, P1745, DOI 10.1016/S0142-9612(02)00537-9
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
NR 23
TC 18
Z9 21
U1 0
U2 5
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2007
VL 17
IS 6
BP 387
EP 395
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 242JF
UT WOS:000251720700006
PM 18032820
DA 2018-10-20
ER

PT S
AU Ou, J
   Yin, GF
   Zhou, DL
   Chen, XC
   Yao, YD
   Yang, WZ
   Wu, BL
   Xue, M
   Cui, J
   Zhu, WF
   Kang, YQ
AF Ou, J.
   Yin, G. F.
   Zhou, D. L.
   Chen, X. C.
   Yao, Y. D.
   Yang, W. Z.
   Wu, B. L.
   Xue, M.
   Cui, J.
   Zhu, W. F.
   Kang, Y. Q.
BE Zhang, XD
   Li, XD
   Fan, HS
   Liu, XY
TI Preparation of merwinite with apatite-formimg ability by sol-gel process
SO BIOCERAMICS, VOL 19, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 19th International Symposium on Ceramics in Medicine
CY OCT 10-13, 2006
CL Chengdu, PEOPLES R CHINA
SP Int Soc Ceram Med
DE merwinite; hydroxyapatite; powder; simulated body fluid
ID DIOPSIDE
AB Merwinite powders were synthesized by a sol-gel process. The bioactivity in vitro of merwinite was investigated by soaking the powders in simulated body fluid (SBF), the growth of hydroxyapatite(HAp) on the surface of the powder was evaluated in various time. It was found that hydroxyapatite was formed after soaking for 14 days. The results indicate that merwinite possessed apatite-formation ability might be a potential candidate biomaterial for hard tissue repair.
C1 [Ou, J.; Yin, G. F.; Zhou, D. L.; Chen, X. C.; Yao, Y. D.; Yang, W. Z.; Xue, M.; Kang, Y. Q.] Sichuan Univ, Coll Mat Sci & Engn, Chengdu 610064, Peoples R China.
   [Cui, J.] Sichuan Univ, West China Coll Stomatol, Dept Prosthodont, Chengdu 610064, Peoples R China.
   [Ou, J.; Wu, B. L.; Zhu, W. F.] Guin Univ Technol, Dept Mat Engn, Guin 541004, Peoples R China.
RP Yin, GF (reprint author), Sichuan Univ, Coll Mat Sci & Engn, Chengdu 610064, Peoples R China.
EM gloujun@126.com; nic0700@scu.edu.cn
FU National High Technology Research and Development Program of
   China(863programs) [2002AA326080]
FX This study was supported by the National High Technology Research and
   Development Program of China(863programs),Grant no.2002AA326080
CR DeAza PN, 1997, BIOMATERIALS, V18, P1285, DOI 10.1016/S0142-9612(97)00063-X
   FRESA R, 1995, BIOMATERIALS, V16, P1249, DOI 10.1016/0142-9612(95)98132-X
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Iwata NY, 2004, COLLOID SURFACE B, V33, P1, DOI 10.1016/j.colsurfb.2003.07.004
   JUHASZ JA, 2003, J MATER SCI-MATER M, V14, P490
   KOKUBO T, 1991, BIOMATERIALS, V12, P155, DOI 10.1016/0142-9612(91)90194-F
   MARTINEZ A, 2001, J SOL-GEL SCI TECHN, V21, P13
   Nonami T, 1999, J MATER SCI-MATER M, V10, P475, DOI 10.1023/A:1008996908797
   Vallet-Regi M, 1999, J BIOMED MATER RES, V44, P416, DOI 10.1002/(SICI)1097-4636(19990315)44:4<416::AID-JBM7>3.0.CO;2-S
   Wu CT, 2005, BIOMATERIALS, V26, P2925, DOI 10.1016/j.biomaterials.2004.09.019
NR 10
TC 6
Z9 6
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2007
VL 330-332
BP 67
EP +
DI 10.4028/www.scientific.net/KEM.330-332.67
PN 1-2
PG 2
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Biomaterials; Materials Science, Composites
SC Materials Science
GA BFV88
UT WOS:000245026800017
DA 2018-10-20
ER

PT S
AU Liao, J
   Mo, AC
   Wu, HK
   Zhang, JC
   Li, YB
   Lv, GY
AF Liao, Juan
   Mo, Anchun
   Wu, Hongkun
   Zhang, Jingchao
   Li, Yubao
   Lv, Guoyu
BE Zhang, XD
   Li, XD
   Fan, HS
   Liu, XY
TI Antibacterial activity of silver-hydroxyapatite/titania nanoparticles on
   oral bacteria
SO BIOCERAMICS, VOL 19, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 19th International Symposium on Ceramics in Medicine
CY OCT 10-13, 2006
CL Chengdu, PEOPLES R CHINA
SP Int Soc Ceram Med
DE hydroxyapatite; sliver; TiO2; antibacterial activity; oral bacteria;
   MICs
ID ZEOLITE
AB Since bacterial accumulation surrounding biomaterials has pathogens known to cause the biomaterials centered infection, it may be important to develop some kind of biomaterial with antibacterial activity as well as biocompatibility. This study focused on evaluating the antibacterial activity of silver-hydroxyapatite/Titania nanoparticles (Ag-nHA/nTiO(2)) against oral bacteria with agar dilution method. Bacteria were seeded on agar plate containing antibacterial material with different concentrations after incubation of 48 hours. The antibacterial activity was demonstrated by MICs. The MICs of Ag-nHA/nTiO(2) ranged between 1000 mu g/ml and 7500 mu g/ml under anaerobic conditions. And it also exhibited remarkable antibacterial activity to all the aerobe bacteria (MIC <= 500 mu g/ml). On the other hand, the antibacterial activities of Ag-nHA/nTiO(2) differentiate to some extent with the bacterial strains. This Ag-nHA/nTiO(2) exhibited remarkable antibacterial activity to anaerobic and aerobe bacteria. This antibacterial effect may reduce the potential for bacterial colonisation of oral biomaterials with Ag-nHA/nTiO(2).
C1 [Liao, Juan; Mo, Anchun; Wu, Hongkun; Zhang, Jingchao] Sichuan Univ, West China Coll Stomatol, Chengdu 610041, Peoples R China.
   [Li, Yubao; Lv, Guoyu] Sichuan Univ, Res Ctr Nano BioMat, Chengdu 610041, Peoples R China.
   [Liao, Juan; Mo, Anchun; Wu, Hongkun; Zhang, Jingchao] Minist Educ, Key Lab Oral Biomed Engn, Chengdu 610041, Peoples R China.
RP Lv, GY (reprint author), Sichuan Univ, West China Coll Stomatol, Chengdu 610041, Peoples R China.
EM juan123liao@163.com; moanchun@163.com; whk-mo@263.net;
   joice2000-2004@sohu.com; nic7504@scu.edu.cn; lgyhxy@yahoo.com.cn
CR Bekbolet M, 1996, CHEMOSPHERE, V32, P959, DOI 10.1016/0045-6535(95)00359-2
   Brook I, 1997, J ANTIMICROB CHEMOTH, V39, P763, DOI 10.1093/jac/39.6.763
   Darouiche RO, 1999, CLIN INFECT DIS, V29, P1371, DOI 10.1086/313561
   ELEK SD, 1957, BRIT J EXP PATHOL, V38, P573
   GENCO RJ, 1992, J PERIODONTOL, V63, P338, DOI 10.1902/jop.1992.63.4s.338
   Grier N., 1983, SILVER ITS COMPOUNDS, P375
   Guggenbichler JP, 1999, INFECTION, V27, pS16, DOI 10.1007/BF02561612
   Hotta M, 1998, J ORAL REHABIL, V25, P485, DOI 10.1046/j.1365-2842.1998.00265.x
   Kawahara K, 2000, DENT MATER, V16, P452, DOI 10.1016/S0109-5641(00)00050-6
   SALTON MRJ, 1994, BACTERIAL CELL WALL, P1
   WICKEN AJ, 1985, BACTERIAL ADHESION M, P45
   Yoshinari M, 2000, J BIOMED MATER RES, V52, P388, DOI 10.1002/1097-4636(200011)52:2<388::AID-JBM20>3.0.CO;2-E
NR 12
TC 5
Z9 6
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2007
VL 330-332
BP 299
EP +
DI 10.4028/www.scientific.net/KEM.330-332.299
PN 1-2
PG 2
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Biomaterials; Materials Science, Composites
SC Materials Science
GA BFV88
UT WOS:000245026800074
DA 2018-10-20
ER

PT S
AU Ploska, U
   Berger, G
AF Ploska, U.
   Berger, G.
BE Zhang, XD
   Li, XD
   Fan, HS
   Liu, XY
TI Spongiosa-like specimen and foils of a biomaterial composed of
   fluorapatite and calcium zirconium phosphate
SO BIOCERAMICS, VOL 19, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 19th International Symposium on Ceramics in Medicine
CY OCT 10-13, 2006
CL Chengdu, PEOPLES R CHINA
SP Int Soc Ceram Med
DE apatite; calcium zirconium phosphate; spongiosa-like specimen; foil
AB A long-term stable material, which has two main crystalline phases - fluorapatite (FA) and calcium zirconium phosphate (CZP) [1, 2] and could be processed to dense sintered samples was tested related to the use with two application forms - spongiosa-like specimen and foils. The suitability of various sintering additives was investigated alone and in diverse combinations. During sintering of the spongiosa-like samples volume shrinkage of about 50% was observed whereas the shrinkage in x,y plane was about twice of the shrinkage in z direction. The cuboid form was not affected by the shrinkage. The compression strength of the spongiosa-like materials was in the range of 1MPa up to 1.6MPa. A ceramic foil was generated via foil slip casting of a slip containing about 38vol% of FA-CZP. Temperature programs were created for debindering and sintering of the green foil and the four-fold laminate, respectively.
C1 [Ploska, U.; Berger, G.] Fed Inst Mat Res & Testing, Unter Eichen 87, D-12200 Berlin, Germany.
RP Ploska, U (reprint author), Fed Inst Mat Res & Testing, Unter Eichen 87, D-12200 Berlin, Germany.
EM ute.ploska@bam.de; georg.berger@bam.de
FU German Research Foundation (DFG), Bonn [BE 1339/8-3]
FX Financial support (BE 1339/8-3) by the German Research Foundation (DFG),
   Bonn, is gratefully acknowledged. Special thanks go to Ms. Annika
   Jaenicke for the preparation of the spongiosa-like specimen and Mr.
   Wolfgang Guther for generating the foil.
CR Berger G, 2003, KEY ENG MAT, V240-2, P607, DOI 10.4028/www.scientific.net/KEM.240-242.607
   OVERGAARD S, 1997, CLIN ORTHOP RELAT R, V336, P2866
   PLOSKA U, 2002, P 17 EUR SOC BIOM C, pL54
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   SZMUKLERMONCLER S, 1992, ADV BIOMAT, V10, P377
   VERBEECK RMH, 1980, BER BUNSEN PHYS CHEM, V84, P159, DOI 10.1002/bbpc.19800840209
   Willmann G., 2001, KEY ENG MATER, V192-195, P111
NR 7
TC 0
Z9 0
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2007
VL 330-332
BP 443
EP +
DI 10.4028/www.scientific.net/KEM.330-332.443
PN 1-2
PG 2
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Biomaterials; Materials Science, Composites
SC Materials Science
GA BFV88
UT WOS:000245026800109
DA 2018-10-20
ER

PT S
AU Li, J
   Wang, YH
   Huang, Y
   He, F
   Wan, YZ
AF Li, Jian
   Wang, Yuhn
   Huang, Yuan
   He, Fang
   Wan, Yizao
BE Zhang, XD
   Li, XD
   Fan, HS
   Liu, XY
TI Study on interface reaction and its control of titanium
   fiber-hydroxyapatite composites
SO BIOCERAMICS, VOL 19, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 19th International Symposium on Ceramics in Medicine
CY OCT 10-13, 2006
CL Chengdu, PEOPLES R CHINA
SP Int Soc Ceram Med
DE interface; titanium fiber; hydroxyapatite; composites
AB Various reinforcements have been used to reinforce hydroxyapatite composites. Bioactivity of hydroxyapatite and excellent mechanical properties of titanium make titanium fiber reinforced hydroxyapatite composite a promising biomaterial. In this work, a titanium fiber was chosen as the reinforcement, and hydroxyapatite powders prepared by wet precipitation method were used as matrix material. The interface between titanium fiber and hydroxyapatite was investigated in terms of microstructure and chemical composition using a combination of scanning electron microscopy (SEM), X-ray diffraction (XRD) and energy disperse spectroscopy (EDS). Experimental results showed that titanium/hydroxyapatite composite with controllable interface could be made by choosing proper preparation method.
C1 [Li, Jian; Wang, Yuhn; Huang, Yuan; He, Fang; Wan, Yizao] Tianjin Univ, Sch Mat Sci & Engn, Tianjin 300072, Peoples R China.
RP Li, J (reprint author), Tianjin Univ, Sch Mat Sci & Engn, Tianjin 300072, Peoples R China.
EM yzwantju@yahoo.com
CR HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   JANSEN JA, 1991, J BIOMED MATER RES, V25, P973, DOI 10.1002/jbm.820250805
   JI HX, 1992, J MATER SCI-MATER M, V3, P283, DOI 10.1007/BF00705294
   Knepper M, 1997, BIOMATERIALS, V18, P1523, DOI 10.1016/S0142-9612(97)00066-5
   Miao X, 2001, J MATER SCI, V36, P3323, DOI 10.1023/A:1017915226015
   Ning CQ, 2002, BIOMATERIALS, V23, P2909, DOI 10.1016/S0142-9612(01)00419-7
   Popa C, 2005, J MATER SCI-MATER M, V16, P1165, DOI 10.1007/s10856-005-4724-5
   Ruan Jian-ming, 2003, Chinese Journal of Nonferrous Metals, V13, P1361
   Yang YZ, 2004, BIOMATERIALS, V25, P2927, DOI 10.1016/j.biomaterials.2003.09.072
NR 9
TC 0
Z9 0
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2007
VL 330-332
BP 507
EP +
DI 10.4028/www.scientific.net/KEM.330-332.507
PN 1-2
PG 2
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Biomaterials; Materials Science, Composites
SC Materials Science
GA BFV88
UT WOS:000245026800125
DA 2018-10-20
ER

PT S
AU Yang, L
   Van Blitterswijk, CA
   Barrere, F
AF Yang, L.
   Van Blitterswijk, C. A.
   Barrere, F.
BE Zhang, XD
   Li, XD
   Fan, HS
   Liu, XY
TI pDNA and calcium phosphate co-precipitation on titanium alloy plate
SO BIOCERAMICS, VOL 19, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 19th International Symposium on Ceramics in Medicine
CY OCT 10-13, 2006
CL Chengdu, PEOPLES R CHINA
SP Int Soc Ceram Med
DE plasmid DNA; calcium phosphate coating; gene delivery; co-precipitation
AB DNA transfection by biomaterial is a promising strategy to stimulate cells in tissue engineering. Co-precipitation of Calcium Phosphate (CaP) with plasmid DNA (pDNA) is known for several decades as non-viral transfection agent [1]. In this study, we report the co-precipitation of different pDNA into biomimetic calcium phosphate coating onto titanium alloy (Ti) plates in order to evaluate their efficiency of incorporation. And it is possible to tune the rate of coprecipitation by changing the volume of Calcium Phosphate Solution (CPS) and the [pDNA]. The structure of coating was affected by the presence of DNA in CPS solution.
C1 [Yang, L.; Van Blitterswijk, C. A.; Barrere, F.] Univ Twente, Inst Biomed Technol, POB 217, NL-7500 AE Enschede, Netherlands.
RP Yang, L (reprint author), Univ Twente, Inst Biomed Technol, POB 217, NL-7500 AE Enschede, Netherlands.
EM Y.Liang-1@tnw.utwente.nl; C.A.Vanblitterswijk@tnw.utwente.nl;
   F.Y.F.Barrere@tnw.utwente.nl
OI van Blitterswijk, Clemens/0000-0003-2371-4615
FU EC [G5RD-CT-2002-00738]
FX This project is funded by the EC G5RD-CT-2002-00738.
CR Barrere F, 2001, J MATER SCI-MATER M, V12, P529, DOI 10.1023/A:1011271713758
   SAMBROOK J, 2001, MOL CLONING LAB MANU, P1614
NR 2
TC 0
Z9 0
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2007
VL 330-332
BP 621
EP +
DI 10.4028/www.scientific.net/KEM.330-332.621
PN 1-2
PG 2
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Biomaterials; Materials Science, Composites
SC Materials Science
GA BFV88
UT WOS:000245026800153
DA 2018-10-20
ER

PT S
AU Chen, WC
   Bao, CY
   Jeyachandran, YL
   Out, GM
   Fan, HS
   Liao, YM
   Zhang, XD
AF Chen, W. C.
   Bao, C. Y.
   Jeyachandran, Y. L.
   Out, G. M.
   Fan, H. S.
   Liao, Y. M.
   Zhang, X. D.
BE Zhang, XD
   Li, XD
   Fan, HS
   Liu, XY
TI Exploring antibacterial and antiadhesive activities of titanium surface
   modified with hydroxyapatite sol-gel containing silver
SO BIOCERAMICS, VOL 19, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 19th International Symposium on Ceramics in Medicine
CY OCT 10-13, 2006
CL Chengdu, PEOPLES R CHINA
SP Int Soc Ceram Med
DE percutaneous devices; permucosal devices; antibacterial biomaterial;
   sol-gel
ID ADHESION
AB Circumambient tissues infection is a common complication of implanted percutaneous and permucosal devices (PDs). In order to Counter the infection, the titanium abutment surface of PDs was modified to achieve antibacterial and antiadhesive activities. Titanium discs were immersed into hydroxyapatite (HA) sol containing different mass fraction silver and thermally treated to get modified discs. The modified discs become more smoother and get crystal HA coatings containing silver. Silver ion release test demonstrate the release rate is very slow and the coating is a reservoir of silver. The antibacterial and antiadhesive effects of modified discs on Staphylococcus aureus and Porphyromonas gingivalis were evaluated. Modified titanium discs with silver significantly inhibited the growth of these two bacteria compared with both the polished titanium discs control and modified titanium discs without silver. And titanium discs modified with more silver have higher antibacterial activity and less bacteria adhesion in this study. These findings indicate that titanium surface modified with the HA sol-gel containing silver could achieve antibacterial and antiadhesive activities, and the abutments of PDs are promising to be modified by this method.
C1 [Chen, W. C.; Bao, C. Y.; Out, G. M.; Liao, Y. M.] Sichuan Univ, West China Sch Stomatol, Chengdu 610041, Peoples R China.
   [Jeyachandran, Y. L.] Bharathiar Univ, Dept Phys, Coimbatore 641046, Tamil Nadu, India.
   [Fan, H. S.; Zhang, X. D.] Sichuan Univ, Engn Res Ctr Biomat, Chengdu 610065, Peoples R China.
RP Bao, CY (reprint author), Sichuan Univ, West China Sch Stomatol, Chengdu 610041, Peoples R China.
EM cwc_ren@sohu.com; cybao9933@sina.com
FU Basic Application Research Project of Science and Technology Department
   of Sichuan province, China [05JY029-004-2]
FX This work was supported by the Basic Application Research Project of
   Science and Technology Department of Sichuan province, China. (Contract
   NO. 05JY029-004-2)
CR GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Katsaros D, 2004, IEEE INTERNET COMPUT, V8, P37, DOI 10.1109/MIC.2004.1297272
   Scheideler L, 2003, MAT SCI ENG C-BIO S, V23, P455, DOI 10.1016/S0928-4931(02)00321-1
   Schierholz JM, 1998, J HOSP INFECT, V40, P257, DOI 10.1016/S0195-6701(98)90301-2
   Shibata Y, 2004, J DENT RES, V83, P115, DOI 10.1177/154405910408300206
   Yoshinari M, 2000, J BIOMED MATER RES, V52, P388, DOI 10.1002/1097-4636(200011)52:2<388::AID-JBM20>3.0.CO;2-E
   Zhao BH, 2005, SURF COAT TECH, V193, P366, DOI 10.1016/j.surfcoat.2004.07.041
NR 7
TC 2
Z9 2
U1 0
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2007
VL 330-332
BP 653
EP +
DI 10.4028/www.scientific.net/KEM.330-332.653
PN 1-2
PG 2
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Biomaterials; Materials Science, Composites
SC Materials Science
GA BFV88
UT WOS:000245026800161
DA 2018-10-20
ER

PT S
AU Chen, B
   Wu, XY
   Peng, XH
AF Chen, Bin
   Wu, Xinyan
   Peng, Xianghe
BE Zhang, XD
   Li, XD
   Fan, HS
   Liu, XY
TI Research on the layered microstructure of shankbone
SO BIOCERAMICS, VOL 19, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 19th International Symposium on Ceramics in Medicine
CY OCT 10-13, 2006
CL Chengdu, PEOPLES R CHINA
SP Int Soc Ceram Med
DE shankbone; layered microstructure; hydroxyapatite sheet; pullout force
ID BONE
AB Bone is a kind of biomaterial in nature. It behaves favorable strength, stiffness and fracture toughness which are closely related to its fine microstructure. SEM observation on a shankbone shows that the bone is a kind of natural bioceramic composite consisted of hydroxyapatite layers and collagen matrix. The observation also shows that the hydroxyapatite layers consist of many hydroxyapatite sheets and are arranged in a parallel distribution. The fracture toughness of the bone is analyzed based on the representative model of the microstructure of the bone and the idea of maximum pullout force. The analytical result shows that the long and thin shape as well as the parallel distribution of the hydroxyapatite sheets improves the maximum Pullout force of the sheets and the fracture toughness of the bone.
C1 [Chen, Bin; Wu, Xinyan; Peng, Xianghe] Chongqing Univ, Dept Mech Engn, Coll Resources & Environm Sci, Chongqing 400044, Peoples R China.
RP Chen, B (reprint author), Chongqing Univ, Dept Mech Engn, Coll Resources & Environm Sci, Chongqing 400044, Peoples R China.
EM bchen@cqu.edu.cn; cdxywu@163.com; xpeng@cqu.edu.cn
FU Natural Science Foundations of China [10572157, 10272120]
FX The authors gratefully acknowledge the financial supports to this work
   from the Natural Science Foundations of China (Grant no. 10572157 and
   10272120).
CR CHONG KP, 1999, MECH AAM, V28, P1
   Currey JD, 2003, J BIOMECH, V36, P1487, DOI 10.1016/S0021-9290(03)00124-6
   HOGAN HA, 1992, P AM SOC COM, P196
   Katti DR, 2001, COMPUT THEOR POLYM S, V11, P397, DOI 10.1016/S1089-3156(01)00012-5
   SARIKAYA M, 1989, P AM COMP, P176
   Zioupos P, 1998, BONE, V22, P57, DOI 10.1016/S8756-3282(97)00228-7
NR 6
TC 2
Z9 2
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2007
VL 330-332
BP 785
EP +
DI 10.4028/www.scientific.net/KEM.330-332.785
PN 1-2
PG 2
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Biomaterials; Materials Science, Composites
SC Materials Science
GA BFV88
UT WOS:000245026800193
DA 2018-10-20
ER

PT S
AU Xu, JL
   Khor, KA
   Chen, WN
AF Xu, J. L.
   Khor, Khiam Aik
   Chen, W. N.
BE Zhang, XD
   Li, XD
   Fan, HS
   Liu, XY
TI A study of osteocalcin production in vitro on various hydroxyapatite
   based biomaterials
SO BIOCERAMICS, VOL 19, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 19th International Symposium on Ceramics in Medicine
CY OCT 10-13, 2006
CL Chengdu, PEOPLES R CHINA
SP Int Soc Ceram Med
DE osteocalcin; hydroxyapatite; in vitro; spark plasma sintering
ID SUBSTITUTED HYDROXYAPATITE; APATITE LAYER; BONE; ADHESION
AB Hydroxyapatite based biomaterials were prepared by a spark plasma sintering technology. The human limb-derived osteoblasts were cultured on the various biomaterial, surfaces (HA, RF21, 1SiHA and 5SiHA) for up to two weeks to investigate the cellular behaviors. The bone gammacarboxyglutamic protein or osteocalcin in the medium were determined at different periods of cell culture. The results indicated that a combined effect of bioceramic surface composition and surface morphology had influenced the osteoblast behaviors. The amount of osteocalcin in the medium increased in the initial periods of culture but decreased in the late periods of culture.
C1 [Xu, J. L.; Khor, Khiam Aik] Nanyang Technol Univ, Sch Mech & Aerosp Engn, 50 Nanyang Ave, Singapore 639798, Singapore.
   [Chen, W. N.] Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore 639798, Singapore.
RP Xu, JL (reprint author), Nanyang Technol Univ, Sch Mech & Aerosp Engn, 50 Nanyang Ave, Singapore 639798, Singapore.
EM jlxu@ntu.edu.sg; mkakhor@ntu.edu.sg; wnchen@ntu.edu.sg
RI Khor, Khiam Aik (Michael)/B-6929-2009; Khor, Khiam Aik/G-2827-2010
OI KHOR, Khiam/0000-0003-1954-8423
CR Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   Loty C, 2000, J BIOMED MATER RES, V49, P423, DOI 10.1002/(SICI)1097-4636(20000315)49:4<423::AID-JBM1>3.3.CO;2-Z
   Matsuura T, 2000, BIOMATERIALS, V21, P1121, DOI 10.1016/S0142-9612(99)00264-1
   Porter AE, 2004, BIOMATERIALS, V25, P3303, DOI 10.1016/j.biomaterials.2003.10.006
   Rammelt S, 2005, J BIOMED MATER RES A, V73A, P284, DOI 10.1002/jbm.a.30263
   Thian ES, 2006, BIOMATERIALS, V27, P2692, DOI 10.1016/j.biomaterials.2005.12.019
   Webster TJ, 2004, BIOMATERIALS, V25, P4731, DOI 10.1016/j.biomaterials.2003.12.002
   Weng J, 1997, BIOMATERIALS, V18, P1027, DOI 10.1016/S0142-9612(97)00022-7
   Xu JL, 2005, BIOMATERIALS, V26, P2197, DOI 10.1016/j.biomaterials.2004.06.042
NR 9
TC 0
Z9 0
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2007
VL 330-332
BP 897
EP +
DI 10.4028/www.scientific.net/KEM.330-332.897
PN 1-2
PG 2
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Biomaterials; Materials Science, Composites
SC Materials Science
GA BFV88
UT WOS:000245026800220
DA 2018-10-20
ER

PT S
AU Chen, XF
   Wang, YJ
   Zhao, NR
   Yang, CR
AF Chen, Xiaofeng
   Wang, Yingjun
   Zhao, Naru
   Yang, Chunrong
BE Zhang, XD
   Li, XD
   Fan, HS
   Liu, XY
TI Investigation on the biomimetic scaffold for bone tissue engineering
   based on bioglass-collagen-hyaluronic acid-phosphatidylserine
SO BIOCERAMICS, VOL 19, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 19th International Symposium on Ceramics in Medicine
CY OCT 10-13, 2006
CL Chengdu, PEOPLES R CHINA
SP Int Soc Ceram Med
DE biomaterial; biomimetics; composite; porous structure; tissue
   engineering
AB The new type of bone tissue engineering scaffold composed of the sol-gel derived bioactive glass particles, type I collagen, hyaluronic acid and phosphatidylserine were prepared through cross-linking and freeze-drying techniques. SEM observation indicated that the scaffold possessed a 3-D interconnected porous structure and a high porosity. The properties of bio-mineralization and cells biocompatibility were investigated using SBF immersion and cells Culture methods combined with SEM, XRD and FTIR techniques. The study revealed that this biomimetic scaffold possessed satisfactory functions of cells attachment, bio-mineralization, and cells biocompatibility. The porous structure and the surface of the scaffold which was covered by a bone-like HA crystal layer due to bio-mineralization were profitable for cells attachment and spread.
C1 [Chen, Xiaofeng; Wang, Yingjun; Zhao, Naru; Yang, Chunrong] South China Univ Technol, Coll Mat Sci & Engn, Biomat Res Inst, Guangzhou 510640, Guangdong, Peoples R China.
   [Chen, Xiaofeng; Wang, Yingjun; Zhao, Naru; Yang, Chunrong] Minst Educ South China Univ Technol, Key Lab Specially Funct Mat, Guangzhou, Peoples R China.
RP Chen, XF (reprint author), South China Univ Technol, Coll Mat Sci & Engn, Biomat Res Inst, Guangzhou 510640, Guangdong, Peoples R China.
EM chenxf@scut.edu.cn
FU National Key Basic Research 973 Program of China [2005CB623902];
   National Natural Science Foundation of China (NSFC) [50472054,
   50572029]; Natural Science Foundation Project Grants of Guangdong
   [4205786, 05006587]; Project of Science and Technology of Guangzhou
   [2003Z1-D0021]
FX The authors acknowledge the financial supports for this study through
   the National Key Basic Research 973 Program of China (Grant
   no.2005CB623902), National Natural Science Foundation of China (NSFC)
   Project Grant 50472054 and 50572029, Natural Science Foundation Project
   Grants of Guangdong (4205786 and 05006587), and the Project of Science
   and Technology of Guangzhou (2003Z1-D0021), P.R. China.
CR Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Kellomaki M, 2000, BIOMATERIALS, V21, P2495, DOI 10.1016/S0142-9612(00)00117-4
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   STAMBOULIS A, 2001, KEY ENG MATER, V192, P729
   Stamboulis AG, 2002, ADV ENG MATER, V4, P105, DOI 10.1002/1527-2648(200203)4:3<105::AID-ADEM105>3.3.CO;2-C
NR 5
TC 1
Z9 1
U1 2
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2007
VL 330-332
BP 939
EP +
DI 10.4028/www.scientific.net/KEM.330-332.939
PN 1-2
PG 2
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Biomaterials; Materials Science, Composites
SC Materials Science
GA BFV88
UT WOS:000245026800230
DA 2018-10-20
ER

PT S
AU Takemoto, M
   Fujibayashi, S
   Neo, M
   So, K
   Akiyama, N
   Matsushita, T
   Kokubo, T
   Nakamura, T
AF Takemoto, M.
   Fujibayashi, S.
   Neo, M.
   So, K.
   Akiyama, N.
   Matsushita, T.
   Kokubo, T.
   Nakamura, T.
BE Zhang, XD
   Li, XD
   Fan, HS
   Liu, XY
TI Bone ingrowth into porous bioactive titanium implant for load-bearing
   use: Experimental study using a novel canine anterior interbody fusion
   model
SO BIOCERAMICS, VOL 19, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 19th International Symposium on Ceramics in Medicine
CY OCT 10-13, 2006
CL Chengdu, PEOPLES R CHINA
SP Int Soc Ceram Med
DE titanium; porous; spine; interbody fuision; animal experiment
AB We have developed a porous titanium implant sintered with spacer particles (porosity = 50 %, average pore size +/- standard deviation = 303 +/- 152 mu m, yield compression strength 100MPa). This porous titanium was successfully treated with chemical and thermal treatment that gives a bioactive inicro-porous titania layer on the titanium surface, and it is expected as effective biomaterial for biological fixation on load bearing condition. In this study, ten adult female beagle dogs underwent anterior lumbar interbody fusion at L6-7 using either BT-implant or non-treated implant (NT-inplant), then followed by posterior interspinous wiring and facet screw fixation. The radiographic evaluations were performed 1, 2 and 3 months postoperatively using X-ray fluoroscopy. Animals were sacrificed after 3 months postoperatively, and fusion status was evaluated by manual palpation. Histological evaluation was also performed. Both histological and radiological evaluation revealed that interbody fusion was achieved in 5 of 5 dogs (100%) in BT-group and 3 of 5 dogs (60%) in NT-group. In BT implants, we could observe a large amount of new bone formation from periphery to the center of the implant, whereas in NT implants, fibrous tissue formation was still observed even in the implants with successful fusion. The results of this study indicate that porous bioactive titanium implant will represent a new osteoconductive biomaterial with improved fusion characteristics.
C1 [Takemoto, M.; Fujibayashi, S.; Neo, M.; So, K.; Akiyama, N.; Nakamura, T.] Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Kyoto, Japan.
   [Matsushita, T.; Kokubo, T.] Chubu Univ, Sci & Technol Res Inst, Nagoya, Aichi, Japan.
RP Takemoto, M (reprint author), Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Kyoto, Japan.
EM m.take@kuhp.kyoto-u.ac.jp
CR Fujibayashi S, 2004, BIOMATERIALS, V25, P443, DOI 10.1016/S0142-9612(03)0051-9
   Takemoto M, 2006, BIOMATERIALS, V27, P2682, DOI 10.1016/j.biomaterials.2005.12.014
   Takemoto M, 2005, BIOMATERIALS, V26, P6014, DOI 10.1016/j.biomaterials.2005.03.019
   TAKEMOTO M, 2006, BIOCERAMICS, V18, P1095
   Wen CE, 2001, SCRIPTA MATER, V45, P1147, DOI 10.1016/S1359-6462(01)01132-0
NR 5
TC 0
Z9 0
U1 1
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2007
VL 330-332
BP 987
EP +
DI 10.4028/www.scientific.net/KEM.330-332.987
PN 1-2
PG 2
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Biomaterials; Materials Science, Composites
SC Materials Science
GA BFV88
UT WOS:000245026800242
DA 2018-10-20
ER

PT S
AU Wang, G
   Tan, YF
   Zhang, XD
   Zhang, YZ
AF Wang, G.
   Tan, Y. F.
   Zhang, X. D.
   Zhang, Y. Z.
BE Zhang, XD
   Li, XD
   Fan, HS
   Liu, XY
TI Development of EGFP-expressing cell line for biocompatibility evaluation
   of osteoinductive CaP ceramics
SO BIOCERAMICS, VOL 19, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 19th International Symposium on Ceramics in Medicine
CY OCT 10-13, 2006
CL Chengdu, PEOPLES R CHINA
SP Int Soc Ceram Med
DE biocompatibility; biomaterial; osteoinductive; EGFP; cell line
ID GREEN FLUORESCENT PROTEIN; MESENCHYMAL STEM-CELLS; MAMMALIAN-CELLS; GFP
AB This study investigated the utility of genetically modified cell line for fast and non-destructive cytotoxicity evaluation of biomaterials. The EGFP(enhanced green fluorescence protein)-expressing plasmid pcDNA-EGFP was constructed, and electroporated into ROS 17/28 osteoblastic cells to generate an EGFP-labeled stable cell line, ROS-EGFP. This genetically modified cell line provided two unique opportunities to qualitative and semi-quantitative evaluation of cell growth on biomaterials without destruction of samples. Firstly, utilizing the fluorescence of EGFP expressed in the cells, the viability state of cells on biomaterials was evaluated using a fluorescent light microscope. Secondly, the proliferation of cells on biomaterials, which was identified by MTT assay, was demonstrated according to the microscopically counted fluorescent cell numbers. From the results, it could be concluded that the ROS-EGFP cell line was an effective tool to trace the fate of cells on biomaterials and to evaluate the biocompatibility of biomaterials to cell growth in vitro.
C1 [Wang, G.; Zhang, Y. Z.] Sichuan Univ, Coll Life Sci, Chengdu 610064, Peoples R China.
   [Tan, Y. F.; Zhang, X. D.] Sichuan Univ, Engn Res Ctr Biomat, Chengdu 610064, Peoples R China.
RP Zhang, YZ (reprint author), Sichuan Univ, Coll Life Sci, Chengdu 610064, Peoples R China.
EM yizzhang@scu.edu.cn
CR Blum JS, 2004, BIOMATERIALS, V25, P5809, DOI 10.1016/j.biomaterials.2004.01.035
   Cheng LZ, 1996, NAT BIOTECHNOL, V14, P606, DOI 10.1038/nbt0596-606
   FARLEY JR, 1991, CALCIFIED TISSUE INT, V48, P297, DOI 10.1007/BF02556147
   Jansen JA, 2004, BIOMATERIALS, V25, P1461, DOI 10.1016/S0142-9612(03)00489-7
   Kotobuki N, 2005, BIOMATERIALS, V26, P779, DOI 10.1016/j.biomaterials.2004.03.020
   PINES J, 1995, TRENDS GENET, V11, P326, DOI 10.1016/S0168-9525(00)89092-7
   WILSON JK, 1990, BRIT J CANCER, V62, P189, DOI 10.1038/bjc.1990.258
   Xia ZD, 2005, BIOMATERIALS, V26, P5790, DOI 10.1016/j.biomaterials.2005.02.018
NR 8
TC 0
Z9 0
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2007
VL 330-332
BP 1079
EP +
DI 10.4028/www.scientific.net/KEM.330-332.1079
PN 1-2
PG 2
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Biomaterials; Materials Science, Composites
SC Materials Science
GA BFV88
UT WOS:000245026800264
DA 2018-10-20
ER

PT S
AU Teixeira, S
   Fernandes, HM
   de Boer, J
   Ferraz, MP
   Monteiro, FJ
AF Teixeira, S.
   Fernandes, H. M.
   de Boer, J.
   Ferraz, M. P.
   Monteiro, F. J.
BE Zhang, XD
   Li, XD
   Fan, HS
   Liu, XY
TI Mesenchymal stem cell proliferation and morphological analysis on
   interconnected macroporous structures
SO BIOCERAMICS, VOL 19, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 19th International Symposium on Ceramics in Medicine
CY OCT 10-13, 2006
CL Chengdu, PEOPLES R CHINA
SP Int Soc Ceram Med
DE macroporous ceramics; hydroxyapatite; cell adhesion; mesenchymal stem
   cells
AB Calcium phosphate ceramics are widely used as bone substitutes since they are biocompatible and bioactive. Given that their chemical composition is close to natural bone, calcium phosphate ceramics are promising bone substitute materials in orthopaedics, maxillofacial surgery and dentistry. Hvdroxyapatite (HA) and tricalcium phosphate (TCP) are the most commonly used calcium phosphates, because their calcium/phosphorus (Ca/P) ratios are close to that of natural bone and they are relatively stable in physiological environment. Furthermore, other critical parameters must be accomplished when designing a biomaterial for bone regeneration, namely: pore size, shape and interconnectivity [1]. Porosity is one of the most important factors since it influences the adhesion, migration nutrient supply and ultimately, proliferation of mesenchymal stem cells. In this study, HA scaffolds with controlled porosity were obtained and their capacity to support human and rat mesenchymal stem cells attachment and proliferation was evaluated.
C1 [Teixeira, S.] INEB, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.
   [Teixeira, S.; Monteiro, F. J.] Faculdade Engenharia Univ, Departamento Engenharia Metalurgica Mat, P-4200465 Oporto, Portugal.
   [Fernandes, H. M.; de Boer, J.] Univ Twente, Inst BioMed Technol, PBM, NL-3723 MB Bilthoven, Netherlands.
   [Ferraz, M. P.] Univ Fernando Pessoa, Faculdade Ciencias Saud, PL-4200150 Oporto, Portugal.
RP Teixeira, S (reprint author), INEB, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.
EM smsilva@ineb.up.pt; h.a.m.fernandes@tnw.utwente.nl;
   j.deboer@tnw.utwente.nl; mpferraz@ufp.pt; fjmont@ineb.up.pt
RI Ferraz, Maria/M-6316-2013; Fernandes, Hugo/H-6192-2014
OI Ferraz, Maria/0000-0002-0274-106X; Fernandes, Hugo/0000-0002-4574-7648;
   Monteiro, Fernando/0000-0002-1361-4605
FU Portuguese Foundation for Science and Technology (FCT)
   [SFRH/BD/17139/2004]; FCT project Col/CPNA [POCTI/SAU - BMA/56061/2004]
FX This work was supported by the Portuguese Foundation for Science and
   Technology (FCT) PhD grant SFRH/BD/17139/2004, and by FCT project
   Col/CPNA ref. POCTI/SAU - BMA/56061/2004.
CR Mastrogiacomo M, 2006, BIOMATERIALS, V27, P3230, DOI 10.1016/j.biomaterials.2006.01.031
   Moroni L, 2006, BIOMATERIALS, V27, P4911, DOI 10.1016/j.biomaterials.2006.05.027
   QUEIROZ AC, 2004, MATER SCI FORUM, P455
   QUEIROZ AC, 2004, KEY ENG MATER, P254
NR 4
TC 2
Z9 2
U1 0
U2 6
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2007
VL 330-332
BP 1129
EP +
DI 10.4028/www.scientific.net/KEM.330-332.1129
PN 1-2
PG 2
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Biomaterials; Materials Science, Composites
SC Materials Science
GA BFV88
UT WOS:000245026800276
DA 2018-10-20
ER

PT S
AU Chan, CW
   Lee, KM
   Qin, L
   Wong, KHK
   Yeung, HY
   Fan, HB
   Hu, YY
   Cheng, JCY
AF Chan, C. W.
   Lee, K. M.
   Qin, L.
   Wong, K. H. K.
   Yeung, H. Y.
   Fan, H. B.
   Hu, Y. Y.
   Cheng, J. C. Y.
BE Zhang, XD
   Li, XD
   Fan, HS
   Liu, XY
TI Mesenchymal stem cell derived osteogenic cells is superior to bone
   marrow aspirate impregnated biomaterial complex in posterior spinal
   fusion
SO BIOCERAMICS, VOL 19, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 19th International Symposium on Ceramics in Medicine
CY OCT 10-13, 2006
CL Chengdu, PEOPLES R CHINA
SP Int Soc Ceram Med
DE tricalcium phosphate; mesenchymal stem cell; posterior spinal fusion;
   bioceramics; bone marrow aspirate
ID EXPRESSION; CULTURE
AB The limited Source of autograft has prompted extensive research on bone substitute and biological enhancement of the fusion mass in spinal fusion. Biomaterials impregnated with bone marrow aspirate has been applied to spinal fusion surgery. In this study, the effect of stein cell therapy in enhancing posterior spinal fusion was compared with the bone marrow aspirate method in a standard rabbit model. Bone marrow was aspirated from rabbit proximal femur (BMA group, n=6) and loaded on beta-tricalcium phosphate ceramics (beta-TCP) in excess. The composite was then implanted onto L5 and L6 transverse processes of the same animal in posterior spinal fusion operation with decortication on the same day. For stein cell therapy group, mesenchymal stem cells (MSCs) were isolated from bone marrow aspirate by adherence on plastic culture-ware. The MSCs were treated with osteogenic supplements (OS) during ex vivo cell expansion (MSC group, n=6). The osteogenic cells were seeded on beta-TCP ceramics and Cultured for one day. The cell-ceramics composite was implanted into the same rabbit as BMA group. The ceramics acted as control (n=6). Three fluorochromes, tetracycline, xyelonol orange and caclein were injected at week 2, 4 and 6 sequentially. The spinal segments were harvested at week 7 post-operation. The manual palpation of vertebral joint was assesses for solid fusion. The gap distance of inter-transverse process was measured by microCT and the bone mineral content (BMC) and volume of transverse processes by peripheral quantitative computed tomography. The specimens were undergone undecalcified histological analysis. The mineralization process was examined by fluorescent microscopy. By manual palpation, 50% of MSC group samples were found to have solid fusion in comparison with the incomplete fusion observed in the BMA and control group. The gap distance of inter-transverse processes in MSC group was the shortest. The volume of the transverse processes in MSC group was significantly greater than BMA and control group by 16% and 26% respectively. The BMC of transverse processes in MSC group was 40% greater than control (p < 0.05) and 8% greater than BMA group. In fluorescent microscopy, both green fluorescent signal (labeled at week 6) and orange fluorescent signal (labeled at week 4) were observed in MSC group compare with the predominantly green fluorescent signal in the BMA group. In conclusion, the augmentation of MSC derived osteogenic cells is superior to bone marrow aspirate in rabbit posterior spinal fusion.
C1 [Chan, C. W.; Lee, K. M.; Cheng, J. C. Y.] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China.
   [Chan, C. W.; Qin, L.; Wong, K. H. K.; Yeung, H. Y.; Cheng, J. C. Y.] Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China.
   [Lee, K. M.] Chinese Univ Hong Kong, Lee Hysan Clin Res Lab, Hong Kong, Hong Kong, Peoples R China.
   [Fan, H. B.; Hu, Y. Y.] Fourth Mil Med Univ, Inst Orthopaed & Traumatol, Xian, Peoples R China.
RP Chan, CW (reprint author), Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China.
EM chanwai@cuhk.edu.hk; simonlee@cuhk.edu.hk; lingqin@cuhk.edu.hk;
   kenneth@ort.cuhk.edu.hk; byeung@cuhk.edu.hk; fanhb75@yahoo.com.cn;
   orthl@fmmu.edu.cn; jackcheng@cuhk.edu.hk
RI Cheng, Jack/J-3878-2018; Qin, Ling/J-9047-2018; Chan, Chun
   Wai/B-5889-2015
OI Cheng, Jack/0000-0001-8153-364X; Qin, Ling/0000-0001-6173-6167; 
FU AO Research Foundation Switzerland [03-C46]; Li Ka Shing Institute of
   Health Sciences
FX This project was supported by AO Research Foundation, Switzerland (ref.
   no. 03-C46) and The Li Ka Shing Institute of Health Sciences Grant, Hong
   Kong.
CR Bi LX, 1999, CALCIFIED TISSUE INT, V64, P63, DOI 10.1007/s002239900580
   Cao T, 2005, TISSUE CELL, V37, P325, DOI 10.1016/j.tice.2005.03.008
   Chan CW, 2005, KEY ENG MAT, V288-289, P491, DOI 10.4028/www.scientific.net/KEM.288-289.491
   CHEN JCY, 2004, 7 WORLD BIOM C SYDN
   Cheng JCY, 2002, SPINE, V27, P467, DOI 10.1097/00007632-200203010-00006
   Cinotti G, 2004, J BONE JOINT SURG BR, V86B, P135, DOI 10.1302/0301-620X.86B1.14308
   Cotler JM, 1990, SPINAL FUSION SCI TE, P361
   Curylo LJ, 1999, SPINE, V24, P434, DOI 10.1097/00007632-199903010-00004
   Guo X, 2002, J ORTHOPAED RES, V20, P740, DOI 10.1016/S0736-0266(01)00167-X
   KAUFMAN HH, 1989, NEUROSURGERY, V24, P264, DOI 10.1227/00006123-198902000-00018
   Ogura Naomi, 2004, J Oral Sci, V46, P207, DOI 10.2334/josnusd.46.207
   Price CT, 2003, SPINE, V28, P793, DOI 10.1097/00007632-200304150-00012
   van Gaalen SM, 2004, TISSUE ENG, V10, P231, DOI 10.1089/107632704322791871
NR 13
TC 0
Z9 0
U1 0
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2007
VL 330-332
BP 1149
EP +
DI 10.4028/www.scientific.net/KEM.330-332.1149
PN 1-2
PG 2
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Biomaterials; Materials Science, Composites
SC Materials Science
GA BFV88
UT WOS:000245026800281
DA 2018-10-20
ER

PT S
AU Pan, YS
   Xiong, DS
   Chen, XL
AF Pan, Yusong
   Xiong, Dangsheng
   Chen, Xiaolin
BE Zhang, XD
   Li, XD
   Fan, HS
   Liu, XY
TI Friction characteristics of poly(vinyl alcohol) hydrogel as an articular
   cartilage biomaterial
SO BIOCERAMICS, VOL 19, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 19th International Symposium on Ceramics in Medicine
CY OCT 10-13, 2006
CL Chengdu, PEOPLES R CHINA
SP Int Soc Ceram Med
DE poly(vinyl alcohol) hydrogel; stainless steel ball; friction coefficient
AB Poly(vinyl alcohol) (PVA) hydrogel is a promising articular cartilage biomaterial. In this paper, the effects of different variable factors on the friction coefficient of Poly(vinyl alcohol) (PVA) hydrogel were investigated when sliding against stainless steel ball by ball-pan tribometer. Factors included lubrication condition, sliding speed, diameter of stainless steel ball, and load. It was shown that the free water in PVA hydrogel has an excellent lubrication on the counterparts. The friction coefficients have little difference between dry and lubricants lubrication condition at initial friction test. With the friction test time prolonged, friction coefficient of PVA hydrogel under dry condition increased rapidly. Friction coefficient decreased with the increase of sliding speed and the diameter of stainless steel ball, and increased with the increasing load. The rising rate of friction coefficient at low load region is obviously larger than that at high load region,
C1 [Pan, Yusong; Xiong, Dangsheng; Chen, Xiaolin] Nanjing Univ Sci & Technol, Dept Mat Sci & Engn, Nanjing 210094, Jiangsu, Peoples R China.
RP Pan, YS (reprint author), Nanjing Univ Sci & Technol, Dept Mat Sci & Engn, Nanjing 210094, Jiangsu, Peoples R China.
EM xiongds@163.com
RI xiong, dangsheng/B-1823-2015
OI xiong, dangsheng/0000-0003-3210-3728
FU National Natural Science Foundation of China [50575106]
FX We are pleased to acknowledge research support from the National Natural
   Science Foundation of China (project number: 50575106).
CR Dowson D, 1986, Eng Med, V15, P63
   KOBAYASHI M, 2005, J BIOMATERIALS, V26, P3243
   Ku DN, 1999, [US Patent, Poly(vinyl alcohol) Cryogel Patent], Patent No. 5981826
   MASANORI K, 2003, J BIOMATERIALS, V24, P639
   Suciu AN, 2004, JSME INT J C-MECH SY, V47, P199, DOI 10.1299/jsmec.47.199
NR 5
TC 4
Z9 4
U1 1
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2007
VL 330-332
BP 1297
EP +
DI 10.4028/www.scientific.net/KEM.330-332.1297
PN 1-2
PG 2
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Biomaterials; Materials Science, Composites
SC Materials Science
GA BFV88
UT WOS:000245026800317
DA 2018-10-20
ER

PT S
AU Mangold, S
   Harneit, K
   Sand, W
AF Mangold, Stefanie
   Harneit, Kerstin
   Sand, Wolfgang
BE Schippers, A
   Sand, W
   Glombitza, F
   Willscher, S
TI Combined atomic force and fluorescence microscopy of biofilms formed by
   leaching bacteria on opaque substrata
SO BIOHYDROMETALLURY: FROM THE SINGLE CELL TO THE ENVIRONMENT
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 17th International Biohydrometallurgy Symposium
CY SEP 02-05, 2007
CL Frankfurt am Main, GERMANY
DE atomic force microscope; contact mode; tapping mode; cantilever spring
   constant; epifluorescence; biofilm; nanobiotechnology
ID THIOBACILLUS
AB Leaching bacteria attach to their substrates, i.e. mineral sulfides, and form monolayered biofilms. In this study the biofilm formation of Acidithiobacillus ferrooxidans A2 on pyrite was examined using atomic force and epifluorescence microscopy (AFM and EFM, respectively). A novel system by JPK instruments, the BioMaterial Workstation (TM), allows the investigation of the same location on an opaque sample with AFM and EFM. Until recently this was only possible for translucent samples. Sessile bacteria on pyrite coupons were stained with 4',6-diamidino-2-phenylindol (DAPI) and visualized by EFM as well as AFM. The best imaging conditions for AFM were assessed. Scans of bacteria attached to pyrite were performed in contact mode in air as well as in tapping mode in fluid. Imaging in fluid was more challenging than imaging in air as bacteria tend to detach from their substratum. To avoid the dislocation of microorganisms by the AFM probe the sample was dried in air for 1 h prior to scanning in fluid. Scanning in air was performed with the whole range of cantilever spring constants tested (k = 0.03 N/m to k = 0.65 N/m) while, for scanning in fluid, best results were achieved using stiffer cantilevers (k = 0.65 N/m).
C1 [Mangold, Stefanie] Univ Duisburg Essen, Biofilm Ctr, Duisburg, Germany.
RP Mangold, S (reprint author), Univ Duisburg Essen, Biofilm Ctr, Duisburg, Germany.
EM thore.rohwerder@uni-due.de; kerstin.harneit@uni-due.de;
   wolfgang.sand@uni-due.de
FU BioMine European project [NMP1-CT-500329-1]; European commision under
   the Sixth Frame work Programme for Research and Development
FX This work was carried out in the frame of the BioMine(European project
   contract NMP1-CT-500329-1).The authors acknowledge the financial support
   given to this project by the European commision under the Sixth Frame
   work Programme for Research and Development.We also wish to thank our
   various partners for their contributions to the work reported in this
   paper.
CR Beech IB, 2002, COLLOID SURFACE B, V23, P231, DOI 10.1016/S0927-7765(01)00233-8
   Dufrene YF, 2002, J BACTERIOL, V184, P5205, DOI 10.1128/JB.184.19.5205-5213.2002
   Engel A, 2000, NAT STRUCT BIOL, V7, P715, DOI 10.1038/78929
   Kelly DP, 2000, INT J SYST EVOL MICR, V50, P511, DOI 10.1099/00207713-50-2-511
   MACKINTOSH ME, 1978, J GEN MICROBIOL, V105, P215, DOI 10.1099/00221287-105-2-215
   Rawlings DE, 2002, ANNU REV MICROBIOL, V56, P65, DOI 10.1146/annurev.micro.56.012302.161052
   Sand W, 2001, HYDROMETALLURGY, V59, P159, DOI 10.1016/S0304-386X(00)00180-8
NR 7
TC 1
Z9 1
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-0-87849-452-1
J9 ADV MATER RES-SWITZ
PY 2007
VL 20-21
BP 371
EP +
DI 10.4028/www.scientific.net/AMR.20-21.371
PG 2
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA BGU37
UT WOS:000250578900084
DA 2018-10-20
ER

PT J
AU Czaja, WK
   Young, DJ
   Kawecki, M
   Brown, RM
AF Czaja, Wojciech K.
   Young, David J.
   Kawecki, Marek
   Brown, R. Malcolm, Jr.
TI The future prospects of microbial cellulose in biomedical applications
SO BIOMACROMOLECULES
LA English
DT Review
ID IN-VIVO BIOCOMPATIBILITY; BACTERIAL CELLULOSE; ACETOBACTER-XYLINUM; SKIN
   SUBSTITUTES; WOUND DRESSINGS; MECHANICAL-PROPERTIES; VASCULAR GRAFTS;
   WATER-VAPOR; TISSUE; MEMBRANES
AB Microbial cellulose has proven to be a remarkably versatile biomaterial and can be used in wide variety of applied scientific endeavors, such as paper products, electronics, acoustics, and biomedical devices. In fact, biomedical devices recently have gained a significant amount of attention because of an increased interest in tissue-engineered products for both wound care and the regeneration of damaged or diseased organs. Due to its unique nanostructure and properties, microbial cellulose is a natural candidate for numerous medical and tissue-engineered applications. For example, a microbial cellulose membrane has been successfully used as a wound-healing device for severely damaged skin and as a small-diameter blood vessel replacement. The nonwoven ribbons of microbial cellulose microfibrils closely resemble the structure of native extracellullar matrices, suggesting that it could function as a scaffold for the production of many tissue-engineered constructs. In addition, microbial cellulose membranes, having a unique nanostructure, could have many other uses in wound healing and regenerative medicine, such as guided tissue regeneration (GTR), periodontal treatments, or as a replacement for dura mater (a membrane that surrounds brain tissue). In effect, microbial cellulose could function as a scaffold material for the regeneration of a wide variety of tissues, showing that it could eventually become an excellent platform technology for medicine. If microbial cellulose can be successfully mass produced, it will eventually become a vital biomaterial and will be used in the creation of a wide variety of medical devices and consumer products.
C1 Univ Texas, Sect Mol Genet & Microbiol, Austin, TX 78713 USA.
   Tech Univ Lodz, Inst Tech Biochem, PL-90924 Lodz, Poland.
   Ctr Burn Healing, Siemianowice Slaskie, Poland.
RP Brown, RM (reprint author), Univ Texas, Sect Mol Genet & Microbiol, Austin, TX 78713 USA.
OI Kawecki, Marek/0000-0001-9925-5297
CR Alvarez OM, 2004, WOUNDS, V16, P224
   Aung B. J., 2004, PODIATRY TODAY, V17, P20
   Backdahl H, 2006, BIOMATERIALS, V27, P2141, DOI 10.1016/j.biomaterials.2005.10.026
   Balasubramani M, 2001, BURNS, V27, P534, DOI 10.1016/S0305-4179(01)00018-3
   BROWN RM, 1982, SCIENCE, V218, P1141, DOI 10.1126/science.218.4577.1141
   BROWN RM, 2006, Patent No. 2914
   Buttafoco L, 2006, BIOMATERIALS, V27, P2380, DOI 10.1016/j.biomaterials.2005.10.017
   Capes JS, 2005, J MATER SCI-MATER M, V16, P1069, DOI 10.1007/s10856-005-4708-5
   Chanliaud E, 1999, PLANT J, V20, P25, DOI 10.1046/j.1365-313X.1999.00571.x
   Charpentier PA, 2006, APPL SURF SCI, V252, P6360, DOI 10.1016/j.apsusc.2005.09.064
   CHEN WYJ, 1992, J INVEST DERMATOL, V99, P559, DOI 10.1111/1523-1747.ep12667378
   Ciechanska D, 2004, FIBRES TEXT EAST EUR, V12, P69
   Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035
   Czaja W, 2007, CELLULOSE MOL STRUCT
   CZAJA W, 2004, 227 NAT M AM CHEM SO
   DAHLIN C, 1988, PLAST RECONSTR SURG, V81, P672, DOI 10.1097/00006534-198805000-00004
   DAVIDSON S, INDEPENDENT EQUITY R
   Delatte SJ, 2001, J PEDIATR SURG, V36, P113, DOI 10.1053/jpsu.2001.20024
   Demling RH, 1999, BURNS, V25, P256, DOI 10.1016/S0305-4179(98)00165-X
   dos Anjos B, 1998, J PERIODONTOL, V69, P454, DOI 10.1902/jop.1998.69.4.454
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Eming SA, 2002, CELLS TISSUES ORGANS, V172, P105, DOI 10.1159/000065611
   FARQUHAR C, 2000, COCHRANE DB SYST REV, V2
   FONTANA JD, 1990, APPL BIOCHEM BIOTECH, V24-5, P253, DOI 10.1007/BF02920250
   *FRANH I SYST INN, 2003, HUM TISS ENG PROD TO
   Frankel Victor H, 2004, Surg Technol Int, V12, P27
   Frantz VK, 1943, ANN SURG, V119, P116
   Fricain JC, 2002, BIOMATERIALS, V23, P971, DOI 10.1016/S0142-9612(01)00152-1
   Gallin WJ, 1998, BURNS, V24, P613, DOI 10.1016/S0305-4179(98)00089-8
   Granja P L, 2005, Eur Cell Mater, V10, P31
   Granja PL, 2001, J MATER SCI-MATER M, V12, P785, DOI 10.1023/A:1013960601330
   HAIGLER CH, 1982, J CELL BIOL, V94, P64, DOI 10.1083/jcb.94.1.64
   HAIGLER CH, 1980, SCIENCE, V210, P903, DOI 10.1126/science.7434003
   Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570
   Heyligers JMM, 2005, ANN VASC SURG, V19, P448, DOI 10.1007/s10016-005-0026-0
   Ishihara Masayuki, 2006, J Artif Organs, V9, P8, DOI 10.1007/s10047-005-0313-0
   Iwata T, 1998, CELLULOSE, V5, P215, DOI 10.1023/A:1009237401548
   JONES DW, 1960, J POLYM SCI, V42, P173, DOI 10.1002/pol.1960.1204213920
   Jones I, 2002, BRIT J PLAST SURG, V55, P185, DOI 10.1054/bjps.2002.3800
   JONKMAN MF, 1990, J INVEST DERMATOL, V94, P477, DOI 10.1111/1523-1747.ep12874624
   Kai A, 1997, INT J BIOL MACROMOL, V20, P221, DOI 10.1016/S0141-8130(97)01167-7
   Kakisis JD, 2005, J VASC SURG, V41, P349, DOI 10.1016/j.jvs.2004.12.026
   Kawecki M, 2004, INT REV C BIOT VIENN
   Kino Y, 1998, J SURG RES, V79, P71, DOI 10.1006/jsre.1998.5389
   Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   KLEMM D, 2003, Patent No. 0113163
   KOLODZIEJCZYK M, 1999, FINAL REPORT REALIZA
   Krystynowicz A, 2002, J IND MICROBIOL BIOT, V29, P189, DOI 10.1038/sj.jim.7000303
   LATARJET J, 1995, BURNS, V21, P221, DOI 10.1016/0305-4179(95)80015-G
   Legeza VI, 2004, B EXP BIOL MED+, V138, P311
   LOURES BR, 2004, Patent No. 2004045458
   Macedo N., 2004, BRAZ J ORAL SCI, V3, P395
   Martson M, 1998, EUR SURG RES, V30, P419, DOI 10.1159/000008608
   Martson M, 1999, BIOMATERIALS, V20, P1989, DOI 10.1016/S0142-9612(99)00094-0
   MAYALL RC, 1990, REV BRAS CIR, V80
   Mello LR, 1997, J NEUROSURG, V86, P143, DOI 10.3171/jns.1997.86.1.0143
   Novaes A B Jr, 1993, Clin Oral Implants Res, V4, P106, DOI 10.1034/j.1600-0501.1993.040207.x
   NOVAES AB, 1993, BRAZ DENT J, V4, P65
   Ong ATL, 2004, HERZ, V29, P187, DOI 10.1007/s00059-004-2574-4
   OSTER GA, 2003, Patent No. 6599518
   OSullivan AC, 1997, CELLULOSE, V4, P173, DOI 10.1023/A:1018431705579
   Park SN, 2004, BIOMATERIALS, V25, P3689, DOI 10.1016/j.biomaterials.2003.10.072
   Prasanna M, 2004, BURNS, V30, P169, DOI 10.1016/j.burns.2003.09.028
   QUINN KJ, 1985, BIOMATERIALS, V6, P369, DOI 10.1016/0142-9612(85)90095-X
   Ratcliffe A, 2000, MATRIX BIOL, V19, P353, DOI 10.1016/S0945-053X(00)00080-9
   REBELLO C, 1987, Revista Brasileira de Cirurgia, V77, P407
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   ROBERTS EM, 1986, Patent No. 0186495
   ROSS P, 1991, MICROBIOL REV, V55, P35
   RuizCardona L, 1996, BIOMATERIALS, V17, P1639, DOI 10.1016/0142-9612(95)00324-X
   RUSZCZAK Z, 2004, EMEDICINE       0415
   Salata LA, 2001, CLIN ORAL IMPLAN RES, V12, P62, DOI 10.1034/j.1600-0501.2001.012001062.x
   Sawada T, 2000, J REPROD MED, V45, P387
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Shirai A, 1997, CARBOHYD POLYM, V32, P223, DOI 10.1016/S0144-8617(97)00009-X
   Slezak A, 2004, MED ENG PHYS, V26, P53, DOI 10.1016/j.medengphy.2003.08.003
   Sokolnicki AM, 2006, J MEMBRANE SCI, V272, P15, DOI 10.1016/j.memsci.2005.06.065
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   Tokoh C, 1998, CELLULOSE, V5, P249, DOI 10.1023/A:1009211927183
   Tomizawa Yasuko, 2005, J Artif Organs, V8, P137, DOI 10.1007/s10047-005-0296-x
   VANDERHART DL, 1984, MACROMOLECULES, V17, P1465, DOI 10.1021/ma00138a009
   VANDERZIJPP JYT, 2003, ARCH PHYSIOL BIOCHEM, V111, P415
   Walker M, 2003, BIOMATERIALS, V24, P883, DOI 10.1016/S0142-9612(02)00414-3
   Wan YZ, 2006, COMPOS SCI TECHNOL, V66, P1825, DOI 10.1016/j.compscitech.2005.11.027
   Watanabe K, 1998, CELLULOSE, V5, P187, DOI 10.1023/A:1009272904582
   WATANABE K, 1993, CYTOTECHNOLOGY, V13, P107, DOI 10.1007/BF00749937
   Whitney SEC, 1999, PLANT PHYSIOL, V121, P657, DOI 10.1104/pp.121.2.657
   Whitney SEC, 1998, CARBOHYD RES, V307, P299, DOI 10.1016/S0008-6215(98)00004-4
   Winslow RD, 2005, MT SINAI J MED, V72, P81
   WINTER GD, 1962, NATURE, V193, P293, DOI 10.1038/193293a0
   Wiseman DM, 1999, J INVEST SURG, V12, P141
   WOODCOCK C, 1980, MACROMOLECULES, V13, P1183, DOI 10.1021/ma60077a030
   WOUK AFP, 1998, ARCH VET SCI, V3, P31
   WU P, 1995, BIOMATERIALS, V16, P171, DOI 10.1016/0142-9612(95)92114-L
   Yamanaka S, 1990, Production of hollow cellulose produced by microorganisms for artificial blood vessels, Patent No. [0396344, EP 0396344, CAN 114:235093]
   Yarlagadda PKDV, 2005, BIO-MED MATER ENG, V15, P159
   Yasuda K, 2005, BIOMATERIALS, V26, P4468, DOI 10.1016/j.biomaterials.2004.11.021
NR 98
TC 551
Z9 584
U1 14
U2 286
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JAN
PY 2007
VL 8
IS 1
BP 1
EP 12
DI 10.1021/bm060620d
PG 12
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 123ZX
UT WOS:000243337600001
PM 17206781
OA Bronze
DA 2018-10-20
ER

PT J
AU Tortora, M
   Cavalieri, F
   Chiessi, E
   Paradossi, G
AF Tortora, Mariarosaria
   Cavalieri, Francesca
   Chiessi, Ester
   Paradossi, Gaio
TI Michael-type addition reactions for the in situ formation of poly(vinyl
   alcohol)-based hydrogels
SO BIOMACROMOLECULES
LA English
DT Article
ID GLYCIDYL METHACRYLATE; VITREOUS BODY; BEHAVIOR; DEXTRAN; POLYMERIZATION;
   RHEOLOGY; DELIVERY
AB Michael-type addition reactions offer the possibility to obtain in situ formation of polymeric hydrogels in the absence of a radical mechanism for the networking process. We explored such a synthetic route for obtaining a poly(vinyl alcohol) (PVA)-based hydrogel as a potential biomaterial for applications in vitro-retinal replacement surgery. The presence of radicals in the reaction medium can represent a risk for in situ surgical treatment. To circumvent this problem we have applied nucleophilic addition to ad hoc modified PVA macromers. The gel formation has been studied with respect to the timing required in this surgery and in terms of the structural characteristics of the obtained network.
C1 Univ Roma Tor Vergata, Dipartimento Sci & Tecnol Chim, I-00133 Rome, Italy.
RP Paradossi, G (reprint author), Univ Roma Tor Vergata, Dipartimento Sci & Tecnol Chim, Via Ric Sci, I-00133 Rome, Italy.
EM paradossi@stc.uniroma2.it
RI Paradossi, Gaio/B-8330-2014
OI Paradossi, Gaio/0000-0003-3051-3811; CAVALIERI,
   FRANCESCA/0000-0001-5391-5069; Chiessi, Ester/0000-0001-7529-2755
CR BALAZS EA, 1983, HEALON GUIDE ITS USE, P5
   Barretta P, 2000, J PHYS CHEM B, V104, P11019, DOI 10.1021/jp001863h
   Cavalieri F, 2004, BIOMACROMOLECULES, V5, P2439, DOI 10.1021/bm049654g
   Chirila TV, 1998, PROG POLYM SCI, V23, P475, DOI 10.1016/S0079-6700(97)00045-2
   Colthurst MJ, 2000, BIOMATERIALS, V21, P649, DOI 10.1016/S0142-9612(99)00220-3
   DE SMEDT SC, 1995, MACROMOLECULES, V28, P5082, DOI 10.1021/ma00118a042
   Elbert DL, 2001, J CONTROL RELEASE, V76, P11, DOI 10.1016/S0168-3659(01)00398-4
   ERMAN B, 1982, MACROMOLECULES, V15, P806, DOI 10.1021/ma00231a023
   FRIEDMAN M, 1965, J AM CHEM SOC, V87, P3672, DOI 10.1021/ja01094a025
   LEE B, 1992, BIORHEOLOGY, V29, P521
   LEE B, 1994, BIORHEOLOGY, V31, P339
   LONNGREN J, 1989, PURE APPL CHEM, V61, P1313, DOI 10.1351/pac198961071313
   LUTHOLF MP, 2003, BIOMACROMOLECULES, V4, P713
   Lutolf MP, 2001, BIOCONJUGATE CHEM, V12, P1051, DOI 10.1021/bc015519e
   Meyvis TKL, 1999, J RHEOL, V43, P933, DOI 10.1122/1.551012
   Paradossi G, 2002, BIOMACROMOLECULES, V3, P1255, DOI 10.1021/bm0256247
   ROZENBERG ME, 1992, POLYVINYL ALCOHOL DE, P689
   Rydholm AE, 2005, BIOMATERIALS, V26, P4495, DOI 10.1016/j.biomaterials.2004.11.046
   Seal BL, 2006, MACROMOLECULES, V39, P2268, DOI 10.1021/ma0524528
   SILVER FH, 1996, POLYSACCHARIDES MED, P689
   vanDijkWolthuis WNE, 1997, MACROMOLECULES, V30, P3411, DOI 10.1021/ma961764v
   VANDIJKWOLTHUIS WNE, 1995, MACROMOLECULES, V28, P6317, DOI 10.1021/ma00122a044
   YAMAUCHI A, 1991, POLYMER GELS, P127
NR 23
TC 27
Z9 27
U1 1
U2 17
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JAN
PY 2007
VL 8
IS 1
BP 209
EP 214
DI 10.1021/bm0607269
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 123ZX
UT WOS:000243337600029
PM 17206809
DA 2018-10-20
ER

PT J
AU Dornburg, V
   van Dam, J
   Faaij, A
AF Dornburg, Veronika
   van Dam, Jinke
   Faaij, Andre
TI Estimating GHG emission mitigation supply curves of large-scale biomass
   use on a country level
SO BIOMASS & BIOENERGY
LA English
DT Article
DE biomass; cost supply curve; GHG emission mitigation; market prices;
   own-price elasticity
ID CARBON SEQUESTRATION; DEMAND; NETHERLANDS; ELECTRICITY; SYSTEMS; CROPS;
   COST
AB This study evaluates the possible influences of a large-scale introduction of biomass material and energy systems and their market volumes on land, material and energy market prices and their feedback to greenhouse gas (GHG) emission mitigation costs. GHG emission mitigation supply curves for large-scale biomass use were compiled using a methodology that combines a bottom-up analysis of biomass applications, biomass cost supply curves and market prices of land, biornaterials and bioenergy carriers. These market prices depend on the scale of biomass use and the market volume of materials and energy carriers and were estimated using own-price elasticities of demand. The methodology was demonstrated for a case study of Poland in the year 2015 applying different scenarios on economic development and trade in Europe. For the key technologies considered, i.e. medium density fibreboard, poly lactic acid, electricity and methanol production, GHG emission mitigation costs increase strongly with the scale of biomass production. Large-scale introduction of biomass use decreases the GHG emission reduction potential at costs below 50EURO/Mg CO2eq with about 13-70% depending on the scenario. Biomaterial production accounts for only a small part of this GHG emission reduction potential due to relatively small material markets and the subsequent strong decrease of biomaterial market prices at large scale of production. GHG emission mitigation costs depend strongly on biomass supply curves, own-price elasticity of land and market volumes of bioenergy carriers. The analysis shows that these influences should be taken into account for developing biomass implementations strategies. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Utrecht, Copernicus Inst, Dept Sci Technol & Soc, NL-3584 CS Utrecht, Netherlands.
RP Dornburg, V (reprint author), Mid Sweden Univ, Dept Ecotecnol, S-83125 Ostersund, Sweden.
EM Sweden.V.Dornburg@0chem.uu.nl
RI Faaij, Andre/E-8424-2014; van Dam, Jinke/A-8802-2010
CR *APME, 2003, PLAST AN PLAST CONS
   Biewinga E. E., 1996, SUSTAINABILITY ENERG
   Bollen J., 2004, 4 FUTURES ENERGY MAR
   CIAIAN P, 2002, 5 INT WORKSH EUR EC
   CRANK M, 2002, UN IND COMMODITY PRO
   De La Torre Ugarte D., 2003, EC IMPACTS BIOENERGY
   *DEFR, 2003, GROW SRC BEST PRACT
   Dornburg V, 2005, CLIMATIC CHANGE, V71, P373, DOI 10.1007/s10584-005-5934-z
   Dornburg V, 2005, BIOMASS BIOENERG, V28, P454, DOI 10.1016/j.biombioe.2004.11.012
   DORNBURG V, IN PRESS RESOURCES C
   *EC BREC, 2003, BIOM EN DEV POL
   ECCP, 2001, EUR CLIM CHANG PROGR
   *EN RES FDN ECN, 2001, ECN EN VERSL NED 200
   ESPEY M, 1998, ENERG ECON, V20, P295
   *EUR, 2004, CODED EUR CONC DEF D
   *EUR, 2003, AGR EUR UN
   Faaij A., 1998, LONG TERM PERSPECTIV
   *FAO, 2003, FERT SU CROP POL
   *FAO, FAO STAT DAT FOR DAT
   FINKE R, 1984, ECON LETT, V14, P137, DOI 10.1016/0165-1765(84)90073-9
   Forintek, 1993, RAW MAT BAL EN PROF
   Gielen D, 2003, BIOMASS BIOENERG, V25, P177, DOI 10.1016/S0961-9534(02)00188-5
   GIELN DJ, 2000, BIOMASS GREENHOUSE G
   GOERTEN J, 2004, ELECT PRICES EU HOUS
   GOERTEN J, 2004, ELECT PRICES EU IND
   GROENENBERG H, 2002, THESIS UTRECHT U UTR
   HAMELINCK C, 2004, THESIS UTRECHT U
   Hamelinck CN, 2002, J POWER SOURCES, V111, P1, DOI 10.1016/S0378-7753(02)00220-3
   Haygreen J. G, 1996, FOREST PRODUCTS WOOD
   HEKKERT MP, 1998, TECHNOLOGY CHARACTER
   HOOGWIJK MM, 2004, THESIS UTRECHT U UTR
   *IEA, 2004, END US PETR PROD PRI
   *IEA, 2002, END US PETR PROD PRI
   *IEA, 2003, EN BAL NONOECD COUNT
   IEA, 2002, EN BAL OECD COUNTR 1
   *ILO, 2001, YEARL STAT EMPL UN H
   *IPCC, 2001, IPCC 3 ASS CLIM MIT
   IPCC [Intergovernmental Panel on Climate Change], 2001, CLIM CHANG 2001 CLIM
   IPCC (Intergovernmental Panel on Climate Change), 2000, SPEC REP EM SCEN, p[96, 98]
   Johansson D., 2000, RENEWABLE RAW MAT WA
   Kaltschmitt M., 1997, NACHWACHSENDE ENERGI
   Kamerschen DR, 2004, ENERG ECON, V26, P87, DOI 10.1016/S0140-9883(03)00033-1
   Keith DW, 2001, CLIMATIC CHANGE, V49, P1, DOI 10.1023/A:1010617015484
   Larsson S, 2003, FULL SCALE IMPLEMENT
   Ledin S, 1996, BIOMASS BIOENERG, V11, P75, DOI 10.1016/0961-9534(96)00022-0
   Lewandowski I, 2003, EUR J AGRON, V19, P45, DOI 10.1016/S1161-0301(02)00018-7
   LONDO M, 2002, THESIS UTRECHT U UTR
   MCALOON A, 2000, DETERMINING COSTS PR
   Nonhebel S, 2002, BIOMASS BIOENERG, V22, P159, DOI 10.1016/S0961-9534(01)00071-X
   OTTO D, 2001, EFFECTS EXPANDING ET
   Patel M, 2005, TECHNO EC FEASIBILIT
   *PAV, 2000, KWANT INF AKK VOLL
   *REU FAL, 1996, REU TECHN SER, V46
   Richards KR, 2004, CLIMATIC CHANGE, V63, P1, DOI 10.1023/B:CLIM.0000018503.10080.89
   RICHTER K, 1995, ENERGIE STOFFBILANZE
   *RIVM, 2001, CDROM PUBL
   SEDJO R., 2001, ESTIMATING CARBON SU
   *SEO, 1998, 483 SEO
   SMEETS E, 2006, AGR CLIMATE 2015 NEW, V46, P147
   STANCZYK K, 2003, ENERGY FOREST DEV AR
   Stavins RN, 1999, AM ECON REV, V89, P994, DOI 10.1257/aer.89.4.994
   SZCZUKOWSKI S, 2000, COSTS PROFITABILITY
   *UBA, BAS UMW
   USDA National Agricultural Statistics Service, 2003, AGR LAND VAL CASH RE
   VanDriel H, 1997, J APPL ECONOM, V12, P509, DOI 10.1002/(SICI)1099-1255(199709/10)12:5<509::AID-JAE451>3.0.CO;2-P
   Vink ETH, 2003, POLYM DEGRAD STABIL, V80, P403, DOI 10.1016/S0141-3910(02)00372-5
   Walsh ME, 2000, BIOMASS BIOENERG, V18, P283, DOI 10.1016/S0961-9534(99)00094-X
   Wolfram CD, 1999, AM ECON REV, V89, P805, DOI 10.1257/aer.89.4.805
   Wooley R., 1999, LIGNOCELLULOSIC BIOM
   *WSRC, 2004, HARV DIR CONT COPP H
NR 70
TC 16
Z9 17
U1 2
U2 8
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0961-9534
J9 BIOMASS BIOENERG
JI Biomass Bioenerg.
PD JAN
PY 2007
VL 31
IS 1
BP 46
EP 65
DI 10.1016/j.biombioe.2006.04.006
PG 20
WC Agricultural Engineering; Biotechnology & Applied Microbiology; Energy &
   Fuels
SC Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels
GA 129DX
UT WOS:000243709700006
DA 2018-10-20
ER

PT J
AU Pompe, T
   Keller, K
   Mothes, G
   Nitschke, M
   Teese, M
   Zimmermann, R
   Werner, C
AF Pompe, Tilo
   Keller, Kristin
   Mothes, Gisela
   Nitschke, Mirko
   Teese, Mark
   Zimmermann, Ralf
   Werner, Carsten
TI Surface modification of poly(hydroxybutyrate) films to control
   cell-matrix adhesion
SO BIOMATERIALS
LA English
DT Article
DE polyhydroxybutyric acid; fibronectin; endothelial cells; extracellular
   matrix (ECM)
ID POLYMER SUBSTRATES CONTROLS; BACTERIAL POLYHYDROXYALKANOATES;
   FIBRONECTIN ANCHORAGE; INTEGRIN BINDING; ACID;
   POLY(3-HYDROXYBUTYRATE-CO-3-HYDROXYVALERATE); BIOMATERIAL; PROTEINS;
   PHBHHX
AB Tailoring surface properties of degradable polymer scaffolds is key to progress in various tissue engineering strategies. Poly(3hydroxybutyrate) and poly(3-hydroxybutyrate-co-4-hydroxybutyrate) thin films were modified by low pressure ammonia plasma, low pressure water vapour plasma, or immersion in a sodium hydroxide solution to elaborate means to control the cell-matrix adhesion of human umbilical cord vein endothelial cells grown on these materials. Fibronectin (FN) heteroexchange and cell adhesion were correlated to the physicochemical characteristics of the modified polymer surfaces which were investigated by X-ray photoelectron spectroscopy (XPS), scanning force microscopy (SFM), electrokinetic measurements, and contact angle measurements. All treatments increased the hydrophilicity of the polymer samples, which could be accounted to newly created amine or carboxyl functionalities for ammonia plasma or water vapour plasma treatments, respectively, and ester hydrolysis for treatments with alkaline aqueous solutions. Main features of cell adhesion and FN reorganisation-evaluated after 1 h and after 5 days-could be attributed to the anchorage strength of pre-coated FN layers at the polymer surface, which was, in turn found to be triggered by the type of modification applied. In line with earlier studies referring to different materials cell adhesion and matrix reorganisation were shown to be sensitively controlled through the physicochemical profile of poly(hydroxybutyrate) surfaces. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Max Bergmann Ctr Biomat Dresden, Leibniz Inst Polymer Res Dresden, D-01069 Dresden, Germany.
   Sachs Inst Angew Biotechnol Leipzig, D-04318 Leipzig, Germany.
RP Pompe, T (reprint author), Max Bergmann Ctr Biomat Dresden, Leibniz Inst Polymer Res Dresden, Hohe Str 6, D-01069 Dresden, Germany.
EM pompe-tilo@ipfdd.de
RI Teese, Mark/B-4307-2008; Umlauf, Ursula/D-3356-2014; Werner,
   Carsten/F-8127-2010; Nitschke, Mirko/E-6486-2011
OI Teese, Mark/0000-0002-8003-4918; Werner, Carsten/0000-0003-0189-3448;
   Pompe, Tilo/0000-0003-1508-4959
CR ANDERSON AJ, 1990, MICROBIOL REV, V54, P450
   Brew Shelsa A., 1994, Journal of Tissue Culture Methods, V16, P197, DOI 10.1007/BF01540650
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   DOI Y, 1995, MACROMOL SYMP, V98, P585, DOI 10.1002/masy.19950980150
   Faucheux N, 2004, BIOMATERIALS, V25, P2721, DOI 10.1016/j.biomaterials.2003.09.069
   Grondahl L, 2005, BIOMACROMOLECULES, V6, P2197, DOI 10.1021/bm050127m
   HAYNES CA, 1994, COLLOID SURFACE B, V2, P517
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Kim HW, 2002, INT J BIOL MACROMOL, V30, P129, DOI 10.1016/S0141-8130(02)00012-0
   Kose GT, 2003, BIOMATERIALS, V24, P1949, DOI 10.1016/S0142-9612(02)00613-0
   Lee SY, 1996, BIOTECHNOL BIOENG, V49, P1
   Li J, 2005, J BIOMED MATER RES A, V75A, P985, DOI 10.1002/jbm.a.30504
   Martin DP, 2003, BIOCHEM ENG J, V16, P97, DOI 10.1016/S1369-703X(03)00040-8
   McClary KB, 2000, J BIOMED MATER RES, V50, P428, DOI 10.1002/(SICI)1097-4636(20000605)50:3<428::AID-JBM18>3.0.CO;2-H
   Mothes G, 2005, ENG LIFE SCI, V5, P58, DOI 10.1002/elsc.200420056
   Nebe B, 2001, BIOMATERIALS, V22, P2425, DOI 10.1016/S0142-9612(00)00430-0
   Nitschke M, 2002, J BIOMED MATER RES, V59, P632, DOI 10.1002/jbm.1274.abs
   Osaki T, 2003, LANGMUIR, V19, P5787, DOI 10.1021/la034439r
   Pompe T, 2005, EUR BIOPHYS J BIOPHY, V34, P1049, DOI 10.1007/s00249-005-0490-z
   Pompe T, 2004, TISSUE ENG, V10, P841, DOI 10.1089/1076327041348356
   Pompe T, 2003, J BIOMED MATER RES A, V67A, P647, DOI 10.1002/jbm.a.10130
   Poulouin L, 1999, PROTEIN EXPRES PURIF, V17, P146, DOI 10.1006/prep.1999.1103
   Qu XH, 2005, BIOMATERIALS, V26, P6991, DOI 10.1016/j.biomaterials.2005.05.034
   Renner L, 2004, LANGMUIR, V20, P2928, DOI 10.1021/la0362627
   Rouxhet L, 1998, J BIOMAT SCI-POLYM E, V9, P1279, DOI 10.1163/156856298X00398
   Salchert K, 2003, J CHROMATOGR A, V1005, P113, DOI 10.1016/S0021-9673(03)00932-4
   Shishatskaya EI, 2005, J BIOMAT SCI-POLYM E, V16, P643, DOI 10.1163/1568562053783678
   Vert M, 2005, BIOMACROMOLECULES, V6, P538, DOI 10.1021/bm0494702
   WEIS JR, 1991, THROMB RES, V61, P171, DOI 10.1016/0049-3848(91)90245-R
   Werner C, 1998, J COLLOID INTERF SCI, V208, P329, DOI 10.1006/jcis.1998.5787
   Yang XS, 2002, BIOMATERIALS, V23, P1391, DOI 10.1016/S0142-9612(01)00260-5
   Zhang DM, 2000, SURF COAT TECH, V131, P350, DOI 10.1016/S0257-8972(00)00810-0
NR 33
TC 79
Z9 85
U1 0
U2 24
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2007
VL 28
IS 1
BP 28
EP 37
DI 10.1016/j.biomaterials.2006.08.028
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 111BE
UT WOS:000242424900004
PM 16963116
DA 2018-10-20
ER

PT J
AU Shin, H
AF Shin, Heungsoo
TI Fabrication methods of an engineered microenvironment for analysis of
   cell-biomaterial interactions
SO BIOMATERIALS
LA English
DT Review
DE micropattering; cell/biomaterial interactions; microfabrication; cell
   adhesion; biomaterial microarray
ID FOCAL ADHESIONS; MICROPATTERNED SURFACES; INTEGRIN BINDING; IN-VITRO;
   MATRIX; SUBSTRATE; HYDROGELS; MECHANOTRANSDUCTION; CYTOSKELETON;
   STIFFNESS
AB Success in tissue engineering requires an understanding of how cells integrate the signals presented from the microenvironment created by biomaterial scaffolds to alter their responses. Besides the presence of chemical stimuli, there is growing evidence that the spatial organization of cells and tissue within a 3-dimensional (3-D) extracellular matrix (ECM) context is a critical element in controlling cellular function. Therefore, in order to direct cells toward a desirable tissue structure, it is necessary to engineer biomaterials to have spatiotemporal control of the presentation of regulatory signals. Given that, micro-patterning techniques have profited by combining micro-fabrication technology with the chemical conjugation of biologically active molecules to provide new culture systems where cells can be cultured within a specific geometry. The micro-engineered environments have been developed as 2- and 3-D structures, which have proven greatly useful as versatile platforms to study cell, biomaterial, and ECM interactions on both macroscopic and microscopic levels. The main focus of this review is a brief summary of the use of micro-engineered substrates in the analysis of cell-biomaterial interactions with the aim to provide an introductory overview of practical applications available in the literature. In particular, topics regarding (1) the soft-lithography technique to prepare micro-patterned substrates for the spatial control of cell adhesion, (2) biomaterials stiffness-dependent cellular responses, and (3) the microarray techniques for analysis of cell/biomaterials interactions are discussed. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Hanyang Univ, Dept Bioengn, Seoul 133791, South Korea.
RP Shin, H (reprint author), Hanyang Univ, Dept Bioengn, 17 Haengdang Dong, Seoul 133791, South Korea.
EM hshin@hanyang.ac.kr
CR Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a
   Albrecht DR, 2005, LAB CHIP, V5, P111, DOI 10.1039/b406953f
   Anderson DG, 2004, SCIENCE, V305, P1923, DOI 10.1126/science.1099987
   Anderson DG, 2005, BIOMATERIALS, V26, P4892, DOI 10.1016/j.biomaterials.2004.11.052
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Andersson H, 2004, LAB CHIP, V4, P98, DOI 10.1039/b314469k
   Anselme K, 2006, BIOMATERIALS, V27, P1187, DOI 10.1016/j.biomaterials.2005.10.009
   Bailey SN, 2004, P NATL ACAD SCI USA, V101, P16144, DOI 10.1073/pnas.0404425101
   Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532
   Bianchi F, 2006, J BIOMAT SCI-POLYM E, V17, P37, DOI 10.1163/156856206774879117
   Brock A, 2003, LANGMUIR, V19, P1611, DOI 10.1021/la026394k
   Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463
   Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014
   Chen CS, 2004, ANNU REV BIOMED ENG, V6, P275, DOI 10.1146/annurev.bioeng.6.040803.140040
   Chen CS, 2003, BIOCHEM BIOPH RES CO, V307, P355, DOI 10.1016/S0006-291X(03)01165-3
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chin VI, 2004, BIOTECHNOL BIOENG, V88, P399, DOI 10.1002/bit.20254
   ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403
   Clark P, 1997, EXP CELL RES, V230, P275, DOI 10.1006/excr.1996.3429
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Damljanovic V, 2005, BIOTECHNIQUES, V39, P847, DOI 10.2144/000112026
   DeMali KA, 2003, CURR OPIN CELL BIOL, V15, P572, DOI 10.1016/S0955-0674(03)00109-1
   den Braber ET, 1998, J BIOMED MATER RES, V40, P291, DOI 10.1002/(SICI)1097-4636(199805)40:2<291::AID-JBM14>3.3.CO;2-8
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Doh J, 2006, P NATL ACAD SCI USA, V103, P5700, DOI 10.1073/pnas.0509404103
   Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736
   Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153
   Gallant ND, 2002, LANGMUIR, V18, P5579, DOI 10.1021/la025554p
   Gallant ND, 2005, MOL BIOL CELL, V16, P4329, DOI 10.1091/mbc.E05-02-0170
   Garcia AJ, 1999, BIOMATERIALS, V20, P2427, DOI 10.1016/S0142-9612(99)00170-2
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Gates BD, 2005, CHEM REV, V105, P1171, DOI 10.1021/cr030076o
   Geissler M, 2004, ADV MATER, V16, P1249, DOI 10.1002/adma.200400835
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   KHATIWALA CB, 2006, AM J PHYSL CELL PHYS
   Kong HJ, 2005, NAT MATER, V4, P460, DOI 10.1038/nmat1392
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lee KY, 2004, NANO LETT, V4, P1501, DOI 10.1021/nl0493592
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lehnert D, 2004, J CELL SCI, V117, P41, DOI 10.1242/jcs.00836
   Liu VA, 2002, BIOMED MICRODEVICES, V4, P257, DOI 10.1023/A:1020932105236
   Liu WF, 2005, MATER TODAY, V8, P28, DOI 10.1016/S1369-7021(05)71222-0
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5
   Matsuzawa M, 1996, J NEUROSCI METH, V69, P189, DOI 10.1016/S0165-0270(96)00052-0
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McDevitt TC, 2003, J BIOMED MATER RES A, V66A, P586, DOI 10.1002/jbm.a.10504
   McDevitt TC, 2002, J BIOMED MATER RES, V60, P472, DOI 10.1002/jbm.1292
   Meredith JC, 2003, J BIOMED MATER RES A, V66A, P483, DOI 10.1002/jbm.a.10004
   Mrksich M, 1996, P NATL ACAD SCI USA, V93, P10775, DOI 10.1073/pnas.93.20.10775
   Oliva AA, 2003, NEUROCHEM RES, V28, P1639
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Peyton SR, 2005, J CELL PHYSIOL, V204, P198, DOI 10.1002/jcp.20274
   Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682
   Revzin A, 2001, LANGMUIR, V17, P5440, DOI 10.1021/la010075w
   Revzin A, 2004, LANGMUIR, V20, P2999, DOI 10.1021/la035827w
   Revzin A, 2005, LAB CHIP, V5, P30, DOI 10.1039/b405557h
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Sniadecki N, 2006, ANN BIOMED ENG, V34, P59, DOI 10.1007/s10439-005-9006-3
   Stegemann JP, 2003, ANN BIOMED ENG, V31, P391, DOI 10.1114/1.1558031
   Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307
   Thomas JA, 2004, ASTM STAND NEWS, V32, P8
   Vogt AK, 2004, J NEUROSCI METH, V134, P191, DOI 10.1016/j.jneumeth.2003.11.004
   WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161
   Wang YL, 1998, METHOD ENZYMOL, V298, P489, DOI 10.1016/S0076-6879(98)98041-7
   Whitesides George M, 2005, Sci Prog, V88, P17, DOI 10.3184/003685005783238462
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
NR 71
TC 81
Z9 85
U1 1
U2 46
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2007
VL 28
IS 2
BP 126
EP 133
DI 10.1016/j.biomaterials.2006.08.007
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 109LV
UT WOS:000242310500002
PM 16945407
DA 2018-10-20
ER

PT J
AU Gilbert, TW
   Stewart-Akers, AM
   Badylak, SF
AF Gilbert, Thomas W.
   Stewart-Akers, Ann M.
   Badylak, Stephen F.
TI A quantitative method for evaluating the degradation of biologic
   scaffold materials
SO BIOMATERIALS
LA English
DT Article
DE extracellular matrix scaffold; radioactive labeling; degradation
ID SMALL-INTESTINAL SUBMUCOSA; ACCELERATOR MASS-SPECTROMETRY;
   EXTRACELLULAR-MATRIX; DOG-MODEL; TISSUE; RECONSTRUCTION; BIOMATERIAL;
   REPAIR
AB Scaffolds derived from naturally occurring extracellular matrix (ECM) have found extensive use in the fields of tissue engineering and regenerative medicine. Many of these scaffolds are designed to degrade rapidly as they are replaced by new host tissue. Other scaffolds are chemically crosslinked to slow the rate of degradation or add strength to the scaffold. Commercially available ECM scaffolds have considerable variability with regards to tissue origin and methods of processing, and little is known about their rate of degradation and the fate of their degradation products. A novel method is described herein to integrally label ECM with a radioactive isotope (C-14). It was found that a number of tissues are efficiently labeled, including heart, liver, trachea, pancreas, small intestine, and urinary bladder tissue. Of the tissues analyzed, only spleen was not found to contain detectable levels of 14C. The technique is extremely sensitive, accurate, and safe, but requires access to accelerator mass spectrometry, and is expensive and time consuming. This model represents the first described quantitative method to determine the rate of degradation for an ECM scaffold and to track the fate of the degradation products. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA.
RP Badylak, SF (reprint author), Univ Pittsburgh, McGowan Inst Regenerat Med, 100 Technol Dr,Suite 200, Pittsburgh, PA 15219 USA.
EM badylaks@upmc.edu
OI Badylak, Stephen/0000-0003-3555-0689
CR BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   Badylak SF, 2005, J SURG RES, V128, P87, DOI 10.1016/j.jss.2005.03.002
   Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   Brown K, 2006, MASS SPECTROM REV, V25, P127, DOI 10.1002/mas.20059
   Chen F, 1999, UROLOGY, V54, P407, DOI 10.1016/S0090-4295(99)00179-X
   Colvert JR, 2002, J UROLOGY, V168, P1872, DOI 10.1097/01.ju.0000027285.05828.e6
   Dejardin LM, 2001, AM J SPORT MED, V29, P175, DOI 10.1177/03635465010290021001
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   GILBERT TW, 2006, UNPUB J BONE JOINT S
   Harper C, 2001, HOSP MED, V62, P90, DOI 10.12968/hosp.2001.62.2.2379
   Hillegonds DJ, 2001, RADIOCARBON, V43, P305
   Huber JE, 2003, ANN OTO RHINOL LARYN, V112, P428, DOI 10.1177/000348940311200508
   KOCHUPURA PV, 2005, CIRCULATION, V112, P1144
   Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2
   Lappin G, 2004, ANAL BIOANAL CHEM, V378, P356, DOI 10.1007/s00216-003-2348-5
   Lee JM, 2004, CARDIOVASC INTER RAD, V27, P151, DOI 10.1007/s00270-003-0048-3
   Liang HC, 2004, BIOMATERIALS, V25, P3541, DOI 10.1016/j.biomaterials.2003.09.109
   McCready RA, 2005, J VASC SURG, V41, P782, DOI 10.1016/j.jvs.2005.02.035
   Metcalf M. H., 2002, OPER TECH ORTHOP, V12, P204, DOI DOI 10.1053/OTOR.2002.36298
   Mostow EN, 2005, J VASC SURG, V41, P837, DOI 10.1016/j.jvs.2005.01.042
   MUNTING E, 1988, ACTA ORTHOP SCAND, V59, P34, DOI 10.3109/17453678809149340
   Niezgoda Jeffrey A, 2005, Adv Skin Wound Care, V18, P258, DOI 10.1097/00129334-200506000-00012
   Ong SR, 2006, BIOMATERIALS, V27, P1930, DOI 10.1016/j.biomaterials.2005.10.018
   Record RD, 2001, BIOMATERIALS, V22, P2653, DOI 10.1016/S0142-9612(01)00007-2
   STETTEN MR, 1949, J BIOL CHEM, V181, P31
   WAINWRIGHT DJ, 1995, BURNS, V21, P243, DOI 10.1016/0305-4179(95)93866-I
NR 26
TC 67
Z9 69
U1 1
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2007
VL 28
IS 2
BP 147
EP 150
DI 10.1016/j.biomaterials.2006.08.022
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 109LV
UT WOS:000242310500004
PM 16949150
DA 2018-10-20
ER

PT J
AU Allen, J
   Liu, Y
   Kim, YL
   Turzhitsky, VM
   Backman, V
   Ameer, GA
AF Allen, Josephine
   Liu, Yang
   Kim, Young L.
   Turzhitsky, Vladimir M.
   Backman, Vadim
   Ameer, Guillermo A.
TI Spectroscopic translation of cell-material interactions
SO BIOMATERIALS
LA English
DT Article
DE light scattering; optics; tissue engineering; cell characterization;
   cell morphology; cell-substrate interaction
ID SMOOTH-MUSCLE-CELLS; LIGHT-SCATTERING SPECTROSCOPY; ENDOTHELIAL-CELLS;
   IN-SITU; PHENOTYPIC MODULATION; FIBRONECTIN; ORGANIZATION; APOPTOSIS;
   MATRIX; DEATH
AB The characterization of cellular interactions with a biomaterial surface is important to the development of novel biomaterials. Traditional methods used to characterize processes such as cellular adhesion and differentiation on biomaterials can be time consuming, and destructive, and are not amenable to quantitative assessment in situ. As the development of novel biomaterials shifts towards small-scale, combinatorial, and high throughput approaches, new techniques will be required to rapidly screen and characterize cell/biomaterial interactions. Towards this goal, we assessed the feasibility of using 4-dimensional elastic light-scattering fingerprinting (4D-ELF) to describe the differentiation of human aortic smooth muscle cells (HASMCs), as well as the adhesion, and apoptotic processes of human aortic endothelial cells (HAECs), in a quantitative and non-perturbing manner. HASMC and HAEC were cultured under conditions to induce cell differentiation, attachment, and apoptosis which were evaluated via immunohistochemistry, microscopy, biochemistry, and 4D-ELF. The results show that 4D-ELF detected changes in the size distributions of subcellular organelles and structures that were associated with these specific cellular processes. 4D-ELF is a novel way to assess cell phenotype, strength of adhesion, and the onset of apoptosis on a biomaterial surface and could potentially be used as a rapid and quantitative screening tool to provide a more in-depth understanding of cell/biomaterial interactions. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.
RP Ameer, GA (reprint author), Northwestern Univ, Dept Biomed Engn, 2145 Sheridan Rd,Room E310, Evanston, IL 60208 USA.
EM g-ameer@northwestern.edu
RI Backman, Vadim/B-6689-2009; Ameer, Guillermo/B-6765-2009; Liu,
   Yang/D-9305-2011
OI Liu, Yang/0000-0002-6388-9674
FU NHLBI NIH HHS [R21 HL071921-03]; NIGMS NIH HHS [2T32GM008449-11]
CR AUSPRUNK DH, 1978, TISSUE CELL, V10, P707, DOI 10.1016/0040-8166(78)90057-5
   Backman V, 1999, IEEE J SEL TOP QUANT, V5, P1019, DOI 10.1109/2944.796325
   Backman V, 2000, NATURE, V406, P35
   Backman V, 2001, IEEE J SEL TOP QUANT, V7, P887, DOI 10.1109/2944.983289
   BORSE GJ, 1991, FORTRAN 77 NUMERICAL
   Boustany NN, 2004, BIOPHYS J, V87, P4163, DOI 10.1529/biophysj.104.048736
   Boustany NN, 2001, OPT LETT, V26, P1063, DOI 10.1364/OL.26.001063
   Bozzola J. J., 1999, ELECT MICROSCOPY PRI
   Chang SY, 2004, GASTROENTEROLOGY, V126, pA342
   Christopher RA, 1997, J CELL SCI, V110, P569
   Christopher RA, 1999, J CELL SCI, V112, P3225
   Consigny PM, 1998, J VASC INTERV RADIOL, V9, P479, DOI 10.1016/S1051-0443(98)70303-3
   DEJANA E, 1987, J CELL BIOL, V104, P1403, DOI 10.1083/jcb.104.5.1403
   Drexler W, 1999, OPT LETT, V24, P1221, DOI 10.1364/OL.24.001221
   Gurjar RS, 2001, NAT MED, V7, P1245, DOI 10.1038/nm1101-1245
   HEDIN U, 1990, DIFFERENTIATION, V44, P222, DOI 10.1111/j.1432-0436.1990.tb00621.x
   Hu WY, 2000, ARTERIOSCL THROM VAS, V20, P1500, DOI 10.1161/01.ATV.20.6.1500
   Hug TS, 2003, ASSAY DRUG DEV TECHN, V1, P479, DOI 10.1089/154065803322163795
   INGBER DE, 1990, P NATL ACAD SCI USA, V87, P3579, DOI 10.1073/pnas.87.9.3579
   Jean RP, 2004, J BIOMECH ENG-T ASME, V126, P552, DOI 10.1115/1.1800559
   Kim YL, 2003, IEEE J SEL TOP QUANT, V9, P243, DOI 10.1109/JSTQE.2003.814183
   Notingher I, 2002, SPECTROSC-INT J, V16, P43, DOI 10.1155/2002/408381
   PRATT KJ, 1988, J VASC SURG, V7, P591, DOI 10.1067/mva.1988.avs0070591
   Reinhart-King CA, 2005, BIOPHYS J, V89, P676, DOI 10.1529/biophysj.104.054320
   Reyes CD, 2003, J BIOMED MATER RES A, V67A, P328, DOI 10.1002/jbm.a.10122
   ROBAYE B, 1991, AM J PATHOL, V138, P447
   Roy HK, 2004, GASTROENTEROLOGY, V126, P1071, DOI 10.1053/j.gastro.2004.01.009
   SCHWARTZMAN RA, 1993, ENDOCR REV, V14, P133, DOI 10.1210/er.14.2.133
   Shortliffe E.H., 1998, MEDINFO, V9, P8
   Suarez-Huerta N, 2000, CELL PROLIFERAT, V33, P101, DOI 10.1046/j.1365-2184.2000.00169.x
   Thyberg J, 1998, HISTOL HISTOPATHOL, V13, P871, DOI 10.14670/HH-13.871
   Thyberg J, 2002, J HISTOCHEM CYTOCHEM, V50, P185, DOI 10.1177/002215540205000206
   THYBERG J, 1994, CELL TISSUE RES, V276, P263, DOI 10.1007/BF00306112
   VANDERHULST HC, 1981, LIGHT SCATTERING SMA
   Verrier S, 2004, BIOPOLYMERS, V74, P157, DOI 10.1002/bip.20063
   Wax A, 2002, BIOPHYS J, V82, P2256, DOI 10.1016/S0006-3495(02)75571-9
   Worth NF, 2001, CELL MOTIL CYTOSKEL, V49, P130, DOI 10.1002/cm.1027
NR 37
TC 8
Z9 8
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2007
VL 28
IS 2
BP 162
EP 174
DI 10.1016/j.biomaterials.2006.07.002
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 109LV
UT WOS:000242310500006
PM 16884769
DA 2018-10-20
ER

PT J
AU Doroski, DM
   Brink, KS
   Temenoff, JS
AF Doroski, Derek M.
   Brink, Kelly S.
   Temenoff, Johnna S.
TI Techniques for biological characterization of tissue-engineered tendon
   and ligament
SO BIOMATERIALS
LA English
DT Review
DE tendon tissue engineering; ligament tissue engineering; biomaterial
   scaffold; characterization techniques
ID ANTERIOR CRUCIATE LIGAMENT; MEDIAL COLLATERAL LIGAMENT; SEEDED COLLAGEN
   SCAFFOLDS; SMALL-INTESTINE SUBMUCOSA; MARROW STROMAL CELL; IN-VITRO;
   EXTRACELLULAR-MATRIX; PATELLAR TENDON; HUMAN TENOCYTES; ANIMAL-MODELS
AB Injuries to tendons and ligaments are prevalent and result in a significant decrease in quality of patient life. Tissue-engineering strategies hold promise as alternatives to current treatments for these injuries, which often fail to fully restore proper joint biomechanics and produce significant donor site morbidity. Commonly, tissue engineering involves the use of a three-dimensional scaffold seeded with cells that can be directed to form tendon/ligament tissue. When determining the success of such approaches, the viability and proliferation of the cells in the construct, as well as extracellular matrix production and structure should be taken into account. Histology and histochemistry, microscopy, colorimetric assays, and real-time reverse transcriptase-polymerase chain reaction (RT-PCR) are techniques that are employed to assess these biological characteristics. This review provides an overview of each of these methods, including specific examples of how they have been used in evaluation of tissue-engineered tendon and ligament tissue. Basic physical principles underlying each method and advantages and disadvantages of the various techniques are summarized. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Georgia Tech, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   Emory Univ, Atlanta, GA 30332 USA.
RP Temenoff, JS (reprint author), Georgia Tech, Wallace H Coulter Dept Biomed Engn, 313 Ferst Dr,Room 2112, Atlanta, GA 30332 USA.
EM johnna.temenoff@bme.gatech.edu
CR Ahmed Z, 2000, CELL MOTIL CYTOSKEL, V46, P6
   Alberts B, 2002, MOL BIOL CELL
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Altman GH, 2002, J BIOMECH ENG-T ASME, V124, P742, DOI 10.1115/1.1519280
   Altman GH, 2001, FASEB J, V15, P270, DOI 10.1096/fj.01-0656fje
   Anderson G, 2002, THEORY PRACTICE HIST, P85
   *APPL BIOS, 2006, REAL TIM PCR VS TRAD
   Arvind CHV, 2006, J SHOULDER ELB SURG, V15, P500, DOI 10.1016/j.jse.2005.11.014
   Awad HA, 2003, J ORTHOPAED RES, V21, P420, DOI 10.1016/S0736-0266(02)00163-8
   Awad HA, 2000, J BIOMED MATER RES, V51, P233, DOI 10.1002/(SICI)1097-4636(200008)51:2<233::AID-JBM12>3.0.CO;2-B
   BRADSHAW AD, 2000, PRINCIPLES TISSUE EN, P119
   Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169
   Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023
   Butler DL, 2004, CLIN ORTHOP RELAT R, pS190, DOI 10.1097/01.blo.0000144585.65450.d2
   Butler DL, 2004, ANNU REV BIOMED ENG, V6, P303, DOI 10.1146/annurev.bioeng.6.040803.140240
   Butler DL, 2003, FUNCTIONAL TISSUE ENGINEERING, P213, DOI 10.1007/0-387-21547-6_16
   BUTLER DL, 1999, CLIN ORTHOP RELAT R, V1, pS324
   Carpenter JE, 1999, CLIN ORTHOP RELAT R, pS296
   Carpenter JE, 2004, BIOMATERIALS, V25, P1715, DOI 10.1016/S0142-9612(03)00507-6
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   Cooper JA, 2006, BIOMATERIALS, V27, P2747, DOI 10.1016/j.biomaterials.2005.12.013
   Cooper JA, 2005, BIOMATERIALS, V26, P1523, DOI 10.1016/j.biomaterials.2004.05.014
   Cormier G, 2006, JOINT BONE SPINE, V73, P411, DOI 10.1016/j.jbspin.2006.01.021
   Cornwell KG, 2004, J BIOMED MATER RES A, V71A, P55, DOI 10.1002/jbm.a.30132
   COVEY DC, 1994, CLIN SPORT MED, V13, P509
   Cristino S, 2005, J BIOMED MATER RES A, V73A, P275, DOI 10.1002/jbm.a.30261
   Curtis A S G, 2005, Eur Cell Mater, V9, P50
   Dawes C.J., 1979, BIOL TECHNIQUES TRAN
   Dejardin LM, 2001, AM J SPORT MED, V29, P175, DOI 10.1177/03635465010290021001
   Derwin K, 2004, CLIN ORTHOP RELAT R, P245, DOI 10.1097/01.blo.0000131235.91264.d7
   Derwin KA, 2001, J ORTHOPAED RES, V19, P269, DOI 10.1016/S0736-0266(00)00032-2
   Ebrahim FS, 2006, RADIOGRAPHICS, V26, P1007, DOI 10.1148/rg.264055117
   Funakoshi T, 2005, J BIOMED MATER RES A, V74A, P338, DOI 10.1002/jbm.a.30237
   Funakoshi T, 2005, AM J SPORT MED, V33, P1193, DOI 10.1177/036354650427689
   Ge ZG, 2005, CELL TRANSPLANT, V14, P573, DOI 10.3727/000000005783982819
   Gentleman E, 2006, ANN BIOMED ENG, V34, P726, DOI 10.1007/s10439-005-9058-4
   Gentleman E, 2003, BIOMATERIALS, V24, P3805, DOI 10.1016/S0142-9612(03)00206-0
   Goulet F, 2000, PRINCIPLES TISSUE EN, P711
   Gu J., 1995, IN SITU POLYM CHAIN, P1
   Haller J, 2006, EUR J RADIOL, V58, P450, DOI 10.1016/j.ejrad.2006.03.008
   HALLIDAY D, 1997, FUNDAMENTALS PHYS 4
   Hansen DB, 2005, CHEM SOC REV, V34, P408, DOI 10.1039/b315496n
   Hanson DA, 1996, J BIOL CHEM, V271, P26508, DOI 10.1074/jbc.271.43.26508
   HARLEY J, 1954, INSTRUMENTAL ANAL
   HARTL D, 2005, GENETICS
   HARWOOD FL, 1992, J APPL PHYSIOL, V72, P1687
   Heftmann E., 2004, CHROMATOGRAPHY FUNDA
   Henshaw DR, 2006, J ORTHOP RES, V24, P481, DOI 10.1002/jor.20050
   Hidalgo FJ, 2004, ANAL BIOCHEM, V334, P155, DOI 10.1016/j.jab.2004.08.001
   Hildebrand KA, 2002, MICROSC RES TECHNIQ, V58, P34, DOI 10.1002/jemt.10114
   Homsi C, 2006, SKELETAL RADIOL, V35, P673, DOI 10.1007/s00256-006-0136-y
   Hopwood D., 2002, THEORY PRACTICE HIST, P63
   HOROBIN RW, 2002, THEORY PRACTICE HIST, P109
   Ide A, 2001, MAT SCI ENG C-BIO S, V17, P95, DOI 10.1016/S0928-4931(01)00315-0
   JENNER J, 2005, 51 ANN M ORTH RES SO
   Jin CZ, 2006, J TRAUMA, V60, P1358, DOI 10.1097/01.ta.0000220385.34197.f9
   Karamuk E, 2004, COMPOS SCI TECHNOL, V64, P885, DOI 10.1016/j.compscitech.2003.09.004
   KHANDPUR R, 1981, HDB MODERN ANAL INST
   KHATOD M, 2003, DANIELS KNEE INJURIE, P31
   KHATOD M, 2003, DANIELS KNEE INJURIE, P185
   Kiernan J.A., 1999, HISTOLOGICAL HISTOCH
   KIM CW, 2003, DANIELS KNEE INJURIE, P435
   Knott L, 1997, BIOCHEM J, V322, P535, DOI 10.1042/bj3220535
   Knott L, 1999, BRIT POULTRY SCI, V40, P371, DOI 10.1080/00071669987476
   Koob TJ, 2002, COMP BIOCHEM PHYS A, V133, P1171, DOI 10.1016/S1095-6433(02)00247-7
   Kuhn K., 1987, STRUCTURE FUNCTION C, P1
   KUO C, 2005, 51 ANN M ORTH RES SO
   Landis WJ, 2005, ORTHOP CLIN N AM, V36, P97, DOI 10.1016/j.ocl.2004.06.006
   Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19
   Laurencin CT, 2005, BIOMATERIALS, V26, P7530, DOI 10.1016/j.biomaterials.2005.05.073
   Lee CH, 2005, BIOMATERIALS, V26, P1261, DOI 10.1016/j.biomaterials.2004.04.037
   LIGHT ND, 1980, BIOL COLLAGEN, P15
   Lin TW, 2004, J BIOMECH, V37, P865, DOI 10.1016/j.jbiomech.2003.11.005
   Lin Wei-Ching, 2006, Chang Gung Med J, V29, P182
   Lu HH, 2005, BIOMATERIALS, V26, P4805, DOI 10.1016/j.biomaterials.2004.11.050
   Majima T, 2005, J ORTHOP SCI, V10, P302, DOI 10.1007/s00776-005-0891-y
   MARTIN RB, 1998, MECH PROPERTIES LIGA, P309
   Martinek V, 2002, J BONE JOINT SURG AM, V84A, P1123, DOI 10.2106/00004623-200207000-00005
   MARTINEZHERNAND, 1994, PATHOLOGY, P69
   MELOAN C, 1968, INSTRUMENTAL ANAL US
   MEYER V, 1988, ION EXCHANGE CHROMAT, P157
   MILLER K, 2002, THEORY PRACTICE HIST, P421
   Milz S, 2006, J ANAT, V208, P671, DOI 10.1111/j.1469-7580.2006.00552.x
   *MOL PROB, 2006, PICOGREEN PROD MAN
   *MOL PROB, 2005, LIVE DEAD PROD MAN
   *MOL PROB, 2005, HOESCHT STAINS PROD
   *MOL PROB, 2006, PHALL PHALL PROD MAN
   *MOL PROB, 2005, AL FLUOR 55 DYE SUP
   *MOL PROB, 2006, DAPI NUCL AC STAIN D
   *MOL PROB, 2005, QUANT IT PICOGREEN D
   Monto Raymond Rocco, 2006, J Knee Surg, V19, P187
   Muller M., 2006, INTRO CONFOCAL FLUOR
   Murray MM, 2006, J ORTHOP RES, V24, P508, DOI 10.1002/jor.20054
   Murray MM, 2001, BIOMATERIALS, V22, P2393
   Murray MM, 2003, J ORTHOPAED RES, V21, P238, DOI 10.1016/S0736-0266(02)00142-0
   Musahl V, 2004, J ORTHOP RES, V22, P214, DOI 10.1016/S0736-0266(03)00163-3
   Nakasa T, 2006, J COMPUT ASSIST TOMO, V30, P543, DOI 10.1097/00004728-200605000-00032
   NELSON DL, 2005, PRINCIPLES BIOCH
   Nikiforov YE, 2001, MORPHOLOGY METHODS, P181
   Ouyang HW, 2005, J BIOMED MATER RES B, V75B, P264, DOI 10.1002/jbm.b.30281
   Patrick Jr C., 1998, FRONTIERS TISSUE ENG, P413
   Persikov AV, 2002, P NATL ACAD SCI USA, V99, P1101, DOI 10.1073/pnas.042707899
   Pesez M., 1974, COLORIMETRIC FLUORIM
   Probstmeier R, 1999, GLYCOBIOLOGY, V9, P101, DOI 10.1093/glycob/9.2.101
   Qin TW, 2005, BIOMATERIALS, V26, P6635, DOI 10.1016/j.biomaterials.2005.04.023
   Rodeo SA, 2004, J BONE JOINT SURG AM, V86A, P2085, DOI 10.2106/00004623-200409000-00034
   Schulze-Tanzil G, 2004, HISTOCHEM CELL BIOL, V122, P219, DOI 10.1007/s00418-004-0694-9
   SCOTTBURDEN T, 1994, NEWS PHYSIOL SCI, V9, P110
   Sheng PY, 2006, ACTA ORTHOP, V77, P512, DOI 10.1080/17453670610012520
   SPALAZZI J, 2005, 51 ANN M ORTH RES SO
   SPALAZZI J, 2006, 52 ANN M ORTH RES SO
   Tanzer M. L., 1976, BIOCH COLLAGEN, P137
   Thomopoulos S, 2003, J ORTHOPAED RES, V21, P413, DOI 10.1016/S0736-0266(03)00057-3
   Torres DS, 2000, BIOMATERIALS, V21, P1607
   Triantafillopoulos IK, 2004, AM J SPORT MED, V32, P934, DOI 10.1177/0363546503261700
   Trieb K, 2004, EUR SURG RES, V36, P148, DOI 10.1159/000077256
   Vanderploeg EJ, 2004, J BIOMECH, V37, P1941, DOI 10.1016/j.jbiomech.2004.02.048
   VIIDIK A, 1980, BIOL COLLAGEN, P257
   Voet D., 1995, BIOCHEMISTRY
   Vogel K. G., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P202
   Vogel KG, 1999, CLIN ORTHOP RELAT R, pS344, DOI 10.1097/00003086-199910001-00033
   Vunjak-Novakovic G, 2004, ANNU REV BIOMED ENG, V6, P131, DOI 10.1146/annurev.bioeng.6.040803.140037
   WANG I, 2005, 51 ANN M ORTH RES SO
   WANG I, 2004, 50 ANN M ORTH RES SO
   Wang JHC, 2006, J BIOMECH, V39, P1563, DOI 10.1016/j.jbiomech.2005.05.011
   WILSON I, 2002, THEORY PRACTICE HIST, P125
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
   Wong MWN, 2004, J BIOMED MATER RES B, V70B, P362, DOI 10.1002/jbm.b.30049
   Woo SLY, 2006, J BIOMECH, V39, P1, DOI 10.1016/j.jbiomech.2004.10.025
   Woo SLY, 2004, ANN BIOMED ENG, V32, P342, DOI 10.1023/B:ABME.0000017551.93144.1a
   Yadao Melissa A, 2004, Instr Course Lect, V53, P607
   Yang Z, 2000, Hand Surg, V5, P49, DOI 10.1142/S0218810400000132
   Yoon J. H., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P22
NR 134
TC 70
Z9 74
U1 1
U2 27
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2007
VL 28
IS 2
BP 187
EP 202
DI 10.1016/j.biomaterials.2006.08.040
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 109LV
UT WOS:000242310500008
PM 16982091
DA 2018-10-20
ER

PT J
AU Underhill, GH
   Chen, AA
   Albrecht, DR
   Bhatia, SN
AF Underhill, Gregory H.
   Chen, Alice A.
   Albrecht, Dirk R.
   Bhatia, Sangeeta N.
TI Assessment of hepatocellular function within PEG hydrogels
SO BIOMATERIALS
LA English
DT Article
DE hydrogel; hepatocyte; progenitor cell; liver
ID TISSUE-ENGINEERING APPLICATIONS; MICROCARRIER-ATTACHED HEPATOCYTES;
   POLYETHYLENE-GLYCOL HYDROGELS; GAP JUNCTIONAL COMMUNICATION; LINKING
   DENSITY INFLUENCES; EPIDERMAL-GROWTH-FACTOR; CELL-CELL INTERACTIONS;
   RAT-LIVER CELLS; POLY(ETHYLENE GLYCOL); STEM-CELLS
AB Tissue-engineered therapies for liver failure offer the potential to augment or replace whole organ transplantation; however, fabrication of hepatic tissue poses unique challenges largely stemming from the complexity of liver structure and function. In this study, we illustrate the utility of highly-tunable, photopolymerizable poly(ethylene glycol) (PEG) hydrogels for 3D encapsulation of hepatic cells and highlight a range of techniques important for examining hepatocellular function in this platform. Owing to our long-term interest in incorporating proliferative progenitor cell types (e.g. hepatoblasts, oval cells, or cells derived from embryonic stem cells) and maintaining the phenotype of differentiated cells, we explored the behavior of bipotential mouse embryonic liver (BMEL) cells as a model progenitor cell and mature, fully differentiated, primary hepatocytes in this biomaterial system. We demonstrated the importance of cell-cell and cell-matrix interactions in the survival and function of these cell types, and the capacity to influence encapsulated cell phenotypes through modulation of hydrogel characteristics or gene silencing. Additionally, we demonstrated imaging techniques critical for the in situ assessment of encapsulated hepatocyte function combined with the ability to control cellular organization and overall architecture through microscale patterning technologies. Further analysis of liver progenitor as well as mature hepatocyte processes within the versatile PEG hydrogel platform will aid in the development of tissue engineered implantable liver systems. (c) 2006 Elsevier Ltd. All rights reserved.
C1 MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
   Brigham & Womens Hosp, Div Med, Boston, MA 02115 USA.
RP Bhatia, SN (reprint author), MIT, Harvard Mit Div Hlth Sci & Technol, 77 Massachusetts Ave,E19-502D, Cambridge, MA 02139 USA.
EM sbhatia@mit.edu
RI Albrecht, Dirk/B-9941-2011
CR Albrecht DR, 2005, LAB CHIP, V5, P111, DOI 10.1039/b406953f
   Albrecht DR, 2006, NAT METHODS, V3, P369, DOI 10.1038/NMETH873
   Alhadlaq A, 2005, TISSUE ENG, V11, P556, DOI 10.1089/ten.2005.11.556
   Allen JW, 2002, SEMIN CELL DEV BIOL, V13, P447, DOI 10.1016/S1084-9521(02)00133-7
   Allen JW, 2002, TISSUE ENG, V8, P725, DOI 10.1089/10763270260424097
   Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501
   Anseth KS, 2002, J CONTROL RELEASE, V78, P199, DOI 10.1016/S0168-3659(01)00500-4
   Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7
   Balis UJ, 1999, METAB ENG, V1, P49, DOI 10.1006/mben.1998.0105
   Bates RC, 2000, CRIT REV ONCOL HEMAT, V36, P61, DOI 10.1016/S1040-8428(00)00077-9
   Beebe DJ, 2000, NATURE, V404, P588, DOI 10.1038/35007047
   Behravesh E, 2003, J BIOMED MATER RES A, V66A, P698, DOI 10.1002/jbm.a.10003
   Bhatia SN, 1999, FASEB J, V13, P1883
   Bryant SJ, 2004, ANN BIOMED ENG, V32, P407, DOI 10.1023/B:ABME.0000017535.00602.ca
   Bryant SJ, 2004, BIOTECHNOL BIOENG, V86, P747, DOI 10.1002/bit.20160
   Bryant SJ, 2004, J ORTHOPAED RES, V22, P1143, DOI 10.1016/j.orthres.2004.02.001
   Burdick JA, 2002, J CONTROL RELEASE, V83, P53, DOI 10.1016/S0168-3659(02)00181-5
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Corlu A, 1997, CELL BIOL TOXICOL, V13, P235, DOI 10.1023/A:1007475122321
   Cruise GM, 1998, BIOMATERIALS, V19, P1287, DOI 10.1016/S0142-9612(98)00025-8
   Davis KA, 2003, BIOMATERIALS, V24, P2485, DOI 10.1016/S0142-9612(02)00582-3
   DeLong SA, 2005, BIOMATERIALS, V26, P3227, DOI 10.1016/j.biomaterials.2004.09.021
   DEMETRIOU AA, 1986, SCIENCE, V233, P1190, DOI 10.1126/science.2426782
   DEMETRIOU AA, 1986, P NATL ACAD SCI USA, V83, P7475, DOI 10.1073/pnas.83.19.7475
   DIXIT V, 1992, ARTIF ORGANS, V16, P336
   DUNN JCY, 1991, BIOTECHNOL PROGR, V7, P237, DOI 10.1021/bp00009a007
   Dvir-Ginzberg M, 2003, TISSUE ENG, V9, P757, DOI 10.1089/107632703768247430
   Eugenin EA, 1998, AM J PHYSIOL-GASTR L, V274, pG1109, DOI 10.1152/ajpgi.1998.274.6.G1109
   FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269
   Fittkau MH, 2005, BIOMATERIALS, V26, P167, DOI 10.1016/j.biomaterials.2004.02.012
   Gobin AS, 2003, BIOTECHNOL PROGR, V19, P1781, DOI 10.1021/bp0341390
   Grossmann J, 2002, APOPTOSIS, V7, P247, DOI 10.1023/A:1015312119693
   Hahn MS, 2006, BIOMATERIALS, V27, P2519, DOI 10.1016/j.biomaterials.2005.11.045
   Hamazaki K, 2002, HEPATO-GASTROENTEROL, V49, P1514
   Hammond JS, 2006, EXPERT REV MED DEVIC, V3, P21, DOI 10.1586/17434440.3.1.21
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Hwang NS, 2006, STEM CELLS, V24, P284, DOI 10.1634/stemcells.2005-0024
   Itle LJ, 2005, BIOTECHNOL PROGR, V21, P926, DOI 10.1021/bp049681i
   James R, 2004, J HISTOTECHNOL, V27, P133, DOI 10.1179/his.2004.27.2.133
   Jun HW, 2005, TISSUE ENG, V11, P1133, DOI 10.1089/ten.2005.11.1133
   Kaihara S, 2000, TISSUE ENG, V6, P105, DOI 10.1089/107632700320739
   Khademhosseini A, 2003, ADV MATER, V15, P1995, DOI 10.1002/adma.200305433
   Khetani SR, 2004, HEPATOLOGY, V40, P545, DOI 10.1002/hep.20351
   LAKE B D, 1970, Histochemical Journal, V2, P441, DOI 10.1007/BF01004725
   LANDRY J, 1985, J CELL BIOL, V101, P914, DOI 10.1083/jcb.101.3.914
   Lee SH, 2005, BIOTECHNOL PROGR, V21, P1736, DOI 10.1021/bp0502429
   Lemaigre F, 2004, CURR OPIN GENET DEV, V14, P582, DOI 10.1016/j.gde.2004.08.004
   Liu VA, 2002, BIOMED MICRODEVICES, V4, P257, DOI 10.1023/A:1020932105236
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Mahoney MJ, 2006, BIOMATERIALS, V27, P2265, DOI 10.1016/j.biomaterials.2005.11.007
   Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5
   Mann BK, 2002, J BIOMED MATER RES, V60, P86, DOI 10.1002/jbm.10042
   Mann BK, 2001, BIOMATERIALS, V22, P439, DOI 10.1016/S0142-9612(00)00196-4
   Martens PJ, 2003, BIOMACROMOLECULES, V4, P283, DOI 10.1021/bm025666v
   Mi LX, 2006, BIOMACROMOLECULES, V7, P38, DOI 10.1021/bm050157p
   Moghe P. V., 1994, Molecular Biology of the Cell, V5, p177A
   Moghe PV, 1996, BIOMATERIALS, V17, P373, DOI 10.1016/0142-9612(96)85576-1
   Moghe PV, 1997, BIOTECHNOL BIOENG, V56, P706, DOI 10.1002/(SICI)1097-0290(19971220)56:6<706::AID-BIT14>3.0.CO;2-5
   MOGHE PV, 1995, MOL BIOL CELL S, V6, pA238
   Mooney DJ, 1997, J BIOMED MATER RES, V37, P413, DOI 10.1002/(SICI)1097-4636(19971205)37:3<413::AID-JBM12>3.0.CO;2-C
   Moore K, 2006, TISSUE ENG, V12, P267, DOI 10.1089/ten.2006.12.267
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   Nuttelman CR, 2006, J BIOMED MATER RES A, V76A, P183, DOI 10.1002/jbm.a.30537
   Nuttelman CR, 2005, MATRIX BIOL, V24, P208, DOI 10.1016/j.matbio.2005.03.004
   Nuttelman CR, 2004, J BIOMED MATER RES A, V68A, P773, DOI 10.1002/jbm.a.20112
   Park Y, 2004, TISSUE ENG, V10, P515, DOI 10.1089/107632704323061870
   Park YD, 2003, BIOMATERIALS, V24, P893, DOI 10.1016/S0142-9612(02)00420-9
   Patel PN, 2005, TISSUE ENG, V11, P1498, DOI 10.1089/ten.2005.11.1498
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   Powers MJ, 2002, BIOTECHNOL BIOENG, V78, P257, DOI 10.1002/bit.10143
   Powers MJ, 2002, TISSUE ENG, V8, P499, DOI 10.1089/107632702760184745
   Quek CH, 2004, BIOMATERIALS, V25, P3531, DOI 10.1016/j.biomaterials.2003.09.112
   Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682
   Revzin A, 2001, LANGMUIR, V17, P5440, DOI 10.1021/la010075w
   RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8
   Riley SL, 2001, J MATER SCI-MATER M, V12, P983, DOI 10.1023/A:1012817317296
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   SAITO S, 1992, TRANSPLANT P, V24, P1520
   SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005
   Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5
   Seliktar D, 2004, J BIOMED MATER RES A, V68A, P704, DOI 10.1002/jbm.a.20091
   Siddiqui MU, 1999, HEPATOLOGY, V29, P1147, DOI 10.1002/hep.510290443
   Strick-Marchand H, 2004, P NATL ACAD SCI USA, V101, P8360, DOI 10.1073/pnas.0401092101
   Strick-Marchand H, 2002, HEPATOLOGY, V36, P794, DOI 10.1053/jhep.2002.36123
   Suh KY, 2004, BIOMATERIALS, V25, P557, DOI 10.1016/S0142-9612(03)00543-X
   Tan W, 2004, BIOMATERIALS, V25, P1355, DOI 10.1016/j.biomaterials.2003.08.021
   Tan W, 2003, BIOMED MICRODEVICES, V5, P235, DOI 10.1023/A:1025764310391
   VACANTI JP, 1988, J PEDIATR SURG, V23, P3, DOI 10.1016/S0022-3468(88)80529-3
   VandeVondele S, 2003, BIOTECHNOL BIOENG, V82, P784, DOI 10.1002/bit.10625
   Wang DA, 2003, BIOMATERIALS, V24, P3969, DOI 10.1016/S0142-9612(03)00280-1
   Wang DA, 2005, TISSUE ENG, V11, P201, DOI 10.1089/ten.2005.11.201
   Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821
   Wang XH, 2006, TISSUE ENG, V12, P83, DOI 10.1089/ten.2006.12.83
   Webster SS, 2003, J HISTOTECHNOL, V26, P57
   Williams CG, 2005, BIOMATERIALS, V26, P1211, DOI 10.1016/j.biomaterials.2004.04.024
   Zahir N, 2004, CURR OPIN GENET DEV, V14, P71, DOI 10.1016/j.gde.2003.12.005
   Zakim D, 1990, HEPATOLOGY TXB LIVER
   Zisch AH, 2003, FASEB J, V17, P2260, DOI 10.1096/fj.02-1041fje
NR 100
TC 121
Z9 125
U1 2
U2 54
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2007
VL 28
IS 2
BP 256
EP 270
DI 10.1016/j.biomaterials.2006.08.043
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 109LV
UT WOS:000242310500014
PM 16979755
DA 2018-10-20
ER

PT J
AU Gomez, N
   Lu, Y
   Chen, SC
   Schmidt, CE
AF Gomez, Natalia
   Lu, Yi
   Chen, Shaochen
   Schmidt, Christine E.
TI Immobilized nerve growth factor and microtopography have distinct
   effects on polarization versus axon elongation in hippocampal cells in
   culture
SO BIOMATERIALS
LA English
DT Article
DE polarization; axon growth; hippocampal neurons; contact guidance; nerve
   growth factor
ID ARTIFICIAL JUXTACRINE STIMULATION; P75 NEUROTROPHIN RECEPTOR; GUIDE
   NEURITE OUTGROWTH; TOPOGRAPHICAL CONTROL; NEURONAL POLARITY;
   CONCENTRATION GRADIENTS; TRK RECEPTORS; PC12 CELLS; GUIDANCE; SURFACES
AB Cell interfacing with biomaterial surfaces dictates important aspects of cell behavior. In particular, axon extension in neurons is effectively influenced by surface properties, both for the initial formation of an axon as well as for the maintenance of axon growth. Here, we investigated how neurons behaved on poly(dimethyl siloxane) (PDMS) surfaces decorated with biochemical and physical cues presented individually or in combination. In particular, nerve growth factor (NGF) was covalently tethered to PDMS to create a bioactive surface, and microtopography was introduced to the material in the form of microchannels. Embryonic hippocampal neurons were used to investigate the impact of these surface cues on polarization (i.e., axon initiation or axogenesis) and overall axon length. We found that topography had a more pronounced effect on polarization (68% increase over controls) compared to immobilized NGF (0.1 ng/mm(2)) (27% increase). However, the effect of NGF was negligible when both types of stimuli were simultaneously presented on the biomaterial surface. In addition to axon formation, chemical and physical cues are also involved in axon growth following the initiation process. Interestingly, for the same studies described above, the effects of microchannels and NGF were opposite from the effects on polarization; the most evident effect was for the immobilized growth factor (10% increase in axon length with respect to controls) whereas there was no effect in general for the micro topography. More importantly, when the two surface stimuli were presented in combination, a synergistic increase in axon length was detected (25% increase with respect to controls), which could be a result of faster polarization triggered by topography plus enhanced growth from NGF. Additionally, axon orientation was also analyzed and we found the well-known tendency of perpendicular or parallel axonal alignment to be dependent on the width and depth of the channels. This investigation thoroughly compared and distinguished the individual and combined impact of material surface properties (chemical and physical) on axogenesis from the effects on axon length. Overall, topography dominated polarization mechanisms, whereas NGF, and particularly a synergy of immobilized NGF plus topography, dominated axon length. These results could be potentially applied for the design of biomaterials in applications were axon growth is critical. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Texas, Dept Chem Engn, Austin, TX 78712 USA.
   Univ Texas, Dept Mech Engn, Austin, TX 78712 USA.
   Univ Texas, Dept Biomed Engn, Austin, TX 78712 USA.
   Univ Texas, Mat Inst, Austin, TX 78712 USA.
   Univ Texas, Ctr Nano & Mol Sci & Technol, Austin, TX 78712 USA.
RP Schmidt, CE (reprint author), Univ Texas, Dept Chem Engn, Austin, TX 78712 USA.
EM schmidt@che.utexas.edu
RI Schmidt, Christine/P-1613-2016
CR AHMED L, 2006, J BIOMED MATER RES A, V76, P851
   Aoki K, 2004, J BIOL CHEM, V279, P713, DOI 10.1074/jbc.M306382200
   BLOCHL A, 1995, EUR J NEUROSCI, V7, P1220, DOI 10.1111/j.1460-9568.1995.tb01112.x
   Brann AB, 2002, J BIOL CHEM, V277, P9812, DOI 10.1074/jbc.M109862200
   Brann AB, 1999, J NEUROSCI, V19, P8199
   Bronfman FC, 2003, J NEUROSCI, V23, P3209
   CAMPENOT RB, 1994, J NEUROBIOL, V25, P599, DOI 10.1002/neu.480250603
   Chen GP, 2001, BIOMATERIALS, V22, P2453, DOI 10.1016/S0142-9612(00)00432-4
   Chen GP, 1997, BBA-MOL CELL RES, V1358, P200, DOI 10.1016/S0167-4889(97)00065-7
   Chung TW, 2002, BIOMATERIALS, V23, P4803, DOI 10.1016/S0142-9612(02)00231-4
   CLARK P, 1990, DEVELOPMENT, V108, P635
   CLARK P, 1991, J CELL SCI, V99, P73
   CLARK P, 1993, J CELL SCI, V105, P203
   CLARK P, 1987, DEVELOPMENT, V99, P439
   Curtis A., 1995, Journal of Cellular Engineering Incorporating Molecular Engineering, V1, P35
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Dalby MJ, 2005, MED ENG PHYS, V27, P730, DOI 10.1016/j.medengphy.2005.04.005
   Dalby MJ, 2003, EXP CELL RES, V284, P274, DOI 10.1016/S0014-4827(02)00053-8
   DOBROWSKY RT, 1995, J BIOL CHEM, V270, P22135, DOI 10.1074/jbc.270.38.22135
   DOTTI CG, 1988, J NEUROSCI, V8, P1454
   Dowell-Mesfin NM, 2004, J NEURAL ENG, V1, P78, DOI 10.1088/1741-2560/1/2/003
   Drotleff S, 2004, EUR J PHARM BIOPHARM, V58, P385, DOI 10.1016/j.ejpb.2004.03.018
   Ebadi M, 1997, NEUROCHEM INT, V30, P347, DOI 10.1016/S0197-0186(96)00071-X
   Foley JD, 2005, BIOMATERIALS, V26, P3639, DOI 10.1016/j.biomaterials.2004.09.048
   Friedman WJ, 2000, J NEUROSCI, V20, P6340, DOI 10.1523/JNEUROSCI.20-17-06340.2000
   Fukata Y, 2002, NEUROSCI RES, V43, P305, DOI 10.1016/S0168-0102(02)00062-7
   Gallo G, 1997, J NEUROSCI, V17, P5445
   Gallo G, 1998, J NEUROSCI, V18, P5403
   GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507
   Harrison RG, 1907, J EXP ZOOL, V4, P239, DOI 10.1002/jez.1400040205
   Ito Y, 1997, FEBS LETT, V403, P159, DOI 10.1016/S0014-5793(97)00045-8
   Ito Y, 1998, BIOCONJUGATE CHEM, V9, P277, DOI 10.1021/bc970190b
   Ito Y, 1998, MAT SCI ENG C-BIO S, V6, P267, DOI 10.1016/S0928-4931(98)00061-7
   Ito Yoshihiro, 1998, Japanese Journal of Artificial Organs, V27, P541
   Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033
   Kapur TA, 2003, J BIOMAT SCI-POLYM E, V14, P383, DOI 10.1163/156856203321478883
   Kapur TA, 2004, J BIOMED MATER RES A, V68A, P235, DOI 10.1002/jbm.a.10168
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   Lamoureux P, 2002, J CELL BIOL, V159, P499, DOI 10.1083/jcb.200207174
   LEACH JK, 2006, BIOMATERIALS, V27, P3749
   LEIN PJ, 1992, DEV BRAIN RES, V69, P191, DOI 10.1016/0165-3806(92)90159-T
   LETOURNEAU PC, 1978, DEV BIOL, V66, P183, DOI 10.1016/0012-1606(78)90283-X
   Liao W, 2004, SENSOR ACTUAT B-CHEM, V101, P361, DOI 10.1016/j.snb.2004.04.006
   Mahoney MJ, 2005, BIOMATERIALS, V26, P771, DOI 10.1016/j.biomaterials.2004.03.015
   MATSUDA T, 1995, LANGMUIR, V11, P2272
   Menager C, 2004, J NEUROCHEM, V89, P109, DOI 10.1046/j.1471-4159.2004.02302.x
   Miller C, 2002, TISSUE ENG, V8, P367, DOI 10.1089/107632702760184646
   Miller C, 2001, TISSUE ENG, V7, P705, DOI 10.1089/107632701753337663
   Moore K, 2006, TISSUE ENG, V12, P267, DOI 10.1089/ten.2006.12.267
   Naka Y, 2004, J BIOSCI BIOENG, V98, P348, DOI 10.1016/S1389-1723(04)00294-4
   Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118
   NORRIS CR, 1991, J NEUROSCI, V11, P3492
   Patai S., 1971, CHEM AZIDO GROUP
   Rajnicek AM, 1997, J CELL SCI, V110, P2905
   Rajnicek AM, 1997, J CELL SCI, V110, P2915
   Saneinejad S, 1998, J BIOMED MATER RES, V42, P13, DOI 10.1002/(SICI)1097-4636(199810)42:1<13::AID-JBM3>3.0.CO;2-R
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295
   Schwarz A, 1997, J NEUROSCI, V17, P2929
   Scriven EFV, 1984, AZIDES NITRENES REAC
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Simmons CA, 2004, BONE, V35, P562, DOI 10.1016/j.bone.2004.02.027
   SINGER M, 1979, J COMP NEUROL, V185, P1, DOI 10.1002/cne.901850102
   SIROIS E, 1993, INT J ARTIF ORGANS, V16, P609
   Xu XY, 2003, BIOMATERIALS, V24, P2405, DOI 10.1016/S0142-9612(03)00109-1
   Zhang N, 2005, BRAIN RES REV, V49, P48, DOI 10.1016/j.brainresrev.2004.11.002
   Zhang YZ, 2000, J NEUROSCI, V20, P5671
   Zhang ZP, 2005, BIOMATERIALS, V26, P47, DOI 10.1016/j.biomaterials.2004.02.004
   ZISCH AH, 2001, J CONTROLL RELEASE, V71, P101
NR 70
TC 123
Z9 126
U1 1
U2 45
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2007
VL 28
IS 2
BP 271
EP 284
DI 10.1016/j.biomaterials.2006.07.043
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 109LV
UT WOS:000242310500015
PM 16919328
DA 2018-10-20
ER

PT J
AU Chung, A
   Gao, Q
   Kao, WJ
AF Chung, Amy
   Gao, Qiang
   Kao, Weiyuan John
TI Macrophage matrix metalloproteinase-2/-9 gene and protein expression
   following adhesion to ECM-derived multifunctional matrices via integrin
   complexation
SO BIOMATERIALS
LA English
DT Article
DE cell adhesion; matrix metalloproteinase; macrophage; RGD peptide;
   gelatin
ID MELANOMA CELL INVASION; IN-VIVO; FIBRONECTIN; TISSUE; MMP-9;
   PARTICIPATION; ANGIOGENESIS; GELATIN; PROFILE; AND-9
AB Macrophages are commonly observed at the biomaterial-tissue interface and interact with the extracellular matrix (ECM) mainly by integrin receptors to play a critical role in ECM turnover by secreting matrix metalloprotemases (MMPs). To investigate beta 1 and beta 3 containing integrin-mediated adhesion and subsequent MMP-2/-9 protein and gene expression in human blood-derived monocytes, biofunctional peptides immobilized onto flexible polyethylene glycol (PEG) arms were grafted onto a gelatin-based interpenetrating network (IPN). Adherent monocyte density was dramatically greater in the presence of RGD immobilized onto flexible PEG arms of the gelatin-based IPN. Pretreatment of monocytes with either anti-integrin beta 1 or beta 3 led to a significant decrease in adherent cell density on RGD-PEG-grafted IPNs. MMP-2 and MMP-9 protein and MMP-9 mRNA expression increased in the presence of IPNs initially, independent of ligand identity. Anti-integrin beta 1 or beta 3 antibody pretreatment of monocytes led to a general decrease in MMP-2/-9 protein expression. These results demonstrate the importance of beta 1 and beta 3 containing integrins in mediating monocyte adhesion onto RGD immobilized onto flexible PEG arms of the IPN. The results also reveal that MMP-2/-9 protein and gene expression is influenced by the presence of gelatin and not the ligands immobilized on the PEG arms of the IPN. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA.
   Univ Wisconsin, Coll Engn, Dept Biomed Engn, Madison, WI USA.
RP Kao, WJ (reprint author), Univ Wisconsin, Sch Pharm, 425 N Charter St, Madison, WI 53706 USA.
EM wjkao@pharmacy.wisc.edu
FU NIBIB NIH HHS [EB6613]; NHLBI NIH HHS [HL77825]
CR Chintala SK, 1996, CANCER LETT, V103, P201, DOI 10.1016/0304-3835(96)04215-2
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   DiPersio C. M., 2005, WOUND HEALING, P49
   Einerson N. J., 2002, BIOMATERIALS, V24, P509
   Elshaw SR, 2001, BRIT J OPHTHALMOL, V85, P732, DOI 10.1136/bjo.85.6.732
   Gao Q, 2005, DIGEST LIVER DIS, V37, P584, DOI 10.1016/j.dld.2005.02.011
   Gattas-Asfura KM, 2005, BIOMACROMOLECULES, V6, P1503, DOI 10.1021/bm049238w
   Gillard JA, 2004, WOUND REPAIR REGEN, V12, P295, DOI 10.1111/j.1067-1927.2004.012314.x
   Kao WJ, 2001, J BIOMED MATER RES, V55, P79, DOI 10.1002/1097-4636(200104)55:1<79::AID-JBM110>3.3.CO;2-Q
   KAO WYJ, 1994, J BIOMED MATER RES, V28, P73, DOI 10.1002/jbm.820280110
   KJELDSEN L, 1994, BLOOD, V83, P1640
   Laquerriere P, 2004, BIOMATERIALS, V25, P2515, DOI 10.1016/j.biomaterials.2003.09.034
   Leroy-Dudal J, 2005, INT J CANCER, V114, P531, DOI 10.1002/ijc.20778
   Lin-Gibson S, 2004, BIOMACROMOLECULES, V5, P1280, DOI 10.1021/bm0498777
   Liu YP, 2002, CELL SIGNAL, V14, P145, DOI 10.1016/S0898-6568(01)00246-7
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   MAILLARD JL, 1995, CLIN CHIM ACTA, V233, P61, DOI 10.1016/0009-8981(94)05955-R
   McNally AK, 2002, AM J PATHOL, V160, P621, DOI 10.1016/S0002-9440(10)64882-1
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   Phillips JM, 2005, TISSUE ENG, V11, P964, DOI 10.1089/ten.2005.11.964
   SEFTOR REB, 1992, P NATL ACAD SCI USA, V89, P1557, DOI 10.1073/pnas.89.5.1557
   Silletti S, 2001, P NATL ACAD SCI USA, V98, P119, DOI 10.1073/pnas.011343298
   WELGUS HG, 1990, J CLIN INVEST, V86, P1496, DOI 10.1172/JCI114867
   Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8
   Whatling C, 2004, ARTERIOSCL THROM VAS, V24, P10, DOI 10.1161/01.ATV.0000100562.63144.C1
   Xie B, 1998, J BIOL CHEM, V273, P11576, DOI 10.1074/jbc.273.19.11576
   YANG H, IN PRESS INT J NANOM
   Zhang HY, 2002, INVEST OPHTH VIS SCI, V43, P955
NR 28
TC 19
Z9 20
U1 1
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2007
VL 28
IS 2
BP 285
EP 298
DI 10.1016/j.biomaterials.2006.08.038
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 109LV
UT WOS:000242310500016
PM 16979234
DA 2018-10-20
ER

PT J
AU Yoon, DM
   Hawkins, EC
   Francke-Carroll, S
   Fisher, JP
AF Yoon, Diana M.
   Hawkins, Emily C.
   Francke-Carroll, Sabine
   Fisher, John P.
TI Effect of construct properties on encapsulated chondrocyte expression of
   insulin-like growth factor-1
SO BIOMATERIALS
LA English
DT Article
DE alginate; cell signaling; chondrocyte; insulin-like growth factor-1
ID ARTICULAR-CARTILAGE; STIMULATION; SCAFFOLDS; CULTURE; SERUM
AB Hydrogels are a promising type of biomaterial for articular cartilage constructs since they have been shown to enable encapsulated chondrocytes to express their predominant phenotypic marker, type II collagen. Endogenously expressed signaling molecules, such as insulin-like growth factor-1 (IGF-1), are also known to facilitate the retention of this chondrocytic phenotype. Recent investigations have attempted to enhance the ability of encapsulated chondrocytes to regenerate cartilage through delivery of exogenous signaling molecules. However, we hypothesize that by altering construct properties, such as cell density and polymer concentration, we can augment the expression of endogenous IGF-1 in chondrocytes. To this end, bovine articular chondrocytes were encapsulated within alginate hydrogels at two different cell densities (25,000 and 100,000 cells/bead) and various alginate concentrations (0.8%, 1.2%, and 2.0% w/v). These parameters were chosen to simultaneously investigate cell-to-cell distance on paracrine signaling and water content on IGF-1 diffusion by chondrocytes. At 1, 4, and 8 d, chondrocytes were analyzed for protein and mRNA expression of IGF-1 as well as type II collagen. Results suggest that cell density and alginate concentration at high cell density can significantly affect the endogenous IGF-1 expression by chondrocytes. Therefore, these results indicate that construct properties can impact chondrocyte gene expression and should be considered in order to create a proper engineered articular cartilage construct. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
   Univ Maryland, Dept Chem & Biomol Engn, College Pk, MD 20742 USA.
   US FDA, Pathol Branch, Ctr Food Safety & Appl Nutr, College Pk, MD 20740 USA.
RP Fisher, JP (reprint author), Univ Maryland, Fischell Dept Bioengn, 3238 Jeong H Kim Engn Bldg, College Pk, MD 20742 USA.
EM jpfisher@umd.edu
RI Fisher, John/F-8078-2012
CR Blunk T, 2002, TISSUE ENG, V8, P73, DOI 10.1089/107632702753503072
   Bunn RC, 2003, TRENDS ENDOCRIN MET, V14, P176, DOI 10.1016/S1043-2760(03)00049-3
   Claeys I, 2002, PEPTIDES, V23, P807, DOI 10.1016/S0196-9781(01)00666-0
   Dupont Joelle, 2003, Birth Defects Research, V69, P257, DOI 10.1002/bdrc.10022
   Elisseeff JH, 2002, ANN NY ACAD SCI, V961, P118, DOI 10.1111/j.1749-6632.2002.tb03062.x
   Fisher JP, 2004, J BIOMED MATER RES A, V71A, P268, DOI 10.1002/jbm.a.30148
   Genes NG, 2004, ARCH BIOCHEM BIOPHYS, V422, P161, DOI 10.1016/j.abb.2003.11.023
   GUO JF, 1989, CONNECT TISSUE RES, V19, P277, DOI 10.3109/03008208909043901
   Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P564, DOI 10.1053/joca.2002.0814
   Lin Z, 2006, TISSUE ENG, V12, P1971, DOI 10.1089/ten.2006.12.1971
   Loeser RF, 2005, ARTHRITIS RHEUM, V52, P3910, DOI 10.1002/art.21472
   MCQUILLAN DJ, 1986, BIOCHEM J, V240, P423, DOI 10.1042/bj2400423
   Murphy CL, 2001, TISSUE ENG, V7, P791, DOI 10.1089/107632701753337735
   Randolph MA, 2003, CLIN PLAST SURG, V30, P519, DOI 10.1016/S0094-1298(03)00070-1
   SCHALKWIJK J, 1989, ARTHRITIS RHEUM, V32, P66, DOI 10.1002/anr.1780320111
   Ulrich-Vinther Michael, 2003, J Am Acad Orthop Surg, V11, P421
   VACANTI CA, 1991, PLAST RECONSTR SURG, V88, P753, DOI 10.1097/00006534-199111000-00001
   van Susante JLC, 2000, J ORTHOP RES, V18, P68, DOI 10.1002/jor.1100180111
   Woodfield TBF, 2002, CRIT REV EUKAR GENE, V12, P209, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i3.40
   Yasuda A, 2006, TISSUE ENG, V12, P1237, DOI 10.1089/ten.2006.12.1237
   Yoon D.M., 2006, POLYM SCAFFOLDS TISS
   YOON DM, 2006, CHONDROCYTE SIGNALIN
NR 23
TC 30
Z9 32
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2007
VL 28
IS 2
BP 299
EP 306
DI 10.1016/j.biomaterials.2006.08.039
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 109LV
UT WOS:000242310500017
PM 16982090
DA 2018-10-20
ER

PT J
AU Harrison, BS
   Atala, A
AF Harrison, Benjamin S.
   Atala, Anthony
TI Carbon nanotube applications for tissue engineering
SO BIOMATERIALS
LA English
DT Review
DE carbon nanotubes; nanocomposite; biosensor; gene transfer; scaffold
ID MRI CONTRAST AGENTS; OPTICAL SENSORS; QUANTUM DOTS; GENE-THERAPY;
   SINGLE; CELLS; FUNCTIONALIZATION; NANOPARTICLES; PURIFICATION;
   TRANSPORTERS
AB As the field of tissue engineering advances, new tools for better monitoring and evaluating of engineered tissues along with new biomaterials to direct tissue growth are needed. Carbon nanotubes may be an important tissue engineering material for improved tracking of cells, sensing of microenvironments, delivering of transfection agents, and scaffolding for incorporating with the host's body. Using carbon nanotubes for optical, magnetic resonance and radiotracer contrast agents would provide better means of evaluating tissue formation. In addition, monitoring and altering intra and intercellular processes would be useful for design of better engineered tissues. Carbon nanotubes can also be incorporated into scaffolds providing structural reinforcement as well as imparting novel properties such as electrical conductivity into the scaffolds may aid in directing cell growth. Potential cytotoxic effects associated with carbon nanotubes may be mitigated by chemically functionalizing the surface. Overall, carbon nanotubes may play an integral role as unique biomaterial for creating and monitoring engineered tissue. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Wake Forest Univ, Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA.
RP Harrison, BS (reprint author), Wake Forest Univ, Wake Forest Inst Regenerat Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.
EM bharriso@wfubmc.edu
OI Atala, Anthony/0000-0001-8186-2160
CR Andrews R, 2001, CARBON, V39, P1681, DOI 10.1016/S0008-6223(00)00301-8
   Ayutsede J, 2006, BIOMACROMOLECULES, V7, P208, DOI 10.1021/bm0505888
   Ballou B, 2004, BIOCONJUGATE CHEM, V15, P79, DOI 10.1021/bc034153y
   Barone PW, 2005, NAT MATER, V4, P86, DOI 10.1038/nmat1276
   Besteman K, 2003, NANO LETT, V3, P727, DOI 10.1021/nl034139u
   Bolskar RD, 2003, J AM CHEM SOC, V125, P5471, DOI 10.1021/ja03400984
   Bulte JWM, 2001, NAT BIOTECHNOL, V19, P1141, DOI 10.1038/nbt1201-1141
   Bulte JWM, 1999, P NATL ACAD SCI USA, V96, P15256, DOI 10.1073/pnas.96.26.15256
   Cassell AM, 1999, J PHYS CHEM B, V103, P6484, DOI 10.1021/jp990957sCCC:$18.00
   Chattopadhyay D, 2002, CARBON, V40, P985, DOI 10.1016/S0008-6223(01)00234-2
   Chen RJ, 2004, J AM CHEM SOC, V126, P1563, DOI 10.1021/ja038702m
   Chen RJ, 2003, P NATL ACAD SCI USA, V100, P4984, DOI 10.1073/pnas.0837064100
   Cherukuri P, 2004, J AM CHEM SOC, V126, P15638, DOI 10.1021/ja0466311
   Correa-Duarte MA, 2004, NANO LETT, V4, P2233, DOI 10.1021/nl048574f
   Denis MC, 2004, P NATL ACAD SCI USA, V101, P12634, DOI 10.1073/pnas.040437101
   DILLON A, 1999, ADV MATER, V16, P1354
   Ding LH, 2005, NANO LETT, V5, P2448, DOI 10.1021/nl051748o
   GABAY T, 2005, PHYSICA A, V250, P611
   Gao XH, 2004, NAT BIOTECHNOL, V22, P969, DOI 10.1038/nbt994
   GUPTAA AK, 2005, BIOMATERIALS, V26, P3559
   Heller DA, 2005, ADV MATER, V17, P2793, DOI 10.1002/adma.200500477
   Hu H, 2004, NANO LETT, V4, P507, DOI 10.1021/nl035193d
   Huczko A, 2001, FULLERENE SCI TECHN, V9, P247, DOI 10.1081/FST-100102972
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   Jia G, 2005, ENVIRON SCI TECHNOL, V39, P1378, DOI 10.1021/es048729l
   Joseph S, 2003, NANO LETT, V3, P1399, DOI 10.1021/nl0346326
   Journet C, 1997, NATURE, V388, P756, DOI 10.1038/41972
   Jung HI, 2004, BIOCONJUGATE CHEM, V15, P983, DOI 10.1021/bc049899q
   Kaempgen M, 2006, J ELECTROANAL CHEM, V586, P72, DOI 10.1016/j.jelechem.2005.09.009
   Kam NWS, 2004, J AM CHEM SOC, V126, P6850, DOI 10.1021/ja0486059
   Kam NWS, 2005, J AM CHEM SOC, V127, P12492, DOI 10.1021/ja053962k
   Kam NWS, 2005, P NATL ACAD SCI USA, V102, P11600, DOI 10.1073/pnas.0502680102
   Lovat V, 2005, NANO LETT, V5, P1107, DOI 10.1021/nl050637m
   MacDonald RA, 2005, J BIOMED MATER RES A, V74A, P489, DOI 10.1002/jbm.a.30386
   Manna SK, 2005, NANO LETT, V5, P1676, DOI 10.1021/nl0507966
   Martin CR, 2003, NAT REV DRUG DISCOV, V2, P29, DOI 10.1038/nrd988
   Maynard AD, 2004, J TOXICOL ENV HEAL A, V67, P87, DOI 10.1080/15287390490253688
   Mornet S, 2004, J MATER CHEM, V14, P2161, DOI 10.1039/b402025a
   Nimmagadda A, 2006, J BIOMED MATER RES A, V76A, P614, DOI 10.1002/jbm.a.30577
   Ostuni E, 2001, LANGMUIR, V17, P6336, DOI 10.1021/la010552a
   Radosavljevic M, 2002, NANO LETT, V2, P761, DOI 10.1021/nl025584c
   Reynolds CH, 2000, J AM CHEM SOC, V122, P8940, DOI 10.1021/ja001426g
   Rochette JF, 2005, ANAL BIOCHEM, V336, P305, DOI 10.1016/j.ab.2004.10.027
   Schellenberger EA, 2004, CHEMBIOCHEM, V5, P275, DOI 10.1002/cbic.200300713
   Schmieder AH, 2005, MAGN RESON MED, V53, P621, DOI 10.1002/mrm.20391
   Shi DL, 2006, ADV MATER, V18, P189, DOI 10.1002/adma.200501680
   Shvedova AA, 2003, J TOXICOL ENV HEAL A, V66, P1909, DOI 10.1080/15287390390231566
   Singh R, 2005, J AM CHEM SOC, V127, P4388, DOI 10.1021/ja0441561
   Singh R, 2006, P NATL ACAD SCI USA, V103, P3357, DOI 10.1073/pnas.0509009103
   Sitharaman B, 2005, CHEM COMMUN, P3915, DOI 10.1039/b504435a
   SORKIN R, 2006, J NEURAL ENG, V3, P1
   Strong KL, 2003, CARBON, V41, P1477, DOI 10.1016/S0008-6223(03)00014-9
   Supronowicz PR, 2002, J BIOMED MATER RES, V59, P499, DOI 10.1002/jbm.10015
   Tan XC, 2005, ANAL BIOCHEM, V337, P111, DOI 10.1016/j.ab.2004.10.040
   Thess A., 1996, SCIENCE, V273, P5274
   Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066
   Toth E, 2005, J AM CHEM SOC, V127, P799, DOI 10.1021/ja044688h
   Verma IM, 1997, NATURE, V389, P239, DOI 10.1038/38410
   Wang SF, 2005, BIOMACROMOLECULES, V6, P3067, DOI 10.1021/bm050378v
   Warheit DB, 2004, TOXICOL SCI, V77, P117, DOI 10.1093/toxsci/kfg228
   Winter PM, 2003, CIRCULATION, V108, P2270, DOI 10.1161/01.CIR.0000093185.16083.95
   Xian YZ, 2005, J CHROMATOGR B, V817, P239, DOI 10.1016/j.jchromb.2004.12.014
   Yokoyama A, 2005, NANO LETT, V5, P157, DOI 10.1021/nl0484752
   Zhao B, 2005, CHEM MATER, V17, P3235, DOI 10.1021/cm0500399
   Zhao M, 2001, NAT MED, V7, P1241, DOI 10.1038/nm1101-1241
NR 65
TC 635
Z9 648
U1 9
U2 263
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2007
VL 28
IS 2
BP 344
EP 353
DI 10.1016/j.biomaterials.2006.07.044
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 109LV
UT WOS:000242310500022
PM 16934866
DA 2018-10-20
ER

PT J
AU Schmidt, DR
   Kao, WJ
AF Schmidt, David Richard
   Kao, Weiyuan John
TI The interrelated role of fibronectin and interleukin-1 in
   biomaterial-modulated macrophage function
SO BIOMATERIALS
LA English
DT Review
DE monocyte; alveolar macrophage; tyrosine phosphorylation; inflammation;
   RGD; PHSRN; cytokine
ID TUMOR-NECROSIS-FACTOR; EXTRACELLULAR-MATRIX PROTEINS; GROWTH-FACTOR
   PRODUCTION; FACTOR-ALPHA; ALVEOLAR MACROPHAGES; PROINFLAMMATORY
   CYTOKINES; ACTIVATED MONOCYTES; RECEPTOR ANTAGONIST;
   SIGNAL-TRANSDUCTION; INTEGRIN BINDING
AB Macrophages play a critical role in mediating the host response to biomaterials, perhaps most notably by guiding the host inflammatory response through the release of inflammatory molecules such as the cytokine interleukin-1 (IL-1). The extent of the macrophage response following interaction with the biomaterial surface contributes greatly to device efficacy, yet the molecular mechanisms of this interaction are still unclear. The extracellular matrix (ECM) protein fibronectin (FN) is recognized by macrophages and frequently used in biomaterial modification to elicit greater cellular adhesion and tissue integration. Macrophage interaction with FN and other ECM molecules on the biomaterial surface has been shown to induce a variety of inflammatory responses, thus both FN and IL-1 can be utilized as model molecules to better understand the mechanisms of material-mediated macrophage responses. This literature review presents a comprehensive survey of past and current research on the interrelated role of IL-1 FN, and FN-derivatives in determining biomaterial-modulated macrophage function. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Wisconsin, Sch Pharm, Madison, WI 53705 USA.
   Univ Wisconsin, Coll Engn, Dept Biomed Engn, Madison, WI 53705 USA.
RP Kao, WJ (reprint author), Univ Wisconsin, Sch Pharm, 777 Highland Ave, Madison, WI 53705 USA.
EM wjkao@pharmacy.wisc.edu
FU NIBIB NIH HHS [EB6613]; NHLBI NIH HHS [HL77825]
CR ADAMS DO, 1984, ANNU REV IMMUNOL, V2, P283, DOI 10.1146/annurev.immunol.2.1.283
   ALSUMIDAIE AM, 1986, J IMMUNOL METHODS, V91, P237, DOI 10.1016/0022-1759(86)90484-9
   Altroff H, 2001, J BIOL CHEM, V276, P38885, DOI 10.1074/jbc.M105868200
   ANDERSON JM, 1995, J BIOMAT SCI-POLYM E, V7, P159, DOI 10.1163/156856295X00670
   Anderson JM, 2004, BIOMATERIALS SCI INT, P296
   AOTA S, 1994, J BIOL CHEM, V269, P24756
   Arend WR, 2002, CYTOKINE GROWTH F R, V13, P323, DOI 10.1016/S1359-6101(02)00020-5
   Bailey LO, 2006, J BIOMED MATER RES A, V76A, P491, DOI 10.1002/jbm.a.30527
   Barilla ML, 2000, SEMIN ARTHRITIS RHEU, V29, P252, DOI 10.1016/S0049-0172(00)80012-8
   Barnes PJ, 2004, CELL MOL BIOL, V50, P627
   Bazan JF, 1996, NATURE, V379, P591, DOI 10.1038/379591a0
   BEEKHUIZEN H, 1993, J LEUKOCYTE BIOL, V54, P363
   BEEZHOLD DH, 1987, IMMUNOL INVEST, V16, P437, DOI 10.3109/08820138709087097
   Benoit DSW, 2005, BIOMATERIALS, V26, P5209, DOI 10.1016/j.biomaterials.2005.01.045
   Bird S, 2002, CYTOKINE GROWTH F R, V13, P483, DOI 10.1016/S1359-6101(02)00028-X
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P837, DOI 10.1002/jbm.820260702
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P457, DOI 10.1002/jbm.820260404
   BORASCHI D, 1995, FRONT BIOSCI, V1, pD270
   BRUGGER W, 1991, INT IMMUNOL, V3, P221, DOI 10.1093/intimm/3.3.221
   CARR I, 1981, MANUAL MACROPHAGE ME, P187
   CHUNG A, 2006, IN PRESS BIOMATERIAL
   Delaleu N, 2004, PERIODONTOL 2000, V35, P42, DOI 10.1111/j.0906-6713.2004.003569.x
   DEVLIN RB, 1994, AM J PHYSIOL, V266, P612
   DINARELLO CA, 1991, J INFECT DIS, V163, P1177, DOI 10.1093/infdis/163.6.1177
   Dinarello CA, 1996, BLOOD, V87, P2095
   DRISCOLL KE, 1995, J TOXICOL ENV HEALTH, V46, P155, DOI 10.1080/15287399509532026
   DRISCOLL KE, 1991, TOXICOL APPL PHARM, V111, P201, DOI 10.1016/0041-008X(91)90024-9
   DRISCOLL KE, 1991, TOXICOL PATHOL, V19, P398, DOI 10.1177/0192623391019004-108
   ERICKSON C, 1989, CLIN IMMUNOLOGY, P27
   FFRENCHCONSTANT C, 1995, EXP CELL RES, V221, P261, DOI 10.1006/excr.1995.1374
   Furth R, 1988, INFLAMMATION BASIC P, P281
   GAO Q, 2006, IN PRESS TISSUE ENG
   Graves KL, 1996, AM J PHYSIOL-LUNG C, V271, pL61
   Gretzer C, 1996, BIOMATERIALS, V17, P851, DOI 10.1016/0142-9612(96)83279-0
   Gwinn MR, 2006, J TOXICOL ENV HEAL B, V9, P27, DOI 10.1080/15287390500196081
   HAZUDA DJ, 1988, J BIOL CHEM, V263, P8473
   Henderson RF, 2005, EXP TOXICOL PATHOL, V57, P155, DOI 10.1016/j.etp.2005.05.004
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hojo K, 2001, BIOORG MED CHEM LETT, V11, P1429, DOI 10.1016/S0960-894X(01)00225-6
   HUAUX F, 1995, TOXICOL APPL PHARM, V132, P53, DOI 10.1006/taap.1995.1086
   Hynes RO, 1999, P NATL ACAD SCI USA, V96, P2588, DOI 10.1073/pnas.96.6.2588
   Kao WJ, 2001, FRONT BIOSCI, V6, pD992, DOI 10.2741/Kao
   KAO WJ, 2001, J CONTROL RELEASE, V78, P219
   KAO WJ, 1998, BIOTECHNOL BIOENG, V59
   Kosmehl H, 1996, VIRCHOWS ARCH, V429, P311
   Labat-Robert J, 2002, SEMIN CANCER BIOL, V12, P187, DOI 10.1016/S1044-579X(02)00022-6
   Levine JS, 1998, J AUTOIMMUN, V11, P141, DOI 10.1006/jaut.1997.0182
   LIN TH, 1994, J CELL BIOL, V126, P1585, DOI 10.1083/jcb.126.6.1585
   LIN TH, 1995, J BIOL CHEM, V270, P16179
   Liu YP, 2002, CELL SIGNAL, V14, P145, DOI 10.1016/S0898-6568(01)00246-7
   LOPEZMORATALLA N, 1995, BBA-MOL CELL RES, V1265, P181, DOI 10.1016/0167-4889(94)00199-O
   MCCOLL SR, 1992, J EXP MED, V176, P593, DOI 10.1084/jem.176.2.593
   McNally AK, 1996, AM J PATHOL, V149, P975
   Murakami Y, 1996, INFECT IMMUN, V64, P2571
   Palsson BO, 2004, TISSUE ENG, P270
   Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059
   PEAT EB, 1995, IMMUNOLOGY, V84, P440
   PENDINO KJ, 1994, AM J RESP CELL MOL, V11, P279, DOI 10.1165/ajrcmb.11.3.8086166
   PEREZARELLANO JL, 1990, ALLERGOL IMMUNOPATH, V18, P175
   Romberger DJ, 1997, INT J BIOCHEM CELL B, V29, P939, DOI 10.1016/S1357-2725(96)00172-0
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Schiffer R, 1999, PATHOBIOLOGY, V67, P233, DOI 10.1159/000028099
   SCHWARTZ DA, 1993, AM REV RESPIR DIS, V148, P68, DOI 10.1164/ajrccm/148.1.68
   Simms H, 1996, J IMMUNOL, V157, P3605
   Simms HH, 1997, ANN SURG, V225, P757, DOI 10.1097/00000658-199706000-00013
   STANDIFORD TJ, 1991, AM J RESP CELL MOL, V5, P579, DOI 10.1165/ajrcmb/5.6.579
   TAKEMURA R, 1984, AM PHYSL SOC, pC1
   THOMPSON PN, 1992, AM J PHYSIOL, V263, pG437
   Wang ACC, 2001, INFLAMM RES, V50, P142, DOI 10.1007/s000110050738
   Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670
   Yamada KM, 2000, J CLIN INVEST, V105, P1507, DOI 10.1172/JCI10119
   YAMADA KM, 2001, J CELL PHYSL, V189, P1
   Yamaguchi Y, 2001, J DERMATOL, V28, P521, DOI 10.1111/j.1346-8138.2001.tb00025.x
   YUROCHKO AD, 1992, P NATL ACAD SCI USA, V89, P9034, DOI 10.1073/pnas.89.19.9034
   ZHANG Y, 1993, J IMMUNOL, V150, P4188
   Zhu P, 1998, BIOCHEM J, V330, P975, DOI 10.1042/bj3300975
   Zuckerman ST, 2006, BIOMATERIALS, V27, P3745, DOI 10.1016/j.biomaterials.2006.02.028
   ZUCKERMAN ST, 2006, UNPUB J BIOMEDICAL M
NR 78
TC 42
Z9 44
U1 4
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2007
VL 28
IS 3
BP 371
EP 382
DI 10.1016/j.biomaterials.2006.08.041
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 118SB
UT WOS:000242960900001
PM 16978691
DA 2018-10-20
ER

PT J
AU Sawyer, AA
   Hennessy, KM
   Bellis, SL
AF Sawyer, Amber A.
   Hennessy, Kristin M.
   Bellis, Susan L.
TI The effect of adsorbed serum proteins, RGD and proteoglycan-binding
   peptides on the adhesion of mesenchymal stem cells to hydroxyapatite
SO BIOMATERIALS
LA English
DT Article
DE cell adhesion; hydroxyapatite; mesenchymal stem cell; protein
   adsorption; RGD peptide; bone
ID OSTEOBLAST ADHESION; SYNTHETIC PEPTIDE; HUMAN BONE; CYTOSKELETAL
   ORGANIZATION; IN-VITRO; FIBRONECTIN; ATTACHMENT; BIOMATERIALS; DOMAIN;
   SURFACES
AB Prior studies from our laboratory have shown that RGD peptides increase the attachment of mesenchymal stem cells (MSCs) to hydroxyapatite (HA), however, RGD does not induce cell spreading when coupled to this type of biomaterial. In all effort to improve MSC spreading, and possibly cell attachment, proteoglycan-binding peptides (KRSR or FHRRIKA) were combined with RGD in the current study. It was found that the peptide combinations did not enhance MSC attachment relative to RGD alone, although a slight amount of spreading was elicited by both KRSR and FHRRIKA. Similar results were obtained with proteoglycan-binding peptides modified with a heptaglutamate domain, a motif that improves peptide tethering to HA. To determine whether differentiation status affected cell responses, MSCs were in vitro differentiated into osteoblasts, and evaluated as before. These experiments revealed that, like MSCs, osteoblasts did not adhere in greater numbers to the peptide combinations. Finally, none of the peptides or peptide combinations were able to stimulate the robust amount of cell adhesion and spreading elicited by serum-coated HA surfaces (of note, five different species of serum were tested). Given the propensity of HA to adsorb proadhesive proteins from blood/serum, we question the utility of functionalizing HA with RGD and/or proteoglycan-binding peptides. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Alabama, Dept Physiol & Biophys, MCLM, Birmingham, AL 35294 USA.
   Univ Alabama, Dept Biomed Engn, Birmingham, AL 35294 USA.
RP Bellis, SL (reprint author), Univ Alabama, Dept Physiol & Biophys, MCLM, Rm 982A,1918 Univ Blvd, Birmingham, AL 35294 USA.
EM bellis@physiology.uab.edu
FU NIAMS NIH HHS [AR51539]
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   AOTA S, 1991, J BIOL CHEM, V266, P15938
   Balasundaram G, 2006, BIOMATERIALS, V27, P2798, DOI 10.1016/j.biomaterials.2005.12.008
   CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21
   Couchman JR, 1999, J CELL SCI, V112, P3415
   DALTON BA, 1995, J CELL SCI, V108, P2083
   Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.3.CO;2-G
   Dettin M, 2002, J BIOMED MATER RES, V60, P466, DOI 10.1002/jbm.10066
   Dettin M, 2005, BIOMATERIALS, V26, P4507, DOI 10.1016/j.biomaterials.2004.11.023
   Durrieu MC, 2004, J MATER SCI-MATER M, V15, P779, DOI 10.1023/B:JMSM.0000032818.09569.d9
   Fujisawa R, 1997, MATRIX BIOL, V16, P21, DOI 10.1016/S0945-053X(97)90113-X
   Garcia AJ, 2002, CRIT REV EUKAR GENE, V12, P151, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i2.50
   Gilbert M, 2003, J BIOMED MATER RES A, V67A, P69, DOI 10.1002/jbm.a.10053
   Gilbert M, 2000, J BIOL CHEM, V275, P16213, DOI 10.1074/jbc.M001773200
   GRZESIK WJ, 1994, J BONE MINER RES, V9, P487, DOI 10.1002/jbmr.5650090408
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   HOWLETT CR, 1994, BIOMATERIALS, V15, P213, DOI 10.1016/0142-9612(94)90070-1
   Itoh D, 2002, J BIOMED MATER RES, V62, P292, DOI 10.1002/jbm.10338
   Kilpadi KL, 2001, J BIOMED MATER RES, V57, P258, DOI 10.1002/1097-4636(200111)57:2<258::AID-JBM1166>3.0.CO;2-R
   Kilpadi KL, 2004, J BIOMED MATER RES A, V68A, P273, DOI 10.1002/jbm.a.20043
   Lebaron RG, 2000, TISSUE ENG, V6, P85, DOI 10.1089/107632700320720
   PEARSON BS, 1988, J DENT RES, V67, P515, DOI 10.1177/00220345880670021701
   PULEO DA, 1991, BONE, V12, P271, DOI 10.1016/8756-3282(91)90075-T
   RABINOVITCH PS, 1993, ANN NY ACAD SCI, V677, P252, DOI 10.1111/j.1749-6632.1993.tb38782.x
   Rezania A, 1999, BIOTECHNOL PROGR, V15, P19, DOI 10.1021/bp980083b
   Sagnella S, 2005, TISSUE ENG, V11, P226, DOI 10.1089/ten.2005.11.226
   Sawyer AA, 2005, BIOMATERIALS, V26, P1467, DOI 10.1016/j.biomaterials.2004.05.008
   Sawyer AA, 2005, BIOMATERIALS, V26, P7046, DOI 10.1016/j.biomaterials.2005.05.006
   Schvartz I, 1999, INT J BIOCHEM CELL B, V31, P539, DOI 10.1016/S1357-2725(99)00005-9
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   STEELE JG, 1993, J BIOMAT SCI-POLYM E, V5, P245
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   WOODS A, 1993, MOL BIOL CELL, V4, P605
   WOODS A, 1986, EMBO J, V5, P665, DOI 10.1002/j.1460-2075.1986.tb04265.x
NR 34
TC 86
Z9 88
U1 1
U2 26
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2007
VL 28
IS 3
BP 383
EP 392
DI 10.1016/j.biomaterials.2006.08.031
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 118SB
UT WOS:000242960900002
PM 16952395
DA 2018-10-20
ER

PT J
AU Nomizu, M
   Yamagata, N
   Mochizuki, M
   Kikkawa, Y
   Kadoya, Y
AF Nomizu, M.
   Yamagata, N.
   Mochizuki, M.
   Kikkawa, Y.
   Kadoya, Y.
TI Peptide-chitosan matrix: a new multifunctional biomaterial
SO BIOPOLYMERS
LA English
DT Meeting Abstract
CT 20th American-Peptide-Society Symposium
CY JUN 26-30, 2007
CL Montreal, CANADA
SP Amer Peptide Soc
C1 Tokyo Univ Pharm & Life Sci, Hachioji, Tokyo 1920392, Japan.
   Kitasato Univ, Sch Med, Sagamihara, Kanagawa 2288555, Japan.
NR 0
TC 0
Z9 0
U1 1
U2 2
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0006-3525
J9 BIOPOLYMERS
JI Biopolymers
PY 2007
VL 88
IS 4
SI SI
BP 518
EP 518
PG 1
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 181GT
UT WOS:000247425900020
DA 2018-10-20
ER

PT J
AU Kidane, AG
   Edirisinghe, MJ
   Bonhoeffer, P
   Seifalian, AM
AF Kidane, Asmeret G.
   Edirisinghe, Mohan J.
   Bonhoeffer, Philipp
   Seifalian, Alexander M.
TI Flow behaviour of a POSS biopolymer solution
SO BIORHEOLOGY
LA English
DT Article
DE biomaterial; biopolymer; solution; viscosity; flow behaviour;
   nanocomposite
ID POLYHEDRAL OLIGOMERIC SILSESQUIOXANE; IN-VITRO; NANOCOMPOSITE;
   POLYURETHANES; POLYMERS; IMPLANTS
AB A non-biodegradable polyhedral oligomeric silsesquioxane (POSS) nanocomposite biopolymer has been developed for fabrication of medical devices and for tissue engineering human organs. The polymer in solution, containing 2 wt% of POSS, has been synthesized, characterized and investigated to determine its key rheological properties. Thus, the variation of shear stress and viscosity as a function of shear rate has been determined at ambient temperature to estimate yield stress and the index of pseudoplasticity, respectively. The temperature dependence of viscosity and the effect of ageing on the viscosity of the polymer have also been investigated. Results are compared with those of a conventional polycarbonate urethane (PCU) polymer solution. The POSS-PCU polymer solution shows near-Newtonian behaviour in the shear rate range to 1000 s(-1), having an apparent viscosity of similar to 3000 mPa s and a pseudoplasticity index of 0.90, decreasing slightly as the polymer solution is aged over 9 months. The temperature dependence of viscosity of the POSS polymer is extremely low and does not change with ageing but the yield strength increases from 2.7 Pa to 8.3 Pa.
C1 [Edirisinghe, Mohan J.] UCL, Dept Mech Engn, London WC1E 7JE, England.
   [Kidane, Asmeret G.; Seifalian, Alexander M.] UCL, BTEC, Acad Div Surg & Intervent Sci, London, England.
   [Bonhoeffer, Philipp] Great Ormond St Hosp Sick Children, London WC1N 3JH, England.
   [Bonhoeffer, Philipp] Inst Child Hlth, London, England.
RP Edirisinghe, MJ (reprint author), UCL, Dept Mech Engn, Torrington Pl, London WC1E 7JE, England.
EM m.edirisinghe@ucl.ac.uk
RI Seifalian, Alexander/I-6028-2013
OI Seifalian, Alexander/0000-0002-1180-3322
CR EDIRISINGHE MJ, 1987, BRIT CERAM TRANS J, V86, P18
   Fina A, 2006, POLYM DEGRAD STABIL, V91, P2275, DOI 10.1016/j.polymdegradstab.2006.04.014
   Gupta A, 2007, J BIOACT COMPAT POL, V22, P265, DOI 10.1177/0883911507078268
   Kannan RY, 2007, PLAST RECONSTR SURG, V119, P1653, DOI 10.1097/01.prs.0000246404.53831.4c
   Kannan RY, 2006, CELL BIOCHEM BIOPHYS, V45, P129, DOI 10.1385/CBB:45:2:129
   Kannan RY, 2006, BIOMATERIALS, V27, P4618, DOI 10.1016/j.biomaterials.2006.04.024
   Kannan RY, 2006, BIOMACROMOLECULES, V7, P215, DOI 10.1021/bm050590z
   Kannan RY, 2006, BIOMATERIALS, V27, P1971, DOI 10.1016/j.biomaterials.2005.10.006
   Li GZ, 2001, J INORG ORGANOMET P, V11, P123, DOI 10.1023/A:1015287910502
   Liu YH, 2006, MACROMOL CHEM PHYSIC, V207, P1842, DOI 10.1002/macp.200600241
   Lligadas G, 2006, BIOMACROMOLECULES, V7, P3521, DOI 10.1021/bm060703u
   Ni Y, 2004, POLYMER, V45, P5557, DOI 10.1016/j.polymer.2004.06.008
   Petro M, 2004, MACROMOL RAPID COMM, V25, P178, DOI 10.1002/marc.200300229
   Pielichowski K, 2006, ADV POLYM SCI, V201, P225, DOI 10.1007/12_077
   Pu KY, 2006, PROG CHEM, V18, P609
   Santerre JP, 2005, BIOMATERIALS, V26, P7457, DOI 10.1016/j.biomaterials.2005.05.079
   Seifalian AM, 2005, Patent, Patent No. [WO2005070998, 2005070998]
NR 17
TC 7
Z9 7
U1 0
U2 3
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0006-355X
EI 1878-5034
J9 BIORHEOLOGY
JI Biorheology
PY 2007
VL 44
IS 4
BP 265
EP 272
PG 8
WC Biophysics; Engineering, Biomedical; Hematology
SC Biophysics; Engineering; Hematology
GA 254TN
UT WOS:000252611000003
PM 18094450
DA 2018-10-20
ER

PT J
AU Sieminski, AL
   Was, AS
   Kim, G
   Gong, H
   Kamm, RD
AF Sieminski, A. L.
   Was, A. S.
   Kim, G.
   Gong, H.
   Kamm, R. D.
TI The stiffness of three-dimensional ionic self-assembling peptide gels
   affects the extent of capillary-like network formation
SO CELL BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE capillary morphogenesis; endothelial cell; biomaterial; self assembly;
   mechanical properties; adhesion
ID ENDOTHELIAL-CELLS; IN-VITRO; MECHANICAL-PROPERTIES; COMPLEMENTARY
   OLIGOPEPTIDE; EXTRACELLULAR MATRICES; LUMEN FORMATION; NONPARENCHYMAL
   CELLS; FIBRIN MATRICES; COLLAGEN GELS; ANGIOGENESIS
AB Improving our ability to control capillary morphogenesis has implications for not only better understanding of basic biology, but also for applications in tissue engineering and in vitro testing. Numerous biomaterials have been investigated as cellular supports for these applications and the biophysical environment biomaterials provide to cells has been increasingly recognized as an important factor in directing cell function. Here, the ability of ionic self-assembling peptide gels to support capillary morphogenesis and the effect of their mechanical properties is investigated. When placed in a physiological salt solution, these oligo-peptides spontaneously self-assemble into gels with an extracellular matrix (ECM)-like microarchitecture. To evaluate the ability of three-dimensional (3D) self-assembled peptide gels to support capillary-like network formation, human umbilical vein endothelial cells (HUVECs) were embedded within RAD16-I ((RADA)4) or RAD16-II ((RARADADA)2) peptide gels with various stiffness values. As peptide stiffness is decreased cells show increased elongation and are increasingly able to contract gels. The observation that capillary morphogenesis is favored in more malleable substrates is consistent with previous reports using natural biomaterials. The structural properties of peptide gels and their ability to support capillary morphogenesis in vitro make them promising biomaterials to investigate for numerous biomedical applications.
C1 MIT, Dept Biol Engn, Cambridge, MA 02139 USA.
   MIT, Dept Mech Engn, Cambridge, MA 02139 USA.
   Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA.
RP Sieminski, AL (reprint author), Franklin W Olin Coll Engn, Needham, MA 02492 USA.
EM alisha.sieminski@olin.edu
OI /0000-0002-7232-304X; Gong, Haiyan/0000-0002-7204-5019
FU NIBIB NIH HHS [R01 EB003805, R01-EB003805]
CR Bayless KJ, 2000, AM J PATHOL, V156, P1673, DOI 10.1016/S0002-9440(10)65038-9
   Bhatia SN, 1999, FASEB J, V13, P1883
   Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478
   Davis GE, 1996, EXP CELL RES, V224, P39, DOI 10.1006/excr.1996.0109
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Egginton S, 2003, MICROCIRCULATION, V10, P45, DOI 10.1038/sj.mn.7800174
   Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   Genove E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012
   Gibson L. J, 1997, CELLULAR SOLIDS STRU
   Gobin AS, 2002, FASEB J, V16, P751, DOI 10.1096/fj.01-0759fje
   GONG H, 2002, EXPT EYE RES, V75, P374
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Holder WD, 1997, TISSUE ENG, V3, P149, DOI 10.1089/ten.1997.3.149
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Holmes TC, 2002, TRENDS BIOTECHNOL, V20, P16, DOI 10.1016/S0167-7799(01)01840-6
   INGBER DE, 1989, J CELL BIOL, V109, P317, DOI 10.1083/jcb.109.1.317
   Kaihara S, 2000, J PEDIATR SURG, V35, P1287, DOI 10.1053/jpsu.2000.9298
   Kamei M, 2006, NATURE, V442, P453, DOI 10.1038/nature04923
   KANZAWA S, 1993, ANN PLAS SURG, V30, P244, DOI 10.1097/00000637-199303000-00008
   Knapp DM, 1999, AICHE J, V45, P2628, DOI 10.1002/aic.690451219
   Korff T, 1999, J CELL SCI, V112, P3249
   Lafleur MA, 2002, J CELL SCI, V115, P3427
   Leon EJ, 1998, J BIOMAT SCI-POLYM E, V9, P297, DOI 10.1163/156856298X00668
   MADRI JA, 1988, J CELL BIOL, V106, P1375, DOI 10.1083/jcb.106.4.1375
   Narmoneva DA, 2004, CIRCULATION, V110, P962, DOI 10.1161/01.CIR.0000140667.37070.07
   Narmoneva DA, 2005, BIOMATERIALS, V26, P4837, DOI 10.1016/j.biomaterials.2005.01.005
   Nave BT, 2002, DRUG DISCOV TODAY, V7, P419, DOI 10.1016/S1359-6446(02)02212-2
   Nehls V, 1996, MICROVASC RES, V51, P347, DOI 10.1006/mvre.1996.0032
   Nor JE, 2001, LAB INVEST, V81, P453
   OPAS M, 1994, DEV BIOL, V161, P440, DOI 10.1006/dbio.1994.1043
   Ozerdem B, 1995, J BIOMECH ENG-T ASME, V117, P397, DOI 10.1115/1.2794198
   Park HJ, 2002, CIRC RES, V91, P143, DOI 10.1161/01.RES.0000028149.15986.4C
   Park J, 2006, BIOPHYS J, V90, P2510, DOI 10.1529/biophysj.105.074906
   Ponec M, 2002, ADV DRUG DELIVER REV, V54, pS19, DOI 10.1016/S0169-409X(02)00112-6
   Pratt AB, 2004, BIOTECHNOL BIOENG, V86, P27, DOI 10.1002/bit.10897
   Roeder BA, 2002, J BIOMECH ENG-T ASME, V124, P214, DOI 10.1115/1.1449904
   Satake S, 1998, BIOCHEM BIOPH RES CO, V244, P642, DOI 10.1006/bbrc.1998.8313
   Semino CE, 2004, TISSUE ENG, V10, P643, DOI 10.1089/107632704323061997
   Semino CE, 2003, DIFFERENTIATION, V71, P262, DOI 10.1046/j.1432-0436.2003.7104503.x
   Sieminski AL, 2005, TISSUE ENG, V11, P1332, DOI 10.1089/ten.2005.11.1332
   Sieminski AL, 2004, EXP CELL RES, V297, P574, DOI 10.1016/j.yexcr.2004.03.035
   Sieminski AL, 2002, TISSUE ENG, V8, P1057, DOI 10.1089/107632702320934155
   Sivaraman A, 2005, CURR DRUG METAB, V6, P569, DOI 10.2174/138920005774832632
   Urech L, 2005, BIOMATERIALS, V26, P1369, DOI 10.1016/j.biomaterials.2004.04.045
   Xin XH, 2001, AM J PATHOL, V158, P1111, DOI 10.1016/S0002-9440(10)64058-8
   Yang S, 1999, AM J PATHOL, V155, P887, DOI 10.1016/S0002-9440(10)65188-7
   ZHANG SG, 1994, BIOPOLYMERS, V34, P663, DOI 10.1002/bip.360340508
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
NR 50
TC 74
Z9 74
U1 2
U2 39
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 1085-9195
J9 CELL BIOCHEM BIOPHYS
JI Cell Biochem. Biophys.
PY 2007
VL 49
IS 2
BP 73
EP 83
DI 10.1007/s12013-007-0046-1
PG 11
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 216DT
UT WOS:000249859100002
PM 17906362
DA 2018-10-20
ER

EF